PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Celik, H; Blouzard, JC; Voigt, B; Becher, D; Trotter, V; Fierobe, HP; Tardif, C; Pages, S; de Philip, P				Celik, Hamza; Blouzard, Jean-Charles; Voigt, Birgit; Becher, Doerte; Trotter, Valentine; Fierobe, Henri-Pierre; Tardif, Chantal; Pages, Sandrine; de Philip, Pascale			A Two-Component System (XydS/R) Controls the Expression of Genes Encoding CBM6-Containing Proteins in Response to Straw in Clostridium cellulolyticum	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATOR; ESCHERICHIA-COLI; CELLULOSOME; BINDING; DOMAIN; METABOLISM; REGULATOR; MECHANISM; ENZYMES; CLUSTER	The composition of the cellulosomes (multi enzymatic complexes involved in the degradation of plant cell wall polysaccharides) produced by Clostridium cellulolyticum differs according to the growth substrate. In particular, the expression of a cluster of 14 hemicellulase-encoding genes (called xyl-doc) seems to be induced by the presence of straw and not of cellulose. Genes encoding a putative two-component regulation system (XydS/R) were found upstream of xyl-doc. First evidence for the involvement of the response regulator, XydR, part of this two-component system, in the expression of xyl-doc genes was given by the analysis of the cellulosomes produced by a regulator overproducing strain when grown on cellulose. Nano-LC MS/MS analysis allowed the detection of the products of all xyl-doc genes and of the product of the gene at locus Ccel_1656 predicted to bear a carbohydrate binding domain targeting hemicellulose. RT-PCR experiments further demonstrated that the regulation occurs at the transcriptional level and that all xyl-doc genes are transcriptionally linked. mRNA quantification in a regulator knock-out strain and in its complemented derivative confirmed the involvement of the regulator in the expression of xyl-doc genes and of the gene at locus Ccel_1656 in response to straw. Electrophoretic mobility shift assays using the purified regulator further demonstrated that the regulator binds to DNA regions located upstream of the first gene of the xyl-doc gene cluster and upstream of the gene at locus Ccel_1656.	[Celik, Hamza; Blouzard, Jean-Charles; Trotter, Valentine; Fierobe, Henri-Pierre; Tardif, Chantal; Pages, Sandrine; de Philip, Pascale] Aix Marseille Univ, CNRS, UMR7283, Marseille, France; [Voigt, Birgit; Becher, Doerte] Ernst Moritz Arndt Univ Greifswald, Inst Mikrobiol, Greifswald, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Ernst Moritz Arndt Universitat Greifswald	de Philip, P (corresponding author), Aix Marseille Univ, CNRS, UMR7283, Marseille, France.	dephilip@imm.cnrs.fr	Becher, Doerte/B-4454-2015; FIEROBE, Henri-Pierre/P-4372-2019; Trotter, Valentine/A-9374-2018	Becher, Doerte/0000-0002-9630-5735; Trotter, Valentine/0000-0002-1784-9487; de philip, pascale/0000-0002-9586-7680	European Community's Seventh Framework Program [237942 (CLOSTNET)]; Centre National de la Recherche Scientifique; Aix-Marseille Universite	European Community's Seventh Framework Program; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite	This research was supported by funding from the European Community's Seventh Framework Program FP7/2007-2013 under grant agreement no. 237942 (CLOSTNET), the Centre National de la Recherche Scientifique and Aix-Marseille Universite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou L, 2008, J BACTERIOL, V190, P1499, DOI 10.1128/JB.01160-07; Anderson I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039331; Blouzard JC, 2010, PROTEOMICS, V10, P541, DOI 10.1002/pmic.200900311; Chow V, 2007, J BACTERIOL, V189, P8863, DOI 10.1128/JB.01141-07; DARE S, 1994, NUCLEIC ACIDS RES, V22, P1555; Dominguez-Cuevas P, 2010, J BACTERIOL, V192, P2682, DOI 10.1128/JB.00165-10; DYBVIG K, 1988, PLASMID, V20, P33, DOI 10.1016/0147-619X(88)90005-4; Eymann C, 2004, PROTEOMICS, V4, P2849, DOI 10.1002/pmic.200400907; Fierobe HP, 1999, BIOCHEMISTRY-US, V38, P12822, DOI 10.1021/bi9911740; Fierobe HP, 2001, J BIOL CHEM, V276, P21257, DOI 10.1074/jbc.M102082200; Gal L, 1997, APPL ENVIRON MICROB, V63, P903, DOI 10.1128/AEM.63.3.903-909.1997; GALINIER A, 1994, J BIOL CHEM, V269, P23784; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gautam US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016500; GIALLO J, 1985, APPL ENVIRON MICROB, V49, P1216, DOI 10.1128/AEM.49.5.1216-1221.1985; GIALLO J, 1983, APPL ENVIRON MICROB, V45, P843, DOI 10.1128/AEM.45.3.843-849.1983; GRIMSLEY JK, 1994, J BIOL CHEM, V269, P16977; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; HERTIG C, 1989, J BACTERIOL, V171, P1736, DOI 10.1128/jb.171.3.1736-1738.1989; Higashide W, 2011, APPL ENVIRON MICROB, V77, P2727, DOI 10.1128/AEM.02454-10; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Ibarra JA, 2003, J BACTERIOL, V185, P2835, DOI 10.1128/JB.185.9.2835-2847.2003; Jennert KCB, 2000, MICROBIOL-SGM, V146, P3071, DOI 10.1099/00221287-146-12-3071; Jordan DB, 2012, BIOCHEM J, V442, P241, DOI 10.1042/BJ20111922; Li YC, 2012, BIOTECHNOL BIOFUELS, V5, DOI [10.1186/1754-6834-5-71, 10.1186/1754-6834-5-2]; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lundgren DH, 2009, CURRENT PROTOCOLS BI, V28; Maamar H, 2004, MOL MICROBIOL, V51, P589, DOI 10.1046/j.1365-2958.2003.03859.x; Maamar H, 2006, J BACTERIOL, V188, P2614, DOI 10.1128/JB.188.7.2614-2624.2006; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; MENON KP, 1990, P NATL ACAD SCI USA, V87, P3708, DOI 10.1073/pnas.87.10.3708; Michel L, 2005, MOL MICROBIOL, V58, P495, DOI 10.1111/j.1365-2958.2005.04837.x; Mohand-Oussaid O, 1999, J BACTERIOL, V181, P4035, DOI 10.1128/JB.181.13.4035-4040.1999; Pages S, 1999, J BACTERIOL, V181, P1801; Perret S, 2004, J BACTERIOL, V186, P6544, DOI 10.1128/JB.186.19.6544-6552.2004; PETITDEMANGE E, 1984, INT J SYST BACTERIOL, V34, P155, DOI 10.1099/00207713-34-2-155; Ruiz R, 2003, J BACTERIOL, V185, P3036, DOI 10.1128/JB.185.10.3036-3041.2003; Schleif R, 2010, FEMS MICROBIOL REV, V34, P779, DOI 10.1111/j.1574-6976.2010.00226.x; Schuller A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/103132; SLOAN J, 1992, PLASMID, V27, P207, DOI 10.1016/0147-619X(92)90023-4; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tamaru Y, 2011, MICROB BIOTECHNOL, V4, P64, DOI 10.1111/j.1751-7915.2010.00210.x; Tardif C, 2001, J IND MICROBIOL BIOT, V27, P271, DOI 10.1038/sj.jim.7000081; Wickstrum JR, 2007, J BACTERIOL, V189, P4984, DOI 10.1128/JB.00530-07; Yoder-Himes DR, 2006, J BACTERIOL, V188, P5167, DOI 10.1128/JB.00318-06	47	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56063	10.1371/journal.pone.0056063	http://dx.doi.org/10.1371/journal.pone.0056063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418511	gold, Green Submitted, Green Published			2022-12-27	WOS:000315970300103
J	Colibazzi, T; Wexler, BE; Bansal, R; Hao, XJ; Liu, J; Sanchez-Pena, J; Corcoran, C; Lieberman, JA; Peterson, BS				Colibazzi, Tiziano; Wexler, Bruce E.; Bansal, Ravi; Hao, Xuejun; Liu, Jun; Sanchez-Pena, Juan; Corcoran, Cheryl; Lieberman, Jeffrey A.; Peterson, Bradley S.			Anatomical Abnormalities in Gray and White Matter of the Cortical Surface in Persons with Schizophrenia	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; VOLUME ABNORMALITIES; CEREBRAL-CORTEX; BRAIN; THICKNESS; ONSET; INTEGRITY; DEFICITS; AREA; GYRIFICATION	Background: Although schizophrenia has been associated with abnormalities in brain anatomy, imaging studies have not fully determined the nature and relative contributions of gray matter (GM) and white matter (WM) disturbances underlying these findings. We sought to determine the pattern and distribution of these GM and WM abnormalities. Furthermore, we aimed to clarify the contribution of abnormalities in cortical thickness and cortical surface area to the reduced GM volumes reported in schizophrenia. Methods: We recruited 76 persons with schizophrenia and 57 healthy controls from the community and obtained measures of cortical and WM surface areas, of local volumes along the brain and WM surfaces, and of cortical thickness. Results: We detected reduced local volumes in patients along corresponding locations of the brain and WM surfaces in addition to bilateral greater thickness of perisylvian cortices and thinner cortex in the superior frontal and cingulate gyri. Total cortical and WM surface areas were reduced. Patients with worse performance on the serial-position task, a measure of working memory, had a higher burden of WM abnormalities. Conclusions: Reduced local volumes along the surface of the brain mirrored the locations of abnormalities along the surface of the underlying WM, rather than of abnormalities of cortical thickness. Moreover, anatomical features of white matter, but not cortical thickness, correlated with measures of working memory. We propose that reductions in WM and smaller total cortical surface area could be central anatomical abnormalities in schizophrenia, driving, at least partially, the reduced regional GM volumes often observed in this illness.	[Colibazzi, Tiziano; Bansal, Ravi; Hao, Xuejun; Liu, Jun; Sanchez-Pena, Juan; Peterson, Bradley S.] Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Div Child & Adolescent Psychiat, New York, NY 10032 USA; [Wexler, Bruce E.] Yale Univ, Sch Med, New Haven, CT USA; [Corcoran, Cheryl; Lieberman, Jeffrey A.] Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Dept Psychiat, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute; Yale University; Columbia University; New York State Psychiatry Institute	Colibazzi, T (corresponding author), Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Div Child & Adolescent Psychiat, New York, NY 10032 USA.	tc2237@columbia.edu	Corcoran, Cheryl M/M-1397-2016; Lieberman, Jeffrey/AAY-8239-2020	Corcoran, Cheryl M/0000-0002-8902-4353; 	NIMH [MH56642, MH01296, MH068318, MH16434, MH36197, MHK02-74677, 5T32MH15144, K23 MH85063-2]; National Alliance for Research on Schizophrenia and Depression (NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH107558, T32MH015144, R01MH036197, K23MH085063, R01MH056642, K23MH066279, R21MH086125, R01MH068318] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by NIMH grants MH56642, MH01296, MH068318, MH16434, MH36197, MHK02-74677, 5T32MH15144, and K23 MH85063-2, and by funding from the National Alliance for Research on Schizophrenia and Depression (NARSAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahman MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018652; Andreasen NC, 2011, BIOL PSYCHIAT, V70, P672, DOI 10.1016/j.biopsych.2011.05.017; Bansal R, 2005, NEUROIMAGE, V24, P150, DOI 10.1016/j.neuroimage.2004.08.054; Bansal R, 2007, IEEE T MED IMAGING, V26, P46, DOI 10.1109/TMI.2006.884187; Boksa P, 2012, J PSYCHIATR NEUROSCI, V37, P75, DOI 10.1503/jpn.120007; Burns J, 2003, BRIT J PSYCHIAT, V182, P439, DOI 10.1192/bjp.182.5.439; Carettri F, 2012, SCHIZOPHRENIA BULL, V38, P1170, DOI 10.1093/schbul/sbs053; Catani M, 2011, BIOL PSYCHIAT, V70, P1143, DOI 10.1016/j.biopsych.2011.06.013; Corradi-Dell'Acqua C, 2012, HUM BRAIN MAPP, V33, P740, DOI 10.1002/hbm.21246; Delis DC., 2000, CALIFORNIA VERBAL LE; Di X, 2009, PROG NEURO-PSYCHOPH, V33, P1390, DOI 10.1016/j.pnpbp.2009.08.020; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Fusar-Poli P, 2013, JAMA PSYCHIAT, V70, P107, DOI 10.1001/jamapsychiatry.2013.269; Gabor F, 2011, INT J DEV NEUROSCI, V29, P305, DOI 10.1016/j.ijdevneu.2011.02.013; Gogtay N, 2008, P NATL ACAD SCI USA, V105, P15979, DOI 10.1073/pnas.0806485105; Goldman AL, 2009, ARCH GEN PSYCHIAT, V66, P467, DOI 10.1001/archgenpsychiatry.2009.24; Haijma S.V., 2012, SCHIZOPHR B; Ho BC, 2011, ARCH GEN PSYCHIAT, V68, P128, DOI 10.1001/archgenpsychiatry.2010.199; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Karlsgodt KH, 2008, BIOL PSYCHIAT, V63, P512, DOI 10.1016/j.biopsych.2007.06.017; KAY SR, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P59, DOI 10.1192/S0007125000291514; Konopaske GT, 2007, NEUROPSYCHOPHARMACOL, V32, P1216, DOI 10.1038/sj.npp.1301233; Landing BH, 2002, PEDIATR PATHOL MOL M, V21, P321, DOI 10.1080/02770930290056541; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Makris N, 2010, PSYCHIAT RES-NEUROIM, V183, P21, DOI 10.1016/j.pscychresns.2010.04.016; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McGuire PK, 1996, PSYCHOL MED, V26, P663, DOI 10.1017/S0033291700037673; Narr KL, 2005, CEREB CORTEX, V15, P708, DOI 10.1093/cercor/bhh172; Nesvag R, 2008, SCHIZOPHR RES, V98, P16, DOI 10.1016/j.schres.2007.09.015; Nesvag R, 2009, PROG NEURO-PSYCHOPH, V33, P482, DOI 10.1016/j.pnpbp.2009.01.013; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P399, DOI 10.1503/jpn.110119; Palaniyappan L, 2012, NEUROIMAGE, V60, P693, DOI 10.1016/j.neuroimage.2011.12.058; Palaniyappan L, 2011, SCHIZOPHR RES, V129, P163, DOI 10.1016/j.schres.2011.03.020; Palaniyappan L, 2011, BIOL PSYCHIAT, V69, P974, DOI 10.1016/j.biopsych.2010.12.012; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Perez-Iglesias R, 2010, AM J PSYCHIAT, V167, P451, DOI 10.1176/appi.ajp.2009.09050716; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Phillips OR, 2011, BIOL PSYCHIAT, V70, P680, DOI 10.1016/j.biopsych.2011.03.039; Pol HEH, 2004, BIOL PSYCHIAT, V55, P126, DOI 10.1016/S0006-3223(03)00728-5; Prasad KM, 2010, SCHIZOPHR RES, V116, P143, DOI 10.1016/j.schres.2009.11.003; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; ROSENFELD A, 1968, PATTERN RECOGN, V1, P33, DOI 10.1016/0031-3203(68)90013-7; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; Schultz CC, 2010, SCHIZOPHR RES, V116, P204, DOI 10.1016/j.schres.2009.11.001; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smieskova R, 2010, NEUROSCI BIOBEHAV R, V34, P1207, DOI 10.1016/j.neubiorev.2010.01.016; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Sun D, 2009, MOL PSYCHIATR, V14, P976, DOI 10.1038/mp.2008.34; Sun D, 2009, SCHIZOPHR RES, V108, P85, DOI 10.1016/j.schres.2008.11.026; Szeszko PR, 2008, NEUROPSYCHOPHARMACOL, V33, P976, DOI 10.1038/sj.npp.1301480; Wexler BE, 2009, AM J PSYCHIAT, V166, P189, DOI 10.1176/appi.ajp.2008.08020258; Whitford TJ, 2007, AM J PSYCHIAT, V164, P1082, DOI 10.1176/appi.ajp.164.7.1082; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; Yamasue H, 2004, PSYCHIAT RES-NEUROIM, V131, P195, DOI 10.1016/j.pscychresns.2004.05.004; Ziermans TB, 2012, SCHIZOPHRENIA BULL, V38, P519, DOI 10.1093/schbul/sbq113; Zuliani R, 2011, PSYCHIAT RES-NEUROIM, V191, P133, DOI 10.1016/j.pscychresns.2010.11.001	61	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55783	10.1371/journal.pone.0055783	http://dx.doi.org/10.1371/journal.pone.0055783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418459	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300050
J	Cun, YP; Dai, N; Xiong, CJ; Li, MX; Sui, JD; Qian, CY; Li, Z; Wang, D				Cun, Yanping; Dai, Nan; Xiong, Chengjie; Li, Mengxia; Sui, Jiangdong; Qian, Chengyuan; Li, Zheng; Wang, Dong			Silencing of APE1 Enhances Sensitivity of Human Hepatocellular Carcinoma Cells to Radiotherapy In Vitro and in a Xenograft Model	PLOS ONE			English	Article							BASE EXCISION-REPAIR; PROGNOSTIC-SIGNIFICANCE; APURINIC ENDONUCLEASE; RADIATION-THERAPY; HEPATOMA-CELLS; DNA-DAMAGE; P53; CANCER; EXPRESSION; APE1/REF-1	Resistance to radiotherapy is a key limitation for the treatment of human hepatocellular carcinoma (HCC). To overcome this problem, we investigated the correlation between radioresistance and the human apurinic/apyrimidinic endonuclease (APE1), a bifunctional protein, which plays an important role in DNA repair and redox regulation activity of transcription factors. In the present study, we examined the radiosensitivity profiles of three human HCC cell lines, HepG2, Hep3B, and MHCC97L, using the adenoviral vector Ad5/F35-mediated APE1 siRNA (Ad5/F35-siAPE1). The p53 mutant cell lines MHCC97L showed radioresistance, compared with HepG2 and Hep3B cells. APE1 was strongly expressed in MHCC97L cells and was induced by irradiation in a dose-dependent manner, and Ad5/F35-siAPE1 effectively inhibited irradiation-induced APE1 and p53 expression. Moreover, silencing of APE1 significantly potentiated the growth inhibition and apoptosis induction by irradiation in all tested human HCC cell lines. In addition, Ad5/F35-siAPE1 significantly enhanced inhibition of tumor growth and potentiated cell apoptosis by irradiation both in HepG2 and MHCC97L xenografts. In conclusion, down regulation of APE1 could enhance sensitivity of human HCC cells to radiotherapy in vitro and in vivo.	[Cun, Yanping; Dai, Nan; Li, Mengxia; Sui, Jiangdong; Qian, Chengyuan; Li, Zheng; Wang, Dong] Third Mil Med Univ, Ctr Canc, Daping Hosp, Chongqing, Peoples R China; [Cun, Yanping; Dai, Nan; Li, Mengxia; Sui, Jiangdong; Qian, Chengyuan; Li, Zheng; Wang, Dong] Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China; [Xiong, Chengjie] Third Mil Med Univ, Dept Orthoped, Xinqiao Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Wang, D (corresponding author), Third Mil Med Univ, Ctr Canc, Daping Hosp, Chongqing, Peoples R China.	dongwang64@hotmail.com	Sui, Jiang-Dong/AAU-6005-2021; Li, Mengxia/AAM-4289-2020	Li, Mengxia/0000-0003-4443-740X	National Natural Science Foundation of China [30872975]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Grant support was provided by the National Natural Science Foundation of China (No. 30872975). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belzile JP, 2006, CURR GENE THER, V6, P111, DOI 10.2174/156652306775515538; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; CHEN DS, 1994, ANN NY ACAD SCI, V726, P306, DOI 10.1111/j.1749-6632.1994.tb52834.x; Concin N, 2000, CANCER LETT, V150, P191, DOI 10.1016/S0304-3835(99)00393-6; Di Bisceglie AM, 2004, GASTROENTEROLOGY, V127, pS104, DOI 10.1053/j.gastro.2004.09.022; Di Maso V, 2007, MOL MED, V13, P89, DOI 10.2119/2006-00084.DiMaso; Ding J, 2006, TRENDS PHARMACOL SCI, V27, P338, DOI 10.1016/j.tips.2006.04.007; DUMENCO L, 1995, HEPATOLOGY, V22, P1279, DOI 10.1016/0270-9139(95)90640-1; Fan JS, 2005, FREE RADICAL BIO MED, V38, P1121, DOI 10.1016/j.freeradbiomed.2005.01.012; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; FORRESTER K, 1995, ONCOGENE, V10, P2103; Hanson S, 2005, ONCOGENE, V24, P1641, DOI 10.1038/sj.onc.1208351; He M, 2011, ONCOGENE, V30, P1947, DOI 10.1038/onc.2010.567; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; Herring CJ, 1998, BRIT J CANCER, V78, P1128, DOI 10.1038/bjc.1998.641; Jakobs TF, 2008, RADIOLOGE, V48, P839, DOI 10.1007/s00117-008-1730-x; Jayaraman L, 1997, GENE DEV, V11, P558, DOI 10.1101/gad.11.5.558; Jia JB, 2011, INVEST NEW DRUG, V29, P861, DOI 10.1007/s10637-010-9435-1; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lai PBS, 2007, APOPTOSIS, V12, P387, DOI 10.1007/s10495-006-0571-1; Madhusudan S, 2005, CANCER TREAT REV, V31, P603, DOI 10.1016/j.ctrv.2005.09.006; McGlynn KA, 2001, INT J CANCER, V94, P290, DOI 10.1002/ijc.1456; Ng LT, 2006, AM J CHINESE MED, V34, P125, DOI 10.1142/S0192415X06003692; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; PUISIEUX A, 1993, FASEB J, V7, P1407, DOI 10.1096/fasebj.7.14.8224613; Robertson KA, 2001, CANCER RES, V61, P2220; Rodemann HP, 2009, RADIOTHER ONCOL, V92, P293, DOI 10.1016/j.radonc.2009.08.023; Schindl M, 2001, INT J ONCOL, V19, P799; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh PK, 2011, EVID-BASED COMPL ALT, V2011; Tanner B, 2004, GYNECOL ONCOL, V92, P568, DOI 10.1016/j.ygyno.2003.10.037; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Toya R, 2007, RADIOTHER ONCOL, V84, P266, DOI 10.1016/j.radonc.2007.07.005; Viani P, 2003, J BIOL CHEM, V278, P9592, DOI 10.1074/jbc.M207729200; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang D, 2004, MOL CANCER THER, V3, P679; Wang D, 2007, CANCER SCI, V98, P1993, DOI 10.1111/j.1349-7006.2007.00616.x; Xiang DB, 2008, CANCER GENE THER, V15, P625, DOI 10.1038/cgt.2008.30; Yang W, 2010, INT J RADIAT BIOL, V86, P445, DOI 10.3109/09553001003668006; Yang ZZ, 2007, CLIN LYMPHOMA MYELOM, V7, P296, DOI 10.3816/CLM.2007.n.006; Yoo DG, 2008, LUNG CANCER, V60, P277, DOI 10.1016/j.lungcan.2007.10.015; You KR, 2002, J BIOL CHEM, V277, P3870, DOI 10.1074/jbc.M109284200; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106; Zurer I, 2004, CARCINOGENESIS, V25, P11, DOI 10.1093/carcin/bgg186	45	33	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55313	10.1371/journal.pone.0055313	http://dx.doi.org/10.1371/journal.pone.0055313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418439	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300029
J	Fan, YP; Korolev, N; Lyubartsev, AP; Nordenskiold, L				Fan, Yanping; Korolev, Nikolay; Lyubartsev, Alexander P.; Nordenskiold, Lars			An Advanced Coarse-Grained Nucleosome Core Particle Model for Computer Simulations of Nucleosome-Nucleosome Interactions under Varying Ionic Conditions	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; MONTE-CARLO-SIMULATION; H4 TAIL ACETYLATIONS; X-RAY-DIFFRACTION; CHROMATIN FIBER; HISTONE TAILS; K+ IONS; POLYELECTROLYTE PROPERTIES; COMPETITIVE-BINDING; PHASE-DIAGRAM	In the eukaryotic cell nucleus, DNA exists as chromatin, a compact but dynamic complex with histone proteins. The first level of DNA organization is the linear array of nucleosome core particles (NCPs). The NCP is a well-defined complex of 147 bp DNA with an octamer of histones. Interactions between NCPs are of paramount importance for higher levels of chromatin compaction. The polyelectrolyte nature of the NCP implies that nucleosome-nucleosome interactions must exhibit a great influence from both the ionic environment as well as the positively charged and highly flexible N-terminal histone tails, protruding out from the NCP. The large size of the system precludes a modelling analysis of chromatin at an all-atom level and calls for coarse-grained approximations. Here, a model of the NCP that include the globular histone core and the flexible histone tails described by one particle per each amino acid and taking into account their net charge is proposed. DNA wrapped around the histone core was approximated at the level of two base pairs represented by one bead (bases and sugar) plus four beads of charged phosphate groups. Computer simulations, using a Langevin thermostat, in a dielectric continuum with explicit monovalent (K+), divalent (Mg2+) or trivalent (Co(NH3)(6)(3+)) cations were performed for systems with one or ten NCPs. Increase of the counterion charge results in a switch from repulsive NCP-NCP interaction in the presence of K+, to partial aggregation with Mg2+ and to strong mutual attraction of all 10 NCPs in the presence of CoHex(3+). The new model reproduced experimental results and the structure of the NCP-NCP contacts is in agreement with available data. Cation screening, ion-ion correlations and tail bridging contribute to the NCP-NCP attraction and the new NCP model accounts for these interactions.	[Fan, Yanping; Korolev, Nikolay; Nordenskiold, Lars] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 639798, Singapore; [Lyubartsev, Alexander P.] Stockholm Univ, Arrhenius Lab, Dept Mat & Environm Chem, Div Phys Chem, S-10691 Stockholm, Sweden	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Stockholm University	Korolev, N (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 639798, Singapore.	Korolev@ntu.edu.sg; alexander.lyubartsev@mmk.su.se	NORDENSKIÖLD, LARS/ABD-4725-2020; Lyubartsev, Alexander/E-5489-2011; Korolev, Nikolay/H-2335-2011	NORDENSKIÖLD, LARS/0000-0002-3681-209X; Lyubartsev, Alexander/0000-0002-9390-5719; 	Singapore Agency for Science Technology and Research (A*STAR) through the Biomedical Research Council [10/1/22/19/666]; Singapore Ministry of Education Academic Research Fund (AcRF) through a Tier 1 [M52080112 RG46/10]; Swedish Research Council [621-2010-5005]	Singapore Agency for Science Technology and Research (A*STAR) through the Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Education Academic Research Fund (AcRF) through a Tier 1(Ministry of Education, Singapore); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work has been supported by the Singapore Agency for Science Technology and Research (A*STAR) through the Biomedical Research Council (LN) (http://www.a-star.edu.sg) grant no. 10/1/22/19/666, by the Singapore Ministry of Education Academic Research Fund (AcRF) through a Tier 1, grant no. M52080112 RG46/10 (LN), and by the Swedish Research Council (http://www.vr.se) grant. no 621-2010-5005 (to APL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdi A, 2011, NUCLEIC ACIDS RES, V39, P1680, DOI 10.1093/nar/gkq900; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Arya G, 2006, P NATL ACAD SCI USA, V103, P16236, DOI 10.1073/pnas.0604817103; Arya G, 2009, J PHYS CHEM A, V113, P4045, DOI 10.1021/jp810375d; Arya G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2428305; Bertin A, 2004, BIOCHEMISTRY-US, V43, P4773, DOI 10.1021/bi036210g; Bertin A, 2007, EUR BIOPHYS J BIOPHY, V36, P1083, DOI 10.1007/s00249-007-0212-9; Bertin A, 2007, BIOPHYS J, V93, P3652, DOI 10.1529/biophysj.107.108365; Bertin A, 2007, BIOPHYS J, V92, P2633, DOI 10.1529/biophysj.106.093815; Bishop TC, 2005, J BIOMOL STRUCT DYN, V22, P673, DOI 10.1080/07391102.2005.10507034; Biswas M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002279; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; Brower-Toland BD, 2002, P NATL ACAD SCI USA, V99, P1960, DOI 10.1073/pnas.022638399; Cao QQ, 2011, SOFT MATTER, V7, P506, DOI 10.1039/c0sm00512f; Cheatham TE, 1997, J AM CHEM SOC, V119, P4805, DOI 10.1021/ja963641w; Cui Y, 2000, P NATL ACAD SCI USA, V97, P127, DOI 10.1073/pnas.97.1.127; Daban JR, 2011, MICRON, V42, P733, DOI 10.1016/j.micron.2011.05.002; Dans PD, 2010, J CHEM THEORY COMPUT, V6, P1711, DOI 10.1021/ct900653p; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; de Frutos M, 2001, BIOPHYS J, V81, P1127, DOI 10.1016/S0006-3495(01)75769-4; DeMille RC, 2011, J PHYS CHEM B, V115, P132, DOI 10.1021/jp107028n; Deserno M, 1998, J CHEM PHYS, V109, P7678, DOI 10.1063/1.477414; Dobrovolskaia IV, 2012, BIOPHYS J, V103, P989, DOI 10.1016/j.bpj.2012.07.043; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Ettig R, 2011, BIOPHYS J, V101, P1999, DOI 10.1016/j.bpj.2011.07.057; FINCH JT, 1981, J MOL BIOL, V145, P757, DOI 10.1016/0022-2836(81)90313-2; FINCH JT, 1977, NATURE, V269, P29, DOI 10.1038/269029a0; GREST GS, 1986, PHYS REV A, V33, P3628, DOI 10.1103/PhysRevA.33.3628; Grigoryev SA, 2012, EXP CELL RES, V318, P1448, DOI 10.1016/j.yexcr.2012.02.014; Grigoryev SA, 2009, P NATL ACAD SCI USA, V106, P13317, DOI 10.1073/pnas.0903280106; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Horn PJ, 2002, SCIENCE, V297, P1824, DOI 10.1126/science.1074200; Kepper N, 2008, BIOPHYS J, V95, P3692, DOI 10.1529/biophysj.107.121079; Kepper N, 2011, BIOPOLYMERS, V95, P435, DOI 10.1002/bip.21598; Koehl P, 2006, CURR OPIN STRUC BIOL, V16, P142, DOI 10.1016/j.sbi.2006.03.001; Korolev N, 2001, J MOL BIOL, V308, P907, DOI 10.1006/jmbi.2001.4642; Korolev N, 2001, BIOPOLYMERS, V58, P268, DOI 10.1002/1097-0282(200103)58:3<268::AID-BIP1004>3.0.CO;2-8; Korolev N, 1999, J PHYS CHEM B, V103, P9008, DOI 10.1021/jp9913517; Korolev N, 1999, BIOPHYS J, V77, P2736, DOI 10.1016/S0006-3495(99)77107-9; Korolev N, 2006, BIOPHYS J, V90, P4305, DOI 10.1529/biophysj.105.080226; Korolev N, 2007, BIOPOLYMERS, V86, P409, DOI 10.1002/bip.20749; Korolev N, 2012, SOFT MATTER, V8, P9322, DOI 10.1039/c2sm25662b; Korolev N, 2012, CURR OPIN STRUC BIOL, V22, P151, DOI 10.1016/j.sbi.2012.01.006; Korolev N, 2012, BIOCHEM BIOPH RES CO, V418, P205, DOI 10.1016/j.bbrc.2011.12.112; Korolev N, 2010, BIOPHYS J, V99, P1896, DOI 10.1016/j.bpj.2010.07.017; Korolev N, 2010, ADV COLLOID INTERFAC, V158, P32, DOI 10.1016/j.cis.2009.08.002; Korolev N, 2009, NUCLEIC ACIDS RES, V37, P7137, DOI 10.1093/nar/gkp683; Kruithof M, 2009, NAT STRUCT MOL BIOL, V16, P534, DOI 10.1038/nsmb.1590; Langowski J, 2006, EUR PHYS J E, V19, P241, DOI 10.1140/epje/i2005-10067-9; Langowski J, 2006, COMPUTATIONAL STUDIE, P605; Langowski J, 2007, SEMIN CELL DEV BIOL, V18, P659, DOI 10.1016/j.semcdb.2007.08.011; Lavelle C, 2010, INT J MOL SCI, V11, P1557, DOI 10.3390/ijms11041557; Lee JY, 2011, J BIOL CHEM, V286, P11099, DOI 10.1074/jbc.M110.192047; Leforestier A, 1997, BIOPHYS J, V73, P1771, DOI 10.1016/S0006-3495(97)78207-9; Leforestier A., 2001, BIOPHYS J, V81, P2114; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Limbach HJ, 2006, COMPUT PHYS COMMUN, V174, P704, DOI 10.1016/j.cpc.2005.10.005; Liu Y, 2011, J MOL BIOL, V414, P749, DOI 10.1016/j.jmb.2011.10.031; Livolant F, 2006, PHILOS T R SOC A, V364, P2615, DOI 10.1098/rsta.2006.1843; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Lyubartsev AP, 1997, PHYS REV E, V55, P5689, DOI 10.1103/PhysRevE.55.5689; Lyubartsev AP, 1998, J BIOMOL STRUCT DYN, V16, P579, DOI 10.1080/07391102.1998.10508271; Lyubartsev AP, 1997, J PHYS CHEM B, V101, P4335, DOI 10.1021/jp963982w; Makde RD, 2010, NATURE IN PRESS; Mangenot S, 2002, BIOPHYS J, V82, P345, DOI 10.1016/S0006-3495(02)75399-X; Mangenot S, 2002, EUR PHYS J E, V7, P221, DOI 10.1140/epje/i200101151; Mangenot S, 2003, BIOPHYS J, V84, P2570, DOI 10.1016/S0006-3495(03)75062-0; Mangenot S, 2003, J MOL BIOL, V333, P907, DOI 10.1016/j.jmb.2003.09.015; Materese CK, 2009, J AM CHEM SOC, V131, P15005, DOI 10.1021/ja905376q; MONTORO JCG, 1995, J CHEM PHYS, V103, P8273, DOI 10.1063/1.470191; Montoro JCG, 1998, J CHEM PHYS, V109, P6200, DOI 10.1063/1.477249; Muhlbacher F, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031919; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Nordenskiold L, 2008, DNA INTERACTIONS POL, P209; PRATT LR, 1994, BIOPHYS CHEM, V51, P147, DOI 10.1016/0301-4622(94)00057-3; Raspaud E, 1999, BIOPHYS J, V77, P1547, DOI 10.1016/S0006-3495(99)77002-5; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Roccatano D, 2007, BIOPOLYMERS, V85, P407, DOI 10.1002/bip.20690; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Ruscio JZ, 2006, BIOPHYS J, V91, P4121, DOI 10.1529/biophysj.106.082099; Savelyev A, 2010, P NATL ACAD SCI USA, V107, P20340, DOI 10.1073/pnas.1001163107; Savelyev A, 2009, BIOPHYS J, V96, P4044, DOI 10.1016/j.bpj.2009.02.067; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Scheffer MP, 2012, J STRUCT BIOL, V178, P207, DOI 10.1016/j.jsb.2011.11.020; Stehr R, 2008, BIOPHYS J, V95, P3677, DOI 10.1529/biophysj.107.120543; Stehr R, 2010, BIOPHYS J, V98, P1028, DOI 10.1016/j.bpj.2009.11.040; Tims HS, 2011, J MOL BIOL, V411, P430, DOI 10.1016/j.jmb.2011.05.044; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; Vasudevan D, 2010, J MOL BIOL, V403, P1, DOI 10.1016/j.jmb.2010.08.039; Voltz K, 2008, J COMPUT CHEM, V29, P1429, DOI 10.1002/jcc.20902; Voltz K, 2012, BIOPHYS J, V102, P849, DOI 10.1016/j.bpj.2011.11.4028; Wedemann G, 2002, BIOPHYS J, V82, P2847, DOI 10.1016/S0006-3495(02)75627-0; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Yang DR, 2011, PHYS CHEM CHEM PHYS, V13, P2911, DOI 10.1039/c0cp01487g; Yang Y, 2009, BIOPHYS J, V96, P2082, DOI 10.1016/j.bpj.2008.10.073; Zheng CY, 2003, BIOPOLYMERS, V68, P539, DOI 10.1002/bip.10303; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	99	43	43	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e54228	10.1371/journal.pone.0054228	http://dx.doi.org/10.1371/journal.pone.0054228			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418426	Green Published, gold			2022-12-27	WOS:000315970300016
J	Kano, Y; Soda, K; Konishi, F				Kano, Yoshihiko; Soda, Kuniyasu; Konishi, Fumio			Suppression of LFA-1 Expression by Spermine Is Associated with Enhanced Methylation of ITGAL, the LFA-1 Promoter Area	PLOS ONE			English	Article							FUNCTION-ASSOCIATED ANTIGEN-1; AGE-RELATED-CHANGES; DNA METHYLATION; S-ADENOSYLMETHIONINE; HISTONE ACETYLATION; CYTOKINE PRODUCTION; T-CELLS; DEMETHYLATION; POLYAMINE; DECARBOXYLASE	Spermine and spermidine, natural polyamines, suppress lymphocyte function-associated antigen 1 (LFA-1) expression and its associated cellular functions through mechanisms that remain unknown. Inhibition of ornithine decarboxylase, which is required for polyamine synthesis, in Jurkat cells by 3 mM D,L-alpha-difluoromethylornithine hydrochloride (DFMO) significantly decreased spermine and spermidine concentrations and was associated with decreased DNA methyltransferase (Dnmt) activity, enhanced demethylation of the LFA-1 gene (ITGAL) promoter area, and increased CD11a expression. Supplementation with extracellular spermine (500 mu M) of cells pretreated with DFMO significantly increased polyamine concentrations, increased Dnmt activity, enhanced methylation of the ITGAL promoter, and decreased CD11a expression. It has been shown that changes in intracellular polyamine concentrations affect activities of -adenosyl-L-methioninede-caroboxylase, and, as a result, affect concentrations of the methyl group donor, S-adenosylmethionine (SAM), and of the competitive Dnmt inhibitor, decarboxylated SAM. Additional treatments designed to increase the amount of SAM and decrease the amount of decarboxylated SAM-such as treatment with methylglyoxal bis-guanylhydrazone (an inhibitor of S-adenosyl- L-methionine-decaroboxylase) and SAM supplementation-successfully decreased CD11a expression. Western blot analyses revealed that neither DFMO nor spermine supplementation affected the amount of active Ras-proximate-1, a member of the Ras superfamily of small GTPases and a key protein for regulation of CD11a expression. The results of this study suggest that polyamine-induced suppression of LFA-1 expression occurs via enhanced methylation of ITGAL.	[Kano, Yoshihiko; Soda, Kuniyasu; Konishi, Fumio] Jichi Med Univ, Saitama Med Ctr, Dept Surg, Saitama, Japan; [Soda, Kuniyasu] Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Res Inst, Saitama, Japan	Jichi Medical University; Jichi Medical University	Soda, K (corresponding author), Jichi Med Univ, Saitama Med Ctr, Dept Surg, Saitama, Japan.	soda@jichi.ac.jp						Bachrach U, 2001, NEWS PHYSIOL SCI, V16, P106, DOI 10.1152/physiologyonline.2001.16.3.106; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Engwerda CR, 1996, J IMMUNOL, V156, P3621; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Frostesjo L, 1997, J BIOL CHEM, V272, P4359, DOI 10.1074/jbc.272.7.4359; Gadek TR, 2002, SCIENCE, V295, P1086, DOI 10.1126/science.295.5557.1086; GARCEA R, 1989, CARCINOGENESIS, V10, P1183, DOI 10.1093/carcin/10.7.1183; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; Heby O, 1988, Adv Exp Med Biol, V250, P291; HIBBS ML, 1991, SCIENCE, V251, P1611, DOI 10.1126/science.1672776; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kim SH, 2004, BIOCHEM BIOPH RES CO, V324, P58, DOI 10.1016/j.bbrc.2004.09.023; Kouzmenko A, 2010, EPIGENOMICS-UK, V2, P765, DOI 10.2217/EPI.10.58; Li YP, 2010, EXP GERONTOL, V45, P312, DOI 10.1016/j.exger.2009.12.008; Lu QJ, 2002, ARTHRITIS RHEUM, V46, P1282, DOI 10.1002/art.10234; MAMONT PS, 1981, BIOCHEM J, V196, P411, DOI 10.1042/bj1960411; Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361; Mor A, 2007, IMMUNOL REV, V218, P114, DOI 10.1111/j.1600-065X.2007.00538.x; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Neubert R, 1998, LIFE SCI, V62, P1099, DOI 10.1016/S0024-3205(98)00033-2; O'Mahony L, 1998, CLIN EXP IMMUNOL, V113, P213; Pan ZX, 2012, J GENET GENOMICS, V39, P111, DOI 10.1016/j.jgg.2012.02.004; Pegg AE, 2011, BIOCHEM J, V433, P139, DOI 10.1042/BJ20101228; Pollard KJ, 1999, EMBO J, V18, P5622, DOI 10.1093/emboj/18.20.5622; POWERS DC, 1992, CELL IMMUNOL, V141, P444, DOI 10.1016/0008-8749(92)90162-I; Pulukuri SMK, 2007, CANCER RES, V67, P930, DOI 10.1158/0008-5472.CAN-06-2892; Richardson BC, 2002, J NUTR, V132, p2401S, DOI 10.1093/jn/132.8.2401S; Sadeghi HM, 1999, EXP GERONTOL, V34, P959, DOI 10.1016/S0531-5565(99)00065-0; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; SHANTZ LM, 1992, BIOCHEM J, V288, P511, DOI 10.1042/bj2880511; Soda K, 2005, J IMMUNOL, V175, P237, DOI 10.4049/jimmunol.175.1.237; Tsuji T, 2001, ONCOGENE, V20, P24, DOI 10.1038/sj.onc.1204051; WACHOLTZ MC, 1989, J EXP MED, V170, P431, DOI 10.1084/jem.170.2.431; Werther WA, 1996, J IMMUNOL, V157, P4986; Whitcup SM, 1999, CLIN IMMUNOL, V93, P107, DOI 10.1006/clim.1999.4775; Winquist RJ, 2001, EUR J PHARMACOL, V429, P297, DOI 10.1016/S0014-2999(01)01328-0; Yamamoto D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012554; Zhang MH, 1997, J EXP MED, V185, P1759, DOI 10.1084/jem.185.10.1759; Zhang ZY, 2002, MECH AGEING DEV, V123, P1257, DOI 10.1016/S0047-6374(02)00014-3	45	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56056	10.1371/journal.pone.0056056	http://dx.doi.org/10.1371/journal.pone.0056056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418509	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300101
J	Oduro-Mensah, E; Kwamie, A; Antwi, E; Bamfo, SA; Bainson, HM; Marfo, B; Coleman, MA; Grobbee, DE; Agyepong, IA				Oduro-Mensah, Ebenezer; Kwamie, Aku; Antwi, Edward; Bamfo, Sarah Amissah; Bainson, Helen Mary; Marfo, Benjamin; Coleman, Mary Amoakoh; Grobbee, Diederick E.; Agyepong, Irene Akua			Care Decision Making of Frontline Providers of Maternal and Newborn Health Services in the Greater Accra Region of Ghana	PLOS ONE			English	Article							CLINICAL-PRACTICE; GUIDELINES; KNOWLEDGE	Objectives: To explore the "how" and "why" of care decision making by frontline providers of maternal and newborn services in the Greater Accra region of Ghana and determine appropriate interventions needed to support its quality and related maternal and neonatal outcomes. Methods: A cross sectional and descriptive mixed method study involving a desk review of maternal and newborn care protocols and guidelines availability, focus group discussions and administration of a structured questionnaire and observational checklist to frontline providers of maternal and newborn care. Results: Tacit knowledge or 'mind lines' was an important primary approach to care decision making. When available, protocols and guidelines were used as decision making aids, especially when they were simple handy tools and in situations where providers were not sure what their next step in management had to be. Expert opinion and peer consultation were also used through face to face discussions, phone calls, text messages, and occasional emails depending on the urgency and communication medium access. Health system constraints such as availability of staff, essential medicines, supplies and equipment; management issues (including leadership and interpersonal relations among staff), and barriers to referral were important influences in decision making. Frontline health providers welcomed the idea of interventions to support clinical decision making and made several proposals towards the development of such an intervention. They felt such an intervention ought to be multi-faceted to impact the multiple influences simultaneously. Effective interventions would also need to address immediate challenges as well as more long-term challenges influencing decision-making. Conclusion: Supporting frontline worker clinical decision making for maternal and newborn services is an important but neglected aspect of improved quality of care towards attainment of MDG 4 & 5. A multi-faceted intervention is probably the best way to make a difference given the multiple inter-related issues.	[Oduro-Mensah, Ebenezer] Ridge Reg Hosp OPD, Adabraka, Accra, Ghana; [Kwamie, Aku] Accra Ghana Wagningen Univ, Greater Accra Reg Hlth Directorate, Accra, Ghana; [Antwi, Edward; Bainson, Helen Mary] Greater Accra Reg Hlth Directorate, Publ Hlth Div, Accra, Ghana; [Bamfo, Sarah Amissah] Greater Accra Reg Hlth Directorate, Clin Care Div, Accra, Ghana; [Marfo, Benjamin] Ghana Hlth Serv, Accra, Ghana; [Coleman, Mary Amoakoh] Univ Med Ctr Utrecht Str 6 131, Univ Ghana, Sch Publ Hlth, Utrecht, Netherlands; [Grobbee, Diederick E.] Univ Med Ctr Utrecht Str 6 131, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Agyepong, Irene Akua] Univ Ghana, Greater Accra Reg Hlth Directorate, Sch Publ Hlth, Accra, Ghana	Ghana Health Service; University of Ghana	Oduro-Mensah, E (corresponding author), Ridge Reg Hosp OPD, Adabraka, Accra, Ghana.	ebomens78@yahoo.co.uk	Antwi, Edward/GQH-0788-2022; Grobbee, Diederick/C-7651-2014	Antwi, Edward/0000-0002-4143-3254; Grobbee, Diederick/0000-0003-4472-4468; Agyepong, Irene Akua/0000-0002-0193-5882	FOCUS Regions Health Project (United States Agency for International Development); Greater Accra Regional Health Directorate through its Sector Budget Support; GOG funding; Netherlands Organization for Scientific Development/Science for Global Development	FOCUS Regions Health Project (United States Agency for International Development)(United States Agency for International Development (USAID)); Greater Accra Regional Health Directorate through its Sector Budget Support; GOG funding; Netherlands Organization for Scientific Development/Science for Global Development	The process received financial support from FOCUS Regions Health Project (United States Agency for International Development), The Greater Accra Regional Health Directorate through its Sector Budget Support and GOG funding and The Netherlands Organization for Scientific Development/Science for Global Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre M, 2002, FAM PRACT, V19, P617, DOI 10.1093/fampra/19.6.617; [Anonymous], LEV TRENDS CHILD MOR; [Anonymous], INV AV US CLIN DEC M; Ansong-Tornui Janet, 2007, Ghana Med J, V41, P125; Baker U, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-31; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bosu Wk, 2007, Ghana Med J, V41, P118; Dopson S, 2002, HEALTH CARE MANAGE R, V27, P35, DOI 10.1097/00004010-200207000-00005; Gabbay J, 2004, BRIT MED J, V329, P1013, DOI 10.1136/bmj.329.7473.1013; Ghana Statistical Service (GSS), 2008, GHAN LIV STAND SURV; Ghana Statistical Service (GSS) Ghana Health Service (GHS) and Macro International, 2009, GHAN HLTH SERV GHS M; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF Macro., 2009, GHAN DEM HLTH SURV 2; GSS GHS and Macro International, 2009, GHAN MAT HLTH SURV 2; Health Research Unit Ghana Health Service Frontiers Program Population Council Prime II IntraHealth International, 2005, IMPR GHAN SAF MOTH P; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Miles A, 2007, J EVAL CLIN PRACT, V13, P481, DOI 10.1111/j.1365-2753.2007.00923.x; Noordam AC, 2011, TROP MED INT HEALTH, V16, P622, DOI 10.1111/j.1365-3156.2011.02747.x; Penfold Suzanne, 2007, Ghana Med J, V41, P100; Rinehart W, 2005, INT FAMILY PLANNING, V31; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Theodorou M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-150; Tornui J, 2006, IMPACT FREE DELIVERY; Turner TJ, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-235; UNICEF, 2012, COUNTD 2015 MAT NEWB; *UNICEF, 2008, COUNTD 2015 TRACK PR; Wagai J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004626; WHO, 2010, MILL DEV GOALS MGDS; Witter S, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1881; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	30	36	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55610	10.1371/journal.pone.0055610	http://dx.doi.org/10.1371/journal.pone.0055610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418446	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300037
J	Wei, HS; Li, BA; Zhang, RW; Hao, XH; Huang, YB; Qiao, Y; Hou, J; Li, X; Li, XW				Wei, Hongshan; Li, Boan; Zhang, Renwen; Hao, Xiaohua; Huang, Yubo; Qiao, Yong; Hou, Jun; Li, Xin; Li, Xingwang			Serum GP73, a Marker for Evaluating Progression in Patients with Chronic HBV Infections	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; CHRONIC HEPATITIS-C; LIVER FIBROSIS; TRANSIENT ELASTOGRAPHY; EXPRESSION; DISEASE; BIOMARKERS; PREVALENCE; GUIDELINES; MANAGEMENT	This study was designed to investigate the role of serum GP73 for diagnosing significant fibrosis in patients with chronic hepatitis B virus (HBV) infections. Two populations were enrollment. All subjects were patients with chronic HBV infections. First population included 761 patients, who received liver stiffness measurement; the second population included 633 patients, who undertaken liver biopsy, in which 472 patients with nearly normal ALT. All patients received serum GP73 test. The effect of GP73 recombinant protein to HepG2 cells and LX2 cells were observed in vitro. Results showed that serum GP73 concentration is correlated with liver stiffness (r = 0.601). The area under ROC curve is 0.76. The sensitivity and specificity of GP73 for significant fibrosis (>= F2) diagnosis were 62.81%, 80.05% respectively (cut off: 76.6 ng/ml). Serum GP73 concentration was significantly correlated with the grading of fibrosis (r = 0.32, and 0.35, in 633 and 472 patients, respectively.) GP73 had a striking performance for diagnosing S2 in patients with chronic HBV infections. In 472 patients with nearly normal ALT, the sensitivity and specificity of GP73 for S2 diagnosis were 62.5% and 80.0% respectively, where the cut-off was set at 82 ng/ml. GP73 recombinant protein may prompt LX2 cells proliferation at the concentration 10-100 ng/ml. The present results indicated that GP73 may be a marker for diagnosing significant fibrosis in patients with chronic HBV infections, and may be a new contributor to fibrogensis.	[Wei, Hongshan; Zhang, Renwen; Hao, Xiaohua; Huang, Yubo; Qiao, Yong; Li, Xin; Li, Xingwang] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China; [Li, Boan; Hou, Jun] 302 Mil Hosp, Ctr Lab Test, Beijing, Peoples R China	Capital Medical University; Fifth Medical Center of Chinese PLA General Hospital	Wei, HS (corresponding author), Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China.	drwei@ccmu.edu.cn		Wei, Hongshan/0000-0001-8893-653X	National Natural Science Foundation of China [30872243, 81071411]; Fund of Capital Clinical Investigation [111107058811068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of Capital Clinical Investigation	Supported by grant from the National Natural Science Foundation of China (No. 30872243; No. 81071411) to Prof. HW; and grant from the Fund of Capital Clinical Investigation (No. 111107058811068) to Prof. BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2011, J GASTROEN HEPATOL, V26, P1536, DOI 10.1111/j.1440-1746.2011.06774.x; Alberti A, 2011, DIGEST LIVER DIS, V43, pS57, DOI 10.1016/S1590-8658(10)60693-7; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Callewaert N, 2004, NAT MED, V10, P429, DOI 10.1038/nm1006; Cao Q, 2007, J HEPATOL, V46, P124, DOI 10.1016/j.jhep.2006.07.027; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Corpechot C, 2012, HEPATOLOGY, V56, P198, DOI 10.1002/hep.25599; Fung J, 2008, AM J GASTROENTEROL, V103, P1421, DOI 10.1111/j.1572-0241.2007.01751.x; Gu YL, 2009, ANN CLIN BIOCHEM, V46, P38, DOI 10.1258/acb.2008.008088; Guha IN, 2011, HEPATOLOGY, V54, P1454, DOI 10.1002/hep.24515; Hoefs JC, 2011, GASTROENTEROLOGY, V141, P900, DOI 10.1053/j.gastro.2011.06.007; Iftikhar R, 2004, AM J GASTROENTEROL, V99, P1087, DOI 10.1111/j.1572-0241.2004.30572.x; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Kladney RD, 2000, GENE, V249, P53, DOI 10.1016/S0378-1119(00)00136-0; Liu XY, 2011, CLIN CHEM LAB MED, V49, P1311, DOI 10.1515/CCLM.2011.640; Maitra A, 2004, AM J GASTROENTEROL, V99, P1096, DOI 10.1111/j.1572-0241.2004.40410.x; Mayo MJ, 2008, HEPATOLOGY, V48, P1549, DOI 10.1002/hep.22517; Munteanu M, 2008, CLIN BIOCHEM, V41, P1113, DOI 10.1016/j.clinbiochem.2008.04.020; Naveau S, 2009, HEPATOLOGY, V49, P97, DOI 10.1002/hep.22576; Poynard Thierry, 2011, Gastroenterol Hepatol (N Y), V7, P445; Riener MO, 2009, HEPATOLOGY, V49, P1602, DOI 10.1002/hep.22843; Sebagh M, 2012, J HEPATOL, V56, P840, DOI 10.1016/j.jhep.2011.11.016; Stabinski L, 2011, ANTIVIR THER, V16, P405, DOI 10.3851/IMP1783; Sun YL, 2011, J GASTROEN HEPATOL, V26, P1207, DOI 10.1111/j.1440-1746.2011.06733.x; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Tian LY, 2011, INT J CANCER, V129, P1923, DOI 10.1002/ijc.25838; Tong MJ, 2008, HEPATOLOGY, V48, P1070, DOI 10.1002/hep.22476; Wong GLH, 2011, J GASTROEN HEPATOL, V26, P300, DOI 10.1111/j.1440-1746.2010.06510.x; Wright LM, 2009, J HEPATOL, V51, P557, DOI 10.1016/j.jhep.2009.05.029; Wright LM, 2009, INT J CLIN EXP PATHO, V2, P34; Zoulim F, 2008, J HEPATOL, V48, pS2, DOI 10.1016/j.jhep.2008.01.011	31	33	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e53862	10.1371/journal.pone.0053862	http://dx.doi.org/10.1371/journal.pone.0053862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418424	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300014
J	Wink, F; Arends, S; McKenna, SP; Houtman, PM; Brouwer, E; Spoorenberg, A				Wink, Freke; Arends, Suzanne; McKenna, Stephen P.; Houtman, Pieternella M.; Brouwer, Elisabeth; Spoorenberg, Anneke			Validity and Reliability of the Dutch Adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) Questionnaire	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; INSTRUMENT; HEALTH; TRANSLATION; SWEDEN; RAQOL; QOL	Objective: The Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire is a disease-specific instrument developed to measure quality of life (QoL) in patients with psoriatic arthritis (PsA). The aim of this study was to translate the measure into Dutch and to determine its psychometric properties. Method: Translation of the original English PsAQoL into Dutch was performed by bilingual and lay panel. Ten field-test interviews with PsA patients were performed to assess face and content validity. In total, 211 PsA patients were included in a test-retest postal survey to investigate the reliability and construct validity of the Dutch adaptation of the PsAQoL. The PsAQoL, Health Assessment Questionnaire (HAQ) and Skindex-17 were administered on two different occasions approximately two weeks apart. Results: The Dutch version of the PsAQoL was found to be relevant, understandable and easy to complete in only a few minutes. It correlated as expected with the HAQ (Spearman's rho = 0.72) and the 2 subscales of the Skindex-17 (rho = 0.40 for the psychosocial and rho = 0.46 for the symptom scale). Furthermore, the measure had good internal consistency (Cronbach's alpha = 0.92) and test-retest reliability (rho = 0.89). The PsAQoL was able to define groups of patients based on self-reported general health status, self-reported severity of PsA and flare of arthritis. Duration of PsA did not influence PsAQoL scores. Conclusions: The Dutch version of the PsAQoL is a valid and reliable questionnaire suitable for use in clinical or research settings to asses PsA-specific QoL.	[Wink, Freke; Arends, Suzanne; Brouwer, Elisabeth; Spoorenberg, Anneke] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Arends, Suzanne; Houtman, Pieternella M.; Spoorenberg, Anneke] Med Ctr Leeuwarden, Leeuwarden, Netherlands; [McKenna, Stephen P.] Galen Res Ltd, Manchester, Lancs, England	University of Groningen; Medical Center Leeuwarden	Wink, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands.	f.r.wink@umcg.nl	Brouwer, Elisabeth/AAL-9029-2020; Arends, Suzanne/M-5436-2015	Brouwer, Elisabeth/0000-0002-5652-4423; Arends, Suzanne/0000-0002-4422-7640				Billing E, 2010, SCAND J RHEUMATOL, V39, P223, DOI 10.3109/03009740903347975; DeJong Z, 1997, BRIT J RHEUMATOL, V36, P878; Doward LC, 2009, ANN RHEUM DIS, V68, P196, DOI 10.1136/ard.2007.086009; Doward LC, 2003, ANN RHEUM DIS, V62, P20, DOI 10.1136/ard.62.1.20; Gilworth G, 2004, J RHEUMATOL, V31, P931; Gladman DD, 2007, J RHEUMATOL, V34, P1167; Hagell P, 2010, VALUE HEALTH, V13, P424, DOI 10.1111/j.1524-4733.2009.00677.x; Healy PJ, 2008, J RHEUMATOL, V35, P1359; Husted JA, 1998, J RHEUMATOL, V25, P2146; Husted JA, 2001, ARTHRIT RHEUM-ARTHR, V45, P151; Keenan AM, 2008, ARTHRIT RHEUM-ARTHR, V59, P841, DOI 10.1002/art.23714; Marzo-Ortega H, 2007, ANN RHEUM DIS, V66, P778, DOI 10.1136/ard.2006.063818; McKenna SP, 2005, VALUE HEALTH, V8, P89, DOI 10.1111/j.1524-4733.2005.08203.x; McKenna SP, 2004, VALUE HEALTH, V7, pS17, DOI 10.1111/j.1524-4733.2004.7s105.x; McKenna SP, 2004, ANN RHEUM DIS, V63, P162, DOI 10.1136/ard.2003.006296; Nijsten TEC, 2006, J INVEST DERMATOL, V126, P1244, DOI 10.1038/sj.jid.5700212; Olivieri I, 2009, J RHEUMATOL, V36, P28, DOI 10.3899/jrheum.090218; Saad AA, 2010, ARTHRIT CARE RES, V62, P345, DOI 10.1002/acr.20104; SCARPA R, 1984, BRIT J RHEUMATOL, V23, P246; Swaine-Verdier A, 2004, VALUE HEALTH, V7, P27; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; WEINER E, 1984, ASSESSING INDIVIDUAL	22	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55912	10.1371/journal.pone.0055912	http://dx.doi.org/10.1371/journal.pone.0055912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418474	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300065
J	Hashem, AM; Gravel, C; Farnsworth, A; Zou, W; Lemieux, M; Xu, KW; Li, CG; Wang, JZ; Goneau, MF; Merziotis, M; He, RT; Gilbert, M; Li, XG				Hashem, Anwar M.; Gravel, Caroline; Farnsworth, Aaron; Zou, Wei; Lemieux, Michelle; Xu, Kangwei; Li, Changgui; Wang, Junzhi; Goneau, Marie-France; Merziotis, Maria; He, Runtao; Gilbert, Michel; Li, Xuguang			A Novel Synthetic Receptor-Based Immunoassay for Influenza Vaccine Quantification	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; SINGLE-RADIAL-IMMUNODIFFUSION; UNIVERSAL ANTIBODIES; VIRUS NEURAMINIDASE; HEMAGGLUTININ; SUBTYPES; IMMUNOGENICITY; ASSAY; REACTOGENICITY; IDENTIFICATION	Vaccination is the most effective prophylactic method for preventing influenza. Quantification of influenza vaccine antigens is critically important before the vaccine is used for human immunization. Currently the vaccine antigen quantification relies on hemagglutinin content quantification, the key antigenic component, by single radial immunodiffusion (SRID) assay. Due to the inherent disadvantages associated with the traditional SRID; i.e. low sensitivity, low throughput and need for annual reagents, several approaches have been proposed and investigated as alternatives. Yet, most alternative methods cannot distinguish native hemagglutinin from denatured form, making them less relevant to antigenic analyses. Here, we developed a quantitative immunoassay based on the sialic acid binding property of influenza vaccine antigens. Specifically, we chemically synthesized human and avian influenza virus receptors analogues, N-acetylneuraminic acid-2,6-lactose and N-acetylneuraminic acid-2,3-lactose derivatives with an azidopropyl aglycon, using alpha-2,6- and alpha-2,3-sialyltransferases, respectively. The azido group of the two sialyllactose-derivatives was reduced and conjugated to mouse serum albumin through a squarate linkage. We showed that the synthetic alpha-2,6- and alpha-2,3-receptors selectively bound to human and avian-derived hemagglutinins, respectively, forming the basis of a new, and robust assay for hemagglutinin quantification. Hemagglutinin treated at high temperature or low pH was measured differentially to untreated samples suggesting native conformation is dependent for optimal binding. Importantly, this receptor-based immunoassay showed excellent specificity and reproducibility, high precision, less turnaround time and significantly higher sensitivity and throughput compared with SRID in analyzing multiple influenza vaccines.	[Hashem, Anwar M.; Gravel, Caroline; Farnsworth, Aaron; Lemieux, Michelle; Li, Xuguang] Hlth Canada, Ctr Vaccine Evaluat, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada; [Hashem, Anwar M.] King Abdulaziz Univ, Fac Med, Dept Microbiol, Jeddah 21413, Saudi Arabia; [Zou, Wei; Goneau, Marie-France; Merziotis, Maria; Gilbert, Michel] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Xu, Kangwei; Li, Changgui; Wang, Junzhi] Natl Inst Food & Drug Control, Beijing, Peoples R China; [He, Runtao] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Hashem, Anwar M.; Li, Xuguang] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	Health Canada; King Abdulaziz University; National Research Council Canada; National Institute of Food & Drug Control - China; Public Health Agency of Canada; University of Ottawa	Gilbert, M (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	michel.gilbert@nrc-cnrc.gc.ca; sean.li@hc-sc.gc.ca	kangwei, xu/B-2185-2018; Hashem, Anwar M/B-2301-2017; Hashem, Anwar/E-9411-2011	kangwei, xu/0000-0002-1375-0586; Hashem, Anwar M/0000-0002-8471-7011; Gilbert, Michel/0000-0002-0204-4408	King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada; Canadian Regulatory Strategy for Biotechnology	King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada; Canadian Regulatory Strategy for Biotechnology	AMH is supported by a scholarship from King Abdulaziz University, through the Saudi Arabian Cultural Bureau in Canada. This work was supported by the Canadian Regulatory Strategy for Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bliu A, 2012, VACCINE, V30, P5506, DOI 10.1016/j.vaccine.2012.06.051; BUCHER DJ, 1976, P NATL ACAD SCI USA, V73, P238, DOI 10.1073/pnas.73.1.238; CATE TR, 1983, REV INFECT DIS, V5, P737; Chan J, 2010, NAT CHEM BIOL, V6, P405, DOI 10.1038/nchembio.352; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Chun S, 2008, VACCINE, V26, P6068, DOI 10.1016/j.vaccine.2008.09.015; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Creskey MC, 2010, ANAL BIOCHEM, V406, P193, DOI 10.1016/j.ab.2010.07.016; Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001; Farnsworth A, 2011, VACCINE, V29, P1529, DOI 10.1016/j.vaccine.2010.12.120; GAMBARYAN AS, 1992, J VIROL METHODS, V39, P111, DOI 10.1016/0166-0934(92)90130-6; Garcia-Canas V, 2007, ANAL CHEM, V79, P3164, DOI 10.1021/ac0621120; Garcia-Canas V, 2006, J CHROMATOGR A, V1123, P225, DOI 10.1016/j.chroma.2006.04.003; Getie-Kebtie M, 2009, PROTEOM CLIN APPL, V3, P979, DOI 10.1002/prca.200800219; Gravel C, 2011, JOVE-J VIS EXP, DOI 10.3791/2784; Gravel C, 2010, VACCINE, V28, P5774, DOI 10.1016/j.vaccine.2010.06.075; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Hardy Stephanie, 2011, Influenza Other Respir Viruses, V5, P438, DOI 10.1111/j.1750-2659.2011.00250.x; Hashem AM, 2012, HUM VACC IMMUNOTHER, V8, P425, DOI 10.4161/hv.19109; Hashem AM, 2011, CURR BIOINFORM, V6, P415; Hashem AM, 2010, BIOCHEM BIOPH RES CO, V403, P247, DOI 10.1016/j.bbrc.2010.11.030; JOHANSSON BE, 1993, VACCINE, V11, P1037, DOI 10.1016/0264-410X(93)90130-P; Kakuta Y, 2008, GLYCOBIOLOGY, V18, P66, DOI 10.1093/glycob/cwm119; Kamath VP, 1996, GLYCOCONJUGATE J, V13, P315, DOI 10.1007/BF00731506; Kapteyn JC, 2009, VACCINE, V27, P1468, DOI 10.1016/j.vaccine.2008.11.113; Kapteyn JC, 2006, VACCINE, V24, P3137, DOI 10.1016/j.vaccine.2006.01.046; LAMONTAGNE JR, 1983, REV INFECT DIS, V5, P723; Legastelois I, 2011, J VIROL METHODS, V178, P129, DOI 10.1016/j.jviromet.2011.08.027; Li CG, 2010, BIOLOGICALS, V38, P284, DOI 10.1016/j.biologicals.2009.12.004; Li CG, 2010, NAT PROTOC, V5, P14, DOI 10.1038/nprot.2009.200; Lindstrom SE, 1999, J VIROL, V73, P4413, DOI 10.1128/JVI.73.5.4413-4426.1999; Luna LG, 2008, ANAL CHEM, V80, P2688, DOI 10.1021/ac701945h; Luykx DMAM, 2004, EUR J PHARM SCI, V23, P65, DOI 10.1016/j.ejps.2004.05.007; Marcelin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026335; MATROSOVICH MN, 1993, VIROLOGY, V196, P111, DOI 10.1006/viro.1993.1459; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; PHELAN MA, 1983, J CHROMATOGR, V266, P55, DOI 10.1016/S0021-9673(01)90879-9; Plennevaux E, 2011, VACCINE, V29, P1569, DOI 10.1016/j.vaccine.2010.12.116; Poland GA, 2001, VACCINE, V19, P2216, DOI 10.1016/S0264-410X(00)00448-5; Pukin AV, 2008, CARBOHYD RES, V343, P636, DOI 10.1016/j.carres.2008.01.007; Quan FS, 2011, VIROLOGY, V417, P196, DOI 10.1016/j.virol.2011.05.014; ROTT R, 1974, J GEN VIROL, V22, P35, DOI 10.1099/0022-1317-22-1-35; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; SCHULMAN JL, 1968, J VIROL, V2, P778, DOI 10.1128/JVI.2.8.778-786.1968; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Takahashi Y, 2009, J INFECT DIS, V199, P1629, DOI 10.1086/598954; Tsukamoto H, 2008, J BIOCHEM, V143, P187, DOI 10.1093/jb/mvm208; Wang YF, 2012, J MED VIROL, V84, P679, DOI 10.1002/jmv.23219; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Weldon WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012466; WHITE JM, 1987, J CELL BIOL, V105, P2887, DOI 10.1083/jcb.105.6.2887; WILLIAMS MS, 1993, VET MICROBIOL, V37, P253, DOI 10.1016/0378-1135(93)90027-5; Williams TL, 2008, VACCINE, V26, P2510, DOI 10.1016/j.vaccine.2008.03.014; Wood J M, 1986, Dev Biol Stand, V64, P169; Wood J M, 1999, Dev Biol Stand, V98, P183; WOOD JM, 1977, J BIOL STAND, V5, P237, DOI 10.1016/S0092-1157(77)80008-5; WRIGHT PF, 1983, REV INFECT DIS, V5, P758; Zambon MC, 1999, J ANTIMICROB CHEMOTH, V44, P3, DOI 10.1093/jac/44.suppl_2.3; Zou W, 2004, J BIOL CHEM, V279, P25390, DOI 10.1074/jbc.M402787200; Zou W, 1996, J CARBOHYD CHEM, V15, P279, DOI 10.1080/07328309608005653	61	20	21	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55428	10.1371/journal.pone.0055428	http://dx.doi.org/10.1371/journal.pone.0055428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424631	Green Published, gold			2022-12-27	WOS:000315965100019
J	Pan, ZL; Pang, LF; Ding, B; Yan, C; Zhang, H; Du, LJ; Wang, BS; Song, Q; Chen, KM; Yan, FH				Pan, Zilai; Pang, Lifang; Ding, Bei; Yan, Chao; Zhang, Huan; Du, Lianjun; Wang, Baisong; Song, Qi; Chen, Kemin; Yan, Fuhua			Gastric Cancer Staging with Dual Energy Spectral CT Imaging	PLOS ONE			English	Article							ROW COMPUTED-TOMOGRAPHY; LYMPH-NODE METASTASES; HELICAL CT; QUANTITATIVE ASSESSMENT; CONTRAST ENHANCEMENT; MULTIDETECTOR CT; PROGNOSTIC VALUE; PREOPERATIVE T; BLOOD-FLOW; CARCINOMA	Purpose: To evaluate the clinical utility of dual energy spectral CT (DEsCT) in staging and characterizing gastric cancers. Materials and Methods: 96 patients suspected of gastric cancers underwent dual-phasic scans (arterial phase (AP) and portal venous phase (PP)) with DEsCT mode. Three types of images were reconstructed for analysis: conventional polychromatic images, material-decomposition images, and monochromatic image sets with photon energies from 40 to 140 keV. The polychromatic and monochromatic images were compared in TNM staging. The iodine concentrations in the lesions and lymph nodes were measured on the iodine-based material-decomposition images. These values were further normalized against that in aorta and the normalized iodine concentration (nIC) values were statistically compared. Results were correlated with pathological findings. Results: The overall accuracies for T, N and M staging were (81.2%, 80.0%, and 98.9%) and (73.9%, 75.0%, and 98.9%) determined with the monochromatic images and the conventional kVp images, respectively. The improvement of the accuracy in N-staging using the keV images was statistically significant (p<0.05). The nIC values between the differentiated and undifferentiated carcinoma and between metastatic and non-metastatic lymph nodes were significantly different both in AP (p = 0.02, respectively) and PP (p = 0.01, respectively). Among metastatic lymph nodes, nIC of the signet-ring cell carcinoma were significantly different from the adenocarcinoma (p = 0.02) and mucinous adenocarcinoma (p = 0.01) in PP. Conclusion: The monochromatic images obtained with DEsCT may be used to improve the N-staging accuracy. Quantitative iodine concentration measurements may be helpful for differentiating between differentiated and undifferentiated gastric carcinoma, and between metastatic and non-metastatic lymph nodes.	[Pan, Zilai; Pang, Lifang; Ding, Bei; Zhang, Huan; Du, Lianjun; Song, Qi; Chen, Kemin; Yan, Fuhua] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Yan, Chao] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surgeon, Shanghai 200030, Peoples R China; [Wang, Baisong] Shanghai Jiao Tong Univ, Sch Med, Dept Biomed Stat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiol, Shanghai 200030, Peoples R China.	huanzhangy@yahoo.com			NSFC [81272746, 81171312]; Shanghai Educational Board [10YE37]	NSFC(National Natural Science Foundation of China (NSFC)); Shanghai Educational Board	This work was supported by NSFC (No. 81272746), NSFC (No. 81171312) and The Shanghai Educational Board Funding (10YE37). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurello P, 2007, AM SURGEON, V73, P359; BLOMLEY MJK, 1993, INVEST RADIOL, V28, pS72, DOI 10.1097/00004424-199311001-00023; Bohle W, 2011, J GASTROINTEST LIVER, V20, P135; Boll DT, 2010, RADIOLOGY, V254, P270, DOI 10.1148/radiol.09090068; Chen CY, 2006, ABDOM IMAGING, V31, P514, DOI 10.1007/s00261-005-0218-7; Chen CY, 2007, RADIOLOGY, V242, P472, DOI 10.1148/radiol.2422051557; Coursey CA, 2010, RADIOGRAPHICS, V30, P1037, DOI 10.1148/rg.304095175; D'Elia F, 2000, EUR RADIOL, V10, P1877, DOI 10.1007/s003300000537; DORFMAN RE, 1991, RADIOLOGY, V180, P319, DOI 10.1148/radiology.180.2.2068292; Dugdale PE, 1999, EUR J RADIOL, V30, P206, DOI 10.1016/S0720-048X(99)00013-3; FUKUYA T, 1995, RADIOLOGY, V197, P705, DOI 10.1148/radiology.197.3.7480743; Habermann CR, 2004, RADIOLOGY, V230, P465, DOI 10.1148/radiol.2302020828; Hermanek P, 2000, CANCER-AM CANCER SOC, V88, P1763, DOI 10.1002/(SICI)1097-0142(20000415)88:8<1763::AID-CNCR1>3.0.CO;2-T; Ichikawa D, 2003, HEPATO-GASTROENTEROL, V50, P301; Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10; Japanese Research Society for Gastric Cancer, 1995, JAP CLASS GASTR CARC; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kadowaki K, 2000, Radiat Med, V18, P47; Kato M, 1999, HEPATO-GASTROENTEROL, V46, P3281; Kim AY, 2005, ABDOM IMAGING, V30, P465, DOI 10.1007/s00261-004-0273-5; Kim YH, 2009, RADIOLOGY, V250, P767, DOI 10.1148/radiol.2502071872; Kranenbarg EK, 2001, BRIT J CANCER, V84, P64, DOI 10.1054/bjoc.2000.1548; Kumano S, 2005, RADIOLOGY, V237, P961, DOI 10.1148/radiol.2373041380; Kwee RM, 2009, GASTRIC CANCER, V12, P6, DOI 10.1007/s10120-008-0492-5; Kwon SJ, 2011, J GASTRIC CANCER, V11, P78, DOI 10.5230/jgc.2011.11.2.78; Lee JH, 2006, J COMPUT ASSIST TOMO, V30, P880, DOI 10.1097/01.rct.0000220800.76276.46; Lee JH, 2000, J COMPUT ASSIST TOMO, V24, P777, DOI 10.1097/00004728-200009000-00020; Li BW, 2012, TOHOKU J EXP MED, V228, P9, DOI 10.1620/tjem.228.9; Lim JS, 2006, RADIOGRAPHICS, V26, P143, DOI 10.1148/rg.261055078; Liu J, 2011, CHINESE MED J-PEKING, V124, P445, DOI 10.3760/cma.j.issn.0366-6999.2011.03.023; Lv PJ, 2011, RADIOLOGY, V259, P720, DOI 10.1148/radiol.11101425; MAGNUSSON A, 1989, ACTA RADIOL, V30, P307; Makino T, 2011, SURGERY, V149, P672, DOI 10.1016/j.surg.2010.12.003; Matsumoto K, 2011, RADIOLOGY, V259, P257, DOI 10.1148/radiol.11100978; Monig SP, 2002, ONKOLOGIE, V25, P342, DOI 10.1159/000066051; Monig SP, 1999, AM J ROENTGENOL, V173, P365; MORIGUCHI S, 1991, J SURG ONCOL, V48, P202, DOI 10.1002/jso.2930480313; Moschetta M, 2010, EUR RADIOL, V20, P138, DOI 10.1007/s00330-009-1482-7; Pan ZL, 2010, EUR RADIOL, V20, P613, DOI 10.1007/s00330-009-1576-2; Park SR, 2010, ANN SURG, V251, P428, DOI 10.1097/SLA.0b013e3181ca69a7; Roberts HC, 2002, AM J NEURORADIOL, V23, P828; Roder JD, 1998, CANCER-AM CANCER SOC, V82, P621, DOI 10.1002/(SICI)1097-0142(19980215)82:4<621::AID-CNCR2>3.3.CO;2-2; Rossi M, 1999, AM J ROENTGENOL, V172, P383, DOI 10.2214/ajr.172.2.9930788; Sahani DV, 2005, RADIOLOGY, V234, P785, DOI 10.1148/radiol.2343040286; Santamaria-Pang A, 2010, PROC SPIE, V7624, DOI 10.1117/12.844059; Shimizu K, 2005, AM J ROENTGENOL, V185, P1152, DOI 10.2214/AJR.04.0651; Sobin LH, 2002, TNM CLASSIFICATION M, V6th; Yan C, 2009, J SURG ONCOL, V100, P205, DOI 10.1002/jso.21316; Yao J, 2010, ABDOM IMAGING, V35, P195, DOI 10.1007/s00261-009-9503-1; Yoshida S, 2005, ABDOM IMAGING, V30, P518, DOI 10.1007/s00261-004-0287-z; Zhang H, 2008, KOREAN J RADIOL, V9, P119, DOI 10.3348/kjr.2008.9.2.119; Zhang MM, 1997, RADIOLOGY, V205, P471, DOI 10.1148/radiology.205.2.9356631; Zhao LQ, 2012, EUR J RADIOL, V81, P1677, DOI 10.1016/j.ejrad.2011.02.063	53	67	88	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e53651	10.1371/journal.pone.0053651	http://dx.doi.org/10.1371/journal.pone.0053651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424614	Green Submitted, Green Published, gold			2022-12-27	WOS:000315965100002
J	Wada, K; Sairenchi, T; Haruyama, Y; Taneichi, H; Ishikawa, Y; Muto, T				Wada, Keiko; Sairenchi, Toshimi; Haruyama, Yasuo; Taneichi, Hiromi; Ishikawa, Yumiko; Muto, Takashi			Relationship between the Onset of Depression and Stress Response Measured by the Brief Job Stress Questionnaire among Japanese Employees: A Cohort Study	PLOS ONE			English	Article							ANNUAL HEALTH EXAMINATIONS; MENTAL-HEALTH; PSYCHOLOGICAL DISTRESS; MAJOR DEPRESSION; SOMATIC SYMPTOMS; CONTROLLED-TRIAL; WORKERS; ASSOCIATION; PROGRAM; STRAIN	Background: The proportion of Japanese workers experiencing intense worry or stress during working life is in excess of 60%, and the incidence of psychiatric disorders and suicide due to psychological burden from work duties is increasing. To confirm whether the stress response measured by the Brief Job Stress Questionnaire (BJSQ) can identify risk for depression, a cohort study was conducted to evaluate whether the stress response measured by BJSQ was associated with the onset of depression. Methods: A total of 1,810 participants aged 20-70 years in 2005 completed the stress response of the BJSQ and were followed-up until August, 2007 by examining sick pay records. Depression was defined by a description in sick pay records that included "depression" or "depressive symptoms" as a reason for sick leave according to a physician's medical certificate. The participants were divided into quartiles (Q1, Q2, Q3, and Q4) according to the total stress response score of BJSQ at baseline. Furthermore, the participants were divided into a higher score category (Q4) and a lower score category (Q1-Q3). Risk ratios of the stress response of the BJSQ for onset of depression were calculated using a multivariable Cox proportional hazard model. Results: Among 1,810 participants, 14 developed depression during a mean of 1.8 years of follow-up. The risk ratio was 2.96 (95% confidence interval [CI], 1.04-8.42, p for trend = 0.002) when the higher stress response score category of BJSQ was compared with the low stress response score category for sick leave due to depression. After adjusting for gender, age, marital status, and having children, the risk ratios were similar to no adjustment. Conclusions: These findings suggest that the stress response measured by the BJSQ can demonstrate risk for the onset of depression.	[Wada, Keiko; Sairenchi, Toshimi; Haruyama, Yasuo; Taneichi, Hiromi; Ishikawa, Yumiko; Muto, Takashi] Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Shimotsugagun Mibu, Tochigi, Japan; [Wada, Keiko; Taneichi, Hiromi; Ishikawa, Yumiko] Dokkyo Med Univ, Sch Nursing, Shimotsugagun Mibu, Tochigi, Japan	Dokkyo Medical University; Dokkyo Medical University	Wada, K (corresponding author), Dokkyo Med Univ, Sch Med, Dept Publ Hlth, Shimotsugagun Mibu, Tochigi, Japan.	k-wada@dokkyomed.ac.jp		Sairenchi, Toshimi/0000-0001-8896-6501	Japan Society for Promotion of Science [KAKENHI: 70453404]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from the Japan Society for Promotion of Science (KAKENHI: 70453404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2007, J AFFECT DISORDERS, V104, P103, DOI 10.1016/j.jad.2007.03.004; [Anonymous], WHIT PAP MENT HLTH P; [Anonymous], 2008, PAT SURV; Clays E, 2007, SCAND J WORK ENV HEA, V33, P252, DOI 10.5271/sjweh.1140; Endo M, 2012, INS HLTH; Frasure-Smith N, 2003, ARCH GEN PSYCHIAT, V60, P627, DOI 10.1001/archpsyc.60.6.627; Fukui Satoe, 2003, JOB STRESS RES, V10, P273; Harada H, 2005, J OCCUP HEALTH, V47, P397, DOI 10.1539/joh.47.397; Hase Yoko, 2008, Sangyo Eiseigaku Zasshi, V50, P111, DOI 10.1539/sangyoeisei.B7010; HOJO K, 2004, AOMORI ROSAI MED J, V14, P1; Ian C, 2010, CAN J PSYCHOL, V55, P622; Ikegami Kazunori, 2010, Journal of UOEH, V32, P141; Ikegami Kazunori, 2008, Sangyo Eiseigaku Zasshi, V50, P120, DOI 10.1539/sangyoeisei.E7008; Japan Ministry of Health Labour and Welfare, MEAS SEC SAF HLTH WO; Japan Ministry of Health Labour and Welfare, ANN HLTH LAB WELF RE; Kato Shoko, 2004, Sangyo Eiseigaku Zasshi, V46, P191, DOI 10.1539/sangyoeisei.46.191; Kawakami N, 2006, J OCCUP HEALTH, V48, P28, DOI 10.1539/joh.48.28; Kawakami N, 2006, J CLIN EXPT MED IGAK, V219, P925; Kawano Y, 2008, J OCCUP HEALTH, V50, P79, DOI 10.1539/joh.50.79; Kobayashi Y, 2008, J OCCUP HEALTH, V50, P455, DOI 10.1539/joh.L7166; Miki A, 2004, P JAPAN NURSING ASS, V35, P74; Mineyama S, 2007, J OCCUP HEALTH, V49, P81, DOI 10.1539/joh.49.81; Ministry of Health Labour and Welfare, 2000, GUID PROM MENT HLTH; Mino Y, 1999, OCCUP ENVIRON MED, V56, P41, DOI 10.1136/oem.56.1.41; Mitani S., 2008, PREHOSPITAL DISASTER, V23, P20, DOI [10.1017/s1049023x00005501, DOI 10.1017/S1049023X00005501]; Muto S, 2007, IND HEALTH, V45, P44, DOI 10.2486/indhealth.45.44; Nakao M, 2006, PSYCHIAT CLIN NEUROS, V60, P219, DOI 10.1111/j.1440-1819.2006.01489.x; Nakao M, 2006, J AFFECT DISORDERS, V90, P29, DOI 10.1016/j.jad.2005.09.010; Niedhammer I, 1998, SCAND J WORK ENV HEA, V24, P197, DOI 10.5271/sjweh.299; Novak M, 2010, PSYCHOSOM MED, V72, P527, DOI 10.1097/PSY.0b013e3181dbbb7d; Sato Y, 2009, OCCUP MED-OXFORD, V59, P14, DOI 10.1093/occmed/kqn141; Shimomitsu T., 2000, INVESTIGATION RES RE, P101; Stansfeld SA, 2008, OCCUP ENVIRON MED, V65, P634, DOI 10.1136/oem.2007.036640; Steinberg BJ, 1997, NEUROPSYCHOPHARMACOL, V17, P264, DOI 10.1016/S0893-133X(97)00051-1; Stoetzer U, 2009, J OCCUP HEALTH, V51, P144, DOI 10.1539/joh.L8134; Suwazono Y, 2008, RISK ANAL, V28, P1689, DOI 10.1111/j.1539-6924.2008.01107.x; Tokuyama M, 2003, PSYCHIAT CLIN NEUROS, V57, P523, DOI 10.1046/j.1440-1819.2003.01158.x; Tsuboi H, 2006, J AFFECT DISORDERS, V91, P63, DOI 10.1016/j.jad.2005.12.010; Umehara K, 2007, J OCCUP HEALTH, V49, P467, DOI 10.1539/joh.49.467; Wang JL, 2009, AM J EPIDEMIOL, V169, P1085, DOI 10.1093/aje/kwp037; Wang JL, 2005, PSYCHOL MED, V35, P865, DOI 10.1017/S0033291704003241; World Federation for Mental Health, 2012, DEPRESSION GLOB CRIS	42	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56319	10.1371/journal.pone.0056319	http://dx.doi.org/10.1371/journal.pone.0056319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104BU	23424656	Green Submitted, Green Published, gold			2022-12-27	WOS:000315965100044
J	Sandebring, A; Welander, H; Winblad, B; Graff, C; Tjernberg, LO				Sandebring, Anna; Welander, Hedvig; Winblad, Bengt; Graff, Caroline; Tjernberg, Lars O.			The Pathogenic A beta 43 Is Enriched in Familial and Sporadic Alzheimer Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CARBOXYL-TERMINAL FRAGMENT; A-BETA; INTRAMEMBRANE CLEAVAGE; TRANSMEMBRANE DOMAIN; SENILE PLAQUES; GAMMA; MUTATION; BRAIN; APP	The amyloid-cascade hypothesis posits that the role of amyloid beta-peptide (A beta) in Alzheimer disease (AD) involves polymerization into structures that eventually are deposited as amyloid plaques. During this process, neurotoxic oligomers are formed that induce synaptic loss and neuronal death. Several different isoforms of A beta are produced, of which the 40 and 42 residue variants (A beta 40 and A beta 42) are the most common. A beta 42 has a strong tendency to form neurotoxic aggregates and is involved in AD pathogenesis. Longer A beta isoforms, like the less studied A beta 43, are gaining attention for their higher propensity to aggregate into neurotoxic oligomers. To further investigate A beta 43 in AD, we conducted a quantitative study on A beta 43 levels in human brain. We homogenized human brain tissue and prepared fractions of various solubility; tris buffered saline (TBS), sodium dodecyl sulfate (SDS) and formic acid (FA). Levels of A beta 43, as well as A beta 40 and A beta 42, were quantified using ELISA. We compared quantitative data showing A beta levels in occipital and frontal cortex from sporadic (SAD) and familial (FAD) AD cases, as well as non-demented (ND) controls. Results showed A beta 43 present in each fraction from the SAD and FAD cases, while its level was lower than the detection limit in the majority of the ND-cases. A beta 42 and A beta 43 were enriched in the less soluble fractions (SDS and FA) of SAD and FAD cases in both occipital and frontal cortex. Thus, although the total levels of A beta 43 in human brain are low compared to A beta 40 and A beta 42, we suggest that A beta 43 could initiate the formation of oligomers and amyloid plaques and thereby be crucial to AD pathogenesis.	[Sandebring, Anna; Winblad, Bengt; Graff, Caroline; Tjernberg, Lars O.] Karolinska Inst, Dept Neurobiol Care Sci & Soc, KI ADRC, Huddinge, Sweden; [Welander, Hedvig] Uppsala Univ, Rudbeck Lab, Dept Publ Hlth Mol Geriatr, Uppsala, Sweden	Karolinska Institutet; Uppsala University	Tjernberg, LO (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, KI ADRC, Huddinge, Sweden.	lars.tjernberg@ki.se	graff, caroline/A-2545-2009	Graff, Caroline/0000-0002-9949-2951; Matton, Anna/0000-0002-7819-0495	Knut & Alice Wallenbergs Stiftelse; Stiftelsen for Gamla Tjanarinnor; Gun och Bertil Stohnes Stiftelse; Riksbanken Jubileumsfonden; Swedish Brain Power Program; Karolinska Institutet Strategic Neuroscience Program; Alzheimerfonden	Knut & Alice Wallenbergs Stiftelse; Stiftelsen for Gamla Tjanarinnor; Gun och Bertil Stohnes Stiftelse; Riksbanken Jubileumsfonden; Swedish Brain Power Program; Karolinska Institutet Strategic Neuroscience Program; Alzheimerfonden	This work was supported by funding from Knut & Alice Wallenbergs Stiftelse, Stiftelsen for Gamla Tjanarinnor, Gun och Bertil Stohnes Stiftelse, Riksbanken Jubileumsfonden, the Swedish Brain Power Program, the Karolinska Institutet Strategic Neuroscience Program and Alzheimerfonden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Attems J, 2007, J NEUROL SCI, V257, P49, DOI 10.1016/j.jns.2007.01.013; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Esh C, 2005, BIOCHEMISTRY-US, V44, P13807, DOI 10.1021/bi051213+; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goda R, 2012, J CHROMATOGR B, V895, P137, DOI 10.1016/j.jchromb.2012.03.032; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kakuda N, 2012, EMBO MOL MED, V4, P344, DOI 10.1002/emmm.201200214; Keller L, 2010, EUR J HUM GENET, V18, P1202, DOI 10.1038/ejhg.2010.107; Kim S, 2011, J CLIN NEUROSCI, V18, P916, DOI 10.1016/j.jocn.2010.12.019; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MIELKE R, 1995, INT J NEUROSCI, V82, P1, DOI 10.3109/00207459508994285; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; Miravalle L, 2005, BIOCHEMISTRY-US, V44, P10810, DOI 10.1021/bi0508237; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; ROHER AE, 1993, J NEUROCHEM, V61, P1916, DOI 10.1111/j.1471-4159.1993.tb09834.x; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shimojo M, 2008, J BIOL CHEM, V283, P16488, DOI 10.1074/jbc.M801279200; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Van Vickle GD, 2008, MOL MED, V14, P184, DOI [10.2119/2007-00094.VanVickle, 10.2119/2007-00094.Van Vickle]; Van Vickle GD, 2007, BIOCHEMISTRY-US, V46, P10317, DOI 10.1021/bi700951u; Vandersteen A, 2012, J BIOL CHEM, V287, P36732, DOI 10.1074/jbc.M112.394635; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vinters HV, 2000, J NEUROPATH EXP NEUR, V59, P931, DOI 10.1093/jnen/59.11.931; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200	45	53	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55847	10.1371/journal.pone.0055847	http://dx.doi.org/10.1371/journal.pone.0055847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409063	Green Submitted, gold, Green Published			2022-12-27	WOS:000315100000025
J	Martini, M; Furtner, MR; Sachse, P				Martini, Markus; Furtner, Marco R.; Sachse, Pierre			Working Memory and Its Relation to Deterministic Sequence Learning	PLOS ONE			English	Article							SHORT-TERM-MEMORY; SERIAL REACTION TASK; TONE-COUNTING TASK; REACTION-TIME-TASK; INDIVIDUAL-DIFFERENCES; CAPACITY; IMPLICIT; ATTENTION; KNOWLEDGE; ORDER	Is there a relation between working memory (WM) and incidental sequence learning? Nearly all of the earlier investigations in the role of WM capacity (WMC) in sequence learning suggest no correlations in incidental learning conditions. However, the theoretical view of WM and operationalization of WMC made strong progress in recent years. The current study related performance in a coordination and transformation task to sequence knowledge in a four-choice incidental deterministic serial reaction time (SRT) task and a subsequent free generation task. The response-to-stimulus interval (RSI) was varied between 0 ms and 300 ms. Our results show correlations between WMC and error rates in condition RSI 0 ms. For condition RSI 300 ms we found relations between WMC and sequence knowledge in the SRT task as well as between WMC and generation task performance. Theoretical implications of these findings for ongoing processes during sequence learning and retrieval of sequence knowledge are discussed.	[Martini, Markus; Furtner, Marco R.; Sachse, Pierre] Leopold Franzens Univ Innsbruck, Dept Psychol, Innsbruck, Austria	University of Innsbruck	Martini, M (corresponding author), Leopold Franzens Univ Innsbruck, Dept Psychol, Innsbruck, Austria.	Markus.Martini@uibk.ac.at	Martini, Markus/AAH-7651-2020	Martini, Markus/0000-0003-2637-4804; Furtner, Marco/0000-0002-7734-5459; Sachse, Pierre/0000-0002-8722-401X				Abrahamse EL, 2010, PSYCHON B REV, V17, P603, DOI 10.3758/PBR.17.5.603; BADDELEY AD, 1965, Q J EXP PSYCHOL, V17, P175, DOI 10.1080/17470216508416429; Botvinick M, 2005, J EXP PSYCHOL LEARN, V31, P351, DOI 10.1037/0278-7393.31.2.351; Botvinick MA, 2005, COGNITION, V97, P135, DOI 10.1016/j.cognition.2004.09.007; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burgess N, 2005, TRENDS COGN SCI, V9, P535, DOI 10.1016/j.tics.2005.09.011; Cleeremans A., 2002, IMPLICIT LEARNING CO, P1; Cleeremans A, 2008, PROG BRAIN RES, V168, P19, DOI 10.1016/S0079-6123(07)68003-0; COHEN A, 1990, J EXP PSYCHOL LEARN, V16, P17, DOI 10.1037/0278-7393.16.1.17; Colzato LS, 2006, J EXP PSYCHOL HUMAN, V32, P705, DOI 10.1037/0096-1523.32.3.705; Conway A. R., 2011, CAMBRIDGE HDB INTELL, P418, DOI DOI 10.1017/CBO9780511977244; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; CONWAY ARA, 1994, J EXP PSYCHOL GEN, V123, P354, DOI 10.1037/0096-3445.123.4.354; Conway ARA, 2001, PSYCHON B REV, V8, P331, DOI 10.3758/BF03196169; Cowan Nelson, 2005, WORKING MEMORY CAPAC; DANEMAN M, 1986, J MEM LANG, V25, P1, DOI 10.1016/0749-596X(86)90018-5; Destrebecqz A, 2001, PSYCHON B REV, V8, P343, DOI 10.3758/BF03196171; Destrebecqz A., 2003, ADV CONSCIOUSNESS RE, V48, P181, DOI [10.1075/aicr.48.11des, DOI 10.1075/AICR.48.11DES]; Ecker UKH, 2010, J EXP PSYCHOL LEARN, V36, P170, DOI 10.1037/a0017891; FELDMAN J, 1995, INTELLIGENCE, V20, P87, DOI 10.1016/0160-2896(95)90007-1; Frensch PA, 1999, J EXP PSYCHOL LEARN, V25, P260, DOI 10.1037/0278-7393.25.1.260; Frensch PA, 2003, CURR DIR PSYCHOL SCI, V12, P13, DOI 10.1111/1467-8721.01213; Frensch PA, 1998, PSYCHOL RES-PSYCH FO, V61, P83, DOI 10.1007/s004260050015; FRENSCH PA, 1994, MEM COGNITION, V22, P95, DOI 10.3758/BF03202765; Fu QF, 2008, CONSCIOUS COGN, V17, P185, DOI 10.1016/j.concog.2007.01.007; Gaschler R, 2012, J EXP PSYCHOL LEARN, V38, P1389, DOI 10.1037/a0028071; Hambrick DZ, 2002, COGNITIVE PSYCHOL, V44, P339, DOI 10.1006/cogp.2001.0769; Hebb D. O., 1961, BRAIN MECH LEARNING; Herwig A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00444; Hitch GJ, 2009, J MEM LANG, V61, P97, DOI 10.1016/j.jml.2009.02.004; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Kaufman SB, 2010, COGNITION, V116, P321, DOI 10.1016/j.cognition.2010.05.011; Keele SW, 2003, PSYCHOL REV, V110, P316, DOI 10.1037/0033-295X.110.2.316; Kyllonen P. C., 1990, LEARN INDIVID DIFFER, V2, P129, DOI DOI 10.1016/1041-6080(90)90020-H; Lewandowsky S, 2010, BEHAV RES METHODS, V42, P571, DOI 10.3758/BRM.42.2.571; Majerus S, 2004, J MEM LANG, V51, P297, DOI 10.1016/j.jml.2004.05.002; Majerus S, 2008, COGNITION, V107, P395, DOI 10.1016/j.cognition.2007.10.003; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Oberauer K, 2003, INTELLIGENCE, V31, P167, DOI 10.1016/S0160-2896(02)00115-0; Oberauer K, 2000, PERS INDIV DIFFER, V29, P1017, DOI 10.1016/S0191-8869(99)00251-2; Oberauer K, 2010, PSYCHOL BELG, V50, P277, DOI 10.5334/pb-50-3-4-277; Oberauer K, 2009, PSYCHOL LEARN MOTIV, V51, P45, DOI 10.1016/S0079-7421(09)51002-X; Oberauer K, 2008, INTELLIGENCE, V36, P641, DOI 10.1016/j.intell.2008.01.007; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; REED J, 1994, J EXP PSYCHOL LEARN, V20, P585, DOI 10.1037/0278-7393.20.3.585; Rosen VM, 1997, J EXP PSYCHOL GEN, V126, P211, DOI 10.1037/0096-3445.126.3.211; Schuck NW, 2012, J EXP PSYCHOL LEARN, V38, P440, DOI 10.1037/a0025816; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schvaneveldt RW, 1998, PSYCHOL RES-PSYCH FO, V61, P175, DOI 10.1007/s004260050023; Shanks DR, 2005, PSYCHOL RES-PSYCH FO, V69, P369, DOI 10.1007/s00426-004-0211-8; STADLER MA, 1995, J EXP PSYCHOL LEARN, V21, P674, DOI 10.1037/0278-7393.21.3.674; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Szmalec A, 2005, MEM COGNITION, V33, P531, DOI 10.3758/BF03193069; Szmalec A, 2011, J EXP PSYCHOL HUMAN, V37, P137, DOI 10.1037/a0020365; Unsworth N, 2005, MEM COGNITION, V33, P213, DOI 10.3758/BF03195310; Unsworth N, 2007, PSYCHOL REV, V114, P104, DOI 10.1037/0033-295X.114.1.104; WHARTON CM, 1994, COGNITIVE PSYCHOL, V26, P64, DOI 10.1006/cogp.1994.1003; Wilkinson L, 2004, J EXP PSYCHOL LEARN, V30, P354, DOI 10.1037/0278-7393.30.2.354	63	10	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56166	10.1371/journal.pone.0056166	http://dx.doi.org/10.1371/journal.pone.0056166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086CJ	23409148	Green Submitted, Green Published, gold			2022-12-27	WOS:000314660300062
J	Zhu, L; Lou, AR				Zhu, Lin; Lou, Anru			Old-Growth Platycladus orientalis as a Resource for Reproductive Capacity and Genetic Diversity	PLOS ONE			English	Article							POPULATIONS; RESERVOIRS; FORESTS; STANDS	Aims: Platycladus orientalis (Cupressaceae) is an old-growth tree species which distributed in the imperial parks and ancient temples in Beijing, China. We aim to (1) examine the genetic diversity and reproductive traits of old-growth and young populations of P. orientalis to ascertain whether the older populations contain a higher genetic diversity, more private alleles and a higher reproductive output compared with younger populations; (2) determine the relationships between the age of the population and the genetic diversity and reproductive traits; and (3) determine whether the imperial parks and ancient temples played an important role in maintaining the reproductive capacity and genetic diversity of Platycladus orientalis. Methods: Samples from seven young (younger than 100 yrs.) and nine old-growth (older than 300 yrs.) artificial populations were collected. For comparison, three young and two old-growth natural populations were also sampled. Nine microsatellite loci were used to analyze genetic diversity parameters. These parameters were calculated using FSTAT version 2.9.3 and GenAlex v 6.41. Important Findings: The old-growth artificial populations of P. orientalis have significantly higher genetic diversity than younger artificial populations and similar levels to those in extant natural populations. The imperial parks and ancient temples, which have protected these old-growth trees for centuries, have played an important role in maintaining the genetic diversity and reproductive capacity of this tree species.	[Zhu, Lin; Lou, Anru] Beijing Normal Univ, Coll Life Sci, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China	Beijing Normal University	Lou, AR (corresponding author), Beijing Normal Univ, Coll Life Sci, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	louanru@bnu.edu.cn			National Natural Science Foundation of China [31070374]; Specialized Research Fund for the Doctoral Program of Higher Education [20120003130003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (project code: 31070374) and Specialized Research Fund for the Doctoral Program of Higher Education (20120003130003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Anami VS, 2007, WITNESSES TIME MAGNI; Asili J, 2004, J NAT PROD, V67, P631, DOI 10.1021/np034033e; Chen X, 2010, SCI TECHNOLOGY ENG, V10, P5; Committee FoCE, 1999, FLORA CHINA; Dong Y, 1989, J BEIJING FORESTRY U, V11, P11; ELLSTRAND NC, 1989, P NATL ACAD SCI USA, V86, P9044, DOI 10.1073/pnas.86.22.9044; England PR, 2003, HEREDITY, V91, P475, DOI 10.1038/sj.hdy.6800308; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GREIPSSON S, 1995, ANN BOT-LONDON, V76, P493, DOI 10.1006/anbo.1995.1125; KONNERT M, 1991, SILVAE GENET, V40, P60; Li H, 2009, CHINESE J TROPICAL C, V30, P6; Li H, 2009, THESIS FORESTRY U; Li JY, 1989, J BEIJING FORESTRY U, V11, P9; Liang M, 2008, SHAANXI FOREST SCI T, V2, P4; Lu W, 2011, RES SOIL WATER CONSE, V18, P4; Lu W, 2011, ENVIRON SCI TECHNOL, V34, P5; Mosseler A, 2003, THEOR APPL GENET, V106, P931, DOI 10.1007/s00122-002-1156-1; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Nie LS, 2005, J BEIJING FORESTRY U, V27, P5; Orellana MR, 2005, CAN J BOT, V83, P183, DOI [10.1139/b04-166, 10.1139/B04-166]; Ostlund L, 2002, ENV HIST, V7, P21; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Reisch C, 2007, NORD J BOT, V25, P366, DOI 10.1111/j.0107-055X.2008.00188.x; Roberts DG, 2007, CONSERV BIOL, V21, P842, DOI 10.1111/j.1523-1739.2007.00691.x; ROHDE CLE, 1994, ENGLISH NATURE SCI, V22; Savard JPL, 2000, LANDSCAPE URBAN PLAN, V48, P131, DOI 10.1016/S0169-2046(00)00037-2; Stanton ML, 1994, ECOLOGY, V65, P8; Templeton AR, 1986, CONSERVATION BIOL SC; Troeh F.R., 1981, SOIL SCI, V132, P189, DOI [10.1097/00010694-198108000-00012, DOI 10.1097/00010694-198108000-00012]; Vaughton G, 1998, AUSTR J ECOLOGY, V23, P10; Xu Z, 1992, CHINESE J ECOL, V11, P5; Zhang J, 2009, J SANMENXIA POLYTECH, V8, P5; Zhu L, 2012, AM J BOT, V99, pE280, DOI 10.3732/ajb.1100583	34	11	12	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56489	10.1371/journal.pone.0056489	http://dx.doi.org/10.1371/journal.pone.0056489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409190	Green Submitted, Green Published, gold			2022-12-27	WOS:000314660300076
J	Gaujoux, S; Hantel, C; Launay, P; Bonnet, S; Perlemoine, K; Lefevre, L; Guillaud-Bataille, M; Beuschlein, F; Tissier, F; Bertherat, J; Rizk-Rabin, M; Ragazzon, B				Gaujoux, Sebastien; Hantel, Constanze; Launay, Pierre; Bonnet, Stephane; Perlemoine, Karine; Lefevre, Lucile; Guillaud-Bataille, Marine; Beuschlein, Felix; Tissier, Frederique; Bertherat, Jerome; Rizk-Rabin, Marthe; Ragazzon, Bruno			Silencing Mutated beta-Catenin Inhibits Cell Proliferation and Stimulates Apoptosis in the Adrenocortical Cancer Cell Line H295R	PLOS ONE			English	Article							SIGNALING PATHWAYS; TUMORS; EXPRESSION; MUTATIONS; GENE; ACTIVATION; CARCINOMA; PROTEIN; GROWTH	Context: Adrenocortical carcinoma (ACC) is a rare and highly aggressive endocrine neoplasm, with limited therapeutic options. Activating beta-catenin somatic mutations are found in ACC and have been associated with a poor clinical outcome. In fact, activation of the Wnt/beta-catenin signaling pathway seems to play a major role in ACC aggressiveness, and might, thus, represent a promising therapeutic target. Objective: Similar to patient tumor specimen the H295 cell line derived from an ACC harbors a natural activating beta-catenin mutation. We herein assess the in vitro and in vivo effect of beta-catenin inactivation using a doxycyclin (dox) inducible shRNA plasmid in H295R adrenocortical cancer cells line (clone named sh beta). Results: Following dox treatment a profound reduction in beta-catenin expression was detectable in sh beta clones in comparison to control clones (Ctr). Accordingly, we observed a decrease in Wnt/beta catenin-dependent luciferase reporter activity as well as a decreased expression of AXIN2 representing an endogenous beta-catenin target gene. Concomitantly, beta-catenin silencing resulted in a decreased cell proliferation, cell cycle alterations with cell accumulation in the G1 phase and increased apoptosis in vitro. In vivo, on established tumor xenografts in athymic nude mice, 9 days of beta-catenin silencing resulted in a significant reduction of CTNNB1 and AXIN2 expression. Moreover, continous beta-catenin silencing, starting 3 days after tumor cell inoculation, was associated with a complete absence of tumor growth in the sh beta group while tumors were present in all animals of the control group. Conclusion: In summary, these experiments provide evidences that Wnt/beta-catenin pathway inhibition in ACC is a promising therapeutic target.	[Gaujoux, Sebastien; Launay, Pierre; Bonnet, Stephane; Perlemoine, Karine; Lefevre, Lucile; Guillaud-Bataille, Marine; Tissier, Frederique; Bertherat, Jerome; Rizk-Rabin, Marthe; Ragazzon, Bruno] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Gaujoux, Sebastien; Launay, Pierre; Bonnet, Stephane; Perlemoine, Karine; Lefevre, Lucile; Guillaud-Bataille, Marine; Tissier, Frederique; Bertherat, Jerome; Rizk-Rabin, Marthe; Ragazzon, Bruno] INSERM, U1016, Paris, France; [Gaujoux, Sebastien; Bonnet, Stephane] Hop Cochin, AP HP, Dept Digest & Endocrine Surg, F-75674 Paris, France; [Hantel, Constanze; Beuschlein, Felix] Univ Munich, Med Klin & Poliklin 4, Endocrine Res Unit, Munich, Germany; [Tissier, Frederique; Bertherat, Jerome] Natl Canc Inst, Rare Adrenal Canc Network Corticomedullosurrenale, Paris, France; [Tissier, Frederique] Hop Cochin, AP HP, Dept Pathol, F-75674 Paris, France; [Bertherat, Jerome] Hop Cochin, AP HP, Dept Endocrinol, Ctr Rare Adrenal Dis, F-75674 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Munich; Institut National du Cancer (INCA) France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Ragazzon, B (corresponding author), Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France.	bruno.ragazzon@inserm.fr	Ragazzon, Bruno/E-6541-2017; Hantel, Constanze/AAJ-3192-2021; Launay, Pierre/AAH-7076-2019; Gaujoux, Sébastien/A-1981-2010; Rizk-Rabin, Marthe/A-1698-2018	Ragazzon, Bruno/0000-0001-9476-4973; Gaujoux, Sébastien/0000-0002-1072-7639; BERTHERAT, Jerome/0000-0003-2551-3008; Beuschlein, Felix/0000-0001-7826-3984; Rizk-Rabin, Marthe/0000-0003-1558-737X	Contrat d'Initiation a la Recherche Clinique [CIRC 05045]; Plan Hospitalier de Recherche Clinique [AOM06179]; Recherche Translationnelle DHOS/INCA [RTD09024]; ESF [07-RNP-067]; Association pour la Recherche sur le Cancer [SFI20111203542]; Weigand Trust Germany; Sander Stiftung [2011.003.1]; Ligue contre le cancer [RS12/75-105];  [259735]	Contrat d'Initiation a la Recherche Clinique; Plan Hospitalier de Recherche Clinique; Recherche Translationnelle DHOS/INCA(Institut National du Cancer (INCA) France); ESF(European Commission); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Weigand Trust Germany; Sander Stiftung; Ligue contre le cancer(Ligue nationale contre le cancer); 	This work was supported in part by the Contrat d'Initiation a la Recherche Clinique (grant CIRC 05045 - AP-HP), the Plan Hospitalier de Recherche Clinique (AOM06179) to the COMETE Network, the Recherche Translationnelle DHOS/INCA 2009 (RTD09024), ESF (07-RNP-067), Association pour la Recherche sur le Cancer (SFI20111203542), the Weigand Trust Germany, the Sander Stiftung (2011.003.1) and the Ligue contre le cancer (RS12/75-105). Furthermore, research leading to these results has received funding from the Seventh Framework Programme (FP7/2007-2013) under grant agreement number 259735 (ENS@T-CANCER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiven G, 2006, J CLIN ENDOCR METAB, V91, P2650, DOI 10.1210/jc.2005-2730; Behrens J, 2004, INT J DEV BIOL, V48, P477, DOI 10.1387/ijdb.041815jb; Berthon A, 2010, HUM MOL GENET, V19, P1561, DOI 10.1093/hmg/ddq029; Bilimoria KY, 2008, CANCER, V113, P3130, DOI 10.1002/cncr.23886; Bonnet S, 2011, J CLIN ENDOCR METAB, V96, pE419, DOI 10.1210/jc.2010-1885; Doghman M, 2008, J CLIN ENDOCR METAB, V93, P3222, DOI 10.1210/jc.2008-0247; Doghman M, 2007, MOL ENDOCRINOL, V21, P2968, DOI 10.1210/me.2007-0120; Fassnacht M, 2009, CANCER-AM CANCER SOC, V115, P243, DOI 10.1002/cncr.24030; Gaujoux S, 2011, CLIN CANC RES; Gaujoux S, 2008, J CLIN ENDOCR METAB, V93, P4135, DOI 10.1210/jc.2008-0631; Groussin L, 2000, J CLIN ENDOCR METAB, V85, P345, DOI 10.1210/jc.85.1.345; Hantel C, 2010, J CLIN ENDOCR METAB, V95, P943, DOI 10.1210/jc.2009-1980; Kim A, 2009, ANN ENDOCRINOL-PARIS, V70, P156, DOI 10.1016/j.ando.2009.02.006; Libe R, 2007, ENDOCR-RELAT CANCER, V14, P13, DOI 10.1677/erc.1.01130; Ragazzon B, 2010, CANCER RES, V70, P8276, DOI 10.1158/0008-5472.CAN-10-2014; Ragazzon B, 2009, CANCER RES, V69, P7278, DOI 10.1158/0008-5472.CAN-09-1601; Rizk-Rabin M, 2008, CANCER EPIDEM BIOMAR, V17, P2275, DOI 10.1158/1055-9965.EPI-07-2924; Tadjine M, 2008, CLIN ENDOCRINOL, V68, P264, DOI 10.1111/j.1365-2265.2007.03033.x; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865	20	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55743	10.1371/journal.pone.0055743	http://dx.doi.org/10.1371/journal.pone.0055743			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409032	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200057
J	Ryu, I; Park, JH; An, S; Kwon, OS; Jang, SK				Ryu, Incheol; Park, Ji Hoon; An, Sihyeon; Kwon, Oh Sung; Jang, Sung Key			eIF4GI Facilitates the MicroRNA-Mediated Gene Silencing	PLOS ONE			English	Article							RNA-BINDING PROTEIN; TRANSLATIONAL REPRESSION; LET-7 MICRORNA; INITIATION; CAP; DEADENYLATION; INHIBITION; ARGONAUTE; PABP; MECHANISMS	MicroRNAs (miRNAs) are small noncoding RNAs that mediate post-transcriptional gene silencing by binding to complementary target mRNAs and recruiting the miRNA-containing ribonucleoprotein complexes to the mRNAs. However, the molecular basis of this silencing is unclear. Here, we show that human Ago2 associates with the cap-binding protein complex and this association is mediated by human eIF4GI, a scaffold protein required for the translation initiation. Using a cap photo-crosslinking method, we show that Ago2 closely associates with the cap structure. Taken together, these data suggest that eIF4GI participates in the miRNA-mediated post-transcriptional gene silencing by promoting the association of Ago2 with the cap-binding complex.	[Ryu, Incheol; Park, Ji Hoon; An, Sihyeon; Kwon, Oh Sung; Jang, Sung Key] Pohang Univ Sci & Technol, Dept Life Sci, POSTECH Biotech Ctr, Mol Virol Lab, Pohang, South Korea; [Jang, Sung Key] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Jang, Sung Key] Pohang Univ Sci & Technol, Biotechnol Res Ctr, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Jang, SK (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, POSTECH Biotech Ctr, Mol Virol Lab, Pohang, South Korea.	sungkey@postech.ac.kr	Jang, Sung K/P-1230-2017		NRF BRL [2010-0019706]	NRF BRL	This research is supported by NRF BRL [2010-0019706]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho SC, 2007, MOL CELL BIOL, V27, P368, DOI 10.1128/MCB.00814-06; Choe J, 2011, FEBS LETT, V585, P2682, DOI 10.1016/j.febslet.2011.07.047; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Djuranovic S, 2010, NAT STRUCT MOL BIOL, V17, P144, DOI 10.1038/nsmb.1736; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Frank F, 2011, EMBO REP, V12, P415, DOI 10.1038/embor.2011.48; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Fukaya T, 2011, EMBO J, V30, P4998, DOI 10.1038/emboj.2011.426; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; Kinch LN, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-2; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lee Y, 2007, METHOD ENZYMOL, V427, P89, DOI 10.1016/S0076-6879(07)27005-3; Lindqvist L, 2008, RNA, V14, P960, DOI 10.1261/rna.971208; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mishima Y, 2012, P NATL ACAD SCI USA, V109, P1104, DOI 10.1073/pnas.1113350109; Moretti F, 2012, NAT STRUCT MOL BIOL, V19, P603, DOI 10.1038/nsmb.2309; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Paek KY, 2008, J VIROL, V82, P12082, DOI 10.1128/JVI.01405-08; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; SONENBERG N, 1978, P NATL ACAD SCI USA, V75, P4843, DOI 10.1073/pnas.75.10.4843; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Unhavaithaya Y, 2009, J BIOL CHEM, V284, P6507, DOI 10.1074/jbc.M809104200; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yanagiya A, 2009, MOL CELL BIOL, V29, P1661, DOI 10.1128/MCB.01187-08; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079	43	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55725	10.1371/journal.pone.0055725	http://dx.doi.org/10.1371/journal.pone.0055725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409027	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200052
J	Abler, B; Kumpfmuller, D; Gron, G; Walter, M; Stingl, J; Seeringer, A				Abler, Birgit; Kumpfmueller, Daniela; Groen, Georg; Walter, Martin; Stingl, Julia; Seeringer, Angela			Neural Correlates of Erotic Stimulation under Different Levels of Female Sexual Hormones	PLOS ONE			English	Article							BRAIN-ACTIVATION; ORAL-CONTRACEPTIVES; PREFRONTAL CORTEX; MENSTRUAL-CYCLE; HUMAN MALES; WOMEN; FMRI; AROUSAL; DYSFUNCTION; FREQUENCY	Previous studies have demonstrated variable influences of sexual hormonal states on female brain activation and the necessity to control for these in neuroimaging studies. However, systematic investigations of these influences, particularly those of hormonal contraceptives as compared to the physiological menstrual cycle are scarce. In the present study, we investigated the hormonal modulation of neural correlates of erotic processing in a group of females under hormonal contraceptives (C group; N = 12), and a different group of females (nC group; N = 12) not taking contraceptives during their mid-follicular and mid-luteal phases of the cycle. We used functional magnetic resonance imaging to measure hemodynamic responses as an estimate of brain activation during three different experimental conditions of visual erotic stimulation: dynamic videos, static erotic pictures, and expectation of erotic pictures. Plasma estrogen and progesterone levels were assessed in all subjects. No strong hormonally modulating effect was detected upon more direct and explicit stimulation (viewing of videos or pictures) with significant activations in cortical and subcortical brain regions previously linked to erotic stimulation consistent across hormonal levels and stimulation type. Upon less direct and less explicit stimulation (expectation), activation patterns varied between the different hormonal conditions with various, predominantly frontal brain regions showing significant within- or between-group differences. Activation in the precentral gyrus during the follicular phase in the nC group was found elevated compared to the C group and positively correlated with estrogen levels. From the results we conclude that effects of hormonal influences on brain activation during erotic stimulation are weak if stimulation is direct and explicit but that female sexual hormones may modulate more subtle aspects of sexual arousal and behaviour as involved in sexual expectation. Results may provide a basis for future imaging studies on sexual processing in females, especially in the context of less explicit erotic stimulation.	[Abler, Birgit; Kumpfmueller, Daniela; Groen, Georg] Univ Ulm, Dept Psychiat & Psychotherapy, D-89069 Ulm, Germany; [Walter, Martin] Otto Von Guericke Univ, Dept Psychiat, Magdeburg, Germany; [Stingl, Julia; Seeringer, Angela] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, D-89069 Ulm, Germany	Ulm University; Otto von Guericke University; Ulm University	Abler, B (corresponding author), Univ Ulm, Dept Psychiat & Psychotherapy, D-89069 Ulm, Germany.	birgit.abler@uni-ulm.de	Stingl, Julia C./ABA-7201-2020; Stingl, Julia/H-2410-2013	Stingl, Julia C./0000-0002-1566-8156; Stingl, Julia/0000-0002-1566-8156; Walter, Martin/0000-0001-7857-4483; Gron, Georg/0000-0002-0282-3575				Abler B, 2011, NEUROPSYCHOPHARMACOL, V36, P1837, DOI 10.1038/npp.2011.66; Archer JS, 2006, MENOPAUSE, V13, P528, DOI 10.1097/01.gme.0000188737.46746.cd; Arnow BA, 2002, BRAIN, V125, P1014, DOI 10.1093/brain/awf108; BANCROFT J, 1983, PSYCHOSOM MED, V45, P509, DOI 10.1097/00006842-198312000-00005; BANCROFT J, 1991, ARCH SEX BEHAV, V20, P121, DOI 10.1007/BF01541939; Bianchi-Demicheli F, 2009, MED SCI MONITOR, V15, pCR545; Davis AR, 2004, ANN REV SEX RES, V15, P297; DENNERSTEIN L, 1976, MED J AUSTRALIA, V1, P796, DOI 10.5694/j.1326-5377.1976.tb141059.x; Dreher JC, 2007, P NATL ACAD SCI USA, V104, P2465, DOI 10.1073/pnas.0605569104; Ferretti A, 2005, NEUROIMAGE, V26, P1086, DOI 10.1016/j.neuroimage.2005.03.025; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Georgiadis JR, 2012, PROG NEUROBIOL, V98, P49, DOI 10.1016/j.pneurobio.2012.05.004; Georgiadis JR, 2010, NEUROIMAGE, V50, P208, DOI 10.1016/j.neuroimage.2009.12.034; Gizewski ER, 2006, EXP BRAIN RES, V174, P101, DOI 10.1007/s00221-006-0429-3; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hamann S, 2004, NAT NEUROSCI, V7, P411, DOI 10.1038/nn1208; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Klucken T, 2009, J SEX MED, V6, P3071, DOI 10.1111/j.1743-6109.2009.01405.x; Kuhn S, 2011, J SEX MED, V8, P2269, DOI 10.1111/j.1743-6109.2011.02322.x; Labbate LA, 2001, PSYCHOTHER PSYCHOSOM, V70, P221, DOI 10.1159/000056257; Lang P.J., 2008, A8 U FLOR; MACLUSKY N J, 1987, Steroids, V50, P459, DOI 10.1016/0039-128X(87)90032-8; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Moulier V, 2006, NEUROIMAGE, V33, P689, DOI 10.1016/j.neuroimage.2006.06.037; Mouras H, 2003, NEUROIMAGE, V20, P855, DOI 10.1016/S1053-8119(03)00408-7; Naidich T. P., 2008, DUVERNOYS ATLAS HUMA; Pfaus JG, 2009, J SEX MED, V6, P1506, DOI 10.1111/j.1743-6109.2009.01309.x; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; Pillsworth EG, 2004, J SEX RES, V41, P55, DOI 10.1080/00224490409552213; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Redoute J, 2000, HUM BRAIN MAPP, V11, P162, DOI 10.1002/1097-0193(200011)11:3<162::AID-HBM30>3.0.CO;2-A; Reinecke A, 2006, VERHALTENSTHERAPIE, V16, P166, DOI 10.1159/000094747; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Rumberg B, 2010, NEUROSCI RES, V66, P366, DOI 10.1016/j.neures.2009.12.011; Rupp HA, 2007, HORM BEHAV, V51, P524, DOI 10.1016/j.yhbeh.2007.01.008; Rupp HA, 2009, ARCH SEX BEHAV, V38, P417, DOI 10.1007/s10508-008-9402-5; Rupp HA, 2009, EVOL HUM BEHAV, V30, P1, DOI 10.1016/j.evolhumbehav.2008.08.006; Schaffir J, 2006, J SEX MARITAL THER, V32, P305, DOI 10.1080/00926230600666311; Stuckey BGA, 2008, J SEX MED, V5, P2282, DOI 10.1111/j.1743-6109.2008.00992.x; Sugiura M, 2008, NEUROIMAGE, V42, P414, DOI 10.1016/j.neuroimage.2008.03.054; Talairach J., 1988, COPLANAR STEREOTAXIC; TRUSSELL J, 1980, FAM PLANN PERSPECT, V12, P246, DOI 10.2307/2134867; Wallen K, 2010, HORM BEHAV, V57, P263, DOI 10.1016/j.yhbeh.2009.12.005; Walter M, 2008, NEUROIMAGE, V40, P1482, DOI 10.1016/j.neuroimage.2008.01.040; Walter M, 2008, MAGN RESON MATER PHY, V21, P103, DOI 10.1007/s10334-007-0103-1; Walter M, 2009, HUM BRAIN MAPP, V30, P312, DOI 10.1002/hbm.20506; Wilcox AJ, 2004, HUM REPROD, V19, P1539, DOI 10.1093/humrep/deh305; Zhu X, 2010, BEHAV BRAIN RES, V206, P279, DOI 10.1016/j.bbr.2009.09.027	52	49	50	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e54447	10.1371/journal.pone.0054447	http://dx.doi.org/10.1371/journal.pone.0054447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418428	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300018
J	Gibbs, EM; Davidson, AE; Trickey-Glassman, A; Backus, C; Hong, Y; Sakowski, SA; Dowling, JJ; Feldman, EL				Gibbs, Elizabeth M.; Davidson, Ann E.; Trickey-Glassman, Arden; Backus, Carey; Hong, Yu; Sakowski, Stacey A.; Dowling, James J.; Feldman, Eva L.			Two Dynamin-2 Genes Are Required for Normal Zebrafish Development	PLOS ONE			English	Article							CENTRONUCLEAR MYOPATHY; CRYSTAL-STRUCTURE; SKELETAL-MUSCLE; GTP-BINDING; EXPRESSION; MUTATIONS; ENDOCYTOSIS	Dynamin-2 (DNM2) is a large GTPase involved in clathrin-mediated endocytosis and related trafficking pathways. Mutations in human DNM2 cause two distinct neuromuscular disorders: centronuclear myopathy and Charcot-Marie-Tooth disease. Zebrafish have been shown to be an excellent animal model for many neurologic disorders, and this system has the potential to inform our understanding of DNM2-related disease. Currently, little is known about the endogenous zebrafish orthologs to human DNM2. In this study, we characterize two zebrafish dynamin-2 genes, dnm2 and dnm2-like. Both orthologs are structurally similar to human DNM2 at the gene and protein levels. They are expressed throughout early development and in all adult tissues examined. Knockdown of dnm2 and dnm2-like gene products resulted in extensive morphological abnormalities during development, and expression of human DNM2 RNA rescued these phenotypes. Our findings suggest that dnm2 and dnm2-like are orthologs to human DNM2, and that they are required for normal zebrafish development.	[Gibbs, Elizabeth M.; Trickey-Glassman, Arden; Backus, Carey; Hong, Yu; Dowling, James J.; Feldman, Eva L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Gibbs, Elizabeth M.; Dowling, James J.] Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA; [Davidson, Ann E.; Dowling, James J.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Sakowski, Stacey A.] Univ Michigan, A Alfred Taubman Med Res Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Feldman, EL (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	efeldman@umich.edu		Feldman, Eva/0000-0002-9162-2694; Vanderwall, Arden/0000-0001-9687-6565	A. Alfred Taubman Medical Research Institute; Program for Neurology Research and Discovery; Walbridge Aldinger Graduate Fellowship fund	A. Alfred Taubman Medical Research Institute; Program for Neurology Research and Discovery; Walbridge Aldinger Graduate Fellowship fund	This work is supported by the A. Alfred Taubman Medical Research Institute and the Program for Neurology Research and Discovery. Support for EMG is provided by the Walbridge Aldinger Graduate Fellowship fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2010, MOL CELLS, V30, P377, DOI 10.1007/s10059-010-0128-6; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Bitoun M, 2009, HUM MUTAT, V30, P1419, DOI 10.1002/humu.21086; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; Cowling BS, 2012, PLOS GENET, V8, P31, DOI 10.1371/journal.pgen.1002595; Cowling BS, 2011, AM J PATHOL, V178, P2224, DOI 10.1016/j.ajpath.2011.01.054; Daniels GD, 1999, DEV COMP IMMUNOL, V23, P139, DOI 10.1016/S0145-305X(98)00051-2; DIATLOFFZITO C, 1995, GENE, V163, P301, DOI 10.1016/0378-1119(95)00275-B; Dowling JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000372; Durieux AC, 2012, TRAFFIC, V13, P869, DOI 10.1111/j.1600-0854.2012.01348.x; Durieux AC, 2010, HUM MOL GENET, V19, P4820, DOI 10.1093/hmg/ddq413; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Feng B, 2002, EXP CELL RES, V279, P14, DOI 10.1006/excr.2002.5579; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kida YS, 2007, P NATL ACAD SCI USA, V104, P6708, DOI 10.1073/pnas.0608946104; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Long QM, 1997, DEVELOPMENT, V124, P4105; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; Pugacheva EM, 2006, GENE, V375, P26, DOI 10.1016/j.gene.2006.01.036; Saint-Amant L, 2008, DEV NEUROBIOL, V68, P45, DOI 10.1002/dneu.20569; Solomaha E, 2005, BIOCHEM J, V391, P601, DOI 10.1042/BJ20050707; SONTAG JM, 1994, J BIOL CHEM, V269, P4547; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	35	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55888	10.1371/journal.pone.0055888	http://dx.doi.org/10.1371/journal.pone.0055888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418470	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300061
J	Sarnacki, SH; Castaneda, MDA; Llana, MN; Giacomodonato, MN; Valvano, MA; Cerquetti, MC				Hernan Sarnacki, Sebastian; Aya Castaneda, Maria del Rosario; Noto Llana, Mariangeles; Nancy Giacomodonato, Monica; Valvano, Miguel Angel; Cristina Cerquetti, Maria			Dam Methylation Participates in the Regulation of PmrA/PmrB and RcsC/RcsD/RcsB Two Component Regulatory Systems in Salmonella enterica Serovar Enteritidis	PLOS ONE			English	Article							DNA ADENINE METHYLATION; LIPOPOLYSACCHARIDE O-ANTIGEN; POLYACRYLAMIDE-GEL-ELECTROPHORESIS; POLYMYXIN-RESISTANT MUTANTS; ESCHERICHIA-COLI; LIPID-A; GENE-EXPRESSION; OUTER-MEMBRANE; ENVIRONMENTAL STIMULI; SIGNAL-TRANSDUCTION	The absence of Dam in Salmonella enterica serovar Enteritidis causes a defect in lipopolysaccharide (LPS) pattern associated to a reduced expression of wzz gene. Wzz is the chain length regulator of the LPS O-antigen. Here we investigated whether Dam regulates wzz gene expression through its two known regulators, PmrA and RcsB. Thus, the expression of rcsB and pmrA was monitored by quantitative real-time RT-PCR and Western blotting using fusions with 3xFLAG tag in wild type (wt) and dam strains of S. Enteritidis. Dam regulated the expression of both rcsB and pmrA genes; nevertheless, the defect in LPS pattern was only related to a diminished expression of RcsB. Interestingly, regulation of wzz in serovar Enteritidis differed from that reported earlier for serovar Typhimurium; RcsB induces wzz expression in both serovars, whereas PmrA induces wzz in S. Typhimurium but represses it in serovar Enteritidis. Moreover, we found that in S. Enteritidis there is an interaction between both wzz regulators: RcsB stimulates the expression of pmrA and PmrA represses the expression of rcsB. Our results would be an example of differential regulation of orthologous genes expression, providing differences in phenotypic traits between closely related bacterial serovars.	[Hernan Sarnacki, Sebastian; Aya Castaneda, Maria del Rosario; Noto Llana, Mariangeles; Nancy Giacomodonato, Monica; Cristina Cerquetti, Maria] Univ Buenos Aires, CONICET, Inst Invest Microbiol & Parasitol Med, IMPaM, Buenos Aires, DF, Argentina; [Valvano, Miguel Angel] Univ Western Ontario, Dept Microbiol & Immunol, Ctr Human Immunol, London, ON, Canada	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Western University (University of Western Ontario)	Sarnacki, SH (corresponding author), Univ Buenos Aires, CONICET, Inst Invest Microbiol & Parasitol Med, IMPaM, Buenos Aires, DF, Argentina.	sebasarnacki@yahoo.com.ar; ccerquetti@fmed.uba.ar	Valvano, Miguel A/G-8759-2012	Valvano, Miguel A/0000-0001-8229-3641	Universidad de Buenos Aires, Buenos Aires, Argentina [UBACyT 20020100100541, UBACyT 20020100300040]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP 0992]	Universidad de Buenos Aires, Buenos Aires, Argentina(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part from grants from Universidad de Buenos Aires, Buenos Aires, Argentina (UBACyT 20020100100541) (http://www.uba.ar/secyt/index.php) and Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (PIP 0992) (http://www.conicet.gov.ar) (to M.C.C.) and Universidad de Buenos Aires, Buenos Aires, Argentina (UBACyT 20020100300040) (http://www.uba.ar/secyt/index.php) (to S.H.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEX LA, 1994, TRENDS GENET, V10, P133, DOI 10.1016/0168-9525(94)90215-1; Balbontin R, 2006, J BACTERIOL, V188, P8160, DOI 10.1128/JB.00847-06; BATCHELOR RA, 1991, J BACTERIOL, V173, P5699, DOI 10.1128/jb.173.18.5699-5704.1991; Bijisma JJE, 2003, TRENDS MICROBIOL, V11, P359, DOI 10.1016/S0966-842X(03)00176-8; Breazeale SD, 2003, J BIOL CHEM, V278, P24731, DOI 10.1074/jbc.M304043200; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Campellone KG, 2007, MOL MICROBIOL, V63, P1468, DOI 10.1111/j.1365-2958.2007.05602.x; Chessa D, 2008, MOL MICROBIOL, V68, P573, DOI 10.1111/j.1365-2958.2008.06185.x; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delgado MA, 2006, MOL MICROBIOL, V60, P39, DOI 10.1111/j.1365-2958.2006.05069.x; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Dueger EL, 2003, VACCINE, V21, P3249, DOI 10.1016/S0264-410X(03)00252-4; Dueger EL, 2003, INT J FOOD MICROBIOL, V80, P153, DOI 10.1016/S0168-1605(02)00152-6; Eguchi Y, 2005, TRENDS BIOCHEM SCI, V30, P70, DOI 10.1016/j.tibs.2004.12.003; Falker S, 2007, INFECT IMMUN, V75, P4990, DOI 10.1128/IAI.00457-07; Goulian M, 2010, CURR OPIN MICROBIOL, V13, P184, DOI 10.1016/j.mib.2010.01.009; GROSSMAN N, 1987, J BACTERIOL, V169, P856, DOI 10.1128/jb.169.2.856-863.1987; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hoare A, 2006, INFECT IMMUN, V74, P1555, DOI 10.1128/IAI.74.3.1555-1564.2006; Jakomin M, 2008, J BACTERIOL, V190, P7406, DOI 10.1128/JB.01136-08; Kato A, 2004, GENE DEV, V18, P2302, DOI 10.1101/gad.1230804; Kato A, 2008, ADV EXP MED BIOL, V631, P7; Kawasaki K, 2007, J BACTERIOL, V189, P4911, DOI 10.1128/JB.00451-07; KOFOID EC, 1988, P NATL ACAD SCI USA, V85, P4981, DOI 10.1073/pnas.85.14.4981; Kox LFF, 2000, EMBO J, V19, P1861, DOI 10.1093/emboj/19.8.1861; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; LESSE AJ, 1990, J IMMUNOL METHODS, V126, P109, DOI 10.1016/0022-1759(90)90018-Q; Lin HH, 2012, CURR MICROBIOL, V64, P412, DOI 10.1007/s00284-012-0087-6; Liu D, 1996, J BACTERIOL, V178, P2102, DOI 10.1128/jb.178.7.2102-2107.1996; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; MARINO PA, 1991, J BACTERIOL, V173, P3128, DOI 10.1128/JB.173.10.3128-3133.1991; Marinus M.G., 1996, E COLI SALMONELLA CE, P782; MAROLDA CL, 1990, J BACTERIOL, V172, P3590, DOI 10.1128/jb.172.7.3590-3599.1990; McGowan CC, 1998, MOL MICROBIOL, V30, P19, DOI 10.1046/j.1365-2958.1998.t01-1-01079.x; MCGRATH BC, 1991, J BACTERIOL, V173, P649, DOI 10.1128/jb.173.2.649-654.1991; Mittal N, 2009, P NATL ACAD SCI USA, V106, P20300, DOI 10.1073/pnas.0906940106; Msadek Tarek, 1993, P729; MULFORD CA, 1983, P NATL ACAD SCI-BIOL, V80, P1159, DOI 10.1073/pnas.80.5.1159; Murata T, 2007, J BACTERIOL, V189, P7213, DOI 10.1128/JB.00973-07; Murray GL, 2006, J BACTERIOL, V188, P2735, DOI 10.1128/JB.188.7.2735-2739.2006; Murray GL, 2005, MICROBES INFECT, V7, P1296, DOI 10.1016/j.micinf.2005.04.015; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Nishino K, 2006, MOL MICROBIOL, V61, P645, DOI 10.1111/j.1365-2958.2006.05273.x; NIXON BT, 1986, P NATL ACAD SCI USA, V83, P7850, DOI 10.1073/pnas.83.20.7850; OSBORN MJ, 1963, P NATL ACAD SCI USA, V50, P499, DOI 10.1073/pnas.50.3.499; Parkinson J.S., 1995, 2 COMPONENT SIGNAL T, P9; Phalipon A, 2006, J IMMUNOL, V176, P1686, DOI 10.4049/jimmunol.176.3.1686; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rick PD, 2003, J BIOL CHEM, V278, P16534, DOI 10.1074/jbc.M301750200; RONSON CW, 1987, CELL, V49, P579, DOI 10.1016/0092-8674(87)90530-7; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sarnacki SH, 2009, J BACTERIOL, V191, P6694, DOI 10.1128/JB.00839-09; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SNAVELY MD, 1991, J BIOL CHEM, V266, P824; SWANSON RV, 1994, TRENDS BIOCHEM SCI, V19, P485, DOI 10.1016/0968-0004(94)90135-X; Torreblanca J, 1999, GENETICS, V152, P31; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; Wales AD, 2011, AVIAN PATHOL, V40, P429, DOI 10.1080/03079457.2011.606799; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Zhou ZM, 2001, J BIOL CHEM, V276, P43111, DOI 10.1074/jbc.M106960200	69	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56474	10.1371/journal.pone.0056474	http://dx.doi.org/10.1371/journal.pone.0056474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418573	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300166
J	Jain, D; Chattopadhyay, D				Jain, Deepti; Chattopadhyay, Debasis			Promoter of CaZF, a Chickpea Gene That Positively Regulates Growth and Stress Tolerance, Is Activated by an AP2-Family Transcription Factor CAP2	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; SALT TOLERANCE; DROUGHT TOLERANCE; DEHYDRATION; COLD; DNA; OVEREXPRESSION; TEMPERATURE; EXPRESSION; REPRESSORS	Plants respond to different forms of stresses by inducing transcription of a common and distinct set of genes by concerted actions of a cascade of transcription regulators. We previously reported that a gene, CaZF encoding a C2H2-zinc finger family protein from chickpea (Cicer arietinum) imparted high salinity tolerance when expressed in tobacco plants. We report here that in addition to promoting tolerance against dehydration, salinity and high temperature, the CaZF overexpressing plants exhibited similar phenotype of growth and development like the plants overexpressing CAP2, encoding an AP2-family transcription factor from chickpea. To investigate any relationship between these two genes, we performed gene expression analysis in the overexpressing plants, promoter-reporter analysis and chromatin immunoprecipitation. A number of transcripts that exhibited enhanced accumulation upon expression of CAP2 or CaZF in tobacco plants were found common. Transient expression of CAP2 in chickpea leaves resulted in increased accumulation of CaZF transcript. Gel mobility shift and transient promoter-reporter assays suggested that CAP2 activates CaZF promoter by interacting with Crepeat elements (CRTs) in CaZF promoter. Chromatin immunoprecipitation (ChIP) assay demonstrated an in vivo interaction of CAP2 protein with CaZF promoter.	[Jain, Deepti; Chattopadhyay, Debasis] Natl Inst Plant Genome Res, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Chattopadhyay, D (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi, India.	debasis@nipgr.ac.in		Chattopadhyay, Debasis/0000-0002-5754-4987	National Institute of Plant Genome Research, New Delhi, India; Council for Scientific and Industrial Research, India	National Institute of Plant Genome Research, New Delhi, India; Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	The project has been funded by National Institute of Plant Genome Research, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge Dr. S. Chakraborty and V. Sharma, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India for experimental help. DJ acknowledges Council for Scientific and Industrial Research, India for fellowship.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Armengaud P, 2004, PHYSIOL PLANTARUM, V120, P442, DOI 10.1111/j.0031-9317.2004.00251.x; Boominathan P, 2004, PLANT PHYSIOL, V135, P1608, DOI 10.1104/pp.104.043141; Dathan N, 2002, NUCLEIC ACIDS RES, V30, P4945, DOI 10.1093/nar/gkf613; Frugier F, 2000, GENE DEV, V14, P475; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Huai JL, 2009, PLANT CELL TISS ORG, V99, P117, DOI 10.1007/s11240-009-9582-2; Huang J, 2005, MOL BIOL REP, V32, P177, DOI 10.1007/s11033-005-2338-0; Huang J, 2007, BBA-GENE STRUCT EXPR, V1769, P220, DOI 10.1016/j.bbaexp.2007.02.006; Jain D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-24; Jain D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005154; JEFFERSON RA, 1987, EMBO J, V6, P3901; Johnson TA, 2001, BIOTECHNIQUES, V31, P740, DOI 10.2144/01314bm05; Kim JC, 2001, PLANT J, V25, P247, DOI 10.1046/j.1365-313x.2001.00947.x; Kodaira KS, 2011, PLANT PHYSIOL, V157, P742, DOI 10.1104/pp.111.182683; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lippuner V, 1996, J BIOL CHEM, V271, P12859, DOI 10.1074/jbc.271.22.12859; Liu QL, 2010, MOL BIOL REP, V37, P1137, DOI 10.1007/s11033-009-9886-7; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Mittler R, 2006, FEBS LETT, V580, P6537, DOI 10.1016/j.febslet.2006.11.002; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Pascuzzi P, 1998, J BIOL CHEM, V273, P26631, DOI 10.1074/jbc.273.41.26631; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Sakamoto A, 1996, PLANT CELL PHYSIOL, V37, P557, DOI 10.1093/oxfordjournals.pcp.a028980; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shukla RK, 2006, PLANT PHYSIOL, V142, P113, DOI 10.1104/pp.106.081752; Shukla RK, 2009, FEBS J, V276, P5252, DOI 10.1111/j.1742-4658.2009.07219.x; Sugano S, 2003, PLANT J, V36, P830, DOI 10.1046/j.1365-313X.2003.01924.x; Sun SJ, 2010, J EXP BOT, V61, P2807, DOI 10.1093/jxb/erq120; Sussman DJ, 2002, BIOTECHNIQUES, V32, P1000, DOI 10.2144/02325bm04; Takatsuji H, 1998, CELL MOL LIFE SCI, V54, P582, DOI 10.1007/s000180050186; Takatsuji H, 1999, PLANT MOL BIOL, V39, P1073, DOI 10.1023/A:1006184519697; Tripathi V, 2009, PLANT J, V58, P778, DOI 10.1111/j.1365-313X.2009.03812.x; TROLL W, 1955, J BIOL CHEM, V215, P655; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Xiong LM, 2006, PLANT PHYSIOL, V142, P1065, DOI 10.1104/pp.106.084632; Xu DQ, 2008, FEBS LETT, V582, P1037, DOI 10.1016/j.febslet.2008.02.052; Xu SM, 2007, PLANT CELL REP, V26, P497, DOI 10.1007/s00299-006-0248-9; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56737	10.1371/journal.pone.0056737	http://dx.doi.org/10.1371/journal.pone.0056737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418595	gold, Green Submitted, Green Published			2022-12-27	WOS:000315970300188
J	Morrison, KM; Anand, SS; Yusuf, S; Atkinson, SA; Schulze, KM; Rao-Melacini, P; McQueen, MJ; McDonald, S; Persadie, R; Hunter, B; Bourgeois, J; Jansen, JW; Teo, KK				Morrison, Katherine M.; Anand, Sonia S.; Yusuf, Salim; Atkinson, Stephanie A.; Schulze, Karleen M.; Rao-Melacini, Purnima; McQueen, Matthew J.; McDonald, Sarah; Persadie, Richard; Hunter, Barry; Bourgeois, Jacqueline; Jansen, Jan W.; Teo, Koon K.		FAMILY Family Atherosclerosis Moni	Maternal and Pregnancy Related Predictors of Cardiometabolic Traits in Newborns	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; INSULIN-RESISTANCE SYNDROME; SYSTOLIC BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; LIPOPROTEIN METABOLISM; PHYSICAL-ACTIVITY; MILK CONSUMPTION; FETAL-GROWTH; 52 COUNTRIES; FAT	Background: The influence of multiple maternal and pregnancy characteristics on offspring cardiometabolic traits at birth is not well understood and was evaluated in this study. Methods and Findings: The Family Atherosclerosis Monitoring In earLY life (FAMILY) Study prospectively evaluated 11 cardiometabolic traits in 901 babies born to 857 mothers. The influence of maternal age, health (pre-pregnancy weight, blood pressure, glycemic status, lipids), health behaviors (diet, activity, smoking) and pregnancy characteristics (gestational age at birth, gestational weight gain and placental-fetal ratio) were examined. Greater gestational age influenced multiple newborn cardiometabolic traits including cord blood lipids, glucose and insulin, body fat and blood pressure. In a subset of 442 singleton mother/infant pairs, principal component analysis grouped 11 newborn cardiometabolic traits into 5 components (anthropometry/insulin, 2 lipid components, blood pressure and glycemia), accounting for 74% of the variance of the 11 outcome variables. Determinants of these components, corrected for sex and gestational age, were examined. Baby anthropometry/insulin was independently predicted by higher maternal pre-pregnancy weight (standardized estimate 0.30) and gestational weight gain (0.30; both p<0.0001) and was inversely related to smoking during pregnancy (-0.144; p = 0.01) and maternal polyunsaturated to saturated fat intake (-0.135; p = 0.01). Component 2 (HDL-C/Apo Apolipoprotein1) was inversely associated with maternal age. Component 3 (blood pressure) was not clustered with any other newborn cardiometabolic trait and no associations with maternal pregnancy characteristics were identified. Component 4 (triglycerides) was positively associated with maternal hypertension and triglycerides, and inversely associated with maternal HDL and age. Component 5 (glycemia) was inversely associated with placental/fetal ratio (-0.141; p = 0.005). LDL-C was a bridging variable between the lipid factors and glycemia. Conclusions: Maternal health, health behaviours and placenta to fetal weight ratio are associated with newborn cardiometabolic traits over and above gestational age. Future investigations are needed to determine if these factors remain important determinants of cardiometabolic health throughout childhood.	[Morrison, Katherine M.; Atkinson, Stephanie A.] Hamilton Hlth Sci, Dept Pediat, Hamilton, ON, Canada; [Morrison, Katherine M.; Anand, Sonia S.; Yusuf, Salim; Atkinson, Stephanie A.; Schulze, Karleen M.; Rao-Melacini, Purnima; McQueen, Matthew J.; Teo, Koon K.] McMaster Univ, Hamilton, ON, Canada; [Morrison, Katherine M.; Anand, Sonia S.; Yusuf, Salim; Schulze, Karleen M.; Rao-Melacini, Purnima; McQueen, Matthew J.; Teo, Koon K.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Anand, Sonia S.; Yusuf, Salim; Teo, Koon K.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Anand, Sonia S.; McDonald, Sarah] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8S 4L8, Canada; [McDonald, Sarah; Persadie, Richard] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada; [McQueen, Matthew J.; Hunter, Barry] Joseph Brant Hosp, Burlington, ON, Canada; [Bourgeois, Jacqueline; Jansen, Jan W.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; McMaster University	Morrison, KM (corresponding author), Hamilton Hlth Sci, Dept Pediat, Hamilton, ON, Canada.	kmorrison@mcmaster.ca	Morrison, Katherine/AAO-8046-2021; Atkinson, Stephanie/AAS-4146-2021; McDonald, Sarah D/G-2653-2013	Morrison, Katherine/0000-0002-1737-256X; Atkinson, Stephanie/0000-0002-5680-7546; Rao, Purnima/0000-0002-7537-9057; Teo, Koon/0000-0002-3731-0956; Yusuf, Salim/0000-0003-4776-5601	Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; Population Health Research Institute; Canadian Institutes of Health Research New Investigator Salary Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Population Health Research Institute; Canadian Institutes of Health Research New Investigator Salary Award(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario and the Population Health Research Institute. S.S.A. holds a Canada Research Chair in Ethnicity and Cardiovascular Disease, and the Michael DeGroote Heart and Stroke Foundation Chair in Population Health. S.D.M. is supported by a Canadian Institutes of Health Research New Investigator Salary Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand SS, 1998, CAN J CARDIOL, V14, P1349; Bakker H, 2011, EUR J EPIDEMIOL, V26, P763, DOI 10.1007/s10654-011-9621-2; Bansal N, 2005, CURR OPIN LIPIDOL, V16, P400, DOI 10.1097/01.mol.0000174154.61307.16; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bonamy AKE, 2011, CIRCULATION, V124, P2839, DOI 10.1161/CIRCULATIONAHA.111.034884; Brizzi P, 1999, AM J OBSTET GYNECOL, V181, P430, DOI 10.1016/S0002-9378(99)70574-0; Canadian Diabetes Association Expert Panel Committee, 2008, CAN J DIABETES, V32, pS168; Chen W, 1999, AM J EPIDEMIOL, V150, P667; DESWIET M, 1975, CLIN SCI MOL MED, V49, P557, DOI 10.1042/cs0490557; DURNIN JVG, 1967, BRIT J NUTR, V21, P681, DOI 10.1079/BJN19670070; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gillman MW, 2004, J PEDIATR-US, V144, P240, DOI 10.1016/j.jpeds.2003.10.064; Goodman E, 2005, CIRCULATION, V111, P1970, DOI 10.1161/01.CIR.0000161957.34198.2B; Harris WS, 2009, CIRCULATION, V119, P902, DOI 10.1161/CIRCULATIONAHA.108.191627; Hatcher L., 1994, STEP BY STEP APPROAC; Held C, 2012, EUR HEART J, V33, P452, DOI 10.1093/eurheartj/ehr432; Heppe DHM, 2011, AM J CLIN NUTR, V94, P501, DOI 10.3945/ajcn.111.013854; Huang RC, 2007, INT J OBESITY, V31, P236, DOI 10.1038/sj.ijo.0803394; Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716; Kelemen LE, 2003, J AM DIET ASSOC, V103, P1178, DOI 10.1016/S0002-8223(03)00985-4; Lambert M, 2004, INT J OBESITY, V28, P833, DOI 10.1038/sj.ijo.0802694; Langlois Kellie, 2009, Health Rep, V20, P11; Lawlor DA, 2004, CIRCULATION, V110, P2417, DOI 10.1161/01.CIR.0000145165.80130.B5; Leary SD, 2006, OBESITY, V14, P2284, DOI 10.1038/oby.2006.268; Luoto R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001036; Martyn CN, 1996, LANCET, V348, P1264, DOI 10.1016/S0140-6736(96)04257-2; Merchant AT, 2008, AM J CLIN NUTR, V87, P168, DOI 10.1093/ajcn/87.1.168; Morrison KM, 2009, AM HEART J, V158, P533, DOI 10.1016/j.ahj.2009.07.005; NEARY RH, 1995, CLIN SCI, V88, P311, DOI 10.1042/cs0880311; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Olsen SF, 2007, AM J CLIN NUTR, V86, P1104, DOI 10.1093/ajcn/86.4.1104; Rodie VA, 2004, ATHEROSCLEROSIS, V176, P181, DOI 10.1016/j.atherosclerosis.2004.04.026; Schmelzle HR, 2002, AM J CLIN NUTR, V76, P1096, DOI 10.1093/ajcn/76.5.1096; Thornburg KL, 2010, PLACENTA, V31, pS54, DOI 10.1016/j.placenta.2010.01.002; TSANG R, 1974, AM J DIS CHILD, V127, P78, DOI 10.1001/archpedi.1974.02110200080011; Uusitalo U, 2002, GLOBALIZATION DIETS, P1; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	34	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55815	10.1371/journal.pone.0055815	http://dx.doi.org/10.1371/journal.pone.0055815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418462	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300053
J	Sun, DB; Zhang, H; Guo, DH; Sun, AG; Wang, HB				Sun, Dongbo; Zhang, Hong; Guo, Donghua; Sun, Anguo; Wang, Hongbin			Shotgun Proteomic Analysis of Plasma from Dairy Cattle Suffering from Footrot: Characterization of Potential Disease-Associated Factors	PLOS ONE			English	Article							FUSOBACTERIUM-NECROPHORUM INFECTIONS; PEPTIDOGLYCAN RECOGNITION PROTEIN; ACUTE-PHASE RESPONSE; LARGE GENE LISTS; KERATAN SULFATE; HEPATIC-ABSCESS; OVARIAN-CANCER; SERUM; IDENTIFICATION; BIOMARKER	The plasma proteome of healthy dairy cattle and those with footrot was investigated using a shotgun LC-MS/MS approach. In total, 648 proteins were identified in healthy plasma samples, of which 234 were non-redundant proteins and 123 were high-confidence proteins; 712 proteins were identified from footrot plasma samples, of which 272 were non-redundant proteins and 138 were high-confidence proteins. The high-confidence proteins showed significant differences between healthy and footrot plasma samples in molecular weight, isoelectric points and the Gene Ontology categories. 22 proteins were found that may differentiate between the two sets of plasma proteins, of which 16 potential differential expression (PDE) proteins from footrot plasma involved in immunoglobulins, innate immune recognition molecules, acute phase proteins, regulatory proteins, and cell adhesion and cytoskeletal proteins; 6 PDE proteins from healthy plasma involved in regulatory proteins, cytoskeletal proteins and coagulation factors. Of these PDE proteins, haptoglobin, SERPINA10 protein, afamin precursor, haptoglobin precursor, apolipoprotein D, predicted peptidoglycan recognition protein L (PGRP-L) and keratan sulfate proteoglycan (KS-PG) were suggested to be potential footrot-associated factors. The PDE proteins PGRP-L and KS-PG were highlighted as potential biomarkers of footrot in cattle. The resulting protein lists and potential differentially expressed proteins may provide valuable information to increase understanding of plasma protein profiles in cattle and to assist studies of footrot-associated factors.	[Sun, Dongbo; Zhang, Hong; Guo, Donghua] Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing, Peoples R China; [Sun, Dongbo; Wang, Hongbin] Northeast Agr Univ, Postdoctoral Mobile Stn Vet Med, Harbin, Peoples R China; [Sun, Anguo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Res Ctr Proteome Anal, Shanghai, Peoples R China	Heilongjiang Bayi Agricultural University; Northeast Agricultural University - China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Sun, DB (corresponding author), Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing, Peoples R China.	dongbosun@yahoo.com.cn; hbwang@neau.edu.cn			Technological Innovation Team Building Program of University of Heilongjiang Province [2010td05]; National Natural Science Foundation of China [31101835]; China Postdoctoral Science Foundation [20110491022]; Postdoctoral Science Foundation of Heilongjiang Province [LBH-Z11230]; Doctor Start Foundation of Heilongjiang Bayi Agricultural University [B2009-4]	Technological Innovation Team Building Program of University of Heilongjiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Science Foundation of Heilongjiang Province(China Postdoctoral Science Foundation); Doctor Start Foundation of Heilongjiang Bayi Agricultural University	This work was supported by the Technological Innovation Team Building Program of University of Heilongjiang Province (Grant No. 2010td05), the National Natural Science Foundation of China (Grant No. 31101835), the China Postdoctoral Science Foundation (Grant No. 20110491022), the Postdoctoral Science Foundation of Heilongjiang Province (Grant No. LBH-Z11230), and the Doctor Start Foundation of Heilongjiang Bayi Agricultural University (B2009-4). The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahmed N, 2004, BRIT J CANCER, V91, P129, DOI 10.1038/sj.bjc.6601882; Alonso-Fauste I, 2012, J PROTEOMICS, V75, P3015, DOI 10.1016/j.jprot.2011.11.035; Angelucci S, 2006, BBA-PROTEINS PROTEOM, V1764, P1775, DOI 10.1016/j.bbapap.2006.09.001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ceciliani F, 2012, J PROTEOMICS, V75, P4207, DOI 10.1016/j.jprot.2012.04.004; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Dai J, 2005, ANAL CHEM, V77, P5793, DOI 10.1021/ac050251w; Fertin M, 2011, J PROTEOMICS, V74, P420, DOI 10.1016/j.jprot.2010.12.005; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Gilmore JM, 2010, J PROTEOMICS, V73, P2078, DOI 10.1016/j.jprot.2010.08.005; Goff JP, 1997, J DAIRY SCI, V80, P1260, DOI 10.3168/jds.S0022-0302(97)76055-7; Goo YA, 2010, J PROTEOMICS, V73, P1839, DOI 10.1016/j.jprot.2010.04.002; Guerrier L, 2008, J PROTEOMICS, V71, P368, DOI 10.1016/j.jprot.2008.06.003; Guo DH, 2010, ANAEROBE, V16, P317, DOI 10.1016/j.anaerobe.2010.03.007; Hall RE, 2004, PROSTATE, V58, P103, DOI 10.1002/pros.10343; He P, 2005, PROTEOMICS, V5, P3442, DOI 10.1002/pmic.200401301; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hutjens M, 1998, P THES HOOV AR MAD W; Issaq HJ, 2007, CHEM REV, V107, P3601, DOI 10.1021/cr068287r; Jackson D, 2007, CLIN CANCER RES, V13, P7370, DOI 10.1158/1078-0432.CCR-07-0747; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; KANOE M, 1990, J VET MED B, V37, P770, DOI 10.1111/j.1439-0450.1990.tb01127.x; Kuiper JI, 1998, SPINE, V23, P657, DOI 10.1097/00007632-199803150-00003; Kujala M, 2010, VET REC, V166, P240, DOI 10.1136/vr.b4770; Lai YH, 2012, J PROTEOMICS, V75, P2500, DOI 10.1016/j.jprot.2012.02.034; Li JY, 2009, J PROTEOME RES, V8, P2620, DOI 10.1021/pr8006123; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; MAKIMURA S, 1982, JPN J VET SCI, V44, P15, DOI 10.1292/jvms1939.44.15; Malard V, 2012, J PROTEOMICS, V75, P1043, DOI 10.1016/j.jprot.2011.10.025; Meng R, 2011, J PROTEOMICS, V75, P366, DOI 10.1016/j.jprot.2011.07.030; MORIMATSU M, 1991, J BIOL CHEM, V266, P11833; Nagaraja TG, 2005, ANAEROBE, V11, P239, DOI 10.1016/j.anaerobe.2005.01.007; Narayanan SK, 2003, VET MICROBIOL, V93, P335, DOI 10.1016/S0378-1135(03)00045-2; Nazifi S, 2012, WORLD J MICROB BIOT, V28, P1791, DOI 10.1007/s11274-011-0995-9; NIELSEN AH, 1987, SCAND J CLIN LAB INV, V47, P175; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Ohtsuka H, 2001, J VET MED SCI, V63, P675, DOI 10.1292/jvms.63.675; Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026; SHINJO T, 1983, ANN INST PASTEUR MIC, VB134, P401; Sun DB, 2009, VET RES COMMUN, V33, P749, DOI 10.1007/s11259-009-9223-6; Tan ZL, 1996, VET RES COMMUN, V20, P113, DOI 10.1007/BF00385634; THONAR EJMA, 1985, ARTHRITIS RHEUM, V28, P1367, DOI 10.1002/art.1780281209; van Gent D, 2003, INT J BIOCHEM CELL B, V35, P1536, DOI 10.1016/S1357-2725(03)00134-1; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994; Wang ZQ, 2012, J PROTEOMICS, V75, P2375, DOI 10.1016/j.jprot.2012.02.005; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhang MZ, 2009, J PROTEOMICS, V72, P952, DOI 10.1016/j.jprot.2009.03.009; Zhou HT, 2009, VET MICROBIOL, V135, P363, DOI 10.1016/j.vetmic.2008.09.084	50	20	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55973	10.1371/journal.pone.0055973	http://dx.doi.org/10.1371/journal.pone.0055973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418487	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300079
J	Tressoldi, PE; Giofre, D; Sella, F; Cumming, G				Tressoldi, Patrizio E.; Giofre, David; Sella, Francesco; Cumming, Geoff			High Impact = High Statistical Standards? Not Necessarily So	PLOS ONE			English	Article							CONFIDENCE-INTERVALS; PSYCHOLOGY; REFORM; NULL	What are the statistical practices of articles published in journals with a high impact factor? Are there differences compared with articles published in journals with a somewhat lower impact factor that have adopted editorial policies to reduce the impact of limitations of Null Hypothesis Significance Testing? To investigate these questions, the current study analyzed all articles related to psychological, neuropsychological and medical issues, published in 2011 in four journals with high impact factors: Science, Nature, The New England Journal of Medicine and The Lancet, and three journals with relatively lower impact factors: Neuropsychology, Journal of Experimental Psychology Applied and the American Journal of Public Health. Results show that Null Hypothesis Significance Testing without any use of confidence intervals, effect size, prospective power and model estimation, is the prevalent statistical practice used in articles published in Nature, 89%, followed by articles published in Science, 42%. By contrast, in all other journals, both with high and lower impact factors, most articles report confidence intervals and/or effect size measures. We interpreted these differences as consequences of the editorial policies adopted by the journal editors, which are probably the most effective means to improve the statistical practices in journals with high or low impact factors.	[Tressoldi, Patrizio E.; Giofre, David] Univ Padua, Dipartimento Psicol Gen, Padua, Italy; [Sella, Francesco] Univ Padua, DPSS, Padua, Italy; [Cumming, Geoff] La Trobe Univ, Sch Psychol Sci, Bundoora, Vic 3086, Australia	University of Padua; University of Padua; La Trobe University	Tressoldi, PE (corresponding author), Univ Padua, Dipartimento Psicol Gen, Padua, Italy.	patrizio.tressoldi@unipd.it	GIOFRE', DAVID/N-8808-2019; GIOFRE', DAVID/A-8788-2013; Tressoldi, Patrizio E./A-5566-2009	GIOFRE', DAVID/0000-0002-1992-6271; GIOFRE', DAVID/0000-0002-1992-6271; Tressoldi, Patrizio E./0000-0002-6404-0058				APA (American Psychological Association), 2010, PUBL MAN AM PSYCH AS; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103; Cumming G., 2013, UNDERSTANDING NEW ST; Cumming G, 2007, PSYCHOL SCI, V18, P230, DOI 10.1111/j.1467-9280.2007.01881.x; Cumming G, 2008, PERSPECT PSYCHOL SCI, V3, P286, DOI 10.1111/j.1745-6924.2008.00079.x; Fidler F, 2004, PSYCHOL SCI, V15, P119, DOI 10.1111/j.0963-7214.2004.01502008.x; Fritz A, 2012, THEOR PSYCHOL, P1; Gigerenzer G., 2004, SAGE HDB QUANTITATIV, P391, DOI DOI 10.4135/9781412986311.N21; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kline R., 2004, SIGNIFICANCE TESTING; Laara E, 2009, ANN ZOOL FENN, V46, P138; Lai J, 2012, METHODOLOGY-EUR, V8, P51, DOI 10.1027/1614-2241/a000037; MEEHL PE, 1967, PHILOS SCI, V34, P103, DOI 10.1086/288135; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ngatia M, 2010, J ENVIRON MONITOR, V12, P172, DOI [10.1039/b912098j, 10.1039/B912098J]; Nickerson RS, 2000, PSYCHOL METHODS, V5, P241, DOI 10.1037//1082-989X.5.2.241; Odgaard EC, 2010, J CONSULT CLIN PSYCH, V78, P287, DOI 10.1037/a0019294; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Strazak AM, 2007, AM STAT, V61, P147, DOI 10/1198/000313007X170242	20	48	49	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56180	10.1371/journal.pone.0056180	http://dx.doi.org/10.1371/journal.pone.0056180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418533	Green Published, Green Accepted, gold			2022-12-27	WOS:000315970300125
J	Wang, X; Qian, YL; Jin, R; Wo, Y; Chen, J; Wang, C; Wang, DR				Wang, Xue; Qian, Yunliang; Jin, Rong; Wo, Yan; Chen, Jun; Wang, Chen; Wang, Danru			Effects of TRAP-1-Like Protein (TLP) Gene on Collagen Synthesis Induced by TGF-beta/Smad Signaling in Human Dermal Fibroblasts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IN-VIVO; HYPERTROPHIC SCARS; FIBROTIC RESPONSE; SMAD 3; EXPRESSION; FIBROSIS; PATHOPHYSIOLOGY; FIBRONECTIN; PATHWAY	Background: Hypertrophic scars are pathologic proliferations of the dermal skin layer resulting from excessive collagen deposition during the healing process of cutaneous wounds. Current research suggests that the TGF-beta/Smad signaling pathway is closely associated with normal scar and hypertrophic scar formation. TRAP-1-like protein (TLP), a cytoplasmic protein, has been reported to efficiently regulate Smad2- and Smad3-dependent signal expression in the TGF-beta pathway. The relationship between TLP and Type I/III collagen (Col I/III) synthesis explored in the present study provides an effective target for wound healing and gene therapy of hypertrophic scarring. Objective: To investigate the effects of TLP on collagen synthesis in human dermal fibroblasts. Methods: Lentiviral vectors encoding TLP was constructed to transfect fibroblasts derived from normal human skin. The expression of Col I/III and phosphorylation of Smad2 and Smad3 in fibroblasts were examined after TLP treatment. In addition, the comparison of TLP expression in normal skin tissues and in hypertrophic scar tissues was performed, and the effect of TLP on cell viability was analyzed by MTT assay. Results: TLP expression in hypertrophic scar tissue was markedly higher than in normal skin tissue. The Real Time PCR and Western blot test results both revealed that the synthesis of Col I/III was positively correlated with the expression of TLP. TLP also facilitate Smad2 phosphorylation while, conversely, inhibiting Smad3 phosphorylation. TLP may play a cooperative role, along with the cytokine TGF-beta 1, in improving the overall cell viability of skin fibroblasts. Conclusions: TLP likely acts as a molecular modulator capable of altering the balance of Smad3- and Smad2-dependent signaling through regulation of phosphorylation, thus facilitating collagen synthesis in fibroblasts. Based on genetic variation in TLP levels in different tissues, these results suggest that TLP plays a key role in the process of TGF-beta 1/Smad3 signaling that contributes to wound healing and genesis of pathologic scars.	[Wang, Xue; Qian, Yunliang; Jin, Rong; Wo, Yan; Chen, Jun; Wang, Chen; Wang, Danru] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, DR (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China.	wangdanru1776@163.com			Shanghai Science and Technology Commission [09ZR1416900, 10PJD008]; National Natural Science Foundation of China [30400467]	Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from Shanghai Science and Technology Commission (09ZR1416900 and 10PJD008) and by a grant from National Natural Science Foundation of China (30400467). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armour A, 2007, WOUND REPAIR REGEN, V15, pS6, DOI 10.1111/j.1524-475X.2007.00219.x; AUTIO P, 1994, BRIT J DERMATOL, V131, P660, DOI 10.1111/j.1365-2133.1994.tb04978.x; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Cheng B, 2008, BRIT J DERMATOL, V158, P713, DOI 10.1111/j.1365-2133.2008.08449.x; Chin GS, 2001, PLAST RECONSTR SURG, V108, P423, DOI 10.1097/00006534-200108000-00022; Cui W, 2010, BRAZ J MED BIOL RES, V43, P36, DOI 10.1590/S0100-879X2009007500017; Dooley A, 2010, RHEUMATOLOGY, V49, P2024, DOI 10.1093/rheumatology/keq208; Felici A, 2003, EMBO J, V22, P4465, DOI 10.1093/emboj/cdg428; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Ghosh AK, 2002, EXP BIOL MED, V227, P301, DOI 10.1177/153537020222700502; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Huang JS, 2002, FASEB J, V16, P1269, DOI 10.1096/fj.02-0103fje; Lan HY, 2008, FRONT BIOSCI-LANDMRK, V13, P4984, DOI 10.2741/3057; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lei B, 2011, J PHARMACOL SCI, V117, P98, DOI 10.1254/jphs.11065FP; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Liu X, 2008, BIOCHEM J, V409, P289, DOI 10.1042/BJ20070545; Messller S, 2011, IMMUNOBIOLOGY, V216, P343, DOI 10.1016/j.imbio.2010.07.006; Moustakas A, 2001, J CELL SCI, V114, P4359; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Sayah DN, 1999, J SURG RES, V87, P209, DOI 10.1006/jsre.1999.5761; Schiller M, 2004, J DERMATOL SCI, V35, P83, DOI 10.1016/j.jdermsci.2003.12.006; Schonthaler HB, 2008, DEVELOPMENT, V135, P387, DOI 10.1242/dev.006098; Singer AJ, 2009, J BURN CARE RES, V30, P329, DOI 10.1097/BCR.0b013e31819a6369; Tan WQ, 2011, EXP DERMATOL, V20, P119, DOI 10.1111/j.1600-0625.2010.01186.x; Uemura M, 2005, MOL BIOL CELL, V16, P4214, DOI 10.1091/mbc.E05-02-0149; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Wang Z, 2007, J PLAST RECONSTR AES, V60, P1193, DOI 10.1016/j.bjps.2006.05.007; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wolfram D, 2009, DERMATOL SURG, V35, P171, DOI 10.1111/j.1524-4725.2008.34406.x; Wurthner JU, 2001, J BIOL CHEM, V276, P19495, DOI 10.1074/jbc.M006473200; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Zhu B, 2010, NEPHROL DIAL TRANSPL, V25, P3180, DOI 10.1093/ndt/gfq239	36	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55899	10.1371/journal.pone.0055899	http://dx.doi.org/10.1371/journal.pone.0055899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418473	gold, Green Submitted, Green Published			2022-12-27	WOS:000315970300064
J	Champion, MD; Gray, V; Eberhard, C; Kumar, S				Champion, Mia D.; Gray, Vanessa; Eberhard, Carl; Kumar, Sudhir			The Evolutionary History of Amino Acid Variations Mediating Increased Resistance of S-aureus Identifies Reversion Mutations in Metabolic Regulators	PLOS ONE			English	Article							METHICILLIN-RESISTANT; RIFAMPIN RESISTANCE; FUSIDIC ACID; SUSCEPTIBILITY; BACTEREMIA	The evolution of resistance in Staphylococcus aureus occurs rapidly, and in response to all known antimicrobial treatments. Numerous studies of model species describe compensatory roles of mutations in mediating competitive fitness, and there is growing evidence that these mutation types also drive adaptation of S. aureus strains. However, few studies have tracked amino acid changes during the complete evolutionary trajectory of antibiotic adaptation or been able to predict their functional relevance. Here, we have assessed the efficacy of computational methods to predict biological resistance of a collection of clinically known Resistance Associated Mutations (RAMs). We have found that >90% of known RAMs are incorrectly predicted to be functionally neutral by at least one of the prediction methods used. By tracing the evolutionary histories of all of the false negative RAMs, we have discovered that a significant number are reversion mutations to ancestral alleles also carried in the MSSA476 methicillin-sensitive isolate. These genetic reversions are most prevalent in strains following daptomycin treatment and show a tendency to accumulate in biological pathway reactions that are distinct from those accumulating non-reversion mutations. Our studies therefore show that in addition to non-reversion mutations, reversion mutations arise in isolates exposed to new antibiotic treatments. It is possible that acquisition of reversion mutations in the genome may prevent substantial fitness costs during the progression of resistance. Our findings pose an interesting question to be addressed by further clinical studies regarding whether or not these reversion mutations lead to a renewed vulnerability of a vancomycin or daptomycin resistant strain to antibiotics administered at an earlier stage of infection.	[Champion, Mia D.; Gray, Vanessa; Kumar, Sudhir] Arizona State Univ, Biodesign Inst, Ctr Evolutionary Med & Informat, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Champion, MD (corresponding author), Mayo Clin, Scottsdale, AZ USA.	Mia.Champion@asu.edu	Kumar, Sudhir/F-1411-2011	Kumar, Sudhir/0000-0002-9918-8212; Hasle, Vanessa/0000-0001-8007-4891	National Institutes of Health [R01LM010834]; The National Institute of General Medical Sciences [R25GM071798]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM071798] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grants from the National Institutes of Health [R01LM010834] (MDC and SK) and The National Institute of General Medical Sciences [R25GM071798] (VG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry-Damon H, 1998, ANTIMICROB AGENTS CH, V42, P2590, DOI 10.1128/AAC.42.10.2590; Besier S, 2005, ANTIMICROB AGENTS CH, V49, P1426, DOI 10.1128/AAC.49.4.1426-1431.2005; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Brandis G, 2012, MOL MICROBIOL, V85, P142, DOI 10.1111/j.1365-2958.2012.08099.x; Cameron DR, 2012, J INFECT DIS; Campbell RE, 2000, BIOCHEMISTRY-US, V39, P14993, DOI 10.1021/bi001627x; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; Charles PGP, 2004, CLIN INFECT DIS, V38, P448, DOI 10.1086/381093; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eng J, 2006, ROC ANAL WEB BASED C; GeneDB, STAPH AUR; Golubchik T, 2012, NAT GENET, V44, P352, DOI 10.1038/ng.1072; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Howden BP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002359; Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kuhn G, 2006, J BACTERIOL, V188, P169, DOI 10.1128/JB.188.1.169-178.2006; Kumar S, 2011, HEALTH INFORM SER, P1, DOI 10.1007/978-0-85729-529-3_1; Kumar S, 2009, GENOME RES, V19, P1562, DOI 10.1101/gr.091991.109; Lannergard J, 2008, ANTIMICROB AGENTS CH, V52, P4017, DOI 10.1128/AAC.00668-08; Lannergard J, 2009, ANTIMICROB AGENTS CH, V53, P2059, DOI 10.1128/AAC.00871-08; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lopes MC, 2012, HUM HERED, V73, P47, DOI 10.1159/000334984; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Nei M., 2000, MOL EVOLUTION PHYLOG; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Peleg AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028316; Reynolds MG, 2000, GENETICS, V156, P1471; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Subramanian S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-306; Sunyaev SR, 1999, PROTEIN ENG, V12, P387, DOI 10.1093/protein/12.5.387; Tamura K, 2011, MOL BIOL EVOL; The Broad Institute of MIT and Harvard, 2011, STAPH AUR DRUG RES P; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034; Zorzet A, 2012, J ANTIMICROB CHEMOTH	39	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56466	10.1371/journal.pone.0056466	http://dx.doi.org/10.1371/journal.pone.0056466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424663	gold, Green Published, Green Submitted			2022-12-27	WOS:000315965100051
J	do Amaral, ASR; Pawlick, RL; Rodrigues, E; Costal, F; Pepper, A; Galvao, FHF; Correa-Giannella, ML; Shapiro, AMJ				Raposo do Amaral, Alexandre S.; Pawlick, Rena L.; Rodrigues, Erika; Costal, Flavia; Pepper, Andrew; Ferreira Galvao, Flavio H.; Correa-Giannella, Maria Lucia; Shapiro, A. M. James			Glutathione Ethyl Ester Supplementation during Pancreatic Islet Isolation Improves Viability and Transplant Outcomes in a Murine Marginal Isleet Mass Model	PLOS ONE			English	Article							MONOETHYL ESTER; UW SOLUTION; RAT-LIVER; HYPOXIA-REOXYGENATION; SUPEROXIDE-DISMUTASE; REPERFUSION INJURY; OXIDATIVE INJURY; PEROXIDASE; MOUSE; ISCHEMIA	Background: The success of pancreatic islet transplantation still faces many challenges, mainly related to cell damage during islet isolation and early post-transplant. The increased generation of reactive oxygen species (ROS) during islet isolation and the consumption of antioxidant defenses appear to be an important pathway related to islet damage. Methodology/Principal Findings: In the present study we evaluated whether supplementation of glutathione-ethyl-ester (GEE) during islet isolation could improve islet viability and transplant outcomes in a murine marginal islet mass model. We also cultured human islets for 24 hours in standard CMRL media with or without GEE supplementation. Supplementation of GEE decreased the content of ROS in isolated islets, leading to a decrease in apoptosis and maintenance of islet viability. A higher percentage of mice transplanted with a marginal mass of GEE treated islets became euglycemic after transplant. The supplementation of 20 mM GEE in cultured human islets significantly reduced the apoptosis rate in comparison to untreated islets. Conclusions/Significance: GEE supplementation was able to decrease the apoptosis rate and intracellular content of ROS in isolated islets and might be considered a potential intervention to improve islet viability during the isolation process and maintenance in culture before islet transplantation.	[Raposo do Amaral, Alexandre S.; Pawlick, Rena L.; Pepper, Andrew; Shapiro, A. M. James] Univ Alberta, Alberta Diabet Inst, Edmonton, AB, Canada; [Raposo do Amaral, Alexandre S.; Rodrigues, Erika; Costal, Flavia; Correa-Giannella, Maria Lucia] Univ Sao Paulo, Fac Med, Hosp Clin, Lab Endocrinol Celular Mol LIM 25, Sao Paulo, Brazil; [Ferreira Galvao, Flavio H.] Univ Sao Paulo, Fac Med, Dept Gastroenterol, Unidade Transplante Cirurgia Figado LIM37, Sao Paulo, Brazil	University of Alberta; Universidade de Sao Paulo; Universidade de Sao Paulo	Shapiro, AMJ (corresponding author), Univ Alberta, Alberta Diabet Inst, Edmonton, AB, Canada.	amjs@islet.ca	de Carvalho Rodrigues, Erika/AAE-9445-2020; Rodrigues, Erika/R-6007-2017; Correa-Giannella, Maria Lúcia/N-3834-2019; Galvao, Flavio Henrique Ferreira/D-3487-2017	de Carvalho Rodrigues, Erika/0000-0001-5464-2963; Rodrigues, Erika/0000-0001-5464-2963; Correa-Giannella, Maria Lúcia/0000-0003-3655-4446; Galvao, Flavio Henrique Ferreira/0000-0003-1924-3208	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil; Juvenile Diabetes Research Foundation (JDRF); JDRF, through the Clinical Islet Transplant Consortium (CIT) from the National Institutes of Health (NIH) National Institute of Diabetes, Digestive Diseases and Kidney (NIDDK); National Institute of Allergy, Immunology and Diabetes (NIAID); Alberta Innovates Healthcare Solutions (AIHS); Diabetes Research Institute Foundation of Canada (DRIFCan)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); JDRF, through the Clinical Islet Transplant Consortium (CIT) from the National Institutes of Health (NIH) National Institute of Diabetes, Digestive Diseases and Kidney (NIDDK); National Institute of Allergy, Immunology and Diabetes (NIAID); Alberta Innovates Healthcare Solutions (AIHS); Diabetes Research Institute Foundation of Canada (DRIFCan)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil and by a research centre grant from the Juvenile Diabetes Research Foundation (JDRF). AMJS is supported through the JDRF, through the Clinical Islet Transplant Consortium (CIT) from the National Institutes of Health (NIH) National Institute of Diabetes, Digestive Diseases and Kidney (NIDDK) and the National Institute of Allergy, Immunology and Diabetes (NIAID). AMJS is further supported through Alberta Innovates Healthcare Solutions (AIHS) as a Senior Clinical Scholar. This work was further supported through the Diabetes Research Institute Foundation of Canada (DRIFCan). AMJS and RLP are members of the Alberta Diabetes Institute. the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MF, 2004, NEUROSCI LETT, V354, P163, DOI 10.1016/j.neulet.2003.09.067; Armann B, 2007, AM J TRANSPLANT, V7, P38, DOI 10.1111/j.1600-6143.2006.01577.x; Avila J, 2005, AM J TRANSPLANT, V5, P2830, DOI 10.1111/j.1600-6143.2005.01109.x; Avila JG, 2003, CELL TRANSPLANT, V12, P877, DOI 10.3727/000000003771000228; Biolo G, 2007, CRIT CARE MED, V35, pS591, DOI 10.1097/01.CCM.0000278913.19123.13; BLAUSTEIN A, 1989, CIRCULATION, V80, P1449, DOI 10.1161/01.CIR.80.5.1449; Bottino R, 2004, DIABETES, V53, P2559, DOI 10.2337/diabetes.53.10.2559; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; Emamaullee JA, 2006, DIABETES, V55, P1907, DOI 10.2337/db05-1254; Eriksson O, 2009, AM J TRANSPLANT, V9, P2816, DOI 10.1111/j.1600-6143.2009.02844.x; FUKUZAWA K, 1995, TRANSPLANTATION, V59, P6, DOI 10.1097/00007890-199501150-00002; GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393; GRATTAGLIANO I, 1995, J PHARMACOL EXP THER, V272, P484; Ichii H, 2005, AM J TRANSPLANT, V5, P1635, DOI 10.1111/j.1600-6143.2005.00913.x; Kevelaitis E, 1997, TRANSPLANTATION, V64, P660, DOI 10.1097/00007890-199708270-00022; Kin T, 2011, TRANSPL P, V43, P3195, DOI 10.1016/j.transproceed.2011.10.003; Kin T., 2010, ISLETS LANGERHANS, P791; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lepore DA, 2004, XENOTRANSPLANTATION, V11, P53, DOI 10.1111/j.1399-3089.2004.00082.x; LEVY EJ, 1993, P NATL ACAD SCI USA, V90, P9171, DOI 10.1073/pnas.90.19.9171; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Littman ED, 1995, J SURG RES, V59, P694, DOI 10.1006/jsre.1995.1225; McCall MD, 2011, ISLETS, V3, P144, DOI 10.4161/isl.3.4.15729; Mysore TB, 2005, DIABETES, V54, P2109, DOI 10.2337/diabetes.54.7.2109; NEUSCHWANDERTETRI BA, 1992, J CLIN INVEST, V89, P109, DOI 10.1172/JCI115550; Pileggi A, 2006, ANN NY ACAD SCI, V1079, P383, DOI 10.1196/annals.1375.059; PURI RN, 1983, P NATL ACAD SCI-BIOL, V80, P5258, DOI 10.1073/pnas.80.17.5258; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Schauer RJ, 2004, ANN SURG, V239, P220, DOI 10.1097/01.sla.0000110321.64275.95; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SOUTHARD JH, 1990, TRANSPLANTATION, V49, P251, DOI 10.1097/00007890-199002000-00004; Sumimoto K, 1996, TRANSPLANTATION, V62, P1391, DOI 10.1097/00007890-199611270-00003; Tonooka N, 2007, CLIN TRANSPLANT, V21, P767, DOI 10.1111/j.1399-0012.2007.00736.x; YU WM, 1990, TRANSPLANTATION, V49, P1060, DOI 10.1097/00007890-199006000-00007; Zeevalk GD, 2007, EXP NEUROL, V203, P512, DOI 10.1016/j.expneurol.2006.09.004	37	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55288	10.1371/journal.pone.0055288	http://dx.doi.org/10.1371/journal.pone.0055288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424628	Green Submitted, gold, Green Published			2022-12-27	WOS:000315965100016
J	Tsushima, H; Malabarba, MG; Confalonieri, S; Senic-Matuglia, F; Verhoef, LGGC; Bartocci, C; D'Ario, G; Cocito, A; Di Fiore, PP; Salcini, AE				Tsushima, Hanako; Malabarba, Maria Grazia; Confalonieri, Stefano; Senic-Matuglia, Francesca; Verhoef, Lisette G. G. C.; Bartocci, Cristina; D'Ario, Giovanni; Cocito, Andrea; Di Fiore, Pier Paolo; Salcini, Anna Elisabetta			A Snapshot of the Physical and Functional Wiring of the Eps15 Homology Domain Network in the Nematode	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; TYROSINE KINASE SUBSTRATE; EH-DOMAIN; ADAPTER PROTEIN; BINDING DOMAIN; CLATHRIN COAT; ENDOCYTOSIS; INTERACTS; FAMILY; NPF	Protein interaction modules coordinate the connections within and the activity of intracellular signaling networks. The Eps15 Homology (EH) module, a protein-protein interaction domain that is a key feature of the EH-network, was originally identified in a few proteins involved in endocytosis and vesicle trafficking, and has subsequently also been implicated in actin reorganization, nuclear shuttling, and DNA repair. Here we report an extensive characterization of the physical connections and of the functional wirings of the EH-network in the nematode. Our data show that one of the major physiological roles of the EH-network is in neurotransmission. In addition, we found that the proteins of the network intersect, and possibly coordinate, a number of "territories" of cellular activity including endocytosis/recycling/vesicle transport, actin dynamics, general metabolism and signal transduction, ubiquitination/degradation of proteins, DNA replication/repair, and miRNA biogenesis and processing.	[Tsushima, Hanako; Malabarba, Maria Grazia; Confalonieri, Stefano; Senic-Matuglia, Francesca; Verhoef, Lisette G. G. C.; Bartocci, Cristina; D'Ario, Giovanni; Cocito, Andrea; Di Fiore, Pier Paolo; Salcini, Anna Elisabetta] Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy; [Malabarba, Maria Grazia; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, Milan, Italy; [Di Fiore, Pier Paolo] Ist Europeo Oncol, Milan, Italy; [Salcini, Anna Elisabetta] Univ Copenhagen, BRIC, Copenhagen, Denmark	IFOM - FIRC Institute of Molecular Oncology; University of Milan; IRCCS European Institute of Oncology (IEO); University of Copenhagen	Di Fiore, PP (corresponding author), Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy.	pierpaolo.difiore@ifom-ieo-campus.it; lisa.salcini@bric.dk	Senic-Matuglia, Francesca/AAQ-3815-2020; Confalonieri, Stefano/AAQ-6786-2020; Malabarba, Maria Grazia/L-4805-2015; Salcini, Anna Elisabetta/G-4472-2017; Di Fiore, Pier Paolo/K-2130-2012	Confalonieri, Stefano/0000-0001-6886-9851; Malabarba, Maria Grazia/0000-0002-9457-2047; Di Fiore, Pier Paolo/0000-0002-2252-0950; Salcini, Anna Elisabetta/0000-0001-5828-2512; Tsushima, Hanako/0000-0003-3179-4301	Associazione Italiana per la Ricerca sul Cancro; Ferrari Foundation; Monzino Foundation to PPDF; Danish National Research Council	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ferrari Foundation; Monzino Foundation to PPDF; Danish National Research Council(Danmarks Grundforskningsfond)	This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro, the Ferrari Foundation and the Monzino Foundation to PPDF; and by grants from the Danish National Research Council to AES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin S, 2011, BIOCH J; Blume JJ, 2007, EXP CELL RES, V313, P219, DOI 10.1016/j.yexcr.2006.10.006; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; BRENNER S, 1974, GENETICS, V77, P71; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chi S, 2008, MOL BIOL CELL, V19, P3564, DOI 10.1091/mbc.E07-10-0997; Coda L, 1998, J BIOL CHEM, V273, P3003, DOI 10.1074/jbc.273.5.3003; Confalonieri S, 2002, FEBS LETT, V513, P24, DOI 10.1016/S0014-5793(01)03241-0; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; DiFiore PP, 1997, TRENDS BIOCHEM SCI, V22, P411, DOI 10.1016/S0968-0004(97)01127-4; Ding XC, 2009, EMBO J, V28, P213, DOI 10.1038/emboj.2008.275; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Doria M, 1999, J CELL BIOL, V147, P1379, DOI 10.1083/jcb.147.7.1379; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Enmon JL, 2000, BIOCHEMISTRY-US, V39, P4309, DOI 10.1021/bi9927383; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fernandez-Chacon R, 2000, J BIOL CHEM, V275, P12752, DOI 10.1074/jbc.275.17.12752; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Galperin E, 2002, TRAFFIC, V3, P575, DOI 10.1034/j.1600-0854.2002.30807.x; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Grabbe C, 2009, CHEM REV, V109, P1481, DOI 10.1021/cr800413p; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Gross GG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002495; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Haffner C, 1997, FEBS LETT, V419, P175, DOI 10.1016/S0014-5793(97)01451-8; Henegouwen PMPVE, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-24; Henry GD, 2010, BIOCHEMISTRY-US, V49, P3381, DOI 10.1021/bi100065r; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Ho A, 2008, J NEUROSCI, V28, P14392, DOI 10.1523/JNEUROSCI.2481-08.2008; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Hyman J, 2000, J CELL BIOL, V149, P537, DOI 10.1083/jcb.149.3.537; Jovic M, 2009, MOL BIOL CELL, V20, P2731, DOI 10.1091/mbc.E08-11-1102; Kamikura DM, 2003, GENE DEV, V17, P2798, DOI 10.1101/gad.1136103; Kieken F, 2010, J BIOL CHEM, V285, P8687, DOI 10.1074/jbc.M109.045666; Kieken F, 2009, PROTEIN SCI, V18, P2471, DOI 10.1002/pro.258; Kim S, 2001, BIOCHEMISTRY-US, V40, P6776, DOI 10.1021/bi002700m; Kins S, 2006, NEURODEGENER DIS, V3, P218, DOI 10.1159/000095259; Krishnamoorthy K, 2006, STAT TEXTB MONOGR, P1; Lanzetti L, 2008, TRAFFIC, V9, P2011, DOI 10.1111/j.1600-0854.2008.00816.x; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Malacombe M, 2006, EMBO J, V25, P3494, DOI 10.1038/sj.emboj.7601247; Martina JA, 2001, J CELL BIOL, V153, P1111, DOI 10.1083/jcb.153.5.1111; Marzolo MP, 2009, SEMIN CELL DEV BIOL, V20, P191, DOI 10.1016/j.semcdb.2008.10.005; Mayer BJ, 1999, CURR BIOL, V9, pR70, DOI 10.1016/S0960-9822(99)80014-1; Miliaras NB, 2004, CELL BIOCHEM BIOPHYS, V41, P295, DOI 10.1385/CBB:41:2:295; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Montesinos ML, 2005, BRAIN RES REV, V49, P416, DOI 10.1016/j.brainresrev.2005.06.002; Morgan JR, 2003, J BIOL CHEM, V278, P33583, DOI 10.1074/jbc.M304346200; Morinaka K, 1999, ONCOGENE IN PRESS; Musacchio Andrea, 2002, Adv Protein Chem, V61, P211; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Naslavsky N, 2007, J BIOL CHEM, V282, P16612, DOI 10.1074/jbc.M609493200; Okamoto M, 2001, NEUROSCIENCE, V104, P653, DOI 10.1016/S0306-4522(01)00124-5; Ow MC, 2008, GENE DEV, V22, P2520, DOI 10.1101/gad.1678808; Page LJ, 1999, J CELL BIOL, V146, P993, DOI 10.1083/jcb.146.5.993; Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986; Paoluzi S, 1998, EMBO J, V17, P6541, DOI 10.1093/emboj/17.22.6541; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pawson T, 2009, CURR OPIN CELL BIOL, V21, P147, DOI 10.1016/j.ceb.2009.02.005; Pece S, 2011, BBA-REV CANCER, V1815, P26, DOI 10.1016/j.bbcan.2010.10.001; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Polo Simona, 2003, Sci STKE, V2003, pre17, DOI 10.1126/stke.2132003re17; Poupon V, 2002, J BIOL CHEM, V277, P8941, DOI 10.1074/jbc.M108385200; Pyrzynska B, 2009, MOL ONCOL, V3, P321, DOI 10.1016/j.molonc.2009.06.001; Regan-Klapisz E, 2005, J CELL SCI, V118, P4437, DOI 10.1242/jcs.02571; Rose S, 2007, MOL BIOL CELL, V18, P5091, DOI 10.1091/mbc.E07-05-0460; Rosenthal JA, 1999, J BIOL CHEM, V274, P33959, DOI 10.1074/jbc.274.48.33959; Roxrud I, 2008, J CELL BIOL, V180, P1205, DOI 10.1083/jcb.200708115; Rumpf J, 2008, EMBO J, V27, P558, DOI 10.1038/sj.emboj.7601980; Salcini AE, 1999, INT J BIOCHEM CELL B, V31, P805, DOI 10.1016/S1357-2725(99)00042-4; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Salcini AE, 2001, NAT CELL BIOL, V3, P755, DOI 10.1038/35087075; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Santolini E, 1999, EXP CELL RES, V253, P186, DOI 10.1006/excr.1999.4694; Santonico Elena, 2007, BMC Biochemistry, V8, P29, DOI 10.1186/1471-2091-8-29; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Serretti A, 2007, J ALZHEIMERS DIS, V12, P73; Shi A, 2007, CURR BIOL, V17, P1913, DOI 10.1016/j.cub.2007.10.045; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Siomi H, 2009, NAT CELL BIOL, V11, P1049, DOI 10.1038/ncb0909-1049; Smith CA, 2004, MOL BIOL CELL, V15, P3698, DOI 10.1091/mbc.E04-01-0026; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Vecchi M, 2001, J CELL BIOL, V153, P1511, DOI 10.1083/jcb.153.7.1511; Wang W, 2008, TRAFFIC, V9, P742, DOI 10.1111/j.1600-0854.2008.00712.x; Wendland B, 1998, J CELL BIOL, V141, P71, DOI 10.1083/jcb.141.1.71; WONG WT, 1995, P NATL ACAD SCI USA, V92, P9530, DOI 10.1073/pnas.92.21.9530; Wu FB, 2009, AGEING RES REV, V8, P147, DOI 10.1016/j.arr.2009.03.002; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014	98	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56383	10.1371/journal.pone.0056383	http://dx.doi.org/10.1371/journal.pone.0056383			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424658	Green Published, Green Submitted, gold			2022-12-27	WOS:000315965100046
J	Brede, M				Brede, Markus			Short Versus Long Term Benefits and the Evolution of Cooperation in the Prisoner's Dilemma Game	PLOS ONE			English	Article							EMERGENCE; NETWORKS; STRATEGY	In this paper I investigate the evolution of cooperation in the prisoner's dilemma when individuals change their strategies subject to performance evaluation of their neighbours over variable time horizons. In the monochrome setting, in which all agents per default share the same performance evaluation rule, weighing past events strongly dramatically enhances the prevalence of cooperators. For co-evolutionary models, in which evaluation time horizons and strategies can co-evolve, I demonstrate that cooperation naturally associates with long-term evaluation of others while defection is typically paired with very short time horizons. Moreover, considering the continuous spectrum in between enhanced and discounted weights of past performance, cooperation is optimally supported when cooperators neither give enhanced weight to past nor more recent events, but simply average payoffs. Payoff averaging is also found to emerge as the dominant strategy for cooperators in co-evolutionary models, thus proposing a natural route to the evolution of cooperation in viscous populations.	Univ Southampton, Dept Elect & Comp Sci, Southampton SO9 5NH, Hants, England	University of Southampton	Brede, M (corresponding author), Univ Southampton, Dept Elect & Comp Sci, Southampton SO9 5NH, Hants, England.	Brede.Markus@gmail.com						Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; Brede M, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/30003; Brede M, 2011, ARTIF LIFE, V17, P365, DOI 10.1162/artl_a_00044; Cao L, 2011, J THEOR BIOL, V272, P8, DOI 10.1016/j.jtbi.2010.12.008; Chadefaux T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013471; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Masuda N, 2007, P R SOC B, V274, P1815, DOI 10.1098/rspb.2007.0294; Mehta A, 2012, PHYS REV E, V85; Moyano LG, 2009, J THEOR BIOL, V259, P84, DOI 10.1016/j.jtbi.2009.03.002; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Santos FC, 2006, P ROY SOC B-BIOL SCI, V273, P51, DOI 10.1098/rspb.2005.3272; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056112; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tanimoto J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.032101; Tanimoto J, 2011, SOCIOBIOLOGY, V58, P315; Tanimoto J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041130; Van Segbroeck S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058105; Wang Z, 2010, PHYS REV E, V82; Weibull Jorgen W., EVOLUTIONARY GAME TH; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118	29	22	22	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56016	10.1371/journal.pone.0056016	http://dx.doi.org/10.1371/journal.pone.0056016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409114	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000315100000040
J	Makamure, B; Mhaka, J; Makumbirofa, S; Mutetwa, R; Mupfumi, L; Mason, P; Metcalfe, JZ				Makamure, Beauty; Mhaka, Jesca; Makumbirofa, Salome; Mutetwa, Reggie; Mupfumi, Lucy; Mason, Peter; Metcalfe, John Z.			Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of Drug-Resistant Tuberculosis in Harare, Zimbabwe	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; PREVALENCE; CULTURE; AFRICA; TRIAL	Introduction: Limited data exist on use of the microscopic-observation drug-susceptibility (MODS) assay among persons suspected of MDR-TB living in high HIV-prevalence settings. Methods: We retrospectively reviewed available clinical and drug susceptibility data for drug-resistant TB suspects referred for culture and drug-susceptibility testing between April 1, 2011 and March 1, 2012. The diagnostic accuracy of MODS was estimated against a reference standard including Lowenstein-Jensen (LJ) media and manual liquid (BACTEC MGIT) culture. The accuracy of MODS drug-susceptibility testing (DST) was assessed against a reference standard absolute concentration method. Results: One hundred thirty-eight sputum samples were collected from 99 drug-resistant TB suspects; in addition, six previously cultured MDR isolates were included for assessment of DST accuracy. Among persons with known HIV infection status, 39/59 (66%) were HIV-infected. Eighty-six percent of patients had a history of prior TB treatment, and 80% of individuals were on antituberculous treatment at the time of sample collection. M. tuberculosis was identified by reference standard culture among 34/98 (35%) MDR-TB suspects. Overall MODS sensitivity for M. tuberculosis detection was 85% (95% CI, 69-95%) and specificity was 93% (95% CI, 84-98%); diagnostic accuracy did not significantly differ by HIV infection status. Median time to positivity was significantly shorter for MODS (7 days; IQR 7-15 days) than MGIT (12 days; IQR 6-16 days) or LJ (28 days; IQR 21-35 days; p < 0.001). Of 33 specimens with concurrent DST results, sensitivity of the MODS assay for detection of resistance to isoniazid, rifampin, and MDR-TB was 88% (95% CI, 68-97%), 96% (95% CI, 79-100%), and 91% (95% CI, 72-99%), respectively; specificity was 89% (95% CI, 52-100%), 89% (95% CI, 52-100%), and 90% (95% CI, 56-100%), respectively. Conclusion: In a high HIV-prevalence setting, MODS diagnosed TB and drug-resistant TB with high sensitivity and shorter turnaround time compared with standard culture and DST methods.	[Makamure, Beauty; Mhaka, Jesca; Makumbirofa, Salome; Mutetwa, Reggie; Mupfumi, Lucy; Mason, Peter] Biomed Res & Training Inst, Harare, Zimbabwe; [Mason, Peter] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe; [Metcalfe, John Z.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, Francis J Curry Int TB Ctr, San Francisco, CA 94143 USA	Biomedical Research Training Institute; University of Zimbabwe; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Metcalfe, JZ (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, Francis J Curry Int TB Ctr, San Francisco, CA 94143 USA.	john.metcalfe@ucsf.edu		Mupfumi, Lucy/0000-0002-2290-2481; Metcalfe, John/0000-0002-2279-7036	National Institutes of Health [K23 AI094251, P30 AI27763]; Robert Wood Johnson Foundation; Trials of Excellence for Southern Africa (TESA) Network; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, K23AI094251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Trials of Excellence for Southern Africa (TESA) Network; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health (K23 AI094251 and P30 AI27763 to J.Z.M.), the Robert Wood Johnson Foundation (AMFDP Medical Faculty Development Award to J.Z.M.), and the Trials of Excellence for Southern Africa (TESA) Network (P. M., site principle investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman C, 2008, SAMJ S AFR MED J, V98, P15; Ben Amor Y, 2008, EMERG INFECT DIS, V14, P1345, DOI 10.3201/eid1409.061524; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2009, JAIDS-J ACQ IMM DEF, V50, P37, DOI 10.1097/QAI.0b013e31818ce6c4; Gumbo T, 2010, ANTIMICROB AGENTS CH, V54, P1484, DOI 10.1128/AAC.01474-09; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; Hesseling AC, 2012, INT J TUBERC LUNG D, V16, P192, DOI 10.5588/ijtld.10.0795; Institute of Medicine, 2009, ADDR THREAT DRUG RES ADDR THREAT DRUG RES; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Leung E, 2012, INT J TUBERC LUNG D, V16, P16, DOI 10.5588/ijtld.10.0065; Minion J, 2010, LANCET INFECT DIS, V10, P688, DOI 10.1016/S1473-3099(10)70165-1; Minion J, 2010, CLIN INFECT DIS, V50, P997, DOI 10.1086/651082; Moore DAJ, 2011, J INFECT DIS, V204, pS1110, DOI 10.1093/infdis/jir448; Reddy KP, 2010, CLIN INFECT DIS, V50, P988, DOI 10.1086/651081; Shah NS, 2011, AM J RESP CRIT CARE, V183, P1427, DOI 10.1164/rccm.201009-1449OC; Vella V, 2011, INT J TUBERC LUNG D, V15, P1170, DOI 10.5588/ijtld.10.0781; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, MULT EXT DRUG RES TU; WHO, 1998, LAB SERV TUB CONTR 2; World Health Organization, 2001, NONC CULT DRUG SUSCC; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	25	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55872	10.1371/journal.pone.0055872	http://dx.doi.org/10.1371/journal.pone.0055872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409072	Green Published, Green Submitted, gold			2022-12-27	WOS:000315100000028
J	Silva, GK; Cunha, LD; Horta, CV; Silva, ALN; Gutierrez, FRS; Silva, JS; Zamboni, DS				Silva, Grace K.; Cunha, Larissa D.; Horta, Catarina V.; Silva, Alexandre L. N.; Gutierrez, Fredy R. S.; Silva, Joao S.; Zamboni, Dario S.			A Parent-of-Origin Effect Determines the Susceptibility of a Non-Informative F1 Population to Trypanosoma cruzi Infection In Vivo	PLOS ONE			English	Article							EXPERIMENTAL CHAGAS-DISEASE; GROWTH-FACTOR-BETA; PLASMODIUM-CHABAUDI; GENETIC-CONTROL; NITRIC-OXIDE; METACYCLIC TRYPOMASTIGOTES; CONGOLENSE INFECTION; MEDIATES RESISTANCE; CANDIDATE GENES; MOUSE STRAINS	The development of Chagas disease is determined by a complex interaction between the genetic traits of both the protozoan parasite, T. cruzi, and the infected host. This process is regulated by multiple genes that control different aspects of the host-parasite interaction. While determination of the relevant genes in humans is extremely difficult, it is feasible to use inbred mouse strains to determine the genes and loci responsible for host resistance to infection. In this study, we investigated the susceptibility of several inbred mouse strains to infection with the highly virulent Y strain of T. cruzi and found a considerable difference in susceptibility between A/J and C57BL/6 mice. We explored the differences between these two mouse strains and found that the A/J strain presented higher mortality, exacerbated and uncontrolled parasitemia and distinct histopathology in the target organs, which were associated with a higher parasite burden and more extensive tissue lesions. We then employed a genetic approach to assess the pattern of inheritance of the resistance phenotype in an F1 population and detected a strong parent-of-origin effect determining the susceptibility of the F1 male mice. This effect is unlikely to result from imprinted genes because the inheritance of this susceptibility was affected by the direction of the parental crossing. Collectively, our genetic approach of using the F1 population suggests that genes contained in the murine chromosome X contribute to the natural resistance against T. cruzi infection. Future linkage studies may reveal the locus and genes participating on the host resistance process reported herein.	[Silva, Grace K.; Cunha, Larissa D.; Horta, Catarina V.; Silva, Alexandre L. N.; Zamboni, Dario S.] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Cell Biol, FMRP USP, Sao Paulo, Brazil; [Silva, Grace K.; Gutierrez, Fredy R. S.; Silva, Joao S.] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Biochem & Immunol, FMRP USP, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Zamboni, DS (corresponding author), Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Cell Biol, FMRP USP, Sao Paulo, Brazil.	dszamboni@fmrp.usp.br	Gutierrez, Fredy R.S./C-3911-2009; Zamboni, Dario S/D-3024-2012; Silva, Joao/A-4484-2008; Cunha, Larissa D/I-4204-2012; Silva, Grace/E-7673-2012	Gutierrez, Fredy R.S./0000-0001-9873-8342; Zamboni, Dario S/0000-0002-7856-7512; Silva, Joao/0000-0002-3410-3927; Silva, Grace/0000-0001-6417-4243; Dias da Cunha, Larissa/0000-0002-1290-0263	Instituto Nacional de Cieancia e Tecnologia em Vacinas (INCTV/CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/50959-4, 2007/53940-0]	Instituto Nacional de Cieancia e Tecnologia em Vacinas (INCTV/CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Instituto Nacional de Cieancia e Tecnologia em Vacinas (INCTV/CNPq) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grants 2010/50959-4 and 2007/53940-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti JCS, 1999, INFECT IMMUN, V67, P4819, DOI 10.1128/IAI.67.9.4819-4826.1999; Aliberti JCS, 1996, INFECT IMMUN, V64, P1961, DOI 10.1128/IAI.64.6.1961-1967.1996; ANDRADE V, 1985, BRAZ J MED BIOL RES, V18, P499; Barretto A C, 1993, Arq Bras Cardiol, V60, P225; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Clapcott SJ, 2000, PARASITE IMMUNOL, V22, P259, DOI 10.1046/j.1365-3024.2000.00308.x; Cummings KL, 2003, MOL BIOCHEM PARASIT, V129, P53, DOI 10.1016/S0166-6851(03)00093-8; da Costa SCG, 2002, HISTOL HISTOPATHOL, V17, P837, DOI 10.14670/HH-17.837; ESPINOSA R, 1985, INT J CARDIOL, V8, P45, DOI 10.1016/0167-5273(85)90262-1; Fernandes AB, 2004, MICROBES INFECT, V6, P460, DOI 10.1016/j.micinf.2004.01.009; GAZZINELLI RT, 1992, EUR J IMMUNOL, V22, P2501, DOI 10.1002/eji.1830221006; Gibson W, 1999, ADV PARASIT, V43, P1, DOI 10.1016/S0065-308X(08)60240-7; Goodhead I, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000880; Graefe SEB, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000057; Iraqi F, 2000, MAMM GENOME, V11, P645, DOI 10.1007/s003350010133; Krucken J, 2005, INFECT IMMUN, V73, P436, DOI 10.1128/IAI.73.1.436-443.2005; Laroque A, 2012, GENES IMMUN, V13, P155, DOI 10.1038/gene.2011.67; Leon JS, 2001, INFECT IMMUN, V69, P5643, DOI 10.1128/IAI.69.9.5643-5649.2001; Machado CR, 2006, MUTAT RES-REV MUTAT, V612, P40, DOI 10.1016/j.mrrev.2005.05.001; Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263; Marinho CRF, 2004, INFECT IMMUN, V72, P2350, DOI 10.1128/IAI.72.4.2350-2357.2004; Min-Oo G, 2008, GENES IMMUN, V9, P383, DOI 10.1038/sj.gene.6364450; MINOPRIO P, 1991, INT IMMUNOL, V3, P427, DOI 10.1093/intimm/3.5.427; MINOPRIO P, 1993, J IMMUNOL, V151, P4200; Morel CM, 2003, NAT REV MICROBIOL, V1, P14, DOI 10.1038/nrmicro735; Noyes H, 2011, P NATL ACAD SCI USA, V108, P9304, DOI 10.1073/pnas.1013486108; O'Gorman GM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-207; RAMIREZ MI, 1993, INFECT IMMUN, V61, P3636, DOI 10.1128/IAI.61.9.3636-3641.1993; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Roberts LJ, 1999, EUR J IMMUNOL, V29, P3047, DOI 10.1002/(SICI)1521-4141(199909)29:09&lt;3047::AID-IMMU3047&gt;3.0.CO;2-L; Silva GK, 2010, J IMMUNOL, V184, P1148, DOI 10.4049/jimmunol.0902254; SILVA JS, 1995, INFECT IMMUN, V63, P4862, DOI 10.1128/IAI.63.12.4862-4867.1995; Silva JS, 2003, FRONT BIOSCI-LANDMRK, V8, pS314, DOI 10.2741/1012; SILVA JS, 1991, J EXP MED, V174, P539, DOI 10.1084/jem.174.3.539; Sima M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001173; Sturm NR, 2010, ACTA TROP, V115, P35, DOI 10.1016/j.actatropica.2009.08.018; Taylor MC, 2011, ADV PARASIT, V75, P231, DOI 10.1016/B978-0-12-385863-4.00011-3; Teixeira Santuza M.R., 2003, Genetics and Molecular Research, V2, pUnpaginated; Villasenor-Cardoso MI, 2011, PARASITE IMMUNOL, V33, P643, DOI 10.1111/j.1365-3024.2011.01327.x; Williams-Blangero S, 2012, PHILOS T R SOC B, V367, P887, DOI 10.1098/rstb.2011.0296; World Health Organization, 2007, REP SCI WORK GROUP C; WUNDERLICH F, 1991, PARASITE IMMUNOL, V13, P357, DOI 10.1111/j.1365-3024.1991.tb00289.x; WUNDERLICH F, 1988, INFECT IMMUN, V56, P2400, DOI 10.1128/IAI.56.9.2400-2406.1988; Yadav JS, 2011, INFECT IMMUN, V79, P3204, DOI 10.1128/IAI.01389-10; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	45	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56347	10.1371/journal.pone.0056347	http://dx.doi.org/10.1371/journal.pone.0056347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409175	Green Published, gold, Green Submitted			2022-12-27	WOS:000315100000048
J	Shroff, RC; Price, KL; Kolatsi-Joannou, M; Todd, AF; Wells, D; Deanfield, J; Johnson, RJ; Rees, L; Woolf, AS; Long, DA				Shroff, Rukshana C.; Price, Karen L.; Kolatsi-Joannou, Maria; Todd, Alexandra F.; Wells, David; Deanfield, John; Johnson, Richard J.; Rees, Lesley; Woolf, Adrian S.; Long, David A.			Circulating Angiopoietin-2 Is a Marker for Early Cardiovascular Disease in Children on Chronic Dialysis	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ENDOTHELIAL FUNCTION; ARTERIAL STIFFNESS; YOUNG-ADULTS; URIC-ACID; EXPRESSION; RELEASE; TIE-2; CALCIFICATION; ANGIOGENESIS	Cardiovascular disease (CVD) is increasingly recognised as a complication of childhood chronic kidney disease (CKD) even in the absence of diabetes and hypertension. We hypothesized that an alteration in angiopoietin-1 and -2, growth factors which regulate endothelial and vascular function could be involved. We report that the endothelial survival factor, angiopoietin-1 is low in children with pre-dialysis CKD whereas the pro-inflammatory angiopoietin-2 is elevated in children on dialysis. In dialysis patients, angiopoietin-2 positively correlated with time on dialysis, systolic blood pressure, and carotid artery intima media thickness. Elevated angiopoietin-2 levels in dialysis versus pre-dialysis CKD patients were also associated with an anti-angiogenic (high soluble VEGFR-1 and low VEGF-A) and pro-inflammatory (high urate, E-selectin, P-selectin and VCAM-1) milieu. Ang-2 was immunodetected in arterial biopsy samples whilst the expression of VEGF-A was significantly downregulated in dialysis patients. Serum urate correlated with angiopoietin-2 levels in dialysis patients and addition of uric acid was able to induce rapid release of angiopoietin-2 from cultured endothelial cells. Thus, angiopoietin-2 is a marker for cardiovascular disease in children on chronic dialysis and may act as an anti-angiogenic and pro-inflammatory effector in this context. The possibility that the release of angiopoietin-2 from endothelia is mediated by urate should be explored further.	[Shroff, Rukshana C.; Price, Karen L.; Kolatsi-Joannou, Maria; Todd, Alexandra F.; Rees, Lesley; Long, David A.] UCL Inst Child Hlth, Nephrourol Unit, London, England; [Shroff, Rukshana C.; Price, Karen L.; Kolatsi-Joannou, Maria; Todd, Alexandra F.; Rees, Lesley; Long, David A.] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Wells, David] Great Ormond St Hosp Sick Children, Dept Chem Pathol, London WC1N 3JH, England; [Deanfield, John] UCL, Natl Ctr Cardiovasc Dis Prevent & Outcomes, London, England; [Johnson, Richard J.] Univ Colorado, Div Renal Dis & Hypertens, Denver, CO 80202 USA; [Woolf, Adrian S.] Univ Manchester, Inst Human Dev, Manchester, Lancs, England; [Woolf, Adrian S.] Royal Manchester Childrens Hosp, Manchester M27 1HA, Lancs, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of Colorado System; University of Colorado Denver; University of Manchester; Royal Manchester Children's Hospital	Long, DA (corresponding author), UCL Inst Child Hlth, Nephrourol Unit, London, England.	d.long@ucl.ac.uk	Price, Karen L/A-5323-2009; Long, David/I-3254-2019; Shroff, Rukshana C/C-7347-2008; Rees, Lesley/C-5027-2008; Shroff, Rukshana/AAG-5383-2019; Woolf, Adrian S./AAZ-1075-2020	Long, David/0000-0001-6580-3435; Shroff, Rukshana C/0000-0001-8501-1072; Shroff, Rukshana/0000-0001-8501-1072; Woolf, Adrian S./0000-0001-5541-1358; Deanfield, John/0000-0001-8806-6052; Price, Karen/0000-0002-8113-1461; Todd, Angelique/0000-0002-9207-4925	Great Ormond Street Hospital; UCL Institute of Child Health Biomedical Research Centre; Kids Kidney Research; Kidney Research UK Senior Non-Clinical Fellowship; Medical Research Council New Investigator Award; Manchester Biomedical Research Centre; MRC [MR/J003638/1] Funding Source: UKRI; Kidney Research UK [RP18/2011, SF1/2008] Funding Source: researchfish; Medical Research Council [MR/J003638/1] Funding Source: researchfish	Great Ormond Street Hospital; UCL Institute of Child Health Biomedical Research Centre; Kids Kidney Research(Kidney Research UK (KRUK)); Kidney Research UK Senior Non-Clinical Fellowship(Kidney Research UK (KRUK)); Medical Research Council New Investigator Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a project grant from the Great Ormond Street Hospital and UCL Institute of Child Health Biomedical Research Centre (to D. A. L., R. C. S. and L. R.) and a studentship from Kids Kidney Research (to L. R., D. A. L. and R. C. S.). D. A. L. is supported by a Kidney Research UK Senior Non-Clinical Fellowship and a Medical Research Council New Investigator Award. A. S. W. acknowledges grant support from the Manchester Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Covic A, 2006, NEPHROL DIAL TRANSPL, V21, P729, DOI 10.1093/ndt/gfi196; David S, 2012, NEPHROL DIAL TRANSPL, V27, P1867, DOI 10.1093/ndt/gfr551; David S, 2010, NEPHROL DIAL TRANSPL, V25, P2571, DOI 10.1093/ndt/gfq060; David S, 2009, AM J KIDNEY DIS, V53, P770, DOI 10.1053/j.ajkd.2008.11.030; Davis S, 2003, NAT STRUCT BIOL, V10, P38, DOI 10.1038/nsb880; Di Marco GS, 2009, J AM SOC NEPHROL, V20, P2235, DOI 10.1681/ASN.2009010061; Dursun I, 2009, NEPHROL DIAL TRANSPL, V24, P2511, DOI 10.1093/ndt/gfp066; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Futrakul N, 2008, RENAL FAILURE, V30, P215, DOI 10.1080/08860220701813335; Goldstein SL, 2006, CLIN J AM SOC NEPHRO, V1, P979, DOI 10.2215/CJN.02291205; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Hubbard NE, 2005, CELL IMMUNOL, V234, P102, DOI 10.1016/j.cellimm.2005.06.001; Jourdan C, 2005, J HYPERTENS, V23, P1707, DOI 10.1097/01.hjh.0000178834.26353.d5; Kari JA, 1997, KIDNEY INT, V52, P468, DOI 10.1038/ki.1997.354; Kim KT, 2005, J BIOL CHEM, V280, P20126, DOI 10.1074/jbc.M500292200; Korff T, 2012, CARDIOVASC RES, V94, P510, DOI 10.1093/cvr/cvs124; Kracht D, 2011, AM J HYPERTENS, V24, P1294, DOI 10.1038/ajh.2011.147; Krausz S, 2012, ANN RHEUM DIS, V71, P1402, DOI 10.1136/annrheumdis-2011-200718; Kuo MC, 2008, J AM SOC NEPHROL, V19, P2321, DOI 10.1681/ASN.2007111200; Lee SW, 2007, INT J MOL MED, V19, P445; Li JJ, 2001, THROMB HAEMOSTASIS, V85, P204, DOI 10.1055/s-0037-1615677; Lieb W, 2010, CIRC-CARDIOVASC GENE, V3, P300, DOI 10.1161/CIRCGENETICS.109.914556; Lilien MR, 2009, NAT REV NEPHROL, V5, P229, DOI 10.1038/nrneph.2009.10; Lilien MR, 2005, PEDIATR NEPHROL, V20, P200, DOI 10.1007/s00467-004-1718-3; Lim HS, 2005, ATHEROSCLEROSIS, V180, P113, DOI 10.1016/j.atherosclerosis.2004.11.004; Litwin M, 2005, J AM SOC NEPHROL, V16, P1494, DOI 10.1681/ASN.2004110932; London GM, 2002, NEPHROL DIAL TRANSPL, V17, P1713, DOI 10.1093/ndt/17.10.1713; Long DA, 2001, J AM SOC NEPHROL, V12, P2721, DOI 10.1681/ASN.V12122721; Long DA, 2008, KIDNEY INT, V74, P300, DOI 10.1038/ki.2008.179; Long DA, 2012, NAT REV NEPHROL, V8, P244, DOI 10.1038/nrneph.2011.219; Lukasz A, 2008, CRIT CARE, V12, DOI 10.1186/cc6966; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; McDonald SP, 2004, NEW ENGL J MED, V350, P2654, DOI 10.1056/NEJMoa031643; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Mitsnefes MM, 2006, PEDIATR NEPHROL, V21, P1167, DOI 10.1007/s00467-006-0180-9; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Nakayama T, 2010, AM J PATHOL, V176, P2198, DOI 10.2353/ajpath.2010.090316; Oh J, 2002, CIRCULATION, V106, P100, DOI 10.1161/01.CIR.0000020222.63035.C0; Otani A, 2001, DIABETES, V50, P867, DOI 10.2337/diabetes.50.4.867; Phelps ED, 2006, AM J PHYSIOL-CELL PH, V290, pC352, DOI 10.1152/ajpcell.00050.2005; Price KL, 2006, J AM SOC NEPHROL, V17, P1791, DOI 10.1681/ASN.2006030264; Reusz GS, 2010, HYPERTENSION, V56, P217, DOI 10.1161/HYPERTENSIONAHA.110.152686; Scholz A, 2011, BLOOD, V118, P5050, DOI 10.1182/blood-2011-03-343293; Shroff RC, 2008, CIRCULATION, V118, P1748, DOI 10.1161/CIRCULATIONAHA.108.783738; Shroff RC, 2007, J AM SOC NEPHROL, V18, P2996, DOI 10.1681/ASN.2006121397; Silverstein DM, 2011, PEDIATR NEPHROL, V26, P1123, DOI 10.1007/s00467-011-1875-0; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; Yuan HT, 2000, J AM SOC NEPHROL, V11, P1055, DOI 10.1681/ASN.V1161055	53	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56273	10.1371/journal.pone.0056273	http://dx.doi.org/10.1371/journal.pone.0056273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409162	Green Submitted, gold, Green Published			2022-12-27	WOS:000314660300069
J	Barault, L; Ellsworth, RE; Harris, HR; Valente, AL; Shriver, CD; Michels, KB				Barault, Ludovic; Ellsworth, Rachel E.; Harris, Holly R.; Valente, Allyson L.; Shriver, Craig D.; Michels, Karin B.			Leukocyte DNA as Surrogate for the Evaluation of Imprinted Loci Methylation in Mammary Tissue DNA	PLOS ONE			English	Article							GROWTH-FACTOR-II; COLORECTAL-CANCER; BREAST-CANCER; IGF2 GENE; EXPRESSION; H19; HYPOMETHYLATION; STABILITY; PATTERNS; DISEASE	There is growing interest in identifying surrogate tissues to identify epimutations in cancer patients since primary target tissues are often difficult to obtain. Methylation patterns at imprinted loci are established during gametogenesis and post fertilization and their alterations have been associated with elevated risk of cancer. Methylation at several imprinted differentially methylated regions (GRB10 ICR, H19 ICR, KvDMR, SNRPN/SNURF ICR, IGF2 DMR0, and IGF2 DMR2) were analyzed in DNA from leukocytes and mammary tissue (normal, benign diseases, or malignant tumors) from 87 women with and without breast cancer (average age of cancer patients: 53; range: 31-77). Correlations between genomic variants and DNA methylation at the studied loci could not be assessed, making it impossible to exclude such effects. Methylation levels observed in leukocyte and mammary tissue DNA were close to the 50% expected for monoallellic methylation. While no correlation was observed between leukocyte and mammary tissue DNA methylation for most of the analyzed imprinted genes, Spearman's correlations were statistically significant for IGF2 DMR0 and IGF2 DMR2, although absolute methylation levels differed. Leukocyte DNA methylation levels of selected imprinted genes may therefore serve as surrogate markers of DNA methylation in cancer tissue.	[Barault, Ludovic; Harris, Holly R.; Michels, Karin B.] Harvard Univ, Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Sch Med,Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Ellsworth, Rachel E.] Henry M Jackson Fdn Adv Mil Med, Clin Breast Care Project, Windber, PA USA; [Valente, Allyson L.] Windber Res Inst, Clin Breast Care Project, Windber, PA USA; [Shriver, Craig D.] Walter Reed Army Med Ctr, Clin Breast Care Project, Washington, DC 20307 USA; [Michels, Karin B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Windber Research Institute; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Harvard University; Harvard T.H. Chan School of Public Health	Barault, L (corresponding author), Harvard Univ, Brigham & Womens Hosp, Obstet & Gynecol Epidemiol Ctr, Sch Med,Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA.	Ludovic.barault@ircc.it	Harris, Holly/AAK-6844-2020; Barault, Ludovic/J-2472-2016	Harris, Holly/0000-0002-2572-6727; Barault, Ludovic/0000-0001-5227-5047	National Cancer Institute, National Institutes of Health, Department of Health and Human Services [R03CA143967]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R03CA143967] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a research grant from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services [R03CA143967 to KBM]; and the Breast Cancer Research Foundation (to KBM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benetatos L, 2010, LEUKEMIA RES, V34, P148, DOI 10.1016/j.leukres.2009.06.019; Byun HM, 2007, CANCER RES, V67, P10753, DOI 10.1158/0008-5472.CAN-07-0329; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Cassidy SB, 1993, PRADER WILLI SYNDROM; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Cui HM, 2002, CANCER RES, V62, P6442; da Rocha ST, 2004, CURR BIOL, V14, pR646, DOI 10.1016/j.cub.2004.08.007; Dammann RH, 2010, INT J ONCOL, V36, P171, DOI 10.3892/ijo_00000488; Dejeux Emelyne, 2009, V507, P189, DOI 10.1007/978-1-59745-522-0_15; Dufresne AM, 2005, ENDOCRINOLOGY, V146, P4399, DOI 10.1210/en.2005-0150; Ellis MJ, 1998, BREAST CANCER RES TR, V52, P175, DOI 10.1023/A:1006127621512; Frost JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013556; Guo L, 2008, DEV BIOL, V320, P79, DOI 10.1016/j.ydbio.2008.04.025; Ito Y, 2008, HUM MOL GENET, V17, P2633, DOI 10.1093/hmg/ddn163; Kaaks R, 2009, CANCER RES, V69, P5400, DOI 10.1158/0008-5472.CAN-08-3020; Lewis A, 2006, CYTOGENET GENOME RES, V113, P81, DOI 10.1159/000090818; McCann AH, 1996, HUM MOL GENET, V5, P1123, DOI 10.1093/hmg/5.8.1123; Monk D, 2010, BRIEF FUNCT GENOMICS, V9, P329, DOI 10.1093/bfgp/elq013; Murphy SK, 2006, MOL CANCER RES, V4, P283, DOI 10.1158/1541-7786.MCR-05-0138; Murrell A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001849; Murrell A, 2006, THESCIENTIFICWORLDJO, V6, P1888, DOI 10.1100/tsw.2006.318; Saal HM, 1993, RUSSELL SILVER SYNDR; Scelfo RAM, 2002, ONCOGENE, V21, P2564, DOI 10.1038/sj.onc.1205336; Shetty PJ, 2011, J CANCER RES CLIN, V137, P339, DOI 10.1007/s00432-010-0890-z; Shuman C, 1993, BECKWITH WIEDEMANN S; Talens RP, 2010, FASEB J, V24, P3135, DOI 10.1096/fj.09-150490; Tobi EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037933; Uribe-Lewis S, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001717; van Roozendaal CEP, 1998, FEBS LETT, V437, P107, DOI 10.1016/S0014-5793(98)01211-3; Woodfine K, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-1; Wu HK, 1997, BIOCHEM BIOPH RES CO, V235, P123, DOI 10.1006/bbrc.1997.6744; Yang Rong, 2009, Wei Sheng Yan Jiu, V38, P423; Yballe CM, 1996, J CLIN ENDOCR METAB, V81, P1607, DOI 10.1210/jc.81.4.1607; Yoshimizu T, 2008, P NATL ACAD SCI USA, V105, P12417, DOI 10.1073/pnas.0801540105; Yun K, 1999, J PATHOL, V187, P518, DOI 10.1002/(SICI)1096-9896(199904)187:5<518::AID-PATH276>3.0.CO;2-3; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	36	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55896	10.1371/journal.pone.0055896	http://dx.doi.org/10.1371/journal.pone.0055896			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409079	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200084
J	Gibson, SM; Ficklin, SP; Isaacson, S; Luo, F; Feltus, FA; Smith, MC				Gibson, Scott M.; Ficklin, Stephen P.; Isaacson, Sven; Luo, Feng; Feltus, Frank A.; Smith, Melissa C.			Massive-Scale Gene Co-Expression Network Construction and Robustness Testing Using Random Matrix Theory	PLOS ONE			English	Article							GENOME BROWSER; ARABIDOPSIS; EXPRESSION; ASSOCIATION; DATABASE; IDENTIFICATION; CONSERVATION; INFORMATION; ANNOTATION; SELECTION	The study of gene relationships and their effect on biological function and phenotype is a focal point in systems biology. Gene co-expression networks built using microarray expression profiles are one technique for discovering and interpreting gene relationships. A knowledge-independent thresholding technique, such as Random Matrix Theory (RMT), is useful for identifying meaningful relationships. Highly connected genes in the thresholded network are then grouped into modules that provide insight into their collective functionality. While it has been shown that co-expression networks are biologically relevant, it has not been determined to what extent any given network is functionally robust given perturbations in the input sample set. For such a test, hundreds of networks are needed and hence a tool to rapidly construct these networks. To examine functional robustness of networks with varying input, we enhanced an existing RMT implementation for improved scalability and tested functional robustness of human (Homo sapiens), rice (Oryza sativa) and budding yeast (Saccharomyces cerevisiae). We demonstrate dramatic decrease in network construction time and computational requirements and show that despite some variation in global properties between networks, functional similarity remains high. Moreover, the biological function captured by co-expression networks thresholded by RMT is highly robust.	[Gibson, Scott M.; Smith, Melissa C.] Clemson Univ, Holcombe Dept Elect & Comp Engn, Clemson, SC USA; [Ficklin, Stephen P.; Feltus, Frank A.] Clemson Univ, Clemson, SC 29634 USA; [Isaacson, Sven] Wittenberg Univ, Dept Comp Sci, Springfield, OH 45501 USA; [Feltus, Frank A.] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA; [Luo, Feng] Clemson Univ, Sch Comp, Clemson, SC USA	Clemson University; Clemson University; Wittenberg University; Clemson University; Clemson University	Feltus, FA (corresponding author), Clemson Univ, Clemson, SC 29634 USA.	ffeltus@clemson.edu	Ficklin, Stephen/L-4324-2019	Ficklin, Stephen/0000-0001-9138-6292; Feltus, Frank/0000-0002-2123-6114; Smith, Melissa/0000-0003-0798-8536				Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atias O, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-86; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2001, PHYSICA A, V299, P559, DOI 10.1016/S0378-4371(01)00369-7; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bassel GW, 2011, PLANT CELL, V23, P3101, DOI 10.1105/tpc.111.088153; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bolstad BM, 2012, RMAEXPRESS; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Chok N.S, 2010, THESIS U PITTSBURGH; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; De Smet F, 2002, BIOINFORMATICS, V18, P735, DOI 10.1093/bioinformatics/18.5.735; Edwards KD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-142; Elo LL, 2007, BIOINFORMATICS, V23, P2096, DOI 10.1093/bioinformatics/btm309; Faccioli P, 2005, PLANT MOL BIOL, V58, P739, DOI 10.1007/s11103-005-8159-7; Ficklin SP, 2011, PLANT PHYSIOL, V156, P1244, DOI 10.1104/pp.111.173047; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; Galassi M., 2003, GNU SCI LIB REFERENC; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Kalinka Alex T, 2011, Bioinformatics, V27, P2011, DOI 10.1093/bioinformatics/btr311; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Lee TH, 2009, PLANT PHYSIOL, V151, P16, DOI 10.1104/pp.109.139030; Leskovec J, 2010, J MACH LEARN RES, V11, P985; Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299; MacLennan NK, 2009, MOL GENET METAB, V98, P203, DOI 10.1016/j.ymgme.2009.05.004; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; Marino-Ramirez L, 2009, IDENTIFICATION CIS R, P1; Mentzen WI, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-76; Mutwil M, 2010, PLANT PHYSIOL, V152, P29, DOI 10.1104/pp.109.145318; Nayak RR, 2009, GENOME RES, V19, P1953, DOI 10.1101/gr.097600.109; Ogata Y, 2009, J WOOD SCI, V55, P395, DOI 10.1007/s10086-009-1058-9; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Perkins AD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S4; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Plerou V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066126; Puelma T, 2012, BIOINFORMATICS, V28, P2256, DOI 10.1093/bioinformatics/bts455; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter A, 2006, BIOINFORMATICS, V22, P2396, DOI 10.1093/bioinformatics/btl392; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tsaparas P, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-70; Tulino A. M., 2004, Foundations and Trends in Communications and Information Theory, V1, P1, DOI 10.1561/0100000001; Wang HY, 2008, BIOINFORMATICS, V24, P1367, DOI 10.1093/bioinformatics/btn134; Wang Y, 2009, INT J MOL SCI, V10, P116, DOI 10.3390/ijms10010116; Wei HR, 2006, PLANT PHYSIOL, V142, P762, DOI 10.1104/pp.106.080358; WIGNER EP, 1967, SIAM REV, V9, P1, DOI 10.1137/1009001; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319	61	35	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55871	10.1371/journal.pone.0055871	http://dx.doi.org/10.1371/journal.pone.0055871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409071	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200080
J	Jonsson, S; Wiberg, R; McGrath, AM; Novikov, LN; Wiberg, M; Novikova, LN; Kingham, PJ				Jonsson, Samuel; Wiberg, Rebecca; McGrath, Aleksandra M.; Novikov, Lev N.; Wiberg, Mikael; Novikova, Liudmila N.; Kingham, Paul J.			Effect of Delayed Peripheral Nerve Repair on Nerve Regeneration, Schwann Cell Function and Target Muscle Recovery	PLOS ONE			English	Article							AXONAL REGENERATION; NEUROTROPHIC FACTOR; CONTRIBUTING FACTORS; NEURONAL SURVIVAL; SATELLITE CELLS; DISTAL STUMP; ADULT-RAT; EXPRESSION; DENERVATION; INJURY	Despite advances in surgical techniques for peripheral nerve repair, functional restitution remains incomplete. The timing of surgery is one factor influencing the extent of recovery but it is not yet clearly defined how long a delay may be tolerated before repair becomes futile. In this study, rats underwent sciatic nerve transection before immediate (0) or 1, 3, or 6 months delayed repair with a nerve graft. Regeneration of spinal motoneurons, 13 weeks after nerve repair, was assessed using retrograde labeling. Nerve tissue was also collected from the proximal and distal stumps and from the nerve graft, together with the medial gastrocnemius (MG) muscles. A dramatic decline in the number of regenerating motoneurons and myelinated axons in the distal nerve stump was observed in the 3- and 6-months delayed groups. After 3 months delay, the axonal number in the proximal stump increased 2-3 folds, accompanied by a smaller axonal area. RT-PCR of distal nerve segments revealed a decline in Schwann cells (SC) markers, most notably in the 3 and 6 month delayed repair samples. There was also a progressive increase in fibrosis and proteoglycan scar markers in the distal nerve with increased delayed repair time. The yield of SC isolated from the distal nerve segments progressively fell with increased delay in repair time but cultured SC from all groups proliferated at similar rates. MG muscle at 3- and 6-months delay repair showed a significant decline in weight (61% and 27% compared with contra-lateral side). Muscle fiber atrophy and changes to neuromuscular junctions were observed with increased delayed repair time suggestive of progressively impaired reinnervation. This study demonstrates that one of the main limiting factors for nerve regeneration after delayed repair is the distal stump. The critical time point after which the outcome of regeneration becomes too poor appears to be 3-months.	[Jonsson, Samuel; Wiberg, Rebecca; McGrath, Aleksandra M.; Novikov, Lev N.; Wiberg, Mikael; Novikova, Liudmila N.; Kingham, Paul J.] Umea Univ, Sect Anat, Dept Integrat Med Biol, Umea, Sweden; [McGrath, Aleksandra M.; Wiberg, Mikael] Umea Univ, Dept Surg & Perioperat Sci, Sect Hand & Plast Surg, Umea, Sweden	Umea University; Umea University	Novikova, LN (corresponding author), Umea Univ, Sect Anat, Dept Integrat Med Biol, Umea, Sweden.	liudmila.novikova@anatomy.umu.se; paul.kingham@anatomy.umu.se		McGrath, Aleksandra/0000-0001-6142-6791; Kingham, Paul/0000-0003-2596-5936; Novikov, Lev/0000-0001-5520-3890	Swedish Medical Research Council; European Union; Umea University; County of Vasterbotten; Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse; Clas Groschinskys Minnesfond; Gunvor and Josef Aner Foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); European Union(European Commission); Umea University; County of Vasterbotten; Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse; Clas Groschinskys Minnesfond; Gunvor and Josef Aner Foundation	This study was supported by the Swedish Medical Research Council, European Union, Umea University, County of Vasterbotten, Ake Wibergs Stiftelse, Magnus Bergvalls Stiftelse, Clas Groschinskys Minnesfond and the Gunvor and Josef Aner Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel PJ, 2009, J ORTHOP RES, V27, P385, DOI 10.1002/jor.20773; Armstrong SJ, 2007, TISSUE ENG, V13, P2863, DOI 10.1089/ten.2007.0055; Ashley Z, 2007, AM J PHYSIOL-CELL PH, V292, pC440, DOI 10.1152/ajpcell.00085.2006; Borisov AB, 2001, ANAT REC, V264, P203, DOI 10.1002/ar.1155; Boyd JG, 2003, EXP NEUROL, V183, P610, DOI 10.1016/S0014-4886(03)00183-3; Boyle K, 2005, NEUROBIOL DIS, V20, P412, DOI 10.1016/j.nbd.2005.03.022; Brauer CA, 2007, J BONE JOINT SURG AM, V89A, P970, DOI 10.2106/JBJS.E.00657; Chen DH, 2010, ACTA OTO-LARYNGOL, V130, P1411, DOI 10.3109/00016489.2010.496464; Dahlin LB, 2001, SCAND J PLAST RECONS, V35, P29, DOI 10.1080/02844310151032510; Davison SP, 1999, LARYNGOSCOPE, V109, P631, DOI 10.1097/00005537-199904000-00021; FU SY, 1995, J NEUROSCI, V15, P3876; FU SY, 1995, J NEUROSCI, V15, P3886; Gordon T, 2011, J NEUROSCI, V31, P5325, DOI 10.1523/JNEUROSCI.6156-10.2011; Hart AM, 2002, EXP BRAIN RES, V142, P308, DOI 10.1007/s00221-001-0929-0; Hashemolhosseini S, 2000, MOL CELL NEUROSCI, V16, P697, DOI 10.1006/mcne.2000.0911; Hoke A, 2002, EXP NEUROL, V173, P77, DOI 10.1006/exnr.2001.7826; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Jivan S, 2006, EXP BRAIN RES, V170, P245, DOI 10.1007/s00221-005-0207-7; Jivan S, 2009, J PLAST RECONSTR AES, V62, P472, DOI 10.1016/j.bjps.2007.11.027; Keilhoff G, 2008, EXP NEUROL, V212, P189, DOI 10.1016/j.expneurol.2008.03.028; Kobayashi J, 1997, MUSCLE NERVE, V20, P858, DOI 10.1002/(SICI)1097-4598(199707)20:7<858::AID-MUS10>3.0.CO;2-O; Kou YH, 2011, ARTIF CELL BLOOD SUB, V39, P223, DOI 10.3109/10731199.2010.533127; Lad SP, 2010, NEUROSURGERY, V66, P953, DOI 10.1227/01.NEU.0000368545.83463.91; Li H, 1998, GLIA, V24, P290; Li H, 1997, GLIA, V20, P333, DOI 10.1002/(SICI)1098-1136(199708)20:4<333::AID-GLIA6>3.0.CO;2-6; Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165; Ma JJ, 2007, J ORTHOP RES, V25, P1498, DOI 10.1002/jor.20414; Ma JJ, 2003, SCAND J PLAST RECONS, V37, P1; Ma JJ, 2001, EXP BRAIN RES, V139, P216, DOI 10.1007/s002210100769; Midrio M, 2006, EUR J APPL PHYSIOL, V98, P1, DOI 10.1007/s00421-006-0256-z; MIYAMOTO Y, 1985, INT ORTHOP, V9, P271, DOI 10.1007/BF00266515; Muir D, 2010, EXP NEUROL, V223, P102, DOI 10.1016/j.expneurol.2009.05.038; Novikov LN, 2000, NEUROSCIENCE, V100, P171, DOI 10.1016/S0306-4522(00)00256-6; Novikova L, 1997, J NEUROSCI METH, V74, P9, DOI 10.1016/S0165-0270(97)02227-9; Pizzi MA, 2007, EXP NEUROL, V204, P496, DOI 10.1016/j.expneurol.2006.12.012; Reid AJ, 2011, HISTOCHEM CELL BIOL, V136, P71, DOI 10.1007/s00418-011-0829-8; Reid AJ, 2010, BRAIN RES, V1310, P1, DOI 10.1016/j.brainres.2009.11.011; Ronkko H, 2011, SCAND J SURG, V100, P223; Rosenfield J, 2001, Bull Hosp Jt Dis, V60, P155; Rueger MA, 2008, NEUROSCI LETT, V434, P253, DOI 10.1016/j.neulet.2008.01.073; Ruijs ACJ, 2005, PLAST RECONSTR SURG, V116, P484, DOI 10.1097/01.prs.0000172896.86594.07; Saito H, 2009, NEUROSCI LETT, V456, P30, DOI 10.1016/j.neulet.2009.03.075; Saito H, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-88; Shen J, 2006, J ORTHOP RES, V24, P1128, DOI 10.1002/jor.20131; SIIRONEN J, 1995, ACTA NEUROPATHOL, V89, P219; Sulaiman OAR, 2002, GLIA, V37, P206, DOI 10.1002/glia.10022; Susarla SM, 2007, J ORAL MAXIL SURG, V65, P1070, DOI 10.1016/j.joms.2006.10.010; Syroid DE, 2000, J NEUROSCI, V20, P5741, DOI 10.1523/JNEUROSCI.20-15-05741.2000; Tandrup T, 2000, J COMP NEUROL, V422, P172, DOI 10.1002/(SICI)1096-9861(20000626)422:2<172::AID-CNE2>3.0.CO;2-H; VEJSADA R, 1995, EUR J NEUROSCI, V7, P108, DOI 10.1111/j.1460-9568.1995.tb01025.x; Welin D, 2008, EXP BRAIN RES, V186, P315, DOI 10.1007/s00221-007-1232-5; Wiberg Mikael, 2009, Lakartidningen, V106, P586; Wiberg Mikael, 2003, Surg Technol Int, V11, P303; Zuo J, 1998, J NEUROBIOL, V34, P41, DOI 10.1002/(SICI)1097-4695(199801)34:1<41::AID-NEU4>3.3.CO;2-4	54	111	113	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56484	10.1371/journal.pone.0056484	http://dx.doi.org/10.1371/journal.pone.0056484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409189	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200136
J	Meyer, ZC; Schreinemakers, JMJ; Mulder, PGH; de Waal, RAL; Ermens, AAM; van der Laan, L				Meyer, Zainna C.; Schreinemakers, Jennifer M. J.; Mulder, Paul G. H.; de Waal, Ruud A. L.; Ermens, Antonius A. M.; van der Laan, Lijckle			The Role of C-Reactive Protein and the SOFA Score as Parameter for Clinical Decision Making in Surgical Patients during the Intensive Care Unit Course	PLOS ONE			English	Article							ORGAN FAILURE; COMPLICATIONS; PREDICTOR; MORTALITY; SEPSIS; DEFINITIONS	Introduction: C-reactive Protein (CRP) is used next to clinical scoring systems to recognize critically ill patients prone to develop complications on the Intensive Care Unit (ICU). The purpose of this study is to assess the predictive value of CRP as parameter for clinical deterioration and/or clinical decision making as ordering diagnostic procedures or performing (re) interventions. Also, we wanted to determine the value of CRP in early detection of surgical complications in the critically ill general surgical patient in the ICU and its interpretation in adjunct to a clinical scoring system, the Sequential Organ Failure Assessment Score. Materials and Methods: In our prospective observational study, 174 general surgical patients admitted into the Intensive Care Unit were included. We evaluated the Sequential Organ Failure Assessment Score (SOFA) and daily measured the C-reactive protein (CRP) concentrations. All events (diagnostic or therapeutic interventions) and surgical complications were registered. Then the relationship between SOFA score, CRP concentrations, events and complications were studied. Results: Each 10% increase in CRP resulted in a 3.5% increase in the odds of an event (odds ratio 1.035, 95% CI: 1.004-1.068; p = 0.028). However, an increase in CRP levels did not lead to a higher odds of complication (OR 0.983, 95% CI: 0.932-1.036; p = 0.52). When adjusting for the SOFA score the effect of CRP on the probability of a first event remained significant (OR 1.033, 95% CI: 1.001-1.065; p = 0.046), and again did not significantly affect the complication probability (OR 0.980, 95% CI: 0.929-1.035; p = 0.46). Conclusions: An increase in C-reactive protein is a poor parameter for early detection of complications in the critically ill surgical patient in the ICU by means of diagnostic procedures or therapeutic (re)-interventions.	[Meyer, Zainna C.; Schreinemakers, Jennifer M. J.; van der Laan, Lijckle] Amphia Hosp, Dept Surg, Breda, Netherlands; [Mulder, Paul G. H.] Amphia Hosp, Amphia Acad, Breda, Netherlands; [de Waal, Ruud A. L.] Amphia Hosp, Dept Intens Care Med, Breda, Netherlands; [Ermens, Antonius A. M.] Amphia Hosp, Lab Clin Chem & Hematol, Breda, Netherlands	Amphia Hospital; Amphia Hospital; Amphia Hospital; Amphia Hospital	Meyer, ZC (corresponding author), Amphia Hosp, Dept Surg, Breda, Netherlands.	zienalove@hotmail.com		van der laan, lijckle/0000-0001-5631-594X				BONE RC, 1992, CRIT CARE MED, V20, P724, DOI 10.1097/00003246-199206000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Prieto MF, 2008, MED INTENSIVA, V32, P424; Korner H, 2009, J GASTROINTEST SURG, V13, P1599, DOI 10.1007/s11605-009-0928-1; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; MacKay GJ, 2011, COLORECTAL DIS, V13, P583, DOI 10.1111/j.1463-1318.2010.02236.x; Matthiessen P, 2008, COLORECTAL DIS, V10, P75, DOI 10.1111/j.1463-1318.2007.01300.x; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; MUSTARD RA, 1987, ARCH SURG-CHICAGO, V122, P69; Nunes BK, 2011, REV ESC ENFERM USP, V45, P1480; Ortega-Deballon P, 2010, WORLD J SURG, V34, P808, DOI 10.1007/s00268-009-0367-x; Platt JJ, 2012, ANN SURG ONCOL; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Warschkow R, 2011, INT J COLORECTAL DIS, V26, P1405, DOI 10.1007/s00384-011-1262-0; Welsch T, 2007, INT J COLORECTAL DIS, V22, P1499, DOI 10.1007/s00384-007-0354-3; Woeste G, 2010, WORLD J SURG, V34, P140, DOI 10.1007/s00268-009-0304-z; Zhang Z, 2011, ANAESTH INTENS CARE, V39, P854, DOI 10.1177/0310057X1103900509	18	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55964	10.1371/journal.pone.0055964	http://dx.doi.org/10.1371/journal.pone.0055964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409097	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200093
J	Patel, SK; Zhang, Y; Pollock, JA; Janjic, JM				Patel, Sravan Kumar; Zhang, Yang; Pollock, John A.; Janjic, Jelena M.			Cyclooxgenase-2 Inhibiting Perfluoropoly (Ethylene Glycol) Ether Theranostic Nanoemulsions-In Vitro Study	PLOS ONE			English	Article							BREAST-CANCER; DRUG-DELIVERY; CREMOPHOR-EL; F-19 MRI; CELECOXIB; TUMOR; CELLS; MACROPHAGES; PHARMACOKINETICS; CHEMOPREVENTION	Cylcooxgenase-2 (COX-2) expressing macrophages, constituting a major portion of tumor mass, are involved in several pro-tumorigenic mechanisms. In addition, macrophages are actively recruited by the tumor and represent a viable target for anticancer therapy. COX-2 specific inhibitor, celecoxib, apart from its anticancer properties was shown to switch macrophage phenotype from tumor promoting to tumor suppressing. Celecoxib has low aqueous solubility, which may limit its tumor inhibiting effect. As opposed to oral administration, we propose that maximum anticancer effect may be achieved by nanoemulsion mediated intravenous delivery. Here we report multifunctional celecoxib nanoemulsions that can be imaged by both near-infrared fluorescence (NIRF) and F-19 magnetic resonance. Celecoxib loaded nanoemulsions showed a dose dependent uptake in mouse macrophages as measured by F-19 NMR and NIRF signal intensities of labeled cells. Dramatic inhibition of intracellular COX-2 enzyme was observed in activated macrophages upon nanoemulsion uptake. COX-2 enzyme inhibition was statistically equivalent between free drug and drug loaded nanoemulsion. However, nanoemulsion mediated drug delivery may be advantageous, helping to avoid systemic exposure to celecoxib and related side effects. Dual molecular imaging signatures of the presented nanoemulsions allow for future in vivo monitoring of the labeled macrophages and may help in examining the role of macrophage COX-2 inhibition in inflammation-cancer interactions. These features strongly support the future use of the presented nanoemulsions as anti-COX-2 theranostic nanomedicine with possible anticancer applications.	[Patel, Sravan Kumar; Zhang, Yang; Janjic, Jelena M.] Duquesne Univ, Grad Sch Pharmaceut Sci, Mylan Sch Pharm, Pittsburgh, PA 15219 USA; [Pollock, John A.] Duquesne Univ, Dept Biol Sci, Bayer Sch Nat & Environm Sci, Pittsburgh, PA 15219 USA	Duquesne University; Duquesne University	Janjic, JM (corresponding author), Duquesne Univ, Grad Sch Pharmaceut Sci, Mylan Sch Pharm, Pittsburgh, PA 15219 USA.	janjicj@duq.edu	Patel, Sravan Kumar/H-2713-2017	Patel, Sravan Kumar/0000-0002-1235-3458; Pollock, John/0000-0001-6602-3676; Janjic, Jelena/0000-0002-0539-8359	Pittsburgh Tissue Engineering Initiative Interface Seed Grant Fund; Duquesne University; NSF/Multi-User Instrumentation grant [0400776]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R41EB009618] Funding Source: NIH RePORTER	Pittsburgh Tissue Engineering Initiative Interface Seed Grant Fund; Duquesne University; NSF/Multi-User Instrumentation grant; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	JMJ, SKP, YZ and JAP research is supported by a grant from the Pittsburgh Tissue Engineering Initiative Interface Seed Grant Fund 2012. JMJ and SKP were also supported by Pennsylvania State Health Formula Research Grants Program (C.U.R.E. Award) and Faculty Development Funds from Duquesne University. JAP acknowledges support from NSF/Multi-User Instrumentation grant NSF# 0400776. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers WJ, 2011, ACS NANO, V5, P173, DOI 10.1021/nn102274q; Baboota S, 2007, ACTA CHROMATOGR, V18, P116; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Basu GD, 2005, BREAST CANCER RES, V7, pR422, DOI 10.1186/bcr1019; Bible E, 2012, BIOMATERIALS, V33, P2858, DOI 10.1016/j.biomaterials.2011.12.033; Celsense Inc. website. Celsense Inc, ANN 1 CLIN TRIAL AUT; Chao TC, 2005, INVEST NEW DRUG, V23, P171; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fang JY, 2009, ULTRASONICS, V49, P39, DOI 10.1016/j.ultras.2008.04.009; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Gelderblom H, 2001, EUR J CANCER, V37, P1590, DOI 10.1016/S0959-8049(01)00171-X; GERHARDT GE, 1978, J ORG CHEM, V43, P4505, DOI 10.1021/jo00417a026; Gianella A, 2011, ACS NANO, V5, P4422, DOI 10.1021/nn103336a; Harris RE, 2000, CANCER RES, V60, P2101; Hertlein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018246; Hitchens TK, 2011, MAGN RESON MED, V65, P1145, DOI 10.1002/mrm.22702; Hoffman H., 1984, PHARM Z, V129, P1730; Janjic JM, 2008, J AM CHEM SOC, V130, P2832, DOI 10.1021/ja077388j; Janjic JM, 2009, WIRES NANOMED NANOBI, V1, P492, DOI 10.1002/wnan.35; Janjic JM, 2012, US, Patent No. [8,277,610 B2, 8277610]; Jendrossek V, 2011, CANC LETT IN PRESS; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kaneda MM, 2010, BIOMATERIALS, V31, P3079, DOI 10.1016/j.biomaterials.2010.01.006; Krafft MP, 2007, J POLYM SCI POL CHEM, V45, P1185, DOI 10.1002/pola.21937; Lanza GM, 2005, CURR TOP DEV BIOL, V70, P57, DOI 10.1016/S0070-2153(05)70003-X; Lee SJ, 2011, J PHYS CHEM B, V115, P15271, DOI 10.1021/jp209543c; Lim YT, 2009, CHEM COMMUN, P6952, DOI 10.1039/b914006a; Mehibel M, 2009, MOL CANCER THER, V8, P1261, DOI 10.1158/1535-7163.MCT-08-0927; Morawski AM, 2004, MAGN RESON MED, V52, P1255, DOI 10.1002/mrm.20287; Moss G, 2009, HDB PHARM EXCIPIENTS, P429; Nakanishi Y, 2011, CARCINOGENESIS, V32, P1333, DOI 10.1093/carcin/bgr128; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; O'Hanlon CE, 2012, J FLUORINE CHEM, V137, P27, DOI 10.1016/j.jfluchem.2012.02.004; Paulson SK, 2000, DRUG METAB DISPOS, V28, P514; Paulson SK, 2001, J PHARMACOL EXP THER, V297, P638; Pogue BW, 2010, AM J ROENTGENOL, V195, P321, DOI 10.2214/AJR.10.5002; Rapoport N, 2011, J CONTROL RELEASE, V153, P4, DOI 10.1016/j.jconrel.2011.01.022; Reddy BS, 2000, CANCER RES, V60, P293; Rieger AM, 2010, DEV COMP IMMUNOL, V34, P1144, DOI 10.1016/j.dci.2010.06.006; Seedher N, 2003, AAPS PharmSciTech, V4, pE33; Shiraishi K, 2011, INT J PHARMACEUT, V421, P379, DOI 10.1016/j.ijpharm.2011.10.006; Singh KK, 2009, HDB PHARM EXCIPIENTS, P572; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Srinivas M, 2007, MAGN RESON MED, V58, P725, DOI 10.1002/mrm.21352; Srinivas M, 2010, TRENDS BIOTECHNOL, V28, P363, DOI 10.1016/j.tibtech.2010.04.002; Sumer B, 2008, NANOMEDICINE-UK, V3, P137, DOI 10.2217/17435889.3.2.137; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Uskokovic V, 2011, ARCH ORAL BIOL, V56, P521, DOI 10.1016/j.archoralbio.2010.11.011; Venkatesan P, 2011, BIOMATERIALS, V32, P3794, DOI 10.1016/j.biomaterials.2011.01.027; Wang Y, 2011, J PEDIAT HEMATOL ONC, V33, P241, DOI 10.1097/MPH.0b013e318207cbf1; Wang YZ, 2007, INT J PHARM, V337, P63, DOI 10.1016/j.ijpharm.2006.12.033; Winter PM, 2007, EXPERT REV MED DEVIC, V4, P137, DOI 10.1586/17434440.4.2.137; Yu JL, 2003, BREAST CANCER RES, V5, P83, DOI 10.1186/bcr573	53	39	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55802	10.1371/journal.pone.0055802	http://dx.doi.org/10.1371/journal.pone.0055802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409048	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200068
J	Yan, L; Xing, ZQ; Guo, ZX; Fang, ZQ; Jiao, W; Guo, XY; Xu, ZH; Fang, ZH; Holmberg, A; Nilsson, S; Liu, ZX				Yan, Lei; Xing, Zhaoquan; Guo, Zhaoxin; Fang, Zhiqing; Jiao, Wei; Guo, Xiaoyu; Xu, Zhonghua; Fang, Zhenghui; Holmberg, Anders; Nilsson, Sten; Liu, Zhaoxu			Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy	PLOS ONE			English	Article							NEUROENDOCRINE DIFFERENTIATION; TUMOR; LNCAP; GRP78; EXPRESSION; PROTEIN; PROGRESSION; METASTASIS; CASTRATION; PATHOGENESIS	Cancer cell metabolism responsive to androgen deprivation therapy (ADT) may be involved in the development and progression of prostate cancer and the ultimate failure of androgen-deprivation therapy. To investigate the metabolism regulation effects on androgen-independent growth of prostate cancer, an established LNCaP-s cell model that resembles the clinical scenario of castration-resistant prostate cancer (CRPC), was used in this current study. This cell line was cultured from androgen-sensitive LNCaP parental cells, in an androgen-reduced condition, resembling clinical androgen deprivation therapy. To assess the effects of smsDX on the invasiveness of prostate cancer cells we used wound healing assay and Matrigel (TM) invasion assay. We evaluated differentially expressed proteins of the parental LNCaP cells and LNCaP-s cells after ADT by means of two-dimensional gel electrophoresis (2-DE) followed by MALDI-TOF mass spectrometric analysis. The covered area in the wound and the number of cells invading through a Matrigel chamber were significantly smaller for cells treated with smsDX than they were for control cells treated with vehicle. 56 proteins were found differentially expressed in LNCaP-s cells compared to LNCaP cells, majority of them were down-regulated after ADT treatment. 104 proteins of LNCaP cells and 86 in LNCaP-s cells, separately, were found differentially expressed after treatment with smsDX, When we explored these protein functions within the website UniProtKB/Swiss-Prot, surprisingly, most of the proteins were found to be involved in the cellular metabolism and mitochondrial function regulation. LNCaP-s as potential metastatic androgen-independent cancer cells, its metabolism and mitochondrial functions could be altered by a new somatostatin derivative smsDX, the smsDX regulatory effects on metabolism in LNCaP-s deliver more therapeutic information with the treatment of CRPC.	[Yan, Lei; Xing, Zhaoquan; Guo, Zhaoxin; Fang, Zhiqing; Jiao, Wei; Xu, Zhonghua; Liu, Zhaoxu] Shandong Univ, Dept Urol, Qilu Hosp, Jinan 250100, Peoples R China; [Guo, Xiaoyu; Liu, Zhaoxu] Shandong Univ, Aging & Hlth Ctr, Sch Nursing, Jinan 250100, Peoples R China; [Fang, Zhenghui] Shandong Univ, Dept Obstet & Gynecol, Jinan Cent Hosp, Jinan 250100, Peoples R China; [Holmberg, Anders; Nilsson, Sten; Liu, Zhaoxu] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Karolinska Institutet	Xu, ZH (corresponding author), Shandong Univ, Dept Urol, Qilu Hosp, Jinan 250100, Peoples R China.	xuzhonghua@163.com; zhaoxvl@sdu.edu.cn			National Natural Science Foundation of China [81172435]; Shandong Natural Science Foundation [ZR2010HM026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Natural Science Foundation(Natural Science Foundation of Shandong Province)	Grant Sponsor: The National Natural Science Foundation of China (No. 81172435) and Shandong Natural Science Foundation (No. ZR2010HM026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSSON PA, 1989, PROSTATE, V14, P71, DOI 10.1002/pros.2990140109; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Arnold JT, 2002, ENDOCR-RELAT CANCER, V9, P61, DOI 10.1677/erc.0.0090061; BREVINI TAL, 1993, J CLIN ENDOCR METAB, V77, P626, DOI 10.1210/jc.77.3.626; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Cai CM, 2011, ENDOCR-RELAT CANCER, V18, pR175, DOI 10.1530/ERC-10-0339; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Dai RY, 2010, FOLIA BIOL-PRAGUE, V56, P37; Dang CV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe75; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FRANZEN B, 1993, ELECTROPHORESIS, V14, P1045, DOI 10.1002/elps.11501401167; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hejna M, 2002, ANN ONCOL, V13, P653, DOI 10.1093/annonc/mdf142; Huang WC, 2010, J BIOL CHEM, V285, P7947, DOI 10.1074/jbc.M109.092759; Jain RK, 1998, P NATL ACAD SCI USA, V95, P10820, DOI 10.1073/pnas.95.18.10820; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Koutsilieris M, 1999, PROSTATE, V38, P313; Leon CG, 2010, PROSTATE, V70, P390, DOI 10.1002/pros.21072; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Liu ZX, 2007, INT J ONCOL, V30, P1173; Liu ZX, 2009, ONCOL REP, V22, P1451, DOI 10.3892/or_00000587; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Mitsogiannis IC, 2009, EXPERT OPIN PHARMACO, V10, P493, DOI [10.1517/14656560802694689 , 10.1517/14656560802694689]; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Nathan C, 2010, CELL, V140, DOI 10.1016/j.cell.2010.03.008; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; RABILLOUD T, 1994, CELL MOL BIOL, V40, P57; Raimundo N, 2011, TRENDS MOL MED, V17, P641, DOI 10.1016/j.molmed.2011.06.001; Sciarra A, 2006, INT J CLIN PRACT, V60, P462, DOI 10.1111/j.1742-1241.2006.00750.x; Sun FC, 2006, BIOCHEM J, V396, P31, DOI 10.1042/BJ20051916; Susini C, 2006, ANN ONCOL, V17, P1733, DOI 10.1093/annonc/mdl105; Swinnen JV, 2004, J STEROID BIOCHEM, V92, P273, DOI 10.1016/j.jsbmb.2004.10.013; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Volante M, 2008, MOL CELL ENDOCRINOL, V286, P219, DOI 10.1016/j.mce.2007.12.002; Ward PS, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006783; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xing ZQ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-162; Yuan TC, 2007, ENDOCR-RELAT CANCER, V14, P531, DOI 10.1677/ERC-07-0061; Yuan TC, 2006, ENDOCR-RELAT CANCER, V13, P151, DOI 10.1677/erc.1.01043	48	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55790	10.1371/journal.pone.0055790	http://dx.doi.org/10.1371/journal.pone.0055790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409045	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200065
J	Engelen, E; Janssens, RC; Yagita, K; Smits, VAJ; van der Horst, GTJ; Tamanini, F				Engelen, Erik; Janssens, Roel C.; Yagita, Kazuhiro; Smits, Veronique A. J.; van der Horst, Gijsbertus T. J.; Tamanini, Filippo			Mammalian TIMELESS Is Involved in Period Determination and DNA Damage-Dependent Phase Advancing of the Circadian Clock	PLOS ONE			English	Article							CELL-CYCLES; IN-VIVO; PROTEIN; GENE; CRY1; CRYPTOCHROME; RHYTHMICITY; INHIBITION; MECHANISMS; NETWORK	The transcription/translation feedback loop-based molecular oscillator underlying the generation of circadian gene expression is preserved in almost all organisms. Interestingly, the animal circadian clock proteins CRYPTOCHROME (CRY), PERIOD (PER) and TIMELESS (TIM) are strongly conserved at the amino acid level through evolution. Within this evolutionary frame, TIM represents a fascinating puzzle. While Drosophila contains two paralogs, dTIM and dTIM2, acting in clock/photoreception and chromosome integrity/photoreception respectively, mammals contain only one TIM homolog. Whereas TIM has been shown to regulate replication termination and cell cycle progression, its functional link to the circadian clock is under debate. Here we show that RNAi-mediated knockdown of TIM in NIH3T3 and U2OS cells shortens the period by 1 hour and diminishes DNA damage-dependent phase advancing. Furthermore, we reveal that the N-terminus of TIM is sufficient for interaction with CRY1 and CHK1 as well for homodimerization, and the C-terminus is necessary for nuclear localization. Interestingly, the long TIM isoform (l-TIM), but not the short (s-TIM), interacts with CRY1 and both proteins can reciprocally regulate their nuclear translocation in transiently transfected COS7 cells. Finally, we demonstrate that co-expression of PER2 abolishes the formation of the TIM/CRY1 complex through affinity binding competition to the C-terminal tail of CRY1. Notably, the presence of the latter protein region evolutionarily and structurally distinguishes mammalian from insect CRYs. We propose that the dynamic interaction between these three proteins could represent a post-translational aspect of the mammalian circadian clock that is important for its pace and adaption to external stimuli, such as DNA damage and/or light.	[Engelen, Erik; Janssens, Roel C.; van der Horst, Gijsbertus T. J.; Tamanini, Filippo] Erasmus Univ, Med Ctr, Dept Genet, Ctr Biomed Genet, Rotterdam, Netherlands; [Engelen, Erik] Erasmus Univ, Med Ctr, Dept Cell Biol, Ctr Biomed Genet, Rotterdam, Netherlands; [Yagita, Kazuhiro] Kyoto Prefectural Univ Med, Dept Neurosci & Cell Biol, Kyoto, Japan; [Smits, Veronique A. J.] Hosp Univ Canarias, Inst Tecnol Biomed, Unidad Invest, Tenerife, Spain	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Kyoto Prefectural University of Medicine; Universidad de la Laguna	van der Horst, GTJ (corresponding author), Erasmus Univ, Med Ctr, Dept Genet, Ctr Biomed Genet, Rotterdam, Netherlands.	g.vanderhorst@erasmusmc.nl; f.tamanini@erasmusmc.nl	van der Horst, Gijsbertus TJ/E-3661-2015; Smits, Veronique A.J./R-2302-2019	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Smits, Veronique A.J./0000-0002-9160-4525	Netherlands Organization for Scientific Research (ZonMW) [918.36.619, 90.201.127]	Netherlands Organization for Scientific Research (ZonMW)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	This work was supported by grants from the Netherlands Organization for Scientific Research (ZonMW Vici grant nr. 918.36.619; ZonMW/ErasSysBio+ grant nr. 90.201.127) to GTJvdH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Balakrishnan A, 2010, EXP CELL RES, V316, P3512, DOI 10.1016/j.yexcr.2010.07.007; Barnes JW, 2003, SCIENCE, V302, P439, DOI 10.1126/science.1086593; Benna C, 2000, CURR BIOL, V10, pR512, DOI 10.1016/S0960-9822(00)00594-7; Benna C, 2010, CURR BIOL, V20, P346, DOI 10.1016/j.cub.2009.12.048; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chaves I, 2006, MOL CELL BIOL, V26, P1743, DOI 10.1128/MCB.26.5.1743-1753.2006; Dekker S, 2003, J VIROL, V77, P12132, DOI 10.1128/JVI.77.22.12132-12139.2003; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Gotter AL, 2003, J MOL BIOL, V331, P167, DOI 10.1016/S0022-2836(03)00633-8; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Oklejewicz M, 2008, CURR BIOL, V18, P286, DOI 10.1016/j.cub.2008.01.047; Pregueiro AM, 2006, SCIENCE, V313, P644, DOI 10.1126/science.1121716; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RUSAK B, 1989, BRAIN RES, V493, P283, DOI 10.1016/0006-8993(89)91163-3; Sasaki M, 2009, J BIOL CHEM, V284, P25149, DOI 10.1074/jbc.M109.040758; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Smith KD, 2009, J CELL BIOL, V187, P15, DOI 10.1083/jcb.200905006; Takumi T, 1999, GENES CELLS, V4, P67, DOI 10.1046/j.1365-2443.1999.00238.x; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xiao J, 2003, DEV DYNAM, V228, P82, DOI 10.1002/dvdy.10346; Yagita K, 2000, GENE DEV, V14, P1353; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yang XM, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.050237; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zylka MJ, 1998, NEURON, V21, P1115, DOI 10.1016/S0896-6273(00)80628-5	37	51	58	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56623	10.1371/journal.pone.0056623	http://dx.doi.org/10.1371/journal.pone.0056623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418588	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300181
J	Hong, IS; Kang, KS				Hong, In-Sun; Kang, Kyung-Sun			The Effects of Hedgehog on the RNA-Binding Protein Msi1 in the Proliferation and Apoptosis of Mesenchymal Stem Cells	PLOS ONE			English	Article							HAIR FOLLICLE DEVELOPMENT; UMBILICAL-CORD BLOOD; C-MYC; SONIC HEDGEHOG; PROGENITOR CELLS; SELF-RENEWAL; EXPRESSION; CANCER; MUSASHI; MARKER	Human umbilical cord blood (UCB)-derived mesenchymal stem cells (MSCs) are essential tools for regenerative medicine due to their capacity for self-renewal and multi-lineage differentiation. As MSCs are found in very small numbers in various tissues, in vitro cell expansion is an essential step that is needed before these cells can be used in clinical applications. Therefore, it is important to identify and characterize factors that are involved in MSC proliferation and apoptosis. In the present study, we focused on Hedgehog (Hh) signaling because several studies have proposed that Hh signaling plays a critical role in controlling the proliferation of stem and progenitor cells. However, the molecular mechanisms underlying the effects on the proliferation and apoptosis of MSCs remain unclear. In this study, we evaluated the direct effects of Hh signaling on the proliferation and apoptosis of hUCB-MSCs as well as investigated potential downstream regulatory mechanisms that may be responsible for Hh signaling. We observed that the Hedgehog agonist purmorphamine enhanced cell proliferation and suppressed apoptosis through the RNA-binding protein Msi1 by regulating the expression of an oncoprotein (i.e., c-Myc), a cell cycle regulatory molecule (i.e., p21(CIP1,WAF1)) and two microRNAs (i.e., miRNA-148a and miRNA-148b). This study provides novel insights into the molecular mechanisms regulating the self-renewal capability of MSCs with relevance to clinical applications.	[Hong, In-Sun; Kang, Kyung-Sun] Seoul Natl Univ, Adult Stem Cell Res Ctr, Seoul, South Korea; [Hong, In-Sun; Kang, Kyung-Sun] Seoul Natl Univ, Dept Vet Publ Hlth, Lab Stem Cell & Tumor Biol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kang, KS (corresponding author), Seoul Natl Univ, Adult Stem Cell Res Ctr, Seoul, South Korea.	kangpub@snu.ac.kr	Kang, Kyung-Sun/G-6205-2013					Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Akasaka Y, 2005, HISTOPATHOLOGY, V47, P348, DOI 10.1111/j.1365-2559.2005.02223.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bhandari DR, 2011, DIFFERENTIATION, V82, P144, DOI 10.1016/j.diff.2011.06.003; Bhandari DR, 2011, J CELL MOL MED, V15, P1603, DOI 10.1111/j.1582-4934.2010.01144.x; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; Copeland N, 2009, CLIN MED, V9, P342, DOI 10.7861/clinmedicine.9-4-342; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; George RJ, 2009, AM J PHYSIOL-GASTR L, V296, pG245, DOI 10.1152/ajpgi.00021.2008; James A.W., 2012, STEM CELLS DEV; Jung CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027740; Kanai R, 2006, J GENE MED, V8, P1329, DOI 10.1002/jgm.965; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kang KS, 2005, CYTOTHERAPY, V7, P368, DOI 10.1080/14653240500238160; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Li N, 2008, STEM CELLS, V26, P1253, DOI 10.1634/stemcells.2007-0691; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Mallick B, 2011, RNA BIOL, V8, P415, DOI 10.4161/rna.8.3.14497; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Muto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033431; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Okano H, 2002, J CELL SCI, V115, P1355; Osterlund T, 2006, TRENDS CELL BIOL, V16, P176, DOI 10.1016/j.tcb.2006.02.004; Park SB, 2012, CELL DEATH DIFFER, V19, P534, DOI 10.1038/cdd.2011.137; Plasilova M, 2009, PLAST RECONSTR SURG, V123, p149S, DOI 10.1097/PRS.0b013e318191c82b; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Raji B, 2007, MOL VIS, V13, P1412; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Sakakibara S, 1997, J NEUROSCI, V17, P8300; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Satoh Y, 2004, J BIOL CHEM, V279, P24986, DOI 10.1074/jbc.M400407200; Saze Z, 2012, DIGEST SURG, V29, P115, DOI 10.1159/000336949; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shin KK, 2012, MOL CELL BIOCH; Shu HJ, 2002, BIOCHEM BIOPH RES CO, V293, P150, DOI 10.1016/S0006-291X(02)00175-4; Siddall NA, 2006, P NATL ACAD SCI USA, V103, P8402, DOI 10.1073/pnas.0600906103; Song Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017687; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Sugiyama-Nakagiri Y, 2006, AM J PATHOL, V168, P80, DOI 10.2353/ajpath.2006.050469; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Wang YM, 2011, RESULTS PROBL CELL D, V53, P459, DOI 10.1007/978-3-642-19065-0_19; Yaddanapudi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026766; Yang Ling, 2012, Int J Biochem Mol Biol, V3, P46; Yokota N, 2004, ONCOGENE, V23, P3444, DOI 10.1038/sj.onc.1207475; Zaragosi LE, 2006, STEM CELLS, V24, P2412, DOI 10.1634/stemcells.2006-0006; Zaragosi LE, 2010, DIABETES, V59, P2513, DOI 10.2337/db10-0013; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	53	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56496	10.1371/journal.pone.0056496	http://dx.doi.org/10.1371/journal.pone.0056496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418578	gold, Green Submitted, Green Published			2022-12-27	WOS:000315970300171
J	Leng, ZW; Tao, KX; Xia, QH; Tan, J; Yue, ZY; Chen, JH; Xi, HL; Li, J; Zheng, H				Leng, Zhengwei; Tao, Kaixiong; Xia, Qinghua; Tan, Jun; Yue, Zhongyi; Chen, Jinhuang; Xi, Hailin; Li, Jie; Zheng, Hai			Kruppel-Like Factor 4 Acts as an Oncogene in Colon Cancer Stem Cell-Enriched Spheroid Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR KLF4; COLORECTAL-CANCER; CARCINOMA CELLS; PROLIFERATION; EXPRESSION; TUMOR; KRUPPEL-LIKE-FACTOR-4; DIFFERENTIATION; INVASION; SURVIVAL	Cancer stem cells (CSCs), a rare population in any type of cancers, including colon cancer, are tumorigenic. It has been thought that CSCs are responsible for cancer recurrence, metastasis, and drug resistance. Isolating CSCs in colon cancers is challenging, and thus the molecular mechanism regulating the self-renewing and differentiation of CSCs remains unknown. We cultured DLD-1 cells, one of types of cells derived from colon cancers, in serum-free medium to obtain spheroid cells. These cells possessed the characteristics of CSCs, with the expression of CD133, CD166, Lgr5, and ALDH1, higher capacities of chemo-resistance, migration, invasion, and tumorigenicity in vitro and in vivo than the adherent DLD-1 cells. Kruppel-like factor 4 (KLF4) is essential factor for maintaining self-renewal of adult and embryonic stem cells. It has been used to induce pluripotent stem cells (iPS) from somatic cells. Since KLF4 is expressed in colon cancer cells, we investigated its role in spheroid cells isolated from DLD-1 cells and found that KLF4 was overexpressed only in spheroid cells and reducing the expression of KLF4 by short-hairpin RNA significantly decreased the capacities of these cells to resist the chemicals, migrate, invade, and generate tumors in vitro and in vivo. The spheroid cells with reduced KLF4 expression also had decreased expression of CSCs markers and mesenchymal markers. Taken together, culturing DLD-1 cells in serum-free medium enriches CSCs and the expression of KLF4 is essential for the characteristics of CSCs in DLD-1; thus KLF4 can be a potential therapeutic target for treating colon cancer.	[Leng, Zhengwei; Tao, Kaixiong; Xia, Qinghua; Tan, Jun; Yue, Zhongyi; Chen, Jinhuang; Xi, Hailin; Zheng, Hai] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gen Surg, Wuhan 430074, Peoples R China; [Li, Jie] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Pediat, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zheng, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gen Surg, Wuhan 430074, Peoples R China.	jixingc2000@yahoo.com.cn			State Foundation for the Natural Sciences of the People's Republic of China [81071541/H1504]	State Foundation for the Natural Sciences of the People's Republic of China	This work was supported by the State Foundation for the Natural Sciences of the People's Republic of China 81071541/H1504 (to HZ) [http://www.nsfc.gov.cn/Portal0/default152.htm]. The funder had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Albasri A, 2009, J PATHOL, V218, P57, DOI 10.1002/path.2508; An J, 2011, FASEB J, V25, P3634, DOI 10.1096/fj.11-186924; Bellizzi A, 2013, J CELL PHYSIOL, V228, P408, DOI 10.1002/jcp.24145; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Carpentino JE, 2009, CANCER RES, V69, P8208, DOI 10.1158/0008-5472.CAN-09-1132; Chen ZY, 2000, FEBS LETT, V477, P67, DOI 10.1016/S0014-5793(00)01764-6; Choijamts B, 2011, STEM CELLS, V29, P1485, DOI 10.1002/stem.711; Clark PA, 2012, NEOPLASIA, V14, P420, DOI 10.1596/neo.12432; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cui X, 2011, CANCER RES, V71, P3676, DOI 10.1158/0008-5472.CAN-10-2926; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dang DT, 2003, ONCOGENE, V22, P3424, DOI 10.1038/sj.onc.1206413; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Elsaba TMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010714; Fan XL, 2012, UROL ONCOL-SEMIN ORI, V30, P314, DOI 10.1016/j.urolonc.2010.03.019; Fan XL, 2011, INT J COLORECTAL DIS, V26, P1279, DOI 10.1007/s00384-011-1248-y; Feng Y, 2012, CELL PROLIFERAT, V45, P413, DOI 10.1111/j.1365-2184.2012.00837.x; Gao DC, 2012, CANCER RES, V72, P4883, DOI 10.1158/0008-5472.CAN-12-1223; Ghaleb AM, 2007, CANCER RES, V67, P7147, DOI 10.1158/0008-5472.CAN-07-1302; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hart LS, 2008, J CLIN ONCOL, V26, P2901, DOI 10.1200/JCO.2008.16.9573; Hart LS, 2011, CELL CYCLE, V10, P2331, DOI 10.4161/cc.10.14.16418; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Kanthan, 2012, PATHOLOG RES INT, V2012, DOI [10.1155/2012/597497, DOI 10.1155/2012/597497]; Kato J, 2011, CANCER RES, V71, P5327, DOI 10.1158/0008-5472.CAN-10-0733; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kobayashi S, 2012, STEM CELLS; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Liu WC, 2012, J HUAZHONG U SCI-MED, V32, P280, DOI 10.1007/s11596-012-0049-z; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Michishita M, 2011, RES VET SCI, V91, P254, DOI 10.1016/j.rvsc.2010.11.016; Nam EH, 2012, CARCINOGENESIS, V33, P563, DOI 10.1093/carcin/bgs005; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; O'Leary DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044176; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rutella S, 2009, CLIN CANCER RES, V15, P4299, DOI 10.1158/1078-0432.CCR-08-1883; Rybak AP, 2011, BBA-MOL CELL RES, V1813, P683, DOI 10.1016/j.bbamcr.2011.01.018; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang SN, 2012, INT J CANCER, V131, P30, DOI 10.1002/ijc.26323; Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Wei B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039069; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wilson BJ, 2011, CURR COLORECT CANC R, V7, P128, DOI 10.1007/s11888-011-0093-2; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zeki SS, 2011, NAT REV GASTRO HEPAT, V8, P90, DOI 10.1038/nrgastro.2010.211; Zhang N, 2012, INT J ONCOL, V40, P2038, DOI 10.3892/ijo.2012.1395; Zhang SS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-85; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	61	91	100	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56082	10.1371/journal.pone.0056082	http://dx.doi.org/10.1371/journal.pone.0056082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418515	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300107
J	Mejak, SL; Bayliss, J; Hanks, SD				Mejak, Sandra L.; Bayliss, Julianne; Hanks, Shayne D.			Long Distance Bicycle Riding Causes Prostate-Specific Antigen to Increase in Men Aged 50 Years and Over	PLOS ONE			English	Article							DIGITAL RECTAL EXAMINATION; ACID-PHOSPHATASE; TRANSURETHRAL RESECTION; FLEXIBLE CYSTOSCOPY; SERUM; EJACULATION; PSA; CANCER; PERCENTAGE; BIOPSY	Objectives: To investigate whether bicycle riding alters total prostate-specific antigen (tPSA) serum concentrations in healthy older men. Methods: 129 male participants, ranging in age from 50 to 71 years (mean 55 years), rode in a recreational group bicycle ride of between 55 and 160 kilometers. Blood samples for tPSA analysis were drawn within 60 minutes before starting, and within 5 minutes after completing the ride. The pre-cycling and post-cycling tPSA values were log transformed for normality and compared using paired t-tests. Linear regression was used to assess the relationship between changes in tPSA with age and distance cycled. Results: Bicycle riding caused tPSA to increase by an average of 9.5% (95% CI = 6.1-12.9; p<0.001) or 0.23 ng/ml. The number of participants with an elevated tPSA (using the standard PSA normal range cut-off of 4.0 ng/ml) increased from two pre-cycle to six post-cycle (or from five to eight when using age-based normal ranges). Univariate linear regression analysis revealed that the change in tPSA was positively correlated with age and the distance cycled. Conclusions: Cycling causes an average 9.5% increase in tPSA, in healthy male cyclists >= 50 years old, when measured within 5 minutes post cycling. We considered the increase clinically significant as the number of participants with an elevated PSA, according to established cut-offs, increased post-ride. Based on the research published to date, the authors suggest a 24-48 hour period of abstinence from cycling and ejaculation before a PSA test, to avoid spurious results.	[Mejak, Sandra L.] Victorian Inst Sport, Dept Sports Med, Melbourne, Vic, Australia; [Bayliss, Julianne] Monash Univ, Alfred Hosp, Dept Med, Melbourne, Vic 3181, Australia; [Hanks, Shayne D.] Performance Boost, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; Monash University	Mejak, SL (corresponding author), Victorian Inst Sport, Dept Sports Med, Melbourne, Vic, Australia.	sandramejak@gmail.com	Bayliss, Julianne/I-2227-2014	Bayliss, Julianne/0000-0003-3578-4952	Victorian Institue of Sport	Victorian Institue of Sport	The Victorian Institue of Sport (www.vis.org.au) funded the blood analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics report, 2009, AUSTRALIAN BUREAU OF; Banfi G, 1997, CLIN CHEM, V43, P1465; Coley CM, 1997, ANN INTERN MED, V126, P468, DOI 10.7326/0003-4819-126-6-199703150-00010; Collins GN, 1997, J UROLOGY, V157, P1744, DOI 10.1016/S0022-5347(01)64849-3; DeCastro BJ, 2009, UROLOGY, V73, P237, DOI 10.1016/j.urology.2008.09.011; DEJTER SW, 1988, UROLOGY, V32, P288, DOI 10.1016/0090-4295(88)90228-2; Dixon SC, 2001, PHARMACOL REV, V53, P73; ELSHIRBINY AMF, 1990, UROLOGY, V35, P88, DOI 10.1016/0090-4295(90)80023-G; Frymann RJ, 2006, INT UROL NEPHROL, V38, P161, DOI 10.1007/s11255-005-1661-7; Gregorakis AK, 2005, CLIN CHIM ACTA, V357, P196, DOI 10.1016/j.cccn.2005.03.027; Herrmann M, 2004, CLIN CHEM LAB MED, V42, P347, DOI 10.1515/CCLM.2004.061; Herschman JD, 1997, UROLOGY, V50, P239, DOI 10.1016/S0090-4295(97)00209-4; Kindermann W, 2011, UROLOGE, V50, P188, DOI 10.1007/s00120-010-2489-z; KIRKALI Z, 1995, EUR UROL, V27, P292; Lechevallier E, 1999, UROLOGY, V54, P857, DOI 10.1016/S0090-4295(99)00239-3; Lechevallier E, 1999, UROLOGY, V53, P731, DOI 10.1016/S0090-4295(98)00607-4; Lippi G, 2005, INT J SPORTS MED, V26, P79, DOI 10.1055/s-2004-830450; Luboldt HJ, 2003, UROLOGY, V61, P1177, DOI 10.1016/S0090-4295(03)00007-4; OESTERLING JE, 1993, UROLOGY, V42, P276, DOI 10.1016/0090-4295(93)90616-I; OESTERLING JE, 1995, J UROLOGY, V154, P1090, DOI 10.1016/S0022-5347(01)66984-2; Oremek GM, 1996, CLIN CHEM, V42, P691; Ornstein DK, 1997, J UROLOGY, V157, P195, DOI 10.1016/S0022-5347(01)65321-7; PRICE A, 1991, CLIN CHEM, V37, P859; RANA A, 1994, J UROLOGY, V151, P700, DOI 10.1016/S0022-5347(17)35053-X; Richardson TD, 1996, UROLOGY, V48, P40, DOI 10.1016/S0090-4295(96)00608-5; Rodriguez-Rubio FI, 1998, EUR UROL, V33, P255, DOI 10.1159/000019577; Safford HR, 1996, J UROLOGY, V156, P103, DOI 10.1016/S0022-5347(01)65954-8; Saka T, 2009, UROLOGY, V74, P1325, DOI 10.1016/j.urology.2009.07.1219; SIMAK R, 1993, J UROLOGY, V150, P895, DOI 10.1016/S0022-5347(17)35642-2; STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501; Stamey TA, 1989, MONOGR UROL, V10, P49; Stenner J, 1998, UROLOGY, V51, P455, DOI 10.1016/S0090-4295(97)00635-3; Swain RA, 1997, ARCH FAM MED, V6, P500, DOI 10.1001/archfami.6.5.500; Tchetgen MB, 1996, UROLOGY, V47, P511, DOI 10.1016/S0090-4295(99)80486-5; The Cancer Council Queensland, THE CANCER COUNCIL Q; THOMSON RD, 1992, AM J CLIN PATHOL, V97, P528, DOI 10.1093/ajcp/97.4.528; WANG MC, 1981, PROSTATE, V2, P89, DOI 10.1002/pros.2990020109	37	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56030	10.1371/journal.pone.0056030	http://dx.doi.org/10.1371/journal.pone.0056030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418500	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300092
J	Morisaki, N; Ohuchi, A; Moriwaki, S				Morisaki, Naoko; Ohuchi, Atsushi; Moriwaki, Shigeru			The Role of Neprilysin in Regulating the Hair Cycle	PLOS ONE			English	Article							NEUTRAL ENDOPEPTIDASE; FOLLICLE DEVELOPMENT; ELASTIC FIBERS; GROWTH CYCLE; DERMAL PAPILLA; MOUSE HAIR; EXPRESSION; MICE; RAT; SKIN	In most mammals, each hair follicle undergoes a cyclic process of growing, regressing and resting phases (anagen, catagen, telogen, respectively) called the hair cycle. Various biological factors have been reported to regulate or to synchronize with the hair cycle. Some factors involved in the extracellular matrix, which is a major component of skin tissue, are also thought to regulate the hair cycle. We have focused on an enzyme that degrades elastin, which is associated with skin elasticity. Since our previous study identified skin fibroblast elastase as neprilysin (NEP), we examined the fluctuation of NEP enzyme activity and its expression during the synchronized hair cycle of rats. NEP activity in the skin was elevated at early anagen, and decreased during catagen to telogen. The expression of NEP mRNA and protein levels was modulated similarly. Immunostaining showed changes in NEP localization throughout the hair cycle, from the follicular epithelium during early anagen to the dermal papilla during catagen. To determine whether NEP plays an important role in regulating the hair cycle, we used a specific inhibitor of NEP (NPLT). NPLT was applied topically daily to the dorsal skin of C3H mice, which had been depilated in advance. Mice treated with NPLT had significantly suppressed hair growth. These data suggest that NEP plays an important role in regulating the hair cycle by its increased expression and activity in the follicular epithelium during early anagen.				morisaki.naoko@kao.co.jp			Kao Corporation	Kao Corporation	This work was supported by Kao Corporation (http://www.kao.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arck PC, 2003, AM J PATHOL, V162, P803, DOI 10.1016/S0002-9440(10)63877-1; Bayer-Garner IB, 2002, AM J DERMATOPATH, V24, P484, DOI 10.1097/00000372-200212000-00005; CASEY ML, 1991, J BIOL CHEM, V266, P23041; CIPRIANI C, 1976, ARCH DERMATOL RES, V256, P319, DOI 10.1007/BF00572498; CONNELLY JC, 1993, J LEUKOCYTE BIOL, V53, P685, DOI 10.1002/jlb.53.6.685; COUCHMAN JR, 1990, J INVEST DERMATOL, V94, P65, DOI 10.1111/1523-1747.ep12873363; CROVATO F, 1975, ARCH DERMATOL FORSCH, V251, P325; DIVANO C, 1979, ARCH DERMATOL RES, V266, P135, DOI 10.1007/BF00694623; DUCROS DL, 1995, J INVEST DERMATOL, V105, P426, DOI 10.1111/1523-1747.ep12321131; Fujita S, 2007, ANTICANCER RES, V27, P3307; Graf K, 1998, BASIC RES CARDIOL, V93, P11, DOI 10.1007/s003950050056; Hamada K, 1996, EXP ANIM TOKYO, V45, P251, DOI 10.1538/expanim.45.251; HANDJISKI BK, 1994, BRIT J DERMATOL, V131, P303, DOI 10.1111/j.1365-2133.1994.tb08515.x; Holub BS, 2012, BRIT J DERMATOL, V167, P10, DOI 10.1111/j.1365-2133.2012.10890.x; Huang WB, 2005, JPN J CLIN ONCOL, V35, P245, DOI 10.1093/jjco/hyi076; KAWABE TT, 1994, J INVEST DERMATOL, V103, P122, DOI 10.1111/1523-1747.ep12391894; KAWABE TT, 1991, DEVELOPMENT, V111, P877; Kramer HH, 2005, EXP NEUROL, V195, P179, DOI 10.1016/j.expneurol.2005.04.015; Maguer-Satta V, 2011, STEM CELLS, V29, P389, DOI 10.1002/stem.592; MANIL L, 1981, BRIT J CANCER, V43, P210, DOI 10.1038/bjc.1981.30; MESSENGER AG, 1991, J INVEST DERMATOL, V96, pS75, DOI 10.1111/1523-1747.ep12471914; Morisaki N, 2010, J BIOL CHEM, V285, P39819, DOI 10.1074/jbc.M110.161547; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nakagawa K, 1987, SKIN RES, V29, P793; Ogawa H, 1983, Curr Probl Dermatol, V11, P159; Oka T, 1993, Nihon Yakurigaku Zasshi, V101, P197; Olerud JE, 1999, J INVEST DERMATOL, V112, P873, DOI 10.1046/j.1523-1747.1999.00596.x; Panteleyev AA, 2000, EXP DERMATOL, V9, P146, DOI 10.1034/j.1600-0625.2000.009002146.x; Paus R, 1999, J INVEST DERM SYMP P, V4, P338, DOI 10.1038/sj.jidsp.5640241; PINKUS H, 1978, J CUTAN PATHOL, V5, P93, DOI 10.1111/j.1600-0560.1978.tb00946.x; Poblet E, 2008, BRIT J DERMATOL, V159, P646, DOI 10.1111/j.1365-2133.2008.08741.x; ROMAN N, 1967, STAIN TECHNOL, V42, P199, DOI 10.3109/10520296709115008; ROQUES BP, 1993, PHARMACOL REV, V45, P87; SAWAYA ME, 1992, J CUTAN PATHOL, V19, P309, DOI 10.1111/j.1600-0560.1992.tb01367.x; Solan NJ, 1998, INFLAMMATION, V22, P107, DOI 10.1023/A:1022304025789; Starcher B, 2005, J HISTOCHEM CYTOCHEM, V53, P431, DOI 10.1369/jhc.4A6484.2005; TAYLOR M, 1992, BRIT J DERMATOL, V126, P479, DOI 10.1111/j.1365-2133.1992.tb15120.x; Toyoda M, 2001, BRIT J DERMATOL, V144, P46, DOI 10.1046/j.1365-2133.2001.03951.x; Tsuji N, 2001, PHOTOCHEM PHOTOBIOL, V74, P283, DOI 10.1562/0031-8655(2001)074<0283:TROESB>2.0.CO;2; VIJAYARAGHAVAN J, 1990, J BIOL CHEM, V265, P14150; Walther T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004590; WOLLINA U, 1995, HISTOL HISTOPATHOL, V10, P39; Yamazaki M, 1999, J INVEST DERM SYMP P, V4, P312, DOI 10.1038/sj.jidsp.5640236; YU DW, 1995, J CELL SCI, V108, P3867; YUSPA SH, 1993, J INVEST DERMATOL, V101, pS27, DOI 10.1111/1523-1747.ep12362567	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55947	10.1371/journal.pone.0055947	http://dx.doi.org/10.1371/journal.pone.0055947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418484	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300076
J	Rey-Santano, C; Mielgo, V; Gastiasoro, E; Valls-i-Soler, A; Murgia, X				Rey-Santano, Carmen; Mielgo, Victoria; Gastiasoro, Elena; Valls-i-Soler, Adolfo; Murgia, Xabier			Effect of Surfactant and Partial Liquid Ventilation Treatment on Gas Exchange and Lung Mechanics in Immature Lambs: Influence of Gestational Age	PLOS ONE			English	Article							PULMONARY MECHANICS; PRETERM LAMBS; CARDIOPULMONARY FUNCTION; EXOGENOUS SURFACTANT; PREMATURE LAMBS; BLOOD-FLOW; PERFLUOROCARBON; INFANTS; HEMODYNAMICS	Objectives: Surfactant (SF) and partial liquid ventilation (PLV) improve gas exchange and lung mechanics in neonatal RDS. However, variations in the effects of SF and PLV with degree of lung immaturity have not been thoroughly explored. Setting: Experimental Neonatal Respiratory Physiology Research Unit, Cruces University Hospital. Design: Prospective, randomized study using sealed envelopes. Subjects: 36 preterm lambs were exposed (at 125 or 133-days of gestational age) by laparotomy and intubated. Catheters were placed in the jugular vein and carotid artery. Interventions: All the lambs were assigned to one of three subgroups given: 20 mL/Kg perfluorocarbon and managed with partial liquid ventilation (PLV), surfactant (Curosurf (R), 200 mg/kg) or (3) no pulmonary treatment (Controls) for 3 h. Measurements and Main Results: Cardiovascular parameters, blood gases and pulmonary mechanics were measured. In 125-day gestation lambs, SF treatment partially improved gas exchange and lung mechanics, while PLV produced significant rapid improvements in these parameters. In 133-day lambs, treatments with SF or PLV achieved similarly good responses. Neither surfactant nor PLV significantly affected the cardiovascular parameters. Conclusion: SF therapy response was more effective in the older gestational age group whereas the effectiveness of PLV therapy was not gestational age dependent.	[Rey-Santano, Carmen; Mielgo, Victoria; Gastiasoro, Elena; Murgia, Xabier] Cruces Univ Hosp, Res Unit Expt Neonatal Resp Physiol, Baracaldo, Bizkaia, Spain; [Valls-i-Soler, Adolfo] Cruces Univ Hosp, Neonatal Intens Care Unit, Baracaldo, Bizkaia, Spain	Hospital Universitario Cruces; Hospital Universitario Cruces	Rey-Santano, C (corresponding author), Cruces Univ Hosp, Res Unit Expt Neonatal Resp Physiol, Baracaldo, Bizkaia, Spain.	macarmen.reysantano@osakidetza.net			Spanish Health Institute Carlos III [FIS 10/943, RD08/072]	Spanish Health Institute Carlos III(Instituto de Salud Carlos III)	This study was partially supported by grants from the Spanish Health Institute Carlos III: FIS 10/943 and RD08/072 (Red SAMID: Maternal, Child Health and Development Research Network, within the framework of the VI National I+D+i Research Program 2008-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALCORN DG, 1981, ANAT REC, V201, P655, DOI 10.1002/ar.1092010410; BHUTANI VK, 1988, PEDIATR PULM, V4, P150, DOI 10.1002/ppul.1950040306; BORN GVR, 1955, J PHYSIOL-LONDON, V130, P191, DOI 10.1113/jphysiol.1955.sp005403; Cochrane CG, 1996, AM J RESP CRIT CARE, V153, P404, DOI 10.1164/ajrccm.153.1.8542150; Cox C, 2003, BIOL NEONATE, V84, P232, DOI 10.1159/000072307; Davies MW, 2010, NEONATOLOGY, V97, P144, DOI 10.1159/000239768; Davies MW, 2002, CRIT CARE MED, V30, P1123, DOI 10.1097/00003246-200205000-00027; Degraeuwe PLJ, 2006, AM J RESP CRIT CARE, V174, P615, DOI 10.1164/ajrccm.174.5.615; DEGRAEUWE PLJ, 1995, INT J ARTIF ORGANS, V18, P674, DOI 10.1177/039139889501801020; Doctor A, 1998, J APPL PHYSIOL, V84, P1540, DOI 10.1152/jappl.1998.84.5.1540; Gastiasoro Cuesta E, 2006, PEDIATRICS, V117, P295; Gastiasoro Cuesta E, 2001, PEDIATR CRIT CARE ME, V2, P334; GREENSPAN JS, 1989, LANCET, V2, P1095; Hillman NH, 2011, AM J PHYSIOL-LUNG C, V300, pL232, DOI 10.1152/ajplung.00294.2010; HIRSCHL RB, 1995, LANCET, V346, P1201, DOI 10.1016/S0140-6736(95)92903-7; HODSON WA, 1992, FETAL NEONATAL PHYSL, P771; Houmes RJM, 1995, INTENS CARE MED, V21, P966, DOI 10.1007/BF01700657; IKEGAMI M, 1987, PEDIATRICS, V79, P38; Ikegami M, 1996, J APPL PHYSIOL, V81, P2517, DOI 10.1152/jappl.1996.81.6.2517; Ikegami M, 1987, J APPL PHYSIOL, V67, P429; JACOBS H, 1982, PEDIATR RES, V16, P424, DOI 10.1203/00006450-198206000-00005; JOBE A, 1983, PEDIATR RES, V17, P444, DOI 10.1203/00006450-198306000-00002; Kacmarek RM, 2006, AM J RESP CRIT CARE, V173, P882, DOI 10.1164/rccm.200508-1196OC; Kusuda S, 2000, J PERINAT MED, V28, P363, DOI 10.1515/JPM.2000.046; Leach CL, 1996, NEW ENGL J MED, V335, P761, DOI 10.1056/NEJM199609123351101; LOWE CA, 1986, J APPL PHYSIOL, V60, P154, DOI 10.1152/jappl.1986.60.1.154; MAETA H, 1988, EUR J PEDIATR, V147, P162, DOI 10.1007/BF00442215; Mrozek JD, 1997, AM J RESP CRIT CARE, V156, P1058, DOI 10.1164/ajrccm.156.4.9610104; Murgia X, 2012, PEDIATR RES, V72, P393, DOI 10.1038/pr.2012.90; Pinkerton KE, 2000, ENVIRON HEALTH PERSP, V108, P457, DOI 10.2307/3454537; Rey-Santano C, 2011, PEDIATR PULM, V46, P991, DOI 10.1002/ppul.21460; Rey-Santano C, 2012, PEDIATR CRIT CARE ME, V13, pE187, DOI 10.1097/PCC.0b013e318238b17f; ROBERTSON B, 1991, EUR J PEDIATR, V150, P433; Rudiger M, 2004, J CRIT CARE, V19, P42, DOI 10.1016/j.jcrc.2004.02.008; SEGERER H, 1991, PEDIATR RES, V30, P591, DOI 10.1203/00006450-199112000-00022; SHAFFER TH, 1983, PEDIATR RES, V17, P303, DOI 10.1203/00006450-198304000-00017; SHAFFER TH, 1983, PEDIATR RES, V17, P680, DOI 10.1203/00006450-198308000-00016; Shaffer TH, 2012, FETAL NEONATAL PHYSL, P1063; Soll R.F., 1994, NEW THERAPIES NEONAT, P49; Sweet D, 2007, J PERINAT MED, V35, P175, DOI 10.1515/JPM.2007.048; Valls-i-Soler A, 2001, BIOL NEONATE, V80, P29, DOI 10.1159/000047175; WILCOX DT, 1995, CRIT CARE MED, V23, P1858, DOI 10.1097/00003246-199511000-00012; WOLFSON MR, 1990, J DEV PHYSIOL, V13, P1; WOLFSON MR, 1992, J APPL PHYSIOL, V72, P1024, DOI 10.1152/jappl.1992.72.3.1024	44	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56127	10.1371/journal.pone.0056127	http://dx.doi.org/10.1371/journal.pone.0056127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418521	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300113
J	Sangster, G; King, BF; Verbelen, P; Trainor, CR				Sangster, George; King, Ben F.; Verbelen, Philippe; Trainor, Colin R.			A New Owl Species of the Genus Otus (Aves: Strigidae) from Lombok, Indonesia	PLOS ONE			English	Article							SCREECH-OWLS; STRIGIFORMES; GLAUCIDIUM; PHYLOGENY	The avifauna of Indonesia is one of the richest in the world but the taxonomic status of many species remains poorly documented. The sole species of scops owl known from Lombok has long been assigned to the widespread Moluccan Scops Owl Otus magicus on the basis of superficial similarities in morphology. Field work in 2003 has shown that the territorial song of the scops owls inhabiting the foothills of Gunung Rinjani differs dramatically from that of O. magicus and is more similar to those of Rufescent Scops Owl O. rufescens and Singapore Scops Owl O. cnephaeus. Detailed comparisons of sound recordings and museum specimens with those of other scops owls in Wallacea and the Indo-Malayan region have confirmed the distinctiveness of the Lombok population. We describe Otus jolandae as a new species, the Rinjani Scops Owl. It is locally common at elevations from 25-1350 m. and occurs within Gunung Rinjani National Park. The new species is known from seven specimens collected by Alfred Everett in 1896. Otus jolandae represents the first endemic bird species from Lombok.	[Sangster, George] Swedish Museum Nat Hist, Dept Vertebrate Zool, S-10405 Stockholm, Sweden; [Sangster, George] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [King, Ben F.] Amer Museum Nat Hist, Dept Ornithol, New York, NY 10024 USA	Swedish Museum of Natural History; Stockholm University; American Museum of Natural History (AMNH)	Sangster, G (corresponding author), Swedish Museum Nat Hist, Dept Vertebrate Zool, S-10405 Stockholm, Sweden.	george.sangster@nrm.se	Trainor, Colin R/E-3751-2010; Sangster, George/H-4901-2019	Trainor, Colin R/0000-0002-0194-7533; Sangster, George/0000-0002-2475-7468				Currie D, 2002, BIRD CONSERV INT, V12, P353, DOI 10.1017/S0959270902002228; Del Hoyo J, 1999, HDB BIRDS WORLD, V5; Dickinson EC., 2003, HOWARD MOORE COMPLET; Eck S, 1973, ZOOLOGISCHEN ABHANDL, V23, P155; Fuchs J, 2007, CONDOR, V109, P408, DOI 10.1650/0010-5422(2007)109[408:GSOGVI]2.0.CO;2; Fuchs J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-197; Gibbs D, 1990, WALLACEA PRIVATELY P; Hartert E., 1896, NOVITATES ZOOLOGICAE, V3, P591; Hartet E., 1896, Novitates Zoologicae, Viii, P537; HEIDRICH P, 1995, Z NATURFORSCH C, V50, P294; Heidrich P, 1996, STUTTGARTER BEITRA A, V534, P1; Hill FAR, 1998, EMU, V98, P209, DOI 10.1071/MU98029; Holyoak DT., 2001, NIGHTJARS THEIR ALLI; HOWELL SNG, 1995, WILSON BULL, V107, P7; Int Commission Zoological Nomencla, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.219.3944; Johnson D H, 2009, ARDEA, V97, P395; K/nig C., 2008, OWLS GUIDE OWLS WORL; Koenig Claus, 2000, P781; Konig C., 1991, Oekologie der Voegel, V13, P15; Konig Claus, 1994, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V511, P1; Kuroda N., 1930, Tori Tokyo, V6, P65; Kusch Heinrich, 1998, Hoehle, V49, P5; Lafontaine Rene-Marie, 1998, Journal of African Zoology, V112, P163; Lambert Frank R., 1998, Bulletin of the British Ornithologists' Club, V118, P204; Marshall JT, 1988, P W FDN VERT ZOOL, V3, p[331, 295]; Marshall JT., 1978, ORNITHOLOGICAL MONOG, V25, P1, DOI [DOI 10.2307/40166757, 10.2307/40166757]; Miranda HC, 2011, WILSON J ORNITHOL, V123, P441, DOI 10.1676/10-185.1; Morony JJ, 1975, REFERENCE LIST BIRDS; Myers Susan D., 2005, Forktail, V21, P147; Norman JA, 1998, EMU, V98, P197, DOI 10.1071/MU98028; RENSCH BERNHARD, 1931, MITTEIL ZOOL MUS BERLIN, V17, P451; Ridgway R., 1912, COLOR STANDARDS COLO; ROBBINS MB, 1995, WILSON BULL, V107, P1; Sangster G., 2004, Zoologische Verhandelingen (Leiden), V350, P7; Smithe F.B, 1975, NATURALISTS COLOR GU; SPSS INSTITUTE, 2008, SPSS WIND VERS 16 0; Van der Weijden W.J., 1973, Bulletin Inst fond Afr noire (Sci nat), V35, P716; VANDERWEYDEN WJ, 1973, IBIS, V115, P129; VANDERWEYDEN WJ, 1974, IBIS, V116, P369; Vorderman AG, 1895, NAT TIJDSCHR NED IND, V54, P327; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wallace AR, 1863, P ZOOL SOC LOND, V1863, P480; WEBSTER PJ, 1978, QUATERNARY RES, V10, P279, DOI 10.1016/0033-5894(78)90024-8; Weick F, 2006, OWLS STRIGIFORMES; White C.M.N., 1986, BIRDS WALLACEA, V7; Widodo Wahyu, 1999, Forktail, V15, P15	46	21	24	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e53712	10.1371/journal.pone.0053712	http://dx.doi.org/10.1371/journal.pone.0053712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418422	gold, Green Published			2022-12-27	WOS:000315970300012
J	Wang, Z; Li, JJ; Wang, CX; Yao, XM; Zhao, XQ; Wang, YL; Li, H; Liu, GF; Wang, AX; Wang, YJ				Wang, Zhan; Li, Jingjing; Wang, Chunxue; Yao, Xiaomei; Zhao, Xingquan; Wang, Yilong; Li, Hao; Liu, Gaifen; Wang, Anxin; Wang, Yongjun			Gender Differences in 1-Year Clinical Characteristics and Outcomes after Stroke: Results from the China National Stroke Registry	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; HEALTH-INSURANCE SYSTEM; SEX-DIFFERENCES; ISCHEMIC-STROKE; MORTALITY; CARE; MANAGEMENT; DISABILITY; SCALE	Background: Previous reports have shown inconsistent results on clinical outcomes between women and men after stroke, and little is known about gender differences on outcomes in Chinese post-stroke patients. The aim of this study was to explore whether there were gender differences on clinical characteristics and outcomes in Chinese patients after ischemic stroke by using the data from the China National Stroke Registry (CNSR). Methods and Findings: Out of 12,415 consecutively recruited patients with acute ischemic stroke in the CNSR from 2007 to 2008, 11,560 (93.1%) patients were followed up for 12 months. Their clinical characteristics and outcomes on death, recurrence, and dependency were recorded. The multivariate logistic regression was performed to determine whether there were gender differences in these outcomes. Women were older than men at baseline (67.9 vs. 64.0 years, P<0.001). Women had a higher mortality, recurrence rate, and dependency rate at 3, 6, and 12 months than men, but after adjusting for age, history of diabetes, pre-stroke dependency, stroke severity, in-hospital complications, and other confounders, there were no statistically significant differences in gender on mortality and recurrence rate at 3, 6, and 12 months; and dependency rate at 3, and 6 months. However, the dependency rate at 12 months remained significantly higher in women (odds ratio, 1.24; 95% confidence interval, 1.06 to 1.45). Conclusions: There are many differences in clinical characteristics between women and men after ischemic stroke in China. Compared with men, women are more dependent at 12 months after stroke. This difference still exists after controlling the potential confounders.	[Wang, Zhan; Li, Jingjing; Wang, Chunxue; Zhao, Xingquan; Wang, Yilong; Li, Hao; Liu, Gaifen; Wang, Anxin; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Yao, Xiaomei] McMaster Univ, Dept Oncol, Hamilton, ON L8S 4L8, Canada	Capital Medical University; McMaster University	Wang, YJ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.	snow_sen@yahoo.com	Li, Hao/GPS-9834-2022		Ministry of Science and Technology; Ministry of Health of the People's Republic of China; National S & T Major Project of China [2011BAI08B02]; Research Special Fund For Public Welfare Industry of Health [200902004]; State Key Development, Program of Basic Research of China [2009CB521905]; National Science Foundation [81071115]; Beijing Science and Technology Committee [7102050]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China; National S & T Major Project of China; Research Special Fund For Public Welfare Industry of Health; State Key Development, Program of Basic Research of China(State Key Development Program for Basic Research of China); National Science Foundation(National Science Foundation (NSF)); Beijing Science and Technology Committee	This study was funded by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China and the Grant No. is National S & T Major Project of China (2011BAI08B02) and by the Research Special Fund For Public Welfare Industry of Health (200902004). Grants were received from State Key Development, Program of Basic Research of China [2009CB521905], the National Science Foundation (grant no. 81071115), and the Beijing Science and Technology Committee (grant no. 7102050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NB, 2009, CEREBROVASC DIS, V27, P254, DOI 10.1159/000196824; [Anonymous], 1989, Stroke, V20, P1407; Bateman BT, 2006, STROKE, V37, P440, DOI 10.1161/01.STR.0000199851.24668.f1; Benatru I, 2006, STROKE, V37, P1674, DOI 10.1161/01.STR.0000226979.56456.a8; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Caso V, 2010, WOMENS HEALTH, V6, P51, DOI [10.2217/whe.09.82, 10.2217/WHE.09.82]; Chen Z, 2008, REPORT 3 NATL DEATH; Deng YZ, 2006, NEUROLOGY, V66, P306, DOI 10.1212/01.wnl.0000196478.77152.fc; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; Dong KY, 2009, CHINA ECON REV, V20, P591, DOI 10.1016/j.chieco.2009.05.011; Eriksson M, 2009, STROKE, V40, P909, DOI 10.1161/STROKEAHA.108.517581; Fukuda M, 2009, INTERNAL MED, V48, P967, DOI 10.2169/internalmedicine.48.1757; Gargano JW, 2008, STROKE, V39, P24, DOI 10.1161/STROKEAHA.107.493262; Gargano JW, 2007, STROKE, V38, P2541, DOI 10.1161/STROKEAHA.107.485482; Glader EL, 2003, STROKE, V34, P1970, DOI 10.1161/01.STR.0000083534.81284.C5; Holroyd-Leduc JM, 2000, STROKE, V31, P1833, DOI 10.1161/01.STR.31.8.1833; Huang YN, 2010, INT J STROKE, V5, P351, DOI 10.1111/j.1747-4949.2010.00460.x; Jia Q, 2011, STROKE, V42, P2758, DOI 10.1161/STROKEAHA.111.621649; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Kapral MK, 2005, STROKE, V36, P809, DOI 10.1161/01.STR.0000157662.09551.e5; Kapral MK, 2011, WOMEN HEALTH ISS, V21, P171, DOI 10.1016/j.whi.2010.10.002; Kong FY, 2010, CEREBROVASC DIS, V29, P255, DOI 10.1159/000267852; Lewsey JD, 2009, STROKE, V40, P1038, DOI 10.1161/STROKEAHA.108.542787; Liu YL, 2004, HEALTH POLICY PLANN, V19, P159, DOI 10.1093/heapol/czh019; Liu YL, 2002, HEALTH POLICY, V60, P133, DOI 10.1016/S0168-8510(01)00207-X; Niewada M, 2005, NEUROEPIDEMIOLOGY, V24, P123, DOI 10.1159/000082999; Oh S, 2009, CEREBROVASC DIS, V28, P427, DOI 10.1159/000235986; Palm F, 2012, CEREBROVASC DIS, V33, P69, DOI 10.1159/000333417; Palnum KD, 2009, STROKE, V40, P1134, DOI 10.1161/STROKEAHA.108.543819; Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Reid JM, 2008, STROKE, V39, P1090, DOI 10.1161/STROKEAHA.107.495143; Roquer J, 2003, STROKE, V34, P1581, DOI 10.1161/01.STR.0000078562.82918.F6; Saji N, 2011, J STROKE CEREBROVASC, V20, P231, DOI 10.1016/j.jstrokecerebrovasdis.2009.12.005; Sheikh K, 2007, STROKE, V38, P1085, DOI 10.1161/01.STR.0000258103.15708.58; Silva GS, 2010, CEREBROVASC DIS, V30, P470, DOI 10.1159/000317088; TEASDALE G, 1974, LANCET, V2, P81; Turaj W, 2009, STROKE, V40, P980, DOI 10.1161/STROKEAHA.108.528422; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; Zhang B, 2011, ATHEROSCLEROSIS, V216, P420, DOI 10.1016/j.atherosclerosis.2011.02.002	41	212	242	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56459	10.1371/journal.pone.0056459	http://dx.doi.org/10.1371/journal.pone.0056459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418571	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300164
J	Yu, JP; Ren, XB; Chen, YZ; Liu, PP; Wei, XY; Li, H; Ying, GG; Chen, KX; Winkler, H; Hao, XS				Yu, Jinpu; Ren, Xiubao; Chen, Yongzi; Liu, Pengpeng; Wei, Xiyin; Li, Hui; Ying, Guoguang; Chen, Kexin; Winkler, Hans; Hao, Xishan			Dysfunctional Activation of Neurotensin/IL-8 Pathway in Hepatocellular Carcinoma Is Associated with Increased Inflammatory Response in Microenvironment, More Epithelial Mesenchymal Transition in Cancer and Worse Prognosis in Patients	PLOS ONE			English	Article							INTERLEUKIN-8 EXPRESSION; TUMOR ANGIOGENESIS; IN-VITRO; CELLS; GROWTH; SUPPRESSION; PREDICTION; TARGET; IDENTIFICATION; SOFTWARE	Aim: To investigate the role of neurotensin (NTS) in hepatocellular carcinoma (HCC) sub-grouping and the clinical and pathological significance of activation of NTS/IL-8 pathway in HCC. Methods: The genome-wide gene expression profiling were conducted in 10 pairs of cancer tissues and corresponding normal adjacent tissues samples using Affymetrix GeneChip (R) Human Genome U133 Plus 2.0 microarray to screen differentially expressing genes and enrich dysfunctional activated pathways among different HCC subgroups. The levels of NTS protein and multiple inflammation and epithelial mesenchymal transition (EMT) related proteins, including IL-8, VEGF, MMP9, CD68, E-Cadherin, beta-Catenin and Vimentin were examined in 64 cases of paraffin-embedded HCC samples using immunohistochemistry (IHC) staining method. The clinical outcome and overall survival (OS) were compared. Results: A subgroup of HCC characterized by up-regulated NTS expression was accompanied by up-regulated inflammatory responses and EMT. The direct interaction between NTS and IL-8 was identified by pathway enrichment analysis. Significantly increased IL-8 protein was confirmed in 90.91% of NTS+HCC samples and significantly positively correlated to the levels of NTS protein in cancer tissues (P = 0.036), which implied activation of NTS/IL-8 pathway in HCC. The levels of VEGF and MMP9 correlated with co-expression of NTS and IL-8. Increased infiltration of CD68(+) macrophages and more cancer cells displaying EMT features were found in NTS+ IL-8(+) samples. The co-expression of NTS and IL-8 in cancer significantly correlated with the clinical outcomes, as the mortality rate of NTS+IL-8(+) HCC patients is 2.5-fold higher than the others after the surgery (P = 0.022). Accordingly, the OS of NTS+IL-8(+) HCC patients significantly decreased who are under a higher hazard of death at an expected hazard ratio (HR) of 3.457. Conclusion: Dysfunctional activation of the NTS/IL-8 pathway was detected in HCC which is associated with increased inflammatory response in microenvironment, enhanced EMT in cancer, and worse prognosis in HCC patients.	[Yu, Jinpu; Liu, Pengpeng; Winkler, Hans; Hao, Xishan] Tianjin Med Univ Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, TMUCIH JnJ Joint Lab, Tianjin, Peoples R China; [Yu, Jinpu; Ren, Xiubao; Liu, Pengpeng; Li, Hui] Tianjin Med Univ Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Dept Immunol, Tianjin, Peoples R China; [Chen, Yongzi; Wei, Xiyin; Ying, Guoguang] Tianjin Med Univ Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Canc Cell Biol Lab, Tianjin, Peoples R China; [Chen, Kexin] Tianjin Med Univ Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Dept Epidemiol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Hao, XS (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, TMUCIH JnJ Joint Lab, Tianjin, Peoples R China.	hxs_yjp@yahoo.com		YU, JINPU/0000-0002-5982-2266; chen, yongzi/0000-0003-3396-7130; Chen, Kexin/0000-0003-4248-7681	National Natural Science Foundation of China [81272360]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81272360), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorino GP, 2007, ONCOGENE, V26, P745, DOI 10.1038/sj.onc.1209814; Andrisani OM, 2011, SEMIN CANCER BIOL, V21, P4, DOI 10.1016/j.semcancer.2010.09.002; Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Budhu A, 2006, CANCER CELL, V10, P99, DOI 10.1016/j.ccr.2006.06.016; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Carraway RE, 2006, PEPTIDES, V27, P2445, DOI 10.1016/j.peptides.2006.04.030; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crivellato E, 2008, CANCER LETT, V269, P1, DOI 10.1016/j.canlet.2008.03.031; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Larco JE, 2004, CLIN CANCER RES, V10, P4895, DOI 10.1158/1078-0432.CCR-03-0760; Ding W, 2010, HEPATOLOGY, V52, P945, DOI 10.1002/hep.23748; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Gohlmann H, 2009, GENE EXPRESSION STUD; Huynh H, 2008, J HEPATOL, V49, P52, DOI 10.1016/j.jhep.2008.02.022; Iizuka N, 2008, CANCER SCI, V99, P659, DOI 10.1111/j.1349-7006.2008.00751.x; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Labbozzetta M, 2006, ANN NY ACAD SCI, V1089, P268, DOI 10.1196/annals.1386.014; Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369; Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168; Liu QY, 2009, J IMMUNOL, V182, P6207, DOI 10.4049/jimmunol.0803926; Mijatovic T, 2007, CELL ONCOL, V29, P315; Myers RM, 2009, ACS CHEM BIOL, V4, P503, DOI 10.1021/cb900038e; Olszewski U, 2009, MOL ONCOL, V3, P204, DOI 10.1016/j.molonc.2009.01.006; Peng HH, 2007, EXP CELL RES, V313, P551, DOI 10.1016/j.yexcr.2006.10.030; Reubi JC, 1999, INT J CANCER, V82, P213, DOI 10.1002/(SICI)1097-0215(19990719)82:2<213::AID-IJC11>3.0.CO;2-8; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shimizu S, 2008, INT J CANCER, V123, P1816, DOI 10.1002/ijc.23710; Sivachenko AY, 2007, EXPERT OPIN THER TAR, V11, P411, DOI 10.1517/14728222.11.3.411; Siveen KS, 2009, IMMUNOL LETT, V123, P97, DOI 10.1016/j.imlet.2009.02.011; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Souaze F, 2006, CARCINOGENESIS, V27, P708, DOI 10.1093/carcin/bgi269; Talloen W, 2007, BIOINFORMATICS, V23, P2897, DOI 10.1093/bioinformatics/btm478; Tang KH, 2012, HEPATOLOGY, V55, P807, DOI 10.1002/hep.24739; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thomas Sterling, 2010, Human Genomics, V4, P353; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; van Malenstein H, 2011, EUR J CANCER, V47, P1789, DOI 10.1016/j.ejca.2011.04.027; van Zijl F, 2009, FUTURE ONCOL, V5, P1169, DOI [10.2217/fon.09.91, 10.2217/FON.09.91]; Wang XF, 2006, CLIN CANCER RES, V12, P5346, DOI 10.1158/1078-0432.CCR-06-0968; Wang XF, 2010, MOL CANCER THER, V9, P2389, DOI 10.1158/1535-7163.MCT-09-1080; Wouters L, 2003, BIOMETRICS, V59, P1131, DOI 10.1111/j.0006-341X.2003.00130.x; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Yao C, 2007, INT J CANCER, V121, P1949, DOI 10.1002/ijc.22930; Yoong KF, 1999, HEPATOLOGY, V30, P100, DOI 10.1002/hep.510300147; Zhao DZ, 2006, PEPTIDES, V27, P2434, DOI 10.1016/j.peptides.2005.12.016; Zhao DZ, 2001, J BIOL CHEM, V276, P44464, DOI 10.1074/jbc.M104942200	48	44	53	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56069	10.1371/journal.pone.0056069	http://dx.doi.org/10.1371/journal.pone.0056069			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418512	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300104
J	Yun, HJ; Im, K; Yang, JJ; Yoon, U; Lee, JM				Yun, Hyuk Jin; Im, Kiho; Yang, Jin-Ju; Yoon, Uicheul; Lee, Jong-Min			Automated Sulcal Depth Measurement on Cortical Surface Reflecting Geometrical Properties of Sulci	PLOS ONE			English	Article							CEREBRAL-CORTEX; ALZHEIMERS-DISEASE; FRACTAL DIMENSION; WILLIAMS-SYNDROME; FOLDING PATTERNS; 3-D EXTRACTION; HUMAN BRAIN; MRI DATA; VARIABILITY; THICKNESS	Sulcal depth that is one of the quantitative measures of cerebral cortex has been widely used as an important marker for brain morphological studies. Several studies have employed Euclidean (EUD) or geodesic (GED) algorithms to measure sulcal depth, which have limitations that ignore sulcal geometry in highly convoluted regions and result in under or overestimated depth. In this study, we proposed an automated measurement for sulcal depth on cortical surface reflecting geometrical properties of sulci, which named the adaptive distance transform (ADT). We first defined the volume region of cerebrospinal fluid between the 3D convex hull and the cortical surface, and constructed local coordinates for that restricted region. Dijkstra's algorithm was then used to compute the shortest paths from the convex hull to the vertices of the cortical surface based on the local coordinates, which may be the most proper approach for defining sulcal depth. We applied our algorithm to both a clinical dataset including patients with mild Alzheimer's disease (AD) and 25 normal controls and a simulated dataset whose shape was similar to a single sulcus. The mean sulcal depth in the mild AD group was significantly lower than controls (p = 0.007, normal [mean +/- SD]: 7.29 +/- 0.23 mm, AD: 7.11 +/- 0.29) and the area under the receiver operating characteristic curve was relatively high, showing the value of 0.818. Results from clinical dataset that were consistent with former studies using EUD or GED demonstrated that ADT was sensitive to cortical atrophy. The robustness against inter-individual variability of ADT was highlighted through simulation dataset. ADT showed a low and constant normalized difference between the depth of the simulated data and the calculated depth, whereas EUD and GED had high and variable differences. We suggest that ADT is more robust than EUD or GED and might be a useful alternative algorithm for measuring sulcal depth.	[Yun, Hyuk Jin; Yang, Jin-Ju; Lee, Jong-Min] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Im, Kiho] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Newborn Med, Boston, MA USA; [Yoon, Uicheul] Catholic Univ Daegu, Coll Hlth & Med Sci, Dept Biomed Engn, Gyongsan, South Korea	Hanyang University; Harvard University; Boston Children's Hospital; Harvard Medical School; Catholic University of Daegu	Lee, JM (corresponding author), Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea.	ljm@hanyang.ac.kr		Yun, Hyuk Jin/0000-0002-9876-314X	Korea Science and Engineering Foundation (KOSEF) NLRL program grant; Korean Government (MEST) [2011-0028333]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology(MEST) [2011-0014862];  [P50AG05681];  [P01AG03991];  [R01AG021910];  [P50MH071616];  [U24RR021382];  [R01MH56584]; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056584, P50MH071616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681, R01AG021910, P01AG003991] Funding Source: NIH RePORTER	Korea Science and Engineering Foundation (KOSEF) NLRL program grant(Korea Science and Engineering Foundation); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); ; ; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Korea Science and Engineering Foundation (KOSEF) NLRL program grant funded by the Korean Government (MEST) (2011-0028333) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology(MEST)(2011-0014862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the following grants (P50AG05681, P01AG03991, R01AG021910, P50MH071616, U24RR021382, R01MH56584) for providing OASIS dataset.	Andrews J, 2007, P NATL ACAD SCI USA, V104, P1118, DOI 10.1073/pnas.0609910104; Boucher M, 2009, MED IMAGE ANAL, V13, P203, DOI 10.1016/j.media.2008.09.001; Cachia A, 2003, IEEE T MED IMAGING, V22, P754, DOI 10.1109/TMI.2003.814781; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cykowski MD, 2008, CEREB CORTEX, V18, P1999, DOI 10.1093/cercor/bhm224; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Hasnain MK, 2006, HUM BRAIN MAPP, V27, P277, DOI 10.1002/hbm.20183; Hasnain MK, 2001, CEREB CORTEX, V11, P702, DOI 10.1093/cercor/11.8.702; Im K, 2008, NEUROIMAGE, V43, P103, DOI 10.1016/j.neuroimage.2008.07.016; Im K, 2008, CEREB CORTEX, V18, P2181, DOI 10.1093/cercor/bhm244; Im K, 2006, HUM BRAIN MAPP, V27, P994, DOI 10.1002/hbm.20238; Im K, 2006, NEUROIMAGE, V31, P31, DOI 10.1016/j.neuroimage.2005.11.042; Im K, 2010, CEREB CORTEX, V20, P602, DOI 10.1093/cercor/bhp127; Kao CY, 2007, IEEE T MED IMAGING, V26, P530, DOI 10.1109/TMI.2006.886810; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; King RD, 2010, NEUROIMAGE, V53, P471, DOI 10.1016/j.neuroimage.2010.06.050; Kippenhan JS, 2005, J NEUROSCI, V25, P7840, DOI 10.1523/JNEUROSCI.1722-05.2005; Kochunov P, 2005, HUM BRAIN MAPP, V26, P210, DOI 10.1002/hbm.20198; Le Goualher G, 1999, IEEE T MED IMAGING, V18, P206, DOI 10.1109/42.764891; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Lohmann G, 1999, CEREB CORTEX, V9, P754, DOI 10.1093/cercor/9.7.754; Lohmann G, 2008, CEREB CORTEX, V18, P1415, DOI 10.1093/cercor/bhm174; Lyttelton O, 2007, NEUROIMAGE, V34, P1535, DOI 10.1016/j.neuroimage.2006.10.041; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Magnotta VA, 1999, CEREB CORTEX, V9, P151, DOI 10.1093/cercor/9.2.151; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Rakic P, 2004, SCIENCE, V303, P1983, DOI 10.1126/science.1096414; Regis J, 2005, NEUROL MED-CHIR, V45, P1, DOI 10.2176/nmc.45.1; Rettmann ME, 2006, CEREB CORTEX, V16, P1584, DOI 10.1093/cercor/bhj095; Rettmann ME, 2002, NEUROIMAGE, V15, P329, DOI 10.1006/nimg.2001.0975; Robbins S, 2004, MED IMAGE ANAL, V8, P311, DOI 10.1016/j.media.2004.06.009; Seong JK, 2010, NEUROIMAGE, V49, P293, DOI 10.1016/j.neuroimage.2009.08.013; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; SMART IHM, 1986, J ANAT, V147, P27; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Turetsky BI, 2009, SCHIZOPHR RES, V115, P8, DOI 10.1016/j.schres.2009.09.005; Van Essen DC, 2006, J NEUROSCI, V26, P5470, DOI 10.1523/JNEUROSCI.4154-05.2006; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; White T, 2003, BIOL PSYCHIAT, V54, P418, DOI 10.1016/S0006-3223(03)00065-9; Zijdenbos A, 1996, LECT NOTES COMPUT SC, V1131, P439, DOI 10.1007/BFb0046984	40	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e5597	10.1371/journal.pone.0055977	http://dx.doi.org/10.1371/journal.pone.0055977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418488	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300080
J	Ino, Y; Yamazaki-Itoh, R; Oguro, S; Shimada, K; Kosuge, T; Zavada, J; Kanai, Y; Hiraoka, N				Ino, Yoshinori; Yamazaki-Itoh, Rie; Oguro, Seiji; Shimada, Kazuaki; Kosuge, Tomoo; Zavada, Jan; Kanai, Yae; Hiraoka, Nobuyoshi			Arginase II Expressed in Cancer-Associated Fibroblasts Indicates Tissue Hypoxia and Predicts Poor Outcome in Patients with Pancreatic Cancer	PLOS ONE			English	Article							ARGININE METABOLISM; SUPPRESSOR-CELLS; PROLIFERATION; ANGIOGENESIS; MACROPHAGES; MOLECULES	An adequate level of arginine in the tissue microenvironment is essential for T cell activity and survival. Arginine levels are regulated by the arginine-catabolizing enzyme, arginase (ARG). It has been reported that arginase II (ARG2), one of two ARGs, is aberrantly expressed in prostate cancer cells, which convert arginine into ornithine, resulting in a lack of arginine that weakens tumor-infiltrating lymphocytes and renders them dysfunctional. However, immune suppression mediated by ARG2-expressing cancer cells in lung cancer has not been observed. Here we studied the expression of ARG2 in pancreatic ductal carcinoma (PDC) tissue clinicopathologically by examining over 200 cases of PDC. In contrast to prostate cancer, ARG2 expression was rarely demonstrated in PDC cells by immunohistochemistry, and instead ARG2 was characteristically expressed in alpha-smooth muscle actin-positive cancer-associated fibroblasts (CAFs), especially those located within and around necrotic areas in PDC. The presence of ARG2-expressing CAFs was closely correlated with shorter overall survival (OS; P = 0.003) and disease-free survival (DFS; P = 0.0006). Multivariate Cox regression analysis showed that the presence of ARG2-expressing CAFs in PDC tissue was an independent predictor of poorer OS (hazard ratio [HR] = 1.582, P = 0.007) and DFS (HR = 1.715, P = 0.001) in PDC patients. In addition to the characteristic distribution of ARG2-expressing CAFs, such CAFs co-expressed carbonic anhydrase IX, SLC2A1, or HIF-1 alpha, markers of hypoxia, in PDC tissue. Furthermore, in vitro experiments revealed that cultured fibroblasts extracted from PDC tissue expressed the ARG2 transcript after exposure to hypoxia, which had arginase activity. These results indicate that cancer cell-mediated immune suppression through ARG2 expression is not a general event and that the presence of ARG2-expressing CAFs is an indicator of poor prognosis, as well as hypoxia, in PDC tissue.	[Ino, Yoshinori; Yamazaki-Itoh, Rie; Oguro, Seiji; Kanai, Yae; Hiraoka, Nobuyoshi] Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 104, Japan; [Shimada, Kazuaki; Kosuge, Tomoo] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Tokyo, Japan; [Zavada, Jan] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic	National Cancer Center - Japan; National Cancer Center - Japan; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Hiraoka, N (corresponding author), Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 104, Japan.	nhiraoka@ncc.go.jp	Oguro, Seiji/M-2224-2017; Kanai, Yae/AAE-6987-2019	Oguro, Seiji/0000-0002-5562-6727; 	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Princess Takamatsu Foundation [10-24216]; Cancer Research and Development Fund	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Princess Takamatsu Foundation; Cancer Research and Development Fund	This work was supported by a Grant-in-Aid for Third Term Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health, Labor and Welfare of Japan (NH), a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (NH), Princess Takamatsu Foundation (10-24216) (NH), and Cancer Research and Development Fund (NH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINA JE, 1995, J IMMUNOL, V155, P4391; Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028; Center for Cancer Control and Information Services and National Cancer Center J, 2009, CANC STAT JAP; Chen B, 2009, AM J PHYSIOL-LUNG C, V297, pL1151, DOI 10.1152/ajplung.00183.2009; Clarkson AN, 2005, FASEB J, V19, P1036, DOI 10.1096/fj.04-3367fje; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hasebe T, 1996, JPN J CANCER RES, V87, P385, DOI 10.1111/j.1349-7006.1996.tb00234.x; Hiraoka N, 2010, BRIT J CANCER, V103, P1057, DOI 10.1038/sj.bjc.6605854; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Hiraoka N, 2011, GASTROENTEROLOGY, V140, P310, DOI 10.1053/j.gastro.2010.10.009; Hruban RH, 2010, WHO CLASSIFICATION T, P281; Japan Pancreas Society, 2003, CLASS PANCR CANC; Krotova K, 2010, AM J PHYSIOL-CELL PH, V299, pC1541, DOI 10.1152/ajpcell.00068.2010; Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75, DOI 10.1152/ajpendo.2001.280.1.E75; Lim JE, 2003, ANN SURG, V237, P74, DOI 10.1097/00000658-200301000-00011; Louis CA, 1998, AM J PHYSIOL-REG I, V274, pR775, DOI 10.1152/ajpregu.1998.274.3.R775; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Philip PA, 2009, J CLIN ONCOL, V27, P5660, DOI 10.1200/JCO.2009.21.9022; Pitman MB, 2007, TUMORS PANCREAS, P111; Rodriguez PC, 2003, J IMMUNOL, V171, P1232, DOI 10.4049/jimmunol.171.3.1232; Rotondo R, 2008, INT J CANCER, V123, P1108, DOI 10.1002/ijc.23437; Semenza GL, 2009, CURR PHARM DESIGN, V15, P3839, DOI 10.2174/138161209789649402; Semenza GL, 2006, EXPERT OPIN THER TAR, V10, P267, DOI 10.1517/14728222.10.2.267; Sessa C, 2008, NAT CLIN PRACT ONCOL, V5, P378, DOI 10.1038/ncponc1150; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sica A, 2011, J MOL MED, V89, P657, DOI 10.1007/s00109-011-0724-8; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sobin LH, 2009, UICC TNM ATLAS; Takahashi Y, 2007, CLIN CANCER RES, V13, P187, DOI 10.1158/1078-0432.CCR-06-1408; Toby IT, 2010, AM J PHYSIOL-LUNG C, V298, pL600, DOI 10.1152/ajplung.00122.2009; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Zavada J, 2000, BRIT J CANCER, V82, P1808, DOI 10.1054/bjoc.2000.1111	40	100	103	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55146	10.1371/journal.pone.0055146	http://dx.doi.org/10.1371/journal.pone.0055146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424623	Green Published, gold, Green Submitted			2022-12-27	WOS:000315965100011
J	Lee, JJ; Chen, CH; Chen, YH; Huang, MJ; Huang, J; Hung, JS; Chen, MT; Huang, MC				Lee, Jian-Jr; Chen, Chia-Hua; Chen, Ya-Hsin; Huang, Miao-Juei; Huang, John; Hung, Ji-Shiang; Chen, Ming-Ting; Huang, Min-Chuan			COSMC Is Overexpressed in Proliferating Infantile Hemangioma and Enhances Endothelial Cell Growth via VEGFR2	PLOS ONE			English	Article							PROTEIN O-GLYCOSYLATION; EXPRESSION; CANCER; RECEPTORS; CHAPERONE; VACCINES; SWEET; MICE	Infantile hemangiomas are localized lesions comprised primarily of aberrant endothelial cells. COSMC plays a crucial role in blood vessel formation and is characterized as a molecular chaperone of T-synthase which catalyzes the synthesis of T antigen (Gal beta 1,3GalNAc). T antigen expression is associated with tumor malignancy in many cancers. However, roles of COSMC in infantile hemangioma are still unclear. In this study, immunohistochemistry showed that COSMC was upregulated in proliferating hemangiomas compared with involuted hemangiomas. Higher levels of T antigen expression were also observed in the proliferating hemangioma. Overexpression of COSMC significantly enhanced cell growth and phosphorylation of AKT and ERK in human umbilical vein endothelial cells (HUVECs). Conversely, knockdown of COSMC with siRNA inhibited endothelial cell growth. Mechanistic investigation showed that O-glycans were present on VEGFR2 and these structures were modulated by COSMC. Furthermore, VEGFR2 degradation was delayed by COSMC overexpression and facilitated by COSMC knockdown. We also showed that COSMC was able to regulate VEGF-triggered phosphorylation of VEGFR2. Our results suggest that COSMC is a novel regulator for VEGFR2 signaling in endothelial cells and dysregulation of COSMC expression may contribute to the pathogenesis of hemangioma.	[Lee, Jian-Jr; Chen, Chia-Hua; Chen, Ya-Hsin; Huang, Miao-Juei; Huang, Min-Chuan] Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, Taipei 10764, Taiwan; [Huang, Miao-Juei; Huang, Min-Chuan] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Huang, John; Hung, Ji-Shiang] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Lee, Jian-Jr; Chen, Ming-Ting] Cathay Gen Hosp, Dept Surg, Div Plast Surg, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Cathay General Hospital	Huang, MC (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, Taipei 10764, Taiwan.	mchuang@ntu.edu.tw		Hung, Ji-Shiang/0000-0001-7392-5694; HUANG, MIN-CHUAN/0000-0002-0704-3447; Chen, Chia-Hua/0000-0003-0536-8085	National Taiwan University [10R71808]; National Science Council [NSC 99-2314-B-002-097-MY2, NSC 98-2320-B-002-032-MY3]	National Taiwan University(National Taiwan University); National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the National Taiwan University 10R71808, and the National Science Council NSC 99-2314-B-002-097-MY2 and NSC 98-2320-B-002-032-MY3 (to Dr. M. C. Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, HISTOPATHOLOGY VASCU, V38, P31; Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012; Berard M, 1997, AM J PATHOL, V150, P1315; Drolet BA, 1999, NEW ENGL J MED, V341, P173, DOI 10.1056/NEJM199907153410307; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Heimburg-Molinaro J, 2011, VACCINE, V29, P8802, DOI 10.1016/j.vaccine.2011.09.009; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Jinnin M, 2008, NAT MED, V14, P1236, DOI 10.1038/nm.1877; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kilcline C, 2008, PEDIATR DERMATOL, V25, P168, DOI 10.1111/j.1525-1470.2008.00626.x; Robinson CJ, 2001, J CELL SCI, V114, P853; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Walter JW, 2002, GENE CHROMOSOME CANC, V33, P295, DOI 10.1002/gcc.10028; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Wu YM, 2011, CANCER RES, V71, P7270, DOI 10.1158/0008-5472.CAN-11-1161; Xia LJ, 2006, METHOD ENZYMOL, V416, P314, DOI 10.1016/S0076-6879(06)16021-8; Yu LG, 2007, GLYCOCONJUGATE J, V24, P411, DOI 10.1007/s10719-007-9034-3; Yu Y, 2001, AM J PATHOL, V159, P2271, DOI 10.1016/S0002-9440(10)63077-5	22	12	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56211	10.1371/journal.pone.0056211	http://dx.doi.org/10.1371/journal.pone.0056211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424651	Green Published, Green Submitted, gold			2022-12-27	WOS:000315965100039
J	Liu, BL; Su, JB; Chen, JW; Cui, GF; Ma, JZ				Liu, Bingliang; Su, Jinbao; Chen, Jianwei; Cui, Guofa; Ma, Jianzhang			Anthropogenic Halo Disturbances Alter Landscape and Plant Richness: A Ripple Effect	PLOS ONE			English	Article							FOREST FRAGMENTATION; HABITAT FRAGMENTATION; MOVEMENT ECOLOGY; TROPICAL FOREST; SEED DISPERSAL; CORRIDORS; POLLINATION; COMMUNITY; SUSTAINABILITY; CONNECTIVITY	Although anthropogenic landscape fragmentation is often considered as the primary threat to biodiversity, other factors such as immediate human disturbances may also simultaneously threaten species persistence in various ways. In this paper, we introduce a conceptual framework applied to recreation landscapes (RLs), with an aim to provide insight into the composite influences of landscape alteration accompanying immediate human disturbances on plant richness dynamics. These impacts largely occur at patch-edges. They can not only alter patch-edge structure and environment, but also permeate into surrounding natural matrices/patches affecting species persistence-here we term these "Halo disturbance effects" (HDEs). We categorized species into groups based on seed or pollen dispersal mode (animal- vs. wind-dispersed) as they can be associated with species richness dynamics. We evaluated the richness of the two groups and total species in our experimental landscapes by considering the distance from patch-edge, the size of RLs and the intensity of human use over a six-year period. Our results show that animal-dispersed species decreased considerably, whereas wind-dispersed species increased while their richness presented diverse dynamics at different distances from patch-edges. Our findings clearly demonstrate that anthropogenic HDEs produce ripple effects on plant, providing an experimental interpretation for the diverse responses of species to anthropogenic disturbances. This study highlights the importance of incorporating these composite threats into conservation and management strategies.	[Liu, Bingliang; Cui, Guofa] Beijing Forestry Univ, Coll Nat Reserve, Beijing, Peoples R China; [Su, Jinbao] Northeast Forestry Univ, Coll Econ & Management, Harbin, Peoples R China; [Chen, Jianwei] Wildlife & Nat Reserve Management Div State Fores, Beijing, Peoples R China; [Ma, Jianzhang] Northeast Forestry Univ, Coll Wildlife Resource, Harbin, Peoples R China	Beijing Forestry University; Northeast Forestry University - China; Northeast Forestry University - China	Su, JB (corresponding author), Northeast Forestry Univ, Coll Econ & Management, 26 Xiangfang Dist, Harbin, Peoples R China.	cites.nature@hotmail.com			postdoctoral scientific foundation of Heilongjiang Province, China [LRB05385]	postdoctoral scientific foundation of Heilongjiang Province, China	This research was partly supported by postdoctoral scientific foundation of Heilongjiang Province, China (LRB05385) from 2006 to 2010. The funders had no role in analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adler P. B., 2007, Ecology, V88, P2673, DOI 10.1890/0012-9658(2007)88[2673:LMQFKP]2.0.CO;2; AIZEN MA, 1994, ECOLOGY, V75, P330, DOI 10.2307/1939538; Antongiovanni M, 2005, BIOL CONSERV, V122, P441, DOI 10.1016/j.biocon.2004.09.005; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Bohrer G, 2008, J ECOL, V96, P569, DOI 10.1111/j.1365-2745.2008.01368.x; Brudvig LA, 2009, P NATL ACAD SCI USA, V106, P9328, DOI 10.1073/pnas.0809658106; Choi HC, 2006, TOURISM MANAGE, V27, P1274, DOI 10.1016/j.tourman.2005.05.018; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Cordeiro NJ, 2003, P NATL ACAD SCI USA, V100, P14052, DOI 10.1073/pnas.2331023100; Cordeiro NJ, 2001, CONSERV BIOL, V15, P1733, DOI 10.1046/j.1523-1739.2001.99579.x; Damschen EI, 2008, P NATL ACAD SCI USA, V105, P19078, DOI 10.1073/pnas.0802037105; FAHRIG L, 1988, THEOR POPUL BIOL, V34, P194, DOI 10.1016/0040-5809(88)90042-1; Fall PL, 2011, PAC SCI, V65, P143, DOI 10.2984/65.2.143; Fazey I, 2005, BIOL CONSERV, V124, P63, DOI 10.1016/j.biocon.2005.01.013; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Francis CD, 2012, P ROY SOC B-BIOL SCI, V279, P2727, DOI 10.1098/rspb.2012.0230; Francis CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027052; Galetti M, 2003, BIOL CONSERV, V111, P269, DOI 10.1016/S0006-3207(02)00299-9; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Greene DF, 2008, ECOLOGY, V89, P118, DOI 10.1890/06-0781.1; Groom MJ, 1998, AM NAT, V151, P487, DOI 10.1086/286135; Haila Y, 2002, ECOL APPL, V12, P321, DOI 10.1890/1051-0761(2002)012[0321:ACGOFR]2.0.CO;2; [蒋依依 JIANG YiYi], 2008, [生态学报, Acta Ecologica Sinica], V28, P1786; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Laurance WF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001017; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Luck GW, 2003, ECOL APPL, V13, P235, DOI 10.1890/1051-0761(2003)013[0235:TCBARC]2.0.CO;2; Malanson George P., 1999, Diversity and Distributions, V5, P27, DOI 10.1046/j.1472-4642.1999.00035.x; Manne LL, 2001, ANIM CONSERV, V4, P221, DOI 10.1017/S1367943001001263; Herrera JM, 2010, CONSERV BIOL, V24, P1089, DOI 10.1111/j.1523-1739.2010.01459.x; McIntyre S, 1999, CONSERV BIOL, V13, P1282, DOI 10.1046/j.1523-1739.1999.97509.x; Nathan R, 2005, DIVERS DISTRIB, V11, P131, DOI 10.1111/j.1366-9516.2005.00146.x; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Orrock JL, 2003, ECOLOGY, V84, P2589, DOI 10.1890/02-0439; Ricketts TH, 2004, P NATL ACAD SCI USA, V101, P12579, DOI 10.1073/pnas.0405147101; ROLSTAD J, 1991, BIOL J LINN SOC, V42, P149, DOI 10.1111/j.1095-8312.1991.tb00557.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sieving KE, 1996, AUK, V113, P944, DOI 10.2307/4088877; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Tewksbury JJ, 2002, P NATL ACAD SCI USA, V99, P12923, DOI 10.1073/pnas.202242699; Tischendorf L, 2000, OIKOS, V90, P7, DOI 10.1034/j.1600-0706.2000.900102.x; Tsaur SH, 2006, TOURISM MANAGE, V27, P640, DOI 10.1016/j.tourman.2005.02.006; Uezu A, 2005, BIOL CONSERV, V123, P507, DOI 10.1016/j.biocon.2005.01.001; Wang Y.L., 1999, INT J ADV EARTH SCI, V14, P235; Wilcock C, 2002, TRENDS PLANT SCI, V7, P270, DOI 10.1016/S1360-1385(02)02258-6; With KA, 1997, CONSERV BIOL, V11, P1069, DOI 10.1046/j.1523-1739.1997.96210.x; Wu J.G., 2000, CHINESE J ECOL, V19, P42	53	3	5	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56109	10.1371/journal.pone.0056109	http://dx.doi.org/10.1371/journal.pone.0056109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424648	gold, Green Published, Green Submitted			2022-12-27	WOS:000315965100036
J	Li, M; Yasumura, D; Ma, AAK; Matthes, MT; Yang, HD; Nielson, G; Huang, Y; Szoka, FC; LaVail, MM; Diamond, MI				Li, Mei; Yasumura, Douglas; Ma, Aye Aye K.; Matthes, Michael T.; Yang, Haidong; Nielson, Gregory; Huang, Yong; Szoka, Francis C.; LaVail, Matthew M.; Diamond, Marc I.			Intravitreal Administration of HA-1077, a ROCK Inhibitor, Improves Retinal Function in a Mouse Model of Huntington Disease	PLOS ONE			English	Article							MUTANT HUNTINGTIN; POLYGLUTAMINE AGGREGATION; SUBARACHNOID HEMORRHAGE; FASUDIL HYDROCHLORIDE; ANTIVASOSPASTIC DRUG; STRUCTURAL-ANALYSIS; TRANSGENIC MICE; LIGHT; DEGENERATION; LIPOSOMES	Huntington disease (HD) is an inherited neurodegenerative disease that affects multiple brain regions. It is caused by an expanded polyglutamine tract in huntingtin (Htt). The development of therapies for HD and other neurodegenerative diseases has been hampered by multiple factors, including the lack of clear therapeutic targets, and the cost and complexity of testing lead compounds in vivo. The R6/2 HD mouse model is widely used for pre-clinical trials because of its progressive and robust neural dysfunction, which includes retinal degeneration. Profilin-1 is a Htt binding protein that inhibits Htt aggregation. Its binding to Htt is regulated by the rho-associated kinase (ROCK), which phosphorylates profilin at Ser-137. ROCK is thus a therapeutic target in HD. The ROCK inhibitor Y-27632 reduces Htt toxicity in fly and mouse models. Here we characterized the progressive retinopathy of R6/2 mice between 6-19 weeks of age to determine an optimal treatment window. We then tested a clinically approved ROCK inhibitor, HA-1077, administered intravitreally via liposome-mediated drug delivery. HA-1077 increased photopic and flicker ERG response amplitudes in R6/2 mice, but not in wild-type littermate controls. By targeting ROCK with a new inhibitor, and testing its effects in a novel in vivo model, these results validate the in vivo efficacy of a therapeutic candidate, and establish the feasibility of using the retina as a readout for CNS function in models of neurodegenerative disease.	[Li, Mei; Ma, Aye Aye K.; Diamond, Marc I.] Washington Univ, Dept Neurol, St Louis, MO 63130 USA; [Yasumura, Douglas; Matthes, Michael T.; Yang, Haidong; Nielson, Gregory; LaVail, Matthew M.] Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA; [Huang, Yong] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, UCSF Sch Pharm, San Francisco, CA 94143 USA; [Szoka, Francis C.] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA	Washington University (WUSTL); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Diamond, MI (corresponding author), Washington Univ, Dept Neurol, St Louis, MO 63130 USA.	diamondm@neuro.wustl.edu	FRECHET, Jean M/P-1497-2016		National Institutes of Health (NIH) [NS076116, NS50284]; Muscular Dystrophy Association; Cure Huntington's Disease Initiative, Inc.; Sandler Family Supporting Foundation; Taube Family Foundation; NIH [EY001919, EY006842, EY002162]; Foundation Fighting Blindness; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY006842, R01EY001919, U01EY006842, P30EY002162, R37EY001919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050284, R21NS076116] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Cure Huntington's Disease Initiative, Inc.; Sandler Family Supporting Foundation; Taube Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants NS076116, NS50284 (MID); Muscular Dystrophy Association (mdausa.org) (MID, ML); Cure Huntington's Disease Initiative, Inc. (chdifoundation.org) (MID, MML); Sandler Family Supporting Foundation (MID); the Taube Family Foundation (MID); NIH grants EY001919, EY006842, EY002162 (MML); The Foundation Fighting Blindness (www.blindness.org) (MML) and an Unrestricted Award to UCSF from the Research to Prevent Blindness (MML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Sleymane G, 2006, HUM MOL GENET, V15, P691, DOI 10.1093/hmg/ddi483; BARZA M, 1987, INVEST OPHTH VIS SCI, V28, P893; Batcha AH, 2012, NEUROBIOL DIS, V45, P887, DOI 10.1016/j.nbd.2011.12.004; Bauer PO, 2009, AUTOPHAGY, V5, P747, DOI 10.4161/auto.5.5.8704; Bauer PO, 2009, J BIOL CHEM, V284, P13153, DOI 10.1074/jbc.M809229200; Bayer AU, 1999, DOC OPHTHALMOL, V98, P233, DOI 10.1023/A:1002416918247; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Hanada Yusei, 2005, J Stroke Cerebrovasc Dis, V14, P47, DOI 10.1016/j.jstrokecerebrovasdis.2004.10.006; Helmlinger D, 2004, J NEUROSCI, V24, P1881, DOI 10.1523/JNEUROSCI.4407-03.2004; Helmlinger D, 2002, HUM MOL GENET, V11, P3351, DOI 10.1093/hmg/11.26.3351; Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; Ishida T, 2006, BIOL PHARM BULL, V29, P397, DOI 10.1248/bpb.29.397; Ishida T, 2002, INT J PHARMACEUT, V232, P59, DOI 10.1016/S0378-5173(01)00896-1; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; LAVAIL MM, 1975, EXP EYE RES, V21, P167, DOI 10.1016/0014-4835(75)90080-9; LAVAIL MM, 1993, J COMP NEUROL, V333, P168, DOI 10.1002/cne.903330204; LAVAIL MM, 1987, INVEST OPHTH VIS SCI, V28, P1043; LaVail MM, 1997, EXP EYE RES, V65, P45, DOI 10.1006/exer.1997.0308; LAVAIL MM, 1982, J COMP NEUROL, V212, P217, DOI 10.1002/cne.902120302; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Li M, 2009, NEUROBIOL DIS, V36, P413, DOI 10.1016/j.nbd.2009.06.011; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Masaoka H, 2001, ACT NEUR S, V77, P209; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McGill TJ, 2007, INVEST OPHTH VIS SCI, V48, P5756, DOI 10.1167/iovs.07-0054; MICHON JJ, 1991, INVEST OPHTH VIS SCI, V32, P280; Mocko JA, 2011, INVEST OPHTH VIS SCI, V52, P4223, DOI 10.1167/iovs.10-6750; Nakashima S, 1998, NEUROL MED-CHIR, V38, P805, DOI 10.2176/nmc.38.805; Pang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035250; Paskowitz DM, 2004, INVEST OPHTH VIS SCI, V45, P4190, DOI 10.1167/iovs.04-0676; Petrasch-Parwez E, 2004, J COMP NEUROL, V479, P181, DOI 10.1002/cne.20327; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; TREMBLAY C, 1985, INVEST OPHTH VIS SCI, V26, P711; Yefimova MG, 2010, NEUROBIOL DIS, V40, P311, DOI 10.1016/j.nbd.2010.06.005; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X; Yvert G, 2000, HUM MOL GENET, V9, P2491, DOI 10.1093/hmg/9.17.2491	42	36	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56026	10.1371/journal.pone.0056026	http://dx.doi.org/10.1371/journal.pone.0056026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409115	Green Published, Green Submitted, gold			2022-12-27	WOS:000315100000041
J	Groza, T; Hunter, J; Zankl, A				Groza, Tudor; Hunter, Jane; Zankl, Andreas			Mining Skeletal Phenotype Descriptions from Scientific Literature	PLOS ONE			English	Article							ONTOLOGY; PERFORMANCE; TOOL	Phenotype descriptions are important for our understanding of genetics, as they enable the computation and analysis of a varied range of issues related to the genetic and developmental bases of correlated characters. The literature contains a wealth of such phenotype descriptions, usually reported as free-text entries, similar to typical clinical summaries. In this paper, we focus on creating and making available an annotated corpus of skeletal phenotype descriptions. In addition, we present and evaluate a hybrid Machine Learning approach for mining phenotype descriptions from free text. Our hybrid approach uses an ensemble of four classifiers and experiments with several aggregation techniques. The best scoring technique achieves an F-1 score of 71.52%, which is close to the state-of-the-art in other domains, where training data exists in abundance. Finally, we discuss the influence of the features chosen for the model on the overall performance of the method.	[Groza, Tudor; Hunter, Jane] Univ Queensland, Sch ITEE, Brisbane, Qld 4072, Australia; [Zankl, Andreas] Univ Queensland, UQCCR, Bone Dysplasia Res Grp, Brisbane, Qld 4072, Australia; [Zankl, Andreas] Royal Brisbane & Womens Hosp, Genet Hlth Queensland, Herston, Qld, Australia	University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital	Groza, T (corresponding author), Univ Queensland, Sch ITEE, Brisbane, Qld 4072, Australia.	tudor.groza@uq.edu.au	Hunter, Jane/E-5213-2013	Hunter, Jane/0000-0002-7163-4137; Groza, Tudor/0000-0003-2267-8333; Zankl, Andreas/0000-0001-8612-1062	Australian Research Council (ARC) [DE120100508, LP100100156]	Australian Research Council (ARC)(Australian Research Council)	This research has been funded by the Australian Research Council (ARC) under the Discovery Early Career Researcher Award (DECRA) - DE120100508 and the Linkage grant SKELETOME - LP100100156. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne A., 2000, TECHNICAL REPORT; Carey JC, 2012, HUM MUTAT, V33, P781, DOI 10.1002/humu.22053; Ciccarese Paolo, 2012, J Biomed Semantics, V3 Suppl 1, pS1, DOI 10.1186/2041-1480-3-S1-S1; Cunningham H., 2011, TEXT PROCESSING GATE; Gkoutos GV, 2009, IEEE ENG MED BIO, P7069, DOI 10.1109/IEMBS.2009.5333362; Groza T, 2011, LECT NOTES COMPUT SC, V7032, P81, DOI 10.1007/978-3-642-25093-4_6; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hoehndorf R., 2011, NUCLEIC ACIDS RES, V39, P1; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; Kudu T., 2000, CONLL, P142; Lafferty John D., 2001, ICML 01, P282, DOI DOI 10.5555/645530.655813; Lee C., 2004, P JOINT WORKSH NAT L, P80; Li LS, 2012, J BIOMED INFORM, V45, P156, DOI 10.1016/j.jbi.2011.10.004; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; McCallum, 2002, MALLET MACHINE LEARN; Paul Razan, 2012, The Semantic Web. 11th International Semantic Web Conference (ISWC 2012). Proceedings, P164, DOI 10.1007/978-3-642-35173-0_11; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007; Schofield PN, 2012, HUM MUTAT, V33, P826, DOI 10.1002/humu.22077; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Tanabe L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S3; Vapnik V., 2013, NATURE STAT LAERNING; Vlachos A, 2007, P 2 BIOCREATIVE CHAL, P85; Wang W. B., 2009, P IEEE INT C BIOINSP, P1, DOI DOI 10.1109/MILCOM.2009.5380133; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247; Wilbur J., 2007, P 2 BIOCREATIVE CHAL, P7; Yang ZH, 2008, COMPUT BIOL CHEM, V32, P287, DOI 10.1016/j.compbiolchem.2008.03.008	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55656	10.1371/journal.pone.0055656	http://dx.doi.org/10.1371/journal.pone.0055656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409017	Green Submitted, gold, Green Published			2022-12-27	WOS:000314660300027
J	Wang, JH; Zhang, J; Xu, L; Shi, YB; Wu, XY; Guo, QH				Wang, Jianhong; Zhang, Jun; Xu, Lan; Shi, Yunbo; Wu, Xunyi; Guo, Qihao			Cognitive Impairments in Hashimoto's Encephalopathy: A Case-Control Study	PLOS ONE			English	Article							SCREENING-TEST; DISEASE; MEMORY	Background/Aims: Hashimoto's encephalopathy is considered as a treatable dementia, but it is often misdiagnosed. We investigated cognitive impairment and the MRI pathology of Hashimoto's encephalopathy patients. Methods: The study comprised eight patients with Hashimoto's encephalopathy, 16 patients with mild Alzheimer's disease and 24 healthy subjects. A neuropsychological battery included assessments of memory, language, attention, executive function and visuospatial ability. Cranial MRI was obtained from all Hashimoto's encephalopathy patients. Results: Hashimoto's encephalopathy and mild Alzheimer's disease showed cognitive impairments in episodic memory, attention, executive function and visuospatial ability, but naming ability was unaffected in Hashimoto's encephalopathy. The MRI of Hashimoto's encephalopathy showed leukoencephalopathy-like type or limbic encephalitis-like type; the lesions did not affect the temporal cortex which plays a role in naming ability. Conclusion: Except that the naming ability was retained, the impairments in cognitive functions for the Hashimoto's encephalopathy patients were similar to those of Alzheimer's disease patients. These results were consistent with the MRI findings.	[Wang, Jianhong; Xu, Lan; Shi, Yunbo; Wu, Xunyi; Guo, Qihao] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Huashan Hosp,Dept Neurol, Shanghai 200433, Peoples R China; [Zhang, Jun] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Radiol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Wu, XY (corresponding author), Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Huashan Hosp,Dept Neurol, Shanghai 200433, Peoples R China.	dr.xunyiwu@hotmail.com; dr.guoqihao@126.com	wang, jian/GVS-0711-2022	zhang, jun/0000-0003-1849-9199	National Natural Science Foundation of China [81100964, 81201071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81100964, 81201071). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BRAIN L, 1966, LANCET, V2, P512; Brooks BL, 2011, J CHILD NEUROL, V26, P786, DOI 10.1177/0883073810391532; Canelo-Aybar Carlos, 2010, J Med Case Rep, V4, P337, DOI 10.1186/1752-1947-4-337; Chang T, 2010, NEUROLOGIST, V16, P394, DOI 10.1097/NRL.0b013e3181d6b6f6; Cummings RR, 2007, GEN HOSP PSYCHIAT, V29, P267, DOI 10.1016/j.genhosppsych.2007.01.003; de Holanda NCP, 2011, J NEUROPSYCH CLIN N, V23, P384, DOI 10.1176/jnp.23.4.jnp384; Fukunaga Mami, 2006, Rinsho Shinkeigaku, V46, P568; Guo Q.H., 2005, CHINESE J NEUROMEDIC, V4, P701, DOI DOI 10.3760/CMA.J.ISSN.1671-8925.2005.07-17; [郭起浩 GUO Qi-hao], 2009, [中华神经科杂志, Chinese Journal of Neurology], V42, P314; Guo QH, 2010, NEUROSCI BULL, V26, P47, DOI 10.1007/s12264-010-0816-4; Guo QH, 2009, ALZ DIS ASSOC DIS, V23, P253, DOI 10.1097/WAD.0b013e3181999e92; [郭起浩 GUO Qihao], 2008, [中华神经科杂志, Chinese Journal of Neurology], V41, P234; [郭起浩 GUO QiHao], 2007, [中国心理卫生杂志, Chinese Mental Health Journal], V21, P622; [郭起浩 GUO Qihao], 2007, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V15, P132; [郭起浩 GUO QiHao], 2006, [中国心理卫生杂志, Chinese Mental Health Journal], V20, P81; Harzheim M, 2006, NEUROL INDIA, V54, P301, DOI 10.4103/0028-3886.27160; Lezak MD, 2004, NEUROPSYCHOLOGICAL A, P562; Livner A, 2009, J NEUROL SCI, V283, P235, DOI 10.1016/j.jns.2009.02.377; Lu JC, 2006, CHIN J CLIN PSYCHOL, V14, P118; Mazzu I, 2012, NEUROL SCI, V33, P653, DOI 10.1007/s10072-011-0813-z; Mijajovic M, 2010, J NEUROL SCI, V288, P194, DOI 10.1016/j.jns.2009.09.030; Mocellin R, 2007, CNS DRUGS, V21, P799, DOI 10.2165/00023210-200721100-00002; Okamoto Kensho, 2007, Rinsho Shinkeigaku, V47, P112; Peschen-Rosin R, 1999, EUR NEUROL, V41, P79, DOI 10.1159/000008007; Raskin SA, 2009, BRAIN IMPAIR, V10, P23, DOI 10.1375/brim.10.1.23; ROBERTS RE, 1983, AM J PSYCHIAT, V140, P41; Schiess N, 2008, ANN NY ACAD SCI, V1142, P254, DOI 10.1196/annals.1444.018; SHAW PJ, 1991, NEUROLOGY, V41, P228, DOI 10.1212/WNL.41.2_Part_1.228; Shindo Akihiro, 2007, Rinsho Shinkeigaku, V47, P629; Strauss E., 2006, COMPENDIUM NEUROPSYC, P617; Tamagno G, 2006, INTERN EMERG MED, V1, P15, DOI 10.1007/BF02934715; Wakai Masakazu, 2004, Rinsho Shinkeigaku, V44, P432; Wang JH, 2011, DEMENT GERIATR COGN, V31, P284, DOI 10.1159/000326908; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Zhao Q, 2007, CHINESE J CLIN PSYCH, V3, P241	36	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55758	10.1371/journal.pone.0055758	http://dx.doi.org/10.1371/journal.pone.0055758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409036	Green Submitted, Green Published, gold			2022-12-27	WOS:000314660300032
J	Nguyen, HV; Giang, TT				Huy Van Nguyen; Thao Thach Giang			Gender Difference in Academic Planning Activity among Medical Students	PLOS ONE			English	Article							MASS-MEDIA; PHILIPPINES; EDUCATION	Background: In Vietnam, as doctor of medicine is socially considered a special career, both men and women who are enrolled in medical universities often study topics of medicine seriously. However, as culturally expected, women often perform better than men. Because of this, teaching leadership and management skill (LMS) to develop academic planning activity (APA) for female medical students would also be expected to be more effective than male counterparts. This research aimed to compare by gender the effect of teaching LMS on increasing APA, using propensity score matching (PSM). Methods: In a cross-sectional survey utilizing a self-reported structured questionnaire on a systematic random sample of 421 male and female medical students in Hanoi Medical University, this study adopted first regression techniques to construct a fit model, then PSM to create a matched control group in order to allow for evaluating the effect of LMS education. Results: There were several interesting gender differences. First, while for females LMS education had both direct and indirect effects on APA, it had only direct effect on males' APA. Second, after PSM to adjust for the possible confounders to balance statistically two groups - with and without LMS education, there is statistically a significant difference in APA between male and female students, making a net difference of 11% (p<.01), equivalent to 173 students. The difference in APA between exposed and matched control group in males and females was 9% and 20%, respectively. These estimates of 9.0 and 20.0 percentage point increase can be translated into the practice of APA by 142 males and 315 females, respectively, in the population. These numbers of APA among male and female students can be explained by LMS education. Conclusions: Gender appears to be a factor explaining in part academic planning activity.	[Huy Van Nguyen] Hanoi Med Univ, Dept Hlth Org & Management, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Thao Thach Giang] Vietnam Natl Hosp Pediat, Hanoi, Vietnam	Hanoi Medical University	Nguyen, HV (corresponding author), Hanoi Med Univ, Dept Hlth Org & Management, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam.	nvanhuy@yahoo.com	Nguyen, Huy/AAF-9560-2019; Nguyen, Huy/GWQ-6433-2022	Nguyen, Huy/0000-0002-5896-9661; 	Department of Undergraduate Training from Hanoi Medical University	Department of Undergraduate Training from Hanoi Medical University	This work was undertaken with the support provided by the Department of Undergraduate Training from Hanoi Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth D., 2012, BOYS LITERACY ATTAIN; Dayioglu M, 2004, GENDER DIFFERENCES A; Eccles JS, 2004, GENDER ACAD PERFORMA; Fortin N. M., 2012, LEAVING BOYS GENDER; Gibb SJ, 2008, AUST J EDUC, V52, P63, DOI 10.1177/000494410805200105; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Keeves JP, 2005, MULTILEVEL MULTIVARI; Keeves JP, 2004, INTRO STAT DATA PROC; Kennedy P., 1996, GUIDE ECONOMETRICS; Kincaid DL, 2006, J HEALTH COMMUN, V11, P69, DOI 10.1080/10810730600974522; Kincaid DL, 2000, COMMUN RES, V27, P723, DOI 10.1177/009365000027006003; Kincaid DL, 2008, ADV RES METHODS EVAL; Kincaid DL, 2009, DATA ANAL USING LOGI; Kincaid DL, 2006, IMPACT AIDS COMMUNIC; Lietz P, 1993, MEDIATED GENDER DIFF; Livaditis M., 2003, ED PSYCHOL, V23, P223; Morgan PL, 2010, J SPEC EDUC, V43, P236, DOI 10.1177/0022466908323007; National Center for Education Statistics, 2007, COND ED 2007; Phinney HM, 2008, AM J PUBLIC HEALTH, V98, P650, DOI 10.2105/AJPH.2007.111534; ROSENBAUM PR, 1986, J EDUC STAT, V11, P207; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Schneider Barbara, 2007, ESTIMATING CAUSAL EF; Warrington M, 2000, BRIT EDUC RES J, V26, P393, DOI 10.1080/01411920050030914; Weaver-Hightower M, 2003, REV EDUC RES, V73, P471, DOI 10.3102/00346543073004471; Zembar M. J., 2009, MIDDLE CHILDHOOD DEV, P212	25	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55845	10.1371/journal.pone.0055845	http://dx.doi.org/10.1371/journal.pone.0055845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418467	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300058
J	Kock, R; Schaumburg, F; Mellmann, A; Koksal, M; Jurke, A; Becker, K; Friedrich, AW				Koeck, Robin; Schaumburg, Frieder; Mellmann, Alexander; Koeksal, Mahir; Jurke, Annette; Becker, Karsten; Friedrich, Alexander W.			Livestock-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) as Causes of Human Infection and Colonization in Germany	PLOS ONE			English	Article							NASAL COLONIZATION; PREVALENCE; PIGS; ORIGIN; ST398; EMERGENCE; CARRIAGE; DENSITY; CC398; MILK	Pigs, cattle and poultry are colonized with MRSA and the zoonotic transmission of such MRSA to humans via direct animal contact, environmental contaminations or meat are a matter of concern. Livestock-associated (LA) MRSA are mostly belonging to clonal complex (CC) 398 as defined by multilocus sequence typing. However, MRSA of other clonal lineages including CC5, CC9 and CC97 have also been detected in livestock animals in Germany. Within the framework of a Dutch-German network project (EUREGIO), 14,036 MRSA isolated from clinical and screening specimens (January 2008 - June 2012) derived from human patients in hospitals as well as general or specialized practices in a German region characterized by a high density of livestock production, were subjected to S. aureus protein A (spa) sequence typing. The prevalence of putative LA-MRSA among the human MRSA isolates was determined by analyzing the detection of livestock-indicator (LI) spa types which had already been reported in German livestock. Overall, 578 spa types were detected among the MRSA isolates. LI spa types t011, t034, t108, t1451, t2011, t571, t1456, t1250, t1255, t1580, t2970, t2346, t1344, t2576, t2330 and t2510 (all of which are indicative for LA-MRSA CC398) accounted for 18.6% of all human isolates. The LI spa types t1430 (CC9), t3992 (CC97), t002 (CC5) and t007 (CC30) were found in 0.14%, 0.01%, 1.01% and 0.04% of all human MRSA isolates, respectively. LI spa types associated with CC398 represented 23% of all MRSA from screening samples and a varying proportion among isolates from clinical specimens ranging between 0% in cerebrospinal fluid, 8% in blood cultures and 14% in deep respiratory fluids. Our findings indicate that LA-MRSA are a major cause for human infection and stress the need for close surveillance. Although LA-MRSA CC398 predominates, the occurrence of putative LA-MRSA from other clonal lineages should be monitored.	[Koeck, Robin; Mellmann, Alexander] Univ Hosp Munster, Inst Hyg, Munster, Germany; [Schaumburg, Frieder; Becker, Karsten] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Koeksal, Mahir; Friedrich, Alexander W.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Jurke, Annette] North Rhine Westphalian Ctr Hlth, Dept Infectiol & Hyg, Munster, Germany	University of Munster; University of Munster; University of Groningen	Kock, R (corresponding author), Univ Hosp Munster, Inst Hyg, Munster, Germany.	robin.koeck@ukmuenster.de	Köck, Robin/AAC-1552-2019; Schaumburg, Frieder/E-4464-2016; Becker, Karsten/O-2302-2018; Friedrich, Alex/ABG-9823-2020	Becker, Karsten/0000-0002-6391-1341; Mellmann, Alexander/0000-0002-0649-5185	German Ministry for Education and Research [MedVet-Staph 01KI1014A]; German Ministry of Health (MRE network Northwest); INTERREG IVa program of the European Union [EurSafety Health-net A-II-2-05 = 025]	German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); German Ministry of Health (MRE network Northwest); INTERREG IVa program of the European Union	This study has been supported by grants to RK, AWF and KB from the German Ministry for Education and Research (MedVet-Staph 01KI1014A), from the German Ministry of Health (MRE network Northwest) and from the INTERREG IVa program of the European Union (EurSafety Health-net A-II-2-05 = 025). The study was done in close collaboration with the ESCMID Study Group of Epidemiological Markers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Argudin MA, 2011, APPL ENVIRON MICROB, V77, P3052, DOI 10.1128/AEM.02260-10; Bisdorff B, 2012, EPIDEMIOL INFECT, V140, P1800, DOI 10.1017/S0950268811002378; Boye K, 2011, FEMS MICROBIOL LETT, V314, P101, DOI 10.1111/j.1574-6968.2010.02151.x; Bundesinstitut fur Risikobewertung, 2012, DTSCH ANT RES LEB DA; Bundesinstitut fur Risikobewertung, 2009, MENSCH KONN SICH KON; Bundesinstitut fur Risikobewertung, 2011, ERR ZOON DEUTSCHL JA; Bundesinstitut fur Risikobewertung, 2009, ZOON LEB BFR S 2 3 N; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; European Centre for Disease Prevention and Control European Food Safety Agency European Medicines Agency, 2009, EFSAQ200900612 EUR C; Feingold BJ, 2012, EMERG INFECT DIS, V18, P1841, DOI 10.3201/eid1811.111850; Fessler AT, 2011, APPL ENVIRON MICROB, V77, P7151, DOI 10.1128/AEM.00561-11; Friese A, 2012, VET MICROBIOL, V158, P129, DOI 10.1016/j.vetmic.2012.01.019; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Hata E, 2010, J CLIN MICROBIOL, V48, P2130, DOI 10.1128/JCM.01940-09; Kock R, 2010, EURO SURVEILL, V15; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Kock R, 2009, J HOSP INFECT, V71, P320, DOI 10.1016/j.jhin.2008.12.001; Kock R, 2012, APPL ENVIRON MICROB, V78, P4046, DOI 10.1128/AEM.00212-12; Kreausukon K, 2012, J DAIRY SCI, V95, P4382, DOI 10.3168/jds.2011-5198; Landwirtschaftskammer Nordrhein-Westfalen, 2008, ZAHL LANDW NORDRH WE; Lekkerkerk WSN, 2012, CLIN MICROBIOL INFEC, V18, P656, DOI 10.1111/j.1469-0691.2011.03662.x; Lozano C, 2011, INT J MED MICROBIOL, V301, P500, DOI 10.1016/j.ijmm.2011.02.004; Meemken D, 2010, ZOONOSES PUBLIC HLTH, V57, pE143, DOI 10.1111/j.1863-2378.2009.01313.x; Mellmann A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-98; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Richter A, 2012, EPIDEMIOL INFECT, V10, P1; Robert Koch Institut, 2011, EPIDEMIOLOGISCHES B, V26, P233; Schaumburg F, 2012, J CLIN MICROBIOL, V50, P3186, DOI 10.1128/JCM.01174-12; Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12; Spohr M, 2011, ZOONOSES PUBLIC HLTH, V58, P252, DOI 10.1111/j.1863-2378.2010.01344.x; Strommenger B, 2006, J CLIN MICROBIOL, V44, P2533, DOI 10.1128/JCM.00420-06; Tenhagen BA, 2009, VET REC, V165, P589, DOI 10.1136/vr.165.20.589; van de Giessen AW, 2009, PREV VET MED, V91, P270, DOI 10.1016/j.prevetmed.2009.05.016; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Verkade E, 2012, INFECT CONT HOSP EP, V33, P624, DOI 10.1086/665726; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x; Wulf MWH, 2012, EUR J CLIN MICROBIOL, V31, P61, DOI 10.1007/s10096-011-1269-z; Wulf MW, 2008, EURO SURVEILL, V13	46	171	174	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55040	10.1371/journal.pone.0055040	http://dx.doi.org/10.1371/journal.pone.0055040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418434	gold, Green Submitted, Green Published			2022-12-27	WOS:000315970300024
J	Luque-Fernandez, MA; Van Cutsem, G; Goemaere, E; Hilderbrand, K; Schomaker, M; Mantangana, N; Mathee, S; Dubula, V; Ford, N; Hernan, MA; Boulle, A				Luque-Fernandez, Miguel Angel; Van Cutsem, Gilles; Goemaere, Eric; Hilderbrand, Katherine; Schomaker, Michael; Mantangana, Nompumelelo; Mathee, Shaheed; Dubula, Vuyiseka; Ford, Nathan; Hernan, Miguel A.; Boulle, Andrew			Effectiveness of Patient Adherence Groups as a Model of Care for Stable Patients on Antiretroviral Therapy in Khayelitsha, Cape Town, South Africa	PLOS ONE			English	Article							TREATMENT PROGRAM; HIV TREATMENT; HEALTH-CARE; OUTCOMES; ZIDOVUDINE; EXPERIENCE; RATES	Background: Innovative models of care are required to cope with the ever-increasing number of patients on antiretroviral therapy in the most affected countries. This study, in Khayelitsha, South Africa, evaluates the effectiveness of a group-based model of care run predominantly by non-clinical staff in retaining patients in care and maintaining adherence. Methods and Findings: Participation in "adherence clubs'' was offered to adults who had been on ART for at least 18 months, had a current CD4 count > 200 cells/ml and were virologically suppressed. Embedded in an ongoing cohort study, we compared loss to care and virologic rebound in patients receiving the intervention with patients attending routine nurse-led care from November 2007 to February 2011. We used inverse probability weighting to estimate the intention-to-treat effect of adherence club participation, adjusted for measured baseline and time-varying confounders. The principal outcome was the combination of death or loss to follow-up. The secondary outcome was virologic rebound in patients who were virologically suppressed at study entry. Of 2829 patients on ART for > 18 months with a CD4 count above 200 cells/mu l, 502 accepted club participation. At the end of the study, 97% of club patients remained in care compared with 85% of other patients. In adjusted analyses club participation reduced loss-to-care by 57% (hazard ratio [HR] 0.43, 95% CI = 0.21-0.91) and virologic rebound in patients who were initially suppressed by 67% (HR 0.33, 95% CI = 0.16-0.67). Discussion: Patient adherence groups were found to be an effective model for improving retention and documented virologic suppression for stable patients in long term ART care. Out-of-clinic group-based models facilitated by non-clinical staff are a promising approach to assist in the long-term management of people on ART in high burden low or middle-income settings.	[Luque-Fernandez, Miguel Angel; Van Cutsem, Gilles; Goemaere, Eric; Hilderbrand, Katherine; Schomaker, Michael; Ford, Nathan; Boulle, Andrew] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Van Cutsem, Gilles; Goemaere, Eric; Hilderbrand, Katherine] Medecins Sans Frontieres, Cape Town, South Africa; [Mantangana, Nompumelelo; Mathee, Shaheed] Prov Govt Western Cape, Dept Hlth, Khayelitsha Community Hlth Ctr, Cape Town, South Africa; [Dubula, Vuyiseka] Treatment Act Campaign, Cape Town, South Africa; [Ford, Nathan] Medecins Sans Frontieres, Geneva, Switzerland; [Hernan, Miguel A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hernan, Miguel A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Hernan, Miguel A.] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Boston, MA USA	University of Cape Town; Doctors Without Borders; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Luque-Fernandez, MA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	miguel.luquefernandez@uct.ac.za	Van Cutsem, Gilles/ABB-1171-2021; Boulle, Andrew/C-1413-2008; FERNANDEZ, MIGUEL ANGEL LUQUE/AAZ-5017-2020; Schomaker, Michael/K-3840-2019; Dubula-Majola, Vuyiseka/AAV-2562-2021; FERNANDEZ, MIGUEL ANGEL LUQUE/AAK-7183-2021; FERNANDEZ, MIGUEL ANGEL LUQUE/L-4053-2015	Van Cutsem, Gilles/0000-0002-8972-4480; Boulle, Andrew/0000-0002-7713-8062; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; Schomaker, Michael/0000-0002-8475-0591; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; Hernan, Miguel/0000-0003-1619-8456; Dubula-Majola, Vuyiseka/0000-0003-0559-5974	University of Cape Town [LQFMIG001]; National Institute of Allergy and Infectious Diseases [U01AI069924-01]; NIH [R01 AI102634]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102634, U01AI069924] Funding Source: NIH RePORTER	University of Cape Town; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MALF was supported by the University of Cape Town with a postdoctoral fellowship (LQFMIG001). AB was partially supported by the National Institute of Allergy and Infectious Diseases (U01AI069924-01). MAH was partly funded by NIH grant R01 AI102634. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Choi HK, 2002, LANCET, V359, P1173, DOI 10.1016/S0140-6736(02)08213-2; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Decroo T, 2010, J ACQ IMMUN DEF SYND; Fewell Z, 2004, STATA J, V4, P402, DOI 10.1177/1536867X0400400403; Ford N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001060; Granich R, 2010, CURR OPIN HIV AIDS, V5, P298, DOI 10.1097/COH.0b013e32833a6c32; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2002, STAT MED, V21, P1689, DOI 10.1002/sim.1144; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Massaquoi M, 2009, T ROY SOC TROP MED H, V103, P594, DOI 10.1016/j.trstmh.2009.02.012; Nabudere H, 2011, INT J TECHNOL ASSESS, V27, P173, DOI 10.1017/S0266462311000055; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; [National Department of Health SA Health Do], 2008, S AFR ANT TREATM GUI; National Department of Health SA, 2010, S AFR ANT TREATM GUI; Organization WH, 2011, WORLD HLTH STAT; ROSENBERG PS, 1995, BIOMETRICS, V51, P874, DOI 10.2307/2532989; Roura M, 2009, AIDS PATIENT CARE ST, V23, P203, DOI 10.1089/apc.2008.0129; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; Van Cutsem G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014684; Wringe A, 2009, AIDS CARE, V21, P632, DOI 10.1080/09540120802385629; Zachariah R, 2010, T ROY SOC TROP MED H, V104, P387, DOI 10.1016/j.trstmh.2010.01.004	30	150	152	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56088	10.1371/journal.pone.0056088	http://dx.doi.org/10.1371/journal.pone.0056088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418518	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000315970300110
J	Liu, YW; Mattila, J; Ruiz, MAM; Paajanen, T; Koikkalainen, J; van Gils, M; Herukka, SK; Waldemar, G; Lotjonen, J; Soininen, H				Liu, Yawu; Mattila, Jussi; Ruiz, Miguel Angel Munoz; Paajanen, Teemu; Koikkalainen, Juha; van Gils, Mark; Herukka, Sanna-Kaisa; Waldemar, Gunhild; Lotjonen, Jyrki; Soininen, Hilkka		Alzheimer's Dis Neuroimaging Initi	Predicting AD Conversion: Comparison between Prodromal AD Guidelines and Computer Assisted PredictAD Tool	PLOS ONE			English	Article							ALZHEIMERS ASSOCIATION WORKGROUPS; MILD COGNITIVE IMPAIRMENT; MEDIAL TEMPORAL-LOBE; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; CSF BIOMARKERS; DISEASE; DEMENTIA; RECOMMENDATIONS; MRI	Purpose: To compare the accuracies of predicting AD conversion by using a decision support system (PredictAD tool) and current research criteria of prodromal AD as identified by combinations of episodic memory impairment of hippocampal type and visual assessment of medial temporal lobe atrophy (MTA) on MRI and CSF biomarkers. Methods: Altogether 391 MCI cases (158 AD converters) were selected from the ADNI cohort. All the cases had baseline cognitive tests, MRI and/or CSF levels of A beta 1-42 and Tau. Using baseline data, the status of MCI patients (AD or MCI) three years later was predicted using current diagnostic research guidelines and the PredictAD software tool designed for supporting clinical diagnostics. The data used were 1) clinical criteria for episodic memory loss of the hippocampal type, 2) visual MTA, 3) positive CSF markers, 4) their combinations, and 5) when the PredictAD tool was applied, automatically computed MRI measures were used instead of the visual MTA results. The accuracies of diagnosis were evaluated with the diagnosis made 3 years later. Results: The PredictAD tool achieved the overall accuracy of 72% (sensitivity 73%, specificity 71%) in predicting the AD diagnosis. The corresponding number for a clinician's prediction with the assistance of the PredictAD tool was 71% (sensitivity 75%, specificity 68%). Diagnosis with the PredictAD tool was significantly better than diagnosis by biomarkers alone or the combinations of clinical diagnosis of hippocampal pattern for the memory loss and biomarkers (p <= 0.037). Conclusion: With the assistance of PredictAD tool, the clinician can predict AD conversion more accurately than the current diagnostic criteria.	[Liu, Yawu; Ruiz, Miguel Angel Munoz; Paajanen, Teemu; Herukka, Sanna-Kaisa; Soininen, Hilkka] Univ Eastern Finland, Kuopio Univ Hosp, Dept Neurol, Kuopio, Finland; [Liu, Yawu] Univ Eastern Finland, Kuopio Univ Hosp, Dept Clin Radiol, Kuopio, Finland; [Mattila, Jussi; Koikkalainen, Juha; van Gils, Mark; Lotjonen, Jyrki] VTT Tech Res Ctr Finland, Tampere, Finland; [Waldemar, Gunhild] Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Memory Disorders Res Grp, Copenhagen, Denmark	Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; VTT Technical Research Center Finland; Rigshospitalet; University of Copenhagen	Soininen, H (corresponding author), Univ Eastern Finland, Kuopio Univ Hosp, Dept Neurol, Kuopio, Finland.	hilkka.soininen@uef.fi	Levey, Allan/F-2104-2011; Hsiung, Robin/AAT-1661-2021; Preda, Adrian/K-8889-2013; Saykin, Andrew/A-1318-2007	Levey, Allan/0000-0002-3153-502X; Hsiung, Robin/0000-0002-8017-0856; Preda, Adrian/0000-0003-3373-2438; Saykin, Andrew/0000-0002-1376-8532; van Gils, Mark/0000-0002-0029-1771; Munoz Ruiz, Miguel/0000-0003-3604-3064	7th Framework Programme by the European Commission [EU-Grant-224328-PredictAD]; University of Eastern Finland for the UEFBRAIN Consortium; EVO grants from Kuopio University Hospital; Health Research Council of The Academy of Finland [121038]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health [U01 AG024904]; National Institute on Aging; Canadian Institutes of Health Research; National Institutes of Health [P30 AG010129,, K01 AG030514]; National Institute of Biomedical Imaging and Bioengineering; NATIONAL INSTITUTE ON AGING [K01AG030514, P30AG013846, P30AG010129, P50AG005138, P50AG008702, U01AG024904] Funding Source: NIH RePORTER	7th Framework Programme by the European Commission; University of Eastern Finland for the UEFBRAIN Consortium; EVO grants from Kuopio University Hospital; Health Research Council of The Academy of Finland(Academy of Finland); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was partially funded under the 7th Framework Programme by the European Commission (http.//cordis.europa.eu/ist; EU-Grant-224328-PredictAD; Name: From Patient Data to Personalized Healthcare in Alzheimer's Disease), strategic funding from University of Eastern Finland for the UEFBRAIN Consortium (HS), EVO grants from Kuopio University Hospital, and by Health Research Council of The Academy of Finland, grant 121038 (HS and YL). The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California Los Angeles. This research was also supported by National Institutes of Health grants P30 AG010129 and K01 AG030514. The investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data, but did not participate in analysis or writing of this report.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Bouwman FH, 2007, NEUROBIOL AGING, V28, P1070, DOI 10.1016/j.neurobiolaging.2006.05.006; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Bruscoli M, 2004, INT PSYCHOGERIATR, V16, P129, DOI 10.1017/S1041610204000092; Burton EJ, 2009, BRAIN, V132, P195, DOI 10.1093/brain/awn298; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Devanand D P, 2012, Int J Alzheimers Dis, V2012, P483469, DOI 10.1155/2012/483469; Devanand DP, 2008, BIOL PSYCHIAT, V64, P871, DOI 10.1016/j.biopsych.2008.06.020; Drago V, 2011, J ALZHEIMERS DIS, V26, P159, DOI 10.3233/JAD-2011-0043; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Ewers M, 2012, NEUROBIOL AGING, V33, P1203, DOI 10.1016/j.neurobiolaging.2010.10.019; Ivnik RJ., 1992, CLIN NEUROPSYCHOL, V6, P83, DOI DOI 10.1080/13854049208401880; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; KAZEE AM, 1993, ALZ DIS ASSOC DIS, V7, P152, DOI 10.1097/00002093-199307030-00004; Kloppel S, 2008, BRAIN, V131, P2969, DOI 10.1093/brain/awn239; Koikkalainen J, 2011, NEUROIMAGE, V56, P1134, DOI 10.1016/j.neuroimage.2011.03.029; Lim A, 1999, J AM GERIATR SOC, V47, P564, DOI 10.1111/j.1532-5415.1999.tb02571.x; Liu YW, 2010, NEUROBIOL AGING, V31, P1375, DOI 10.1016/j.neurobiolaging.2010.01.022; Lotjonen J, 2011, NEUROIMAGE, V56, P185, DOI 10.1016/j.neuroimage.2011.01.062; Luis CA, 2003, NEUROLOGY, V61, P438, DOI 10.1212/01.WNL.0000080366.90234.7F; Mattila J, 2011, J ALZHEIMERS DIS, V27, P163, DOI 10.3233/JAD-2011-110365; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Petrovitch H, 2001, NEUROLOGY, V57, P226, DOI 10.1212/WNL.57.2.226; Rey A, 1964, EXAMEN CLIN PSYCHOL, V2e; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Vemuri P, 2009, NEUROLOGY, V73, P287, DOI 10.1212/WNL.0b013e3181af79e5; Vemuri P, 2009, NEUROLOGY, V73, P294, DOI 10.1212/WNL.0b013e3181af79fb; Wahlund LO, 2000, J NEUROL NEUROSUR PS, V69, P630, DOI 10.1136/jnnp.69.5.630; Westman E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022506; Wolz R, 2010, LECT NOTES COMPUT SC, V6357, P116, DOI 10.1007/978-3-642-15948-0_15	34	27	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55246	10.1371/journal.pone.0055246	http://dx.doi.org/10.1371/journal.pone.0055246			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424625	Green Published, gold			2022-12-27	WOS:000315965100013
J	Seymour, R; Shirley, BJ; HogenEsch, H; Shultz, LD; Sundberg, JP				Seymour, Rosemarie; Shirley, Bobbi-Jo; HogenEsch, Harm; Shultz, Leonard D.; Sundberg, John P.			Loss of Function of the Mouse Sharpin Gene Results in Peyer's Patch Regression	PLOS ONE			English	Article							CHRONIC PROLIFERATIVE DERMATITIS; TUMOR-NECROSIS-FACTOR; LYMPH-NODE GENESIS; NF-KAPPA-B; LYMPHOTOXIN BETA-RECEPTOR; DISTINCT ROLES; DEFICIENT MICE; ORGANOGENESIS; CELLS; INFLAMMATION	Peyer's patches (PP) are an important component in the immune response against intestinal pathogens. Two independent, spontaneous mutations in the mouse Sharpin gene (Sharpin(cpdm) and Sharpin(cpdm-Dem)) result in the absence of PP and disrupted splenic white pulp in adult mice, although a full complement of lymph nodes is present. Here we report that rudimentary PP begin to develop in Sharpin(cpdm) mice during embryogenesis, but lack the organizational patterns that are typical of this tissue. In the present study, small intestines examined at weekly intervals from birth to maturity showed spontaneous regression of PP in mutant mice with concurrent infiltration of granulocytes. At 5 to 6 weeks of age, only indistinct remnants of granulocytic accumulations remain. Transplantation of normal bone marrow into Sharpin(cpdm) mice at 7 days of age did not prevent regression of PP in bone marrow chimeras examined at 7 to 8 weeks of age. These findings indicate that SHARPIN expression is required for the normal development and maintenance, but not initiation, of PP.	[Seymour, Rosemarie; Shirley, Bobbi-Jo; Shultz, Leonard D.; Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA; [HogenEsch, Harm] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA	Jackson Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Seymour, R (corresponding author), Amer Vet Med Assoc, Schaumburg, IL USA.	rosemarie.seymour@gmail.com		HogenEsch, Harm/0000-0002-2738-9189	United States National Institutes of Health [AR049288, AI060707, CA34196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI060707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049288] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded in part by grants from the United States National Institutes of Health (AR049288, AI060707, and CA34196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 1997, INT IMMUNOL, V9, P507, DOI 10.1093/intimm/9.4.507; Adachi S, 1998, INT IMMUNOL, V10, P1, DOI 10.1093/intimm/10.1.1; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; BANKS TA, 1995, J IMMUNOL, V155, P1685; CERNY A, 1988, CELL TISSUE RES, V254, P449; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Fukuyama S, 2002, IMMUNITY, V17, P31, DOI 10.1016/S1074-7613(02)00339-4; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; Hashi H, 2001, J IMMUNOL, V166, P3702, DOI 10.4049/jimmunol.166.6.3702; HOGENESCH H, 1993, AM J PATHOL, V143, P972; HogenEsch H, 1999, J IMMUNOL, V162, P3890; HogenEsch H, 2001, EUR J IMMUNOL, V31, P734, DOI 10.1002/1521-4141(200103)31:3<734::AID-IMMU734>3.0.CO;2-9; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; McElwee KJ, 1998, J INVEST DERMATOL, V111, P797, DOI 10.1046/j.1523-1747.1998.00380.x; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; National Center for Biotechnology Information U.S. National Library of Medicine, GEN REP SHARPIN SHAN; Neumann B, 1996, J EXP MED, V184, P259, DOI 10.1084/jem.184.1.259; PARK CM, 1987, J MICROSC-OXFORD, V145, P115, DOI 10.1111/j.1365-2818.1987.tb01321.x; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Ruuls SR, 2001, IMMUNITY, V15, P533, DOI 10.1016/S1074-7613(01)00215-1; Scheu S, 2002, J EXP MED, V195, P1613, DOI 10.1084/jem.20020215; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Sundberg JP, 2000, J EXP ANIM SCI, V41, P101, DOI 10.1016/S0939-8600(00)80001-2; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Ueno M, 2005, INVEST OPHTH VIS SCI, V46, P4097, DOI 10.1167/iovs.05-0548; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Webb CM, 2012, VET PATHOL, V49, P727, DOI 10.1177/0300985811414033; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Yilmaz ZB, 2003, EMBO J, V22, P121, DOI 10.1093/emboj/cdg004; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643	44	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55224	10.1371/journal.pone.0055224	http://dx.doi.org/10.1371/journal.pone.0055224			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424624	gold, Green Published, Green Submitted			2022-12-27	WOS:000315965100012
J	Amaral, J; Lee, JW; Chou, J; Campos, MM; Rodriguez, IR				Amaral, Juan; Lee, Jung Wha; Chou, Joshua; Campos, Maria M.; Rodriguez, Ignacio R.			7-Ketocholesterol Induces Inflammation and Angiogenesis In Vivo: A Novel Rat Model	PLOS ONE			English	Article							EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION; LOW-DENSITY-LIPOPROTEIN; MACULAR DEGENERATION; CELLS; OXYSTEROLS; VEGF; CHOLESTEROL; MACROPHAGES; OXIDATION; MEMBRANE	Accumulation of 7-Ketocholesterol (7KCh) in lipid deposits has been implicated in a variety of chronic diseases including atherosclerosis, Alzheimer's disease and age-related macular degeneration. 7KCh is known to be pro-inflammatory and cytotoxic to various types of cultured cells but little is known about its effects in vivo. In this study we have investigated the effects of 7KCh in vivo by implanting biodegradable wafers into the anterior chamber of the rat eye. The wafers were prepared using a mixture of two biodegradable polymers with different amounts of 7KCh. The 7KCh-containing implants induced massive angiogenesis and inflammation. By contrast, no angiogenesis and very little inflammation were observed with cholesterol-containing implants. The neovessel growth was monitored by fluorescein angiography. Neovessels were observed 4 days post implantation and peaked between 7 to 10 days. The angiography and isolectin IB4 labeling demonstrated that the neovessels originated from the limbus and grew through the cornea. Immunolabeling with anti-CD68 suggested that the 7KCh-containing implants had extensive macrophage infiltration as well as other cell types. A significant increase in VEGF was also observed in 7KCh-containing implants by fluorescent immunolabeling and by immunoblot of the aqueous humor (AH). Direct measurement of VEGF, IL-1 beta and GRO/KC demonstrated a marked elevation of these factors in the AH of the 7KCh-implants. In summary this study demonstrates two important things: 1) 7KCh is pro-angiogenic and pro-inflammatory in vivo and 2) implants containing 7KCh may be used to create a novel angiogenesis model in rats.	[Amaral, Juan; Lee, Jung Wha; Chou, Joshua; Rodriguez, Ignacio R.] NEI, Mech Retinal Dis Sect, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Campos, Maria M.] NEI, Biol Imaging Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Rodriguez, IR (corresponding author), NEI, Mech Retinal Dis Sect, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA.	rodriguezi@nei.nih.gov		Amaral, Juan/0000-0001-8755-9170	National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000307] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Eye Institute intramural research program (IRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2010, AM J PATHOL, V176, P3085, DOI 10.2353/ajpath.2010.090989; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Brown AJ, 1996, J LIPID RES, V37, P320; Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005; Busch TP, 2010, J AM OIL CHEM SOC, V87, P955, DOI 10.1007/s11746-010-1572-3; Campa C, 2011, CURR DRUG TARGETS, V12, P173, DOI 10.2174/138945011794182674; Campos M, 2006, INVEST OPHTH VIS SCI, V47, P5163, DOI 10.1167/iovs.06-0156; Curcio CA, 2011, BRIT J OPHTHALMOL, V95, P1638, DOI 10.1136/bjophthalmol-2011-300344; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; DOBI ET, 1989, ARCH OPHTHALMOL-CHIC, V107, P264, DOI 10.1001/archopht.1989.01070010270035; Dugas B, 2010, EUR J NUTR, V49, P435, DOI 10.1007/s00394-010-0102-2; Haghnegahdar H, 2000, J LEUKOCYTE BIOL, V67, P53, DOI 10.1002/jlb.67.1.53; Huang JD, 2012, BBA-MOL CELL BIOL L, V1821, P637, DOI 10.1016/j.bbalip.2012.01.013; Larrayoz IM, 2010, INVEST OPHTH VIS SCI, V51, P4942, DOI 10.1167/iovs.09-4854; Lee WH, 2009, Z NATURFORSCH C, V64, P307; Moreira EF, 2009, INVEST OPHTH VIS SCI, V50, P523, DOI 10.1167/iovs.08-2373; Ohtsuka M, 2006, J ATHEROSCLER THROMB, V13, P256, DOI 10.5551/jat.13.256; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; PYLE R, 1962, BRIT J RADIOL, V35, P554, DOI 10.1259/0007-1285-35-416-554; Rodriguez IR, 2010, J LIPID RES, V51, P2847, DOI 10.1194/jlr.R004820; Rodriguez IR, 2004, INVEST OPHTH VIS SCI, V45, P2830, DOI 10.1167/iovs.04-0075; Smith LL, 1996, LIPIDS, V31, P453, DOI 10.1007/BF02522641; Spaide RF, 1999, RETINA-J RET VIT DIS, V19, P141, DOI 10.1097/00006982-199902000-00010; Tang ZS, 2011, JOVE-J VIS EXP, DOI 10.3791/3077; van Reyk DM, 2006, REDOX REP, V11, P255, DOI 10.1179/135100006X155003	25	38	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56099	10.1371/journal.pone.0056099	http://dx.doi.org/10.1371/journal.pone.0056099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409131	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300058
J	Balog, A; Schmitz, OJ				Balog, Adalbert; Schmitz, Oswald J.			Predation Determines Different Selective Pressure on Pea Aphid Host Races in a Complex Agricultural Mosaic	PLOS ONE			English	Article							APPARENT COMPETITION; POPULATION DIFFERENTIATION; ECOLOGICAL SPECIALIZATION; REPRODUCTIVE ISOLATION; PHENOTYPIC PLASTICITY; SYMPATRIC SPECIATION; GENETIC-VARIATION; PLANT; BEHAVIOR; DIVERGENCE	Field assessments were conducted to examine the interplay between host plant and predation in complex agricultural mosaic on pea aphid clover and alfalfa races. In one experiment, we examined the relative fitness on clover race (CR) and alfalfa race (AR) pea aphids on broad bean, red clover and alfalfa alone. But because clover is typically grown in a more complex agricultural mosaic with alfalfa and broad bean, a second experiment was conducted to assess the fitness consequences under predation in a more complex agricultural field setting that also included potential apparent competition with AR pea aphids. In a third experiment we tested for the effect of differential host race density on the fitness of the other host race mediated by a predator effect. CR pea aphids always had fitness losses when on broad bean (had lower fitness on broad bean relative to red clover) and fitness benefits when on red clover (higher fitness on red clover relative to broad bean), whether or not in apparent competition with alfalfa race aphids on bean and alfalfa. AR suffered fitness loss on both alfalfa and bean in apparent competition with CR on clover. Therefore we can conclude that the predation rate between host races was highly asymmetrical. The complexity of the agricultural mosaic thus can influence prey selection by predators on different host plants. These may have evolutionary consequences through context dependent fitness benefits on particular host plants.	[Balog, Adalbert; Schmitz, Oswald J.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Balog, Adalbert] Sapientia Univ, Dept Hort, Fac Tech Sci, Targu Mures, Romania	Yale University; Sapientia Hungarian University of Transylvania	Balog, A (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	adalbert.balog@fulbrightmail.org	Adalbert, Balog/AAR-4097-2021; Balog, Adalbert/O-9649-2019	BALOG, Adalbert/0000-0001-7772-7783	Romanian National Authority for Scientific Research; CNCS - Unitatea Executiva pentru Finantarea Invatamantului Superior; Cercetarii, Dezvoltarii si Inovarii [PN-II-RU-TE-2011-3-0096]	Romanian National Authority for Scientific Research; CNCS - Unitatea Executiva pentru Finantarea Invatamantului Superior(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Cercetarii, Dezvoltarii si Inovarii	This work was supported by the grant of the Romanian National Authority for Scientific Research, CNCS - Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii, project number PN-II-RU-TE-2011-3-0096. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilino KM, 2005, OIKOS, V108, P275, DOI 10.1111/j.0030-1299.2005.13418.x; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; Braendle C, 2001, J INSECT BEHAV, V14, P497, DOI 10.1023/A:1011124122873; Brassil CE, 2004, THEOR POPUL BIOL, V66, P71, DOI 10.1016/j.tpb.2004.04.001; Caillaud CM, 1996, EXPERIENTIA, V52, P927, DOI 10.1007/BF01938882; Caillaud MC, 2000, AM NAT, V156, P606, DOI 10.1086/316991; Chaneton EJ, 2000, OIKOS, V88, P380, DOI 10.1034/j.1600-0706.2000.880217.x; De Boer JG, 2004, J CHEM ECOL, V30, P2215, DOI 10.1023/B:JOEC.0000048784.79031.5e; Dixon AFG, 1999, P ROY SOC B-BIOL SCI, V266, P1549, DOI 10.1098/rspb.1999.0814; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Eubanks MD, 2000, ECOL ENTOMOL, V25, P140, DOI 10.1046/j.1365-2311.2000.00243.x; Ferrari J, 2006, ECOL RES, V21, P9, DOI 10.1007/s11284-005-0136-8; Ferrari J, 2001, EVOLUTION, V55, P1805, DOI 10.1111/j.0014-3820.2001.tb00829.x; Ferrari J, 2008, EVOLUTION, V62, P2508, DOI 10.1111/j.1558-5646.2008.00468.x; Ferrari J, 2006, EVOLUTION, V60, P1574, DOI 10.1111/j.0014-3820.2006.tb00502.x; Fordyce JA, 2006, J EXP BIOL, V209, P2377, DOI 10.1242/jeb.02271; Frommen JG, 2011, EVOL ECOL, V25, P641, DOI 10.1007/s10682-010-9454-6; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Hawlena D, 2011, FUNCT ECOL, V25, P279, DOI 10.1111/j.1365-2435.2010.01767.x; Kunert G, 2008, B ENTOMOL RES, V98, P57, DOI 10.1017/S0007485307005391; Kunert G, 2010, ECOL ENTOMOL, V35, P147, DOI 10.1111/j.1365-2311.2009.01146.x; Morris RJ, 2005, ANN ZOOL FENN, V42, P449; Nelson EH, 2006, ENTOMOL EXP APPL, V118, P211, DOI 10.1111/j.1570-7458.2006.00378.x; Nelson EH, 2007, OECOLOGIA, V151, P22, DOI 10.1007/s00442-006-0573-2; Nosil P, 2006, P NATL ACAD SCI USA, V103, P9090, DOI 10.1073/pnas.0601575103; Peccoud J, 2010, ECOL ENTOMOL, V35, P119, DOI 10.1111/j.1365-2311.2009.01147.x; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P16315, DOI 10.1073/pnas.0905129106; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Relyea RA, 2003, ECOLOGY, V84, P1840, DOI 10.1890/0012-9658(2003)084[1840:PCAPGT]2.0.CO;2; Relyea RA, 2001, ECOLOGY, V82, P1947, DOI 10.1890/0012-9658(2001)082[1947:TLEOAP]2.0.CO;2; Simon JC, 2003, P ROY SOC B-BIOL SCI, V270, P1703, DOI 10.1098/rspb.2003.2430; Snyder WE, 2003, ECOLOGY, V84, P91, DOI 10.1890/0012-9658(2003)084[0091:IBSAGN]2.0.CO;2; Sword GA, 2005, MOL ECOL, V14, P2197, DOI 10.1111/j.1365-294X.2005.02546.x; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; van Poecke RMP, 2003, ENTOMOL EXP APPL, V107, P229, DOI 10.1046/j.1570-7458.2003.00060.x; van Veen FJF, 2006, ANNU REV ENTOMOL, V51, P187, DOI 10.1146/annurev.ento.51.110104.151120; Via S, 2000, EVOLUTION, V54, P1626, DOI 10.1111/j.0014-3820.2000.tb00707.x; Via S, 1999, EVOLUTION, V53, P1446, DOI 10.1111/j.1558-5646.1999.tb05409.x	40	7	7	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55900	10.1371/journal.pone.0055900	http://dx.doi.org/10.1371/journal.pone.0055900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409081	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200085
J	Yuan, TZ; Overstreet, CM; Moody, IS; Weiss, GA				Yuan, Tom Z.; Overstreet, Cathie M.; Moody, Issa S.; Weiss, Gregory A.			Protein Engineering with Biosynthesized Libraries from Bordetella bronchiseptica Bacteriophage	PLOS ONE			English	Article							PHAGE DISPLAY; SELECTION; DYNAMICS; RECOGNITION; GENERATION; ANTIBODIES; AFFINITY; CELLS	Phage display offers a powerful approach to engineer protein affinity. A naturally occurring analog to phage display, the Bordetella bronchiseptica bacteriophage (BP) employs a highly variable protein termed the major tropism determinant (Mtd) to recognize its dynamic host. Propagation of BP provides a self-made phage library (SMPL) with vast numbers of phage particles, each displaying a single Mtd variant. We report applying the diversity of the BP-SMPL to access a tyrosine-rich library of Mtd variants. Expression of the SMPL-engineered Mtd variant as a GST-bound fusion protein demonstrated specific binding to the target T4 lysozyme with dissociation constants in the sub-micromolar range. The results guide future experiments with SMPLs applied to protein engineering.	[Yuan, Tom Z.; Overstreet, Cathie M.; Moody, Issa S.; Weiss, Gregory A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Weiss, Gregory A.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Weiss, GA (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	gweiss@uci.edu	Weiss, Gregory/AEN-4604-2022		National Institute of General Medical Sciences of the National Institutes of Health [R01 GM078528-01]; NATIONAL CANCER INSTITUTE [T32CA009054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078528] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was financially supported by the National Institute of General Medical Sciences of the National Institutes of Health (R01 GM078528-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1959, BACTERIOPHAGES; AKERLEY BJ, 1995, CELL, V80, P611, DOI 10.1016/0092-8674(95)90515-4; Arter JA, 2010, NANO LETT; Arter JA, 2012, ANAL CHEM, V84, P2776, DOI 10.1021/ac203143y; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Bock A, 2001, INT J MED MICROBIOL, V291, P119, DOI 10.1078/1438-4221-00109; Choi Y, 2012, J AM CHEM SOC, V134, P2032, DOI 10.1021/ja211540z; Choi YK, 2012, SCIENCE, V335, P319, DOI 10.1126/science.1214824; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Coia G, 1997, GENE, V201, P203, DOI 10.1016/S0378-1119(97)00452-6; Dai W, 2010, P NATL ACAD SCI USA, V107, P4347, DOI 10.1073/pnas.0915008107; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Doulatov S, 2004, NATURE, V431, P476, DOI 10.1038/nature02833; Ebersbach H, 2007, J MOL BIOL, V372, P172, DOI 10.1016/j.jmb.2007.06.045; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Guo HT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002414; HAN JC, 1994, ANAL BIOCHEM, V220, P5, DOI 10.1006/abio.1994.1290; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Hosse RJ, 2006, PROTEIN SCI, V15, P14, DOI 10.1110/ps.051817606; Kehoe JW, 2005, CHEM REV, V105, P4056, DOI 10.1021/cr000261r; Koide S, 2009, ACS CHEM BIOL, V4, P325, DOI 10.1021/cb800314v; Liu MS, 2004, J BACTERIOL, V186, P1503, DOI 10.1128/JB.186.5.1503-1517.2004; Liu MS, 2002, SCIENCE, V295, P2091, DOI 10.1126/science.1067467; McMahon SA, 2005, NAT STRUCT MOL BIOL, V12, P886, DOI 10.1038/nsmb992; Medhekar B, 2007, CURR OPIN MICROBIOL, V10, P388, DOI 10.1016/j.mib.2007.06.004; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Miller JL, 2008, PLOS BIOL, V6, P1195, DOI 10.1371/journal.pbio.0060131; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Overstreet CM, 2012, PROTEIN ENG DES SEL, V25, P145, DOI 10.1093/protein/gzr068; ROBERTS BL, 1992, P NATL ACAD SCI USA, V89, P2429, DOI 10.1073/pnas.89.6.2429; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Sidhu SS, 2007, CURR OPIN CHEM BIOL, V11, P347, DOI 10.1016/j.cbpa.2007.05.001; Sidhu SS, 2000, CURR OPIN BIOTECH, V11, P610, DOI 10.1016/S0958-1669(00)00152-X; Smothers JF, 2002, SCIENCE, V298, P621, DOI 10.1126/science.298.5593.621; Subramanian L, 2006, CALCIUM BINDING PROT, V1, P54	37	5	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55617	10.1371/journal.pone.0055617	http://dx.doi.org/10.1371/journal.pone.0055617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409008	gold, Green Published			2022-12-27	WOS:000315157200044
J	Bailleul, AM; Hall, BK; Horner, JR				Bailleul, Alida M.; Hall, Brian K.; Horner, John R.			Secondary Cartilage Revealed in a Non-Avian Dinosaur Embryo	PLOS ONE			English	Article							GROWTH; REPAIR; TISSUE; BONE; EGG	The skull and jaws of extant birds possess secondary cartilage, a tissue that arises after bone formation during embryonic development at articulations, ligamentous and muscular insertions. Using histological analysis, we discovered secondary cartilage in a non-avian dinosaur embryo, Hypacrosaurus stebingeri (Ornithischia, Lambeosaurinae). This finding extends our previous report of secondary cartilage in post-hatching specimens of the same dinosaur species. It provides the first information on the ontogeny of avian and dinosaurian secondary cartilages, and further stresses their developmental similarities. Secondary cartilage was found in an embryonic dentary within a tooth socket where it is hypothesized to have arisen due to mechanical stresses generated during tooth formation. Two patterns were discerned: secondary cartilage is more restricted in location in this Hypacrosaurus embryo, than it is in Hypacrosaurus post-hatchlings; secondary cartilage occurs at far more sites in bird embryos and nestlings than in Hypacrosaurus. This suggests an increase in the number of sites of secondary cartilage during the evolution of birds. We hypothesize that secondary cartilage provided advantages in the fine manipulation of food and was selected over other types of tissues/articulations during the evolution of the highly specialized avian beak from the jaws of their dinosaurian ancestors.	[Bailleul, Alida M.; Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Bailleul, Alida M.; Horner, John R.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; [Hall, Brian K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Dalhousie University	Bailleul, AM (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.	alida.bailleul@msu.montana.edu			Natural Sciences and Engineering Research Council of Canada [A5056]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	AMB and JRH are indebted to Gerry Ohrstrom for funding. BKH is supported by Natural Sciences and Engineering Research Council of Canada (Grant A5056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, CHONDROID BONE SECON; Bailleul AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036112; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; BENJAMIN M, 1989, J ANAT, V164, P145; BOCK WALTER J., 1960, AUK, V77, P19; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gillis JA, 2006, J FISH BIOL, V68, P1133, DOI 10.1111/j.0022-1112.2006.00998.x; Goret-Nicaise M, 1986, THESIS U LOUVAIN UCL; GORETNICAISE M, 1984, ARCH ANAT MICROSC MO, V73, P291; HALL B. K., 1967, AUST J ZOOL, V15, P685, DOI 10.1071/ZO9670685; HALL B K, 1968, Australian Journal of Zoology, V16, P795, DOI 10.1071/ZO9680795; Hall B.K., 2015, BONES CARTILAGE DEV; HALL BK, 1986, J EMBRYOL EXP MORPH, V93, P133; HALL BK, 1985, J EXP ZOOL, V233, P359, DOI 10.1002/jez.1402330304; Hall BK, 2000, WENN GR INT, V76, P101; HALL BK, 1971, CLIN ORTHOP RELAT R, P182, DOI 10.1097/00003086-197107000-00015; Holliday CM, 2009, ANAT REC, V292, P1246, DOI 10.1002/ar.20982; Homer J. R., 1994, DINOSAUR EGGS BABIES, P312; Horner John R., 1994, P116; Horner JR, 1999, J VERTEBR PALEONTOL, V19, P607, DOI 10.1080/02724634.1999.10011174; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; IRWIN CR, 1986, J ANAT, V146, P53; Lengele B, 1996, ANAT REC, V246, P377, DOI 10.1002/(SICI)1097-0185(199611)246:3<377::AID-AR9>3.0.CO;2-V; Masquelin MH, 1878, B ACAD ROY BELGE, V45, P430; MURRAY P. D. F., 1963, AUSTRALIAN JOUR ZOOL, V11, P368, DOI 10.1071/ZO9630368; Murray P. D. F., 1965, Australian Journal of Zoology, V13, P351, DOI 10.1071/ZO9650351; Payne SL, 2011, ANAT REC, V294, P399, DOI 10.1002/ar.21329; PRITCHARD JJ, 1956, J ANAT, V90, P73; RAHN H, 1974, CONDOR, V76, P147, DOI 10.2307/1366724; Ricklefs Robert E., 1998, Oxford Ornithology Series, V8, P31; Vickaryous MK, 2008, J MORPHOL, V269, P398, DOI 10.1002/jmor.10575; VINKKAPUHAKKA H, 1993, ARCH ORAL BIOL, V38, P49, DOI 10.1016/0003-9969(93)90154-E; Weishampel DB., 2004, DINOSAURIA; WILLIAMS DLG, 1984, PALAEOGEOGR PALAEOCL, V45, P23, DOI 10.1016/0031-0182(84)90107-X; Zusi Richard L., 1993, P391	35	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56937	10.1371/journal.pone.0056937	http://dx.doi.org/10.1371/journal.pone.0056937			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418610	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300205
J	Camolotto, SA; Racca, AC; Ridano, ME; Genti-Raimondi, S; Panzetta-Dutari, GM				Camolotto, Soledad A.; Racca, Ana C.; Ridano, Magali E.; Genti-Raimondi, Susana; Panzetta-Dutari, Graciela M.			PSG Gene Expression Is Up-Regulated by Lysine Acetylation Involving Histone and Nonhistone Proteins	PLOS ONE			English	Article							PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN; KRUPPEL-LIKE FACTOR-6; SP1 TRANSCRIPTION FACTOR; DEACETYLASE INHIBITORS; TROPHOBLAST DIFFERENTIATION; CHORIOCARCINOMA CELLS; GLYCOPROTEIN GENES; PROMOTER REGION; MATERNAL SERUM; HUMAN PLACENTA	Background: Lysine acetylation is an important post-translational modification that plays a central role in eukaryotic transcriptional activation by modifying chromatin and transcription-related factors. Human pregnancy-specific glycoproteins (PSG) are the major secreted placental proteins expressed by the syncytiotrophoblast at the end of pregnancy and represent early markers of cytotrophoblast differentiation. Low PSG levels are associated with complicated pregnancies, thus highlighting the importance of studying the mechanisms that control their expression. Despite several transcription factors having been implicated as key regulators of PSG gene family expression; the role of protein acetylation has not been explored. Methodology/Principal Findings: Here, we explored the role of acetylation on PSG gene expression in the human placental-derived JEG-3 cell line. Pharmacological inhibition of histone deacetylases (HDACs) up-regulated PSG protein and mRNA expression levels, and augmented the amount of acetylated histone H3 associated with PSG 5' regulatory regions. Moreover, PSG5 promoter activation mediated by Sp1 and KLF6, via the core promoter element motif (CPE, -147/-140), was markedly enhanced in the presence of the HDAC inhibitor trichostatin A (TSA). This effect correlated with an increase in Sp1 acetylation and KLF6 nuclear localization as revealed by immunoprecipitation and subcellular fractionation assays. The co-activators PCAF, p300, and CBP enhanced Sp1-dependent PSG5 promoter activation through their histone acetylase (HAT) function. Instead, p300 and CBP acetyltransferase domain was dispensable for sustaining co-activation of PSG5 promoter by KLF6. Conclusions/Significance: Results are consistent with a regulatory role of lysine acetylation on PSG expression through a relaxed chromatin state and an increase in the transcriptional activity of Sp1 and KLF6 following an augmented Sp1 acetylation and KLF6 nuclear localization.	[Camolotto, Soledad A.; Racca, Ana C.; Ridano, Magali E.; Genti-Raimondi, Susana; Panzetta-Dutari, Graciela M.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Ctr Invest Bioquim Clin & Inmunol CIBICI CONICET, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Panzetta-Dutari, GM (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Ctr Invest Bioquim Clin & Inmunol CIBICI CONICET, RA-5000 Cordoba, Argentina.	gpan@fcq.unc.edu.ar		Racca, Ana Cristina/0000-0002-5909-2451	Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba; Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (SECyT-UNC); FONCYT fellowship; CONICET fellowship	Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (SECyT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); FONCYT fellowship(FONCyT); CONICET fellowship(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Consejo Nacional de Investigaciones Cientificas y Tecnicas de Argentina (CONICET), the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), the Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba, and the Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (SECyT-UNC). S.G.-R. and G.M.P.-D. are Career Investigators of CONICET. S.A.C. was a holder of FONCYT and CONICET fellowships. A.C.R. and M.E.R. thank CONICET for their fellowships. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aronow BJ, 2001, PHYSIOL GENOMICS, V6, P105, DOI 10.1152/physiolgenomics.2001.6.2.105; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Blanchon L, 2006, BIOCHEM BIOPH RES CO, V343, P745, DOI 10.1016/j.bbrc.2006.03.032; Camolotto S, 2010, PLACENTA, V31, P312, DOI 10.1016/j.placenta.2010.01.004; Cao WS, 2008, J EXP MED, V205, P1491, DOI 10.1084/jem.20071728; CHAMBERLIN ME, 1994, J BIOL CHEM, V269, P17152; Chiba T, 2004, ONCOLOGY-BASEL, V66, P481, DOI 10.1159/000079503; Chuang HC, 2006, NUCLEIC ACIDS RES, V34, P1459, DOI 10.1093/nar/gkl048; Chuang JY, 2011, BIOCHEM BIOPH RES CO, V407, P587, DOI 10.1016/j.bbrc.2011.03.068; Dokras A, 2006, MOL HUM REPROD, V12, P611, DOI 10.1093/molehr/gal074; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Enya K, 2008, J LEUKOCYTE BIOL, V83, P190, DOI 10.1189/jlb.0106008; Gardner MO, 1997, ACTA OBSTET GYN SCAN, V76, P56; Gehrau RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008929; Gray SG, 2004, INT J ONCOL, V24, P773; Greer SF, 2003, NAT IMMUNOL, V4, P1074, DOI 10.1038/ni985; GRUDZINSKAS JG, 1983, AM J OBSTET GYNECOL, V147, P10, DOI 10.1016/0002-9378(83)90075-3; Ha CT, 2010, BIOL REPROD, V83, P27, DOI 10.1095/biolreprod.109.082412; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Jung JW, 2005, CANCER LETT, V225, P199, DOI 10.1016/j.canlet.2004.11.029; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; KARG NJ, 1981, ARCH GYNECOL, V231, P69, DOI 10.1007/BF02110026; Kawamata N, 2007, BLOOD, V110, P2667, DOI 10.1182/blood-2005-11-026344; Kimura AP, 2007, MOL CELL BIOL, V27, P6555, DOI 10.1128/MCB.00273-07; Knofler M, 2004, ENDOCRINOLOGY, V145, P1685, DOI 10.1210/en.2003-0954; Kodani M, 2005, ONCOL REP, V13, P477; Koritschoner NP, 1996, EUR J BIOCHEM, V236, P365, DOI 10.1111/j.1432-1033.1996.00365.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kruger I, 2007, DEV DYNAM, V236, P2235, DOI 10.1002/dvdy.21222; Kumar P, 2009, MOL ENDOCRINOL, V23, P784, DOI 10.1210/me.2008-0371; Kuninger D, 2006, AM J PHYSIOL-CELL PH, V291, pC699, DOI 10.1152/ajpcell.00056.2006; Lehrmann H, 2002, ADV CANCER RES, V86, P41, DOI 10.1016/S0065-230X(02)86002-X; Li D, 2005, J BIOL CHEM, V280, P26941, DOI 10.1074/jbc.M500463200; Li D, 2005, CANCER RES, V65, P9216, DOI 10.1158/0008-5472.CAN-05-1040; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Lisboa FA, 2011, J BIOL CHEM, V286, P7577, DOI 10.1074/jbc.M110.161810; Liu J, 2010, MOL CELL BIOCHEM, V335, P29, DOI 10.1007/s11010-009-0237-8; Lopez-Diaz F, 2007, PLACENTA, V28, P898, DOI 10.1016/j.placenta.2007.03.002; Masumi A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/640610; Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916; Motran CC, 2003, EUR J IMMUNOL, V33, P3007, DOI 10.1002/eji.200323993; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; Nores R, 2004, PLACENTA, V25, P9, DOI 10.1016/S0143-4004(03)00213-3; Nunes MJ, 2010, J NEUROCHEM, V113, P418, DOI 10.1111/j.1471-4159.2010.06612.x; PANZETTADUTARI GM, 1992, MOL BIOL REP, V16, P255, DOI 10.1007/BF00419665; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Piao YS, 1997, ENDOCRINOLOGY, V138, P3417, DOI 10.1210/en.138.8.3417; Racca A, 2010, PLACENTA, V31, pA14; Racca AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022438; Rando OJ, 2007, CURR OPIN GENET DEV, V17, P94, DOI 10.1016/j.gde.2007.02.006; Rena V, 2011, MOL ENDOCRINOL, V25, P1364, DOI 10.1210/me.2010-0503; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; SILVER RM, 1993, PLACENTA, V14, P583, DOI 10.1016/S0143-4004(05)80211-5; Slavin DA, 2004, ONCOGENE, V23, P8196, DOI 10.1038/sj.onc.1208020; Snyder SK, 2001, AM J REPROD IMMUNOL, V45, P205, DOI 10.1111/j.8755-8920.2001.450403.x; Song CZ, 2002, J BIOL CHEM, V277, P7029, DOI 10.1074/jbc.M108826200; Su XD, 2007, EXPERT REV PROTEOMIC, V4, P211, DOI 10.1586/14789450.4.2.211; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; Swingler TE, 2010, BIOCHEM J, V427, P391, DOI 10.1042/BJ20091798; TEGLUND S, 1994, GENOMICS, V23, P669, DOI 10.1006/geno.1994.1556; THOMPSON J, 1990, BIOCHEM BIOPH RES CO, V167, P848, DOI 10.1016/0006-291X(90)92103-7; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang X, 2008, ONCOGENE, V27, P1894, DOI 10.1038/sj.onc.1210821; Wessells J, 2000, EUR J IMMUNOL, V30, P1830, DOI 10.1002/1521-4141(200007)30:7&lt;1830::AID-IMMU1830&gt;3.0.CO;2-M; Wolfe MW, 2006, METH MOLEC MED, V121, P229; WU SM, 1993, MOL CELL BIOCHEM, V122, P147, DOI 10.1007/BF01076099; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yoshikawa M, 2010, EUR J PHARMACOL, V642, P28, DOI 10.1016/j.ejphar.2010.05.055; Zhou CL, 2006, INT J ONCOL, V29, P269; Zhou GQ, 1997, PLACENTA, V18, P491, DOI 10.1016/0143-4004(77)90002-9	74	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55992	10.1371/journal.pone.0055992	http://dx.doi.org/10.1371/journal.pone.0055992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418492	gold, Green Published			2022-12-27	WOS:000315970300084
J	Gupta, A; Wood, R; Kaplan, R; Bekker, LG; Lawn, SD				Gupta, Ankur; Wood, Robin; Kaplan, Richard; Bekker, Linda-Gail; Lawn, Stephen D.			Prevalent and Incident Tuberculosis Are Independent Risk Factors for Mortality among Patients Accessing Antiretroviral Therapy in South Africa	PLOS ONE			English	Article							HIV-ASSOCIATED TUBERCULOSIS; IMMUNE RECONSTITUTION DISEASE; SUB-SAHARAN AFRICA; PULMONARY TUBERCULOSIS; TREATMENT PROGRAM; INFECTED PATIENTS; EARLY OUTCOMES; RURAL UGANDA; ADULTS; DETERMINANTS	Background: Patients with prevalent or incident tuberculosis (TB) in antiretroviral treatment (ART) programmes in sub-Saharan Africa have high mortality risk. However, published data are contradictory as to whether TB is a risk factor for mortality that is independent of CD4 cell counts and other patient characteristics. Methods/Findings: This observational ART cohort study was based in Cape Town, South Africa. Deaths from all causes were ascertained among patients receiving ART for up to 8 years. TB diagnoses and 4-monthly CD4 cell counts were recorded. Mortality rates were calculated and Poisson regression models were used to calculate incidence rate ratios (IRR) and identify risk factors for mortality. Of 1544 patients starting ART, 464 patients had prevalent TB at baseline and 424 developed incident TB during a median of 5.0 years follow-up. Most TB diagnoses (73.6%) were culture-confirmed. A total of 208 (13.5%) patients died during ART and mortality rates were 8.84 deaths/100 person-years during the first year of ART and decreased to 1.14 deaths/100 person-years after 5 years. In multivariate analyses adjusted for baseline and time-updated risk factors, both prevalent and incident TB were independent risk factors for mortality (IRR 1.7 [95% CI, 1.2-2.3] and 2.7 [95% CI, 1.9-3.8], respectively). Adjusted mortality risks were higher in the first 6 months of ART for those with prevalent TB at baseline (IRR 2.33; 95% CI, 1.5-3.5) and within the 6 months following diagnoses of incident TB (IRR 3.8; 95% CI, 2.6-5.7). Conclusions: Prevalent TB at baseline and incident TB during ART were strongly associated with increased mortality risk. This effect was time-dependent, suggesting that TB and mortality are likely to be causally related and that TB is not simply an epiphenomenon among highly immunocompromised patients. Strategies to rapidly diagnose, treat and prevent TB prior to and during ART urgently need to be implemented.	[Gupta, Ankur; Lawn, Stephen D.] London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England; [Wood, Robin; Kaplan, Richard; Bekker, Linda-Gail; Lawn, Stephen D.] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town	Lawn, SD (corresponding author), London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England.	stephen.lawn@lshtm.ac.uk	Bekker, Linda-Gail/AAZ-8929-2020	BEKKER, LINDA-GAIL/0000-0002-0755-4386; Kaplan, Richard/0000-0003-1565-4704; Gupta-Wright, Ankur/0000-0002-5150-2970	Wellcome Trust, London, UK [074641]; International Epidemiologic Database to Evaluate Aids; National Institute of Allergy and Infectious Diseases (NIAID) [5U01AI069924-02]; National Institutes of Health (NIH) [5R01AI058736-02]; USAID Right to Care [CA 674 A 00 08 0000 700]; South African Centre for Epidemiological Modelling and Analysis (SACEMA); Cost-Effectiveness of Preventing AIDS Complications (CEPAC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924, R01AI058736] Funding Source: NIH RePORTER	Wellcome Trust, London, UK(Wellcome Trust); International Epidemiologic Database to Evaluate Aids; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USAID Right to Care(United States Agency for International Development (USAID)); South African Centre for Epidemiological Modelling and Analysis (SACEMA); Cost-Effectiveness of Preventing AIDS Complications (CEPAC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SDL is funded by the Wellcome Trust, London, UK with grant number 074641. RW was funded in part by the International Epidemiologic Database to Evaluate Aids with a grant from the National Institute of Allergy and Infectious Diseases (NIAID: 5U01AI069924-02); Cost-Effectiveness of Preventing AIDS Complications (CEPAC) funded by the National Institutes of Health (NIH, 5R01AI058736-02); USAID Right to Care (CA 674 A 00 08 0000 700) and the South African Centre for Epidemiological Modelling and Analysis (SACEMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuron B, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-39; Bassett IV, 2012, JAIDS-J ACQ IMM DEF, V59, P25, DOI 10.1097/QAI.0b013e31823d3aba; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Brinkhof MWG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014149; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Del Amo J, 1999, AIDS, V13, P1151, DOI 10.1097/00002030-199907090-00002; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Hosseinipour MC, 2010, HIV MED, V11, P510, DOI 10.1111/j.1468-1293.2010.00825.x; Houlihan CF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-23; Komati S, 2010, AIDS, V24, P1849, DOI 10.1097/QAD.0b013e32833a2507; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2011, LANCET INFECT DIS, DOI [10.1016/S1473-3099(1011)70251-70251, DOI 10.1016/S1473-3099(1011)70251-70251]; Lawn SD, 2012, AIDS IN PRESS; Lawn SD, 2012, 17 INT AIDS C MEX CI, V26, P1730; Lawn SD, 2012, AIDS, DOI [10.1097/QAD.1090b1013e3283553685, DOI 10.1097/QAD.1090B1013E3283553685]; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lawn SD, 2011, SAMJ S AFR MED J, V101, P258, DOI 10.7196/SAMJ.4392; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Maro I, 2010, INT J TUBERC LUNG D, V14, P1447; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Moore DM, 2011, JAIDS-J ACQ IMM DEF, V58, P289, DOI 10.1097/QAI.0b013e3182303716; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Murphy RA, 2010, AIDS, V24, P1007, DOI 10.1097/QAD.0b013e3283333639; Omar GS, 2010, ABSTRACTS OF THE 18T; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Seyler C, 2005, AM J RESP CRIT CARE, V172, P123, DOI 10.1164/rccm.200410-1342OC; Straetemans M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015241; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; Westreich D, 2009, AIDS, V23, P707, DOI 10.1097/QAD.0b013e328325d115; World Health Organisation, 2002, SCALING UP ANTIRETRO; World Health Organisation, 2007, IMPROVING THE DIAGNO; World Health Organization, 2011, WHO HTM TB 2011 16; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	47	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55824	10.1371/journal.pone.0055824	http://dx.doi.org/10.1371/journal.pone.0055824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418463	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000315970300054
J	Lu, J; Carter, DA; Turnbull, L; Rosendale, D; Hedderley, D; Stephens, J; Gannabathula, S; Steinhorn, G; Schlothauer, RC; Whitchurch, CB; Harry, EJ				Lu, Jing; Carter, Dee A.; Turnbull, Lynne; Rosendale, Douglas; Hedderley, Duncan; Stephens, Jonathan; Gannabathula, Swapna; Steinhorn, Gregor; Schlothauer, Ralf C.; Whitchurch, Cynthia B.; Harry, Elizabeth J.			The Effect of New Zealand Kanuka, Manuka and Clover Honeys on Bacterial Growth Dynamics and Cellular Morphology Varies According to the Species	PLOS ONE			English	Article							LEPTOSPERMUM-SCOPARIUM HONEY; ANTIBACTERIAL ACTIVITY; ESCHERICHIA-COLI; METHYLGLYOXAL PRODUCTION; DIVISION; ANTIMICROBIALS; PROTEINS; BIOFILM; SITE; DNA	Treatment of chronic wounds is becoming increasingly difficult due to antibiotic resistance. Complex natural products with antimicrobial activity, such as honey, are now under the spotlight as alternative treatments to antibiotics. Several studies have shown honey to have broad-spectrum antibacterial activity at concentrations present in honey dressings, and resistance to honey has not been attainable in the laboratory. However not all honeys are the same and few studies have used honey that is well defined both in geographic and chemical terms. Here we have used a range of concentrations of clover honey and a suite of manuka and kanuka honeys from known geographical locations, and for which the floral source and concentration of methylglyoxal and hydrogen peroxide potential were defined, to determine their effect on growth and cellular morphology of four bacteria: Bacillus subtilis, Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa. While the general trend in effectiveness of growth inhibition was manuka>manuka-kanuka blend>kanuka>clover, the honeys had varying and diverse effects on the growth and cellular morphology of each bacterium, and each organism had a unique response profile to these honeys. P. aeruginosa showed a markedly different pattern of growth inhibition to the other three organisms when treated with sub-inhibitory concentrations of honey, being equally sensitive to all honeys, including clover, and the least sensitive to honey overall. While hydrogen peroxide potential contributed to the antibacterial activity of the manuka and kanuka honeys, it was never essential for complete growth inhibition. Cell morphology analysis also showed a varied and diverse set of responses to the honeys that included cell length changes, cell lysis, and alterations to DNA appearance. These changes are likely to reflect the different regulatory circuits of the organisms that are activated by the stress of honey treatment.	[Lu, Jing; Turnbull, Lynne; Whitchurch, Cynthia B.; Harry, Elizabeth J.] Univ Technol Sydney, Inst I3, Sydney, NSW 2007, Australia; [Carter, Dee A.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Rosendale, Douglas; Hedderley, Duncan] New Zealand Inst Plant & Food Res Ltd, Food Ind Sci Ctr, Palmerston North, New Zealand; [Stephens, Jonathan; Steinhorn, Gregor; Schlothauer, Ralf C.] Comvita NZ Ltd, Te Puke, New Zealand; [Gannabathula, Swapna] Univ Auckland, Fac Med & Hlth Sci, Dept Mol Med & Pathol, Auckland 1, New Zealand	University of Technology Sydney; University of Sydney; New Zealand Institute for Plant & Food Research Ltd; University of Auckland	Harry, EJ (corresponding author), Univ Technol Sydney, Inst I3, Sydney, NSW 2007, Australia.	liz.harry@uts.edu.au	Harry, Liz/AAT-9396-2020; Harry, Elizabeth/G-8123-2017; Rosendale, Doug/E-4938-2010; Carter, Dee/C-1331-2010; Turnbull, Lynne/A-2605-2012; Whitchurch, Cynthia/A-5954-2008	Rosendale, Doug/0000-0001-9561-335X; Carter, Dee/0000-0002-4638-0059; Hedderley, Duncan/0000-0001-7522-2212; Turnbull, Lynne/0000-0002-9255-9033; Whitchurch, Cynthia/0000-0003-2296-3791; Harry, Elizabeth/0000-0003-0858-9473	Australian Research Council; Comvita NZ Ltd.	Australian Research Council(Australian Research Council); Comvita NZ Ltd.	This work was supported by the following sources: 1) Australian Research Council http://www.arc.gov.au/. 2) Comvita NZ Ltd. http://www.comvita.co.nz/. The Australian Research Council had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Comvita NZ, Ltd. provided partial funding for the work described in the manuscript. Employees of Comvita played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CJ, 2008, CARBOHYD RES, V343, P651, DOI 10.1016/j.carres.2007.12.011; Adams CJ, 2009, CARBOHYD RES, V344, P1050, DOI 10.1016/j.carres.2009.03.020; ALLEN KL, 1991, J PHARM PHARMACOL, V43, P817, DOI 10.1111/j.2042-7158.1991.tb03186.x; Blair SE, 2005, INFECT DIS HEALTH, V10, P24, DOI 10.1071/HI05024; Blair SE, 2009, EUR J CLIN MICROBIOL, V28, P1199, DOI 10.1007/s10096-009-0763-z; Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; Brudzynski K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00213; Chen C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00265; Chien AC, 2012, CURR BIOL, V22, pR340, DOI 10.1016/j.cub.2012.02.032; COOPER RA, 1984, ANNU REV MICROBIOL, V38, P49, DOI 10.1146/annurev.mi.38.100184.000405; Cooper R, 2012, EXPERT REV ANTI-INFE, V10, P623, DOI [10.1586/ERI.12.46, 10.1586/eri.12.46]; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; EGYUD LG, 1966, P NATL ACAD SCI USA, V56, P203, DOI 10.1073/pnas.56.1.203; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; FRAVAL HNA, 1980, J GEN MICROBIOL, V117, P127; Gannabathula S, 2012, IMMUNOPHARM IMMUNOT, V34, P598, DOI 10.3109/08923973.2011.641974; Henriques AF, 2010, EUR J CLIN MICROBIOL, V29, P45, DOI 10.1007/s10096-009-0817-2; Irish J, 2006, MED MYCOL, V44, P289, DOI 10.1080/13693780500417037; Irish J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018229; Kwakman PHS, 2011, EUR J CLIN MICROBIOL, V30, P251, DOI 10.1007/s10096-010-1077-x; Kwakman PHS, 2012, IUBMB LIFE, V64, P48, DOI 10.1002/iub.578; Kwakman PHS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017709; Kwakman PHS, 2010, FASEB J, V24, P2576, DOI 10.1096/fj.09-150789; Lee DS, 2011, AM J CLIN DERMATOL, V12, P181, DOI 10.2165/11538930-000000000-00000; Lin SM, 2011, EUR J CLIN MICROBIOL, V30, P569, DOI 10.1007/s10096-010-1121-x; Maddocks SE, 2012, MICROBIOL-SGM, V158, P781, DOI 10.1099/mic.0.053959-0; Majtan J, 2012, FITOTERAPIA, V83, P671, DOI 10.1016/j.fitote.2012.02.002; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; Merckoll P, 2009, SCAND J INFECT DIS, V41, P341, DOI 10.1080/00365540902849383; Molan P., 2008, N BEEKEEP, V16, P11; MOLAN PC, 1992, BEE WORLD, V73, P59, DOI 10.1080/0005772X.1992.11099118; Monahan LG, 2009, MOL MICROBIOL, V74, P1004, DOI 10.1111/j.1365-2958.2009.06914.x; Moriya S, 2010, MOL MICROBIOL, V76, P634, DOI 10.1111/j.1365-2958.2010.07102.x; Ngo DK, 2007, ANZ J SURG, V77, pA66; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Projan SJ, 2002, CURR OPIN MICROBIOL, V5, P463, DOI 10.1016/S1369-5274(02)00364-8; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; SETLOW B, 1991, J BACTERIOL, V173, P6270, DOI 10.1128/jb.173.19.6270-6278.1991; Silva-Rocha R, 2010, ANNU REV MICROBIOL, V64, P257, DOI 10.1146/annurev.micro.091208.073229; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Smaropoulos E, 2011, WOUNDS UK, V7, P33; Stephens JM, 2010, FOOD CHEM, V120, P78, DOI 10.1016/j.foodchem.2009.09.074; Sukdeo N, 2007, BBA-PROTEINS PROTEOM, V1774, P756, DOI 10.1016/j.bbapap.2007.04.005; Thomas M, 2011, WOUNDS UK, V2, P46; Totemeyer S, 1998, MOL MICROBIOL, V27, P553, DOI 10.1046/j.1365-2958.1998.00700.x; Weston RJ, 2000, FOOD CHEM, V71, P235, DOI 10.1016/S0308-8146(00)00162-X; Wolcott R D, 2008, J Wound Care, V17, P333; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	49	67	69	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55898	10.1371/journal.pone.0055898	http://dx.doi.org/10.1371/journal.pone.0055898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418472	gold, Green Submitted, Green Published			2022-12-27	WOS:000315970300063
J	Mehairi, AE; Khouri, AA; Naqbi, MM; Muhairi, SJ; Maskari, FA; Nagelkerke, N; Shah, SM				Mehairi, Aaesha E.; Khouri, Aysha A.; Naqbi, Muna M.; Muhairi, Shamma J.; Maskari, Fatima A.; Nagelkerke, Nico; Shah, Syed M.			Metabolic Syndrome among Emirati Adolescents: A School-Based Study	PLOS ONE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE; CARDIOVASCULAR RISK; HIGH PREVALENCE; CHILDHOOD; DEFINITION; OBESITY; CHILDREN	Objectives: Population-based data on metabolic syndrome (MetS) among children is lacking in the United Arab Emirates which has among the highest rates of diabetes in the world. In this study we determined the prevalence of MetS and its correlates in a sample of adolescents. Materials and Methods: A cross-sectional school-based study was conducted on 1,018 adolescents (48.4% girls) aged 12-18 years from Al Ain Abu Dhabi Emirates. A self-administered questionnaire was used to assess socio-demographic characteristics, physical activity and dietary habits. Blood pressure, height, weight, waist circumference, fasting glucose, HDL-cholesterol and triglycerides were measured. MetS was defined using the International Diabetes Federation (IDF) criteria. Results: The prevalence of metabolic syndrome was 13%. Boys compared to girls were more likely to have MetS (21% vs. 4%, odds ratio [OR]: 6.57, 95% CI: 4.01 to 10.75). The prevalence of MetS increased with increase in body mass index and reached 59 percent in obese boys. After multivariable adjustment boys who were overweight (adjusted OR: 2.72 [1.37 to 5.35]), or obese (AOR: 12.70 [7.31 to 22.05]), or spent two or more than two hours on screen in a day (AOR: 1.65 [1.01 to 2.69) were more likely to have MetS. Girls who were overweight (AOR: 4.23 [1.32 to 13.62]) or obese (AOR: 8.32 [2.73 to 25.32]) were more likely to have MetS. Conclusions: The prevalence of MetS is high among UAE boys. Population-based strategies are needed to address the high burden of metabolic syndrome targeted at the identified risk factors.	[Mehairi, Aaesha E.; Khouri, Aysha A.; Naqbi, Muna M.; Muhairi, Shamma J.] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Family Med, Al Ain, U Arab Emirates; [Maskari, Fatima A.; Nagelkerke, Nico; Shah, Syed M.] United Arab Emirates Univ, Inst Publ Hlth, Coll Med & Hlth Sci, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University	Shah, SM (corresponding author), United Arab Emirates Univ, Inst Publ Hlth, Coll Med & Hlth Sci, Al Ain, U Arab Emirates.	syeds@uaeu.ac.ae		Al-Maskari, Fatma/0000-0001-6598-4942	UAE University Individual Faculty [01-14-8-11/09]; Tawam Hospital - Al Ain, United Arab Emirates; Faculty of Medicine and Health Sciences, UAE University	UAE University Individual Faculty; Tawam Hospital - Al Ain, United Arab Emirates; Faculty of Medicine and Health Sciences, UAE University	The authors' research was supported by a grant from the UAE University Individual Faculty Grant (# 01-14-8-11/09), Shah et al. Parents Assisting Children and Teachers (PACT) for Obesity Prevention, Seed grant by Faculty of Medicine and Health Sciences, UAE University (Al Maskari et al). The laboratory investigations of this study were funded by Tawam Hospital - Al Ain, United Arab Emirates and help of laboratory staff at Tawam hospital is greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirbasli M, 2006, METABOLISM, V55, P1002, DOI 10.1016/j.metabol.2006.03.009; Agirbasli M, 2009, METABOLISM, V58, P1256, DOI 10.1016/j.metabol.2009.03.024; Al-Daghri NM, 2010, EUR J CLIN INVEST, V40, P1063, DOI 10.1111/j.1365-2362.2010.02341.x; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Caprio S, 2002, J PEDIATR ENDOCR MET, V15, P487; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Ferranti SD, 2004, CIRCULATION, V110, P2494, DOI 10.1161/01.CIR.0000145117.40114.C7; Eapen V, 2010, J TROP PEDIATRICS, V56, P325, DOI 10.1093/tropej/fmp128; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ella NAA, 2010, J CLIN LIPIDOL, V4, P185, DOI 10.1016/j.jacl.2010.03.007; Esmaillzadeh A, 2006, OBESITY, V14, P377, DOI 10.1038/oby.2006.50; Ford ES, 2008, DIABETES CARE, V31, P587, DOI 10.2337/dc07-1030; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Giordano P, 2011, EUROPEAN J PEDIAT, V13; IPAQ Research Committee, 2005, GUID DAT PROC AN INT; Juhola J, 2011, J PEDIATR-US, V159, P584, DOI 10.1016/j.jpeds.2011.03.021; Kang HT, 2010, DIABETES RES CLIN PR, V89, P72, DOI 10.1016/j.diabres.2010.02.016; Katzmarzyk PT, 2004, PEDIATRICS, V114, P198; Khader Y, 2010, INT J PEDIAT ENDOCRI, V3, P161; Kohen-Avramoglu R, 2003, CLIN BIOCHEM, V36, P413, DOI 10.1016/S0009-9120(03)00038-9; Mark AE, 2008, J PUBLIC HEALTH-UK, V30, P153, DOI 10.1093/pubmed/fdn022; Mirhosseini NZ, 2009, ASIA PAC J CLIN NUTR, V18, P131; Morrison JA, 2008, J PEDIAT, V152, P210; Morrison JA, 2007, PEDIATRICS, V120, P340, DOI 10.1542/peds.2006-1699; Ng SW, 2011, EUR J CLIN NUTR, V65, P1328, DOI 10.1038/ejcn.2011.135; Nguyen THHD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-141; Park J, 2010, J KOREAN MED SCI, V25, P75, DOI 10.3346/jkms.2010.25.1.75; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Wan Nai-jun, 2007, Zhonghua Er Ke Za Zhi, V45, P417	30	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56159	10.1371/journal.pone.0056159	http://dx.doi.org/10.1371/journal.pone.0056159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418529	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300121
J	Miyamoto, T; Chen, Y; Slone, J; Amrein, H				Miyamoto, Tetsuya; Chen, Yan; Slone, Jesse; Amrein, Hubert			Identification of a Drosophila Glucose Receptor Using Ca2+ Imaging of Single Chemosensory Neurons	PLOS ONE			English	Article							MOLECULAR EVOLUTION; GUSTATORY RECEPTORS; CAFFEINE RESPONSE; BITTER TASTE; FLY BRAIN; MELANOGASTER; GENES; SUPERFAMILY; PERCEPTION; TREHALOSE	Evaluation of food compounds by chemosensory cells is essential for animals to make appropriate feeding decisions. In the fruit fly Drosophila melanogaster, structurally diverse chemicals are detected by multimeric receptors composed of members of a large family of Gustatory receptor (Gr) proteins. Putative sugar and bitter receptors are expressed in distinct subsets of Gustatory Receptor Neurons (GRN) of taste sensilla, thereby assigning distinct taste qualities to sugars and bitter tasting compounds, respectively. Here we report a Ca2+ imaging method that allows association of ligand-mediated responses to a single GRN. We find that different sweet neurons exhibit distinct response profiles when stimulated with various sugars, and likewise, different bitter neurons exhibit distinct response profiles when stimulated with a set of bitter chemicals. These observations suggest that individual neurons within a taste modality are represented by distinct repertoires of sweet and bitter taste receptors, respectively. Furthermore, we employed this novel method to identify glucose as the primary ligand for the sugar receptor Gr61a, which is not only expressed in sweet sensing neurons of classical chemosensory sensilla, but also in two supersensitive neurons of atypical taste sensilla. Thus, single cell Ca2+ imaging can be employed as a powerful tool to identify ligands for orphan Gr proteins.	[Miyamoto, Tetsuya; Chen, Yan; Slone, Jesse; Amrein, Hubert] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Amrein, H (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX USA.	amrein@tamhsc.edu	Amrein, Hubert/AAG-9480-2021	Amrein, Hubert/0000-0001-8799-7250; Chen, Yan/0000-0002-5321-3064; Slone, Jesse/0000-0002-2478-3295	Taste Receptor Genes and Sensory Coding [NIH-1RO1GMDC0560]; Pheromone Receptor [NIH-1RO1DC009014]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009014, R01DC005606] Funding Source: NIH RePORTER	Taste Receptor Genes and Sensory Coding; Pheromone Receptor; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding provided by Taste Receptor Genes and Sensory Coding (NIH-1RO1GMDC0560) and From Pheromone Receptor to Social Behaviors (NIH-1RO1DC009014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein H, 2005, CURR BIOL, V15, pR673, DOI 10.1016/j.cub.2005.08.021; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Chen ZJ, 2010, J NEUROSCI, V30, P6247, DOI 10.1523/JNEUROSCI.0627-10.2010; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dahanukar A, 2005, CURR OPIN NEUROBIOL, V15, P423, DOI 10.1016/j.conb.2005.06.001; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Ishimoto H, 2004, CELL MOL LIFE SCI, V61, P10, DOI 10.1007/s00018-003-3182-9; Jiao Y, 2007, P NATL ACAD SCI USA, V104, P14110, DOI 10.1073/pnas.0702421104; Jiao YC, 2008, CURR BIOL, V18, P1797, DOI 10.1016/j.cub.2008.10.009; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Meunier N, 2003, CHEM SENSES, V28, P671, DOI 10.1093/chemse/bjg059; Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235; Meunier N, 2000, CURR BIOL, V10, P1583, DOI 10.1016/S0960-9822(00)00860-5; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1801; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Slone J, 2007, CURR BIOL, V17, P1809, DOI 10.1016/j.cub.2007.09.027; Tanimura Teiichi, 2009, SEB Experimental Biology Series, V63, P59; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001	33	44	48	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56304	10.1371/journal.pone.0056304	http://dx.doi.org/10.1371/journal.pone.0056304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418550	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300143
J	Wang, M; Gu, BL; Huang, J; Jiang, S; Chen, YJ; Yin, YL; Pan, YF; Yu, GJ; Li, YM; Wong, BHC; Liang, Y; Sun, H				Wang, Man; Gu, Bianli; Huang, Jie; Jiang, Shuai; Chen, Yijie; Yin, Yalin; Pan, Yongfu; Yu, Guojun; Li, Yamu; Wong, Barry Hon Cheung; Liang, Yi; Sun, Hui			Transcriptome and Proteome Exploration to Provide a Resource for the Study of Agrocybe aegerita	PLOS ONE			English	Article							EDIBLE MUSHROOM; AGARICUS-BISPORUS; GENOME SEQUENCE; FRUITING BODY; CARBOHYDRATE-METABOLISM; COPRINOPSIS-CINEREA; HYDROPHOBIN GENES; MASS-SPECTROMETRY; DEGRADING ENZYMES; GANODERMA-LUCIDUM	Background: Agrocybe aegerita, the black poplar mushroom, has been highly valued as a functional food for its medicinal and nutritional benefits. Several bioactive extracts from A. aegerita have been found to exhibit antitumor and antioxidant activities. However, limited genetic resources for A. aegerita have hindered exploration of this species. Methodology/Principal Findings: To facilitate the research on A. aegerita, we established a deep survey of the transcriptome and proteome of this mushroom. We applied high-throughput sequencing technology (Illumina) to sequence A. aegerita transcriptomes from mycelium and fruiting body. The raw clean reads were de novo assembled into a total of 36,134 expressed sequences tags (ESTs) with an average length of 663 bp. These ESTs were annotated and classified according to Gene Ontology (GO), Clusters of Orthologous Groups (COG), and Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathways. Gene expression profile analysis showed that 18,474 ESTs were differentially expressed, with 10,131 up-regulated in mycelium and 8,343 up-regulated in fruiting body. Putative genes involved in polysaccharide and steroid biosynthesis were identified from A. aegerita transcriptome, and these genes were differentially expressed at the two stages of A. aegerita. Based on one-dimensional gel electrophoresis (1-DGE) coupled with electrospray ionization liquid chromatography tandem MS (LC-ESI-MS/MS), we identified a total of 309 non-redundant proteins. And many metabolic enzymes involved in glycolysis were identified in the protein database. Conclusions/Significance: This is the first study on transcriptome and proteome analyses of A. aegerita. The data in this study serve as a resource of A. aegerita transcripts and proteins, and offer clues to the applications of this mushroom in nutrition, pharmacy and industry.	[Wang, Man; Gu, Bianli; Huang, Jie; Jiang, Shuai; Chen, Yijie; Yin, Yalin; Pan, Yongfu; Yu, Guojun; Li, Yamu; Wong, Barry Hon Cheung; Liang, Yi; Sun, Hui] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liang, Yi] Guangdong Med Coll, Dept Clin Immunol, Dongguan, Peoples R China; [Sun, Hui] Hubei Univ Technol, Minist Educ, Key Lab Fermentat Engn, Wuhan, Peoples R China; [Sun, Hui] Wuhan Univ, Minist Educ, Key Lab Combinatorial Biosynth & Drug Discovey, Wuhan 430072, Peoples R China; [Gu, Bianli] Henan Univ Sci & Technol, Affiliated Hosp 1, Mol Diag Ctr, Luoyang, Peoples R China	Wuhan University; Guangdong Medical University; Hubei University of Technology; Wuhan University; Henan University of Science & Technology	Sun, H (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	sunhui@whu.edu.cn		Huang, Jie/0000-0003-3842-6181	National Key Technologies RD Program [2009ZX09103-676]; Natural Science Foundation of China (NSFC) program [81102850]; Major State Basic Research Development Program of China, 973 Program [2011CB811302]; National Mega Project on Major Drug Development [2009ZX09301-014-1]; Chinese 111 project [B06018]; Wuhan municipal project [201160923296]; Office of Science of the U.S. Department of Energy	National Key Technologies RD Program(National Key Technology R&D Program); Natural Science Foundation of China (NSFC) program(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China, 973 Program(National Basic Research Program of China); National Mega Project on Major Drug Development; Chinese 111 project(Ministry of Education, China - 111 Project); Wuhan municipal project; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was funded by the National Key Technologies R&D Program [2009ZX09103-676], the Natural Science Foundation of China (NSFC) program [81102850], the Major State Basic Research Development Program of China, 973 Program [2011CB811302], National Mega Project on Major Drug Development [2009ZX09301-014-1], the Chinese 111 project [B06018] and Wuhan municipal project (No. 201160923296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Professor Xiangdong Fu (University of California, San Diego, USA) for his advice and technical assistance. We also thank Professors Igor V. Grigoriev (Joint Genome Institute, California, USA), Han A. B. Wosten (Utrecht University, Utrecht, The Netherlands), Jason E. Stajich (University of California, Riverside, CA 92521) and Francis Martin (INRA-Nancy University, France) for their help and support. Annotation information used in this study was obtained from the U.S. Department of Energy's Joint Genome Institute (JGI), and is supported by the Office of Science of the U.S. Department of Energy (http://www.jgi.doe. gov.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ando A, 2001, CURR GENET, V39, P190, DOI 10.1007/s002940100193; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barros L, 2007, FOOD CHEM, V105, P140, DOI 10.1016/j.foodchem.2007.03.052; Bayry J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002700; Berg Miller ME, 2009, PLOS ONE, V4, pe6650, DOI DOI 10.1371/journal.pone.0006650; Berne S, 2002, BBA-GEN SUBJECTS, V1570, P153, DOI 10.1016/S0304-4165(02)00190-3; Boh B, 2007, BIOTECHNOL ANN REV, V13, P265, DOI 10.1016/S1387-2656(07)13010-6; BONNEN AM, 1994, APPL ENVIRON MICROB, V60, P960, DOI 10.1128/AEM.60.3.960-965.1994; Ceccaroli P, 2011, NEW PHYTOL, V189, P751, DOI 10.1111/j.1469-8137.2010.03520.x; Chakraborty TK, 2003, J BASIC MICROB, V43, P462, DOI 10.1002/jobm.200310275; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Chin CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-672; Chum WWY, 2011, FUNGAL GENET BIOL, V48, P359, DOI 10.1016/j.fgb.2011.01.009; Chum WWY, 2008, MYCOL RES, V112, P950, DOI 10.1016/j.mycres.2008.01.028; Combet Emilie, 2006, Mycoscience, V47, P317, DOI 10.1007/s10267-006-0318-4; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; Deveau A, 2008, NEW PHYTOL, V180, P379, DOI 10.1111/j.1469-8137.2008.02581.x; Diyabalanage T, 2008, FOOD CHEM, V108, P97, DOI 10.1016/j.foodchem.2007.10.049; Donadio S, 2007, NAT PROD REP, V24, P1073, DOI 10.1039/b514050c; Douglas CM, 2001, MED MYCOL, V39, P55, DOI 10.1080/mmy.39.1.55.66; Elvan H, 2010, FOOD CHEM, V123, P291, DOI 10.1016/j.foodchem.2010.04.034; Espinar MTF, 1997, CURR GENET, V32, P420, DOI 10.1007/s002940050297; Guo ZH, 2009, VACCINE, V27, P660, DOI 10.1016/j.vaccine.2008.11.038; Heneghan MN, 2009, APPL ENVIRON MICROB, V75, P792, DOI 10.1128/AEM.01897-08; Hirosue S, 2011, BIOCHEM BIOPH RES CO, V407, P118, DOI 10.1016/j.bbrc.2011.02.121; Hooff GP, 2010, BBA-MOL CELL BIOL L, V1801, P896, DOI 10.1016/j.bbalip.2010.03.014; Horcajada C, 2006, J BIOL CHEM, V281, P2923, DOI 10.1074/jbc.M507394200; Horie K, 2008, J PROTEOME RES, V7, P1819, DOI 10.1021/pr070369o; Huang BF, 2011, CURR MICROBIOL, V62, P1160, DOI 10.1007/s00284-010-9838-4; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Ide M, 2012, ARCH MICROBIOL, V194, P243, DOI 10.1007/s00203-011-0753-2; Iordachescu M, 2008, J INTEGR PLANT BIOL, V50, P1223, DOI 10.1111/j.1744-7909.2008.00736.x; Jensen KA, 2002, APPL ENVIRON MICROB, V68, P2699, DOI 10.1128/AEM.68.6.2699-2703.2002; Joh JH, 2004, FEMS MICROBIOL LETT, V239, P57, DOI 10.1016/j.femsle.2004.08.020; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KAWAGISHI H, 1990, BIOCHIM BIOPHYS ACTA, V1034, P247, DOI 10.1016/0304-4165(90)90045-X; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Kelly DJ, 2001, CITRIC ACID CYCLE FA; Kershaw MJ, 1998, FUNGAL GENET BIOL, V23, P18, DOI 10.1006/fgbi.1997.1022; Kim SY, 2011, J BIOL CHEM, V286, P31932, DOI 10.1074/jbc.M111.267633; Kinne M, 2009, J BIOL CHEM, V284, P29343, DOI 10.1074/jbc.M109.040857; Kolbe A, 2005, P NATL ACAD SCI USA, V102, P11118, DOI 10.1073/pnas.0503410102; Kues U, 2000, MICROBIOL MOL BIOL R, V64, P316, DOI 10.1128/MMBR.64.2.316-353.2000; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Kurita T, 2012, J BIOL CHEM, V287, P17415, DOI 10.1074/jbc.M111.321018; Larsen PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009780; Lee IK, 2007, BIOORG MED CHEM LETT, V17, P6678, DOI 10.1016/j.bmcl.2007.10.072; Lee IK, 2006, BIOORG MED CHEM LETT, V16, P5621, DOI 10.1016/j.bmcl.2006.08.016; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YR, 2008, BBA-GEN SUBJECTS, V1780, P51, DOI 10.1016/j.bbagen.2007.09.004; Lin WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033716; Lin YL, 2011, INT J MED MUSHROOMS, V13, P473, DOI 10.1615/IntJMedMushr.v13.i5.70; Lugones LG, 1998, MICROBIOL-UK, V144, P2345, DOI 10.1099/00221287-144-8-2345; Luk SU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019804; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Matis M, 2005, PROTEOMICS, V5, P67, DOI 10.1002/pmic.200400904; Medina ML, 2005, PROTEOMICS, V5, P3153, DOI 10.1002/pmic.200401136; Miyazaki Y, 2005, FUNGAL GENET BIOL, V42, P493, DOI 10.1016/j.fgb.2005.03.003; Moktali V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-525; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng WL, 2000, FEMS MICROBIOL LETT, V185, P139, DOI 10.1111/j.1574-6968.2000.tb09052.x; Oba K, 2007, CANCER IMMUNOL IMMUN, V56, P905, DOI 10.1007/s00262-006-0248-1; Oguri S, 1996, J BACTERIOL, V178, P5692, DOI 10.1128/jb.178.19.5692-5698.1996; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Panagiotou G, 2009, APPL ENVIRON MICROB, V75, P2212, DOI 10.1128/AEM.01461-08; Park J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-402; Patterson SD, 2000, PHYSIOL GENOMICS, V2, P59, DOI 10.1152/physiolgenomics.2000.2.2.59; Pecyna MJ, 2009, APPL MICROBIOL BIOT, V84, P885, DOI 10.1007/s00253-009-2000-1; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Piontek K, 2010, ACTA CRYSTALLOGR F, V66, P693, DOI 10.1107/S1744309110013515; Plett JM, 2012, FUNGAL GENET BIOL, V49, P199, DOI 10.1016/j.fgb.2012.01.002; Qin L, 2011, FUNGAL GENET BIOL, V48, P956, DOI 10.1016/j.fgb.2011.06.007; SALVADO JC, 1991, CURR GENET, V20, P205, DOI 10.1007/BF00326234; Sarikaya A, 1997, APPL BIOCHEM BIOTECH, V62, P131, DOI 10.1007/BF02787990; Sarikurkcu C, 2008, BIORESOURCE TECHNOL, V99, P6651, DOI 10.1016/j.biortech.2007.11.062; Schimoler-O'Rourke R, 2003, CURR MICROBIOL, V46, P408, DOI 10.1007/s00284-002-3884-5; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Sirand-Pugnet P, 2003, CURR GENET, V44, P124, DOI 10.1007/s00294-003-0435-y; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Sunde M, 2008, MICRON, V39, P773, DOI 10.1016/j.micron.2007.08.003; Sweetlove LJ, 2010, TRENDS PLANT SCI, V15, P462, DOI 10.1016/j.tplants.2010.05.006; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Toth EA, 2000, STRUCT FOLD DES, V8, P163, DOI 10.1016/S0969-2126(00)00092-7; Tsai SY, 2006, FOOD CHEM, V98, P670, DOI 10.1016/j.foodchem.2005.07.003; Tsivileva Olga M., 2001, International Microbiology, V4, P41; Ulrich R, 2004, APPL ENVIRON MICROB, V70, P4575, DOI 10.1128/AEM.70.8.4575-4581.2004; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; van Vliet AHM, 2010, FEMS MICROBIOL LETT, V302, P1, DOI 10.1111/j.1574-6968.2009.01767.x; Vanden Wymelenberg A, 2006, APPL ENVIRON MICROB, V72, P4871, DOI 10.1128/AEM.00375-06; Vesper SJ, 2004, ADV APPL MICROBIOL, V55, P191, DOI 10.1016/S0065-2164(04)55007-4; Wan JMF, 2008, INT J ONCOL, V32, P689; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wanke M, 2001, ACTA BIOCHIM POL, V48, P663; Wasser SP, 2011, APPL MICROBIOL BIOT, V89, P1323, DOI 10.1007/s00253-010-3067-4; Wasser SP, 1999, CRIT REV IMMUNOL, V19, P65; Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7; Whitaker JW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r36; Wu YY, 2011, J MICROBIOL BIOTECHN, V21, P256, DOI 10.4014/jmb.1010.10060; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030646; Xu ZT, 2011, AM J CHINESE MED, V39, P15, DOI 10.1142/S0192415X11008610; Yamada M, 2006, FEMS MICROBIOL LETT, V254, P165, DOI 10.1111/j.1574-6968.2005.00023.x; Yang F, 2012, J BIOSCI BIOENG, V114, P228, DOI 10.1016/j.jbiosc.2012.03.009; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; YU LG, 1993, CANCER RES, V53, P4627; Yuan JP, 2008, APPL MICROBIOL BIOT, V80, P459, DOI 10.1007/s00253-008-1589-9; Zhang Y, 2003, PHYTOMEDICINE, V10, P386, DOI 10.1078/0944-7113-00272	112	46	48	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56686	10.1371/journal.pone.0056686	http://dx.doi.org/10.1371/journal.pone.0056686			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418592	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300185
J	Hillaire, MLB; Nieuwkoop, NJ; Boon, ACM; de Mutsert, G; Vogelzang-van Trierum, SE; Fouchier, RAM; Osterhaus, ADME; Rimmelzwaan, GF				Hillaire, Marine L. B.; Nieuwkoop, Nella J.; Boon, Adrianus C. M.; de Mutsert, Gerrie; Vogelzang-van Trierum, Stella E.; Fouchier, Ron A. M.; Osterhaus, Albert D. M. E.; Rimmelzwaan, Guus F.			Binding of DC-SIGN to the Hemagglutinin of Influenza A Viruses Supports Virus Replication in DC-SIGN Expressing Cells	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; RESPIRATORY SYNDROME CORONAVIRUS; N-LINKED GLYCOSYLATION; RECEPTOR-BINDING; IN-VITRO; MANNOSE RECEPTOR; STRUCTURAL BASIS; TRANS-INFECTION; ENTRY; RECOGNITION	Dendritic cells express lectins receptors, like DC-SIGN, which allow these cells to sense glycans that are present on various bacterial and viral pathogens. Interaction of DC-SIGN with carbohydrate moieties induces maturation of dendritic cells and promotes endocytosis of pathogens which is an important property of these professional antigen presenting cells. Uptake of pathogens by dendritic cells may lead to cross-presentation of antigens or infection of these cells, which ultimately results in activation of virus-specific T cells in draining lymph nodes. Little is known about the interaction of DC-SIGN with influenza A viruses. Here we show that a virus with a non-functional receptor binding site in its hemagglutinin, can replicate in cells expressing DC-SIGN. Also in the absence of sialic acids, which is the receptor for influenza A viruses, these viruses replicate in DC-SIGN expressing cells including human dendritic cells. Furthermore, the efficiency of DC-SIGN mediated infection is dependent on the extent of glycosylation of the viral hemagglutinin.	[Hillaire, Marine L. B.; Nieuwkoop, Nella J.; de Mutsert, Gerrie; Vogelzang-van Trierum, Stella E.; Fouchier, Ron A. M.; Osterhaus, Albert D. M. E.; Rimmelzwaan, Guus F.] Erasmus MC, Rotterdam, Netherlands; [Osterhaus, Albert D. M. E.; Rimmelzwaan, Guus F.] Viroclin Biosci BV, Rotterdam, Netherlands; [Boon, Adrianus C. M.] Erasmus MC, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Rimmelzwaan, GF (corresponding author), Erasmus MC, Rotterdam, Netherlands.	g.rimmelzwaan@erasmusmc.nl	Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; Boon, Adrianus/0000-0002-4700-8224; Osterhaus, Albert/0000-0002-6074-1172; Hillaire, Marine/0000-0002-3672-3935				Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; de Vries E, 2012, P NATL ACAD SCI USA, V109, P7457, DOI 10.1073/pnas.1200987109; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Gambaryan AS, 1997, VIROLOGY, V232, P345, DOI 10.1006/viro.1997.8572; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; Hillaire MLB, 2012, VIRUS RES, V169, P301, DOI 10.1016/j.virusres.2012.08.003; Hillaire MLB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025005; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Londrigan SL, 2012, J LEUKOCYTE BIOL, V92, P97, DOI 10.1189/jlb.1011492; Londrigan SL, 2011, J VIROL, V85, P2990, DOI 10.1128/JVI.01705-10; Martin J, 1998, VIROLOGY, V241, P101, DOI 10.1006/viro.1997.8958; Martina BEE, 2008, VIRUS RES, V135, P64, DOI 10.1016/j.virusres.2008.02.008; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; Qi L, 2011, VIROLOGY, V412, P426, DOI 10.1016/j.virol.2011.01.029; Reading PC, 1997, J VIROL, V71, P8204, DOI 10.1128/JVI.71.11.8204-8212.1997; Reading PC, 2000, J VIROL, V74, P5190, DOI 10.1128/JVI.74.11.5190-5197.2000; Rimmelzwaan GF, 1998, J VIROL METHODS, V74, P57, DOI 10.1016/S0166-0934(98)00071-8; Rimmelzwaan GF, 2007, VIRUS RES, V129, P175, DOI 10.1016/j.virusres.2007.07.007; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Stray SJ, 2000, GLYCOBIOLOGY, V10, P649, DOI 10.1093/glycob/10.7.649; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; Svajger U, 2010, CELL SIGNAL, V22, P1397, DOI 10.1016/j.cellsig.2010.03.018; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Tate MD, 2011, J IMMUNOL, V187, P1884, DOI 10.4049/jimmunol.1100295; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Upham JP, 2010, J VIROL, V84, P3730, DOI 10.1128/JVI.02148-09; Van Pottelberge GR, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-35; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Wang SF, 2008, BIOCHEM BIOPH RES CO, V373, P561, DOI 10.1016/j.bbrc.2008.06.078; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004	41	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56164	10.1371/journal.pone.0056164	http://dx.doi.org/10.1371/journal.pone.0056164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424649	Green Published, Green Submitted, gold			2022-12-27	WOS:000315965100037
J	Lin, GJ; Stralberg, D; Gong, GQ; Huang, ZL; Ye, WH; Wu, LF				Lin, Guojun; Stralberg, Diana; Gong, Guiquan; Huang, Zhongliang; Ye, Wanhui; Wu, Linfang			Separating the Effects of Environment and Space on Tree Species Distribution: From Population to Community	PLOS ONE			English	Article							GROWTH TEMPERATE FOREST; BETA-DIVERSITY; ECOLOGICAL DATA; SPATIAL DISTRIBUTIONS; NEIGHBOR MATRICES; TROPICAL FOREST; SEED DISPERSAL; CHINA; NICHE; PATTERNS	Quantifying the relative contributions of environmental conditions and spatial factors to species distribution can help improve our understanding of the processes that drive diversity patterns. In this study, based on tree inventory, topography and soil data from a 20-ha stem-mapped permanent forest plot in Guangdong Province, China, we evaluated the influence of different ecological processes at different spatial scales using canonical redundancy analysis (RDA) at the community level and multiple linear regression at the species level. At the community level, the proportion of explained variation in species distribution increased with grid-cell sizes, primarily due to a monotonic increase in the explanatory power of environmental variables. At the species level, neither environmental nor spatial factors were important determinants of overstory species' distributions at small cell sizes. However, purely spatial variables explained most of the variation in the distributions of understory species at fine and intermediate cell sizes. Midstory species showed patterns that were intermediate between those of overstory and understory species. At the 20-m cell size, the influence of spatial factors was stronger for more dispersal-limited species, suggesting that much of the spatial structuring in this community can be explained by dispersal limitation. Comparing environmental factors, soil variables had higher explanatory power than did topography for species distribution. However, both topographic and edaphic variables were highly spatial structured. Our results suggested that dispersal limitation has an important influence on fine-intermediate scale (from several to tens of meters) species distribution, while environmental variability facilitates species distribution at intermediate (from ten to tens of meters) and broad (from tens to hundreds of meters) scales.	[Lin, Guojun; Gong, Guiquan; Huang, Zhongliang; Ye, Wanhui; Wu, Linfang] Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, S China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Lin, Guojun; Gong, Guiquan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Stralberg, Diana] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Alberta	Huang, ZL (corresponding author), Chinese Acad Sci, Key Lab Vegetat Restorat & Management Degraded Ec, S China Bot Garden, Guangzhou, Guangdong, Peoples R China.	huangzlscbg@163.com	Stralberg, Diana/W-9267-2019	Stralberg, Diana/0000-0003-4900-024X	National Natural Science Foundation of China [30970544]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (30970544). URL is http://www.nsfc.gov.cn/Portal0/default166.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Bin Y, 2010, PLANT ECOL, V209, P237, DOI 10.1007/s11258-009-9708-y; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Boulangeat I, 2012, ECOL LETT, V15, P584, DOI 10.1111/j.1461-0248.2012.01772.x; Brady NC, 2002, NATURE PROPERTIES SO, P363; Cain ML, 1998, ECOL MONOGR, V68, P325, DOI 10.1890/0012-9615(1998)068[0325:SDATHM]2.0.CO;2; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Condit R, 1998, TROPICAL FOREST CENS, P37; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Diniz JAF, 2012, OIKOS, V121, P201, DOI 10.1111/j.1600-0706.2011.19563.x; Dray S, 2007, FORWARD SELECTION PE, P46; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Freestone AL, 2006, ECOLOGY, V87, P2425, DOI 10.1890/0012-9658(2006)87[2425:DLAEHS]2.0.CO;2; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; Gleason SM, 2010, OECOLOGIA, V162, P1047, DOI 10.1007/s00442-009-1527-2; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; He J, 1997, ACTA ECOLOGICA SINIC, V17, P91; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Jombart T, 2009, ECOGRAPHY, V32, P161, DOI 10.1111/j.1600-0587.2008.05567.x; Jones MM, 2008, OECOLOGIA, V155, P593, DOI 10.1007/s00442-007-0923-8; Laliberte E, 2009, OECOLOGIA, V159, P377, DOI 10.1007/s00442-008-1214-8; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Li L, 2009, OIKOS, V118, P495, DOI 10.1111/j.1600-0706.2009.16753.x; Lu XK, 2010, GLOBAL CHANGE BIOL, V16, P2688, DOI 10.1111/j.1365-2486.2010.02174.x; Mo JM, 2006, PLANT SOIL, V282, P135, DOI 10.1007/s11104-005-5446-7; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Oksanen J., 2007, VEGAN COMMUNITY ECOL; Partel M, 2010, ECOLOGY, V91, P2565, DOI 10.1890/09-1016.1; Partel M, 2007, ECOLOGY, V88, P1091, DOI 10.1890/06-0997; Pebesma EJ, 2010, GEOSTATISTICAL MODEL; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; Phillips OL, 2003, J ECOL, V91, P757, DOI 10.1046/j.1365-2745.2003.00815.x; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Smith TW, 2010, ECOGRAPHY, V33, P648, DOI 10.1111/j.1600-0587.2009.06105.x; Stevenson PR, 2011, OECOLOGIA, V166, P693, DOI 10.1007/s00442-011-1926-z; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Tuomisto H, 2003, ECOL APPL, V13, P352, DOI 10.1890/1051-0761(2003)013[0352:LFPWSH]2.0.CO;2; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Tuomisto H, 2012, ECOGRAPHY, V35, P961, DOI 10.1111/j.1600-0587.2012.07339.x; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Wang XG, 2008, ACTA OECOL, V33, P345, DOI 10.1016/j.actao.2008.01.005; Wang Z, 2009, BASIC APPL ECOL, V10, P648, DOI 10.1016/j.baae.2009.03.002; Ye Wan-Hui, 2008, Zhiwu Shengtai Xuebao, V32, P274, DOI 10.3773/j.issn.1005-264x.2008.02.005; Zhang J, 2009, FOREST ECOL MANAG, V257, P2115, DOI 10.1016/j.foreco.2009.02.016; Zhang LW, 2011, PLANT SOIL, V347, P211, DOI 10.1007/s11104-011-0839-2	55	41	44	1	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56171	10.1371/journal.pone.0056171	http://dx.doi.org/10.1371/journal.pone.0056171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409151	Green Submitted, Green Published, gold			2022-12-27	WOS:000314660300063
J	Hennessey, JC; McGuire, JJ				Hennessey, John C.; McGuire, John J.			Attenuated Vasodilator Effectiveness of Protease-Activated Receptor 2 Agonist in Heterozygous par2 Knockout Mice	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT RELAXATION; OXIDATIVE STRESS; MOUSE MODEL; RAT AORTA; DYSFUNCTION; DISEASES; FEMALE	Studies of homozygous PAR2 gene knockout mice have described a mix of phenotypic effects in vitro and in vivo. However, there have been few studies of PAR2 heterozygous (wild-type/knockout; PAR2-HET) mice. The phenotypes of many hemi and heterozygous transgenic mice have been described as intermediates between those of wild-type and knockout animals. In our study we aimed to determine the effects of intermediary par2 gene zygosity on vascular tissue responses to PAR2 activation. Specifically, we compared the vasodilator effectiveness of the PAR2 activating peptide 2-furoyl-LIGRLO-amide in aortas of wild-type PAR2 homozygous (PAR2-WT) and PAR2-HET mice. In myographs under isometric tension conditions, isolated aortic rings were contracted by alpha 1-adrenoeceptor agonist (phenylephrine), and thromboxane receptor agonist (U46619) and then relaxation responses by the additions of 2-furoyl-LIGRLO-amide, acetylcholine, and nitroprusside were recorded. A Schild regression analysis of the inhibition by a PAR2 antagonist (GB-83) of PAR2 agonist-induced aortic ring relaxations was used to compare receptor expression in PAR2-WT to PAR2-HET. PAR2 mRNA in aortas was measured by quantitative real-time PCR. In aortas contracted by either phenylephrine or U46619, the maximum relaxations induced by 2-furoyl- LIGRLO-amide were less in PAR2-HET than in the gender-matched PAR2-WT. GB-83 was 3- to 4-fold more potent for inhibition of 2fly in PAR2-HET than in PAR2-WT. PAR2 mRNA content of aortas from PAR2-HET was not significantly different than in PAR2-WT. Acetylcholine-and nitroprusside-induced relaxations of aortas from PAR2-HET were not significantly different than in PAR2-WT and PAR2 knockout. An interesting secondary finding was that relaxations induced by agonists of PAR2 and muscarinic receptors were larger in females than in males. We conclude that the lower PAR2-mediated responses in PAR2-HET aortas are consistent with evidence of a lower quantity of functional receptor expression, despite the apparently normal PAR2 mRNA content in PAR2-HET aortas.	[Hennessey, John C.; McGuire, John J.] Mem Univ Newfoundland, Fac Med, Cardiovasc Res Grp, Div Biomed Sci, St John, NF, Canada	Memorial University Newfoundland	McGuire, JJ (corresponding author), Mem Univ Newfoundland, Fac Med, Cardiovasc Res Grp, Div Biomed Sci, St John, NF, Canada.	mcguire@mun.ca		McGuire, John/0000-0003-0302-3884	Canadian Institutes of Health Research Regional Partnership Program (CIHR RPP) [ROP 88065, RNL 120409]; Research and Development Corporation of Newfoundland and Labrador (Industrial Research and Innovation Fund [RDC NL: IRIF 0708-022, Leverage RD 5404.1146.106]; Canadian Foundation of Innovation (CFI) [10027]	Canadian Institutes of Health Research Regional Partnership Program (CIHR RPP)(Canadian Institutes of Health Research (CIHR)); Research and Development Corporation of Newfoundland and Labrador (Industrial Research and Innovation Fund; Canadian Foundation of Innovation (CFI)(Canada Foundation for Innovation)	This study was funded by grants to JJM from Canadian Institutes of Health Research Regional Partnership Program (CIHR RPP, ROP 88065; RNL 120409; http://www.cihr-irsc.gc.ca/), the Research and Development Corporation of Newfoundland and Labrador (Industrial Research and Innovation Fund; RDC NL: IRIF 0708-022, Leverage R&D 5404.1146.106; http://www.rdc.org/) and supported by infrastructure from the Canadian Foundation of Innovation (CFI; New Opportunities Fund 10027; http://www.innovation.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MN, 2012, N-S ARCH PHARMACOL, V385, P861, DOI 10.1007/s00210-012-0783-6; Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Al-Ani B, 1999, BRIT J PHARMACOL, V128, P1105, DOI 10.1038/sj.bjp.0702834; Aloysius UI, 2012, VASC PHARMACOL, V57, P81, DOI 10.1016/j.vph.2011.11.009; Barry GD, 2010, J MED CHEM, V53, P7428, DOI 10.1021/jm100984y; Bazalakova MH, 2007, GENES BRAIN BEHAV, V6, P411, DOI 10.1111/j.1601-183X.2006.00269.x; Chia Elizabeth, 2011, BMC Pharmacology, V11, P10, DOI 10.1186/1471-2210-11-10; Colquhoun D, 2007, TRENDS PHARMACOL SCI, V28, P608, DOI 10.1016/j.tips.2007.09.011; Ferrell WR, 2003, J CLIN INVEST, V111, P35, DOI 10.1172/JCI200316913; FEUERSTEIN TJ, 1994, N-S ARCH PHARMACOL, V350, P1; Grenczer M, 2010, CAN J PHYSIOL PHARM, V88, P1074, DOI [10.1139/Y10-089, 10.1139/y10-089]; Hansen KK, 2008, N-S ARCH PHARMACOL, V377, P377, DOI 10.1007/s00210-007-0194-2; Hollenberg MD, 1996, MOL PHARMACOL, V49, P229; Huang A, 2001, AM J PHYSIOL-HEART C, V280, pH2462, DOI 10.1152/ajpheart.2001.280.6.H2462; Javeshghani D, 2009, J AM SOC HYPERTENS, V3, P295, DOI 10.1016/j.jash.2009.07.002; Kagota S, 2011, BRIT J PHARMACOL, V164, P358, DOI 10.1111/j.1476-5381.2011.01356.x; Kanda Y, 2009, ENDOCR J, V56, P997, DOI 10.1507/endocrj.K09E-028; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; Lindner JR, 2000, J IMMUNOL, V165, P6504, DOI 10.4049/jimmunol.165.11.6504; Loch T, 2009, CARDIOVASC RES, V82, P448, DOI 10.1093/cvr/cvp092; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; McGuire JJ, 2004, CURR PHARM DESIGN, V10, P2769, DOI 10.2174/1381612043383656; McGuire JJ, 2007, PFLUG ARCH EUR J PHY, V454, P535, DOI 10.1007/s00424-007-0226-2; Penela P, 2008, EMBO J, V27, P1206, DOI 10.1038/emboj.2008.55; Roganovic J, 2011, EUR J ORAL SCI, V119, P352, DOI 10.1111/j.1600-0722.2011.00851.x; Ryckebusch L, 2010, CIRC RES, V106, P686, DOI 10.1161/CIRCRESAHA.109.205732; Stauber AJ, 2005, MOL PHARMACOL, V67, P681, DOI 10.1124/mol.104.007278; Taguchi K, 2012, PHARMACOL RES, V65, P56, DOI 10.1016/j.phrs.2011.08.009; TAKEYASU K, 1979, LIFE SCI, V25, P1761, DOI 10.1016/0024-3205(79)90480-6	29	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55965	10.1371/journal.pone.0055965	http://dx.doi.org/10.1371/journal.pone.0055965			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409098	gold, Green Accepted, Green Published			2022-12-27	WOS:000315157200094
J	Huang, M; Lu, SY; Shi, T; Zhao, YX; Chen, YY; Li, XB; Liu, XY; Huang, ZM; Zhang, J				Huang, Min; Lu, Shaoyong; Shi, Ting; Zhao, Yaxue; Chen, Yingyi; Li, Xiaobai; Liu, Xinyi; Huang, Zhimin; Zhang, Jian			Conformational Transition Pathway in the Activation Process of Allosteric Glucokinase	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; MINIMUM ENERGY PATHS; ELASTIC BAND METHOD; REGULATORY BEHAVIOR; MNEMONICAL ENZYME; DIABETES-MELLITUS; MONOMERIC ENZYMES; SLOW TRANSITION; NUCLEIC-ACIDS; SADDLE-POINTS	Glucokinase (GK) is a glycolytic enzyme that plays an important role in regulating blood glucose level, thus acting as a potentially attractive target for drug discovery in the treatment of diabetes of the young type 2 and persistent hyperinsulinemic hypoglycemia of infancy. To characterize the activation mechanism of GK from the super-open state (inactive state) to the closed state (active state), a series of conventional molecular dynamics (MD) and targeted MD (TMD) simulations were performed on this enzyme. Conventional MD simulation showed a specific conformational ensemble of GK when the enzyme is inactive. Seven TMD simulations depicted a reliably conformational transition pathway of GK from the inactive state to the active state, and the components important to the conformational change of GK were identified by analyzing the detailed structures of the TMD trajectories. In combination with the inactivation process, our findings showed that the whole conformational pathway for the activation-inactivation-activation of GK is a one-direction circulation, and the active state is less stable than the inactive state in the circulation. Additionally, glucose was demonstrated to gradually modulate its binding pose with the help of residues in the large domain and connecting region of GK during the activation process. Furthermore, the obtained energy barriers were used to explain the preexisting equilibrium and the slow binding kinetic process of the substrate by GK. The simulated results are in accordance with the recent findings from the mutagenesis experiments and kinetic analyses. Our observations reveal a complicated conformational process in the allosteric protein, resulting in new knowledge about the delicate mechanisms for allosteric biological macromolecules that will be useful in drug design for targeting allosteric proteins.	[Huang, Min; Lu, Shaoyong; Shi, Ting; Zhao, Yaxue; Chen, Yingyi; Li, Xiaobai; Liu, Xinyi; Huang, Zhimin; Zhang, Jian] Shanghai Jiao Tong Univ, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ,Sch Med, Shanghai 200030, Peoples R China; [Zhang, Jian] Shanghai Jiao Tong Univ, Shanghai Key Lab Tumor Microenvironm & Inflammat, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ,Sch Med, Shanghai 200030, Peoples R China.	jian.zhang@sjtu.edu.cn	huang, zhimin o/R-4712-2018; Zhang, Jian/GXA-1303-2022; liu, xinyi/GWZ-8739-2022; huang, zhimin/H-7878-2013	huang, zhimin o/0000-0001-9230-6039; Zhang, Jian/0000-0002-6558-791X; 	National Basic Research Program of China (973 Program) [2011CB504001]; National Natural Science Foundation of China [21002062, 21102090]; Innovative Research Team of Shanghai Municipal Education Commission; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai PuJiang Program [10PJ406800]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Team of Shanghai Municipal Education Commission; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai PuJiang Program(Shanghai Pujiang Program)	This work was supported in part by grants from the National Basic Research Program of China (973 Program) (2011CB504001), the National Natural Science Foundation of China (21002062, 21102090), the Innovative Research Team of Shanghai Municipal Education Commission, the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, and Shanghai PuJiang Program (10PJ406800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSLIE GR, 1972, J BIOL CHEM, V247, P7088; Al-Hasani Hadi, 2003, Mol Interv, V3, P367, DOI 10.1124/mi.3.7.367; Aleshin AE, 1998, J MOL BIOL, V282, P345, DOI 10.1006/jmbi.1998.2017; Antoine M, 2009, BIOCHEMISTRY-US, V48, P5466, DOI 10.1021/bi900374c; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bergonzo C, 2009, INT J QUANTUM CHEM, V109, P3781, DOI 10.1002/qua.22405; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Christesen HBT, 2002, DIABETES, V51, P1240, DOI 10.2337/diabetes.51.4.1240; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Gloyn AL, 2005, J BIOL CHEM, V280, P14105, DOI 10.1074/jbc.M413146200; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Henkelman G, 2000, J CHEM PHYS, V113, P9978, DOI 10.1063/1.1323224; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Heredia VV, 2006, BIOCHEMISTRY-US, V45, P7553, DOI 10.1021/bi060253q; Huang ZM, 2011, NUCLEIC ACIDS RES, V39, pD663, DOI 10.1093/nar/gkq1022; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kim YB, 2007, BIOCHEMISTRY-US, V46, P1423, DOI 10.1021/bi0617308; Kong YF, 2006, J MOL BIOL, V356, P237, DOI 10.1016/j.jmb.2005.10.064; Kong YF, 2002, P NATL ACAD SCI USA, V99, P5999, DOI 10.1073/pnas.092051099; Larion M, 2010, BIOCHEMISTRY-US, V49, P8902, DOI 10.1021/bi1008672; LIN SX, 1990, J BIOL CHEM, V265, P9670; Lindsley JE, 2006, P NATL ACAD SCI USA, V103, P10533, DOI 10.1073/pnas.0604452103; Lu SY, 2012, AMINO ACIDS, V43, P267, DOI 10.1007/s00726-011-1070-4; Lu SY, 2011, J MOL GRAPH MODEL, V30, P167, DOI 10.1016/j.jmgm.2011.07.003; Lu SY, 2011, J CHEM INF MODEL, V51, P1025, DOI 10.1021/ci100493j; Lu SY, 2011, BIOPOLYMERS, V95, P669, DOI 10.1002/bip.21629; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; MEUNIER JC, 1974, EUR J BIOCHEM, V49, P209, DOI 10.1111/j.1432-1033.1974.tb03826.x; Molnes J, 2008, FEBS J, V275, P2467, DOI 10.1111/j.1742-4658.2008.06391.x; Munro G, 2009, TRENDS PHARMACOL SCI, V30, P453, DOI 10.1016/j.tips.2009.06.004; Neet K E, 1980, Methods Enzymol, V64, P192; NEET KE, 1990, BIOCHEMISTRY-US, V29, P770, DOI 10.1021/bi00455a026; Ralph EC, 2009, BIOCHEMISTRY-US, V48, P2514, DOI 10.1021/bi900020n; RICARD J, 1974, EUR J BIOCHEM, V49, P195, DOI 10.1111/j.1432-1033.1974.tb03825.x; Rodriguez-Barrios F, 2005, J AM CHEM SOC, V127, P7570, DOI 10.1021/ja042289g; Rodriguez-Barrios F, 2004, J AM CHEM SOC, V126, P15386, DOI 10.1021/ja045409t; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; VANSCHAFTINGEN E, 1994, DIABETOLOGIA, V37, pS43, DOI 10.1007/BF00400825; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Zelent B, 2008, BIOCHEM J, V413, P269, DOI 10.1042/BJ20071718; Zhang J, 2006, P NATL ACAD SCI USA, V103, P13368, DOI 10.1073/pnas.0605738103	53	11	11	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55857	10.1371/journal.pone.0055857	http://dx.doi.org/10.1371/journal.pone.0055857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409066	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200077
J	Liu, Y; Wang, DK; Jiang, DZ; Qin, X; Xie, ZD; Wang, QK; Liu, MG; Chen, LM				Liu, Ying; Wang, Deng-Ke; Jiang, De-Zhi; Qin, Xue; Xie, Zhang-Dong; Wang, Qing K.; Liu, Mugen; Chen, Li-Ming			Cloning and Functional Characterization of Novel Variants and Tissue-Specific Expression of Alternative Amino and Carboxyl Termini of Products of Slc4a10	PLOS ONE			English	Article							DRIVEN CL-/HCO3-EXCHANGER; CHRONIC CONTINUOUS HYPOXIA; NA+-HCO3-COTRANSPORTER; SPLICE VARIANTS; CHOROID-PLEXUS; BASOLATERAL MEMBRANE; GENE-PRODUCT; NBCE1; NCBE; IDENTIFICATION	Previous studies have shown that the electroneutral Na+/HCO3- cotransporter NBCn2 (SLC4A10) is predominantly expressed in the central nervous system (CNS). The physiological and pathological significances of NBCn2 have been well recognized. However, little is known about the tissue specificity of expression of different NBCn2 variants. Moreover, little is known about the expression of NBCn2 proteins in systems other than CNS. Here, we identified a set of novel Slc4a10 variants differing from the originally described ones by containing a distinct 59 untranslated region encoding a new extreme amino-terminus (Nt). Electrophysiology measurements showed that both NBCn2 variants with alternative Nt contain typical electroneutral Na+-coupled HCO3- transport activity in Xenopus oocytes. Luciferase reporter assay showed that Slc4a10 contains two alternative promoters responsible for expression of the two types of NBCn2 with distinct extreme Nt. Western blotting showed that NBCn2 proteins with the original Nt are primarily expressed in CNS, whereas those with the novel Nt are predominantly expressed in the kidney and to a lesser extent in the small intestine. Due to alternative splicing, the known NBCn2 variants contain two types of carboxyl-termini (CT) differing in the optional inclusion of a PDZ-binding motif. cDNA cloning showed that virtually all NBCn2 variants expressed in epithelial tissues contain, but the vast majority of those from the neural tissues lack the PDZ-binding motif. We conclude that alternative transcription and splicing of Slc4a10 products are regulated in a tissue-specific manner. Our findings provide critical insights that will greatly influence the study of the physiology of NBCn2.	[Liu, Ying; Wang, Deng-Ke; Jiang, De-Zhi; Xie, Zhang-Dong; Chen, Li-Ming] Huazhong Univ Sci & Technol, Dept Biophys & Mol Physiol, Key Lab Mol Biophys, Minist Educ,Sch Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Qin, Xue] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Wang, Qing K.; Liu, Mugen] Huazhong Univ Sci & Technol, Dept Genet & Dev Biol, Key Lab Mol Biophys, Minist Educ,Sch Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Case Western Reserve University; Huazhong University of Science & Technology	Chen, LM (corresponding author), Huazhong Univ Sci & Technol, Dept Biophys & Mol Physiol, Key Lab Mol Biophys, Minist Educ,Sch Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	liming.chen@mail.hust.edu.cn	Chen, Li-Ming/AAU-2363-2021	Chen, Li-Ming/0000-0002-8129-9563	National Natural Science Foundation of China [30900513, 31000517, 31271208]; Fundamental Research Funds for the Central Universities of China [2011TS031, 2010MS123]; National Institutes of Health [NS18400 (WFB)]; American Heart Association [09POST2060873, 11POST7670014]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018400] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Natural Science Foundation of China grants 30900513 (YL), 31000517 and 31271208 (L-MC) as well as by grants 2011TS031 (L-MC) and 2010MS123 (YL) from the Fundamental Research Funds for the Central Universities of China as well as National Institutes of Health grant NS18400 (WFB). XQ was supported by grants 09POST2060873 and 11POST7670014 from American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuladze N, 2000, GENE, V251, P109, DOI 10.1016/S0378-1119(00)00204-3; Abuladze N, 1998, J BIOL CHEM, V273, P17689, DOI 10.1074/jbc.273.28.17689; Bevensee MO, 2000, AM J PHYSIOL-CELL PH, V278, pC1200, DOI 10.1152/ajpcell.2000.278.6.C1200; Boedtkjer E, 2012, INT J CANC; Boron WF, 2009, J EXP BIOL, V212, P1697, DOI 10.1242/jeb.028563; BORON WF, 1983, J GEN PHYSIOL, V81, P53, DOI 10.1085/jgp.81.1.53; Chen LM, 2008, NEUROSCIENCE, V151, P374, DOI 10.1016/j.neuroscience.2007.10.015; Chen LM, 2008, BRAIN RES, V1238, P85, DOI 10.1016/j.brainres.2008.08.033; Chen LM, 2007, AM J PHYSIOL-REG I, V293, pR2412, DOI 10.1152/ajpregu.00497.2007; Chen LM, 2011, J PHYSIOL-LONDON, V589, P877, DOI 10.1113/jphysiol.2010.198713; Choi I, 2002, FASEB J, V16, pA796; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; Damkier HH, 2010, PHYSIOLOGY, V25, P239, DOI 10.1152/physiol.00011.2010; Damkier HH, 2007, AM J PHYSIOL-REG I, V293, pR2136, DOI 10.1152/ajpregu.00356.2007; Damkier HH, 2012, AM J PHYSIOL-CELL PH, V302, pC1452, DOI 10.1152/ajpcell.00285.2011; Damkier HH, 2010, J BIOL CHEM, V285, P26998, DOI 10.1074/jbc.M110.108712; Damkier HH, 2009, AM J PHYSIOL-CELL PH, V296, pC1291, DOI 10.1152/ajpcell.00062.2009; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Giffard RG, 2003, EUR J NEUROSCI, V18, P2935, DOI 10.1046/j.1460-9568.2003.03053.x; Groger N, 2012, HUM MOL GENET, V21, P1025, DOI 10.1093/hmg/ddr533; Gurnett CA, 2008, ARCH NEUROL-CHICAGO, V65, P550, DOI 10.1001/archneur.65.4.550; Hilgen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046155; Horita S, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/391762; Jacobs S, 2008, P NATL ACAD SCI USA, V105, P311, DOI 10.1073/pnas.0705487105; Lee SK, 2012, AM J PHYSIOL-CELL PH, V302, pC518, DOI 10.1152/ajpcell.00352.2011; Lee YS, 2006, FEBS LETT, V580, P4865, DOI 10.1016/j.febslet.2006.07.075; Leviel F, 2010, J CLIN INVEST, V120, P1627, DOI 10.1172/JCI40145; Liu Y, 2010, NEUROSCIENCE, V169, P951, DOI 10.1016/j.neuroscience.2010.06.005; Liu Ying, 2012, Shengli Xuebao, V64, P729; Liu Y, 2011, GENOMICS, V98, P112, DOI 10.1016/j.ygeno.2011.04.010; Liu Y, 2011, BRAIN RES, V1390, P33, DOI 10.1016/j.brainres.2011.03.046; Marino CR, 1999, AM J PHYSIOL-GASTR L, V277, pG487, DOI 10.1152/ajpgi.1999.277.2.G487; McAlear SD, 2006, J GEN PHYSIOL, V127, P639, DOI 10.1085/jgp.200609520; Paine ML, 2008, J DENT RES, V87, P391, DOI 10.1177/154405910808700415; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Parker MD, 2008, J BIOL CHEM, V283, P12777, DOI 10.1074/jbc.M707829200; Parker MD, 2008, PHYSIOL GENOMICS, V34, P265, DOI 10.1152/physiolgenomics.90259.2008; Parker MD, 2007, FASEB J, V21, pA1285; Parker MD, 2013, PHYSL REV IN PRESS; Praetorius J, 2004, AM J PHYSIOL-RENAL, V286, pF903, DOI 10.1152/ajprenal.00437.2002; Praetorius J, 2004, AM J PHYSIOL-CELL PH, V286, pC601, DOI 10.1152/ajpcell.00240.2003; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shirakabe K, 2006, P NATL ACAD SCI USA, V103, P9542, DOI 10.1073/pnas.0602250103; Snead CM, 2011, EUR J ORAL SCI, V119, P136, DOI 10.1111/j.1600-0722.2011.00867.x; SOLEIMANI M, 1987, J CLIN INVEST, V79, P1276, DOI 10.1172/JCI112948; Stutz AM, 2009, EUR J HUM GENET, V17, P1481, DOI 10.1038/ejhg.2009.64; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Krepischi AC, 2010, EPILEPSIA, V51, P2457, DOI 10.1111/j.1528-1167.2010.02742.x; Vorum H, 2000, AM J PHYSIOL-RENAL, V279, pF901, DOI 10.1152/ajprenal.2000.279.5.F901; Wang CZ, 2000, J BIOL CHEM, V275, P35486, DOI 10.1074/jbc.C000456200; Yang DK, 2011, J CLIN INVEST, V121, P956, DOI 10.1172/JCI43475; Yano H, 2000, CYTOGENET CELL GENET, V89, P276, DOI 10.1159/000015633; Yu HY, 2009, AM J PHYSIOL-GASTR L, V297, pG1223, DOI 10.1152/ajpgi.00157.2009	55	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55974	10.1371/journal.pone.0055974	http://dx.doi.org/10.1371/journal.pone.0055974			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409100	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200095
J	Pepin, KM; Wang, J; Webb, CT; Hoeting, JA; Poss, M; Hudson, PJ; Hong, WS; Zhu, HC; Guan, Y; Riley, S				Pepin, Kim M.; Wang, Jia; Webb, Colleen T.; Hoeting, Jennifer A.; Poss, Mary; Hudson, Peter J.; Hong, Wenshan; Zhu, Huachen; Guan, Yi; Riley, Steven			Anticipating the Prevalence of Avian Influenza Subtypes H9 and H5 in Live-Bird Markets	PLOS ONE			English	Article							TRANSMISSION CHARACTERISTICS; PANDEMIC PREPAREDNESS; MATHEMATICAL-MODELS; RELATIVE-HUMIDITY; MEASLES EPIDEMICS; HUMAN INFECTIONS; A VIRUS; DYNAMICS; PERSISTENCE; SALINITY	An ability to forecast the prevalence of specific subtypes of avian influenza viruses (AIV) in live-bird markets would facilitate greatly the implementation of preventative measures designed to minimize poultry losses and human exposure. The minimum requirement for developing predictive quantitative tools is surveillance data of AIV prevalence sampled frequently over several years. Recently, a 4-year time series of monthly sampling of hemagglutinin subtypes 1-13 in ducks, chickens and quail in live-bird markets in southern China has become available. We used these data to investigate whether a simple statistical model, based solely on historical data (variables such as the number of positive samples in host X of subtype Y time t months ago), could accurately predict prevalence of H5 and H9 subtypes in chickens. We also examined the role of ducks and quail in predicting prevalence in chickens within the market setting because between-species transmission is thought to occur within markets but has not been measured. Our best statistical models performed remarkably well at predicting future prevalence (pseudo-R-2 = 0.57 for H9 and 0.49 for H5), especially considering the multi-host, multi-subtype nature of AIVs. We did not find prevalence of H5/H9 in ducks or quail to be predictors of prevalence in chickens within the Chinese markets. Our results suggest surveillance protocols that could enable more accurate and timely predictive statistical models. We also discuss which data should be collected to allow the development of mechanistic models.	[Pepin, Kim M.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Pepin, Kim M.; Webb, Colleen T.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Wang, Jia; Hong, Wenshan; Zhu, Huachen; Guan, Yi] Shantou Univ, Coll Med, Int Inst Infect & Immun, Shantou, Peoples R China; [Wang, Jia; Zhu, Huachen; Guan, Yi; Riley, Steven] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Hoeting, Jennifer A.] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA; [Poss, Mary; Hudson, Peter J.] Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Riley, Steven] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Colorado State University; Shantou University; University of Hong Kong; Colorado State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Imperial College London	Guan, Y (corresponding author), Shantou Univ, Coll Med, Int Inst Infect & Immun, Shantou, Peoples R China.	yguan@hkucc.hku.hk; s.riley@imperial.ac.uk	Hudson, Peter/AAB-8080-2020; Zhu, Huachen/A-8252-2017	Hudson, Peter/0000-0003-0468-3403; Zhu, Huachen/0000-0003-2711-0501; Riley, Steven/0000-0001-7904-4804; Guan, Yi/0000-0001-6057-9243	RAPIDD program of the Science and Technology Directorate; U.S. Department of Homeland Security; Fogarty International Center, NIH; NIH Fogarty Center [R01 TW008246-01]; Wellcome Trust [093488/Z/10/Z]; Medical Research Council (UK) [MR/J008761/1]; European Union [278433-PREDEMICS]; Medical Research Council [G0600719B, MR/K010174/1B, MR/K010174/1, MR/J008761/1] Funding Source: researchfish; MRC [MR/K010174/1, MR/J008761/1] Funding Source: UKRI; FOGARTY INTERNATIONAL CENTER [R01TW008246] Funding Source: NIH RePORTER	RAPIDD program of the Science and Technology Directorate; U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH Fogarty Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the RAPIDD program of the Science and Technology Directorate, U.S. Department of Homeland Security, and the Fogarty International Center, NIH. SR was also funded by: the NIH Fogarty Center (R01 TW008246-01), the Wellcome Trust (University Award 093488/Z/10/Z), The Medical Research Council (UK, Project Grant MR/J008761/1) and European Union Seventh Framework Programme (FP7/2007-2013, Grant Agreement no278433-PREDEMICS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017643; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Bouma A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000281; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Czado C, 2009, BIOMETRICS, V65, P1254, DOI 10.1111/j.1541-0420.2009.01191.x; Farnsworth ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032729; Gotway CA, 2003, STAT MED, V22, P1415, DOI 10.1002/sim.1523; Grenfell BT, 2002, ECOL MONOGR, V72, P185, DOI 10.1890/0012-9615(2002)072[0185:DOMESN]2.0.CO;2; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Jadhao SJ, 2009, ARCH VIROL, V154, P1249, DOI 10.1007/s00705-009-0429-2; Jia N, 2009, J CLIN VIROL, V44, P225, DOI 10.1016/j.jcv.2008.12.014; Lebarbenchon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026566; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Long JS, 1997, REGRESSION MODELS CA, P104; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lu CT, 2008, INT J ARTIF INTELL T, V17, P1; McVernon J, 2007, INFLUENZA OTHER RESP, V1, P43, DOI 10.1111/j.1750-2659.2007.00008.x; Negovetich NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019311; Ostrowsky B, 2012, EMERG INFECT DIS, V18, P1128, DOI 10.3201/eid1807.111913; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Peiris JSM, 2009, REV SCI TECH OIE, V28, P161, DOI 10.20506/rst.28.1.1871; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Pepin KM, 2013, INFLUENZA OTHER RESP, V7, P97, DOI 10.1111/j.1750-2659.2012.00354.x; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; Ssematimba A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031114; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Tsukamoto K, 2007, AVIAN DIS, V51, P129, DOI 10.1637/0005-2086(2007)051[0129:IODHCO]2.0.CO;2; Van der Goot JA, 2003, EPIDEMIOL INFECT, V131, P1003, DOI 10.1017/S0950268803001067; Van Kerkhove MD, 2012, B WORLD HEALTH ORGAN, V90, P306, DOI 10.2471/BLT.11.097949; Venables WN., 2002, MODERN APPL STAT S 4; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; Wu JT, 2011, EXP BIOL MED, V236, P955, DOI 10.1258/ebm.2010.010271; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341; Yang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050770; Yao ML, 2011, BERL MUNCH TIERARZTL, V124, P136, DOI 10.2376/0005-9366-124-136; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	41	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56157	10.1371/journal.pone.0056157	http://dx.doi.org/10.1371/journal.pone.0056157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409145	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200118
J	Tham, LK; Abu Osman, NA; Abas, WAW; Lim, KS				Tham, Lai Kuan; Abu Osman, Noor Azuan; Abas, Wan Abu Bakar Wan; Lim, Kheng Seang			The Validity and Reliability of Motion Analysis in Patellar Tendon Reflex Assessment	PLOS ONE			English	Article							QUANTITATION; LATENCIES; CHILDREN	Background: The deep tendon reflex assessments that are essential to the accurate diagnosis of neurological or neuromuscular disorders are conducted subjectively in clinical neurology. Our aim was to assess deep tendon reflexes objectively with a new reflex quantification method. Methodology/Principal Findings: The present study used a motion analysis technique to collect quantitative measurements for both the input and output of normal patellar tendon reflex. Reflex responses were measured as knee angles. The patellar tendon reflexes of 100 healthy subjects were examined using 6 levels of tendon taps, where all the assessments were captured using motion capture system. A linear relationship was found between the experimental maximum tapping velocity and tapping angle (coefficient of determination = 0.989), which was consistent with the theoretical values. Tapping velocities were predictable according to tapping angles. The findings proved the reproducibility of tapping method in producing consistent input. The reflex amplitude was consistent between two randomly assigned groups, and linearly proportionate to the tapping velocity. Conclusions/Significance: The findings on reflex amplitude indicate that motion analysis is a valid and reliable method of assessing and measuring deep tendon reflexes.	[Tham, Lai Kuan; Abu Osman, Noor Azuan; Abas, Wan Abu Bakar Wan] Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur, Malaysia; [Lim, Kheng Seang] Univ Malaya, Fac Med, Div Neurol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Tham, LK (corresponding author), Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur, Malaysia.	laikuan_tam@hotmail.com	ABU OSMAN, NOOR AZUAN/B-9265-2010; LIM, KHENG SEANG/B-8863-2010	ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; LIM, KHENG SEANG/0000-0002-2787-2365	Malaysia UM/MOHE/HIR grant [D000010-16001]	Malaysia UM/MOHE/HIR grant	This study was supported by the Malaysia UM/MOHE/HIR grant (Project number: D000010-16001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISHOP B, 1968, Archives of Physical Medicine and Rehabilitation, V49, P698; Dafkin C, 2013, MUSCLE NERVE, V47, P81, DOI 10.1002/mus.23487; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; DEWEERD AW, 1986, EUR NEUROL, V25, P304, DOI 10.1159/000116026; Frijns CJM, 1997, CLIN NEUROL NEUROSUR, V99, P31, DOI 10.1016/S0303-8467(96)00593-8; Johnsen B, 2000, NEUROPHYSIOL CLIN, V30, P339, DOI 10.1016/S0987-7053(00)00237-9; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Karandreas N, 2000, Electromyogr Clin Neurophysiol, V40, P83; Kuruoglu R, 1993, Electromyogr Clin Neurophysiol, V33, P347; Lebiedowska MK, 2003, ARCH PHYS MED REHAB, V84, P828, DOI 10.1016/S0003-9993(02)04946-8; Lemoyne R, 2008, J MECH MED BIOL, V8, P75, DOI 10.1142/S0219519408002462; Mamizuka N, 2007, J BIOMECH, V40, P2107, DOI 10.1016/j.jbiomech.2006.10.003; Manschot S, 1998, J NEUROL NEUROSUR PS, V64, P253, DOI 10.1136/jnnp.64.2.253; Marshall Garrett L, 2002, J Spinal Cord Med, V25, P94; Pereon Y, 2004, NEUROPHYSIOL CLIN, V34, P131, DOI 10.1016/j.neucli.2004.04.005; RICO RE, 1982, J NEUROL NEUROSUR PS, V45, P791, DOI 10.1136/jnnp.45.9.791; SCHOTT K, 1991, ACTA NEUROL SCAND, V84, P273, DOI 10.1111/j.1600-0404.1991.tb04953.x; SIMONS DG, 1971, AMER J PHYSICAL MED, V50, P72; STAM J, 1989, J NEUROL, V236, P231, DOI 10.1007/BF00314505; STAM J, 1987, ELECTROEN CLIN NEURO, V67, P463, DOI 10.1016/0013-4694(87)90010-1; STAM J, 1990, J NEUROL, V237, P427, DOI 10.1007/BF00314735; Tham LK, 2011, MED ENG PHYS, V33, P407, DOI 10.1016/j.medengphy.2010.11.002; TOFT E, 1989, ACTA NEUROL SCAND, V79, P384, DOI 10.1111/j.1600-0404.1989.tb03805.x; VandeCrommert HWAA, 1996, BRAIN RES, V734, P341, DOI 10.1016/S0006-8993(96)00885-2; Zhang L Q, 1999, IEEE Trans Rehabil Eng, V7, P193, DOI 10.1109/86.769410	25	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55702	10.1371/journal.pone.0055702	http://dx.doi.org/10.1371/journal.pone.0055702			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409022	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000315157200050
J	Zuena, AR; Giuli, C; Pesciolini, AV; Tramutola, A; Ajmone-Cat, MA; Cinque, C; Alema, GS; Giovine, A; Peluso, G; Minghetti, L; Nicolai, R; Calamandrei, G; Casolini, P				Zuena, Anna Rita; Giuli, Chiara; Pesciolini, Aldina Venerosi; Tramutola, Antonella; Ajmone-Cat, Maria Antonietta; Cinque, Carlo; Alema, Giovanni Sebastiano; Giovine, Angela; Peluso, Gianfranco; Minghetti, Luisa; Nicolai, Raffaella; Calamandrei, Gemma; Casolini, Paola			Transplacental Exposure to AZT Induces Adverse Neurochemical and Behavioral Effects in a Mouse Model: Protection by L-Acetylcarnitine	PLOS ONE			English	Article							ACETYL-L-CARNITINE; REVERSE-TRANSCRIPTASE INHIBITORS; PERSISTENT MITOCHONDRIAL DYSFUNCTION; METABOTROPIC GLUTAMATE RECEPTORS; ANTIRETROVIRAL TOXIC NEUROPATHY; TO-CHILD TRANSMISSION; IN-UTERO EXPOSURE; PERINATAL EXPOSURE; SYNAPTIC PLASTICITY; CD-1 MICE	Maternal-fetal HIV-1 transmission can be prevented by administration of AZT, alone or in combination with other antiretroviral drugs to pregnant HIV-1-infected women and their newborns. In spite of the benefits deriving from this life-saving prophylactic therapy, there is still considerable uncertainty on the potential long-term adverse effects of antiretroviral drugs on exposed children. Clinical and experimental studies have consistently shown the occurrence of mitochondrial dysfunction and increased oxidative stress following prenatal treatment with antiretroviral drugs, and clinical evidence suggests that the developing brain is one of the targets of the toxic action of these compounds possibly resulting in behavioral problems. We intended to verify the effects on brain and behavior of mice exposed during gestation to AZT, the backbone of antiretroviral therapy during human pregnancy. We hypothesized that glutamate, a neurotransmitter involved in excitotoxicity and behavioral plasticity, could be one of the major actors in AZT-induced neurochemical and behavioral alterations. We also assessed the antioxidant and neuroprotective effect of L-acetylcarnitine, a compound that improves mitochondrial function and is successfully used to treat antiretroviral-induced polyneuropathy in HIV-1 patients. We found that transplacental exposure to AZT given per os to pregnant mice from day 10 of pregnancy to delivery impaired in the adult offspring spatial learning and memory, enhanced corticosterone release in response to acute stress, increased brain oxidative stress also at birth and markedly reduced expression of mGluR1 and mGluR5 subtypes and GluR1 subunit of AMPA receptors in the hippocampus. Notably, administration during the entire pregnancy of L-acetylcarnitine was effective in preventing/ameliorating the neurochemical, neuroendocrine and behavioral adverse effects induced by AZT in the offspring. The present preclinical findings provide a mechanistic hypothesis for the neurobehavioral effects of AZT and strongly suggest that preventive administration of L-acetylcarnitine might be effective in reducing the neurological side-effects of antiretroviral therapy in fetus/newborn.	[Zuena, Anna Rita; Giuli, Chiara; Tramutola, Antonella; Cinque, Carlo; Alema, Giovanni Sebastiano; Giovine, Angela; Casolini, Paola] Univ Roma La Sapienza, Fac Med 1, Dept Physiol & Pharmacol Vittorio Erspamer, Rome, Italy; [Pesciolini, Aldina Venerosi; Ajmone-Cat, Maria Antonietta; Calamandrei, Gemma] Ist Super Sanita, Dept Cell Biol & Neurosci, Sect Neurotoxicol & Neuroendocrinol, I-00161 Rome, Italy; [Minghetti, Luisa] Ist Super Sanita, Dept Cell Biol & Neurosci, Sect Expt Neurol, I-00161 Rome, Italy; [Nicolai, Raffaella] Corp R&D Sigma Tau SpA, Therapeut Area Life Cycle Management, Rome, Italy; [Peluso, Gianfranco] CNR, Inst Biochem Prot, I-80125 Naples, Italy	Sapienza University Rome; Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR)	Calamandrei, G (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Sect Neurotoxicol & Neuroendocrinol, Viale Regina Elena 299, I-00161 Rome, Italy.	gemma.calamandrei@iss.it	Tramutola, Antonella/AAA-9240-2022; Cinque, Carlo/AAD-6216-2019; Alemà, Giovanni Sebastiano/D-2672-2009; Minghetti, Luisa/I-9540-2014; CAT, MARIA ANTONIETTA AJMONE/E-7699-2018; Venerosi, Aldina/AAI-2808-2020; Calamandrei, Gemma/M-3815-2014	Tramutola, Antonella/0000-0002-9564-2086; Alemà, Giovanni Sebastiano/0000-0003-2350-6365; Minghetti, Luisa/0000-0002-7065-4689; CAT, MARIA ANTONIETTA AJMONE/0000-0002-7003-0972; Venerosi, Aldina/0000-0002-6599-0581; Calamandrei, Gemma/0000-0003-3762-3132	University of Rome [C26F09YEXM]; Sigma-Tau I.F.R. SpA (Rome) [D.S./2007/C.R./no6]; Sigma Tau-IFR S.p.A., Italy	University of Rome; Sigma-Tau I.F.R. SpA (Rome); Sigma Tau-IFR S.p.A., Italy	The study was supported by funds to P.C. from University of Rome (faculty project 2009 prot. C26F09YEXM) and partly sponsored by Sigma-Tau I.F.R. SpA (Rome) (D.S./2007/C.R./no6). Raffaella Niccolai is an employee of the SIGMA TAU and participated in manuscript preparation and data analysis as an expert of acetylcarnitine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Doctor Raffaella Nicolai is employed at Sigma-tau S.p.A. as Medical Research Senior Advisor; Raffaella Nicolai and Paola Casolini have been designated among inventors in the following European patent application: 11137170.3-2112 "Compound useful for preventing cognitive deficit disorders in a new born from HIV-seropositive pregnant female who is on treatment with azidothymidine". Part of this study has been financially supported by Sigma Tau-IFR S.p.A., Italy that has synthesized and provided L-acetylcarnitine. Sigma-tau is an Italian pharmaceutical company involved in research on carnitine system which produces and sells carnitine as drugs. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. There are no other competing interests to declare.	Akirav I, 2004, LEARN MEMORY, V11, P188, DOI 10.1101/lm.61704; Balschun D, 1999, LEARN MEMORY, V6, P138; Bannerman DM, 2006, PSYCHOPHARMACOLOGY, V188, P552, DOI 10.1007/s00213-006-0403-6; Barret B, 2003, AIDS, V17, P1769, DOI 10.1097/00002030-200308150-00006; Bergink V, 2004, EUR NEUROPSYCHOPHARM, V14, P175, DOI 10.1016/S0924-977X(03)00100-7; Bikbaev A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002155; Bishop JB, 2004, ENVIRON MOL MUTAGEN, V43, P3, DOI 10.1002/em.10210; Blanche S, 1999, LANCET, V354, P1084, DOI 10.1016/S0140-6736(99)07219-0; Bortolotto ZA, 1999, CURR OPIN NEUROBIOL, V9, P299, DOI 10.1016/S0959-4388(99)80044-0; BRANN DW, 1994, FRONT NEUROENDOCRIN, V15, P3, DOI 10.1006/frne.1994.1002; Brogly SB, 2011, AIDS RES HUM RETROV, V27, P777, DOI [10.1089/aid.2010.0204, 10.1089/AID.2010.0204]; Busidan Y, 1999, PHARMACOL BIOCHEM BE, V64, P479, DOI 10.1016/S0091-3057(99)00157-4; Busidan Y, 1999, NEUROTOXICOL TERATOL, V21, P359, DOI 10.1016/S0892-0362(99)00003-3; Calamandrei G, 2002, NEUROTOXICOL TERATOL, V24, P529, DOI 10.1016/S0892-0362(02)00234-9; Calamandrei G, 2000, PHARMACOL BIOCHEM BE, V67, P511, DOI 10.1016/S0091-3057(00)00386-5; Calamandrei G, 1999, NEUROTOXICOLOGY, V20, P17; Calamandrei G, 1999, NEUROTOXICOL TERATOL, V21, P29, DOI 10.1016/S0892-0362(98)00035-X; Chan SSL, 2007, ENVIRON MOL MUTAGEN, V48, P190, DOI 10.1002/em.20191; Chappuy H, 2004, ANTIMICROB AGENTS CH, V48, P4332, DOI 10.1128/AAC.48.11.4332-4336.2004; Chase C, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.2.e25; Cinque C, 2003, NEUROSCIENCE, V122, P277, DOI 10.1016/S0306-4522(03)00442-1; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Dagan T, 2002, MITOCHONDRION, V1, P397, DOI 10.1016/S1567-7249(02)00003-X; DARLINGTON DN, 1989, AM J PHYSIOL, V256, pR112, DOI 10.1152/ajpregu.1989.256.1.R112; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Diamond DM, 1996, BEHAV NEUROSCI, V110, P661, DOI 10.1037/0735-7044.110.4.661; Divi RL, 2007, ENVIRON MOL MUTAGEN, V48, P201, DOI 10.1002/em.20201; Divi RL, 2010, TOXICOL SCI, V118, P191, DOI 10.1093/toxsci/kfq235; Divi RL, 2004, AIDS, V18, P1013, DOI 10.1097/00002030-200404300-00009; Esposito S, 1999, J DEV BEHAV PEDIATR, V20, P411, DOI 10.1097/00004703-199912000-00002; Famularo G, 1997, AIDS, V11, P185, DOI 10.1097/00002030-199702000-00008; Ferraguti F, 2008, PHARMACOL REV, V60, P536, DOI 10.1124/pr.108.000166; Frick KM, 2000, NEUROSCIENCE, V95, P293; Friese G, 2001, ANTIVI THER S4, V6, P44; Gerschenson M, 2000, AIDS RES HUM RETROV, V16, P635, DOI 10.1089/088922200308864; Greco A, 2004, CURR NEUROVASC RES, V1, P341, DOI 10.2174/1567202043362036; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Hart AM, 2004, AIDS, V18, P1549, DOI 10.1097/01.aids.0000131354.14408.fb; Heidari S, 2011, JAIDS-J ACQ IMM DEF, V57, P290, DOI 10.1097/QAI.0b013e318221c56a; Herman JP, 2004, ANN NY ACAD SCI, V1018, P35, DOI 10.1196/annals.1296.004; Herzmann C, 2005, HIV CLIN TRIALS, V6, P344, DOI 10.1310/CH1N-YBNU-G3CU-JBXR; Jezova D, 2005, ENDOCRINE, V28, P287, DOI 10.1385/ENDO:28:3:287; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kohler JJ, 2007, ENVIRON MOL MUTAGEN, V48, P166, DOI 10.1002/em.20223; Landreau-Mascaro A, 2002, LANCET, V359, P583, DOI 10.1016/S0140-6736(02)07717-6; Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201; Liu L, 1999, BRAIN RES, V821, P134, DOI 10.1016/S0006-8993(99)01085-9; LUINE V, 1994, BRAIN RES, V639, P167, DOI 10.1016/0006-8993(94)91778-7; MAKARA GB, 1975, NEUROENDOCRINOLOGY, V18, P213, DOI 10.1159/000122400; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Mellins CA, 2005, J ADOLESCENT HEALTH, V36, P342, DOI 10.1016/j.jadohealth.2004.02.038; Mellins CA, 2003, PEDIATRICS, V111, P384, DOI 10.1542/peds.111.2.384; Melnick SM, 2005, NEUROTOXICOL TERATOL, V27, P599, DOI 10.1016/j.ntt.2005.05.010; Minghetti L, 2000, J NEUROPATH EXP NEUR, V59, P866, DOI 10.1093/jnen/59.10.866; Mofenson Lynne M, 2003, Semin Pediatr Infect Dis, V14, P295, DOI 10.1053/j.spid.2003.09.003; Naie K, 2004, CEREB CORTEX, V14, P189, DOI 10.1093/cercor/bhg118; Nedelska Z, 2012, P NATL ACAD SCI USA, V109, P2590, DOI 10.1073/pnas.1121588109; Newell ML, 2003, JAIDS-J ACQ IMM DEF, V32, P380, DOI 10.1097/00126334-200304010-00006; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Osio M, 2006, J PERIPHER NERV SYST, V11, P72, DOI 10.1111/j.1085-9489.2006.00066.x; Panel on Treatment of HIV- Infected Pregnant Women and Prevention of Perinatal Transmission, 2011, MMWR RECOMM REP, V51, P1; PETRUZZELLA V, 1992, ARCH GERONTOL GERIAT, V14, P131, DOI 10.1016/0167-4943(92)90048-9; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; Poirier MC, 1999, J ACQ IMMUN DEF SYND, V22, P477; Poirier MC, 2003, JAIDS-J ACQ IMM DEF, V33, P175, DOI 10.1097/00126334-200306010-00010; Pugh CR, 1997, BEHAV NEUROSCI, V111, P503, DOI 10.1037/0735-7044.111.3.503; Rondinini C, 1999, PSYCHOPHARMACOLOGY, V145, P317, DOI 10.1007/s002130051064; Roozendaal B, 1997, NEUROBIOL LEARN MEM, V67, P176, DOI 10.1006/nlme.1996.3765; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Scarpini E, 1997, J Peripher Nerv Syst, V2, P250; Schroder UH, 2008, NEUROSCIENCE, V157, P385, DOI 10.1016/j.neuroscience.2008.08.063; Scruggs ER, 2008, PHARMACOLOGY, V82, P83, DOI 10.1159/000134943; Shapiro ML, 1999, HIPPOCAMPUS, V9, P365, DOI 10.1002/(SICI)1098-1063(1999)9:4<365::AID-HIPO4>3.3.CO;2-K; Shiramizu B, 2003, JAIDS-J ACQ IMM DEF, V32, P370, DOI 10.1097/00126334-200304010-00004; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Tardieu M, 2005, AM J NEURORADIOL, V26, P695; Thorne C, 2007, DRUG SAFETY, V30, P203, DOI 10.2165/00002018-200730030-00004; Torres SM, 2007, ENVIRON MOL MUTAGEN, V48, P224, DOI 10.1002/em.20264; Torres SM, 2010, CARDIOVASC TOXICOL, V10, P37, DOI 10.1007/s12012-010-9061-3; Tortorella C, 2009, INT J MOL MED, V23, P799, DOI 10.3892/ijmm_00000195; Valcour V, 2009, HIV MED, V10, P103, DOI 10.1111/j.1468-1293.2008.00658.x; Venerosi A, 2005, NEUROTOXICOL TERATOL, V27, P169, DOI 10.1016/j.ntt.2004.09.008; Venerosi A, 2003, PHARMACOL BIOCHEM BE, V74, P671, DOI 10.1016/S0091-3057(02)01068-7; Venerosi A, 2001, TERATOLOGY, V63, P26, DOI 10.1002/1096-9926(200101)63:1<26::AID-TERA1005>3.0.CO;2-G; Venerosi A, 2000, PSYCHOPHARMACOLOGY, V150, P404, DOI 10.1007/s002130000455; Walker Dale M, 2004, Cardiovasc Toxicol, V4, P133, DOI 10.1385/CT:4:2:133; Walker VE, 2007, ENVIRON MOL MUTAGEN, V48, P159, DOI 10.1002/em.20296; Watts DH, 2006, DRUG SAFETY, V29, P467, DOI 10.2165/00002018-200629060-00002; Yamaguchi T, 2002, EUR J BIOCHEM, V269, P2782, DOI 10.1046/j.1432-1033.2002.02954.x; Yokoi N, 2012, INT REV CEL MOL BIO, V297, P1, DOI 10.1016/B978-0-12-394308-8.00001-7; Youle M, 2007, HIV MED, V8, P241, DOI 10.1111/j.1468-1293.2007.00467.x; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	96	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55753	10.1371/journal.pone.0055753	http://dx.doi.org/10.1371/journal.pone.0055753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409035	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200060
J	Ando, M; Sato, Y; Takata, K; Nomoto, J; Nakamura, S; Ohshima, K; Takeuchi, T; Orita, Y; Kobayashi, Y; Yoshino, T				Ando, Midori; Sato, Yasuharu; Takata, Katsuyoshi; Nomoto, Junko; Nakamura, Shigeo; Ohshima, Koichi; Takeuchi, Tamotsu; Orita, Yorihisa; Kobayashi, Yukio; Yoshino, Tadashi			A20 (TNFAIP3) Deletion in Epstein-Barr Virus-Associated Lymphoproliferative Disorders/Lymphomas	PLOS ONE			English	Article							B-CELL LYMPHOMA; NF-KAPPA-B; TUMOR-SUPPRESSOR GENE; HODGKIN LYMPHOMA; MUTATIONS; EXPRESSION; MULTIPLE	A negative regulator of the nuclear factor (NF)-kappa B pathway, A20 (TNFAIP3), is inactivated in several types of lymphomas; particularly in diffuse large B-cell lymphoma (DLBCL), classical Hodgkin's lymphoma, and extranodal marginal zone lymphoma of the mucosa-associated lymphoid tissue. These findings suggest that the NF-kappa B activation is related to A20 inactivation. Recently, A20 inactivation has also been observed in Epstein-Barr virus (EBV)-related lymphomas; however, this occurrence has not been well investigated. Moreover, NF-kappa B is a key molecule in activated B-cell-like (ABC)-type DLBCL; EBV-associated DLBCL is of the ABC type. Therefore, we focused on A20 deletions in EBV-associated lymphoproliferative disorders/lymphomas. Using fluorescent in situ hybridization analysis, A20 deletions were identified in 4 of 13 samples from patients with pyothorax-associated lymphoma (PAL) (31%), 3 of 20 samples from nasal-type NK/T cell lymphomas (NKTLs) (15%), 1 of 8 samples of EBV-positive DLBCL of the elderly (DLBCL-e) (13%), but not in any of the 11 samples from individuals with methotrexate-related lymphoproliferative disorder (MTX-LPD) (0%). Among the samples with A20 deletions, EBV latent membrane protein 1 (LMP-1) expression was detected in all 4 of the PAL samples with A20 deletions and in the DLBCL-e sample with an A20 deletion, but not in any of the 3 NKTL samples. This finding indicated that A20 deletions were not directly related to the EBV latency pattern of lymphomas, although such deletions might be related to the diagnostic category. Immunohistologically, the A20 protein was absent in 2 (15%) of the13 PAL samples, 1 (9%) of 11 MTX-LPD samples, and in none of the 20 NKTL (0%) or 8 DLBCL-e samples. In conclusion, A20 deletion and/or dysfunctional expression are frequently associated with PALs, and A20 abnormalities may be related to the pathogenesis of PAL.	[Ando, Midori; Sato, Yasuharu; Takata, Katsuyoshi; Yoshino, Tadashi] Okayama Univ, Dept Pathol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Nomoto, Junko; Kobayashi, Yukio] Natl Canc Ctr, Div Hematol, Tokyo, Japan; [Nakamura, Shigeo] Nagoya Univ Hosp, Dept Pathol & Clin Lab, Nagoya, Aichi, Japan; [Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Fukuoka, Japan; [Takeuchi, Tamotsu] Gifu Univ, Grad Sch Med, Dept Immunopathol, Gifu, Japan; [Orita, Yorihisa] Okayama Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	Okayama University; National Cancer Center - Japan; Nagoya University; Kurume University; Gifu University; Okayama University	Sato, Y (corresponding author), Okayama Univ, Dept Pathol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	satou-y@cc.okayama-u.ac.jp	Nakamura, Shigeo/I-1571-2012; Kobayahi, Yukio/E-9081-2017	Kobayahi, Yukio/0000-0003-2378-7865				Aozasa K, 2006, J CLIN EXP HEMATOP, V46, P5, DOI 10.3960/jslrt.46.5; Bi Y., 2011, HAEMATOLOGICA, V97, P926; Braun FCM, 2011, LEUKEMIA, V25, P1494, DOI 10.1038/leu.2011.101; Chanudet E, 2009, J PATHOL, V217, P420, DOI 10.1002/path.2466; Chao C, 2012, CLIN CANCER RES, V18, P4702, DOI 10.1158/1078-0432.CCR-11-3169; Chiang AKS, 1996, INT J CANCER, V68, P285, DOI 10.1002/(SICI)1097-0215(19961104)68:3<285::AID-IJC3>3.0.CO;2-Y; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dong GH, 2011, CLIN CANCER RES, V17, P1440, DOI 10.1158/1078-0432.CCR-10-1859; FUKAYAMA M, 1993, AM J PATHOL, V143, P1044; Giulino L, 2011, BLOOD, V117, P4852, DOI 10.1182/blood-2010-10-310995; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Iqbal J, 2004, AM J PATHOL, V165, P159, DOI 10.1016/S0002-9440(10)63284-1; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karube K, 2011, BLOOD, V118, P3195, DOI 10.1182/blood-2011-04-346890; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kim WS, 2007, GENE CHROMOSOME CANC, V46, P776, DOI 10.1002/gcc.20463; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Montes-Moreno S, 2012, MODERN PATHOL, V25, P968, DOI 10.1038/modpathol.2012.52; Nomoto J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-457; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; Rossi D, 2011, BLOOD, V118, P4930, DOI 10.1182/blood-2011-06-359166; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Swerdlow SH, 2008, WHO CLASSIFICATION T; vanGorp J, 1996, J CLIN PATHOL, V49, P72, DOI 10.1136/jcp.49.1.72; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	26	22	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56741	10.1371/journal.pone.0056741	http://dx.doi.org/10.1371/journal.pone.0056741			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418597	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300190
J	Fantin, M; van der Kooij, MA; Grosse, J; Krummenacher, C; Sandi, C				Fantin, Martina; van der Kooij, Michael A.; Grosse, Jocelyn; Krummenacher, Claude; Sandi, Carmen			A Key Role for Nectin-1 in the Ventral Hippocampus in Contextual Fear Memory	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; HERPES-SIMPLEX-VIRUS; ENTRY RECEPTOR NECTIN-1; LONG-TERM POTENTIATION; GLYCOPROTEIN-D; DORSAL HIPPOCAMPUS; INTRAVENTRICULAR INFUSIONS; DIFFERENTIAL CONTRIBUTION; SYNAPTIC PLASTICITY; GENE-EXPRESSION	Nectins are cell adhesion molecules that are widely expressed in the brain. Nectin expression shows a dynamic spatiotemporal regulation, playing a role in neural migratory processes during development. Nectin-1 and nectin-3 and their heterophilic trans-interactions are important for the proper formation of synapses. In the hippocampus, nectin-1 and nectin-3 localize at puncta adherentia junctions and may play a role in synaptic plasticity, a mechanism essential for memory and learning. We evaluated the potential involvement of nectin-1 and nectin-3 in memory consolidation using an emotional learning paradigm. Rats trained for contextual fear conditioning showed transient nectin-1- but not nectin-3-protein upregulation in synapse-enriched hippocampal fractions at about 2 h posttraining. The upregulation of nectin-1 was found exclusively in the ventral hippocampus and was apparent in the synaptoneurosomal fraction. This upregulation was induced by contextual fear conditioning but not by exposure to context or shock alone. When an antibody against nectin-1, R165, was infused in the ventral-hippocampus immediately after training, contextual fear memory was impaired. However, treatment with the antibody in the dorsal hippocampus had no effect in contextual fear memory formation. Similarly, treatment with the antibody in the ventral hippocampus did not interfere with acoustic memory formation. Further control experiments indicated that the effects of ventral hippocampal infusion of the nectin-1 antibody in contextual fear memory cannot be ascribed to memory non-specific effects such as changes in anxiety-like behavior or locomotor behavior. Therefore, we conclude that nectin-1 recruitment to the perisynaptic environment in the ventral hippocampus plays an important role in the formation of contextual fear memories. Our results suggest that these mechanisms could be involved in the connection of emotional and contextual information processed in the amygdala and dorsal hippocampus, respectively, thus opening new venues for the development of treatments to psychopathological alterations linked to impaired contextualization of emotions.	[Fantin, Martina; van der Kooij, Michael A.; Grosse, Jocelyn; Sandi, Carmen] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Behav Genet, CH-1015 Lausanne, Switzerland; [Krummenacher, Claude] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Pennsylvania	Sandi, C (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Behav Genet, CH-1015 Lausanne, Switzerland.	carmen.sandi@epfl.ch		Krummenacher, Claude/0000-0002-3492-4987; van der Kooij, Michael/0000-0001-7415-1379; Sandi, Carmen/0000-0001-7713-8321	European Union integrated project MEMSTICK [FP7-HEALTH-F2M-2007-201600]; Swiss National Science Foundation [310000-120791, 31003AB-135710, CRSIK3-122691]; EPFL; Public Health Service grants from the National Institutes of Health [AI-097171, DE-022137]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI097171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE022137] Funding Source: NIH RePORTER	European Union integrated project MEMSTICK; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EPFL; Public Health Service grants from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the European Union integrated project MEMSTICK (FP7-HEALTH-F2M-2007-201600; MemStick), the Swiss National Science Foundation (310000-120791 and 31003AB-135710; Sinergia CRSIK3-122691; and the NCCR "The synaptic basis of mental diseases") as well as the intramural funding from the EPFL. C.K. is supported by Public Health Service grants from the National Institutes of Health AI-097171 and DE-022137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2010, INT J NEUROPSYCHOPH, V13, P661, DOI 10.1017/S1461145709991106; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Baringer JR, 2008, NEUROL CLIN, V26, P657, DOI 10.1016/j.ncl.2008.03.005; Bast T, 2001, PSYCHOPHARMACOLOGY, V156, P225, DOI 10.1007/s002130100775; BEERS DR, 1995, J NEUROL SCI, V131, P119, DOI 10.1016/0022-510X(95)00099-N; Bisaz R, 2010, GENES BRAIN BEHAV, V9, P353, DOI 10.1111/j.1601-183X.2010.00563.x; Bisaz R, 2009, NEUROBIOL LEARN MEM, V91, P333, DOI 10.1016/j.nlm.2008.11.003; Bojesen KB, 2012, J BIOL CHEM, V287, P37420, DOI 10.1074/jbc.M112.345215; Cambon K, 2004, J NEUROSCI, V24, P4197, DOI 10.1523/JNEUROSCI.0436-04.2004; Cambon K, 2003, NEUROSCIENCE, V122, P183, DOI 10.1016/S0306-4522(03)00597-9; Chang HP, 2001, NEUROSCIENCE, V102, P289, DOI 10.1016/S0306-4522(00)00478-4; Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005; Conboy L, 2010, NEUROPSYCHOPHARMACOL, V35, P674, DOI 10.1038/npp.2009.172; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; Czerniawski J, 2012, HIPPOCAMPUS, V22, P1528, DOI 10.1002/hipo.20992; Czerniawski J, 2011, J NEUROSCI, V31, P11200, DOI 10.1523/JNEUROSCI.2211-11.2011; Di Giovine P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002277; Dickerson FB, 2004, BIOL PSYCHIAT, V55, P588, DOI 10.1016/j.biopsych.2003.10.008; Dityatev A, 2008, NEURON GLIA BIOL, V4, P197, DOI 10.1017/S1740925X09990111; DOYLE E, 1992, J NEUROCHEM, V59, P1570, DOI 10.1111/j.1471-4159.1992.tb08477.x; Esclassan F, 2009, HIPPOCAMPUS, V19, P33, DOI 10.1002/hipo.20473; Fabre S, 2002, J BIOL CHEM, V277, P27006, DOI 10.1074/jbc.M203228200; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Foley AG, 2003, J NEUROSCI RES, V74, P570, DOI 10.1002/jnr.10758; FOX GB, 1995, J NEUROCHEM, V65, P2796; Frankland PW, 2004, HIPPOCAMPUS, V14, P557, DOI 10.1002/hipo.10208; Gafford GM, 2011, NEUROSCIENCE, V182, P98, DOI 10.1016/j.neuroscience.2011.03.023; Garcia R, 1998, NEUROSCIENCE, V82, P139; GORDON B, 1990, ARCH NEUROL-CHICAGO, V47, P646, DOI 10.1001/archneur.1990.00530060054017; Haarr L, 2001, VIROLOGY, V287, P301, DOI 10.1006/viro.2001.1041; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hobin JA, 2006, HIPPOCAMPUS, V16, P174, DOI 10.1002/hipo.20144; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Horvath S, 2006, J NEUROVIROL, V12, P161, DOI 10.1080/13550280600760594; Huff NC, 2006, J NEUROSCI, V26, P1616, DOI 10.1523/JNEUROSCI.4964-05.2006; Huff NC, 2004, BEHAV NEUROSCI, V118, P53, DOI 10.1037/0735-7044.118.1.53; Hunsaker MR, 2008, NEUROBIOL LEARN MEM, V89, P61, DOI 10.1016/j.nlm.2007.08.016; Igaz LM, 2002, J NEUROSCI, V22, P6781; Kenney JW, 2012, HIPPOCAMPUS, V22, P1681, DOI 10.1002/hipo.22003; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kiss JZ, 2001, REV NEUROSCIENCE, V12, P297; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Kopp SJ, 2009, P NATL ACAD SCI USA, V106, P17916, DOI 10.1073/pnas.0908892106; Krummenacher C, 2003, J VIROL, V77, P8985, DOI 10.1128/JVI.77.16.8985-8999.2003; Krummenacher C, 2002, J VIROL, V76, P2424, DOI 10.1128/JVI.76.5.2424-2433.2002; Krummenacher C, 1998, J VIROL, V72, P7064, DOI 10.1128/JVI.72.9.7064-7074.1998; Lim ST, 2012, J NEUROCHEM, V120, P741, DOI 10.1111/j.1471-4159.2011.07592.x; Lopez-Fernandez MA, 2007, J NEUROSCI, V27, P4552, DOI 10.1523/JNEUROSCI.0396-07.2007; Maren S, 2004, BEHAV NEUROSCI, V118, P97, DOI 10.1037/0735-7044.118.1.97; Maren S, 1999, BEHAV NEUROSCI, V113, P283, DOI 10.1037/0735-7044.113.2.283; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McNaughton N, 2000, J AFFECT DISORDERS, V61, P161, DOI 10.1016/S0165-0327(00)00344-X; Merino JJ, 2000, EUR J NEUROSCI, V12, P3283, DOI 10.1046/j.1460-9568.2000.00191.x; Mitsushima D, 2011, P NATL ACAD SCI USA, V108, P12503, DOI 10.1073/pnas.1104558108; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Motanis H, 2010, EUR J NEUROSCI, V32, P840, DOI 10.1111/j.1460-9568.2010.07334.x; Murphy KJ, 1998, NEUROBIOL LEARN MEM, V70, P73, DOI 10.1006/nlme.1998.3839; Niedringhaus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042631; O'Sullivan NC, 2007, J NEUROCHEM, V101, P1085, DOI 10.1111/j.1471-4159.2006.04418.x; OConnell AW, 1997, J NEUROCHEM, V68, P2538; Okabe N, 2004, DEV BIOL, V273, P244, DOI 10.1016/j.ydbio.2004.05.034; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Restivo L, 2009, J NEUROSCI, V29, P8206, DOI 10.1523/JNEUROSCI.0966-09.2009; Richart SM, 2003, J VIROL, V77, P3307, DOI 10.1128/JVI.77.5.3307-3311.2003; Richmond MA, 1999, BEHAV NEUROSCI, V113, P1189, DOI 10.1037/0735-7044.113.6.1189; RONN LCB, 1995, BRAIN RES, V677, P145, DOI 10.1016/0006-8993(95)00147-I; Rudy JW, 2001, COGN AFFECT BEHAV NE, V1, P66, DOI 10.3758/CABN.1.1.66; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Sandi C, 2003, BIOL PSYCHIAT, V54, P599, DOI 10.1016/S0006-3223(03)00182-3; Seymour CM, 2008, NEUROSCIENCE, V157, P813, DOI 10.1016/j.neuroscience.2008.09.041; Shapiro M, 2001, ARCH NEUROL-CHICAGO, V58, P874, DOI 10.1001/archneur.58.6.874; Shukla D, 2000, J VIROL, V74, P11773, DOI 10.1128/JVI.74.24.11773-11781.2000; Stiles KM, 2008, VIROLOGY, V373, P98, DOI 10.1016/j.virol.2007.11.012; Stork O, 2000, EUR J NEUROSCI, V12, P3291, DOI 10.1046/j.1460-9568.2000.00197.x; Sutherland RJ, 2008, HIPPOCAMPUS, V18, P710, DOI 10.1002/hipo.20431; Takai Y, 2003, CURR OPIN NEUROBIOL, V13, P520, DOI 10.1016/j.conb.2003.09.003; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Togashi H, 2006, J CELL BIOL, V174, P141, DOI 10.1083/jcb.200601089; Trivedi MA, 2004, NEUROBIOL LEARN MEM, V81, P172, DOI 10.1016/j.nlm.2004.02.005; Venero C, 2006, EUR J NEUROSCI, V23, P1585, DOI 10.1111/j.1460-9568.2006.04663.x; Wang XD, 2011, NEUROBIOL DIS, V42, P300, DOI 10.1016/j.nbd.2011.01.020; Zhang WN, 2001, BEHAV BRAIN RES, V126, P159, DOI 10.1016/S0166-4328(01)00256-X	87	15	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56897	10.1371/journal.pone.0056897	http://dx.doi.org/10.1371/journal.pone.0056897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418609	gold, Green Submitted, Green Published			2022-12-27	WOS:000315970300204
J	Iskandarsyah, A; de Klerk, C; Suardi, DR; Soemitro, MP; Sadarjoen, SS; Passchier, J				Iskandarsyah, Aulia; de Klerk, Cora; Suardi, Dradjat R.; Soemitro, Monty P.; Sadarjoen, Sawitri S.; Passchier, Jan			The Distress Thermometer and Its Validity: A First Psychometric Study in Indonesian Women with Breast Cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; HOSPITAL ANXIETY; PSYCHOLOGICAL DISTRESS; DEPRESSION SCALE; VALIDATION; ONCOLOGISTS; PREVALENCE; JAKARTA; CARE	Purpose: This study aims to translate the Distress Thermometer (DT) into Indonesian, test its validity in Indonesian women with breast cancer and determine norm scores of the Indonesian DT for clinically relevant distress. Methods: First, the original version of the DT was translated using a forward and backward translation procedure according to the guidelines. Next, a group of 120 breast cancer patients who were treated at the Outpatient Surgical Oncology Clinic in Hasan Sadikin Hospital in Indonesia completed a standard socio-demographic form, the DT and the Problem List, the Hospital Anxiety and Depression Scale (HADS) and the WHO Quality of Life (WHOQOL-BREF). Results: Receiver operating characteristic (ROC) curve analyses identified an area under the curve = 0.81 when compared to the HADS cutoff score of 15. A cutoff score of 5 on the DT had the best sensitivity (0.81) and specificity (0.64). Patients who scored above this cutoff reported more problems in the practical, family, emotional, spiritual/religious and physical domains (30 out of 36 problems, p-value<0.05) than patients below the cutoff score. Patients at advanced stages of cancer experienced more emotional and physical problems. Patient's distress level was negatively correlated with overall quality of life, general health and all quality of life domains. Conclusions: The DT was found to be a valid tool for screening distress in Indonesian breast cancer patients. We recommend using a cutoff score of 5 in this population.	[Iskandarsyah, Aulia; de Klerk, Cora; Passchier, Jan] Erasmus MC Univ Med Ctr, Sect Med Psychol & Psychotherapy, Dept Psychiat, Rotterdam, Netherlands; [Iskandarsyah, Aulia; Passchier, Jan] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Iskandarsyah, Aulia; Sadarjoen, Sawitri S.] Padjadjaran State Univ, Dept Clin Psychol, Bandung, Indonesia; [Suardi, Dradjat R.; Soemitro, Monty P.] Hasan Sadikin Hosp, Dept Surg Oncol, Bandung, Indonesia	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Universitas Padjadjaran; Dr Hasan Sadikin General Hospital	Iskandarsyah, A (corresponding author), Erasmus MC Univ Med Ctr, Sect Med Psychol & Psychotherapy, Dept Psychiat, Rotterdam, Netherlands.	a.iskandarsyah@erasmusmc.nl	Iskandarsyah, Aulia/GRJ-7939-2022	Iskandarsyah, Aulia/0000-0002-9526-6922	Directorate General of Higher Education of Indonesia	Directorate General of Higher Education of Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	AI received a PhD scholarship from the Directorate General of Higher Education of Indonesia (http://www.dikti.go.id/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizuki N, 2003, CANCER-AM CANCER SOC, V97, P2605, DOI 10.1002/cncr.11358; Al-Shahri M, 2002, WESTERN J MED, V176, P60, DOI 10.1136/ewjm.176.1.60; Albar ZA, 2004, PROTOKOL PERABOI 200; [Anonymous], 2003, J NATL COMPR CANC NE, V1, P344, DOI [DOI 10.6004/JNCCN.2003.0031, 10.6004/jnccn.2003.0031]; Chen ML, 2006, SUPPORT CARE CANCER, V14, P825, DOI 10.1007/s00520-006-0019-8; Claramita M, 2011, ADV HEALTH SCI EDUC, V16, P69, DOI 10.1007/s10459-010-9242-7; Dabrowski Michele, 2007, J Natl Compr Canc Netw, V5, P104; Departemen Kesehatan RI, 2011, PROF KES IND 2010; Ferlay J, 2010, IARC CANCERBASE, V2; Gessler S, 2008, PSYCHO-ONCOLOGY, V17, P538, DOI 10.1002/pon.1273; Gil F, 2005, SUPPORT CARE CANCER, V13, P600, DOI 10.1007/s00520-005-0780-0; Graves KD, 2007, LUNG CANCER, V55, P215, DOI 10.1016/j.lungcan.2006.10.001; Hegel MT, 2006, CANCER-AM CANCER SOC, V107, P2924, DOI 10.1002/cncr.22335; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Hoffman BM, 2004, PSYCHO-ONCOLOGY, V13, P792, DOI 10.1002/pon.796; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; IBBOTSON T, 1994, EUR J CANCER, V30A, P37, DOI 10.1016/S0959-8049(05)80015-2; Jacobsen PB, 2005, CANCER-AM CANCER SOC, V103, P1494, DOI 10.1002/cncr.20940; Kennard BD, 2004, J CLIN PSYCHOL MED S, V11, P31, DOI 10.1023/B:JOCS.0000016267.21912.74; Khatib J, 2004, PSYCHO-ONCOL, V13, pS42; Kusumaratna RK, 2007, UNIVERSA MED, V26, P179; LICKISS JN, 1993, J PAIN SYMPTOM MANAG, V8, P423, DOI 10.1016/0885-3924(93)90071-3; Mitchell AJ, 2007, J CLIN ONCOL, V25, P4670, DOI 10.1200/JCO.2006.10.0438; Montazeri A, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-32; Moore MA, 2010, ASIAN PAC J CANCER P, V11, P81; National Comprehensive Cancer Network, 2010, CLIN PRACT GUID ONC; National Institute of Clinical Excellence, 2004, GUID CANC SERV IMPR; Ng CH, 2011, ASIAN PAC J CANCER P, V12, P2943; Ozalp E, 2007, PSYCHO-ONCOLOGY, V16, P304, DOI 10.1002/pon.1059; Passik SD, 1998, J CLIN ONCOL, V16, P1594, DOI 10.1200/JCO.1998.16.4.1594; Patrick-Miller LJ, 2004, J CLIN ONCOL, V22, p525S; Peters M, 2006, HEADACHE, V46, P82, DOI 10.1111/j.1526-4610.2006.00298.x; Ransom S, 2006, PSYCHO-ONCOLOGY, V15, P604, DOI 10.1002/pon.993; Roth AJ, 1998, CANCER, V82, P1904, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1904::AID-CNCR13>3.0.CO;2-X; Shim EJ, 2008, PSYCHO-ONCOLOGY, V17, P548, DOI 10.1002/pon.1275; Skarstein J, 2000, J PSYCHOSOM RES, V49, P27, DOI 10.1016/S0022-3999(00)00080-5; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Sollner W, 2001, BRIT J CANCER, V84, P179, DOI 10.1054/bjoc.2000.1545; Tuinman MA, 2008, CANCER-AM CANCER SOC, V113, P870, DOI 10.1002/cncr.23622; van Dooren S, 2009, PSYCHO-ONCOLOGY, V18, P1080, DOI 10.1002/pon.1451; vantSpijker A, 1997, PSYCHOSOM MED, V59, P280, DOI 10.1097/00006842-199705000-00011; von Essen L, 2002, EUR J CANCER CARE, V11, P91; Wada T, 2005, ARCH GERONTOL GERIAT, V41, P271, DOI 10.1016/j.archger.2005.03.003; Wakai K, 2000, INT J EPIDEMIOL, V29, P20, DOI 10.1093/ije/29.1.20; Walsh D, 2000, SUPPORT CARE CANCER, V8, P175, DOI 10.1007/s005200050281; Zabora J, 2001, PSYCHO-ONCOL, V10, P19, DOI 10.1002/1099-1611(200101/02)10:1<19::AID-PON501>3.3.CO;2-Y; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	47	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56353	10.1371/journal.pone.0056353	http://dx.doi.org/10.1371/journal.pone.0056353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418561	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300154
J	Kikuchi, M; Yoshimura, Y; Shitamichi, K; Ueno, S; Hiraishi, H; Munesue, T; Hirosawa, T; Ono, Y; Tsubokawa, T; Inoue, Y; Oi, M; Niida, Y; Remijn, GB; Takahashi, T; Suzuki, M; Higashida, H; Minabe, Y				Kikuchi, Mitsuru; Yoshimura, Yuko; Shitamichi, Kiyomi; Ueno, Sanae; Hiraishi, Hirotoshi; Munesue, Toshio; Hirosawa, Tetsu; Ono, Yasuki; Tsubokawa, Tsunehisa; Inoue, Yoshihiro; Oi, Manabu; Niida, Yo; Remijn, Gerard B.; Takahashi, Tsutomu; Suzuki, Michio; Higashida, Haruhiro; Minabe, Yoshio			Anterior Prefrontal Hemodynamic Connectivity in Conscious 3-to 7-Year-Old Children with Typical Development and Autism Spectrum Disorder	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; NEAR-INFRARED SPECTROSCOPY; JOINT ATTENTION EXPERIENCE; YOUNG-CHILDREN; SENTENCE COMPREHENSION; SOCIAL COGNITION; CORPUS-CALLOSUM; FRONTAL-LOBE; BLOOD-FLOW; CORTEX	Socio-communicative impairments are salient features of autism spectrum disorder (ASD) from a young age. The anterior prefrontal cortex (aPFC), or Brodmann area 10, is a key processing area for social function, and atypical development of this area is thought to play a role in the social deficits in ASD. It is important to understand these brain functions in developing children with ASD. However, these brain functions have not yet been well described under conscious conditions in young children with ASD. In the present study, we focused on the brain hemodynamic functional connectivity between the right and the left aPFC in children with ASD and typically developing (TD) children and investigated whether there was a correlation between this connectivity and social ability. Brain hemodynamic fluctuations were measured non-invasively by near-infrared spectroscopy (NIRS) in 3-to 7-year-old children with ASD (n = 15) and gender-and age-matched TD children (n = 15). The functional connectivity between the right and the left aPFC was assessed by measuring the coherence for low-frequency spontaneous fluctuations (0.01 - 0.10 Hz) during a narrated picture-card show. Coherence analysis demonstrated that children with ASD had a significantly higher inter-hemispheric connectivity with 0.02-Hz fluctuations, whereas a power analysis did not demonstrate significant differences between the two groups in terms of low frequency fluctuations (0.01 - 0.10 Hz). This aberrant higher connectivity in children with ASD was positively correlated with the severity of social deficit, as scored with the Autism Diagnostic Observation Schedule. This is the first study to demonstrate aberrant brain functional connectivity between the right and the left aPFC under conscious conditions in young children with ASD.	[Kikuchi, Mitsuru; Yoshimura, Yuko; Munesue, Toshio; Oi, Manabu; Niida, Yo; Higashida, Haruhiro; Minabe, Yoshio] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan; [Kikuchi, Mitsuru; Shitamichi, Kiyomi; Ueno, Sanae; Hiraishi, Hirotoshi; Munesue, Toshio; Hirosawa, Tetsu; Ono, Yasuki; Minabe, Yoshio] Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan; [Kikuchi, Mitsuru; Yoshimura, Yuko; Munesue, Toshio; Oi, Manabu; Higashida, Haruhiro; Minabe, Yoshio] Chiba Univ, Hamamatsu Univ Sch Med, United Grad Sch Child Dev, Dept Child Dev,Osaka Univ,Kanazawa Univ, Osaka, Japan; [Kikuchi, Mitsuru; Yoshimura, Yuko; Munesue, Toshio; Oi, Manabu; Higashida, Haruhiro; Minabe, Yoshio] Osaka Univ, Fukui Univ, Osaka, Japan; [Remijn, Gerard B.] Kyushu Univ, Int Educ Ctr, Fukuoka 812, Japan; [Tsubokawa, Tsunehisa] Kanazawa Univ, Grad Sch Med Sci, Dept Anesthesiol, Kanazawa, Ishikawa, Japan; [Inoue, Yoshihiro] Shimadzu Co Ltd, Med Syst Div, R&D Dept, Kyoto, Japan; [Takahashi, Tsutomu; Suzuki, Michio] Toyama Univ, Dept Neuropsychiat, Toyama 930, Japan	Kanazawa University; Kanazawa University; Chiba University; Hamamatsu University School of Medicine; Kanazawa University; Osaka University; Osaka University; Kyushu University; Kanazawa University; Shimadzu Corporation; University of Toyama	Kikuchi, M (corresponding author), Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan.	mitsuru@zc4.so-net.ne.jp	Remijn, Gerard/CAF-9960-2022; higashida, haruhiro/L-3773-2015	higashida, haruhiro/0000-0002-1779-0606; Remijn, Gerard/0000-0002-8681-9951	Hokuriku Innovation Cluster for Health Science (MEXT Program for Fostering Regional Innovation); Strategic Research Program for Brain Sciences from MEXT, Japan	Hokuriku Innovation Cluster for Health Science (MEXT Program for Fostering Regional Innovation); Strategic Research Program for Brain Sciences from MEXT, Japan	This study was supported by the Hokuriku Innovation Cluster for Health Science (MEXT Program for Fostering Regional Innovation) and the Strategic Research Program for Brain Sciences from MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell F, 1999, NEUROREPORT, V10, P1647, DOI 10.1097/00001756-199906030-00005; Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson JS, 2011, BRAIN, V134, P3739, DOI 10.1093/brain/awr263; Badre D, 2007, J COGNITIVE NEUROSCI, V19, P2082, DOI 10.1162/jocn.2007.19.12.2082; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; BARONCOHEN S, 1991, PSYCHIAT CLIN N AM, V14, P33; Bashat DB, 2007, NEUROIMAGE, V37, P40, DOI 10.1016/j.neuroimage.2007.04.060; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Calarge C, 2003, AM J PSYCHIAT, V160, P1954, DOI 10.1176/appi.ajp.160.11.1954; Chevallier C, 2011, NEUROPSYCHOLOGIA, V49, P507, DOI 10.1016/j.neuropsychologia.2010.11.042; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; de Bie HMA, 2012, HUM BRAIN MAPP, V33, P1189, DOI 10.1002/hbm.21280; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; Eigsti IM, 2003, MENT RETARD DEV D R, V9, P205, DOI 10.1002/mrdd.10081; Eyler LT, 2012, BRAIN, V135, P949, DOI 10.1093/brain/awr364; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fox PT, 2012, NEUROIMAGE, V61, P407, DOI 10.1016/j.neuroimage.2011.12.051; Happe F, 1996, BRAIN, V119, P1377, DOI 10.1093/brain/119.4.1377; Homae F, 2010, J NEUROSCI, V30, P4877, DOI 10.1523/JNEUROSCI.5618-09.2010; Hoshi Y, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2142325; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Kana RK, 2007, BIOL PSYCHIAT, V62, P198, DOI 10.1016/j.biopsych.2006.08.004; Kana RK, 2006, BRAIN, V129, P2484, DOI 10.1093/brain/awl164; Kaufman A. S, 2004, KAUFMAN BRIEF INTELL; Kawakubo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025944; Kikuchi M, 2010, NEUROREPORT, V21, P1106, DOI 10.1097/WNR.0b013e3283406615; Kleinhans NM, 2008, BRAIN, V131, P1000, DOI 10.1093/brain/awm334; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koshino H, 2005, NEUROIMAGE, V24, P810, DOI 10.1016/j.neuroimage.2004.09.028; Kumar A, 2010, CEREB CORTEX, V20, P2103, DOI 10.1093/cercor/bhp278; Lainhart JE, 2006, AM J MED GENET C, V142C, P33, DOI 10.1002/ajmg.c.30080; Lee PS, 2009, CEREB CORTEX, V19, P1787, DOI 10.1093/cercor/bhn209; Lord C., 1999, AUTISM DIAGNOSTIC OB; McCaffery P, 2005, PROG NEUROBIOL, V77, P38, DOI 10.1016/j.pneurobio.2005.10.005; Mizuno A, 2006, BRAIN RES, V1104, P160, DOI 10.1016/j.brainres.2006.05.064; Monk CS, 2009, NEUROIMAGE, V47, P764, DOI 10.1016/j.neuroimage.2009.04.069; Muller RA, 2011, CEREB CORTEX, V21, P2233, DOI 10.1093/cercor/bhq296; Mundy P, 2009, AUTISM RES, V2, P2, DOI 10.1002/aur.61; Noonan SK, 2009, BRAIN RES, V1262, P48, DOI 10.1016/j.brainres.2008.12.076; Ohnishi T, 2000, BRAIN, V123, P1838, DOI 10.1093/brain/123.9.1838; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Redcay E, 2008, BIOL PSYCHIAT, V64, P589, DOI 10.1016/j.biopsych.2008.05.020; Remijn GB, 2011, BRAIN RES, V1383, P242, DOI 10.1016/j.brainres.2011.01.090; Roca M, 2011, NEUROPSYCHOLOGIA, V49, P3525, DOI 10.1016/j.neuropsychologia.2011.09.003; Shih P, 2011, BIOL PSYCHIAT, V70, P270, DOI 10.1016/j.biopsych.2011.03.040; Shih P, 2010, NEUROPSYCHOLOGIA, V48, P2931, DOI 10.1016/j.neuropsychologia.2010.05.035; Sundaram SK, 2008, CEREB CORTEX, V18, P2659, DOI 10.1093/cercor/bhn031; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Toth K, 2006, J AUTISM DEV DISORD, V36, P993, DOI 10.1007/s10803-006-0137-7; Villalobos ME, 2005, NEUROIMAGE, V25, P916, DOI 10.1016/j.neuroimage.2004.12.022; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Waiter GD, 2004, NEUROIMAGE, V22, P619, DOI 10.1016/j.neuroimage.2004.02.029; Walker L, 2012, BIOL PSYCHIAT, V72, P1043, DOI 10.1016/j.biopsych.2012.08.001; Weinstein M, 2011, HUM BRAIN MAPP, V32, P534, DOI 10.1002/hbm.21042; Welchew DE, 2005, BIOL PSYCHIAT, V57, P991, DOI 10.1016/j.biopsych.2005.01.028; Williams JHG, 2005, NEUROIMAGE, V25, P133, DOI 10.1016/j.neuroimage.2004.10.047; Wing L, 2002, J CHILD PSYCHOL PSYC, V43, P307, DOI 10.1111/1469-7610.00023; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447; Zhu BH, 2009, BEHAV BRAIN RES, V202, P32, DOI 10.1016/j.bbr.2009.03.029	65	14	16	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56087	10.1371/journal.pone.0056087	http://dx.doi.org/10.1371/journal.pone.0056087			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418517	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300109
J	Silva, TM; Andersson, S; Sukumaran, SK; Marques, MP; Persson, L; Oredsson, S				Silva, Tania Magalhaes; Andersson, Sara; Sukumaran, Sunil Kumar; Marques, Maria Paula; Persson, Lo; Oredsson, Stina			Norspermidine and Novel Pd(II) and Pt(II) Polynuclear Complexes of Norspermidine as Potential Antineoplastic Agents Against Breast Cancer	PLOS ONE			English	Article							POLYAMINE ANALOGS; CELL-CYCLE; ORNITHINE DECARBOXYLASE; MOLECULAR-MECHANISMS; BIOGENIC POLYAMINES; ANTITUMOR-ACTIVITY; SPERMINE ANALOG; METAL-COMPLEXES; DNA-SYNTHESIS; PLATINUM(II)	Background: New strategies are needed for breast cancer treatment and one initial step is to test new chemotherapeutic drugs in breast cancer cell lines, to choose candidates for further studies towards clinical use. Methodology and Findings: The cytotoxic effects of a biogenic polyamine analogue - norspermidine - and its trinuclear Pd(II) and Pt(II) complexes - Pd(3)NSpd(2) and Pt(3)NSpd(2), respectively - were investigated in one immortalized normal-like and three breast cancer cell lines. The normal-like MCF-10A cells were least sensitive to the compounds, while growth inhibition and cell death was observed in the cancer cell lines. Norspermidine and its Pd(II) complex were generally shown to have stronger antiproliferative effects than the corresponding Pt(II) complex. Moreover, both norspermidine and the Pd(II) complex reduced the cellular activity of the growth-related enzyme, ornithine decarboxylase (ODC) to a lower level than the Pt(II) complex in most of the cell lines examined. Treatment with norspermidine or the Pd(II) complex reduced the number of colonies formed in a soft agar assay performed with the breast cancer cell lines, indicating that these compounds reduced the malignancy of the breast cancer cells. The effect of norspermidine or the Pd(II) complex on colony formation was much stronger than that observed for the Pt(II) complex. The results from a new mammalian genotoxicity screen together with those of a single cell gel electrophoresis assay indicated that none of the drugs were genotoxic at a 25 mu M concentration. Main Conclusions: Overall, norspermidine and its Pd(II) complex were shown to have strong antiproliferative effects. In comparison, the effects obtained with the Pd(II) complex were much stronger than that of the Pt(II) complex. The results obtained in the present study demonstrate that the trinuclear Pd(II) complex of norspermidine (Pd(3)NSpd(2)) may be regarded as a potential new metal-based drug against breast cancer, coupling a significant efficiency to a low toxicity.	[Silva, Tania Magalhaes; Marques, Maria Paula] Univ Coimbra, Res Unit Mol Phys Chem, P-3000 Coimbra, Portugal; [Silva, Tania Magalhaes; Andersson, Sara; Oredsson, Stina] Lund Univ, Dept Biol, S-22100 Lund, Sweden; [Silva, Tania Magalhaes; Persson, Lo] Lund Univ, Dept Expt Med Sci, S-22100 Lund, Sweden; [Sukumaran, Sunil Kumar] Anthem Biosci Pvt Ltd, Bangalore, Karnataka, India; [Marques, Maria Paula] Univ Coimbra, Dept Life Sci, Fac Sci & Technol, P-3000 Coimbra, Portugal	Universidade de Coimbra; Lund University; Lund University; Universidade de Coimbra	Oredsson, S (corresponding author), Lund Univ, Dept Biol, S-22100 Lund, Sweden.	stina.oredsson@biol.lu.se	Marques, Maria Paula M./M-4130-2013; Silva, Tania/I-4730-2012	Marques, Maria Paula M./0000-0002-8391-0055; Silva, Tania/0000-0003-2914-3120; Oredsson, Stina/0000-0003-2529-7106	Portuguese Foundation for Science and Technology [SFRH/BD/46364/2008, PTDC/QUI/66701/2006, Pest-OE/Qui/UIOO700/2011]; European Community fund FEDER	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Community fund FEDER(European Commission)	The authors also acknowledge financial support from the Portuguese Foundation for Science and Technology - SFRH/BD/46364/2008, projects PTDC/QUI/66701/2006 (co-financed by the European Community fund FEDER) and Pest-OE/Qui/UIOO700/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli E, 2010, AMINO ACIDS, V38, P393, DOI 10.1007/s00726-009-0396-7; Alm K, 1999, J CELL BIOCHEM, V75, P46, DOI 10.1002/(SICI)1097-4644(19991001)75:1<46::AID-JCB5>3.3.CO;2-E; Amado AM, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2787528; de Carvalho LAEB, 2011, CHEMPHYSCHEM, V12, P1334, DOI 10.1002/cphc.201001067; BEGG AC, 1985, CYTOMETRY, V6, P620, DOI 10.1002/cyto.990060618; Bergeron RJ, 1997, J MED CHEM, V40, P1475, DOI 10.1021/jm960849j; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Casero RA, 2001, J MED CHEM, V44, P1, DOI 10.1021/jm000084m; Casero RA, 2009, J MED CHEM, V52, P4551, DOI 10.1021/jm900187v; Cirenajwis H, 2010, ANTI-CANCER DRUG, V21, P897, DOI 10.1097/CAD.0b013e32833f2f77; Collins A, 1997, ENVIRON MOL MUTAGEN, V30, P139, DOI 10.1002/(SICI)1098-2280(1997)30:2<139::AID-EM6>3.0.CO;2-I; Davidson NE, 1999, ENDOCR-RELAT CANCER, V6, P69, DOI 10.1677/erc.0.0060069; Decatris MP, 2005, CLIN ONCOL-UK, V17, P249, DOI 10.1016/j.clon.2005.04.001; Fiuza SM, 2006, LETT DRUG DES DISCOV, V3, P149, DOI 10.2174/157018006776286989; Fiuza SM, 2011, CHEM BIOL DRUG DES, V77, P477, DOI 10.1111/j.1747-0285.2011.01081.x; FREDLUND JO, 1994, CELL PROLIFERAT, V27, P243, DOI 10.1111/j.1365-2184.1994.tb01422.x; Fredlund JO, 1997, EUR J BIOCHEM, V249, P232, DOI 10.1111/j.1432-1033.1997.00232.x; Fredlund JO, 1996, CELL PROLIFERAT, V29, P457, DOI 10.1111/j.1365-2184.1996.tb00988.x; Freiburghaus C, 2009, J DAIRY SCI, V92, P2477, DOI 10.3168/jds.2008-1851; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Goncalves RF, 2011, LETT DRUG DES DISCOV, V8, P897; Gugliucci A, 2004, CLIN CHIM ACTA, V344, P23, DOI 10.1016/j.cccn.2004.02.022; HAMANA K, 1982, J BIOCHEM-TOKYO, V91, P1321, DOI 10.1093/oxfordjournals.jbchem.a133818; Heinick A, 2010, FASEB J, V24, P206, DOI 10.1096/fj.09-135889; Holst CM, 2008, ANTI-CANCER DRUG, V19, P871, DOI 10.1097/CAD.0b013e32830f902b; Holst CM, 2006, TOXICOLOGY, V223, P71, DOI 10.1016/j.tox.2006.03.009; Holst CM, 2005, TOXICOL IN VITRO, V19, P379, DOI 10.1016/j.tiv.2004.10.005; Huang Y, 2003, CLIN CANCER RES, V9, P2769; JANNE J, 1971, J BIOL CHEM, V246, P1725; Johannsson OT, 2003, LAB INVEST, V83, P387, DOI 10.1097/01.LAB.0000060030.10652.8C; Johansson VM, 2008, DNA CELL BIOL, V27, P511, DOI 10.1089/dna.2008.0750; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Kjellstrom J, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-20; Lawley PD, 1996, MUTAT RES-FUND MOL M, V355, P13, DOI 10.1016/0027-5107(96)00020-6; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; Marques MPM, 2002, BBA-MOL CELL RES, V1589, P63, DOI 10.1016/S0167-4889(01)00186-0; Miklasova N, 2012, EUR J MED CHEM, V49, P41, DOI 10.1016/j.ejmech.2011.12.001; Myhre L, 2008, ANTI-CANCER DRUG, V19, P359, DOI 10.1097/CAD.0b013e3282f7f518; Nasizadeh S, 2005, EXP CELL RES, V308, P254, DOI 10.1016/j.yexcr.2005.04.027; Palmer AJ, 2010, AMINO ACIDS, V38, P415, DOI 10.1007/s00726-009-0400-2; PEGG AE, 1988, CANCER RES, V48, P759; PRAKASH NJ, 1988, ANTICANCER RES, V8, P563; Rezler EM, 1997, J MED CHEM, V40, P3508, DOI 10.1021/jm960854n; RODRIGUEZGARAY B, 1989, PLANT PHYSIOL, V89, P525, DOI 10.1104/pp.89.2.525; Seiler N, 2005, PHARMACOL THERAPEUT, V107, P99, DOI 10.1016/j.pharmthera.2005.02.001; SEILER N, 1990, INT J BIOCHEM, V22, P211, DOI 10.1016/0020-711X(90)90332-W; Silva TM, 2012, J INORG BIOCHEM, V108, P1, DOI 10.1016/j.jinorgbio.2011.11.021; Simstein R, 2003, EXP BIOL MED, V228, P995, DOI 10.1177/153537020322800903; Soares AS, 2007, LETT DRUG DES DISCOV, V4, P460, DOI 10.2174/157018007781788516; SOULE HD, 1990, CANCER RES, V50, P6075; Takao K, 2006, INT J BIOCHEM CELL B, V38, P621, DOI 10.1016/j.biocel.2005.10.020; Teixeira LJ, 2004, J MED CHEM, V47, P2917, DOI 10.1021/jm0311238; THORNTHWAITE JT, 1980, CYTOMETRY, V1, P229, DOI 10.1002/cyto.990010309; Tummala R, 2010, ONCOL REP, V24, P15, DOI 10.3892/or_00000823; Wallace HM, 2007, AMINO ACIDS, V33, P261, DOI 10.1007/s00726-007-0534-z; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Wallace HM, 2003, BIOCHEM SOC T, V31, P393, DOI 10.1042/BST0310393; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691	59	27	28	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55651	10.1371/journal.pone.0055651	http://dx.doi.org/10.1371/journal.pone.0055651			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418450	Green Published, gold			2022-12-27	WOS:000315970300041
J	Spooner, E; McLaughlin, BM; Lepow, T; Durns, TA; Randall, J; Upchurch, C; Miller, K; Campbell, EM; Fares, H				Spooner, Ellen; McLaughlin, Brooke M.; Lepow, Talya; Durns, Tyler A.; Randall, Justin; Upchurch, Cameron; Miller, Katherine; Campbell, Erin M.; Fares, Hanna			Systematic Screens for Proteins That Interact with the Mucolipidosis Type IV Protein TRPML1	PLOS ONE			English	Article							MEMBRANE-PROTEIN; ABNORMAL TRANSPORT; STATISTICAL-MODEL; CHANNEL ACTIVITY; CATION CHANNEL; IDENTIFICATION; TRAFFICKING; ACTIN; ACCUMULATION; MUTATIONS	Mucolipidosis type IV is a lysosomal storage disorder resulting from mutations in the MCOLN1 gene, which encodes the endosomal/lysosomal Transient Receptor Potential channel protein mucolipin-1/TRPML1. Cells isolated from Mucolipidosis type IV patients and grown in vitro and in in vivo models of this disease both show several lysosome-associated defects. However, it is still unclear how TRPML1 regulates the transport steps implicated by these defects. Identifying proteins that associate with TRPML1 will facilitate the elucidation of its cellular and biochemical functions. We report here two saturation screens for proteins that interact with TRPML1: one that is based on immunoprecipitation/mass spectrometry and the other using a genetic yeast two-hybrid approach. From these screens, we identified largely non-overlapping proteins, which represent potential TRPML1-interactors., Using additional interaction assays on some of the potential interactors from each screen, we validated some proteins as candidate TRPML1 interactors In addition, our analysis indicates that each of the two screens not only identified some false-positive interactors, as expected from any screen, but also failed to uncover potential TRPML1 interactors. Future studies on the true interactors, first identified in these screens, will help elucidate the structure and function of protein complexes containing TRPML1.	[Spooner, Ellen; McLaughlin, Brooke M.; Lepow, Talya; Durns, Tyler A.; Randall, Justin; Upchurch, Cameron; Miller, Katherine; Campbell, Erin M.; Fares, Hanna] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona	Fares, H (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	fares@email.arizona.edu		Upchurch, Cameron/0000-0002-8003-0749	National Science Foundation [1052166]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a National Science Foundation grant number 1052166 to HF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306; Bach G, 2001, MOL GENET METAB, V73, P197, DOI 10.1006/mgme.2001.3195; Bach Gideon, 2005, Hum Mutat, V26, P591, DOI 10.1002/humu.9385; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Bargal R, 1997, J INHERIT METAB DIS, V20, P625, DOI 10.1023/A:1005362123443; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Blazer-Yost BL, 2005, PFLUG ARCH EUR J PHY, V450, P75, DOI 10.1007/s00424-004-1371-5; Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Cantiello HF, 2005, PFLUG ARCH EUR J PHY, V451, P304, DOI 10.1007/s00424-005-1448-9; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Chen EI, 2006, MOL CELL PROTEOMICS, V5, P53, DOI 10.1074/mcp.T500013-MCP200; Chun DK, 2008, MOL BIOL CELL, V19, P2682, DOI 10.1091/mbc.E07-11-1120; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Curcio-Morelli C, 2010, J CELL PHYSIOL, V222, P328, DOI 10.1002/jcp.21956; Dang HP, 2011, TRAFFIC, V12, P1417, DOI 10.1111/j.1600-0854.2011.01243.x; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Eichelsdoerfer JL, 2010, J BIOL CHEM, V285, P34304, DOI 10.1074/jbc.C110.165480; Hilpela P, 2004, CURR TOP MICROBIOL, V282, P117; Jennings JJ, 2006, J BIOL CHEM, V281, P39041, DOI 10.1074/jbc.M607982200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906; LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016; LaPlante JM, 2002, FEBS LETT, V532, P183, DOI 10.1016/S0014-5793(02)03670-0; LaPlante JM, 2004, BIOCHEM BIOPH RES CO, V322, P1384, DOI 10.1016/j.bbrc.2004.08.045; Liu HB, 2002, BIOTECHNIQUES, V32, P898, DOI 10.2144/02324pt01; Lorente-Rodriguez A, 2011, COLD SPRING HARB PER, P3; Lu Q, 2008, DEVELOPMENT, V135, P1069, DOI 10.1242/dev.016063; Mairhofer M, 2009, J BIOL CHEM, V284, P29218, DOI 10.1074/jbc.M109.014993; Manzoni M, 2004, FEBS LETT, V567, P219, DOI 10.1016/j.febslet.2004.04.080; Matern H, 2000, EMBO J, V19, P4485, DOI 10.1093/emboj/19.17.4485; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P6624, DOI 10.1021/bi00344a049; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Schaheen B, 2009, J CELL SCI, V122, P2228, DOI 10.1242/jcs.048892; Schiffmann R, 1993, GENEREVIEWS; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Thaminy Safia, 2004, Methods Mol Biol, V261, P297; Thompson EG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-54; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Venugopal B, 2009, J CELL PHYSIOL, V219, P344, DOI 10.1002/jcp.21676; Vergarajauregui S, 2008, AUTOPHAGY, V4, P832, DOI 10.4161/auto.6567; Vergarajauregui S, 2008, BIOCHEM J, V410, P417, DOI 10.1042/BJ20070713; Vergarajauregui S, 2011, J CELL SCI, V124, P459, DOI 10.1242/jcs.076240; Vergarajauregui S, 2009, J BIOL CHEM, V284, P36357, DOI 10.1074/jbc.M109.047241; Waselle L, 2005, MOL ENDOCRINOL, V19, P3097, DOI 10.1210/me.2004-0530; Weernink PAO, 2004, EUR J PHARMACOL, V500, P87, DOI 10.1016/j.ejphar.2004.07.014; Yu M, 2007, MOL BIOL CELL, V18, P688, DOI 10.1091/mbc.E06-10-0914; Zeevi DA, 2010, J CELL SCI, V123, P3112, DOI 10.1242/jcs.067330; ZEIGLER M, 1992, PRENATAL DIAG, V12, P1037, DOI 10.1002/pd.1970121209	53	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56780	10.1371/journal.pone.0056780	http://dx.doi.org/10.1371/journal.pone.0056780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418601	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300194
J	Wang, GD; Cheng, LG; Fan, RX; Irwin, DM; Tang, SS; Peng, JG; Zhang, YP				Wang, Guo-dong; Cheng, Lu-guang; Fan, Ruo-xi; Irwin, David M.; Tang, Shu-sheng; Peng, Jian-guo; Zhang, Ya-ping			Signature of Balancing Selection at the MC1R Gene in Kunming Dog Populations	PLOS ONE			English	Article							MELANOCORTIN 1 RECEPTOR; DNA POLYMORPHISM DATA; DOMESTIC DOGS; COAT COLOR; HAPLOTYPE RECONSTRUCTION; STATISTICAL-METHOD; MUTATION; BLACK; IDENTIFICATION; RECOMBINATION	Coat color in dog breeds is an excellent character for revealing the power of artificial selection, as it is extremely diverse and likely the result of recent domestication. Coat color is generated by melanocytes, which synthesize pheomelanin (a red or yellow pigment) or eumelanin (a black or brown pigment) through the pigment type-switching pathway, and is regulated by three genes in dogs: MC1R (melanocortin receptor 1), CBD103 (beta-defensin 103), and ASIP (agouti-signaling protein precursor). The genotypes of these three gene loci in dog breeds are associated with coat color pattern. Here, we resequenced these three gene loci in two Kunming dog populations and analyzed these sequences using population genetic approaches to identify evolutionary patterns that have occurred at these loci during the recent domestication and breeding of the Kunming dog. The analysis showed that MC1R undergoes balancing selection in both Kunming dog populations, and that the Fst value for MC1R indicates significant genetic differentiation across the two populations. In contrast, similar results were not observed for CBD103 or ASIP. These results suggest that high heterozygosity and allelic differences at the MC1R locus may explain both the mixed color coat, of yellow and black, and the difference in coat colors in both Kunming dog populations.	[Wang, Guo-dong; Irwin, David M.; Zhang, Ya-ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Fan, Ruo-xi; Zhang, Ya-ping] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Cheng, Lu-guang; Tang, Shu-sheng; Peng, Jian-guo] Minist Publ Secur, Kunming Police Dog Base, Kunming, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada; [Irwin, David M.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 1L5, Canada	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Ministry of Public Security (China); University of Toronto; University of Toronto	Zhang, YP (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	zhangyp1@263.net.cn		Irwin, David/0000-0001-6131-4933	National Basic Research Program of China (973 Program) [2013CB835200]; National Natural Science Foundation of China [91231108]; Chinese Academy of Sciences; Bureau of Science and Technology of Yunnan Province	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Bureau of Science and Technology of Yunnan Province	This work was supported by grants from the National Basic Research Program of China (973 Program, 2013CB835200), National Natural Science Foundation of China (91231108), Chinese Academy of Sciences, and Bureau of Science and Technology of Yunnan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison A., 1964, POLYMORPHISM NATURAL, P137; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Andersson L, 2003, ANN NY ACAD SCI, V994, P313, DOI 10.1111/j.1749-6632.2003.tb03195.x; Andersson L, 2001, NAT REV GENET, V2, P130, DOI 10.1038/35052563; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cagliani R, 2010, HUM GENET; Cagliani R, 2010, MOL BIOL EVOL, V27, P1945, DOI 10.1093/molbev/msq082; Cagliani R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r143; Candille SI, 2007, SCIENCE; Chhajlani V, 1996, BIOCHEM BIOPH RES CO, V219, P521, DOI 10.1006/bbrc.1996.0266; CHHAJLANI V, 1992, FEBS LETT, V309, P417, DOI 10.1016/0014-5793(92)80820-7; COCKERHAM CC, 1987, P NATL ACAD SCI USA, V84, P8512, DOI 10.1073/pnas.84.23.8512; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Dreger DL, 2011, J HERED, V102, pS11, DOI 10.1093/jhered/esr042; Everts RE, 2000, ANIM GENET, V31, P194, DOI 10.1046/j.1365-2052.2000.00639.x; FRANDBERG PA, 1994, BIOCHEM BIOPH RES CO, V202, P1266, DOI 10.1006/bbrc.1994.2067; Frandberg PA, 1997, BIOCHEM BIOPH RES CO, V236, P489, DOI 10.1006/bbrc.1997.6994; Fumagalli M, 2009, GENOME RES, V19, P199, DOI 10.1101/gr.082768.108; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1985, GENETICS, V111, P147; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Kerns JA, 2004, MAMM GENOME, V15, P798, DOI 10.1007/s00335-004-2377-1; Kerns JA, 2003, J HERED, V94, P75, DOI 10.1093/jhered/esg016; Kerns JA, 2007, GENETICS, V176, P1679, DOI 10.1534/genetics.107.074237; Klungland H, 2003, ANN NY ACAD SCI, V994, P331, DOI 10.1111/j.1749-6632.2003.tb03197.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Marklund L, 1996, MAMM GENOME, V7, P895, DOI 10.1007/s003359900264; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Newton JM, 2000, MAMM GENOME, V11, P24, DOI 10.1007/s003350010005; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Schmutz SM, 2007, ANIM GENET, V38, P539, DOI 10.1111/j.1365-2052.2007.01664.x; Schmutz SM, 2003, J HERED, V94, P69, DOI 10.1093/jhered/esg014; SIMONSEN KL, 1995, GENETICS, V141, P413; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; TAJIMA F, 1989, GENETICS, V123, P585; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Xu XL, 1996, NAT GENET, V14, P384, DOI 10.1038/ng1296-384	47	15	20	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55469	10.1371/journal.pone.0055469	http://dx.doi.org/10.1371/journal.pone.0055469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424634	Green Published, gold, Green Submitted			2022-12-27	WOS:000315965100022
J	Schlochtermeier, LH; Kuchinke, L; Pehrs, C; Urton, K; Kappelhoff, H; Jacobs, AM				Schlochtermeier, Lorna H.; Kuchinke, Lars; Pehrs, Corinna; Urton, Karolina; Kappelhoff, Hermann; Jacobs, Arthur M.			Emotional Picture and Word Processing: An fMRI Study on Effects of Stimulus Complexity	PLOS ONE			English	Article							VISUAL-CORTEX; BRAIN ACTIVATION; VALENCE; AMYGDALA; AROUSAL; PERCEPTION; FACES; PAIN	Neuroscientific investigations regarding aspects of emotional experiences usually focus on one stimulus modality (e. g., pictorial or verbal). Similarities and differences in the processing between the different modalities have rarely been studied directly. The comparison of verbal and pictorial emotional stimuli often reveals a processing advantage of emotional pictures in terms of larger or more pronounced emotion effects evoked by pictorial stimuli. In this study, we examined whether this picture advantage refers to general processing differences or whether it might partly be attributed to differences in visual complexity between pictures and words. We first developed a new stimulus database comprising valence and arousal ratings for more than 200 concrete objects representable in different modalities including different levels of complexity: words, phrases, pictograms, and photographs. Using fMRI we then studied the neural correlates of the processing of these emotional stimuli in a valence judgment task, in which the stimulus material was controlled for differences in emotional arousal. No superiority for the pictorial stimuli was found in terms of emotional information processing with differences between modalities being revealed mainly in perceptual processing regions. While visual complexity might partly account for previously found differences in emotional stimulus processing, the main existing processing differences are probably due to enhanced processing in modality specific perceptual regions. We would suggest that both pictures and words elicit emotional responses with no general superiority for either stimulus modality, while emotional responses to pictures are modulated by perceptual stimulus features, such as picture complexity.	[Schlochtermeier, Lorna H.; Kuchinke, Lars; Pehrs, Corinna; Urton, Karolina; Kappelhoff, Hermann; Jacobs, Arthur M.] Free Univ Berlin, Berlin, Germany; [Schlochtermeier, Lorna H.; Pehrs, Corinna; Jacobs, Arthur M.] Free Univ Berlin, Dept Educ & Psychol, Berlin, Germany; [Kappelhoff, Hermann] Free Univ Berlin, Dept Philosophy & Humanities, Berlin, Germany; [Kuchinke, Lars] Ruhr Univ Bochum, Dept Psychol, Bochum, Germany; [Schlochtermeier, Lorna H.; Kuchinke, Lars; Pehrs, Corinna; Jacobs, Arthur M.] Free Univ Berlin, Dahlem Inst Neuroimaging Emot, Berlin, Germany	Free University of Berlin; Free University of Berlin; Free University of Berlin; Ruhr University Bochum; Free University of Berlin	Schlochtermeier, LH (corresponding author), Free Univ Berlin, Berlin, Germany.	l.schlochtermeier@fu-berlin.de	Urton, Karolina/GLR-9779-2022	Urton, Karolina/0000-0002-5912-8143; Jacobs, Arthur/0000-0002-7910-3955	DFG; Dahlem Institute for Neuroimaging of Emotion (D.I.N.E.), Freie Universitat Berlin	DFG(German Research Foundation (DFG)); Dahlem Institute for Neuroimaging of Emotion (D.I.N.E.), Freie Universitat Berlin	This research was funded by the DFG-funded Cluster of Excellence "Languages of Emotion'' and the Dahlem Institute for Neuroimaging of Emotion (D.I.N.E.), Freie Universitat Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizian A, 2006, BRAIN TOPOGR, V18, P213, DOI 10.1007/s10548-006-0270-9; Bermpohl F, 2006, NEUROIMAGE, V30, P588, DOI 10.1016/j.neuroimage.2005.09.040; Binder JR, 1997, HUMAN BRAIN LANGUAGE, V17; Booth JR, 2007, BRAIN RES, V1133, P136, DOI 10.1016/j.brainres.2006.11.074; Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; Britton JC, 2006, NEUROIMAGE, V31, P397, DOI 10.1016/j.neuroimage.2005.11.027; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cano ME, 2009, INT J PSYCHOPHYSIOL, V71, P17, DOI 10.1016/j.ijpsycho.2008.07.016; Caramazza A, 1996, NATURE, V383, P216, DOI 10.1038/383216a0; Codispoti M, 2012, PSYCHOPHYSIOLOGY, V49, P11, DOI 10.1111/j.1469-8986.2011.01284.x; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; DeHouwer J, 1994, DIFFERENCES AFFECTIV, V8; Ferstl EC, 2008, HUM BRAIN MAPP, V29, P581, DOI 10.1002/hbm.20422; GLASER WR, 1989, J EXP PSYCHOL GEN, V118, P13, DOI 10.1037/0096-3445.118.1.13; GLASER WR, 1992, COGNITION, V42, P61, DOI 10.1016/0010-0277(92)90040-O; Herbert C, 2009, SOC COGN AFFECT NEUR, V4, P35, DOI 10.1093/scan/nsn027; Hinojosa JA, 2009, COGN AFFECT BEHAV NE, V9, P173, DOI 10.3758/CABN.9.2.173; Jacobsen T, 2006, NEUROIMAGE, V29, P276, DOI 10.1016/j.neuroimage.2005.07.010; Keil A, 2009, HUM BRAIN MAPP, V30, P532, DOI 10.1002/hbm.20521; Kensinger EA, 2006, COGN AFFECT BEHAV NE, V6, P110, DOI 10.3758/CABN.6.2.110; Khateb A, 2002, BRAIN TOPOGR, V14, P197, DOI 10.1023/A:1014502925003; Kiefer M, 2011, CORTEX IN PRESS; Kuchinke L, 2011, NEUROIMAGE, V54, P2412, DOI 10.1016/j.neuroimage.2010.08.062; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; Lang P.J., 2008, A8 U FLOR; Lang PJ, 1998, PSYCHOPHYSIOLOGY, V35, P199, DOI 10.1017/S0048577298001991; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Maratos EJ, 2000, NEUROPSYCHOLOGIA, V38, P1452, DOI 10.1016/S0028-3932(00)00061-0; Martinovic J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003781; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Paivio A, 1991, DUAL CODING THEORY R, V45; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phan KL, 2003, BIOL PSYCHIAT, V53, P211, DOI 10.1016/S0006-3223(02)01485-3; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schendan HE, 1998, PSYCHOPHYSIOLOGY, V35, P240, DOI 10.1017/S004857729897010X; Seifert LS, 1997, J EXPT PSYCHOL LEARN, V23; Sevostianov A, 2002, HUM BRAIN MAPP, V16, P168, DOI 10.1002/hbm.10037; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; VANDERPLOEG RD, 1987, INT J PSYCHOPHYSIOL, V5, P193, DOI 10.1016/0167-8760(87)90006-7; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vuilleumier P, 2004, NAT NEUROSCI, V7, P1271, DOI 10.1038/nn1341; WALLACE GK, 1991, COMMUN ACM, V34, P30, DOI 10.1145/103085.103089; Wiens S, 2011, BIOL PSYCHOL, V86, P83, DOI 10.1016/j.biopsycho.2010.11.001; Worsley KJ, 2000, STAT PROBABIL LETT, V47, P135, DOI 10.1016/S0167-7152(99)00149-2	48	52	55	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55619	10.1371/journal.pone.0055619	http://dx.doi.org/10.1371/journal.pone.0055619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409009	gold, Green Published, Green Submitted			2022-12-27	WOS:000315100000018
J	Bohrer, G; Zhu, KP; Jones, RL; Curtis, PS				Bohrer, Gil; Zhu, Kunpeng; Jones, Robert L.; Curtis, Peter S.			Optimizing Wind Power Generation while Minimizing Wildlife Impacts in an Urban Area	PLOS ONE			English	Article							ENERGY DEVELOPMENT; BIRD MORTALITY; GOLDEN EAGLES; RESOURCE AREA; TURBINES; FARMS; RAPTORS; OPTIMIZATION; CONSERVATION; MIGRATION	The location of a wind turbine is critical to its power output, which is strongly affected by the local wind field. Turbine operators typically seek locations with the best wind at the lowest level above ground since turbine height affects installation costs. In many urban applications, such as small-scale turbines owned by local communities or organizations, turbine placement is challenging because of limited available space and because the turbine often must be added without removing existing infrastructure, including buildings and trees. The need to minimize turbine hazard to wildlife compounds the challenge. We used an exclusion zone approach for turbine-placement optimization that incorporates spatially detailed maps of wind distribution and wildlife densities with power output predictions for the Ohio State University campus. We processed public GIS records and airborne lidar point-cloud data to develop a 3D map of all campus buildings and trees. High resolution large-eddy simulations and long-term wind climatology were combined to provide land-surface-affected 3D wind fields and the corresponding wind-power generation potential. This power prediction map was then combined with bird survey data. Our assessment predicts that exclusion of areas where bird numbers are highest will have modest effects on the availability of locations for power generation. The exclusion zone approach allows the incorporation of wildlife hazard in wind turbine siting and power output considerations in complex urban environments even when the quantitative interaction between wildlife behavior and turbine activity is unknown.	[Bohrer, Gil; Zhu, Kunpeng; Jones, Robert L.] Ohio State Univ, Dept Civil Environm & Geodet Engn, Columbus, OH 43210 USA; [Curtis, Peter S.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bohrer, G (corresponding author), Ohio State Univ, Dept Civil Environm & Geodet Engn, Columbus, OH 43210 USA.	bohrer.17@osu.edu	Bohrer, Gil/A-9731-2008	Bohrer, Gil/0000-0002-9209-9540	OSU Institute for Energy and the Environment; NASA-ROSES-2010-Climate and Biological Response grant [NNX11AP61G]; U.S. Department of Agriculture-National Institute for Food & Agriculture (NIFA) [CSREES-OHOR-2009-04566]; NSF [DEB0911461, DEB0918869, CBET-1033451]; U.S. Geological Survey through the Ohio Water Resources Center [G11AP20099]; Ohio Supercomputer Center [PAS0409-2]; Division Of Environmental Biology [0911461] Funding Source: National Science Foundation	OSU Institute for Energy and the Environment; NASA-ROSES-2010-Climate and Biological Response grant; U.S. Department of Agriculture-National Institute for Food & Agriculture (NIFA); NSF(National Science Foundation (NSF)); U.S. Geological Survey through the Ohio Water Resources Center; Ohio Supercomputer Center; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	OSU Institute for Energy and the Environment 2009 Seed grant. NASA-ROSES-2010-Climate and Biological Response grant #NNX11AP61G. RAFLES representation of buildings was developed with funding from U.S. Department of Agriculture-National Institute for Food & Agriculture (NIFA) - Air Quality grant CSREES-OHOR-2009-04566 and additional improvements to RAFLES were funded in part by NSF grants #DEB0911461 and #DEB0918869, data analysis for the campus 3-D map and eddy flux observations at the ORWRP were funded in part by NSF grant CBET-1033451, and The U.S. Geological Survey through the Ohio Water Resources Center grant #G11AP20099. Simulations were conducted at The Ohio Supercomputer Center grant #PAS0409-2. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2011, RENEW SUST ENERG REV, V15, P3839, DOI 10.1016/j.rser.2011.07.004; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Aydin NY, 2010, RENEW SUST ENERG REV, V14, P364, DOI 10.1016/j.rser.2009.07.023; Baisner AJ, 2010, ENVIRON MANAGE, V46, P801, DOI 10.1007/s00267-010-9541-z; Barrios L, 2004, J APPL ECOL, V41, P72, DOI 10.1111/j.1365-2664.2004.00876.x; Bohrer G, 2008, J ECOL, V96, P569, DOI 10.1111/j.1365-2745.2008.01368.x; Bohrer G, 2012, ECOL LETT, V15, P96, DOI 10.1111/j.1461-0248.2011.01713.x; Bohrer G, 2009, BOUND-LAY METEOROL, V132, P351, DOI 10.1007/s10546-009-9404-4; Bright J, 2008, BIOL CONSERV, V141, P2342, DOI 10.1016/j.biocon.2008.06.029; Carrete M, 2012, BIOL CONSERV, V145, P102, DOI 10.1016/j.biocon.2011.10.017; Celik AN, 2007, P I MECH ENG A-J POW, V221, P1107, DOI 10.1243/09576509JPE452; Chinnasamy T. V., 1991, Renewable Energy, V1, P815, DOI 10.1016/0960-1481(91)90032-K; Cionco RM, 1998, ATMOS ENVIRON, V32, P7, DOI 10.1016/S1352-2310(97)00274-4; de Lucas M, 2008, J APPL ECOL, V45, P1695, DOI 10.1111/j.1365-2664.2008.01549.x; de Lucas M, 2012, BIOL CONSERV, V147, P184, DOI 10.1016/j.biocon.2011.12.029; Dodge S, 2012, WORKSH GISCIENCE BIG, P35; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Eichhorn M, 2012, ECOL SOC, V17, DOI 10.5751/ES-04594-170201; El-Shimy M, 2010, RENEW ENERG, V35, P1870, DOI 10.1016/j.renene.2009.12.013; Everaert J, 2007, BIODIVERS CONSERV, V16, P3345, DOI 10.1007/s10531-006-9082-1; Ferrer M, 2012, J APPL ECOL, V49, P38, DOI 10.1111/j.1365-2664.2011.02054.x; Gao YF, 2012, RENEW ENERG, V46, P148, DOI 10.1016/j.renene.2012.03.005; Garvin JC, 2011, J APPL ECOL, V48, P199, DOI 10.1111/j.1365-2664.2010.01912.x; Heath MA, 2007, WIND ENERGY, V10, P271, DOI 10.1002/we.222; Katsaprakakis DA, 2012, RENEW SUST ENERG REV, V16, P2850, DOI 10.1016/j.rser.2012.02.041; Katzner TE, 2012, J APPL ECOL, V49, P1178, DOI 10.1111/j.1365-2664.2012.02185.x; Kikuchi R, 2008, J NAT CONSERV, V16, P44, DOI 10.1016/j.jnc.2007.11.001; Kranstauber B, 2011, ENVIRON MODELL SOFTW, V26, P834, DOI 10.1016/j.envsoft.2010.12.005; Kunz TH, 2007, J WILDLIFE MANAGE, V71, P2449, DOI 10.2193/2007-270; Kuvlesky WP, 2007, J WILDLIFE MANAGE, V71, P2487, DOI 10.2193/2007-248; Ledo L, 2011, RENEW ENERG, V36, P1379, DOI 10.1016/j.renene.2010.10.030; Leung DYC, 2012, RENEW SUST ENERG REV, V16, P1031, DOI 10.1016/j.rser.2011.09.024; Mandel JT, 2011, ECOL APPL, V21, P2258, DOI 10.1890/10-1651.1; Marmidis G, 2008, RENEW ENERG, V33, P1455, DOI 10.1016/j.renene.2007.09.004; Masden EA, 2012, J R SOC INTERFACE, V9, P2120, DOI 10.1098/rsif.2012.0121; Mertens S., 2002, REFOCUS, V3, P22, DOI [DOI 10.1016/S1471-0846(02)80023-3, 10.1016/S1471-0846(02)80023-3]; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; MOSETTI G, 1994, J WIND ENG IND AEROD, V51, P105, DOI 10.1016/0167-6105(94)90080-9; Noguera JC, 2010, ARDEOLA, V57, P41; Osborn RG, 2000, AM MIDL NAT, V143, P41, DOI 10.1674/0003-0031(2000)143[0041:BMAWWT]2.0.CO;2; Pennington DN, 2008, BIOL CONSERV, V141, P1235, DOI 10.1016/j.biocon.2008.02.021; Rinne J, 2007, TELLUS B, V59, P449, DOI 10.1111/j.1600-0889.2007.00261.x; Rodewald PG, 2005, CONDOR, V107, P259, DOI 10.1650/7810; Smallwood KS, 2008, J WILDLIFE MANAGE, V72, P215, DOI 10.2193/2007-032; Smallwood KS, 2009, J WILDLIFE MANAGE, V73, P1082, DOI 10.2193/2008-555; van Haaren R, 2011, RENEW SUST ENERG REV, V15, P3332, DOI 10.1016/j.rser.2011.04.010; Yu BL, 2010, LANDSCAPE URBAN PLAN, V98, P210, DOI 10.1016/j.landurbplan.2010.08.004; Yu W, 2006, WIND ENG, V30, P15, DOI 10.1260/030952406777641450	48	5	5	0	182	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56036	10.1371/journal.pone.0056036	http://dx.doi.org/10.1371/journal.pone.0056036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409117	Green Published, Green Submitted, gold			2022-12-27	WOS:000314660300051
J	Morita-Ishihara, T; Miura, M; Iyoda, S; Izumiya, H; Watanabe, H; Ohnishi, M; Terajima, J				Morita-Ishihara, Tomoko; Miura, Masashi; Iyoda, Sunao; Izumiya, Hidemasa; Watanabe, Haruo; Ohnishi, Makoto; Terajima, Jun			EspO1-2 Regulates EspM2-Mediated RhoA Activity to Stabilize Formation of Focal Adhesions in Enterohemorrhagic Escherichia coli-Infected Host Cells	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; PEDESTAL FORMATION; EFFECTORS TIR; STRESS FIBERS; RECEPTOR; GTPASES; CONTRACTILITY; PATHOGENS; MIGRATION; VIRULENCE	Enterohemorrhagic Escherichia coli (EHEC) Sakai strain encodes two homologous type III effectors, EspO1-1 and EspO1-2. These EspO1s have amino acid sequence homology with Shigella OspE, which targets integrin-linked kinase to stabilize formation of focal adhesions (FAs). Like OspE, EspO1-1 was localized to FAs in EHEC-infected cells, but EspO1-2 was localized in the cytoplasm. An EHEC Delta espO1-1 Delta espO1-2 double mutant induced cell rounding and FA loss in most of infected cells, but neither the Delta espO1-1 nor Delta espO1-2 single mutant did. These results suggested that EspO1-2 functioned in the cytoplasm by a different mechanism from EspO1-1 and OspE. Since several type III effectors modulate Rho GTPase, which contributes to FA formation, we investigated whether EspO1-2 modulates the function of these type III effectors. We identified a direct interaction between EspO1-2 and EspM2, which acts as a RhoA guanine nucleotide exchange factor. Upon ectopic co-expression, EspO1-2 co-localized with EspM2 in the cytoplasm and suppressed EspM2-mediated stress fiber formation. Consistent with these findings, an Delta espO1-1 Delta espO1-2 Delta espM2 triple mutant did not induce cell rounding in epithelial cells. These results indicated that EspO1-2 interacted with EspM2 to regulate EspM2-mediated RhoA activity and stabilize FA formation during EHEC infection.	[Morita-Ishihara, Tomoko; Iyoda, Sunao; Izumiya, Hidemasa; Watanabe, Haruo; Ohnishi, Makoto; Terajima, Jun] Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo, Japan; [Miura, Masashi] Nagasaki Univ, Dept Ecoepidemiol, Inst Trop Med, Nagasaki 852, Japan	National Institute of Infectious Diseases (NIID); Nagasaki University	Morita-Ishihara, T (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo, Japan.	ishihara@nih.go.jp	IYODA, SUNAO/AAS-8036-2020		Ministry of Education, Culture, Sports, Science and Technology of Japan [B-21790433]; Ministry of Health, Labour and Welfare of Japan [H24-Shinkou-Ippan-005]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grant-in-aid for young scientists from the Ministry of Education, Culture, Sports, Science and Technology of Japan (B-21790433) and grant-in-aids from the Ministry of Health, Labour and Welfare of Japan (H24-Shinkou-Ippan-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Arbeloa A, 2008, CELL MICROBIOL, V10, P1429, DOI 10.1111/j.1462-5822.2008.01136.x; Arbeloa A, 2010, CELL MICROBIOL, V12, P654, DOI 10.1111/j.1462-5822.2009.01423.x; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Bulgin R, 2010, INFECT IMMUN, V78, P1417, DOI 10.1128/IAI.01250-09; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng WY, 2010, J BIOL CHEM, V285, P6790, DOI 10.1074/jbc.M109.086603; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Dong N, 2010, EMBO J, V29, P1363, DOI 10.1038/emboj.2010.33; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hayward RD, 2006, NAT REV MICROBIOL, V4, P358, DOI 10.1038/nrmicro1391; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Helfman DM, 1999, MOL BIOL CELL, V10, P3097, DOI 10.1091/mbc.10.10.3097; Iyoda S, 2006, J BACTERIOL, V188, P5682, DOI 10.1128/JB.00352-06; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Khyrul WAKM, 2004, J BIOL CHEM, V279, P54131, DOI 10.1074/jbc.M410051200; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; KNUTTON S, 1989, INFECT IMMUN, V57, P1290, DOI 10.1128/IAI.57.4.1290-1298.1989; Matsuzawa T, 2004, EMBO J, V23, P3570, DOI 10.1038/sj.emboj.7600359; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ogura Y, 2009, P NATL ACAD SCI USA, V106, P17939, DOI 10.1073/pnas.0903585106; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Simovitch M, 2010, CELL MICROBIOL, V12, P489, DOI 10.1111/j.1462-5822.2009.01410.x; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Vingadassalom D, 2009, P NATL ACAD SCI USA, V106, P6754, DOI 10.1073/pnas.0809131106; Weiss SM, 2009, CELL HOST MICROBE, V5, P244, DOI 10.1016/j.chom.2009.02.003	40	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55960	10.1371/journal.pone.0055960	http://dx.doi.org/10.1371/journal.pone.0055960			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409096	Green Submitted, gold, Green Published			2022-12-27	WOS:000314660300048
J	Demidyuk, IV; Shubin, AV; Gasanov, EV; Kurinov, AM; Demkin, VV; Vinogradova, TV; Zinovyeva, MV; Sass, AV; Zborovskaya, IB; Kostrov, SV				Demidyuk, Ilya V.; Shubin, Andrey V.; Gasanov, Eugene V.; Kurinov, Alexander M.; Demkin, Vladimir V.; Vinogradova, Tatyana V.; Zinovyeva, Marina V.; Sass, Alexander V.; Zborovskaya, Irina B.; Kostrov, Sergey V.			Alterations in Gene Expression of Proprotein Convertases in Human Lung Cancer Have a Limited Number of Scenarios	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; SQUAMOUS-CELL CARCINOMA; NEURON-SPECIFIC ENOLASE; NEUROENDOCRINE DIFFERENTIATION; MATRIX METALLOPROTEINASES; PULMONARY ADENOCARCINOMA; PROGNOSTIC-SIGNIFICANCE; OVARIAN-CANCER; GROWTH-FACTOR; TUMOR-CELLS	Proprotein convertases (PCs) is a protein family which includes nine highly specific subtilisin-like serine endopeptidases in mammals. The system of PCs is involved in carcinogenesis and levels of PC mRNAs alter in cancer, which suggests expression status of PCs as a possible marker for cancer typing and prognosis. The goal of this work was to assess the information value of expression profiling of PC genes. Quantitative polymerase chain reaction was used for the first time to analyze mRNA levels of all PC genes as well as matrix metalloproteinase genes MMP2 and MMP14, which are substrates of PCs, in 30 matched pairs of samples of human lung cancer tumor and adjacent tissues without pathology. Significant changes in the expression of PCs have been revealed in tumor tissues: increased FURIN mRNA level (p<0.00005) and decreased mRNA levels of PCSK2 (p<0.007), PCSK5 (p<0.0002), PCSK7 (p<0.002), PCSK9 (p<0.00008), and MBTPS1 (p<0.00004) as well as a tendency to increase in the level of PCSK1 mRNA. Four distinct groups of samples have been identified by cluster analysis of the expression patterns of PC genes in tumor vs. normal tissue. Three of these groups covering 80% of samples feature a strong elevation in the expression of a single gene in cancer: FURIN, PCSK1, or PCSK6. Thus, the changes in the expression of PC genes have a limited number of scenarios, which may reflect different pathways of tumor development and cryptic features of tumors. This finding allows to consider the mRNAs of PC genes as potentially important tumor markers.	[Demidyuk, Ilya V.; Shubin, Andrey V.; Gasanov, Eugene V.; Kurinov, Alexander M.; Demkin, Vladimir V.; Kostrov, Sergey V.] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia; [Vinogradova, Tatyana V.; Zinovyeva, Marina V.; Sass, Alexander V.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Zborovskaya, Irina B.] Russian Acad Med Sci, Blokhin Canc Res Ctr, Moscow, Russia	Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences	Demidyuk, IV (corresponding author), Russian Acad Sci, Inst Mol Genet, Kurchatov Sq, Moscow 123182, Russia.	duk@img.ras.ru	Kostrov, Sergey/J-6612-2018; Gasanov, Eugene/U-7902-2018; Demidyuk, Ilya V/D-1245-2009; Demkin, Vladimir/A-2122-2014	Gasanov, Eugene/0000-0002-5020-9406; Demidyuk, Ilya V/0000-0001-8140-2287; Kurinov, Alexander M./0000-0002-8190-5973; Demkin, Vladimir/0000-0002-3408-6100	Russian Academy of Sciences for Molecular and Cell Biology; Russian Academy of Sciences "Fundamental Science for Medicine"; Russian Foundation for Basic Research [12-04-00961, 12-04-01438]; Federal Program "R&D in Priority Directions of the Russian Scientific-Technological Complex Development" [02.522.11.2005, 16.512.12.2002]; Federal Program "The development of pharmaceutical and medical industry in the Russian Federation" [11411.1008700.13.084]; President of Russian Federation for Scientific Schools [5638.2010.4]	Russian Academy of Sciences for Molecular and Cell Biology; Russian Academy of Sciences "Fundamental Science for Medicine"; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Federal Program "R&D in Priority Directions of the Russian Scientific-Technological Complex Development"; Federal Program "The development of pharmaceutical and medical industry in the Russian Federation"; President of Russian Federation for Scientific Schools	This work was supported in part by the Program of the Russian Academy of Sciences for Molecular and Cell Biology, the Program of the Russian Academy of Sciences "Fundamental Science for Medicine", Russian Foundation for Basic Research (project nos. 12-04-00961 and 12-04-01438), the Federal Program "R&D in Priority Directions of the Russian Scientific-Technological Complex Development in 2007-2012" (state contracts 02.522.11.2005 and 16.512.12.2002), the Federal Program "The development of pharmaceutical and medical industry in the Russian Federation until 2020 and beyond" (state contract 11411.1008700.13.084), and a grant of the President of Russian Federation for Scientific Schools (no. 5638.2010.4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson JM, 2007, EUR J CANCER, V43, P1764, DOI 10.1016/j.ejca.2007.05.009; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bassi DE, 2001, MOL CARCINOGEN, V31, P224, DOI 10.1002/mc.1057; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; BERENDSEN HH, 1989, J CLIN ONCOL, V7, P1614, DOI 10.1200/JCO.1989.7.11.1614; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; CARLES J, 1993, LUNG CANCER, V10, P209, DOI 10.1016/0169-5002(93)90181-V; Cheng M, 1997, INT J CANCER, V71, P966, DOI 10.1002/(SICI)1097-0215(19970611)71:6<966::AID-IJC10>3.3.CO;2-A; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Chretien M, 2008, EXPERT OPIN THER TAR, V12, P1289, DOI 10.1517/14728222.12.10.1289 ; Cox G, 2001, THORAX, V56, P561, DOI 10.1136/thorax.56.7.561; Creemers JWM, 2008, FRONT BIOSCI-LANDMRK, V13, P4960, DOI 10.2741/3055; CREEMERS JWM, 1992, FEBS LETT, V300, P82, DOI 10.1016/0014-5793(92)80169-H; D'Anjou F, 2011, TRANSL ONCOL, V4, P157, DOI 10.1593/tlo.10295; de Cicco RL, 2004, CLIN CANCER RES, V10, P4480, DOI 10.1158/1078-0432.CCR-03-0670; Eren B, 2008, ANN ACAD MED SINGAP, V37, P32; Estilo CL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-11; Fu YX, 2003, MOL CANCER RES, V1, P569; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gruber MP, 2006, AM J RESP CELL MOL, V35, P65, DOI 10.1165/rcmb.2004-0261OC; Hiroshima K, 2002, ANN THORAC SURG, V73, P1732, DOI 10.1016/S0003-4975(02)03504-X; Hoikkala S, 2006, CANCER LETT, V236, P125, DOI 10.1016/j.canlet.2005.05.012; Howe MC, 2005, HISTOPATHOLOGY, V46, P195, DOI 10.1111/j.1365-2559.2005.02047.x; Hubbard FC, 1997, CANCER RES, V57, P5226; Ionescu DN, 2007, AM J SURG PATHOL, V31, P26, DOI 10.1097/01.pas.0000213319.04919.97; Ishikawa S, 2004, CLIN CANCER RES, V10, P6579, DOI 10.1158/1078-0432.CCR-04-0272; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Koo BH, 2009, FEBS J, V276, P6271, DOI 10.1111/j.1742-4658.2009.07335.x; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Leinonen T, 2008, HISTOL HISTOPATHOL, V23, P693, DOI 10.14670/HH-23.693; LINNOILA RI, 1988, AM J CLIN PATHOL, V90, P641, DOI 10.1093/ajcp/90.6.641; LINNOILA RI, 1994, CHEST, V106, pS367, DOI 10.1378/chest.106.6.367S; Matei D, 2002, ONCOGENE, V21, P6289, DOI 10.1038/sj.onc.1205785; Mbikay M, 1997, BRIT J CANCER, V75, P1509, DOI 10.1038/bjc.1997.258; NAKAGAWA H, 1994, JPN J CANCER RES, V85, P934, DOI 10.1111/j.1349-7006.1994.tb02971.x; Nawrocki B, 1997, INT J CANCER, V72, P556, DOI 10.1002/(SICI)1097-0215(19970807)72:4<556::AID-IJC2>3.3.CO;2-#; Page RE, 2007, CELL ONCOL, V29, P289; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Pelosi G, 2003, CANCER-AM CANCER SOC, V97, P2487, DOI 10.1002/cncr.11376; Polette M, 1996, VIRCHOWS ARCH, V428, P29; Pujol JL, 2001, LUNG CANCER, V31, P221, DOI 10.1016/S0169-5002(00)00186-0; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Remacle AG, 2006, ONCOGENE, V25, P5648, DOI 10.1038/sj.onc.1209572; Rounseville MP, 2000, J MOL ENDOCRINOL, V25, P121, DOI 10.1677/jme.0.0250121; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; Sato H, 2010, CANCER SCI, V101, P843, DOI 10.1111/j.1349-7006.2010.01498.x; SCHALKEN JA, 1987, J CLIN INVEST, V80, P1545, DOI 10.1172/JCI113240; SCOPSI L, 1995, J CLIN ENDOCR METAB, V80, P294, DOI 10.1210/jc.80.1.294; Segawa Y, 2009, J CANCER RES CLIN, V135, P1055, DOI 10.1007/s00432-009-0544-1; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; SEIDAH NG, 1992, MOL ENDOCRINOL, V6, P1559, DOI 10.1210/me.6.10.1559; SEIDAH NG, 1990, DNA CELL BIOL, V9, P415, DOI 10.1089/dna.1990.9.415; Shibru D, 2008, CANCER-AM CANCER SOC, V113, P930, DOI 10.1002/cncr.23703; SKOV BG, 1991, ANN ONCOL, V2, P355, DOI 10.1093/oxfordjournals.annonc.a057955; Stearman RS, 2005, AM J PATHOL, V167, P1763, DOI 10.1016/S0002-9440(10)61257-6; Sterlacci W, 2009, VIRCHOWS ARCH, V455, P125, DOI 10.1007/s00428-009-0812-0; Tadros H, 2001, J REPROD IMMUNOL, V49, P133, DOI 10.1016/S0165-0378(00)00085-1; Thomas P, 2000, J PATHOL, V190, P150; TORII S, 1993, FEBS LETT, V316, P12, DOI 10.1016/0014-5793(93)81726-G; Tzimas GN, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-149; Valk K, 2010, ONCOLOGY-BASEL, V79, P283, DOI 10.1159/000322116; Yamamura T, 2002, LUNG CANCER-J IASLC, V35, P249, DOI 10.1016/S0169-5002(01)00431-7; Yuasa K, 2007, GENE, V402, P103, DOI 10.1016/j.gene.2007.07.028; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	65	23	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55752	10.1371/journal.pone.0055752	http://dx.doi.org/10.1371/journal.pone.0055752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409034	gold, Green Submitted, Green Published			2022-12-27	WOS:000315157200059
J	Franck, D; Gil, ES; Adam, RM; Kaplan, DL; Chung, YG; Estrada, CR; Mauney, JR				Franck, Debra; Gil, Eun Seok; Adam, Rosalyn M.; Kaplan, David L.; Chung, Yeun Goo; Estrada, Carlos R., Jr.; Mauney, Joshua R.			Evaluation of Silk Biomaterials in Combination with Extracellular Matrix Coatings for Bladder Tissue Engineering with Primary and Pluripotent Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SMALL-INTESTINAL SUBMUCOSA; SMOOTH-MUSCLE-CELLS; URINARY-BLADDER; UROTHELIAL CELLS; ACELLULAR MATRIX; RETINOIC ACID; MURINE MODEL; DIFFERENTIATION; AUGMENTATION	Silk-based biomaterials in combination with extracellular matrix (ECM) coatings were assessed as templates for cell-seeded bladder tissue engineering approaches. Two structurally diverse groups of silk scaffolds were produced by a gel spinning process and consisted of either smooth, compact multi-laminates (Group 1) or rough, porous lamellar-like sheets (Group 2). Scaffolds alone or coated with collagen types I or IV or fibronectin were assessed independently for their ability to support attachment, proliferation, and differentiation of primary cell lines including human bladder smooth muscle cells (SMC) and urothelial cells as well as pluripotent cell populations, such as murine embryonic stem cells (ESC) and induced pluripotent stem (iPS) cells. AlamarBlue evaluations revealed that fibronectin-coated Group 2 scaffolds promoted the highest degree of primary SMC and urothelial cell attachment in comparison to uncoated Group 2 controls and all Group 1 scaffold variants. Real time RT-PCR and immunohistochemical (IHC) analyses demonstrated that both fibronectin-coated silk groups were permissive for SMC contractile differentiation as determined by significant upregulation of alpha-actin and SM22 alpha mRNA and protein expression levels following TGF beta 1 stimulation. Prominent expression of epithelial differentiation markers, cytokeratins, was observed in urothelial cells cultured on both control and fibronectin-coated groups following IHC analysis. Evaluation of silk matrices for ESC and iPS cell attachment by alamarBlue showed that fibronectin-coated Group 2 scaffolds promoted the highest levels in comparison to all other scaffold formulations. In addition, real time RT-PCR and IHC analyses showed that fibronectin-coated Group 2 scaffolds facilitated ESC and iPS cell differentiation toward both urothelial and smooth muscle lineages in response to all trans retinoic acid as assessed by induction of uroplakin and contractile gene and protein expression. These results demonstrate that silk scaffolds support primary and pluripotent cell responses pertinent to bladder tissue engineering and that scaffold morphology and fibronectin coatings influence these processes.	[Franck, Debra; Adam, Rosalyn M.; Chung, Yeun Goo; Estrada, Carlos R., Jr.; Mauney, Joshua R.] Boston Childrens Hosp, Urol Dis Res Ctr, Dept Urol, Boston, MA 02115 USA; [Adam, Rosalyn M.; Estrada, Carlos R., Jr.; Mauney, Joshua R.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Gil, Eun Seok; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Tufts University	Mauney, JR (corresponding author), Boston Childrens Hosp, Urol Dis Res Ctr, Dept Urol, Boston, MA 02115 USA.	joshua.mauney@childrens.harvard.edu	Estrada, Carlos R/H-2199-2015	Estrada, Carlos R/0000-0003-0586-9832	United States National Institutes of Health (NIH)/NIDDK [P50 DK065298]; NIH/NIDDK [K99DK083616-01A2]; NIH/NIBIB [P41 EB002520]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK083616, R00DK083616, P50DK065298] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant support was provided by United States National Institutes of Health (NIH)/NIDDK P50 DK065298 (ADAM/FREEMAN); NIH/NIDDK K99DK083616-01A2 (MAUNEY); NIH/NIBIB P41 EB002520 (KAPLAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbal C, 2006, J UROLOGY, V176, P1706, DOI 10.1016/j.juro.2006.04.085; Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Atala A, 2000, WORLD J UROL, V18, P364, DOI 10.1007/s003450000152; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003; Baker SC, 2008, BIOMATERIALS, V29, P3357, DOI 10.1016/j.biomaterials.2008.04.033; Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7; Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0; Ceonzo K, 2006, TISSUE ENG, V12, P301, DOI 10.1089/ten.2006.12.301; Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Choudhary S, 2006, INT J NANOMED, V1, P41, DOI 10.2147/nano.2006.1.1.41; Chun YW, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/8/085104; Garcia-Fuentes M, 2009, BIOMATERIALS, V30, P5068, DOI 10.1016/j.biomaterials.2009.06.008; Gomez P, 2011, BIOMATERIALS, V32, P7562, DOI 10.1016/j.biomaterials.2011.06.067; Hensle Terry W, 2007, Curr Urol Rep, V8, P157, DOI 10.1007/s11934-007-0066-9; Hipp JA, 2008, BJU INT, V102, P741, DOI 10.1111/j.1464-410X.2008.07606.x; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Hwang WS, 2005, STEM CELL REV, V1, P99, DOI 10.1385/SCR:1:2:099; Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035; Kaimoto T, 2010, HYPERTENSION, V56, P247, DOI 10.1161/HYPERTENSIONAHA.110.149781; Kanematsu A, 2003, J UROLOGY, V170, P1633, DOI 10.1097/01.ju.0000084021.51099.8a; Kim J, 2011, IN VITRO CELL DEV-AN, V47, P2, DOI 10.1007/s11626-010-9350-y; Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044; Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064; Lovett ML, 2008, BIOMATERIALS, V29, P4650, DOI 10.1016/j.biomaterials.2008.08.025; Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051; Mauney JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011513; Mauney JR, 2004, BIOMATERIALS, V25, P3233, DOI 10.1016/j.biomaterials.2003.10.005; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; Ning JW, 2011, CYTOTECHNOLOGY, V63, P531, DOI 10.1007/s10616-011-9376-3; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Rooney GE, 2010, REGEN MED, V5, P365, DOI 10.2217/RME.10.20; Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568; Subramaniam R, 2011, J UROLOGY, V186, P2014, DOI 10.1016/j.juro.2011.07.031; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian H, 2010, TISSUE ENG PT A, V16, P1769, DOI [10.1089/ten.tea.2009.0625, 10.1089/ten.TEA.2009.0625]; Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002; Wilson CB, 1996, WORLD J UROL, V14, pS30; Woodman JR, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-5; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Xie CQ, 2009, STEM CELLS DEV, V18, P741, DOI 10.1089/scd.2008.0179; Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x; Zhu WD, 2011, UROLOGE, V50, P1420, DOI 10.1007/s00120-011-2627-2	47	42	43	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56237	10.1371/journal.pone.0056237	http://dx.doi.org/10.1371/journal.pone.0056237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409160	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200124
J	Jovanovic, V; Aziz, NA; Lim, YT; Poh, ANA; Chan, SJH; Pei, EHX; Lew, FC; Shui, GH; Jenner, AM; Li, BW; McKinney, EF; Lyons, PA; Kemeny, MD; Smith, KGC; Wenk, MR; MacAry, PA				Jovanovic, Vojislav; Aziz, Nurhuda Abdul; Lim, Yan Ting; Poh, Amanda Ng Ai; Chan, Sherlynn Jin Hui; Pei, Eliza Ho Xin; Lew, Fei Chuin; Shui, Guanghou; Jenner, Andrew M.; Li Bowen; McKinney, Eoin F.; Lyons, Paul A.; Kemeny, Michael D.; Smith, Kenneth G. C.; Wenk, Markus R.; MacAry, Paul A.			Lipid Anti-Lipid Antibody Responses Correlate with Disease Activity in Systemic Lupus Erythematosus	PLOS ONE			English	Article							APOPTOTIC CELLS; CHOLESTEROL HOMEOSTASIS; OXIDATIVE STRESS; ACTIVITY INDEX; HUMAN BRAIN; 24S-HYDROXYCHOLESTEROL; AUTOANTIBODIES; BILAG; TRANSDUCTION; CIRCULATION	Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disorder characterized by broad clinical manifestations including cardiovascular and renal complications with periodic disease flares and significant morbidity and mortality. One of the main contributing factors to the pathology of SLE is the accumulation and impaired clearance of immune complexes of which the principle components are host auto-antigens and antibodies. The contribution of host lipids to the formation of these autoimmune complexes remains poorly defined. The aim of the present study was to identify and analyze candidate lipid autoantigens and their corresponding anti-lipid antibody responses in a well-defined SLE patient cohort using a combination of immunological and biophysical techniques. Disease monitoring in the SLE cohort was undertaken with serial British Isles Lupus Assessment Group (BILAG) scoring. Correlations between specific lipid/anti-lipid responses were investigated as disease activity developed from active flares to quiescent during a follow up period. We report a significant negative correlation between anti-lipid antibodies for 24S-hydroxycholesterol, cardiolipin and phosphatidylserine with SLE disease activity. Taken together, these data suggest that lipid autoantigens represent a new family of biomarkers that can be employed to monitor disease activity plus the efficacy of therapeutic intervention in SLE.	[Jovanovic, Vojislav; Aziz, Nurhuda Abdul; Lim, Yan Ting; Poh, Amanda Ng Ai; Chan, Sherlynn Jin Hui; Pei, Eliza Ho Xin; Lew, Fei Chuin; Kemeny, Michael D.; MacAry, Paul A.] Natl Univ Singapore, Immunol Programme, Singapore 117548, Singapore; [Jovanovic, Vojislav; Aziz, Nurhuda Abdul; Lim, Yan Ting; Poh, Amanda Ng Ai; Chan, Sherlynn Jin Hui; Pei, Eliza Ho Xin; Lew, Fei Chuin; Kemeny, Michael D.; MacAry, Paul A.] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [McKinney, Eoin F.; Lyons, Paul A.; Smith, Kenneth G. C.] Cambridge Inst Med Res, Cambridge, England; [McKinney, Eoin F.; Lyons, Paul A.; Smith, Kenneth G. C.] Univ Cambridge, Sch Clin Med, Dept Med, Addenbrookes Hosp, Cambridge CB2 2QQ, England; [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Jenner, Andrew M.] Univ Wollongong, Illawara Hlth & Med Res Inst, Sch Biol Sci, Wollongong, NSW 2522, Australia	National University of Singapore; National University of Singapore; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; National University of Singapore; University of Wollongong	MacAry, PA (corresponding author), Natl Univ Singapore, Immunol Programme, Singapore 117548, Singapore.	micpam@nus.edu.sg	jenner, andrew M/H-4791-2016; Wenk, Markus Rene/D-1441-2014; jenner, andrew/AGZ-2767-2022	jenner, andrew M/0000-0003-1767-2033; jenner, andrew/0000-0003-1767-2033; MacAry, Paul/0000-0002-1139-8996; McKinney, Eoin/0000-0003-3516-3072; Smith, Kenneth/0000-0003-3829-4326; Shui, Guanghou/0000-0002-1621-9643	Singapore National Research Foundation [NRF370062-HUJ-NUS]; Singapore National Medical Research Council [NMRC/1164/2008, 2007-04]; National Medical Research Council, "STOP-Dengue TCR"; National Medical Research Council; STOP-Dengue TCR; NCIS [C-000-999-002-001]; National Research Foundation [NRF-182-000-218-281, NRF2-182-005-172-281]; Wellcome Trust; NIHR Cambridge Biomedical Research Centre; Biomedical Research Council of Singapore [R-183-000-211-305];  [NMRC-182-003-220-275]	Singapore National Research Foundation(National Research Foundation, Singapore); Singapore National Medical Research Council(National Medical Research Council, Singapore); National Medical Research Council, "STOP-Dengue TCR"(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); STOP-Dengue TCR; NCIS; National Research Foundation; Wellcome Trust(Wellcome Trust); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); 	This work was supported by a grant from the Singapore National Research Foundation NRF370062-HUJ-NUS, "Generation of monoclonal antibodies as tools for targeting inflammatory diseases" (to P.A.M. and D.M.K); a grant from the Singapore National Medical Research Council NMRC/1164/2008, "A comparative transcriptional analysis of Systemic Lupus Erythematosus in UK (Caucasian) and Singapore (Chinese) Patients" (to P.A.M. and D.M.K); National Medical Research Council, "STOP-Dengue TCR", NMRC-182-003-220-275, and NCIS C-000-999-002-001 and the National Research Foundation NRF-182-000-218-281 and NRF2-182-005-172-281 (to P.A.M). K.G.C.S was supported by the Wellcome Trust and NIHR Cambridge Biomedical Research Centre. M.R.W. was supported by Singapore National Research Foundation under CRPAward No. 2007-04 and the Biomedical Research Council of Singapore (R-183-000-211-305).	Abou-Raya A, 2004, CLIN INVEST MED, V27, P306; Alarcon GS, 1998, ARTHRITIS RHEUM-US, V41, P1173, DOI 10.1002/1529-0131(199807)41:7<1173::AID-ART5>3.0.CO;2-A; Ames PRJ, 1999, RHEUMATOLOGY, V38, P529, DOI 10.1093/rheumatology/38.6.529; Basu S, 2008, ANTIOXID REDOX SIGN, V10, P1405, DOI 10.1089/ars.2007.1956; Berthier A, 2005, FEBS J, V272, P3093, DOI 10.1111/j.1742-4658.2005.04723.x; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Bjorkhem I, 2011, J LIPID RES, V52, P170, DOI 10.1194/jlr.D011072; Bjorkhem I, 2002, CURR OPIN LIPIDOL, V13, P247, DOI 10.1097/00041433-200206000-00003; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Bjorkhem I, 2011, NAT IMMUNOL, V12, P577, DOI 10.1038/ni0711-577a; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005; Cheng D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017299; Descloux E, 2008, RHEUMATOLOGY, V47, P183, DOI 10.1093/rheumatology/kem335; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis L, 2009, EXPERT OPIN PHARMACO, V10, P1481, DOI 10.1517/14656560902971003; Fusaro AE, 2010, J CLIN IMMUNOL, V30, P872, DOI 10.1007/s10875-010-9453-y; Gaipl US, 2006, CURR DIRECT AUTOIMMU, V9, P173; Griffiths WJ, 2010, J LIPID RES, V52, P4; Gronwall C, 2012, CLIN IMMUNOL, V142, P390, DOI 10.1016/j.clim.2012.01.002; HAY EM, 1993, Q J MED, V86, P447; Isenberg DA, 2005, RHEUMATOLOGY, V44, P902, DOI 10.1093/rheumatology/keh624; Isenberg DA, 2000, LUPUS, V9, P651, DOI 10.1191/096120300672904669; Jenks SA, 2009, AUTOIMMUN REV, V8, P209, DOI 10.1016/j.autrev.2008.07.047; Kim JH, 2010, J NEUROCHEM, V112, P34, DOI 10.1111/j.1471-4159.2009.06449.x; Kirou KA, 2006, RHEUM DIS CLIN N AM, V32, P103, DOI 10.1016/j.rdc.2005.12.001; KOSUGI I, 1992, J HEPATOL, V16, P106, DOI 10.1016/S0168-8278(05)80102-3; Kritharides L, 1996, J BIOL CHEM, V271, P27450, DOI 10.1074/jbc.271.44.27450; Leoni V, 2005, J LIPID RES, V46, P191, DOI 10.1194/jlr.C400005-JLR200; Leoni V, 2004, CLIN CHEM LAB MED, V42, P186, DOI 10.1515/CCLM.2004.034; Leoni V, 2002, NEUROSCI LETT, V331, P163, DOI 10.1016/S0304-3940(02)00887-X; Li W, 2009, FREE RADICAL RES, V43, P1072, DOI 10.1080/10715760903176919; Liu CC, 2005, CURR OPIN RHEUMATOL, V17, P543, DOI 10.1097/01.bor.0000174182.70159.22; Lutjohann D, 2000, J LIPID RES, V41, P195; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; McKinney EF, 2010, NAT MED, V16, P586, DOI 10.1038/nm.2130; Mehrani T, 2011, J RHEUMATOL, V38, P450, DOI 10.3899/jrheum.100650; Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Munoz LE, 2008, AUTOIMMUN REV, V7, P594, DOI 10.1016/j.autrev.2008.06.003; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Navarra SV, 2010, LUPUS; Niederer HA, 2010, HUM MOL GENET, V19, P3282, DOI 10.1093/hmg/ddq216; Ortona E, 2010, BLOOD, V116, P2960, DOI 10.1182/blood-2010-04-279208; Pascual V, 2003, CURR OPIN RHEUMATOL, V15, P548, DOI 10.1097/00002281-200309000-00005; Qin J, 2007, J NEUROSCI RES, V85, P977, DOI 10.1002/jnr.21206; Schule R, 2010, J LIPID RES, V51, P819, DOI 10.1194/jlr.M002543; Seet RCS, 2010, FREE RADICAL BIO MED, V48, P560, DOI 10.1016/j.freeradbiomed.2009.11.026; Shafaati M, 2011, J LIPID RES; Shui GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019731; Smith MF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2834; Smith PP, 2010, AUTOIMMUN REV, V10, P43, DOI 10.1016/j.autrev.2010.08.016; Smith RM, 2010, NAT REV RHEUMATOL, V6, P547, DOI 10.1038/nrrheum.2010.117; Sorice M, 2000, CLIN EXP IMMUNOL, V122, P277, DOI 10.1046/j.1365-2249.2000.01353.x; Szodoray P, 2009, AUTOIMMUNITY, V42, P497, DOI 10.1080/08916930902882731; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tenbrock K, 2007, RHEUMATOLOGY, V46, P1525, DOI 10.1093/rheumatology/kem154; Yasunobu Y, 2001, ATHEROSCLEROSIS, V155, P445, DOI 10.1016/S0021-9150(00)00581-5; Zuliani G, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-121	60	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55639	10.1371/journal.pone.0055639	http://dx.doi.org/10.1371/journal.pone.0055639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409013	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200046
J	Yeo, SK; Huggett, MJ; Eiler, A; Rappe, MS				Yeo, Sara K.; Huggett, Megan J.; Eiler, Alexander; Rappe, Michael S.			Coastal Bacterioplankton Community Dynamics in Response to a Natural Disturbance	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; GRADIENT GEL-ELECTROPHORESIS; LIVING BACTERIAL COMMUNITIES; ESTUARINE BACTERIOPLANKTON; PHYLOGENETIC ANALYSIS; MICROBIAL DIVERSITY; SALINITY GRADIENT; MARINE-BACTERIA; CLONE LIBRARIES; CHESAPEAKE BAY	In order to characterize how disturbances to microbial communities are propagated over temporal and spatial scales in aquatic environments, the dynamics of bacterial assemblages throughout a subtropical coastal embayment were investigated via SSU rRNA gene analyses over an 8-month period, which encompassed a large storm event. During non-perturbed conditions, sampling sites clustered into three groups based on their microbial community composition: an offshore oceanic group, a freshwater group, and a distinct and persistent coastal group. Significant differences in measured environmental parameters or in the bacterial community due to the storm event were found only within the coastal cluster of sampling sites, and only at 5 of 12 locations; three of these sites showed a significant response in both environmental and bacterial community characteristics. These responses were most pronounced at sites close to the shoreline. During the storm event, otherwise common bacterioplankton community members such as marine Synechococcus sp. and members of the SAR11 clade of Alphaproteobacteria decreased in relative abundance in the affected coastal zone, whereas several lineages of Gammaproteobacteria, Betaproteobacteria, and members of the Roseobacter clade of Alphaproteobacteria increased. The complex spatial patterns in both environmental conditions and microbial community structure related to freshwater runoff and wind convection during the perturbation event leads us to conclude that spatial heterogeneity was an important factor influencing both the dynamics and the resistance of the bacterioplankton communities to disturbances throughout this complex subtropical coastal system. This heterogeneity may play a role in facilitating a rapid rebound of regions harboring distinctly coastal bacterioplankton communities to their pre-disturbed taxonomic composition.	[Yeo, Sara K.; Huggett, Megan J.; Eiler, Alexander; Rappe, Michael S.] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Yeo, Sara K.] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii System	Rappe, MS (corresponding author), Univ Hawaii, Sch Ocean & Earth Sci & Technol, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.	rappe@hawaii.edu	Eiler, Alexander/V-9220-2017; Yeo, Sara K./A-5430-2009; Huggett, Megan/ABB-9400-2021; Huggett, Megan/G-3328-2012	Eiler, Alexander/0000-0001-9916-9567; Yeo, Sara K./0000-0002-2043-8400; Huggett, Megan/0000-0002-3401-0704	National Science Foundation [DEB-0207085]; Center for Microbial Oceanography: Research and Education (NSF Science and Technology Center) [EF-0424599]; Hawaii Sea Grant [R/EL-37]; Pacific Research Center for Marine Biomedicine [NSF OCE04-32479, NIEHS P50 ES012740]	National Science Foundation(National Science Foundation (NSF)); Center for Microbial Oceanography: Research and Education (NSF Science and Technology Center)(National Science Foundation (NSF)); Hawaii Sea Grant; Pacific Research Center for Marine Biomedicine	This research was supported by funding from National Science Foundation grant DEB-0207085, the Center for Microbial Oceanography: Research and Education (NSF Science and Technology Center Award EF-0424599), Hawaii Sea Grant Project R/EL-37, and the Pacific Research Center for Marine Biomedicine (NSF OCE04-32479, NIEHS P50 ES012740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2007, FEMS MICROBIOL ECOL, V60, P98, DOI 10.1111/j.1574-6941.2006.00276.x; ARMSTRONG FA, 1967, DEEP-SEA RES, V14, P381, DOI 10.1016/0011-7471(67)90082-4; Azam F, 2001, NATURE, V414, P495, DOI 10.1038/35107174; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Bernhard AE, 2005, FEMS MICROBIOL ECOL, V52, P115, DOI 10.1016/j.femsec.2004.10.016; Bernhardt H, 1967, TECHN S; BIDLE KD, 1995, APPL ENVIRON MICROB, V61, P944, DOI 10.1128/AEM.61.3.944-952.1995; Bouvier TC, 2002, LIMNOL OCEANOGR, V47, P453, DOI 10.4319/lo.2002.47.2.0453; Brandon ML, 2006, THESIS U HAWAII MANO; Brown MV, 2005, ENVIRON MICROBIOL, V7, P1466, DOI 10.1111/j.1462-2920.2005.00835.x; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Clarke AR, 1993, MAR ECOL PROG SER, V92, P205; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cotner JB, 2002, ECOSYSTEMS, V5, P105, DOI 10.1007/s10021-001-0059-3; Cox EF, 2006, MAR ECOL PROG SER, V324, P19, DOI 10.3354/meps324019; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Drupp P, 2011, AQUAT GEOCHEM, V17, P473, DOI 10.1007/s10498-010-9115-y; GIOVANNONI SJ, 2000, MICROBIAL ECOLOGY OC, P47; Gonzalez JM, 1997, APPL ENVIRON MICROB, V63, P4237; Gonzalez JM, 2000, APPL ENVIRON MICROB, V66, P4237, DOI 10.1128/AEM.66.10.4237-4246.2000; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hoover DJ, 2002, THESIS U HAWAII MANO; Kan J, 2008, AQUAT MICROB ECOL, V51, P55, DOI 10.3354/ame01177; Kan JJ, 2006, AQUAT MICROB ECOL, V42, P7, DOI 10.3354/ame042007; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Liao PC, 2007, MICROB ECOL, V54, P497, DOI 10.1007/s00248-007-9217-2; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Maidak BL, 1996, NUCLEIC ACIDS RES, V24, P82, DOI 10.1093/nar/24.1.82; Miller M. A., 2010, CIPRES PORTALS; MONGER BC, 1993, APPL ENVIRON MICROB, V59, P905, DOI 10.1128/AEM.59.3.905-911.1993; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; Nelson CE, 2011, ISME J, V5, P1374, DOI 10.1038/ismej.2011.12; Nogales B, 2007, ENVIRON MICROBIOL, V9, P1913, DOI 10.1111/j.1462-2920.2007.01308.x; Osborne CA, 2006, APPL ENVIRON MICROB, V72, P1270, DOI 10.1128/AEM.72.2.1270-1278.2006; Ostrander CE, 2008, ESTUAR COAST, V31, P192, DOI 10.1007/s12237-007-9001-z; Piccini C, 2006, APPL ENVIRON MICROB, V72, P6560, DOI 10.1128/AEM.01089-06; Rappe MS, 2000, FEMS MICROBIOL ECOL, V33, P219, DOI 10.1016/S0168-6496(00)00064-7; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; Ringuet S, 2005, ESTUARIES, V28, P327, DOI 10.1007/BF02693916; Simu K, 2004, APPL ENVIRON MICROB, V70, P2445, DOI 10.1128/AEM.70.4.2445-2451.2004; SMITH SV, 1981, PAC SCI, V35, P279; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; Suzuki MT, 2001, ENVIRON MICROBIOL, V3, P323, DOI 10.1046/j.1462-2920.2001.00198.x; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; US Environmental Protection Agency, 1983, METH CHEM AN WAT WAS; Vieira RP, 2008, ENVIRON MICROBIOL, V10, P189, DOI 10.1111/j.1462-2920.2007.01443.x; WILLEMS A, 1989, INT J SYST BACTERIOL, V39, P319, DOI 10.1099/00207713-39-3-319; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001	58	60	61	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56207	10.1371/journal.pone.0056207	http://dx.doi.org/10.1371/journal.pone.0056207			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409156	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200122
J	Costa, A; Oliveri, M; Barban, F; Bonni, S; Koch, G; Caltagirone, C; Carlesimo, GA				Costa, Alberto; Oliveri, Massimiliano; Barban, Francesco; Bonni, Sonia; Koch, Giacomo; Caltagirone, Carlo; Carlesimo, Giovanni A.			The Right Frontopolar Cortex Is Involved in Visual-Spatial Prospective Memory	PLOS ONE			English	Article							ROSTRAL PREFRONTAL CORTEX; STIMULATION; AREA-10; REGIONS	The involvement of frontopolar cortex in mediating prospective memory processes has been evidenced by various studies, mainly by means of neuroimaging techniques. Recently, one transcranial magnetic stimulation study documented that transient inhibition of left Brodmann Area (BA) 10 impaired verbal prospective memory. This result raises the issue of whether the BA 10 involvement in prospective memory functioning may be modulated by the physical characteristics of the stimuli used. The present study aimed to investigate the role of the frontopolar cortex in visual-spatial PM by means of the application of inhibitory theta-burst stimulation. Twelve volunteers were evaluated after inhibitory theta-burst stimulation over left BA 10, right BA10 and CZ (control condition). In the prospective memory procedure, sequences of four spatial positions (black squares) each were presented. During the inter-sequence delay, subjects had to reproduce the sequence in the observed order (ongoing task forward) or the reverse order (backward). At the occurrence of a target position, subjects had to press a key on the keyboard (prospective memory score). Recall and recognition of the target positions were also tested. We found that prospective memory accuracy was lower after theta-burst stimulation over right BA10 than CZ (p<0.01), whereas it was comparable in left BA10 and CZ conditions. No significant difference was found among the three conditions on recall and recognition of target positions and on ongoing task performance. Our findings provide a novel strong evidence for a specific involvement of right frontopolar cortex in visual-spatial prospective memory. In the context of previous data providing evidence for left BA 10 involvement in verbal prospective memory, our results also suggest material-specific lateralization of prospective memory processes in BA 10.	[Costa, Alberto; Oliveri, Massimiliano; Barban, Francesco; Bonni, Sonia; Koch, Giacomo; Caltagirone, Carlo; Carlesimo, Giovanni A.] Santa Lucia Fdn, Ist Ricovero & Cura Carattere Sci, Clin & Behav Neurol Lab, Rome, Italy; [Oliveri, Massimiliano] Univ Palermo, Dept Psychol, Palermo, Italy; [Koch, Giacomo; Caltagirone, Carlo; Carlesimo, Giovanni A.] Univ Roma Tor Vergata, Rome, Italy	IRCCS Santa Lucia; University of Palermo; University of Rome Tor Vergata	Costa, A (corresponding author), Santa Lucia Fdn, Ist Ricovero & Cura Carattere Sci, Clin & Behav Neurol Lab, Rome, Italy.	a.costa@hsantalucia.it	Koch, Giacomo/G-3155-2012; Oliveri, Massimiliano/HDO-5602-2022; Costa, Alberto/AAA-7038-2019	KOch, Giacomo/0000-0001-6155-9439; COSTA, Alberto/0000-0002-4784-5524				Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Benoit RG, 2012, CEREB CORTEX, V22, P1876, DOI 10.1093/cercor/bhr264; Bunge SA, 2009, NEUROIMAGE, V46, P338, DOI 10.1016/j.neuroimage.2009.01.064; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa A, 2011, CEREB CORTEX, V21, P2696, DOI 10.1093/cercor/bhr052; Gilbert SJ, 2011, J NEUROSCI, V31, P2888, DOI 10.1523/JNEUROSCI.5336-10.2011; Gilbert SJ, 2005, EUR J NEUROSCI, V21, P1423, DOI 10.1111/j.1460-9568.2005.03981.x; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Koch G, 2007, J NEUROSCI, V27, P6815, DOI 10.1523/JNEUROSCI.0598-07.2007; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Pollmann S, 2001, NEUROIMAGE, V14, pS118, DOI 10.1006/nimg.2001.0837; Poppenk J, 2010, NEUROIMAGE, V49, P905, DOI 10.1016/j.neuroimage.2009.08.049; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rea M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026290; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sandrini M, 2011, NEUROSCI BIOBEHAV R, V35, P516, DOI 10.1016/j.neubiorev.2010.06.005; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Uretzky S, 2010, J COGNITIVE NEUROSCI, V22, P2745, DOI 10.1162/jocn.2010.21419; Volle E, 2011, NEUROPSYCHOLOGIA, V49, P2185, DOI 10.1016/j.neuropsychologia.2011.02.045; Wendelken C, 2012, HUM BRAIN MAPP, V33, P1952, DOI 10.1002/hbm.21336	29	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56039	10.1371/journal.pone.0056039	http://dx.doi.org/10.1371/journal.pone.0056039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418505	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300097
J	Jacobs, EG; Kroenke, C; Lin, J; Epel, ES; Kenna, HA; Blackburn, EH; Rasgon, NL				Jacobs, Emily G.; Kroenke, Candyce; Lin, Jue; Epel, Elissa S.; Kenna, Heather A.; Blackburn, Elizabeth H.; Rasgon, Natalie L.			Accelerated Cell Aging in Female APOE-epsilon 4 Carriers: Implications for Hormone Therapy Use	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; LEUKOCYTE TELOMERE LENGTH; APOLIPOPROTEIN-E GENOTYPE; COGNITIVE PERFORMANCE; LONGITUDINAL FINDINGS; ALZHEIMER-DISEASE; APOE EPSILON-4; MORTALITY; ASSOCIATION; EXPRESSION	Apolipoprotein-epsilon 4 (APOE-epsilon 4) is a major genetic risk factor for cognitive decline, Alzheimer's disease (AD) and early mortality. An accelerated rate of biological aging could contribute to this increased risk. Here, we determined whether APOE-epsilon 4 status impacts leukocyte telomere length (TL) and the rate of cellular senescence in healthy mid-life women and, further, whether hormone replacement therapy (HT) modifies this association. Post-menopausal women (N = 63, Mean age = 57.7), all HT users for at least one year, were enrolled in a randomized longitudinal study. Half of the participants (N = 32) remained on their HT regimen and half (N = 31) went off HT for approximately two years (Mean = 1.93 years). Participants included 24 APOE-epsilon 4 carriers and 39 non-carrier controls. Leukocyte TL was measured at baseline and the end of year 2 using quantitative polymerase chain reaction. Logistic regression analysis indicated that the odds of an APOE-epsilon 4 carrier exhibiting telomere shortening (versus maintenance/growth) over the 2-year study were more than 6 (OR = 6.26, 95% CI = 1.02, 38.49) times higher than a non-carrier, adjusting for established risk factors and potential confounds. Despite the high-functioning, healthy mid-life status of study participants, APOE-epsilon 4 carriers had marked telomere attrition during the 2-year study window, the equivalent of approximately one decade of additional aging compared to non-carriers. Further analyses revealed a modulatory effect of hormone therapy on the association between APOE status and telomere attrition. APOE-epsilon 4 carriers who went off their HT regimen exhibited TL shortening, as predicted for the at-risk population. APOE-epsilon 4 carriers who remained on HT, however, did not exhibit comparable signs of cell aging. The opposite pattern was found in noncarriers. The results suggest that hormone use might buffer against accelerated cell aging in mid-life women at risk for dementia. Importantly, for non-carrier women there was no evidence that HT conferred protective effects on telomere dynamics.	[Jacobs, Emily G.] Univ Calif San Francisco, Ctr Hlth & Community, Robert Wood Johnson Fdn, Hlth & Soc Scholars Program, San Francisco, CA 94143 USA; [Kroenke, Candyce] Kaiser Permanente, Div Res, Oakland, CA USA; [Lin, Jue; Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Epel, Elissa S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Kenna, Heather A.; Rasgon, Natalie L.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford Ctr Neurosci Womens Hlth, Stanford, CA 94305 USA	Robert Wood Johnson Foundation (RWJF); University of California System; University of California San Francisco; Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Jacobs, EG (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA.	egjacobs@nmr.mgh.harvard.edu; nrasgon@stanford.edu	Rasgon, Natalie/ABH-9813-2020		National Institute on Aging [R01 AG22008]; National Center for Research Resources, National Institutes of Health [M01 RR-00070]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022008] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by a grant from the National Institute on Aging (R01 AG22008 to NR) and the National Center for Research Resources, National Institutes of Health (M01 RR-00070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviv A, 2011, HDB BIOL AGING, P163; Aviv Abraham, 2005, Sci Aging Knowledge Environ, V2005, ppe16, DOI 10.1126/sageke.2005.23.pe16; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Bakaysa SL, 2007, AGING CELL, V6, P769, DOI 10.1111/j.1474-9726.2007.00340.x; Bayne S, 2007, ANN NY ACAD SCI, V1114, P48, DOI 10.1196/annals.1396.023; Benetos A, 2004, HYPERTENSION, V43, P182, DOI 10.1161/01.HYP.0000113081.42868.f4; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Calado RT, 2009, BLOOD, V114, P2236, DOI 10.1182/blood-2008-09-178871; Carrero JJ, 2008, J INTERN MED, V263, P302, DOI 10.1111/j.1365-2796.2007.01890.x; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cha Y, 2008, MOL CELLS, V26, P454; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Damoiseaux JS, 2012, J NEUROSCI, V32, P8254, DOI 10.1523/JNEUROSCI.0305-12.2012; Devore EE, 2011, NEUROSCI LETT, V492, P15, DOI 10.1016/j.neulet.2011.01.041; Epel ES, 2009, AGING-US, V1, P81; Farlow MR, 1998, NEUROLOGY, V50, P669, DOI 10.1212/WNL.50.3.669; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Fitzpatrick AL, 2011, J GERONTOL A-BIOL, V66, P421, DOI 10.1093/gerona/glq224; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Grasselli A, 2008, CIRC RES, V103, P34, DOI 10.1161/CIRCRESAHA.107.169037; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HIXSON JE, 1990, J LIPID RES, V31, P545; Honig LS, 2006, ANN NEUROL, V60, P181, DOI 10.1002/ana.20894; Imanishi T, 2005, J HYPERTENS, V23, P1699, DOI 10.1097/01.hjh.0000176788.12376.20; Iwama H, 1998, HUM GENET, V102, P397, DOI 10.1007/s004390050711; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Lee DC, 2005, YONSEI MED J, V46, P471, DOI 10.3349/ymj.2005.46.4.471; Lin J, 2009, HDB NEUROSCIENCE BEH, P1280; Lin J, 2011, BRAIN RES, V1379, P224, DOI 10.1016/j.brainres.2010.10.033; Little DM, 2009, J AM GERIATR SOC, V57, P231, DOI 10.1111/j.1532-5415.2008.02113.x; Martin-Ruiz C, 2006, ANN NEUROL, V60, P174, DOI 10.1002/ana.20869; Mather KA, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-62; Misiti S, 2000, MOL CELL BIOL, V20, P3764, DOI 10.1128/MCB.20.11.3764-3771.2000; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; O'Donovan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019687; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Payami H, 1996, AM J HUM GENET, V58, P803; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; ROSES AD, 1995, ANN NEUROL, V38, P6, DOI 10.1002/ana.410380105; SACK MN, 1994, LANCET, V343, P269, DOI 10.1016/S0140-6736(94)91117-7; Song JY, 2009, J STEROID BIOCHEM, V117, P74, DOI 10.1016/j.jsbmb.2009.07.006; Srivastava RAK, 1997, J BIOL CHEM, V272, P33360, DOI 10.1074/jbc.272.52.33360; Stone DJ, 1998, J NEUROSCI, V18, P3180; Su B, 2008, CURR ALZHEIMER RES, V5, P525, DOI 10.2174/156720508786898451; Takata Y, 2012, J GERONTOL A-BIOL, V67, P330, DOI 10.1093/gerona/glr185; Valdes AM, 2010, NEUROBIOL AGING, V31, P986, DOI 10.1016/j.neurobiolaging.2008.07.012; von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184; Wang JM, 2006, P NATL ACAD SCI USA, V103, P16983, DOI 10.1073/pnas.0608128103; Wikgren M, 2012, NEUROBIOL AGING, V33, P335, DOI 10.1016/j.neurobiolaging.2010.03.004; Williams CD, 2001, J CLIN ENDOCR METAB, V86, P3912, DOI 10.1210/jc.86.8.3912; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837; Wong CM, 2008, BRIT J PHARMACOL, V155, P326, DOI 10.1038/bjp.2008.262; Xu Q, 2009, AM J CLIN NUTR, V89, P1857, DOI 10.3945/ajcn.2008.26986; Yaffe K, 2000, NEUROLOGY, V54, P1949, DOI 10.1212/WNL.54.10.1949; Yaffe K, 1997, ARCH NEUROL-CHICAGO, V54, P1110, DOI 10.1001/archneur.1997.00550210044011; Yaffe K, 2006, ANN NY ACAD SCI, V949, P215; Yaffe K, 2011, NEUROBIOL AGING, V32, P2055, DOI 10.1016/j.neurobiolaging.2009.12.006; Yokoyama Y, 1998, MOL HUM REPROD, V4, P173, DOI 10.1093/molehr/4.2.173	65	40	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e54713	10.1371/journal.pone.0054713	http://dx.doi.org/10.1371/journal.pone.0054713			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418430	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300020
J	Jalmar, O; Francois-Moutal, L; Garcia-Saez, AJ; Perry, M; Granjon, T; Gonzalvez, F; Gottlieb, E; Ayala-Sanmartin, J; Klosgen, B; Schwille, P; Petit, PX				Jalmar, Olivier; Francois-Moutal, Liberty; Garcia-Saez, Ana-Jesus; Perry, Mark; Granjon, Thierry; Gonzalvez, Francois; Gottlieb, Eyal; Ayala-Sanmartin, Jesus; Klosgen, Beate; Schwille, Petra; Petit, Patrice X.			Caspase-8 Binding to Cardiolipin in Giant Unilamellar Vesicles Provides a Functional Docking Platform for Bid	PLOS ONE			English	Article							MITOCHONDRIAL CONTACT SITES; SIGNALING COMPLEX DISC; INDUCED CELL-DEATH; LIPID-BILAYERS; BCL-2 FAMILY; PHOSPHOLIPID-VESICLES; LAURDAN FLUORESCENCE; APOPTOSIS REGULATOR; TBID INTERACTION; NUCLEAR-BODIES	Caspase-8 is involved in death receptor-mediated apoptosis in type II cells, the proapoptotic programme of which is triggered by truncated Bid. Indeed, caspase-8 and Bid are the known intermediates of this signalling pathway. Cardiolipin has been shown to provide an anchor and an essential activating platform for caspase-8 at the mitochondrial membrane surface. Destabilisation of this platform alters receptor-mediated apoptosis in diseases such as Barth Syndrome, which is characterised by the presence of immature cardiolipin which does not allow caspase-8 binding. We used a simplified in vitro system that mimics contact sites and/or cardiolipin-enriched microdomains at the outer mitochondrial surface in which the platform consisting of caspase-8, Bid and cardiolipin was reconstituted in giant unilamellar vesicles. We analysed these vesicles by flow cytometry and confirm previous results that demonstrate the requirement for intact mature cardiolipin for caspase-8 activation and Bid binding and cleavage. We also used confocal microscopy to visualise the rupture of the vesicles and their revesiculation at smaller sizes due to alteration of the curvature following caspase-8 and Bid binding. Biophysical approaches, including Laurdan fluorescence and rupture/tension measurements, were used to determine the ability of these three components (cardiolipin, caspase-8 and Bid) to fulfil the minimal requirements for the formation and function of the platform at the mitochondrial membrane. Our results shed light on the active functional role of cardiolipin, bridging the gap between death receptors and mitochondria.	[Jalmar, Olivier; Gonzalvez, Francois; Petit, Patrice X.] Univ Paris 05, Ctr Rech St Peres, UMR S Toxicol Pharmacol & Signalisat Cellulaire 7, Paris, France; [Francois-Moutal, Liberty; Granjon, Thierry] CNRS, Inst Chim & Biochim Mol & Supramol, UMR 5246, ICBMS, Villeurbanne, France; [Garcia-Saez, Ana-Jesus; Schwille, Petra] Tech Univ Dresden, Biophys Grp, BIOTEC, Dresden, Germany; [Perry, Mark; Klosgen, Beate] Univ So Denmark, Dept Phys Chem & Pharm, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark; [Gonzalvez, Francois; Gottlieb, Eyal] Canc Res UK, Beatson Inst, Glasgow, Lanark, Scotland; [Ayala-Sanmartin, Jesus] Ecole Normale Super, CNRS, UMR 7203, Lab Biomol, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Technische Universitat Dresden; University of Southern Denmark; Beatson Institute; Cancer Research UK; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Petit, PX (corresponding author), Univ Paris 05, Ctr Rech St Peres, UMR S Toxicol Pharmacol & Signalisat Cellulaire 7, Paris, France.	patrice.petit@inserm.fr	Kloesgen, Beate M./D-2709-2015; Schwille, Petra/A-4983-2010; Petit, patrice/AAF-6774-2020; Gottlieb, Eyal/G-6450-2010; Petit, Patrice X./A-3692-2009; Saez, Ana J. Garcia/U-1611-2019	Kloesgen, Beate M./0000-0002-2334-0388; Gottlieb, Eyal/0000-0002-9770-0956; Petit, Patrice X./0000-0002-5038-9101; Francois-Moutal, Liberty/0000-0003-1277-660X	Centre National de la Recherche Scientifique (CNRS); Association de Recherche sur le Cancer (ARC) [4493]; Association Francaise contre les Myopathies [13313/2008, 14219/2010]; Danish National Research Foundation; Oticon	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association de Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Danish National Research Foundation(Danmarks Grundforskningsfond); Oticon	This work was supported by the Centre National de la Recherche Scientifique (CNRS), and by the Association de Recherche sur le Cancer (ARC no4493 to PXP) and Association Francaise contre les Myopathies (grant no13313/2008 and grant no14219/2010 to PXP). BK is grateful for the generous support of the Danish National Research Foundation via the grant to MEMPHYS. MP was benefitting from an Oticon scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Apellaniz B, 2010, FEBS LETT, V584, P1591, DOI 10.1016/j.febslet.2010.03.021; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; ARDAIL D, 1990, BIOCHEM BIOPH RES CO, V173, P878, DOI 10.1016/S0006-291X(05)80868-X; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Epand RF, 2002, J BIOL CHEM, V277, P32632, DOI 10.1074/jbc.M202396200; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Garcia-Saez AJ, 2009, NAT STRUCT MOL BIOL, V16, P1178, DOI 10.1038/nsmb.1671; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P614, DOI 10.1038/sj.cdd.4401571; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gonzalvez F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009342; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Granjon T, 2001, BIOCHEMISTRY-US, V40, P6016, DOI 10.1021/bi002293e; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Jalmar O, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.81; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Keller N, 2009, STRUCTURE, V17, P438, DOI 10.1016/j.str.2008.12.019; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Krieghoff E, 2007, CELL CYCLE, V6, P771, DOI 10.4161/cc.6.7.4046; KROEMER G, 1995, FASEB J, V9, P1277, DOI 10.1096/fasebj.9.13.7557017; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lamblet M, 2008, EUR PHYS J E, V26, P205, DOI 10.1140/epje/i2007-10317-x; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Li JH, 1998, J IMMUNOL, V161, P3943; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Lutter M, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-22; Marsh D, 2008, BBA-BIOMEMBRANES, V1778, P1545, DOI 10.1016/j.bbamem.2008.01.015; Marsh D, 2006, BIOPHYS J, V91, P227, DOI 10.1529/biophysj.105.079004; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Milovic-Holm K, 2007, EMBO J, V26, P391, DOI 10.1038/sj.emboj.7601504; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; NEEDHAM D, 1988, BIOCHEMISTRY-US, V27, P8261, DOI 10.1021/bi00421a041; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; Ratanabanangkoon P, 2003, LANGMUIR, V19, P1054, DOI 10.1021/la026251y; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schug ZT, 2011, CELL DEATH DIFFER, V18, P538, DOI 10.1038/cdd.2010.135; Shearman GC, 2007, BIOCHEM SOC T, V35, P498, DOI 10.1042/BST0350498; Stegh AH, 2002, J BIOL CHEM, V277, P4351, DOI 10.1074/jbc.M108947200; Stegh AH, 2000, MOL CELL BIOL, V20, P5665, DOI 10.1128/MCB.20.15.5665-5679.2000; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Torres VA, 2010, MOL BIOL CELL, V21, P369, DOI 10.1091/mbc.E09-09-0769; Torres VA, 2008, J BIOL CHEM, V283, P36280, DOI 10.1074/jbc.M805878200; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597; Zhang SQ, 1998, PLANT CELL, V10, P435, DOI 10.1105/tpc.10.3.435	65	22	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55250	10.1371/journal.pone.0055250	http://dx.doi.org/10.1371/journal.pone.0055250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418437	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000315970300027
J	Lai, J; Kong, CM; Mahalingam, D; Xie, XJ; Wang, XY				Lai, Jason; Kong, Chiou Mee; Mahalingam, Dashayini; Xie, Xiaojin; Wang, Xueying			Elite Model for the Generation of Induced Pluripotent Cancer Cells (iPCs)	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; LUNG-CANCER; DEFINED FACTORS; TUMOR; HETEROGENEITY; NETWORK; GENE	The inefficiency of generating induced pluripotent somatic cells (iPS) engendered two contending models, namely the Stochastic model and Elite model. Although the former is more favorable to explain the inherent inefficiencies, it may be fallible to extrapolate the same working model to reprogramming of cancer cells. Indeed, tumor cells are known to be inherently heterogeneous with respect to distinctive characteristics thus providing a suitable platform to test whether the reprogramming process of cancer cells is biased. Here, we report our observations that all randomly picked induced pluripotent cancer cells (iPCs) established previously do not possess mutations known in the parental population. This unanticipated observation is most parsimoniously explained by the Elite model, whereby putative early tumor progenies were selected during induction to pluripotency.	[Lai, Jason; Kong, Chiou Mee; Mahalingam, Dashayini; Xie, Xiaojin; Wang, Xueying] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	National University of Singapore	Wang, XY (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	bchwxy@nus.edu.sg		Lai, Jason Kuan Han/0000-0002-3476-4733	Ministry of Education Academic Research Fund Tier 1 [R-183-000-259-112, R-183-000-295-112]; Yong Loo Lin School of Medicine, NUHS, NUS, Singapore	Ministry of Education Academic Research Fund Tier 1; Yong Loo Lin School of Medicine, NUHS, NUS, Singapore	Ministry of Education Academic Research Fund Tier 1 grants, R-183-000-259-112 and R-183-000-295-112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Chiou Mee Kong is a recipient of research scholarships from Yong Loo Lin School of Medicine, NUHS, NUS, Singapore. We thank Dr. Patrick Tan for insightful comments as well as Dr. Phillip Koeffler for his kind gift of H460 cells.	Banito A, 2010, EMBO REP, V11, P353, DOI 10.1038/embor.2010.47; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carette JE, 2010, BLOOD, V115, P4039, DOI 10.1182/blood-2009-07-231845; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Duesberg P, 2011, CELL CYCLE, V10, P2100, DOI 10.4161/cc.10.13.16352; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; FITZGERALD PJ, 1986, INT J PANCREATOL, V1, P91; HIRSCH FR, 1983, VIRCHOWS ARCH A, V402, P147, DOI 10.1007/BF00695056; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Jeppesen P, 2000, IMMUNOFLUORESCENCE C; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kruger S, 2003, Int Urol Nephrol, V35, P169, DOI 10.1023/B:UROL.0000020305.70637.c6; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mahalingam D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00592; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Russnes HG, 2011, J CLIN INVEST, V121, P3810, DOI 10.1172/JCI57088; Shan ZH, 2004, ONCOGENE, V23, P6612, DOI 10.1038/sj.onc.1207857; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; vanderPoel HG, 1997, UROLOGY, V49, P652, DOI 10.1016/S0090-4295(96)00557-2; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; ZHANG X, 2012, ONCOGENE	32	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56702	10.1371/journal.pone.0056702	http://dx.doi.org/10.1371/journal.pone.0056702			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418593	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300186
J	Singh, S; Bora-Singhal, N; Kroeger, J; Laklai, H; Chellappan, SP				Singh, Sandeep; Bora-Singhal, Namrata; Kroeger, Jodi; Laklai, Hanane; Chellappan, Srikumar P.			beta Arrestin-1 and Mcl-1 Modulate Self-Renewal Growth of Cancer Stem-Like Side-Population Cells in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE; MELANOMA-CELLS; RESISTANCE; IDENTIFICATION; STATISTICS; ADENOCARCINOMA; PROLIFERATION; DETERMINANT; ACTIVATION; INHIBITORS	Side population (SP) cells have been reported to have properties of cancer stem-like cells (CSCs) in non-small cell lung carcinoma (NSCLC), yet their molecular features have not been fully elucidated. Here we show that, NSCLC-SP cells were enriched in G(0)/G-(1) phase of cell cycle, had higher aldehyde dehydrogenase activity as well as higher clonogenic and self-renewing ability compared to main population (MP) cells. Interestingly, SP cells were also able to trans-differentiate into angiogenic tubules in vitro and were highly tumorigenic as compared to MP cells. SP-derived tumors demonstrated the intratumoral heterogeneity comprising of both SP and MP cells, suggesting the self-renewal and differentiation ability of SP cells are manifested in vivo as well. beta Arrestin-1 (beta Arr1) is involved in the progression of various cancers including NSCLCs and we find that depletion of beta Arr1 significantly blocked the SP phenotype; whereas depletion of beta Arr2 had relatively minor effects. Ectopic expression of beta Arr1 resulted in increased SP frequency and ABCG2 expression while abrogation of beta Arr1 expression suppressed the self-renewal growth and expansion of A549 cells. Anti-apoptotic protein Mcl-1 is known to be one of the key regulators of self-renewal of tissue stem cells and is thought to contribute to survival of NSCLC cells. Our experiments show that higher levels of Mcl-1 were expressed in SP cells compared to MP cells at both transcriptional and translational levels. In addition, Obatoclax, a pharmacological inhibitor of Mcl-1, could effectively prevent the self-renewal of both EGFR-inhibitor sensitive and resistant NSCLC cells. In conclusion, our findings suggest that beta Arr1 and Mcl-1 are involved in the self-renewal and expansion of NSCLC-CSCs and are potential targets for anti-cancer therapy.	[Singh, Sandeep; Bora-Singhal, Namrata; Laklai, Hanane; Chellappan, Srikumar P.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Kroeger, Jodi] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Flow Cytomerty Core Facil, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Chellappan, SP (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	Srikumar.Chellappan@moffitt.org			National Cancer Institute [CA127725]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA127725] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the grant CA127725 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; Bai F, 2012, BIOORG MED CHEM LETT, V22, P1365, DOI 10.1016/j.bmcl.2011.12.067; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Campbell CJV, 2010, BLOOD, V116, P1433, DOI 10.1182/blood-2009-12-258095; Cetin Z, 2010, MED ONCOL, V27, P853, DOI 10.1007/s12032-009-9296-7; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Cianfrocca R, 2010, CAN J PHYSIOL PHARM, V88, P796, DOI 10.1139/Y10-052; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clevers H, 2005, NAT GENET, V37, P1027, DOI 10.1038/ng1005-1027; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; Dasgupta P, 2011, JNCI-J NATL CANCER I, V103, P317, DOI 10.1093/jnci/djq541; Doki Y, 1999, BRIT J CANCER, V79, P1121, DOI 10.1038/sj.bjc.6690178; Driessens G, 2012, NATURE; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Johnson JL, 2011, CANC RES; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim J. I., 2010, MOL CANCER RES, V8, P569, DOI DOI 10.1158/1541-7786.MCR-09-0511.PUBMED:20353998; Kinkade R, 2008, CANCER RES, V68, P3810, DOI 10.1158/0008-5472.CAN-07-6672; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Krajewska M, 1996, AM J PATHOL, V148, P1567; Li TT, 2009, MOL CANCER RES, V7, P1064, DOI 10.1158/1541-7786.MCR-08-0578; Liu H, 2011, INT J HEMATOL, V93, P494, DOI 10.1007/s12185-011-0824-9; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076; Moreb J, 1996, CANCER GENE THER, V3, P24; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Proctor RN, 2001, NAT REV CANCER, V1, P82, DOI 10.1038/35094091; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Robey RW, 2004, CANCER RES, V64, P1242, DOI 10.1158/0008-5472.CAN-03-3298; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rosano L, 2009, P NATL ACAD SCI USA, V106, P2806, DOI 10.1073/pnas.0807158106; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh S, 2010, MOL CANCER THER, V9, P3330, DOI 10.1158/1535-7163.MCT-10-0442; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Song LX, 2005, CANCER BIOL THER, V4, P267, DOI 10.4161/cbt.4.3.1496; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wei G, 2012, CANCER CELL, V21, P547, DOI 10.1016/j.ccr.2012.02.028; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Zhang H, 2011, ONCOGENE, V30, P1963, DOI 10.1038/onc.2010.559; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	64	33	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55982	10.1371/journal.pone.0055982	http://dx.doi.org/10.1371/journal.pone.0055982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418490	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300082
J	Sun, CL; Shi, ZZ; Zhou, XB; Chen, LN; Zhao, XM				Sun, Chenglei; Shi, Zheng-Zheng; Zhou, Xiaobo; Chen, Luonan; Zhao, Xing-Ming			Prediction of S-Glutathionylation Sites Based on Protein Sequences	PLOS ONE			English	Article							PHOSPHORYLATION SITES; MOLECULAR-MECHANISMS; ACCURATE PREDICTION; IDENTIFICATION; CYSTEINES; STRESS; INDEX; TOOL	S-glutathionylation, the reversible formation of mixed disulfides between glutathione(GSH) and cysteine residues in proteins, is a specific form of post-translational modification that plays important roles in various biological processes, including signal transduction, redox homeostasis, and metabolism inside cells. Experimentally identifying S-glutathionylation sites is labor-intensive and time consuming, whereas bioinformatics methods provide an alternative way to this problem by predicting S-glutathionylation sites in silico. The bioinformatics approaches give not only candidate sites for further experimental verification but also bio-chemical insights into the mechanism of S-glutathionylation. In this paper, we firstly collect experimentally determined S-glutathionylated proteins and their corresponding modification sites from the literature, and then propose a new method for predicting S-glutathionylation sites by employing machine learning methods based on protein sequence data. Promising results are obtained by our method with an AUC (area under ROC curve) score of 0.879 in 5-fold cross-validation, which demonstrates the predictive power of our proposed method. The datasets used in this work are available at http://csb.shu.edu.cn/SGDB.	[Sun, Chenglei] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Sun, Chenglei] Shanghai Univ, Sch Commun & Informat Engn, Shanghai, Peoples R China; [Zhao, Xing-Ming] Tongji Univ, Dept Comp Sci, Sch Elect & Informat Engn, Shanghai 200092, Peoples R China; [Chen, Luonan] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Shi, Zheng-Zheng; Zhou, Xiaobo] Cornell Univ, Dept Radiol, Methodist Hosp, Res Inst,Weill Med Coll, Houston, TX USA	Shanghai University; Shanghai University; Tongji University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Zhou, XB (corresponding author), Cornell Univ, Dept Radiol, Methodist Hosp, Res Inst,Weill Med Coll, Houston, TX USA.	XZhou@tmhs.org; lnchen@sibs.ac.cn; zhaoxingming@gmail.com			National Natural Science Foundation of China [91130032, 61103075, 91029301, 61134013]; Innovation Program of Shanghai Municipal Education Commission [13ZZ072]; JSPS/CSTP through the FIRST Program; Shanghai Pujiang Program; Chief Scientist Program of SIBS from CAS [2009CSP002]; Graduate Innovation Funding of Shanghai University [SHUCX102039]; National Institutes of Health [R01 CA155069-01, R01 LM010185-02]; NATIONAL CANCER INSTITUTE [R01CA155069] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010185] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); JSPS/CSTP through the FIRST Program; Shanghai Pujiang Program(Shanghai Pujiang Program); Chief Scientist Program of SIBS from CAS; Graduate Innovation Funding of Shanghai University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Dr. XMZ was partly supported by National Natural Science Foundation of China (91130032, 61103075) and Innovation Program of Shanghai Municipal Education Commission (13ZZ072). Dr. LC was supported by National Natural Science Foundation of China (91029301, 61134013), and JSPS/CSTP through the FIRST Program, Shanghai Pujiang Program, Chief Scientist Program of SIBS from CAS (2009CSP002). CS was supported by Graduate Innovation Funding of Shanghai University (Grant No. SHUCX102039). Drs. ZZS and XZ were partially funded by National Institutes of Health (R01 CA155069-01, and R01 LM010185-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen XW, 2009, BIOINFORMATICS, V25, P585, DOI 10.1093/bioinformatics/btp039; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Gao JJ, 2010, MOL CELL PROTEOMICS, V9, P2586, DOI 10.1074/mcp.M110.001388; Ghezzi P, 2006, PROTEOMICS, V6, P817, DOI 10.1002/pmic.200500177; Hamnell-Pamment Y, 2005, BIOCHEM BIOPH RES CO, V332, P362, DOI 10.1016/j.bbrc.2005.04.130; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-553; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Marino SM, 2012, J BIOL CHEM, V287, P4419, DOI 10.1074/jbc.R111.275578; Marino SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000383; Martelli PL, 2004, PROTEOMICS, V4, P1665, DOI 10.1002/pmic.200300745; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mucchielli-Giorgi MHM, 2002, PROTEINS, V46, P243, DOI 10.1002/prot.10047; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Shao JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004920; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Song JN, 2007, BIOINFORMATICS, V23, P3147, DOI 10.1093/bioinformatics/btm505; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Sun CL, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S12; Townsend DM, 2007, MOL INTERV, V7, P313, DOI 10.1124/mi.7.6.7; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Xia JF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-174; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zhao XM, 2005, NEURAL NETWORKS, V18, P1019, DOI 10.1016/j.neunet.2005.07.002	31	36	37	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55512	10.1371/journal.pone.0055512	http://dx.doi.org/10.1371/journal.pone.0055512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418443	gold, Green Submitted, Green Published			2022-12-27	WOS:000315970300034
J	Uroz, S; Ioannidis, P; Lengelle, J; Cebron, A; Morin, E; Buee, M; Martin, F				Uroz, Stephane; Ioannidis, Panos; Lengelle, Juliette; Cebron, Aurelie; Morin, Emmanuelle; Buee, Marc; Martin, Francis			Functional Assays and Metagenomic Analyses Reveals Differences between the Microbial Communities Inhabiting the Soil Horizons of a Norway Spruce Plantation	PLOS ONE			English	Article							PYROSEQUENCING-BASED ANALYSIS; FUNGAL COMMUNITIES; BACTERIAL COMMUNITIES; LITTER DECOMPOSITION; ENZYME-ACTIVITIES; FOREST SOILS; DIVERSITY; QUANTIFICATION; SEDIMENT; GRADIENT	In temperate ecosystems, acidic forest soils are among the most nutrient-poor terrestrial environments. In this context, the long-term differentiation of the forest soils into horizons may impact the assembly and the functions of the soil microbial communities. To gain a more comprehensive understanding of the ecology and functional potentials of these microbial communities, a suite of analyses including comparative metagenomics was applied on independent soil samples from a spruce plantation (Breuil-Chenue, France). The objectives were to assess whether the decreasing nutrient bioavailability and pH variations that naturally occurs between the organic and mineral horizons affects the soil microbial functional biodiversity. The 14 Gbp of pyrosequencing and Illumina sequences generated in this study revealed complex microbial communities dominated by bacteria. Detailed analyses showed that the organic soil horizon was significantly enriched in sequences related to Bacteria, Chordata, Arthropoda and Ascomycota. On the contrary the mineral horizon was significantly enriched in sequences related to Archaea. Our analyses also highlighted that the microbial communities inhabiting the two soil horizons differed significantly in their functional potentials according to functional assays and MG-RAST analyses, suggesting a functional specialisation of these microbial communities. Consistent with this specialisation, our shotgun metagenomic approach revealed a significant increase in the relative abundance of sequences related glycoside hydrolases in the organic horizon compared to the mineral horizon that was significantly enriched in glycoside transferases. This functional stratification according to the soil horizon was also confirmed by a significant correlation between the functional assays performed in this study and the functional metagenomic analyses. Together, our results suggest that the soil stratification and particularly the soil resource availability impact the functional diversity and to a lesser extent the taxonomic diversity of the bacterial communities.	[Uroz, Stephane; Ioannidis, Panos; Lengelle, Juliette; Morin, Emmanuelle; Buee, Marc; Martin, Francis] Univ Lorraine Interact Arbres Microorganismes, Ctr INRA Nancy, INRA, UMR INRA 1136, Champenoux, France; [Uroz, Stephane] Ctr INRA Nancy, INRA UR Biogeochim Ecosyst Forestiers 1138, Champenoux, France; [Cebron, Aurelie] Univ Lorraine, LIMOS, UMR CNRS 7137, Fac Sci, Vandoeuvre Les Nancy, France	INRAE; Universite de Lorraine; INRAE; Universite de Lorraine	Uroz, S (corresponding author), Univ Lorraine Interact Arbres Microorganismes, Ctr INRA Nancy, INRA, UMR INRA 1136, Champenoux, France.	uroz@nancy.inra.fr	morin, emmanuelle/AAA-1246-2019; Ioannidis, Panagiotis/I-4281-2014	morin, emmanuelle/0000-0002-7268-972X; Ioannidis, Panagiotis/0000-0003-0939-6745; Buee, Marc/0000-0001-8614-3886	Lorraine Region Council; INRA (Institut National de la Recherche Agronomique) Center of Nancy; French National Research Agency (ANR Metasoil) [ANR-08-GENM-025]; European project 'ECOFINDER'; Labex 'ARBRE'	Lorraine Region Council(Region Grand-Est); INRA (Institut National de la Recherche Agronomique) Center of Nancy; French National Research Agency (ANR Metasoil)(French National Research Agency (ANR)); European project 'ECOFINDER'; Labex 'ARBRE'	This work was funded by the "Lorraine Region Council", the INRA (Institut National de la Recherche Agronomique) Center of Nancy, the French National Research Agency (ANR Metasoil, Project ANR-08-GENM-025) and the European project 'ECOFINDER'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The UMR1136 INRA 'Interactions arbres microorganisms' is supported by the Labex 'ARBRE'. We thank Drs J. Ranger, P. Frey-Klett and L.C. Kelly for helpful discussions. The English language was reviewed by American Journal Experts. We would like to thank the reviewers, and especially Reviewer 1 for his assiduous implication in the improvement of our manuscript.	Albertsen M, 2012, ISME J, V6, P1094, DOI 10.1038/ismej.2011.176; Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Buee M, 2011, FUNGAL ECOL, V4, P22, DOI 10.1016/j.funeco.2010.07.003; Calvaruso C, 2007, MICROB ECOL, V54, P567, DOI 10.1007/s00248-007-9260-z; Calvaruso C, 2010, APPL ENVIRON MICROB, V76, P4780, DOI 10.1128/AEM.03040-09; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cebron A, 2008, J MICROBIOL METH, V73, P148, DOI 10.1016/j.mimet.2008.01.009; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Courty PE, 2010, SOIL BIOL BIOCHEM, V42, P679, DOI 10.1016/j.soilbio.2009.12.006; Damon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028967; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; Delmont TO, 2011, APPL ENVIRON MICROB, V77, P1315, DOI 10.1128/AEM.01526-10; Feinstein LM, 2009, APPL ENVIRON MICROB, V75, P5428, DOI 10.1128/AEM.00120-09; Felske A, 1998, APPL ENVIRON MICROB, V64, P4581; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fulthorpe RR, 2008, ISME J, V2, P901, DOI 10.1038/ismej.2008.55; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; Jaenicke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014519; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Jumpponen A, 2010, MYCOLOGIA, V102, P1027, DOI 10.3852/09-316; Kanokratana P, 2011, MICROB ECOL, V61, P518, DOI 10.1007/s00248-010-9766-7; Lepleux C, 2012, APPL ENVIRON MICROB, V78, P7114, DOI 10.1128/AEM.00996-12; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Littman R, 2011, ENV MICROBIOL REP, V3, P651, DOI 10.1111/j.1758-2229.2010.00234.x; Lueders T, 2004, APPL ENVIRON MICROB, V70, P5778, DOI 10.1128/AEM.70.10.5778-5786.2004; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Mareschal L, 2010, EUR J SOIL SCI, V61, P14, DOI 10.1111/j.1365-2389.2009.01206.x; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pennanen T, 1999, MICROB ECOL, V38, P168, DOI 10.1007/s002489900161; Pfister CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010518; Pritsch K, 2004, J MICROBIOL METH, V58, P233, DOI 10.1016/j.mimet.2004.04.001; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sandnes A, 2005, SOIL BIOL BIOCHEM, V37, P259, DOI 10.1016/j.soilbio.2004.07.036; Schmid I, 2002, FOREST ECOL MANAG, V159, P37, DOI 10.1016/S0378-1127(01)00708-3; Simon C, 2009, APPL ENVIRON MICROB, V75, P7519, DOI 10.1128/AEM.00946-09; Snajdr J, 2008, SOIL BIOL BIOCHEM, V40, P2068, DOI 10.1016/j.soilbio.2008.01.015; Suen G, 2011, PLOS GENETIC, V6; Thion C, 2012, INT BIODETER BIODEGR, V68, P28, DOI 10.1016/j.ibiod.2011.10.012; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Uroz S, 2012, APPL ENVIRON MICROB, V78, P3020, DOI 10.1128/AEM.06742-11; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; Uroz S, 2009, TRENDS MICROBIOL, V17, P378, DOI 10.1016/j.tim.2009.05.004; Wallander H, 2010, NEW PHYTOL, V187, P1124, DOI 10.1111/j.1469-8137.2010.03324.x; Wardle DA, 2006, ECOL LETT, V9, P870, DOI 10.1111/j.1461-0248.2006.00931.x; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Xie W, 2011, ISME J, V5, P414, DOI 10.1038/ismej.2010.144	59	114	116	4	234	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55929	10.1371/journal.pone.0055929	http://dx.doi.org/10.1371/journal.pone.0055929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418476	Green Published, gold			2022-12-27	WOS:000315970300067
J	Spencer, KL; Malinowski, J; Carty, CL; Franceschini, N; Fernandez-Rhodes, L; Young, A; Cheng, I; Ritchie, MD; Haiman, CA; Wilkens, L; ChunyuanWu; Matise, TC; Carlson, CS; Brennan, K; Park, A; Rajkovic, A; Hindorff, LA; Buyske, S; Crawford, DC				Spencer, Kylee L.; Malinowski, Jennifer; Carty, Cara L.; Franceschini, Nora; Fernandez-Rhodes, Lindsay; Young, Alicia; Cheng, Iona; Ritchie, Marylyn D.; Haiman, Christopher A.; Wilkens, Lynne; ChunyuanWu; Matise, Tara C.; Carlson, Christopher S.; Brennan, Kathleen; Park, Amy; Rajkovic, Aleksandar; Hindorff, Lucia A.; Buyske, Steven; Crawford, Dana C.			Genetic Variation and Reproductive Timing: African American Women from the Population Architecture Using Genomics and Epidemiology (PAGE) Study	PLOS ONE			English	Article							BODY-MASS INDEX; NATURAL MENOPAUSE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; WIDE ASSOCIATION; BREAST-CANCER; FUNCTIONAL-ANALYSIS; INFLUENCE AGE; RSF-1 HBXAP; MENARCHE	Age at menarche (AM) and age at natural menopause (ANM) define the boundaries of the reproductive lifespan in women. Their timing is associated with various diseases, including cancer and cardiovascular disease. Genome-wide association studies have identified several genetic variants associated with either AM or ANM in populations of largely European or Asian descent women. The extent to which these associations generalize to diverse populations remains unknown. Therefore, we sought to replicate previously reported AM and ANM findings and to identify novel AM and ANM variants using the Metabochip (n = 161,098 SNPs) in 4,159 and 1,860 African American women, respectively, in the Women's Health Initiative (WHI) and Atherosclerosis Risk in Communities (ARIC) studies, as part of the Population Architecture using Genomics and Epidemiology (PAGE) Study. We replicated or generalized one previously identified variant for AM, rs1361108/CENPW, and two variants for ANM, rs897798/BRSK1 and rs769450/APOE, to our African American cohort. Overall, generalization of the majority of previously-identified variants for AM and ANM, including LIN28B and MCM8, was not observed in this African American sample. We identified three novel loci associated with ANM that reached significance after multiple testing correction (LDLR rs189596789, p = 5 x 10(-08); KCNQ1 rs79972789, p = 1.9 x 10(-07); COL4A3BP rs181686584, p = 2.9 x 10(-07)). Our most significant AM association was upstream of RSF1, a gene implicated in ovarian and breast cancers (rs11604207, p = 1.6 x 10(-06)). While most associations were identified in either AM or ANM, we did identify genes suggestively associated with both: PHACTR1 and ARHGAP42. The lack of generalization coupled with the potentially novel associations identified here emphasize the need for additional genetic discovery efforts for AM and ANM in diverse populations.	[Malinowski, Jennifer; Ritchie, Marylyn D.; Crawford, Dana C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37232 USA; [Matise, Tara C.; Buyske, Steven] Rutgers State Univ, Dept Genet, Piscataway, NJ USA; [Buyske, Steven] Rutgers State Univ, Dept Stat, Piscataway, NJ USA; [Franceschini, Nora; Fernandez-Rhodes, Lindsay] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Carty, Cara L.; Young, Alicia; ChunyuanWu; Carlson, Christopher S.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Cheng, Iona; Wilkens, Lynne] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Brennan, Kathleen] Univ Calif Los Angeles, Dept Obstet & Gynecol, Los Angeles, CA 90024 USA; [Park, Amy] Georgetown Univ, Sch Med, Dept Obstet & Gynecol, Washington, DC 20007 USA; [Rajkovic, Aleksandar] Univ Pittsburgh, Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Hindorff, Lucia A.] NHGRI, Off Populat Genom, NIH, Bethesda, MD 20892 USA; [Spencer, Kylee L.] Heidelberg Univ, Dept Biol & Environm Sci, Tiffin, OH USA; [Ritchie, Marylyn D.] Penn State Univ, University Pk, MD USA	Vanderbilt University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of North Carolina; University of North Carolina Chapel Hill; Fred Hutchinson Cancer Center; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; University of California System; University of California Los Angeles; Georgetown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Heidelberg University USA	Crawford, DC (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37232 USA.	dana.c.crawford@vanderbilt.edu	Crawford, Dana/O-5578-2019	Crawford, Dana/0000-0002-6437-6248; Malinowski, Jennifer/0000-0001-7500-2199; Buyske, Steven/0000-0001-8539-5416; Fernandez-Rhodes, Lindsay/0000-0001-6985-423X	National Human Genome Research Institute (NHGRI); Causal Variants Across the Life Course, known as CALiCo [U01HG004803]; Epidemiologic Architecture for Genes Linked to Environment, known as EAGLE [U01HG004798]; Multiethnic Cohort, known as MEC [U01HG004802]; Women's Health Initiative, known as WHI [U01HG004790]; Coordinating Center [U01HG004801]; NHLBI [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; National Cancer Institute [R37CA54281, R01 CA63, P01CA33619, U01CA136792, U01CA98758]; National Heart, Lung, and Blood Institute (NHLBI) (NIH); U.S. Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; National Institutes of Mental Health; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055020, N01HC055022, N01HC055021, N01HC055015, N01HC055018, N01HC055016, N01HC055019] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA136792, P01CA033619, R37CA054281, U01CA098758] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004790, U01HG004803, U01HG004798, U01HG004802, U01HG004801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032122, N01WH032111, N01WH032108, N01WH032105, N01WH032118, N01WH022110, N01WH032100, N01WH042129, N01WH042107, N01WH032115] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Causal Variants Across the Life Course, known as CALiCo; Epidemiologic Architecture for Genes Linked to Environment, known as EAGLE; Multiethnic Cohort, known as MEC; Women's Health Initiative, known as WHI; Coordinating Center; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute (NHLBI) (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Department of Health and Human Services; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Population Architecture Using Genomics and Epidemiology (PAGE) program is funded by the National Human Genome Research Institute (NHGRI), supported by U01HG004803 (Causal Variants Across the Life Course, known as CALiCo), U01HG004798 (Epidemiologic Architecture for Genes Linked to Environment, known as EAGLE), U01HG004802 (the Multiethnic Cohort, known as MEC), U01HG004790 (Women's Health Initiative, known as WHI), and U01HG004801 (Coordinating Center). The Atherosclerosis Risk in Communities (ARIC) Study is carried out as a collaborative study supported by NHLBI contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022. The Multiethnic Cohort (MEC) study is funded through the National Cancer Institute (R37CA54281, R01 CA63, P01CA33619, U01CA136792, and U01CA98758). The Women's Health Initiative (WHI) program is funded by the National Heart, Lung, and Blood Institute (NHLBI) (NIH) and by U.S. Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. The National Institutes of Mental Health also contributes to the support for the Coordinating Center. NHGRI collaborators (LAH) assisted in the study design, analysis, and preparation of the manuscript.	Adair LS, 2001, AM J PUBLIC HEALTH, V91, P642, DOI 10.2105/AJPH.91.4.642; Adams Hillard Paula J, 2008, Medscape J Med, V10, P295; Anderson CA, 2008, J CLIN ENDOCR METAB, V93, P3965, DOI 10.1210/jc.2007-2568; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson SE, 2005, J PEDIATR-US, V147, P753, DOI 10.1016/j.jpeds.2005.07.016; Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Buber J, 2011, CIRCULATION, V123, P2784, DOI 10.1161/CIRCULATIONAHA.110.000620; Buyske S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035651; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Carter R, 2011, J YOUTH ADOLESCENCE, V40, P1394, DOI 10.1007/s10964-010-9611-9; Casazza K, 2008, J CLIN ENDOCR METAB, V93, P2610, DOI 10.1210/jc.2007-2776; Cerne JZ, 2011, EUR J CONTRACEP REPR, V16, P241, DOI 10.3109/13625187.2011.575481; Chen CTL, 2012, HUM MOL GENET, V21, P1419, DOI 10.1093/hmg/ddr570; Choi JH, 2009, CANCER RES, V69, P1407, DOI 10.1158/0008-5472.CAN-08-3602; Cui B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022353; De Castro-Oros I, 2011, HUM MUTAT, V32, P868, DOI 10.1002/humu.21520; Deardorff J, 2011, J ADOLESCENT HEALTH, V48, P441, DOI 10.1016/j.jadohealth.2010.07.032; Diakou M, 2011, EUR J INTERN MED, V22, pE55, DOI 10.1016/j.ejim.2011.01.003; Dishi M, 2011, DIABETES RES CLIN PR, V93, P437, DOI 10.1016/j.diabres.2011.07.001; Dossus L, 2010, INT J CANCER, V127, P442, DOI 10.1002/ijc.25050; Dvornyk V, 2012, HUM REPROD UPDATE, V18, P198, DOI 10.1093/humupd/dmr050; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Elias SG, 2005, HUM REPROD, V20, P2483, DOI 10.1093/humrep/dei090; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gold EB, 2011, OBSTET GYN CLIN N AM, V38, P425, DOI 10.1016/j.ogc.2011.05.002; Guo Y, 2006, HUM MOL GENET, V15, P2401, DOI 10.1093/hmg/ddl155; Hartge P, 2009, NAT GENET, V41, P637, DOI 10.1038/ng0609-637; He CY, 2010, HUM GENET, V128, P515, DOI 10.1007/s00439-010-0878-4; He CY, 2010, AM J EPIDEMIOL, V171, P334, DOI 10.1093/aje/kwp372; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; He LN, 2007, J GENET, V86, P269, DOI 10.1007/s12041-007-0034-7; He LN, 2009, MATURITAS, V62, P37, DOI 10.1016/j.maturitas.2008.10.011; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; HSIEH CC, 1990, INT J CANCER, V46, P796, DOI 10.1002/ijc.2910460508; Jasen P, 2011, CAN BULL MED HIST, V28, P43, DOI 10.3138/cbmh.28.1.43; Jenkins BWC, 2011, INT J ENV RES PUB HE, V8, P2491, DOI 10.3390/ijerph8062491; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jurvansuu JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025317; Kallen AN, 2011, CURR OPIN OBSTET GYN, V23, P258, DOI 10.1097/GCO.0b013e3283488a21; Kaplowitz P, 2006, CURR OPIN OBSTET GYN, V18, P487, DOI 10.1097/01.gco.0000242949.02373.09; Kinney A, 2007, HUM REPROD, V22, P1175, DOI 10.1093/humrep/del496; Kok HS, 2005, HUM REPROD UPDATE, V11, P483, DOI 10.1093/humupd/dmi024; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Lisabeth LD, 2009, STROKE, V40, P1044, DOI 10.1161/STROKEAHA.108.542993; Liu P, 2010, MENOPAUSE, V17, P185, DOI 10.1097/gme.0b013e3181aa2597; Long JR, 2006, MATURITAS, V55, P238, DOI 10.1016/j.maturitas.2006.03.005; Lu Y, 2010, MENOPAUSE, V17, P1048, DOI 10.1097/gme.0b013e3181d5d523; Lunetta KL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S13; Maeda D, 2011, INT J GYNECOL PATHOL, V30, P30, DOI 10.1097/PGP.0b013e3181e9a319; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; Meng FT, 2012, AGE, V34, P1023, DOI 10.1007/s11357-011-9287-4; Milne FH, 2011, MED HYPOTHESES, V77, P626, DOI 10.1016/j.mehy.2011.07.001; Mitchell ES, 2008, MENOPAUSE, V15, P105, DOI 10.1097/gme.0b013e31804d2406; Mondul AM, 2005, AM J EPIDEMIOL, V162, P1089, DOI 10.1093/aje/kwi324; Morris DH, 2011, PAEDIATR PERINAT EP, V25, P306, DOI 10.1111/j.1365-3016.2010.01183.x; Murray A, 2011, HUM MOL GENET, V20, P186, DOI 10.1093/hmg/ddq417; Must A, 2002, AM J EPIDEMIOL, V155, P672, DOI 10.1093/aje/155.7.672; Narod SA, 2011, CURR ONCOL, V18, P204; Narod SA, 2011, JAMA-J AM MED ASSOC, V306, P1920, DOI 10.1001/jama.2011.1589; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Opdahl S, 2011, BRIT J CANCER, V105, P731, DOI 10.1038/bjc.2011.286; Pan L, 2007, GENET EPIDEMIOL, V31, P338, DOI 10.1002/gepi.20214; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJeal, 2010, LOCUSZOOM REGIONAL V, P26; R Development Core Team, 2012, R LANG ENV STAT COMP; Rees SD, 2011, DIABETOLOGIA, V54, P1368, DOI 10.1007/s00125-011-2063-2; Remsberg KE, 2005, J CLIN ENDOCR METAB, V90, P2718, DOI 10.1210/jc.2004-1991; Reynolds RF, 2001, ANN HUM BIOL, V28, P21; Reynolds RF, 2003, ANN HUM BIOL, V30, P97, DOI 10.1080/03014460210165908; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Saif-Ali R, 2011, ANN ACAD MED SINGAP, V40, P488; Saif-Ali R, 2011, INT J MOL SCI, V12, P5705, DOI 10.3390/ijms12095705; Salpeter SR, 2006, J GEN INTERN MED, V21, P363, DOI 10.1111/j.1525-1497.2006.00389.x; Salsberry PJ, 2009, NURS RES, V58, P382, DOI 10.1097/NNR.0b013e3181b4b921; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Snieder H, 1998, J CLIN ENDOCR METAB, V83, P1875, DOI 10.1210/jc.83.6.1875; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Stolk L, 2009, NAT GENET, V41, P645, DOI 10.1038/ng.387; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Towne B, 2005, AM J PHYS ANTHROPOL, V128, P210, DOI 10.1002/ajpa.20106; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; van Asselt KM, 2004, FERTIL STERIL, V82, P1348, DOI 10.1016/j.fertnstert.2004.04.047; vanNoord PAH, 1997, FERTIL STERIL, V68, P95, DOI 10.1016/S0015-0282(97)81482-3; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Voorhuis M, 2011, J CLIN ENDOCR METAB, V96, pE473, DOI 10.1210/jc.2010-1799; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zhao J, 2007, HUM REPROD, V22, P1789, DOI 10.1093/humrep/dem052	95	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55258	10.1371/journal.pone.0055258	http://dx.doi.org/10.1371/journal.pone.0055258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424626	gold, Green Published, Green Accepted			2022-12-27	WOS:000315965100014
J	Yang, BH; Li, HP; Wang, D; He, XJ; Zhang, C; Yang, PL				Yang, Baohui; Li, Haopeng; Wang, Dong; He, Xijing; Zhang, Chun; Yang, Pinglin			Systematic Review and Meta-Analysis of Perioperative Intravenous Tranexamic Acid Use in Spinal Surgery	PLOS ONE			English	Article							BLOOD-LOSS; ANTIFIBRINOLYTIC AGENTS; EFFICACY; TRANSFUSION	Background: Tranexamic acid (TXA) is well-established as a versatile oral, intramuscular, and intravenous (IV) antifibrinolytic agent. However, the efficacy of IV TXA in reducing perioperative blood transfusion in spinal surgery is poorly documented. Methodology: We conducted a meta-analysis of randomized controlled trials (RCTs) and quasi-randomized (qi-RCTs) trials that included patients for various spinal surgeries, such as adolescent scoliosis surgery administered with perioperative IV TXA according to Cochrane Collaboration guidelines using electronic PubMed, Cochrane Central Register of Controlled Trials, and Embase databases. Additional journal articles and conference proceedings were manually located by two independent researchers. Results: Totally, nine studies were included, with a total sample size of 581 patients. Mean blood loss was decreased in patients treated with perioperative IV TXA by 128.28 ml intraoperatively (ranging from 33.84 to 222.73 ml), 98.49 ml postoperatively (ranging from 83.22 to 113.77 ml), and 389.21 ml combined (ranging from 177.83 to 600.60 ml). The mean volume of transfused packed cells were reduced by 134.55 ml (ranging 51.64 to 217.46) (95% CI; P = 0.0001). Overall, the number of patients treated with TXA who required blood transfusions was lower by 35% than that of patients treated with the comparator and who required blood transfusions (RR 0.65; 95% CI; 0.53 to 0.85; P<0.0001, I-2 = 0%). A dose-independent beneficial effect of TXA was observed, and confirmed in subgroup and sensitivity analyses. A total of seven studies reported DVT data. The study containing only a single DVT case was not combined. Conclusions: The blood loss was reduced in spinal surgery patients with perioperative IV TXA treatment. Also the percentage of spinal surgery patients who required blood transfusion was significantly decreased. Further evaluation is required to confirm our findings before TXA can be safely used in patients undergoing spine surgery.	[Yang, Baohui; Li, Haopeng; Wang, Dong; He, Xijing; Zhang, Chun; Yang, Pinglin] Xi An Jiao Tong Univ, Dept Orthopaed Surg, Affiliated Hosp 2, Coll Med, Xian 710049, Shaanxi Provinc, Peoples R China	Xi'an Jiaotong University	Li, HP (corresponding author), Xi An Jiao Tong Univ, Dept Orthopaed Surg, Affiliated Hosp 2, Coll Med, Xian 710049, Shaanxi Provinc, Peoples R China.	LHP-3993@163.com	Li, Hao/GPS-9834-2022; He, Xijing/AAE-7424-2021	He, Xijing/0000-0002-0465-5376				Abou-Diwan C, 2011, J CHROMATOGR B, V879, P553, DOI 10.1016/j.jchromb.2011.01.005; Alshryda S, 2011, J BONE JOINT SURG BR, V93B, P1577, DOI 10.1302/0301-620X.93B12.26989; Bednar DA, 2006, SPINE, V31, P954, DOI 10.1097/01.brs.0000209304.76581.c5; Brown JR, 2007, CIRCULATION, V115, P2801, DOI 10.1161/CIRCULATIONAHA.106.671222; Cardone D, 2009, EUR J ANAESTH, V26, P722, DOI 10.1097/EJA.0b013e32832c5280; Crescenti A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5701; Elgafy H, 2010, SPINE, V35, pS47, DOI 10.1097/BRS.0b013e3181d833f6; Elwatidy S, 2008, SPINE, V33, P2577, DOI 10.1097/BRS.0b013e318188b9c5; Endres S, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-29; Farrokhi MR, 2011, J NEUROSURG ANESTH, V23, P290, DOI 10.1097/ANA.0b013e31822914a1; Gill JB, 2008, J BONE JOINT SURG AM, V90A, P2399, DOI 10.2106/JBJS.G.01179; Gillette BP, 2012, CLIN ORTHOP RELAT RE; Grant JA, 2009, J PEDIATR ORTHOPED, V29, P300, DOI 10.1097/BPO.0b013e31819a85de; GULBA DC, 1994, ANN HEMATOL, V69, pS41, DOI 10.1007/BF02215958; Hardy JF, 1997, CAN J ANAESTH, V44, P913, DOI 10.1007/BF03011960; Henry DA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub4; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Huang C, 2011, CHIN J POSTGRAD MED, V34, P17; Kebaish KM, 2004, NEUROSURG FOCUS, V16, P21; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Khurana A, 2012, EUR SPINE J, V21, P1121, DOI 10.1007/s00586-012-2205-3; Kim MO, 2000, KOREAN J ANESTHESIOL, V39, P645; Kumar Ajay, 2009, Cleve Clin J Med, V76 Suppl 4, pS112, DOI 10.3949/ccjm.76.s4.18; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Neilipovitz DT, 2001, ANESTH ANALG, V93, P82; Newton PO, 2012, SPINE PHILA PA 1976; Nuttall GA, 2000, SPINE, V25, P596, DOI 10.1097/00007632-200003010-00010; Ross J, 2012, CURR DRUG SAF, V7, P44, DOI 10.2174/157488612800492744; Sethna NF, 2005, ANESTHESIOLOGY, V102, P727, DOI 10.1097/00000542-200504000-00006; Sokolowski MJ, 2008, SPINE, V33, P108, DOI 10.1097/BRS.0b013e31815e39af; Taghaddomi RJ, 2009, IRAN RED CRESCENT ME, V11, P265; Tsutsumimoto T, 2011, SPINE, V36, P1913, DOI 10.1097/BRS.0b013e3181fb3a42; Wong J, 2008, ANESTH ANALG, V107, P1479, DOI 10.1213/ane.0b013e3181831e44; Zufferey P, 2006, ANESTHESIOLOGY, V105, P1034, DOI 10.1097/00000542-200611000-00026	34	82	87	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55436	10.1371/journal.pone.0055436	http://dx.doi.org/10.1371/journal.pone.0055436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424632	Green Submitted, gold, Green Published			2022-12-27	WOS:000315965100020
J	Das, PJ; McCarthy, F; Vishnoi, M; Paria, N; Gresham, C; Li, G; Kachroo, P; Sudderth, AK; Teague, S; Love, CC; Varner, DD; Chowdhary, BP; Raudsepp, T				Das, Pranab J.; McCarthy, Fiona; Vishnoi, Monika; Paria, Nandina; Gresham, Cathy; Li, Gang; Kachroo, Priyanka; Sudderth, A. Kendrick; Teague, Sheila; Love, Charles C.; Varner, Dickson D.; Chowdhary, Bhanu P.; Raudsepp, Terje			Stallion Sperm Transcriptome Comprises Functionally Coherent Coding and Regulatory RNAs as Revealed by Microarray Analysis and RNA-seq	PLOS ONE			English	Article							MITOCHONDRIAL-TYPE RIBOSOMES; POLYMERASE-CHAIN-REACTION; HUMAN SPERMATOZOAL RNAS; SWINE SUS-SCROFA; MESSENGER-RNA; EJACULATED SPERMATOZOA; EPIGENETIC INHERITANCE; REVERSE-TRANSCRIPTASE; BOVINE SPERMATOZOA; EMBRYO DEVELOPMENT	Mature mammalian sperm contain a complex population of RNAs some of which might regulate spermatogenesis while others probably play a role in fertilization and early development. Due to this limited knowledge, the biological functions of sperm RNAs remain enigmatic. Here we report the first characterization of the global transcriptome of the sperm of fertile stallions. The findings improved understanding of the biological significance of sperm RNAs which in turn will allow the discovery of sperm-based biomarkers for stallion fertility. The stallion sperm transcriptome was interrogated by analyzing sperm and testes RNA on a 21,000-element equine whole-genome oligoarray and by RNA-seq. Microarray analysis revealed 6,761 transcripts in the sperm, of which 165 were sperm-enriched, and 155 were differentially expressed between the sperm and testes. Next, 70 million raw reads were generated by RNA-seq of which 50% could be aligned with the horse reference genome. A total of 19,257 sequence tags were mapped to all horse chromosomes and the mitochondrial genome. The highest density of mapped transcripts was in gene-rich ECA11, 12 and 13, and the lowest in gene-poor ECA9 and X; 7 gene transcripts originated from ECAY. Structural annotation aligned sperm transcripts with 4,504 known horse and/or human genes, rRNAs and 82 miRNAs, whereas 13,354 sequence tags remained anonymous. The data were aligned with selected equine gene models to identify additional exons and splice variants. Gene Ontology annotations showed that sperm transcripts were associated with molecular processes (chemoattractant-activated signal transduction, ion transport) and cellular components (membranes and vesicles) related to known sperm functions at fertilization, while some messenger and micro RNAs might be critical for early development. The findings suggest that the rich repertoire of coding and non-coding RNAs in stallion sperm is not a random remnant from spermatogenesis in testes but a selectively retained and functionally coherent collection of RNAs.	[Das, Pranab J.; Vishnoi, Monika; Paria, Nandina; Li, Gang; Kachroo, Priyanka; Chowdhary, Bhanu P.; Raudsepp, Terje] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77840 USA; [McCarthy, Fiona] Mississippi State Univ, Dept Basic Sci, Mississippi State, MS 39762 USA; [Gresham, Cathy] Mississippi State Univ, Dept Comp Sci & Engn, Mississippi State, MS 39762 USA; [Sudderth, A. Kendrick; Teague, Sheila; Love, Charles C.; Varner, Dickson D.] Texas A&M Univ, Dept Large Anim Clin Sci, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Mississippi State University; Mississippi State University; Texas A&M University System; Texas A&M University College Station	Raudsepp, T (corresponding author), Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77840 USA.	traudsepp@cvm.tamu.edu	Das, Pranab Jyoti/GNW-4748-2022; Vishnoi, Monika/AAP-4871-2021; li, gang/E-5640-2014	Das, Pranab Jyoti/0000-0003-3871-1628; Vishnoi, Monika/0000-0002-3934-7285; li, gang/0000-0001-7400-5486	American Quarter Horse Association; USDA [2006-04801]; CVMBS LINK Endowment for Equine Genomics	American Quarter Horse Association; USDA(United States Department of Agriculture (USDA)); CVMBS LINK Endowment for Equine Genomics	This study was supported by grants from American Quarter Horse Association, USDA grant 2006-04801 and CVMBS LINK Endowment for Equine Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki VW, 2006, FERTIL STERIL, V86, P1408, DOI 10.1016/j.fertnstert.2006.04.024; Arangasamy A, 2011, THERIOGENOLOGY, V76, P570, DOI 10.1016/j.theriogenology.2011.03.009; Avendano C, 2009, HUM REPROD, V24, P270, DOI 10.1093/humrep/den381; Bader M, 2010, DEVELOPMENT, V137, P1679, DOI 10.1242/dev.050088; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bench GS, 1996, CYTOMETRY, V23, P263, DOI 10.1002/(SICI)1097-0320(19960401)23:4<263::AID-CYTO1>3.3.CO;2-9; BETLACH CJ, 1973, NATURE, V242, P114, DOI 10.1038/242114a0; Bissonnette N, 2009, REPRODUCTION, V138, P65, DOI 10.1530/REP-08-0503; Blanchard TL, 1997, VET MED-US, V92, P815; Boerke A, 2007, THERIOGENOLOGY, V68, pS147, DOI 10.1016/j.theriogenology.2007.05.058; Boyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029764; Bright LA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S8; Cao XR, 2010, DISCRETE EVENT DYN S, V20, P1, DOI 10.1007/s10626-010-0088-1; Carreau S, 2007, BIOCHEM SOC T, V35, P634, DOI 10.1042/BST0350634; Cavalcanti MCO, 2011, MOL HUM REPROD, V17, P415, DOI 10.1093/molehr/gar011; CHIANG MH, 1994, FERTIL STERIL, V61, P276; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; CHOUDHARY SK, 1995, J BIOL CHEM, V270, P8755, DOI 10.1074/jbc.270.15.8755; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Coleman SJ, 2010, ANIM GENET, V41, P121, DOI 10.1111/j.1365-2052.2010.02118.x; Colenbrander B, 2003, REPROD DOMEST ANIM, V38, P305, DOI 10.1046/j.1439-0531.2003.00451.x; Curry E, 2009, MOL REPROD DEV, V76, DOI 10.1002/mrd.20980; Cuzin F, 2010, ESSAYS BIOCHEM, V48, P101, DOI [10.1042/BSE0480101, 10.1042/bse0480101]; Dadoune JP, 2009, MICROSC RES TECHNIQ, V72, P536, DOI 10.1002/jemt.20697; Das PJ, 2010, ANIMAL REPROD SCI, V121S, pS175; Das PJ, 2010, THERIOGENOLOGY, V74, P1099, DOI 10.1016/j.theriogenology.2010.04.023; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Dun MD, 2012, HUM REPROD UPDATE; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Etkovitz N, 2009, DEV BIOL, V334, P447, DOI 10.1016/j.ydbio.2009.08.002; Feugang JM, 2010, REPROD BIOMED ONLINE, V21, P312, DOI 10.1016/j.rbmo.2010.06.022; Feugang JM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-176; Florman HM, 2008, INT J DEV BIOL, V52, P503, DOI 10.1387/ijdb.082696hf; Florman HM, 2007, P NATL ACAD SCI USA, V104, P11123, DOI 10.1073/pnas.0703626104; Fujita K, 2003, GENES CELLS, V8, P559, DOI 10.1046/j.1365-2443.2003.00656.x; Galeraud-Denis I, 2007, ASIAN J ANDROL, V9, P587, DOI 10.1111/j.1745-7262.2007.00310.x; Garcia-Herrero S, 2011, REPROD BIOMED ONLINE, V22, P25, DOI 10.1016/j.rbmo.2010.09.013; Garrido N, 2009, FERTIL STERIL, V91, P1307, DOI 10.1016/j.fertnstert.2008.01.078; Gilbert I, 2007, REPRODUCTION, V133, P1073, DOI 10.1530/REP-06-0292; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Grunewald S, 2005, ANDROLOGIA, V37, P69, DOI 10.1111/j.1439-0272.2005.00656.x; Gur Y, 2006, GENE DEV, V20, P411, DOI 10.1101/gad.367606; Gur Yael, 2007, Soc Reprod Fertil Suppl, V65, P391; Gur Y, 2008, MOL CELL ENDOCRINOL, V282, P45, DOI 10.1016/j.mce.2007.11.015; Hamatani T, 2012, FERTIL STERIL, V97, P275, DOI 10.1016/j.fertnstert.2011.12.035; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; He ZP, 2009, REPRODUCTION, V137, P901, DOI 10.1530/REP-08-0494; Huber C, 2008, J BIOL CHEM, V283, P34002, DOI 10.1074/jbc.M803957200; Imai T, 2008, CURR OPIN NEUROBIOL, V18, P251, DOI 10.1016/j.conb.2008.07.009; Johnson AR, 2010, FASEB J, V24, P2752, DOI 10.1096/fj.09-153718; Johnson GD, 2011, MOL HUM REPROD, V17, P721, DOI 10.1093/molehr/gar054; Kameshwari DB, 2010, ASIAN J ANDROL, V12, P344, DOI 10.1038/aja.2010.19; Kawano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044542; Kempisty B, 2008, REPROD FERT DEVELOP, V20, P513, DOI 10.1071/RD07211; Krawetz SA, 2005, NAT REV GENET, V6, P633, DOI 10.1038/nrg1654; Krawetz SA, 2011, HUM REPROD, V26, P3401, DOI 10.1093/humrep/der329; Kumar A, 2003, J BIOL CHEM, V278, P11480, DOI 10.1074/jbc.M300080200; Lalancette C, 2008, BIOL REPROD, V78, P618, DOI 10.1095/biolreprod.106.059030; Lee TL, 2012, METHODS MOL BIOL, V825, P105, DOI 10.1007/978-1-61779-436-0_9; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Martins R P, 2007, Soc Reprod Fertil Suppl, V64, P1; McIver SC, 2012, HUM REPROD UPDATE, V18, P44, DOI 10.1093/humupd/dmr041; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Meunier J, 2012, GENOME RES; Miller D, 2006, Gynecol Obstet Fertil, V34, P840, DOI 10.1016/j.gyobfe.2006.07.013; Miranda-Vizuete A, 2001, J BIOL CHEM, V276, P31567, DOI 10.1074/jbc.M101760200; MOORE GD, 1993, DEV BIOL, V159, P669, DOI 10.1006/dbio.1993.1273; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Neuhaus EM, 2006, J CELL SCI, V119, P3047, DOI 10.1242/jcs.03046; Nguyen MT, 2008, FERTIL STERIL; Ostermeier CG, 2005, FERTIL STERIL, V83, P1687, DOI 10.1016/j.fertnstert.2004.12.046; Ostermeier GC, 2005, J ANDROL, V26, P70; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Ostermeier GC, 2002, LANCET, V360, P772, DOI 10.1016/S0140-6736(02)09899-9; Ostermeier GC, 2002, BIOINFORMATICS, V18, P949, DOI 10.1093/bioinformatics/18.7.949; Paillisson A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-76; Paria N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021374; PAUL IJ, 1975, MOL CELL BIOCHEM, V9, P9, DOI 10.1007/BF01731728; Peddinti D, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-19; Peng HY, 2012, CELL RES, V22, P1609, DOI 10.1038/cr.2012.141; PESSOT CA, 1989, BIOCHEM BIOPH RES CO, V158, P272, DOI 10.1016/S0006-291X(89)80208-6; Pittoggi C, 2006, MOL REPROD DEV, V73, P1239, DOI 10.1002/mrd.20550; Platts AE, 2007, HUM MOL GENET, V16, P763, DOI 10.1093/hmg/ddm012; Puri D, 2010, EPIGENETICS-US, V5, P386, DOI 10.4161/epi.5.5.12005; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Rozen S, 2000, Methods Mol Biol, V132, P365; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Saengsoi W, 2011, ANIM REPROD SCI, V127, P114, DOI 10.1016/j.anireprosci.2011.07.004; Samplaski MK, 2010, INT J UROL, V17, P839, DOI 10.1111/j.1442-2042.2010.02619.x; Saxena DK, 2002, REPRODUCTION, V123, P435, DOI 10.1530/rep.0.1230435; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spadafora C, 2008, HUM REPROD, V23, P735, DOI 10.1093/humrep/dem425; Spehr M, 2006, MOL CELL ENDOCRINOL, V250, P128, DOI 10.1016/j.mce.2005.12.035; Srivastava J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-303; Sudderth AK, 2010, ANIMAL REPROD SCI S, V121S, pS149; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; Varner DD, 2008, THERIOGENOLOGY, V70, P448, DOI 10.1016/j.theriogenology.2008.04.023; Varner DD, 2000, ANIM REPROD SCI, V60, P493, DOI 10.1016/S0378-4320(00)00115-9; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Woods J, 2000, THERIOGENOLOGY, V53, P1827, DOI 10.1016/S0093-691X(00)00318-6; XU XF, 1994, GENE, V148, P357, DOI 10.1016/0378-1119(94)90713-7; Yamazaki K, 2006, BIOL REPROD, V75, P462, DOI 10.1095/biolreprod.105.048058; Yang CC, 2010, ANIM REPROD SCI, V119, P76, DOI 10.1016/j.anireprosci.2009.12.002; Yang CC, 2009, ANIM REPROD SCI, V113, P143, DOI 10.1016/j.anireprosci.2008.08.012; Yao CJ, 2010, ASIAN J ANDROL, V12, P567, DOI 10.1038/aja.2010.28; Yao CJ, 2010, MOL REPROD DEV, V77, P158, DOI 10.1002/mrd.21116; Zhao C, 2009, PROTEOMICS, V9, P1385, DOI 10.1002/pmic.200800353; Zhao M, 2001, MOL CELL BIOL, V21, P7243, DOI 10.1128/MCB.21.21.7243-7255.2001; Zhou M, 2009, GENOMICS, V94, P125, DOI 10.1016/j.ygeno.2009.04.006	113	67	69	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56535	10.1371/journal.pone.0056535	http://dx.doi.org/10.1371/journal.pone.0056535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409192	gold, Green Published, Green Submitted			2022-12-27	WOS:000315100000057
J	Yao, K; Ge, W				Yao, Kai; Ge, Wei			Spatial Distribution and Receptor Specificity of Zebrafish Kit System - Evidence for a Kit-Mediated Bi-Directional Communication System in the Preovulatory Ovarian Follicle	PLOS ONE			English	Article							STEM-CELL FACTOR; EPIDERMAL-GROWTH-FACTOR; SRC FAMILY KINASE; C-KIT; TYROSINE KINASE; OOCYTE GROWTH; SWISS-MODEL; EXPRESSION PATTERNS; TEMPORAL EXPRESSION; LIGAND EXPRESSION	Consisting of Kit ligand and receptor Kit, the Kit system is involved in regulating many ovarian functions such as follicle activation, granulosa cell proliferation, and oocyte growth and maturation. In mammals, Kit ligand is derived from the granulosa cells and Kit receptor is expressed in the oocyte and theca cells. In the zebrafish, the Kit system contains two ligands (Kitlga and Kitlgb) and two receptors (Kita and Kitb). Interestingly, Kitlga and Kitb are localized in the somatic follicle cells, but Kitlgb and Kita are expressed in the oocyte. Using recombinant zebrafish Kitlga and Kitlgb, we demonstrated that Kitlga preferentially activated Kita whereas Kitlgb specifically activated Kitb by Western analysis for receptor phosphorylation. In support of this, Kitlgb triggered a stronger and longer MAPK phosphorylation in follicle cells than Kitlga, whereas Kitlga but not Kitlgb activated MAPK in the denuded oocytes, in agreement with the distribution of Kita and Kitb in the follicle and their specificity for Kitlga and Kitlgb. Further analysis of the interaction between Kit ligands and receptors by homology modeling showed that Kitlga-Kita and Kitlgb-Kitb both have more stable electrostatic interaction than Kitlgb-Kita or Kitlga-Kitb. A functional study of Kit involvement in final oocyte maturation showed that Kitlga and Kitlgb both suppressed the spontaneous maturation significantly; in contrast, Kitlgb but not Kitlga significantly promoted 17 alpha, 20 beta-dihydroxy-4-pregnen-3-one (DHP) -induced oocyte maturation. Our results provided strong evidence for a Kit-mediated bi-directional communication system in the zebrafish ovarian follicle, which could be part of the complex interplay between the oocyte and the follicle cells in the development of follicles.	[Ge, Wei] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Ctr Cell & Dev Biol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Ge, W (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	weige@cuhk.edu.hk		, Kai/0000-0002-8122-430X	Research Grants Council [CUHK464707, 464308, 464409]; Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region	Research Grants Council(Hong Kong Research Grants Council); Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region	The work was substantially supported by grants from the Research Grants Council (CUHK464707, 464308 and 464409) and the Areas of Excellence (AoE) Scheme on Marine Environmental Research and Innovative Technology (MERIT) of the Hong Kong Special Administrative Region to W. Ge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bondzi C, 2000, CELL GROWTH DIFFER, V11, P305; Brankin Victoria, 2003, Reprod Biol Endocrinol, V1, P55, DOI 10.1186/1477-7827-1-55; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; Cheng GFY, 2007, J ENDOCRINOL, V195, P373, DOI 10.1677/JOE-07-0265; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; Dorsey JF, 2002, BLOOD, V99, P1388, DOI 10.1182/blood.V99.4.1388; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; Ge W, 1997, J MOL ENDOCRINOL, V19, P47, DOI 10.1677/jme.0.0190047; Ge W, 2005, MOL CELL ENDOCRINOL, V237, P1, DOI 10.1016/j.mce.2005.03.012; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HORIE K, 1991, BIOL REPROD, V45, P547, DOI 10.1095/biolreprod45.4.547; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; Hultman KA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030017; Ismail RS, 1997, DEV BIOL, V184, P333, DOI 10.1006/dbio.1997.8531; Ismail RS, 1996, MOL REPROD DEV, V43, P458, DOI 10.1002/(SICI)1098-2795(199604)43:4&lt;458::AID-MRD8&gt;3.0.CO;2-O; Jiang XL, 2000, EMBO J, V19, P3192, DOI 10.1093/emboj/19.13.3192; Joyce IM, 1999, DEV BIOL, V214, P342, DOI 10.1006/dbio.1999.9437; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klinger FG, 2002, DEV BIOL, V244, P85, DOI 10.1006/dbio.2002.0592; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Liu HL, 2007, EMBO J, V26, P891, DOI 10.1038/sj.emboj.7601545; Liu L, 2007, BIOL REPROD, V76, P294, DOI 10.1095/biolreprod.106.054668; MANOVA K, 1993, DEV BIOL, V157, P85, DOI 10.1006/dbio.1993.1114; MATSUI Y, 1990, NATURE, V347, P667, DOI 10.1038/347667a0; Mellgren EM, 2005, DEV GENES EVOL, V215, P470, DOI 10.1007/s00427-005-0001-3; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Misawa A, 2000, CANCER RES, V60, P64; MOTRO B, 1993, DEV DYNAM, V197, P69, DOI 10.1002/aja.1001970107; Nelson SN, 2010, GEN COMP ENDOCR, V168, P111, DOI 10.1016/j.ygcen.2010.04.020; Otsuka F, 2002, P NATL ACAD SCI USA, V99, P8060, DOI 10.1073/pnas.122066899; PACKER AI, 1994, DEV BIOL, V161, P194, DOI 10.1006/dbio.1994.1020; Pang YF, 2002, BIOL REPROD, V66, P259, DOI 10.1095/biolreprod66.2.259; Pang YF, 2002, ENDOCRINOLOGY, V143, P47, DOI 10.1210/en.143.1.47; Parrott JA, 2000, MOL REPROD DEV, V55, P55, DOI 10.1002/(SICI)1098-2795(200001)55:1&lt;55::AID-MRD8&gt;3.0.CO;2-L; Parrott JA, 1997, ENDOCRINOLOGY, V138, P3819, DOI 10.1210/en.138.9.3819; Parrott JA, 1998, ENDOCRINOLOGY, V139, P2240, DOI 10.1210/en.139.5.2240; Peyton C, 2011, BIOL REPROD, V85, P42, DOI 10.1095/biolreprod.110.088765; Reynaud K, 2000, MOL REPROD DEV, V56, P483, DOI 10.1002/1098-2795(200008)56:4&lt;483::AID-MRD6&gt;3.0.CO;2-O; Rojas M, 1996, J BIOL CHEM, V271, P27456, DOI 10.1074/jbc.271.44.27456; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; So WK, 2005, BIOL REPROD, V72, P1382, DOI 10.1095/biolreprod.104.038216; Thomas FH, 2008, BIOL REPROD, V78, P167, DOI 10.1095/biolreprod.106.058529; Thomas FH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-19; Thommes K, 1999, BIOCHEM J, V341, P211, DOI 10.1042/0264-6021:3410211; Tse AC, 2009, GEN COMP ENDOCRINOL; Ueda S, 2002, BLOOD, V99, P3342, DOI 10.1182/blood.V99.9.3342; Wang YJ, 2003, BIOL REPROD, V69, P1998, DOI 10.1095/biolreprod.103.020826; Wang YJ, 2002, GEN COMP ENDOCR, V127, P209, DOI 10.1016/S0016-6480(02)00041-2; Yao K, 2010, BIOL REPROD, V82, P1216, DOI 10.1095/biolreprod.109.082644; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; Yoshida H, 1997, DEV BIOL, V184, P122, DOI 10.1006/dbio.1997.8503; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; Zhang ZT, 2000, P NATL ACAD SCI USA, V97, P7732, DOI 10.1073/pnas.97.14.7732; Zhou R, 2011, BIOL REPROD, V85, P615, DOI 10.1095/biolreprod.111.091884	58	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56192	10.1371/journal.pone.0056192	http://dx.doi.org/10.1371/journal.pone.0056192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409152	Green Submitted, gold, Green Published			2022-12-27	WOS:000314660300064
J	Castagnino, P; Kothapalli, D; Hawthorne, EA; Liu, SL; Xu, TN; Rao, S; Yung, Y; Assoian, RK				Castagnino, Paola; Kothapalli, Devashish; Hawthorne, Elizabeth A.; Liu, Shu-Lin; Xu, Tina; Rao, Shilpa; Yung, Yuval; Assoian, Richard K.			miR-221/222 Compensates for Skp2-Mediated p27 Degradation and Is a Primary Target of Cell Cycle Regulation by Prostacyclin and cAMP	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; G1 PHASE; S-PHASE; INHIBITOR P27(KIP1); STENT RESTENOSIS; GENE-EXPRESSION; CDK INHIBITORS; D1 EXPRESSION; ACTIVATION; SKP2	p27(kip1) (p27) is a cdk-inhibitory protein with an important role in the proliferation of many cell types. SCFSkp2 is the best studied regulator of p27 levels, but Skp2-mediated p27 degradation is not essential in vivo or in vitro. The molecular pathway that compensates for loss of Skp2-mediated p27 degradation has remained elusive. Here, we combine vascular injury in the mouse with genome-wide profiling to search for regulators of p27 during cell cycling in vivo. This approach, confirmed by RT-qPCR and mechanistic analysis in primary cells, identified miR-221/222 as a compensatory regulator of p27. The expression of miR221/222 is sensitive to proteasome inhibition with MG132 suggesting a link between p27 regulation by miRs and the proteasome. We then examined the roles of miR-221/222 and Skp2 in cell cycle inhibition by prostacyclin (PGI(2)), a potent cell cycle inhibitor acting through p27. PGI(2) inhibited both Skp2 and miR221/222 expression, but epistasis, ectopic expression, and time course experiments showed that miR-221/222, rather than Skp2, was the primary target of PGI(2). PGI(2) activates Gs to increase cAMP, and increasing intracellular cAMP phenocopies the effect of PGI(2) on p27, miR-221/222, and mitogenesis. We conclude that miR-221/222 compensates for loss of Skp2-mediated p27 degradation during cell cycling, contributes to proteasome-dependent G1 phase regulation of p27, and accounts for the anti-mitogenic effect of cAMP during growth inhibition.	[Castagnino, Paola; Kothapalli, Devashish; Hawthorne, Elizabeth A.; Liu, Shu-Lin; Xu, Tina; Yung, Yuval; Assoian, Richard K.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Rao, Shilpa] Univ Penn, Perelman Sch Med, Mol Profiling Facil, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Assoian, RK (corresponding author), Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA.	assoian@mail.med.upenn.edu			National Institutes of Health (NIH) [HL083367, HL62250, HL094491]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094491, P01HL062250, R01HL083367] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants HL083367, HL62250 and HL094491. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkarain A, 2004, BREAST CANCER RES, V6, P13, DOI 10.1186/bcr722; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Castagnino P, 2010, PROSTAG OTH LIPID M, V93, P20, DOI 10.1016/j.prostaglandins.2010.04.004; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; DeSalle LM, 2001, FEBS LETT, V490, P179, DOI 10.1016/S0014-5793(01)02121-4; Diez-Juan A, 2001, FASEB J, V15, P1989, DOI 10.1096/fj.01-0130com; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Ii M, 2001, CARDIOVASC RES, V52, P500, DOI 10.1016/S0008-6363(01)00411-4; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Klein EA, 2007, METHOD ENZYMOL, V426, P155, DOI 10.1016/S0076-6879(07)26008-2; Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069; Kothapalli D, 2003, MOL PHARMACOL, V64, P249, DOI 10.1124/mol.64.2.249; Kothapalli D, 2007, J CELL BIOL, V176, P535, DOI 10.1083/jcb.200611058; Kuiperij HB, 2005, ONCOGENE, V24, P2087, DOI 10.1038/sj.onc.1208450; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Marks AR, 2003, NEW ENGL J MED, V349, P1307, DOI 10.1056/NEJMp038141; Marx SO, 2001, CIRCULATION, V104, P852, DOI 10.1161/01.CIR.104.8.852; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Miranda-Carboni GA, 2008, GENE DEV, V22, P3121, DOI 10.1101/gad.1692808; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Stewart SA, 2004, J BIOL CHEM, V279, P29109, DOI 10.1074/jbc.M404271200; Terasawa K, 2009, FEBS J, V276, P3269, DOI 10.1111/j.1742-4658.2009.07041.x; Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950; Wu YJ, 2006, CIRC RES, V98, P1141, DOI 10.1161/01.RES.0000219905.16312.28; Wu YJ, 2009, J VASC SURG, V50, P1135, DOI 10.1016/j.jvs.2009.07.066; Yokota T, 2006, STEM CELLS, V24, P13, DOI 10.1634/stemcells.2004-0346; Yung Y, 2007, J CELL BIOL, V178, P741, DOI 10.1083/jcb.200703034; Zhang L, 2006, ONCOGENE, V25, P2615, DOI 10.1038/sj.onc.1209286	48	18	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56140	10.1371/journal.pone.0056140	http://dx.doi.org/10.1371/journal.pone.0056140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409140	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200114
J	Ferguson, NS; Lamb, KE; Wang, Y; Ogilvie, D; Ellaway, A				Ferguson, Neil S.; Lamb, Karen E.; Wang, Yang; Ogilvie, David; Ellaway, Anne			Access to Recreational Physical Activities by Car and Bus: An Assessment of Socio-Spatial Inequalities in Mainland Scotland	PLOS ONE			English	Article							MEASURING ACCESSIBILITY; SOCIOECONOMIC-STATUS; ACTIVITY FACILITIES; RESOURCES; AVAILABILITY; DISPARITIES	Obesity and other chronic conditions linked with low levels of physical activity (PA) are associated with deprivation. One reason for this could be that it is more difficult for low-income groups to access recreational PA facilities such as swimming pools and sports centres than high-income groups. In this paper, we explore the distribution of access to PA facilities by car and bus across mainland Scotland by income deprivation at datazone level. GIS car and bus networks were created to determine the number of PA facilities accessible within travel times of 10, 20 and 30 minutes. Multilevel negative binomial regression models were then used to investigate the distribution of the number of accessible facilities, adjusting for datazone population size and local authority. Access to PA facilities by car was significantly (p<0.01) higher for the most affluent quintile of area-based income deprivation than for most other quintiles in small towns and all other quintiles in rural areas. Accessibility by bus was significantly lower for the most affluent quintile than for other quintiles in urban areas and small towns, but not in rural areas. Overall, we found that the most disadvantaged groups were those without access to a car and living in the most affluent areas or in rural areas.	[Ferguson, Neil S.; Wang, Yang] Univ Strathclyde, Dept Civil & Environm Engn, Glasgow, Lanark, Scotland; [Lamb, Karen E.; Ellaway, Anne] MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Ogilvie, David] Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England; [Ogilvie, David] Univ Cambridge, Cambridge Inst Publ Hlth, United Kingdom Clin Res Collaborat Ctr Diet & Act, Cambridge, England	University of Strathclyde; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Cambridge; University of Cambridge	Ferguson, NS (corresponding author), Univ Strathclyde, Dept Civil & Environm Engn, Glasgow, Lanark, Scotland.	n.s.ferguson@strath.ac.uk	Lamb, Karen/P-4988-2016; Ellaway, Anne/A-3065-2009	Lamb, Karen/0000-0001-9782-8450; Ferguson, Neil/0000-0002-3166-2694; Ogilvie, David/0000-0002-0270-4672; Ellaway, Anne/0000-0002-2117-4451	National Prevention Research Initiative [G0701082]; Alzheimer's Research Trust; Alzheimer's Society; Biotechnology and Biological Sciences Research Council; British Heart Foundation; Cancer Research United Kingdom (UK); Chief Scientist Office, Scottish Government Health Directorate; Department of Health; Economic and Social Research Council; Engineering and Physical Sciences Research Council; Food Standards Agency; Health and Social Care Research and Development Office for Northern Ireland; Medical Research Council; Stroke Association; Welsh Assembly Government; World Cancer Research Fund; Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; National Institute for Health Research (NIHR); Wellcome Trust; UK Clinical Research Collaboration; Diabetes UK; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_UU_12015/6, MC_UU_12017/8, MC_UP_A540_1022, MC_UP_1001/1, MC_EX_G0701942] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_EX_G0701942, MC_UP_1001/1, MC_UU_12015/6, MC_UU_12017/8, MC_UP_A540_1022] Funding Source: UKRI	National Prevention Research Initiative(Diabetes UK); Alzheimer's Research Trust; Alzheimer's Society; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Cancer Research United Kingdom (UK); Chief Scientist Office, Scottish Government Health Directorate; Department of Health; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Food Standards Agency; Health and Social Care Research and Development Office for Northern Ireland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; Welsh Assembly Government; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); UK Clinical Research Collaboration; Diabetes UK(Diabetes UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the National Prevention Research Initiative (www.npri.org.uk, G0701082), with support from the following organisations: Alzheimer's Research Trust; Alzheimer's Society; Biotechnology and Biological Sciences Research Council; British Heart Foundation; Cancer Research United Kingdom (UK); Chief Scientist Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council; Food Standards Agency; Health and Social Care Research and Development Office for Northern Ireland; Medical Research Council; The Stroke Association; Welsh Assembly Government; and World Cancer Research Fund. AE and KL are employed by the UK Medical Research Council in the Neighbourhoods and Health Programme (wbs U.1300.00.011.). DO is employed by the Medical Research Council and is also supported by the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, the Economic and Social Research Council, the Medical Research Council, the National Institute for Health Research (NIHR), and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health or other funders.	[Anonymous], 2010, R LANG ENV STAT COMP; Apparicio P, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-4; Apparicio P, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-7; Belanger M, 2011, PREV MED, V52, P247, DOI 10.1016/j.ypmed.2011.02.008; Billaudeau N, 2011, HEALTH PLACE, V17, P114, DOI 10.1016/j.healthplace.2010.09.004; Bradshaw P, 2012, SCOTTISH HLTH SURVEY; Caliper Corporation, 2011, TRANSCAD TRANSP PLAN; Dargay J, 1999, TRANSPORT RES A-POL, V33, P101, DOI 10.1016/S0965-8564(98)00026-3; Department of Health, 2011, START ACT STAY ACT R; Estabrooks PA, 2003, ANN BEHAV MED, V25, P100, DOI 10.1207/S15324796ABM2502_05; Frank L, 2003, COMMUNITY DESIGN IMP; Geurs K.T., 2004, J TRANSP GEOGR, V12, P127, DOI [10.1016/j.jtrangeo.2003.10.005, DOI 10.1016/J.JTRANGEO.2003.10.005]; Geurs KT, 2003, ENVIRON PLANN B, V30, P69, DOI 10.1068/b12940; Giles-Corti B, 2002, PREV MED, V35, P601, DOI 10.1006/pmed.2002.1115; Google, 2011, GOOGL MAPS; Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058; Handy SL, 2002, AM J PREV MED, V23, P64, DOI 10.1016/S0749-3797(02)00475-0; Handy SL, 1997, ENVIRON PLANN A, V29, P1175, DOI 10.1068/a291175; Hillsdon M, 2007, AM J PREV MED, V32, P506, DOI 10.1016/j.amepre.2007.02.018; HM Government, 2011, NAT PUBL TRANSP DAT; JOSEPH AE, 1982, SOC SCI MED, V16, P85, DOI 10.1016/0277-9536(82)90428-2; Juff B, 2011, FURTHER REV DEMAND R; Lamb KE, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-55; Lamb KE, 2010, INTERNATIONAL JOURNA, P7; Lee D, 2010, J R STAT SOC C-APPL, V59, P905, DOI 10.1111/j.1467-9876.2010.00725.x; Lee RE, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.054098; Litman, 2012, EVALUATING ACCESSIBI; London 2012, 2012, LOND 2012; Lynch K., 1984, GOOD CITY FORM; Macintyre S, 2008, SOC SCI MED, V67, P900, DOI 10.1016/j.socscimed.2008.05.029; McCormack GR, 2006, INT J BEHAV NUTR PHY, P3; McDonald M., 1984, GEOMETRIC DELAY NONS; Moore LV, 2008, AM J PREV MED, V34, P16, DOI 10.1016/j.amepre.2007.09.021; Ogilvie D, 2011, HEALTH PLACE, V17, P1015, DOI 10.1016/j.healthplace.2011.07.003; Ordnance Survey, 2011, OS MAST MAK ALL DIFF; Panter, 2007, FORESIGHT TACKLING O; Panter J, 2008, PREV MED, V46, P303, DOI 10.1016/j.ypmed.2007.11.005; Physical Activity Task Force, 2003, LETS MAK SCOTL MOR A; PIRIE GH, 1979, ENVIRON PLANN A, V11, P299, DOI 10.1068/a110299; Powell LM, 2006, AM J PUBLIC HEALTH, V96, P1676, DOI 10.2105/AJPH.2005.065573; Scottish Executive, 2006, SCOTT IND MULT DEPR; Scottish Executive, 2001, CARS VANS NUMB AV HO; Scottish Executive, 2008, SCOTT EX URB RUR CLA; Scottish Executive, 2004, SCOTT NEIGHB STAT DA; Scottish Executive, 2001, CENS DAY POP; Scottish Government, 2009, PEOPL SPORT SCOTL RE; Scottish Government, 2012, LEG 2014 BE PART IT; Scottish Government, 2008, EQ WELL REP MIN TASK; Scottish Government, 2012, NAT PERF FRAM; Shen Q, 1998, ENVIRON PLANN B, V25, P345, DOI 10.1068/b250345; van Lenthe FJ, 2005, SOC SCI MED, V60, P763, DOI 10.1016/j.socscimed.2004.06.013	51	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55638	10.1371/journal.pone.0055638	http://dx.doi.org/10.1371/journal.pone.0055638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092XV	23409012	Green Accepted, gold, Green Published			2022-12-27	WOS:000315157200045
J	Petelinc, T; Polak, T; Demsar, L; Jamnik, P				Petelinc, Tanja; Polak, Tomaz; Demsar, Lea; Jamnik, Polona			Fractionation of Phenolic Compounds Extracted from Propolis and Their Activity in the Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; CELL-CULTURE; BIOLOGICAL-PROPERTIES; MASS-SPECTROMETRY; GENERATION; OXIDATION	We have here investigated the activities of Slovenian propolis extracts in the yeast Saccharomyces cerevisiae, and identified the phenolic compounds that appear to contribute to these activities. We correlated changes in intracellular oxidation and cellular metabolic energy in these yeasts with the individual fractions of the propolis extracts obtained following solid-phase extraction. The most effective fraction was further investigated according to its phenolic compounds.	[Petelinc, Tanja; Polak, Tomaz; Demsar, Lea; Jamnik, Polona] Univ Ljubljana, Dept Food Sci & Technol, Biotech Fac, Ljubljana, Slovenia	University of Ljubljana	Jamnik, P (corresponding author), Univ Ljubljana, Dept Food Sci & Technol, Biotech Fac, Ljubljana, Slovenia.	polona.jamnik@bf.uni-lj.si			European Social Fund within the National Programme -Innovative scheme [278246]	European Social Fund within the National Programme -Innovative scheme	This work was partly supported by European Social Fund within the National Programme -Innovative scheme for funding the doctoral program (278246). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankova V, 2005, J ETHNOPHARMACOL, V100, P114, DOI 10.1016/j.jep.2005.05.004; Burdock GA, 1998, FOOD CHEM TOXICOL, V36, P347, DOI 10.1016/S0278-6915(97)00145-2; Castaldo S, 2002, FITOTERAPIA, V73, pS1, DOI 10.1016/S0367-326X(02)00185-5; Cigut T, 2011, J AGR FOOD CHEM, V59, P11449, DOI 10.1021/jf2022258; Clement MV, 2001, ANTIOXID REDOX SIGN, V3, P157, DOI 10.1089/152308601750100687; de Castro PA, 2011, EUKARYOT CELL, V10, P398, DOI 10.1128/EC.00256-10; Falcao SI, 2010, ANAL BIOANAL CHEM, V396, P887, DOI 10.1007/s00216-009-3232-8; Gardana C, 2007, J PHARMACEUT BIOMED, V45, P390, DOI 10.1016/j.jpba.2007.06.022; Halliwell B, 2000, IUBMB LIFE, V50, P251, DOI 10.1080/15216540051080930; Hvattum E, 2002, RAPID COMMUN MASS SP, V16, P655, DOI 10.1002/rcm.622; Jakubowski W, 1997, INT J BIOCHEM CELL B, V29, P1297, DOI 10.1016/S1357-2725(97)00056-3; Justesen U, 2000, J CHROMATOGR A, V902, P369, DOI 10.1016/S0021-9673(00)00861-X; Kumazawa S, 2004, FOOD CHEM, V84, P329, DOI 10.1016/S0308-8146(03)00216-4; Long LH, 2001, BIOCHEM BIOPH RES CO, V286, P991, DOI 10.1006/bbrc.2001.5514; Long LH, 2000, BIOCHEM BIOPH RES CO, V273, P50, DOI 10.1006/bbrc.2000.2895; MARCUCCI MC, 1995, APIDOLOGIE, V26, P83, DOI 10.1051/apido:19950202; Medana C, 2008, PHYTOCHEM ANALYSIS, V19, P32, DOI 10.1002/pca.1010; Molyneux P., 2004, SONGKLANAKARIN J SCI, V26, P211, DOI DOI 10.1287/ISRE.6.2.144; Pellati F, 2011, J PHARMACEUT BIOMED, V55, P934, DOI 10.1016/j.jpba.2011.03.024; Sforcin JM, 2007, J ETHNOPHARMACOL, V113, P1, DOI 10.1016/j.jep.2007.05.012; Sigler K, 1999, FOLIA MICROBIOL, V44, P587, DOI 10.1007/BF02825650; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Tsibranska H, 2011, J MEMBRA SCI TECHNOL, V348, P124; Wang BJ, 2004, FOOD CHEM, V86, P237, DOI 10.1016/j.foodchem.2003.09.031	24	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56104	10.1371/journal.pone.0056104	http://dx.doi.org/10.1371/journal.pone.0056104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409133	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200109
J	Shimizu, YK; Hijikata, M; Oshima, M; Shimizu, K; Alter, HJ; Purcell, RH; Yoshikura, H; Hotta, H				Shimizu, Yohko K.; Hijikata, Minako; Oshima, Masamichi; Shimizu, Kazufumi; Alter, Harvey J.; Purcell, Robert H.; Yoshikura, Hiroshi; Hotta, Hak			Isolation of Human Monoclonal Antibodies to the Envelope E2 Protein of Hepatitis C Virus and Their Characterization	PLOS ONE			English	Article							CELL-CULTURE SYSTEMS; NON-B HEPATITIS; NEUTRALIZING ANTIBODIES; NON-A; GLYCOPROTEIN; INFECTION; IDENTIFICATION; CHIMPANZEES; BINDING; ESCAPE	We isolated and characterized two human monoclonal antibodies to the envelope E2 protein of hepatitis C virus (HCV). Lymphoblastoid cell lines stably producing antibodies were obtained by immortalizing peripheral blood mononuclear cells of a patient with chronic hepatitis C using Epstein-Barr virus. Screening for antibody-positive clones was carried out by immunofluorescence with Huh7 cells expressing the E2 protein of HCV strain H (genotype 1a) isolated from the same patient. Isotype of resulting antibodies, #37 and #55, was IgG1/kappa and IgG1/lambda, respectively. Epitope mapping revealed that #37 and #55 recognize conformational epitopes spanning amino acids 429 to 652 and 508 to 607, respectively. By immunofluorescence using virus-infected Huh7.5 cells as targets both antibodies were reactive with all of the nine different HCV genotypes/subtypes tested. The antibodies showed a different pattern of immuno-staining; while #37 gave granular reactions mostly located in the periphery of the nucleus, #55 gave diffuse staining throughout the cytoplasm. Both antibodies were shown by immuno-gold electron microscopy to bind to intact viral particles. In a neutralization assay (focus-forming unit reduction using chimeric infectious HCV containing structural proteins derived from genotypes 1a, 1b, 2a, 2b, 3a, 4a, 5a, 6a, and 7a), #55 inhibited the infection of all HCV genotypes tested but genotype 7a to a lesser extent. #37 did not neutralize any of these viruses. As a broadly cross-neutralizing human antibody, #55 may be useful for passive immunotherapy of HCV infection.	[Shimizu, Yohko K.; Hotta, Hak] Kobe Univ, Div Microbiol, Ctr Infect Dis, Grad Sch Med, Kobe, Hyogo 657, Japan; [Hijikata, Minako] Natl Ctr Global Hlth & Med, Dept Resp Dis, Res Inst, Tokyo, Japan; [Oshima, Masamichi] Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan; [Shimizu, Kazufumi] Nihon Univ, Sch Med, Dept Gynecol, Tokyo, Japan; [Alter, Harvey J.] NIH, Dept Transfus Med, Warren Grant Magnuson Clin Ctr, Bethesda, MD 20892 USA; [Purcell, Robert H.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Yoshikura, Hiroshi] Minist Hlth Labor & Welf, Food Safety Div, Tokyo, Japan	Kobe University; National Center for Global Health & Medicine - Japan; National Institute of Infectious Diseases (NIID); Nihon University; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shimizu, YK (corresponding author), Kobe Univ, Div Microbiol, Ctr Infect Dis, Grad Sch Med, Kobe, Hyogo 657, Japan.	yshimizu@nih.go.jp			Science and Technology Partnership for Sustainable Development (SATREPS) program of Japan; Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Intramural Research Program of the National Institute of Allergy and Infectious Diseases; CLINICAL CENTER [ZIACL002078] Funding Source: NIH RePORTER	Science and Technology Partnership for Sustainable Development (SATREPS) program of Japan; Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan International Cooperation Agency (JICA); Intramural Research Program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CLINICAL CENTER	This work was supported, in part, by the Science and Technology Partnership for Sustainable Development (SATREPS) program of Japan Science and Technology Agency (JST) and Japan International Cooperation Agency (JICA) and the Intramural Research Program of the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Broering TJ, 2009, J VIROL, V83, P12473, DOI 10.1128/JVI.01138-09; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; FEINSTONE SM, 1981, J INFECT DIS, V144, P588, DOI 10.1093/infdis/144.6.588; Forns X, 2000, VIROLOGY, V274, P75, DOI 10.1006/viro.2000.0419; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Giang E, 2012, P NATL ACAD SCI USA, V109, P6205, DOI 10.1073/pnas.1114927109; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; HIJIKATA M, 1993, J VIROL, V67, P1953, DOI 10.1128/JVI.67.4.1953-1958.1993; Ishii K, 1998, HEPATOLOGY, V28, P1117, DOI 10.1002/hep.510280429; Jensen TB, 2008, J INFECT DIS, V198, P1756, DOI 10.1086/593021; Keck ZY, 2011, J VIROL, V85, P10451, DOI 10.1128/JVI.05259-11; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Mancini N, 2009, PLOS ONS, V4, P1; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Owsianka AM, 2008, J GEN VIROL, V89, P653, DOI 10.1099/vir.0.83386-0; Owsianka AM, 2006, J VIROL, V80, P8695, DOI 10.1128/JVI.00271-06; Perotti M, 2008, J VIROL, V82, P1047, DOI 10.1128/JVI.01986-07; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Sasayama M, 2012, J MED VIROL, V84, P229, DOI 10.1002/jmv.22257; Scheel TKH, 2008, P NATL ACAD SCI USA, V105, P997, DOI 10.1073/pnas.0711044105; Shimizu YK, 2006, J VIRAL HEPATITIS, V13, P746, DOI 10.1111/j.1365-2893.2006.00745.x; SHIMIZU YK, 1993, P NATL ACAD SCI USA, V90, P6037, DOI 10.1073/pnas.90.13.6037; SHIMIZU YK, 1994, J VIROL, V68, P1494, DOI 10.1128/JVI.68.3.1494-1500.1994; SHIMIZU YK, 1985, P NATL ACAD SCI USA, V82, P2138, DOI 10.1073/pnas.82.7.2138; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yi-Ping L, 2011, P NATL ACAD SCI USA, V108, P4991	28	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55874	10.1371/journal.pone.0055874	http://dx.doi.org/10.1371/journal.pone.0055874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409074	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200082
J	Smith, MG; Croy, I; Ogren, M; Waye, KP				Smith, Michael G.; Croy, Ilona; Ogren, Mikael; Waye, Kerstin Persson			On the Influence of Freight Trains on Humans: A Laboratory Investigation of the Impact of Nocturnal Low Frequency Vibration and Noise on Sleep and Heart Rate	PLOS ONE			English	Article							AIRCRAFT NOISE; RAILWAY NOISE; TRAFFIC NOISE; CARDIOVASCULAR-RESPONSES; ENVIRONMENTAL NOISE; ROAD; FRAGMENTATION; DISTURBANCES; PERFORMANCE; EXPOSURE	Background: A substantial increase in transportation of goods on railway may be hindered by public fear of increased vibration and noise leading to annoyance and sleep disturbance. As the majority of freight trains run during night time, the impact upon sleep is expected to be the most serious adverse effect. The impact of nocturnal vibration on sleep is an area currently lacking in knowledge. We experimentally investigated sleep disturbance with the aim to ascertain the impact of increasing vibration amplitude. Methodology/Principal Findings: The impacts of various amplitudes of horizontal vibrations on sleep disturbance and heart rate were investigated in a laboratory study. Cardiac accelerations were assessed using a combination of polysomnography and ECG recordings. Sleep was assessed subjectively using questionnaires. Twelve young, healthy subjects slept for six nights in the sleep laboratory, with one habituation night, one control night and four nights with a variation of vibration exposures whilst maintaining the same noise exposure. With increasing vibration amplitude, we found a decrease in latency and increase in amplitude of heart rate as well as a reduction in sleep quality and increase in sleep disturbance. Conclusions/Significance: We concluded that nocturnal vibration has a negative impact on sleep and that the impact increases with greater vibration amplitude. Sleep disturbance has short- and long-term health consequences. Therefore, it is necessary to	[Smith, Michael G.; Croy, Ilona; Waye, Kerstin Persson] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Ogren, Mikael] Swedish Natl Rd & Transport Res Inst, Gothenburg, Sweden	University of Gothenburg; VTI	Smith, MG (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden.	michael.smith@amm.gu.se	Smith, Michael G/G-8365-2012; Smith, Michael G./AAF-3764-2019; Persson Waye, Kerstin/J-7136-2012	Smith, Michael G/0000-0001-8541-9625; Smith, Michael G./0000-0001-8541-9625; Croy, Ilona/0000-0002-0361-5559; Persson Waye, Kerstin/0000-0003-3789-4557; Ogren, Mikael/0000-0002-4559-4127	Seventh Framework Programme [266248]	Seventh Framework Programme(European Commission)	The work was supported by grant 266248 from the Seventh Framework Programme (ec.europa.eu/research/fp7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasvang GM, 2008, J ACOUST SOC AM, V124, P257, DOI 10.1121/1.2932074; Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; ARNBERG PW, 1990, J ACOUST SOC AM, V88, P1486, DOI 10.1121/1.400305; Babisch Wolfgang, 2006, Noise Health, V8, P1; Basner M, 2004, Noise Health, V6, P83; Basner M., 2005, SOMNOLOGIE, V9, P84; Basner M, 2008, PHYSIOL MEAS, V29, P1089, DOI 10.1088/0967-3334/29/9/007; Basner M, 2008, SLEEP MED, V9, P382, DOI 10.1016/j.sleep.2007.07.002; Basner M, 2011, SLEEP, V34, P11, DOI 10.1093/sleep/34.1.11; Berglund B., 1999, GUIDELINES COMMUNITY; Bonnet MH, 2003, SLEEP MED REV, V7, P297, DOI 10.1053/smrv.2001.0245; Carter N, 2002, SLEEP, V25, P457; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; de Kluizenaar Y, 2009, J ACOUST SOC AM, V126, P626, DOI 10.1121/1.3158834; DINISI J, 1990, SLEEP, V13, P108, DOI 10.1093/sleep/13.2.108; Elmenhorst EM, 2012, SCI TOTAL ENVIRON, V424, P48, DOI 10.1016/j.scitotenv.2012.02.024; European Commission, 2001, WHIT PAP EUR TRANSP; Griefahn B, 2009, INT 2009 OTT CAN; Griefahn B, 2008, SLEEP, V31, P569, DOI 10.1093/sleep/31.4.569; Haines MM, 2002, J EPIDEMIOL COMMUN H, V56, P139, DOI 10.1136/jech.56.2.139; Haines MM, 2001, PSYCHOL MED, V31, P265, DOI 10.1017/S0033291701003282; Iber C., 2007, AASM MANUAL SCORING; International Organization for Standardization, 1997, ISO 2631 1 MECH VI 1; Ising H, 2004, Noise Health, V6, P5; Janssen S. A., 2011, BURDEN DIS ENV NOISE, P55; Kageyama T, 1997, SLEEP, V20, P963; Kjellberg A., 2000, 14 TRIENN C INT ERG, V5, P63, DOI [DOI 10.1177/154193120004402917, 10.1177/154193120004402917]; KNIPSCHILD P, 1977, INT ARCH OCC ENV HEA, V40, P197, DOI 10.1007/BF01842083; Madshus C, 1996, J SOUND VIB, V193, P195, DOI 10.1006/jsvi.1996.0259; Maeda S, 1999, IND HEALTH, V37, P404, DOI 10.2486/indhealth.37.404; Miedema Henk M E, 2007, Behav Sleep Med, V5, P1, DOI 10.1207/s15402010bsm0501_1; Muzet A, 2007, SLEEP MED REV, V11, P135, DOI 10.1016/j.smrv.2006.09.001; Ogren M, 2009, EFFECTS RAILWAY NOIS; Ogren M, 2008, 9 INT C NOIS PUBL HL; Ohrstrom E, 2004, J SOUND VIB, V271, P279, DOI 10.1016/S0022-460X(03)00753-3; Ohrstrom E, 2009, EFFECTS RAILWAY NOIS; Ohrstrom E, 1993, NOISE MAN 1993 NOISE, P393; Passchier-Vermeer W., 2003, NIGHT TIME NOISE EVE; Pennig S, 2012, J ACOUST SOC AM, V132, P3109, DOI 10.1121/1.4757732; Saremi M, 2008, INT J PSYCHOPHYSIOL, V70, P184, DOI 10.1016/j.ijpsycho.2008.08.002; Smith M, 2012, P M AC 15, P15; Standardiseringskommissionen i Sverige, 1992, SS 460 48 61 VIBR SH; Stepanski EJ, 2002, SLEEP, V25, P268, DOI 10.1093/sleep/25.3.268; Tassi P, 2010, ENVIRON INT, V36, P683, DOI 10.1016/j.envint.2010.05.001; Tassi P, 2010, EUR J APPL PHYSIOL, V108, P671, DOI 10.1007/s00421-009-1270-8; THIESSEN GJ, 1988, J ACOUST SOC AM, V84, P1741, DOI 10.1121/1.397189; Turunen-Rise IH, 2003, APPL ACOUST, V64, P71, DOI 10.1016/S0003-682X(02)00052-X; Waye KP, 2003, LIFE SCI, V72, P863, DOI 10.1016/S0024-3205(02)02336-6; Xia H, 2009, EARTHQ ENG ENG VIB, V8, P137, DOI 10.1007/s11803-009-8101-0	49	60	63	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55829	10.1371/journal.pone.0055829	http://dx.doi.org/10.1371/journal.pone.0055829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092XV	23409055	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200072
J	Xu, Y; Ding, J; Wu, LY; Chou, KC				Xu, Yan; Ding, Jun; Wu, Ling-Yun; Chou, Kuo-Chen			iSNO-PseAAC: Predict Cysteine S-Nitrosylation Sites in Proteins by Incorporating Position Specific Amino Acid Propensity into Pseudo Amino Acid Composition	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; GENERAL-FORM; PROTEOMIC ANALYSIS; IDENTIFICATION; SIGNAL; SEQUENCES; REPRESENTATION; ATTRIBUTES	Posttranslational modifications (PTMs) of proteins are responsible for sensing and transducing signals to regulate various cellular functions and signaling events. S-nitrosylation (SNO) is one of the most important and universal PTMs. With the avalanche of protein sequences generated in the post-genomic age, it is highly desired to develop computational methods for timely identifying the exact SNO sites in proteins because this kind of information is very useful for both basic research and drug development. Here, a new predictor, called iSNO-PseAAC, was developed for identifying the SNO sites in proteins by incorporating the position-specific amino acid propensity (PSAAP) into the general form of pseudo amino acid composition (PseAAC). The predictor was implemented using the conditional random field (CRF) algorithm. As a demonstration, a benchmark dataset was constructed that contains 731 SNO sites and 810 non-SNO sites. To reduce the homology bias, none of these sites were derived from the proteins that had >= 40 pairwise sequence identity to any other. It was observed that the overall cross-validation success rate achieved by iSNO-PseAAC in identifying nitrosylated proteins on an independent dataset was over 90%, indicating that the new predictor is quite promising. Furthermore, a user-friendly web-server for iSNO-PseAAC was established at http://app.aporc.org/iSNO-PseAAC/, by which users can easily obtain the desired results without the need to follow the mathematical equations involved during the process of developing the prediction method. It is anticipated that iSNO-PseAAC may become a useful high throughput tool for identifying the SNO sites, or at the very least play a complementary role to the existing methods in this area.	[Xu, Yan; Ding, Jun] Univ Sci & Technol Beijing, Dept Informat & Comp Sci, Beijing 100083, Peoples R China; [Wu, Ling-Yun] Chinese Acad Sci, Inst Appl Math, Acad Math & Syst Sci, Beijing, Peoples R China; [Xu, Yan; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	University of Science & Technology Beijing; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS	Xu, Y (corresponding author), Univ Sci & Technol Beijing, Dept Informat & Comp Sci, Beijing 100083, Peoples R China.	yxu@gordonlifescience.org; kcchou@gordonlifescience.org	Chou, Kuo-Chen/A-8340-2009; Wu, Ling-Yun/C-4222-2008	Wu, Ling-Yun/0000-0001-9487-0215; Xu, Yan/0000-0001-9462-580X	National Natural Science Foundation of China [11101029, 10971223, 60970091, 11131009, 11071013]; Fundamental Research Funds for the Central Universities, NCET of China [NCET-11-0574]; Knowledge Innovation Program of the Chinese Academy of Sciences [kjcx-yw-s7]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, NCET of China; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This work is partially supported by the National Natural Science Foundation of China (No. 11101029, No. 10971223, No. 60970091, No. 11131009, No. 11071013) and the Fundamental Research Funds for the Central Universities, NCET of China (No. NCET-11-0574), and Knowledge Innovation Program of the Chinese Academy of Sciences (No. kjcx-yw-s7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1; Aranda E, 2012, CURR MOL MED, V12, P50, DOI 10.2174/156652412798376099; Chang WC, 2009, J COMPUT CHEM, V30, P2526, DOI 10.1002/jcc.21258; Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047843; Chen YJ, 2010, J PROTEOME RES, V9, P6417, DOI 10.1021/pr100680a; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2001, PEPTIDES, V22, P1973, DOI 10.1016/S0196-9781(01)00540-X; Chou KC, 2001, PROTEINS, V42, P136, DOI 10.1002/1097-0134(20010101)42:1<136::AID-PROT130>3.0.CO;2-F; CHOU KC, 1993, J BIOL CHEM, V268, P16938; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2001, PROTEIN ENG, V14, P75, DOI 10.1093/protein/14.2.75; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; DeCaprio D, 2007, GENOME RES, V17, P1389, DOI 10.1101/gr.6558107; Derakhshan B, 2007, NAT PROTOC, V2, P1685, DOI 10.1038/nprot.2007.210; Du PF, 2012, ANAL BIOCHEM, V425, P117, DOI 10.1016/j.ab.2012.03.015; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Guo JX, 2011, J COMPUT CHEM, V32, P1612, DOI 10.1002/jcc.21740; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hayat M, 2012, PROTEIN PEPTIDE LETT, V19, P411, DOI 10.2174/092986612799789387; Hayat M, 2012, J THEOR BIOL, V292, P93, DOI 10.1016/j.jtbi.2011.09.026; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jahandideh S, 2012, J THEOR BIOL, V312, P65, DOI 10.1016/j.jtbi.2012.07.013; Kim JH, 2004, BIOINFORMATICS, V20, P3179, DOI 10.1093/bioinformatics/bth382; Lafferty J, 2001, P 18 INT C MACH LEAR, P282, DOI DOI 10.1038/NPROT.2006.61; Li BQ, 2012, J PROTEOMICS, V75, P1654, DOI 10.1016/j.jprot.2011.12.003; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Li YX, 2011, PROTEIN PEPTIDE LETT, V18, P573, DOI 10.2174/092986611795222731; Lin WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049040; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Mohabatkar H, 2013, MED CHEM, V9, P133, DOI 10.2174/157340613804488341; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Mohammad Beigi Majid, 2011, J Struct Funct Genomics, V12, P191, DOI 10.1007/s10969-011-9120-4; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Nanni L, 2012, AMINO ACIDS, V43, P657, DOI 10.1007/s00726-011-1114-9; Nanni L, 2012, IEEE ACM T COMPUT BI, V9, P467, DOI 10.1109/TCBB.2011.117; Niu XH, 2012, PROTEIN PEPTIDE LETT, V19, P940, DOI 10.2174/092986612802084492; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Schonhoff CM, 2006, P NATL ACAD SCI USA, V103, P2404, DOI 10.1073/pnas.0507243103; Seth D, 2011, CURR OPIN CHEM BIOL, V15, P129, DOI 10.1016/j.cbpa.2010.10.012; Shao JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004920; Sun XY, 2012, MOL BIOSYST, V8, P3178, DOI 10.1039/c2mb25280e; Tang YR, 2007, PROTEIN ENG DES SEL, V20, P405, DOI 10.1093/protein/gzm035; Tsang AHK, 2009, P NATL ACAD SCI USA, V106, P4900, DOI 10.1073/pnas.0810595106; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Wu LJ, 2009, STROKE, V40, P2973, DOI 10.1161/STROKEAHA.109.551747; Xiao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030869; Xue Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011290; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Zhang SW, 2008, AMINO ACIDS, V34, P565, DOI 10.1007/s00726-007-0010-9; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001; Zia-ur-Rehman, 2012, PROTEIN PEPTIDE LETT, V19, P890; Zou DS, 2011, J COMPUT CHEM, V32, P271, DOI 10.1002/jcc.21616	66	354	354	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55844	10.1371/journal.pone.0055844	http://dx.doi.org/10.1371/journal.pone.0055844			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409062	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200076
J	Afrane, YA; Zhou, GF; Githeko, AK; Yan, GY				Afrane, Yaw A.; Zhou, Guofa; Githeko, Andrew K.; Yan, Guiyun			Utility of Health Facility-based Malaria Data for Malaria Surveillance	PLOS ONE			English	Article							AFRICAN CHILDREN; TRANSMISSION; AREA; MANAGEMENT; MISDIAGNOSIS; PNEUMONIA; DIAGNOSIS; MORTALITY; OVERLAP; UGANDA	Background: Currently, intensive malaria control programs are being implemented in Africa to reduce the malaria burden. Clinical malaria data from hospitals are valuable for monitoring trends in malaria morbidity and for evaluating the impacts of these interventions. However, the reliability of hospital-based data for true malaria incidence is often questioned because of diagnosis accuracy issues and variation in access to healthcare facilities among sub-groups of the population. This study investigated how diagnosis and treatment practices of malaria cases in hospitals affect reliability of hospital malaria data. Methodology/Principal Findings: The study was undertaken in health facilities in western Kenya. A total of 3,569 blood smears were analyzed after being collected from patients who were requested by clinicians to go to the hospital's laboratory for malaria testing. We applied several quality control measures for clinical malaria diagnosis. We compared our slide reading results with those from the hospital technicians. Among the 3,390 patients whose diagnoses were analyzed, only 36% had clinical malaria defined as presence of any level of parasitaemia and fever. Sensitivity and specificity of clinicians' diagnoses were 60.1% (95% CI: 61.1-67.5) and 75.0% (95% CI: 30.8-35.7), respectively. Among the 980 patients presumptively treated with an anti-malarial by the clinicians without laboratory diagnosis, only 47% had clinical malaria. Conclusions/Significance: These findings revealed substantial over-prescription of anti-malarials and misdiagnosis of clinical malaria. More than half of the febrile cases were not truly clinical malaria, but were wrongly diagnosed and treated as such. Deficiency in malaria diagnosis makes health facility data unreliable for monitoring trends in malaria morbidity and for evaluating impacts of malaria interventions. Improving malaria diagnosis should be a top priority in rural African health centers.	[Afrane, Yaw A.; Githeko, Andrew K.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Climate & Human Hlth Res Unit, Kisumu, Kenya; [Afrane, Yaw A.] Bondo Univ Coll, Sch Hlth Sci, Bondo, Kenya; [Zhou, Guofa; Yan, Guiyun] Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA 92717 USA	Kenya Medical Research Institute; University of California System; University of California Irvine	Yan, GY (corresponding author), Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA 92717 USA.	guiyuny@uci.edu			National Institute of Health [R01 AI094580, D43 TW01505, R01 A150243]; FOGARTY INTERNATIONAL CENTER [D43TW001505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050243, R01AI094580] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institute of Health (R01 AI094580, D43 TW01505 and R01 A150243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Font F, 2001, TROP MED INT HEALTH, V6, P423, DOI 10.1046/j.1365-3156.2001.00727.x; Hume JCC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-33; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; McCombie SC, 2002, HEALTH POLICY PLANN, V17, P333, DOI 10.1093/heapol/17.4.333; Munyekenye OG, 2005, EMERG INFECT DIS, V11, P1571, DOI 10.3201/eid1110.050106; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043[0200:PDOMVI]2.0.CO;2; Ndyomugyenyi R, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-39; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Okech BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004050; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-285; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; *SAS, 1994, JMP US GUID; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wiseman V, 2003, AM J TROP MED HYG, V68, P161, DOI 10.4269/ajtmh.2003.68.161; Zurovac D, 2008, TROP MED INT HEALTH, V13, P784, DOI 10.1111/j.1365-3156.2008.02072.x	21	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e54305	10.1371/journal.pone.0054305	http://dx.doi.org/10.1371/journal.pone.0054305			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418427	Green Published, gold			2022-12-27	WOS:000315970300017
J	Bornmann, L; Leydesdorff, L				Bornmann, Lutz; Leydesdorff, Loet			Macro-Indicators of Citation Impacts of Six Prolific Countries: InCites Data and the Statistical Significance of Trends	PLOS ONE			English	Article								Using the InCites tool of Thomson Reuters, this study compares normalized citation impact values calculated for China, Japan, France, Germany, United States, and the UK throughout the time period from 1981 to 2010. InCites offers a unique opportunity to study the normalized citation impacts of countries using (i) a long publication window (1981 to 2010), (ii) a differentiation in (broad or more narrow) subject areas, and (iii) allowing for the use of statistical procedures in order to obtain an insightful investigation of national citation trends across the years. Using four broad categories, our results show significantly increasing trends in citation impact values for France, the UK, and especially Germany across the last thirty years in all areas. The citation impact of papers from China is still at a relatively low level (mostly below the world average), but the country follows an increasing trend line. The USA exhibits a stable pattern of high citation impact values across the years. With small impact differences between the publication years, the US trend is increasing in engineering and technology but decreasing in medical and health sciences as well as in agricultural sciences. Similar to the USA, Japan follows increasing as well as decreasing trends in different subject areas, but the variability across the years is small. In most of the years, papers from Japan perform below or approximately at the world average in each subject area.	[Bornmann, Lutz] Adm Headquarters Max Planck Soc, Div Sci & Innovat Studies, Munich, Germany; [Leydesdorff, Loet] Univ Amsterdam, Amsterdam Sch Commun Res ASCoR, Amsterdam, Netherlands	Max Planck Society; University of Amsterdam	Bornmann, L (corresponding author), Adm Headquarters Max Planck Soc, Div Sci & Innovat Studies, Munich, Germany.	bornmann@gv.mpg.de	Bornmann, Lutz/A-3926-2008; Leydesdorff, Loet/E-2903-2010	Bornmann, Lutz/0000-0003-0810-7091; Leydesdorff, Loet/0000-0002-7835-3098				Adams J., 2010, GLOBAL RES REPORT; Adler R, 2009, STAT SCI, V24, P1, DOI 10.1214/09-STS285; Bornmann L., 2008, ETHICS SCI ENV POLIT, V2014, DOI [10.3354/esep00084, DOI 10.3354/ESEP00084]; Bornmann L, 2012, J INFORMETR, V6, P333, DOI 10.1016/j.joi.2011.11.006; Bornmann L, 2011, J R STAT SOC A STAT, V174, P857, DOI 10.1111/j.1467-985X.2011.00689.x; Council of Canadian Academies, 2012, INF RES CHOIC IND JU; Department of Business Innovation and Skills-BIS, 2011, INT COMP PERF UK RES; Egghe L, 2012, J INFORMETR, V6, P307, DOI 10.1016/j.joi.2011.12.007; Gingras Y, 2011, J INFORMETR, V5, P226, DOI 10.1016/j.joi.2010.10.005; Glass G.V., 1970, STAT METHODS ED PSYC; InCitesTM Thomson Reuters, 2011, REP CREAT 02 2012 DA; Lariviere V, 2006, SCIENTOMETRICS, V68, P519, DOI 10.1007/s11192-006-0127-8; Leydesdorff L, 2011, J AM SOC INF SCI TEC, V62, P1370, DOI 10.1002/asi.21534; Leydesdorff L, 2009, SCIENTOMETRICS, V78, P23, DOI 10.1007/s11192-008-1830-4; Marshall E, 2011, SCIENCE, V334, P443, DOI 10.1126/science.334.6055.443; National Science Board, 2012, 1201 NSB; Organisation for Economic Co-operation and Development, 2007, REV FIELD SCI TECHN; Research Evaluation and Policy Project, 2005, 051 REPP AUSTR NAT U; Sheskin D. J., 2007, HDB PARAMETRIC NONPA; StataCorp, 2011, STAT STAT SOFTW REL, P173	20	39	41	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56768	10.1371/journal.pone.0056768	http://dx.doi.org/10.1371/journal.pone.0056768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418600	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300193
J	Garringer, HJ; Murrell, J; Sammeta, N; Gnezda, A; Ghetti, B; Vidal, R				Garringer, Holly J.; Murrell, Jill; Sammeta, Neeraja; Gnezda, Anita; Ghetti, Bernardino; Vidal, Ruben			Increased Tau Phosphorylation and Tau Truncation, and Decreased Synaptophysin Levels in Mutant BRI2/Tau Transgenic Mice	PLOS ONE			English	Article							FAMILIAL BRITISH DEMENTIA; STRAUSSLER-SCHEINKER DISEASE; NEUROFIBRILLARY TANGLES; AMYLOID DEPOSITION; ALZHEIMERS-DISEASE; DANISH DEMENTIA; SYNAPSE LOSS; A-BETA; PRECURSOR PROTEIN; MICROGLIAL ACTIVATION	Familial Danish dementia (FDD) is an autosomal dominant neurodegenerative disease caused by a 10-nucleotide duplication-insertion in the BRI2 gene. FDD is clinically characterized by loss of vision, hearing impairment, cerebellar ataxia and dementia. The main neuropathologic findings in FDD are the deposition of Danish amyloid (ADan) and the presence of neurofibrillary tangles (NFTs). Here we investigated tau accumulation and truncation in double transgenic (Tg-FDD-Tau) mice generated by crossing transgenic mice expressing human Danish mutant BRI2 (Tg-FDD) with mice expressing human 4-repeat mutant Tau-P301S (Tg-Tau). Compared to Tg-Tau mice, we observed a significant enhancement of tau deposition in Tg-FDD-Tau mice. In addition, a significant increase in tau cleaved at aspartic acid (Asp) 421 was observed in Tg-FDD-Tau mice. Tg-FDD-Tau mice also showed a significant decrease in synaptophysin levels, occurring before widespread deposition of fibrillar ADan and tau can be observed. Thus, the presence of soluble ADan/mutant BRI2 can lead to significant changes in tau metabolism and synaptic dysfunction. Our data provide new in vivo insights into the pathogenesis of FDD and the pathogenic pathway(s) by which amyloidogenic peptides, regardless of their primary amino acid sequence, can cause neurodegeneration.	[Garringer, Holly J.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA; Indiana Univ Sch Med, Indiana Alzheimer Dis Ctr, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Garringer, HJ (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA.	hjgarrin@iupui.edu; rvidal@iupui.edu			National Institute on Neurological Disorders and Stroke [NS050227]; National Institute on Aging [AG037338, AG10133]; American Health Assistance Foundation [A2008-304]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG037338, P30AG010133] Funding Source: NIH RePORTER	National Institute on Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Health Assistance Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the National Institute on Neurological Disorders and Stroke NS050227 (RV), by the National Institute on Aging AG037338 (RV) and AG10133 (BG), and by the American Health Assistance Foundation A2008-304 (RV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, ACTA NEUROPATHOL, V107, P53, DOI 10.1007/s00401-003-0783-1; Allen B, 2002, J NEUROSCI, V22, P9340; Barbeito AG, 2009, J NEUROCHEM, V109, P1067, DOI 10.1111/j.1471-4159.2009.06028.x; Bellucci A, 2011, NEURODEGENER DIS, V8, P221, DOI 10.1159/000322228; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Boutajangout A, 2004, NEUROBIOL DIS, V15, P47, DOI 10.1016/j.nbd.2003.09.007; Brendza RP, 2003, J COMP NEUROL, V456, P375, DOI 10.1002/cne.10536; Choi SI, 2003, FASEB J, V17, P373, DOI 10.1096/fj.03-0730fje; Coomaraswamy J, 2010, P NATL ACAD SCI USA, V107, P7969, DOI 10.1073/pnas.1001056107; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Delobel P, 2008, AM J PATHOL, V172, P123, DOI 10.2353/ajpath.2008.070627; Dong HX, 2007, J COMP NEUROL, V500, P311, DOI 10.1002/cne.21176; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Garringer HJ, 2010, BRAIN STRUCT FUNCT, V214, P235, DOI 10.1007/s00429-009-0221-9; GHETTI B, 1989, NEUROLOGY, V39, P1453, DOI 10.1212/WNL.39.11.1453; Giaccone G, 2008, NEUROBIOL AGING, V29, P1864, DOI 10.1016/j.neurobiolaging.2007.04.026; GIACCONE G, 1990, BRAIN RES, V530, P325, DOI 10.1016/0006-8993(90)91304-Y; Giliberto L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007900; Goedert M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006254; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Holton JL, 2002, J NEUROPATH EXP NEUR, V61, P254, DOI 10.1093/jnen/61.3.254; Holton JL, 2001, AM J PATHOL, V158, P515, DOI 10.1016/S0002-9440(10)63993-4; Hurtado DE, 2010, AM J PATHOL, V177, P1977, DOI 10.2353/ajpath.2010.100346; Ikeda M, 2005, AM J PATHOL, V166, P521, DOI 10.1016/S0002-9440(10)62274-2; Kim SH, 2002, J BIOL CHEM, V277, P1872, DOI 10.1074/jbc.M108739200; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; Knafo S, 2009, CEREB CORTEX, V19, P586, DOI 10.1093/cercor/bhn111; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Murrell J, 2006, BRAIN PATHOL, V16, pS44; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Sahara N, 2002, J NEUROCHEM, V83, P1498, DOI 10.1046/j.1471-4159.2002.01241.x; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Sasaki A, 2008, BRAIN RES, V1214, P159, DOI 10.1016/j.brainres.2008.02.084; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Spires-Jones TL, 2008, J NEUROSCI, V28, P862, DOI 10.1523/JNEUROSCI.3072-08.2008; STROMGREN E, 1970, ACTA NEUROL SCAND, V46, P261; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; Tamayev R, 2011, EMBO J, V30, P2501, DOI 10.1038/emboj.2011.161; Tamayev R, 2010, P NATL ACAD SCI USA, V107, P20822, DOI 10.1073/pnas.1011689107; Tamayev R, 2010, J NEUROSCI, V30, P14915, DOI 10.1523/JNEUROSCI.3917-10.2010; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 2004, J NEUROPATH EXP NEUR, V63, P787, DOI 10.1093/jnen/63.8.787; Vidal R, 1999, NATURE, V399, P776; Vidal R, 2001, GENE, V266, P95, DOI 10.1016/S0378-1119(01)00374-2; Vidal R, 2008, J NEUROSCI, V28, P60, DOI 10.1523/JNEUROSCI.3962-07.2008; Vidal R, 2012, FASEB J, V26, P2899, DOI 10.1096/fj.12-205542; Vidal R, 2009, BRAIN PATHOL, V19, P58, DOI 10.1111/j.1750-3639.2008.00164.x; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; Worster-Drought C, 1933, J NEUROL PSYCHOPATHO, V14, P27; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang QP, 2009, ACTA NEUROPATHOL, V117, P687, DOI 10.1007/s00401-009-0491-6; Zilka N, 2009, ACTA NEUROPATHOL, V118, P71, DOI 10.1007/s00401-009-0499-y	61	15	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56426	10.1371/journal.pone.0056426	http://dx.doi.org/10.1371/journal.pone.0056426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418567	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300160
J	Yu, YJ; Yang, XJ; Wang, HY; Shi, FX; Liu, Y; Liu, JS; Li, LF; Wang, DL; Liu, B				Yu, Yingjie; Yang, Xuejiao; Wang, Huaying; Shi, Fengxue; Liu, Ying; Liu, Jushan; Li, Linfeng; Wang, Deli; Liu, Bao			Cytosine Methylation Alteration in Natural Populations of Leymus chinensis Induced by Multiple Abiotic Stresses	PLOS ONE			English	Article							ADAPTIVE GENETIC-VARIATION; DNA-METHYLATION; EVOLUTIONARY RESPONSES; EPIGENETIC VARIATION; TRANSPOSON TAM3; CLIMATE-CHANGE; ADAPTATION; CONSEQUENCES; TOLERANCE; TOBACCO	Background: Human activity has a profound effect on the global environment and caused frequent occurrence of climatic fluctuations. To survive, plants need to adapt to the changing environmental conditions through altering their morphological and physiological traits. One known mechanism for phenotypic innovation to be achieved is environment-induced rapid yet inheritable epigenetic changes. Therefore, the use of molecular techniques to address the epigenetic mechanisms underpinning stress adaptation in plants is an important and challenging topic in biological research. In this study, we investigated the impact of warming, nitrogen (N) addition, and warming+nitrogen (N) addition stresses on the cytosine methylation status of Leymus chinensis Tzvel. at the population level by using the amplified fragment length polymorphism (AFLP), methylation-sensitive amplified polymorphism (MSAP) and retrotransposon based sequence-specific amplification polymorphism (SSAP) techniques. Methodology/Principal Findings: Our results showed that, although the percentages of cytosine methylation changes in SSAP are significantly higher than those in MSAP, all the treatment groups showed similar alteration patterns of hypermethylation and hypomethylation. It meant that the abiotic stresses have induced the alterations in cytosine methylation patterns, and the levels of cytosine methylation changes around the transposable element are higher than the other genomic regions. In addition, the identification and analysis of differentially methylated loci (DML) indicated that the abiotic stresses have also caused targeted methylation changes at specific loci and these DML might have contributed to the capability of plants in adaptation to the abiotic stresses. Conclusions/Significance: Our results demonstrated that abiotic stresses related to global warming and nitrogen deposition readily evoke alterations of cytosine methylation, and which may provide a molecular basis for rapid adaptation by the affected plant populations to the changed environments.	[Yu, Yingjie; Liu, Jushan; Wang, Deli] NE Normal Univ, Inst Grassland Sci, Minist Educ, Key Lab Vegetat Ecol, Changchun, Peoples R China; [Yu, Yingjie; Yang, Xuejiao; Wang, Huaying; Shi, Fengxue; Liu, Ying; Li, Linfeng; Liu, Bao] NE Normal Univ, Key Lab Mol Epigenet, Minist Educ, Changchun, Peoples R China; [Yu, Yingjie; Yang, Xuejiao; Wang, Huaying; Shi, Fengxue; Liu, Ying; Li, Linfeng; Liu, Bao] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Northeast Normal University - China	Li, LF (corresponding author), NE Normal Univ, Key Lab Mol Epigenet, Minist Educ, Changchun, Peoples R China.	lilf241@nenu.edu.cn; wangd@nenu.edu.cn		Liu, Bao/0000-0001-5481-1675; zakaria, seyed moein/0000-0002-0086-1279	Programme for Introducing Talents to Universities [B07017]; National Natural Science Foundation of China [30870178, 31100157, 31230012]; Fundamental Research Funds for the Central Universities [10QNJJ011, 11CXPY003]	Programme for Introducing Talents to Universities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by the Programme for Introducing Talents to Universities (B07017), National Natural Science Foundation of China (30870178, 31100157 and 31230012) and Fundamental Research Funds for the Central Universities (10QNJJ011, 11CXPY003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Beguiristain T, 2001, PLANT PHYSIOL, V127, P212, DOI 10.1104/pp.127.1.212; Bijlsma R, 2005, J EVOLUTION BIOL, V18, P744, DOI 10.1111/j.1420-9101.2005.00962.x; Bouwman AF, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003576; Boyko A, 2008, ENVIRON MOL MUTAGEN, V49, P61, DOI 10.1002/em.20347; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Davis MB, 2005, ECOLOGY, V86, P1704, DOI 10.1890/03-0788; Dong ZY, 2006, THEOR APPL GENET, V113, P196, DOI 10.1007/s00122-006-0286-2; Doyle J. J., 1987, PHYTOCHEM B, P11; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Gao Y, 2008, ENVIRON EXP BOT, V63, P113, DOI 10.1016/j.envexpbot.2007.10.030; Grativol C, 2011, BIOCHIM BIOPHYS ACTA, V1819, P176; Hashida S, 2003, PLANT PHYSIOL, V132, P1207, DOI 10.1104/pp.102.017533; Hashida SN, 2006, PLANT CELL, V18, P104, DOI 10.1105/tpc.105.037655; Herrera CM, 2011, MOL ECOL, V20, P1675, DOI 10.1111/j.1365-294X.2011.05026.x; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; Huang NC, 2010, PLANT SCI, V178, P41, DOI 10.1016/j.plantsci.2009.10.005; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kalendar R, 2000, P NATL ACAD SCI USA, V97, P6603, DOI 10.1073/pnas.110587497; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Katori T, 2010, J EXP BOT, V61, P1125, DOI 10.1093/jxb/erp376; Keyte AL, 2006, J HERED, V97, P444, DOI 10.1093/jhered/esl023; Kim JM, 2010, PLANT CELL ENVIRON, V33, P604, DOI 10.1111/j.1365-3040.2009.02076.x; Kovarik A, 1997, THEOR APPL GENET, V95, P301, DOI 10.1007/s001220050563; Lai CP, 2004, PLANT PHYSIOL, V134, P1586, DOI 10.1104/pp.103.037820; Lang-Mladek C, 2010, MOL PLANT, V3, P594, DOI 10.1093/mp/ssq014; Li YD, 2008, ECOL RES, V23, P927, DOI 10.1007/s11284-007-0459-8; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; LOVEJOY TE, 2004, CLIMATE CHANGE BIODI; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Manel S, 2010, MOL ECOL, V19, P3824, DOI 10.1111/j.1365-294X.2010.04716.x; Manel S, 2012, MOL ECOL, V21, P3729, DOI 10.1111/j.1365-294X.2012.05656.x; Manel S, 2010, MOL ECOL, V19, P3760, DOI 10.1111/j.1365-294X.2010.04717.x; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Morin X, 2008, J ECOL, V96, P784, DOI 10.1111/j.1365-2745.2008.01369.x; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Niu SL, 2011, GLOBAL CHANGE BIOL, V17, P1073, DOI 10.1111/j.1365-2486.2010.02280.x; Ohta M, 2000, PLANT J, V22, P29, DOI 10.1046/j.1365-313x.2000.00709.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Qi B, 2010, J GENET GENOMICS, V37, P737, DOI 10.1016/S1673-8527(09)60091-6; Rapp RA, 2005, NEW PHYTOL, V168, P81, DOI 10.1111/j.1469-8137.2005.01491.x; Reusch TBH, 2007, MOL ECOL, V16, P3973, DOI 10.1111/j.1365-294X.2007.03454.x; Richards EJ, 2011, CURR OPIN PLANT BIOL, V14, P204, DOI 10.1016/j.pbi.2011.03.009; Roy SJ, 2011, CURR OPIN PLANT BIOL, V14, P232, DOI 10.1016/j.pbi.2011.03.002; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; Santos AP, 2011, CYTOGENET GENOME RES, V132, P297, DOI 10.1159/000322287; Savolainen O, 2004, FOREST ECOL MANAG, V197, P79, DOI 10.1016/j.foreco.2004.05.006; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Sha AH, 2005, MOL GENET GENOMICS, V273, P484, DOI 10.1007/s00438-005-1148-3; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Trontin C, 2011, CURR OPIN PLANT BIOL, V14, P225, DOI 10.1016/j.pbi.2011.03.024; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wan SQ, 2009, ECOLOGY, V90, P2700, DOI 10.1890/08-2026.1; Wang YM, 2005, GENETICS, V170, P1945, DOI 10.1534/genetics.105.040964; Yaish MW, 2011, J EXP BOT, V62, P3727, DOI 10.1093/jxb/err177; Yakovlev IA, 2011, PLANT SCI, V180, P132, DOI 10.1016/j.plantsci.2010.07.004; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhu TC, 2004, BIOL ECOLOGY, P523	76	32	36	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55772	10.1371/journal.pone.0055772	http://dx.doi.org/10.1371/journal.pone.0055772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418457	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300048
J	Chen, AP; Chu, W; Gu, YP; Cunnhingham, CH				Chen, Albert P.; Chu, William; Gu, Yi-Ping; Cunnhingham, Charles H.			Probing Early Tumor Response to Radiation Therapy Using Hyperpolarized [1-C-13]pyruvate in MDA-MB-231 Xenografts	PLOS ONE			English	Article							IN-VIVO; ACCELERATED SENESCENCE; GROWTH-FACTOR; CANCER-CELLS; ANGIOGENESIS; METABOLISM; CARCINOMA; PATHWAYS; SPECTROSCOPY; RADIOTHERAPY	Following radiation therapy (RT), tumor morphology may remain unchanged for days and sometimes weeks, rendering anatomical imaging methods inadequate for early detection of therapeutic response. Changes in the hyperpolarized [1-C-13]lactate signals observed in vivo following injection of pre-polarized [1-C-13]pyruvate has recently been shown to be a marker for tumor progression or early treatment response. In this study, the feasibility of using C-13 metabolic imaging with [1-C-13]pyruvate to detect early radiation treatment response in a breast cancer xenograft model was demonstrated in vivo and in vitro. Significant decreases in hyperpolarized [1-C-13]lactate relative to [1-C-13]pyruvate were observed in MDA-MB-231 tumors 96 hrs following a single dose of ionizing radiation. Histopathologic data from the treated tumors showed higher cellular apoptosis and senescence; and changes in the expression of membrane monocarboxylate transporters and lactate dehydrogenase B were also observed. Hyperpolarized C-13 metabolic imaging may be a promising new tool to develop novel and adaptive therapeutic regimens for patients undergoing RT.	[Chen, Albert P.] GE Healthcare, Toronto, ON, Canada; [Chu, William] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Gu, Yi-Ping; Cunnhingham, Charles H.] Sunnybrook Hlth Sci Ctr, Imaging Res, Toronto, ON M4N 3M5, Canada; [Cunnhingham, Charles H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	General Electric; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Chen, AP (corresponding author), GE Healthcare, Toronto, ON, Canada.	Albert.Chen@ge.com	Cunningham, Charles H/ABD-4550-2021	Cunningham, Charles/0000-0001-9636-8130	Ontario Institute for Cancer Research; Canadian Institutes of Health Research; GE Healthcare	Ontario Institute for Cancer Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); GE Healthcare(General ElectricGE Healthcare)	Ontario Institute for Cancer Research, the Canadian Institutes of Health Research and GE Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers M, 2007, CANCER RES, V68, P8607; Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Bohndiek SE, 2012, CANCER RES, V72, P854, DOI 10.1158/0008-5472.CAN-11-2795; Bourboulia D, 2011, AM J PATHOL, V179, P2589, DOI 10.1016/j.ajpath.2011.07.035; Bussink J, 2011, NAT REV CLIN ONCOL, V8, P233, DOI 10.1038/nrclinonc.2010.218; Chen AP, 2011, NMR BIOMED, V24, P514, DOI 10.1002/nbm.1618; Cunningham CH, 2008, J MAGN RESON, V193, P139, DOI 10.1016/j.jmr.2008.03.012; Dafni H, 2010, CANCER RES, V70, P7400, DOI 10.1158/0008-5472.CAN-10-0883; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; Day SE, 2011, MAGN RESON MED, V65, P557, DOI 10.1002/mrm.22698; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gewirtz DA, 2008, BIOCHEM PHARMACOL, V76, P947, DOI 10.1016/j.bcp.2008.06.024; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heimann R, 2000, EUR J CANCER, V36, P1631, DOI 10.1016/S0959-8049(00)00151-9; HOWARD RB, 1991, CANCER RES, V51, P3274; Hurd RE, 2010, J CEREBR BLOOD F MET, V30, P1734, DOI 10.1038/jcbfm.2010.93; Hurkmans CW, 2012, RADIOTHER ONCOL, V103, P183, DOI 10.1016/j.radonc.2011.12.014; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Jones KR, 2005, INT J RADIAT BIOL, V81, P445, DOI 10.1080/09553000500168549; Ko EC, 2011, CANCER RADIOTHER, V15, P221, DOI 10.1016/j.canrad.2010.12.007; Kohler SJ, 2007, MAGN RESON MED, V58, P65, DOI 10.1002/mrm.21253; Kurtz JM, 2006, CLIN ONCOL-UK, V18, P162, DOI 10.1016/j.clon.2005.11.007; Larson PEZ, 2008, J MAGN RESON, V194, P121, DOI 10.1016/j.jmr.2008.06.010; Lau AZ, 2011, NMR BIOMED, V24, P988, DOI 10.1002/nbm.1743; Lund EL, 2000, CLIN CANCER RES, V6, P4287; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Messa C, 2006, Q J NUCL MED MOL IM, V50, P4; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Park I, 2011, J MAGN RESON IMAGING, V33, P1284, DOI 10.1002/jmri.22563; Robertson FM, 2007, ANTICANCER RES, V27, P719; Schoder H, 2009, J NUCL MED, V50, p74S, DOI 10.2967/jnumed.108.057208; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Sirover MA, 2012, J CELL BIOCH; Tei K, 2002, CANCER RES, V62, P6289; Tinkey P T, 1999, Sarcoma, V3, P129, DOI 10.1080/13577149977767; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wilson DM, 2010, J MAGN RESON, V205, P141, DOI 10.1016/j.jmr.2010.04.012; Witney TH, 2010, BRIT J CANCER, V103, P1400, DOI 10.1038/sj.bjc.6605945; Woo M, 2006, BIOMEDICAL IMAGING I, V2	44	53	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56551	10.1371/journal.pone.0056551	http://dx.doi.org/10.1371/journal.pone.0056551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424666	Green Published, Green Submitted, gold			2022-12-27	WOS:000315965100054
J	Li, D; Wang, X; Wu, JL; Quan, WQ; Ma, L; Yang, F; Wu, KY; Wan, HY				Li, Dong; Wang, Xuan; Wu, Jun-Lu; Quan, Wen-Qiang; Ma, Li; Yang, Fan; Wu, Kai-Yin; Wan, Hai-Ying			Tumor-Produced Versican V1 Enhances hCAP18/LL-37 Expression in Macrophages through Activation of TLR2 and Vitamin D3 Signaling to Promote Ovarian Cancer Progression In Vitro	PLOS ONE			English	Article							PUTATIVE GROWTH-FACTOR; MYELOID CELLS; INFLAMMATORY CYTOKINES; BREAST-CANCER; PEPTIDE LL-37; INVASIVENESS; RECEPTOR; PROLIFERATION; INTERLEUKIN-6; TRANSDUCTION	Tumor-associated macrophages have been shown to promote tumor growth. They may have an obligatory function in angiogenesis, invasion, and metastasis through release of inflammatory mediators. Their presence in ovarian cancer has been correlated with poor prognosis in these patients. The human cationic antimicrobial protein-18 (hCAP18)/LL-37 was originally identified as an effector molecule of the innate immune system. It is released by innate immune cells, such as macrophages, to combat microorganisms. Previous studies have characterized the hCAP18/LL-37 as a growth factor that has been shown to promote ovarian tumor progression. However, the role hCAP18/LL-37 has in macrophage-promoted ovarian tumor development and how its expression is controlled in this context remains poorly understood. Here, we demonstrate in co-culture experiments of macrophages and ovarian cancer cells a significant increase in the in vitro proliferation and invasiveness of the tumor cells is observed. These enhanced growth and invasion properties correlated with hCAP18/LL-37 induction. HCAP18/LL-37 expression was diminished by addition of two neutralizing antibodies, TLR2 or TLR6, as well as Cyp27B1 or VDR inhibitors. Furthermore, either the TLR2 or TLR6 antibody reduced vitamin D3 signaling and tumor cell progression in vitro. Addition of Cyp27B1 or VDR inhibitors abrogated TLR2/6 activation-induced expression of hCAP18/LL-37 in macrophages. Knockdown of tumor-produced versican V1 by RNAi in these tumor cells led to a decreased induction of hCAP18/LL-37 in macrophages. Versican V1 knockdown also inhibited TLR2 and vitamin D3 signaling, as well as growth and invasiveness of these tumor cells in the in vitro co-culture. In summary, we have found that versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and subsequent vitamin D-dependent mechanisms which promote ovarian tumor progression in vitro.	[Li, Dong; Wu, Jun-Lu; Quan, Wen-Qiang; Ma, Li; Yang, Fan; Wan, Hai-Ying] Tongji Univ, Tongji Hosp, Dept Clin Lab, Shanghai 200092, Peoples R China; [Wang, Xuan] Putuo Peoples Hosp, Dept Pharm, Shanghai, Peoples R China; [Wu, Kai-Yin] Charite, Inst Pathol, Berlin, Germany	Tongji University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wan, HY (corresponding author), Tongji Univ, Tongji Hosp, Dept Clin Lab, Shanghai 200092, Peoples R China.	186ldwx@googlemail.com			National Natural Science Foundation of China Grants [81272603]; Research Program of the Committee of Science and Technology of Putuo District, Shanghai [PTKW09-B02]	National Natural Science Foundation of China Grants(National Natural Science Foundation of China (NSFC)); Research Program of the Committee of Science and Technology of Putuo District, Shanghai	This work was supported by National Natural Science Foundation of China Grants (81272603); Research Program of the Committee of Science and Technology of Putuo District, Shanghai (PTKW09-B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beisswenger Christoph, 2005, V86, P55, DOI 10.1159/000086651; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bucki R, 2010, ARCH IMMUNOL THER EX, V58, P15, DOI 10.1007/s00005-009-0057-2; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Coffelt SB, 2008, CANCER RES, V68, P6482, DOI 10.1158/0008-5472.CAN-08-0044; Coffelt SB, 2008, INT J CANCER, V122, P1030, DOI 10.1002/ijc.23186; Coffelt SB, 2009, MOL CANCER RES, V7, P907, DOI 10.1158/1541-7786.MCR-08-0326; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Erdag G, 2002, ANN SURG, V235, P113, DOI 10.1097/00000658-200201000-00015; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Hagemann T, 2004, CARCINOGENESIS, V25, P1543, DOI 10.1093/carcin/bgh146; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hagemann T, 2009, BLOOD, V113, P3139, DOI 10.1182/blood-2008-12-172825; Heilborn JD, 2005, INT J CANCER, V114, P713, DOI 10.1002/ijc.20795; Hensel JA, 2011, PROSTATE, V71, P659, DOI 10.1002/pros.21282; Hess C, 2010, EUR RESPIR J, V35, P343, DOI 10.1183/09031936.00196408; Kim JE, 2010, BRIT J DERMATOL, V163, P959, DOI 10.1111/j.1365-2133.2010.09957.x; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Koukourakis MI, 1998, BRIT J CANCER, V77, P1696, DOI 10.1038/bjc.1998.280; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Ricciardelli C, 2006, SEMIN REPROD MED, V24, P270, DOI 10.1055/s-2006-948556; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Shaykhiev R, 2005, AM J PHYSIOL-LUNG C, V289, pL842, DOI 10.1152/ajplung.00286.2004; Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583; Standiford TJ, 2011, ONCOGENE, V30, P2475, DOI 10.1038/onc.2010.619; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; von Haussen J, 2008, LUNG CANCER, V59, P12, DOI 10.1016/j.lungcan.2007.07.014; Voutilainen K, 2003, INT J CANCER, V107, P359, DOI 10.1002/ijc.11423; Wu WKK, 2010, INT J CANCER, V127, P1741, DOI 10.1002/ijc.25489; Xiao S, 2006, P NATL ACAD SCI USA, V103, P16448, DOI 10.1073/pnas.0607830103; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x	40	48	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56616	10.1371/journal.pone.0056616	http://dx.doi.org/10.1371/journal.pone.0056616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424670	gold, Green Submitted, Green Published			2022-12-27	WOS:000315965100058
J	Rashed, A; Kwan, J; Baraff, B; Ling, D; Daugherty, MP; Killiny, N; Almeida, RPP				Rashed, Arash; Kwan, Joyce; Baraff, Breanna; Ling, Diane; Daugherty, Matthew P.; Killiny, Nabil; Almeida, Rodrigo P. P.			Relative Susceptibility of Vitis vinifera Cultivars to Vector-Borne Xylella fastidiosa through Time	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; PIERCES DISEASE BACTERIUM; ARABIDOPSIS-THALIANA; GENETIC-VARIATION; RESISTANCE; GRAPEVINE; PLANT; TRANSMISSION; PREFERENCE; TOLERANCE	Understanding the interactions between pathogen, crop and vector are necessary for the development of disease control practices of vector-borne pathogens. For instance, resistant plant genotypes can help constrain disease symptoms due to infections and limit pathogen spread by vectors. On the other hand, genotypes susceptible to infection may increase pathogen spread owing to their greater pathogen quantity, regardless of their symptom status. In this study, we evaluated under greenhouse conditions the relative levels of resistance (i.e. relatively lower pathogen quantity) versus tolerance (i.e. less symptom severity) of 10 commercial grapevine (Vitis vinifera) cultivars to Pierce's disease etiological agent, the bacterium Xylella fastidiosa. Overall, no correlation was detected between pathogen quantity and disease severity, indicating the existence of among-cultivar variation in plant response to infection. Thompson Seedless and Barbera were the two most susceptible among 10 evaluated cultivars. Rubired showed the least severe disease symptoms and was categorized as one of the most resistant genotypes in this study. However, within each cultivar the degree of resistance/tolerance was not consistent across sampling dates. These cultivar and temporal differences in susceptibility to infection may have important consequences for disease epidemiology and the effectiveness of management protocols.	[Rashed, Arash; Kwan, Joyce; Baraff, Breanna; Ling, Diane; Almeida, Rodrigo P. P.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Daugherty, Matthew P.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Killiny, Nabil] Univ Florida, Dept Entomol & Nematol, Citrus Res & Educ Ctr, IFAS, Lake Alfred, FL USA	University of California System; University of California Berkeley; University of California System; University of California Riverside; State University System of Florida; University of Florida	Rashed, A (corresponding author), Texas A&M AgriLife Res & Extens Ctr, Amarillo, TX USA.	arashed@ag.tamu.edu	Almeida, Rodrigo/GZH-0682-2022	Killiny, Nabil/0000-0002-3895-6943; Almeida, Rodrigo/0000-0003-2888-9617	California Department of Food and Agriculture, Pierce's Disease Research Grant Program [CDFA 08-0173, 2010-34442-21101]; United States Department of Agriculture (USDA-CSREES) [2009-05174]	California Department of Food and Agriculture, Pierce's Disease Research Grant Program; United States Department of Agriculture (USDA-CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This study was funded by California Department of Food and Agriculture, Pierce's Disease Research Grant Program (CDFA 08-0173 to RPPA, and 2010-34442-21101 to MPD), and United States Department of Agriculture (USDA-CSREES #2009-05174 to MPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves E, 2004, J PHYTOPATHOL, V152, P291, DOI 10.1111/j.1439-0434.2004.00843.x; ANDERSON TR, 1986, PLANT DIS, V70, P468, DOI 10.1094/PD-70-468; Baccari C, 2011, PHYTOPATHOLOGY, V101, P77, DOI 10.1094/PHYTO-04-10-0104; Blua M. J., 1999, California Agriculture, V53, P22, DOI 10.3733/ca.v053n02p22; BLUA MJ, 1992, ENVIRON ENTOMOL, V21, P578, DOI 10.1093/ee/21.3.578; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Crawley M. J., 2009, R BOOK; Daugherty MP, 2009, ANN APPL BIOL, V155, P361, DOI 10.1111/j.1744-7348.2009.00346.x; Daugherty MP, 2011, ECOL ENTOMOL, V36, P654, DOI 10.1111/j.1365-2311.2011.01309.x; Daugherty MP, 2010, ECOL ENTOMOL, V35, P360, DOI 10.1111/j.1365-2311.2010.01189.x; Feil H, 2001, PLANT DIS, V85, P1230, DOI 10.1094/PDIS.2001.85.12.1230; Francis M, 2006, EUR J PLANT PATHOL, V115, P203, DOI 10.1007/s10658-006-9009-4; Fritschi FB, 2008, PLANT DIS, V92, P276, DOI 10.1094/PDIS-92-2-0276; Fritschi FB, 2007, AM J ENOL VITICULT, V58, P326; FRY SM, 1990, PHYTOPATHOLOGY, V80, P61, DOI 10.1094/Phyto-80-61; Goss EM, 2006, EVOLUTION, V60, P1562, DOI 10.1111/j.0014-3820.2006.tb00501.x; Guilhabert MR, 2005, MOL PLANT MICROBE IN, V18, P856, DOI 10.1094/MPMI-18-0856; Hewitt Wm. B., 1942, CALIFORNIA AGRIC EXP STA CIRC, V353, P1; HILL BL, 1995, PHYTOPATHOLOGY, V85, P1368, DOI 10.1094/Phyto-85-1368; Hill BL, 1997, PHYTOPATHOLOGY, V87, P1197, DOI 10.1094/PHYTO.1997.87.12.1197; HOPKINS DL, 1989, ANNU REV PHYTOPATHOL, V27, P271, DOI 10.1146/annurev.py.27.090189.001415; HOPKINS DL, 1981, PHYTOPATHOLOGY, V71, P415, DOI 10.1094/Phyto-71-415; Hopkins DL, 2002, PLANT DIS, V86, P1056, DOI 10.1094/PDIS.2002.86.10.1056; Kolmer JA, 1996, ANNU REV PHYTOPATHOL, V34, P435, DOI 10.1146/annurev.phyto.34.1.435; Kover PX, 2002, P NATL ACAD SCI USA, V99, P11270, DOI 10.1073/pnas.102288999; Krivanek AF, 2005, PHYTOPATHOLOGY, V95, P44, DOI 10.1094/PHYTO-95-0044; Krivanek AF, 2005, PHYTOPATHOLOGY, V95, P36, DOI 10.1094/PHYTO-95-0036; Laine AL, 2007, J EVOLUTION BIOL, V20, P2371, DOI 10.1111/j.1420-9101.2007.01406.x; Laine AL, 2011, J ECOL, V99, P96, DOI 10.1111/j.1365-2745.2010.01738.x; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075; MCELHANY P, 1995, ECOLOGY, V76, P444, DOI 10.2307/1941203; Meung H, 2003, PLANT DIS, V87, P1156, DOI 10.1094/PDIS.2003.87.10.1156; Newman KL, 2003, APPL ENVIRON MICROB, V101, P1737; Purcell A., 2001, Pesticide Outlook, V12, P199, DOI 10.1039/b108599a; Purcell A. H., 1997, Journal of Plant Pathology, V79, P99; PURCELL AH, 1974, AM J ENOL VITICULT, V25, P162; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; RAJU BC, 1981, AM J ENOL VITICULT, V32, P155; Rashed A, 2011, ENVIRON ENTOMOL, V40, P1192, DOI 10.1603/EN11108; Restif O, 2004, AM NAT, V164, pE90, DOI 10.1086/423713; Sisterson MS, 2008, J ECON ENTOMOL, V101, P1, DOI 10.1603/0022-0493(2008)101[1:EOIPFH]2.0.CO;2; Sorensen JT, 1996, PAN-PAC ENTOMOL, V72, P160; Stenger DC, 2010, VIROLOGY, V407, P53, DOI 10.1016/j.virol.2010.08.002; TYSON GE, 1985, PHYTOPATHOLOGY, V75, P264, DOI 10.1094/Phyto-75-264	45	18	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55326	10.1371/journal.pone.0055326	http://dx.doi.org/10.1371/journal.pone.0055326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424629	Green Published, gold, Green Submitted			2022-12-27	WOS:000315965100017
J	Liu, YS; Zhao, Y; Zhang, X; Chen, T; Zhao, XH; Ma, GE; Zhou, YS				Liu, Yunsong; Zhao, Yan; Zhang, Xiao; Chen, Tong; Zhao, Xianghui; Ma, Gui-e; Zhou, Yongsheng			Flow Cytometric Cell Sorting and In Vitro Pre-Osteoinduction Are Not Requirements for In Vivo Bone Formation by Human Adipose-Derived Stromal Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; TISSUE REGENERATION; CALVARIAL DEFECTS; GROWTH-FACTOR; SCAFFOLDS; MARROW; ENHANCEMENT; REPAIR; INDUCTION	Human adipose-derived stromal cells (hASCs) are a promising cell source for bone tissue engineering. However, before the clinical application of hASCs for the treatment of bone defects, key questions require answers, including whether pre-osteoinduction (OI) and flow cytometric cell purification are indispensible steps for in vivo bone formation by hASCs. In this study, hASCs were purified by flow cytometric cell sorting (FCCS). The osteogenic capabilities of hASCs and purified hASCs with or without pre-osteoinduction were examined through in vitro and in vivo experiments. We found that pre-OI enhanced the in vitro osteogenic capacity of hASCs. However, 8 weeks after in vivo implantation, there were no significant differences between hASCs and hASCs that had undergone OI (hASCs+OI) or between purified hASCs and purified hASCs+OI (P>0.05). Interestingly, we also found that purified hASCs had an osteogenic potential similar to that of unpurified hASCs in vitro and in vivo. These results suggest that FCCS and in vitro pre-OI are not requirements for in vivo bone formation by hASCs.	[Liu, Yunsong; Zhang, Xiao; Chen, Tong; Zhao, Xianghui; Zhou, Yongsheng] Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing 100871, Peoples R China; [Zhao, Yan] Peking Univ, Sch & Hosp Stomatol, Clin Branch 2, Beijing 100871, Peoples R China; [Ma, Gui-e] Chinese Acad Med Sci, Plast Surg Hosp, Body Sculpture Ctr, Beijing 100730, Peoples R China	Peking University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS	Zhou, YS (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Prosthodont, Beijing 100871, Peoples R China.	kqzhouysh@hsc.pku.edu.cn			National Natural Science Foundation of China [30901693, 81170937]; Program for New Century Excellent Talents in University from Ministry of Education [BMU20110274]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University from Ministry of Education(Program for New Century Excellent Talents in University (NCET))	This study was supported by grants from the National Natural Science Foundation of China (No. 30901693, No. 81170937), http://www.nsfc.gov.cn/Portal0/default152.htm. This study was also supported by the Program for New Century Excellent Talents in University from Ministry of Education (BMU20110274), http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/A16/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Battah F, 2011, THESCIENTIFICWORLDJO, V11, P1568, DOI [10.1100/tsw.2011.146., 10.1100/tsw.2011.146]; Amos PJ, 2008, ANN PLAS SURG, V60, P437, DOI 10.1097/SAP.0b013e318095a771; Behr B, 2011, STEM CELLS, V29, P286, DOI 10.1002/stem.581; Cheng NC, 2012, J BIOMED MATER RES B, V100B, P1369, DOI 10.1002/jbm.b.32706; Coelho PG, 2009, MAT SCI ENG C-MATER, V29, P2085, DOI 10.1016/j.msec.2009.04.013; Cooper MS, 1999, J ENDOCRINOL, V163, P159, DOI 10.1677/joe.0.1630159; Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Csaki C, 2007, HISTOCHEM CELL BIOL, V128, P507, DOI 10.1007/s00418-007-0337-z; Dudas JR, 2006, ANN PLAS SURG, V56, P543, DOI 10.1097/01.sap.0000210629.17727.bd; Endres M, 2003, TISSUE ENG, V9, P689, DOI 10.1089/107632703768247386; Fan ZP, 2009, NAT CELL BIOL, V11, P1002, DOI 10.1038/ncb1913; Ge WS, 2011, STEM CELLS, V29, P1112, DOI 10.1002/stem.663; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019; Hong JM, 2012, ACTA BIOMATER, V8, P2578, DOI 10.1016/j.actbio.2012.03.041; Kang JM, 2012, ACTA BIOMATER, V8, P1759, DOI 10.1016/j.actbio.2012.01.005; Kim HP, 2012, CURR STEM CELL RES T, V7, P165; Levi B, 2011, STEM CELLS, V29, P576, DOI 10.1002/stem.612; Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177; Li XM, 2011, J BIOMED MATER RES B, V97B, P10, DOI 10.1002/jbm.b.31773; Li XY, 2010, ARTIF ORGANS, V34, P46, DOI 10.1111/j.1525-1594.2009.00795.x; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Liu YS, 2008, BIOMATERIALS, V29, P3338, DOI 10.1016/j.biomaterials.2008.04.037; Locke M, 2011, STEM CELLS, V29, P404, DOI 10.1002/stem.593; Lu ZF, 2012, NANOMED-NANOTECHNOL, V8, P507, DOI 10.1016/j.nano.2011.07.012; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Monaco E, 2011, THERIOGENOLOGY, V75, P1381, DOI 10.1016/j.theriogenology.2010.11.020; Morelhao SL, 2010, EUR BIOPHYS J BIOPHY, V39, P861, DOI 10.1007/s00249-009-0541-y; Niemeyer P, 2008, CYTOTHERAPY, V10, P784, DOI 10.1080/14653240802419302; Niemeyer P, 2007, TISSUE ENG, V13, P111, DOI 10.1089/ten.2006.0114; Phinney DG, 2007, CELL CYCLE, V6, P2884, DOI 10.4161/cc.6.23.5095; Rada T, 2011, STEM CELL REV REP, V7, P64, DOI 10.1007/s12015-010-9147-0; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Santo VE, 2012, J CONTROL RELEASE, V162, P19, DOI 10.1016/j.jconrel.2012.06.001; Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589; Szpalski C, 2012, J CRANIOFAC SURG, V23, P638, DOI 10.1097/SCS.0b013e31824db8d4; Xu JJ, 2012, CELL TRANSPLANT, V21, P1679, DOI 10.3727/096368911X637434; Ying XZ, 2012, INT ORTHOP, V36, P647, DOI 10.1007/s00264-011-1303-x; Yuan J, 2007, BIOMATERIALS, V28, P1005, DOI 10.1016/j.biomaterials.2006.10.015; Zhou YL, 2011, TISSUE ENG PT A, V17, P2981, DOI 10.1089/ten.tea.2010.0707; Zhou YS, 2006, CHINESE MED J-PEKING, V119, P1278, DOI 10.1097/00029330-200608010-00008; Zhou YS, 2010, BIOMATERIALS, V31, P5325, DOI 10.1016/j.biomaterials.2010.03.037; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	46	60	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56002	10.1371/journal.pone.0056002	http://dx.doi.org/10.1371/journal.pone.0056002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409111	Green Published, Green Submitted, gold			2022-12-27	WOS:000315100000037
J	van der Groep, P; van Diest, PJ; Smolders, YHCM; Ausems, MGEM; van der Luijt, RB; Menko, FH; Bart, J; de Vries, EGE; van der Wall, E				van der Groep, Petra; van Diest, Paul J.; Smolders, Yvonne H. C. M.; Ausems, Margreet G. E. M.; van der Luijt, Rob B.; Menko, Fred H.; Bart, Joost; de Vries, Elisabeth G. E.; van der Wall, Elsken			HIF-1 alpha Overexpression in Ductal Carcinoma In Situ of the Breast in BRCA1 and BRCA2 Mutation Carriers	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; COMPARATIVE GENOMIC HYBRIDIZATION; BASAL EPITHELIAL PHENOTYPE; GROWTH-FACTOR EXPRESSION; MOLECULAR CLASSIFICATION; ESTROGEN-RECEPTOR; REDUCES HYPOXIA; HIGH PREVALENCE; TUMOR-GROWTH; CANCER	Recent studies have revealed that BRCA1 and BRCA2 germline mutation-related breast cancers show frequent overexpression of hypoxia inducible factor-1 alpha (HIF-1 alpha), the key regulator of the hypoxia response. However, the question remained whether hypoxia is a late stage bystander or a true carcinogenetic event in patients with hereditary predisposition. We therefore studied HIF-1 alpha overexpression in ductal carcinoma in situ (DCIS), an established precursor of invasive breast cancer. We used immunohistochemistry to examine the expression of the hypoxia markers HIF-1 alpha, CAIX and Glut-1 in DCIS and available invasive carcinoma lesions of 32 BRCA1, 16 BRCA2 and 77 non-BRCA mutation-related cases. HIF-1 alpha expression was detected in 63% of BRCA1 and 62% of BRCA2 as compared to 34% of non-BRCA mutation-related DCIS cases (p = 0.005). CAIX overexpression was present in 56% of BRCA1 and 44% of BRCA2 as compared to 6% of non-BRCA mutation-related DCIS cases (p = 0.000). Glut-1 overexpression was observed in 59% of BRCA1, 75% of BRCA2 and 67% of non-BRCA mutation-related DCIS cases (p = 0.527). Overall, HIF-1 alpha, CAIX and Glut-1 expression in BRCA mutation-related DCIS matched the expression in the accompanying invasive cancers in 60% or more of cases. In non-BRCA mutation-related cases the expression of the hypoxia markers in DCIS matched the expression in the invasive part in 46% or more of the cases. Although BRCA1 and BRCA2 germline mutation-related invasive breast cancers are different in many ways, the hypoxia-related proteins HIF-1 alpha, CAIX and Glut-1 are expressed in both DCIS and invasive lesions of BRCA1 and BRCA2 mutation carriers. This suggests that hypoxia may already play a role in the DCIS stage of BRCA1 and BRCA2 germline mutation related breast carcinogenesis, and may also drive cancer progression. Hypoxia-related proteins are therefore putative targets for therapy and molecular imaging for early detection and monitoring therapy response in BRCA mutation patients.	[van der Groep, Petra; van Diest, Paul J.; Smolders, Yvonne H. C. M.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van der Groep, Petra; van der Wall, Elsken] Univ Med Ctr Utrecht, Dept Internal Med, Utrecht, Netherlands; [Ausems, Margreet G. E. M.; van der Luijt, Rob B.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Menko, Fred H.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Bart, Joost] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands; [de Vries, Elisabeth G. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Groningen; University of Groningen	van der Groep, P (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands.	p.vandergroep@umcutrecht.nl	Bart, Joost/A-5642-2013	Bart, Joost/0000-0002-0985-071X; de Vries, Elisabeth/0000-0002-8949-7425; van der Luijt, Rob/0000-0002-0018-1089	Aegon Inc; Pink Ribbon The Netherlands; Aegon	Aegon Inc; Pink Ribbon The Netherlands(Netherlands Government); Aegon	This study has been supported by unrestricted educational grants from Aegon Inc and Pink Ribbon The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received an unrestricted educational grant from Aegon. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abdelmohsen K, 2008, P NATL ACAD SCI USA, V105, P20297, DOI 10.1073/pnas.0809376106; Alvarez S, 2005, CLIN CANCER RES, V11, P1146; Arun B, 2009, CANCER PREV RES, V2, P122, DOI 10.1158/1940-6207.CAPR-08-0050; Bane AL, 2009, BREAST CANCER RES TR, V117, P183, DOI 10.1007/s10549-008-0087-1; Blum R, 2005, CANCER RES, V65, P999; Boecker W, 2006, PRENEOPLASIA BREAST, pp407; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Bos R, 2002, J CLIN ONCOL, V20, P379, DOI 10.1200/JCO.20.2.379; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Bos R, 2003, ONCOGENE, V22, P8948, DOI 10.1038/sj.onc.1206995; Bos R, 2004, BREAST CANCER RES, V6, pR450, DOI 10.1186/bcr813; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Bussolati G, 2000, VIRCHOWS ARCH, V437, P360, DOI 10.1007/s004280000267; Chappuis PO, 2000, SEMIN SURG ONCOL, V18, P287, DOI 10.1002/(SICI)1098-2388(200006)18:4<287::AID-SSU3>3.3.CO;2-X; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Claus EB, 2001, EXP MOL PATHOL, V70, P303, DOI 10.1006/exmp.2001.2366; Claus EB, 2005, JAMA-J AM MED ASSOC, V293, P964, DOI 10.1001/jama.293.8.964; Delmas C, 2003, CLIN CANCER RES, V9, P6062; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Hedenfalk I, 2003, P NATL ACAD SCI USA, V100, P2532, DOI 10.1073/pnas.0533805100; Helczynska K, 2008, CANCER RES, V68, P9212, DOI 10.1158/0008-5472.CAN-08-1135; Hoogerbrugge N, 2006, EUR J CANCER, V42, P2492, DOI 10.1016/j.ejca.2006.05.027; Hoogerbrugge N, 2003, J CLIN ONCOL, V21, P41, DOI 10.1200/JCO.2003.02.137; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hwang ES, 2007, J CLIN ONCOL, V25, P642, DOI 10.1200/JCO.2005.04.0345; Jonsson G, 2005, CANCER RES, V65, P7612, DOI 10.1158/0008-5472.CAN-05-0570; Kang HJ, 2006, J BIOL CHEM, V281, P13047, DOI 10.1074/jbc.M513033200; Kauff ND, 2003, CANCER-AM CANCER SOC, V97, P1601, DOI 10.1002/cncr.11225; Koh MY, 2011, CANCER RES, V71, P4015, DOI 10.1158/0008-5472.CAN-10-4142; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Lakhani SR, 1997, LANCET, V349, P1505; Luwor RB, 2005, ONCOGENE, V24, P4433, DOI 10.1038/sj.onc.1208625; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Marcus JN, 1996, CANCER-AM CANCER SOC, V77, P697, DOI 10.1002/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W; Ricker JL, 2004, CLIN CANCER RES, V10, P8665, DOI 10.1158/1078-0432.CCR-04-1393; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Sgroi DC, 2010, ANNU REV PATHOL-MECH, V5, P193, DOI 10.1146/annurev.pathol.4.110807.092306; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Tan C, 2005, CANCER RES, V65, P605; Tirkkonen M, 1997, CANCER RES, V57, P1222; Trastour C, 2007, INT J CANCER, V120, P1451, DOI 10.1002/ijc.22436; van Beers EH, 2005, CANCER RES, V65, P822; van der Groep P, 2006, J CLIN PATHOL, V59, P611, DOI 10.1136/jcp.2005.032151; van der Groep P, 2004, JNCI-J NATL CANCER I, V96, P712, DOI 10.1093/jnci/djh114; van der Groep P, 2009, J CLIN PATHOL, V62, P926, DOI 10.1136/jcp.2009.065524; van der Groep P, 2008, BREAST CANCER RES TR, V111, P475, DOI 10.1007/s10549-007-9817-z; Van Diest PJ, 1999, J PATHOL, V187, P383, DOI 10.1002/(SICI)1096-9896(199903)187:4<383::AID-PATH299>3.0.CO;2-H; van Diest PJ, 2002, BMJ-BRIT MED J, V325, P648, DOI 10.1136/bmj.325.7365.648; VANDIEST PJ, 1992, HUM PATHOL, V23, P603, DOI 10.1016/0046-8177(92)90313-R; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Vleugel MM, 2005, J CLIN PATHOL, V58, P172, DOI 10.1136/jcp.2004.019885; Welsh S, 2004, MOL CANCER THER, V3, P233; Wessels LFA, 2002, CANCER RES, V62, P7110; Wykoff CC, 2000, CANCER RES, V60, P7075; Yan M, 2009, BRIT J CANCER, V101, P1168, DOI 10.1038/sj.bjc.6605287	59	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56055	10.1371/journal.pone.0056055	http://dx.doi.org/10.1371/journal.pone.0056055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409121	gold, Green Submitted, Green Published			2022-12-27	WOS:000314660300054
J	Bueno, RS; Guevara, R; Ribeiro, MC; Culot, L; Bufalo, FS; Galetti, M				Bueno, Rafael S.; Guevara, Roger; Ribeiro, Milton C.; Culot, Laurence; Bufalo, Felipe S.; Galetti, Mauro			Functional Redundancy and Complementarities of Seed Dispersal by the Last Neotropical Megafrugivores	PLOS ONE			English	Article							ATLANTIC FOREST; FLESHY FRUITS; PATTERNS; SIZE; MONKEYS; DISTANCE; DIET; CONSERVATION; RECRUITMENT; FRUGIVORES	Background: Functional redundancy has been debated largely in ecology and conservation, yet we lack detailed empirical studies on the roles of functionally similar species in ecosystem function. Large bodied frugivores may disperse similar plant species and have strong impact on plant recruitment in tropical forests. The two largest frugivores in the neotropics, tapirs (Tapirus terrestris) and muriquis (Brachyteles arachnoides) are potential candidates for functional redundancy on seed dispersal effectiveness. Here we provide a comparison of the quantitative, qualitative and spatial effects on seed dispersal by these megafrugivores in a continuous Brazilian Atlantic forest. Methodology/Principal Findings: We found a low overlap of plant species dispersed by both muriquis and tapirs. A group of 35 muriquis occupied an area of 850 ha and dispersed 5 times more plant species, and 13 times more seeds than 22 tapirs living in the same area. Muriquis dispersed 2.4 times more seeds in any random position than tapirs. This can be explained mainly because seed deposition by muriquis leaves less empty space than tapirs. However, tapirs are able to disperse larger seeds than muriquis and move them into sites not reached by primates, such as large forest gaps, open areas and fragments nearby. Based on published information we found 302 plant species that are dispersed by at least one of these megafrugivores in the Brazilian Atlantic forest. Conclusions/Significance: Our study showed that both megafrugivores play complementary rather than redundant roles as seed dispersers. Although tapirs disperse fewer seeds and species than muriquis, they disperse larger-seeded species and in places not used by primates. The selective extinction of these megafrugivores will change the spatial seed rain they generate and may have negative effects on the recruitment of several plant species, particularly those with large seeds that have muriquis and tapirs as the last living seed dispersers.	[Bueno, Rafael S.; Culot, Laurence; Bufalo, Felipe S.; Galetti, Mauro] Univ Estadual Paulista, Dept Ecol, Lab Biol Conservacao, Sao Paulo, Brazil; [Guevara, Roger] Inst Ecol, AC Dept Biol Evolut, Xalapa, Veracruz, Mexico; [Ribeiro, Milton C.] Univ Estadual Paulista, Dept Ecol, Lab Ecol Espacial & Conservacao, Sao Paulo, Brazil	Universidade Estadual Paulista; Instituto de Ecologia - Mexico; Universidade Estadual Paulista	Galetti, M (corresponding author), Univ Estadual Paulista, Dept Ecol, Lab Biol Conservacao, Sao Paulo, Brazil.	mgaletti@rc.unesp.br	Culot, Laurence/H-9120-2012; Galetti, Mauro/C-5275-2008; Galetti, Mauro/M-8751-2013; Bufalo, Felipe S./B-2356-2013; Guevara, Roger/F-3287-2010	Culot, Laurence/0000-0002-3353-0134; Galetti, Mauro/0000-0002-8187-8696; Galetti, Mauro/0000-0002-8187-8696; Bufalo, Felipe S./0000-0002-2621-9858; Guevara, Roger/0000-0003-0768-3580; Da Silveira Bueno, Rafael/0000-0001-8964-8572	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [BIOTA - FAPESP 2007/03392-6]; FAPESP; CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) through the process BIOTA - FAPESP 2007/03392-6. RSB and LC receive a FAPESP fellowship, MG receives a CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Neto M, 2008, GLOBAL ECOL BIOGEOGR, V17, P503, DOI 10.1111/j.1466-8238.2008.00386.x; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Beck H, 2006, J MAMMAL, V87, P519, DOI 10.1644/05-MAMM-A-174R1.1; Beisiegel BD, 2004, MAMMALIA, V68, P65, DOI 10.1515/mamm.2004.009; Blake S, 2009, BIOTROPICA, V41, P459, DOI 10.1111/j.1744-7429.2009.00512.x; da Silva JMC, 2000, NATURE, V404, P72, DOI 10.1038/35003563; Dirzo R., 1991, PLANT ANIMAL INTERAC, P273; Dirzo R, 2007, BIOTROPICA, V39, P355, DOI 10.1111/j.1744-7429.2007.00274.x; Donatti C. I., 2007, Seed dispersal: theory and its application in a changing world, P104, DOI 10.1079/9781845931650.0104; Donatti CI, 2011, ECOL LETT, V14, P773, DOI 10.1111/j.1461-0248.2011.01639.x; Fragoso JMV, 1997, J ECOL, V85, P519, DOI 10.2307/2960574; Fragoso JMV, 2003, ECOLOGY, V84, P1998, DOI 10.1890/01-0621; Fragoso JMV, 2000, J TROP ECOL, V16, P369, DOI 10.1017/S0266467400001462; Galetti M, 1997, BIOL CONSERV, V82, P31, DOI 10.1016/S0006-3207(97)00004-9; Galetti M, 2001, BIOTROPICA, V33, P723, DOI 10.1111/j.1744-7429.2001.tb00232.x; GALETTI M, 1994, MAMMALIA, V58, P111, DOI 10.1515/mamm.1994.58.1.111; Galetti M, 2011, BIOTA NEOTROP, V11, P181, DOI 10.1590/S1676-06032011000100019; Galetti M, 2009, BIOL CONSERV, V142, P1229, DOI 10.1016/j.biocon.2009.01.023; GAUTIERHION A, 1985, OECOLOGIA, V65, P324, DOI 10.1007/BF00378906; Gayot M, 2004, J TROP ECOL, V20, P31, DOI 10.1017/S0266467404006157; Guimaraes Paulo R. Jr, 2008, PLoS ONE, V3, pUnpaginated, DOI 10.1371/journal.pone.0001745; Hansen DM, 2009, SCIENCE, V324, P42, DOI 10.1126/science.1172393; Haugaasen T, 2005, J TROP ECOL, V21, P133, DOI 10.1017/s026646740400207X; Hibert F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025850; Holbrook KM, 2011, BIOTROPICA, V43, P357, DOI 10.1111/j.1744-7429.2010.00710.x; Izar P, 2008, PRIMATOLOGIA BRASIL, P8; Jerusalinsky L., 2011, PLANO ACAO NACL CONS; JORDANO P, 1995, ECOLOGY, V76, P2627, DOI 10.2307/2265833; Julliot C, 1997, J ECOL, V85, P431, DOI 10.2307/2960567; Kitamura S, 2002, OECOLOGIA, V133, P559, DOI 10.1007/s00442-002-1073-7; LAWTON JH, 1993, ECOL STU AN, V99, P255; Lima RAF, 2011, BIOTA NEOTROP, P11; Lorenzi H, 1998, ARVORES BRASILEIRAS; Martins MM, 2006, BIOTROPICA, V38, P57, DOI 10.1111/j.1744-7429.2005.00100.x; McConkey KR, 2011, ECOLOGY, V92, P1492, DOI 10.1890/10-1255.1; Medici PE, 2012, INTEGRATIVE IN PRESS; Moles AT, 2004, J ECOL, V92, P372, DOI 10.1111/j.0022-0477.2004.00884.x; Moraes PLR, 1992, REV I FLORESTAL, V4, P1193; Mourthe IMC, 2007, AM J PRIMATOL, V69, P706, DOI 10.1002/ajp.20405; O'Farrill G, 2013, INTEGR ZOOL, V8, P4, DOI 10.1111/j.1749-4877.2012.00316.x; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Peres CA, 2000, OECOLOGIA, V122, P175, DOI 10.1007/PL00008845; Peres Carlos A., 2002, P407, DOI 10.1079/9780851995250.0407; Petroni LM, 2000, THESIS U SAO PAULO S; Quiroga-Castro VD, 2001, BIOTROPICA, V33, P472, DOI 10.1111/j.1744-7429.2001.tb00200.x; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rios RS, 2006, BIOTROPICA, V38, P778, DOI 10.1111/j.1744-7429.2006.00209.x; Russo SE, 2006, ECOLOGY, V87, P3160, DOI 10.1890/0012-9658(2006)87[3160:IABISD]2.0.CO;2; Russo SE, 2004, ECOL LETT, V7, P1058, DOI 10.1111/j.1461-0248.2004.00668.x; SCHUPP EW, 1993, VEGETATIO, V108, P15; Silva Wesley R., 2002, P423, DOI 10.1079/9780851995250.0423; Stevenson P. R., 2007, Seed dispersal: theory and its application in a changing world, P340, DOI 10.1079/9781845931650.0340; Stevenson PR, 2011, BIOTROPICA, V43, P512, DOI 10.1111/j.1744-7429.2010.00708.x; Stevenson PR, 2000, AM J PRIMATOL, V50, P275, DOI 10.1002/(SICI)1098-2345(200004)50:4&lt;275::AID-AJP4&gt;3.0.CO;2-K; STRIER KB, 1992, FACES FOREST ENDANGE; Talebi M, 2005, INT J PRIMATOL, V26, P1175, DOI 10.1007/s10764-005-6463-3; Therneau T.M., 2000, MODELING SURVIVAL DA; WHEELWRIGHT NT, 1985, ECOLOGY, V66, P808, DOI 10.2307/1940542; Wotton DM, 2012, J BIOGEOGR, V39, P1973, DOI 10.1111/jbi.12000; Wright SJ, 2007, BIOTROPICA, V39, P363, DOI 10.1111/j.1744-7429.2007.00289.x	61	98	104	0	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56252	10.1371/journal.pone.0056252	http://dx.doi.org/10.1371/journal.pone.0056252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409161	Green Published, gold			2022-12-27	WOS:000315157200125
J	Chung, RWS; Kamili, A; Tandy, S; Weir, JM; Gaire, R; Wong, G; Meikle, PJ; Cohn, JS; Rye, KA				Chung, Rosanna W. S.; Kamili, Alvin; Tandy, Sally; Weir, Jacquelyn M.; Gaire, Raj; Wong, Gerard; Meikle, Peter J.; Cohn, Jeffrey S.; Rye, Kerry-Anne			Dietary Sphingomyelin Lowers Hepatic Lipid Levels and Inhibits Intestinal Cholesterol Absorption in High-Fat-Fed Mice	PLOS ONE			English	Article							SECRETORY PHOSPHOLIPASE A(2); EGG SPHINGOMYELIN; LXR-ALPHA; METABOLISM; TRANSPORT; CELLS; ATHEROSCLEROSIS; SREBP-1C; MODELS; PLASMA	Controlling intestinal lipid absorption is an important strategy for maintaining lipid homeostasis. Accumulation of lipids in the liver is a major risk factor for metabolic syndrome and nonalcoholic fatty liver disease. It is well-known that sphingomyelin (SM) can inhibit intestinal cholesterol absorption. It is, however, unclear if dietary SM also lowers liver lipid levels. In the present study (i) the effect of pure dietary egg SM on hepatic lipid metabolism and intestinal cholesterol absorption was measured with [C-14] cholesterol and [H-3] sitostanol in male C57BL/6 mice fed a high-fat (HF) diet with or without 0.6% wt/wt SM for 18 days; and (ii) hepatic lipid levels and gene expression were determined in mice given a HF diet with or without egg SM (0.3, 0.6 or 1.2% wt/wt) for 4 weeks. Mice supplemented with SM (0.6% wt/wt) had significantly increased fecal lipid and cholesterol output and reduced hepatic [C-14] cholesterol levels after 18 days. Relative to HF-fed mice, SM-supplemented HF-fed mice had significantly lower intestinal cholesterol absorption (-30%). Liver weight was significantly lower in the 1.2% wt/wt SM-supplemented mice (-18%). Total liver lipid (mg/organ) was significantly reduced in the SM-supplemented mice (-33% and -40% in 0.6% wt/wt and 1.2% wt/wt SM, respectively), as were triglyceride and cholesterol levels. The reduction in liver triglycerides was due to inactivation of the LXR-SREBP-1c pathway. In conclusion, dietary egg SM has pronounced hepatic lipid-lowering properties in mice maintained on an obesogenic diet.	[Chung, Rosanna W. S.; Kamili, Alvin; Tandy, Sally; Cohn, Jeffrey S.] Heart Res Inst, Nutr & Metab Grp, Sydney, NSW, Australia; [Chung, Rosanna W. S.; Rye, Kerry-Anne] Heart Res Inst, Lipid Res Grp, Sydney, NSW, Australia; [Weir, Jacquelyn M.; Gaire, Raj; Wong, Gerard; Meikle, Peter J.] Baker IDI Heart & Diabet Inst, Metabol Lab, Melbourne, Vic, Australia; [Rye, Kerry-Anne] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; [Rye, Kerry-Anne] Univ Melbourne, Dept Med, Melbourne, Vic, Australia	University of Sydney; Heart Research Institute; University of Sydney; Heart Research Institute; Baker Heart and Diabetes Institute; University of Sydney; University of Melbourne	Rye, KA (corresponding author), Heart Res Inst, Lipid Res Grp, Sydney, NSW, Australia.	karye@ozemail.com.au	Gaire, Raj/H-4553-2014; Meikle, Peter J/B-4023-2009; Gaire, Raj/S-6923-2019	Gaire, Raj/0000-0003-2499-2553; Gaire, Raj/0000-0003-2499-2553; Kamili, Alvin/0000-0002-4864-1195; Meikle, Peter/0000-0002-2593-4665	National Health and Medical Research Council of Australia [482800]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia Grant 482800 (http://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; Eckhardt ERM, 2002, GASTROENTEROLOGY, V122, P948, DOI 10.1053/gast.2002.32539; Feng D, 2010, DIGEST DIS SCI, V55, P3377, DOI 10.1007/s10620-010-1202-9; Greenberg ME, 2009, ARTERIOSCL THROM VAS, V29, P1745, DOI 10.1161/ATVBAHA.109.194605; Kamili A, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-90; Koumanov K, 1997, BIOCHEM J, V326, P227, DOI 10.1042/bj3260227; Koumanov KS, 1998, BIOCHEM J, V336, P625, DOI 10.1042/bj3360625; Li ZQ, 2005, BBA-MOL CELL BIOL L, V1735, P130, DOI 10.1016/j.bbalip.2005.05.004; NILSSON A, 1968, BIOCHIM BIOPHYS ACTA, V164, P575, DOI 10.1016/0005-2760(68)90187-2; Noh SK, 2004, J NUTR, V134, P2611, DOI 10.1093/jn/134.10.2611; Noh SK, 2003, J NUTR, V133, P3571, DOI 10.1093/jn/133.11.3571; Nyberg L, 2000, J NUTR BIOCHEM, V11, P244, DOI 10.1016/S0955-2863(00)00069-3; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Schreyer SA, 1998, ATHEROSCLEROSIS, V136, P17, DOI 10.1016/S0021-9150(97)00165-2; Sehayek E, 2008, ARTERIOSCL THROM VAS, V28, P1296, DOI 10.1161/ATVBAHA.108.165803; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tandy S, 2010, ATHEROSCLEROSIS, V213, P142, DOI 10.1016/j.atherosclerosis.2010.07.050; Tandy S, 2009, J AGR FOOD CHEM, V57, P9339, DOI 10.1021/jf9016042; TSO P, 1986, AM J PHYSIOL, V250, pG715, DOI 10.1152/ajpgi.1986.250.6.G715; Wang DQH, 2003, J LIPID RES, V44, P1042, DOI 10.1194/jlr.D200041-JLR200; Wang DQH, 2001, J LIPID RES, V42, P1820; Wat E, 2009, ATHEROSCLEROSIS, V205, P144, DOI 10.1016/j.atherosclerosis.2008.12.004; Young SC, 1999, BIOCHEM J, V339, P615, DOI 10.1042/0264-6021:3390615; Yunki K, 2010, J AGR FOOD CHEM, V58, P7030, DOI 10.1021/jf100722f	28	43	47	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55949	10.1371/journal.pone.0055949	http://dx.doi.org/10.1371/journal.pone.0055949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409094	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200092
J	Bierbaum, V; Lipowsky, R				Bierbaum, Veronika; Lipowsky, Reinhard			Dwell Time Distributions of the Molecular Motor Myosin V	PLOS ONE			English	Article							STEPPING KINETICS; POWER STROKE; PROCESSIVITY; COORDINATION; MODEL; LOAD; MECHANISM; PATHWAYS; WALKING; MOTION	The dwell times between two successive steps of the two-headed molecular motor myosin V are governed by non-exponential distributions. These distributions have been determined experimentally for various control parameters such as nucleotide concentrations and external load force. First, we use a simplified network representation to determine the dwell time distributions of myosin V, with the associated dynamics described by a Markov process on networks with absorbing boundaries. Our approach provides a direct relation between the motor's chemical kinetics and its stepping properties. In the absence of an external load, the theoretical distributions quantitatively agree with experimental findings for various nucleotide concentrations. Second, using a more complex branched network, which includes ADP release from the leading head, we are able to elucidate the motor's gating effect. This effect is caused by an asymmetry in the chemical properties of the leading and the trailing head of the motor molecule. In the case of an external load acting on the motor, the corresponding dwell time distributions reveal details about the motor's backsteps.	[Bierbaum, Veronika; Lipowsky, Reinhard] Max Planck Inst Colloids & Interfaces, Potsdam, Germany	Max Planck Society	Bierbaum, V (corresponding author), Max Planck Inst Colloids & Interfaces, Potsdam, Germany.	bierbaum@mpikg.mpg.de		Lipowsky, Reinhard/0000-0001-8417-8567				Astumian RD, 2010, BIOPHYS J, V98, P2401, DOI 10.1016/j.bpj.2010.02.040; Astumian RD, 1996, BIOPHYS J, V70, P637, DOI 10.1016/S0006-3495(96)79605-4; Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Bierbaum V, 2011, BIOPHYS J, V100, P1747, DOI 10.1016/j.bpj.2011.02.012; Cappello G, 2007, P NATL ACAD SCI USA, V104, P15328, DOI 10.1073/pnas.0706653104; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; Clemen AEM, 2005, BIOPHYS J, V88, P4402, DOI 10.1529/biophysj.104.053504; Craig EM, 2009, P NATL ACAD SCI USA, V106, P18261, DOI 10.1073/pnas.0908192106; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Dunn AR, 2007, NAT STRUCT MOL BIOL, V14, P246, DOI 10.1038/nsmb1206; Forgacs E, 2008, J BIOL CHEM, V283, P766, DOI 10.1074/jbc.M704313200; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; Hyeon C, 2009, PHYS CHEM CHEM PHYS, V11, P4899, DOI 10.1039/b903536b; Kad NM, 2008, J BIOL CHEM, V283, P17477, DOI 10.1074/jbc.M800539200; Kodera N, 2010, NATURE, V468, P72, DOI 10.1038/nature09450; Komori Y, 2007, NAT STRUCT MOL BIOL, V14, P968, DOI 10.1038/nsmb1298; Liao JC, 2007, P NATL ACAD SCI USA, V104, P3171, DOI 10.1073/pnas.0611519104; Liepelt S, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/50002; Liepelt S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.258102; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Oguchi Y, 2008, P NATL ACAD SCI USA, V105, P7714, DOI 10.1073/pnas.0800564105; Oke OA, 2010, P NATL ACAD SCI USA, V107, P2509, DOI 10.1073/pnas.0906907107; Pierobon P, 2009, BIOPHYS J, V96, P4268, DOI 10.1016/j.bpj.2009.02.045; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Rosenfeld SS, 2004, J BIOL CHEM, V279, P40100, DOI 10.1074/jbc.M402583200; Sellers JR, 2010, NAT STRUCT MOL BIOL, V17, P590, DOI 10.1038/nsmb.1820; Shiroguchi K, 2007, SCIENCE, V316, P1208, DOI 10.1126/science.1140468; Uemura S, 2004, NAT STRUCT MOL BIOL, V11, P877, DOI 10.1038/nsmb806; Valleriani A, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/28011; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732	35	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55366	10.1371/journal.pone.0055366	http://dx.doi.org/10.1371/journal.pone.0055366			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418440	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300030
J	Niesen, CE; Xu, J; Fan, XM; Li, XJ; Wheeler, CJ; Mamelak, AN; Wang, C				Niesen, Charles E.; Xu, Jun; Fan, Xuemo; Li, Xiaojin; Wheeler, Christopher J.; Mamelak, Adam N.; Wang, Charles			Transcriptomic Profiling of Human Peritumoral Neocortex Tissues Revealed Genes Possibly Involved in Tumor-Induced Epilepsy	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUE; TEMPORAL-LOBE EPILEPSY; EPILEPTIFORM ACTIVITY; BRAIN-TUMORS; EXTRACELLULAR-MATRIX; EXPRESSION PROFILES; HIPPOCAMPAL-NEURONS; CELL-MIGRATION; IN-VITRO; FORMALIN	The molecular mechanism underlying tumor-induced epileptogenesis is poorly understood. Alterations in the peritumoral microenvironment are believed to play a significant role in inducing epileptogenesis. We hypothesize that the change of gene expression in brain peritumoral tissues may contribute to the increased neuronal excitability and epileptogenesis. To identify the genes possibly involved in tumor-induced epilepsy, a genome-wide gene expression profiling was conducted using Affymetrix HG U133 plus 2.0 arrays and RNAs derived from formalin-fixed paraffin embedded (FFPE) peritumoral cortex tissue slides from 5-seizure vs. 5-non-seizure low grade brain tumor patients. We identified many differentially expressed genes (DEGs). Seven dysregulated genes (i.e., C1QB, CALCRL, CCR1, KAL1, SLC1A2, SSTR1 and TYRO3) were validated by qRT-PCR, which showed a high concordance. Principal Component Analysis (PCA) showed that epilepsy subjects were clustered together tightly (except one sample) and were clearly separated from the non-epilepsy subjects. Molecular functional categorization showed that significant portions of the DEGs functioned as receptor activity, molecular binding including enzyme binding and transcription factor binding. Pathway analysis showed these DEGs were mainly enriched in focal adhesion, ECM-receptor interaction, and cell adhesion molecules pathways. In conclusion, our study showed that dysregulation of gene expression in the peritumoral tissues may be one of the major mechanisms of brain tumor induced-epilepsy. However, due to the small sample size of the present study, further validation study is needed. A deeper characterization on the dysregulated genes involved in brain tumor-induced epilepsy may shed some light on the management of epilepsy due to brain tumors.	[Niesen, Charles E.] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA; [Xu, Jun] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Fan, Xuemo] Cedars Sinai Med Ctr, Dept Pathol, Los Angeles, CA 90048 USA; [Fan, Xuemo; Wang, Charles] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Li, Xiaojin; Wang, Charles] City Hope Comprehens Canc Ctr, Funct Genom Core, Duarte, CA USA; [Li, Xiaojin; Wang, Charles] City Hope Comprehens Canc Ctr, Dept Mol & Cellular Biol, Duarte, CA USA; [Wheeler, Christopher J.; Mamelak, Adam N.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; City of Hope; City of Hope; Cedars Sinai Medical Center	Wang, C (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	cwang@coh.org	Mamelak, Adam/H-8347-2014	Mamelak, Adam/0000-0002-4245-6431	Cedars-Sinai Medical Center (CSMC); GCRC [2M01 RR00425-38]; NCI cancer center grant at City of Hope Comprehensive Cancer Center [5P30 CA033572-27]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER	Cedars-Sinai Medical Center (CSMC); GCRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI cancer center grant at City of Hope Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded by 2 internal grants awarded to CEN and CW respectively from Cedars-Sinai Medical Center (CSMC). CW was supported by the GCRC (2M01 RR00425-38) when the study was carried at CSMC. CW's salary was partially covered by the NCI cancer center grant (5P30 CA033572-27) at City of Hope Comprehensive Cancer Center, while the manuscript was completed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdueva D, 2010, J MOL DIAGN, V12, P409, DOI 10.2353/jmoldx.2010.090155; Aronica E, 2001, NEUROPATH APPL NEURO, V27, P223, DOI 10.1046/j.0305-1846.2001.00314.x; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Beaumont A, 2000, ACTA NEUROCHIR, V142, P1, DOI 10.1007/s007010050001; Berg D, 2012, J CELL PHYSIOL, V227, P204, DOI 10.1002/jcp.22718; BLENDY JA, 1990, J NEUROSCI, V10, P2580; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Budczies J, 2011, J HISTOCHEM CYTOCHEM, V59, P146, DOI 10.1369/jhc.2010.956607; Carter DS, 2006, J PHARMACOL EXP THER, V319, P1021, DOI 10.1124/jpet.106.110403; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Chung JY, 2006, DIAGN MOL PATHOL, V15, P229, DOI 10.1097/01.pdm.0000213468.91139.2d; Churn SB, 2000, P NATL ACAD SCI USA, V97, P5604, DOI 10.1073/pnas.080071697; Coudry RA, 2007, J MOL DIAGN, V9, P70, DOI 10.2353/jmoldx.2007.060004; de Groot J, 2011, GLIA, V59, P1181, DOI 10.1002/glia.21113; DELCASTILLO I, 1992, NAT GENET, V2, P305, DOI 10.1038/ng1292-305; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dietrich JB, 2002, J NEUROIMMUNOL, V128, P58, DOI 10.1016/S0165-5728(02)00114-5; Dityatev Alexander, 2006, V43, P69, DOI 10.1007/025; Dityatev A, 2010, EPILEPSIA, V51, P61, DOI 10.1111/j.1528-1167.2010.02612.x; Elmer E, 1997, NEUROREPORT, V8, P1193, DOI 10.1097/00001756-199703240-00027; Fowler CB, 2008, LAB INVEST, V88, P785, DOI 10.1038/labinvest.2008.43; Frank M, 2007, VIRCHOWS ARCH, V450, P699, DOI 10.1007/s00428-007-0412-9; Gall CM, 2004, ADV EXP MED BIOL, V548, P12; GUNDLACH AL, 1995, BRAIN RES, V672, P214, DOI 10.1016/0006-8993(94)01338-I; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; HAMBERGER A, 1991, EPILEPSY RES, V9, P32, DOI 10.1016/0920-1211(91)90044-G; Heck N, 2004, NEUROSCIENCE, V129, P309, DOI 10.1016/j.neuroscience.2004.06.078; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hossmann K A, 1990, Adv Neurol, V52, P449; Hu YL, 2009, J BIOL CHEM, V284, P29905, DOI 10.1074/jbc.M109.049155; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Jacobson TAS, 2011, INT J ONCOL, V38, P1075, DOI 10.3892/ijo.2011.936; Jian BX, 2009, CELL CYCLE, V8, P3770, DOI 10.4161/cc.8.22.10066; KEMPSKI O, 1988, STROKE, V19, P385, DOI 10.1161/01.STR.19.3.385; Kohling R, 2006, NEURODEGENER DIS, V3, P56, DOI 10.1159/000092094; Krafft AE, 1997, MOL DIAGN, V2, P217, DOI 10.1016/S1084-8592(97)80032-X; Kurzwelly D, 2010, ADV TECH STAND NEURO, V35, P80; Lee CH, 2005, WORLD J GASTROENTERO, V11, P1937, DOI 10.3748/wjg.v11.i13.1937; Lerner JT, 2008, CELL MOL LIFE SCI, V65, P1864, DOI 10.1007/s00018-008-8161-8; Librizzi L, 2007, EPILEPSIA, V48, P743, DOI 10.1111/j.1528-1167.2007.01047.x; Mathie A, 2007, J PHYSIOL-LONDON, V578, P377, DOI 10.1113/jphysiol.2006.121582; Matveeva EA, 2007, EPILEPSY RES, V73, P266, DOI 10.1016/j.eplepsyres.2006.11.003; Mittempergher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017163; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Peterson LE, 2003, COMPUT METH PROG BIO, V70, P107, DOI 10.1016/S0169-2607(02)00009-3; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; Rajneesh KF, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.5.FOCUS09101; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Ricci R, 2007, AM J NEURORADIOL, V28, P1287, DOI 10.3174/ajnr.A0564; Ruda R, 2010, CURR OPIN ONCOL, V22, P611, DOI 10.1097/CCO.0b013e32833de99d; RUTECKI PA, 1995, EPILEPSY RES, V20, P125, DOI 10.1016/0920-1211(94)00078-B; Sadegh M, 2007, NEUROSCIENCE, V150, P396, DOI 10.1016/j.neuroscience.2007.09.068; Salin P, 1995, J NEUROSCI, V15, P8234; Scicchitano MS, 2006, J HISTOCHEM CYTOCHEM, V54, P1229, DOI 10.1369/jhc.6A6999.2006; Shamji MF, 2009, NEUROSURG REV, V32, P275, DOI 10.1007/s10143-009-0191-7; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; STANTA G, 1991, BIOTECHNIQUES, V11, P304; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tan YX, 2006, BIOINFORMATICS, V22, P77, DOI 10.1093/bioinformatics/bti737; Tan YX, 2005, NUCLEIC ACIDS RES, V33, P56, DOI 10.1093/nar/gki144; van Breemen MSM, 2007, LANCET NEUROL, V6, P421, DOI 10.1016/S1474-4422(07)70103-5; Veznedaroglu E, 2002, J NEUROSURG, V97, P1125, DOI 10.3171/jns.2002.97.5.1125; Werner M, 2000, AM J SURG PATHOL, V24, P1016, DOI 10.1097/00000478-200007000-00014; Whiteheart SW, 2001, INT REV CYTOL, V207, P71; Wolf HK, 1996, ACTA NEUROPATHOL, V91, P376, DOI 10.1007/s004010050439; Xu J, 2008, STEM CELLS DEV, V17, P143, DOI 10.1089/scd.2007.0094; Zucchini S, 2008, J NEUROSCI, V28, P13112, DOI 10.1523/JNEUROSCI.1472-08.2008	68	16	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56077	10.1371/journal.pone.0056077	http://dx.doi.org/10.1371/journal.pone.0056077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418513	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300105
J	Du, MM; Prescott, J; Cornelis, MC; Hankinson, SE; Giovannucci, E; Kraft, P; De Vivo, I				Du, Mengmeng; Prescott, Jennifer; Cornelis, Marilyn C.; Hankinson, Susan E.; Giovannucci, Edward; Kraft, Peter; De Vivo, Immaculata			Genetic Predisposition to Higher Body Mass Index or Type 2 Diabetes and Leukocyte Telomere Length in the Nurses' Health Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; OXIDATIVE STRESS; MENDELIAN RANDOMIZATION; CIGARETTE-SMOKING; RISK; ASSOCIATION; CANCER; OBESITY; ADIPOSITY	Background: Although cross-sectional studies have linked higher body mass index (BMI) and type 2 diabetes (T2D) to shortened telomeres, whether these metabolic conditions play a causal role in telomere biology is unknown. We therefore examined whether genetic predisposition to higher BMI or T2D was associated with shortened leukocyte telomere length (LTL). Methodology: We conducted an analysis of 3,968 women of European ancestry aged 43-70 years from the Nurses' Health Study, who were selected as cases or controls in genome-wide association studies and studies of telomeres and disease. Pre-diagnostic relative telomere length in peripheral blood leukocytes, collected in 1989-1990, was measured by quantitative PCR. We combined information from multiple risk variants by calculating genetic risk scores based on 32 polymorphisms near 32 loci for BMI, and 36 polymorphisms near 35 loci for T2D. Findings: After adjustment for age and case-control status, there was no association between the BMI genetic risk score and LTL (beta per standard deviation increase: -0.01; SE: 0.02; P = 0.52). Similarly, the T2D genetic score was not associated with LTL (b per standard deviation increase: -0.006; SE: 0.02; P = 0.69). Conclusions: In this population of middle-aged and older women of European ancestry, those genetically predisposed to higher BMI or T2D did not possess shortened telomeres. Although we cannot exclude weak or modest effects, our findings do not support a causal relation of strong magnitude between these metabolic conditions and telomere dynamics.	[Du, Mengmeng] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Du, Mengmeng] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Du, Mengmeng; Prescott, Jennifer; Hankinson, Susan E.; Giovannucci, Edward; De Vivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Du, Mengmeng; Prescott, Jennifer; Hankinson, Susan E.; Giovannucci, Edward; De Vivo, Immaculata] Harvard Univ, Sch Med, Boston, MA USA; [Prescott, Jennifer; Kraft, Peter; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Cornelis, Marilyn C.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hankinson, Susan E.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Div Biostat & Epidemiol, Amherst, MA 01003 USA; [Giovannucci, Edward; Kraft, Peter; De Vivo, Immaculata] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Harvard T.H. Chan School of Public Health	Du, MM (corresponding author), Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA.	mdu@fhcrc.org		De Vivo, Immaculata/0000-0002-7185-7402	National Institutes of Health (NIH) [R01 CA082838, P01 CA87969, R01 CA49449, R01 HL034594, R01 HL088521, CA065725, CA139586, CA140790, CA132190, CA132175, CA133914, JP: T32 ES01664, T32 CA09001, R25 CA94880]; American Health Association Foundation; Canadian Institutes of Health Research Fellowship; NIH [HL35464, CA55075, HHSN268200782096C]; Merck/Rosetta Research Laboratories, North Wales, PA; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [5P01DK070756]; NIH Genes, Environment, and Health Initiative (GEI) [U01HG004399, U01HG004738, U01HG004422, U01HG004402, U01HG004729, U01HG004726, 01HG004735, U01HG004415, U01HG004436, U01HG004423, U01HG004728, AHG006033]; NIH Institutes [NIDCR: U01DE018993, U01DE018903, NIAAA: U10AA008401, NIDA: P01CA089392, 01DA013423, NCI: CA63464, CA54281, CA136792, Z01CP010200]; NIH GEI [U01HG04424, U01HG004438]; Johns Hopkins University Center for Inherited Disease Research; Merck/Rosetta Research Laboratories;  [R01CA134958-01A1]; NATIONAL CANCER INSTITUTE [R37CA054281, R03CA132175, R01CA063464, P01CA089392, R01CA049449, R01CA134958, R25CA094880, T32CA009001, U01CA136792, K07CA140790, Z01CP010200, R03CA139586, R03CA133914, R03CA132190, P01CA087969, R01CA054281, R01CA082838, R01CA065725, U01CA063464] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464, R01HL088521, R01HL034594] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004415, U01HG004726, U01HG004446, U01HG004423, U01HG004436, U01HG004438, U01HG004424, U01HG004738, U01HG004735, U01HG004729, U01HG004399, U01HG004402, U01HG004422, U01HG004728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE018903, U01DE018993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK070756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES001664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013423] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Association Foundation; Canadian Institutes of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck/Rosetta Research Laboratories, North Wales, PA; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Genes, Environment, and Health Initiative (GEI); NIH Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH GEI; Johns Hopkins University Center for Inherited Disease Research; Merck/Rosetta Research Laboratories; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The current study was supported by the National Institutes of Health (NIH) (www.nih.gov) (grants R01 CA082838, P01 CA87969, R01 CA49449, R01 HL034594, R01 HL088521; for telomere data: CA065725, CA139586, CA140790, CA132190, CA132175, CA133914; for MD and JP: T32 ES01664, T32 CA09001, R25 CA94880). Telomere data for women in the cognitive sub-study was funded by the American Health Association Foundation. MCC is a recipient of a Canadian Institutes of Health Research Fellowship. The breast cancer GWAS was performed as part of the Cancer Genetic Markers of Susceptibility initiative of the NCI. The CHD GWAS was supported by HL35464 and CA55075 from the NIH with additional support for genotyping from Merck/Rosetta Research Laboratories, North Wales, PA. The Kidney GWAS was supported by The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): 5P01DK070756. The endometrial cancer GWAS was supported by R01CA134958-01A1. The type 2 diabetes GWAS (U01HG004399) is a component of a collaborative project that includes 13 other GWAS funded as part of the Gene Environment-Association Studies (GENEVA) under the NIH Genes, Environment, and Health Initiative (GEI) (U01HG004738, U01HG004422, U01HG004402, U01HG004729, U01HG004726, 01HG004735, U01HG004415, U01HG004436, U01HG004423, U01HG004728, AHG006033) with additional support from individual NIH Institutes (NIDCR: U01DE018993, U01DE018903; NIAAA: U10AA008401; NIDA: P01CA089392, 01DA013423; NCI: CA63464, CA54281, CA136792, Z01CP010200). Assistance with genotype cleaning and general study coordination was provided by the GENEVA Coordinating Center (U01HG004446). Assistance with data cleaning was provided by the NCBI. Genotyping was performed at the Broad Institute of MIT and Harvard, with funding support from the NIH GEI (U01HG04424), and Johns Hopkins University Center for Inherited Disease Research, with support from the NIH GEI (U01HG004438) and the NIH contract "High throughput genotyping for studying the genetic contributions to human disease" (HHSN268200782096C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents hereof are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.; The genome-wide association study of cardiovascular disease was supported in part by Merck/Rosetta Research Laboratories. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adaikalakoteswari A, 2007, ATHEROSCLEROSIS, V195, P83, DOI 10.1016/j.atherosclerosis.2006.12.003; Al-Attas OS, 2010, ACTA PAEDIATR, V99, P896, DOI 10.1111/j.1651-2227.2010.01720.x; Al-Attas OS, 2010, EUR J ENDOCRINOL, V163, P601, DOI 10.1530/EJE-10-0241; Aviv A., 2004, SCI AGING KNOWLEDGE, V2004, pp, DOI [10.1126/sageke.2004.51.pe43, DOI 10.1126/SAGEKE.2004.51.PE43]; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Buxton JL, 2011, J CLIN ENDOCR METAB, V96, P1500, DOI 10.1210/jc.2010-2924; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cassidy A, 2010, AM J CLIN NUTR, V91, P1273, DOI 10.3945/ajcn.2009.28947; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chiuve SE, 2008, CIRCULATION, V118, P947, DOI 10.1161/CIRCULATIONAHA.108.781062; Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; de Miguel-Yanes JM, 2011, DIABETES CARE, V34, P121, DOI 10.2337/dc10-1265; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Diaz VA, 2010, INT J OBESITY, V34, P261, DOI 10.1038/ijo.2009.198; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Du MM, 2012, AM J EPIDEMIOL, V175, P414, DOI 10.1093/aje/kwr330; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Franks PW, 2011, CURR DIABETES REP, V11, P552, DOI 10.1007/s11892-011-0224-9; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Gavin JR, 1997, DIABETES CARE, V20, P1183; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; HANKINSON SE, 1995, J NATL CANCER I, V87, P1297, DOI 10.1093/jnci/87.17.1297; HARRIS M, 1979, DIABETES, V28, P1039; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kejariwal Deepak, 2008, BMC Endocr Disord, V8, P12, DOI 10.1186/1472-6823-8-12; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Lee M, 2011, AM J HUM BIOL, V23, P100, DOI 10.1002/ajhb.21109; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Li Y, 2006, AM J HUM GENET S, VS79, P2290; MacEneaney OJ, 2010, OBESITY, V18, P1677, DOI 10.1038/oby.2009.494; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Monickaraj F, 2012, MOL CELL BIOCH; Moreno-Navarrete JM, 2010, INT J OBESITY, V34, P1345, DOI 10.1038/ijo.2010.49; Njajou OT, 2011, INT J OBES LOND; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; O'Callaghan NJ, 2009, REJUV RES, V12, P169, DOI 10.1089/rej.2008.0819; Olivieri F, 2009, ATHEROSCLEROSIS, V206, P588, DOI 10.1016/j.atherosclerosis.2009.03.034; Peterson RE, 2011, HUM GENET, V129, P221, DOI 10.1007/s00439-010-0917-1; Pierce BL, 2011, INT J EPIDEMIOL, V40, P740, DOI 10.1093/ije/dyq151; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Prescott J, 2010, CANCER-AM CANCER SOC, V116, P4275, DOI 10.1002/cncr.25328; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qi L, 2008, NUTR REV, V66, P684, DOI 10.1111/j.1753-4887.2008.00128.x; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; ROSNER B, 1983, TECHNOMETRICS, V25, P165, DOI 10.2307/1268549; Roux AVD, 2009, AGING CELL, V8, P251, DOI 10.1111/j.1474-9726.2009.00470.x; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P35, DOI 10.1016/j.atherosclerosis.2009.12.021; Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Shen Q, 2012, J CLIN ENDOCRINOL ME; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sun Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038374; Testa R, 2011, DIABETIC MED, V28, P1388, DOI 10.1111/j.1464-5491.2011.03370.x; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Wiggs JL, 2011, HUM MOL GENET, V20, P4707, DOI 10.1093/hmg/ddr382; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; WILLETT WC, 1987, J AM DIET ASSOC, V87, P43; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Xiao F, 2011, DIABETES CARE, V34, P2273, DOI 10.2337/dc10-2431; Zannolli R, 2008, ACTA PAEDIATR, V97, P952, DOI 10.1111/j.1651-2227.2008.00783.x; Zee RYL, 2011, ATHEROSCLEROSIS, V218, P144, DOI 10.1016/j.atherosclerosis.2011.05.013; Zee RYL, 2010, TRANSL RES, V155, P166, DOI 10.1016/j.trsl.2009.09.012; Zhu HD, 2011, J PEDIATR-US, V158, P215, DOI 10.1016/j.jpeds.2010.08.007	74	16	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e52240	10.1371/journal.pone.0052240	http://dx.doi.org/10.1371/journal.pone.0052240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424613	gold, Green Published			2022-12-27	WOS:000315965100001
J	Gatford, KL; Sulaiman, SA; Mohammad, SNB; De Blasio, MJ; Harland, ML; Simmons, RA; Owens, JA				Gatford, Kathryn L.; Sulaiman, Siti A.; Mohammad, Saidatul N. B.; De Blasio, Miles J.; Harland, M. Lyn; Simmons, Rebecca A.; Owens, Julie A.			Neonatal Exendin-4 Reduces Growth, Fat Deposition and Glucose Tolerance during Treatment in the Intrauterine Growth-Restricted Lamb	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BETA-CELL FUNCTION; CARDIOVASCULAR RISK-FACTORS; MESSENGER-RNA EXPRESSION; FOR-GESTATIONAL-AGE; PLACENTAL RESTRICTION; INSULIN SENSITIVITY; EXENATIDE EXENDIN-4; GLYCEMIC CONTROL; BIRTH-WEIGHT	Background: IUGR increases the risk of type 2 diabetes mellitus (T2DM) in later life, due to reduced insulin sensitivity and impaired adaptation of insulin secretion. In IUGR rats, development of T2DM can be prevented by neonatal administration of the GLP-1 analogue exendin-4. We therefore investigated effects of neonatal exendin-4 administration on insulin action and beta-cell mass and function in the IUGR neonate in the sheep, a species with a more developed pancreas at birth. Methods: Twin IUGR lambs were injected s.c. daily with vehicle (IUGR+Veh, n = 8) or exendin-4 (1 nmol.kg(-1), IUGR+Ex-4, n = 8), and singleton control lambs were injected with vehicle (CON, n = 7), from d 1 to 16 of age. Glucose-stimulated insulin secretion and insulin sensitivity were measured in vivo during treatment (d 12-14). Body composition, beta-cell mass and in vitro insulin secretion of isolated pancreatic islets were measured at d 16. Principal Findings: IUGR+Veh did not alter in vivo insulin secretion or insulin sensitivity or beta-cell mass, but increased glucose-stimulated insulin secretion in vitro. Exendin-4 treatment of the IUGR lamb impaired glucose tolerance in vivo, reflecting reduced insulin sensitivity, and normalised glucose-stimulated insulin secretion in vitro. Exendin-4 also reduced neonatal growth and visceral fat accumulation in IUGR lambs, known risk factors for later T2DM. Conclusions: Neonatal exendin-4 induces changes in IUGR lambs that might improve later insulin action. Whether these effects of exendin-4 lead to improved insulin action in adult life after IUGR in the sheep, as in the PR rat, requires further investigation.	[Gatford, Kathryn L.; Sulaiman, Siti A.; Mohammad, Saidatul N. B.; De Blasio, Miles J.; Harland, M. Lyn; Owens, Julie A.] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia; [Gatford, Kathryn L.; Sulaiman, Siti A.; Mohammad, Saidatul N. B.; De Blasio, Miles J.; Harland, M. Lyn; Owens, Julie A.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia; [Simmons, Rebecca A.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	Robinson Research Institute; University of Adelaide; University of Adelaide; University of Pennsylvania; Pennsylvania Medicine	Gatford, KL (corresponding author), Univ Adelaide, Robinson Inst, Adelaide, SA, Australia.	kathy.gatford@adelaide.edu.au	De Blasio, Miles J/GQB-1536-2022; Gatford, Kathryn L/B-8136-2013; Owens, Julie A/C-9744-2009; De Blasio, Miles/AAB-7234-2019; Sulaiman, Siti Aishah/Q-9863-2019; De Blasio, Miles/D-5460-2011; Sulaiman, Siti Aishah/O-9240-2015	De Blasio, Miles J/0000-0002-4797-5193; Gatford, Kathryn L/0000-0002-2823-3004; Owens, Julie A/0000-0002-7498-1353; De Blasio, Miles/0000-0002-4797-5193; Sulaiman, Siti Aishah/0000-0001-7309-3381; Sulaiman, Siti Aishah/0000-0001-7309-3381; Simmons, Rebecca/0000-0002-2901-8904	Diabetes Australia Research Trust; National Health and Medical Research Council of Australia [627123]	Diabetes Australia Research Trust; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported from project funding from the Diabetes Australia Research Trust (http://www.diabetesaustralia.com.au/en/Research/DART/) and National Health and Medical Research Council of Australia (grant 627123, http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa M, 2009, BIOCHEM BIOPH RES CO, V390, P809, DOI 10.1016/j.bbrc.2009.10.054; BASSETT JM, 1977, ANN RECH VET, V8, P362; Belfiore F, 1998, MOL GENET METAB, V65, P121, DOI 10.1006/mgme.1998.2727; Blonde L, 2006, DIABETES OBES METAB, V8, P436, DOI 10.1111/j.1463-1326.2006.00602.x; Brissova M, 2005, AM J PHYSIOL-ENDOC M, V288, pE707, DOI 10.1152/ajpendo.00252.2004; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Cabou C, 2008, DIABETES, V57, P2577, DOI 10.2337/db08-0121; Cabou C, 2011, DIABETES, V60, P2245, DOI 10.2337/db11-0464; Cersosimo E, 2011, J CLIN ENDOCR METAB, V96, P1763, DOI 10.1210/jc.2010-2146; De Blasio MJ, 2007, AM J PHYSIOL-REG I, V292, pR875, DOI 10.1152/ajpregu.00430.2006; De Blasio MJ, 2007, ENDOCRINOLOGY, V148, P1350, DOI 10.1210/en.2006-0653; De Blasio MJ, 2006, AM J PHYSIOL-REG I, V291, pR1016, DOI 10.1152/ajpregu.00103.2006; De Blasio MJ, 2012, ENDOCRINOLOGY, V153, P2142, DOI 10.1210/en.2011-1955; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; DeFronzo RA, 2008, CURR MED RES OPIN, V24, P2943, DOI 10.1185/03007990802418851 ; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Doyle ME, 2001, RECENT PROG HORM RES, V56, P377, DOI 10.1210/rp.56.1.377; Duffield JA, 2008, AM J PHYSIOL-REG I, V294, pR1413, DOI 10.1152/ajpregu.00787.2007; Duffield JA, 2009, PEDIATR RES, V66, P59, DOI 10.1203/PDR.0b013e3181a7c121; Edwards CMB, 2001, AM J PHYSIOL-ENDOC M, V281, pE155, DOI 10.1152/ajpendo.2001.281.1.E155; Eriksson M, 2004, J INTERN MED, V255, P236, DOI 10.1046/j.1365-2796.2003.01289.x; Fehse F, 2005, J CLIN ENDOCR METAB, V90, P5991, DOI 10.1210/jc.2005-1093; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; FOWDEN AL, 1980, J ENDOCRINOL, V87, P293, DOI 10.1677/joe.0.0870293; Garber AJ, 2011, DIABETES CARE, V34, pS258, DOI 10.2337/dc11-s230; Gatford KL, 2008, ENDOCRINOLOGY, V149, P5118, DOI 10.1210/en.2008-0233; Gatford KL, 2004, AM J PHYSIOL-ENDOC M, V286, pE1050, DOI 10.1152/ajpendo.00340.2003; Gedulin BR, 2005, ENDOCRINOLOGY, V146, P2069, DOI 10.1210/en.2004-1349; HANSEN BC, 1990, AM J PHYSIOL, V259, pR612, DOI 10.1152/ajpregu.1990.259.3.R612; Imeryuz N, 1997, AM J PHYSIOL-GASTR L, V273, pG920, DOI 10.1152/ajpgi.1997.273.4.G920; JAHR H, 1983, METABOLISM, V32, P1101, DOI 10.1016/0026-0495(83)90055-0; Jensen CB, 2002, DIABETES, V51, P1271, DOI 10.2337/diabetes.51.4.1271; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Kaijser M, 2009, DIABETES, V58, P523, DOI 10.2337/db08-0558; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206; Katsumata M, 1999, FASEB J, V13, P1405, DOI 10.1096/fasebj.13.11.1405; Kelly AS, 2012, OBESITY, V20, P364, DOI 10.1038/oby.2011.337; Kolterman OG, 2003, J CLIN ENDOCR METAB, V88, P3082, DOI 10.1210/jc.2002-021545; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Kwon DY, 2009, J PHARMACOL SCI, V111, P361, DOI 10.1254/jphs.09178FP; Li L, 2008, DIABETES OBES METAB, V10, P921, DOI 10.1111/j.1463-1326.2007.00832.x; Limesand SW, 2006, ENDOCRINOLOGY, V147, P1488, DOI 10.1210/en.2005-0900; Limesand SW, 2005, AM J PHYSIOL-REG I, V288, pR1297, DOI 10.1152/ajpregu.00494.2004; Linnebjerg H, 2008, REGUL PEPTIDES, V151, P123, DOI 10.1016/j.regpep.2008.07.003; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; Muhlhausler BS, 2009, J PHYSIOL-LONDON, V587, P4199, DOI 10.1113/jphysiol.2009.173161; National Health and Medical Research Council, 2004, AUSTR COD PRACT CAR; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Navarro-Tableros V, 2007, AM J PHYSIOL-ENDOC M, V292, pE1018, DOI 10.1152/ajpendo.00457.2006; Newsome CA, 2003, DIABETIC MED, V20, P339, DOI 10.1046/j.1464-5491.2003.00871.x; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; OTONKOSKI T, 1988, DIABETES, V37, P286, DOI 10.2337/diabetes.37.3.286; Owens JA, 2007, EARLY HUM DEV, V83, pS134, DOI 10.1016/S0378-3782(07)70351-1; Owens JA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1879, DOI 10.1152/ajpendo.00706.2006; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Petrik J, 1999, ENDOCRINOLOGY, V140, P4861, DOI 10.1210/en.140.10.4861; Petrik J, 1998, ENDOCRINOLOGY, V139, P2994, DOI 10.1210/en.139.6.2994; Pinney SE, 2011, DIABETOLOGIA, V54, P2606, DOI 10.1007/s00125-011-2250-1; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; REDDY S, 1988, EXPERIENTIA, V44, P1, DOI 10.1007/BF01960221; Robinson JS, 1996, PEDIAT PERINATOLOGY, P290; Rozance PJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE404, DOI 10.1152/ajpendo.00643.2005; Sano H, 1999, J ANIM SCI, V77, P2564; Scaglia L, 1997, ENDOCRINOLOGY, V138, P1736, DOI 10.1210/en.138.4.1736; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Stoffers DA, 2003, DIABETES, V52, P734, DOI 10.2337/diabetes.52.3.734; Summermatter S, 2009, DIABETES, V58, P2228, DOI 10.2337/db08-1793; Tan C, 2002, DIABETES, V51, P2989, DOI 10.2337/diabetes.51.10.2989; THOMPSON GE, 1983, BRIT J NUTR, V50, P151, DOI 10.1079/BJN19830082; Veening MA, 2003, DIABETES, V52, P1756, DOI 10.2337/diabetes.52.7.1756; Wang Q, 2002, DIABETOLOGIA, V45, P1263, DOI 10.1007/s00125-002-0828-3; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Young AA, 1999, DIABETES, V48, P1026, DOI 10.2337/diabetes.48.5.1026; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7	76	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56553	10.1371/journal.pone.0056553	http://dx.doi.org/10.1371/journal.pone.0056553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424667	gold, Green Published, Green Submitted			2022-12-27	WOS:000315965100055
J	Yu, FF; Jarver, P; Nygren, PA				Yu, Feifan; Jarver, Peter; Nygren, Per-Ake			Tailor-Making a Protein A-Derived Domain for Efficient Site-Specific Photocoupling to Fc of Mouse IgG(1)	PLOS ONE			English	Article							ANTIBODY-BINDING; BIOTINYLATION; SUBSTRATE; FRAGMENT	Affinity proteins binding to antibody constant regions have proved to be invaluable tools in biotechnology. Here, protein engineering was used to expand the repertoire of available immunoglobulin binding proteins via improvement of the binding strength between the widely used staphylococcal protein A-derived Z domain and the important immunoglobulin isotype mouse IgG(1) (mIgG(1)). Addressing seven positions in the 58-residue three-helix bundle Z domain by single or double amino acid substitutions, a total of 170 variants were individually constructed, produced in E. coli and tested for binding to a set of mouse IgG(1) monoclonal antibodies (mAbs). The best variant, denoted Z(F5I) corresponding to a Phe to Ile substitution at position 5, showed a typical ten-fold higher affinity than the wild-type as determined by biosensor technology. Eight amino acid positions in the Z(F5I) variant were separately mutated to cysteine for incorporation of a photoactivable maleimide-benzophenone (MBP) group as a probe for site-specific photoconjugation to Fc of mIgG(1), The best photocoupling efficiency to mIgG(1) Fc was seen when the MBP group was coupled to Cys at position 32, resulting in adduct formation to more than 60% of all heavy chains, with no observable non-selective conjugation to the light chains. A similar coupling yield was obtained for a panel of 19 different mIgG(1) mAbs, indicating a general characteristic. To exemplify functionalization of a mIgG(1) antibody via site-specific biotinylation, the Z(F5I-Q32C-MBP) protein was first biotinylated using an amine reactive reagent and subsequently photoconjugated to an anti-human interferon-gamma mIgG(1) mAb. When comparing the specific antigen binding ability of the probe-biotinylated mAb to that of the directly biotinylated mAb, a significantly h`igher bioactivity was observed for the sample biotinylated using the Z(F5I-Q32C-MBP) probe. This result indicates that the use of a site-specific and affinity probe-mediated conjugation strategy can result in antibody reagents with increased assay sensitivity.	[Yu, Feifan; Jarver, Peter; Nygren, Per-Ake] AlbaNova Univ Ctr, Royal Inst Technol KTH, Div Mol Biotechnol, Stockholm, Sweden	Royal Institute of Technology	Nygren, PA (corresponding author), AlbaNova Univ Ctr, Royal Inst Technol KTH, Div Mol Biotechnol, Stockholm, Sweden.	perake@biotech.kth.se	Nygren, Per-Åke/AAM-7888-2020	Nygren, Per-Åke/0000-0003-4214-6991; Jarver, Peter/0000-0001-9643-5874	The ProNova VINN Excellence Centre for Protein Technology	The ProNova VINN Excellence Centre for Protein Technology	The ProNova VINN Excellence Centre for Protein Technology (www.biotech.kth.se/pronova) is acknowledged for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Chapman-Smith A, 1999, BIOMOL ENG, V16, P119, DOI 10.1016/S1050-3862(99)00046-7; Clausson CM, 2011, NAT METHODS, V8, P892, DOI 10.1038/nmeth.1743; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Gallagher S, 2011, CURR PROTOC CELL BIO; Holm L, 2009, J BIOL CHEM, V284, P32906, DOI 10.1074/jbc.M109.034322; Jung YW, 2009, ANAL CHEM, V81, P936, DOI 10.1021/ac8014565; KATO K, 1993, FEBS LETT, V328, P49, DOI 10.1016/0014-5793(93)80963-U; Konrad A, 2011, BIOCONJUGATE CHEM, V22, P2395, DOI 10.1021/bc200052h; Nagaoka M, 2003, PROTEIN ENG, V16, P243, DOI 10.1093/proeng/gzg037; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; Page M, 1998, METH MOL B, V80, P113; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Stadler C, 2012, J PROTEOMICS, V75, P2236, DOI 10.1016/j.jprot.2012.01.030; Tavoosidana G, 2011, P NATL ACAD SCI USA, V108, P8809, DOI 10.1073/pnas.1019330108; Vashist SK, 2012, ANAL BIOCHEM, V421, P336, DOI 10.1016/j.ab.2011.10.036	16	36	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56597	10.1371/journal.pone.0056597	http://dx.doi.org/10.1371/journal.pone.0056597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424669	Green Submitted, Green Published, gold			2022-12-27	WOS:000315965100057
J	Du, WT; Shen, YW; Lee, WH; Wang, D; Paz, S; Kandeel, F; Liu, CP				Du, Weiting; Shen, Yueh-Wei; Lee, Wen-Hui; Wang, Ding; Paz, Sachiko; Kandeel, Fouad; Liu, Chih-Pin			Foxp3(+) Treg Expanded from Patients with Established Diabetes Reduce Helios Expression while Retaining Normal Function Compared to Healthy Individuals	PLOS ONE			English	Article							REGULATORY T-CELLS; SELF-TOLERANCE; EXPANSION; DEFECTS; DISEASE; FREQUENCY; APOPTOSIS; PREVENT; TARGET; CD25	Foxp3(+) regulatory T cells (Treg) play a crucial role in regulating immune tolerance. The use of Treg to restore immune tolerance is considered an attractive novel approach to inhibit autoimmune disease, including type 1 diabetes (T1D), and to prevent rejection of organ transplants. In view of the goal of developing autologous Treg-based cell therapy for patients with long-term (>15 years) T1D, it will be necessary to expand a sufficient amount of functional Treg in vitro in order to study and compare Treg from T1D patients and healthy subjects. Our results have demonstrated that there is a comparable frequency of Treg in the peripheral blood lymphocytes (PBLs) of patients with long-term T1D relative to those in healthy subjects; however, Th1 cells, but not Th17 cells, were increased in the T1D patients. Further, more Treg in PBLs from T1D patients than from healthy subjects expressed the CD45RO(+) memory cell phenotype, suggesting they were antigen-experienced cells. After isolation, Treg from both T1D patients and healthy subjects were successfully expanded with high purity. Although there was no difference in Helios expression on Treg in PBLs, in vitro expansion led to fewer Helios-expressing Treg from T1D patients than healthy subjects. While more Th1-like Treg expressing IFN-gamma or TNF-alpha were found in the PBLs of T1D patients than healthy controls, there was no such difference in the expanded Treg. Importantly, expanded Treg from both subject groups were able to suppress autologous or allogeneic CD8(+) effector T cells equally well. Our findings demonstrate that a large number of ex vivo expanded functional Treg can be obtained from long-term T1D patients, although fewer expanded Treg expressed a high level of Helios. Thus, based on the positive outcomes, these potent expanded Treg from diabetic human patients may be useful in treating T1D or preventing islet graft rejection.	[Du, Weiting; Shen, Yueh-Wei; Lee, Wen-Hui; Wang, Ding; Paz, Sachiko; Kandeel, Fouad; Liu, Chih-Pin] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA; [Liu, Chih-Pin] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Liu, CP (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA.	cpliu@coh.org	Du, Weiting/C-9971-2014		American Diabetes Association; Juvenile Diabetes Research Foundation; National Institutes of Health; Jonas Brother Funds; H. L. Snyder Medical Foundation	American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jonas Brother Funds; H. L. Snyder Medical Foundation	This work was supported, in part, by funds from American Diabetes Association, Juvenile Diabetes Research Foundation, National Institutes of Health, the Jonas Brother Funds, and the H. L. Snyder Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Battaglia M, 2006, DIABETES, V55, P1571, DOI 10.2337/db05-1576; Battaglia M, 2011, SEMIN IMMUNOL, V23, P182, DOI 10.1016/j.smim.2011.07.007; Booth NJ, 2010, J IMMUNOL, V184, P4317, DOI 10.4049/jimmunol.0903781; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Brusko T, 2007, DIABETES, V56, P604, DOI 10.2337/db06-1248; Cao TH, 2009, CELL IMMUNOL, V258, P65, DOI 10.1016/j.cellimm.2009.03.013; Chen C, 2006, J IMMUNOL, V176, P3449, DOI 10.4049/jimmunol.176.6.3449; Chen C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007863; Chen X, 2010, EUR J IMMUNOL, V40, P1099, DOI 10.1002/eji.200940022; Csorba TR, 2010, CRIT REV CL LAB SCI, V47, P51, DOI 10.3109/10408361003787171; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Eisenbarth GS, 2007, J CLIN ENDOCR METAB, V92, P2403, DOI 10.1210/jc.2007-0339; Ferraro A, 2011, DIABETES, V60, P2903, DOI 10.2337/db11-0090; Gavin JR, 1999, DIABETES CARE, V22, pS5; Glisic-Milosavljevic S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000146; Gottschalk RA, 2011, J IMMUNOL; Hippen KL, 2011, AM J TRANSPLANT, V11, P1148, DOI 10.1111/j.1600-6143.2011.03558.x; Issa F, 2010, TRANSPLANTATION, V90, P1321, DOI 10.1097/TP.0b013e3181ff8772; Jaeckel E, 2008, HORM METAB RES, V40, P126, DOI 10.1055/s-2008-1042427; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Lawson JM, 2008, CLIN EXP IMMUNOL, V154, P353, DOI 10.1111/j.1365-2249.2008.03810.x; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; McClymont SA, 2011, J IMMUNOL, V186, P3918, DOI 10.4049/jimmunol.1003099; Monti P, 2008, DIABETES, V57, P2341, DOI 10.2337/db08-0138; Nadig SN, 2010, NAT MED, V16, P809, DOI 10.1038/nm.2154; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Putnam AL, 2005, J AUTOIMMUN, V24, P55, DOI 10.1016/j.jaut.2004.11.004; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; von Boehmer H, 2010, NAT IMMUNOL, V11, P14, DOI 10.1038/ni.1794; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; You S, 2007, P NATL ACAD SCI USA, V104, P6335, DOI 10.1073/pnas.0701171104; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	43	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56209	10.1371/journal.pone.0056209	http://dx.doi.org/10.1371/journal.pone.0056209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409157	gold, Green Published, Green Submitted			2022-12-27	WOS:000315100000046
J	Mirkovic, K; Doorenbos, CRC; Dam, WA; Heerspink, HJL; Slagman, MCJ; Nauta, FL; Kramer, AB; Gansevoort, RT; van den Born, J; Navis, G; de Borst, MH				Mirkovic, Katarina; Doorenbos, Carolina R. C.; Dam, Wendy A.; Heerspink, Hiddo J. Lambers; Slagman, Maartje C. J.; Nauta, Ferdau L.; Kramer, Andrea B.; Gansevoort, Ronald T.; van den Born, Jacob; Navis, Gerjan; de Borst, Martin H.			Urinary Vitamin D Binding Protein: A Potential Novel Marker of Renal Interstitial Inflammation and Fibrosis	PLOS ONE			English	Article							DIETARY-SODIUM RESTRICTION; ADRIAMYCIN NEPHROTIC RATS; ACE-INHIBITION; PROGRESSION; DAMAGE; METABOLISM; MECHANISMS; EXCRETION; DISEASE; ALBUMIN	Non-invasive tubulointerstitial damage markers may allow better titration and monitoring of renoprotective therapy. We investigated the value of urinary vitamin D binding protein excretion (uVDBP) as a tubulointerstitial inflammation and fibrosis marker in adriamycin rats, and tested whether uVDBP parallels renal damage and responds to therapy intensification in humans. In adriamycin (ADR) rats, uVDBP was strongly elevated vs controls (CON) already 6 wks after nephrosis induction (ADR: 727+/-674 [mean+/-SD] vs CON: 9+/-12 mu g/d, p<0.01), i.e. before onset of pre-fibrotic and inflammatory tubulointerstitial damage, and at all following 6-wk time points until end of follow up at 30 wks (ADR: 1403+/-1026 vs CON: 206+/-132 mu g/d, p<0.01). In multivariate regression analysis, uVDBP was associated with tubulointerstitial macrophage accumulation (standardized beta = 0.47, p = 0.01) and collagen III expression (standardized beta = 0.44, p = 0.02) independently of albuminuria. In humans, uVDBP was increased in 100 microalbuminuric subjects (44+/-93 mu g/d) and in 47 CKD patients with overt proteinuria (9.2+/-13.0 mg/d) compared to 100 normoalbuminuric subjects (12+/-12 mu g/d, p<0.001). In CKD patients, uVDBP responded to intensification of renoprotective therapy (ACEi+liberal sodium: 9.2+/-13.0 mg/d vs dual RAAS blockade+low sodium: 2747+/-4013, p<0.001), but remained still >100-fold increased during maximal therapy vs normoalbuminurics (p<0.001), consistent with persisting tubulointerstitial damage. UVDBP was associated with tubular and inflammatory damage markers KIM-1 (standardized beta = 0.52, p<0.001), beta-2-microglobuline (st.beta = 0.45, p<0.001), cystatin C (st.beta = 0.40, p<0.001), MCP-1 (st. beta = 0.31, p<0.001) and NGAL (st. beta = 0.20, p = 0.005), independently of albuminuria. UVDBP may be a novel urinary biomarker of tubulointerstitial damage. Prospectively designed studies are required to validate our findings and confirm its relevance in the clinical setting.	[Mirkovic, Katarina; Doorenbos, Carolina R. C.; Dam, Wendy A.; Slagman, Maartje C. J.; Nauta, Ferdau L.; Kramer, Andrea B.; Gansevoort, Ronald T.; van den Born, Jacob; Navis, Gerjan; de Borst, Martin H.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [Heerspink, Hiddo J. Lambers] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands	University of Groningen; University of Groningen	de Borst, MH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands.	m.h.de.borst@umcg.nl	Heerspink, Hiddo J Lambers/K-3358-2014	Heerspink, Hiddo J Lambers/0000-0002-3126-3730; De Borst, Martin/0000-0002-4127-8733	Dutch Kidney foundation [KJPB.08.07]; University Medical Center Groningen; European Union (FP7, Systems Biology towards Novel Chronic Kidney Disease Diagnosis and Treatment Project consortium (SysKid) [241544]; Dutch Kidney Foundation (NIGRAM consortium) [CP10.11]	Dutch Kidney foundation; University Medical Center Groningen; European Union (FP7, Systems Biology towards Novel Chronic Kidney Disease Diagnosis and Treatment Project consortium (SysKid); Dutch Kidney Foundation (NIGRAM consortium)	Dr. de Borst is supported by personal development grants from the Dutch Kidney foundation (KJPB.08.07) and the University Medical Center Groningen (Mandema stipend), and by the European Union (FP7, Systems Biology towards Novel Chronic Kidney Disease Diagnosis and Treatment Project consortium (SysKid), project number 241544). This work is supported by a consortium grant from the Dutch Kidney Foundation (NIGRAM consortium, grant no CP10.11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTANI T, 1986, KIDNEY INT, V30, P488, DOI 10.1038/ki.1986.212; De Boer E, 1999, J AM SOC NEPHROL, V10, P2359; de Borst MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037957; Doorenbos CRC, 2012, J STEROID BIOCHEM, V128, P56, DOI 10.1016/j.jsbmb.2011.09.002; Doorenbos CRC, 2009, NAT REV NEPHROL, V5, P691, DOI 10.1038/nrneph.2009.185; Gekle M, 2003, J PHYSIOL-LONDON, V552, P471, DOI 10.1113/jphysiol.2003.048074; Hamming I, 2006, J PATHOL, V209, P129, DOI 10.1002/path.1956; Hosojima M, 2009, ENDOCRINOLOGY, V150, P871, DOI 10.1210/en.2008-0886; Kramer AB, 2005, J PATHOL, V207, P483, DOI 10.1002/path.1856; Kramer AB, 2003, J PATHOL, V201, P160, DOI 10.1002/path.1405; Leheste JR, 1999, AM J PATHOL, V155, P1361, DOI 10.1016/S0002-9440(10)65238-8; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Malard V, 2009, BBA-PROTEINS PROTEOM, V1794, P882, DOI 10.1016/j.bbapap.2009.01.010; Nauta FL, 2011, DIABETES CARE, V34, P975, DOI 10.2337/dc10-1545; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Nykjaer A, 2001, P NATL ACAD SCI USA, V98, P13895, DOI 10.1073/pnas.241516998; Perico N, 2009, AM J KIDNEY DIS, V53, P1, DOI 10.1053/j.ajkd.2008.11.002; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Slagman MCJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4366; Thrailkill KM, 2011, J CLIN ENDOCR METAB, V96, P142, DOI 10.1210/jc.2010-0980; Vegter S, 2012, J AM SOC NEPHROL, V23, P165, DOI 10.1681/ASN.2011040430; Verboven C, 2002, NAT STRUCT BIOL, V9, P131, DOI 10.1038/nsb754	23	39	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55887	10.1371/journal.pone.0055887	http://dx.doi.org/10.1371/journal.pone.0055887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409077	Green Published, gold, Green Submitted			2022-12-27	WOS:000315100000030
J	Souaze, F; Bou-Hanna, C; Kandel, C; Leclair, F; Devalliere, J; Charreau, B; Bezieau, S; Mosnier, JF; Laboisse, CL				Souaze, Frederique; Bou-Hanna, Chantal; Kandel, Christine; Leclair, Francois; Devalliere, Julie; Charreau, Beatrice; Bezieau, Stephane; Mosnier, Jean-Francois; Laboisse, Christian L.			Differential Roles of Hath1, MUC2 and P27Kip1 in Relation with Gamma-Secretase Inhibition in Human Colonic Carcinomas: A Translational Study	PLOS ONE			English	Article							CELL-CYCLE; COLORECTAL-CANCER; PROGENITOR CELLS; NOTCH; EXPRESSION; PROLIFERATION; TUMORIGENESIS; P27(KIP1); PATHWAY; LINE	Hath1, a bHLH transcription factor negatively regulated by the gamma-secretase-dependent Notch pathway, is required for intestinal secretory cell differentiation. Our aim was fourfold: 1) determine whether Hath1 is able to alter the phenotype of colon cancer cells that are committed to a differentiated phenotype, 2) determine whether the Hath1-dependent alteration of differentiation is coupled to a restriction of anchorage-dependent growth, 3) decipher the respective roles of three putative tumor suppressor genes Hath1, MUC2 and P27kip1 in this coupling and, 4) examine how our findings translate to primary tumors. Human colon carcinoma cell lines that differentiate along a mucin secreting (MUC2/MUC5AC) and/or enterocytic (DPPIV) lineages were maintained on inserts with or without a gamma-secretase inhibitor (DBZ). Then the cells were detached and their ability to survive/proliferate in the absence of substratum was assessed. gamma-secretase inhibition led to a Hath1-mediated preferential induction of MUC2 over MUC5AC, without DPPIV modification, in association with a decrease in anchorage-independent growth. While P27kip1 silencing relieved the cells from the Hath1-induced decrease of anchorage-independent growth, MUC2 silencing did not modify this parameter. Hath1 ectopic expression in the Hath1 negative enterocytic Caco2 cells led to a decreased anchorage-independent growth in a P27kip1-independent manner. In cultured primary human colon carcinomas, Hath1 was up-regulated in 7 out of 10 tumors upon DBZ treatment. Parallel MUC2 up-regulation occurred in 4 (4/7) and P27kip1 in only 2 (2/7) tumors. Interestingly, the response patterns of primary tumors to DBZ fitted with the hierarchical model of divergent signalling derived from our findings on cell lines.	[Souaze, Frederique; Bou-Hanna, Chantal; Kandel, Christine; Leclair, Francois; Bezieau, Stephane; Mosnier, Jean-Francois; Laboisse, Christian L.] Univ Nantes, EA Biometadys, Nantes, France; [Kandel, Christine; Leclair, Francois; Mosnier, Jean-Francois; Laboisse, Christian L.] CHU Nantes, Serv Anat & Cytol Pathol, F-44035 Nantes 01, France; [Devalliere, Julie; Charreau, Beatrice] Univ Nantes, UMR INSERM, U1064, Nantes, France; [Bezieau, Stephane] CHU Nantes, Serv Genet, F-44035 Nantes 01, France	Nantes Universite; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes	Souaze, F (corresponding author), Univ Nantes, EA Biometadys, Nantes, France.	frederique.souaze@inserm.fr	CHARREAU, Beatrice/AAK-8186-2020; Bézieau, stéphane/G-5621-2015; Souazé, Frédérique/K-7937-2015; souazé, frédérique/AAE-6478-2021	CHARREAU, Beatrice/0000-0001-5870-4615; Bézieau, stéphane/0000-0003-0095-1319; Frederique, Souaze/0000-0003-0476-2603	Ligue Departementale contre le cancer de Loire-Atlantique; GEFLUC (Groupement des Entreprises Francaises dans la Lutte contre le Cancer); Federation Hospitaliere de France	Ligue Departementale contre le cancer de Loire-Atlantique; GEFLUC (Groupement des Entreprises Francaises dans la Lutte contre le Cancer); Federation Hospitaliere de France	This work was supported in part by "Ligue Departementale contre le cancer de Loire-Atlantique'', and GEFLUC (Groupement des Entreprises Francaises dans la Lutte contre le Cancer). CK is a recipient of a predoctoral fellowship from the Federation Hospitaliere de France. FS is recipient of a tenure position supported by the Institut National de la Sante et de la Recherche Medicale (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGERON C, 1984, CANCER RES, V44, P3961; Bara J, 1998, INT J CANCER, V75, P767, DOI 10.1002/(SICI)1097-0215(19980302)75:5<767::AID-IJC17>3.3.CO;2-S; BARA J, 1980, BRIT J CANCER, V41, P209, DOI 10.1038/bjc.1980.32; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; CHANTRET I, 1988, CANCER RES, V48, P1936; CZERNICHOW B, 1989, INT J CANCER, V44, P238, DOI 10.1002/ijc.2910440209; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Deschenes C, 2001, GASTROENTEROLOGY, V120, P423, DOI 10.1053/gast.2001.21199; Fenoglio-Preiser, 2008, GASTRO INTESTINAL PA; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; GRASSET E, 1984, AM J PHYSIOL, V247, pC260, DOI 10.1152/ajpcell.1984.247.3.C260; HO SB, 1989, GASTROENTEROLOGY, V97, P392, DOI 10.1016/0016-5085(89)90075-9; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Jarry A, 2006, BRIT J PHARMACOL, V147, P64, DOI 10.1038/sj.bjp.0706449; Jarry A, 2004, CANCER RES, V64, P4227, DOI 10.1158/0008-5472.CAN-04-0254; Kazanjian A, 2010, GASTROENTEROLOGY, V139, P918, DOI 10.1053/j.gastro.2010.05.081; Kim DH, 2005, INT J ONCOL, V27, P957; Kocer B, 2002, PATHOL INT, V52, P470, DOI 10.1046/j.1440-1827.2002.01369.x; LABOISSE CL, 1981, CANCER RES, V41, P310; LABOISSE CL, 1988, CANCER RES, V48, P2498; Leow CC, 2004, CANCER RES, V64, P6050, DOI 10.1158/0008-5472.CAN-04-0290; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Pandrea IV, 2000, EXP MOL PATHOL, V69, P37, DOI 10.1006/exmp.2000.2309; Peignon G, 2011, GUT, V60, P166, DOI 10.1136/gut.2009.204719; Quillard T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008244; Rao SS, 2009, CANCER RES, V69, P3060, DOI 10.1158/0008-5472.CAN-08-4295; Reedijk M, 2008, INT J ONCOL, V33, P1223, DOI 10.3892/ijo_00000112; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; Stanley R, 2000, WHO CLASSIFICATION T; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; Veenendaal LM, 2008, CELL ONCOL, V30, P1; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; von Kleist S, 1975, J Natl Cancer Inst, V55, P555; Wang LF, 2009, MOLECULES, V14, P3589, DOI 10.3390/molecules14093589; Yang WC, 2003, CANCER RES, V63, P4990; Yeung TM, 2011, P NATL ACAD SCI USA, V108, P4382, DOI 10.1073/pnas.1014519107	42	4	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55904	10.1371/journal.pone.0055904	http://dx.doi.org/10.1371/journal.pone.0055904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409082	Green Submitted, gold, Green Published			2022-12-27	WOS:000315100000032
J	Foucher, ED; Blanchard, S; Preisser, L; Garo, E; Ifrah, N; Guardiola, P; Delneste, Y; Jeannin, P				Foucher, Etienne D.; Blanchard, Simon; Preisser, Laurence; Garo, Erwan; Ifrah, Norbert; Guardiola, Philippe; Delneste, Yves; Jeannin, Pascale			IL-34 Induces the Differentiation of Human Monocytes into Immunosuppressive Macrophages. Antagonistic Effects of GM-CSF and IFN gamma	PLOS ONE			English	Article							LEUKEMIA-INHIBITORY FACTOR; STIMULATING FACTOR CSF; LANGERHANS CELLS; EXPRESSION; RECEPTOR; INTERLEUKIN-34; POLARIZATION; GENERATION; PLASTICITY; CYTOKINE	IL-34 is a recently identified cytokine that signals via the M-CSF receptor and promotes monocyte survival. Depending on the environment, monocytes can differentiate into macrophages (M phi) or dendritic cells (DC). A wide spectrum of M phi and DC subsets, with distinct phenotypes and functions, has been described. To date, the phenotype of monocytes exposed to IL-34 remains unexplored. We report here that IL-34 induces the differentiation of monocytes into CD14(high) CD163(high) CD1a(-) M phi (IL-34-M phi). Upon LPS stimulation, IL-34-M phi exhibit an IL-10(high) IL-12(low) M2 profile and express low levels of the costimulatory molecules CD80 and CD86. IL-34-M phi exhibit poor T cell costimulatory properties, and have potent immunosuppressive properties (decrease of TCR-stimulated T cell proliferation). For all the parameters analyzed, IL-34-M phi are phenotypically and functionally similar to M-CSF-M phi. IL-34 appears as efficient as M-CSF in inducing the generation of immunosuppressive M phi. Moreover, the generation of IL-34-M phi is mediated through the M-CSF receptor, is independent of endogenous M-CSF consumption and is potentiated by IL-6. In an attempt to identify strategies to prevent a deleterious M2 cell accumulation in some pathological situations, we observed that IFN gamma and GM-CSF prevent the generation of immunosuppressive M phi induced by IL-34. IFN gamma also switches established IL-34-M phi into immunostimulatory M phi. In conclusion, we demonstrate that IL-34 drives the differentiation of monocytes into immunosuppressive M2, in a manner similar to M-CSF, and that IFN gamma and GM-CSF prevent this effect.	[Foucher, Etienne D.; Blanchard, Simon; Preisser, Laurence; Garo, Erwan; Ifrah, Norbert; Guardiola, Philippe; Delneste, Yves; Jeannin, Pascale] Univ Angers, LUNAM Univ, Angers, France; [Foucher, Etienne D.; Blanchard, Simon; Preisser, Laurence; Garo, Erwan; Ifrah, Norbert; Guardiola, Philippe; Delneste, Yves; Jeannin, Pascale] INSERM, U892, Angers, France; [Foucher, Etienne D.; Blanchard, Simon; Preisser, Laurence; Garo, Erwan; Ifrah, Norbert; Guardiola, Philippe; Delneste, Yves; Jeannin, Pascale] CNRS, Unit 6299, Angers, France; [Blanchard, Simon; Garo, Erwan; Delneste, Yves; Jeannin, Pascale] Univ Angers, Ctr Hosp Univ, Lab Immunol & Allergol, Angers, France; [Ifrah, Norbert] Univ Angers, Ctr Hosp Univ, Serv Malad Sang, Angers, France; [Guardiola, Philippe] CHU Angers, Plateforme SNP, Angers, France	Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Jeannin, P (corresponding author), Univ Angers, LUNAM Univ, Angers, France.	pascale.jeannin@univ-angers.fr	Delneste, Yves/O-3956-2016; preisser, laurence/K-7583-2015; DELNESTE, Yves/K-7367-2015; Blanchard, Simon/L-1417-2015; guardiola, philippe/L-2910-2015; Ifrah, Norbert/L-5238-2015; JEANNIN, Pascale/K-8656-2015; Foucher, Etienne/K-7581-2015	DELNESTE, Yves/0000-0002-2142-596X; JEANNIN, Pascale/0000-0002-3666-3856; IFRAH, Norbert/0000-0003-3063-850X; Garo, Erwan/0000-0003-4411-9161	INSERM (Institut national de la sante et de la recherche medicale); University of Angers; La ligue contre le Cancer (Equipe labellisee)	INSERM (Institut national de la sante et de la recherche medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Angers; La ligue contre le Cancer (Equipe labellisee)	This work was supported by institutional grants from INSERM (Institut national de la sante et de la recherche medicale) and the University of Angers and by a grant from La ligue contre le Cancer (Equipe labellisee 2012-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud'Huin M, 2010, J PATHOL, V221, P77, DOI 10.1002/path.2684; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Brocheriou I, 2011, ATHEROSCLEROSIS, V214, P316, DOI 10.1016/j.atherosclerosis.2010.11.023; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chemel M, 2012, ANN RHEUM DIS, V71, P150, DOI 10.1136/annrheumdis-2011-200096; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018689; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Droin N, 2010, J LEUKOCYTE BIOL, V87, P745, DOI 10.1189/jlb.1209780; Duluc D, 2007, BLOOD, V110, P4319, DOI 10.1182/blood-2007-02-072587; Duluc D, 2009, INT J CANCER, V125, P367, DOI 10.1002/ijc.24401; ESPINOZADELGADO I, 1990, J IMMUNOL, V145, P1137; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Fraticelli P, 2001, J CLIN INVEST, V107, P1173, DOI 10.1172/JCI11517; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; GLINIAK BC, 1992, MOL BIOL CELL, V3, P535, DOI 10.1091/mbc.3.5.535; GLINIAK BC, 1990, CELL, V63, P1073, DOI 10.1016/0092-8674(90)90510-L; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Hwang SJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3693; Jeannin P, 2011, IMMUNOTHERAPY-UK, V3, P23, DOI [10.2217/IMT.11.30, 10.2217/imt.11.30]; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Ma XL, 2012, STRUCTURE, V20, P676, DOI 10.1016/j.str.2012.02.010; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; METCALF D, 1991, SCIENCE, V254, P529, DOI 10.1126/science.1948028; Mizuno T, 2011, AM J PATHOL, V179, P2016, DOI 10.1016/j.ajpath.2011.06.011; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nandi S., 2012, DEV BIOL; Narni-Mancinelli E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002457; PANDIT J, 1992, SCIENCE, V258, P1358, DOI 10.1126/science.1455231; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822	39	115	132	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56045	10.1371/journal.pone.0056045	http://dx.doi.org/10.1371/journal.pone.0056045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409120	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300053
J	Liu, R; Xu, HP; Wang, GP; Li, J; Gou, L; Zhang, LH; Miao, JT; Li, ZY				Liu, Rui; Xu, Hanpeng; Wang, Guiping; Li, Jie; Gou, Lin; Zhang, Lihua; Miao, Jianting; Li, Zhuyi			Extraocular Muscle Characteristics Related to Myasthenia Gravis Susceptibility	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR; SAFETY FACTOR; EXPRESSION; ATTACK	Background: The pathogenesis of extraocular muscle (EOM) weakness in myasthenia gravis might involve a mechanism specific to the EOM. The aim of this study was to investigate characteristics of the EOM related to its susceptibility to myasthenia gravis. Methods: Female F344 rats and female Sprague-Dawley rats were assigned to experimental and control groups. The experimental group received injection with Ringer solution containing monoclonal antibody against the acetylcholine receptor (AChR), mAb35 (0.25 mg/kg), to induce experimental autoimmune myasthenia gravis, and the control group received injection with Ringer solution alone. Three muscles were analyzed: EOM, diaphragm, and tibialis anterior. Tissues were examined by light microscopy, fluorescence histochemistry, and transmission electron microscopy. Western blot analysis was used to assess marker expression and ELISA analysis was used to quantify creatine kinase levels. Microarray assay was conducted to detect differentially expressed genes. Results: In the experimental group, the EOM showed a simpler neuromuscular junction (NMJ) structure compared to the other muscles; the NMJ had fewer synaptic folds, showed a lesser amount of AChR, and the endplate was wider compared to the other muscles. Results of microarray assay showed differential expression of 54 genes in the EOM between the experimental and control groups. Conclusion: Various EOM characteristics appear to be related to the increased susceptibility of the EOM and the mechanism of EOM weakness in myasthenia gravis.	[Liu, Rui; Zhang, Lihua] Fourth Mil Med Univ, Tangdu Hosp, Dept Geratol, Xian 710032, Shaanxi Provinc, Peoples R China; [Xu, Hanpeng; Gou, Lin] Univ Calif Los Angeles, Dept Neurol, LONI, Los Angeles, CA 90024 USA; [Wang, Guiping] 208th Hosp PLA, Dept Neurosurg, Changchun, Jilin Province, Peoples R China; [Li, Jie] 451 Hosp PLA, Dept Endocrinol, Xian, Shaanxi Provinc, Peoples R China; [Miao, Jianting; Li, Zhuyi] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; University of California System; University of California Los Angeles; Air Force Military Medical University	Miao, JT (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, Xian 710032, Shaanxi Provinc, Peoples R China.	miaojt@163.com; lizhuyi@fmmu.edu.cn			National Natural Science Foundation of China [81200966]; Natural Science Fund of Shaanxi province [2010JQ4014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Shaanxi province(Natural Science Foundation of Shaanxi Province)	This research was supported by the National Natural Science Foundation of China (No. 81200966) and Natural Science Fund of Shaanxi province (No. 2010JQ4014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christadoss P, 2000, CLIN IMMUNOL, V94, P75, DOI 10.1006/clim.1999.4807; Crosby LM, 2000, TOXICOL APPL PHARM, V169, P205, DOI 10.1006/taap.2000.9049; ENGEL AG, 1984, ANN NEUROL, V16, P519, DOI 10.1002/ana.410160502; Felice KJ, 1998, J NEUROL SCI, V160, pS30, DOI 10.1016/S0022-510X(98)00195-6; Fischer MD, 2005, PHYSIOL GENOMICS, V22, P283, DOI 10.1152/physiolgenomics.00158.2004; Heckmann JM, 2010, GENES IMMUN, V11, P1, DOI 10.1038/gene.2009.61; Hughes BW, 2004, SEMIN NEUROL, V24, P21, DOI 10.1055/s-2004-829585; Kaminski HJ, 1997, ANN NEUROL, V41, P419, DOI 10.1002/ana.410410402; Kaminski HJ, 1996, INVEST OPHTH VIS SCI, V37, P345; Kaminski HJ, 2004, EXP NEUROL, V189, P333, DOI 10.1016/j.expneurol.2004.06.005; Kaminski HJ, 2003, ANN NY ACAD SCI, V998, P362, DOI 10.1196/annals.1254.043; Kaminski HJ LZ, 2002, NEW YORK SCI SESS MY; Leite MI, 2007, AM J PATHOL, V171, P893, DOI 10.2353/ajpath.2007.070240; Lin F, 2002, J CLIN INVEST, V110, P1269, DOI 10.1172/JCI200216086; LOUTRARI H, 1992, EUR J IMMUNOL, V22, P2449, DOI 10.1002/eji.1830220939; MAYHEW TM, 1979, J NEUROCYTOL, V8, P121, DOI 10.1007/BF01175556; McManamny P, 2002, HUM MOL GENET, V11, P2103, DOI 10.1093/hmg/11.18.2103; Morgan BP, 2006, CLIN EXP IMMUNOL, V146, P294, DOI 10.1111/j.1365-2249.2006.03205.x; Poulas K, 2000, CLIN EXP IMMUNOL, V120, P363, DOI 10.1046/j.1365-2249.2000.01202.x; Ruff RL, 2008, J NEUROIMMUNOL, V201, P13, DOI 10.1016/j.jneuroim.2008.04.038; Soltys J, 2008, ANN NY ACAD SCI, V1132, P220, DOI 10.1196/annals.1405.037; Wang ZY, 2000, J NEUROIMMUNOL, V108, P29, DOI 10.1016/S0165-5728(00)00250-2; Wood SJ, 1997, J PHYSIOL-LONDON, V500, P165, DOI 10.1113/jphysiol.1997.sp022007	23	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55611	10.1371/journal.pone.0055611	http://dx.doi.org/10.1371/journal.pone.0055611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409007	Green Submitted, Green Published, gold			2022-12-27	WOS:000314660300024
J	Hopkins, PCR				Hopkins, Paul C. R.			Neurodegeneration in a Drosophila Model for the Function of TMCC2, an Amyloid Protein Precursor-Interacting and Apolipoprotein E-Binding Protein	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; GLIAL-CELLS; A-BETA; GENE; TAU; MIGRATION; CIRCUITS; MUTATION; SYSTEM; ALTERS	We previously identified TMCC2 as a protein that interacted differentially with normal versus Alzheimer's disease-risk forms of both apolipoprotein E (apoE) and the amyloid protein precursor (APP). We hypothesized that disrupted function of TMCC2 would affect neurodegeneration. To test this hypothesis, we investigated the Drosophila orthologue of TMCC2, that we have named Dementin. We showed that Dementin interacts genetically both with human APP and its Drosophila orthologue, the APP-like protein (APPL). Ectopic expression of Dementin in Drosophila rescued developmental and behavioral defects caused by expression of human APP. Both a hypomorphic lethal mutation in the dementin gene (dmtn(1)) and RNAi for Dementin caused the accumulation of fragments derived from APPL. We found that Dementin was required for normal development of the brain, and that glial Dementin was required for development of the Drosophila medulla neuropil. Expression of wild-type Dementin in either the neurons or glia of dmtn(1) flies rescued developmental lethality. Adult dmtn(1) flies rescued by expression of wild-type Dementin in glia, i.e. whose neurons expressed only dmtn(1), showed pathological features resembling early onset Alzheimer's disease, accumulation of abnormal APPL metabolites, synaptic pathology, mis-localized microtubule-binding proteins, neurodegeneration, and early death.	[Hopkins, Paul C. R.] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Hopkins, Paul C. R.] Kings Coll London, MRC, Ctr Dev Neurobiol, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Hopkins, PCR (corresponding author), Kings Coll London, Inst Psychiat, London WC2R 2LS, England.	hopkins.dementin@gmail.com			Alzheimer's Society; Alzheimer's Research UK; Alzheimers Research UK [ART-ESG2009-6] Funding Source: researchfish	Alzheimer's Society; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	The work was funded by grants from the Alzheimer's Society (alzheimers.org.uk) and Alzheimer's Research UK (www.alzheimersresearchuk.org) awarded to PCRH. The author thanks benefactor JAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Buttini M, 2002, J NEUROSCI, V22, P10539; Buttini M, 2010, AM J PATHOL, V177, P563, DOI 10.2353/ajpath.2010.090973; Carmine-Simmen K, 2009, NEUROBIOL DIS, V33, P274, DOI 10.1016/j.nbd.2008.10.014; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dodart JC, 2002, BRAIN RES, V955, P191, DOI 10.1016/S0006-8993(02)03437-6; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; Fossgreen A, 1998, P NATL ACAD SCI USA, V95, P13703, DOI 10.1073/pnas.95.23.13703; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hadjieconomou D, 2011, CURR OPIN NEUROBIOL, V21, P76, DOI 10.1016/j.conb.2010.07.012; Hasegawa E, 2011, DEVELOPMENT, V138, P983, DOI 10.1242/dev.058370; Heidary G, 2001, MECH DEVELOP, V108, P171, DOI 10.1016/S0925-4773(01)00487-7; Hida Y, 2010, J BIOCHEM, V148, P131, DOI 10.1093/jb/mvq065; Hopkins PCR, 2011, J ALZHEIMERS DIS, V26, P239, DOI 10.3233/JAD-2011-102115; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Li Y, 2004, J NEUROBIOL, V61, P343, DOI 10.1002/neu.20048; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; MARTINMORRIS LE, 1990, DEVELOPMENT, V110, P185; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Nochlin D, 1998, ANN NEUROL, V43, P131, DOI 10.1002/ana.410430124; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Van Dooren T, 2006, AM J PATHOL, V168, P245, DOI 10.2353/ajpath.2006.050752; Verkkoniemi A, 2000, NEUROLOGY, V54, P1103, DOI 10.1212/WNL.54.5.1103; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; Wentzell JS, 2012, NEUROBIOL DIS, V46, P78, DOI 10.1016/j.nbd.2011.12.047; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	45	18	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55810	10.1371/journal.pone.0055810	http://dx.doi.org/10.1371/journal.pone.0055810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409049	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200069
J	Mann, RA; Smits, THM; Buhlmann, A; Blom, J; Goesmann, A; Frey, JE; Plummer, KM; Beer, SV; Luck, J; Duffy, B; Rodoni, B				Mann, Rachel A.; Smits, Theo H. M.; Buehlmann, Andreas; Blom, Jochen; Goesmann, Alexander; Frey, Juerg E.; Plummer, Kim M.; Beer, Steven V.; Luck, Joanne; Duffy, Brion; Rodoni, Brendan			Comparative Genomics of 12 Strains of Erwinia amylovora Identifies a Pan-Genome with a Large Conserved Core	PLOS ONE			English	Article							HRP PATHOGENICITY ISLAND; FIRE BLIGHT; MOLECULAR DIFFERENTIATION; STREPTOCOCCUS-PNEUMONIAE; PLASMID PEA29; BACTERIAL; DIVERSITY; INFECTION; VIRULENCE; SEQUENCE	The plant pathogen Erwinia amylovora can be divided into two host-specific groupings; strains infecting a broad range of hosts within the Rosaceae subfamily Spiraeoideae (e.g., Malus, Pyrus, Crataegus, Sorbus) and strains infecting Rubus (raspberries and blackberries). Comparative genomic analysis of 12 strains representing distinct populations (e.g., geographic, temporal, host origin) of E. amylovora was used to describe the pan-genome of this major pathogen. The pan-genome contains 5751 coding sequences and is highly conserved relative to other phytopathogenic bacteria comprising on average 89% conserved, core genes. The chromosomes of Spiraeoideae-infecting strains were highly homogeneous, while greater genetic diversity was observed between Spiraeoideae- and Rubus-infecting strains (and among individual Rubus-infecting strains), the majority of which was attributed to variable genomic islands. Based on genomic distance scores and phylogenetic analysis, the Rubus-infecting strain ATCC BAA-2158 was genetically more closely related to the Spiraeoideae-infecting strains of E. amylovora than it was to the other Rubus-infecting strains. Analysis of the accessory genomes of Spiraeoideae- and Rubus-infecting strains has identified putative host-specific determinants including variation in the effector protein HopX1(Ea) and a putative secondary metabolite pathway only present in Rubus-infecting strains.	[Mann, Rachel A.; Plummer, Kim M.; Luck, Joanne; Rodoni, Brendan] Cooperat Res Ctr Natl Plant Biosecur, Bruce, ACT, Australia; [Mann, Rachel A.; Plummer, Kim M.] La Trobe Univ, Dept Bot, Bundoora, Vic 3083, Australia; [Mann, Rachel A.; Beer, Steven V.] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA; [Mann, Rachel A.; Luck, Joanne; Rodoni, Brendan] Dept Primary Ind, Biosci Res Div, Knoxfield, Vic, Australia; [Smits, Theo H. M.; Buehlmann, Andreas; Frey, Juerg E.; Duffy, Brion] Agroscope Changins Wadenswil ACW, Swiss Natl Competence Ctr Fire Blight, Div Plant Protect, Wadenswil, Switzerland; [Blom, Jochen; Goesmann, Alexander] Univ Bielefeld, CeBiTec, D-33615 Bielefeld, Germany	La Trobe University; Cornell University; Swiss Federal Research Station Agroscope; University of Bielefeld	Smits, THM (corresponding author), Agroscope Changins Wadenswil ACW, Swiss Natl Competence Ctr Fire Blight, Div Plant Protect, Wadenswil, Switzerland.	theo.smits@acw.admin.ch	; Plummer, Kim/B-4911-2016	Goesmann, Alexander/0000-0002-7086-2568; Plummer, Kim/0000-0001-6846-642X; Smits, Theo H.M./0000-0002-1237-235X	Australian Government's Cooperative Research Centre's program; Horticulture Australia Limited; United States Department of Agriculture CSREES for research on fire blight in New York; Swiss Federal Office of Agriculture [08.02]; European Science Foundation [864]	Australian Government's Cooperative Research Centre's program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Horticulture Australia Limited(Horticulture Australia Limited); United States Department of Agriculture CSREES for research on fire blight in New York; Swiss Federal Office of Agriculture; European Science Foundation(European Science Foundation (ESF)European Commission)	The authors would like to acknowledge the support of the Australian Government's Cooperative Research Centre's program, Horticulture Australia Limited, a Special Grant provided by the United States Department of Agriculture CSREES for research on fire blight in New York and the Swiss Federal Office of Agriculture (BLW Nr. 08.02). This research was conducted in part within the European Science Foundation funded research network COST Action 864. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asselin JE, 2011, PHYTOPATHOLOGY, V101, P935, DOI 10.1094/PHYTO-12-10-0339; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Bocsanczy AM, 2012, J BACTERIOL, V194, P553, DOI 10.1128/JB.05065-11; Boissy R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-187; Bonn WG, 2000, FIRE BLIGHT, P37, DOI 10.1079/9780851992945.0037; Braun PG, 2005, CAN J PLANT PATHOL, V27, P338; Brennan JM, 2002, J PHYTOPATHOL, V150, P414, DOI 10.1046/j.1439-0434.2002.00789.x; De Maayer P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-576; Deloger M, 2009, J BACTERIOL, V191, P91, DOI 10.1128/JB.01202-08; Deng XY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-500; Donat V, 2007, J APPL MICROBIOL, V103, P1639, DOI 10.1111/j.1365-2672.2007.03399.x; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Dye DW, 1968, NZ J SCI, V11; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Jock S, 2002, ENVIRON MICROBIOL, V4, P106, DOI 10.1046/j.1462-2920.2002.00277.x; Jock S, 2004, ENVIRON MICROBIOL, V6, P480, DOI 10.1111/j.1462-2920.2004.00583.x; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kim J. H., 1996, Acta Horticulturae, P183; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Kulinska A, 2008, APPL ENVIRON MICROB, V74, P4119, DOI 10.1128/AEM.00229-08; Langille MGI, 2010, NAT REV MICROBIOL, V8, P372, DOI 10.1038/nrmicro2350; LAURENT J, 1989, Molecular Plant-Microbe Interactions, V2, P160, DOI 10.1094/MPMI-2-160; Lecomte P, 1997, EUR J PLANT PATHOL, V103, P91, DOI 10.1023/A:1008607226805; Llop P, 2012, TREES-STRUCT FUNCT, V26, P31, DOI 10.1007/s00468-011-0630-2; Llop P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028651; Maes M, 2001, EUR J PLANT PATHOL, V107, P839, DOI 10.1023/A:1012215201253; Mann RA, 2012, GENE, V504, P6, DOI 10.1016/j.gene.2012.05.002; Mavrodi DV, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-8; McGhee GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041706; McGhee GC, 2000, APPL ENVIRON MICROB, V66, P4897, DOI 10.1128/AEM.66.11.4897-4907.2000; McGhee GC, 2002, ACTA HORTIC, P413, DOI 10.17660/ActaHortic.2002.590.64; McHardy AC, 2004, BIOINFORMATICS, V20, P1622, DOI 10.1093/bioinformatics/bth137; McManus PS, 1995, PHYTOPATHOLOGY, V85, P1547, DOI 10.1094/Phyto-85-1547; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Momol MT, 2000, FIRE BLIGHT, P55, DOI 10.1079/9780851992945.0055; NORELLI JL, 1984, PHYTOPATHOLOGY, V74, P136, DOI 10.1094/Phyto-74-136; Oh CS, 2005, MOL PLANT PATHOL, V6, P125, DOI 10.1111/j.1364-3703.2005.00269.x; PAULIN J-P, 1973, Annales de Phytopathologie, V5, P389; Powney R, 2011, AUSTRALAS PLANT PATH, V40, P87, DOI 10.1007/s13313-010-0017-7; Powney R, 2011, J BACTERIOL, V193, P785, DOI 10.1128/JB.01352-10; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; Remenant B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-379; Rezzonico F, 2012, MOL PLANT PATHOL, V13, P975, DOI 10.1111/j.1364-3703.2012.00807.x; Rezzonico F, 2011, APPL ENVIRON MICROB, V77, P3819, DOI 10.1128/AEM.00177-11; Rico A, 2004, J APPL MICROBIOL, V96, P302, DOI 10.1046/j.1365-2672.2003.02156.x; RIES SM, 1977, PLANT DIS REP, V61, P232; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Seth-Smith H, 2009, NAT REV MICROBIOL, V7, P328, DOI 10.1038/nrmicro2137; Shao YC, 2010, NUCLEIC ACIDS RES, V38, pW194, DOI 10.1093/nar/gkq326; Smits THM, 2011, J BIOTECHNOL, V155, P34, DOI 10.1016/j.jbiotec.2010.10.075; Smits THM, 2010, MOL PLANT MICROBE IN, V23, P384, DOI 10.1094/MPMI-23-4-0384; Smits THM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-2; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Triplett LR, 2006, APPL ENVIRON MICROB, V72, P7359, DOI 10.1128/AEM.01159-06; Triplett LR, 2009, MOL PLANT MICROBE IN, V22, P1282, DOI 10.1094/MPMI-22-10-1282; Wang DP, 2010, PHYTOPATHOLOGY, V100, P192, DOI 10.1094/PHYTO-100-2-0192; Wang DP, 2009, MOL PLANT PATHOL, V10, P277, DOI 10.1111/j.1364-3703.2008.00531.x; Watanabe S, 2006, J BIOL CHEM, V281, P2612, DOI 10.1074/jbc.M506477200; Whittle G, 2002, CELL MOL LIFE SCI, V59, P2044, DOI 10.1007/s000180200004; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; Wozniak M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S2-S6; Xu TG, 2010, NUCLEIC ACIDS RES, V38, P7133, DOI 10.1093/nar/gkq610; Zhao YF, 2005, J BACTERIOL, V187, P8088, DOI 10.1128/JB.187.23.8088-8103.2005; Zhao YF, 2006, MOL PLANT MICROBE IN, V19, P644, DOI 10.1094/MPMI-19-0644	70	62	64	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55644	10.1371/journal.pone.0055644	http://dx.doi.org/10.1371/journal.pone.0055644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409014	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200047
J	Chen, JH; Wang, WL; Zhang, QB; Li, F; Lei, TH; Luo, DL; Zhou, H; Yang, BX				Chen, Jihui; Wang, Weiling; Zhang, Quanbin; Li, Fei; Lei, Tianluo; Luo, Dali; Zhou, Hong; Yang, Baoxue			Low Molecular Weight Fucoidan against Renal Ischemia-Reperfusion Injury via Inhibition of the MAPK Signaling Pathway	PLOS ONE			English	Article							UNDARIA-PINNATIFIDA; FREE-RADICALS; PC12 CELLS; APOPTOSIS; JNK; ACTIVATION; ERK; PHOSPHORYLATION; DIFFERENTIATION; POLYSACCHARIDE	Background: Ischemia reperfusion injury (IRI) is a leading cause of acute kidney injury (AKI) in both native and transplanted kidneys. The objective of the present study was to evaluate whether low-molecular-weight fucoidan (LMWF) could attenuate renal IRI in an animal model and in vitro cell models and study the mechanisms in which LMWF protected from IRI. Methodology/Principal Findings: Male mice were subjected to right renal ischemia for 30 min and reperfusion for 24 h, or to a sham operation with left kidney removed. Kidneys undergone IR showed characteristic morphological changes, such as tubular dilatation, and brush border loss. However, LMWF significantly corrected the renal dysfunction and the abnormal levels of MPO, MDA and SOD induced by IR. LMWF also inhibited the activation of MAPK pathways, which consequently resulted in a significant decrease in the release of cytochrome c from mitochondria, ratios of Bax/Bcl-2 and cleaved caspase3/ caspase-3, and phosphorylation of p53. LMWF alleviated hypoxia-reoxygenation or CoCl2 induced cell viability loss and Delta Psi m dissipation in HK2 renal tubular epithelial cells, which indicates LMWF may result in an inhibition of the apoptosis pathway through reducing activity of MAPK pathways in a dose-dependent manner. Conclusions/Significance: Our in vivo and in vitro studies show that LMWF ameliorates acute renal IRI via inhibiting MAPK signaling pathways. The data provide evidence that LMWF may serve as a potential therapeutic agent for acute renal IRI.	[Chen, Jihui; Wang, Weiling; Li, Fei; Lei, Tianluo; Zhou, Hong; Yang, Baoxue] Peking Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing 100871, Peoples R China; [Chen, Jihui; Wang, Weiling; Li, Fei; Lei, Tianluo; Zhou, Hong; Yang, Baoxue] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Zhang, Quanbin] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Luo, Dali] Capital Med Univ, Dept Pharmacol, Beijing, Peoples R China	Peking University; Chinese Academy of Sciences; Institute of Oceanology, CAS; Capital Medical University	Zhou, H (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Pharmacol, Beijing 100871, Peoples R China.	rainbow_zhou@126.com; baoxue@bjmu.edu.cn		Chen, Jihui/0000-0002-9819-9921	National Natural Science Foundation of China [30870921, 31200869, 81170632, 81261160507]; Drug Discovery Program grant [2009ZX09301-010-30]; Doctoral Training Fund [20100001110047]; International Science and Technology Cooperation Program of China [2012DFA11070]; Beijing Natural Science Foundation grant [7102105]; 111 Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Drug Discovery Program grant; Doctoral Training Fund; International Science and Technology Cooperation Program of China; Beijing Natural Science Foundation grant; 111 Project(Ministry of Education, China - 111 Project)	This work was supported by National Natural Science Foundation of China grants 30870921, 31200869, 81170632 and 81261160507, Drug Discovery Program grant 2009ZX09301-010-30, Doctoral Training Fund 20100001110047, 111 Project, International Science and Technology Cooperation Program of China 2012DFA11070 and Beijing Natural Science Foundation grant 7102105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; BECKMAN JK, 1991, FREE RADICAL BIO MED, V11, P335, DOI 10.1016/0891-5849(91)90148-V; Boisson-Vidal C., 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P67; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Chatterjee PK, 2007, N-S ARCH PHARMACOL, V376, P1, DOI 10.1007/s00210-007-0183-5; Chen SL, 2010, CLIN EXP PHARMACOL P, V37, P316, DOI 10.1111/j.1440-1681.2009.05289.x; Chung HJ, 2010, PHYTOTHER RES, V24, P1078, DOI 10.1002/ptr.3138; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cumashi A, 2007, GLYCOBIOLOGY, V17, P541, DOI 10.1093/glycob/cwm014; Deux JF, 2002, ARTERIOSCL THROM VAS, V22, P1604, DOI 10.1161/01.ATV.0000032034.91020.0A; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Eschwege P, 1999, J UROLOGY, V162, P553, DOI 10.1016/S0022-5347(05)68626-0; Gao YL, 2012, CELL MOL NEUROBIOL, V32, P523, DOI 10.1007/s10571-011-9792-0; GOLDBERG MA, 1994, J BIOL CHEM, V269, P4355; Gueler F, 2004, KIDNEY INT, V66, P523, DOI 10.1111/j.1523-1755.2004.761_11.x; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Hayashi K, 2008, INT IMMUNOPHARMACOL, V8, P109, DOI 10.1016/j.intimp.2007.10.017; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hsu MJ, 2007, J NEUROSCI, V27, P5719, DOI 10.1523/JNEUROSCI.1874-06.2007; Hussein AAM, 2012, ACTA PHYSIOL, V204, P308, DOI 10.1111/j.1748-1716.2011.02372.x; IWATA M, 1994, J AM SOC NEPHROL, V5, P1307; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kim KJ, 2011, FOOD CHEM TOXICOL, V48, P1101; Kim KJ, 2012, NUTR RES, V32, P439, DOI 10.1016/j.nutres.2012.04.003; Kotake-Nara E, 2006, THESCIENTIFICWORLDJO, V6, P176, DOI 10.1100/tsw.2006.37; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Kyung Jangbeen, 2012, Lab Anim Res, V28, P91, DOI 10.5625/lar.2012.28.2.91; Lake AC, 2006, J BIOL CHEM, V281, P37844, DOI 10.1074/jbc.M600686200; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li CM, 2011, FOOD CHEM TOXICOL, V49, P2090, DOI 10.1016/j.fct.2011.05.022; Linnemann G, 2000, INTENS CARE MED, V26, P1540, DOI 10.1007/s001340000642; Liu B, 2009, CANCER LETT, V275, P54, DOI 10.1016/j.canlet.2008.09.042; Luyt CE, 2003, J PHARMACOL EXP THER, V305, P24, DOI 10.1124/jpet.102.046144; Manzo-Silberman S, 2011, J CARDIOVASC PHARM, V58, P626, DOI 10.1097/FJC.0b013e3182308c64; Nagata Y, 1999, BLOOD, V94, P853, DOI 10.1182/blood.V94.3.853.415a12_853_863; Omata M, 1997, J CARDIOVASC PHARM, V30, P717, DOI 10.1097/00005344-199712000-00003; PALLER MS, 1984, J CLIN INVEST, V74, P1156, DOI 10.1172/JCI111524; Snoeijs MGJ, 2010, CURR OPIN ORGAN TRAN, V15, P190, DOI 10.1097/MOT.0b013e32833593eb; Song MY, 2012, FOOD CHEM TOXICOL, V50, P790, DOI 10.1016/j.fct.2011.11.010; Wang J, 2012, J ETHNOPHARMACOL, V139, P807, DOI 10.1016/j.jep.2011.12.022; Wang J, 2010, INT J BIOL MACROMOL, V46, P6, DOI 10.1016/j.ijbiomac.2009.10.015; WANG XY, 1993, ARCH BIOCHEM BIOPHYS, V306, P402, DOI 10.1006/abbi.1993.1529; Wang Y, 2007, LIFE SCI, V80, P2067, DOI 10.1016/j.lfs.2007.03.010; Wolfs TGAM, 2005, AM J TRANSPLANT, V5, P68, DOI 10.1111/j.1600-6143.2004.00657.x; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang SJ, 2004, J BIOCHEM MOL BIOL, V37, P480; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200; Zager RA, 2005, AM J PHYSIOL-RENAL, V289, pF289, DOI 10.1152/ajprenal.00023.2005; Zhang QB, 2003, PLANTA MED, V69, P537, DOI 10.1055/s-2003-40634; Zhao X, 2012, THROMB RES, V129, P771, DOI 10.1016/j.thromres.2011.07.041; Zou WG, 2001, J NEUROSCI RES, V64, P646, DOI 10.1002/jnr.1118	51	45	54	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56224	10.1371/journal.pone.0056224	http://dx.doi.org/10.1371/journal.pone.0056224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418539	Green Published, gold			2022-12-27	WOS:000315970300131
J	Chowdhury, RA; Lina, JM; Kobayashi, E; Grova, C				Chowdhury, Rasheda Arman; Lina, Jean Marc; Kobayashi, Eliane; Grova, Christophe			MEG Source Localization of Spatially Extended Generators of Epileptic Activity: Comparing Entropic and Hierarchical Bayesian Approaches	PLOS ONE			English	Article							CORTICAL CURRENT-DENSITY; EEG SOURCE LOCALIZATION; SOURCE RECONSTRUCTION; INVERSE PROBLEM; INTERICTAL SPIKES; INTRACRANIAL EEG; LOBE EPILEPSY; HUMAN-BRAIN; MAGNETOENCEPHALOGRAPHY; FMRI	Localizing the generators of epileptic activity in the brain using Electro-EncephaloGraphy (EEG) or Magneto-EncephaloGraphy (MEG) signals is of particular interest during the pre-surgical investigation of epilepsy. Epileptic discharges can be detectable from background brain activity, provided they are associated with spatially extended generators. Using realistic simulations of epileptic activity, this study evaluates the ability of distributed source localization methods to accurately estimate the location of the generators and their sensitivity to the spatial extent of such generators when using MEG data. Source localization methods based on two types of realistic models have been investigated: (i) brain activity may be modeled using cortical parcels and (ii) brain activity is assumed to be locally smooth within each parcel. A Data Driven Parcellization (DDP) method was used to segment the cortical surface into non-overlapping parcels and diffusion-based spatial priors were used to model local spatial smoothness within parcels. These models were implemented within the Maximum Entropy on the Mean (MEM) and the Hierarchical Bayesian (HB) source localization frameworks. We proposed new methods in this context and compared them with other standard ones using Monte Carlo simulations of realistic MEG data involving sources of several spatial extents and depths. Detection accuracy of each method was quantified using Receiver Operating Characteristic (ROC) analysis and localization error metrics. Our results showed that methods implemented within the MEM framework were sensitive to all spatial extents of the sources ranging from 3 cm(2) to 30 cm(2), whatever were the number and size of the parcels defining the model. To reach a similar level of accuracy within the HB framework, a model using parcels larger than the size of the sources should be considered.	[Chowdhury, Rasheda Arman; Grova, Christophe] McGill Univ, Dept Biomed Engn, Multimodal Funct Imaging Lab, Montreal, PQ, Canada; [Kobayashi, Eliane; Grova, Christophe] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Lina, Jean Marc] Ecole Technol Super, Dept Elect Engn, Montreal, PQ, Canada; [Lina, Jean Marc; Grova, Christophe] Univ Montreal, Ctr Rech Math, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; University of Quebec; Ecole de Technologie Superieure - Canada; Universite de Montreal	Chowdhury, RA (corresponding author), McGill Univ, Dept Biomed Engn, Multimodal Funct Imaging Lab, Montreal, PQ, Canada.	rasheda.chowdhury@mail.mcgill.ca		Chowdhury, Rasheda/0000-0001-9691-594X; Kobayashi, Eliane/0000-0002-1713-1563; Grova, Christophe/0000-0003-2775-9968	Natural Sciences and Engineering Research Council of Canada Discovery Grant Program; Canadian Institutes of Health Research [MOP 93614]; Montreal Neurological Institute-CECR; Savoy Foundation scholarship; Fonds de Recherche en Sante du Quebec (FRSQ); American Epilepsy Society Early Career Physician-Scientist award; FRSQ	Natural Sciences and Engineering Research Council of Canada Discovery Grant Program(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Montreal Neurological Institute-CECR; Savoy Foundation scholarship; Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); American Epilepsy Society Early Career Physician-Scientist award; FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Natural Sciences and Engineering Research Council of Canada Discovery Grant Program (CG and JML), the Canadian Institutes of Health Research MOP 93614 (EK) and the Montreal Neurological Institute-CECR (EK). RC was partially supported by a Savoy Foundation scholarship (http://www.savoy-foundation.ca/index.htm). CG was also supported by a salary award from the Fonds de Recherche en Sante du Quebec (FRSQ). EK was also supported by the American Epilepsy Society Early Career Physician-Scientist award and by the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre-Arrizubieta Z, 2009, BRAIN, V132, P3060, DOI 10.1093/brain/awp137; Ahlfors SP, 2009, HUM BRAIN MAPP, P140; Amblard U, 2004, IEEE T BIO-MED ENG, V51, P427, DOI 10.1109/TBME.2003.820999; Attal Y, 2007, P ANN INT IEEE EMBS, P4937, DOI 10.1109/IEMBS.2007.4353448; Baillet S, 1997, IEEE T BIO-MED ENG, V44, P374, DOI 10.1109/10.568913; Baillet S, 2001, IEEE SIGNAL PROCESSI, P1053; BARTH DS, 1984, SCIENCE, V223, P293, DOI 10.1126/science.6422552; Baune A, 1999, NEUROIMAGE, V9, P477, DOI 10.1006/nimg.1999.0429; Bellec P, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00007; Bellec P, 2010, NEUROIMAGE, V51, P1126, DOI 10.1016/j.neuroimage.2010.02.082; Birot G, 2011, NEUROIMAGE, V56, P102, DOI 10.1016/j.neuroimage.2011.01.054; Bouet R, 2012, NEUROIMAGE, V59, P3955, DOI 10.1016/j.neuroimage.2011.10.052; Chauvel P, 1996, MULTIMETHODOLOGICAL, P80; Cheyne D., 2010, FRONTIERS NEUROSCIEN, V4; Cosandier-Rimele D, 2008, NEUROIMAGE, V42, P135, DOI 10.1016/j.neuroimage.2008.04.185; Cosandier-Rimele D, 2007, IEEE T BIO-MED ENG, V54, P380, DOI 10.1109/TBME.2006.890489; Cottereau B, 2007, NEUROIMAGE, V38, P439, DOI 10.1016/j.neuroimage.2007.07.046; Dale A., 1993, IMPROVED LOCALIZATIO; Daunizeau J, 2006, IEEE T BIO-MED ENG, V53, P503, DOI 10.1109/TBME.2005.869791; Daunizeau J, 2007, NEUROIMAGE, V36, P69, DOI 10.1016/j.neuroimage.2007.01.044; David O, 2002, IEEE T BIO-MED ENG, V49, P975, DOI 10.1109/TBME.2002.802013; Ding L, 2009, PHYS MED BIOL, V54, P2683, DOI 10.1088/0031-9155/54/9/006; Dorst L, 2005, IEEE T PATTERN ANAL, V27, P221, DOI 10.1109/TPAMI.2005.29; Ebersole JS, 1997, EPILEPSIA, V38, pS1, DOI 10.1111/j.1528-1157.1997.tb04533.x; Ebersole JS, 1997, J CLIN NEUROPHYSIOL, V14, P470, DOI 10.1097/00004691-199711000-00003; Friston KJ, 2008, NEUROIMAGE, V39, P1104, DOI 10.1016/j.neuroimage.2007.09.048; Friston KJ, 2007, NEUROIMAGE, V34, P220, DOI 10.1016/j.neuroimage.2006.08.035; Friston KJ, 2002, NEUROIMAGE, V16, P465, DOI 10.1006/nimg.2002.1090; Genow A, 2004, NEUROIMAGE, V21, P444, DOI 10.1016/j.neuroimage.2003.08.029; Grova C, 2008, NEUROIMAGE, V39, P755, DOI 10.1016/j.neuroimage.2007.08.020; Grova C, 2006, NEUROIMAGE, V29, P734, DOI 10.1016/j.neuroimage.2005.08.053; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Harrison LM, 2007, NEUROIMAGE, V38, P677, DOI 10.1016/j.neuroimage.2007.07.032; Henson RN, 2007, NEUROIMAGE, V38, P422, DOI 10.1016/j.neuroimage.2007.07.026; Henson RN, 2009, NEUROIMAGE, V46, P168, DOI 10.1016/j.neuroimage.2009.01.062; Henson RN, 2010, HUM BRAIN MAPP, V31, P1512, DOI 10.1002/hbm.20956; Huiskamp G, 2010, BRAIN TOPOGR, V23, P159, DOI 10.1007/s10548-010-0134-1; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jerbi K, 2002, PHYS MED BIOL, V47, P523, DOI 10.1088/0031-9155/47/4/301; Kincses WE, 1999, HUM BRAIN MAPP, V8, P182, DOI 10.1002/(SICI)1097-0193(1999)8:4<182::AID-HBM3>3.0.CO;2-M; Kincses WE, 2003, HUM BRAIN MAPP, V18, P100, DOI 10.1002/hbm.10079; Knowlton RC, 2004, EPILEPSIA, V45, P61, DOI 10.1111/j.0013-9580.2004.04012.x; Kybic J, 2006, PHYS MED BIOL, V51, P1333, DOI 10.1088/0031-9155/51/5/021; Lapalme E, 2006, NEUROIMAGE, V30, P160, DOI 10.1016/j.neuroimage.2005.08.067; LeSage JP, 2007, J ECONOMETRICS, V140, P190, DOI 10.1016/j.jeconom.2006.09.007; Limpiti T, 2006, IEEE T BIO-MED ENG, V53, P1740, DOI 10.1109/TBME.2006.873743; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Lin FH, 2006, HUM BRAIN MAPP, V27, P1, DOI 10.1002/hbm.20155; Litvak V, 2008, NEUROIMAGE, V42, P1490, DOI 10.1016/j.neuroimage.2008.06.022; LUDERS HO, 1992, EPILEPSY SURGERY, P51; Mangin J.-F., 1995, Journal of Mathematical Imaging and Vision, V5, P297, DOI 10.1007/BF01250286; Mattout J, 2005, NEUROIMAGE, V26, P356, DOI 10.1016/j.neuroimage.2005.01.026; METZ CE, 1986, INVEST RADIOL, V21, P720, DOI 10.1097/00004424-198609000-00009; Mikuni N, 1997, NEUROIMAGE, V5, P298, DOI 10.1006/nimg.1997.0272; Murakami S, 2006, J PHYSIOL-LONDON, V575, P925, DOI 10.1113/jphysiol.2006.105379; Noachtar S, 2009, EPILEPSY BEHAV, V15, P22, DOI 10.1016/j.yebeh.2009.02.035; Oishi M, 2002, EPILEPSIA, V43, P1390, DOI 10.1046/j.1528-1157.2002.10702.x; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ou WM, 2010, NEUROIMAGE, V52, P97, DOI 10.1016/j.neuroimage.2010.03.001; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Phillips C, 2002, NEUROIMAGE, V17, P287, DOI 10.1006/nimg.2002.1175; Phillips C, 2005, NEUROIMAGE, V24, P997, DOI 10.1016/j.neuroimage.2004.10.030; Placantonakis DG, 2009, NEUROL CLIN, V27, P1015, DOI 10.1016/j.ncl.2009.08.004; Santiuste M, 2008, J CLIN NEUROPHYSIOL, V25, P331, DOI 10.1097/WNP.0b013e31818e7913; Stefan H, 2003, BRAIN, V126, P2396, DOI 10.1093/brain/awg239; Sutherling WW, 2008, NEUROLOGY, V71, P990, DOI 10.1212/01.wnl.0000326591.29858.1a; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tao JX, 2007, J CLIN NEUROPHYSIOL, V24, P96, DOI 10.1097/WNP.0b013e31803ecdaf; Thirion B, 2004, MED IMAGE ANAL, V8, P403, DOI 10.1016/j.media.2004.09.001; Trujillo-Barreto NJ, 2004, NEUROIMAGE, V21, P1300, DOI 10.1016/j.neuroimage.2003.11.008	71	75	75	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55969	10.1371/journal.pone.0055969	http://dx.doi.org/10.1371/journal.pone.0055969			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418485	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300077
J	Gao, ZW; Lin, Z; Huang, WD; Lai, CC; Fan, JS; Yang, DW				Gao, Zhenwei; Lin, Zhi; Huang, Weidong; Lai, Chong Cheong; Fan, Jing-song; Yang, Daiwen			Structural Characterization of Minor Ampullate Spidroin Domains and Their Distinct Roles in Fibroin Solubility and Fiber Formation	PLOS ONE			English	Article							SPIDER SILK PROTEINS; NMR; EVOLUTION; PEPTIDE	Spider silk is protein fibers with extraordinary mechanical properties. Up to now, it is still poorly understood how silk proteins are kept in a soluble form before spinning into fibers and how the protein molecules are aligned orderly to form fibers. Minor ampullate spidroin is one of the seven types of silk proteins, which consists of four types of domains: N-terminal domain, C-terminal domain (CTD), repetitive domain (RP) and linker domain (LK). Here we report the tertiary structure of CTD and secondary structures of RP and LK in aqueous solution, and their roles in protein stability, solubility and fiber formation. The stability and solubility of individual domains are dramatically different and can be explained by their distinct structures. For the tri-domain miniature fibroin, RP-LK-CTDMi, the three domains have no or weak interactions with one another at low protein concentrations (<1 mg/ml). The CTD in RP-LK-CTDMi is very stable and soluble, but it cannot stabilize the entire protein against chemical and thermal denaturation while it can keep the entire tri-domain in a highly water-soluble state. In the presence of shear force, protein aggregation is greatly accelerated and the aggregation rate is determined by the stability of folded domains and solubility of the disordered domains. Only the tri-domain RP-LK-CTDMi could form silk-like fibers, indicating that all three domains play distinct roles in fiber formation: LK as a nucleation site for assembly of protein molecules, RP for assistance of the assembly and CTD for regulating alignment of the assembled molecules.	[Gao, Zhenwei; Lin, Zhi; Huang, Weidong; Lai, Chong Cheong; Fan, Jing-song; Yang, Daiwen] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Yang, DW (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsydw@nus.edu.sg	LIN, ZHI/B-1254-2016; yang, daiwen/H-8408-2012	yang, daiwen/0000-0002-6804-0071; LIN, ZHI/0000-0002-8902-4935	Ministry of Education, Singapore [R154000453112]	Ministry of Education, Singapore(Ministry of Education, Singapore)	This work was supported by a grant from Ministry of Education, Singapore (R154000453112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Beena K, 2004, BIOCHEMISTRY-US, V43, P3608, DOI 10.1021/bi0360509; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bittencourt D, 2007, COMP BIOCHEM PHYS B, V147, P597, DOI 10.1016/j.cbpb.2007.03.013; Challis RJ, 2006, INSECT MOL BIOL, V15, P45, DOI 10.1111/j.1365-2583.2005.00606.x; Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102; Greenwood MJ, 2010, BEHAV ECOL, V21, P1227, DOI 10.1093/beheco/arq140; Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y; Heim M, 2009, ANGEW CHEM INT EDIT, V48, P3584, DOI 10.1002/anie.200803341; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5; Huang W, 2006, BIOCHIMIE, V88, P849, DOI 10.1016/j.biochi.2006.02.010; La Mattina C, 2008, BIOCHEMISTRY-US, V47, P4692, DOI 10.1021/bi800140q; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g; Lin Z, 2013, ADV MATER, V25, P1216, DOI 10.1002/adma.201204357; Lin Z, 2009, P NATL ACAD SCI USA, V106, P8906, DOI 10.1073/pnas.0813255106; Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x; Rising A, 2011, CELL MOL LIFE SCI, V68, P169, DOI 10.1007/s00018-010-0462-z; ROSEMAN MA, 1988, J MOL BIOL, V200, P513, DOI 10.1016/0022-2836(88)90540-2; Spiess K, 2010, MACROMOL BIOSCI, V10, P998, DOI 10.1002/mabi.201000071; Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y; Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250; Tian MZ, 2005, BIOCHEMISTRY-US, V44, P8006, DOI 10.1021/bi050366u; Wang SJ, 2012, J BIOMOL NMR, V54, P415, DOI 10.1007/s10858-012-9679-5; Xu YQ, 2007, J AM CHEM SOC, V129, P7722, DOI 10.1021/ja071442e; Xu YQ, 2006, NAT METHODS, V3, P931, DOI 10.1038/NMETH938; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang DW, 2004, J AM CHEM SOC, V126, P3710, DOI 10.1021/ja039102q; Yang SA, 2009, BIOCHEMISTRY-US, V48, P4040, DOI 10.1021/bi9000936; Zhao AC, 2005, J BIOCHEM, V138, P593, DOI 10.1093/jb/mvi155; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	39	26	29	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56142	10.1371/journal.pone.0056142	http://dx.doi.org/10.1371/journal.pone.0056142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418525	gold, Green Submitted, Green Published			2022-12-27	WOS:000315970300117
J	Gutteridge, A; Rukstalis, JM; Ziemek, D; Tie, M; Ji, L; Ramos-Zayas, R; Nardone, NA; Norquay, LD; Brenner, MB; Tang, K; McNeish, JD; Rowntree, RK				Gutteridge, Alex; Rukstalis, J. Michael; Ziemek, Daniel; Tie, Mark; Ji, Lin; Ramos-Zayas, Rebeca; Nardone, Nancy A.; Norquay, Lisa D.; Brenner, Martin B.; Tang, Kim; McNeish, John D.; Rowntree, Rebecca K.			Novel Pancreatic Endocrine Maturation Pathways Identified by Genomic Profiling and Causal Reasoning	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; INTERPRETING TRANSCRIPTIONAL CHANGES; BETA-CELL; EXPRESSION ANALYSIS; SACCHAROMYCES-CEREVISIAE; CHOLESTEROL HOMEOSTASIS; INSULIN-SECRETION; GENE-EXPRESSION; HISTONE H3; IN-VIVO	We have used a previously unavailable model of pancreatic development, derived in vitro from human embryonic stem cells, to capture a time-course of gene, miRNA and histone modification levels in pancreatic endocrine cells. We investigated whether it is possible to better understand, and hence control, the biological pathways leading to pancreatic endocrine formation by analysing this information and combining it with the available scientific literature to generate models using a casual reasoning approach. We show that the embryonic stem cell differentiation protocol is highly reproducible in producing endocrine precursor cells and generates cells that recapitulate many aspects of human embryonic pancreas development, including maturation into functional endocrine cells when transplanted into recipient animals. The availability of whole genome gene and miRNA expression data from the early stages of human pancreatic development will be of great benefit to those in the fields of developmental biology and diabetes research. Our causal reasoning algorithm suggested the involvement of novel gene networks, such as NEUROG3/E2F1/KDM5B and SOCS3/STAT3/IL-6, in endocrine cell development We experimentally investigated the role of the top-ranked prediction by showing that addition of exogenous IL-6 could affect the expression of the endocrine progenitor genes NEUROG3 and NKX2.2.	[Rukstalis, J. Michael; Tie, Mark; Ji, Lin; Ramos-Zayas, Rebeca; Tang, Kim; McNeish, John D.; Rowntree, Rebecca K.] Pfizer Regenerat Med, Cambridge, MA USA; [Gutteridge, Alex] Pfizer Regenerat Med, Cambridge, England; [Ziemek, Daniel] Pfizer Computat Sci Ctr Emphasis, Cambridge, MA USA; [Rukstalis, J. Michael; Ji, Lin; Nardone, Nancy A.; Norquay, Lisa D.; Brenner, Martin B.] Pfizer Cardiovasc & Metab Dis, Cambridge, MA USA	Pfizer; Pfizer; Pfizer; Pfizer	Gutteridge, A (corresponding author), Pfizer Regenerat Med, Cambridge, England.	alex.gutteridge@pfizer.com; rownrk@yahoo.co.uk		Gutteridge, Alex/0000-0001-7515-634X	Pfizer Inc	Pfizer Inc(Pfizer)	This work was funded by Pfizer Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; Bhandare R, 2010, GENOME RES; Billon N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r80; Bolmeson C, 2011, BIOCHEM BIOPH RES CO, V404, P16, DOI 10.1016/j.bbrc.2010.11.024; Bravo-Egana V, 2008, BIOCHEM BIOPH RES CO, V366, P922, DOI 10.1016/j.bbrc.2007.12.052; Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100; Cervantes S, 2009, DEV BIOL, V326, P285, DOI 10.1016/j.ydbio.2008.11.020; Champeris Tsaniras S, 2010, J ENDOCRINOLOGY; Chen BZ, 2011, CELL BIOL INT, V35, P29, DOI 10.1042/CBI20090081; Chindelevitch L, 2012, BIOINFORMATICS, V28, P1114, DOI 10.1093/bioinformatics/bts090; Chindelevitch L, 2011, LECT N BIOINFORMAT, V6577, P34, DOI 10.1007/978-3-642-20036-6_4; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dey BK, 2011, MOL CELL BIOL, V31, P203, DOI 10.1128/MCB.01009-10; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; Fiaschi-Taesch N, 2009, DIABETES, V58, P882, DOI 10.2337/db08-0631; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaulton KJ, 2010, NAT GENET; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grouwels G, 2010, DIABETES, V59, P1435, DOI 10.2337/db09-1295; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Gysemans C, 2008, BIOCHEM SOC T, V36, P328, DOI 10.1042/BST0360328; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Hayami S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-59; Heimberg H, 2008, NEW ENGL J MED, V359, P2723, DOI 10.1056/NEJMcibr0807675; Higuchi Y, 2010, J CELL SCI, V123, P2733, DOI 10.1242/jcs.066886; Inoshita S, 1999, KIDNEY INT, V56, P1238, DOI 10.1046/j.1523-1755.1999.00705.x; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Joglekar MV, 2007, DEV BIOL, V311, P603, DOI 10.1016/j.ydbio.2007.09.008; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kapasa M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-49; Kim SY, 2011, DEVELOPMENT; Kobayashi M, 2008, ENDOCRINOLOGY, V149, P5662, DOI 10.1210/en.2008-0236; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kumar R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-419; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Kutlu B, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-3; Li W, 2011, P NATL ACAD SCI US; Liechti R, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq024; Listyorini D, 2006, DEV GROWTH DIFFER, V48, P243, DOI [10.1111/j.1440-169x.2006.00861.x, 10.1111/j.1440-169X.2006.00861.x]; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Liu F, 2005, CELL CYCLE, V4, P63, DOI 10.4161/cc.4.1.1366; Mfopou JK, 2010, GASTROENTEROLOGY, V138, P2233, DOI 10.1053/j.gastro.2010.02.056; Miyatsuka T, 2011, P NATL ACAD SCI USA, V108, P185, DOI 10.1073/pnas.1004842108; Morgan M, 2009, BIOINFORMATICS; Mwangi S, 2008, GASTROENTEROLOGY, V134, P727, DOI 10.1053/j.gastro.2007.12.033; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; Pollard Jack Jr, 2005, Diabetes Technol Ther, V7, P323, DOI 10.1089/dia.2005.7.323; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Ramachandran D, 2011, FEBS J, V278, P1167, DOI 10.1111/j.1742-4658.2011.08042.x; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rezende LF, 2009, CYTOKINE, V46, P65, DOI 10.1016/j.cyto.2008.12.014; Sarkar SA, 2012, PANCREAS; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shen SM, 2010, CARCINOGENESIS, V31, P419, DOI 10.1093/carcin/bgp320; SPENCE JR, 2010, NATURE; Stitzel ML, 2010, CELL METAB, V12, P443, DOI 10.1016/j.cmet.2010.09.012; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106; White P, 2009, METHODS MOL BIOL, V560, P239, DOI 10.1007/978-1-59745-448-3_16; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Wong CK, 2012, J CELL PHYSIOL, V227, P2519, DOI 10.1002/jcp.22990; Wong WPS, 2010, P NATL ACAD SCI USA, V107, P13057, DOI 10.1073/pnas.0914501107; Woollett LA, 2008, ANNU REV NUTR, V28, P97, DOI 10.1146/annurev.nutr.26.061505.111311; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	83	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56024	10.1371/journal.pone.0056024	http://dx.doi.org/10.1371/journal.pone.0056024			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418498	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300090
J	Salvemini, M; D'Amato, R; Petrella, V; Aceto, S; Nimmo, D; Neira, M; Alphey, L; Polito, LC; Saccone, G				Salvemini, Marco; D'Amato, Rocco; Petrella, Valeria; Aceto, Serena; Nimmo, Derric; Neira, Marco; Alphey, Luke; Polito, Lino C.; Saccone, Giuseppe			The Orthologue of the Fruitfly Sex Behaviour Gene Fruitless in the Mosquito Aedes aegypti: Evolution of Genomic Organisation and Alternative Splicing	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; CERATITIS-CAPITATA; TRANSFORMER GENE; FUNCTIONAL CONSERVATION; EXPRESSION PATTERNS; REGULATORY ELEMENTS; NEURAL CIRCUITRY; MUSCA-DOMESTICA; FLIES DIPTERA; DOUBLESEX	In Drosophila melanogaster the doublesex (dsx) and fruitless (fru) regulatory genes act at the bottom of the somatic sex determination pathway. Both are regulated via alternative splicing by an upstream female-specific TRA/TRA-2 complex, recognizing a common cis element. dsx controls somatic sexual differentiation of non-neural as well as of neural tissues. fru, on the other hand, expresses male-specific functions only in neural system where it is required to built the neural circuits underlying proper courtship behaviour. In the mosquito Aedes aegypti sex determination is different from Drosophila. The key male determiner M, which is located on one of a pair of homomorphic sex chromosomes, controls sex-specific splicing of the mosquito dsx orthologue. In this study we report the genomic organization and expression of the fru homologue in Ae. aegypti (Aeafru). We found that it is sex-specifically spliced suggesting that it is also under the control of the sex determination pathway. Comparative analyses between the Aeafru and Anopheles gambiae fru (Angfru) genomic loci revealed partial conservation of exon organization and extensive divergence of intron lengths. We find that Aeadsx and Aeafru share novel cis splicing regulatory elements conserved in the alternatively spliced regions. We propose that in Aedes aegypti sex-specific splicing of dsx and fru is most likely under the control of splicing regulatory factors which are different from TRA and TRA-2 found in other dipteran insects and discuss the potential use of fru and dsx for developing new genetic strategies in vector control.	[Salvemini, Marco; D'Amato, Rocco; Petrella, Valeria; Aceto, Serena; Polito, Lino C.; Saccone, Giuseppe] Univ Naples Federico II, Sect Genet & Mol Biol, Dept Biol Sci, Naples, Italy; [Nimmo, Derric; Neira, Marco; Alphey, Luke] Oxitec Ltd, Oxford, England; [Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Naples Federico II; University of Oxford	Salvemini, M (corresponding author), Univ Naples Federico II, Sect Genet & Mol Biol, Dept Biol Sci, Naples, Italy.	marco.salvemini@unina.it	saccone, giuseppe/F-8627-2013; Aceto, Serena/E-5350-2010; Salvemini, Marco/AAJ-5560-2021	saccone, giuseppe/0000-0002-9835-3693; Alphey, Luke/0000-0002-2916-3802; SALVEMINI, Marco/0000-0003-2297-9267; Aceto, Serena/0000-0003-3906-4872; Neira, Marco/0000-0001-8068-5772	WHO Grant [A30289]	WHO Grant	This work was funded by WHO Grant A30289 (2004-2006) to Giuseppe Saccone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2001, GENETICS, V158, P1569; Arbeitman M, 2010, CURR BIOL, V20, pR804, DOI 10.1016/j.cub.2010.08.021; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Barbosa-Morais NL, 2006, GENOME RES, V16, P66, DOI 10.1101/gr.3936206; Bertossa RC, 2009, MOL BIOL EVOL, V26, P1557, DOI 10.1093/molbev/msp067; Billeter JC, 2002, ADV GENET, V47, P87, DOI 10.1016/S0065-2660(02)47003-4; Boerjan B, 2011, INSECT BIOCHEM MOLEC, V41, P340, DOI 10.1016/j.ibmb.2011.01.012; Brooks AN, 2011, RNA, V17, P1884, DOI 10.1261/rna.2696311; Burghardt G, 2005, DEV GENES EVOL, V215, P165, DOI 10.1007/s00427-004-0464-7; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Cator LJ, 2009, SCIENCE, V323, P1077, DOI 10.1126/science.1166541; Churbanov A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-508; Clements A. N., 1999, BIOL MOSQUITOES; Clynen E, 2011, DEV GENES EVOL, V221, P43, DOI 10.1007/s00427-011-0352-x; Concha C, 2009, GENETICS, V182, P785, DOI 10.1534/genetics.109.100982; Dafa'alla T, 2010, J GENET, V89, P301, DOI 10.1007/s12041-010-0041-y; Dauwalder B, 1996, P NATL ACAD SCI USA, V93, P9004, DOI 10.1073/pnas.93.17.9004; Dauwalder B, 2011, INT REV NEUROBIOL, V99, P87, DOI 10.1016/B978-0-12-387003-2.00004-5; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dissanayake Sumudu N, 2010, BMC Res Notes, V3, P248, DOI 10.1186/1756-0500-3-248; Dornan AJ, 2005, GENESIS, V42, P236, DOI 10.1002/gene.20143; Ruiz MF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001239; Fu GL, 2007, NAT BIOTECHNOL, V25, P353, DOI 10.1038/nbt1283; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Gailey DA, 2006, MOL BIOL EVOL, V23, P633, DOI 10.1093/molbev/msj070; Goodwin SF, 2000, GENETICS, V154, P725; Graham P, 2003, BIOESSAYS, V25, P1, DOI 10.1002/bies.10207; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hediger M, 2004, DEV GENES EVOL, V214, P29, DOI 10.1007/s00427-003-0372-2; Hediger M, 2010, GENETICS, V184, P155, DOI 10.1534/genetics.109.109249; HEDLEY ML, 1991, CELL, V65, P579, DOI 10.1016/0092-8674(91)90090-L; Heinrichs V, 1997, P NATL ACAD SCI USA, V94, P115, DOI 10.1073/pnas.94.1.115; Heinrichs V, 1998, MOL CELL BIOL, V18, P450, DOI 10.1128/MCB.18.1.450; Hertel KJ, 1996, RNA, V2, P969; HOSHIJIMA K, 1991, SCIENCE, V252, P833, DOI 10.1126/science.1902987; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Ibrahim EC, 2005, P NATL ACAD SCI USA, V102, P5002, DOI 10.1073/pnas.0500543102; INOUE K, 1992, P NATL ACAD SCI USA, V89, P8092, DOI 10.1073/pnas.89.17.8092; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; Kapitonov Vladimir V, 2008, Nat Rev Genet, V9, P411, DOI 10.1038/nrg2165-c1; Keleman K, 2012, NATURE; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kuhn S, 2000, GENOME, V43, P1011, DOI 10.1139/gen-43-6-1011; Lam BJ, 2003, J BIOL CHEM, V278, P22740, DOI 10.1074/jbc.M301036200; Lee G, 2000, BEHAV GENET, V30, P263, DOI 10.1023/A:1026541215546; Lee G, 2001, J NEUROSCI, V21, P513, DOI 10.1523/JNEUROSCI.21-02-00513.2001; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pane A, 2005, GENETICS, V171, P615, DOI 10.1534/genetics.105.041004; Pane A, 2002, DEVELOPMENT, V129, P3715; Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5; Qi JL, 2007, MOL CELL BIOL, V27, P699, DOI 10.1128/MCB.01572-06; Ruiz MF, 2005, GENETICS, V171, P849, DOI 10.1534/genetics.105.044925; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Saccone G, 2011, GENETICA, V139, P99, DOI 10.1007/s10709-010-9503-7; Saccone G, 2008, INT J DEV BIOL, V52, P1051, DOI 10.1387/ijdb.082657gs; Salvemini M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-41; Salvemini M, 2010, J GENET, V89, P287, DOI 10.1007/s12041-010-0040-z; Salvemini M, 2009, INT J DEV BIOL, V53, P109, DOI 10.1387/ijdb.082681ms; Salz HK, 2011, CURR OPIN GENET DEV, V21, P395, DOI 10.1016/j.gde.2011.03.001; Sarno F, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-140; Scali C, 2005, J EXP BIOL, V208, P3701, DOI 10.1242/jeb.01819; Schetelig MF, 2012, P NATL ACAD SCI USA, V109, P9348, DOI 10.1073/pnas.1203352109; Schwartz SH, 2008, GENOME RES, V18, P88, DOI 10.1101/gr.6818908; Shearman DCA, 1998, INSECT MOL BIOL, V7, P355, DOI 10.1046/j.1365-2583.1998.740355.x; Shin D, 2012, J HERED, V103, P303, DOI 10.1093/jhered/esr134; Shukla JN, 2010, J GENET, V89, P341, DOI 10.1007/s12041-010-0046-6; Song HJ, 2002, GENETICS, V162, P1703; South SH, 2011, ANIM BEHAV, V81, P645, DOI 10.1016/j.anbehav.2010.12.014; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tu ZJ, 1999, MOL BIOL EVOL, V16, P760, DOI 10.1093/oxfordjournals.molbev.a026161; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Ustinova J, 2006, J MOL EVOL, V63, P788, DOI 10.1007/s00239-005-6230-2; Usui-Aoki K, 2000, NAT CELL BIOL, V2, P500, DOI 10.1038/35019537; Verhulst EC, 2010, SCIENCE, V328, P620, DOI 10.1126/science.1185805; Villella A, 1997, GENETICS, V147, P1107; Yamamoto D, 2008, J NEUROGENET, V22, P309, DOI 10.1080/01677060802298491; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yu JY, 2006, CURR BIOL, V16, pR23, DOI 10.1016/j.cub.2005.12.009; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	86	35	39	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e48554	10.1371/journal.pone.0048554	http://dx.doi.org/10.1371/journal.pone.0048554			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418412	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300002
J	Sunami, T; Kono, H				Sunami, Tomoko; Kono, Hidetoshi			Local Conformational Changes in the DNA Interfaces of Proteins	PLOS ONE			English	Article							NUCLEIC ACID RECOGNITION; STRUCTURAL ALPHABET; CRYSTAL-STRUCTURE; INTRINSIC DISORDER; BINDING DOMAIN; SEQUENCES; CLASSIFICATION; DEFORMATION; FLEXIBILITY; ALIGNMENT	When a protein binds to DNA, a conformational change is often induced so that the protein will fit into the DNA structure. Therefore, quantitative analyses were conducted to understand the conformational changes in proteins. The results showed that conformational changes in DNA interfaces are more frequent than in non-interfaces, and DNA interfaces have more conformational variations in the DNA-free form. As expected, the former indicates that interaction with DNA has some influence on protein structure. The latter suggests that the intrinsic conformational flexibility of DNA interfaces is important for adjusting their conformation for DNA. The amino acid propensities of the conformationally changed regions in DNA interfaces indicate that hydrophilic residues are preferred over the amino acids that appear in the conformationally unchanged regions. This trend is true for disordered regions, suggesting again that intrinsic flexibility is of importance not only for DNA binding but also for interactions with other molecules. These results demonstrate that fragments destined to be DNA interfaces have an intrinsic flexibility and are composed of amino acids with the capability of binding to DNA. This information suggests that the prediction of DNA binding sites may be improved by the integration of amino acid preference for DNA and one for disordered regions.	[Sunami, Tomoko; Kono, Hidetoshi] Japan Atom Energy Agcy, Mol Modeling & Simulat Grp, Quantum Beam Sci Directorate, Kyoto, Japan	Japan Atomic Energy Agency	Kono, H (corresponding author), Japan Atom Energy Agcy, Mol Modeling & Simulat Grp, Quantum Beam Sci Directorate, Kyoto, Japan.	kono.hidetoshi@jaea.go.jp		Kono, Hidetoshi/0000-0001-5729-8707	Japan Society for the Promotion of Science (JSPS) KAKENHI [23700354]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [23114723]; Grants-in-Aid for Scientific Research [23700354] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI grant number 23700354 and The Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI grant number 23114723. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baussand J, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-9; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biswas S, 2008, BIOINFORMATION, V2, P422, DOI 10.6026/97320630002422; BRENNAN RG, 1990, P NATL ACAD SCI USA, V87, P8165, DOI 10.1073/pnas.87.20.8165; Dan A, 2010, PROTEINS, V78, P236, DOI 10.1002/prot.22531; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; Deschavanne P, 2009, PROTEINS, V76, P129, DOI 10.1002/prot.22324; Dudev M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-106; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2012, MOL BIOSYST, V8, P97, DOI 10.1039/c1mb05258f; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; EISENHABER F, 1993, J COMPUT CHEM, V14, P1272, DOI 10.1002/jcc.540141103; Etchebest C, 2005, PROTEINS, V59, P810, DOI 10.1002/prot.20458; Falconi M, 2008, BIOPHYS J, V95, P1108, DOI 10.1529/biophysj.108.130849; Falconi M, 2007, FEBS J, V274, P2385, DOI 10.1111/j.1742-4658.2007.05773.x; Friedberg I, 2007, BIOINFORMATICS, V23, pE219, DOI 10.1093/bioinformatics/btl310; Galburt EA, 2000, J MOL BIOL, V300, P877, DOI 10.1006/jmbi.2000.3874; Gunther S, 2006, BIOSYSTEMS, V85, P126, DOI 10.1016/j.biosystems.2005.12.007; Hegde RS, 1998, J MOL BIOL, V284, P1479, DOI 10.1006/jmbi.1998.2260; Hegde RS, 1998, J MOL BIOL, V276, P797, DOI 10.1006/jmbi.1997.1587; Jones S, 1999, J MOL BIOL, V287, P877, DOI 10.1006/jmbi.1999.2659; Kolodny R, 2002, J MOL BIOL, V323, P297, DOI 10.1016/S0022-2836(02)00942-7; Le Q, 2009, J MOL BIOL, V387, P431, DOI 10.1016/j.jmb.2008.12.044; Lejeune D, 2005, PROTEINS, V61, P258, DOI 10.1002/prot.20607; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; MacDonald JT, 2010, PROTEINS, V78, P1311, DOI 10.1002/prot.22651; Martin J, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-12; Mezei M, 1998, PROTEIN ENG, V11, P411, DOI 10.1093/protein/11.6.411; Minezaki Y, 2006, J MOL BIOL, V359, P1137, DOI 10.1016/j.jmb.2006.04.016; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nadassy K, 1999, BIOCHEMISTRY-US, V38, P1999, DOI 10.1021/bi982362d; NAGADOI A, 1995, STRUCTURE, V3, P1217, DOI 10.1016/S0969-2126(01)00257-X; Offmann B, 2007, CURR BIOINFORM, V2, P165, DOI 10.2174/157489307781662105; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; SAUER RT, 1988, GENE DEV, V2, P807, DOI 10.1101/gad.2.7.807; Schrodinger L., 2020, PYMOL; Tan S, 1998, NATURE, V391, P660, DOI 10.1038/35563; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tung CH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r31; VERSHON AK, 1993, CELL, V72, P105, DOI 10.1016/0092-8674(93)90054-T	42	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56080	10.1371/journal.pone.0056080	http://dx.doi.org/10.1371/journal.pone.0056080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418514	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300106
J	Takatalo, J; Karppinen, J; Taimela, S; Niinimaki, J; Laitinen, J; Sequeiros, RB; Samartzis, D; Korpelainen, R; Nayha, S; Remes, J; Tervonen, O				Takatalo, Jani; Karppinen, Jaro; Taimela, Simo; Niinimaki, Jaakko; Laitinen, Jaana; Sequeiros, Roberto Blanco; Samartzis, Dino; Korpelainen, Raija; Nayha, Simo; Remes, Jouko; Tervonen, Osmo			Association of Abdominal Obesity with Lumbar Disc Degeneration - A Magnetic Resonance Imaging Study	PLOS ONE			English	Article							LOW-BACK-PAIN; VISCERAL ADIPOSE-TISSUE; FOLLOW-UP; COMPUTED-TOMOGRAPHY; CARDIOVASCULAR RISK; POPULATION; OVERWEIGHT; SPINE; ATHEROSCLEROSIS; PREVALENCE	Purpose: To evaluate whether midsagittal (abdominal) obesity in magnetic resonance imaging (MRI), waist circumference (WC) and body fat percentage are associated with lumbar disc degeneration in early adulthood. Methods: We obtained the lumbar MRI (1.5-T scanner) of 325 females and 233 males at a mean age of 21 years. Lumbar disc degeneration was evaluated using Pfirrmann classification. We analysed the associations of MRI measures of obesity (abdominal diameter (AD), sagittal diameter (SAD), ventral subcutaneous thickness (VST), and dorsal subcutaneous thickness (DST)), WC and body fat percentage with disc degeneration sum scores using ordinal logistic regression. Results: A total of 155 (48%) females and 147 (63%) males had disc degeneration. AD and SAD were associated with a disc degeneration sum score of >= 3 compared to disc degeneration sum score of 0-2 (OR 1.67; 95% confidence interval (CI) 1.20-2.33 and OR 1.40; 95% CI 1.12-1.75, respectively) among males, but we found no association among females. WC was also associated with disc degeneration among males (OR 1.03 per one cm; 95% CI 1.00-1.05), but not among females. Conclusion: Measures of abdominal obesity in MRI and waist circumference were associated with disc degeneration among 21-year-old males.	[Takatalo, Jani; Karppinen, Jaro] Univ Oulu, Inst Clin Med, Oulu, Finland; [Karppinen, Jaro; Laitinen, Jaana; Remes, Jouko] Finnish Inst Occupat Hlth, Oulu, Finland; [Karppinen, Jaro; Korpelainen, Raija] Oulu Univ Hosp, Oulu, Finland; [Taimela, Simo] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Niinimaki, Jaakko; Sequeiros, Roberto Blanco; Tervonen, Osmo] Univ Oulu, Inst Diagnost, Oulu, Finland; [Samartzis, Dino] Univ Hong Kong, Dept Orthopaed & Traumatol, Pokfulam, Hong Kong, Peoples R China; [Korpelainen, Raija; Nayha, Simo] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Korpelainen, Raija] Oulu Deaconess Inst, Dept Sports & Exercise Med, Oulu, Finland	University of Oulu; Finnish Institute of Occupational Health; University of Oulu; University of Helsinki; University of Oulu; University of Hong Kong; University of Oulu	Takatalo, J (corresponding author), Univ Oulu, Inst Clin Med, Oulu, Finland.	jani.takatalo@fimnet.fi	Takatalo, Jani M/H-5395-2016; Niinimäki, Jaakko/O-2186-2014	Takatalo, Jani M/0000-0002-1008-7416; Korpelainen, Raija/0000-0002-3627-0542; Blanco Sequeiros, Roberto/0000-0002-0167-9639; Samartzis, Dino/0000-0002-7473-1311; Niinimaki, Jaakko/0000-0002-5591-3726; Taimela, Simo/0000-0001-6755-2983	TBGS (National Graduate School of Musculoskeletal Disorders and Biomaterials); Yrjo Jahnsson Foundation; Academy of Finland [121620, 129504]; TBDP (National Graduate School of Musculoskeletal Disorders and Biomaterials)	TBGS (National Graduate School of Musculoskeletal Disorders and Biomaterials); Yrjo Jahnsson Foundation; Academy of Finland(Academy of Finland); TBDP (National Graduate School of Musculoskeletal Disorders and Biomaterials)	The first author acknowledges the TBGS (National Graduate School of Musculoskeletal Disorders and Biomaterials) and the Yrjo Jahnsson Foundation for their financial support. This study was partly funded by the Academy of Finland (grants 121620 and 129504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The first author acknowledges the TBDP (National Graduate School of Musculoskeletal Disorders and Biomaterials) for its support.	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Altman DG., 1999, PRACTICAL STAT MED R; American College of Sports Medicine, 2021, ACSMS GUIDELINES EXE; Ananth CV, 1997, INT J EPIDEMIOL, V26, P1323, DOI 10.1093/ije/26.6.1323; Borenstein DG, 2001, J BONE JOINT SURG AM, V83A, P1306, DOI 10.2106/00004623-200109000-00002; Carrino JA, 2009, RADIOLOGY, V250, P161, DOI 10.1148/radiol.2493071999; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Chou D, 2011, SPINE, V36, pS43, DOI 10.1097/BRS.0b013e31822ef700; Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; ERKINTALO MO, 1995, RADIOLOGY, V196, P529, DOI 10.1148/radiology.196.2.7617872; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Ford ES, 2001, J PEDIATR-US, V138, P486, DOI 10.1067/mpd.2001.112898; Girn HRS, 2007, VASC MED, V12, P299, DOI 10.1177/1358863X07083387; Guzzaloni G, 2009, INT J OBESITY, V33, P233, DOI 10.1038/ijo.2008.271; Hu HH, 2011, OBES REV, V12, pe504, DOI 10.1111/j.1467-789X.2010.00824.x; Iatridis JC, 2006, J BONE JOINT SURG AM, V88A, P41, DOI 10.2106/JBJS.E.01407; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Kauppila LI, 2009, EUR J VASC ENDOVASC, V37, P661, DOI 10.1016/j.ejvs.2009.02.006; Kautiainen S, 2002, INT J OBESITY, V26, P544, DOI 10.1038/sj.ijo.0801928; Kjaer P, 2005, SPINE, V30, P798, DOI 10.1097/01.brs.0000157424.72598.ec; KVIST H, 1988, AM J CLIN NUTR, V48, P1351, DOI 10.1093/ajcn/48.6.1351; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Leino-Arjas P, 2006, SPINE, V31, P1032, DOI 10.1097/01.brs.0000214889.31505.08; Liuke M, 2005, INT J OBESITY, V29, P903, DOI 10.1038/sj.ijo.0802974; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; PRITCHARD JE, 1993, EUR J CLIN NUTR, V47, P216; Rolfe ED, 2010, OBESITY, V18, P625, DOI 10.1038/oby.2009.309; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Roubenoff R, 1996, AM J CLIN NUTR, V64, P459; Salminen JJ, 1999, SPINE, V24, P1316, DOI 10.1097/00007632-199907010-00008; SALMINEN JJ, 1995, SPINE, V20, P2101, DOI 10.1097/00007632-199510000-00006; Samartzis D, 2012, ARTHRITIS RHEUM-US, V64, P1488, DOI 10.1002/art.33462; Samartzis D, 2011, J BONE JOINT SURG AM, V93A, P662, DOI 10.2106/JBJS.I.01568; SEIDELL JC, 1990, AM J CLIN NUTR, V51, P953, DOI 10.1093/ajcn/51.6.953; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Stata Corporation, 2009, STAT STAT SOFTW REL; Stevens J, 2010, EUR J CLIN NUTR, V64, P6, DOI 10.1038/ejcn.2009.101; Takatalo J, 2011, SPINE, V36, P2180, DOI 10.1097/BRS.0b013e3182077122; Takatalo J, 2009, SPINE, V34, P1716, DOI 10.1097/BRS.0b013e3181ac5fec; The NS, 2010, JAMA-J AM MED ASSOC, V304, P2042, DOI 10.1001/jama.2010.1635; Tsai AG, 2011, OBES REV, V12, P50, DOI 10.1111/j.1467-789X.2009.00708.x; Tzotzas Themistoklis, 2004, Pediatr Endocrinol Rev, V1 Suppl 3, P448; Urquhart DM, 2011, SPINE, V36, P1320, DOI 10.1097/BRS.0b013e3181f9fb66; Videman T, 2008, SPINE, V33, P1484, DOI 10.1097/BRS.0b013e3181753bb1; Warnberg J, 2006, AM J CLIN NUTR, V84, P505; Weiler Christoph, 2011, BMC Res Notes, V4, P497, DOI 10.1186/1756-0500-4-497; Williams FMK, 2011, ANN RHEUM DIS, V70, P1203, DOI 10.1136/ard.2010.146001; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104; Yim JY, 2010, DIABETES CARE, V33, P2665, DOI 10.2337/dc10-0606	50	60	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56244	10.1371/journal.pone.0056244	http://dx.doi.org/10.1371/journal.pone.0056244			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418543	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300136
J	Tsai, JS; Wu, CH; Chen, SC; Huang, KC; Chen, CY; Chang, CI; Chuang, LM; Chen, CY				Tsai, Jaw-Shiun; Wu, Chih-Hsun; Chen, Su-Chiu; Huang, Kuo-Chin; Chen, Chin-Ying; Chang, Ching-I; Chuang, Lee-Ming; Chen, Ching-Yu			Plasma Adiponectin Levels Correlate Positively with an Increasing Number of Components of Frailty in Male Elders	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; METABOLIC SYNDROME; CIRCULATING ADIPONECTIN; CARDIOVASCULAR-DISEASE; INFLAMMATORY MARKERS; POSTMENOPAUSAL WOMEN; INSULIN SENSITIVITY; HEART-FAILURE; OLDER-ADULTS; MEN	Objective: Frailty is an important geriatric syndrome. Adiponectin is an important adipokine that regulates energy homeostasis. The aim of this study is to investigate the relationship between plasma adiponectin levels and frailty in elders. Methods: The demographic data, body weight, metabolic and inflammatory parameters, including plasma glucose, total cholesterol, triglyceride, tumor necrosis factor alpha (TNF-alpha), c-reactive protein (CRP) and adiponectin levels, were assessed. The frailty score was assessed using the Fried Frailty Index (FFI). Results: The mean (SD) age of the 168 participants [83 (49.4%) men and 85 (50.6%) women] was 76.86 (6.10) years. Judged by the FFI score, 42 (25%) elders were robust, 92 (54.7%) were pre-frail, and 34 (20.3%) were frail. The mean body mass index was 25.19 (3.42) kg/m(2). The log-transformed mean (SD) plasma adiponectin (mu g/mL) level was 1.00 (0.26). The logtransformed mean plasma adiponectin (mu g/mL) levels were 0.93 (0.23) in the robust elders, 1.00 (0.27) in the pre-frail elders, and 1.10 (0.22) in the frail elders, and the differences between these values were statistically significant (p = 0.012). Further analysis showed that plasma adiponectin levels rose progressively with an increasing number of components of frailty in all participants as a whole (p for trend = 0.024) and males (p for trend = 0.037), but not in females (p for trend = 0.223). Conclusion: Plasma adiponectin levels correlate positively with an increasing number of components of frailty in male elders. The difference between the sexes suggests that certain sex-specific mechanisms may exist to affect the association between adiponectin levels and frailty.	[Tsai, Jaw-Shiun; Huang, Kuo-Chin; Chen, Chin-Ying; Chen, Ching-Yu] Natl Taiwan Univ, Coll Med, Dept Family Med, Taipei 10764, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Wu, Chih-Hsun] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Chen, Su-Chiu] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan; [Chang, Ching-I; Chen, Ching-Yu] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Geriatr & Gerontol, Ju Nan, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taipei University of Nursing & Health Science (NTUNHS); National Health Research Institutes - Taiwan	Chuang, LM (corresponding author), Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan.	leeming@ntu.edu.tw; chency@nhri.org.tw	Chuang, Lee-Ming/AAF-3324-2019	Tsai, Jaw-Shiun/0000-0002-5227-8894; Wu, Chih-Hsun/0000-0003-4613-5915; HUANG, KUO-CHIN/0000-0002-6029-5520; CHEN, CHING-YU/0000-0002-4095-4197; CHEN, CHIN-YING/0000-0001-7827-8764; CHUANG, LEE-MING/0000-0003-0978-2662	National Science Council [NSC 98-2314-B-002-118-MY2, NSC 97-2314-B-002-178-MY3, PH-098-PP-48]; National Health Research Institute, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan)	This work is supported by the grants (NSC 98-2314-B-002-118-MY2 to JST; NSC 97-2314-B-002-178-MY3 and PH-098-PP-48 to Ching-Yu Chen) from the National Science Council (http://web1.nsc.gov.tw) and the National Health Research Institute (http://www.nhri.org.tw), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1; Chiarugi P, 2010, EXPERT OPIN THER TAR, V14, P193, DOI 10.1517/14728220903530712; Cnop M, 2003, DIABETOLOGIA, V46, P459, DOI 10.1007/s00125-003-1074-z; Dekker JM, 2008, J CLIN ENDOCR METAB, V93, P1489, DOI 10.1210/jc.2007-1436; Dridi S, 2009, J NUTR BIOCHEM, V20, P831, DOI 10.1016/j.jnutbio.2009.06.003; Efstathiou SP, 2009, ATHEROSCLEROSIS, V205, P632, DOI 10.1016/j.atherosclerosis.2009.01.022; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008; Heid IM, 2010, ATHEROSCLEROSIS, V208, P412, DOI 10.1016/j.atherosclerosis.2009.11.035; Isobe T, 2005, EUR J ENDOCRINOL, V153, P91, DOI 10.1530/eje.1.01930; Jurimae J, 2007, AM J PHYSIOL-ENDOC M, V293, pE42, DOI 10.1152/ajpendo.00610.2006; Kalyani RR, 2012, J NUTR HEALTH AGING, V16, P679, DOI [10.1007/s12603-012-0066-4, 10.1007/s12603-012-0369-5]; Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972; Kizer JR, 2011, J GERONTOL A-BIOL, V66, P1100, DOI 10.1093/gerona/glr098; Kizer JR, 2010, J GERONTOL A-BIOL, V65, P1208, DOI 10.1093/gerona/glq122; Komura N, 2008, CIRC J, V72, P23, DOI 10.1253/circj.72.23; Lang PO, 2009, GERONTOLOGY, V55, P539, DOI 10.1159/000211949; Lihn AS, 2005, OBES REV, V6, P13, DOI 10.1111/j.1467-789X.2005.00159.x; Liu YM, 2004, THESIS NATL TAIWAN U; Otsuka F, 2009, J CARDIOL, V53, P219, DOI 10.1016/j.jjcc.2008.11.004; Park SH, 2010, CLIN BIOCHEM, V43, P1069, DOI 10.1016/j.clinbiochem.2010.06.002; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rizza S, 2010, J AM GERIATR SOC, V58, P702, DOI 10.1111/j.1532-5415.2010.02773.x; Rizza S, 2009, NUTR METAB CARDIOVAS, V19, P54, DOI 10.1016/j.numecd.2007.12.001; Roubenoff R, 2003, AM J MED, V115, P429, DOI 10.1016/j.amjmed.2003.05.001; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Topinkova E, 2008, ANN NUTR METAB, V52, P6, DOI 10.1159/000115340; Tsou PL, 2004, DIABETES CARE, V27, P308, DOI 10.2337/diacare.27.2.308; Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x; Wannamethee SG, 2007, ARCH INTERN MED, V167, P1510, DOI 10.1001/archinte.167.14.1510; Woods NF, 2005, J AM GERIATR SOC, V53, P1321, DOI 10.1111/j.1532-5415.2005.53405.x; Wu HY, 2010, J CLIN ENDOCR METAB, V95, P4389, DOI 10.1210/jc.2010-0181; Yang WS, 2002, OBES RES, V10, P1104, DOI 10.1038/oby.2002.150; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Yu ZJ, 2009, CIRCULATION, V119, P2969, DOI 10.1161/CIRCULATIONAHA.108.833574; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134	38	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56250	10.1371/journal.pone.0056250	http://dx.doi.org/10.1371/journal.pone.0056250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418545	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300138
J	Zhao, MD; Zhang, RJ; Xu, XY; Liu, Y; Zhang, HX; Zhai, XY; Hu, XM				Zhao, Mingdong; Zhang, Ruijin; Xu, Xiaoyan; Liu, Yang; Zhang, Haixia; Zhai, Xiaoyu; Hu, Xuemei			IL-10 Reduces Levels of Apoptosis in Toxoplasma gondii-Infected Trophoblasts	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HLA-G EXPRESSION; PLACENTAL TROPHOBLASTS; TNF-ALPHA; CELLS; PREGNANCY; INTERLEUKIN-10; MODULATION; GAMMA; MICE	Background: To analyze the effects of IL-10 on the HLA-G expression and the apoptosis of trophoblasts infected with Toxoplasma gondii. Methods: T. gondii-infected or uninfected human trophoblasts and immortalized human placental BeWo cells were cultured with or without human IL-10. Uninfected and infected cells without IL-10 cells served as controls. HLA-G expression was measured by real-time PCR and flow cytometry, respectively. Cells apoptosis were analyzed by flow cytometry. Apoptosis associated moleculars were measured by real-time PCR and Western bolt. Results: HLA-G expression was increased in the infected trophoblasts and BeWo cells compared to uninfected cells. Treatment of infected cells with IL-10 decreased HLA-G expression compared to infected cells while no change in treatment of uninfected cells compared with uninfected cells. Levels of apoptosis and apoptosis associated caspase-3 and caspase-8 decreased and c-FLIP levels increased in treated infected cells with IL-10 compared to infected cells and no difference in IL-10 treated uninfected cells compared to uninfected cells. Conclusions: IL-10 regulates HLA-G expression in T. gondii-infected trophoblasts. IL-10 treatment of infected trophoblasts reduced levels of apoptosis. This may contribute to the improvement in pregnancy outcomes when women infected with T. gondii treated with IL-10.	[Zhang, Ruijin; Xu, Xiaoyan; Liu, Yang; Zhang, Haixia; Zhai, Xiaoyu; Hu, Xuemei] Binzhou Med Univ, Dept Immunol, Yantai, Peoples R China; [Zhao, Mingdong] Binzhou Med Univ, Yantai Affiliated Hosp, Dept Radiol, Yantai, Peoples R China	Binzhou Medical University; Binzhou Medical University	Hu, XM (corresponding author), Binzhou Med Univ, Dept Immunol, Yantai, Peoples R China.	xue-mei-hu@163.com			National Natural Science Foundation of China [81171591, 81273243]; Science and Technology Development Planning Project of Shandong Province [2012GSF11809]; Natural Science Foundation of Shandong Province [ZR2010HM 012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Planning Project of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported in part by funds from the National Natural Science Foundation of China 81171591 and 81273243, Science and Technology Development Planning Project of Shandong Province 2012GSF11809, and Natural Science Foundation of Shandong Province ZR2010HM 012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi M, 2003, J INFECT DIS, V188, P608, DOI 10.1086/377132; Almasry SM, 2012, J MOL HISTOL, V43, P253, DOI 10.1007/s10735-012-9410-6; Barbosa BF, 2008, CLIN EXP IMMUNOL, V151, P536, DOI 10.1111/j.1365-2249.2007.03583.x; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; Chan G, 2002, AM J PATHOL, V161, P1371, DOI 10.1016/S0002-9440(10)64413-6; CHAOUAT G, 1995, J IMMUNOL, V154, P4261; Commodaro AG, 2009, MEM I OSWALDO CRUZ, V104, P345, DOI 10.1590/S0074-02762009000200030; Eslick J, 2004, INFLAMMATION, V28, P139, DOI 10.1023/B:IFLA.0000039560.00231.cd; Ferro EAV, 1999, PARASITOL RES, V85, P647, DOI 10.1007/s004360050609; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; John T, 2007, CYTOKINE, V40, P226, DOI 10.1016/j.cyto.2007.10.002; Kanai T, 2001, AM J REPROD IMMUNOL, V45, P94, DOI 10.1111/j.8755-8920.2001.450205.x; Lafon M, 2005, J VIROL, V79, P15226, DOI 10.1128/JVI.79.24.15226-15237.2005; Moreau P, 1999, INT IMMUNOL, V11, P803, DOI 10.1093/intimm/11.5.803; Mouillot G, 2007, HUM IMMUNOL, V68, P277, DOI 10.1016/j.humimm.2006.10.016; Nash PB, 1998, J IMMUNOL, V160, P1824; Onno M, 2000, HUM IMMUNOL, V61, P1086, DOI 10.1016/S0198-8859(00)00191-9; Poulaki V, 2002, AM J PATHOL, V161, P643, DOI 10.1016/S0002-9440(10)64220-4; Rieger L, 2002, MOL HUM REPROD, V8, P255, DOI 10.1093/molehr/8.3.255; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Santiago B, 2004, J IMMUNOL, V172, P560, DOI 10.4049/jimmunol.172.1.560; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; VINCE G, 1992, CLIN EXP IMMUNOL, V88, P174; Wang T, 2011, EXP PARASITOL, V127, P107, DOI 10.1016/j.exppara.2010.07.003; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Zhang RJ, 2012, GYNECOL OBSTET INVES, V73, P223, DOI 10.1159/000333310; Zhou X, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.03.013	29	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56455	10.1371/journal.pone.0056455	http://dx.doi.org/10.1371/journal.pone.0056455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418570	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300163
J	Goveas, JS; Xie, CM; Chen, G; Li, WJ; Ward, BD; Franczak, MB; Jones, JL; Antuono, PG; Li, SJ				Goveas, Joseph S.; Xie, Chunming; Chen, Gang; Li, Wenjun; Ward, B. Douglas; Franczak, Malgorzata B.; Jones, Jennifer L.; Antuono, Piero G.; Li, Shi-Jiang			Functional Network Endophenotypes Unravel the Effects of Apolipoprotein E Epsilon 4 in Middle-Aged Adults	PLOS ONE			English	Article							MILD ALZHEIMERS-DISEASE; RESTING STATE FMRI; HUMAN BRAIN; COGNITIVE IMPAIRMENT; DEPRESSIVE SYMPTOMS; MEMORY DEFICITS; GENETIC RISK; OLDER-ADULTS; CONNECTIVITY; APOE	Apolipoprotein E-epsilon 4 (APOE-epsilon 4) accentuates memory decline, structural volume loss and cerebral amyloid deposition in cognitively healthy adults. We investigated whether APOE-epsilon 4 carriers will show disruptions in the intrinsic cognitive networks, including the default mode (DMN), executive control (ECN) and salience (SN) networks, relative to noncarriers in middle-aged healthy adults; and the extent to which episodic-memory performance is related to the altered functional connectivity (Fc) in these networks. Resting-state functional connectivity MRI (R-fMRI) was used to measure the differences in the DMN, ECN and SN Fc between 20 APOE-epsilon 4 carriers and 26 noncarriers. Multiple linear regression analyses were performed to determine the relationship between episodic-memory performance and Fc differences in the three resting-state networks across all subjects. There were no significant differences in the demographic and neuropsychological characteristics and the gray-matter volumes in the carriers and noncarriers. While mostly diminished DMN and ECN functional connectivities were seen, enhanced connections to the DMN structures were found in the SN in epsilon 4 carriers. Altered DMN and ECN were associated with episodic memory performance. Significant Fc differences in the brain networks implicated in cognition were seen in middle-aged individuals with a genetic risk for AD, in the absence of cognitive decline and gray-matter atrophy. Prospective studies are essential to elucidate the potential of R-fMRI technique as a biomarker for predicting conversion from normal to early AD in healthy APOE-epsilon 4 carriers.	[Goveas, Joseph S.; Li, Shi-Jiang] Med Coll Wisconsin, Dept Psychiat & Behav Med, Milwaukee, WI 53226 USA; [Xie, Chunming; Chen, Gang; Li, Wenjun; Ward, B. Douglas; Li, Shi-Jiang] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Franczak, Malgorzata B.; Jones, Jennifer L.; Antuono, Piero G.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Li, SJ (corresponding author), Med Coll Wisconsin, Dept Psychiat & Behav Med, Milwaukee, WI 53226 USA.	sjli@mcw.edu	Yue, Chunlin/B-3554-2014; Li, Shi-Jiang/M-2534-2017	Yue, Chunlin/0000-0002-2261-6725; 	Extendicare Foundation grant; National Institutes of Health grant [R01 AD20279]; Alzheimer's Association New Investigator [IRG-11-204070]; Advancing Healthier Wisconsin Endowment for Research; National Natural Science of Foundation of China [81171021, 91132727, 81171323]; Clinical and Translational Science Award program of the National Center for Research Resources [1UL1RR031973]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031973] Funding Source: NIH RePORTER	Extendicare Foundation grant; National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association New Investigator(Alzheimer's Association); Advancing Healthier Wisconsin Endowment for Research; National Natural Science of Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical and Translational Science Award program of the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Extendicare Foundation grant (to PGA), National Institutes of Health grant R01 AD20279 (to SJL), Alzheimer's Association New Investigator IRG-11-204070 (to JSG), Advancing Healthier Wisconsin Endowment for Research to MCW (to JSG), 1UL1RR031973 from the Clinical and Translational Science Award program of the National Center for Research Resources (to PGA, JSG, SJL), and the National Natural Science of Foundation of China 81171021, 91132727, 81171323 (to CX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bondi MW, 2005, NEUROLOGY, V64, P501, DOI 10.1212/01.WNL.0000150885.00929.7E; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Caselli RJ, 2011, NEUROLOGY, V76, P1078, DOI 10.1212/WNL.0b013e318211c3ae; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Chen G, 2011, RADIOLOGY, V259, P213, DOI 10.1148/radiol.10100734; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Donix M, 2010, NEUROIMAGE, V53, P37, DOI 10.1016/j.neuroimage.2010.06.009; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fleisher AS, 2009, NEUROIMAGE, V47, P1678, DOI 10.1016/j.neuroimage.2009.06.021; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gong JS, 2002, J BIOL CHEM, V277, P29919, DOI 10.1074/jbc.M203934200; Goveas J, 2011, BEHAV BRAIN RES, V219, P205, DOI 10.1016/j.bbr.2011.01.008; Goveas JS, 2011, J MAGN RESON IMAGING, V34, P764, DOI 10.1002/jmri.22662; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Johnson SC, 2006, J NEUROSCI, V26, P6069, DOI 10.1523/JNEUROSCI.0959-06.2006; Kelly C, 2012, TRENDS COGN SCI, V16, P181, DOI 10.1016/j.tics.2012.02.001; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Li WJ, 2012, NEUROIMAGE, V60, P1083, DOI 10.1016/j.neuroimage.2011.12.077; Machulda MM, 2011, ARCH NEUROL-CHICAGO, V68, P1131, DOI 10.1001/archneurol.2011.108; Mayeux R, 1998, NEW ENGL J MED, V338, P506, DOI 10.1056/NEJM199802193380804; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Muraskin J, 2012, NEUROIMAGE; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Orfanidis SJ, 1996, INTRO SIGNAL PROCESS, V1st; Petrella JR, 2008, RADIOLOGY, V246, P20, DOI 10.1148/radiol.2461061994; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Rapp A, 2006, BIOCHIMIE, V88, P473, DOI 10.1016/j.biochi.2005.10.007; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Resnick SM, 2010, NEUROLOGY, V74, P807, DOI 10.1212/WNL.0b013e3181d3e3e9; Rombouts SARB, 2003, NEUROIMAGE, V20, P1236, DOI 10.1016/S1053-8119(03)00386-0; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; Saunders AM, 1996, LANCET, V348, P90, DOI 10.1016/S0140-6736(96)01251-2; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seidenberg M, 2009, NEUROLOGY, V73, P612, DOI 10.1212/WNL.0b013e3181b389ad; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; Sheline YI, 2010, BIOL PSYCHIAT, V67, P584, DOI 10.1016/j.biopsych.2009.08.024; Sojkova J, 2011, ARCH NEUROL-CHICAGO, V68, P232, DOI 10.1001/archneurol.2010.357; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Storandt M, 2006, NEUROLOGY, V67, P467, DOI 10.1212/01.wnl.0000228231.26111.6e; Tiraboschi P, 2004, NEUROLOGY, V62, P1977, DOI 10.1212/01.WNL.0000128091.92139.0F; Trachtenberg AJ, 2012, NEUROIMAGE, V59, P565, DOI 10.1016/j.neuroimage.2011.07.059; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vemuri P, 2010, ANN NEUROL, V67, P308, DOI 10.1002/ana.21953; Villemagne VL, 2008, NEUROPSYCHOLOGIA, V46, P1688, DOI 10.1016/j.neuropsychologia.2008.02.008; Westlye ET, 2011, J NEUROSCI, V31, P7775, DOI 10.1523/JNEUROSCI.1230-11.2011; Xie CM, 2012, HUM BRAIN MAPP, V33, P1352, DOI 10.1002/hbm.21291; Xu GF, 2009, BRAIN, V132, P383, DOI 10.1093/brain/awn254; Yip AG, 2005, NEUROLOGY, V65, P259, DOI 10.1212/01.wnl.0000168863.49053.4d; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zhong N, 2009, CURR ALZHEIMER RES, V6, P415, DOI 10.2174/156720509789207921; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	71	36	37	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55902	10.1371/journal.pone.0055902	http://dx.doi.org/10.1371/journal.pone.0055902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424640	Green Published, gold			2022-12-27	WOS:000315965100028
J	Kuehne, LM; Padgham, BL; Olden, JD				Kuehne, Lauren M.; Padgham, Britta L.; Olden, Julian D.			The Soundscapes of Lakes across an Urbanization Gradient	PLOS ONE			English	Article							TRAFFIC NOISE; LANDSCAPE; BIODIVERSITY; ENVIRONMENT; ECOSYSTEMS; CHALLENGES; DIVERSITY; ANIMALS; IMPACT; TESTS	Background/Methodology: A significant implication of increasing urbanization is anthropogenic noise pollution. Although noise is strongly associated with disruption of animal communication systems and negative health effects for humans, the study of these consequences at ecologically relevant spatial and temporal scales (termed soundscape ecology) is in early stages of application. In this study, we examined the above- and below-water soundscape of recreational and residential lakes in the region surrounding a large metropolitan area. Using univariate and multivariate approaches we test the importance of large- and local-scale landscape factors in driving acoustic characteristics across an urbanization gradient, and visualize changes in the soundscape over space and time. Principal Findings: Anthropogenic noise (anthrophony) was strongly predicted by a landcover-based metric of urbanization (within a 10 km radius), with presence of a public park as a secondary influence; this urbanization signal was apparent even in below-water recordings. The percent of hourly measurements exceeding noise thresholds associated with outdoor disturbance was 67%, 17%, and 0%, respectively, for lakes characterized as High, Medium, and Low urbanization. Decreased biophony (proportion of natural sounds) was associated with presence of a public park followed by increased urbanization; time of day was also a significant predictor of biophony. Local-scale (shoreline) residential development was not related to changes in anthrophony or biophony. The patterns we identify are illustrated with a multivariate approach which allows use of entire sound samples and facilitates interpretation of changes in a soundscape. Conclusions/Significance: As highly valued residential and recreation areas, lakes represent everyday soundscapes important to both humans and wildlife. Our findings that many of these areas, particularly those with public parks, routinely experience sound types and levels associated with disturbance, suggests that urban planners need to account for the effect of increasing development on soundscapes to avoid compromising goals for ecological and human health.	[Kuehne, Lauren M.; Olden, Julian D.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Padgham, Britta L.] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kuehne, LM (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	lkuehne@uw.edu	Olden, Julian D/A-8535-2010; Kuehne, Lauren Marie/AGZ-0367-2022; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Olden, Julian/0000-0003-2143-1187	National Science Foundation Graduate Research Fellowship Grant [DGE-0718124]; H. Mason Keeler Endowed Professorship from the School of Aquatic and Fishery Sciences	National Science Foundation Graduate Research Fellowship Grant; H. Mason Keeler Endowed Professorship from the School of Aquatic and Fishery Sciences	This work was supported in part by a National Science Foundation Graduate Research Fellowship Grant (# DGE-0718124), as well as the contributions of 49 individuals (none of whom are profit-making organizations) who funded the project via a crowdfunding campaign. JDO acknowledges support from the H. Mason Keeler Endowed Professorship from the School of Aquatic and Fishery Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti M, 2007, LANDSCAPE URBAN PLAN, V80, P345, DOI 10.1016/j.landurbplan.2006.08.001; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; [Anonymous], 2001, 60651 IEC; Barber JR, 2011, LANDSCAPE ECOL, V26, P1281, DOI 10.1007/s10980-011-9646-7; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Beatley T., 2011, BIOPHILIC CITIES INT; Carpenter SR, 2007, BIOSCIENCE, V57, P323, DOI 10.1641/B570407; CORNILLON PC, 1977, J ACOUST SOC AM, V61, P739, DOI 10.1121/1.381362; Depraetere M, 2012, ECOL INDIC, V13, P46, DOI 10.1016/j.ecolind.2011.05.006; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Dumyahn SL, 2011, LANDSCAPE ECOL, V26, P1327, DOI 10.1007/s10980-011-9635-x; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; Environmental Protection Agency, 1980, EPA NOIS CONTR PROGR; Francis CD, 2012, P ROY SOC B-BIOL SCI, V279, P2727, DOI 10.1098/rspb.2012.0230; Francis CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027052; Frumkin P, 2001, AM J PREV MED, V20, P234, DOI 10.1016/S0749-3797(00)00317-2; Galloway W. J., 1974, POPULATION DISTRIBUT; Halfwerk W, 2011, J APPL ECOL, V48, P210, DOI 10.1111/j.1365-2664.2010.01914.x; Hansen AJ, 2002, BIOSCIENCE, V52, P151, DOI 10.1641/0006-3568(2002)052[0151:ECACOD]2.0.CO;2; Hempton Gordon, 2009, ONE SQUARE INCH SILE; Joo W, 2011, LANDSCAPE URBAN PLAN, V103, P259, DOI 10.1016/j.landurbplan.2011.08.001; Kight CR, 2011, ECOL LETT, V14, P1052, DOI 10.1111/j.1461-0248.2011.01664.x; Krause B, 2011, LANDSCAPE ECOL, V26, P1247, DOI 10.1007/s10980-011-9639-6; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Melles S, 2003, CONSERV ECOL, V7; Miller NP, 2008, APPL ACOUST, V69, P77, DOI 10.1016/j.apacoust.2007.04.008; Mosisch Thorsten D., 1998, Lakes Reservoirs Research and Management, V3, P1, DOI 10.1111/j.1440-1770.1998.tb00028.x; National Marine Fisheries Service, 2008, REC PLAN SO RES KILL; National Park Service, 2000, 47 US DEP INT NAT PA; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Pergams ORW, 2008, P NATL ACAD SCI USA, V105, P2295, DOI 10.1073/pnas.0709893105; Pijanowski BC, 2011, BIOSCIENCE, V61, P203, DOI 10.1525/bio.2011.61.3.6; Popper AN, 2003, MAR TECHNOL SOC J, V37, P35, DOI 10.4031/002533203787537050; Reed SE, 2012, ENVIRON MODELL SOFTW, V37, P1, DOI 10.1016/j.envsoft.2012.04.012; Schindler DW, 2009, LIMNOL OCEANOGR, V54, P2349, DOI 10.4319/lo.2009.54.6_part_2.2349; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; SOUTHWORTH M, 1969, ENVIRON BEHAV, V1, P49; Sueur J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004065; Theobald DM, 2010, LANDSCAPE ECOL, V25, P999, DOI 10.1007/s10980-010-9484-z; US EPA, 1974, INF LEV ENV NOIS REQ; Villanueva-Rivera LJ, 2011, LANDSCAPE ECOL, V26, P1233, DOI 10.1007/s10980-011-9636-9; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014; York D, 1994, RECREATIONAL BOATING	46	25	27	7	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55661	10.1371/journal.pone.0055661	http://dx.doi.org/10.1371/journal.pone.0055661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424636	Green Published, gold, Green Submitted			2022-12-27	WOS:000315965100024
J	Savinkova, L; Drachkova, I; Arshinova, T; Ponomarenko, P; Ponomarenko, M; Kolchanov, N				Savinkova, Ludmila; Drachkova, Irina; Arshinova, Tatyana; Ponomarenko, Petr; Ponomarenko, Mikhail; Kolchanov, Nikolay			An Experimental Verification of the Predicted Effects of Promoter TATA-Box Polymorphisms Associated with Human Diseases on Interactions between the TATA Boxes and TATA-Binding Protein	PLOS ONE			English	Article							TRIOSEPHOSPHATE ISOMERASE; BETA-THALASSEMIA; MUTATION; GENE; ELEMENTS; SEQUENCE; IDENTIFICATION; RECOGNITION; CONSENSUS; PATIENT	Human genome sequencing has resulted in a great body of data, including a stunningly large number of single nucleotide polymorphisms (SNPs) with unknown phenotypic manifestations. Identification and comprehensive analysis of regulatory SNPs in human gene promoters will help quantify the effects of these SNPs on human health. Based on our experimental and computer-aided study of SNPs in TATA boxes and the use of literature data, we have derived an equation for TBP/TATA equilibrium binding in three successive steps: TATA-binding protein (TBP) sliding along DNA due to their nonspecific affinity for each other <-> recognition of the TATA box <-> stabilization of the TBP/TATA complex. Using this equation, we have analyzed TATA boxes containing SNPs associated with human diseases and made in silico predictions of changes in TBP/TATA affinity. An electrophoretic mobility shift assay (EMSA)-based experimental study performed under the most standardized conditions demonstrates that the experimentally measured values are highly correlated with the predicted values: the coefficient of linear correlation, r, was 0.822 at a significance level of alpha<10(-7) for equilibrium K-D values, (-ln K-D), and 0.785 at a significance level of alpha<10(-3) for changes in equilibrium K-D (delta) due to SNPs in the TATA boxes (delta= ln[K-D,K- (TATAMut)] ( ln [K-D,K- TATA])). It has been demonstrated that the SNPs associated with increased risk of human diseases such as alpha-, beta- and delta-thalassemia, myocardial infarction and thrombophlebitis, changes in immune response, amyotrophic lateral sclerosis, lung cancer and hemophilia B Leyden cause 2-4-fold changes in TBP/TATA affinity in most cases. The results obtained strongly suggest that the TBP/TATA equilibrium binding equation derived can be used for analysis of TATA-box sequences and identification of SNPs with a potential of being functionally important.	[Savinkova, Ludmila; Drachkova, Irina; Arshinova, Tatyana; Ponomarenko, Petr; Ponomarenko, Mikhail; Kolchanov, Nikolay] Russian Acad Sci, Inst Cytol & Genet, Siberian Div, Novosibirsk 630090, Russia; [Kolchanov, Nikolay] Novosibirsk State Univ, Novosibirsk 630090, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University	Savinkova, L (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Div, Novosibirsk 630090, Russia.	savinkl@mail.ru	Ponomarenko, Mikhail P/Q-7909-2016; Drachkova, Irina/AAZ-5324-2020; Ponomarenko, Mikhail/AHD-3920-2022; Kolchanov, Nikolay/A-9916-2014	Ponomarenko, Mikhail P/0000-0003-1663-318X; Drachkova, Irina/0000-0002-2522-1657; Kolchanov, Nikolay/0000-0001-6800-8787	Russian Foundation for Basic Research [10-04-00462-a, 5278.2012.4]; Siberian Branch of the Russian Academy of Sciences [136]; Russian Academy of Sciences [B. 30, 30.29]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Siberian Branch of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Academy of Sciences(Russian Academy of Sciences)	The authors are grateful to Prof. Tatyana Merkulova for her valuable advice and Vladimir Koval for the MALDI-TOF/ MS analysis of oligodeoxynucleotides. This work was supported by grants 10-04-00462-a and Research schools - 5278.2012.4 from the Russian Foundation for Basic Research, grant 136 from the Siberian Branch of the Russian Academy of Sciences, "Biological Diversity" from the Russian Academy of Sciences, grant B. 30, #30.29, "Molecular and Cell Biology" RAS integration 6.8 "System biology: the computer-experimental approaches" and #28 "Life Origin and Biosphere becoming problems" programs (Russian Academy of Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi A, 2003, COMPUTER AIDED MULTI; ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P1154, DOI 10.1073/pnas.81.4.1154; ANTONIOU M, 1995, NUCLEIC ACIDS RES, V23, P3473, DOI 10.1093/nar/23.17.3473; Arnaud E, 2000, ARTERIOSCL THROM VAS, V20, P892, DOI 10.1161/01.ATV.20.3.892; Badens C, 1999, HEMOGLOBIN, V23, P339, DOI 10.3109/03630269909090749; Batley J, 2009, METHODS MOL BIOL, V537, P303, DOI 10.1007/978-1-59745-251-9_15; Baumann M, 2010, MOL BIOTECHNOL, V45, P241, DOI 10.1007/s12033-010-9265-6; Boldt AB, 2006, DIVERSITY MBL2 GENE; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Burgner D, 2003, GENES IMMUN, V4, P506, DOI 10.1038/sj.gene.6364022; CAI SP, 1989, AM J HUM GENET, V45, P112; COLEMAN RA, 1995, J BIOL CHEM, V270, P13850, DOI 10.1074/jbc.270.23.13850; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; Drachkova I A, 2005, Mol Biol (Mosk), V39, P139; Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324; Faiger H, 1995, NUCLEIC ACIDS RES, V34, P104; FEI YJ, 1988, BIOCHEM BIOPH RES CO, V153, P741, DOI 10.1016/S0006-291X(88)81157-4; Frischknecht H, 2005, HEMOGLOBIN, V29, P151, DOI 10.1081/HEM-200058593; GODDE JS, 1995, NUCLEIC ACIDS RES, V23, P4557, DOI 10.1093/nar/23.22.4557; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; Humphries A, 1999, HUM GENET, V104, P486, DOI 10.1007/s004390050992; Ioshikhes I, 1999, P NATL ACAD SCI USA, V96, P2891, DOI 10.1073/pnas.96.6.2891; Juo ZS, 1996, J MOL BIOL, V261, P239, DOI 10.1006/jmbi.1996.0456; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kel A, 1999, J MOL BIOL, V288, P353, DOI 10.1006/jmbi.1999.2684; Muncie HL, 2009, AM FAM PHYSICIAN, V80, P339; Niemann S, 2007, MUSCLE NERVE, V36, P704, DOI 10.1002/mus.20855; ORKIN SH, 1983, NUCLEIC ACIDS RES, V11, P4727, DOI 10.1093/nar/11.14.4727; Orosz F, 2006, IUBMB LIFE, V58, P703, DOI 10.1080/15216540601115960; Pelkonen O, 2000, TOXICOLOGY, V144, P139, DOI 10.1016/S0300-483X(99)00200-0; PONCZ M, 1982, J BIOL CHEM, V257, P5994; Ponomarenko MP, 1999, BIOINFORMATICS, V15, P687, DOI 10.1093/bioinformatics/15.7.687; Ponomarenko PM, 2008, DOKL BIOCHEM BIOPHYS, V419, P88, DOI 10.1134/S1607672908020117; Powell RM, 2002, J BIOL CHEM, V277, P7776, DOI 10.1074/jbc.M110147200; Pugh B F, 1995, Methods Mol Biol, V37, P359; REIJNEN MJ, 1992, P NATL ACAD SCI USA, V89, P6300, DOI 10.1073/pnas.89.14.6300; RUF W, 1994, FASEB J, V8, P385, DOI 10.1096/fasebj.8.6.8168689; Savinkova LK, 2009, BIOCHEMISTRY-MOSCOW+, V74, P117, DOI 10.1134/S0006297909020011; Savinkova LK, 2007, ECOLOGICAL GENETIC, VV, P44, DOI [10.17816/ecogen5244-49, DOI 10.17816/ECOGEN5244-49]; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Stewart JJ, 2006, J BIOL CHEM, V281, P22665, DOI 10.1074/jbc.M603237200; Stewart JJ, 2001, J BIOL CHEM, V276, P30078, DOI 10.1074/jbc.M105276200; Takahashi K, 2005, CLIN INFECT DIS, V41, pS440, DOI 10.1086/431987; TAKIHARA Y, 1986, BLOOD, V67, P547; Wang X, 2008, J CANCER RES CLIN, V134, P995, DOI 10.1007/s00432-008-0367-5; Wang Y, 2003, HEPATOLOGY, V37, P65, DOI 10.1053/jhep.2003.50017; Watanabe M, 1996, AM J HUM GENET, V58, P308; WOBBE CR, 1990, MOL CELL BIOL, V10, P3859, DOI 10.1128/MCB.10.8.3859; Wolner BS, 2001, J BIOL CHEM, V276, P6260, DOI 10.1074/jbc.M008273200; Zienolddiny S, 2004, INT J CANCER, V109, P353, DOI 10.1002/ijc.11695	51	37	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e54626	10.1371/journal.pone.0054626	http://dx.doi.org/10.1371/journal.pone.0054626			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424617	gold, Green Submitted, Green Published			2022-12-27	WOS:000315965100005
J	Yu, GH; Zhang, MW; Rao, DQ; Yang, JX				Yu, Guohua; Zhang, Mingwang; Rao, Dingqi; Yang, Junxing			Effect of Pleistocene Climatic Oscillations on the Phylogeography and Demography of Red Knobby Newt (Tylototriton shanjing) from Southwestern China	PLOS ONE			English	Article							TERMINALIA-FRANCHETII COMBRETACEAE; QINGHAI-TIBETAN PLATEAU; POPULATION-GROWTH; CHLOROPLAST PHYLOGEOGRAPHY; HISTORICAL DEMOGRAPHY; GENETIC CONSEQUENCES; EVOLUTIONARY HISTORY; DNA POLYMORPHISM; MTDNA SEQUENCES; ICE AGES	Factors that determine the genetic structure of species in southwestern China remain largely unknown. In this study, phylogeography and demography of Tylototriton shanjing was investigated from a mitochondrial perspective to address the role of the Quaternary ice ages in shaping phylogeographic history and genetic diversity of Yunnan. A total of 146 individuals from 19 populations across the entire range of the species were collected. We detected four maternal phylogenetic lineages corresponding to four population groups, and found that major glaciation events during the Pleistocene have triggered the intra-specific divergence. Coalescent simulations indicated that the populations retreated to different refugia located in southern Yunnan, northwestern Yunnan, the border region of western Yunnan with Myanmar, and middle-western Yunnan, respectively, during previous glacial periods in the Pleistocene, and these four refugia were not retained during the Last Glacial Maximum. Population expansions occurred during the last inter-glaciation, during which ice core and pollen data indicated that the temperature and precipitation gradually increased, and declines of population sizes started after the beginning of the Last Glacial Maximum when the climate became cooler and dryer. The paleodrainage system had no contribution to the current genetic structure and the rivers were not dispersal barriers for this salamander.	[Yu, Guohua; Zhang, Mingwang; Rao, Dingqi; Yang, Junxing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Yu, Guohua] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Mingwang] Sichuan Agr Univ, Coll Anim Sci & Technol, Yaan, Sichuan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sichuan Agricultural University	Zhang, MW (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	mwzhangkiz@hotmail.com; raodq@mail.kiz.ac.cn; yangjx@mail.kiz.ac.cn			State Key Laboratory of Genetic Resource and Evolution, Kunming Institute of Zoology; Chinese Academy of Sciences [GREKF11-01]; Shuang Zhi Ji Hua Foundation of Sichuan Agricultural University [01570709]	State Key Laboratory of Genetic Resource and Evolution, Kunming Institute of Zoology; Chinese Academy of Sciences(Chinese Academy of Sciences); Shuang Zhi Ji Hua Foundation of Sichuan Agricultural University	This study was supported by the open funds of the State Key Laboratory of Genetic Resource and Evolution, Kunming Institute of Zoology, the Chinese Academy of Sciences (GREKF11-01) and Shuang Zhi Ji Hua Foundation of Sichuan Agricultural University (01570709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2003, MOL ECOL, V12, P299, DOI 10.1046/j.1365-294X.2003.01731.x; Axelrod D., 1996, FLORISTIC CHARACTERI, P43; Carranza S, 2008, J BIOGEOGR, V35, P724, DOI 10.1111/j.1365-2699.2007.01817.x; Carranza S, 2005, ZOOL J LINN SOC-LOND, V145, P555, DOI 10.1111/j.1096-3642.2005.00197.x; Carranza S, 2004, ZOOTAXA, P1; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; [崔之久 Cui Zhijiu], 2011, [第四纪研究, Quaternary Sciences], V31, P749; Depraz A, 2008, MOL ECOL, V17, P2449, DOI 10.1111/j.1365-294X.2008.03760.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fei L., 2010, COLORED ATLAS CHINES; FELSENSTEIN J, 1992, GENET RES, V59, P139, DOI 10.1017/S0016672300030354; Fu YX, 1997, GENETICS, V147, P915; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gavrilets S, 2003, EVOLUTION, V57, P2197; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Jijun L., 2001, QUAT SCI, V21, P381, DOI DOI 10.3321/J.ISSN:1001-7410.2001.05.001; Knowles LL, 2001, MOL ECOL, V10, P691, DOI 10.1046/j.1365-294x.2001.01206.x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Li J.J., 1998, CHINESE SCI BULL, V43, P1569, DOI DOI 10.1360/CSB1998-43-15-1569; [李吉均 Li Jijun], 2004, [冰川冻土, Journal of Glaciology and Geocryology], V26, P235; Li SH, 2009, MOL ECOL, V18, P622, DOI 10.1111/j.1365-294X.2008.04028.x; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034013; Liu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031453; Lopez-Pujol J, 2011, J BIOGEOGR, V38, P1267, DOI 10.1111/j.1365-2699.2011.02504.x; Maddison W., 2018, MESQUITE MODULAR SYS; Mao XG, 2010, MOL ECOL, V19, P2754, DOI 10.1111/j.1365-294X.2010.04704.x; Measey GJ, 2011, CONSERV GENET, V12, P61, DOI 10.1007/s10592-009-9989-7; Michaux JR, 2005, HEREDITY, V94, P52, DOI 10.1038/sj.hdy.6800561; Monaghan MT, 2001, HEREDITY, V86, P395, DOI 10.1046/j.1365-2540.2001.00843.x; MORITZ C, 1992, SYST BIOL, V41, P273, DOI 10.2307/2992567; NUSSBAUM RA, 1995, HERPETOLOGICA, V51, P257; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qiu YX, 2009, NEW PHYTOL, V183, P480, DOI 10.1111/j.1469-8137.2009.02876.x; Qu Y, 2010, MOL ECOL, V19, P338, DOI 10.1111/j.1365-294X.2009.04445.x; Qu YH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-174; Rambaut A, 2007, TRACER V 1 4; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shi Y.F., 1998, UPLIFT ENV CHANGES Q; Shi Y.F., 1999, ACTA GEOGRAPH SIN, V54, P10, DOI DOI 10.1007/S11295-016-0968-0; [施雅风 Shi Yafeng], 2002, [冰川冻土, Journal of Glaciology and Geocryology], V24, P687; SLATKIN M, 1989, GENETICS, V123, P603; Sotiropoulos K, 2007, MOL PHYLOGENET EVOL, V45, P211, DOI 10.1016/j.ympev.2007.03.012; Sun YB, 2006, DATA CONTRIBUTION SE; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tang LY, 1998, J GLACIOL GEOCRYOL, V20, P133; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P19715, DOI 10.1073/pnas.0902956106; Yang D-T, 2008, AMPHIBIA REPTILIA YU; Yuan QJ, 2008, MOL ECOL, V17, P1054, DOI 10.1111/j.1365-294X.2007.03628.x; Zhan XJ, 2011, MOL ECOL, V20, P3014, DOI 10.1111/j.1365-294X.2011.05144.x; Zhang DR, 2010, MOL ECOL, V19, P3406, DOI 10.1111/j.1365-294X.2010.04747.x; Zhang MW, 2010, MOL PHYLOGENET EVOL, V54, P47, DOI 10.1016/j.ympev.2009.10.019; Zhang Rong-Zu (Yong-Zu), 2002, Acta Zoologica Sinica, V48, P141; Zhang TC, 2011, MOL PHYLOGENET EVOL, V60, P1, DOI 10.1016/j.ympev.2011.04.009; Zhang TC, 2011, J PLANT RES, V124, P63, DOI 10.1007/s10265-010-0360-3; Zhang W, 2006, QUATERN INT, V154, P32, DOI 10.1016/j.quaint.2006.02.012; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X; 唐领余, 2004, [中国科学. D辑, 地球科学, Science in China], V34, P436	73	24	26	8	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56066	10.1371/journal.pone.0056066	http://dx.doi.org/10.1371/journal.pone.0056066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424644	gold, Green Submitted, Green Published			2022-12-27	WOS:000315965100032
J	Guo, SJ; Li, XB; Gao, M; Li, YQ; Song, B; Niu, WQ				Guo, Shujie; Li, Xiaobo; Gao, Min; Li, Yuqiong; Song, Bei; Niu, Wenquan			The Relationship between XRCC1 and XRCC3 Gene Polymorphisms and Lung Cancer Risk in Northeastern Chinese	PLOS ONE			English	Article							MULTIFACTOR DIMENSIONALITY REDUCTION; EXCISION-REPAIR; HAN CHINESE; METAANALYSIS; ASSOCIATION; HYPERTENSION	Background: The prevalence of lung cancer in China will be the world's highest if allowed to proceed uncurbed. To unravel its genetic underpinnings, we sought to investigate the association of three well-characterized nonsynonymous polymorphisms in XRCC1 (Arg194Trp and Arg399Gln) and XRCC3 (Thr241Met) genes with lung cancer risk in northeastern Chinese. Methodology/Principal Findings: This study was hospital-based in design, encompassing 684 patients with lung cancer and 604 cancer-free controls. Genotyping was performed using the PCR-LDR (ligase detection reactions) method. Data were analyzed by R language and multifactor dimensionality reduction (MDR) software. Single-locus analysis identified significance in genotype distributions of polymorphism Arg194Trp (P = 0.002) and Arg399Gln (P = 0.017), and in allele distributions of Thr241Met (P = 0.005). Carriers of 399Gln/Gln genotype conferred a 147% increased risk relative to the non-carriers (odds ratio (OR): 2.47; 95% confidence interval (95% CI): 1.48-4.13; P<0.001). For Thr241Met, significance persisted under allelic (OR = 1.63; 95% CI: 1.14-2.33; P = 0.005), additive (OR = 1.64; 95% CI: 1.16-2.32; P = 0.005) and dominant (OR = 1.67; 95% CI: 1.17-2.38; P = 0.004) models. However, common allele combinations were comparable in frequency between patients and controls. In interaction analysis, the overall best MDR model included Arg399Gln and Thr241Met polymorphisms, with a maximal testing accuracy of 63.18% and a maximal cross-validation consistency of 10 out of 10 (P = 0.0175). Conclusions: Our study significantly demonstrated an independent and synergistic contribution of XRCC1 Arg399Gln and XRCC3 Thr241Met polymorphisms to lung cancer susceptibility in northeastern Chinese.	[Guo, Shujie; Li, Xiaobo; Li, Yuqiong; Song, Bei; Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Gao, Min] Harbin Med Univ, Affiliated Hosp 4, Dept Resp Med, Harbin, Heilongjiang, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Harbin Medical University	Niu, WQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China.	niuwenquan@yahoo.cn			Shanghai Rising Star Program [11QA1405500]; National Natural Science Foundation of China [30900808]	Shanghai Rising Star Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Shanghai Rising Star Program (11QA1405500), and the National Natural Science Foundation of China (30900808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cui ZG, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-71; De Ruyck K, 2007, MUTAT RES-GEN TOX EN, V631, P101, DOI 10.1016/j.mrgentox.2007.03.010; Gao M, 2012, J RENIN ANGIOTENSIN; Guo SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039814; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Han SZ, 2006, EUR J HUM GENET, V14, P1136, DOI 10.1038/sj.ejhg.5201681; Hu ZB, 2005, CANCER EPIDEM BIOMAR, V14, P1810, DOI 10.1158/1055-9965.EPI-04-0793; Ma Xj, 2008, Biomed Imaging Interv J, V4, pe39, DOI 10.2349/biij.4.3.e39; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Niu WQ, 2010, CLIN CHIM ACTA, V411, P1491, DOI 10.1016/j.cca.2010.06.004; Niu WQ, 2009, J HYPERTENS, V27, P1384, DOI 10.1097/HJH.0b013e32832b7e0d; Pachouri SS, 2007, DNA CELL BIOL, V26, P186, DOI 10.1089/dna.2006.9999; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Wang YD, 2009, CANCER LETT, V285, P134, DOI 10.1016/j.canlet.2009.05.005; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Zheng HL, 2009, LUNG CANCER, V65, P268, DOI 10.1016/j.lungcan.2009.02.002	20	43	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56213	10.1371/journal.pone.0056213	http://dx.doi.org/10.1371/journal.pone.0056213			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409158	Green Submitted, Green Published, gold			2022-12-27	WOS:000314660300068
J	Caorsi, V; Toepfer, C; Sikkel, MB; Lyon, AR; MacLeod, K; Ferenczi, MA				Caorsi, Valentina; Toepfer, Christopher; Sikkel, Markus B.; Lyon, Alexander R.; MacLeod, Ken; Ferenczi, Mike A.			Non-Linear Optical Microscopy Sheds Light on Cardiovascular Disease	PLOS ONE			English	Article							2ND-HARMONIC GENERATION; HEART-FAILURE; IN-VIVO; FIBROSIS; CARDIOMYOPATHY; FLUORESCENCE; TISSUES; CORNEA; CELLS	Many cardiac diseases have been associated with increased fibrosis and changes in the organization of fibrillar collagen. The degree of fibrosis is routinely analyzed with invasive histological and immunohistochemical methods, giving a limited and qualitative understanding of the tissue's morphological adaptation to disease. Our aim is to quantitatively evaluate the increase in fibrosis by three-dimensional imaging of the collagen network in the myocardium using the non-linear optical microscopy techniques Two-Photon Excitation microscopy (TPE) and Second Harmonic signal Generation (SHG). No sample staining is needed because numerous endogenous fluorophores are excited by a two-photon mechanism and highly non-centrosymmetric structures such as collagen generate strong second harmonic signals. We propose for the first time a 3D quantitative analysis to carefully evaluate the increased fibrosis in tissue from a rat model of heart failure post myocardial infarction. We show how to measure changes in fibrosis from the backward SHG (B-SHG) alone, as only backward-propagating SHG is accessible for true in vivo applications. A 5-fold increase in collagen I fibrosis is detected in the remote surviving myocardium measured 20 weeks after infarction. The spatial distribution is also shown to change markedly, providing insight into the morphology of disease progression.	[Caorsi, Valentina; Toepfer, Christopher; Sikkel, Markus B.; Lyon, Alexander R.; Ferenczi, Mike A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Lyon, Alexander R.; MacLeod, Ken] Royal Brompton Hosp, Cardiovasc Biomed Res Unit, London SW3 6LY, England; [Ferenczi, Mike A.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore	Imperial College London; Royal Brompton Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Caorsi, V (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	v.caorsi@imperial.ac.uk	Ferenczi, Michael/F-9510-2015; Sikkel, Markus/ABC-1043-2020	Ferenczi, Michael/0000-0002-0349-331X; Sikkel, Markus/0000-0001-9801-8978; Toepfer, Christopher/0000-0003-4671-2030	Royal Society (Newton International fellowship); Biotechnology and Biological Sciences Research Council [BB/I019448/1]; Wellcome Trust [091460/Z/10/Z, 092852/Z/10/Z]; British Heart Foundation Intermediate Research Fellowship [FS/11/67/28954]; National Institute for Health Research; British Heart Foundation [RG/11/20/29266, FS/11/67/28954] Funding Source: researchfish; BBSRC [BB/I019448/1] Funding Source: UKRI	Royal Society (Newton International fellowship); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation Intermediate Research Fellowship; National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Royal Society (Newton International fellowship to VC), the Biotechnology and Biological Sciences Research Council [grant number BB/I019448/1] and the Wellcome Trust [grant numbers 091460/Z/10/Z, 092852/Z/10/Z]. ARL was supported by a British Heart Foundation Intermediate Research Fellowship (FS/11/67/28954) and the National Institute for Health Research-funded Cardiovascular Biomedical Research Unit at the Royal Brompton Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambekar R, 2012, BIOMED OPT EXPRESS, V3, P2021, DOI 10.1364/BOE.3.002021; Booth MJ, 2007, PHILOS T R SOC A, V365, P2829, DOI 10.1098/rsta.2007.0013; Burlew Brad S., 2000, Cardiology Clinics, V18, P435, DOI 10.1016/S0733-8651(05)70154-5; Campagnola P, 2011, ANAL CHEM, V83, P3224, DOI 10.1021/ac1032325; Campagnola PJ, 1999, BIOPHYS J, V77, P3341, DOI 10.1016/S0006-3495(99)77165-1; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Chen J, 2001, PLOS ONE, V6; Chen XY, 2012, NAT PROTOC, V7, P654, DOI 10.1038/nprot.2012.009; Cittadini A, 2003, CARDIOVASC RES, V58, P555, DOI 10.1016/S0008-6363(03)00251-7; Diaspro A, 2006, WILEY ENCY BIOMEDICA; Edgley AJ, 2012, CARDIOVASC THER, V30, pe30, DOI 10.1111/j.1755-5922.2010.00228.x; Francis GS, 1995, EUR HEART J, V16, P31, DOI 10.1093/eurheartj/16.suppl_N.31; GOLDMAN YE, 1984, J PHYSIOL-LONDON, V350, P497, DOI 10.1113/jphysiol.1984.sp015215; Gusachenko I, 2012, BIOPHYS J, V102, P2220, DOI 10.1016/j.bpj.2012.03.068; Han M, 2005, OPT EXPRESS, V13, P5791, DOI 10.1364/OPEX.13.005791; He G. S., 1999, PHYS NONLINEAR OPTIC; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Kiernan J.A., 1999, HISTOLOGICAL HISTOCH, V3rd ed; Klein G, 2005, CIRC RES, V96, P748, DOI 10.1161/01.RES.0000161999.86198.1e; LaComb R, 2008, BIOPHYS J, V94, P4504, DOI 10.1529/biophysj.107.114405; LaComb R, 2008, OPT COMMUN, V281, P1823, DOI 10.1016/j.optcom.2007.10.040; LaComb R, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907207; Latour G, 2012, BIOMED OPT EXPRESS, V3, P1, DOI 10.1364/BOE.3.000001; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Oheim M, 2006, ADV DRUG DELIVER REV, V58, P788, DOI 10.1016/j.addr.2006.07.005; Plotnikov SV, 2006, BIOPHYS J, V90, P693, DOI 10.1529/biophysj.105.071555; Psilodimitrakopoulos S, 2009, OPT EXPRESS, V17, P14418, DOI 10.1364/OE.17.014418; Rivera DR, 2011, P NATL ACAD SCI USA, V108, P17598, DOI 10.1073/pnas.1114746108; Sato M, 2005, GENE THER, V12, P936, DOI 10.1038/sj.gt.3302476; Schenke-Layland K, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1896966; Schenke-Layland K, 2009, EUR HEART J, V30, P2254, DOI 10.1093/eurheartj/ehp267; See F, 2005, CURR PHARM DESIGN, V11, P477, DOI 10.2174/1381612053382098; Su PJ, 2011, BIOPHYS J, V100, P2053, DOI 10.1016/j.bpj.2011.02.015; Sun WX, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3041159; Thayil A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3569614; THIRLWELL H, 1994, BIOPHYS J, V67, P2436, DOI 10.1016/S0006-3495(94)80730-1; Tsai MR, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3365943; Wallenburg MA, 2011, J BIOPHOTONICS, V4, P297, DOI 10.1002/jbio.201000059; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; Wu YC, 2009, OPT EXPRESS, V17, P7907, DOI 10.1364/OE.17.007907; Zhang Y, 2012, EUR J HEART FAIL, V14, P549, DOI 10.1093/eurjhf/hfs011; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	43	16	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56136	10.1371/journal.pone.0056136	http://dx.doi.org/10.1371/journal.pone.0056136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409139	Green Published, gold			2022-12-27	WOS:000315157200113
J	Ji, HZ; Li, Y; Liang, BH; Pilon, R; MacPherson, P; Bergeron, M; Kim, J; Graham, M; Van Domselaar, G; Sandstrom, P; Brooks, J				Ji, Hezhao; Li, Yang; Liang, Binhua; Pilon, Richard; MacPherson, Paul; Bergeron, Michele; Kim, John; Graham, Morag; Van Domselaar, Gary; Sandstrom, Paul; Brooks, James			Pyrosequencing Dried Blood Spots Reveals Differences in HIV Drug Resistance between Treatment Naive and Experienced Patients	PLOS ONE			English	Article							PERIPHERAL-BLOOD; WHOLE-BLOOD; ANTIRETROVIRAL THERAPY; RNA QUANTIFICATION; STORAGE-CONDITIONS; PCR AMPLIFICATION; GENOTYPING ASSAY; SUBTYPE-C; DNA; PLASMA	Dried blood spots (DBS) are an alternative specimen collection format for HIV-1 genotyping. DBS produce HIV genotyping results that are robust and equivalent to plasma when using conventional sequencing methods. However, using tagged, pooled pyrosequencing, we demonstrate that concordance between plasma and DBS is not absolute and varies according to viral load (VL), duration of HIV infection and antiretroviral therapy (ART) status. The plasma/DBS concordance is the highest when VL is >= 5,000 copies/ml and/or the patient has no ART exposure and/or when the duration of HIV infection is <= 2 years. Stepwise regression analysis revealed that VL is most important independent predictor for concordance of DBS with plasma genotypes. This is the first study to use next generation sequencing to identify discordance between DBS and plasma genotypes. Consideration should be given to VL, duration of infection, and ART exposure when interpreting DBS genotypes produced using next generation sequencing. These findings are of particular significance when DBS are to be used for clinical monitoring purposes.	[Ji, Hezhao; Li, Yang; Pilon, Richard; Bergeron, Michele; Kim, John; Sandstrom, Paul; Brooks, James] Publ Hlth Agcy Canada, Natl Microbiol Lab, Natl HIV & Retrovirol Labs, Ottawa, ON, Canada; [Liang, Binhua; Van Domselaar, Gary] Publ Hlth Agcy Canada, Natl Microbiol Lab, Bioinformat Core, Winnipeg, MB, Canada; [Liang, Binhua; Graham, Morag] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [MacPherson, Paul] Ottawa Hosp, Div Infect Dis, Ottawa, ON, Canada; [Graham, Morag] Publ Hlth Agcy Canada, Natl Microbiol Lab, Genom Core Facil, Winnipeg, MB, Canada	Public Health Agency of Canada; Public Health Agency of Canada; University of Manitoba; University of Ottawa; Ottawa Hospital Research Institute; Public Health Agency of Canada	Brooks, J (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Natl HIV & Retrovirol Labs, Ottawa, ON, Canada.	james_brooks@phac-aspc.gc.ca	Liang, Binhua/ABN-9806-2022	liang, binhua/0000-0002-1108-6407; Ji, Hezhao/0000-0002-5451-6294; Pilon, Richard/0000-0003-0100-6917	federal initiative to address HIV/AIDS in Canada	federal initiative to address HIV/AIDS in Canada	This work was supported by the federal initiative to address HIV/AIDS in Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertagnolio S, 2007, ANTIVIR THER, V12, P107; Bertagnolio S, 2010, AIDS REV, V12, P195; Bi XQ, 2003, JAIDS-J ACQ IMM DEF, V34, P1, DOI 10.1097/00126334-200309010-00001; Hallack R, 2008, J CLIN VIROL, V41, P283, DOI 10.1016/j.jcv.2007.12.011; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Ji H, 2011, 18 C RETR OPP INF CR; Ji HZ, 2011, ANTIVIR THER, V16, P871, DOI 10.3851/IMP1839; Ji HZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009263; Johannessen A, 2010, ANTIVIR THER, V15, P1003, DOI 10.3851/IMP1660; Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108; KROODSMA KL, 1994, J INFECT DIS, V170, P1292, DOI 10.1093/infdis/170.5.1292; Masciotra S, 2007, AIDS, V21, P2503, DOI 10.1097/QAD.0b013e3281c618db; McNulty A, 2007, J CLIN MICROBIOL, V45, P517, DOI 10.1128/JCM.02016-06; Monleau M, 2010, J ANTIMICROB CHEMOTH, V65, P1562, DOI 10.1093/jac/dkq205; Monleau M, 2009, J CLIN MICROBIOL, V47, P1107, DOI 10.1128/JCM.02255-08; Novitsky V, 2009, VIROLOGY, V383, P47, DOI 10.1016/j.virol.2008.09.017; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; Rottinghaus EK, 2012, CLIN INFECT DIS, V54, P1187, DOI 10.1093/cid/cis015; Saracino A, 2008, J MED VIROL, V80, P1695, DOI 10.1002/jmv.21261; Steegen K, 2007, J CLIN MICROBIOL, V45, P3342, DOI 10.1128/JCM.00814-07; UNAIDS, 2010, AIDS EP UPD DEC 2009; Vicenti I, 2007, CLIN INFECT DIS, V44, P1657, DOI 10.1086/518287; Wei XR, 2011, J CLIN VIROL, V50, P148, DOI 10.1016/j.jcv.2010.11.006; WHO, 2010, ANT THER HIV INF AD; Ziemniak C, 2006, J VIROL METHODS, V136, P238, DOI 10.1016/j.jviromet.2006.05.030	26	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56170	10.1371/journal.pone.0056170	http://dx.doi.org/10.1371/journal.pone.0056170			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409150	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200121
J	Talavera, D; Sheoran, R; Lovell, SC				Talavera, David; Sheoran, Ritika; Lovell, Simon C.			Analysis of Genetic Interaction Networks Shows That Alternatively Spliced Genes Are Highly Versatile	PLOS ONE			English	Article							MESSENGER-RNA DECAY; C-ELEGANS; PROTEIN-INTERACTION; TRANSCRIPTION; LIN-35/RB; CELL; THERAPY; CONTEXT	Alternative splicing has the potential to increase the diversity of the transcriptome and proteome. Where more than one transcript arises from a gene they are often so different that they are quite unlikely to have the same function. However, it remains unclear if alternative splicing generally leads to a gene being involved in multiple biological processes or whether it alters the function within a single process. Knowing that genetic interactions occur between functionally related genes, we have used them as a proxy for functional versatility, and have analysed the sets of genes of two well-characterised model organisms: Caenorhabditis elegans and Drosophila melanogaster. Using network analyses we find that few genes are functionally homogenous (only involved in a few functionally-related biological processes). Moreover, there are differences between alternatively spliced genes and genes with a single transcript; specifically, genes with alternatively splicing are, on average, involved in more biological processes. Finally, we suggest that factors other than specific functional classes determine whether a gene is alternatively spliced.	[Talavera, David; Sheoran, Ritika; Lovell, Simon C.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Talavera, D (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	David.Talavera@manchester.ac.uk; simon.lovell@manchester.ac.uk	Talavera, David/AAD-2088-2021	Lovell, Simon/0000-0002-4092-8458; Talavera, David/0000-0002-8820-3931	BBSRC [BB/F013337/1, BB/H006818/1]; Biotechnology and Biological Sciences Research Council [BB/H006818/1, BB/F013337/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC grants BB/F013337/1 and BB/H006818/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734; Bellay J, 2011, GENOME RES, V21, P1375, DOI 10.1101/gr.117176.110; Bender AM, 2004, DEV BIOL, V273, P335, DOI 10.1016/j.ydbio.2004.06.009; Bracco L, 2003, TRENDS BIOTECHNOL, V21, P346, DOI 10.1016/S0167-7799(03)00146-X; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Ceol CJ, 2001, MOL CELL, V7, P461, DOI 10.1016/S1097-2765(01)00194-0; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cui MX, 2004, GENETICS, V167, P1177, DOI 10.1534/genetics.103.024554; de Silva E, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-39; Deeds EJ, 2007, P NATL ACAD SCI USA, V104, P14952, DOI 10.1073/pnas.0702766104; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Fay DS, 2003, DEVELOPMENT, V130, P3319, DOI 10.1242/dev.00561; Fay DS, 2002, GENE DEV, V16, P503, DOI 10.1101/gad.952302; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hagiwara M, 2005, BBA-PROTEINS PROTEOM, V1754, P324, DOI 10.1016/j.bbapap.2005.09.010; Hicks MJ, 2006, PLOS BIOL, V4, P943, DOI 10.1371/journal.pbio.0040147; Jiao YX, 2008, J NEUROCHEM, V105, P1746, DOI 10.1111/j.1471-4159.2008.05280.x; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kruse S, 1999, INT IMMUNOL, V11, P1965, DOI 10.1093/intimm/11.12.1965; Laity JH, 2000, P NATL ACAD SCI USA, V97, P11932, DOI 10.1073/pnas.97.22.11932; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; Magtanong L, 2011, NAT BIOTECHNOL, V29, P505, DOI 10.1038/nbt.1855; Michaut M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001092; Neu-Yilik G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-218; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Szappanos B, 2011, NAT GENET, V43, P656, DOI 10.1038/ng.846; Talavera D, 2007, PLOS COMPUT BIOL, V3, P375, DOI 10.1371/journal.pcbi.0030033; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Zhang L, 2003, BIOCHEM BIOPH RES CO, V303, P1169, DOI 10.1016/S0006-291X(03)00495-9	37	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55671	10.1371/journal.pone.0055671	http://dx.doi.org/10.1371/journal.pone.0055671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409018	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200049
J	Filevich, E; Kuhn, S; Haggard, P				Filevich, Elisa; Kuehn, Simone; Haggard, Patrick			There Is No Free Won't: Antecedent Brain Activity Predicts Decisions to Inhibit	PLOS ONE			English	Article							CONTINGENT NEGATIVE-VARIATION; FREE WILL; REACTION-TIME; VARIATION CNV; POTENTIALS; MOVEMENTS; MODEL; SPECIALIZATION; PERCEPTION; ATTENTION	Inhibition of prepotent action is an important aspect of self-control, particularly in social contexts. Action inhibition and its neural bases have been extensively studied. However, the neural precursors of free decisions to inhibit have hardly been studied. We asked participants to freely choose to either make a rapid key press in response to a visual cue, or to transiently inhibit action, and briefly delay responding. The task required a behavioural response on each trial, so trials involving inhibition could be distinguished from those without inhibition as those showing slower reaction times. We used this criterion to classify free-choice trials as either rapid or inhibited/delayed. For 13 participants, we measured the mean amplitude of the ERP activity at electrode Cz in three subsequent 50 ms time windows prior to the onset of the signal that either instructed to respond or inhibit, or gave participants a free choice. In two of these 50 ms time windows (-150 to -100, and -100 to -50 ms relative to action onset), the amplitude of prestimulus ERP differed between trials where participants ''freely'' chose whether to inhibit or to respond rapidly. Larger prestimulus ERP amplitudes were associated with trials in which participants decided to act rapidly as compared to trials in which they decided to delay their responses. Last-moment decisions to inhibit or delay may depend on unconscious preparatory neural activity.	[Filevich, Elisa; Haggard, Patrick] UCL, Inst Cognit Neurosci, London, England; [Kuehn, Simone] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Kuehn, Simone] Univ Ghent, Ghent Inst Funct & Metab Imaging, B-9000 Ghent, Belgium; [Filevich, Elisa; Kuehn, Simone] Max Planck Inst Human Dev & Educ, Ctr Lifespan Psychol, Berlin, Germany	University of London; University College London; Ghent University; Ghent University; Max Planck Society	Filevich, E (corresponding author), UCL, Inst Cognit Neurosci, London, England.	e.filevich@ucl.ac.uk	Kuehn, Simone/P-6145-2014	Haggard, Patrick/0000-0001-7798-793X; Kuhn, Simone/0000-0001-6823-7969; Filevich, Elisa/0000-0002-1158-8220	Wellcome Trust; Overseas Research Students award from the British Council; Research Foundation Flanders; European Science Foundation-European Collaborative Research Project/Economic and social Research Council grant [RES-062-23-2183]; Leverhulme Trust Major Research Fellowship	Wellcome Trust(Wellcome TrustEuropean Commission); Overseas Research Students award from the British Council; Research Foundation Flanders(FWO); European Science Foundation-European Collaborative Research Project/Economic and social Research Council grant; Leverhulme Trust Major Research Fellowship	This work was supported by the Wellcome Trust (http://www.wellcome.ac.uk/), an Overseas Research Students award from the British Council (http://www.britishcouncil.org/new/) [EF], a Postdoctoral Fellowship from the Research Foundation Flanders (http://www.fwo.be/) [SK], an European Science Foundation-European Collaborative Research Project/Economic and social Research Council grant (RES-062-23-2183, http://www.esf.org/), and by a Leverhulme Trust Major Research Fellowship (http://www.leverhulme.ac.uk/) [PH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks WP, 2009, PSYCHOL SCI, V20, P17, DOI 10.1111/j.1467-9280.2008.02254.x; Bradshaw JL, 2001, TRENDS COGN SCI, V5, P184, DOI 10.1016/S1364-6613(00)01656-9; Brass M, 2008, NEUROSCIENTIST, V14, P319, DOI 10.1177/1073858408317417; Brass M, 2007, J NEUROSCI, V27, P9141, DOI 10.1523/JNEUROSCI.0924-07.2007; Britz J, 2010, NEUROIMAGE, V49, P2774, DOI 10.1016/j.neuroimage.2009.10.033; Busch NA, 2010, P NATL ACAD SCI USA, V107, P16048, DOI 10.1073/pnas.1004801107; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Cheyne JA, 2009, COGNITION, V111, P98, DOI 10.1016/j.cognition.2008.12.009; DEIBER MP, 1991, EXP BRAIN RES, V84, P393; Dirnberger G, 1998, EXP BRAIN RES, V120, P263, DOI 10.1007/s002210050400; Dirnberger G, 2011, INT J PSYCHOPHYSIOL, V81, P127, DOI 10.1016/j.ijpsycho.2011.04.008; Filevich E, 2012, NEUROSCI BIOBEHAV R, V36, P1107, DOI 10.1016/j.neubiorev.2012.01.006; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; Goldberg I, 2008, CONSCIOUS COGN, V17, P587, DOI 10.1016/j.concog.2007.10.003; Gruber MJ, 2010, J NEUROSCI, V30, P9793, DOI 10.1523/JNEUROSCI.0915-10.2010; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; HILLYARD SA, 1969, PHYSIOL BEHAV, V4, P351, DOI 10.1016/0031-9384(69)90188-7; Hughes G, 2009, PSYCHOPHYSIOLOGY, V46, P1258, DOI 10.1111/j.1469-8986.2009.00873.x; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; LIBET B, 1982, ELECTROEN CLIN NEURO, V54, P322, DOI 10.1016/0013-4694(82)90181-X; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Luck S.J., 2005, INTRO EVENT RELATED; Mazaheri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016243; Nagai Y, 2004, NEUROIMAGE, V21, P1232, DOI 10.1016/j.neuroimage.2003.10.036; Nichols S, 2011, SCIENCE, V331, P1401, DOI 10.1126/science.1192931; Otten LJ, 2006, NAT NEUROSCI, V9, P489, DOI 10.1038/nn1663; Passingham RE, 2009, TRENDS COGNITIVE SCI; Rigoni D, 2011, PSYCHOL SCI; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; SAS Institute, 1999, SAS STAT US GUID VER; Schlaghecken F, 2004, PSYCHON B REV, V11, P463, DOI 10.3758/BF03196596; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Stroop JR, 1935, J EXP PSYCHOL, V18, P3; TECCE JJ, 1972, PSYCHOL BULL, V77, P73, DOI 10.1037/h0032177; Velmans M, 2002, J CONSCIOUSNESS STUD, V9, P3; Vohs KD, 2008, PSYCHOL SCI, V19, P49, DOI 10.1111/j.1467-9280.2008.02045.x; Wald A, 1940, ANN MATH STAT, V11, P147, DOI 10.1214/aoms/1177731909; Walsh E, 2010, NEUROPSYCHOLOGIA, V48, P619, DOI 10.1016/j.neuropsychologia.2009.10.026; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Wittmann M, 2001, COGNITIVE BRAIN RES, V10, P341, DOI 10.1016/S0926-6410(00)00052-5	46	33	34	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e53053	10.1371/journal.pone.0053053	http://dx.doi.org/10.1371/journal.pone.0053053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418420	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300010
J	Hayward, DC; Dosztanyi, Z; Clark-Walker, GD				Hayward, David C.; Dosztanyi, Zsuzsanna; Clark-Walker, George Desmond			The N-Terminal Intrinsically Disordered Domain of Mgm101p Is Localized to the Mitochondrial Nucleoid	PLOS ONE			English	Article							UNSTRUCTURED PROTEINS; SACCHAROMYCES-CEREVISIAE; DNA RECOMBINATION; MAINTENANCE; EVOLUTION; GENOME; MTDNA; PREDICTION; SERVER; SITES	The mitochondrial genome maintenance gene, MGM101, is essential for yeasts that depend on mitochondrial DNA replication. Previously, in Saccharomyces cerevisiae, it has been found that the carboxy-terminal two-thirds of Mgm101p has a functional core. Furthermore, there is a high level of amino acid sequence conservation in this region from widely diverse species. By contrast, the amino-terminal region, that is also essential for function, does not have recognizable conservation. Using a bioinformatic approach we find that the functional core from yeast and a corresponding region of Mgm101p from the coral Acropora millepora have an ordered structure, while the N-terminal domains of sequences from yeast and coral are predicted to be disordered. To examine whether ordered and disordered domains of Mgm101p have specific or general functions we made chimeric proteins from yeast and coral by swapping the two regions. We find, by an in vivo assay in S. cerevisiae, that the ordered domain of A. millepora can functionally replace the yeast core region but the disordered domain of the coral protein cannot substitute for its yeast counterpart. Mgm101p is found in the mitochondrial nucleoid along with enzymes and proteins involved in mtDNA replication. By attaching green fluorescent protein to the N-terminal disordered domain of yeast Mgm101p we find that GFP is still directed to the mitochondrial nucleoid where full-length Mgm101p-GFP is targeted.	[Hayward, David C.; Clark-Walker, George Desmond] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Dosztanyi, Zsuzsanna] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Clark-Walker, George Desmond] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia	Australian National University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Australian National University	Clark-Walker, GD (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	des.clark-walker@anu.edu.au	Dosztanyi, Zsuzsanna/G-6422-2010; Dosztanyi, Zsuzsanna/M-9943-2019	Dosztanyi, Zsuzsanna/0000-0002-3624-5937; Hayward, David/0000-0003-2937-2425	Australian Research Council through the Centre for Molecular Genetics of Development; Centre of Excellence for Coral Reef Studies; Bolyai Janos fellowship;  [DP1095343]	Australian Research Council through the Centre for Molecular Genetics of Development(Australian Research Council); Centre of Excellence for Coral Reef Studies; Bolyai Janos fellowship(Hungarian Academy of Sciences); 	The authors thank the Australian Research Council for support through the Centre for Molecular Genetics of Development, the Centre of Excellence for Coral Reef Studies, and Discovery Grant DP1095343. Bolyai Janos fellowship for ZD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005; Brown CJ, 2011, CURR OPIN STRUC BIOL, V21, P441, DOI 10.1016/j.sbi.2011.02.005; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; CHEN XJ, 1993, NUCLEIC ACIDS RES, V21, P3473, DOI 10.1093/nar/21.15.3473; ClarkWalker GD, 1996, MOL GEN GENET, V252, P746, DOI 10.1007/s004380050285; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Daughdrill GW, 2007, J MOL EVOL, V65, P277, DOI 10.1007/s00239-007-9011-2; DENTE L, 1983, NUCLEIC ACIDS RES, V11, P1645, DOI 10.1093/nar/11.6.1645; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2010, BRIEF BIOINFORM, V11, P225, DOI 10.1093/bib/bbp061; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Elbaz Y, 2011, TRENDS BIOCHEM SCI, V36, P616, DOI 10.1016/j.tibs.2011.08.004; Galea CA, 2008, BIOCHEMISTRY-US, V47, P7598, DOI 10.1021/bi8006803; Garner, 1998, Genome Inform Ser Workshop Genome Inform, V9, P201; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Hegyi H, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-65; Hobbs AEA, 2001, J CELL BIOL, V152, P401, DOI 10.1083/jcb.152.2.401; Ito M, 2012, GENES CELLS; Itoh K, 2011, MITOCHONDRION, V11, P575, DOI 10.1016/j.mito.2011.03.002; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mbantenkhu M, 2011, J BIOL CHEM, V286, P42360, DOI 10.1074/jbc.M111.307512; Meeusen S, 1999, J CELL BIOL, V145, P291, DOI 10.1083/jcb.145.2.291; Meeusen S, 2003, J CELL BIOL, V163, P503, DOI 10.1083/jcb.200304040; Miyakawa I, 2009, MICROBIOL-SGM, V155, P1558, DOI 10.1099/mic.0.027474-0; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; Nardozzi JD, 2012, J BIOL CHEM, V287, P37259, DOI 10.1074/jbc.M112.389965; Okamoto K, 1998, J CELL BIOL, V142, P613, DOI 10.1083/jcb.142.3.613; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Tillett D, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e26; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zuo X, 2001, CHARACTERISATION SAC; Zuo XM, 2007, FEMS YEAST RES, V7, P131, DOI 10.1111/j.1567-1364.2006.00141.x; Zuo XM, 2002, GENETICS, V160, P1389	46	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56465	10.1371/journal.pone.0056465	http://dx.doi.org/10.1371/journal.pone.0056465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418572	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000315970300165
J	Kasahara, K; Shirota, M; Kinoshita, K				Kasahara, Kota; Shirota, Matsuyuki; Kinoshita, Kengo			Ion Concentration-Dependent Ion Conduction Mechanism of a Voltage-Sensitive Potassium Channel	PLOS ONE			English	Article							CONSTANT ELECTRIC-FIELD; MOLECULAR-DYNAMICS; K+ CHANNEL; PERMEATION THEORY; FILE; SIMULATIONS; SELECTIVITY; ENERGETICS	Voltage-sensitive potassium ion channels are essential for life, but the molecular basis of their ion conduction is not well understood. In particular, the impact of ion concentration on ion conduction has not been fully studied. We performed several micro-second molecular dynamics simulations of the pore domain of the Kv1.2 potassium channel in KCl solution at four different ion concentrations, and scrutinized each of the conduction events, based on graphical representations of the simulation trajectories. As a result, we observed that the conduction mechanism switched with different ion concentrations: at high ion concentrations, potassium conduction occurred by Hodgkin and Keynes' knock-on mechanism, where the association of an incoming ion with the channel is tightly coupled with the dissociation of an outgoing ion, in a one-step manner. On the other hand, at low ion concentrations, ions mainly permeated by a two-step association/dissociation mechanism, in which the association and dissociation of ions were not coupled, and occurred in two distinct steps. We also found that this switch was triggered by the facilitated association of an ion from the intracellular side within the channel pore and by the delayed dissociation of the outermost ion, as the ion concentration increased.	[Kasahara, Kota; Shirota, Matsuyuki; Kinoshita, Kengo] Tohoku Univ, Grad Sch Informat Sci, Dept Appl Informat Sci, Sendai, Miyagi 980, Japan; [Shirota, Matsuyuki; Kinoshita, Kengo] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Kinoshita, Kengo] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Kinoshita, K (corresponding author), Tohoku Univ, Grad Sch Informat Sci, Dept Appl Informat Sci, Sendai, Miyagi 980, Japan.	kengo@ecei.tohoku.ac.jp	Kinoshita, Kengo/E-9688-2011	Kinoshita, Kengo/0000-0003-3453-2171; Kasahara, Kota/0000-0003-0207-6271	 [22136005]; Grants-in-Aid for Scientific Research [22136005] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by the "HD-Physiology'' Grant-in-Aid for Scientific Research on Innovative Areas (22136005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2011, J GEN PHYSIOL, V137, P397, DOI 10.1085/jgp.201010546; Ando H, 2005, J GEN PHYSIOL, V126, P529, DOI 10.1085/jgp.200509377; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Bowers K. J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1145/1188455.1188544; Chakrapani S, 2011, NAT STRUCT MOL BIOL, V18, P67, DOI 10.1038/nsmb.1968; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gumbart J, 2012, BBA-BIOMEMBRANES, V1818, P294, DOI 10.1016/j.bbamem.2011.09.030; HEGINBOTHAM L, 1993, BIOPHYS J, V65, P2089, DOI 10.1016/S0006-3495(93)81244-X; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Iwamoto M, 2011, J NEUROSCI, V31, P12180, DOI 10.1523/JNEUROSCI.1377-11.2011; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Khalili-Araghi F, 2006, BIOPHYS J, V91, pL2, DOI 10.1529/biophysj.106.091926; Kim I, 2011, P NATL ACAD SCI USA, V108, P17963, DOI 10.1073/pnas.1110735108; Kraszewski S, 2007, PHYS CHEM CHEM PHYS, V9, P1219, DOI 10.1039/b613668k; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MacKinnon R, 2003, FEBS LETT, V555, P62, DOI 10.1016/S0014-5793(03)01104-9; Miller C., 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-4-reviews0004.REVIEWS0004, DOI 10.1186/GB-2000-1-4-REVIEWS0004.REVIEWS0004, 10.1186/gb-2000-1-4-reviews0004, DOI 10.1186/GB-2000-1-4-REVIEWS0004]; Miloshevsky GV, 2004, TRENDS NEUROSCI, V27, P308, DOI 10.1016/j.tins.2004.03.013; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Nelson PH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3580562; Nelson PH, 2003, J CHEM PHYS, V119, P6981, DOI 10.1063/1.1604112; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Oiki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016578; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Roux B, 2008, BIOPHYS J, V95, P4205, DOI 10.1529/biophysj.108.136499; Shaw DE, 2007, CONF PROC INT SYMP C, P1, DOI 10.1145/1273440.1250664; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Ye S, 2010, NAT STRUCT MOL BIOL, V17, P1019, DOI 10.1038/nsmb.1865; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	42	11	11	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56342	10.1371/journal.pone.0056342	http://dx.doi.org/10.1371/journal.pone.0056342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418558	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300151
J	Kim, JH; Choi, KH; Jang, YJ; Bae, SS; Shin, BC; Choi, BT; Shin, HK				Kim, Ji Hyun; Choi, Kyung Ha; Jang, Young Jung; Bae, Sun Sik; Shin, Byung-Cheul; Choi, Byung Tae; Shin, Hwa Kyoung			Electroacupuncture Acutely Improves Cerebral Blood Flow and Attenuates Moderate Ischemic Injury via an Endothelial Mechanism in Mice	PLOS ONE			English	Article							NITRIC-OXIDE; STROKE PATIENTS; FUNCTIONAL RECOVERY; ARTERY OCCLUSION; BRAIN-INJURY; ACUPUNCTURE; STIMULATION; ARTERIOLES; EXPRESSION; RECEPTORS	Electroacupuncture (EA) is a novel therapy based on traditional acupuncture combined with modern eletrotherapy that is currently being investigated as a treatment for acute ischemic stroke. Here, we studied whether acute EA stimulation improves tissue and functional outcome following experimentally induced cerebral ischemia in mice. We hypothesized that endothelial nitric oxide synthase (eNOS)-mediated perfusion augmentation was related to the beneficial effects of EA by interventions in acute ischemic injury. EA stimulation at Baihui (GV20) and Dazhui (GV14) increased cerebral perfusion in the cerebral cortex, which was suppressed in eNOS KO, but there was no mean arterial blood pressure (MABP) response. The increased perfusion elicited by EA were completely abolished by a muscarinic acetylcholine receptor (mAChR) blocker (atropine), but not a beta-adrenergic receptor blocker (propranolol), an a-adrenergic receptor blocker (phentolamine), or a nicotinic acetylcholine receptor (nAChR) blocker (mecamylamine). In addition, EA increased acetylcholine (ACh) release and mAChR M3 expression in the cerebral cortex. Acute EA stimulation after occlusion significantly reduced infarct volume by 34.5% when compared to a control group of mice at 24 h after 60 min-middle cerebral artery occlusion (MCAO) (moderate ischemic injury), but not 90-min MCAO (severe ischemic injury). Furthermore, the impact of EA on moderate ischemic injury was totally abolished in eNOS KO. Consistent with a smaller infarct size, acute EA stimulation led to prominent improvement of neurological function and vestibule-motor function. Our results suggest that acute EA stimulation after moderate focal cerebral ischemia, but not severe ischemia improves tissue and functional recovery and ACh/eNOS-mediated perfusion augmentation might be related to these beneficial effects of EA by interventions in acute ischemic injury.	[Kim, Ji Hyun; Choi, Kyung Ha; Jang, Young Jung; Choi, Byung Tae; Shin, Hwa Kyoung] Pusan Natl Univ, Sch Korean Med, Div Meridian & Struct Med, Yangsan, Gyeongnam, South Korea; [Bae, Sun Sik] Pusan Natl Univ, Sch Med, Dept Pharmacol, Yangsan, Gyeongnam, South Korea; [Shin, Byung-Cheul] Pusan Natl Univ, Sch Korean Med, Div Clin Med, Yangsan, Gyeongnam, South Korea	Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University	Choi, BT (corresponding author), Pusan Natl Univ, Sch Korean Med, Div Meridian & Struct Med, Yangsan, Gyeongnam, South Korea.	choibt@pusan.ac.kr; julie@pusan.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0007470]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0007470). The funders had no role in study design, data collection and analysis.	Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Cummings M, 2001, Acupunct Med, V19, P64; DACEY RG, 1987, AM J PHYSIOL, V253, pH1253, DOI 10.1152/ajpheart.1987.253.5.H1253; DAUPHIN F, 1995, PHARMACOL THERAPEUT, V67, P385, DOI 10.1016/0163-7258(95)00022-4; DAUPHIN F, 1990, EUR J PHARMACOL, V178, P203, DOI 10.1016/0014-2999(90)90476-M; Dong H, 2009, NEUROL RES, V31, P853, DOI 10.1179/174313209X393960; Du YH, 2011, NEUROL RES, V33, P101, DOI 10.1179/016164110X12714125204317; Elhusseiny A, 2000, J CEREBR BLOOD F MET, V20, P298, DOI 10.1097/00004647-200002000-00011; Elhusseiny A, 1999, J CEREBR BLOOD F MET, V19, P794, DOI 10.1097/00004647-199907000-00010; ESTRADA C, 1983, BRAIN RES, V266, P261, DOI 10.1016/0006-8993(83)90657-1; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; Gao HM, 2002, ACUPUNCTURE ELECTRO, V27, P45, DOI 10.3727/036012902816026112; Gao HM, 2006, ACUPUNCTURE ELECTRO, V31, P259, DOI 10.3727/036012906815844247; Hamel E, 2004, PROG BRAIN RES, V145, P171, DOI 10.1016/S0079-6123(02)45012-7; Han XH, 2010, BRAIN INJURY, V24, P773, DOI 10.3109/02699051003610482; Hartig W, 2002, REV NEUROSCIENCE, V13, P95; Hopwood V, 2005, J ALTERN COMPLEM MED, V11, P175, DOI 10.1089/acm.2005.11.175; Huang Y, 2007, INT J NEUROSCI, V117, P1029, DOI 10.1080/00207450600936825; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; KALARIA RN, 1994, J AUTONOM NERV SYST, V49, pS3; Kang KA, 2010, NEUROL RES, V32, pS84, DOI 10.1179/016164109X12537002794246; Kim DD, 2006, MICROCIRCULATION, V13, P577, DOI 10.1080/10739680600885210; Lee JD, 2003, NEURORADIOLOGY, V45, P780, DOI 10.1007/s00234-003-1080-3; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; Limbourg FP, 2002, J CLIN INVEST, V110, P1729, DOI 10.1172/JCI200215481; Liu Ruihua, 2005, J Tradit Chin Med, V25, P190; Liu SY, 2009, AM J CHINESE MED, V37, P483, DOI 10.1142/S0192415X09006990; Liu Y, 2010, NEUROSCI LETT, V485, P74, DOI 10.1016/j.neulet.2010.08.068; NAESER MA, 1994, ACUPUNCTURE ELECTRO, V19, P227, DOI 10.3727/036012994816357231; Ren L, 2008, NEUROL RES, V30, P985, DOI 10.1179/174313208X325182; SAGHER O, 1993, J CEREBR BLOOD F MET, V13, P676, DOI 10.1038/jcbfm.1993.86; SATO A, 1995, ALZ DIS ASSOC DIS, V9, P28, DOI 10.1097/00002093-199505000-00007; Shiflett SC, 2007, TOP STROKE REHABIL, V14, P40, DOI 10.1310/tsr1404-40; SHIMIZU T, 1993, AM J PHYSIOL, V264, pH665, DOI 10.1152/ajpheart.1993.264.3.H665; Si QM, 1998, ACUPUNCTURE ELECTRO, V23, P117, DOI 10.3727/036012998816356562; Siu FKW, 2004, NEUROSCI LETT, V354, P158, DOI 10.1016/j.neulet.2003.10.009; Sun N, 2005, BRAIN RES, V1064, P98, DOI 10.1016/j.brainres.2005.09.060; Tao J, 2010, NEUROL RES, V32, P198, DOI 10.1179/174313209X414506; Tsuchiya M, 2007, ANESTH ANALG, V104, P301, DOI 10.1213/01.ane.0000230622.16367.fb; Uchida S, 2000, JPN J PHYSIOL, V50, P495, DOI 10.2170/jjphysiol.50.495; Wang QA, 2011, STROKE, V42, P389, DOI 10.1161/STROKEAHA.110.597336; Wang Q, 2009, STROKE, V40, P2157, DOI 10.1161/STROKEAHA.108.541490; Wang SJ, 2002, NEUROSCI LETT, V331, P115, DOI 10.1016/S0304-3940(02)00866-2; Yin CS, 2008, RES VET SCI, V84, P159, DOI 10.1016/j.rvsc.2007.04.004; Zhong SB, 2009, EVID-BASED COMPL ALT, V6, P51, DOI 10.1093/ecam/nem062; Zhou F, 2011, J APPL PHYSIOL, V111, P1877, DOI 10.1152/japplphysiol.00313.2011	47	52	56	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56736	10.1371/journal.pone.0056736	http://dx.doi.org/10.1371/journal.pone.0056736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418594	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300187
J	Leone, MA; Raymkulova, O; Naldi, P; Lochner, P; Bolamperti, L; Coppo, L; Stecco, A; Liboni, W				Leone, Maurizio A.; Raymkulova, Olga; Naldi, Paola; Lochner, Piergiorgio; Bolamperti, Laura; Coppo, Lorenzo; Stecco, Alessandro; Liboni, William			Chronic Cerebrospinal Venous Insufficiency Is Not Associated with Multiple Sclerosis and Its Severity: A Blind-Verified Study	PLOS ONE			English	Article							HEMODYNAMICS; DISABILITY; ULTRASOUND; FATIGUE; SCALE; CCSVI	Background: Chronic Cerebrospinal Venous Insufficiency (CCSVI) has been associated with multiple sclerosis (MS) with a risk ranging from as high as two-hundred-fold to a protective effect. However, not all studies were blinded, and the efficacy of blinding was never assessed. Objective: To evaluate the association of CCSVI with MS in a cross-sectional blinded study and look for any association of CCSVI with the severity of MS. Methodology/Principal Findings: The Echo-color Doppler examination was carried out in accordance with Zamboni's five criteria in 68 consecutive MS patients and 68 healthy controls, matched by gender and age (+/- 5 years). Four experienced neurosonologists, blinded to the status of cases and controls, performed the study and were then asked to guess the status (case or control) of each participant. The number of positive CCSVI criteria was similar in the two groups. CCSVI, defined as the presence of two or more criteria, was detected in 21 cases (30.9%) and 23 controls (33.8%), with an OR of 0.9 (95%CL = 0.4-1.8, p = 0.71). The prevalence of CCSVI was related to age in cases (OR increasing from 0.2 to 1.4), but not in controls. CCSVI positive (N = 21) and negative (N = 47) MS patients were similar in clinical type, age at disease onset, disability, and fatigue. Disease duration was longer (16.5 +/- 9.8 years) in CCSVI positive than negative patients (11.5 +/- 7.4; p = 0.04). The operators correctly guessed 34/68 cases (50%) and 45/68 controls (66%) (p = 0.06), indicating a different success of blinding. Conclusions/Significance: CCSVI was not associated with MS itself, nor its severity. We cannot rule out the possibility that CCSVI is a consequence of MS or of aging. Blinding of sonographers is a key point in studying CCSVI and its verification should be a requisite of future studies.	[Leone, Maurizio A.; Raymkulova, Olga; Naldi, Paola] AOU Maggiore Carita, Head & Neck Dept, MS Ctr, Novara, Italy; [Leone, Maurizio A.] Interdisciplinary Res Ctr Autoimmune Dis, Novara, Italy; [Lochner, Piergiorgio] Hosp Tappeiner, Dept Neurol, Merano, Italy; [Bolamperti, Laura; Coppo, Lorenzo] AOU Maggiore Carita, Head & Neck Dept, SCDU Neurol, Novara, Italy; [Stecco, Alessandro] AOU Maggiore Carita, Ist Radiol Diagnost & Interventist, Novara, Italy; [Liboni, William] Gradenigo Hosp, SNC Neurol, Turin, Italy; [Liboni, William] Fdn Passo Insieme, Valdellatorre, Italy	Azienda Ospedaliera Maggiore della Carita di Novara; University of Eastern Piedmont Amedeo Avogadro; Azienda Ospedaliera Maggiore della Carita di Novara; University of Eastern Piedmont Amedeo Avogadro; Azienda Ospedaliera Maggiore della Carita di Novara; University of Eastern Piedmont Amedeo Avogadro; Humanitas Hospital Gradenigo	Leone, MA (corresponding author), AOU Maggiore Carita, Head & Neck Dept, MS Ctr, Novara, Italy.	maurizio.leone@maggioreosp.novara.it	Leone, Maurizio A./J-4130-2016; Lochner, Piergiorgio/AAB-6784-2020; Stecco, Alessandro/O-4872-2018	Leone, Maurizio A./0000-0002-6339-5738; Lochner, Piergiorgio/0000-0002-2101-6066; Stecco, Alessandro/0000-0002-0712-7595	Merck-Serono; Biogen-Idec; Sanofi Aventis	Merck-Serono(Merck & Company); Biogen-Idec(Biogen); Sanofi Aventis(Sanofi-Aventis)	Maurizio A. Leone has received funds for travel, and research grants from Merck-Serono, Biogen-Idec, and Sanofi Aventis, and has been invited to meeting by ESAOTE. He is Associate Editor of the European Journal of Neurology. William Liboni was supported by ESAOTE for his course at the Zamboni laboratory. Paola Naldi has received funds for travel from Merck-Serono. Alessandro Stecco, Laura Bolamperti, Lorenzo Coppo, Piergiorgio Lochner, and Olga Raymkulova have nothing to disclose. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials	Al-Omari MH, 2010, INT ANGIOL, V29, P115; Amato MP, 2012, MULT SCLER J, V18, P1791, DOI 10.1177/1352458512445943; [Anonymous], 2011, R LANG ENV STAT COMP; Auriel E, 2011, J NEUROL SCI, V309, P102, DOI 10.1016/j.jns.2011.07.005; Bang HJ, 2004, CONTROL CLIN TRIALS, V25, P143, DOI 10.1016/j.cct.2003.10.016; Baracchini C, 2011, NEUROLOGY, V77, P844, DOI 10.1212/WNL.0b013e31822c6208; Baracchini C, 2012, J NEUROL, V259, P2585, DOI 10.1007/s00415-012-6541-3; Baracchini C, 2011, ANN NEUROL, V69, P90, DOI 10.1002/ana.22228; Bastianello S, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-132; Bergamaschi R, 2007, J NEUROL NEUROSUR PS, V78, P757, DOI 10.1136/jnnp.2006.107052; Blinkenberg M, 2012, ACTA NEUROL SCAND, V126, P421, DOI 10.1111/j.1600-0404.2012.01671.x; Centonze D, 2011, ANN NEUROL, V70, P51, DOI 10.1002/ana.22436; Doepp F, 2010, ANN NEUROL, V68, P173, DOI 10.1002/ana.22085; Fleiss JL, 2007, STAT METHODS RATES P, P140; Khan O, 2010, ANN NEUROL, V67, P286, DOI 10.1002/ana.22001; Krogias C, 2010, NERVENARZT, V81, P740, DOI 10.1007/s00115-010-2972-1; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Laupacis A, 2011, CAN MED ASSOC J, V183, pE1203, DOI 10.1503/cmaj.111074; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Malagoni AM, 2010, INT ANGIOL, V29, P176; Marder E, 2011, ARCH NEUROL-CHICAGO, V68, P1521, DOI 10.1001/archneurol.2011.185; Mayer CA, 2011, J NEUROL NEUROSUR PS, V82, P436, DOI 10.1136/jnnp.2010.231613; Monti L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025012; Patti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041227; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Radak D, 2012, PHLEBOLOGY, V27, P168, DOI 10.1258/phleb.2011.011004; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; SAS Institute Inc, 1999, SUGI SUPPL LIB US GU; Thapar A, 2011, PHLEBOLOGY, V26, P319, DOI 10.1258/phleb.2011.011098; Tsivgoulis G, 2011, NEUROLOGY, V77, P1241, DOI 10.1212/WNL.0b013e318230a149; Zamboni P, 2011, INT ANGIOL, V30, P571; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zaniewski M, 2013, PHLEBOLOGY, V28, P24, DOI 10.1258/phleb.2011.011070; Zivadinov R, 2011, NEUROLOGY, V77, P138, DOI 10.1212/WNL.0b013e318212a901	35	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56031	10.1371/journal.pone.0056031	http://dx.doi.org/10.1371/journal.pone.0056031			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418501	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300093
J	Xi, B; Cheng, H; Shen, Y; Chandak, GR; Zhao, XY; Hou, DQ; Wu, LJ; Wang, XY; Mi, J				Xi, Bo; Cheng, Hong; Shen, Yue; Chandak, Giriraj R.; Zhao, Xiaoyuan; Hou, Dongqing; Wu, Lijun; Wang, Xingyu; Mi, Jie			Study of 11 BMI-Associated Loci Identified in GWAS for Associations with Central Obesity in the Chinese Children	PLOS ONE			English	Article							BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; WAIST CIRCUMFERENCE; ABDOMINAL OBESITY; COMMON VARIANTS; FTO GENE; RISK-FACTORS; FAT MASS; ADOLESCENTS; POLYMORPHISMS	Objective: Recent genome-wide association studies have identified many single nucleotide polymorphisms (SNPs) associated with body mass index (BMI)/generalized obesity. In this study, we aimed to examine the associations of identified SNPs with risk of central obesity in a child population from China. Methods: We genotyped 11 SNPs (FTO rs9939609, MC4R rs17782313, GNPDA2 rs10938397, BDNF rs6265, FAIM2 rs7138803, NPC1 rs1805081, SEC16B rs10913469, SH2B1 rs4788102, PCSK1rs6235, KCTD15 rs29941, BAT2 rs2844479) in the Chinese children (N = 3502, age range 6-18 years) from the Beijing Child and Adolescent Metabolic Syndrome (BCAMS). Based on the age- and sex- specific waist circumference (WC) standards generated in the BCAMS study, 1196 central obese cases and 2306 controls were identified. Results: Of 11 studied SNPs, four SNPs and genetic risk score (GRS) based on them were statistically significantly associated with central obesity by WC criteria (FTO rs9939609: OR = 1.29, 95%CI = 1.10-1.50, p = 0.001; MC4R rs17782313: OR = 1.27, 95%CI = 1.12-1.44, p = 1.32 x 10(-4); GNPDA2 rs10938397: OR = 1.22, 95%CI = 1.09-1.37, p = 4.09 x 10(-4); BDNF rs6265: OR = 1.20, 95%CI = 1.08-1.34, p = 8.86 x 10(-4); GRS: OR = 1.25, 95% CI 1.16-1.34, p = 2.58 x 10(-9)) after adjustment for sex, age, pubertal stage, physical activity and family history of obesity. Similar observations were made using weight-to-height ratio (WHtR) criterion. However, other SNPs were not associated with central obesity by WC as well as WHtR criterion. Conclusions: Our study replicates the statistically significant association of four SNPs (FTO rs9939609, MC4R rs17782313, GNPDA2 rs10938397, BDNF rs6265) with risk of central obesity in the Chinese children.	[Xi, Bo] Shandong Univ, Sch Publ Hlth, Dept Maternal & Child Hlth Care, Jinan 250100, Peoples R China; [Xi, Bo; Cheng, Hong; Shen, Yue; Zhao, Xiaoyuan; Hou, Dongqing; Wu, Lijun; Mi, Jie] Capital Inst Pediat, Dept Epidemiol, Beijing, Peoples R China; [Chandak, Giriraj R.] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Wang, Xingyu] Beijing Hypertens League Inst, Lab Human Genet, Beijing, Peoples R China	Shandong University; Capital Institute of Pediatrics (CIP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Chinese Hypertension League	Mi, J (corresponding author), Capital Inst Pediat, Dept Epidemiol, Beijing, Peoples R China.	jiemi@vip.163.com		Chandak, Giriraj Ratan/0000-0002-3095-9453	National Natural Science Foundation of China [81172746]; Beijing Municipal Science & Technology Commission [D111100000611002]; National 'Twelfth Five-Year' Plan for Science & Technology Support Program [2012BAI03B03]; Beijing Health System Leading Talent Fund [2009-1-08]; Foundation for Outstanding Young Scientist in Shandong Province [BS2011YY026]; The Research Fund for the Doctoral Program of Higher Education of China [20120131120004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); National 'Twelfth Five-Year' Plan for Science & Technology Support Program; Beijing Health System Leading Talent Fund; Foundation for Outstanding Young Scientist in Shandong Province; The Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This study was supported by grants from the National Natural Science Foundation of China (81172746), the Beijing Municipal Science & Technology Commission (D111100000611002), the National 'Twelfth Five-Year' Plan for Science & Technology Support Program (2012BAI03B03), the Beijing Health System Leading Talent Fund (2009-1-08), and the Foundation for Outstanding Young Scientist in Shandong Province (BS2011YY026). The Research Fund for the Doctoral Program of Higher Education of China (20120131120004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Chen F, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031645, 10.1371/journal.pone.0039197]; Cheung CYY, 2011, EUR J ENDOCRINOL, V164, P381, DOI 10.1530/EJE-10-0902; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freedman DS, 2009, AM J CLIN NUTR, V90, P210, DOI 10.3945/ajcn.2009.27525; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Janssen I, 2011, OBES REV, V12, P397, DOI 10.1111/j.1467-789X.2010.00815.x; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Liang YJ, 2012, PEDIATR OBES, V7, P355, DOI 10.1111/j.2047-6310.2012.00066.x; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; Meng LH., 2008, CHIN J EVID BASED PE, V3, P324; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Razquin C, 2011, MOL NUTR FOOD RES, V55, P136, DOI 10.1002/mnfr.201000445; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Shan XY, 2010, INT J PEDIATR OBES, V5, P383, DOI 10.3109/17477160903572001; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tanaka M, 2012, J ATHEROSCLER THROMB, V19, P633, DOI 10.5551/jat.11940; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu LJ, 2010, DIABETES, V59, P3085, DOI 10.2337/db10-0273; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Xi B, 2013, CLIN ENDOCRINOL, V79, P523, DOI 10.1111/cen.12091; Xi B, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-107; Xi B, 2009, BIOMED ENVIRON SCI, V22, P449, DOI 10.1016/S0895-3988(10)60001-3	33	38	41	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56472	10.1371/journal.pone.0056472	http://dx.doi.org/10.1371/journal.pone.0056472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424664	Green Published, gold, Green Submitted			2022-12-27	WOS:000315965100052
J	Dong, J; Chen, Y; Xu, X; Jin, R; Teng, F; Yan, F; Tang, H; Li, PP; Sun, XY; Li, Y; Wu, HN; Zhang, Y; Ge, Q				Dong, Jie; Chen, Yu; Xu, Xi; Jin, Rong; Teng, Fei; Yan, Fan; Tang, Hui; Li, Pingping; Sun, Xiuyuan; Li, Yan; Wu, Hounan; Zhang, Yu; Ge, Qing			Homeostatic Properties and Phenotypic Maturation of Murine CD4(+) Pre-Thymic Emigrants in the Thymus	PLOS ONE			English	Article							T-CELLS; DENDRITIC CELLS; THYMOCYTE DEVELOPMENT; MEDULLARY THYMOCYTES; LYMPHOKINE SECRETION; CENTRAL TOLERANCE; AGED MICE; IN-VIVO; SELECTION; REPERTOIRE	After a tightly regulated developmental program in the thymus, "mature" single positive (SP) thymocytes leave the thymus and enter the periphery. These newly arrived recent thymic emigrants (RTEs) are phenotypically and functionally immature, and will complete a dynamic maturation in the peripheral lymphoid organs before being licensed to be resident naive T cells. To study the early events occurring in the RTE maturation process, we identified the phenotype of CD4(+) pre-RTEs, a population of CD4(+) SP thymocytes that have acquired the thymus egress capability. Compared to peripheral naive T cells, CD4(+) pre-RTEs displayed superior survival capability in lymphoreplete mice and faster proliferation under lymphopenic condition. The differences in Bcl2/Bim expression and/or heightened IL-7 signaling pathway may account for the pre-RTEs' better responsiveness to homeostatic signals. Qa2, the expression of which indicates the phenotypic maturation of SPs and RTEs, was found to be upregulated in CD4(+) pre-RTEs in thymic perivascular space. Migratory dendritic cells that surround this region contribute to Qa2 expression in pre-RTEs. The dendritic cell-driven Qa2 induction of CD4(+) pre-RTEs is independent of MHC class II and Aire molecules.	[Dong, Jie; Chen, Yu; Xu, Xi; Jin, Rong; Teng, Fei; Yan, Fan; Tang, Hui; Li, Pingping; Sun, Xiuyuan; Li, Yan; Zhang, Yu; Ge, Qing] Peking Univ, Dept Immunol, Hlth Sci Ctr, Key Lab Med Immunol,Minist Hlth, Beijing 100871, Peoples R China; [Wu, Hounan] Peking Univ, Med & Hlth Analyt Ctr, Hlth Sci Ctr, Beijing 100871, Peoples R China	Peking University; Peking University	Wu, HN (corresponding author), Peking Univ, Med & Hlth Analyt Ctr, Hlth Sci Ctr, Beijing 100871, Peoples R China.	wuhounan@yahoo.com; zhangyu007@bjmu.edu.cn; qingge@bjmu.edu.cn	Li, Ping/GYV-4914-2022		Natural Basic Research Program of China [2010CB945301, 2011CB711000, 2011CB946100]; National Natural Sciences Foundation of China [31070787, 30830091]; Program for New Century Excellent Talents in University [NCET-10-0175/BMU20100005]; Research Fund for the Doctoral Program of Higher Education [20100001110049]	Natural Basic Research Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by grants from the Natural Basic Research Program of China (2010CB945301, QG, 2011CB711000, QG, and 2011CB946100, YZ), the National Natural Sciences Foundation of China (31070787, QG, 30830091, YZ), Program for New Century Excellent Talents in University (NCET-10-0175/BMU20100005), and the Research Fund for the Doctoral Program of Higher Education (20100001110049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2011, CURR OPIN IMMUNOL, V23, P198, DOI 10.1016/j.coi.2010.11.007; Baba T, 2009, J IMMUNOL, V183, P3053, DOI 10.4049/jimmunol.0900438; BENDELAC A, 1991, NATURE, V353, P68, DOI 10.1038/353068a0; Berzins SP, 1999, P NATL ACAD SCI USA, V96, P9787, DOI 10.1073/pnas.96.17.9787; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Bousso P, 2000, P NATL ACAD SCI USA, V97, P274, DOI 10.1073/pnas.97.1.274; CHANG JF, 1991, J IMMUNOL, V147, P851; Clise-Dwyer K, 2007, J IMMUNOL, V178, P1321, DOI 10.4049/jimmunol.178.3.1321; DYALL R, 1995, J EXP MED, V181, P235, DOI 10.1084/jem.181.1.235; Fink PJ, 2011, NAT REV IMMUNOL, V11, P544, DOI 10.1038/nri3028; FUNAUCHI M, 1995, CLIN EXP IMMUNOL, V101, P82; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; Ge Q, 2002, P NATL ACAD SCI USA, V99, P2989, DOI 10.1073/pnas.052714099; Ge Q, 1999, IMMUNOLOGY, V97, P665; Ge Q, 2000, INT IMMUNOL, V12, P1127, DOI 10.1093/intimm/12.8.1127; Hadeiba H, 2012, IMMUNITY, V36, P438, DOI 10.1016/j.immuni.2012.01.017; Haines CJ, 2009, J EXP MED, V206, P275, DOI 10.1084/jem.20080996; Hale JS, 2006, P NATL ACAD SCI USA, V103, P8447, DOI 10.1073/pnas.0601040103; Houston EG, 2008, J IMMUNOL, V181, P5213, DOI 10.4049/jimmunol.181.8.5213; Houston EG, 2011, P NATL ACAD SCI USA, V108, P5366, DOI 10.1073/pnas.1015286108; Houston Jr EG, 2012, CELL IMMUNOL; Jin R, 2008, J IMMUNOL, V180, P2256, DOI 10.4049/jimmunol.180.4.2256; Jones SC, 2008, J IMMUNOL, V180, P4465, DOI 10.4049/jimmunol.180.7.4465; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Lee CK, 2001, BLOOD, V97, P1360, DOI 10.1182/blood.V97.5.1360; Li JC, 2009, J EXP MED, V206, P607, DOI 10.1084/jem.20082232; Li J, 2007, P NATL ACAD SCI USA, V104, P18175, DOI 10.1073/pnas.0708884104; LUCAS B, 1994, J IMMUNOL, V153, P53; Mackall C L, 1997, Semin Immunol, V9, P339, DOI 10.1006/smim.1997.0091; Makaroff LE, 2009, P NATL ACAD SCI USA, V106, P4799, DOI 10.1073/pnas.0812354106; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; Mori K, 2007, INT IMMUNOL, V19, P745, DOI 10.1093/intimm/dxm041; NANDA NK, 1991, P NATL ACAD SCI USA, V88, P9503, DOI 10.1073/pnas.88.21.9503; Opiela SJ, 2009, BLOOD, V113, P5635, DOI 10.1182/blood-2008-08-173658; Priyadharshini B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015038; Proietto AI, 2009, IMMUNOL CELL BIOL, V87, P39, DOI 10.1038/icb.2008.86; RAMSDELL F, 1991, J IMMUNOL, V147, P1779; Schnell FJ, 2005, J IMMUNOL, V175, P2270, DOI 10.4049/jimmunol.175.4.2270; Swain S, 2005, SEMIN IMMUNOL, V17, P370, DOI 10.1016/j.smim.2005.05.007; Teng F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025567; VICARI A, 1994, J IMMUNOL, V152, P2207; Weinreich MA, 2008, J IMMUNOL, V181, P2265, DOI 10.4049/jimmunol.181.4.2265; WOODLAND DL, 1990, J IMMUNOL, V144, P379; Wu L, 2005, SEMIN IMMUNOL, V17, P304, DOI 10.1016/j.smim.2005.05.001; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; Yamano T, 2011, BLOOD, V117, P2640, DOI 10.1182/blood-2010-07-293860; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222	47	17	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56378	10.1371/journal.pone.0056378	http://dx.doi.org/10.1371/journal.pone.0056378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409179	gold, Green Published, Green Submitted			2022-12-27	WOS:000315100000051
J	Mateo, RG; Vanderpoorten, A; Munoz, J; Laenen, B; Desamore, A				Mateo, Ruben G.; Vanderpoorten, Alain; Munoz, Jesus; Laenen, Benjamin; Desamore, Aurelie			Modeling Species Distributions from Heterogeneous Data for the Biogeographic Regionalization of the European Bryophyte Flora	PLOS ONE			English	Article							DISTRIBUTION PATTERNS; ANNOTATED CHECKLIST; BIODIVERSITY; PLANTS; PERFORMANCE; DIVERSITY; REGIONS; CLIMATE; MOSS; PHYLOGEOGRAPHY	The definition of biogeographic regions provides a fundamental framework for a range of basic and applied questions in biogeography, evolutionary biology, systematics and conservation. Previous research suggested that environmental forcing results in highly congruent regionalization patterns across taxa, but that the size and number of regions depends on the dispersal ability of the taxa considered. We produced a biogeographic regionalization of European bryophytes and hypothesized that (1) regions defined for bryophytes would differ from those defined for other taxa due to the highly specific eco-physiology of the group and (2) their high dispersal ability would result in the resolution of few, large regions. Species distributions were recorded using 10,000 km(2) MGRS pixels. Because of the lack of data across large portions of the area, species distribution models employing macroclimatic variables as predictors were used to determine the potential composition of empty pixels. K-means clustering analyses of the pixels based on their potential species composition were employed to define biogeographic regions. The optimal number of regions was determined by v-fold cross-validation and Moran's I statistic. The spatial congruence of the regions identified from their potential bryophyte assemblages with large-scale vegetation patterns is at odds with our primary hypothesis. This reinforces the notion that post-glacial migration patterns might have been much more similar in bryophytes and vascular plants than previously thought. The substantially lower optimal number of clusters and the absence of nested patterns within the main biogeographic regions, as compared to identical analyses in vascular plants, support our second hypothesis. The modelling approach implemented here is, however, based on many assumptions that are discussed but can only be tested when additional data on species distributions become available, highlighting the substantial importance of developing integrated mapping projects for all taxa in key biogeographically areas of Europe, and the Mediterranean peninsulas in particular.	[Mateo, Ruben G.; Vanderpoorten, Alain; Laenen, Benjamin; Desamore, Aurelie] Univ Liege, Inst Bot, Liege, Belgium; [Munoz, Jesus] CSIC, Real Jardin Bot, Madrid, Spain; [Vanderpoorten, Alain] Univ Acores, Dept Ciencias Agr, Azorean Biodivers Grp CITA A, Terceira, Acores, Portugal; [Vanderpoorten, Alain] Univ Acores, Dept Ciencias Agr, Terceira, Acores, Portugal; [Munoz, Jesus] Univ Tecnol Indoamer, Ambato, Ecuador	University of Liege; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Universidade dos Acores; Universidade dos Acores	Mateo, RG (corresponding author), Univ Liege, Inst Bot, Liege, Belgium.	rubeng.mateo@gmail.com	Munoz, Jesus/B-7809-2008; Mateo, Rubén/M-3545-2015	Mateo, Rubén/0000-0001-8577-001X; Munoz, Jesus/0000-0002-9266-2268; Desamore, Aurelie/0000-0003-1922-3557	Belgian Funds for Scientific Research [1.5036.11, 2.4557.11]; University of Liege [C 11/32]; FP7 Synthesys program of the European Community Research Infrastructure Action at the Real Jardin Botanico (CSIC); Ministry of Science and Technology of Spain [CGL2009-09530-BOS]	Belgian Funds for Scientific Research(Fonds de la Recherche Scientifique - FNRS); University of Liege(University of Liege); FP7 Synthesys program of the European Community Research Infrastructure Action at the Real Jardin Botanico (CSIC); Ministry of Science and Technology of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Financial support from the Belgian Funds for Scientific Research (grants 1.5036.11 and 2.4557.11) and the University of Liege (grant C 11/32) is gratefully acknowledged. AD, BL and AV further acknowledge financial support from the FP7 Synthesys program of the European Community Research Infrastructure Action at the Real Jardin Botanico (CSIC). JM acknowledges the funding of the Ministry of Science and Technology of Spain (grant CGL2009-09530-BOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda SC, 2011, ECOGRAPHY, V34, P31, DOI 10.1111/j.1600-0587.2010.06134.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Bohn U., 2000, KARTE NATURLICHEN VE; Carine MA, 2009, J BIOGEOGR, V36, P593, DOI 10.1111/j.1365-2699.2008.02016.x; Cox CB, 2010, J BIOGEOGR, V37, P2027, DOI 10.1111/j.1365-2699.2010.02420.x; Cox CB, 2001, J BIOGEOGR, V28, P511; Desamore A, 2012, GLOBAL CHANGE BIOL, V18, P2915, DOI 10.1111/j.1365-2486.2012.02752.x; Desamore A, 2011, J BIOGEOGR, V38, P164, DOI 10.1111/j.1365-2699.2010.02387.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dull R, 1985, BRYOLOGISCHE BEITRAG, V5, P1; DULL R., 1983, BRYOL BEITR, V2, P1; Dull R., 1984, BRYOLOGISCHE BEITRAG, V4, P1; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2007, DIVERS DISTRIB, V13, P265, DOI 10.1111/j.1472-4642.2007.00340.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ellis CJ, 2000, J ECOL, V88, P869, DOI 10.1046/j.1365-2745.2000.00495.x; Engler R, 2012, ECOGRAPHY, V35, P872, DOI 10.1111/j.1600-0587.2012.07608.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Finnie TJR, 2007, J BIOGEOGR, V34, P1848, DOI 10.1111/j.1365-2699.2007.01750.x; Gignac LD, 2000, J BIOGEOGR, V27, P1139, DOI 10.1046/j.1365-2699.2000.00458.x; Grolle R, 2000, J BRYOL, V22, P103, DOI 10.1179/jbr.2000.22.2.103; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Heikinheimo H, 2012, J BIOGEOGR, V39, P1633, DOI 10.1111/j.1365-2699.2012.02723.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2012, SPECIES DISTRIBUTION; Hill MO, 2006, J BRYOL, V28, P198, DOI 10.1179/174328206X119998; Hutsemekers V, 2008, DIVERS DISTRIB, V14, P483, DOI 10.1111/j.1472-4642.2007.00454.x; Hutsemekersa V, 2011, P NATL ACAD SCI USA, V108, P18989, DOI 10.1073/pnas.1109119108; Jonsgard Birgitte, 1995, Lindbergia, V20, P64; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Laenen B, 2011, J BIOGEOGR, V38, P631, DOI 10.1111/j.1365-2699.2010.02440.x; Latimer AM, 2005, SCIENCE, V309, P1722, DOI 10.1126/science.1115576; Lengyel S, 2008, BIODIVERS CONSERV, V17, P3327, DOI 10.1007/s10531-008-9395-3; Linder HP, 2012, J BIOGEOGR, V39, P1189, DOI 10.1111/j.1365-2699.2012.02728.x; Mackey BG, 2008, J BIOGEOGR, V35, P213, DOI 10.1111/j.1365-2699.2007.01822.x; Mateo RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032586; Mateo RG, 2011, REV CHIL HIST NAT, V84, P217, DOI 10.4067/S0716-078X2011000200008; Metzger MJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P549, DOI 10.1111/j.1466-822x.2005.00190.x; Migliore J, 2012, J BIOGEOGR, V39, P942, DOI 10.1111/j.1365-2699.2011.02646.x; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; Normand S, 2011, P ROY SOC B-BIOL SCI, V278, P3644, DOI 10.1098/rspb.2010.2769; Ozenda P, 2009, CR BIOL, V332, P1092, DOI 10.1016/j.crvi.2009.09.018; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Petit RJ, 2005, TAXON, V54, P877, DOI 10.2307/25065474; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Preston CD, 1999, J BIOGEOGR, V26, P629, DOI 10.1046/j.1365-2699.1999.00314.x; Preston CD, 1997, BOT J LINN SOC, V124, P1, DOI 10.1006/bojl.1996.0084; Preston CD, 2011, J BRYOL, V33, P3, DOI 10.1179/1743282010Y.0000000001; Proches S, 2001, BIOL J LINN SOC, V74, P197, DOI 10.1006/bijl.2001.0565; Rosenzweig ML, 2005, SPECIES DIVERSITY SP; Rozzi R, 2008, FRONT ECOL ENVIRON, V6, P131, DOI 10.1890/070020; Rueda M, 2010, J BIOGEOGR, V37, P2067, DOI 10.1111/j.1365-2699.2010.02388.x; Rydin H., 2009, BRYOPHYTE BIOL, V104, P393, DOI [10.1093/aob/mcp111, DOI 10.1017/CBO9780511754807.011, 10.1017/CBO9780511754807.011]; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Shaw AJ, 2005, TAXON, V54, P337, DOI 10.2307/25065362; SHAW J, 1985, BRYOLOGIST, V88, P199, DOI 10.2307/3243029; Soderstrom Lars, 1992, P131; Sotiaux A, 2009, J BRYOL, V31, P186, DOI 10.1179/174328209X455299; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Syphard AD, 2010, J VEG SCI, V21, P177, DOI 10.1111/j.1654-1103.2009.01133.x; Szovenyi P, 2006, NEW PHYTOL, V172, P784, DOI 10.1111/j.1469-8137.2006.01870.x; Takhtajan AL., 1986, FLORISTIC REGIONS WO; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Van der Velde M, 2003, BIOL J LINN SOC, V78, P203, DOI 10.1046/j.1095-8312.2003.00151.x; van Rooy J, 2011, J BRYOL, V33, P17, DOI 10.1179/1743282010Y.0000000007; Vanderpoorten A, 2007, AM J BOT, V94, P625, DOI 10.3732/ajb.94.4.625; Vanderpoorten A, 1999, BRYOLOGIST, V102, P720, DOI 10.2307/3244258; Vanderpoorten A, 2009, INTRODUCTION TO BRYOPHYTES, P1, DOI 10.1017/CBO9780511626838; Vanderpoorten A., 2011, The biology of island floras, P338; Vanderpoorten A, 2002, ECOGRAPHY, V25, P513, DOI 10.1034/j.1600-0587.2002.250501.x; Vanderpoorten A, 2010, PHYTOTAXA, V9, P229; Vanderpoorten A, 2010, BIOL REV, V85, P471, DOI 10.1111/j.1469-185X.2009.00111.x; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106; Wohlgemuth Thomas, 1996, Biodiversity Letters, V3, P180, DOI 10.2307/2999675; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Zechmeister HG, 2007, APPL VEG SCI, V10, P111, DOI 10.1658/1402-2001(2007)10[111:SDPORM]2.0.CO;2	80	40	43	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55648	10.1371/journal.pone.0055648	http://dx.doi.org/10.1371/journal.pone.0055648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409015	Green Published, gold, Green Submitted			2022-12-27	WOS:000315100000019
J	Soodgupta, D; Hurchla, MA; Jiang, MJ; Zheleznyak, A; Weilbaecher, KN; Anderson, CJ; Tomasson, MH; Shokeen, M				Soodgupta, Deepti; Hurchla, Michelle A.; Jiang, Majiong; Zheleznyak, Alexander; Weilbaecher, Katherine N.; Anderson, Carolyn J.; Tomasson, Michael H.; Shokeen, Monica			Very Late Antigen-4 (alpha(4)beta(1) Integrin) Targeted PET Imaging of Multiple Myeloma	PLOS ONE			English	Article							MEDIATED DRUG-RESISTANCE; MARROW STROMAL CELLS; BONE-DISEASE; MURINE MODEL; ADHESION MOLECULES; IN-VIVO; VLA-4; BINDING; EXPRESSION; MANAGEMENT	Biomedical imaging techniques such as skeletal survey and F-18-fluorodeoxyglucose (FDG)/Positron Emission Tomography (PET) are frequently used to diagnose and stage multiple myeloma (MM) patients. However, skeletal survey has limited sensitivity as it can detect osteolytic lesions only after 30-50% cortical bone destruction, and FDG is a marker of cell metabolism that has limited sensitivity for intramedullary lesions in MM. Targeted, and non-invasive novel probes are needed to sensitively and selectively image the unique molecular signatures and cellular processes associated with MM. Very late antigen-4 (VLA-4; also called alpha(4)beta(1) integrin) is over-expressed on MM cells, and is one of the key mediators of myeloma cell adhesion to the bone marrow (BM) that promotes MM cell trafficking and drug resistance. Here we describe a proof-of-principle, novel molecular imaging strategy for MM tumors using a VLA-4 targeted PET radiopharmaceutical, Cu-64-CB-TE1A1P-LLP2A. Cell uptake studies in a VLA-4-positive murine MM cell line, 5TGM1, demonstrated receptor specific uptake (P<0.0001, block vs. non-block). Tissue biodistribution at 2 h of Cu-64-CB-TE1A1P-LLP2A in 5TGM1 tumor bearing syngeneic KaLwRij mice demonstrated high radiotracer uptake in the tumor (12 +/- 4.5%ID/g), and in the VLA-4 rich organs, spleen (8.8 +/- 1.0%ID/g) and marrow (11.6 +/- 2.0%ID/g). Small animal PET/CT imaging with Cu-64-CB-TE1A1P-LLP2A demonstrated high uptake in the 5TGM1 tumors (SUV 6.6 +/- 1.1). There was a 3-fold reduction in the in vivo tumor uptake in the presence of blocking agent (2.3 +/- 0.4). Additionally, Cu-64-CB-TE1A1P-LLP2A demonstrated high binding to the human MM cell line RPMI-8226 that was significantly reduced in the presence of the cold targeting agent. These results provide preclinical evidence that VLA-4-targeted imaging using Cu-64-CB-TE1A1P-LLP2A is a novel approach to imaging MM tumors.	[Soodgupta, Deepti; Hurchla, Michelle A.; Weilbaecher, Katherine N.; Tomasson, Michael H.] Washington Univ, Dept Med, St Louis, MO 63130 USA; [Jiang, Majiong] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Jiang, Majiong; Zheleznyak, Alexander; Anderson, Carolyn J.] Washington Univ, Mallinckrodt Inst Radiol, St Louis, MO USA; [Anderson, Carolyn J.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tomasson, MH (corresponding author), Washington Univ, Dept Med, St Louis, MO 63130 USA.	Tomasson@dom.wustl.edu; mshokeen@wustl.edu	Jiang, Majiong/I-3630-2013	Anderson, Carolyn/0000-0002-5663-282X; Tomasson, Michael/0000-0003-4518-7123	Mallinckrodt Institute of Radiology Imaging grant [10-015]; Multiple Myeloma Research Foundation (MMRF);  [P01-CA100730-06];  [R01-CA097250]; NATIONAL CANCER INSTITUTE [P01CA078378, R01CA176221, P01CA100730, P01CA155258, P30CA091842, P50CA100707, R01CA097250] Funding Source: NIH RePORTER	Mallinckrodt Institute of Radiology Imaging grant; Multiple Myeloma Research Foundation (MMRF); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was supported in part by funds from the Mallinckrodt Institute of Radiology Imaging grant # 10-015 (MS). KNW and MH were supported by P01-CA100730-06 and R01-CA097250. MHT is also supported by a Senior Research Award from the Multiple Myeloma Research Foundation (MMRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abe M, 2009, J BONE MINER METAB, V27, P16, DOI 10.1007/s00774-008-0012-z; Asosingh K, 2000, Hematol J, V1, P351, DOI 10.1038/sj.thj.6200052; Breyer RJ, 2006, SKELETAL RADIOL, V35, P632, DOI 10.1007/s00256-006-0127-z; Collins CD, CANC IMAGING, V10, P20; Dallas SL, 1999, BLOOD, V93, P1697, DOI 10.1182/blood.V93.5.1697.405a17_1697_1706; Damiano JS, 2000, LEUKEMIA LYMPHOMA, V38, P71, DOI 10.3109/10428190009060320; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Durie BGM, 2002, J NUCL MED, V43, P1457; Durie BGM, 2006, EUR J CANCER, V42, P1539, DOI 10.1016/j.ejca.2005.11.037; Eckelman WC, 2009, NUCL MED BIOL, V36, P235, DOI 10.1016/j.nucmedbio.2008.12.002; Ferdani R, DALTON T, V41, P1938; Ferdani R, 2012, DALTON T, V41, P1938, DOI 10.1039/c1dt11743b; Fonti R, 2008, J NUCL MED, V49, P195, DOI 10.2967/jnumed.107.045641; Garrett IR, 1997, BONE, V20, P515, DOI 10.1016/S8756-3282(97)00056-2; Hurchla MA, 2012, LEUKEMIA; Hyun YM, 2009, J IMMUNOL, V183, P359, DOI 10.4049/jimmunol.0803388; Imai Y, 2010, INT J HEMATOL, V91, P569, DOI 10.1007/s12185-010-0555-3; Jiang M, NUCL MED BIOL; Katz BZ, 2010, SEMIN CANCER BIOL, V20, P186, DOI 10.1016/j.semcancer.2010.04.003; KOMORIYA A, 1991, J BIOL CHEM, V266, P15075; Kristinsson SY, 2011, EXPERT REV MOL DIAGN, V11, P593, DOI [10.1586/ERM.11.44, 10.1586/erm.11.44]; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Lu YY, 2012, CLIN NUCL MED, V37, P833, DOI 10.1097/RLU.0b013e31825b2071; McCarthy DW, 1997, NUCL MED BIOL, V24, P35, DOI 10.1016/S0969-8051(96)00157-6; Michigami T, 2000, BLOOD, V96, P1953, DOI 10.1182/blood.V96.5.1953.h8001953_1953_1960; Mortimer JE, 2001, J CLIN ONCOL, V19, P2797, DOI 10.1200/JCO.2001.19.11.2797; Mulligan ME, 2007, SKELETAL RADIOL, V36, P5, DOI 10.1007/s00256-006-0184-3; Noborio-Hatano K, 2009, ONCOGENE, V28, P231, DOI 10.1038/onc.2008.385; Olson DL, 2005, MOL CANCER THER, V4, P91; Orchard K, 2002, BRIT J HAEMATOL, V117, P133, DOI 10.1046/j.1365-2141.2002.03407.x; OSBORN L, 1994, J CELL BIOL, V124, P601, DOI 10.1083/jcb.124.4.601; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Palumbo A, 2010, HAEMATOL-HEMATOL J, V95, P1144, DOI 10.3324/haematol.2009.017913; PELLATDECEUNYNCK C, 1995, CANCER RES, V55, P3647; Peng L, 2006, NAT CHEM BIOL, V2, P381, DOI 10.1038/nchembio798; Qi JY, 2000, IEEE T MED IMAGING, V19, P493, DOI 10.1109/42.870259; RADL J, 1979, J IMMUNOL, V122, P609; Raje N, 2011, CLIN CANCER RES, V17, P1278, DOI 10.1158/1078-0432.CCR-10-1804; Sanz-Rodriguez F, 2001, LEUKEMIA LYMPHOMA, V41, P239, DOI 10.3109/10428190109057979; Schmidmaier R, 2006, INT J BIOL MARKER, V21, P218, DOI 10.1177/172460080602100404; VACCA A, 1995, AM J HEMATOL, V50, P9, DOI 10.1002/ajh.2830500103; Wagner LI, J PAIN SYMPTOM MANAG, V43, P1094; Zamagni E, 2012, BRIT J HAEMATOL, V159, P499, DOI 10.1111/bjh.12007; Zwingenberger AL, 2012, VET IMMUNOL IMMUNOP, V145, P298, DOI 10.1016/j.vetimm.2011.11.018	44	32	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55841	10.1371/journal.pone.0055841	http://dx.doi.org/10.1371/journal.pone.0055841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409060	Green Accepted, Green Published, gold			2022-12-27	WOS:000314660300038
J	Vissers, D; Hens, W; Taeymans, J; Baeyens, JP; Poortmans, J; Van Gaal, L				Vissers, Dirk; Hens, Wendy; Taeymans, Jan; Baeyens, Jean-Pierre; Poortmans, Jacques; Van Gaal, Luc			The Effect of Exercise on Visceral Adipose Tissue in Overweight Adults: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ACTIVITY ENERGY-EXPENDITURE; METABOLIC SYNDROME; ABDOMINAL OBESITY; PHYSICAL-ACTIVITY; AEROBIC EXERCISE; RISK-FACTORS; BODY-COMPOSITION; SEX-DIFFERENCES; BLOOD-PRESSURE; WEIGHT-LOSS	Excessive visceral adipose tissue appears to trigger a cascade of metabolic disturbances that seem to coexist with ectopic fat storage in muscle, liver, heart and the beta-cell. Therefore, the reduction of visceral adipose tissue potentially plays a pivotal role in the treatment of the metabolic syndrome. The purpose of this systematic review and meta-analysis is to describe the overall effect of exercise on visceral adipose tissue and to provide an overview of the effect of different exercise regimes, without caloric restriction, on visceral adipose tissue in obese persons. A systematic literature search was performed according to the PRISMA statement for reporting systematic reviews and meta-analyses. The initial search resulted in 87 articles after removing duplicates. After screening on title, abstract and full-text 15 articles (totalling 852 subjects) fulfilled the a priori inclusion criteria. The quality of each eligible study was assessed in duplicate with "The Critical Review Form for Quantitative Studies". Using random-effects weights, the standardized mean difference (Hedge's g) of the change in visceral adipose tissue was -0.497 with a 95% confidence interval of -0.655 to -0.340. The Z-value was -6.183 and the p-value (two tailed) was <0.001. A subgroup analysis was performed based on gender, type of training and intensity. Aerobic training of moderate or high intensity has the highest potential to reduce visceral adipose tissue in overweight males and females. These results suggest that an aerobic exercise program, without hypocaloric diet, can show beneficial effects to reduce visceral adipose tissue with more than 30 cm 2 (on CT analysis) in women and more than 40 cm(2) in men, even after 12 weeks.	[Vissers, Dirk; Hens, Wendy; Van Gaal, Luc] Univ Antwerp, Fac Med & Hlth Sci, B-2020 Antwerp, Belgium; [Taeymans, Jan] Bern Univ Appl Sci, Dept Hlth, Bern, Switzerland; [Baeyens, Jean-Pierre] Vrije Univ Brussel, Fac Phys Educ & Physiotherapy, Brussels, Belgium; [Poortmans, Jacques] Univ Libre Bruxelles, Higher Inst Phys Educ & Phys Therapy, Brussels, Belgium; [Van Gaal, Luc] Univ Antwerp Hosp, Dept Endocrinol Diabet & Metab, Edegem, Belgium	University of Antwerp; Vrije Universiteit Brussel; Universite Libre de Bruxelles; University of Antwerp	Vissers, D (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, B-2020 Antwerp, Belgium.	dirk.vissers@ua.ac.be	hens, wendy/I-9841-2016	hens, wendy/0000-0002-9881-6248; Vissers, Dirk/0000-0001-5901-6515				Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Boudou P, 2001, INT J OBESITY, V25, P1108, DOI 10.1038/sj.ijo.0801637; Brewer HB, 2003, AM J CARDIOL, V92, p10K, DOI 10.1016/S0002-9149(03)00769-0; Carroll JF, 2009, OBESITY, V17, P1420, DOI 10.1038/oby.2008.657; Christiansen T, 2009, EUR J ENDOCRINOL, V160, P759, DOI 10.1530/EJE-08-1009; Coker RH, 2009, METAB SYNDR RELAT D, V7, P363, DOI 10.1089/met.2008.0060; Couillard C, 2001, ARTERIOSCL THROM VAS, V21, P1226, DOI 10.1161/hq0701.092137; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Despres JP, 2000, ARTERIOSCL THROM VAS, V20, P1932, DOI 10.1161/01.ATV.20.8.1932; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Ekelund U, 2005, DIABETES CARE, V28, P1195, DOI 10.2337/diacare.28.5.1195; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; Friedenreich CM, 2011, INT J OBESITY, V35, P427, DOI 10.1038/ijo.2010.147; Gonzalez JT, 2012, BRIT J NUTR, V107, P339, DOI 10.1017/S0007114511006684; Gutin B, 2002, AM J CLIN NUTR, V75, P818, DOI 10.1093/ajcn/75.5.818; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Holloszy John O., 1998, Frontiers in Bioscience, V3, pD1011; Irving BA, 2008, MED SCI SPORT EXER, V40, P1863, DOI 10.1249/MSS.0b013e3181801d40; Irwin ML, 2003, JAMA-J AM MED ASSOC, V289, P323, DOI 10.1001/jama.289.3.323; Ismail I, 2012, OBES REV, V13, P68, DOI 10.1111/j.1467-789X.2011.00931.x; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Kay SJ, 2006, OBES REV, V7, P183, DOI 10.1111/j.1467-789X.2006.00250.x; Kilburn SA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004299.pub2; Kim MK, 2009, J APPL PHYSIOL, V106, P5, DOI 10.1152/japplphysiol.90756.2008; Koga R, 2008, AM J MED SCI, V336, P450, DOI 10.1097/MAJ.0b013e31817242a5; Koo BK, 2010, DIABETIC MED, V27, P1088, DOI 10.1111/j.1464-5491.2010.03045.x; Kuk JL, 2007, NUTR METAB, V32, P1210; Law M, 1998, GUIDELINES CRITICAL; Lovejoy JC, 2009, OBES REV, V10, P154, DOI 10.1111/j.1467-789X.2008.00529.x; Mathieu P, 2010, CLIN PHARMACOL THER, V87, P407, DOI 10.1038/clpt.2009.311; McTiernan A, 2007, OBESITY, V15, P1496, DOI 10.1038/oby.2007.178; Micklesfield LK, 2012, OBESITY, V20, P1109, DOI 10.1038/oby.2011.367; Miyatake N, 2003, DIABETES RES CLIN PR, V62, P149, DOI 10.1016/S0168-8227(03)00176-1; Oda E, 2008, HYPERTENS RES, V31, P1283, DOI 10.1291/hypres.31.1283; Okauchi Y, 2007, DIABETES CARE, V30, P2392, DOI 10.2337/dc07-0218; Okura T, 2005, INT J OBESITY, V29, P1259, DOI 10.1038/sj.ijo.0803013; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Power ML, 2008, BRIT J NUTR, V99, P931, DOI 10.1017/S0007114507853347; Redman LM, 2007, J CLIN ENDOCR METAB, V92, P865, DOI 10.1210/jc.2006-2184; Ritchie SA, 2007, NUTR METAB CARDIOVAS, V17, P319, DOI 10.1016/j.numecd.2006.07.005; Ross R, 2003, INT J OBESITY, V27, P204, DOI 10.1038/sj.ijo.802222; Sasai H, 2010, JAPANESE J PHYS FITN, V59, P68; Schmitz KH, 2007, AM J CLIN NUTR, V86, P566, DOI 10.1093/ajcn/86.3.566; Shaw K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003817.pub3; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Sigal RJ, 2010, DIABETES CARE, V33, P147, DOI DOI 10.2337/DC10-9990; Skelton JA, 2009, ACAD PEDIAT; Slentz CA, 2004, ARCH INTERN MED, V164, P31, DOI 10.1001/archinte.164.1.31; Slentz CA, 2011, AM J PHYSIOL-ENDOC M, V301, pE1033, DOI 10.1152/ajpendo.00291.2011; Surmi BK, 2008, FUTURE LIPIDOL, V3, P545, DOI 10.2217/17460875.3.5.545; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Verrijken A, 2010, INT J OBESITY, V34, P899, DOI 10.1038/ijo.2010.4; Warren A, 2009, INT J SPORT NUTR EXE, V19, P607, DOI 10.1123/ijsnem.19.6.607; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006; You TJ, 2008, CURR DIABETES REP, V8, P7, DOI 10.1007/s11892-008-0003-4	57	183	189	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56415	10.1371/journal.pone.0056415	http://dx.doi.org/10.1371/journal.pone.0056415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409182	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300073
J	Yang, MM; Zhang, WW; Ji, SY; Cao, PH; Chen, YL; Zhao, X				Yang, Mingming; Zhang, Weiwei; Ji, Shengyue; Cao, Pinghua; Chen, Yulin; Zhao, Xin			Generation of an Artificial Double Promoter for Protein Expression in Bacillus subtilis through a Promoter Trap System	PLOS ONE			English	Article							METHYL PARATHION HYDROLASE; CONSTRUCTION; VECTOR; INTEGRATION; GENE	Bacillus subtilis is an attractive host for production of recombinant proteins. Promoters and expression plasmid backbones have direct impacts on the efficiency of gene expression. To screen and isolate strong promoters, a promoter trap vector pShuttleF was developed in this study. Using the vector, approximately 1000 colonies containing likely promoters from Bacillus licheniformis genomic DNA were obtained. Amongst them, pShuttle-09 exhibited the highest beta-Gal activities in both Escherichia coli and B. subtilis. The activity of pShuttle-09 in B. subtilis was eight times of that of the P43 promoter, a commonly used strong promoter for B. subtilis. A sequence analysis showed that pShuttle-09 contained P-luxS and truncated luxS in-frame fused with the reporter gene as well as another fragment upstream of P-luxS containing a putative promoter. This putative promoter was a hybrid promoter and its beta-Gal activity was higher than P-luxS. Reconstructing the hybrid promoter from pShuttle-09 to P-lapS further improved the beta-Gal production by 60%. The usefulness of our promoter trap system is likely due to random shuffling and recombination of DNA fragments and adoption of a rapid and high-throughput screening. Thus, our data provide additional evidence to support the concept of using a promoter trap system to create new promoters.	[Yang, Mingming; Zhang, Weiwei; Ji, Shengyue; Cao, Pinghua; Chen, Yulin; Zhao, Xin] NW A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi Provinc, Peoples R China; [Zhao, Xin] McGill Univ, Dept Anim Sci, Quebec City, PQ, Canada	Northwest A&F University - China; McGill University	Chen, YL (corresponding author), NW A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi Provinc, Peoples R China.	xylgene@126.com; zhaoxin@nwsuaf.edu.cn	Zhao, Xin/M-4312-2015	Zhao, Xin/0000-0002-1078-7332	Chinese National Natural Science Foundation [30871813, 31072060]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Chinese National Natural Science Foundation (30871813 and 31072060). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki S, 2002, J MICROBIOL METH, V49, P265, DOI 10.1016/S0167-7012(01)00376-1; Bendtsen KM, 2011, NUCLEIC ACIDS RES, V39, P6879, DOI 10.1093/nar/gkr390; Bhavsar AP, 2001, APPL ENVIRON MICROB, V67, P403, DOI 10.1128/AEM.67.1.403-410.2001; Carroll JA, 2003, MICROBIOL-SGM, V149, P1819, DOI 10.1099/mic.0.26165-0; Cui ZL, 2004, BIOTECHNOL LETT, V26, P1115, DOI 10.1023/B:BILE.0000035481.03854.41; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; Gat O, 2003, INFECT IMMUN, V71, P801, DOI 10.1128/IAI.71.2.801-813.2003; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Hartl B, 2001, J BACTERIOL, V183, P2696, DOI 10.1128/JB.183.8.2696-2699.2001; Heravi KM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-83; HIRATA H, 1986, J BACTERIOL, V166, P722, DOI 10.1128/jb.166.3.722-727.1986; Kaltwasser M, 2002, APPL ENVIRON MICROB, V68, P2624, DOI 10.1128/AEM.68.5.2624-2628.2002; Kang HK, 2010, WORLD J MICROB BIOT, V26, P1915, DOI 10.1007/s11274-010-0351-5; Kim JH, 2011, WORLD J MICROB BIOT, V27, P2747, DOI 10.1007/s11274-011-0749-8; Lee SJ, 2010, J BIOTECHNOL, V149, P16, DOI 10.1016/j.jbiotec.2010.06.021; Li MJ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-19; Li W, 2007, BIOCHEM BIOPH RES CO, V358, P1148, DOI 10.1016/j.bbrc.2007.05.064; Maniatis T., 1982, MOL CLONING; Meijer WJJ, 2004, NUCLEIC ACIDS RES, V32, P1166, DOI 10.1093/nar/gkh290; Ming YM, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-55; Phan TTP, 2010, PROTEIN EXPRES PURIF, V71, P174, DOI 10.1016/j.pep.2009.11.010; Phan TTP, 2006, PROTEIN EXPRES PURIF, V46, P189, DOI 10.1016/j.pep.2005.07.005; Rhodius VA, 2010, P NATL ACAD SCI USA, V107, P2854, DOI 10.1073/pnas.0915066107; Schallmey M, 2004, CAN J MICROBIOL, V50, P1, DOI 10.1139/W03-076; Schumann W, 2007, ADV APPL MICROBIOL, V62, P137, DOI 10.1016/S0065-2164(07)62006-1; Sun TQ, 2010, J BACTERIOL, V192, P2128, DOI 10.1128/JB.01673-09; Trang TPP, 2012, J BIOTECHNOL, V157, P167, DOI 10.1016/j.jbiotec.2011.10.006; WANG PZ, 1984, J BIOL CHEM, V259, P8619; Wang YG, 2012, APPL MICROBIOL BIOT, V93, P1585, DOI 10.1007/s00253-011-3684-6; Widner B, 2000, J IND MICROBIOL BIOT, V25, P204, DOI 10.1038/sj.jim.7000051; Wu SM, 2011, WORLD J MICROB BIOT, V27, P99, DOI 10.1007/s11274-010-0432-5; Yang MM, 2006, BIOTECHNOL LETT, V28, P1713, DOI 10.1007/s10529-006-9146-z; Yang MM, 2010, MOL BIOL REP, V37, P2207, DOI 10.1007/s11033-009-9704-2; Zhang AL, 2007, BIOCHEM BIOPH RES CO, V354, P90, DOI 10.1016/j.bbrc.2006.12.137; Zhang XZ, 2005, APPL ENVIRON MICROB, V71, P4101, DOI 10.1128/AEM.71.7.4101-4103.2005; Zhu FM, 2008, MOL BIOTECHNOL, V39, P225, DOI 10.1007/s12033-008-9030-2	36	37	48	5	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56321	10.1371/journal.pone.0056321	http://dx.doi.org/10.1371/journal.pone.0056321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409173	Green Submitted, gold, Green Published			2022-12-27	WOS:000314660300072
J	Koivuniemi, R; Makela, J; Hokkanen, ME; Bruelle, C; Ho, TH; Ola, R; Korhonen, L; Schroder, J; Kataoka, H; Lindholm, D				Koivuniemi, Raili; Makela, Johanna; Hokkanen, Marie-Estelle; Bruelle, Celine; Ho, Tho Huu; Ola, Roxana; Korhonen, Laura; Schroder, Jim; Kataoka, Hiroaki; Lindholm, Dan			Hepatocyte Growth Factor Activator Inhibitor-1 Is Induced by Bone Morphogenetic Proteins and Regulates Proliferation and Cell Fate of Neural Progenitor Cells	PLOS ONE			English	Article							SERINE-PROTEASE INHIBITOR; TUMOR-SUPPRESSOR GENE; STEM-CELLS; TYPE-1 HAI-1; RAT HIPPOCAMPUS; NEURONAL DIFFERENTIATION; ADULT NEUROGENESIS; GLIOBLASTOMA CELLS; KUNITZ DOMAINS; TUBE CLOSURE	Background: Neural progenitor cells (NPCs) in the developing neuroepithelium are regulated by intrinsic and extrinsic factors. There is evidence that NPCs form a self-supporting niche for cell maintenance and proliferation. However, molecular interactions and cell-cell contacts and the microenvironment within the neuroepithelium are largely unknown. We hypothesized that cellular proteases especially those associated with the cell surface of NPCs play a role in regulation of progenitor cells in the brain. Methodology/Principal Findings: In this work, we show that NPCs, isolated from striatal anlage of developing rat brain, express hepatocyte growth factor activator inhibitor-1 and -2 (HAI-1 and HAI-2) that are cell surface-linked serine protease inhibitors. In addition, radial glia cells derived from mouse embryonic stem cells also express HAI-1 and HAI-2. To study the functional significance of HAI-1 and HAI-2 in progenitor cells, we modulated their levels using expression plasmids or silencing RNA (siRNA) transfected into the NPCs. Data showed that overexpression of HAI-1 or HAI-2 decreased cell proliferation of cultured NPCs, whilst their siRNAs had opposite effects. HAI-1 also influenced NPC differentiation by increasing the number of glial fibrillary acidic protein (GFAP) expressing cells in the culture. Expression of HAI-1 in vivo decreased cell proliferation in developing neuroepithelium in E15 old animals and promoted astrocyte cell differentiation in neonatal animals. Studying the regulation of HAI-1, we observed that Bone morphogenetic protein-2 (BMP-2) and BMP-4 increased HAI-1 levels in the NPCs. Experiments using HAI-1-siRNA showed that these BMPs act on the NPCs partly in a HAI-1-dependent manner. Conclusions: This study shows that the cell-surface serine protease inhibitors, HAI-1 and HAI-2 influence proliferation and cell fate of NPCs and their expression levels are linked to BMP signaling. Modulation of the levels and actions of HAI-1 in NPCs may be of a potential value in stem cell therapies in various brain diseases.	[Koivuniemi, Raili; Makela, Johanna; Bruelle, Celine; Ola, Roxana; Korhonen, Laura; Lindholm, Dan] Univ Helsinki, Inst Biomed Biochem & Dev Biol, Helsinki, Finland; [Koivuniemi, Raili; Makela, Johanna; Bruelle, Celine; Ho, Tho Huu; Korhonen, Laura; Schroder, Jim; Lindholm, Dan] Minerva Fdn, Biomedicum Helsinki 2, Helsinki, Finland; [Hokkanen, Marie-Estelle] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Kataoka, Hiroaki] Miyazaki Univ, Fac Med, Dept Pathol, Miyazaki, Japan	University of Helsinki; University of Helsinki; University of Helsinki; University of Miyazaki	Lindholm, D (corresponding author), Univ Helsinki, Inst Biomed Biochem & Dev Biol, Helsinki, Finland.	dan.lindholm@helsinki.fi	Korhonen, Laura/AAW-3256-2020; Koivuniemi, Raili/AAF-2173-2021; Lindholm, Dan/B-3777-2014	Koivuniemi, Raili/0000-0002-0359-7178; Korhonen, Laura/0000-0002-1837-5930; Ho, Tho/0000-0002-8363-1427	Sigrid Juselius Foundation; Nona and Kullervo Vare Foundation; Academy of Finland; Liv och Halsa Foundation; Finska Lakaresallskapet; Magnus Ehrnrooth; Minerva Foundation	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Nona and Kullervo Vare Foundation; Academy of Finland(Academy of Finland); Liv och Halsa Foundation; Finska Lakaresallskapet; Magnus Ehrnrooth; Minerva Foundation	This work was supported by Sigrid Juselius Foundation, Nona and Kullervo Vare Foundation, Academy of Finland, Liv och Halsa Foundation, Finska Lakaresallskapet, Magnus Ehrnrooth and Minerva Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Brannvall K, 2005, EUR J NEUROSCI, V21, P871, DOI 10.1111/j.1460-9568.2005.03942.x; Brannvall K, 2002, MOL CELL NEUROSCI, V21, P512, DOI 10.1006/mcne.2002.1194; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chen HL, 2007, STEM CELLS, V25, P63, DOI 10.1634/stemcells.2006-0339; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Dalgin G, 2007, DEV BIOL, V310, P454, DOI 10.1016/j.ydbio.2007.08.012; Denda K, 2002, J BIOL CHEM, V277, P14053, DOI 10.1074/jbc.M112263200; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; Enarsson M, 2002, MOL CANCER RES, V1, P147; Fan B, 2007, DEV BIOL, V303, P222, DOI 10.1016/j.ydbio.2006.11.005; Fang JD, 2011, J BIOL CHEM, V286, P5667, DOI 10.1074/jbc.M110.153866; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Do HT, 2012, J BIOL CHEM, V287, P12602, DOI 10.1074/jbc.M112.341248; Hallikas OK, 2006, J HISTOCHEM CYTOCHEM, V54, P745, DOI 10.1369/jhc.5A6816.2006; Hamasuna R, 2001, INT J CANCER, V93, P339, DOI 10.1002/ijc.1349; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Itoh H, 2001, BBA-GENE STRUCT EXPR, V1519, P92, DOI 10.1016/S0167-4781(01)00216-0; Kataoka H, 2000, J BIOL CHEM, V275, P40453, DOI 10.1074/jbc.M006412200; Kataoka H, 2002, BIOCHEM BIOPH RES CO, V290, P1096, DOI 10.1006/bbrc.2001.6313; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kokuzawa J, 2003, MOL CELL NEUROSCI, V24, P190, DOI 10.1016/S1044-7431(03)00160-X; Kongkham PN, 2008, CANCER RES, V68, P9945, DOI 10.1158/0008-5472.CAN-08-2169; Korhonen L, 2000, EUR J NEUROSCI, V12, P3453, DOI 10.1046/j.1460-9568.2000.00260.x; Korhonen L, 2003, J NEUROSCI RES, V71, P769, DOI 10.1002/jnr.10546; Korhonen L, 2001, MOL CELL NEUROSCI, V17, P364, DOI 10.1006/mcne.2000.0935; Li WW, 1998, J NEUROSCI, V18, P8853; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Makela J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011091; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Miyata S, 2005, CANCER LETT, V227, P83, DOI 10.1016/j.canlet.2005.01.010; Miyata S, 2007, HUM CELL, V20, P100, DOI 10.1111/j.1749-0774.2007.00035.x; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Putkonen N, 2011, EUR J NEUROSCI, V34, P1212, DOI 10.1111/j.1460-9568.2011.07858.x; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Sippel M, 2009, FEBS LETT, V583, P2213, DOI 10.1016/j.febslet.2009.06.018; Soderstrom S, 1996, CELL TISSUE RES, V286, P269, DOI 10.1007/s004410050697; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Sundberg M, 2006, J NEUROSCI, V26, P5402, DOI 10.1523/JNEUROSCI.4906-05.2006; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Tanaka H, 2005, MOL CELL BIOL, V25, P5687, DOI 10.1128/MCB.25.13.5687-5698.2005; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tervonen TA, 2009, NEUROBIOL DIS, V33, P250, DOI 10.1016/j.nbd.2008.10.010; Tung HH, 2012, J BIOL CHEM, V287, P22497, DOI 10.1074/jbc.M111.330589; Yamada T, 1998, EXP NEUROL, V153, P60, DOI 10.1006/exnr.1998.6874	53	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56117	10.1371/journal.pone.0056117	http://dx.doi.org/10.1371/journal.pone.0056117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409135	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200110
J	Gabor, CR; Fisher, MC; Bosch, J				Gabor, Caitlin R.; Fisher, Matthew C.; Bosch, Jaime			A Non-Invasive Stress Assay Shows That Tadpole Populations Infected with Batrachochytrium dendrobatidis Have Elevated Corticosterone Levels	PLOS ONE			English	Article							AMPHIBIAN DECLINES; CHYTRIDIOMYCOSIS; DISEASE; METAMORPHOSIS; PREVALENCE; MORTALITY; RESPONSES; GENOTYPE; BEHAVIOR; STEROIDS	Batrachochytrium dendrobatidis (Bd) is a fungus that causes the disease chytridiomycosis and is associated with widespread amphibian declines. Populations vary in their susceptibility to Bd infections, and the virulence of the infecting lineage can also vary. Both of these factors may manifest as a differential physiological stress response. In addition, variation in disease susceptibility across amphibian populations may be influenced by immunosuppression caused by chronic stress imposed by environmental factors. Here, we use a non-invasive water-borne hormone technique to assess stress levels (corticosterone) of free-living tadpole populations that are infected by Bd. We found that corticosterone release rates were higher in infected populations of two species of tadpoles (Alytes obstetricans and A. muletensis) than in an uninfected population for both species. The relationship between corticosterone and the intensity of infection differed between species, with only the infected A. obstetricans population showing a significant positive correlation. The higher corticosterone release rates found in A. obstetricans may be an outcome of infection by a highly virulent lineage of Bd (BdGPL), whereas A. muletensis is infected with a less virulent lineage (BdCAPE). These results suggest that different lineages of Bd impose different levels of stress on the infected animals, and that this may influence survival. The next step is to determine whether higher corticosterone levels make individuals more susceptible to Bd or if Bd infections drive the higher corticosterone levels.	[Gabor, Caitlin R.] Texas State Univ, Dept Biol, San Marcos, TX USA; [Fisher, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Bosch, Jaime] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain	Texas State University System; Texas State University San Marcos; Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Gabor, CR (corresponding author), Texas State Univ, Dept Biol, San Marcos, TX USA.	gabor@txstate.edu	Fisher, Matthew/B-9094-2011; Bosch, Jaime/H-3042-2011; Gabor, Caitlin/AAK-8369-2020	Fisher, Matthew/0000-0002-1862-6402; Bosch, Jaime/0000-0002-0099-7934; 	Cero Project (FGCSIC); Cero Project (Banco de Santander); Biodiversa Project RACE; Natural Environment Research Council [NE/G001944/1] Funding Source: researchfish; NERC [NE/G001944/1] Funding Source: UKRI	Cero Project (FGCSIC); Cero Project (Banco de Santander); Biodiversa Project RACE; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by Cero Project (FGCSIC and Banco de Santander to JB) and the Biodiversa Project RACE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaustein AR, 2012, PHILOS T R SOC B, V367, P1688, DOI 10.1098/rstb.2012.0011; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Davis A. K., 2010, Comparative Clinical Pathology, V19, P49, DOI 10.1007/s00580-009-0914-8; Denver RJ, 2009, GEN COMP ENDOCR, V164, P20, DOI 10.1016/j.ygcen.2009.04.016; Dhabhar FS, 2002, INTEGR COMP BIOL, V42, P556, DOI 10.1093/icb/42.3.556; Earley RL, 2008, HORM BEHAV, V53, P442, DOI 10.1016/j.yhbeh.2007.11.017; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Gabor CR, AMPHIBIA RE IN PRESS; Garner TWJ, 2011, GLOBAL CHANGE BIOL, V17, P667, DOI 10.1111/j.1365-2486.2010.02272.x; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Glennemeier KA, 2002, J EXP ZOOL, V292, P32, DOI 10.1002/jez.1140; Gosner K. L., 1960, Herpetologica, V16, P183; Hayes TB, 2006, ENVIRON HEALTH PERSP, V114, P40, DOI 10.1289/ehp.8051; JAUDET GJ, 1984, GEN COMP ENDOCR, V56, P59, DOI 10.1016/0016-6480(84)90061-3; KIKUYAMA S, 1993, INT REV CYTOL, V145, P105, DOI 10.1016/S0074-7696(08)60426-X; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kindermann C, 2012, COMP BIOCHEM PHYS A, V162, P171, DOI 10.1016/j.cbpa.2012.02.018; Martin LB, 2010, ANN NY ACAD SCI, V1195, P129, DOI 10.1111/j.1749-6632.2010.05454.x; McMahon TA, 2011, ENVIRON HEALTH PERSP, V119, P1098, DOI 10.1289/ehp.1002956; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rollins-Smith LA, 2001, IMMUNOL RES, V23, P273, DOI 10.1385/IR:23:2-3:273; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Scott AP, 2008, BEHAVIOUR, V145, P1307, DOI 10.1163/156853908785765854; Scott AP, 2007, GEN COMP ENDOCR, V153, P392, DOI 10.1016/j.ygcen.2006.11.006; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tobler U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010927; Walker SF, 2008, CURR BIOL, V18, pR853, DOI 10.1016/j.cub.2008.07.033; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Warne RW, 2011, FUNCT ECOL, V25, P139, DOI 10.1111/j.1365-2435.2010.01793.x; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	35	52	54	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56054	10.1371/journal.pone.0056054	http://dx.doi.org/10.1371/journal.pone.0056054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418508	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300100
J	Rotman, SR; Bishop, TF				Rotman, Stephen R.; Bishop, Tara F.			Proton Pump Inhibitor Use in the US Ambulatory Setting, 2002-2009	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; COMMUNITY-ACQUIRED PNEUMONIA; HEALTH-CARE SERVICES; ENTERIC INFECTION; ACID SUPPRESSION; UNITED-STATES; HIP FRACTURE; RISK; THERAPY; OVERUSE	Background and Aims: Anecdotal reports and studies of select populations suggest that the use of proton pump inhibitors (PPIs) has increased since their introduction. We sought to determine recent trends in PPI use in the U. S. outpatient setting and characteristics of patients and physicians that may predict their use. Methods: We used data from the National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS) to estimate the prevalence of visits in which patients used PPIs from 2002 to 2009. We tested for associations between PPI use and patient, physician, and practice characteristics using data from 2009. We also estimated the prevalence of visits in which PPIs were used by patients without gastrointestinal complaints, diagnoses, or other indications for their use and tested for associations between patient and physician characteristics and PPI use in patients with no documented indication. Results: PPIs were used in 4.0% of visits in 2002 and 9.2% in 2009 (p < 0.001 for trend across years). The use of omeprazole (0.9% in 2002 to 3.9% in 2009, p < 0.001), esomeprazole (0.9% in 2002 to 2.3% in 2009, p < 0.001), and pantoprazole (0.6% in 2002 to 1.6% in 2009, p < 0.001) increased significantly over the study period. Among visits by patients using PPIs, 62.9% documented no gastrointestinal complaints, gastrointestinal diagnoses, or other indicated reason for their use. Conclusions: We found that PPI use increased significantly from 2002 to 2009 as did documented indications for their use. Newly-prescribed PPI use did not change from 2006 to 2009. More research is needed to determine whether PPIs are overused in the U. S. outpatient setting.	[Rotman, Stephen R.] New York Presbyterian Hosp, Dept Med, New York, NY USA; [Bishop, Tara F.] Weill Cornell Med Coll, Dept Publ Hlth, Div Outcomes & Effectiveness, New York, NY USA; [Bishop, Tara F.] Weill Cornell Med Coll, Dept Med, New York, NY USA	NewYork-Presbyterian Hospital; Cornell University; Cornell University	Bishop, TF (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, Div Outcomes & Effectiveness, New York, NY USA.	tlfernan@med.cornell.edu			National Institute On Aging Career Development Award [K23AG043499]; NATIONAL INSTITUTE ON AGING [K23AG043499] Funding Source: NIH RePORTER	National Institute On Aging Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	TFB is supported by a National Institute On Aging Career Development Award (K23AG043499) and in by funds provided to her as a Nanette Laitman Clinical Scholar in Public Health at Weill Cornell Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality website, UND HEALTHC QUAL; Arasaradnam RP, 2003, CLIN MED, V3, P387, DOI 10.7861/clinmedicine.3-4-387; Barozzi N, 2009, CLIN THER, V31, P849, DOI 10.1016/j.clinthera.2009.04.012; Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; Canani RB, 2006, PEDIATRICS, V117, pE817, DOI 10.1542/peds.2005-1655; Centers for Disease Control and Prevention, NAMCS EST PROC; Centers for Disease Control and Prevention, NAMCS SCOP SAMPL DES; Chen TJ, 2003, INT J CLIN PHARM TH, V41, P207; Friedenberg FK, 2010, DIGEST DIS SCI, V55, P1911, DOI 10.1007/s10620-009-1004-0; George CJ, 2008, AM J GERIATR PHARMAC, V6, P249, DOI 10.1016/j.amjopharm.2008.12.001; Gottlieb DJ, 2010, HEALTH AFFAIR, V29, P537, DOI 10.1377/hlthaff.2009.0609; Gray SL, 2010, ARCH INTERN MED, V170, P765, DOI 10.1001/archinternmed.2010.94; Heidelbaugh JJ, 2010, AM J MANAG CARE, V16, pE228; Herzig SJ, 2009, JAMA-J AM MED ASSOC, V301, P2120, DOI 10.1001/jama.2009.722; Hollingworth S, 2010, PHARMACOEPIDEM DR S, V19, P1019, DOI 10.1002/pds.1969; Howell MD, 2010, ARCH INTERN MED, V170, P784, DOI 10.1001/archinternmed.2010.89; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kantorova I, 2004, HEPATO-GASTROENTEROL, V51, P757; Keyhani S, 2012, MED CARE, V50, P257, DOI 10.1097/MLR.0b013e3182422b0f; Korenstein D, 2012, ARCH INTERN MED, V172, P171, DOI 10.1001/archinternmed.2011.772; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; Lanza FL, 2009, AM J GASTROENTEROL, V104, P728, DOI 10.1038/ajg.2009.115; Leonard J, 2007, AM J GASTROENTEROL, V102, P2047, DOI 10.1111/j.1572-0241.2007.01275.x; National Committee for Quality Assurance, 2007, ESS GUID HEALTHC QUA; Polinski JM, 2011, J AM GERIATR SOC, V59, P1922, DOI 10.1111/j.1532-5415.2011.03537.x; Sutherland JM, 2009, NEW ENGL J MED, V361, P1227, DOI 10.1056/NEJMp0907172; van der Velden AW, 2010, DIGESTION, V81, P43, DOI 10.1159/000236025; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947; Yu EW, 2011, AM J MED, V124, P519, DOI 10.1016/j.amjmed.2011.01.007	29	94	96	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56060	10.1371/journal.pone.0056060	http://dx.doi.org/10.1371/journal.pone.0056060			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418510	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300102
J	Schmidt, JA; Crowe, FL; Appleby, PN; Key, TJ; Travis, RC				Schmidt, Julie A.; Crowe, Francesca L.; Appleby, Paul N.; Key, Timothy J.; Travis, Ruth C.			Serum Uric Acid Concentrations in Meat Eaters, Fish Eaters, Vegetarians and Vegans: A Cross-Sectional Analysis in the EPIC-Oxford Cohort	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; RANDOMIZED CONTROLLED-TRIAL; CALCIUM SUPPLEMENTATION; CARDIOVASCULAR-DISEASE; ANTIOXIDANT STATUS; WEIGHED RECORDS; NATIONAL-HEALTH; DAIRY-PRODUCTS; RISK; GOUT	Introduction: Circulating concentrations of uric acid may be affected by dietary components such as meat, fish and dairy products, but only a few studies have compared uric acid concentrations among individuals who exclude some or all of these foods from their diet. The aim of this study was to investigate differences in serum uric acid concentrations between meat eaters, fish eaters, vegetarians and vegans. Subjects and Methods: A sample of 670 men and 1,023 women (424 meat eaters, 425 fish eaters, 422 vegetarians and 422 vegans, matched on age and sex) from the European Prospective Investigation into Cancer and Nutrition Oxford cohort were included in this cross-sectional analysis. Diet was assessed using a semi-quantitative food frequency questionnaire and serum concentrations of uric acid were measured. Mean concentrations of uric acid by diet group were calculated after adjusting for age, body mass index, calcium and alcohol intake. Results: In both men and women, serum uric acid concentrations differed significantly by diet group (p<0.0001 and p = 0.01, respectively). The differences between diet groups were most pronounced in men; vegans had the highest concentration (340, 95% confidence interval 329-351 mu mol/l), followed by meat eaters (315, 306-324 mu mol/l), fish eaters (309, 300-318 mu mol/l) and vegetarians (303, 294-312 mu mol/l). In women, serum uric acid concentrations were slightly higher in vegans (241, 234-247 mu mol/l) than in meat eaters (237, 231-242 mu mol/l) and lower in vegetarians (230, 224-236 mu mol/l) and fish eaters (227, 221-233 mu mol/l). Conclusion: Individuals consuming a vegan diet had the highest serum concentrations of uric acid compared to meat eaters, fish eaters and vegetarians, especially in men. Vegetarians and individuals who eat fish but not meat had the lowest concentrations of serum uric acid.	[Schmidt, Julie A.; Crowe, Francesca L.; Appleby, Paul N.; Key, Timothy J.; Travis, Ruth C.] Univ Oxford, Nuffield Dept Med, Canc Epidemiol Unit, Oxford, England	University of Oxford	Schmidt, JA (corresponding author), Univ Oxford, Nuffield Dept Med, Canc Epidemiol Unit, Oxford, England.	julie.schmidt@ceu.ox.ac.uk		Crowe, Francesca/0000-0003-4026-1726	Cancer Research UK [C570/A11692]	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK, grant number: C570/A11692 (www.cancerresearchuk.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates CJ, 2005, HUMAN NUTR, P573; BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064; BINGHAM SA, 1995, BRIT J NUTR, V73, P531, DOI 10.1079/BJN19950057; Chan W., 1995, MCCANCE WIDDOWSONS S; CHAN W, 1994, MCCANCE WIDDOWSONS S; Chan W., 1996, MCCANCE WIDDOWSONS S; Choi HK, 2005, ARTHRITIS RHEUM-US, V52, P283, DOI 10.1002/art.20761; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Dalbeth N, 2009, RHEUMATOLOGY, V48, P195, DOI 10.1093/rheumatology/ken416; Dalbeth N, 2011, CURR RHEUMATOL REP, V13, P132, DOI 10.1007/s11926-010-0160-8; Dalbeth N, 2010, ANN RHEUM DIS, V69, P1677, DOI 10.1136/ard.2009.124230; Davey GK, 2003, PUBLIC HEALTH NUTR, V6, P259, DOI 10.1079/PHN2002430; Feig DI, 2009, CURR OPIN NEPHROL HY, V18, P526, DOI 10.1097/MNH.0b013e328330d9d0; Gagliardi ACM, 2009, ATHEROSCLEROSIS, V202, P11, DOI 10.1016/j.atherosclerosis.2008.05.022; GHADIRIAN P, 1995, EUR J EPIDEMIOL, V11, P275, DOI 10.1007/BF01719431; Haldar S, 2007, EUR J CLIN NUTR, V61, P1011, DOI 10.1038/sj.ejcn.1602615; Holland B., 1991, MCCANCE WIDDOWSONS C, V5; Holland B, 1991, MCCANCE WIDDOWSONS S; Holland B., 1989, MCCANCE WIDDOWSONS S; Holland B, 1993, MCCANCE WIDDOWSONS S; Holland B., 1992, MCCANCE WIDDOWSONS S; Holland B., 1988, MCCANCE WIDDOWSONS S; Kramer HM, 2002, AM J KIDNEY DIS, V40, P37, DOI 10.1053/ajkd.2002.33911; Kuo CS, 2004, EUR J CLIN NUTR, V58, P312, DOI 10.1038/sj.ejcn.1601783; Lee SJ, 2006, CURR OPIN RHEUMATOL, V18, P193, DOI 10.1097/01.bor.0000209434.82096.1f; LOENEN HMJA, 1990, J CLIN EPIDEMIOL, V43, P1297, DOI 10.1016/0895-4356(90)90095-7; McCarthy GT, 2002, CARING CHILDREN LESC; Messina M, 2011, ASIA PAC J CLIN NUTR, V20, P347; Ministry of Agriculture Fisheries and Food, 1993, FOOD PORTION SIZES, V2nd ed; PAN WH, 1993, AM J CLIN NUTR, V58, P354, DOI 10.1093/ajcn/58.3.354; Poornima K, 2003, Indian J Clin Biochem, V18, P197, DOI 10.1007/BF02867387; Reid IR, 2008, ARCH INTERN MED, V168, P2276, DOI 10.1001/archinte.168.20.2276; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Stockl D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032668; Strasak AM, 2007, ANN ONCOL, V18, P1893, DOI 10.1093/annonc/mdm338; Strasak AM, 2007, CANCER CAUSE CONTROL, V18, P1021, DOI 10.1007/s10552-007-9043-3; Strasak AM, 2009, ANN EPIDEMIOL, V19, P15, DOI 10.1016/j.annepidem.2008.08.009; Szeto YT, 2004, NUTRITION, V20, P863, DOI 10.1016/j.nut.2004.06.006; Wheeler JG, 2005, PLOS MED, V2, P236, DOI 10.1371/journal.pmed.0020076; Zgaga L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038123; Zoppini G, 2011, J ENDOCRINOL INVEST, V34, P881, DOI 10.1007/BF03346733	41	40	44	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56339	10.1371/journal.pone.0056339	http://dx.doi.org/10.1371/journal.pone.0056339			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418557	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300150
J	Goto, K; Nagano, Y				Goto, Kenta; Nagano, Yukio			Ultra-Low Background DNA Cloning System	PLOS ONE			English	Article							POLYMERASE EXTENSION CLONING; IN-VIVO; NUCLEOTIDE-SEQUENCE; FRAGMENTS; YEAST; TRANSFORMATION; RECOMBINATION; CONSTRUCTION; PURIFICATION; COMPLEX	Yeast-based in vivo cloning is useful for cloning DNA fragments into plasmid vectors and is based on the ability of yeast to recombine the DNA fragments by homologous recombination. Although this method is efficient, it produces some by-products. We have developed an "ultra-low background DNA cloning system" on the basis of yeast-based in vivo cloning, by almost completely eliminating the generation of by-products and applying the method to commonly used Escherichia coli vectors, particularly those lacking yeast replication origins and carrying an ampicillin resistance gene (Amp(r)). First, we constructed a conversion cassette containing the DNA sequences in the following order: an Amp(r) 5' UTR (untranslated region) and coding region, an autonomous replication sequence and a centromere sequence from yeast, a TRP1 yeast selectable marker, and an Amp(r) 3' UTR. This cassette allowed conversion of the Amp(r)-containing vector into the yeast/E. coli shuttle vector through use of the Amp(r) sequence by homologous recombination. Furthermore, simultaneous transformation of the desired DNA fragment into yeast allowed cloning of this DNA fragment into the same vector. We rescued the plasmid vectors from all yeast transformants, and by-products containing the E. coli replication origin disappeared. Next, the rescued vectors were transformed into E. coli and the by-products containing the yeast replication origin disappeared. Thus, our method used yeast-and E. coli-specific "origins of replication" to eliminate the generation of by-products. Finally, we successfully cloned the DNA fragment into the vector with almost 100% efficiency.	[Goto, Kenta; Nagano, Yukio] Saga Univ, Analyt Res Ctr Expt Sci, Honjo, Saga, Japan; [Goto, Kenta] Saga Univ, Dept Appl Biochem & Food Sci, Honjo, Saga, Japan	Saga University; Saga University	Goto, K (corresponding author), Saga Univ, Analyt Res Ctr Expt Sci, Honjo, Saga, Japan.	nagano@cc.saga-u.ac.jp	Nagano, Yukio/H-8734-2019	Nagano, Yukio/0000-0001-5030-676X	A-STEP (FS-stage) from the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science	A-STEP (FS-stage) from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Part of this work was supported by A-STEP (FS-stage) from the Japan Science and Technology Agency (JST) and by a Grant-in-Aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; ENGLER JA, 1981, GENE, V14, P155, DOI 10.1016/0378-1119(81)90111-6; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hua SB, 1997, PLASMID, V38, P91, DOI 10.1006/plas.1997.1305; Iizasa E, 2006, BIOTECHNIQUES, V40, P79, DOI 10.2144/000112041; Iizasa E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.027540; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kouprina N, 2006, NAT REV GENET, V7, P805, DOI 10.1038/nrg1943; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; MARYKWAS DL, 1995, P NATL ACAD SCI USA, V92, P11701, DOI 10.1073/pnas.92.25.11701; Nagano Y, 2007, PLANT CELL REP, V26, P2111, DOI 10.1007/s00299-007-0428-2; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Raymond CK, 2002, GENOME RES, V12, P190, DOI 10.1101/gr.205201; SCHONER B, 1981, GENE, V14, P165, DOI 10.1016/0378-1119(81)90112-8; Spiliotis M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035407; Thieme F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020556	21	5	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56530	10.1371/journal.pone.0056530	http://dx.doi.org/10.1371/journal.pone.0056530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409191	Green Submitted, Green Published, gold			2022-12-27	WOS:000314660300077
J	Kamiya, K; Shimizu, K; Kobashi, H; Igarashi, A; Komatsu, M				Kamiya, Kazutaka; Shimizu, Kimiya; Kobashi, Hidenaga; Igarashi, Akihito; Komatsu, Mari			Three-Year Follow-Up of Posterior Chamber Toric Phakic Intraocular Lens Implantation for Moderate to High Myopic Astigmatism	PLOS ONE			English	Article							ADMINISTRATION CLINICAL-TRIAL; COLLAMER LENS; CONTACT-LENS; SURGERY	Purpose: To assess the 3-year clinical outcomes of toric phakic intraocular lens (Visian ICL (TM); STAAR Surgical) implantation for moderate to high myopic astigmatism. Methods: This retrospective study evaluated fifty eyes of 28 patients who underwent toric ICL implantation for the correction of moderate to high myopic astigmatism and who regularly returned for postoperative examination. Before, and 1, 3, and 6 months after, and 1, 2, and 3 years after surgery, we assessed the safety, efficacy, predictability, stability, and adverse events of the surgery in eyes undergoing toric ICL implantation. Results: The logarithm of the minimal angle of resolution (LogMAR) uncorrected visual acuity and LogMAR best spectacle-corrected visual acuity were -0.10 (corresponding to Snellen equivalents 20/16) +/- 0.16 and -0.20 (corresponding to 20/12.5) +/- 0.07, 3 years postoperatively, respectively. The safety and efficacy indices were 1.16 +/- 0.20 and 0.94 +/- 0.28. At 3 year, 82% and 98% of the eyes were within 0.5 and 1.0 D, respectively, of the targeted correction. Manifest refraction changes of -0.15 +/- 0.31 D occurred from 1 month to 3 year. No vision-threatening complications occurred during the observation period. Conclusions: On the basis of the clinical results of this study, toric ICL implantation was good in all measures of safety, efficacy, predictability, and stability for the correction of moderate to high myopic astigmatism throughout a 3-year observation period.	[Kamiya, Kazutaka; Shimizu, Kimiya; Kobashi, Hidenaga; Igarashi, Akihito] Kitasato Univ, Sch Med, Dept Ophthalmol, Kanagawa, Japan; [Komatsu, Mari] Sanno Hosp, Tokyo, Japan	Kitasato University	Kamiya, K (corresponding author), Kitasato Univ, Sch Med, Dept Ophthalmol, Kanagawa, Japan.	kamiyak-tky@umin.ac.jp						Alfonso JF, 2012, GRAEFES ARCH CLIN EX; Alfonso JF, 2011, J CATARACT REFR SURG, V37, P873, DOI 10.1016/j.jcrs.2010.11.040; Alfonso JF, 2010, J CATARACT REFR SURG, V36, P1349, DOI 10.1016/j.jcrs.2010.02.022; Alfonso JF, 2010, J CATARACT REFR SURG, V36, P906, DOI 10.1016/j.jcrs.2009.11.032; Alfonso JF, 2010, J CATARACT REFR SURG, V36, P568, DOI 10.1016/j.jcrs.2009.10.052; Bhikoo R, 2010, CLIN EXP OPHTHALMOL, V38, P467, DOI 10.1111/j.1442-9071.2010.02273.x; Bloomenstein Marc R, 2002, Optometry, V73, P435; Choi SH, 2011, J REFRACT SURG, V27, P91, DOI 10.3928/1081597X-20100414-01; Fernandes P, 2011, J REFRACT SURG, V27, P765, DOI 10.3928/1081597X-20110617-01; Jimenez-Alfaro I, 2001, J REFRACT SURG, V17, P641; Kamiya K, 2009, BRIT J OPHTHALMOL, V93, P1648, DOI 10.1136/bjo.2009.160044; Kamiya K, 2008, J CATARACT REFR SURG, V34, P1687, DOI 10.1016/j.jcrs.2008.06.030; Kamiya K, 2010, OPHTHALMOLOGY, V117, P2287, DOI 10.1016/j.ophtha.2010.03.054; Kamiya K, 2009, ARCH OPHTHALMOL-CHIC, V127, P845, DOI 10.1001/archophthalmol.2009.67; Lackner B, 2004, J CATARACT REFR SURG, V30, P2269, DOI 10.1016/j.jcrs.2004.07.018; Matsumura K, 2011, IOL RS, V25, P247; Pineda-Fernandez A, 2004, J CATARACT REFR SURG, V30, P2277, DOI 10.1016/j.jcrs.2004.03.035; Sanders DR, 2008, J REFRACT SURG, V24, P566, DOI 10.3928/1081597X-20080601-04; Sanders DR, 2007, OPHTHALMOLOGY, V114, P54, DOI 10.1016/j.ophtha.2006.08.049; Sanders DR, 2004, OPHTHALMOLOGY, V111, P1683, DOI 10.1016/j.ophtha.2004.03.026; Sanders DR, 1998, J CATARACT REFR SURG, V24, P607, DOI 10.1016/S0886-3350(98)80254-X; Sari ES, 2012, GRAEFES ARCH CLIN EX; Sarver EJ, 2004, J REFRACT SURG, V20, P472; Schallhorn S, 2007, J REFRACT SURG, V23, P853, DOI 10.3928/1081-597X-20071101-01; Thibos LN, 2001, J CATARACT REFR SURG, V27, P80, DOI 10.1016/S0886-3350(00)00797-5; Uusitalo RJ, 2002, J CATARACT REFR SURG, V28, P29, DOI 10.1016/S0886-3350(01)01218-4; Vukich JA, 2003, OPHTHALMOLOGY, V110, P255, DOI 10.1016/S0161-6420(02)01771-2; Zaldivar R, 1998, J REFRACT SURG, V14, P294	28	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56453	10.1371/journal.pone.0056453	http://dx.doi.org/10.1371/journal.pone.0056453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409187	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300075
J	Matvienko, M; Kozik, A; Froenicke, L; Lavelle, D; Martineau, B; Perroud, B; Michelmore, R				Matvienko, Marta; Kozik, Alexander; Froenicke, Lutz; Lavelle, Dean; Martineau, Belinda; Perroud, Bertrand; Michelmore, Richard			Consequences of Normalizing Transcriptomic and Genomic Libraries of Plant Genomes Using a Duplex-Specific Nuclease and Tetramethylammonium Chloride	PLOS ONE			English	Article							REFERENCE SEQUENCES REFSEQ; WIDE COMPARATIVE-ANALYSIS; ARABIDOPSIS-THALIANA; CDNA LIBRARIES; RNA-SEQ; DNA; MAIZE; FAMILY; GENES; RETROTRANSPOSONS	Several applications of high throughput genome and transcriptome sequencing would benefit from a reduction of the high-copy-number sequences in the libraries being sequenced and analyzed, particularly when applied to species with large genomes. We adapted and analyzed the consequences of a method that utilizes a thermostable duplex-specific nuclease for reducing the high-copy components in transcriptomic and genomic libraries prior to sequencing. This reduces the time, cost, and computational effort of obtaining informative transcriptomic and genomic sequence data for both fully sequenced and non-sequenced genomes. It also reduces contamination from organellar DNA in preparations of nuclear DNA. Hybridization in the presence of 3 M tetramethylammonium chloride (TMAC), which equalizes the rates of hybridization of GC and AT nucleotide pairs, reduced the bias against sequences with high GC content. Consequences of this method on the reduction of high-copy and enrichment of low-copy sequences are reported for Arabidopsis and lettuce.	[Matvienko, Marta; Kozik, Alexander; Froenicke, Lutz; Lavelle, Dean; Martineau, Belinda; Perroud, Bertrand; Michelmore, Richard] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Michelmore, Richard] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Michelmore, Richard] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Michelmore, Richard] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Michelmore, R (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	rwmichelmore@ucdavis.edu	Martineau, Belinda/GOH-1630-2022		National Science Foundation [DBI0421630]; Division Of Integrative Organismal Systems [0820451] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by funding from the National Science Foundation Plant Genome Program (http://www.nsf.gov/bio/pubs/awards/pgr.htm) Grant #DBI0421630 as part of the Compositae Genome Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Bogdanova EA, 2008, MOL BIOSYST, V4, P205, DOI 10.1039/b715110c; Britten R J, 1974, Methods Enzymol, V29, P363; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; CHEVET E, 1995, NUCLEIC ACIDS RES, V23, P3343, DOI 10.1093/nar/23.16.3343; Christodoulou Danos C, 2011, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0412s94; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooley MB, 1999, PLANT PHYSIOL, V121, P1339, DOI 10.1104/pp.121.4.1339; Copenhaver GP, 1996, PLANT J, V9, P273, DOI 10.1046/j.1365-313X.1996.09020273.x; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Emberton J, 2005, GENOME RES, V15, P1441, DOI 10.1101/gr.3362105; Fritjers ACJ, 1997, THEOR APPL GENET, V94, P390; Giannoukos G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r23; Gurushidze M, 2012, SYST BOT, V37, P96, DOI 10.1600/036364412X616675; Hewitt E. J., 1966, Technical Communications. Commonwealth Bureau of Horticulture and Plantation Crops, P547; Hoagland DR, 1933, P AM SOC HORTIC SCI, V30, P88; HONORE B, 1993, J BIOCHEM BIOPH METH, V27, P39, DOI 10.1016/0165-022X(93)90066-W; Hosouchi T, 2002, DNA RES, V9, P117, DOI 10.1093/dnares/9.4.117; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jurka J, 2007, ANNU REV GENOM HUM G, V8, P241, DOI 10.1146/annurev.genom.8.080706.092416; Kamal M, 2006, P NATL ACAD SCI USA, V103, P2740, DOI 10.1073/pnas.0511238103; Kapitonov V.V., 2004, ENCY MOL CELL BIOL M, V1, P251; Kelly LJ, 2011, CHROMOSOME RES, V19, P939, DOI 10.1007/s10577-011-9246-z; KO MSH, 1990, NUCLEIC ACIDS RES, V18, P5705, DOI 10.1093/nar/18.19.5705; Kovach A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-420; LEUTWILER LS, 1984, MOL GEN GENET, V194, P15, DOI 10.1007/BF00383491; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; Li Y, 2006, GENOMICS, V87, P645, DOI 10.1016/j.ygeno.2005.12.010; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; MCCOUCH SR, 1988, THEOR APPL GENET, V76, P815, DOI 10.1007/BF00273666; MELCHIOR WB, 1973, P NATL ACAD SCI USA, V70, P298, DOI 10.1073/pnas.70.2.298; Melters DP, 2012, CHROMOSOME RES, V20, P579, DOI 10.1007/s10577-012-9292-1; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Moolhuijzen P, 2007, AUST J AGR RES, V58, P470, DOI 10.1071/AR06155; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Peterson DG, 2002, GENOME RES, V12, P795, DOI 10.1101/gr.226102; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; Riechmann JL, 1998, BIOL CHEM, V379, P633; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; SASAKI YF, 1994, NUCLEIC ACIDS RES, V22, P987, DOI 10.1093/nar/22.6.987; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shagin DA, 2002, GENOME RES, V12, P1935, DOI 10.1101/gr.547002; Shagina I, 2010, BIOTECHNIQUES, V48, P455, DOI 10.2144/000113422; Shilperoort, 1994, PLANT MOL BIOL MAN D, P1, DOI 10.1007/978-94-011-0511-8_16; Sijak-Yakovev S, 2003, PLANT SYST EVOL, V236, P165, DOI [10.1007/s00606-002-0240-y, 10.1007/S00606-002-0240-y]; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Turner EH, 2009, ANNU REV GENOM HUM G, V10, P263, DOI 10.1146/annurev-genom-082908-150112; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wicker T, 2007, GENOME RES, V17, P1072, DOI 10.1101/gr.6214107; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; Yeager M, 2008, HUM GENET, V124, P161, DOI 10.1007/s00439-008-0535-3; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang XY, 2004, P NATL ACAD SCI USA, V101, P5589, DOI 10.1073/pnas.0401243101; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	69	29	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55913	10.1371/journal.pone.0055913	http://dx.doi.org/10.1371/journal.pone.0055913			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409088	Green Submitted, gold, Green Published			2022-12-27	WOS:000314660300045
J	McKim-Louder, MI; Hoover, JP; Benson, TJ; Schelsky, WM				McKim-Louder, Matthew I.; Hoover, Jeffrey P.; Benson, Thomas J.; Schelsky, Wendy M.			Juvenile Survival in a Neotropical Migratory Songbird Is Lower than Expected	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; PROTHONOTARY WARBLERS; REPRODUCTIVE SUCCESS; NATAL DISPERSAL; PARASITISM; BIRDS; RATES; SIZE; RECRUITMENT; PHILOPATRY	Attempts to estimate and identify factors influencing first-year survival in passerines, survival between fledging and the first reproductive attempt (i.e. juvenile survival), have largely been confounded by natal dispersal, particularly in long-distance migratory passerines. We studied Prothonotary Warblers (Protonotaria citrea) breeding in nest boxes to estimate first-year survival while accounting for biases related to dispersal that are common in mark-recapture studies. The natal dispersal distribution (median = 1420 m; n = 429) and a distance-dependent recruitment rate, which controls for effects of study site configuration, both indicated a pattern of short-distance natal dispersal. This pattern was consistent with results of a systematic survey for birds returning outside the nest box study sites (up to 30 km in all directions) within a majority (81%) of total available bottomland forest habitat, further suggesting that permanent emigration outside of the study system was rare. We used multistate mark-recapture modeling to estimate first-year survival and incorporated factors thought to influence survival while accounting for the potential confounding effects of dispersal on recapture probabilities for warblers that fledged during 2004-2009 (n = 6093). Overall, the average first-year survival for warblers reared without cowbird nestmates was 0.11 (95% CI = 0.09-0.13), decreased with fledging date (0.22 early to 0.03 late) and averaged 40% lower for warblers reared with a brood parasite nestmate. First-year survival was less than half of the rate thought to represent population replacement in migratory passerines (similar to 0.30). This very low rate suggests that surviving the first year of life for many Neotropical migratory species is even more difficult than previously thought, forcing us to rethink estimates used in population models.	[McKim-Louder, Matthew I.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [McKim-Louder, Matthew I.; Hoover, Jeffrey P.; Benson, Thomas J.; Schelsky, Wendy M.] Univ Illinois, Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	McKim-Louder, MI (corresponding author), Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA.	mckimlouder@gmail.com	McKim-Louder, Matthew/G-1596-2013; Benson, Thomas J/B-8526-2013; Schelsky, Wendy/ABF-3948-2020	Benson, Thomas J/0000-0002-7287-7499; Louder, Matthew/0000-0003-4421-541X; Schelsky, Wendy/0000-0002-5742-757X	United States Fish and Wildlife Service [INT 1448-0003-95-1007]; Nature Conservancy; Illinois Department of Natural Resources Wildlife Preservation Fund; University of Illinois; North American Bluebird Society; Champaign County and Decatur Audubon Societies; Sigma Xi	United States Fish and Wildlife Service(US Fish & Wildlife Service); Nature Conservancy; Illinois Department of Natural Resources Wildlife Preservation Fund; University of Illinois; North American Bluebird Society; Champaign County and Decatur Audubon Societies; Sigma Xi	Financial support was provided by the United States Fish and Wildlife Service (INT 1448-0003-95-1007), The Nature Conservancy, the Illinois Department of Natural Resources Wildlife Preservation Fund, the University of Illinois, the North American Bluebird Society, the Champaign County and Decatur Audubon Societies, and Sigma Xi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AAY, 2006, ECOLOGY, V87, P178, DOI 10.1890/04-1922; Anders AD, 2005, CONSERV BIOL, V19, P66, DOI 10.1111/j.1523-1739.2005.00543.x; Anders AD, 1998, AUK, V115, P349, DOI 10.2307/4089193; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Cichon M, 2005, J EVOLUTION BIOL, V18, P962, DOI 10.1111/j.1420-9101.2005.00910.x; Clark ME, 2007, ECOL MODEL, V209, P110, DOI 10.1016/j.ecolmodel.2007.06.008; Cooper CB, 2008, ECOLOGY, V89, P3349, DOI 10.1890/08-0315.1; Donovan TM, 1995, CONSERV BIOL, V9, P1380, DOI 10.1046/j.1523-1739.1995.09061380.x; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Gilroy JJ, 2012, ECOLOGY, V93, P1509, DOI 10.1890/12-0124.1; Gotmark F, 2002, OECOLOGIA, V130, P25, DOI 10.1007/s004420100769; Hoover JP, 2009, WETLANDS, V29, P563, DOI 10.1672/08-75.1; Hoover JP, 2003, ANIM BEHAV, V65, P923, DOI 10.1006/anbe.2003.2155; Hoover JP, 2003, ANIM BEHAV, V65, P935, DOI 10.1006/anbe.2003.2154; Hoover JP, 2003, ECOLOGY, V84, P416, DOI 10.1890/0012-9658(2003)084[0416:DRFSFI]2.0.CO;2; Hoover JP, 2009, TUNDRA TROPICS CONNE, P128; Hoover JP, 2001, EXPT STUDY BEHAV RES; Kilner RM, 2004, SCIENCE, V305, P877, DOI 10.1126/science.1098487; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lebreton JD, 2009, ADV ECOL RES, V41, P87, DOI 10.1016/S0065-2504(09)00403-6; Lichtenstein G, 1998, P ROY SOC B-BIOL SCI, V265, P249, DOI 10.1098/rspb.1998.0289; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Mitchell GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028838; Moller AP, 2004, ECOLOGY, V85, P206, DOI 10.1890/02-0451; MURPHY MT, 1983, ECOLOGY, V64, P914, DOI 10.2307/1937213; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; Peterson SM, 2012, WILSON J ORNITHOL, V124, P179, DOI 10.1676/11-050.1; Petit L. J., 1999, BIRDS N AM; Redmond LJ, 2012, J FIELD ORNITHOL, V83, P247, DOI 10.1111/j.1557-9263.2012.00373.x; Reilly JR, 2009, J ANIM ECOL, V78, P990, DOI 10.1111/j.1365-2656.2009.01576.x; Ricklefs R.E., 1973, P366; Ridley AR, 2012, IBIS, V154, P195, DOI 10.1111/j.1474-919X.2011.01190.x; Robinson RA, 2004, J ANIM ECOL, V73, P670, DOI 10.1111/j.0021-8790.2004.00841.x; SAETHER BE, 1988, NATURE, V331, P616, DOI 10.1038/331616a0; Schaub M, 2012, OECOLOGIA, V168, P97, DOI 10.1007/s00442-011-2070-5; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Sim IMW, 2011, J ANIM ECOL, V80, P159, DOI 10.1111/j.1365-2656.2010.01750.x; Stearns S.C., 1992, pi; Tarof SA, 2011, AUK, V128, P716, DOI 10.1525/auk.2011.11087; Tarwater CE, 2011, ECOLOGY, V92, P1271, DOI 10.1890/10-1386.1; Tittler R, 2009, ECOGRAPHY, V32, P1051, DOI 10.1111/j.1600-0587.2009.05680.x; van Noordwijk AJ, 2011, J ORNITHOL, V152, P239, DOI 10.1007/s10336-010-0637-2; vanNoordwijk AJ, 1995, J APPL STAT, V22, P683, DOI 10.1080/02664769524540; Verhulst S, 2008, PHILOS T R SOC B, V363, P399, DOI 10.1098/rstb.2007.2146; WEATHERHEAD PJ, 1994, BEHAV ECOL, V5, P426, DOI 10.1093/beheco/5.4.426; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Winkler DW, 2005, J ANIM ECOL, V74, P1080, DOI 10.1111/j.1365-2656.2005.01007.x	51	48	48	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56059	10.1371/journal.pone.0056059	http://dx.doi.org/10.1371/journal.pone.0056059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409122	gold, Green Submitted, Green Published			2022-12-27	WOS:000314660300055
J	Roncaglia-Denissen, MP; Schmidt-Kassow, M; Kotz, SA				Roncaglia-Denissen, Maria Paula; Schmidt-Kassow, Maren; Kotz, Sonja A.			Speech Rhythm Facilitates Syntactic Ambiguity Resolution: ERP Evidence	PLOS ONE			English	Article							WORKING-MEMORY; WORD SEGMENTATION; PROSODY; PERCEPTION; COMPREHENSION; PREFERENCES; RECALL; FRENCH	In the current event-related potential (ERP) study, we investigated how speech rhythm impacts speech segmentation and facilitates the resolution of syntactic ambiguities in auditory sentence processing. Participants listened to syntactically ambiguous German subject-and object-first sentences that were spoken with either regular or irregular speech rhythm. Rhythmicity was established by a constant metric pattern of three unstressed syllables between two stressed ones that created rhythmic groups of constant size. Accuracy rates in a comprehension task revealed that participants understood rhythmically regular sentences better than rhythmically irregular ones. Furthermore, the mean amplitude of the P600 component was reduced in response to object-first sentences only when embedded in rhythmically regular but not rhythmically irregular context. This P600 reduction indicates facilitated processing of sentence structure possibly due to a decrease in processing costs for the less-preferred structure (object-first). Our data suggest an early and continuous use of rhythm by the syntactic parser and support language processing models assuming an interactive and incremental use of linguistic information during language processing.	[Roncaglia-Denissen, Maria Paula; Kotz, Sonja A.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Schmidt-Kassow, Maren] Goethe Univ Frankfurt, Inst Med Psychol, D-60054 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt	Roncaglia-Denissen, MP (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	roncaglia@cbs.mpg.de			Max Planck International Research Network on Aging (MaxNetAging); German Research Foundation [DFG SCHM 2693/1, DFG KO 2268/1]	Max Planck International Research Network on Aging (MaxNetAging); German Research Foundation(German Research Foundation (DFG))	M. Paula Roncaglia-Denissen was supported by the Max Planck International Research Network on Aging (MaxNetAging), Maren Schmidt-Kassow by the German Research Foundation (DFG SCHM 2693/1), and Sonja A. Kotz by the German Research Foundation (DFG KO 2268/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEACH CM, 1991, J MEM LANG, V30, P644, DOI 10.1016/0749-596X(91)90030-N; Bogels S, 2010, J COGNITIVE NEUROSCI, V22, P1036, DOI 10.1162/jocn.2009.21269; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Bornkessel I, 2004, J MEM LANG, V51, P495, DOI 10.1016/j.jml.2004.06.011; Bornkessel I, 2006, PSYCHOL REV, V113, P787, DOI 10.1037/0033-295X.113.4.787; Boucher VJ, 2006, LANG SPEECH, V49, P495, DOI 10.1177/00238309060490040301; Carpenter PA, 1989, COMPLEX INFORM PROCE; Carroll Patrick J., 1987, MODULARITY KNOWLEDGE, P221; Croft RJ, 2000, NEUROPHYSIOL CLIN, V30, P5, DOI 10.1016/S0987-7053(00)00055-1; CUTLER A, 1994, COGNITION, V50, P79, DOI 10.1016/0010-0277(94)90021-3; CUTLER A, 1994, LINGUA, V92, P81, DOI 10.1016/0024-3841(94)90338-7; Dilley LC, 2008, J MEM LANG, V59, P294, DOI 10.1016/j.jml.2008.06.006; DOOLING DJ, 1974, J VERB LEARN VERB BE, V13, P255, DOI 10.1016/S0022-5371(74)80062-9; Eckstein K, 2006, J COGNITIVE NEUROSCI, V18, P1696, DOI 10.1162/jocn.2006.18.10.1696; Frazier L, 2006, TRENDS COGN SCI, V10, P244, DOI 10.1016/j.tics.2006.04.002; Friederici AD, 1996, J PSYCHOLINGUIST RES, V25, P157, DOI 10.1007/BF01708424; Friederici AD, 1998, BIOL PSYCHOL, V47, P193, DOI 10.1016/S0301-0511(97)00033-1; Friederici AD, 2001, COGNITIVE BRAIN RES, V11, P305, DOI 10.1016/S0926-6410(00)00065-3; Frisch S, 2002, COGNITION, V85, pB83, DOI 10.1016/S0010-0277(02)00126-9; Gerken L. A., 1996, SIGNAL SYNTAX BOOTST; Gorrell Paul, 2000, GERMAN SENTENCE PROC, P25; Gussenhoven C, 1984, GRAMMAR SEMANTICS SE; Handy T.C., 2004, EVENT RELATED POTENT; Haupt FS, 2008, J MEM LANG, V59, P54, DOI 10.1016/j.jml.2008.02.003; Hayes Bruce, 1995, METRICAL STRESS THEO; Hayes Bruce, 1989, RHYTHM METER; Henson RNA, 2000, NEUROPSYCHOLOGIA, V38, P426, DOI 10.1016/S0028-3932(99)00098-6; Hitch GJ, 1996, Q J EXP PSYCHOL-A, V49, P116, DOI 10.1080/713755609; Hohle B, 2009, INFANT BEHAV DEV, V32, P262, DOI 10.1016/j.infbeh.2009.03.004; JOHNSON RE, 1970, J VERB LEARN VERB BE, V9, P12, DOI 10.1016/S0022-5371(70)80003-2; Jusczyk PW, 1999, TRENDS COGN SCI, V3, P323, DOI 10.1016/S1364-6613(99)01363-7; JUSCZYK PW, 1992, COGNITIVE PSYCHOL, V24, P252, DOI 10.1016/0010-0285(92)90009-Q; Jusczyk PW, 2002, CURR DIR PSYCHOL SCI, V11, P15, DOI 10.1111/1467-8721.00159; Kennedy A, 1989, LANG COGNITIVE PROC, V4, pSI51, DOI 10.1080/01690968908406363; Kerkhofs R, 2007, J COGNITIVE NEUROSCI, V19, P1421, DOI 10.1162/jocn.2007.19.9.1421; Kjelgaard MM, 1999, J MEM LANG, V40, P153, DOI 10.1006/jmla.1998.2620; Lehiste I, 1973, PHONETIC DISAMBIGUAT; Lehiste I., 1970, SUPRASEGMENTALS; Magne C, 2004, J MUSIC MEANING; Magne C, 2007, CEREB CORTEX, V17, P2659, DOI 10.1093/cercor/bhl174; MARSLENWILSON WD, 1992, Q J EXP PSYCHOL-A, V45, P73, DOI 10.1080/14640749208401316; MARTIN JG, 1967, J VERB LEARN VERB BE, V6, P903, DOI 10.1016/S0022-5371(67)80157-9; Mattys SL, 1999, COGNITIVE PSYCHOL, V38, P465, DOI 10.1006/cogp.1999.0721; MECKLINGER A, 1995, MEM COGNITION, V23, P477, DOI 10.3758/BF03197249; Morgan JL, 1996, LANG COGNITIVE PROC, V11, P69, DOI 10.1080/016909696387222; Murray WS, 1998, PARSING AMBIGU UNPUB; Nazzi T, 2003, SPEECH COMMUN, V41, P233, DOI 10.1016/S0167-6393(02)00106-1; Nespor Marina, 1986, PROSODIC PHONOLOGY; Niebuhr O, 2009, PHONETICA, V66, P95, DOI 10.1159/000208933; Nooteboom S., 1997, HDB PHONETIC SCI, V5, P640; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; PRICE PJ, 1991, J ACOUST SOC AM, V90, P2956, DOI 10.1121/1.401770; Ramus F., 2002, ANN REV LANGUAGE ACQ, V2, P85, DOI [10.1075/arla.2.05ram, DOI 10.1075/ARLA.2.05RAM]; ROBINSON GM, 1977, J EXP PSYCHOL HUMAN, V3, P83; Rothermich K, 2012, NEUROPSYCHOLOGIA, V50, P232, DOI 10.1016/j.neuropsychologia.2011.10.025; Schafer A, 1996, LANG COGNITIVE PROC, V11, P135, DOI 10.1080/016909696387240; Schafer A. J., 1997, PROSODIC PARSING ROL; Schmidt-Kassow M, 2009, J COGNITIVE NEUROSCI, V21, P1693, DOI 10.1162/jocn.2008.21153; Shriberg E, 2000, SPEECH COMMUN, V32, P127, DOI 10.1016/S0167-6393(00)00028-5; Slowiaczek M. L., 1981, PROSODIC UNITS LANGU; Speer SR, 1996, J PSYCHOLINGUIST RES, V25, P249, DOI 10.1007/BF01708573; Steinhauer K, 1997, Z EXP PSYCHOL, V44, P305; Steinhauer K, 1999, NAT NEUROSCI, V2, P191, DOI 10.1038/5757; Stirling L, 1996, LANG COGNITIVE PROC, V11, P193, DOI 10.1080/016909696387268; STREETER LA, 1978, J ACOUST SOC AM, V64, P1582, DOI 10.1121/1.382142; Swets B, 2007, J EXP PSYCHOL GEN, V136, P64, DOI 10.1037/0096-3445.136.1.64; TYLER LK, 1987, J MEM LANG, V26, P638, DOI 10.1016/0749-596X(87)90107-0; Vos SH, 2001, LANG COGNITIVE PROC, V16, P65, DOI 10.1080/01690960042000085; WARREN P, 1995, LANG COGNITIVE PROC, V10, P457, DOI 10.1080/01690969508407112; Warren P., 1985, TEMPORAL ORG PERCEPT; Watt SM, 1996, J PSYCHOLINGUIST RES, V25, P291, DOI 10.1007/BF01708575	71	41	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56000	10.1371/journal.pone.0056000	http://dx.doi.org/10.1371/journal.pone.0056000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086CJ	23409109	Green Published, gold			2022-12-27	WOS:000314660300050
J	Ornelas, JF; Sosa, V; Soltis, DE; Daza, JM; Gonzalez, C; Soltis, PS; Gutierrez-Rodriguez, C; de los Monteros, AE; Castoe, TA; Bell, C; Ruiz-Sanchez, E				Francisco Ornelas, Juan; Sosa, Victoria; Soltis, Douglas E.; Daza, Juan M.; Gonzalez, Clementina; Soltis, Pamela S.; Gutierrez-Rodriguez, Carla; Espinosa de los Monteros, Alejandro; Castoe, Todd A.; Bell, Charles; Ruiz-Sanchez, Eduardo			Comparative Phylogeographic Analyses Illustrate the Complex Evolutionary History of Threatened Cloud Forests of Northern Mesoamerica	PLOS ONE			English	Article							POPULATION-GENETICS; MEXICO; DIVERSIFICATION; FRAGMENTATION; DIVERGENCE; VOLCANISM; TIME; HERPETOFAUNA; TEHUANTEPEC; PLEISTOCENE	Comparative phylogeography can elucidate the influence of historical events on current patterns of biodiversity and can identify patterns of co-vicariance among unrelated taxa that span the same geographic areas. Here we analyze temporal and spatial divergence patterns of cloud forest plant and animal species and relate them to the evolutionary history of naturally fragmented cloud forests-among the most threatened vegetation types in northern Mesoamerica. We used comparative phylogeographic analyses to identify patterns of co-vicariance in taxa that share geographic ranges across cloud forest habitats and to elucidate the influence of historical events on current patterns of biodiversity. We document temporal and spatial genetic divergence of 15 species (including seed plants, birds and rodents), and relate them to the evolutionary history of the naturally fragmented cloud forests. We used fossil-calibrated genealogies, coalescent-based divergence time inference, and estimates of gene flow to assess the permeability of putative barriers to gene flow. We also used the hierarchical Approximate Bayesian Computation (HABC) method implemented in the program msBayes to test simultaneous versus non-simultaneous divergence of the cloud forest lineages. Our results show shared phylogeographic breaks that correspond to the Isthmus of Tehuantepec, Los Tuxtlas, and the Chiapas Central Depression, with the Isthmus representing the most frequently shared break among taxa. However, dating analyses suggest that the phylogeographic breaks corresponding to the Isthmus occurred at different times in different taxa. Current divergence patterns are therefore consistent with the hypothesis of broad vicariance across the Isthmus of Tehuantepec derived from different mechanisms operating at different times. This study, coupled with existing data on divergence cloud forest species, indicates that the evolutionary history of contemporary cloud forest lineages is complex and often lineage-specific, and thus difficult to capture in a simple conservation strategy.	[Francisco Ornelas, Juan; Sosa, Victoria; Gonzalez, Clementina; Gutierrez-Rodriguez, Carla; Espinosa de los Monteros, Alejandro; Ruiz-Sanchez, Eduardo] Inst Ecol AC, Dept Evolut Biol, Xalapa, Veracruz, Mexico; [Soltis, Douglas E.] Univ Florida, Dept Biol, Gainesville, FL USA; [Daza, Juan M.] Univ Antioquia, Inst Biol, Medellin, Antioquia, Colombia; [Soltis, Pamela S.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Castoe, Todd A.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Bell, Charles] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA	Instituto de Ecologia - Mexico; State University System of Florida; University of Florida; Universidad de Antioquia; State University System of Florida; University of Florida; University of Texas System; University of Texas Arlington; University of Louisiana System; University of New Orleans	Ornelas, JF (corresponding author), Inst Ecol AC, Dept Evolut Biol, Xalapa, Veracruz, Mexico.	francisco.ornelas@inecol.edu.mx	Sosa, Victoria/A-5798-2013; Ornelas, Juan Francisco/A-2250-2014; Soltis, Pamela S/GNH-5557-2022; Espinosa de los Monteros, Alejandro/Q-6207-2018; Soltis, Douglas/L-5957-2015; Ruiz-Sanchez, Eduardo/L-8073-2013; Gutiérrez-Rodríguez, Carla/E-1559-2015; Ruiz-Sanchez, Eduardo/P-3539-2019; Soltis, Pamela S/L-5184-2015	Sosa, Victoria/0000-0002-0584-1672; Ornelas, Juan Francisco/0000-0002-1124-1163; Soltis, Pamela S/0000-0001-9310-8659; Espinosa de los Monteros, Alejandro/0000-0002-7742-5977; Ruiz-Sanchez, Eduardo/0000-0002-7981-4490; Gutiérrez-Rodríguez, Carla/0000-0002-7142-4164; Ruiz-Sanchez, Eduardo/0000-0002-7981-4490; 	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [61710, 25888, 49062, 203259]; International Foundation for Science [D/4050-1]; Departamento de Biologia Evolutiva, Instituto de Ecologia [902-12-563]; Direccion General of the Instituto de Ecologia	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); International Foundation for Science(International Foundation for Science); Departamento de Biologia Evolutiva, Instituto de Ecologia; Direccion General of the Instituto de Ecologia	This work was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACyT, http://www.conacyt.gob.mx) under agreement no. 61710 for the project Filogeografia y genetica de poblaciones del bosque mesofilo de montana: refugios, dispersion y divergencia en un archipielago directed by Juan Francisco Ornelas. Additional research funds were provided by research grants from CONACyT to C. G. R. (25888) and C. G. (49062), the International Foundation for Science to C. G. R. and J.F.O (D/4050-1), the Departamento de Biologia Evolutiva, Instituto de Ecologia to J.F.O. (902-12-563), and by the Direccion General of the Instituto de Ecologia, AC to V. S. A postdoctoral fellowship (61710) and a doctoral scholarship (203259) from CONACyT were granted to E. R. S. and C. G., respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH MP, 2000, BOSQUES NUBLADOS TRO; Arbelaez-Cortes E, 2010, MOL PHYLOGENET EVOL, V57, P658, DOI 10.1016/j.ympev.2010.06.013; Avise J.C., 2000, HIST FORMATION SPECI; Barber BR, 2010, P ROY SOC B-BIOL SCI, V277, P2675, DOI 10.1098/rspb.2010.0343; Barrier E, 1998, TECTONOPHYSICS, V287, P77, DOI 10.1016/S0040-1951(98)80062-0; Beaumont MA, 2002, GENETICS, V162, P2025; Bell RC, 2012, P ROY SOC B-BIOL SCI, V279, P991, DOI 10.1098/rspb.2011.1229; Caballero Margarita, 2010, Bol. Soc. Geol. Mex, V62, P359; Castoe TA, 2009, J BIOGEOGR, V36, P88, DOI 10.1111/j.1365-2699.2008.01991.x; Cavender-Bares J, 2011, J BIOGEOGR, V38, P962, DOI 10.1111/j.1365-2699.2010.02451.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CONABIO, 2010, BOSQUE MESOFILO MONT; Cortes-Rodriguez N, 2008, MOL PHYLOGENET EVOL, V48, P1, DOI 10.1016/j.ympev.2008.02.005; Daza JM, 2010, ECOGRAPHY, V33, P343, DOI 10.1111/j.1600-0587.2010.06281.x; De Cserna Z., 1989, GEOLOGY N AM AN OVER, P233, DOI DOI 10.1130/DNAG-GNA-A.233; Devitt TJ, 2006, MOL ECOL, V15, P4387, DOI 10.1111/j.1365-294X.2006.03015.x; DIRZO R, 1992, CONSERV BIOL, V6, P84, DOI 10.1046/j.1523-1739.1992.610084.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards SV, 2000, EVOLUTION, V54, P1839; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferrari L, 1999, GEOLOGY, V27, P303, DOI 10.1130/0091-7613(1999)027<0303:STPOCA>2.3.CO;2; Ferrari L, 2005, J VOLCANOL GEOTH RES, V146, P284, DOI 10.1016/j.jvolgeores.2005.02.004; Flores-Villela O, 2009, REV MEX BIODIVERS, V80, P817; Ornelas JF, 2010, J BIOGEOGR, V37, P2384, DOI 10.1111/j.1365-2699.2010.02372.x; Gonzalez C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-38; Gonzalez-Rodriguez A, 2004, MOL ECOL, V13, P3467, DOI 10.1111/j.1365-294X.2004.02344.x; Graham A, 1999, AM J BOT, V86, P17, DOI 10.2307/2656951; Gutierrez-Rodriguez C, 2011, MOL PHYLOGENET EVOL, V61, P603, DOI 10.1016/j.ympev.2011.08.023; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hickerson MJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-268; Hickerson MJ, 2006, EVOLUTION, V60, P2435; Hickerson MJ, 2006, MOL ECOL, V15, P209, DOI 10.1111/j.1365-294X.2005.02718.x; Huang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ilves KL, 2010, MOL ECOL, V19, P4505, DOI 10.1111/j.1365-294X.2010.04790.x; Jaramillo-Correa JP, 2009, CAN J FOREST RES, V39, P286, DOI 10.1139/X08-181; Jennette D, 2003, AAPG BULL, V87, P1599, DOI 10.1306/05130302010; JOHNSON JD, 1990, SOUTHWEST NAT, V35, P268, DOI 10.2307/3671939; Kuhner MK, 2007, GENETICS, V175, P155, DOI 10.1534/genetics.106.056457; Lachniet MS, 2005, QUATERN INT, V138, P129, DOI 10.1016/j.quaint.2005.02.010; Lawson LP, 2010, MOL ECOL, V19, P4046, DOI 10.1111/j.1365-294X.2010.04788.x; Leache AD, 2007, BIOL LETTERS, V3, P646, DOI 10.1098/rsbl.2007.0368; Leon-Paniagua L, 2007, MOL PHYLOGENET EVOL, V42, P653, DOI 10.1016/j.ympev.2006.08.019; Lozano-Garcia S., 1989, GEOFISC INT, V28, P335, DOI [10.22201/igeof.00167169p.1989.28.2.1034, DOI 10.22201/IGEOF.00167169P.1989.28.2.1034]; Luna Vega Isolda, 2000, Diversity and Distributions, V6, P137, DOI 10.1046/j.1472-4642.2000.00079.x; Martins FD, 2011, BIOL J LINN SOC, V104, P499, DOI 10.1111/j.1095-8312.2011.01745.x; Morris AB, 2008, MOL ECOL, V17, P3889, DOI 10.1111/j.1365-294X.2008.03875.x; Morris AB, 2010, J BIOGEOGR, V37, P1657, DOI 10.1111/j.1365-2699.2010.02315.x; Munoz-Villers LE, 2008, INT J REMOTE SENS, V29, P71, DOI 10.1080/01431160701280967; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Navarro-Siguenza AG, 2008, MOL PHYLOGENET EVOL, V47, P21, DOI 10.1016/j.ympev.2007.11.030; Nieto-Samaniego AF, 1999, GEOL SOC AM BULL, V111, P347, DOI 10.1130/0016-7606(1999)111<0347:VOCEAV>2.3.CO;2; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Pineda E, 2005, CONSERV BIOL, V19, P400, DOI 10.1111/j.1523-1739.2005.00531.x; Pineda E, 2004, BIOL CONSERV, V117, P499, DOI 10.1016/j.biocon.2003.08.009; Piperno DR, 2007, P NATL ACAD SCI USA, V104, P11874, DOI 10.1073/pnas.0703442104; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pyron RA, 2010, J BIOGEOGR, V37, P2005, DOI 10.1111/j.1365-2699.2010.02336.x; Rambaut A, 2008, TREESTAT V 1 2 TREE; Rodriguez SR, 2010, J VOLCANOL GEOTH RES, V197, P149, DOI 10.1016/j.jvolgeores.2009.08.003; Rodriguez-Gomez F, 2013, J BIOGEOGR, V40, P1360, DOI 10.1111/jbi.12093; Rogers RD, 2002, GEOLOGY, V30, P1031, DOI 10.1130/0091-7613(2002)030<1031:EUAADS>2.0.CO;2; Rzedowski J., 1996, Acta Botanica Mexicana, P25; RZEDOWSKI J, 1981, VEGETACION MEXICO; Sanchez-Gonzalez LA, 2008, BIOL J LINN SOC, V94, P175, DOI 10.1111/j.1095-8312.2008.00979.x; Still CJ, 1999, NATURE, V398, P608, DOI 10.1038/19293; Stone GN, 2012, CURR BIOL, V22, P532, DOI 10.1016/j.cub.2012.01.059; Sullivan J, 1997, SYST BIOL, V46, P426, DOI 10.2307/2413690; Sullivan J, 2000, AM NAT, V155, P755, DOI 10.1086/303362; Weir JT, 2008, MOL PHYLOGENET EVOL, V47, P650, DOI 10.1016/j.ympev.2008.02.004; Williams H., 1960, U CALIFORNIA PUBLICA, V38, P1; WilliamsLinera G, 1997, GLOBAL ECOL BIOGEOGR, V6, P115, DOI 10.2307/2997568	73	135	139	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56283	10.1371/journal.pone.0056283	http://dx.doi.org/10.1371/journal.pone.0056283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409165	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200126
J	Wang, D; Cao, L; Xu, Z; Fang, LR; Zhong, Y; Chen, QG; Luo, R; Chen, HC; Li, K; Xiao, SB				Wang, Dang; Cao, Lu; Xu, Zheng; Fang, Liurong; Zhong, Yao; Chen, Quangang; Luo, Rui; Chen, Huanchun; Li, Kui; Xiao, Shaobo			MiR-125b Reduces Porcine Reproductive and Respiratory Syndrome Virus Replication by Negatively Regulating the NF-kappa B Pathway	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INTERFERON-BETA PRODUCTION; CELLULAR MICRORNAS; EXPRESSION; MODULATION; INFECTION; PRRSV; SUPPRESSION; ACTIVATION; INHIBITION	Porcine reproductive and respiratory syndrome virus (PRRSV) is an Arterivirus that has been devastating the swine industry worldwide since the late 1980s. To investigate the impact of cellular microRNAs (miRNAs) on the replication of PRRSV, we screened 10 highly conserved miRNAs implicated in innate immunity or antiviral function and identified miR-125b as an inhibitor of PRRSV replication. Virus titer and western blot assays demonstrated that miR-125b reduced PRRSV replication and viral gene expression in a dose-dependent manner in both MARC-145 cell line and primary porcine alveolar macrophages. Mechanistically, miR-125b did not target the PRRSV genome. Rather, it inhibited activation of NF-kappa B, which we found to be required for PRRSV replication. PRRSV, in turn, down-regulated miR-125b expression post-infection to promote viral replication. Collectively, miR-125b is an antiviral host factor against PRRSV, but it is subject to manipulation by PRRSV. Our study reveals an example of manipulation of a cellular miRNA by an arterivirus to re-orchestrate host gene expression for viral propagation and sheds new light on targeting host factors to develop effective control measures for PRRS.	[Wang, Dang; Cao, Lu; Xu, Zheng; Fang, Liurong; Zhong, Yao; Chen, Quangang; Luo, Rui; Chen, Huanchun; Xiao, Shaobo] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Div Anim Infect Dis, Wuhan, Peoples R China; [Li, Kui] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	Huazhong Agricultural University; University of Tennessee System; University of Tennessee Health Science Center	Xiao, SB (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Div Anim Infect Dis, Wuhan, Peoples R China.	vet@mail.hzau.edu.cn		Xiao, Shaobo/0000-0003-0023-9188	National Natural Sciences Foundation of China [30972189, 31001054, 31201890, 31225027]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Sciences Foundation of China (30972189, 31001054, 31201890 and 31225027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asamitsu K, 2008, J BIOCHEM, V144, P581, DOI 10.1093/jb/mvn104; Asirvatham AJ, 2008, MOL IMMUNOL, V45, P1995, DOI 10.1016/j.molimm.2007.10.035; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beura LK, 2010, J VIROL, V84, P1574, DOI 10.1128/JVI.01326-09; Boss IW, 2010, CURR OPIN MICROBIOL, V13, P540, DOI 10.1016/j.mib.2010.05.017; Calzada-Nova G, 2011, J VIROL, V85, P2703, DOI 10.1128/JVI.01616-10; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Chaudhuri AA, 2011, J IMMUNOL, V187, P5062, DOI 10.4049/jimmunol.1102001; Chen ZH, 2010, J GEN VIROL, V91, P1047, DOI 10.1099/vir.0.016212-0; Darwich L, 2010, VIRUS RES, V154, P123, DOI 10.1016/j.virusres.2010.07.017; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kim O, 2010, VIROLOGY, V402, P315, DOI 10.1016/j.virol.2010.03.039; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kong FF, 2011, J HUAZHONG U SCI-MED, V31, P543, DOI 10.1007/s11596-011-0487-z; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee SM, 2005, VIROLOGY, V342, P47, DOI 10.1016/j.virol.2005.07.034; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li B, 2009, VACCINE, V27, P1957, DOI 10.1016/j.vaccine.2009.01.098; Ludwig S, 2008, BIOL CHEM, V389, P1307, DOI 10.1515/BC.2008.148; Luo R, 2008, MOL IMMUNOL, V45, P2839, DOI 10.1016/j.molimm.2008.01.028; Luo R, 2011, ANTIVIR RES, V91, P99, DOI 10.1016/j.antiviral.2011.04.017; Luo R, 2011, VIRUS GENES, V42, P76, DOI 10.1007/s11262-010-0548-6; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Meng XJ, 2000, VET MICROBIOL, V74, P309, DOI 10.1016/S0378-1135(00)00196-6; Meulenberg JJM, 2000, VET RES, V31, P11, DOI 10.1051/vetres:2000054; Muller S, 2007, IMMUNITY, V27, P1, DOI 10.1016/j.immuni.2007.07.003; Murakami Y, 2009, J HEPATOL, V50, P453, DOI 10.1016/j.jhep.2008.06.010; Murphy AJ, 2010, J IMMUNOL, V184, P5029, DOI 10.4049/jimmunol.0903463; Murtaugh MP, 2010, VIRUS RES, V154, P18, DOI 10.1016/j.virusres.2010.08.015; Murtaugh MP, 2002, VIRAL IMMUNOL, V15, P533, DOI 10.1089/088282402320914485; Nimmerjahn F, 2004, J GEN VIROL, V85, P2347, DOI 10.1099/vir.0.79958-0; Norman KL, 2010, J VIROL, V84, P666, DOI 10.1128/JVI.01156-09; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Patel D, 2010, J VIROL, V84, P11045, DOI 10.1128/JVI.00655-10; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Roberts APE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-201; Rossow KD, 1998, VET PATHOL, V35, P1, DOI 10.1177/030098589803500101; Sarnow P, 2006, NAT REV MICROBIOL, V4, P651, DOI 10.1038/nrmicro1473; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Song C, 2010, VIROLOGY, V407, P268, DOI 10.1016/j.virol.2010.08.025; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Song S, 2013, DEV COMP IMMUNOL, V39, P265, DOI 10.1016/j.dci.2012.10.001; Sun Z, 2010, J VIROL, V84, P7832, DOI 10.1128/JVI.00217-10; Surdziel E, 2011, BLOOD, V117, P4338, DOI 10.1182/blood-2010-06-289058; Wang D, 2010, BIOCHEM BIOPH RES CO, V399, P72, DOI 10.1016/j.bbrc.2010.07.044; Wang FZ, 2008, J VIROL, V82, P9065, DOI 10.1128/JVI.00961-08; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wessner B, 2010, EXERC IMMUNOL REV, V16, P22; Williams SA, 2007, J VIROL, V81, P6043, DOI 10.1128/JVI.02074-06; Wurzer WJ, 2004, J BIOL CHEM, V279, P30931, DOI 10.1074/jbc.M403258200; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yoo D, 2010, VIRUS RES, V154, P48, DOI 10.1016/j.virusres.2010.07.019; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008	65	54	61	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55838	10.1371/journal.pone.0055838	http://dx.doi.org/10.1371/journal.pone.0055838			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409058	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200074
J	Zhang, W; Fan, XH; Zhu, SF; Zhao, H; Fu, LZ				Zhang, Wei; Fan, Xiaohong; Zhu, Shuifang; Zhao, Hong; Fu, Lianzhong			Species-Specific Identification from Incomplete Sampling: Applying DNA Barcodes to Monitoring Invasive Solanum Plants	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; PHYLOGENETIC-RELATIONSHIPS; LAND PLANTS; CHLOROPLAST; SEQUENCE; REGION; RATES; SUBSTITUTION; DISCRIMINATE; CHARACTERS	Comprehensive sampling is crucial to DNA barcoding, but it is rarely performed because materials are usually unavailable. In practice, only a few rather than all species of a genus are required to be identified. Thus identification of a given species using a limited sample is of great importance in current application of DNA barcodes. Here, we selected 70 individuals representing 48 species from each major lineage of Solanum, one of the most species-rich genera of seed plants, to explore whether DNA barcodes can provide reliable specific-species discrimination in the context of incomplete sampling. Chloroplast genes ndhF and trnS-trnG and the nuclear gene waxy, the commonly used markers in Solanum phylogeny, were selected as the supplementary barcodes. The tree-building and modified barcode gap methods were employed to assess species resolution. The results showed that four Solanum species of quarantine concern could be successfully identified through the two-step barcoding sampling strategy. In addition, discrepancies between nuclear and cpDNA barcodes in some samples demonstrated the ability to discriminate hybrid species, and highlights the necessity of using barcode regions with different modes of inheritance. We conclude that efficient phylogenetic markers are good candidates as the supplementary barcodes in a given taxonomic group. Critically, we hypothesized that a specific-species could be identified from a phylogenetic framework using incomplete sampling-through this, DNA barcoding will greatly benefit the current fields of its application.	[Zhang, Wei; Fan, Xiaohong; Zhu, Shuifang] Chinese Acad Inspect & Quarantine, Inst Plant Quarantine, Beijing, Peoples R China; [Zhang, Wei; Zhao, Hong] Shandong Univ Weihai, Marine Coll, Weihai, Peoples R China; [Fu, Lianzhong] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China	Chinese Academy of Inspection & Quarantine; Shandong University; Chinese Academy of Sciences; Institute of Botany, CAS	Fan, XH (corresponding author), Chinese Acad Inspect & Quarantine, Inst Plant Quarantine, Beijing, Peoples R China.	fan98494@sina.com	ZHANG, WEI/AAJ-2716-2020		General Administration of Quality Supervision, Inspection and Quarantine, P. R. China [2010IK268]; Ministry of Science and Technology, P. R. China [2012BAK11B03]; Shandong University (Weihai) [1070501312002, 1070511300001, 2012ZRXT004]	General Administration of Quality Supervision, Inspection and Quarantine, P. R. China; Ministry of Science and Technology, P. R. China(Ministry of Science and Technology, China); Shandong University (Weihai)	This work was supported by a grant from the General Administration of Quality Supervision, Inspection and Quarantine, P. R. China (grant number 2010IK268) to XHF and by a grant from the Ministry of Science and Technology, P. R. China (grant number 2012BAK11B03). Independent innovation youth fund of Shandong University (Weihai) (1070501312002; 1070511300001) and collaborative innovation system construction fund of Shandong University (Weihai) (2012ZRXT004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bohs L, 1997, SYST BOT, V22, P5, DOI 10.2307/2419674; Bohs L., 2005, SYST BOT, V104, P27, DOI DOI 10.1111/J.1365-2699.2007.01870.X; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Doyle J. J., 1987, PHYTOCHEM B, P11; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamilton MB, 1999, MOL ECOL, V8, P521; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Kovach WL, 1999, MULTIVARIATE STAT PA; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Levin RA, 2006, AM J BOT, V93, P157, DOI 10.3732/ajb.93.1.157; Levin RA, 2005, AM J BOT, V92, P603, DOI 10.3732/ajb.92.4.603; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; OLMSTEAD RG, 1994, SYST BIOL, V43, P467, DOI 10.2307/2413546; Olmstead RG, 2008, TAXON, V57, P1159, DOI 10.1002/tax.574010; Prendini L, 2005, CAN J ZOOL, V83, P498, DOI 10.1139/Z05-025; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; Rieseberg LH, 2006, NATURE, V440, P524, DOI 10.1038/nature04402; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANDERLEIJ FR, 1991, MOL GEN GENET, V228, P240, DOI 10.1007/BF00282472; Walsh BM, 2001, INT J PLANT SCI, V162, P1409, DOI 10.1086/323273; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Weese TL, 2007, SYST BOT, V32, P445, DOI 10.1600/036364407781179671; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI 10.1007/978-1-4615-5419-6_10; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; WOLFE KH, 1989, J MOL EVOL, V29, P208, DOI 10.1007/BF02100204; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Young ND, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-6	51	17	20	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55927	10.1371/journal.pone.0055927	http://dx.doi.org/10.1371/journal.pone.0055927			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409092	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200091
J	Kullgren, JT; Volpp, KG; Polsky, D				Kullgren, Jeffrey T.; Volpp, Kevin G.; Polsky, Daniel			Are the Healthy Behaviors of US High-Deductible Health Plan Enrollees Driven by People Who Chose These Plans? Smoking as a Case Study	PLOS ONE			English	Article							ANTE MORAL HAZARD; EMPLOYEE CHOICE; POPULATION; BENEFITS	Purpose: To determine whether negative associations between enrollment in a high-deductible health plan (HDHP) and one exemplar unhealthy behavior - daily smoking - are found only among people who chose these plans. Design: Cross-sectional analysis of nationally-representative data. Setting: United States from 2007 to 2008. Subjects: 6,941 privately insured non-elderly adult participants in the 2007 Health Tracking Household Survey. Measures: Self-reported smoking status. Analysis: We classified subjects as HDHP or traditional health plan enrollees with employer-sponsored insurance (ESI) and no choice of plans, ESI with a choice of plans, or coverage through the non-group market. We used multivariate logistic regression to measure associations between HDHP enrollment and daily smoking within each of the 3 coverage source groups while controlling for potential confounders. Results: HDHP enrollment was associated with lower odds of smoking among individuals with ESI and a choice of plans (AOR 0.55, 95% CI 0.33-0.90) and those with non-group coverage (AOR 0.64, 95% CI 0.34-1.22), though the latter association was not statistically significant. HDHP enrollment was not associated with lower odds of smoking among individuals with ESI and no choice of plans (AOR 1.04, 95% CI 0.69-1.56). Conclusions: HDHP enrollment is associated with lower odds of smoking only among individuals who chose to enroll in an HDHP. Lower rates of unhealthy behaviors among HDHP enrollees may be a reflection of individuals who choose these plans.	[Kullgren, Jeffrey T.] Vet Affairs Ann Arbor Healthcare Syst, Vet Affairs Ctr Clin Management Res, Ann Arbor, MI USA; [Kullgren, Jeffrey T.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Kullgren, Jeffrey T.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Volpp, Kevin G.; Polsky, Daniel] Univ Penn, Leonard Davis Inst Hlth Econ, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Polsky, Daniel] Penn Carnegie Mellon Univ, Roybal Ctr Behav Econ & Hlth P30, Philadelphia, PA USA; [Volpp, Kevin G.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA USA; [Volpp, Kevin G.; Polsky, Daniel] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Polsky, Daniel] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; Carnegie Mellon University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Kullgren, JT (corresponding author), Vet Affairs Ann Arbor Healthcare Syst, Vet Affairs Ctr Clin Management Res, Ann Arbor, MI USA.	jkullgre@med.umich.edu		Volpp, Kevin/0000-0003-1423-4599	US Department of Veterans Affairs; Robert Wood Johnson Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER	US Department of Veterans Affairs(US Department of Veterans Affairs); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The US Department of Veterans Affairs and the Robert Wood Johnson Foundation funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. These contents do not represent the views of the Department of Veterans Affairs, the United States Government, or the Robert Wood Johnson Foundation.	Adams PF, 2011, VITAL HLTH STAT, V10; Agrawal V, 2005, CONSUMER DIRECTED HL; Blue Cross and Blue Shield Association, 2008, 2008 CONS DRIV HLTH; Cannon MF, 2007, HLTH COMPETITION WHA; Center for Studying Health System Change, 2009, 2007 HLTH TRACK HOUS; Champion VL, 2008, HLTH BEHAV HLTH ED T, P41; Claxton G, 2008, HEALTH AFFAIR, V27, pW492, DOI 10.1377/hlthaff.27.6.w492; Claxton G, 2010, HEALTH AFFAIR, V29, P1942, DOI 10.1377/hlthaff.2010.0725; Dave D, 2009, INT J HEALTH CARE FI, V9, P367, DOI 10.1007/s10754-009-9056-4; de Preux LB, 2011, HEALTH ECON, V20, P1056, DOI 10.1002/hec.1778; Draper Debra A, 2008, Issue Brief Cent Stud Health Syst Change, P1; Fowles JB, 2004, HEALTH SERV RES, V39, P1141, DOI 10.1111/j.1475-6773.2004.00279.x; Goodman JC, 1994, PATIENT POWER FREE E; Haddock CK, 1998, TOB CONTROL, V7, P232, DOI 10.1136/tc.7.3.232; Independence Blue Cross, 2008, CONS; Lave JR, 2011, HEALTH SERV RES, V46, P138, DOI 10.1111/j.1475-6773.2010.01167.x; McLaughlin CG, 1999, MED CARE RES REV, V56, P24, DOI 10.1177/107755899773743855; Merlis M, 2005, FUNDAMENTALS UNDERWI; Newhouse JP, 1993, FREE ALL LESSONS RAN; Rohleder H, 2009, MODERN HEALTHCARE, V39, P20; Saver BG, 2000, MED CARE, V38, P141, DOI 10.1097/00005650-200002000-00004; Schoenborn CA, 2010, VITAL HLTH STAT, V10; Shrank WH, 2011, J GEN INTERN MED, V26, P546, DOI 10.1007/s11606-010-1609-1; Spenkuch JL, 2012, J HEALTH ECON, V31, P72, DOI 10.1016/j.jhealeco.2011.12.004; Strouse R, 2009, COMMUNITY TRACKING S; The Henry J. Kaiser Family Foundation, 2010, COMP EXP NONGR EMPL; Towers Watson, 2010, HLTH CAR REF LOOM FE; Towers Watson/ National Business Group on Health, 2011, 16 ANN TOW WATS NAT; Trish E., 2011, PROFILE HLTH INSURAN; Turner Grace-Marie, 2005, MedGenMed, V7, P42; Ward KD, 2002, AM J HEALTH PROMOT, V16, P259, DOI 10.4278/0890-1171-16.5.259; Yilma Z, 2012, SOC SCI MED, V75, P138, DOI 10.1016/j.socscimed.2012.02.035	32	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56154	10.1371/journal.pone.0056154	http://dx.doi.org/10.1371/journal.pone.0056154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418528	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300120
J	Park, KW; Park, JJ; Kang, J; Jeon, KH; Kang, SH; Han, JK; Lee, SE; Yang, HM; Lee, HY; Kang, HJ; Koo, BK; Oh, BH; Park, YB; Kim, HS				Park, Kyung Woo; Park, Jin Joo; Kang, Jeehoon; Jeon, Ki-Hyun; Kang, Si-Hyuck; Han, Jung-Kyu; Lee, Sang Eun; Yang, Han-Mo; Lee, Hae-Young; Kang, Hyun-Jae; Koo, Bon-Kwon; Oh, Byung-Hee; Park, Young-Bae; Kim, Hyo-Soo			Paraoxonase 1 Gene Polymorphism Does Not Affect Clopidogrel Response Variability but Is Associated with Clinical Outcome after PCI	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; PON1 GENE; Q192R POLYMORPHISM; STENT THROMBOSIS; HEART-DISEASE; RISK; EVENTS; ATHEROSCLEROSIS; RESPONSIVENESS; ARYLESTERASE	Background: Paraoxonase (PON) is a high-density-lipoprotein (HDL) associated enzyme with antioxidative and anti-atherogenic property. Its function is associated with coronary artery disease and its activity genetically controlled. We evaluated whether genetic variation of PON-1 is associated with clinical outcome in a large cohort of Korean patients with drug-eluting stents implantation. Methods: A total of 1676 patients with drug-eluting stent implantation were enrolled in the prospective CROSS-VERIFY cohort from June 2006 to June 2010. We genotyped the PON1-Q192R gene, measured clopidogrel on-treatment platelet reactivity (OPR), and analyzed lipid profiles. The primary endpoint was the composite of cardiac death, myocardial infarction, and stent thrombosis at 12 months. Results: PON-1 genotyping data were available in 1336 patients. Since the Q-allele is associated with decreased PON-activity, we analyzed the outcome between patients with QQ/QR (815 patients, 61%) and those with RR-genotype (521 patients, 39%). After adjustment for common cardiac risk factors, the QQ/QR-genotype was an independent predictor of the primary thrombotic endpoint with an 11-fold increased risk (HR 11.6, 95% CI: 1.55-87.0), but not repeat revascularization (HR 1.12, 95% CI: 0.78-1.61). The QQ/QR-genotype was not associated with OPR (QQ/QR: 231 +/- 86 PRU vs. RR 236 +/- 82 PRU, p = 0.342) but higher small-dense LDL levels (1.20 +/- 0.12 mg/dL vs. 0.76 +/- 0.15 mg/dL, p = 0.027). The increased risk of thrombotic outcomes was more profound in acute coronary syndrome (ACS) patients compared with non-ACS patients. Conclusion: PON1 Q-allele is an independent predictor of worse cardiovascular outcome independent of platelet function and is associated with significantly higher levels of small dense LDL-C.	[Kim, Hyo-Soo] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul 110744, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, HS (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.	hyosoo@snu.ac.kr	Kim, Hyo Soo/J-2753-2012; Park, Kyung Woo/AAX-3046-2020; Kang, Si-Hyuck/AAR-9790-2020; Kang, Hyun-Jae/D-6121-2012; Oh, Byung-Hee/G-9875-2011	Kang, Si-Hyuck/0000-0003-4755-6367; Kang, Hyun-Jae/0000-0002-3500-1746; Oh, Byung-Hee/0000-0002-9945-4306; Han, Jung-Kyu/0000-0002-0016-0747; Lee, Hae-Young/0000-0002-9521-4102	Clinical Research Center for Ischemic Heart Disease, Seoul, Republic of Korea [A102065]; Innovative Research Institute for Cell Therapy, Seoul National University Hospital [A062260]; Ministry of Health, Welfare & Family, Republic of Korea; Korean Liver Research Foundation, Seoul, Korea	Clinical Research Center for Ischemic Heart Disease, Seoul, Republic of Korea; Innovative Research Institute for Cell Therapy, Seoul National University Hospital; Ministry of Health, Welfare & Family, Republic of Korea; Korean Liver Research Foundation, Seoul, Korea	This study was supported by a grant from the Clinical Research Center for Ischemic Heart Disease, Seoul, Republic of Korea (A102065) and a grant from the Innovative Research Institute for Cell Therapy, Seoul National University Hospital (A062260), sponsored by the Ministry of Health, Welfare & Family, Republic of Korea. This study was funded in part by a grant from the Korean Liver Research Foundation, Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINS S, 1993, AM J HUM GENET, V52, P598; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Bouman HJ, 2011, NAT MED, V17, P110, DOI 10.1038/nm.2281; Campo G, 2011, J THROMB HAEMOST, V9, P2106, DOI 10.1111/j.1538-7836.2011.04457.x; Chen Q, 2003, AM J HUM GENET, V72, P13, DOI 10.1086/345312; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Eom SY, 2011, J KOREAN MED SCI, V26, P720, DOI 10.3346/jkms.2011.26.6.720; Fontana P, 2011, J THROMB HAEMOST, V9, P1664, DOI 10.1111/j.1538-7836.2011.04409.x; Gaidukov L, 2006, J LIPID RES, V47, P2492, DOI 10.1194/jlr.M600297-JLR200; Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875; Hoefner DM, 2001, CLIN CHEM, V47, P266; Huang Q, 2006, NEUROL RES, V28, P549, DOI 10.1179/016164106X110337; Krauss Ronald M., 1994, Current Opinion in Lipidology, V5, P339, DOI 10.1097/00041433-199410000-00005; LADU BN, 1993, CHEM-BIOL INTERACT, V87, P25, DOI 10.1016/0009-2797(93)90022-Q; Lee Chul-Ho, 2005, J Prev Med Public Health, V38, P345; Lewis JP, 2011, CLIN PHARMACOL THER, V90, P568, DOI 10.1038/clpt.2011.194; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; Mackness B, 2003, CIRCULATION, V107, P2775, DOI 10.1161/01.CIR.0000070954.00271.13; Mackness MI, 1998, CURR OPIN LIPIDOL, V9, P319, DOI 10.1097/00041433-199808000-00006; PLAYFER JR, 1976, J MED GENET, V13, P337, DOI 10.1136/jmg.13.5.337; Regieli JJ, 2009, J AM COLL CARDIOL, V54, P1238, DOI 10.1016/j.jacc.2009.05.061; Reny JL, 2012, J THROMB HAEMOST, V10, P1242, DOI 10.1111/j.1538-7836.2012.04756.x; Sibbing D, 2011, EUR HEART J, V32, P1605, DOI 10.1093/eurheartj/ehr155; Slottow TLP, 2007, CATHETER CARDIO INTE, V69, P1064, DOI 10.1002/ccd.21179; Srinivasan SR, 2004, ATHEROSCLEROSIS, V177, P167, DOI 10.1016/j.atherosclerosis.2004.06.013; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Trenk D, 2011, CIRC-CARDIOVASC GENE, V4, P429, DOI 10.1161/CIRCGENETICS.111.960112; Turban S, 2001, ATHEROSCLEROSIS, V154, P633, DOI 10.1016/S0021-9150(00)00495-0; Wheeler JG, 2004, LANCET, V363, P689, DOI 10.1016/S0140-6736(04)15642-0	30	22	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e52779	10.1371/journal.pone.0052779	http://dx.doi.org/10.1371/journal.pone.0052779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418418	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300008
J	Raisanen, S; Sokka, A; Georgiadis, L; Harju, M; Gissler, M; Keski-Nisula, L; Kalviainen, R; Heinonen, S				Raisanen, Sari; Sokka, Arja; Georgiadis, Leena; Harju, Maija; Gissler, Mika; Keski-Nisula, Leea; Kalviainen, Reetta; Heinonen, Seppo			Infertility Treatment and Umbilical Cord Length-Novel Markers of Childhood Epilepsy?	PLOS ONE			English	Article							RISK-FACTORS; GESTATIONAL-AGE; INSERTION; WOMEN; EPIDEMIOLOGY; PREGNANCY; FERTILITY; CHILDREN; DOPPLER; FINLAND	Background: Epilepsy is one of the most common neurologic disorders of childhood, affecting about 0.4-0.8% of all children up to the age of 20. Methodology: A population-based retrospective cohort study. Aim was to determine incidence and identify perinatal and reproductive risk factors of epilepsy in children born between 1989 and 2008 among women (n = 43,389) delivered in Kuopio University Hospital. Risk factors of childhood epilepsy were determined by using logistic regression analysis. Principal Findings: The incidence of childhood epilepsy was 0.7% (n = 302 of 43,389). Maternal epilepsy, major congenital anomalies and use of assisted reproductive technology (ART) were associated with 4.25-, 3.61-, and 1.67- fold increased incidence of childhood epilepsy. A 10 cm increase in umbilical cord length was associated with a 15% decrease in the incidence of epilepsy (adjusted OR 0.85, 95% CI 0.78-0.94). However, the above reproductive factors accounted for less than 2% of total incidence, whereas maternal epilepsy proved to be the highest risk factor. Conclusions: Perinatal and reproductive factors were shown to be minor risk factors of childhood epilepsy, implying that little can be done in obstetric care to prevent childhood epilepsy. Infertility treatment and umbilical cord length, independent of gestational age and congenital malformations, may be novel markers of childhood epilepsy.	[Raisanen, Sari; Georgiadis, Leena; Harju, Maija; Keski-Nisula, Leea; Heinonen, Seppo] Kuopio Univ Hosp, Dept Obstet & Gynaecol, SF-70210 Kuopio, Finland; [Sokka, Arja] Kuopio Univ Hosp, Dept Pediat Neurol, SF-70210 Kuopio, Finland; [Sokka, Arja; Georgiadis, Leena; Harju, Maija; Keski-Nisula, Leea; Kalviainen, Reetta; Heinonen, Seppo] Univ Eastern Finland, Kuopio, Finland; [Gissler, Mika] Natl Inst Hlth & Welf, Dept Informat, Welf & Hlth Data Resources Unit, Helsinki, Finland; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden; [Kalviainen, Reetta] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Finland National Institute for Health & Welfare; Kuopio University Hospital; University of Eastern Finland	Raisanen, S (corresponding author), Kuopio Univ Hosp, Dept Obstet & Gynaecol, SF-70210 Kuopio, Finland.	shraisan@student.uef.fi		Gissler, Mika/0000-0001-8254-7525	Medical Research Council [MR/K006525/1] Funding Source: Medline; MRC [MR/K006525/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Artama M, 2004, AM J EPIDEMIOL, V159, P1057, DOI 10.1093/aje/kwh140; Cowan LD, 2002, MENT RETARD DEV D R, V8, P171, DOI 10.1002/mrdd.10035; Ehrenstein V, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-23; Ehrenstein V, 2007, PEDIATRICS, V119, pE554, DOI 10.1542/peds.2006-1308; Ericson A, 2002, HUM REPROD, V17, P929, DOI 10.1093/humrep/17.4.929; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Guerrini R, 2006, LANCET, V367, P499, DOI 10.1016/S0140-6736(06)68182-8; Heinonen S, 2001, PLACENTA, V22, P399, DOI 10.1053/plac.2001.0630; Heinonen S, 1996, OBSTET GYNECOL, V87, P112, DOI 10.1016/0029-7844(95)00339-8; Heiskanen JTM, 2001, AM J OBSTET GYNECOL, V185, P600, DOI 10.1067/mob.2001.116722; Izumi K, 2006, FETAL PEDIATR PATHOL, V25, P233, DOI 10.1080/15513810601123326; Krakowiak P, 2004, OBSTET GYNECOL, V103, P119, DOI 10.1097/01.AOG.0000102706.84063.C7; Mann JR, 2011, EPILEPSY BEHAV, V20, P506, DOI 10.1016/j.yebeh.2011.01.006; MOESSINGER AC, 1982, PEDIATR RES, V16, P109, DOI 10.1203/00006450-198202000-00006; NAEYE RL, 1985, J PEDIATR-US, V107, P278, DOI 10.1016/S0022-3476(85)80149-9; Norgaard M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030850; Papinniemi M, 2007, AM J PERINAT, V24, P353, DOI 10.1055/s-2007-984403; Raatikainen K, 2012, HUM REPROD IN PRESS, V2012; Raatikainen K, 2007, PREV MED, V44, P59, DOI 10.1016/j.ypmed.2006.07.017; Sarwono E, 1991, Paediatr Indones, V31, P136; Schupf N, 1996, EPILEPSIA, V37, P833, DOI 10.1111/j.1528-1157.1996.tb00035.x; Sen Wu C, 2008, PEDIATRICS, V122, P1072, DOI 10.1542/peds.2007-3666; Sillanpaa M, 2006, EPILEPSY RES, V71, P206, DOI 10.1016/j.eplepsyres.2006.06.017; Sillanpaa M, 2011, EPILEPSIA, V52, P1857, DOI 10.1111/j.1528-1167.2011.03186.x; SORNES T, 1989, ACTA OBSTET GYN SCAN, V68, P439, DOI 10.3109/00016348909021017; Sun YL, 2006, EPIDEMIOLOGY, V17, P296, DOI 10.1097/01.ede.0000208478.47401.b6; Sun YL, 2007, HUM REPROD, V22, P215, DOI 10.1093/humrep/del333; Sun Y, 2008, AM J EPIDEMIOL, V167, P262, DOI 10.1093/aje/kwm316; Toivonen S, 2002, AM J PERINAT, V19, P451, DOI 10.1055/s-2002-36868; vandeMheen H, 1997, SOC SCI MED, V44, P13, DOI 10.1016/S0277-9536(96)00090-1; Viinikainen K, 2006, EPILEPSIA, V47, P186, DOI 10.1111/j.1528-1167.2006.00386.x; Viinikainen K, 2007, NEUROLOGY, V69, P2107, DOI 10.1212/01.wnl.0000277451.06420.b6; Whitehead E, 2006, PEDIATRICS, V117, P1298, DOI 10.1542/peds.2005-1660	33	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55394	10.1371/journal.pone.0055394	http://dx.doi.org/10.1371/journal.pone.0055394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418441	gold, Green Submitted, Green Published			2022-12-27	WOS:000315970300031
J	Samur, MK; Yan, ZY; Wang, XJ; Cao, QY; Munshi, NC; Li, C; Shah, PK				Samur, Mehmet Kemal; Yan, Zhenyu; Wang, Xujun; Cao, Qingyi; Munshi, Nikhil C.; Li, Cheng; Shah, Parantu K.			canEvolve: A Web Portal for Integrative Oncogenomics	PLOS ONE			English	Article							GENE-EXPRESSION OMNIBUS; COPY NUMBER ALTERATIONS; CANCER MICROARRAY; MULTIPLE-MYELOMA; LUNG-CANCER; DATABASE; GENOME; SURVIVAL; QUANTIFICATION; DIAGNOSIS	Background & Objective: Genome-wide profiles of tumors obtained using functional genomics platforms are being deposited to the public repositories at an astronomical scale, as a result of focused efforts by individual laboratories and large projects such as the Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium. Consequently, there is an urgent need for reliable tools that integrate and interpret these data in light of current knowledge and disseminate results to biomedical researchers in a user-friendly manner. We have built the canEvolve web portal to meet this need. Results: canEvolve query functionalities are designed to fulfill most frequent analysis needs of cancer researchers with a view to generate novel hypotheses. canEvolve stores gene, microRNA (miRNA) and protein expression profiles, copy number alterations for multiple cancer types, and protein-protein interaction information. canEvolve allows querying of results of primary analysis, integrative analysis and network analysis of oncogenomics data. The querying for primary analysis includes differential gene and miRNA expression as well as changes in gene copy number measured with SNP microarrays. canEvolve provides results of integrative analysis of gene expression profiles with copy number alterations and with miRNA profiles as well as generalized integrative analysis using gene set enrichment analysis. The network analysis capability includes storage and visualization of gene co-expression, inferred gene regulatory networks and protein-protein interaction information. Finally, canEvolve provides correlations between gene expression and clinical outcomes in terms of univariate survival analysis. Conclusion: At present canEvolve provides different types of information extracted from 90 cancer genomics studies comprising of more than 10,000 patients. The presence of multiple data types, novel integrative analysis for identifying regulators of oncogenesis, network analysis and ability to query gene lists/pathways are distinctive features of canEvolve. canEvolve will facilitate integrative and meta-analysis of oncogenomics datasets.	[Samur, Mehmet Kemal; Yan, Zhenyu; Li, Cheng; Shah, Parantu K.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Samur, Mehmet Kemal; Yan, Zhenyu; Li, Cheng; Shah, Parantu K.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Samur, Mehmet Kemal] Akdeniz Univ, Dept Biostat & Med Informat, TR-07058 Antalya, Turkey; [Wang, Xujun] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China; [Cao, Qingyi] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Munshi, Nikhil C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Munshi, Nikhil C.] Harvard Univ, Sch Med, VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Akdeniz University; Tongji University; Zhejiang University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System	Li, C (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.	cli@hsph.harvard.edu; parantu.shah@gmail.com	Munshi, Nikhil/ABE-2338-2021	Samur, Mehmet/0000-0002-9978-5682; wang, xujun/0000-0002-7152-611X	National Institutes of Health (NIH) [R01 GM077122]; Claudia Adams Barr Program in Innovative Basic Cancer Research; Multiple Myeloma Career Development award; National Basic Research [973] Program of China [2010CB944904]; Department of Veterans Affairs Merit Review Awards [NIH RO1-124929, PO1-155258, P50-100007, PO1-78378]; NATIONAL CANCER INSTITUTE [P01CA155258, P01CA078378, P50CA100707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077122] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claudia Adams Barr Program in Innovative Basic Cancer Research; Multiple Myeloma Career Development award; National Basic Research [973] Program of China(National Basic Research Program of China); Department of Veterans Affairs Merit Review Awards(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) R01 GM077122 (C.L.), the Claudia Adams Barr Program in Innovative Basic Cancer Research (P.K.S.), the Multiple Myeloma Career Development award (P.K.S.) and National Basic Research [973] Program of China No. 2010CB944904 (X.W.) This work was also supported in part by NIH RO1-124929, PO1-155258, P50-100007 and PO1-78378 to N.C.M. and C.L. and from the Department of Veterans Affairs Merit Review Awards to N.C.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Blaine SA, 2001, J BIOL CHEM, V276, P42737, DOI 10.1074/jbc.M107773200; Cao QY, 2011, NUCLEIC ACIDS RES, V39, pD968, DOI 10.1093/nar/gkq997; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Chen LJ, 2011, CANCER LETT, V309, P62, DOI 10.1016/j.canlet.2011.05.017; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chng WJ, 2007, CANCER RES, V67, P2982, DOI 10.1158/0008-5472.CAN-06-4046; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Davies FE, 2003, BLOOD, V102, P4504, DOI 10.1182/blood-2003-01-0016; Dickens NJ, 2010, CLIN CANCER RES, V16, P1856, DOI 10.1158/1078-0432.CCR-09-2831; Dudoit S, 2008, SPRINGER SER STAT, P1; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egan JB, 2012, BLOOD, V120, P1060, DOI 10.1182/blood-2012-01-405977; Fulciniti M, 2011, CLIN CANCER RES, V17, P6500, DOI 10.1158/1078-0432.CCR-11-1036; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hu J, 2007, BIOINFORMATICS, V23, P1986, DOI 10.1093/bioinformatics/btm283; Huang N, 2012, BRIEF BIOINFORM, V13, P305, DOI 10.1093/bib/bbr056; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Keats JJ, 2012, BLOOD, V120, P1067, DOI 10.1182/blood-2012-01-405985; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; Liu FL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-46; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Miecznikowski JC, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-573; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Pennisi E, 2011, SCIENCE, V331, P666, DOI 10.1126/science.331.6018.666; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rajkumar SV, 2010, MAYO CLIN PROC, V85, P945, DOI 10.4065/mcp.2010.0520; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Salari K, 2010, BIOINFORMATICS, V26, P414, DOI 10.1093/bioinformatics/btp702; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tian WZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005028; Yan Z, 2012, NUCL ACIDS RES; Yan ZY, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks395	52	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56228	10.1371/journal.pone.0056228	http://dx.doi.org/10.1371/journal.pone.0056228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418540	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300132
J	Wu, XQ; Marmarelis, ME; Hodi, FS				Wu, Xinqi; Marmarelis, Melina E.; Hodi, F. Stephen			Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in Melanoma	PLOS ONE			English	Article							CELL-CYCLE ARREST; HSP90 INHIBITOR; METASTATIC MELANOMA; CANCER-CELLS; B-RAF; ACQUIRED-RESISTANCE; SIGNAL-TRANSDUCTION; BRAF INHIBITION; KINASE CASCADE; IN-VITRO	Heat shock protein 90 (HSP90) is involved in the regulation of diverse biological processes such as cell signaling, proliferation and survival, and has been recently recognized as a potential target for cancer therapy. Ganetespib is a potent ATP competitive inhibitor of HSP90. Ganetespib downregulated the expression of multiple signal transducing molecules including EGFR, IGF-1R, c-Met, Akt, B-RAF and C- RAF, resulting in pronounced decrease in phosphorylation of Akt and Erk1/2 in a panel of five cutaneous melanoma cell lines including those harboring B-RAF and N-RAS mutations. Ganetespib exhibited potent antiproliferative activity on all five of these cell lines, with IC50 values between 37.5 and 84 nM. Importantly, Ganetespib is active on B-RAF mutated melanoma cells that have acquired resistance to B-RAF inhibition. Ganetespib induced apoptosis and cell cycle arrest at G1 and/or G2/M phase. Ganetespib induced cell cycle arrest was accompanied by altered expression of cyclin-dependent kinase inhibitor (CDKI) p21(Cip1) and p27(Kip1), cyclins B1, D1 and E, and/or cyclin-dependent kinases 1, 2 and 4. HSP90 is functionally important for melanoma cells and HSP90 inhibitors such as ganetespib could potentially be effective therapeutics for melanoma with various genetic mutations and acquired resistance to B-RAF inhibition.	[Wu, Xinqi; Hodi, F. Stephen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wu, Xinqi; Marmarelis, Melina E.; Hodi, F. Stephen] Harvard Univ, Sch Med, Boston, MA USA; [Wu, Xinqi; Hodi, F. Stephen] Dana Farber Brigham & Womens Canc Ctr, Melanoma Dis Ctr, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Hodi, FS (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	stephen_hodi@dfci.harvard.edu			Sharon Crowley Martin Memorial Fund for Melanoma Research at Dana-Farber Cancer Institute; Malcolm and Emily Mac Naught Fund for Melanoma Research at Dana-Farber Cancer Institute	Sharon Crowley Martin Memorial Fund for Melanoma Research at Dana-Farber Cancer Institute; Malcolm and Emily Mac Naught Fund for Melanoma Research at Dana-Farber Cancer Institute	This work was supported in part by Sharon Crowley Martin Memorial Fund for Melanoma Research (F. S. Hodi), the Malcolm and Emily Mac Naught Fund for Melanoma Research (F. S. Hodi) at Dana-Farber Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Basto R, 2007, J CELL SCI, V120, P1278, DOI 10.1242/jcs.000604; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Caldon CE, 2006, J CELL BIOCHEM, V97, P261, DOI 10.1002/jcb.20690; Cheung CHA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-77; Cohen-Saidon C, 2006, BLOOD, V107, P1413, DOI 10.1182/blood-2005-07-2648; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Foijer F, 2006, CELL CYCLE, V5, P831, DOI 10.4161/cc.5.8.2687; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Goel VK, 2006, J INVEST DERMATOL, V126, P154, DOI 10.1038/sj.jid.5700026; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Guida M, 2012, EXPERT OPIN THER TAR, V16, pS61, DOI 10.1517/14728222.2011.645807; Gysin S, 2005, CANCER RES, V65, P4870, DOI 10.1158/0008-5472.CAN-04-2848; Hingorani SR, 2003, CANCER RES, V63, P5198; Hiromura K, 1999, J CLIN INVEST, V103, P597, DOI 10.1172/JCI5461; Hoeflich KP, 2009, CANCER RES, V69, P3042, DOI 10.1158/0008-5472.CAN-08-3563; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Jaiswal RK, 1996, J BIOL CHEM, V271, P23626, DOI 10.1074/jbc.271.39.23626; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Lin TY, 2008, EXP HEMATOL, V36, P1266, DOI 10.1016/j.exphem.2008.05.001; Luke JJ, 2012, CLIN CANCER RES, V18, P9, DOI 10.1158/1078-0432.CCR-11-2197; Martins AS, 2008, CANCER RES, V68, P6260, DOI 10.1158/0008-5472.CAN-07-3074; McCleese JK, 2009, INT J CANCER, V125, P2792, DOI 10.1002/ijc.24660; Medema RH, 1998, ONCOGENE, V16, P431, DOI 10.1038/sj.onc.1201558; Meier F, 2005, FRONT BIOSCI-LANDMRK, V10, P2986, DOI 10.2741/1755; Miyata Y, 2001, J BIOL CHEM, V276, P21841, DOI 10.1074/jbc.M010944200; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Paraiso KHT, 2012, CLIN CANCER RES, V18, P2502, DOI 10.1158/1078-0432.CCR-11-2612; Porter Lisa A, 2003, Prog Cell Cycle Res, V5, P335; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; Prince T, 2005, BIOCHEMISTRY-US, V44, P15287, DOI 10.1021/bi051423m; Proia DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018552; Rassidakis GZ, 2005, BLOOD, V105, P827, DOI 10.1182/blood-2004-06-2125; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schreiber M, 1999, ONCOGENE, V18, P1663, DOI 10.1038/sj.onc.1202466; Schwock J, 2008, CANCER CHEMOTH PHARM, V61, P669, DOI 10.1007/s00280-007-0522-8; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slupianek A, 2004, EXP HEMATOL, V32, P1265, DOI 10.1016/j.exphem.2004.11.002; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Srethapakdi M, 2000, CANCER RES, V60, P3940; Stancato LF, 1997, J BIOL CHEM, V272, P4013, DOI 10.1074/jbc.272.7.4013; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Takayama S, 2003, ONCOGENE, V22, P9041, DOI 10.1038/sj.onc.1207114; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang S, 2009, CELL CYCLE, V8, P2050, DOI 10.4161/cc.8.13.8861; Wang XT, 1997, ONCOGENE, V15, P2991, DOI 10.1038/sj.onc.1201450; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Wu XQ, 2012, MELANOMA RES, V22, P123, DOI 10.1097/CMR.0b013e3283507ffd; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755	62	31	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56134	10.1371/journal.pone.0056134	http://dx.doi.org/10.1371/journal.pone.0056134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418523	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300115
J	Xu, JC; Xu, W; Yao, HX; Sun, WX; Zhou, Q; Cai, L				Xu, Jiancheng; Xu, Wei; Yao, Hanxin; Sun, Weixia; Zhou, Qi; Cai, Lu			Associations of Serum and Urinary Magnesium with the Pre-Diabetes, Diabetes and Diabetic Complications in the Chinese Northeast Population	PLOS ONE			English	Article							DIETARY MAGNESIUM; PLASMA MAGNESIUM; RISK; HYPOMAGNESEMIA; PATHOGENESIS; PREVALENCE; DEFICIENCY; MELLITUS; CALCIUM; COPPER	The effect of magnesium (Mg) deficiency on the prevalence of diabetes and diabetic complications has received a great attention. The present study investigated the association of Mg level in the serum or urine of the patients, lived in the Northeast areas of China, with either pre-diabetes or diabetes with and without complications. From January 2010 to October 2011, patients with type 1 diabetes (T1D, n = 25), type 2 diabetes (T2D, n = 137), impaired fasting glucose (IFG, n = 12) or impaired glucose tolerance (IGT, n = 15), and age/gender matched control (n = 50) were enrolled in the First Hospital of Jilin University. In T2D group, there were 24, 34, and 50 patients with nephropathy, retinopathy or peripheral neuropathy. Serum Mg levels in the patients with IGT, IFG, T2D, and T1D were significantly lower than that of control. The urinary Mg levels were significantly increased only in T2D and T1D patients compared to control. There was no difference for these two changes among T2D with and without complications; In addition, there was a significantly positive correlation of serum Mg levels with serum Ca levels only in T2D patients, and also a significantly positive correlation of urinary Mg levels with urinary Ca levels in control, IGT patients, and T2D patients. Simvastatin treatment in T2D patients selectively reduced serum Ca levels and urinary Mg levels. These results suggest that the potential impact of Mg deficiency on metabolic syndrome, diabetes and diabetic complications needs to be received special attention.	[Xu, Jiancheng; Xu, Wei; Yao, Hanxin] Jilin Univ, Hosp 1, Dept Clin Lab, Changchun 130023, Peoples R China; [Zhou, Qi] Jilin Univ, Hosp 1, Dept Pediat, Changchun 130023, Peoples R China; [Sun, Weixia; Cai, Lu] Univ Louisville, Dept Pediat, Kosair Children Hosp Res Inst, Louisville, KY 40292 USA	Jilin University; Jilin University; University of Louisville	Zhou, Q (corresponding author), Jilin Univ, Hosp 1, Dept Pediat, Changchun 130023, Peoples R China.	qiqi0522@yeah.net; l0cai001@louisville.edu	Cai, Lu/AAG-9920-2019	xu, jiancheng/0000-0001-8796-271X; Zhou, Qi/0000-0002-5084-8697	National Science Foundation of China [81000330]; Jilin Science and Technology Development Program [20100124]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Science and Technology Development Program	The data cited from the laboratories of authors were supported in part by grants from National Science Foundation of China (81000330, to Dr. JC Xu) and Jilin Science and Technology Development Program (20100124, to Dr. JC Xu). The authors are grateful to Zhenxing Chu and Jing Jiang who have assisted them to make statistical analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P, 2011, DIABETES METAB SYND, V5, P41, DOI 10.1016/j.dsx.2010.12.003; Canagaratna M C, 1984, Ceylon Med J, V29, P109; de Valk HW, 1999, DIABETES CARE, V22, P864, DOI 10.2337/diacare.22.5.864; Derakhshan R, 2011, MINERVA PEDIATR, V63, P27; Dong JY, 2011, DIABETES CARE, V34, P2116, DOI 10.2337/dc11-0518; ELIN RJ, 1987, CLIN CHEM, V33, P1965; ERASMUS RT, 1989, TROP GEOGR MED, V41, P234; Haenni A, 2001, METABOLISM, V50, P1147, DOI 10.1053/meta.2001.26755; HATWAL A, 1989, ACTA OPHTHALMOL, V67, P714; Kao WHL, 1999, ARCH INTERN MED, V159, P2151, DOI 10.1001/archinte.159.18.2151; Kousa A, 2012, ENVIRON RES, V112, P126, DOI 10.1016/j.envres.2011.11.001; Kupetsky-Rincon EA, 2012, ANN NUTR METAB, V61, P102, DOI 10.1159/000339380; Lee CT, 2006, KIDNEY INT, V69, P1786, DOI 10.1038/sj.ki.5000344; Leibowitz D, 2012, CLIN CARDIOL, V35, P764, DOI 10.1002/clc.22049; Li B, 2012, TOXICOL MECH METHODS; Li Y, 2009, MAGNESIUM RES, V22, P66, DOI 10.1684/mrh.2009.0163; Liu QJ, 2009, CURR MED CHEM, V16, P113, DOI 10.2174/092986709787002862; Mangou Apostolis, 2012, Endocrinol Nutr, V59, P109, DOI 10.1016/j.endonu.2011.10.003; MCNAIR P, 1978, DIABETES, V27, P1075, DOI 10.2337/diabetes.27.11.1075; Ohira T, 2009, AM J EPIDEMIOL, V169, P1437, DOI 10.1093/aje/kwp071; OLUKOGA AO, 1989, CENT AFR J MED, V35, P378; Pham PC, 2012, CLIN NEPHROL; Pham PCT, 2005, CLIN NEPHROL, V63, P429; Rodriguez-Moran M, 2001, ARCH MED RES, V32, P300, DOI 10.1016/S0188-4409(01)00298-3; Rodriguez-Moran M, 2011, MAGNESIUM RES, V24, P156, DOI 10.1684/mrh.2011.0299; Rosanoff A, 2004, J AM COLL NUTR, V23, p501S, DOI 10.1080/07315724.2004.10719389; Shaikh S, 2011, J PAK MED ASSOC, V61, P901; Sharma A, 2007, J INDIAN MED ASSOC, V105, P18; SHARMA A, 2007, J INDIAN MED ASSOC, V105, P20; Sharma Aradhana, 2007, J Indian Med Assoc, V105, P20; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Simmons D, 2010, DIABETES RES CLIN PR, V87, P261, DOI 10.1016/j.diabres.2009.11.003; Sun L, 2008, J CLIN ENDOCR METAB, V93, P4690, DOI 10.1210/jc.2008-1159; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038845; Viktorinova A, 2009, METABOLISM, V58, P1477, DOI 10.1016/j.metabol.2009.04.035; Wegner M, 2010, MAGNESIUM RES, V23, P97, DOI 10.1684/mrh.2010.0207; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zargar AH, 2002, SAUDI MED J, V23, P539; Zheng Y, 2008, HEMOGLOBIN, V32, P135, DOI 10.1080/03630260701727077	40	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56750	10.1371/journal.pone.0056750	http://dx.doi.org/10.1371/journal.pone.0056750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418599	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300192
J	Chan, MM; Wooden, JM; Tsang, M; Gilligan, DM; Hirenallur-S, DK; Finney, GL; Rynes, E; MacCoss, M; Ramirez, JA; Park, H; Iritani, BM				Chan, Maia M.; Wooden, Jason M.; Tsang, Mark; Gilligan, Diana M.; Hirenallur-S, Dinesh K.; Finney, Greg L.; Rynes, Eric; MacCoss, Michael; Ramirez, Julita A.; Park, Heon; Iritani, Brian M.			Hematopoietic Protein-1 Regulates the Actin Membrane Skeleton and Membrane Stability in Murine Erythrocytes	PLOS ONE			English	Article							RHO-GTPASES; INNATE IMMUNITY; CELL MEMBRANE; ALPHA-ADDUCIN; KINASE-C; IN-VIVO; ACTIVATION; CYTOSKELETON; SPECTRIN; MICE	Hematopoietic protein-1 (Hem-1) is a hematopoietic cell specific member of the WAVE (Wiskott-Aldrich syndrome verprolin-homologous protein) complex, which regulates filamentous actin (F-actin) polymerization in many cell types including immune cells. However, the roles of Hem-1 and the WAVE complex in erythrocyte biology are not known. In this study, we utilized mice lacking Hem-1 expression due to a non-coding point mutation in the Hem1 gene to show that absence of Hem-1 results in microcytic, hypochromic anemia characterized by abnormally shaped erythrocytes with aberrant F-actin foci and decreased lifespan. We find that Hem-1 and members of the associated WAVE complex are normally expressed in wildtype erythrocyte progenitors and mature erythrocytes. Using mass spectrometry and global proteomics, Coomassie staining, and immunoblotting, we find that the absence of Hem-1 results in decreased representation of essential erythrocyte membrane skeletal proteins including alpha- and beta-spectrin, dematin, p55, adducin, ankyrin, tropomodulin 1, band 3, and band 4.1. Hem1(-/-) erythrocytes exhibit increased protein kinase C-dependent phosphorylation of adducin at Ser724, which targets adducin family members for dissociation from spectrin and actin, and subsequent proteolysis. Increased adducin Ser724 phosphorylation in Hem1(-/-) erythrocytes correlates with decreased protein expression of the regulatory subunit of protein phosphatase 2A (PP2A), which is required for PP2A-dependent dephosphorylation of PKC targets. These results reveal a novel, critical role for Hem-1 in the homeostasis of structural proteins required for formation and stability of the actin membrane skeleton in erythrocytes.	[Chan, Maia M.; Tsang, Mark; Hirenallur-S, Dinesh K.; Ramirez, Julita A.; Park, Heon; Iritani, Brian M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Wooden, Jason M.; Gilligan, Diana M.] Puget Sound Blood Ctr, Seattle, WA 98104 USA; [Finney, Greg L.; Rynes, Eric; MacCoss, Michael] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Puget Sound Blood Center; University of Washington; University of Washington Seattle	Iritani, BM (corresponding author), Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA.	biritani@uw.edu		Iritani, Brian/0000-0003-1903-7850	National Institutes of Health (NIH) [P41 GM103533, P30 AG013280]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013280] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD010554] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grants P41 GM103533 and P30 AG013280. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XL, 2007, BLOOD, V109, P1284, DOI 10.1182/blood-2006-07-036954; Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; Barkalow KL, 2003, J CELL BIOL, V161, P557, DOI 10.1083/jcb.200211122; BAUMGARTNER S, 1995, J MOL BIOL, V251, P41, DOI 10.1006/jmbi.1995.0414; BEUTLER E, 1976, J LAB CLIN MED, V88, P328; Beutler E, 2007, BRIT J HAEMATOL, V136, P3, DOI 10.1111/j.1365-2141.2006.06351.x; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bompard G, 2004, J CELL BIOL, V166, P957, DOI 10.1083/jcb.200403127; Boukharov AA, 1998, BIOCHEM J, V330, P1391, DOI 10.1042/bj3301391; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Campanella ME, 2008, BLOOD, V112, P3900, DOI 10.1182/blood-2008-03-146159; Chen HQ, 2007, J BIOL CHEM, V282, P4124, DOI 10.1074/jbc.M610231200; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Finney GL, 2008, ANAL CHEM, V80, P961, DOI 10.1021/ac701649e; Fowler VM, 1996, CURR OPIN CELL BIOL, V8, P86, DOI 10.1016/S0955-0674(96)80052-4; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; George A, 2010, BLOOD CELL MOL DIS, V45, P41, DOI 10.1016/j.bcmd.2010.02.006; Gilligan DM, 2002, BLOOD, V99, P2418, DOI 10.1182/blood.V99.7.2418; Harwood NE, 2011, COLD SPRING HARB PER, V3; Iolascon Achille, 2003, Rev Clin Exp Hematol, V7, P22; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kalfa TA, 2006, BLOOD, V108, P3637, DOI 10.1182/blood-2006-03-005942; Khan AA, 2008, J BIOL CHEM, V283, P14600, DOI 10.1074/jbc.M707818200; Konstantinidis DG, 2010, TRANSFUS CLIN BIOL, V17, P126, DOI 10.1016/j.tracli.2010.05.002; Kuhlman PA, 1997, BIOCHEMISTRY-US, V36, P13461, DOI 10.1021/bi970601b; Lach A, 2012, J BIOL CHEM, V287, P18974, DOI 10.1074/jbc.M111.332981; Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Moyer JD, 2010, BLOOD, V116, P2590, DOI 10.1182/blood-2010-02-268458; Mulloy JC, 2010, BLOOD, V115, P936, DOI 10.1182/blood-2009-09-198127; Park H, 2010, FEBS LETT, V584, P4923, DOI 10.1016/j.febslet.2010.10.018; Park H, 2008, J EXP MED, V205, P2899, DOI 10.1084/jem.20080340; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Porro F, 2004, FEBS LETT, V576, P36, DOI 10.1016/j.febslet.2004.08.057; Ringrose JH, 2008, J PROTEOME RES, V7, P3060, DOI 10.1021/pr8001029; Ruediger R, 1997, VIROLOGY, V238, P432, DOI 10.1006/viro.1997.8873; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Sents W, 2012, FEBS J; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shi ZT, 1999, J CLIN INVEST, V103, P331, DOI 10.1172/JCI3858; Slater SJ, 2001, BIOCHEMISTRY-US, V40, P4437, DOI 10.1021/bi001654n; Suzuki K, 2005, J CELL PHYSIOL, V203, P487, DOI 10.1002/jcp.20249; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; TCHERNIA G, 1981, J CLIN INVEST, V68, P454, DOI 10.1172/JCI110275; van de Water B, 2000, J BIOL CHEM, V275, P25805, DOI 10.1074/jbc.M001680200; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Wooden JM, 2011, BRIT J HAEMATOL, V154, P492, DOI 10.1111/j.1365-2141.2011.08612.x	50	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e54902	10.1371/journal.pone.0054902	http://dx.doi.org/10.1371/journal.pone.0054902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424621	Green Submitted, Green Published, gold			2022-12-27	WOS:000315965100009
J	Zhu, YX; Ma, A; Zhang, HX; Li, CJ				Zhu, Yunxia; Ma, Ai; Zhang, Hongxiu; Li, Chaojun			PPAR gamma Activation Attenuates Glycated-Serum Induced Pancreatic Beta-Cell Dysfunction through Enhancing Pdx1 and Mafa Protein Stability	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; RECEPTOR-GAMMA; PEROXISOME-PROLIFERATOR; OXIDATIVE STRESS; MITOCHONDRIAL BIOGENESIS; RESPONSE ELEMENT; APOPTOSIS; EXPRESSION; INHIBITION; THIAZOLIDINEDIONES	Pancreatic-duodenal homeobox-1 (Pdx1) and v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (Mafa) play important roles in sustaining the pancreatic beta-cell differentiation phenotype. Peroxisome proliferator-activated receptor-gamma (PPAR gamma) is also a regulator of cell differentiation. Our previous study revealed that glycated serum (GS) causes beta-cell dedifferentiation by down-regulating beta-cell specific genes, such as insulin and Pdx1. Here, we show that GS enhanced the cellular accumulation of ubiquitin-conjugated proteins, including Pdx1 and Mafa, in pancreatic beta-cells. Pharmacologic inhibition of proteolytic activity restored the protein levels of Pdx1 and Mafa, whereas inhibition of de novo protein synthesis accelerated their degradation. These findings suggest that both Pdx1 and Mafa are regulated at the post-transcriptional level. We further show that activation of PPAR gamma could restore GS-induced reduction of Pdx1 and Mafa protein levels, leading to improved insulin secretion and synthesis. Moreover, ectopic expression of Bcl-xl, a mitochondrial regulator, also restored Pdx1 and Mafa protein levels, linking mitochondrial function to Pdx1 and Mafa stability. Taken together, our results identify a key role of PPAR gamma in regulating pancreatic beta-cell function by improving the stability of Pdx1 and Mafa proteins.	[Zhu, Yunxia; Ma, Ai; Li, Chaojun] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Li, Chaojun] Nanjing Univ, Natl Resource Ctr Mutant Mice, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210008, Jiangsu, Peoples R China; [Li, Chaojun] Nanjing Univ, Natl Resource Ctr Mutant Mice, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Hongxiu] Nanjing Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing University; Nanjing University; Nanjing Medical University	Li, CJ (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China.	licj@nju.edu.cn	Zhu, Yunxia/G-6273-2014		National Basic Research Program of China (973 program) [2012CB524901]; National Natural Science Foundation of China [81200559]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (973 program, 2012CB524901) to Chaojun Li, and the National Natural Science Foundation of China (81200559) to Yunxia Zhu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian KN, 2011, NAT CELL BIOL, V13, P1224, DOI 10.1038/ncb2330; Andersson AK, 2005, MOL CELL ENDOCRINOL, V240, P50, DOI 10.1016/j.mce.2005.06.001; Brown KK, 1999, DIABETES, V48, P1415, DOI 10.2337/diabetes.48.7.1415; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chang-Chen KJ, 2008, REV ENDOCR METAB DIS, V9, P329, DOI 10.1007/s11154-008-9101-5; Dhar A, 2011, DIABETES, V60, P899, DOI 10.2337/db10-0627; Dubois M, 2000, DIABETOLOGIA, V43, P1165, DOI 10.1007/s001250051508; Dubois M, 2002, ANN ENDOCRINOL-PARIS, V63, P511; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Fong WH, 2010, MOL NEUROBIOL, V41, P180, DOI 10.1007/s12035-010-8103-y; Fuenzalida K, 2007, J BIOL CHEM, V282, P37006, DOI 10.1074/jbc.M700447200; Fukami K, 2008, CURR PHARM DESIGN, V14, P946, DOI 10.2174/138161208784139710; Grillo MA, 2008, AMINO ACIDS, V35, P29, DOI 10.1007/s00726-007-0606-0; Gupta D, 2008, J BIOL CHEM, V283, P32462, DOI 10.1074/jbc.M801813200; Han X, 2001, DIABETES, V50, P1047, DOI 10.2337/diabetes.50.5.1047; Higa M, 1999, P NATL ACAD SCI USA, V96, P11513, DOI 10.1073/pnas.96.20.11513; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Kaneto H, 2009, CURR MED CHEM, V16, P3144, DOI 10.2174/092986709788802980; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kanjanabuch T, 2007, KIDNEY INT, V71, P1232, DOI 10.1038/sj.ki.5002248; Kim H, 2004, DIABETES, V53, pS60, DOI 10.2337/diabetes.53.2007.S60; Kim H, 2000, DIABETES, V49, P1517, DOI 10.2337/diabetes.49.9.1517; Kim HI, 2002, DIABETES, V51, P676, DOI 10.2337/diabetes.51.3.676; Kim SK, 2002, NAT GENET, V30, P430, DOI 10.1038/ng860; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Lee JW, 2009, CELL SIGNAL, V21, P69, DOI 10.1016/j.cellsig.2008.09.015; Leibowitz G, 2001, DIABETES, V50, pS113, DOI 10.2337/diabetes.50.2007.S113; Li J, 2010, DIABETES OBES METAB, V12, P35, DOI 10.1111/j.1463-1326.2009.01093.x; Meng ZX, 2009, ENDOCRINOLOGY, V150, P5284, DOI 10.1210/en.2009-0671; Miglio G, 2009, NEUROCHEM INT, V55, P496, DOI 10.1016/j.neuint.2009.05.001; Moibi JA, 2007, DIABETES, V56, P88, DOI 10.2337/db06-0948; Okada K, 1999, J BIOL CHEM, V274, P23787, DOI 10.1074/jbc.274.34.23787; Puddu A, 2010, BIOCHEM BIOPH RES CO, V395, P122, DOI 10.1016/j.bbrc.2010.03.152; Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053; Ren YS, 2009, VASC PHARMACOL, V51, P169, DOI 10.1016/j.vph.2009.06.004; Rosen ED, 2003, MOL CELL BIOL, V23, P7222, DOI 10.1128/MCB.23.20.7222-7229.2003; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Satoh T, 1997, J NEUROSCI RES, V50, P413, DOI 10.1002/(SICI)1097-4547(19971101)50:3<413::AID-JNR7>3.0.CO;2-L; Shimizu S, 1996, ONCOGENE, V13, P21; Shu TT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018782; Soro-Paavonen A, 2008, DIABETES, V57, P2461, DOI 10.2337/db07-1808; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Strum JC, 2007, J ALZHEIMERS DIS, V11, P45; Tornero D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020423; Toth C, 2008, DIABETES, V57, P1002, DOI 10.2337/db07-0339; Vivas Y, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-86; Vlassara H, 2002, J INTERN MED, V251, P87, DOI 10.1046/j.1365-2796.2002.00932.x; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Wu JS, 2009, J CELL PHYSIOL, V220, P58, DOI 10.1002/jcp.21730; Xu ZK, 2006, ACTA BIOCH BIOPH SIN, V38, P1, DOI 10.1111/j.1745-7270.2006.00128.x; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; You YH, 2011, DIABETES METAB J, V35, P119, DOI 10.4093/dmj.2011.35.2.119; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhang XF, 2009, ENDOCRINOLOGY, V150, P4065, DOI 10.1210/en.2009-0343; Zhao ZS, 2009, ENDOCRINOLOGY, V150, P2569, DOI 10.1210/en.2008-1342; Zhu YX, 2011, BIOCHEM BIOPH RES CO, V404, P159, DOI 10.1016/j.bbrc.2010.11.085	58	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56386	10.1371/journal.pone.0056386	http://dx.doi.org/10.1371/journal.pone.0056386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424659	Green Submitted, gold, Green Published			2022-12-27	WOS:000315965100047
J	Abu-Jamous, B; Fa, R; Roberts, DJ; Nandi, AK				Abu-Jamous, Basel; Fa, Rui; Roberts, David J.; Nandi, Asoke K.			Paradigm of Tunable Clustering Using Binarization of Consensus Partition Matrices (Bi-CoPaM) for Gene Discovery	PLOS ONE			English	Article							MICROARRAY DATA; EXPRESSION; TRANSCRIPTION; MODEL	Clustering analysis has a growing role in the study of co-expressed genes for gene discovery. Conventional binary and fuzzy clustering do not embrace the biological reality that some genes may be irrelevant for a problem and not be assigned to a cluster, while other genes may participate in several biological functions and should simultaneously belong to multiple clusters. Also, these algorithms cannot generate tight clusters that focus on their cores or wide clusters that overlap and contain all possibly relevant genes. In this paper, a new clustering paradigm is proposed. In this paradigm, all three eventualities of a gene being exclusively assigned to a single cluster, being assigned to multiple clusters, and being not assigned to any cluster are possible. These possibilities are realised through the primary novelty of the introduction of tunable binarization techniques. Results from multiple clustering experiments are aggregated to generate one fuzzy consensus partition matrix (CoPaM), which is then binarized to obtain the final binary partitions. This is referred to as Binarization of Consensus Partition Matrices (Bi-CoPaM). The method has been tested with a set of synthetic datasets and a set of five real yeast cell-cycle datasets. The results demonstrate its validity in generating relevant tight, wide, and complementary clusters that can meet requirements of different gene discovery studies.	[Abu-Jamous, Basel; Fa, Rui; Nandi, Asoke K.] Univ Liverpool, Dept Elect Engn & Elect, Liverpool L69 3BX, Merseyside, England; [Roberts, David J.] Natl Hlth Serv Blood & Transplant, Oxford, England; [Roberts, David J.] Univ Oxford, John Radcliffe Hosp, Oxford OX3 9DU, England; [Nandi, Asoke K.] Univ Jyvaskyla, Dept Math Informat Technol, Jyvaskyla, Finland	University of Liverpool; NHS Blood & Transplant (NHSBT); University of Oxford; University of Jyvaskyla	Nandi, AK (corresponding author), Univ Liverpool, Dept Elect Engn & Elect, Brownlow Hill, Liverpool L69 3BX, Merseyside, England.	a.nandi@liverpool.ac.uk		Fa, Rui/0000-0003-4588-7971; Roberts, David/0000-0003-0648-6585	National Institute for Health Research (NIHR), UK [NIHR-RP-PG-0310-1004-AN]; National Institute for Health Research [RP-PG-0310-1004] Funding Source: researchfish	National Institute for Health Research (NIHR), UK(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The project (Ref. NIHR-RP-PG-0310-1004-AN) is supported by National Institute for Health Research (NIHR), UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Jamous B, 2012, IEEE INT WORKS MACH; Abu-Jamous B, 2012, EUR SIGNAL PR CONF, P2193; Avogadri R., 2008, SUPERVISED UNSUPERVI; Ayad HG, 2010, PATTERN RECOGN, V43, P1943, DOI 10.1016/j.patcog.2009.11.012; Babuska R, 2001, ARTIF INTELL MED, V21, P91, DOI 10.1016/S0933-3657(00)00075-0; Baumgartner R, 1998, MAGN RESON IMAGING, V16, P115, DOI 10.1016/S0730-725X(97)00277-4; Boor C., 1978, PRACTICAL GUIDE SPLI; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Dimitriadou E., 2002, Advances in Soft Computing - AFSS 2002. 2002 AFSS International Conference on Fuzzy Systems. Proceedings (Lecture Notes in Artificial Intelligence Vol.2275), P332; Dimitriadou E, 2002, INT J PATTERN RECOGN, V16; Dudoit S, 2003, BIOINFORMATICS, V19, P1090, DOI 10.1093/bioinformatics/btg038; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fa R, 2011, IEEE INT WORKS MACH; Fern X. Z., 2004, P 21 INT C MACH LEAR, P36; Filkov V, 2003, PROC INT C TOOLS ART, P418, DOI 10.1109/TAI.2003.1250220; Fischer B, 2003, IEEE T PATTERN ANAL, V25, P1411, DOI 10.1109/TPAMI.2003.1240115; Fred ALN, 2002, INT C PATT RECOG, P276, DOI 10.1109/ICPR.2002.1047450; Gibbons FD, 2002, GENOME RES, V12, P1574, DOI 10.1101/gr.397002; Greene D, 2008, BIOINFORMATICS, V24, P1722, DOI 10.1093/bioinformatics/btn286; Haykin S, 1999, P842; Kohonen T., 1997, SELF ORGANIZING MAPS; Kuhn H, 1955, NAVAL RES LOGISTICS, V2; Liu DL, 2004, P NATL ACAD SCI USA, V101, P7240, DOI 10.1073/pnas.0402285101; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Nwamadi O, 2011, IET COMMUN, V5, P1020, DOI 10.1049/iet-com.2010.0316; Pena JM, 1999, PATTERN RECOGN LETT, V20, P1027, DOI 10.1016/S0167-8655(99)00069-0; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Rhouma MBH, 2001, IEEE T PATTERN ANAL, V23, P180, DOI 10.1109/34.908968; Salem SA, 2008, IEEE T NANOBIOSCI, V7, P65, DOI 10.1109/TNB.2008.2000151; Slonim N, 2005, P NATL ACAD SCI USA, V102, P18297, DOI 10.1073/pnas.0507432102; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; Tumer K, 2008, PATTERN RECOGN LETT, V29, P1947, DOI 10.1016/j.patrec.2008.06.011; Vega-Pons S, 2009, LECT NOTES COMPUT SC, V5856, P481, DOI 10.1007/978-3-642-10268-4_56; Vega-Pons S, 2008, LECT NOTES COMPUT SC, V5197, P195, DOI 10.1007/978-3-540-85920-8_24; Vega-Pons S, 2011, PATTERN RECOGN LETT, V32, P2163, DOI 10.1016/j.patrec.2011.05.006; Vega-Pons S, 2011, INT J PATTERN RECOGN, V25, P337, DOI 10.1142/S0218001411008683; Wei Wang, 2010, Proceedings of the 2010 International Conference on Machine Vision and Human-Machine Interface (MVHI 2010), P604, DOI 10.1109/MVHI.2010.72; Weingessel A, 2003, DISTRIBUTED STAT COM; Xiao X., 2003, IEEE PAR DISTR PROC, P10, DOI [DOI 10.1109/IPDPS.2003.1213290, 10.1109/IPDPS.2003.1213290]; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977; Yu ZW, 2007, BIOINFORMATICS, V23, P2888, DOI 10.1093/bioinformatics/btm463; Zhao LP, 2001, P NATL ACAD SCI USA, V98, P5631, DOI 10.1073/pnas.101013198; Zhou X, 2005, BIOINFORMATICS, V21, P1559, DOI 10.1093/bioinformatics/bti216	45	44	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56432	10.1371/journal.pone.0056432	http://dx.doi.org/10.1371/journal.pone.0056432			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409186	Green Published, Green Submitted, gold			2022-12-27	WOS:000315100000055
J	Matsuo, J; Nakamura, S; Ito, A; Yamazaki, T; Ishida, K; Hayashi, Y; Yoshida, M; Takahashi, K; Sekizuka, T; Takeuchi, F; Kuroda, M; Nagai, H; Hayashida, K; Sugimoto, C; Yamaguchi, H				Matsuo, Junji; Nakamura, Shinji; Ito, Atsushi; Yamazaki, Tomohiro; Ishida, Kasumi; Hayashi, Yasuhiro; Yoshida, Mitsutaka; Takahashi, Kaori; Sekizuka, Tsuyoshi; Takeuchi, Fumihiko; Kuroda, Makoto; Nagai, Hiroki; Hayashida, Kyoko; Sugimoto, Chihiro; Yamaguchi, Hiroyuki			Protochlamydia Induces Apoptosis of Human HEp-2 Cells through Mitochondrial Dysfunction Mediated by Chlamydial Protease-Like Activity Factor	PLOS ONE			English	Article							III SECRETION; PARACHLAMYDIA-ACANTHAMOEBAE; INTRACELLULAR BACTERIA; CAUSAL AGENTS; TRACHOMATIS; PNEUMONIAE; CPAF; EXPRESSION; INCLUSION; PROTEINS	Obligate amoebal endosymbiotic bacterium Protochlamydia with ancestral pathogenic chlamydial features evolved to survive within protist hosts, such as Acanthamoba, 0.7-1.4 billion years ago, but not within vertebrates including humans. This observation raises the possibility that interactions between Protochlamydia and human cells may result in a novel cytopathic effect, leading to new insights into host-parasite relationships. Previously, we reported that Protochlamydia induces apoptosis of the immortalized human cell line, HEp-2. In this study, we attempted to elucidate the molecular mechanism underlying this apoptosis. We first confirmed that, upon stimulation with the bacteria, poly (ADP-ribose) polymerase (PARP) was cleaved at an early stage in HEp-2 cells, which was dependent on the amount of bacteria. A pan-caspase inhibitor and both caspase-3 and -9 inhibitors similarly inhibited the apoptosis of HEp-2 cells. A decrease of the mitochondrial membrane potential was also confirmed. Furthermore, lactacystin, an inhibitor of chlamydial protease-like activity factor (CPAF), blocked the apoptosis. Cytochalasin D also inhibited the apoptosis, which was dependent on the drug concentration, indicating that bacterial entry into cells was required to induce apoptosis. Interestingly, Yersinia type III inhibitors (ME0052, ME0053, and ME0054) did not have any effect on the apoptosis. We also confirmed that the Protochlamydia used in this study possessed a homologue of the cpaf gene and that two critical residues, histidine-101 and serine-499 of C. trachomatis CPAF in the active center, were conserved. Thus, our results indicate that after entry, Protochlamydia-secreted CPAF induces mitochondrial dysfunction with a decrease of the membrane potential, followed by caspase-9, caspase-3 and PARP cleavages for apoptosis. More interestingly, because C. trachomatis infection can block the apoptosis, our finding implies unique features of CPAF between pathogenic and primitive chlamydiae.	[Matsuo, Junji; Ito, Atsushi; Yamazaki, Tomohiro; Ishida, Kasumi; Hayashi, Yasuhiro; Yamaguchi, Hiroyuki] Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Sapporo, Hokkaido, Japan; [Nakamura, Shinji] Juntendo Univ, Grad Sch Med, Div Biomed Imaging Res, Tokyo, Japan; [Yoshida, Mitsutaka; Takahashi, Kaori] Juntendo Univ, Grad Sch Med, Div Ultrastruct Res, Tokyo, Japan; [Sekizuka, Tsuyoshi; Takeuchi, Fumihiko; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, Tokyo, Japan; [Nagai, Hiroki] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 565, Japan; [Hayashida, Kyoko; Sugimoto, Chihiro] Hokkaido Univ, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; Juntendo University; Juntendo University; National Institute of Infectious Diseases (NIID); Osaka University; Hokkaido University	Yamaguchi, H (corresponding author), Hokkaido Univ, Fac Hlth Sci, Dept Med Lab Sci, Sapporo, Hokkaido, Japan.	hiroyuki@med.hokudai.ac.jp	Ito, Atsushi/GWU-9716-2022; Sugimoto, Chihiro/F-6583-2012; HAYASHIDA, Kyouko/ABH-6260-2020; Nagai, Hiroki/G-4113-2015; Nagai, Hiroki/GXZ-7815-2022	Sugimoto, Chihiro/0000-0002-8708-0140; HAYASHIDA, Kyouko/0000-0001-9266-5162; Nagai, Hiroki/0000-0003-1659-2197; Sekizuka, Tsuyoshi/0000-0002-1302-5472	KAKENHI [21590474, 24659194, 24117501]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants-in-aid for scientific research from KAKENHI [21590474, 24659194, 24117501 "Innovation Areas (Matryoshika-type evolution)"](http://www.jsps.go.jp/j-grantsinaid/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; Baud D, 2011, CLIN MICROBIOL INFEC, V17, P1312, DOI 10.1111/j.1469-0691.2011.03604.x; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Bertelli C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010890; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Burillo A, 2010, INFECT DIS CLIN N AM, V24, P61, DOI 10.1016/j.idc.2009.10.002; Chen AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002842; Chen D, 2009, ARCH BIOCHEM BIOPHYS, V485, P16, DOI 10.1016/j.abb.2009.01.014; Christian J, 2010, J BIOL CHEM, V285, P41320, DOI 10.1074/jbc.M110.152280; Christian JG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002283; Da Ros CT, 2008, ASIAN J ANDROL, V10, P110, DOI 10.1111/j.1745-7262.2008.00367.x; Elwell CA, 2012, CELL MICROBIOL, V14, P1010, DOI 10.1111/j.1462-5822.2012.01794.x; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; Greub G, 2009, CLIN MICROBIOL INFEC, V15, P18, DOI 10.1111/j.1469-0691.2008.02633.x; Greub G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-48; Greub G, 2003, APPL ENVIRON MICROB, V69, P5530, DOI 10.1128/AEM.69.9.5530-5535.2003; Heinz E, 2010, J BACTERIOL, V192, P5093, DOI 10.1128/JB.00605-10; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Ito A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030270; Jorgensen I, 2011, CELL HOST MICROBE, V10, P21, DOI 10.1016/j.chom.2011.06.008; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Lamoth F, 2010, EXPERT REV ANTI-INFE, V8, P775, DOI 10.1586/ERI.10.52; Lamoth F, 2010, FEMS MICROBIOL REV, V34, P260, DOI 10.1111/j.1574-6976.2009.00207.x; Lutter EI, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/362104; Matsuo J, 2008, APPL ENVIRON MICROB, V74, P6397, DOI 10.1128/AEM.00841-08; Matsuo J, 2010, ENV MICROBIOL REP, V2, P524, DOI 10.1111/j.1758-2229.2009.00094.x; Munoz-Pinedo C, 2012, ADV EXP MED BIOL, V738, P124, DOI 10.1007/978-1-4614-1680-7_8; Mylonas I, 2012, ARCH GYNECOL OBSTET, V285, P1271, DOI 10.1007/s00404-012-2240-7; Paschen SA, 2008, J CELL BIOL, V182, P117, DOI 10.1083/jcb.200804023; Perez-Alvarez S, 2009, BRIT J PHARMACOL, V158, P1121, DOI 10.1111/j.1476-5381.2009.00388.x; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Pustisek N, 2011, COLLEGIUM ANTROPOL, V35, P339; Robertson DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000664; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Sixt BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029565; Slepenkin A, 2003, INFECT IMMUN, V71, P2555, DOI 10.1128/IAI.71.5.2555-2562.2003; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Ueland Thor, 2012, Curr Heart Fail Rep, V9, P92, DOI 10.1007/s11897-012-0088-6; Wilson DP, 2006, B MATH BIOL, V68, P161, DOI 10.1007/s11538-005-9024-1; Zhong GM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00014	41	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56005	10.1371/journal.pone.0056005	http://dx.doi.org/10.1371/journal.pone.0056005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409113	gold, Green Published			2022-12-27	WOS:000315100000039
J	Sumagin, R; Robin, AZ; Nusrat, A; Parkos, CA				Sumagin, Ronen; Robin, Alex Z.; Nusrat, Asma; Parkos, Charles A.			Activation of PKC beta II by PMA Facilitates Enhanced Epithelial Wound Repair through Increased Cell Spreading and Migration	PLOS ONE			English	Article							PROTEIN-KINASE-C; EPIDERMAL-GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; PHORBOL ESTERS; RHO FAMILY; ALPHA; PAXILLIN; ADHESION; EPSILON; INHIBITOR	Rapid repair of epithelial wounds is essential for intestinal homeostasis, and involves cell proliferation and migration, which in turn are mediated by multiple cellular signaling events including PKC activation. PKC isoforms have been implicated in regulating cell proliferation and migration, however, the role of PKCs in intestinal epithelial cell (IEC) wound healing is still not completely understood. In the current work we used phorbol 12-myristate 13-acetate (PMA), a well recognized agonist of classical and non-conventional PKC subfamilies to investigate the effect of PKC activation on IEC wound healing. We found that PMA treatment of wounded IEC monolayers resulted in 5.8+/-0.7-fold increase in wound closure after 24 hours. The PMA effect was specifically mediated by PKC beta II, as its inhibition significantly diminished the PMA-induced increase in wound closure. Furthermore, we show that the PKC beta II-mediated increase in IEC wound closure after PMA stimulation was mediated by increased cell spreading/cell migration but not proliferation. Cell migration was mediated by PKC beta II dependent actin cytoskeleton reorganization, enhanced formation of lamellipodial extrusions at the leading edge and increased activation of the focal adhesion protein, paxillin. These findings support a role for PKC beta II in IEC wound repair and further demonstrate the ability of epithelial cells to migrate as a sheet thereby efficiently covering denuded surfaces to recover the intestinal epithelial barrier.	[Sumagin, Ronen; Robin, Alex Z.; Nusrat, Asma; Parkos, Charles A.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Epithelial Pathobiol & Mucosal Inflammat Res Unit, Atlanta, GA 30322 USA	Emory University	Sumagin, R (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Epithelial Pathobiol & Mucosal Inflammat Res Unit, Atlanta, GA 30322 USA.	ronen.sumagin@emory.edu			NIH [DK061379, DK72564, DK079392, DK055679, DK59888]; Crohn's and Colitis Foundation of America Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072564, R01DK055679, R01DK079392, R29DK055679, R01DK059888, R01DK061379] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	NIH (DK061379, DK72564, DK079392 to C. A. P., DK055679 and DK59888 to A.N.), and Crohn's and Colitis Foundation of America Career Development Award (R. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 1999, GASTROENTEROLOGY, V116, P64, DOI 10.1016/S0016-5085(99)70230-1; Babbin BA, 2007, AM J PATHOL, V170, P951, DOI 10.2353/ajpath.2007.060647; Banan A, 2001, AM J PHYSIOL-GASTR L, V281, pG833, DOI 10.1152/ajpgi.2001.281.3.G833; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; Chang Q, 2003, BRIT J PHARMACOL, V140, P41, DOI 10.1038/sj.bjp.0705398; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Dong ZZ, 2005, MOL CELL PROTEOMICS, V4, P993, DOI 10.1074/mcp.M500044-MCP200; Farhadi A, 2006, J PHARMACOL EXP THER, V316, P1, DOI 10.1124/jpet.105.085449; Gao QY, 2009, MOL VIS, V15, P2683; Gavrielides MV, 2004, CURR DRUG TARGETS, V5, P431, DOI 10.2174/1389450043345380; Goel G, 2007, INT J TOXICOL, V26, P279, DOI 10.1080/10915810701464641; Gonzalez MI, 2003, J NEUROSCI, V23, P5589; Graff JR, 2005, CANCER RES, V65, P7462, DOI 10.1158/0008-5472.CAN-05-0071; He H, 2010, PROSTATE, V70, P1119, DOI 10.1002/pros.21146; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Hopkins AM, 2004, AM J PHYSIOL-GASTR L, V287, pG886, DOI 10.1152/ajpgi.00065.2004; Hu KL, 2000, AM J PHYSIOL-HEART C, V279, pH2658, DOI 10.1152/ajpheart.2000.279.6.H2658; Inagaki K, 2005, CIRCULATION, V111, P44, DOI 10.1161/01.CIR.0000151614.22282.F1; Ivanov AI, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-36; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Kiley SC, 1999, ONCOGENE, V18, P6748, DOI 10.1038/sj.onc.1203101; Koch S, 2009, MOL BIOL CELL, V20, P4816, DOI 10.1091/mbc.E09-05-0415; Koivunen J, 2004, CANCER RES, V64, P5693, DOI 10.1158/0008-5472.CAN-03-3511; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; Larsen EC, 2000, J IMMUNOL, V165, P2809, DOI 10.4049/jimmunol.165.5.2809; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Matthews JD, 2009, VIROLOGY, V390, P315, DOI 10.1016/j.virol.2009.05.019; MURPHY TL, 1995, EXP EYE RES, V60, P683, DOI 10.1016/S0014-4835(05)80010-7; Musashi M, 2000, INT J HEMATOL, V72, P12; Nomura N, 2007, MOL VIS, V13, P2320; NUSRAT A, 1992, J CLIN INVEST, V89, P1501, DOI 10.1172/JCI115741; Owen KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023123; Pan J, 2005, J CELL PHYSIOL, V202, P536, DOI 10.1002/jcp.20151; PARKOS CA, 1992, J CELL BIOL, V117, P757, DOI 10.1083/jcb.117.4.757; Polk DB, 1998, GASTROENTEROLOGY, V114, P493, DOI 10.1016/S0016-5085(98)70532-3; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; RYVES WJ, 1991, FEBS LETT, V288, P5, DOI 10.1016/0014-5793(91)80989-G; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Song JC, 2002, AM J PHYSIOL-CELL PH, V283, pC1548, DOI 10.1152/ajpcell.00105.2002; Souroujon MC, 1998, NAT BIOTECHNOL, V16, P919, DOI 10.1038/nbt1098-919; Stebbins EG, 2001, J BIOL CHEM, V276, P29644, DOI 10.1074/jbc.M101044200; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Tepperman BL, 2005, EUR J PHARMACOL, V518, P1, DOI 10.1016/j.ejphar.2005.06.008; Umar S, 2000, AM J PHYSIOL-GASTR L, V279, pG223, DOI 10.1152/ajpgi.2000.279.1.G223; Verstovsek G, 1998, GASTROENTEROLOGY, V115, P75, DOI 10.1016/S0016-5085(98)70367-1; Wade R, 2002, ONCOGENE, V21, P96, DOI 10.1038/sj.onc.1205013; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Xu KP, 2002, INVEST OPHTH VIS SCI, V43, P3673	53	28	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55775	10.1371/journal.pone.0055775	http://dx.doi.org/10.1371/journal.pone.0055775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409039	Green Submitted, Green Published, gold			2022-12-27	WOS:000315100000023
J	Koen, EL; Bowman, J; Garroway, CJ; Wilson, PJ				Koen, Erin L.; Bowman, Jeff; Garroway, Colin J.; Wilson, Paul J.			The Sensitivity of Genetic Connectivity Measures to Unsampled and Under-Sampled Sites	PLOS ONE			English	Article							LANDSCAPE GENETICS; SPATIAL-ANALYSIS; MIGRATION RATES; MISSING DATA; POPULATION; FLOW; INFERENCE; SOFTWARE; PACKAGE; MARKERS	Landscape genetic analyses assess the influence of landscape structure on genetic differentiation. It is rarely possible to collect genetic samples from all individuals on the landscape and thus it is important to assess the sensitivity of landscape genetic analyses to the effects of unsampled and under-sampled sites. Network-based measures of genetic distance, such as conditional genetic distance (cGD), might be particularly sensitive to sampling intensity because pairwise estimates are relative to the entire network. We addressed this question by subsampling microsatellite data from two empirical datasets. We found that pairwise estimates of cGD were sensitive to both unsampled and under-sampled sites, and F-ST, D-est, and d(eucl) were more sensitive to under-sampled than unsampled sites. We found that the rank order of cGD was also sensitive to unsampled and under-sampled sites, but not enough to affect the outcome of Mantel tests for isolation by distance. We simulated isolation by resistance and found that although cGD estimates were sensitive to unsampled sites, by increasing the number of sites sampled the accuracy of conclusions drawn from landscape genetic analyses increased, a feature that is not possible with pairwise estimates of genetic differentiation such as F-ST, D-est, and d(eucl). We suggest that users of cGD assess the sensitivity of this measure by subsampling within their own network and use caution when making extrapolations beyond their sampled network.	[Koen, Erin L.] Trent Univ, Peterborough, ON K9J 7B8, Canada; [Bowman, Jeff] Ontario Minist Nat Resources, Wildlife Res & Dev Sect, Peterborough, ON, Canada; [Garroway, Colin J.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Wilson, Paul J.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada	Trent University; Ministry of Natural Resources & Forestry; University of Oxford; Trent University	Koen, EL (corresponding author), Trent Univ, Peterborough, ON K9J 7B8, Canada.	erinkoen@trentu.ca	Bowman, Jeff/B-4147-2009	Bowman, Jeff/0000-0002-1892-4469; Garroway, Colin/0000-0002-0955-0688	NSERC; Canada Research Chair; Ontario Living Legacy Trust; Ontario Ministry of Natural Resources	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ontario Living Legacy Trust; Ontario Ministry of Natural Resources	Funding was provided by NSERC (Discovery grants to JB and PJW and a scholarship to ELK), a Canada Research Chair to PJW, the Ontario Living Legacy Trust, and the Ontario Ministry of Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Carr D, 2007, J WILDLIFE MANAGE, V71, P1853, DOI 10.2193/2006-274; Carr D, 2007, OIKOS, V116, P629, DOI 10.1111/j.2007.0030-1299.15568.x; Chessel D., 2004, R NEWS, V4, P5; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coulon A, 2004, MOL ECOL, V13, P2841, DOI 10.1111/j.1365-294X.2004.02253.x; Crawford LA, 2011, CONSERV GENET, V12, P991, DOI 10.1007/s10592-011-0202-4; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Dyer RJ, 2012, PACKAGE GSTUDIO VERS; Dyer RJ, 2010, MOL ECOL, V19, P3746, DOI 10.1111/j.1365-294X.2010.04748.x; Dyer RJ, 2009, MOL ECOL RESOUR, V9, P110, DOI 10.1111/j.1755-0998.2008.02384.x; Frantz TL, 2009, COMPUT MATH ORGAN TH, V15, P303, DOI 10.1007/s10588-009-9063-5; Galpern P, 2012, MOL ECOL, V21, P3996, DOI 10.1111/j.1365-294X.2012.05677.x; Garroway CJ, 2008, EVOL APPL, V1, P620, DOI 10.1111/j.1752-4571.2008.00047.x; Giordano AR, 2007, MOL ECOL, V16, P1625, DOI 10.1111/j.1365-294X.2006.03223.x; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; Hagerty BE, 2011, LANDSCAPE ECOL, V26, P267, DOI 10.1007/s10980-010-9550-6; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hokit DG, 2010, CONSERV GENET, V11, P149, DOI 10.1007/s10592-009-0014-y; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kim PJ, 2007, EUR PHYS J B, V55, P109, DOI 10.1140/epjb/e2007-00033-7; Koen EL, 2012, LANDSCAPE ECOL, V27, P29, DOI 10.1007/s10980-011-9675-2; Kossinets G, 2006, SOC NETWORKS, V28, P247, DOI 10.1016/j.socnet.2005.07.002; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Landguth EL, 2012, MOL ECOL RESOUR, V12, P276, DOI 10.1111/j.1755-0998.2011.03077.x; Landguth EL, 2010, MOL ECOL RESOUR, V10, P156, DOI 10.1111/j.1755-0998.2009.02719.x; Lange R, 2012, LANDSCAPE ECOL, V27, P381, DOI 10.1007/s10980-011-9692-1; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Leng L, 2011, MOL ECOL, V20, P2494, DOI 10.1111/j.1365-294X.2011.05108.x; Maindonald JH, 2012, DATA ANAL GRAPHICS U; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; MANTEL N, 1967, CANCER RES, V27, P209; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Naujokaitis-Lewis IR, 2013, CONSERV GENET, V14, P287, DOI 10.1007/s10592-012-0385-3; Oyler-McCance SJ, 2013, CONSERV GENET, V14, P275, DOI 10.1007/s10592-012-0415-1; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Robins G, 2004, SOC NETWORKS, V26, P257, DOI 10.1016/j.socnet.2004.05.001; Rogers JS, 1972, STUDIES GENETICS, P145; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Slatkin M, 2005, MOL ECOL, V14, P67, DOI 10.1111/j.1365-294X.2004.02393.x; Spear SF, 2012, ECOL APPL, V22, P856, DOI 10.1890/11-0627.1; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Wasserman TN, 2010, LANDSCAPE ECOL, V25, P1601, DOI 10.1007/s10980-010-9525-7; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x	54	20	20	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56204	10.1371/journal.pone.0056204	http://dx.doi.org/10.1371/journal.pone.0056204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409155	gold, Green Published			2022-12-27	WOS:000314660300067
J	Mansure, JJ; Nassim, R; Chevalier, S; Szymanski, K; Rocha, J; Aldousari, S; Kassouf, W				Mansure, Jose Joao; Nassim, Roland; Chevalier, Simone; Szymanski, Konrad; Rocha, Joice; Aldousari, Saad; Kassouf, Wassim			A Novel Mechanism of PPAR Gamma Induction via EGFR Signalling Constitutes Rational for Combination Therapy in Bladder Cancer	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; GROWTH-FACTOR RECEPTOR; LUNG-CANCER; KINASE INHIBITORS; CARCINOMA-CELLS; IN-VITRO; EXPRESSION; GEFITINIB; GENE; MUTATIONS	Background: Two signalling molecules that are attractive for targeted therapy are the epidermal growth factor receptor (EGFR) and the peroxisome proliferator-activated receptor gamma (PPAR gamma). We investigated possible crosstalk between these 2 pathways, particularly in light of the recent evidence implicating PPAR gamma for anticancer therapy. Principal Findings: As evaluated by MTT assays, gefitinib (EGFR inhibitor) and DIM-C (PPAR gamma agonist) inhibited growth of 9 bladder cancer cell lines in a dose-dependent manner but with variable sensitivity. In addition, combination of gefitinib and DIM-C demonstrated maximal inhibition of cell proliferation compared to each drug alone. These findings were confirmed in vivo, where combination therapy maximally inhibited tumor growth in contrast to each treatment alone when compared to control (p<0.04). Induction of PPAR gamma expression along with nuclear accumulation was observed in response to increasing concentrations of gefitinib via activation of the transcription factor CCAT/enhancer-binding protein-beta (CEBP-beta). In these cell lines, DIM-C significantly sensitized bladder cancer cell lines that were resistant to EGFR inhibition in a schedule-specific manner. Conclusion: These results suggest that PPAR gamma agonist DIM-C can be an excellent alternative to bladder tumors resistant to EGFR inhibition and combination efficacy might be achieved in a schedule-specific manner.	[Mansure, Jose Joao; Nassim, Roland; Chevalier, Simone; Szymanski, Konrad; Rocha, Joice; Aldousari, Saad; Kassouf, Wassim] McGill Univ, Div Urol, Ctr Hlth, Montreal, PQ, Canada	McGill University	Kassouf, W (corresponding author), McGill Univ, Div Urol, Ctr Hlth, Montreal, PQ, Canada.	wassim.kassouf@muhc.mcgill.ca			Cancer Research Society; FRSQ	Cancer Research Society; FRSQ(Fonds de la Recherche en Sante du Quebec)	This study was supported by the Cancer Research Society. (http://www.src-crs.ca/en-CA) W. Kassouf is a recipient of a clinical research scholar award from the FRSQ. (http://www.frsq.gouv.qc.ca/en/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; Blehm KN, 2006, CLIN CANCER RES, V12, P4671, DOI 10.1158/1078-0432.CCR-06-0407; Burgermeister E, 2003, ONCOGENE, V22, P3888, DOI 10.1038/sj.onc.1206625; Ciardiello F, 2000, DRUGS, V60, P25, DOI 10.2165/00003495-200060001-00003; DINNEY CPN, 1995, J UROLOGY, V154, P1532, DOI 10.1016/S0022-5347(01)66923-4; Dormandy J, 2009, DRUG SAFETY, V32, P187, DOI 10.2165/00002018-200932030-00002; Emmans VC, 2004, BIOCHEM SOC T, V32, P840, DOI 10.1042/BST0320840; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Guan You-Fei, 1999, Neoplasia (New York), V1, P330, DOI 10.1038/sj.neo.7900050; Hau P, 2007, ONCOLOGY-BASEL, V73, P21, DOI 10.1159/000120028; Kassouf W, 2006, CANCER RES, V66, P412, DOI 10.1158/0008-5472.CAN-05-2755; Kassouf W, 2005, CANCER RES, V65, P10524, DOI 10.1158/0008-5472.CAN-05-1536; Kassouf W, 2008, J UROLOGY, V179, P353, DOI 10.1016/j.juro.2007.08.087; Lee SY, 2006, LUNG CANCER, V51, P297, DOI 10.1016/j.lungcan.2005.10.010; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Lin JG, 2008, LAB INVEST, V88, P529, DOI 10.1038/labinvest.2008.20; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mansure J. J., 2009, CANCER BIOL THER, V8, P6, DOI DOI 10.4161/CBT.8.7.7853; Mendelsohn J, 2001, J UROLOGY, V165, P1152, DOI 10.1016/S0022-5347(05)66453-1; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Motomura W, 2000, CANCER RES, V60, P5558; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; PETTAWAY CA, 1995, J UROLOGY, V154, P1999, DOI 10.1016/S0022-5347(01)66671-0; Sabichi A, 2006, J UROLOGY, V175, P1133, DOI 10.1016/S0022-5347(05)00323-X; Shrader M, 2007, MOL CANCER THER, V6, P277, DOI 10.1158/1535-7163.MCT-06-0513; Suzuki T, 2003, LUNG CANCER-J IASLC, V42, P35, DOI 10.1016/S0169-5002(03)00278-2; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Xin XH, 1999, J BIOL CHEM, V274, P9116, DOI 10.1074/jbc.274.13.9116; Zhou YJ, 2007, LAB INVEST, V87, P488, DOI 10.1038/labinvest.3700532; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	31	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55997	10.1371/journal.pone.0055997	http://dx.doi.org/10.1371/journal.pone.0055997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409107	Green Submitted, gold, Green Published			2022-12-27	WOS:000314660300049
J	Figueroa, L; Shkryl, VM; Blatter, LA; Rios, E				Figueroa, Lourdes; Shkryl, Vyacheslav M.; Blatter, Lothar A.; Rios, Eduardo			Using Two Dyes with the Same Fluorophore to Monitor Cellular Calcium Concentration in an Extended Range	PLOS ONE			English	Article							MUSCLE; CA2+	We extend the sensitivity of quantitative concentration imaging to an approximately 1000-fold range of concentrations by a method that uses two fluorescent dyes with the same fluorophore, having different affinity for the monitored species. While the formulation and illustration refer to a monitor of calcium concentration, the method is applicable to any species that binds to multiple indicators with the same spectral properties. The use of a common fluorophore has the virtue of leaving vast regions of the electromagnetic spectrum available for other applications. We provide the exact analytic expression relating measured fluorescence to [Ca2+] at equilibrium and an approximate analytic expression that does not require the equilibrium assumption. The sensitivity of the method is calculated numerically for two useful dye pairs. As illustrative application of the enhanced measurement, we use fluo-4 and fluo-4FF to image the calcium wave produced by a cardiac myocyte in response to a small artificial calcium spark.	[Figueroa, Lourdes; Blatter, Lothar A.; Rios, Eduardo] Rush Univ, Dept Mol Biophys & Physiol, Sect Cellular Signaling, Chicago, IL 60612 USA; [Shkryl, Vyacheslav M.] AA Bogomoletz Inst Physiol, Lab Biophys Ion Channels, Dept Gen Physiol Nervous Syst, Kiev, Ukraine	Rush University; National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology	Rios, E (corresponding author), Rush Univ, Dept Mol Biophys & Physiol, Sect Cellular Signaling, Chicago, IL 60612 USA.	erios@rush.edu	Blatter, Lothar/AAC-8431-2020	Figueroa, Lourdes Carolina/0000-0002-4323-4507	National Center for Research Resources; Rush University's Hasterlik Philanthropic Fund; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIAMS [AR049184, AR032808]; National Heart and Lung Institute [HL62231, HL80101, HL101235]; Leducq Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024707] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062231, R01HL101235, P01HL080101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049184, R01AR032808, R37AR032808] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Rush University's Hasterlik Philanthropic Fund; National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Leducq Foundation(Leducq Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Center for Research Resources, Rush University's Hasterlik Philanthropic Fund and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIAMS, (AR049184 and AR032808) to E. Rios, and the National Heart and Lung Institute (HL62231, HL80101 and HL101235) and the Leducq Foundation to L. Blatter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Figueroa L, 2012, J PHYSIOL-LONDON, V590, P1389, DOI 10.1113/jphysiol.2011.225854; Launikonis BS, 2005, J PHYSIOL-LONDON, V567, P523, DOI 10.1113/jphysiol.2005.087973; Shkryl VM, 2012, J GEN PHYSIOL, V139, P189, DOI 10.1085/jgp.201110709	3	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55778	10.1371/journal.pone.0055778	http://dx.doi.org/10.1371/journal.pone.0055778			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409040	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200061
J	Lu, L; Dai, YH; Du, XP; She, WD; Zhang, XL; Wu, Q; Yuan, WJ; Chen, F				Lu, Ling; Dai, Yanhong; Du, Xiaoping; She, Wandong; Zhang, Xiuling; Wu, Qin; Yuan, Wenjie; Chen, Feng			Relationship of Glucocorticoid Receptor Expression in Peripheral Blood Mononuclear Cells and the Cochlea of Guinea Pigs and Effects of Dexamethasone Administration	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; RESISTANCE; BETA; MUTATIONS; THERAPY; EAR	Background: Glucocorticoids (GCs) are widely used to treat sudden sensorineural hearing loss (SSNHL) and significantly improve hearing. However, GC insensitivity has been observed in some patients of SSNHL. Objective: To study the correlation between GR expression in peripheral blood mononuclear cells (PBMCs) and in the cochlea of guinea pigs at mRNA and protein levels. Methods: One group of guinea pigs received dexamethasone (10 mg/kg/day) intraperitoneally for 7 consecutive days (dexamethasone group), and another group of guinea pigs received normal saline (control group). Real time PCR and Western blotting were used to detect the expression of GR mRNA and GR protein in PBMCs and the cochleae. Results: The GR mRNA and GR protein were detected in both PBMCs and the cochlear tissue of guinea pigs. GR mRNA and GR protein levels in PBMCs were positively correlated with those in the cochlea. The expression of GR mRNA and GR protein was significantly increased in the dexamethasone group compared to the control group. Conclusions: Levels of GR mRNA and GR protein in the PBMCs were positively correlated with those in the cochlea of guinea pigs. Systemic dexamethasone treatment can significantly up-regulate GR expression in PBMCs and in the cochlea. Measurement of the GR level in PBMCs could be used as an indicator of GR level in the cochlea.	[Lu, Ling; Dai, Yanhong; She, Wandong; Chen, Feng] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Otolaryngol Head & Neck Surg, Nanjing 210008, Jiangsu, Peoples R China; [Du, Xiaoping] Hough Ear Inst, Oklahoma City, OK USA; [Zhang, Xiuling] Southeast Univ, Coll Med, Jiangyin Peoples Hosp, Jiangyin, Jiangsu, Peoples R China; [Wu, Qin; Yuan, Wenjie] Nanjing Univ, Sch Med, Microbiol Lab, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Southeast University - China; Nanjing University	She, WD (corresponding author), Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Otolaryngol Head & Neck Surg, Nanjing 210008, Jiangsu, Peoples R China.	shewandong@163.com			Six Talents Peak Projects from Jiangsu Province; Health Bureau of Nanjing City, China [WKK09105]; international cooperation projects from Nanjing Municipal Science and Technology Commission, China [2012sd311038]	Six Talents Peak Projects from Jiangsu Province; Health Bureau of Nanjing City, China; international cooperation projects from Nanjing Municipal Science and Technology Commission, China	The funders included a grant of Six Talents Peak Projects from Jiangsu Province (2009), a grant for the Development of Medical Sciences from the Health Bureau of Nanjing City, China (NO: WKK09105), and a grant of international cooperation projects from Nanjing Municipal Science and Technology Commission, China (NO: 2012sd311038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Charmandari E, 2009, METHODS MOL BIOL, V590, P33, DOI 10.1007/978-1-60327-378-7_3; CORRIGAN CJ, 1991, AM REV RESPIR DIS, V144, P1026, DOI 10.1164/ajrccm/144.5.page; Dodson Kelley M, 2004, Ear Nose Throat J, V83, P394; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Fuse T, 2002, ORL J OTO-RHINO-LARY, V64, P6, DOI 10.1159/000049079; Gordijn MS, 2012, COCHRANE DB SYST REV, V5; GREENSTEIN B, 1994, LUPUS, V3, P143, DOI 10.1177/096120339400300302; Gross KL, 2009, MOL CELL ENDOCRINOL, V300, P7, DOI 10.1016/j.mce.2008.10.001; He Xiao-jie, 2005, Zhonghua Er Ke Za Zhi, V43, P109; Jewell CM, 2012, MOL ENDOCRINOL, V26, P244, DOI 10.1210/me.2011-1116; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; KIRKHAM BW, 1991, J RHEUMATOL, V18, P821; Kumagami H, 2013, OTOL NEUROTOL, V34, P151, DOI 10.1097/MAO.0b013e31826a55ad; Leung DYM, 1997, J EXP MED, V186, P1567, DOI 10.1084/jem.186.9.1567; Lewis-Tuffin LJ, 2006, ANN NY ACAD SCI, V1069, P1, DOI 10.1196/annals.1351.001; Mazurek B, 2010, HEARING RES, V259, P55, DOI 10.1016/j.heares.2009.10.006; McMahon SK, 2010, J CLIN ENDOCR METAB, V95, P297, DOI 10.1210/jc.2009-1003; Morawski K, 2009, OTOL NEUROTOL, V30, P851, DOI 10.1097/MAO.0b013e3181b12296; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; Pujols L, 2008, ALLERGY, V63, P1377, DOI 10.1111/j.1398-9995.2008.01745.x; Rarey KE, 1996, OTOLARYNG HEAD NECK, V115, P38, DOI 10.1016/S0194-5998(96)70133-X; Rauch SD, 2004, OTOLARYNG CLIN N AM, V37, P1061, DOI 10.1016/j.otc.2004.04.004; Schreiber BE, 2010, LANCET, V375, P1203, DOI 10.1016/S0140-6736(09)62071-7; She WD, 2010, OTOLARYNG HEAD NECK, V142, P266, DOI 10.1016/j.otohns.2009.10.046; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Trune DR, 2006, HEARING RES, V212, P22, DOI 10.1016/j.heares.2005.10.006; Wallace AD, 2001, J BIOL CHEM, V276, P42714, DOI 10.1074/jbc.M106033200; Westerlaken BO, 2007, LARYNGOSCOPE, V117, P684, DOI 10.1097/mlg.0b013e3180316d3b; Yoo YM, 2011, LIFE SCI, V89, P615, DOI 10.1016/j.lfs.2011.08.001	32	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56323	10.1371/journal.pone.0056323	http://dx.doi.org/10.1371/journal.pone.0056323			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409174	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200133
J	Zhang, B; Zhang, L; Dai, RX; Yu, MY; Zhao, GP; Ding, XM				Zhang, Bo; Zhang, Lin; Dai, Ruixue; Yu, Meiying; Zhao, Guoping; Ding, Xiaoming			An Efficient Procedure for Marker-Free Mutagenesis of S. coelicolor by Site-Specific Recombination for Secondary Metabolite Overproduction	PLOS ONE			English	Article							GENE-TARGETING VECTORS; STREPTOMYCES PHAGE PHI-BT1; FUNCTIONAL-ANALYSIS; BIOSYNTHESIS; INTEGRATION; CLONING; SYSTEM	Streptomyces bacteria are known for producing important natural compounds by secondary metabolism, especially antibiotics with novel biological activities. Functional studies of antibiotic-biosynthesizing gene clusters are generally through homologous genomic recombination by gene-targeting vectors. Here, we present a rapid and efficient method for construction of gene-targeting vectors. This approach is based on Streptomyces phage phi BT1 integrase-mediated multisite in vitro site-specific recombination. Four 'entry clones' were assembled into a circular plasmid to generate the destination gene-targeting vector by a one-step reaction. The four 'entry clones' contained two clones of the upstream and downstream flanks of the target gene, a selectable marker and an E. coli-Streptomyces shuttle vector. After targeted modification of the genome, the selectable markers were removed by phi C31 integrase-mediated in vivo site-specific recombination between pre-placed attB and attP sites. Using this method, part of the calcium-dependent antibiotic (CDA) and actinorhodin (Act) biosynthetic gene clusters were deleted, and the rrdA encoding RrdA, a negative regulator of Red production, was also deleted. The final prodiginine production of the engineered strain was over five times that of the wildtype strain. This straightforward phi BT1 and phi C31 integrase-based strategy provides an alternative approach for rapid genetargeting vector construction and marker removal in streptomycetes.	[Zhang, Bo; Zhang, Lin; Dai, Ruixue; Yu, Meiying; Zhao, Guoping; Ding, Xiaoming] Fudan Univ, Dept Microbiol & Microbial Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Zhang, Lin; Zhao, Guoping] Chinese Acad Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Zhao, Guoping] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guoping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Zhao, GP (corresponding author), Fudan Univ, Dept Microbiol & Microbial Engn, Sch Life Sci, Shanghai 200433, Peoples R China.	gpzhao@sibs.ac.cn; xmding74@fudan.edu.cn		Zhao, Guo-Ping/0000-0002-7621-6620; Dai, Ruixue/0000-0002-3703-0153; Zhang, Lin/0000-0001-5431-5006	National High Technology Research and Development Program of China (863 Program) [2007AA021206]; National Basic Research Program of China (973 Program) [2012CB721102]; China Postdoctoral Science Foundation [2012T50444, 2012M520947]; National Natural Science Foundation of China [30600009, 30830002]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National High Technology Research and Development Program of China (863 Program) (grant number 2007AA021206), National Basic Research Program of China (973 Program) (grant number 2012CB721102), the China Postdoctoral Science Foundation funded project (grant numbers 2012T50444 and 2012M520947) and the National Natural Science Foundation of China (grant numbers 30600009, 30830002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Cotta-De-Almeida V, 2003, GENOME RES, V13, P2190, DOI 10.1101/gr.1356503; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fedoryshyn M, 2008, GENE, V419, P43, DOI 10.1016/j.gene.2008.04.011; Frandsen RJN, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-70; Fu CL, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn167; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Gust B, 2002, STREPTOMYCES COELI A; HARTLEY JL, 2000, GENOME RES, V10, P1788, DOI DOI 10.1101/GR.143000; Herrmann S, 2012, APPL ENVIRON MICROB, V78, P1804, DOI 10.1128/AEM.06054-11; Iiizumi S, 2006, BIOTECHNIQUES, V41, P311, DOI 10.2144/000112233; Inoue K, 2009, GENE THER, V16, P1383, DOI 10.1038/gt.2009.105; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Ou XJ, 2009, APPL ENVIRON MICROB, V75, P2158, DOI 10.1128/AEM.02209-08; Raynal A, 2006, APPL ENVIRON MICROB, V72, P4839, DOI 10.1128/AEM.00167-06; Sambrook J., 2001, MOL CLONING LAB MANU; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Turakainen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004341; Turan S, 2011, FASEB J, V25, P4088, DOI 10.1096/fj.11-186940; Vilen H, 2001, TRANSGENIC RES, V10, P69, DOI 10.1023/A:1008959231644; Williamson NR, 2006, NAT REV MICROBIOL, V4, P887, DOI 10.1038/nrmicro1531; Williamson NR, 2005, MOL MICROBIOL, V56, P971, DOI 10.1111/j.1365-2958.2005.04602.x; Wu S, 2008, NAT PROTOC, V3, P1056, DOI 10.1038/nprot.2008.70; Zhang CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni014; Zhang L, 2008, J BACTERIOL, V190, P6392, DOI 10.1128/JB.00777-08; Zhang L, 2011, SCI REP-UK, V1, DOI 10.1038/srep00141; Zhang L, 2010, J MOL CELL BIOL, V2, P264, DOI 10.1093/jmcb/mjq025; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	32	11	12	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55906	10.1371/journal.pone.0055906	http://dx.doi.org/10.1371/journal.pone.0055906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409083	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200086
J	Di Luccio, E; Ishida, Y; Leal, WS; Wilson, DK				Di Luccio, Eric; Ishida, Yuko; Leal, Walter S.; Wilson, David K.			Crystallographic Observation of pH-Induced Conformational Changes in the Amyelois transitella Pheromone-Binding Protein AtraPBP1	PLOS ONE			English	Article							NAVEL ORANGEWORM MOTH; CRYSTAL-STRUCTURE; MACROMOLECULAR STRUCTURES; RELEASE MECHANISM; LIGAND RELEASE; NMR STRUCTURE; COMMUNICATION	The navel orangeworm, Amyelois transitella is a major agricultural pest causing large losses in a variety of tree crops. Control of this insect pest may be achieved by interfering with olfactory pathways to block detection of female-produced sex pheromones and consequently, disrupt mating. The first component of this pathway is the pheromone-binding protein AtraPBP1, which recognizes the pheromone and presents it to the odorant receptor housed in a sensory neuron of the male antennae. Release of the ligand depends on a pH-induced conformational change associated with the acidity of the membrane surface. To characterize this conformational change and to understand how pheromones bind, we have determined the high resolution crystal structures of AtraPBP1 in complex with two main constituents of the sex pheromone, i.e., (11Z, 13Z)-hexadecadienal and (11Z, 13Z)-hexadecadienol. Comparison with the structure of the unliganded form demonstrates a large similar to 90 degrees movement of the C-terminal helix which is observed in other pheromone- or odorant-binding proteins accompanied by an unpredicted 37 degrees displacement of the N-terminal helix. Molecular dynamic trajectories suggest that the conformational change of the alpha 1 helix facilitates the movement of the C-terminal helix.	[Di Luccio, Eric; Wilson, David K.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Ishida, Yuko; Leal, Walter S.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Wilson, DK (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	dave@alanine.ucdavis.edu	di Luccio, Eric/Z-5388-2019; Leal, Walter/ABC-6940-2021	Leal Filho, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-6800-1240; di Luccio, Eric/0000-0002-2256-2157	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2010-65105-20582]; National Science Foundation [0918177]; National Institutes of Health [1R01AI095514-01A1]; National Research Foundation of Korea [2010-010837]; Kyungpook National University [2010-05950000]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095514] Funding Source: NIH RePORTER	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); Kyungpook National University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Agriculture and Food Research Initiative Competitive Grant no. 2010-65105-20582 from the USDA National Institute of Food and Agriculture, the National Science Foundation grant #0918177, National Institutes of Health 1R01AI095514-01A1, the National Research Foundation of Korea (grant 2010-010837 to EDL) and Kyungpook National University (grant 2010-05950000 to EDL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burks CS, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.40; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kowcun A, 2001, J BIOL CHEM, V276, P44770, DOI 10.1074/jbc.M104688200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Lartigue A, 2004, J BIOL CHEM, V279, P4459, DOI 10.1074/jbc.M311212200; Lartigue A, 2003, J BIOL CHEM, V278, P30213, DOI 10.1074/jbc.M304688200; Lautenschlager C, 2007, STRUCTURE, V15, P1148, DOI 10.1016/j.str.2007.07.013; Leal WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007235; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leal WS, 2005, NATURWISSENSCHAFTEN, V92, P139, DOI 10.1007/s00114-004-0598-5; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lescop E, 2001, J BIOMOL NMR, V21, P181, DOI 10.1023/A:1012428527813; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pesenti ME, 2008, J MOL BIOL, V380, P158, DOI 10.1016/j.jmb.2008.04.048; Pesenti ME, 2009, J MOL BIOL, V390, P981, DOI 10.1016/j.jmb.2009.05.067; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Schrodinger L., 2020, PYMOL; Witzgall P, 2008, ANNU REV ENTOMOL, V53, P503, DOI 10.1146/annurev.ento.53.103106.093323; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Wriggers W, 1997, PROTEINS, V29, P1; Xu W, 2011, BIOCHEM BIOPH RES CO, V404, P335, DOI 10.1016/j.bbrc.2010.11.119; Xu XZ, 2010, BIOCHEMISTRY-US, V49, P1469, DOI 10.1021/bi9020132; Zubkov S, 2005, J MOL BIOL, V354, P1081, DOI 10.1016/j.jmb.2005.10.015	35	30	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e53840	10.1371/journal.pone.0053840	http://dx.doi.org/10.1371/journal.pone.0053840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418423	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300013
J	Sun, ZL; Lam, KM; Dong, ZY; Wang, H; Gao, QW; Zheng, CH				Sun, Zhan-Li; Lam, Kin-Man; Dong, Zhao-Yang; Wang, Han; Gao, Qing-Wei; Zheng, Chun-Hou			Face Recognition with Multi-Resolution Spectral Feature Images	PLOS ONE			English	Article							SINGLE EXAMPLE IMAGE; ONE TRAINING IMAGE; EXPRESSION; SAMPLE; FLDA	The one-sample-per-person problem has become an active research topic for face recognition in recent years because of its challenges and significance for real-world applications. However, achieving relatively higher recognition accuracy is still a difficult problem due to, usually, too few training samples being available and variations of illumination and expression. To alleviate the negative effects caused by these unfavorable factors, in this paper we propose a more accurate spectral feature image-based 2DLDA (two-dimensional linear discriminant analysis) ensemble algorithm for face recognition, with one sample image per person. In our algorithm, multi-resolution spectral feature images are constructed to represent the face images; this can greatly enlarge the training set. The proposed method is inspired by our finding that, among these spectral feature images, features extracted from some orientations and scales using 2DLDA are not sensitive to variations of illumination and expression. In order to maintain the positive characteristics of these filters and to make correct category assignments, the strategy of classifier committee learning (CCL) is designed to combine the results obtained from different spectral feature images. Using the above strategies, the negative effects caused by those unfavorable factors can be alleviated efficiently in face recognition. Experimental results on the standard databases demonstrate the feasibility and efficiency of the proposed method.	[Sun, Zhan-Li; Gao, Qing-Wei; Zheng, Chun-Hou] Anhui Univ, Sch Elect Engn & Automat, Hefei 230039, Peoples R China; [Lam, Kin-Man] Hong Kong Polytech Univ, Dept Elect & Informat Engn, Hong Kong, Hong Kong, Peoples R China; [Dong, Zhao-Yang] Univ Newcastle, Ctr Intelligent Elect Networks, Newcastle, NSW 2300, Australia; [Wang, Han] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore	Anhui University; Hong Kong Polytechnic University; University of Newcastle; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zheng, CH (corresponding author), Anhui Univ, Sch Elect Engn & Automat, Hefei 230039, Peoples R China.	zhengch99@126.com	han, wang/GXV-3286-2022; Kan, Kin-Man/A-9352-2014; yang, dong zhao/AFP-5094-2022; Wang, Han/GPW-9809-2022; han, wang/GXV-3327-2022; Wang, Han/A-5016-2011	Kan, Kin-Man/0000-0002-0422-8454; Wang, Han/0000-0001-5448-9903; Dong, Zhao Yang/0000-0001-9659-0858	National Science Foundation of China [60905023, 61272339]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by grants from National Science Foundation of China (Nos. 60905023, 61272339). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowyer KW, 2006, COMPUT VIS IMAGE UND, V101, P1, DOI 10.1016/j.cviu.2005.05.005; Cai D, 2006, IEEE T IMAGE PROCESS, V15, P3608, DOI 10.1109/TIP.2006.881945; Chen SC, 2004, PATTERN RECOGN LETT, V25, P1173, DOI 10.1016/j.patrec.2004.03.012; Chen SC, 2004, PATTERN RECOGN, V37, P1553, DOI 10.1016/j.patcog.2003.12.010; Chen YM, 2010, NEUROCOMPUTING, V73, P3089, DOI 10.1016/j.neucom.2010.06.007; Chen YM, 2010, PATTERN RECOGN LETT, V31, P1833, DOI 10.1016/j.patrec.2010.03.018; De la Torre F, 2005, PROC CVPR IEEE, P266; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Gao QX, 2008, APPL MATH COMPUT, V205, P726, DOI 10.1016/j.amc.2008.05.019; Huang D.-S., 1996, SYSTEMATIC THEORY NE; Huang DS, 2004, IEEE T NEURAL NETWOR, V15, P477, DOI 10.1109/TNN.2004.824424; Huang G., 2007, LABELED FACES WILD D, P10; Jain A.K., 2011, HDB FACE RECOGNITION, V1; Kanan HR, 2008, PATTERN RECOGN, V41, P3799, DOI 10.1016/j.patcog.2008.05.024; Kanan HR, 2010, IMAGE VISION COMPUT, V28, P438, DOI 10.1016/j.imavis.2009.06.013; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Lam KM, 1998, IEEE T PATTERN ANAL, V20, P673, DOI 10.1109/34.689299; Levine MD, 2009, PATTERN RECOGN LETT, V30, P908, DOI 10.1016/j.patrec.2009.03.011; Levine MD, 2006, COMPUT VIS IMAGE UND, V104, P1, DOI 10.1016/j.cviu.2006.06.004; Li M, 2005, PATTERN RECOGN LETT, V26, P527, DOI 10.1016/j.patrec.2004.09.007; Martinez AM, 2002, IEEE T PATTERN ANAL, V24, P748, DOI 10.1109/TPAMI.2002.1008382; Niyogi P, 1998, P IEEE, V86, P2196, DOI 10.1109/5.726787; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Quaglia A., 2012, FACE RECOGNITION MET; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; Sun ZL, 2013, IEEE T IMAGE PROCESS, V22, P17, DOI 10.1109/TIP.2012.2204269; Sun ZL, 2010, NEUROCOMPUTING, V73, P2971, DOI 10.1016/j.neucom.2010.07.004; Sun ZL, 2011, IEEE T INF FOREN SEC, V6, P360, DOI 10.1109/TIFS.2011.2118207; Tan XY, 2006, PATTERN RECOGN, V39, P1725, DOI 10.1016/j.patcog.2006.03.013; Wu JX, 2002, PATTERN RECOGN LETT, V23, P1711, DOI 10.1016/S0167-8655(02)00134-4; Xie XD, 2008, PATTERN RECOGN, V41, P406, DOI 10.1016/j.patcog.2007.03.020; Yang J, 2010, PATTERN RECOGN, V43, P1454, DOI 10.1016/j.patcog.2009.11.014; Ye J., 2004, P ADV NEUR INF PROC, P1569; Zhang DQ, 2005, APPL MATH COMPUT, V163, P895, DOI 10.1016/j.amc.2004.04.016	34	5	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55700	10.1371/journal.pone.0055700	http://dx.doi.org/10.1371/journal.pone.0055700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418451	Green Published, gold			2022-12-27	WOS:000315970300042
J	He, X; Li, D; Luo, ZW; Liang, H; Peng, H; Zhao, YY; Wang, ND; Liu, DH; Qin, C; Wei, Q; Yan, HM; Shao, YM				He, Xuan; Li, Dan; Luo, Zhenwu; Liang, Hua; Peng, Hong; Zhao, Yangyang; Wang, Nidan; Liu, Donghua; Qin, Chuan; Wei, Qiang; Yan, Huimin; Shao, Yiming			Compromised NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Chronic SIV/SHIV Infection	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DELTA T-CELLS; RHESUS MACAQUES; PROTECTIVE EFFICACY; IN-VITRO; ACTIVATION; METALLOPROTEASE; IDENTIFICATION; STIMULATION; INHIBITORS	Increasing evidence indicates that antibody-dependent cellular cytotoxicity (ADCC) contributes to the control of HIV/SIV infection. However, little is known about the ADCC function of natural killer (NK) cells in non-human primate model. Here we demonstrated that ADCC function of NK cells was significantly compromised in chronic SIV/SHIV infection, correlating closely with the expression of Fc gamma RIIIa receptor (CD16) on NK cells. CD32, another class of IgG Fc receptors, was identified on NK cells with higher expression in the infected macaques and the blockade of CD32 impacted the ability of NK cells to respond to antibody-coated target cells. The inhibition of matrix metalloproteases (MMPs), a group of enzymes normally involved in tissue/receptor remodeling, could restore NK cell-mediated ADCC with increased CD16 expression on macaque NK cells. These data offer a clearer understanding of NK cell-mediated ADCC in rhesus macaques, which will allow us to evaluate the ADCC repertoire arising from preclinical vaccination studies in non-human primates and inform us in the future design of effective HIV vaccination strategies.	[He, Xuan; Luo, Zhenwu; Yan, Huimin] Chinese Acad Sci, Wuhan Inst Virol, Beijing 100864, Peoples R China; [He, Xuan; Li, Dan; Luo, Zhenwu; Liang, Hua; Peng, Hong; Zhao, Yangyang; Wang, Nidan; Liu, Donghua; Shao, Yiming] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Qin, Chuan; Wei, Qiang] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100730, Peoples R China; [Qin, Chuan; Wei, Qiang] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yan, HM (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Beijing 100864, Peoples R China.	hmyan@wh.iov.cn; yshao08@gmail.com	zhao, yang/GXF-4424-2022; Luo, Zhenwu/H-9478-2018	Yan, Huimin/0000-0002-7243-8429	National Major projects for Infectious Diseases Control and Prevention [2012ZX10001008]; National Natural Science Foundation of China [81020108030, 31100126]; SKLID Development grant [2012SKLID103, 2011SKLID207]; Analysis of genetic and immunological background of Macaque Rhesus in China [2012ZX10004501-001-006]	National Major projects for Infectious Diseases Control and Prevention; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SKLID Development grant; Analysis of genetic and immunological background of Macaque Rhesus in China	This work was supported by National Major projects for Infectious Diseases Control and Prevention (2012ZX10001008), National Natural Science Foundation of China (81020108030, 31100126), SKLID Development grant (2012SKLID103, 2011SKLID207), Analysis of genetic and immunological background of Macaque Rhesus in China (2012ZX10004501-001-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD A, 1994, J ACQ IMMUN DEF SYND, V7, P428; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Angelini DF, 2004, BLOOD, V104, P1801, DOI 10.1182/blood-2004-01-0331; Asmal M, 2011, J VIROL, V85, P5465, DOI 10.1128/JVI.00313-11; Berman NEJ, 1999, NEUROBIOL DIS, V6, P486, DOI 10.1006/nbdi.1999.0261; Boulet S, 2010, J IMMUNOL, V184, P2057, DOI 10.4049/jimmunol.0902621; Choi EI, 2008, J VIROL, V82, P6758, DOI 10.1128/JVI.02277-07; Couzi L, 2012, BLOOD, V119, P1418, DOI 10.1182/blood-2011-06-363655; Craston R, 1997, J IMMUNOL METHODS, V209, P37, DOI 10.1016/S0022-1759(97)00143-9; Dutertre CA, 2008, J LEUKOCYTE BIOL, V84, P1511, DOI 10.1189/jlb.0608343; Florese RH, 2006, J IMMUNOL, V177, P4028, DOI 10.4049/jimmunol.177.6.4028; Florese RH, 2009, J IMMUNOL, V182, P3718, DOI 10.4049/jimmunol.0803115; Forthal DN, 2001, AIDS RES HUM RETROV, V17, P553, DOI 10.1089/08892220151126661; Forthal DN, 1999, J INFECT DIS, V180, P1338, DOI 10.1086/314988; Gomez-Roman VR, 2006, J IMMUNOL METHODS, V308, P53, DOI 10.1016/j.jim.2005.09.018; Gomez-Roman VR, 2005, J IMMUNOL, V174, P2185, DOI 10.4049/jimmunol.174.4.2185; Grzywacz B, 2007, LEUKEMIA, V21, P356, DOI 10.1038/sj.leu.2404499; HARRISON D, 1991, J IMMUNOL, V147, P3459; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Lichtfuss GF, 2011, J LEUKOCYTE BIOL, V89, P149, DOI 10.1189/jlb.0610371; Liu QQ, 2009, J VIROL, V83, P8705, DOI 10.1128/JVI.02666-08; Mastroianni CM, 2007, TRENDS MOL MED, V13, P449, DOI 10.1016/j.molmed.2007.09.001; Mavilio D, 2005, BLOOD, V106, P1718, DOI 10.1182/blood-2004-12-4762; Mehlhop E, 2002, J IMMUNOL METHODS, V260, P219, DOI 10.1016/S0022-1759(01)00544-0; Pereira LE, 2008, CELL IMMUNOL, V254, P10, DOI 10.1016/j.cellimm.2008.06.006; Permar SR, 2010, J VIROL, V84, P8209, DOI 10.1128/JVI.00656-10; Poonia B, 2012, CYTOTHERAPY, V14, P173, DOI 10.3109/14653249.2011.623693; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sankatsing SUC, 2004, AIDS, V18, P1925, DOI 10.1097/00002030-200409240-00008; SAWYER LA, 1990, AIDS RES HUM RETROV, V6, P341, DOI 10.1089/aid.1990.6.341; Sun Y, 2011, J VIROL, V85, P6906, DOI 10.1128/JVI.00326-11; Thobakgale CF, 2011, AIDS RES HUM RETROV, V27, P1005, DOI 10.1089/aid.2010.0227; Vargas-Inchaustegui DA, 2011, IMMUNOLOGY, V134, P326, DOI 10.1111/j.1365-2567.2011.03493.x; Wren L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038580; Xiao P, 2010, J VIROL, V84, P7161, DOI 10.1128/JVI.00410-10	37	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56309	10.1371/journal.pone.0056309	http://dx.doi.org/10.1371/journal.pone.0056309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424655	Green Published, gold, Green Submitted			2022-12-27	WOS:000315965100043
J	Korner, A; Deichmann, C; Rossetti, FF; Kohler, A; Konovalov, OV; Wedlich, D; Tanaka, M				Koerner, Alexander; Deichmann, Christina; Rossetti, Fernanda F.; Koehler, Almut; Konovalov, Oleg V.; Wedlich, Doris; Tanaka, Motomu			Cell Differentiation of Pluripotent Tissue Sheets Immobilized on Supported Membranes Displaying Cadherin-11	PLOS ONE			English	Article							X-RAY REFLECTIVITY; EPITHELIAL-MESENCHYMAL TRANSITIONS; QUARTZ-CRYSTAL MICROBALANCE; NEURAL CREST MIGRATION; LIPID-MEMBRANES; PHOSPHOLIPID-BILAYERS; MODEL MEMBRANE; ADHESION; XENOPUS; SURFACE	Investigating cohesive tissue sheets in controlled cultures still poses a challenge since the complex intercellular interactions are difficult to mimic in in vitro models. We used supported lipid membranes functionalized by the adhesive part of the extracellular domain of the cell adhesion molecule cadherin-11 for the immobilization of pluripotent tissue sheets, the animal cap isolated from Xenopus laevis blastula stage embryos. Cadherin-11 was bound via histidine tag to lipid membranes with chelator head groups. In the first step, quantitative functionalization of the membranes with cadherin-11 was confirmed by quartz crystal microbalance and high energy specular X-ray reflectivity. In the next step, animal cap tissue sheets induced to neural crest cell fate were cultured on the membranes functionalized with cadherin-11. The adhesion of cells within the cohesive tissue was significantly dependent on changes in lateral densities of cadherin-11. The formation of filopodia and lamellipodia in the cohesive tissue verified the viability and sustainability of the culture over several hours. The expression of the transcription factor slug in externally induced tissue demonstrated the applicability of lipid membranes displaying adhesive molecules for controlled differentiation of cohesive pluripotent tissue sheets.	[Koerner, Alexander; Rossetti, Fernanda F.; Tanaka, Motomu] Heidelberg Univ, Inst Phys Chem, Heidelberg, Germany; [Deichmann, Christina; Koehler, Almut; Wedlich, Doris] Karlsruhe Inst Technol KIT, Inst Zool, Karlsruhe, Germany; [Konovalov, Oleg V.] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Tanaka, Motomu] Karlsruhe Inst Technol KIT, Inst Toxicol & Genet, Cell Biophys Lab, Karlsruhe, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology; European Synchrotron Radiation Facility (ESRF); Helmholtz Association; Karlsruhe Institute of Technology	Rossetti, FF (corresponding author), Heidelberg Univ, Inst Phys Chem, Neuenheimer Feld 253, Heidelberg, Germany.	rossetti@uni-heidelberg.de; Doris.Wedlich@kit.edu	Koehler, Almut/AAW-8028-2020; Rossetti, Fernanda/AAG-2193-2020; Tanaka, Motomu/S-5949-2016; Konovalov, Oleg/C-6702-2019	Koehler, Almut/0000-0002-7575-0602; Tanaka, Motomu/0000-0003-3663-9554; Konovalov, Oleg/0000-0002-0390-5900	Heidelberg Academy of Sciences through the WIN Kolleg program, project BioForm; Helmholtz Association through the BioInterfaces program; DFG [RO 3643/1-1]	Heidelberg Academy of Sciences through the WIN Kolleg program, project BioForm; Helmholtz Association through the BioInterfaces program(Helmholtz Association); DFG(German Research Foundation (DFG))	This work was supported by the Heidelberg Academy of Sciences through the WIN Kolleg program, project BioForm (A. K., C. D., F. F. R., and A. K.), the Helmholtz Association through the BioInterfaces program (D. W. and M. T.) and the DFG (F. F. R, research fellowship RO 3643/1-1). M. T. is a member of German Cluster of Excellence "Cell Network". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1958, EXP CELL RES, V15, P332, DOI 10.1016/0014-4827(58)90034-X; Albersdorfer A, 1997, BIOPHYS J, V73, P245, DOI 10.1016/S0006-3495(97)78065-2; ARIIZUMI T, 2009, CURR PROTOC STEM CEL, pCH1; Basch Martin L, 2004, Birth Defects Res C Embryo Today, V72, P109, DOI 10.1002/bdrc.20015; BAYER EA, 1979, BIOCHIM BIOPHYS ACTA, V550, P464, DOI 10.1016/0005-2736(79)90149-4; Becker SF, 2012, ARCH BIOCH BIOPHYSIC; BLANKENBURG R, 1989, BIOCHEMISTRY-US, V28, P8214, DOI 10.1021/bi00446a037; Borchers A, 2001, DEVELOPMENT, V128, P3049; Boulbitch A, 2001, BIOPHYS J, V81, P2743, DOI 10.1016/S0006-3495(01)75917-6; BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159; BRIEHER WM, 1994, J CELL BIOL, V126, P519, DOI 10.1083/jcb.126.2.519; Brochard-Wyart F, 2002, P NATL ACAD SCI USA, V99, P7854, DOI 10.1073/pnas.112221299; Bruinsma R, 2001, CR ACAD SCI IV-PHYS, V2, P803, DOI 10.1016/S1296-2147(01)01225-2; Bruinsma R, 2000, PHYS REV E, V61, P4253, DOI 10.1103/PhysRevE.61.4253; Dorn IT, 1998, BIOL CHEM, V379, P1151, DOI 10.1515/bchm.1998.379.8-9.1151; Fukui Y, 2003, DEV GROWTH DIFFER, V45, P499; Garcia AS, 2009, LANGMUIR, V25, P2994, DOI 10.1021/la802772y; Goennenwein S, 2003, BIOPHYS J, V85, P646, DOI 10.1016/S0006-3495(03)74508-1; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hadeball B, 1998, MECH DEVELOP, V72, P101, DOI 10.1016/S0925-4773(98)00022-7; Hammerschmidt M, 2008, DEVELOPMENT, V135, P3625, DOI 10.1242/dev.015701; HERZBERG F, 1991, MECH DEVELOP, V35, P33, DOI 10.1016/0925-4773(91)90039-9; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u; Kashef J, 2009, GENE DEV, V23, P1393, DOI 10.1101/gad.519409; Keller CA, 2000, PHYS REV LETT, V84, P5443, DOI 10.1103/PhysRevLett.84.5443; Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3; KERN W, 1970, RCA REV, V31, P187; Kloboucek A, 1999, BIOPHYS J, V77, P2311, DOI 10.1016/S0006-3495(99)77070-0; Komura S, 2000, EUR PHYS J E, V3, P259, DOI 10.1007/s101890070018; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Kulesa PM, 2006, P NATL ACAD SCI USA, V103, P3752, DOI 10.1073/pnas.0506977103; Kuriyama S, 2008, PHILOS T R SOC B, V363, P1349, DOI 10.1098/rstb.2007.2252; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Larsson C, 2003, ANAL CHEM, V75, P5080, DOI 10.1021/ac034269n; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; Limozin L, 2009, CHEMPHYSCHEM, V10, P2752, DOI 10.1002/cphc.200900601; Malkova S, 2005, BIOPHYS J, V89, P1861, DOI 10.1529/biophysj.105.061515; Marchi-Artzner V, 2001, CHEM-EUR J, V7, P1095, DOI 10.1002/1521-3765(20010302)7:5<1095::AID-CHEM1095>3.0.CO;2-B; MARRA J, 1985, BIOCHEMISTRY-US, V24, P4608, DOI 10.1021/bi00338a020; Marsh D, 2001, P NATL ACAD SCI USA, V98, P7777, DOI 10.1073/pnas.131023798; Marsh D., 1990, CRC HDB LIPID BILAYE; Martel L, 2002, J PHYS IV, V12, P365, DOI 10.1051/jp4:20020245; MAYOR R, 1995, DEVELOPMENT, V121, P767; Miller CE, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.238104; Morgan MJ, 2004, J BIOL CHEM, V279, P46826, DOI 10.1074/jbc.M406140200; MULLER HAJ, 1994, MECH DEVELOP, V47, P213, DOI 10.1016/0925-4773(94)90040-X; Nelson A, 2006, J APPL CRYSTALLOGR, V39, P273, DOI 10.1107/S0021889806005073; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Ninomiya H, 2008, NAT CELL BIOL, V10, P61, DOI 10.1038/ncb1669; PARRATT LG, 1954, PHYS REV, V95, P359, DOI 10.1103/PhysRev.95.359; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; RADLER J, 1993, J PHYS II, V3, P727; Rossetti FF, 2005, LANGMUIR, V21, P6443, DOI 10.1021/la0509100; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; Sackmann E., 1995, HDB BIOL PHYS A&B, V1, P1; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; SCHMITT L, 1994, J AM CHEM SOC, V116, P8485, DOI 10.1021/ja00098a008; Schubert T, 2008, J PHYS CHEM B, V112, P10041, DOI 10.1021/jp803937m; Seitz PC, 2009, CHEMPHYSCHEM, V10, P2876, DOI 10.1002/cphc.200900553; Shindo A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008897; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Steventon B, 2005, SEMIN CELL DEV BIOL, V16, P647, DOI 10.1016/j.semcdb.2005.06.001; Stroumpoulis D, 2007, LANGMUIR, V23, P3849, DOI 10.1021/la062375p; Takeichi M, 2011, DEV CELL, V21, P24, DOI 10.1016/j.devcel.2011.06.002; TAMM LK, 1985, BIOPHYS J, V47, P105, DOI 10.1016/S0006-3495(85)83882-0; Tanaka M, 2005, NATURE, V437, P656, DOI 10.1038/nature04164; Tanaka M, 2007, LANGMUIR, V23, P5638, DOI 10.1021/la0628219; Tao QH, 2007, DEVELOPMENT, V134, P2651, DOI 10.1242/dev.002824; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vallin J, 2001, J BIOL CHEM, V276, P30350, DOI 10.1074/jbc.M103167200; Weikl TR, 2002, EUROPHYS LETT, V59, P916, DOI 10.1209/epl/i2002-00130-3	74	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e54749	10.1371/journal.pone.0054749	http://dx.doi.org/10.1371/journal.pone.0054749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424619	Green Published, Green Submitted, gold			2022-12-27	WOS:000315965100007
J	Shao, L; Guo, H; Yan, LM; Liu, H; Fang, Q				Shao, Ling; Guo, Hong; Yan, Li-Ming; Liu, Huan; Fang, Qin			Aquareovirus NS80 Recruits Viral Proteins to Its Inclusions, and Its C-Terminal Domain Is the Primary Driving Force for Viral Inclusion Formation	PLOS ONE			English	Article							GRASS CARP REOVIRUS; GREEN FLUORESCENT PROTEIN; FACTORY-LIKE INCLUSIONS; MU-NS; BLUETONGUE VIRUS; SIGMA-NS; MAMMALIAN REOVIRUSES; INFECTED-CELLS; REPLICATION; ASSOCIATION	Cytoplasmic inclusion bodies formed in reovirus-infected cells are the sites of viral replication and assembly. Previous studies have suggested that the NS80 protein of aquareovirus may be involved in the formation of viral inclusion bodies. However, it remains unknown whether other viral proteins are involved in the process, and what regions of NS80 may act coordinately in mediating inclusion formation. Here, we observed that globular cytoplasmic inclusions were formed in virus-infected cells and viral proteins NS80 and NS38 colocalized in the inclusions. During transfection, singly expressed NS80 could form cytoplasmic inclusions and recruit NS38 and GFP-tagged VP4 to these structures. Further treatment of cells with nocodazole, a microtubule inhibitor, did not disrupt the inclusion, suggesting that inclusion formation does not rely on microtubule network. Besides, we identified that the region 530-742 of NS80 was likely the minimal region required for inclusion formation, and the C-tail, coiled-coil region as well as the conserved linker region were essential for inclusion phenotype. Moreover, with series deletions from the N-terminus, a stepwise conversion occurred from large condensed cytoplasmic to small nuclear inclusions, then to a diffused intracellular distribution. Notablely, we found that the nuclear inclusions, formed by NS80 truncations (471 to 513-742), colocalized with cellular protein beta-catenin. These data indicated that NS80 could be a major mediator in recruiting NS38 and VP4 into inclusion structures, and the C-terminus of NS80 is responsible for inclusion formation.	[Shao, Ling; Guo, Hong; Yan, Li-Ming; Liu, Huan; Fang, Qin] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Shao, Ling; Yan, Li-Ming] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fang, Q (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	qfang@wh.iov.cn	fang, qin/GQA-8223-2022	shao, ling/0000-0001-9110-1963	National Natural Science Foundation of China [31072233, 31172434]; National Basic Research Program of China 973 Program [2009CB118701]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China 973 Program(National Basic Research Program of China)	This work was supported in part by grants from the National Natural Science Foundation of China (31072233, 31172434), and National Basic Research Program of China 973 Program, 2009CB118701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold MM, 2008, VIROLOGY, V375, P412, DOI 10.1016/j.virol.2008.02.024; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Becker MM, 2003, J VIROL, V77, P5948, DOI 10.1128/JVI.77.10.5948-5963.2003; Brandariz-Nunez A, 2010, J VIROL, V84, P4289, DOI 10.1128/JVI.02534-09; Broering TJ, 2005, J VIROL, V79, P6194, DOI 10.1128/JVI.79.10.6194-6206.2005; Broering TJ, 2004, J VIROL, V78, P1882, DOI 10.1128/JVI.78.4.1882-1892.2004; Broering TJ, 2002, J VIROL, V76, P8285, DOI 10.1128/JVI.76.16.8285-8297.2002; BROOKES SM, 1993, J GEN VIROL, V74, P525, DOI 10.1099/0022-1317-74-3-525; Busch LK, 2011, J GEN VIROL, V92, P2566, DOI 10.1099/vir.0.036459-0; Cai L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-168; Cheng LP, 2008, J MOL BIOL, V382, P213, DOI 10.1016/j.jmb.2008.06.075; DALES S, 1963, P NATL ACAD SCI USA, V50, P268, DOI 10.1073/pnas.50.2.268; EATON BT, 1987, VIROLOGY, V157, P107, DOI 10.1016/0042-6822(87)90319-9; Eichwald C, 2004, J GEN VIROL, V85, P625, DOI 10.1099/vir.0.19611-0; Fan C, 2010, ARCH VIROL, V155, P1755, DOI 10.1007/s00705-010-0753-6; Fang Q, 2008, ARCH VIROL, V153, P675, DOI 10.1007/s00705-008-0048-3; Fang Q, 2005, SCI CHINA SER C, V48, P593, DOI 10.1360/062004-105; FANG Q, 1989, VIROL SIN, V3, P314; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Heath CM, 2001, J CELL BIOL, V153, P449, DOI 10.1083/jcb.153.3.449; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; Ivanovic T, 2011, TRAFFIC, V12, P1179, DOI 10.1111/j.1600-0854.2011.01233.x; Jain RK, 2001, BIOCHEM J, V360, P645, DOI 10.1042/0264-6021:3600645; Kar AK, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-4; Ke L., 1990, Acta Hydrobiologica Sinica, V14, P153; Kobayashi T, 2006, J VIROL, V80, P9053, DOI 10.1128/JVI.00276-06; Kobayashi T, 2009, J VIROL, V83, P2892, DOI 10.1128/JVI.01495-08; LEE PWK, 1981, VIROLOGY, V108, P134, DOI 10.1016/0042-6822(81)90533-X; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupiani Blanca, 1995, Annual Review of Fish Diseases, V5, P175, DOI 10.1016/0959-8030(95)00006-2; McCutcheon AM, 1999, VIROLOGY, V264, P16, DOI 10.1006/viro.1999.9990; McPhillips TH, 1998, J VIROL, V72, P3387, DOI 10.1128/JVI.72.4.3387-3389.1998; Miller CL, 2010, J VIROL, V84, P867, DOI 10.1128/JVI.01571-09; Miller CL, 2003, J VIROL, V77, P4566, DOI 10.1128/JVI.77.8.4566-4576.2003; Mohan KVK, 2003, J VIROL, V77, P12184, DOI 10.1128/JVI.77.22.12184-12192.2003; MORA M, 1987, VIROLOGY, V159, P265, DOI 10.1016/0042-6822(87)90464-8; Nason EL, 2000, J VIROL, V74, P6546, DOI 10.1128/JVI.74.14.6546-6555.2000; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Patton JT, 2006, CURR TOP MICROBIOL, V309, P169; Shao Ling, 2010, Virologica Sinica, V25, P123, DOI 10.1007/s12250-010-3115-3; SHARPE AH, 1982, VIROLOGY, V120, P399, DOI 10.1016/0042-6822(82)90040-X; Silvestri LS, 2004, J VIROL, V78, P7763, DOI 10.1128/JVI.78.14.7763-7774.2004; Touris-Otero F, 2004, VIROLOGY, V319, P94, DOI 10.1016/j.virol.2003.10.034; VIRGIN HW, 1988, J VIROL, V62, P4594, DOI 10.1128/JVI.62.12.4594-4604.1988; WIENER JR, 1989, VIROLOGY, V169, P293, DOI 10.1016/0042-6822(89)90154-2; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; WINTON JR, 1987, J GEN VIROL, V68, P353, DOI 10.1099/0022-1317-68-2-353; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041	50	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55334	10.1371/journal.pone.0055334	http://dx.doi.org/10.1371/journal.pone.0055334			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424630	Green Submitted, gold, Green Published			2022-12-27	WOS:000315965100018
J	Tunc-Ozdemir, M; Rato, C; Brown, E; Rogers, S; Mooneyham, A; Frietsch, S; Myers, CT; Poulsen, LR; Malho, R; Harper, JF				Tunc-Ozdemir, Meral; Rato, Claudia; Brown, Elizabeth; Rogers, Stephanie; Mooneyham, Amanda; Frietsch, Sabine; Myers, Candace T.; Poulsen, Lisbeth Rosager; Malho, Rui; Harper, Jeffrey F.			Cyclic Nucleotide Gated Channels 7 and 8 Are Essential for Male Reproductive Fertility	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; POLARIZED TIP GROWTH; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; CATION CHANNEL; INSERTIONAL MUTAGENESIS; REVERSE GENETICS; ION CHANNELS; IN-VITRO; PROTEIN	The Arabidopsis thaliana genome contains 20 CNGCs, which are proposed to encode cyclic nucleotide gated, non-selective, Ca2+-permeable ion channels. CNGC7 and CNGC8 are the two most similar with 74% protein sequence identity, and both genes are preferentially expressed in pollen. Two independent loss-of-function T-DNA insertions were identified for both genes and used to generate plant lines in which only one of the two alleles was segregating (e.g., cngc7-1+/-/cngc8-2-/- and cngc7-3-/-/cngc8-1+/-). While normal pollen transmission was observed for single gene mutations, pollen harboring mutations in both cngc7 and 8 were found to be male sterile (transmission efficiency reduced by more than 3000-fold). Pollen grains harboring T-DNA disruptions of both cngc7 and 8 displayed a high frequency of bursting when germinated in vitro. The male sterile defect could be rescued through pollen expression of a CNGC7 or 8 transgene including a CNGC7 with an N-terminal GFP-tag. However, rescue efficiencies were reduced similar to 10- fold when the CNGC7 or 8 included an F to W substitution (F589W and F624W, respectively) at the junction between the putative cyclic nucleotide binding-site and the calmodulin binding-site, identifying this junction as important for proper functioning of a plant CNGC. Using confocal microscopy, GFP-CNGC7 was found to preferentially localize to the plasma membrane at the flanks of the growing tip. Together these results indicate that CNGC7 and 8 are at least partially redundant and provide an essential function at the initiation of pollen tube tip growth.	[Tunc-Ozdemir, Meral; Brown, Elizabeth; Rogers, Stephanie; Mooneyham, Amanda; Frietsch, Sabine; Myers, Candace T.; Poulsen, Lisbeth Rosager; Harper, Jeffrey F.] Univ Nevada, Dept Biochem, Reno, NV 89557 USA; [Rato, Claudia; Malho, Rui] Univ Lisbon, Fac Ciencias Lisboa, BioFIG, P-1699 Lisbon, Portugal; [Poulsen, Lisbeth Rosager] Univ Copenhagen, Dept Plant Biol & Biotechnol, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, Frederiksberg, Denmark	Nevada System of Higher Education (NSHE); University of Nevada Reno; Universidade de Lisboa; Danmarks Grundforskningsfond; University of Copenhagen	Harper, JF (corresponding author), Univ Nevada, Dept Biochem, Reno, NV 89557 USA.	jfharper@unr.edu	Poulsen, Lisbeth R/I-1843-2014; Malho, Rui/I-4503-2012; Poulsen, Lisbeth Rosager/AAP-1301-2020	Poulsen, Lisbeth R/0000-0002-9133-3358; Malho, Rui/0000-0001-5287-869X; Rato, Claudia/0000-0002-3971-046X	National Institutes of Health [1RO1 GM070813-01]; Department of Energy [DE-FG03-94ER20152]; COBRE NIH [GM103554]; Fundacao Ciencia e Tecnologia [PTDC/AGR-GPL/108156/2008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070813, P20GM103554] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); COBRE NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to JFH from National Institutes of Health (1RO1 GM070813-01) for genetic analyses into the formation of calcium signals in pollen, and Department of Energy (DE-FG03-94ER20152) for subcellular localization studies on membrane proteins and regulation of plant cell growth. Funding for operation of the confocal microscope core came from COBRE NIH grant GM103554. This work was also supported by a grant to RM from Fundacao Ciencia e Tecnologia (PTDC/AGR-GPL/108156/2008; FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Amien S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000388; Boavida LC, 2007, PLANT J, V52, P570, DOI 10.1111/j.1365-313X.2007.03248.x; Boisson-Dernier A, 2009, DEVELOPMENT, V136, P3279, DOI 10.1242/dev.040071; Cardenas L, 2008, PLANT PHYSIOL, V146, P1611, DOI 10.1104/pp.107.113035; Chae K, 2011, ANN BOT-LONDON, V108, P627, DOI 10.1093/aob/mcr015; Chaiwongsar S, 2009, NEW PHYTOL, V183, P76, DOI 10.1111/j.1469-8137.2009.02833.x; Chang F, 2007, J INTEGR PLANT BIOL, V49, P1261, DOI 10.1111/j.1672-9072.2007.00524.x; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; Cheung AY, 2008, ANNU REV PLANT BIOL, V59, P547, DOI 10.1146/annurev.arplant.59.032607.092921; CHIANG CM, 1993, PEPTIDE RES, V6, P62; Christopher DA, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-48; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Frietsch S, 2007, P NATL ACAD SCI USA, V104, P14531, DOI 10.1073/pnas.0701781104; Gao F, 2012, PLANT J, V70, P1056, DOI 10.1111/j.1365-313X.2012.04969.x; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hepler PK, 2012, TRENDS PLANT SCI, V17, P32, DOI 10.1016/j.tplants.2011.10.007; Higashiyama T, 2000, PLANT PHYSIOL, V122, P11, DOI 10.1104/pp.122.1.11; Hill AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036585; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Hua BG, 2003, PLANT PHYSIOL, V132, P1353, DOI 10.1104/pp.103.020560; Iwano M, 2009, PLANT PHYSIOL, V150, P1322, DOI 10.1104/pp.109.139329; Jayaprakash P, 2001, J EXP BOT, V52, P851, DOI 10.1093/jexbot/52.357.851; Jiang LX, 2005, PLANT CELL, V17, P584, DOI 10.1105/tpc.104.027631; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; KAMMANN M, 1989, NUCLEIC ACIDS RES, V17, P5404, DOI 10.1093/nar/17.13.5404; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kessler SA, 2011, CURR OPIN PLANT BIOL, V14, P622, DOI 10.1016/j.pbi.2011.07.012; Kohler C, 1999, PLANT J, V18, P97, DOI 10.1046/j.1365-313X.1999.00422.x; Konrad KR, 2011, CURR OPIN PLANT BIOL, V14, P721, DOI 10.1016/j.pbi.2011.09.005; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Li H, 2001, PLANT PHYSIOL, V126, P670, DOI 10.1104/pp.126.2.670; Li H, 1999, PLANT CELL, V11, P1731, DOI 10.1105/tpc.11.9.1731; Lin YK, 1997, PLANT CELL, V9, P1647, DOI 10.1105/tpc.9.9.1647; Ma LG, 2000, PLANT CELL PHYSIOL, V41, P372; Michard E, 2011, SCIENCE, V332, P434, DOI 10.1126/science.1201101; Moore I, 2009, PLANT CELL, V21, P1632, DOI 10.1105/tpc.109.068668; Moutinho A, 2001, P NATL ACAD SCI USA, V98, P10481, DOI 10.1073/pnas.171104598; Myers C, 2009, PLANT J, V59, P528, DOI 10.1111/j.1365-313X.2009.03894.x; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Potocky M, 2012, J PLANT PHYSIOL, V169, P1654, DOI 10.1016/j.jplph.2012.05.014; Qin Y, 2011, SEMIN CELL DEV BIOL, V22, P816, DOI 10.1016/j.semcdb.2011.06.004; Qin Y, 2009, PLOS GENET, V5, DOI [10.1371/journal.pgen.1000621, 10.1109/BMEI.2009.5304794]; Rato C, 2004, PLANT J, V38, P887, DOI 10.1111/j.1365-313X.2004.02091.x; Robertson WR, 2004, GENETICS, V168, P1677, DOI 10.1534/genetics.104.032326; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Schiott M, 2004, P NATL ACAD SCI USA, V101, P9502, DOI 10.1073/pnas.0401542101; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Spalding EP, 2011, CURR OPIN PLANT BIOL, V14, P715, DOI 10.1016/j.pbi.2011.08.001; Takeuchi H, 2011, CURR OPIN PLANT BIOL, V14, P614, DOI 10.1016/j.pbi.2011.07.010; Wu JY, 2011, PLANT CELL REP, V30, P1193, DOI 10.1007/s00299-011-1027-9; Yan A, 2009, P NATL ACAD SCI USA, V106, P22002, DOI 10.1073/pnas.0910811106; Zhou LM, 2009, J INTEGR PLANT BIOL, V51, P751, DOI 10.1111/j.1744-7909.2009.00847.x	55	58	64	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55277	10.1371/journal.pone.0055277	http://dx.doi.org/10.1371/journal.pone.0055277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424627	Green Published, Green Submitted, gold			2022-12-27	WOS:000315965100015
J	Mujahid, S; Nielsen, HC; Volpe, MV				Mujahid, Sana; Nielsen, Heber C.; Volpe, MaryAnn V.			MiR-221 and miR-130a Regulate Lung Airway and Vascular Development	PLOS ONE			English	Article							DEVELOPING MOUSE LUNG; BRANCHING MORPHOGENESIS; EMBRYONIC LUNG; IN-VITRO; EXPRESSION; MICRORNAS; HOXA5; ANGIOGENESIS; HOXB-5; GENES	Epithelial-mesenchymal interactions play a crucial role in branching morphogenesis, but very little is known about how endothelial cells contribute to this process. Here, we examined how anti-angiogenic miR-221 and pro-angiogenic miR-130a affect airway and vascular development in the fetal lungs. Lung-specific effects of miR-130a and miR-221 were studied in mouse E14 whole lungs cultured for 48 hours with anti-miRs or mimics to miR-130a and miR-221. Anti-miR 221 treated lungs had more distal branch generations with increased Hoxb5 and VEGFR2 around airways. Conversely, mimic 221 treated lungs had reduced airway branching, dilated airway tips and decreased Hoxb5 and VEGFR2 in mesenchyme. Anti-miR 130a treatment led to reduced airway branching with increased Hoxa5 and decreased VEGFR2 in the mesenchyme. Conversely, mimic 130a treated lungs had numerous finely arborized branches extending into central lung regions with diffusely localized Hoxa5 and increased VEGFR2 in the mesenchyme. Vascular morphology was analyzed by GSL-B4 (endothelial cell-specific lectin) immunofluorescence. Observed changes in airway morphology following miR-221 inhibition and miR-130a enhancement were mirrored by changes in vascular plexus formation around the terminal airways. Mouse fetal lung endothelial cells (MFLM-91U) were used to study microvascular cell behavior. Mimic 221 treatment resulted in reduced tube formation and cell migration, where as the reverse was observed with mimic 130a treatment. From these data, we conclude that miR-221 and miR-130a have opposing effects on airway and vascular morphogenesis of the developing lung.	[Mujahid, Sana; Nielsen, Heber C.] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cell Mol & Dev Biol, Sch Med, Boston, MA 02111 USA; [Nielsen, Heber C.] Tufts Univ, Sch Med, Dept Anat & Cell Biol, Boston, MA 02111 USA; [Nielsen, Heber C.; Volpe, MaryAnn V.] Tufts Med Ctr, Div Newborn Med, Dept Pediat, Floating Hosp Children, Boston, MA USA	Tufts University; Tufts University; Floating Hospital For Children; Tufts Medical Center	Volpe, MV (corresponding author), Tufts Med Ctr, Div Newborn Med, Dept Pediat, Floating Hosp Children, Boston, MA USA.	mvolpe1@tuftsmedicalcenter.org		Nielsen, Heber/0000-0002-9382-0539	National Institutes of Health (NIH) [HL037930, NIH HL085648, NIH P30 NS047243]; Peabody Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085648, R01HL037930, R21HL097231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peabody Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) HL037930, NIH HL085648, NIH P30 NS047243, and the Peabody Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunzo M, 2012, ONCOGENE, V31, P634, DOI 10.1038/onc.2011.260; Akeson AL, 2003, DEV BIOL, V264, P443, DOI 10.1016/j.ydbio.2003.09.004; Akeson AL, 2000, DEV DYNAM, V217, P11, DOI 10.1002/(SICI)1097-0177(200001)217:1<11::AID-DVDY2>3.0.CO;2-L; Aubin J, 1997, DEV BIOL, V192, P432, DOI 10.1006/dbio.1997.8746; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Chen Y, 2010, MOL CELL BIOL, V30, P3902, DOI 10.1128/MCB.01237-09; Colvin JS, 2001, DEVELOPMENT, V128, P2095; Del Moral PM, 2006, DEV BIOL, V290, P177, DOI 10.1016/j.ydbio.2005.11.022; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010854; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Golpon HA, 2001, AM J PATHOL, V158, P955, DOI 10.1016/S0002-9440(10)64042-4; Graba Y, 1997, BIOESSAYS, V19, P379, DOI 10.1002/bies.950190505; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hombria JCG, 2003, DIFFERENTIATION, V71, P461, DOI 10.1046/j.1432-0436.2003.7108004.x; Kim HJ, 2008, J NUCL MED, V49, P1686, DOI 10.2967/jnumed.108.052894; Kinkead R, 2004, PEDIATR RES, V56, P553, DOI 10.1203/01.PDR.0000139427.26083.3D; Lazarus A, 2011, DEVELOPMENT, V138, P2359, DOI 10.1242/dev.060723; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mandeville I, 2006, AM J PATHOL, V169, P1312, DOI 10.2353/ajpath.2006.051333; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Nicoli S, 2012, DEV CELL, V22, P418, DOI 10.1016/j.devcel.2012.01.008; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Podolska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014494; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Rhoads Kim, 2005, Lymphatic Research and Biology, V3, P240, DOI 10.1089/lrb.2005.3.240; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Tuyl M, 2005, AM J PHYSIOL-LUNG C, V288, pL167, DOI 10.1152/ajplung.00185.2004; Volpe MV, 2007, FRONT BIOSCI-LANDMRK, V12, P860, DOI 10.2741/2108; Volpe MV, 2008, BIRTH DEFECTS RES A, V82, P571, DOI 10.1002/bdra.20481; Volpe MV, 2003, MOL GENET METAB, V80, P242, DOI 10.1016/j.ymgme.2003.08.018; Volpe MV, 2003, BIRTH DEFECTS RES A, V67, P550, DOI 10.1002/bdra.10086; Volpe MV, 1997, HISTOCHEM CELL BIOL, V108, P495, DOI 10.1007/s004180050190; Volpe MV, 2000, BBA-GEN SUBJECTS, V1475, P337, DOI 10.1016/S0304-4165(00)00087-8; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Winnik S, 2009, CARDIOVASC RES, V83, P558, DOI 10.1093/cvr/cvp133; Wu YX, 2003, MOL CELL BIOL, V23, P5680, DOI 10.1128/MCB.23.16.5680-5691.2003; Yang Y, 2012, INT J MOL MED, V29, P393, DOI 10.3892/ijmm.2011.855; Zhu N, 2011, ATHEROSCLEROSIS, V215, P286, DOI 10.1016/j.atherosclerosis.2010.12.024	40	30	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55911	10.1371/journal.pone.0055911	http://dx.doi.org/10.1371/journal.pone.0055911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409087	Green Published, Green Submitted, gold			2022-12-27	WOS:000314660300044
J	Liu, J; Fan, HJ; Ma, YY; Liang, DM; Huang, RX; Wang, JS; Zhou, FY; Kan, QC; Ming, L; Li, HX; Giercksky, KE; Nesland, JM; Suo, ZH				Liu, Jian; Fan, Huijie; Ma, Yuanyuan; Liang, Dongming; Huang, Ruixia; Wang, Junsheng; Zhou, Fuyou; Kan, Quancheng; Ming, Liang; Li, Huixiang; Giercksky, Karl-Erik; Nesland, Jahn Martin; Suo, Zhenhe			Notch1 Is a 5-Fluorouracil Resistant and Poor Survival Marker in Human Esophagus Squamous Cell Carcinomas	PLOS ONE			English	Article							SIGNALING PATHWAY; CANCER CELLS; STEM-CELLS; TUMOR-SUPPRESSOR; DIFFERENTIATION; INHIBITORS; APOPTOSIS; TARGETS; GROWTH; ACTIVATION	Notch signaling involves the processes that govern cell proliferation, cell fate decision, cell differentiation and stem cell maintenance. Due to its fundamental role in stem cells, it has been speculated during the recent years that Notch family may have critical functions in cancer stem cells or cancer cells with a stem cell phenotype, therefore playing an important role in the process of oncogenesis. In this study, expression of Notch family in KYSE70, KYSE140 and KYSE450 squamous esophageal cancer cell lines and virus transformed squamous esophageal epithelial cell line Het-1A was examined by quantitative RT-PCR. Compared to the Het-1A cells, higher levels of Nocth1 and Notch3 expression in the cancer cell lines were identified. Due to the finding that NOTCH3 mainly mediates squamous cell differentiation, NOTCH1 expression was further studied in these cell lines. By Western blot analyses, the KYSE70 cell line which derived from a poorly differentiated tumor highly expressed Notch1, and the Notch1 expression in this cell line was hypoxia inducible, while the KYSE450 cell line which derived from a well differentiated tumor was always negative for Notch1, even in hypoxia. Additional studies demonstrated that the KYSE70 cell line was more 5-FU resistant than the KYSE450 cell line and such 5-FU resistance is correlated to Notch1 expression verified by Notch1 knockdown experiments. In clinical samples, Notch1 protein expression was detected in the basal cells of human esophagus epithelia, and its expression in squamous cell carcinomas was significantly associated with higher pathological grade and shorter overall survival. We conclude that Notch1 expression is associated with cell aggressiveness and 5-FU drug resistance in human esophageal squamous cell carcinoma cell lines in vitro and is significantly associated with a poor survival in human esophageal squamous cell carcinomas.	[Liu, Jian; Li, Huixiang] Zhengzhou Univ, Basic Med Coll, Teaching Hosp 1, Dept Pathol, Zhengzhou, Henan Province, Peoples R China; [Liu, Jian; Ma, Yuanyuan; Liang, Dongming; Huang, Ruixia; Nesland, Jahn Martin; Suo, Zhenhe] Univ Oslo, Norwegian Radium Hosp, Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Fan, Huijie; Suo, Zhenhe] Zhengzhou Univ, Teaching Hosp 1, Dept Oncol, Zhengzhou, Henan Province, Peoples R China; [Ma, Yuanyuan; Huang, Ruixia; Nesland, Jahn Martin; Suo, Zhenhe] Univ Oslo, Fac Med, Inst Clin Med, Dept Pathol, Oslo, Norway; [Wang, Junsheng] Anyang Tumor Hosp, Dept Oncol, Anyang, Henan Province, Peoples R China; [Zhou, Fuyou] Anyang Tumor Hosp, Dept Surg, Anyang, Henan Province, Peoples R China; [Kan, Quancheng] Zhengzhou Univ, Teaching Hosp 1, Dept Pharmacol, Zhengzhou, Henan Province, Peoples R China; [Ming, Liang] Zhengzhou Univ, Teaching Hosp 1, Dept Lab Med, Zhengzhou, Henan Province, Peoples R China; [Giercksky, Karl-Erik] Univ Oslo, Oslo Univ Hosp, Norwegian Radium Hosp, Dept Surg,Inst Canc Res, Oslo, Norway	Zhengzhou University; University of Oslo; Zhengzhou University; University of Oslo; Zhengzhou University; Zhengzhou University; University of Oslo	Suo, ZH (corresponding author), Univ Oslo, Norwegian Radium Hosp, Oslo Univ Hosp, Dept Pathol, Oslo, Norway.	zhenhesuo@yahoo.com.cn		Huang, Ruixia/0000-0001-7214-647X	Norwegian Radium Hospital Legat	Norwegian Radium Hospital Legat	This work is financially supported by The Norwegian Radium Hospital Legat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Bellavia D, 2007, EMBO J, V26, P1670, DOI 10.1038/sj.emboj.7601626; Cao HQ, 2012, APMIS, V120, P441, DOI 10.1111/j.1600-0463.2011.02825.x; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Christofori G, 2011, CANCER CELL, V19, P6, DOI 10.1016/j.ccr.2011.01.003; Demarest RM, 2008, ONCOGENE, V27, P5082, DOI 10.1038/onc.2008.222; Donnem T, 2010, CANCER-AM CANCER SOC, V116, P5676, DOI 10.1002/cncr.25551; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Dotto GP, 2009, NAT REV CANCER, V9, P587, DOI 10.1038/nrc2675; Engin F, 2009, HUM MOL GENET, V18, P1464, DOI 10.1093/hmg/ddp057; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hu CY, 2006, AM J PATHOL, V168, P973, DOI 10.2353/ajpath.2006.050416; Katoh M, 2007, INT J ONCOL, V30, P247; Koch U, 2007, CELL MOL LIFE SCI, V64, P2746, DOI 10.1007/s00018-007-7164-1; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Liu SY, 2009, ANN HEMATOL, V88, P613, DOI 10.1007/s00277-008-0646-x; Lu ZM, 2008, INT J ONCOL, V32, P643; Ma Y, 2012, PLOS ONE, V6; Ma YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033414; Main H, 2010, EXP CELL RES, V316, P1610, DOI 10.1016/j.yexcr.2009.12.012; Meng RD, 2009, CANCER RES, V69, P573, DOI 10.1158/0008-5472.CAN-08-2088; Miyamoto S, 2011, CANCER SCI, V102, P1938, DOI 10.1111/j.1349-7006.2011.02049.x; Nefedova Y, 2004, BLOOD, V103, P3503, DOI 10.1182/blood-2003-07-2340; Nefedova Y, 2008, BLOOD, V111, P2220, DOI 10.1182/blood-2007-07-102632; Nefedova Y, 2008, DRUG RESIST UPDATE, V11, P210, DOI 10.1016/j.drup.2008.09.002; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nyhan KC, 2010, BBA-MOL CELL RES, V1803, P1386, DOI 10.1016/j.bbamcr.2010.09.001; Ohashi S, 2011, CANCER RES, V71, P6836, DOI 10.1158/0008-5472.CAN-11-0846; Ohashi S, 2010, GASTROENTEROLOGY, V139, P2113, DOI 10.1053/j.gastro.2010.08.040; Pistollato F, 2010, STEM CELLS, V28, P1918, DOI 10.1002/stem.518; Ponnurangam S, 2012, MOL CANCER THER, V11, P963, DOI 10.1158/1535-7163.MCT-11-0999; Purow B, 2009, CURR PHARM BIOTECHNO, V10, P154, DOI 10.2174/138920109787315060; Raimondi C, 2010, CURR CANCER DRUG TAR, V10, P496, DOI 10.2174/156800910791517154; Reedijk M, 2008, INT J ONCOL, V33, P1223, DOI 10.3892/ijo_00000112; Ristorcelli E, 2010, EXPERT OPIN THER TAR, V14, P541, DOI 10.1517/14728221003769895; Sikandar SS, 2010, CANCER RES, V70, P1469, DOI 10.1158/0008-5472.CAN-09-2557; South AP, 2012, SEMIN CELL DEV BIOL, V23, P458, DOI 10.1016/j.semcdb.2012.01.017; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; Tanaka M, 2009, BRIT J CANCER, V100, P1957, DOI 10.1038/sj.bjc.6605060; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Wang ZW, 2010, CURR PROTEIN PEPT SC, V11, P398, DOI 10.2174/138920310791824039; Wang ZW, 2010, CURR DRUG TARGETS, V11, P745, DOI 10.2174/138945010791170860; Wang ZW, 2009, CANCER LETT, V279, P8, DOI 10.1016/j.canlet.2008.09.030; Yang HH, 2002, ACTA CYTOL, V46, P445, DOI 10.1159/000326859; Yin L, 2010, BIOCHEM PHARMACOL, V80, P690, DOI 10.1016/j.bcp.2010.03.026; Yoon JH, 2009, BIOCHIM BIOPHYS ACTA, V1800, P352; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	49	25	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56141	10.1371/journal.pone.0056141	http://dx.doi.org/10.1371/journal.pone.0056141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409141	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200115
J	Villalobos, F; Dobrovolski, R; Provete, DB; Gouveia, SF				Villalobos, Fabricio; Dobrovolski, Ricardo; Provete, Diogo B.; Gouveia, Sidney F.			Is Rich and Rare the Common Share? Describing Biodiversity Patterns to Inform Conservation Practices for South American Anurans	PLOS ONE			English	Article							SPECIES RICHNESS; DIVERSITY; HOTSPOTS; CLIMATE; IMPLEMENTATION; ECOREGIONS	Species richness and range size are key features of biogeographic and macroecological analyses, which can yield a first assessment tool to define conservation priorities. Here we combined both features in a simultaneous analysis, based on range-diversity plots, to identify sets of rich-rare (high species richness with restricted ranges) and poor-rare cells (low species richness with restricted ranges). We applied this analysis to the anurans of South America and evaluated the representation of those sets of cells within the protected area system. South American anurans showed high species richness in the Brazilian Atlantic Forest and East Tropical Andes, while regions harboring most of the rare species were concentrated in the Andes and Atlantic Coast from North-Eastern Brazil to River Plate. Based on such patterns, we identified as rich-rare cells the Brazilian Atlantic Forest and Tropical Andes and as poor-rare cells the southern part of Andes and Uruguay. A low fraction of both sets of cells was represented within the protected area system. We show that a simultaneous consideration of species richness and rarity provides a rapid assessment of large-scale biodiversity patterns and may contribute to the definition of conservation priorities.	[Villalobos, Fabricio; Dobrovolski, Ricardo] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil; [Provete, Diogo B.; Gouveia, Sidney F.] Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Programa Posgrad Ecol & Evolucao, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Villalobos, F (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil.	fabricio.villalobos@gmail.com	Gouveia, Sidney F/G-6438-2013; Provete, Diogo B./B-3704-2008; Villalobos, Fabricio/J-6246-2012; Dobrovolski, Ricardo/B-2580-2013	Gouveia, Sidney F/0000-0003-4941-7440; Provete, Diogo B./0000-0002-0097-0651; Villalobos, Fabricio/0000-0002-5230-2217; Dobrovolski, Ricardo/0000-0002-8775-5486	CONACYT [172694]; CNPq [150355/2012-2]; CAPES-DS; PDSE [0278-12-2]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-DS(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PDSE	FV research is supported by grants from CONACYT (#172694) and CNPq (#150355/2012-2). RD is supported by a CNPq fellowship. DBP receives a CAPES-DS doctoral fellowship. SFG receives a CAPES-DS and a PDSE (0278-12-2) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Arita HT, 2008, AM NAT, V172, P519, DOI 10.1086/590954; Arita HT, 2012, GLOBAL ECOL BIOGEOGR, V21, P282, DOI 10.1111/j.1466-8238.2011.00662.x; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Cabeza M, 2001, TRENDS ECOL EVOL, V16, P242, DOI 10.1016/S0169-5347(01)02125-5; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Diniz JAF, 2006, ACTA OECOL, V29, P9, DOI 10.1016/j.actao.2005.07.004; Duellman WE, 1994, BIOL AMPHIBIANS; Gaston K. J, 1994, RARITY, V13, P1; Gotelli NJ, 2009, ECOL LETT, V12, P873, DOI 10.1111/j.1461-0248.2009.01353.x; Gouveia SF, 2013, ECOGRAPHY, V36, P104, DOI 10.1111/j.1600-0587.2012.07553.x; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; IUCN Conservation International NatureServe, 2009, GLOB AMPH ASS; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267; Knight AT, 2006, CONSERV BIOL, V20, P739, DOI 10.1111/j.1523-1739.2006.00452.x; Knight AT, 2011, BIOL CONSERV, V144, P202, DOI 10.1016/j.biocon.2010.08.017; Ladle R. J., 2011, CONSERVATION BIOGEOG, DOI 10.1002/9781444390001; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Loyola RD, 2007, DIVERS DISTRIB, V13, P389, DOI 10.1111/j.1472-4642.2007.00345.x; Loyola RD, 2009, BIODIVERS CONSERV, V18, P2017, DOI 10.1007/s10531-008-9570-6; Loyola RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002120; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Moilanen A, 2011, BIOL CONSERV, V144, P650, DOI 10.1016/j.biocon.2010.09.006; Urbina-Cardona JN, 2008, TROP CONSERV SCI, V1, P417, DOI 10.1177/194008290800100408; Ochoa-Ochoa LM, 2012, BIOL CONSERV, V150, P94, DOI 10.1016/j.biocon.2012.03.010; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; PRESSEY RL, 1994, CONSERV BIOL, V8, P662, DOI 10.1046/j.1523-1739.1994.08030662.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Soberon J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019359; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Villalobos F, 2013, BIOL CONSERV, V158, P313, DOI 10.1016/j.biocon.2012.10.002; WDPA Consortium, 2009, WORLD DAT PROT AR; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Whitton FJS, 2012, GLOBAL ECOL BIOGEOGR, V21, P179, DOI 10.1111/j.1466-8238.2011.00660.x; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223	48	34	35	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56073	10.1371/journal.pone.0056073	http://dx.doi.org/10.1371/journal.pone.0056073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409124	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200105
J	Becker, S; Oelschlaeger, TA; Wullaert, A; Pasparakis, M; Wehkamp, J; Stange, EF; Gersemann, M				Becker, Svetlana; Oelschlaeger, Tobias A.; Wullaert, Andy; Pasparakis, Manolis; Wehkamp, Jan; Stange, Eduard F.; Gersemann, Michael			Bacteria Regulate Intestinal Epithelial Cell Differentiation Factors Both In Vitro and In Vivo	PLOS ONE			English	Article							COLI NISSLE 1917; CROHNS-DISEASE; ESCHERICHIA-COLI; PORPHYROMONAS-GINGIVALIS; ANTIMICROBIAL PEPTIDES; ALPHA-DEFENSINS; EXPRESSION; ASSOCIATION; CANCER; INDUCTION	Background: The human colon harbours a plethora of bacteria known to broadly impact on mucosal metabolism and function and thought to be involved in inflammatory bowel disease pathogenesis and colon cancer development. In this report, we investigated the effect of colonic bacteria on epithelial cell differentiation factors in vitro and in vivo. As key transcription factors we focused on Hes1, known to direct towards an absorptive cell fate, Hath1 and KLF4, which govern goblet cell. Methods: Expression of the transcription factors Hes1, Hath1 and KLF4, the mucins Muc1 and Muc2 and the defensin HBD2 were measured by real-time PCR in LS174T cells following incubation with several heat-inactivated E. coli strains, including the probiotic E. coli Nissle 1917+/- flagellin, Lactobacilli and Bifidobacteria. For protein detection Western blot experiments and chamber-slide immunostaining were performed. Finally, mRNA and protein expression of these factors was evaluated in the colon of germfree vs. specific pathogen free vs. conventionalized mice and colonic goblet cells were counted. Results: Expression of Hes1 and Hath1, and to a minor degree also of KLF4, was reduced by E. coli K-12 and E. coli Nissle 1917. In contrast, Muc1 and HBD2 expression were significantly enhanced, independent of the Notch signalling pathway. Probiotic E. coli Nissle 1917 regulated Hes1, Hath1, Muc1 and HBD2 through flagellin. In vivo experiments confirmed the observed in vitro effects of bacteria by a diminished colonic expression of Hath1 and KLF4 in specific pathogen free and conventionalized mice as compared to germ free mice whereas the number of goblet cells was unchanged in these mice. Conclusions: Intestinal bacteria influence the intestinal epithelial differentiation factors Hes1, Hath1 and KLF4, as well as Muc1 and HBD2, in vitro and in vivo. The induction of Muc1 and HBD2 seems to be triggered directly by bacteria and not by Notch.	[Becker, Svetlana; Wehkamp, Jan; Gersemann, Michael] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Becker, Svetlana; Wehkamp, Jan; Gersemann, Michael] Univ Tubingen, Tubingen, Germany; [Oelschlaeger, Tobias A.] Univ Wurzburg, Inst Mol Biol Infect, D-97070 Wurzburg, Germany; [Wullaert, Andy; Pasparakis, Manolis] Univ Cologne, Inst Genet, Cologne, Germany; [Pasparakis, Manolis] EMBL Mouse Biol Unit, Monterotondo, Italy; [Wehkamp, Jan; Stange, Eduard F.; Gersemann, Michael] Robert Bosch Krankenhaus, Dept Internal Med 1, Stuttgart, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University of Wurzburg; University of Cologne; European Molecular Biology Laboratory (EMBL); Bosch; Robert Bosch Krankenhaus	Gersemann, M (corresponding author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, Stuttgart, Germany.	m.gersemann@kk-es.de	Pasparakis, Manolis/H-9292-2017; Wehkamp, Jan/B-7319-2011; Oelschlaeger, Tobias/B-5624-2015; Wullaert, Andy/D-2975-2018; Wullaert, Andy/R-1924-2019; Pasparakis, Manolis/N-4350-2019	Pasparakis, Manolis/0000-0002-9870-0966; Wullaert, Andy/0000-0001-5012-654X; Wullaert, Andy/0000-0001-5012-654X; Pasparakis, Manolis/0000-0002-9870-0966; Wehkamp, Jan/0000-0001-6788-841X	Robert Bosch fundation; Emmy Noether program of the Deutsche Forschungsgemeinschaft (DFG); Robert Bosch Foundation (Stuttgart, Germany); Sonderforschungsbereich (SFB) 685 (University of Tuebingen)	Robert Bosch fundation; Emmy Noether program of the Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Robert Bosch Foundation (Stuttgart, Germany); Sonderforschungsbereich (SFB) 685 (University of Tuebingen)(German Research Foundation (DFG))	This work was supported by the Robert Bosch fundation and by Emmy Noether program of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Robert Bosch Foundation (Stuttgart, Germany), the Sonderforschungsbereich (SFB) 685 (University of Tuebingen) and Emmy Noether program (J.W.) of the Deutsche Forschungsgemeinschaft (DFG). The authors are grateful to Dr. Katerina Vlantis, Jutta Bader and Marion Schiffmann for excellent technical support.	Abdulamir AS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-11; Abdulamir AS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-403; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Biarc J, 2004, CARCINOGENESIS, V25, P1477, DOI 10.1093/carcin/bgh091; Caballero-Franco C, 2007, AM J PHYSIOL-GASTR L, V292, pG315, DOI 10.1152/ajpgi.00265.2006; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Chen C. C., 2011, BRIT J NUTR, V30, P1; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Croix JA, 2011, EXP BIOL MED, V236, P1402, DOI 10.1258/ebm.2011.011186; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; Fyderek K, 2009, WORLD J GASTROENTERO, V15, P5287, DOI 10.3748/wjg.15.5287; Gersemann M, 2012, J INTERN MED, V271, P421, DOI 10.1111/j.1365-2796.2012.02515.x; Gersemann M, 2008, WORLD J GASTROENTERO, V14, P5499, DOI 10.3748/wjg.14.5499; Gersemann M, 2011, WORLD J GASTROENTERO, V17, P3198, DOI 10.3748/wjg.v17.i27.3198; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Gupta A, 2010, COLORECTAL DIS, V12, P164, DOI 10.1111/j.1463-1318.2009.01814.x; Henckaerts L, 2007, GUT, V56, P1536, DOI 10.1136/gut.2007.125468; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kapoor N, 2010, J IMMUNOL, V184, P3117, DOI 10.4049/jimmunol.0903174; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kim Y, 2008, J MICROBIOL BIOTECHN, V18, P1278; Koslowski MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004496; Leow CC, 2004, CANCER RES, V64, P6050, DOI 10.1158/0008-5472.CAN-04-0290; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Liong MT, 2008, INT J MOL SCI, V9, P854, DOI 10.3390/ijms9050854; Lucke K, 2006, J MED MICROBIOL, V55, P617, DOI 10.1099/jmm.0.46198-0; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Marteau P, 2011, DIGEST DIS, V29, P166, DOI 10.1159/000323879; MCCORMICK DA, 1990, J CLIN PATHOL, V43, P143, DOI 10.1136/jcp.43.2.143; Meyer-Hoffert U, 2008, GUT, V57, P764, DOI 10.1136/gut.2007.141481; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Obata Y, 2012, J IMMUNOL, V188, P2427, DOI 10.4049/jimmunol.1101128; Otte JM, 2004, AM J PHYSIOL-GASTR L, V286, pG613, DOI 10.1152/ajpgi.00341.2003; Park ET, 2006, CLIN CANCER RES, V12, P5403, DOI 10.1158/1078-0432.CCR-06-0573; Park JH, 2005, BIOCHEM BIOPH RES CO, V332, P1081, DOI 10.1016/j.bbrc.2005.05.060; Peignon G, 2011, GUT, V60, P166, DOI 10.1136/gut.2009.204719; PULLAN RD, 1994, GUT, V35, P353, DOI 10.1136/gut.35.3.353; Reedijk M, 2008, INT J ONCOL, V33, P1223, DOI 10.3892/ijo_00000112; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schlee M, 2007, INFECT IMMUN, V75, P2399, DOI 10.1128/IAI.01563-06; Schmid M, 2007, J LEUKOCYTE BIOL, V81, P907, DOI 10.1189/jlb.0906581; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Shirazi T, 2000, POSTGRAD MED J, V76, P473, DOI 10.1136/pmj.76.898.473; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5; Swidsinski A, 2007, GUT, V56, P343, DOI 10.1136/gut.2006.098160; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wehkamp J, 2004, INFECT IMMUN, V72, P5750, DOI 10.1128/IAI.72.10.5750-5758.2004; Wehkamp J, 2003, INFLAMM BOWEL DIS, V9, P215, DOI 10.1097/00054725-200307000-00001; Wehkamp J, 2007, J IMMUNOL, V179, P3109, DOI 10.4049/jimmunol.179.5.3109; Wehkamp J, 2007, CURR OPIN GASTROEN, V23, P370, DOI 10.1097/MOG.0b013e328136c580; Xing QA, 2010, J CELL PHYSIOL, V225, P106, DOI 10.1002/jcp.22201; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006; Zhao CQ, 1996, FEBS LETT, V396, P319, DOI 10.1016/0014-5793(96)01123-4; Zheng X, 2011, INFLAMM BOWEL DIS, V17, P2251, DOI 10.1002/ibd.21611; Zhou QD, 2007, J IMMUNOL, V179, P7777, DOI 10.4049/jimmunol.179.11.7777	66	39	41	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55620	10.1371/journal.pone.0055620	http://dx.doi.org/10.1371/journal.pone.0055620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418447	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300038
J	Chang, TI; Kang, EW; Lee, YK; Shin, SK				Chang, Tae Ik; Kang, Ea Wha; Lee, Yong Kyu; Shin, Sug Kyun			Higher Peritoneal Protein Clearance as a Risk Factor for Cardiovascular Disease in Peritoneal Dialysis Patient	PLOS ONE			English	Article							MEMBRANE-TRANSPORT STATUS; TECHNIQUE FAILURE; CAPACITY TEST; SURVIVAL; MORTALITY; ALBUMIN; HYPOALBUMINEMIA; NUTRITION; INFLAMMATION; SUPERIOR	Background and Aims: Although a number of studies have been published on peritoneal protein clearance (PrCl) and its association with patient outcomes, the results have been inconsistent. Therefore, the intent of this study was to evaluate the impact of PrCl on cardiovascular disease (CVD) and mortality in peritoneal dialysis (PD) patients. Methods: This prospective observational study included a total of 540 incident patients who started PD at NHIC Ilsan Hospital, Korea from January 2000 to December 2009. Two different types of analyses such as intention-to-treat and astreated were used. Results: Correlation analyses revealed that PrCl was positively correlated with diabetes, pulse pressure, C-reactive protein (CRP) level, dialysate/plasma creatinine ratio (D/P cr) at 4 h, and peritoneal Kt/V urea. PrCl was inversely correlated with serum albumin and triglyceride levels. On multivariate analysis, serum albumin, pulse pressure, D/P cr at 4 h, and peritoneal Kt/V urea were found to be independent determinants of PrCl. A total of 129 (23.9%) patients in intention-to-treat analysis and 117 (21.7%) patients in as-treated analysis developed new cardiovascular events. Time to occurrence of cardiovascular event was significantly longer in patients with a value of PrCl below the median (89.4 ml/day). In multivariate analysis, older age, presence of diabetes or previous CVD, and higher PrCl were independent predictors of cardiovascular events. Patients above the median value of PrCl had a significantly lower rate of survival than those below the median. However, a higher PrCl was not associated with increased mortality in multivariate Cox analysis. Conclusions: A higher PrCl is a risk for occurrence of cardiovascular event, but not mortality in PD patients. Large randomized clinical trials are warranted to confirm this finding.	[Chang, Tae Ik; Kang, Ea Wha; Lee, Yong Kyu; Shin, Sug Kyun] Ilsan Hosp, NHIC Med Ctr, Dept Internal Med, Goyangshi, Gyeonggi Do, South Korea	NHIS Ilsan Hospital	Shin, SK (corresponding author), Ilsan Hosp, NHIC Med Ctr, Dept Internal Med, Goyangshi, Gyeonggi Do, South Korea.	sskyun@hotmail.com		Lee, Yong Kyu/0000-0002-8262-601X				Balafa O, 2011, CLIN J AM SOC NEPHRO, V6, P561, DOI 10.2215/CJN.05540610; BLUMENKRANTZ MJ, 1981, KIDNEY INT, V19, P593, DOI 10.1038/ki.1981.57; Brimble KS, 2006, J AM SOC NEPHROL, V17, P2591, DOI 10.1681/ASN.2006030194; Churchill DN, 1996, J AM SOC NEPHROL, V7, P198; Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285; de Mutsert R, 2009, J RENAL NUTR, V19, P127, DOI 10.1053/j.jrn.2008.08.003; Dukkipati R, 2009, SEMIN NEPHROL, V29, P39, DOI 10.1016/j.semnephrol.2008.10.006; Elsurer R, 2009, NEPHROLOGY, V14, P712, DOI 10.1111/j.1440-1797.2009.01103.x; Friedman AN, 2010, J AM SOC NEPHROL, V21, P223, DOI 10.1681/ASN.2009020213; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; Han SH, 2012, NAT REV NEPHROL, V8, P163, DOI 10.1038/nrneph.2012.12; Heaf JG, 2005, NEPHROL DIAL TRANSPL, V20, P2194, DOI 10.1093/ndt/gfi008; Johnson DW, 2010, NEPHROL DIAL TRANSPL, V25, P1973, DOI 10.1093/ndt/gfp780; Kathuria P, 1997, PERITON DIALYSIS INT, V17, P449; Kaysen GA, 1998, J AM SOC NEPHROL, V9, P2368; KOPPLE JD, 1994, AM J KIDNEY DIS, V24, P1002, DOI 10.1016/S0272-6386(12)81075-4; Krediet RT, 2010, NAT REV NEPHROL, V6, P451, DOI 10.1038/nrneph.2010.68; Lee H, 2009, NEPHROLOGY CARLTON, V16, P656; Malone AF, 2010, PERITON DIALYSIS INT, V30, P265, DOI 10.3747/pdi.2010.00002; Margetts PJ, 2000, PERITON DIALYSIS INT, V20, P14; Nakamoto H, 2002, AM J KIDNEY DIS, V40, P1045, DOI 10.1053/ajkd.2002.36343; NOLPH KD, 1993, PERITON DIALYSIS INT, V13, P178; Oh KH, 2010, NEPHROL DIAL TRANSPL, V25, P1639, DOI 10.1093/ndt/gfp670; Pecoits R, 2002, NEPHROL DIAL TRANSPL, V17, P28, DOI 10.1093/ndt/17.suppl_11.28; Perl J, 2009, CLIN J AM SOC NEPHRO, V4, P1201, DOI 10.2215/CJN.01910309; Rippe B, 1993, Perit Dial Int, V13 Suppl 2, pS35; Rodrigues AS, 2006, NEPHROL DIAL TRANSPL, V21, P763, DOI 10.1093/ndt/gfi245; Rumpsfeld M, 2006, J AM SOC NEPHROL, V17, P271, DOI 10.1681/ASN.2005050566; Sanchez-Villanueva R, 2009, NEPHROL DIAL TRANSPL, V24, P1009, DOI 10.1093/ndt/gfn595; Szeto CC, 2005, PERITON DIALYSIS INT, V25, P445; Van Biesen W, 2006, CLIN J AM SOC NEPHRO, V1, P269, DOI 10.2215/CJN.00820805; Wang T, 1999, PERITON DIALYSIS INT, V19, P17; Weir MR, 2007, CLIN J AM SOC NEPHRO, V2, P581, DOI 10.2215/CJN.03190906; Wiggins KJ, 2007, NEPHROL DIAL TRANSPL, V22, P3005, DOI 10.1093/ndt/gfm324; Zoccali C, 2006, KIDNEY INT, V70, P26, DOI 10.1038/sj.ki.5000417	35	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56223	10.1371/journal.pone.0056223	http://dx.doi.org/10.1371/journal.pone.0056223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418538	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300130
J	Christensen, MHE; Apalset, EM; Nordbo, Y; Varhaug, JE; Mellgren, G; Lien, EA				Christensen, Monika H. E.; Apalset, Ellen M.; Nordbo, Yngve; Varhaug, Jan Erik; Mellgren, Gunnar; Lien, Ernst A.			1,25-Dihydroxyvitamin D and the Vitamin D Receptor Gene Polymorphism Apa1 Influence Bone Mineral Density in Primary Hyperparathyroidism	PLOS ONE			English	Article							ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; 25-HYDROXYVITAMIN D; D INSUFFICIENCY; D DEFICIENCY; D REPLETION; OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN LIGAND; POSTMENOPAUSAL WOMEN; PARATHYROID-HORMONE; ASSOCIATION	Objective: Parathyroid hormone (PTH) and vitamin D are the most important hormones regulating calcium metabolism. In primary hyperparathyroidism (PHPT) excessive amounts of PTH are produced. Bone turnover is enhanced, leading to reduced bone mineral density and elevated levels of serum calcium. The aim of this study was to investigate relations between serum levels of 25-hydroxyvitamin D (25(OH)D), 1,25-dihydroxyvitamin D (1,25(OH)(2)D) and bone mineral density, as well as known genetic polymorphisms in the vitamin D receptor and enzymes metabolising vitamin D in patients with PHPT. Design/Subjects: We conducted a cross-sectional study of 52 patients with PHPT. Results: Mean level of 25(OH)D was 58.2 nmol/L and median 1,25(OH)(2)D level was 157 pmol/L. Among our patients with PHPT 36.5% had 25(OH)D levels below 50 nmol/L. Serum 1,25(OH)(2)D was inversely correlated to bone mineral density in distal radius (p = 0.002), but not to bone mineral density at lumbar spine or femoral neck. The vitamin D receptor polymorphism Apa1 (rs7975232) was associated with bone mineral density in the lumbar spine. Conclusions: The results suggest that PHPT patients with high blood concentrations of 1,25(OH)(2)D may have the most deleterious skeletal effects. Randomized, prospective studies are necessary to elucidate whether vitamin D supplementation additionally increases serum 1,25(OH)(2)D and possibly enhances the adverse effects on the skeleton in patients with PHPT.	[Christensen, Monika H. E.; Mellgren, Gunnar; Lien, Ernst A.] Univ Bergen, Inst Med, Bergen, Norway; [Christensen, Monika H. E.; Mellgren, Gunnar; Lien, Ernst A.] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; [Apalset, Ellen M.] Haukeland Hosp, Dept Rheumatol, N-5021 Bergen, Norway; [Apalset, Ellen M.] Univ Bergen, Res Grp Lifestyle Epidemiol, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Nordbo, Yngve; Varhaug, Jan Erik] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway; [Varhaug, Jan Erik] Univ Bergen, Dept Surg Sci, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen	Christensen, MHE (corresponding author), Univ Bergen, Inst Med, Bergen, Norway.	monika.christensen@med.uib.no	Mellgren, Gunnar/AAG-6573-2020	Mellgren, Gunnar/0000-0001-6282-4986	Samarbeidsorganet Helse Vest RHF	Samarbeidsorganet Helse Vest RHF	Funding for this project was provided by Samarbeidsorganet Helse Vest RHF (http://helse-bergen.no/forskning/samarbeidsorganet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilezikian JP, 2009, J CLIN ENDOCR METAB, V94, P335, DOI 10.1210/jc.2008-1763; Bischoff-Ferrari HA, 2008, ADV EXP MED BIOL, V624, P55, DOI 10.1007/978-0-387-77574-6_5; BOLLERSLEV J, 1991, BONE, V12, P339, DOI 10.1016/8756-3282(91)90020-J; Bollerslev J, 2007, J CLIN ENDOCR METAB, V92, P1687, DOI 10.1210/jc.2006-1836; Bollerslev J, 2011, EUR J ENDOCRINOL, V165, P851, DOI 10.1530/EJE-11-0589; Boudou P, 2006, J ENDOCRINOL INVEST, V29, P511, DOI 10.1007/BF03344140; Christensen MHE, 2010, SCAND J CLIN LAB INV, V70, P281, DOI 10.3109/00365511003797172; CHRISTIANSEN P, 1993, BONE, V14, P755, DOI 10.1016/8756-3282(93)90207-Q; Dundar U, 2009, CLIN RHEUMATOL, V28, P1187, DOI 10.1007/s10067-009-1220-1; Fang Y, 2007, J CLIN ENDOCR METAB, V92, P1491, DOI 10.1210/jc.2006-1134; FLICKER L, 1995, J BONE MINER RES, V10, P1607; Fraser WD, 2009, LANCET, V374, P145, DOI 10.1016/S0140-6736(09)60507-9; Goltzman D, 2004, J STEROID BIOCHEM, V89-90, P485, DOI 10.1016/j.jsbmb.2004.03.058; Grey A, 2005, J CLIN ENDOCR METAB, V90, P2122, DOI 10.1210/jc.2004-1772; Grimnes G, 2010, EUR J ENDOCRINOL, V163, P339, DOI 10.1530/EJE-10-0150; Health Canada, 2010, DIETARY REFERENCE IN; HOLICK MF, 1995, AM J CLIN NUTR, V61, p638S, DOI 10.1093/ajcn/61.3.638S; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Holm PI, 2003, CLIN CHEM, V49, P286, DOI 10.1373/49.2.286; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Jones G, 2011, ARCH BIOCH BIOPHYS; Kantorovich V, 2000, J CLIN ENDOCR METAB, V85, P3541, DOI 10.1210/jc.85.10.3541; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Langsetmo L, 2012, BONE, V50, P401, DOI 10.1016/j.bone.2011.11.009; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Lips P, 2010, CLIN ENDOCRINOL, V73, P277, DOI 10.1111/j.1365-2265.2009.03701.x; Macdonald HM, 2008, BONE, V42, P996, DOI 10.1016/j.bone.2008.01.011; Moosgaard B, 2008, CLIN ENDOCRINOL, V68, P707, DOI 10.1111/j.1365-2265.2007.03109.x; Moosgaard B, 2005, CLIN ENDOCRINOL, V63, P506, DOI 10.1111/j.1365-2265.2005.02371.x; MOSEKILDE L, 1989, BONE MINER, V5, P279, DOI 10.1016/0169-6009(89)90006-8; Norman AW, 2002, STEROIDS, V67, P457, DOI 10.1016/S0039-128X(01)00167-2; Omdahl JL, 2002, ANNU REV NUTR, V22, P139, DOI 10.1146/annurev.nutr.22.120501.150216; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramos-Lopez E, 2008, DIABETES OBES METAB, V10, P683, DOI 10.1111/j.1463-1326.2008.00879.x; Rao RR, 2012, ENDOCR CONNECT, V1, P13, DOI 10.1530/EC-12-0008; Rubin MR, 2008, J CLIN ENDOCR METAB, V93, P3462, DOI 10.1210/jc.2007-1215; Russell RGG, 2006, CURR OPIN RHEUMATOL, V18, pS3, DOI 10.1097/01.bor.0000229521.95384.7d; Shen HQ, 2010, ARTERIOSCL THROM VAS, V30, P2648, DOI 10.1161/ATVBAHA.110.211805; SILVERBERG SJ, 1989, J BONE MINER RES, V4, P283, DOI 10.1002/jbmr.5650040302; Simon KC, 2011, J NEUROL, V258, P1676, DOI 10.1007/s00415-011-6001-5; Suda T, 2003, J CELL BIOCHEM, V88, P259, DOI 10.1002/jcb.10331; Tashiro K, 2004, MOL CELL ENDOCRINOL, V226, P27, DOI 10.1016/j.mce.2004.07.012; Ueno Y, 2003, J CELL BIOCHEM, V90, P267, DOI 10.1002/jcb.10623; Uitterlinden AG, 2006, ANN INTERN MED, V145, P255, DOI 10.7326/0003-4819-145-4-200608150-00005; van Driel M, 2006, FASEB J, V20, P2417, DOI 10.1096/fj.06-6374fje; Vestergaard P, 2000, BRIT MED J, V321, P598, DOI 10.1136/bmj.321.7261.598; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0	49	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56019	10.1371/journal.pone.0056019	http://dx.doi.org/10.1371/journal.pone.0056019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418495	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300087
J	de la Riva, GT; Hart, BL; Farver, TB; Oberbauer, AM; Messam, LLM; Willits, N; Hart, LA				de la Riva, Gretel Torres; Hart, Benjamin L.; Farver, Thomas B.; Oberbauer, Anita M.; Messam, Locksley L. McV; Willits, Neil; Hart, Lynette A.			Neutering Dogs: Effects on Joint Disorders and Cancers in Golden Retrievers	PLOS ONE			English	Article							CRANIAL CRUCIATE LIGAMENT; RISK-FACTORS; MAMMARY-TUMORS; BREED; GONADECTOMY; SEX; AGE; EPIDEMIOLOGY; BONE	In contrast to European countries, the overwhelming majority of dogs in the U.S. are neutered (including spaying), usually done before one year of age. Given the importance of gonadal hormones in growth and development, this cultural contrast invites an analysis of the multiple organ systems that may be adversely affected by neutering. Using a single breed-specific dataset, the objective was to examine the variables of gender and age at the time of neutering versus leaving dogs gonadally intact, on all diseases occurring with sufficient frequency for statistical analyses. Given its popularity and vulnerability to various cancers and joint disorders, the Golden Retriever was chosen for this study. Veterinary hospital records of 759 client-owned, intact and neutered female and male dogs, 1-8 years old, were examined for diagnoses of hip dysplasia (HD), cranial cruciate ligament tear (CCL), lymphosarcoma (LSA), hemangiosarcoma (HSA), and mast cell tumor (MCT). Patients were classified as intact, or neutered early (<12 mo) or late (>= 12 mo). Statistical analyses involved survival analyses and incidence rate comparisons. Outcomes at the 5 percent level of significance are reported. Of early-neutered males, 10 percent were diagnosed with HD, double the occurrence in intact males. There were no cases of CCL diagnosed in intact males or females, but in early-neutered males and females the occurrences were 5 percent and 8 percent, respectively. Almost 10 percent of early-neutered males were diagnosed with LSA, 3 times more than intact males. The percentage of HSA cases in late-neutered females (about 8 percent) was 4 times more than intact and early-neutered females. There were no cases of MCT in intact females, but the occurrence was nearly 6 percent in late-neutered females. The results have health implications for Golden Retriever companion and service dogs, and for oncologists using dogs as models of cancers that occur in humans.	[de la Riva, Gretel Torres; Farver, Thomas B.; Hart, Lynette A.] Univ Calif Davis, Dept Populat Hlth & Reprod, Sch Vet Med, Davis, CA 95616 USA; [Hart, Benjamin L.] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Sch Vet Med, Davis, CA 95616 USA; [Oberbauer, Anita M.] Univ Calif Davis, Coll Agr & Environm Sci, Dept Anim Sci, Davis, CA 95616 USA; [Messam, Locksley L. McV] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Willits, Neil] Univ Calif Davis, Dept Stat, Stat Lab, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Hart, BL (corresponding author), Univ Calif Davis, Dept Anat Physiol & Cell Biol, Sch Vet Med, Davis, CA 95616 USA.	blhart@ucdavis.edu	Fiumefreddo, Andrea/T-2977-2019; Hart, Lynette/L-4833-2019	Hart, Lynette/0000-0002-7133-6535; Messam, Locksley L. McV./0000-0001-5791-555X; hart, benjamin/0000-0003-2342-6058	Canine Health Foundation [01488-A]; Center for Companion 330 Animal Health University of California, Davis [2009-54-F/M]	Canine Health Foundation; Center for Companion 330 Animal Health University of California, Davis(University of California System)	Supported by the Canine Health Foundation (#01488-A) and the Center for Companion 330 Animal Health University of California, Davis (# 2009-54-F/M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauvais W, 2012, J SMALL ANIM PRACT, V53, P314, DOI 10.1111/j.1748-5827.2011.01220.x; Cooley DM, 2002, CANCER EPIDEM BIOMAR, V11, P1434; Diesel G, 2010, VET REC, V166, P455, DOI 10.1136/vr.b4798; Duerr FM, 2007, JAVMA-J AM VET MED A, V231, P1688, DOI 10.2460/javma.231.11.1688; Duval JM, 1999, J AM VET MED ASSOC, V215, P811; Egenvall A, 2005, PREV VET MED, V69, P109, DOI 10.1016/j.prevetmed.2005.01.014; Glickman LG., 1999, GOLDEN RETRIEVER CLU; Grumbach MM, 2000, J PEDIATR ENDOCR MET, V13, P1439; Hart BL, 2001, J AM VET MED ASSOC, V219, P51, DOI 10.2460/javma.2001.219.51; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kasstrom H, 1975, Acta Radiol Suppl, V344, P135; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; Kustritz MVR, 2007, JAVMA-J AM VET MED A, V231, P1665, DOI 10.2460/javma.231.11.1665; PRYMAK C, 1988, J AM VET MED ASSOC, V193, P706; Rothman K., 1998, MODERN EPIDEMIOLOGY; Ru G, 1998, VET J, V156, P31, DOI 10.1016/S1090-0233(98)80059-2; Sallander M, 2001, ACTA VET SCAND, V42, P71, DOI 10.1186/1751-0147-42-71; SALMERI KR, 1991, J AM VET MED ASSOC, V198, P1193; Slattery ML, 2001, CANCER RES, V61, P126; Teske E, 2002, MOL CELL ENDOCRINOL, V197, P251, DOI 10.1016/S0303-7207(02)00261-7; Trevejo R, 2011, JAVMA-J AM VET MED A, V238, P898, DOI 10.2460/javma.238.7.898; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Villamil JA, 2009, J CANCER EPIDEMIOL, V2009, DOI [10.1155/2009/591753, 10.1155/2009/747803]; Ware WA, 1999, J VET INTERN MED, V13, P95, DOI 10.1892/0891-6640(1999)013&lt;0095:CTID&gt;2.3.CO;2; White CR, 2011, J AM ANIM HOSP ASSOC, V47, P210, DOI 10.5326/JAAHA-MS-5621; Witsberger TH, 2008, JAVMA-J AM VET MED A, V232, P1818, DOI 10.2460/javma.232.12.1818; Zatloukal J, 2005, ACTA VET BRNO, V74, P103, DOI 10.2754/avb200574010103	28	101	101	1	201	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55937	10.1371/journal.pone.0055937	http://dx.doi.org/10.1371/journal.pone.0055937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418479	Green Published, gold			2022-12-27	WOS:000315970300071
J	Solimini, AG				Solimini, Angelo G.			Are There Side Effects to Watching 3D Movies? A Prospective Crossover Observational Study on Visually Induced Motion Sickness	PLOS ONE			English	Article							SYMPTOMS; ADAPTATION; DISCOMFORT; VECTION; VISION; IMAGES	Background: The increasing popularity of commercial movies showing three dimensional (3D) images has raised concern about possible adverse side effects on viewers. Methods and Findings: A prospective carryover observational study was designed to assess the effect of exposure (3D vs. 2D movie views) on self reported symptoms of visually induced motion sickness. The standardized Simulator Sickness Questionnaire (SSQ) was self administered on a convenience sample of 497 healthy adult volunteers before and after the vision of 2D and 3D movies. Viewers reporting some sickness (SSQ total score>15) were 54.8% of the total sample after the 3D movie compared to 14.1% of total sample after the 2D movie. Symptom intensity was 8.8 times higher than baseline after exposure to 3D movie (compared to the increase of 2 times the baseline after the 2D movie). Multivariate modeling of visually induced motion sickness as response variables pointed out the significant effects of exposure to 3D movie, history of car sickness and headache, after adjusting for gender, age, self reported anxiety level, attention to the movie and show time. Conclusions: Seeing 3D movies can increase rating of symptoms of nausea, oculomotor and disorientation, especially in women with susceptible visual-vestibular system. Confirmatory studies which include examination of clinical signs on viewers are needed to pursue a conclusive evidence on the 3D vision effects on spectators.	Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy	Sapienza University Rome	Solimini, AG (corresponding author), Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy.	angelo.solimini@uniroma1.it	Solimini, Angelo G/C-9290-2018	Solimini, Angelo/0000-0002-5281-7624	Sapienza University	Sapienza University	This work has been funded with internal Sapienza University funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AmericanOptometricAssociation, 2011, CAR PAT ACC VERG DYS; Ames SL, 2005, OPTOMETRY VISION SCI, V82, P168, DOI 10.1097/01.OPX.0000156307.95086.6; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bates D., 2005, R R NEWS, V5, P27, DOI DOI 10.18637/JSS.V067.I01; Blehm C, 2005, SURV OPHTHALMOL, V50, P253, DOI 10.1016/j.survophthal.2005.02.008; Bos JE, 2008, DISPLAYS, V29, P47, DOI 10.1016/j.displa.2007.09.002; Bos JE, 2011, DISPLAYS, V32, P189, DOI 10.1016/j.displa.2010.09.005; CUTRER FM, 1992, HEADACHE, V32, P300, DOI 10.1111/j.1526-4610.1992.hed3206300.x; Diels C, 2011, DISPLAYS, V32, P175, DOI 10.1016/j.displa.2011.02.005; Emoto M, 2008, DISPLAYS, V29, P90, DOI 10.1016/j.displa.2007.09.010; Emoto M, 2005, J DISP TECHNOL, V1, P328, DOI 10.1109/JDT.2005.858938; Flanagan MB, 2005, AVIAT SPACE ENVIR MD, V76, P642; Golding JF, 2006, AUTON NEUROSCI-BASIC, V129, P67, DOI 10.1016/j.autneu.2006.07.019; Hakkinen J, 2010, PROC SPIE, V7524, DOI 10.1117/12.838857; Hoffman DM, 2008, J VISION, V8, DOI 10.1167/8.3.33; Howarth PA, 2008, DISPLAYS, V29, P45, DOI 10.1016/j.displa.2007.09.012; Howarth PA, 1997, DISPLAYS, V18, P107, DOI 10.1016/S0141-9382(97)00011-5; Ijsselsteijn W, 1998, DISPLAYS, V18, P207, DOI 10.1016/S0141-9382(98)00022-5; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kennedy RS, 2010, APPL ERGON, V41, P494, DOI 10.1016/j.apergo.2009.11.006; KURITZKY A, 1981, HEADACHE, V21, P227, DOI 10.1111/j.1526-4610.1981.hed2105227.x; Kuze J, 2008, DISPLAYS, V29, P159, DOI 10.1016/j.displa.2007.09.007; Lambooij M, 2009, J IMAGING SCI TECHN, V53, DOI 10.2352/J.ImagingSci.Technol.2009.53.3.030201; Maino D, 2011, REV OPTOMETRY, V148, P54; Maino DM, 2011, REV OPTOMETRY, V148, P28; Palmisano S, 2002, PERCEPTION, V31, P463, DOI 10.1068/p3321; Polonen M, 2009, J SOC INF DISPLAY, V17, P459, DOI 10.1889/JSID17.5.459; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; Sheedy JE, 2003, OPTOMETRY VISION SCI, V80, P732, DOI 10.1097/00006324-200311000-00008; Shibata T, 2011, J VISION, V11, DOI 10.1167/11.8.11; Smart LJ, 2002, HUM FACTORS, V44, P451, DOI 10.1518/0018720024497745; Solimini AG, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-779; Turner M, 1999, BRIT J PSYCHOL, V90, P519, DOI 10.1348/000712699161594; Ujike H, 2004, P ANN INT IEEE EMBS, V26, P2399; Ujike H, 2008, DISPLAYS, V29, P81, DOI 10.1016/j.displa.2007.09.003; Ukai K, 2008, DISPLAYS, V29, P106, DOI 10.1016/j.displa.2007.09.004; van Emmerik ML, 2011, DISPLAYS, V32, P169, DOI 10.1016/j.displa.2010.11.003; Wann JP, 2002, HUM FAC ER, P731; Webb NA, 2003, AVIAT SPACE ENVIR MD, V74, P622; Wilkins A.J., 1995, VISUAL STRESS; Wilkins AJ, 2010, APPL ERGON, V41, P509, DOI 10.1016/j.apergo.2009.01.011; Yano S, 2004, DISPLAYS, V25, P141, DOI 10.1016/j.displa.2004.09.002	42	65	67	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56160	10.1371/journal.pone.0056160	http://dx.doi.org/10.1371/journal.pone.0056160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418530	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300122
J	Todd, G; Noyes, C; Flavel, SC; Della Vedova, CB; Spyropoulos, P; Chatterton, B; Berg, D; White, JM				Todd, Gabrielle; Noyes, Carolyn; Flavel, Stanley C.; Della Vedova, Chris B.; Spyropoulos, Peter; Chatterton, Barry; Berg, Daniela; White, Jason M.			Illicit Stimulant Use Is Associated with Abnormal Substantia Nigra Morphology in Humans	PLOS ONE			English	Article							IDIOPATHIC PARKINSONS-DISEASE; TRANSCRANIAL SONOGRAPHY; MONOAMINE-OXIDASE; MDMA ECSTASY; METHAMPHETAMINE ABUSERS; CLINICAL-PHARMACOLOGY; DOPAMINE TRANSPORTERS; MOVEMENT-DISORDERS; RAT-BRAIN; AMPHETAMINE	Use of illicit stimulants such as methamphetamine, cocaine, and ecstasy is an increasing health problem. Chronic use can cause neurotoxicity in animals and humans but the long-term consequences are not well understood. The aim of the current study was to investigate the long-term effect of stimulant use on the morphology of the human substantia nigra. We hypothesised that history of illicit stimulant use is associated with an abnormally bright and enlarged substantia nigra (termed 'hyperechogenicity') when viewed with transcranial sonography. Substantia nigra morphology was assessed in abstinent stimulant users (n = 36; 31 +/- 9 yrs) and in two groups of control subjects: non-drug users (n = 29; 24 +/- 5 yrs) and cannabis users (n = 12; 2567 yrs). Substantia nigra morphology was viewed with transcranial sonography and the area of echogenicity at the anatomical site of the substantia nigra was measured at its greatest extent. The area of substantia nigra echogenicity was significantly larger in the stimulant group (0.273 +/- 0.078 cm(2)) than in the control (0.201 +/- 0.054 cm(2); P<0.001) and cannabis (0.202 +/- 0.045 cm(2); P<0.007) groups. 53% of stimulant users exhibited echogenicity that exceeded the 90th percentile for the control group. The results of the current study suggest that individuals with a history of illicit stimulant use exhibit abnormal substantia nigra morphology. Substantia nigra hyperechogenicity is a strong risk factor for developing Parkinson's disease later in life and further research is required to determine if the observed abnormality in stimulant users is associated with a functional deficit of the nigro-striatal system.	[Todd, Gabrielle; Noyes, Carolyn; Flavel, Stanley C.; Della Vedova, Chris B.; White, Jason M.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Todd, Gabrielle; White, Jason M.] Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia; [Spyropoulos, Peter; Chatterton, Barry] Royal Adelaide Hosp, Dept Nucl Med PET & Bone Densitometry & Radiol, Adelaide, SA 5000, Australia; [Berg, Daniela] Hertie Inst Clin Brain Res, Dept Neurodegenerat, Tubingen, Germany; [Berg, Daniela] German Ctr Neurodegenerat Dis, Tubingen, Germany	University of South Australia; University of South Australia; Royal Adelaide Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Todd, G (corresponding author), Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia.	gabrielle.todd@unisa.edu.au	Todd, Gabrielle/K-7122-2012; Berg, Daniela/A-8728-2019; Della Vedova, Chris B/F-4583-2013; White, Jason M/A-2795-2011	Todd, Gabrielle/0000-0002-2465-6026; Berg, Daniela/0000-0001-5796-5442; Della Vedova, Chris B/0000-0002-2361-3729; White, Jason M/0000-0001-6750-1078	Clive and Vera Ramaciotti Foundation [ID 2974/2010]; National Health and Medical Research Council of Australia [ID 627003]; University of South Australia	Clive and Vera Ramaciotti Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of South Australia	This work was supported by the Clive and Vera Ramaciotti Foundation (establishment grant, ID 2974/2010), National Health and Medical Research Council of Australia (GT holds a Career Development Award; ID 627003), and University of South Australia (GT holds a Rsearch SA Fellowship; SF held an Australian Postgraduate Award; CDV, GT, and JW hold a Division of Health Sciences Research Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, 2011, 2010 NAT DRUG STRAT; *AUSTR I HLTH WELF, 2005, 2004 NAT DRUG STRAT; Beck A.T., 1996, PSYCHOL ASSESS, V2, DOI DOI 10.1037/T00742-000; Behnke S, 2009, NEUROIMAGE, V47, P1237, DOI 10.1016/j.neuroimage.2009.05.072; BENOWITZ NL, 1993, PHARMACOL TOXICOL, V72, P3, DOI 10.1111/j.1600-0773.1993.tb01331.x; Benton AL, 1983, MULTILINGUAL APHASIA; Berg D, 2010, J NEURAL TRANSM, V117, P1287, DOI 10.1007/s00702-010-0504-6; Berg D, 2002, ARCH NEUROL-CHICAGO, V59, P999, DOI 10.1001/archneur.59.6.999; Berg D, 2001, J NEUROL, V248, P684, DOI 10.1007/s004150170114; Berg D, 2001, NEUROLOGY, V56, P13, DOI 10.1212/WNL.56.1.13; Berg D, 1999, ULTRASOUND MED BIOL, V25, P901, DOI 10.1016/S0301-5629(99)00046-0; Berg D, 1999, NEUROLOGY, V53, P1026, DOI 10.1212/WNL.53.5.1026; Berg D, 2008, LANCET NEUROL, V7, P1044, DOI 10.1016/S1474-4422(08)70239-4; Berg D, 2007, PARKINSONISM RELAT D, V13, pS429, DOI 10.1016/S1353-8020(08)70043-9; Berg D, 2011, ARCH NEUROL-CHICAGO, V68, P932, DOI 10.1001/archneurol.2011.141; Bouwmans AEP, 2010, INT REV NEUROBIOL, V90, P121, DOI 10.1016/S0074-7742(10)90009-3; Breen C, 2006, SUBST USE MISUSE, V41, P1095, DOI 10.1080/10826080500411528; Callaghan RC, 2010, MOVEMENT DISORD, V25, P2333, DOI 10.1002/mds.23263; COMMINS DL, 1987, J PHARMACOL EXP THER, V241, P338; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Doepp F, 2008, MOVEMENT DISORD, V23, P405, DOI 10.1002/mds.21861; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; GRIGSBY J, 1995, PERCEPT MOTOR SKILL, V80, P732, DOI 10.2466/pms.1995.80.3.732; Hatzidimitriou G, 1999, J NEUROSCI, V19, P5096; Hochstrasser H, 2004, NEUROLOGY, V63, P1912, DOI 10.1212/01.WNL.0000144276.29988.C3; Huang YW, 2007, MOV DISORD; Jones SR, 1998, J NEUROSCI, V18, P1979; Kalant H, 2001, CAN MED ASSOC J, V165, P917; KEARCOLWELL JJ, 1978, J CLIN PSYCHOL, V34, P437, DOI 10.1002/1097-4679(197804)34:2<437::AID-JCLP2270340239>3.0.CO;2-K; Kim JY, 2007, MOVEMENT DISORD, V22, P1922, DOI 10.1002/mds.21628; Kish SJ, 2010, J PSYCHOPHARMACOL, V24, P281, DOI 10.1177/0269881108097724; Lew R, 1996, J PHARMACOL EXP THER, V276, P855; Lewis AJ, 2012, TOB CONTROL, V21, P39, DOI 10.1136/tc.2010.040287; Little KY, 2009, PSYCHIAT RES, V168, P173, DOI 10.1016/j.psychres.2008.10.034; MANTLE TJ, 1976, BIOCHEM PHARMACOL, V25, P2073, DOI 10.1016/0006-2952(76)90432-9; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; Melega WP, 2007, NEUROREPORT, V18, P1741, DOI 10.1097/WNR.0b013e3282f0d4f4; Melega WP, 1996, SYNAPSE, V22, P63, DOI 10.1002/(SICI)1098-2396(199601)22:1<63::AID-SYN7>3.0.CO;2-G; Moore DJ, 2003, NEUROMOL MED, V4, P95, DOI 10.1385/NMM:4:1-2:95; Mrazik M, 2010, ARCH CLIN NEUROPSYCH, V25, P236, DOI 10.1093/arclin/acq006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Quan Li, 2005, Legal Medicine, V7, P144, DOI 10.1016/j.legalmed.2004.11.002; Reneman L, 2002, NEUROPSYCHOPHARMACOL, V26, P387, DOI 10.1016/S0893-133X(01)00366-9; RICAURTE GA, 1992, J PHARMACOL EXP THER, V261, P616; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; SCHMIDT CJ, 1987, BIOCHEM PHARMACOL, V36, P4095, DOI 10.1016/0006-2952(87)90566-1; Scorza MC, 1997, BIOCHEM PHARMACOL, V54, P1361, DOI 10.1016/S0006-2952(97)00405-X; Skoloudik D, 2007, ULTRASOUND MED BIOL, V33, P1347, DOI 10.1016/j.ultrasmedbio.2007.03.013; Skoloudik D, 2010, INT REV NEUROBIOL, V90, P7, DOI 10.1016/S0074-7742(10)90002-0; Spiegel J, 2006, BRAIN, V129, P1188, DOI 10.1093/brain/awl042; Subramanian T, 2010, ULTRASOUND MED BIOL, V36, P604, DOI 10.1016/j.ultrasmedbio.2009.12.001; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; SULZER D, 1995, J NEUROSCI, V15, P4102; Thompson G.B., 1992, PSYCHOL ASSESSMENT, V4, P363; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tsai CF, 2007, J NEUROL, V254, P501, DOI 10.1007/s00415-006-0403-9; Volkow ND, 2001, J NEUROSCI, V21, P9414, DOI 10.1523/JNEUROSCI.21-23-09414.2001; Volkow ND, 2001, AM J PSYCHIAT, V158, P2015, DOI 10.1176/appi.ajp.158.12.2015; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Yamamoto Bryan K., 2005, Critical Reviews in Neurobiology, V17, P87; Yamamoto BK, 2010, ANN NY ACAD SCI, V1187, P101, DOI 10.1111/j.1749-6632.2009.05141.x; Zecca L, 2005, MOVEMENT DISORD, V20, P1278, DOI 10.1002/mds.20550	65	36	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56438	10.1371/journal.pone.0056438	http://dx.doi.org/10.1371/journal.pone.0056438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418568	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000315970300161
J	Vargas, MR; Burton, NC; Gan, L; Johnson, DA; Schafer, M; Werner, S; Johnson, JA				Vargas, Marcelo R.; Burton, Neal C.; Gan, Li; Johnson, Delinda A.; Schaefer, Matthias; Werner, Sabine; Johnson, Jeffrey A.			Absence of Nrf2 or Its Selective Overexpression in Neurons and Muscle Does Not Affect Survival in ALS-Linked Mutant hSOD1 Mouse Models	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ANTIOXIDANT RESPONSE ELEMENT; MOTOR-NEURON; SUPEROXIDE-DISMUTASE; SPINAL-CORD; GLUTATHIONE BIOSYNTHESIS; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; SKELETAL-MUSCLE; PRIMARY TARGET	The nuclear factor erythroid 2-related factor 2 (Nrf2) governs the expression of antioxidant and phase II detoxifying enzymes. Nrf2 activation can prevent or reduce cellular damage associated with several types of injury in many different tissues and organs. Dominant mutations in Cu/Zn-superoxide dismutase (SOD1) cause familial forms of amyotrophic lateral sclerosis (ALS), a fatal disorder characterized by the progressive loss of motor neurons and subsequent muscular atrophy. We have previously shown that Nrf2 activation in astrocytes delays neurodegeneration in ALS mouse models. To further investigate the role of Nrf2 in ALS we determined the effect of absence of Nrf2 or its restricted overexpression in neurons or type II skeletal muscle fibers on symptoms onset and survival in mutant hSOD1 expressing mice. We did not observe any detrimental effect associated with the lack of Nrf2 in two different mutant hSOD1 animal models of ALS. However, restricted Nrf2 overexpression in neurons or type II skeletal muscle fibers delayed disease onset but failed to extend survival in hSOD1(G93A) mice. These results highlight the concept that not only the pharmacological target but also the cell type targeted may be relevant when considering a Nrf2-mediated therapeutic approach for ALS.	[Vargas, Marcelo R.; Burton, Neal C.; Gan, Li; Johnson, Delinda A.; Johnson, Jeffrey A.] Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53706 USA; [Johnson, Jeffrey A.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Johnson, Jeffrey A.] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI USA; [Johnson, Jeffrey A.] Univ Wisconsin, Ctr Neurosci, Madison, WI USA; [Schaefer, Matthias; Werner, Sabine] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, Hongg, Switzerland	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Johnson, JA (corresponding author), Univ Wisconsin, Div Pharmaceut Sci, Madison, WI 53706 USA.	jajohnson@pharmacy.wisc.edu	Schäfer, Matthias/K-1911-2012; Gan, Li/K-8775-2012	Schäfer, Matthias/0000-0001-6754-0448; Gan, Li/0000-0001-9522-0177; Werner, Sabine/0000-0001-7397-8710; Vargas, Marcelo/0000-0003-1039-4210	National Institute of Environmental Health Sciences (NIEHS) [ES08089, ES019186]; National Institute of General Medical Sciences [GM103542]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015, R01ES008089, R00ES019186, R29ES008089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103542] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of Environmental Health Sciences (NIEHS) ES08089 to J.A.J. Salary support for M. R. V. was provided by NIEHS grant ES019186 and National Institute of General Medical Sciences grant GM103542. The authors thank Dr. Albee Messing and the Waisman Intellectual and Developmental Disabilities Research Center (Waisman IDDRC, P30HD03352) for their technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckman JS, 2001, TRENDS NEUROSCI, V24, pS15, DOI 10.1016/S0166-2236(00)01981-0; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Dewachter I, 2002, J NEUROSCI, V22, P3445; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frey D, 2000, J NEUROSCI, V20, P2534; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Innamorato NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011838; Jakel RJ, 2007, BRAIN RES, V1144, P192, DOI 10.1016/j.brainres.2007.01.131; Johnson DA, 2002, J NEUROCHEM, V81, P1233, DOI 10.1046/j.1471-4159.2002.00913.x; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Kraft AD, 2007, EXP NEUROL, V207, P107, DOI 10.1016/j.expneurol.2007.05.026; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Manfredi G, 2005, MITOCHONDRION, V5, P77, DOI 10.1016/j.mito.2005.01.002; Miller TM, 2006, P NATL ACAD SCI USA, V103, P19546, DOI 10.1073/pnas.0609411103; Mimoto T, 2012, BRAIN RES, V1446, P109, DOI 10.1016/j.brainres.2011.12.064; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Pehar M, 2007, J NEUROSCI, V27, P7777, DOI 10.1523/JNEUROSCI.0823-07.2007; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sarlette A, 2008, J NEUROPATH EXP NEUR, V67, P1055, DOI 10.1097/NEN.0b013e31818b4906; Schafer M, 2010, GENE DEV, V24, P1045, DOI 10.1101/gad.568810; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Vargas MR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001094; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Vargas MR, 2006, J NEUROCHEM, V97, P687, DOI 10.1111/j.1471-4159.2006.03742.x; Vargas MR, 2005, J BIOL CHEM, V280, P25571, DOI 10.1074/jbc.M501920200; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047	41	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56625	10.1371/journal.pone.0056625	http://dx.doi.org/10.1371/journal.pone.0056625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418589	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300182
J	Yang, XK; Wang, QX; Gao, ZY; Zhou, Z; Peng, S; Chang, WL; Lin, HY; Zhang, WY; Wang, HM				Yang, Xiaokui; Wang, Qingxin; Gao, Zhiying; Zhou, Zhi; Peng, Sha; Chang, Wen-Lin; Lin, Hai-Yan; Zhang, Weiyuan; Wang, Hongmei			Proprotein Convertase Furin Regulates Apoptosis and Proliferation of Granulosa Cells in the Rat Ovary	PLOS ONE			English	Article							LINE IN-VITRO; FOLLICLE DEVELOPMENT; SECRETORY PATHWAY; PROTEASE PC4; CANCER CELLS; EXPRESSION; GROWTH; MICE; OOCYTE; PROGRESSION	Folliculogenesis is tightly controlled by a series of hormones, growth factors and cytokines, many of which are secreted as proproteins and require processing by proteases before becoming functional. Furin is a member of the subtilisin-like proteases that activate large numbers of proprotein substrates and is ubiquitously expressed and implicated in many physiological and pathological processes. However, the precise role of furin during folliculogenesis has not been thoroughly investigated. The goal of the present work is to identify the role of furin in the development of granulosa cells during folliculogenesis, using immunohistochemistry, RT-PCR, Western blot and functional studies in primary cultured rat granulosa cells. Our results demonstrate that furin is highly expressed in granulosa cells and oocytes of the ovary with very limited expression in other ovarian cells such as the epithelial, stromal or theca cells. Furin siRNA significantly increases apoptosis of the granulosa cells from large antral/preovulatory follicles, in part via downregulation of the anti-apoptotic proteins, XIAP and p-AKT. On the contrary, furin siRNA markedly decreases proliferation of granulosa cells based on the downregulation of proliferation cell nuclear antigen (PCNA). Taken together, these data suggest that furin may play an important role in regulating apoptosis and proliferation of granulosa cells.	[Yang, Xiaokui; Wang, Qingxin; Peng, Sha; Zhang, Weiyuan] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Human Reprod Med, Beijing, Peoples R China; [Wang, Qingxin; Zhou, Zhi; Chang, Wen-Lin; Lin, Hai-Yan; Wang, Hongmei] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Gao, Zhiying] Peoples Liberat Army Gen Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China; [Zhou, Zhi] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, WY (corresponding author), Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Human Reprod Med, Beijing, Peoples R China.	zhangwy9921@hotmail.com; wanghm@ioz.ac.cn			Natural Science Foundation of China [30872746, 30971088]; Natural Science Foundation of Beijing [7082034]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by funding from the Natural Science Foundation of China (30872746) and Natural Science Foundation of Beijing (7082034) to XKY, and a grant from Natural Science Foundation of China (30971088) to HMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JMJ, 2010, REPROD DOMEST ANIM, V45, P171, DOI 10.1111/j.1439-0531.2008.01302.x; Aerts JMJ, 2010, REPROD DOMEST ANIM, V45, P180, DOI 10.1111/j.1439-0531.2008.01298.x; Antenos M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017348; Antenos M, 2008, J BIOL CHEM, V283, P33059, DOI 10.1074/jbc.M804190200; Bae JA, 2008, MOL CELL ENDOCRINOL, V289, P29, DOI 10.1016/j.mce.2008.04.006; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Bassi DE, 2003, AM J PATHOL, V162, P439, DOI 10.1016/S0002-9440(10)63838-2; Buratini J, 2011, REPROD FERT DEVELOP, V23, P32, DOI 10.1071/RD10224; Carabatsos MJ, 1998, DEV BIOL, V204, P373, DOI 10.1006/dbio.1998.9087; de Cicco RL, 2005, CANCER RES, V65, P4162, DOI 10.1158/0008-5472.CAN-04-2820; Diaz FJ, 2008, BIOL REPROD, V78, P176, DOI 10.1095/biolreprod.107.063537; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; Gosden RG, 1998, REPROD FERT DEVELOP, V10, P73, DOI 10.1071/R98043; Gougeon A, 2010, ANN ENDOCRINOL-PARIS, V71, P132, DOI 10.1016/j.ando.2010.02.021; Gyamera-Acheampong C, 2006, BIOL REPROD, V74, P666, DOI 10.1095/biolreprod.105.046821; Homburg R, 1998, J ENDOCRINOL INVEST, V21, P552, DOI 10.1007/BF03350780; Jin Xuan, 2011, Front Biosci (Schol Ed), V3, P680, DOI 10.2741/s180; Kelty BP, 2010, BIOL REPROD, V83, P147, DOI 10.1095/biolreprod.109.079947; Lapierre M, 2007, CANCER RES, V67, P9030, DOI 10.1158/0008-5472.CAN-07-0807; Mbikay M, 1997, BRIT J CANCER, V75, P1509, DOI 10.1038/bjc.1997.258; Mbikay M, 1997, P NATL ACAD SCI USA, V94, P6842, DOI 10.1073/pnas.94.13.6842; Miao S, 2011, INT J MOL SCI, V12, P3831, DOI 10.3390/ijms12063831; Morita Y, 1999, DEV BIOL, V213, P1, DOI 10.1006/dbio.1999.9344; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Ogiwara K, 2004, J EXP ZOOL PART A, V301A, P449, DOI 10.1002/jez.a.20071; Page RE, 2007, CELL ONCOL, V29, P289; Sasanami T, 2003, BIOL REPROD, V68, P1613, DOI 10.1095/biolreprod.102.011841; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Tadros H, 2001, J REPROD IMMUNOL, V49, P133, DOI 10.1016/S0165-0378(00)00085-1; Tamura H, 2009, FERTIL STERIL, V92, P328, DOI 10.1016/j.fertnstert.2008.05.016; Taylor NA, 2003, FASEB J, V17, P1215, DOI 10.1096/fj.02-0831rev; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Visser JA, 2007, ENDOCRINOLOGY, V148, P2301, DOI 10.1210/en.2006-1265; Wang H, 2006, MOL ENDOCRINOL, V20, P2469, DOI 10.1210/me.2005-0446; Webber LJ, 2007, J CLIN ENDOCR METAB, V92, P1975, DOI 10.1210/jc.2006-1422; Wunsch A, 2007, ANN ENDOCRINOL-PARIS, V68, P160, DOI 10.1016/j.ando.2007.04.006; Xu QA, 2011, J ZHEJIANG UNIV-SC B, V12, P247, DOI 10.1631/jzus.B1000373; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745; Zhou Z, 2009, PLACENTA, V30, P929, DOI 10.1016/j.placenta.2009.09.003	44	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e50479	10.1371/journal.pone.0050479	http://dx.doi.org/10.1371/journal.pone.0050479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418414	gold, Green Submitted, Green Published			2022-12-27	WOS:000315970300004
J	Carvalhais, LC; Dennis, PG; Badri, DV; Tyson, GW; Vivanco, JM; Schenk, PM				Carvalhais, Lilia C.; Dennis, Paul G.; Badri, Dayakar V.; Tyson, Gene W.; Vivanco, Jorge M.; Schenk, Peer M.			Activation of the Jasmonic Acid Plant Defence Pathway Alters the Composition of Rhizosphere Bacterial Communities	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; ANTIHERBIVORE DEFENSE; RESOURCE AVAILABILITY; GENE-EXPRESSION; RESISTANCE; SOIL; FLAVONOIDS; SPHAERICUS; RESPONSES; PROTEINS	Jasmonic acid (JA) signalling plays a central role in plant defences against necrotrophic pathogens and herbivorous insects, which afflict both roots and shoots. This pathway is also activated following the interaction with beneficial microbes that may lead to induced systemic resistance. Activation of the JA signalling pathway via application of methyl jasmonate (MeJA) alters the composition of carbon containing compounds released by roots, which are implicated as key determinants of rhizosphere microbial community structure. In this study, we investigated the influence of the JA defence signalling pathway activation in Arabidopsis thaliana on the structure of associated rhizosphere bacterial communities using 16S rRNA gene amplicon pyrosequencing. Application of MeJA did not directly influence bulk soil microbial communities but significant changes in rhizosphere community composition were observed upon activation of the jasmonate signalling pathway. Our results suggest that JA signalling may mediate plant-bacteria interactions in the soil upon necrotrophic pathogen and herbivorous insect attacks.	[Carvalhais, Lilia C.; Schenk, Peer M.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia; [Dennis, Paul G.; Tyson, Gene W.] Univ Queensland, Sch Chem & Mol Biosci, Australian Ctr Ecogen, Brisbane, Qld, Australia; [Dennis, Paul G.; Tyson, Gene W.] Univ Queensland, Adv Water Management Ctr, Brisbane, Qld, Australia; [Badri, Dayakar V.; Vivanco, Jorge M.] Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA; [Badri, Dayakar V.; Vivanco, Jorge M.] Colorado State Univ, Ctr Rhizosphere Biol, Ft Collins, CO 80523 USA	University of Queensland; University of Queensland; University of Queensland; Colorado State University; Colorado State University	Carvalhais, LC (corresponding author), Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia.	l.carvalhais@uq.edu.au	Schenk, Peer/B-7879-2016; Dennis, Paul G/H-2141-2017; Tyson, Gene W/C-6558-2013	Schenk, Peer/0000-0003-4878-3799; Dennis, Paul G/0000-0002-4895-3105; Tyson, Gene W/0000-0001-8559-9427; Carvalhais, Lilia C./0000-0001-9882-526X	Australian Research Council [DP1094749]; National Science Foundation of the United States of America [MCB-0950857]; Div Of Molecular and Cellular Bioscience [0950857] Funding Source: National Science Foundation	Australian Research Council(Australian Research Council); National Science Foundation of the United States of America(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support for this work was provided by the Australian Research Council (DP1094749) and the National Science Foundation of the United States of America (MCB-0950857). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Shanab RAI, 2007, CHEMOSPHERE, V68, P360, DOI 10.1016/j.chemosphere.2006.12.051; Achouak W, 1999, INT J SYST BACTERIOL, V49, P961, DOI 10.1099/00207713-49-3-961; Badri DV, 2008, NEW PHYTOL, V179, P209, DOI 10.1111/j.1469-8137.2008.02458.x; Berry C, 2012, J INVERTEBR PATHOL, V109, P1, DOI 10.1016/j.jip.2011.11.008; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; BRYANT JP, 1989, NATURE, V340, P227, DOI 10.1038/340227a0; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Campbell EJ, 2003, PLANT PHYSIOL, V133, P1272, DOI 10.1104/pp.103.024182; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carvalhais LC, 2012, J MICROBIOL METH, V91, P246, DOI 10.1016/j.mimet.2012.08.011; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Dennis PG, 2013, BIORESOURCE IN PRESS; Doornbos RF, 2011, MOL PLANT MICROBE IN, V24, P395, DOI 10.1094/MPMI-05-10-0115; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Faure D, 2009, PLANT SOIL, V321, P279, DOI 10.1007/s11104-008-9839-2; Hassan S, 2012, J EXP BOT, V63, P3429, DOI 10.1093/jxb/err430; Hein JW, 2008, MICROB ECOL, V55, P333, DOI 10.1007/s00248-007-9279-1; Hu XM, 2008, J BACTERIOL, V190, P2892, DOI 10.1128/JB.01652-07; Jin HJ, 2011, MICROBIOLOGY+, V80, P117, DOI 10.1134/S0026261711010097; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Laluk K., 2010, Arabidopsis Book, V8, pe0136, DOI 10.1199/tab.0136; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; Naz I, 2010, PLANT SOIL, V334, P199, DOI 10.1007/s11104-010-0372-8; Puthoff DP, 2007, PLANT CELL REP, V26, P71, DOI 10.1007/s00299-006-0201-y; Rasmann S, 2008, PLANT PHYSIOL, V146, P875, DOI 10.1104/pp.107.112045; Raymond B, 2010, TRENDS MICROBIOL, V18, P189, DOI 10.1016/j.tim.2010.02.006; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Sgroy V, 2009, APPL MICROBIOL BIOT, V85, P371, DOI 10.1007/s00253-009-2116-3; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stearns JC, 2012, MOL PLANT MICROBE IN, V25, P668, DOI 10.1094/MPMI-08-11-0213; Tjamos SE, 2005, MOL PLANT MICROBE IN, V18, P555, DOI 10.1094/MPMI-18-0555; Validov S, 2007, J APPL MICROBIOL, V102, P461, DOI 10.1111/j.1365-2672.2006.03083.x; van Frankenhuyzen K, 2009, J INVERTEBR PATHOL, V101, P1, DOI 10.1016/j.jip.2009.02.009; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Viruel E, 2011, ARCH MICROBIOL, V193, P489, DOI 10.1007/s00203-011-0692-y; Yadav S, 2011, J BASIC MICROB, V51, P98, DOI 10.1002/jobm.201000098; Yu XM, 2011, FEMS MICROBIOL LETT, V325, P30, DOI 10.1111/j.1574-6968.2011.02409.x; Zou CS, 2007, SOIL BIOL BIOCHEM, V39, P2371, DOI 10.1016/j.soilbio.2007.04.009	44	107	111	3	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56457	10.1371/journal.pone.0056457	http://dx.doi.org/10.1371/journal.pone.0056457			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424661	Green Submitted, Green Published, gold			2022-12-27	WOS:000315965100049
J	Kish, LB; Nevels, RD				Kish, Laszlo B.; Nevels, Robert D.			Twisted Radio Waves and Twisted Thermodynamics	PLOS ONE			English	Article								We present and analyze a gedanken experiment and show that the assumption that an antenna operating at a single frequency can transmit more than two independent information channels to the far field violates the Second Law of Thermodynamics. Transmission of a large number of channels, each associated with an angular momenta 'twisted wave' mode, to the far field in free space is therefore not possible.	[Kish, Laszlo B.] Texas A&M Univ, Dept Elect & Comp Engn, Solid State Elect Photon & Nanoengn Div, College Stn, TX 77843 USA; [Nevels, Robert D.] Texas A&M Univ, Dept Elect & Comp Engn, Electromagnet & Microwaves Div, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Kish, LB (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, Solid State Elect Photon & Nanoengn Div, College Stn, TX 77843 USA.	Laszlokish@tamu.edu						Boltzmann L., 1964, LECT GAS THEORY; Cartlidge E, 2011, NATURE NEWS, DOI [10.1038/news.2011.114, DOI 10.1038/NEWS.2011.114]; Edfors O, 2012, IEEE T ANTENN PROPAG, V60, P1126, DOI 10.1109/TAP.2011.2173142; Mair A, 2001, NATURE, V412, P313, DOI 10.1038/35085529; Nyquist H, 1928, PHYS REV, V32, P110, DOI 10.1103/PhysRev.32.110; Planck M., 1914, THEORY HEAT RAD; Tamagnone M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/118001; Tamburini F, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033001; Tamburini F, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3659466; Tamburini F, 2011, NAT PHYS, V7, P195, DOI [10.1038/nphys1907, 10.1038/NPHYS1907]; Thide B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.087701; Wang J, 2012, NAT PHOTONICS, V6, P488, DOI [10.1038/NPHOTON.2012.138, 10.1038/nphoton.2012.138]	12	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56086	10.1371/journal.pone.0056086	http://dx.doi.org/10.1371/journal.pone.0056086			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424647	Green Published, gold, Green Submitted			2022-12-27	WOS:000315965100035
J	McMahon, JH; Elliott, JH; Hong, SY; Bertagnolio, S; Jordan, MR				McMahon, James H.; Elliott, Julian H.; Hong, Steven Y.; Bertagnolio, Silvia; Jordan, Michael R.			Effects of Physical Tracing on Estimates of Loss to Follow-Up, Mortality and Retention in Low and Middle Income Country Antiretroviral Therapy Programs: A Systematic Review	PLOS ONE			English	Review							SUB-SAHARAN AFRICA; HIV TREATMENT PROGRAM; SOUTH-AFRICA; DRUG-RESISTANCE; SCALING-UP; VIROLOGICAL RESPONSE; PATIENT RETENTION; RURAL DISTRICT; 2 CLINICS; OUTCOMES	Background: A large proportion of patients receiving antiretroviral therapy (ART) in low and middle income countries (LMICs) have unknown treatment outcomes and are classified as lost to follow-up (LTFU). Physical tracing of patients classified as LTFU is common; however, effects of tracing on outcomes remains unclear. The objective of this systematic review is to compare estimates of LTFU, mortality and retention in LMIC in cohorts of patients with and without physical tracing. Methods and Findings: We systematically identified studies in LMIC programmatic settings using MEDLINE (2003-2011) and HIV conference abstracts (2009-2011). Studies reporting the proportion LTFU 12-months after ART initiation were included. Tracing activities were determined from manuscripts or by contacting study authors. Studies were classified as "tracing studies" if physical tracing was available for the majority of patients. Summary estimates from the 2 groups of studies (tracing and non-tracing) for LTFU, mortality, stop of ART, transfers out, and retention on ART were determined. 261 papers and 616 abstracts were identified of which 39 studies comprising 54 separate cohorts (n = 187,666) met inclusion criteria. Of those, physical tracing was available for 46% of cohorts. Treatment programs with physical tracing activities had lower estimated LTFU (7.6% vs. 15.1%; p<.001), higher estimated mortality (10.5% vs. 6.6%; p = .006), higher retention on ART (80.0 vs. 75.8%; p = .04) and higher retention at the original site (80.0% vs. 72.9%; p = .02). Conclusions: Knowledge of patient tracing is critical when interpreting program outcomes of LTFU, mortality and retention. The reduction of the proportion LTFU in tracing studies was only partially explained by re-classification of unknown outcomes. These data suggest that tracing may lead to increased re-engagement of patients in care, rather than just improved classification of unknown outcomes.	[McMahon, James H.; Elliott, Julian H.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [McMahon, James H.; Hong, Steven Y.; Jordan, Michael R.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Elliott, Julian H.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Elliott, Julian H.] Burnet Inst, Melbourne, Vic, Australia; [Hong, Steven Y.; Jordan, Michael R.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA; [Bertagnolio, Silvia] UCL, London, England	Florey Institute of Neuroscience & Mental Health; Massachusetts Department of Public Health; Tufts University; Monash University; Burnet Institute; Tufts Medical Center; University of London; University College London	McMahon, JH (corresponding author), Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia.	ja.mcmahon@alfred.org.au		McMahon, James/0000-0003-1460-5572	Tufts Medical Center Department of Geographic Medicine and Infectious Diseases; Australian National Health and Medical Research Council (NHMRC) Postgraduate Scholarship; National Institutes of Health Career Development Award [5K23AI074423-04]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI074423, K23AI097010] Funding Source: NIH RePORTER	Tufts Medical Center Department of Geographic Medicine and Infectious Diseases; Australian National Health and Medical Research Council (NHMRC) Postgraduate Scholarship(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JM was supported by a fellowship from Tufts Medical Center Department of Geographic Medicine and Infectious Diseases, and an Australian National Health and Medical Research Council (NHMRC) Postgraduate Scholarship. MRJ was supported by an National Institutes of Health Career Development Award (5K23AI074423-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, PAT MON GUID HIV CAR; Assefa Y, 2010, AIDS PATIENT CARE ST, V24, P521, DOI 10.1089/apc.2009.0286; Auld A, 2010, TREATMENT OUTCOMES M; Balestre E, 2011, 272 CROI; Barth RE, 2008, EUR J CLIN MICROBIOL, V27, P977, DOI 10.1007/s10096-008-0534-2; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bertagnolio S, 2011, 52 CROI; Bisson GP, 2006, AIDS, V20, P1333, DOI 10.1097/01.aids.0000232245.36039.2b; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Charalambous S, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000279696.63438.aa; Chi BH, 2009, INT J EPIDEMIOL, V38, P746, DOI 10.1093/ije/dyp004; Chinh N, 2010, 517 CROI; Chung MH, 2010, JAIDS-J ACQ IMM DEF, V53, P422, DOI 10.1097/QAI.0b013e3181b32bd6; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Collini P, 2009, CLIN INFECT DIS, V48, P988, DOI 10.1086/597353; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Cortes C, 2010, 523 CROI; Culbert H, 2007, PLOS MED, V4, P794, DOI 10.1371/journal.pmed.0040129; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Desilva MB, 2009, AIDS CARE, V21, P70, DOI 10.1080/09540120802017636; Ehmer J, 2009, CHARACTERISTICS OUTC; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Forgione L, 2012, 1123 CROI; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; Hawkins C, 2007, JAIDS-J ACQ IMM DEF, V45, P304; Hingankar NK, 2012, CLIN INFECT DIS, V54, pS348, DOI 10.1093/cid/cis005; Hong SY, 2010, JAIDS-J ACQ IMM DEF, V55, pE27, DOI 10.1097/QAI.0b013e3181f5376d; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, MON DECL COMM HIV AI; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Laurent C, 2005, CLIN INFECT DIS, V41, P108, DOI 10.1086/430712; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Marston Barbara J, 2007, J Int Assoc Physicians AIDS Care (Chic), V6, P106, DOI 10.1177/1545109707300688; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Montaner JSG, 2010, JAIDS-J ACQ IMM DEF, V55, pS5, DOI 10.1097/QAI.0b013e3181f9c1f0; Moore E, 2010, J INFECTION, V61, P155, DOI 10.1016/j.jinf.2010.04.009; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; O'Brien Daniel P, 2009, Confl Health, V3, P1, DOI 10.1186/1752-1505-3-1; Oleckno W, 2008, BASIC MEASURES OCCUR, P98; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palombi L, 2009, CLIN INFECT DIS, V48, P115, DOI 10.1086/593312; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; PEPFAR, 2009, NEXT GEN IND REF GUI; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Sharma SK, 2010, B WORLD HEALTH ORGAN, V88, P222, DOI 10.2471/BLT.09.068759; Somi G, 2011, 1019 CROI; Tassie JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013899; Thai S, 2009, TROP MED INT HEALTH, V14, P1048, DOI 10.1111/j.1365-3156.2009.02334.x; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Ugbena R, 2012, CLIN INFECT DIS, V54, pS375, DOI 10.1093/cid/cir1064; Vella V, 2010, JAIDS-J ACQ IMM DEF, V55, P109, DOI 10.1097/QAI.0b013e3181e7744e; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; Wester CW, 2005, JAIDS-J ACQ IMM DEF, V40, P336, DOI 10.1097/01.qai.0000159668.80207.5b; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; World Health Organization, 2010, HIV DRUG RES EARL WA; World Health Organization, 2011, UN ACC SCAL PRIOR HI; Zachariah R, 2007, T ROY SOC TROP MED H, V101, P79, DOI 10.1016/j.trstmh.2006.05.010	66	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56047	10.1371/journal.pone.0056047	http://dx.doi.org/10.1371/journal.pone.0056047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424643	Green Published, gold, Green Submitted			2022-12-27	WOS:000315965100031
J	Ma, SH; Richardson, JA; Bitmansour, A; Solberg, TD; Pidikiti, R; Song, K; Stojadinovic, S; Vitetta, ES; Meyer, JJ				Ma, Shihong; Richardson, James A.; Bitmansour, Andrew; Solberg, Timothy D.; Pidikiti, Rajesh; Song, Kwang; Stojadinovic, Strahinja; Vitetta, Ellen S.; Meyer, Jeffrey J.			Partial Depletion of Regulatory T Cells Does Not Influence the Inflammation Caused by High Dose Hemi-Body Irradiation	PLOS ONE			English	Article							ANTITUMOR IMMUNITY; RADIATION-THERAPY; ENHANCEMENT; CANCER; TUMORS; STRATEGIES; SYSTEM; BLOOD	There is clinical interest in the modulation of regulatory T cells for cancer therapy. The safety of these therapies in combination with conventional anti-cancer therapies, including radiation therapy, can be studied in animal models. The effects of partial depletion of regulatory T (Treg) cells with an anti-CD25 antibody in conjunction with ionizing radiation on inflammation and tissue injury were analyzed in C57BL/6 mice. An anti-CD25 antibody (PC61) was administered 3 days prior to 13 Gy lower-half hemi-body irradiation (HBI). The blood, spleen, mesenteric lymph nodes (mLNs) and inguinal lymph nodes (iLNs) were harvested at various times thereafter. Alterations in the proportion of leukocyte subsets including CD4(+) T cells, CD8(+) T cells, Treg cells, B cells, NK cells, NK1.1(+) T cells, macrophages and granulocytes were analyzed by FACS. The lungs, liver, pancreas, stomach, jejunum, duodenum, ileum, colon and kidney were harvested and studied by H&E staining. Expression of inflammatory mediators in plasma and tissue were investigated by ELISA. HBI significantly decreased the leukocyte pool though the various leukocyte subsets had different sensitivities to HBI. The administration of PC61 significantly decreased the proportion of Treg cells in spleen, iLN, mLN and blood (reduction of approximately 60%). Irradiation significantly increased the proportion of Treg cells in the spleen, iLN and mLN. HBI induced a systemic inflammatory reaction as demonstrated by increased plasma levels of IL-6, KC/CXCL1 and circulating granulocytes in the blood. Neutrophils also infiltrated the small bowel. The same general patterns were observed whether or not Treg cells were partially depleted with PC61 prior to HBI. These data demonstrate that partial depletion of Treg cells in these mice does not influence HBI-induced inflammatory response and tissue injury, and that combining anti-CD25 therapy with radiation may be safe and well tolerated in a clinical setting.	[Ma, Shihong; Solberg, Timothy D.; Pidikiti, Rajesh; Song, Kwang; Stojadinovic, Strahinja; Meyer, Jeffrey J.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Ma, Shihong; Bitmansour, Andrew; Vitetta, Ellen S.] Univ Texas SW Med Ctr Dallas, Canc Immunobiol Cente, Dallas, TX 75390 USA; [Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Vitetta, Ellen S.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Vitetta, Ellen S.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Meyer, JJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	Jeffrey.Meyer@UTSouthwestern.edu	Stojadinovic, Strahinja/R-3818-2019; Ma, Shihong/E-1111-2015; Pidikiti, Rajesh/E-2686-2013	Stojadinovic, Strahinja/0000-0002-6840-5747; Solberg, Timothy/0000-0001-8829-7774	Horchow Foundation; Department of Radiation Oncology; Cancer Immunobiology Center, University of Texas Southwestern Medical Center	Horchow Foundation; Department of Radiation Oncology; Cancer Immunobiology Center, University of Texas Southwestern Medical Center	The work was supported by The Horchow Foundation, the Department of Radiation Oncology and the Cancer Immunobiology Center, University of Texas Southwestern Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billiard F, 2011, INT J RADIAT ONCOL, V80, P869, DOI 10.1016/j.ijrobp.2010.12.041; Carrigan SO, 2009, IMMUNOBIOLOGY, V214, P211, DOI 10.1016/j.imbio.2008.07.027; Chambers KA, 1998, CYTOMETRY, V31, P45, DOI 10.1002/(SICI)1097-0320(19980101)31:1<45::AID-CYTO6>3.0.CO;2-I; Couper KN, 2007, J IMMUNOL, V178, P4136, DOI 10.4049/jimmunol.178.7.4136; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Gridley DS, 2002, AM J PHYSIOL-REG I, V282, pR677, DOI 10.1152/ajpregu.00435.2001; JANKOVIC DL, 1990, J IMMUNOL, V145, P4136; Kachikwu EL, 2011, INT J RADIAT ONCOL, V81, P1128, DOI 10.1016/j.ijrobp.2010.09.034; Kajioka EH, 2000, RADIAT RES, V153, P587, DOI 10.1667/0033-7587(2000)153[0587:AEOWBP]2.0.CO;2; Komatsu N, 2007, P NATL ACAD SCI USA, V104, P8959, DOI 10.1073/pnas.0702004104; Lee H, 2010, KIDNEY INT, V78, P1100, DOI 10.1038/ki.2010.139; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Li JL, 2003, CANCER RES, V63, P8384; Liu RJ, 2010, CELL MOL IMMUNOL, V7, P157, DOI 10.1038/cmi.2009.117; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Lugade AA, 2005, J IMMUNOL, V174, P7516, DOI 10.4049/jimmunol.174.12.7516; Moyer JS, 2008, J IMMUNOTHER, V31, P885, DOI 10.1097/CJI.0b013e3181880f1e; Nesslinger NJ, 2007, CLIN CANCER RES, V13, P1493, DOI 10.1158/1078-0432.CCR-06-1772; Ni Choileain N, 2006, J IMMUNOL, V176, P225; Paganetti H. Y. T., 2011, HUMAN RAD INJURY, P114; Pidikiti R, 2011, PHYS MED BIOL, V56, P2585, DOI 10.1088/0031-9155/56/8/016; Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101; Rusthoven KE, 2009, J CLIN ONCOL, V27, P1572, DOI 10.1200/JCO.2008.19.6329; Sharp HJ, 2007, FRONT BIOSCI-LANDMRK, V12, P4900, DOI 10.2741/2436; Song KH, 2010, PHYS MED BIOL, V55, P7345, DOI 10.1088/0031-9155/55/23/011; Teitz-Tennenbaum S, 2008, J IMMUNOTHER, V31, P345, DOI 10.1097/CJI.0b013e318163628c; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Wei WZ, 2005, CANCER RES, V65, P8471, DOI 10.1158/0008-5472.CAN-05-0934; Wing K, 2006, INT IMMUNOL, V18, P991, DOI 10.1093/intimm/dxl044; Woo EY, 2001, CANCER RES, V61, P4766	30	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56607	10.1371/journal.pone.0056607	http://dx.doi.org/10.1371/journal.pone.0056607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409194	Green Submitted, Green Published, gold			2022-12-27	WOS:000315100000059
J	Perganta, G; Barnard, AR; Katti, C; Vachtsevanos, A; Douglas, RH; MacLaren, RE; Votruba, M; Sekaran, S				Perganta, Georgia; Barnard, Alun R.; Katti, Christiana; Vachtsevanos, Athanasios; Douglas, Ron H.; MacLaren, Robert E.; Votruba, Marcela; Sekaran, Sumathi			Non-Image-Forming Light Driven Functions Are Preserved in a Mouse Model of Autosomal Dominant Optic Atrophy	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; CYCLASE-ACTIVATING POLYPEPTIDE; MASKING RESPONSES; OPA1 DEFICIENCY; MELANOPSIN; SLEEP; NERVE; PROJECTIONS; FEATURES; REVEALS	Autosomal dominant optic atrophy (ADOA) is a slowly progressive optic neuropathy that has been associated with mutations of the OPA1 gene. In patients, the disease primarily affects the retinal ganglion cells (RGCs) and causes optic nerve atrophy and visual loss. A subset of RGCs are intrinsically photosensitive, express the photopigment melanopsin and drive non-image-forming (NIF) visual functions including light driven circadian and sleep behaviours and the pupil light reflex. Given the RGC pathology in ADOA, disruption of NIF functions might be predicted. Interestingly in ADOA patients the pupil light reflex was preserved, although NIF behavioural outputs were not examined. The B6; C3-Opa1(Q285STOP) mouse model of ADOA displays optic nerve abnormalities, RGC dendropathy and functional visual disruption. We performed a comprehensive assessment of light driven NIF functions in this mouse model using wheel running activity monitoring, videotracking and pupillometry. Opa1 mutant mice entrained their activity rhythm to the external light/dark cycle, suppressed their activity in response to acute light exposure at night, generated circadian phase shift responses to 480 nm and 525 nm pulses, demonstrated immobility-defined sleep induction following exposure to a brief light pulse at night and exhibited an intensity dependent pupil light reflex. There were no significant differences in any parameter tested relative to wildtype littermate controls. Furthermore, there was no significant difference in the number of melanopsin-expressing RGCs, cell morphology or melanopsin transcript levels between genotypes. Taken together, these findings suggest the preservation of NIF functions in Opa1 mutants. The results provide support to growing evidence that the melanopsin-expressing RGCs are protected in mitochondrial optic neuropathies.	[Perganta, Georgia; Barnard, Alun R.; Katti, Christiana; Vachtsevanos, Athanasios; MacLaren, Robert E.; Sekaran, Sumathi] Univ Oxford, Nuffield Lab Ophthalmol, Nuffield Dept Clin Neurosci, Oxford OX2 6AW, England; [Douglas, Ron H.] City Univ London, London EC1V 0HB, England; [MacLaren, Robert E.] Moorfields Eye Hosp NHS Fdn Trust, London, England; [MacLaren, Robert E.] NIHR Biomed Res Ctr, London, England; [Votruba, Marcela] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales	University of Oxford; City University London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Cardiff University	Sekaran, S (corresponding author), Univ Oxford, Nuffield Lab Ophthalmol, Nuffield Dept Clin Neurosci, Walton St, Oxford OX2 6AW, England.	sumathi.sekaran@eye.ox.ac.uk	Votruba, Marcela/B-7306-2015; Votruba, Marcela/A-6182-2011	Votruba, Marcela/0000-0002-7680-9135; Votruba, Marcela/0000-0002-7680-9135; MacLaren, Robert/0000-0002-3096-4682	Biotechnology and Biological Sciences Research Council [BB/G003602/1]; Wellcome Trust [090684, 091984]; Royal College of Surgeons of Edinburgh; Health Foundation; Oxford NIHR Biomedical Research Centre; BBSRC [BB/G003602/1] Funding Source: UKRI; MRC [G0500790, G108/523, G0700949] Funding Source: UKRI; Medical Research Council [G108/523, G0500790, G0700949] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Royal College of Surgeons of Edinburgh; Health Foundation; Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council (BB/G003602/1 to SS), the Wellcome Trust (090684 to SS; 091984 to REM), the Royal College of Surgeons of Edinburgh (ARB), the Health Foundation (REM, GP, AV), and the Oxford NIHR Biomedical Research Centre (REM, ARB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Barnard AR, 2011, EXP EYE RES, V93, P771, DOI 10.1016/j.exer.2011.07.004; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Benca RM, 1998, SLEEP, V21, P451, DOI 10.1093/sleep/21.5.451; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bremner FD, 2001, INVEST OPHTH VIS SCI, V42, P675; Bremner FD, 1999, INVEST OPHTH VIS SCI, V40, P2528; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Estevez ME, 2012, J NEUROSCI, V32, P13608, DOI 10.1523/JNEUROSCI.1422-12.2012; Fisher SP, 2012, J BIOL RHYTHM, V27, P48, DOI 10.1177/0748730411431550; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Heiduschka P, 2010, INVEST OPHTH VIS SCI, V51, P1424, DOI 10.1167/iovs.09-3606; JOHNSTON PB, 1979, AM J OPHTHALMOL, V88, P868, DOI 10.1016/0002-9394(79)90565-8; Kawasaki A, 2010, CLIN EXP OPHTHALMOL, V38, P322, DOI 10.1111/j.1442-9071.2010.02212.x; KJER P, 1959, Acta Ophthalmol Suppl, V164, P1; KJER P, 1983, ACTA OPHTHALMOL, V61, P300; KLINE LB, 1979, ARCH OPHTHALMOL-CHIC, V97, P1680, DOI 10.1001/archopht.1979.01020020248013; La Morgia C, 2010, BRAIN, V133, P2426, DOI 10.1093/brain/awq155; Li RS, 2006, INVEST OPHTH VIS SCI, V47, P2951, DOI 10.1167/iovs.05-1295; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mrosovsky N, 1999, J COMP PHYSIOL A, V184, P423, DOI 10.1007/s003590050341; Mrosovsky N, 2001, J BIOL RHYTHM, V16, P585, DOI 10.1177/074873001129002277; Pires SS, 2009, J NEUROSCI, V29, P12332, DOI 10.1523/JNEUROSCI.2036-09.2009; Robinson GA, 2004, VISION RES, V44, P2667, DOI 10.1016/j.visres.2004.06.010; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Seki T, 2006, ANN NY ACAD SCI, V1070, P531, DOI 10.1196/annals.1317.074; Seki T, 2011, J MOL NEUROSCI, V43, P30, DOI 10.1007/s12031-010-9410-5; Tamas A, 2004, NEUROSCI LETT, V372, P110, DOI 10.1016/j.neulet.2004.09.021; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125; Votruba M, 1998, ARCH OPHTHALMOL-CHIC, V116, P351, DOI 10.1001/archopht.116.3.351; WAKAKURA M, 1995, BRIT J OPHTHALMOL, V79, P442, DOI 10.1136/bjo.79.5.442; White KE, 2009, INVEST OPHTH VIS SCI, V50, P2567, DOI 10.1167/iovs.08-2913; Williams PA, 2010, BRAIN, V133, P2942, DOI 10.1093/brain/awq218; Zele AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017860	50	22	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56350	10.1371/journal.pone.0056350	http://dx.doi.org/10.1371/journal.pone.0056350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409176	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000315100000049
J	Shimizu, A; Kobayashi, N; Shimada, K; Oura, K; Tanaka, T; Okamoto, A; Kondo, K				Shimizu, Akihiro; Kobayashi, Nobuyuki; Shimada, Kazuya; Oura, Kuniaki; Tanaka, Tadao; Okamoto, Aikou; Kondo, Kazuhiro			Novel Gene Therapy Viral Vector Using Non-Oncogenic Lymphotropic Herpesvirus	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; SHORT-INTERFERING RNAS; MAMMALIAN-CELLS; CHROMOSOMAL INTEGRATION; HUMAN CYTOMEGALOVIRUS; TARGETED INTEGRATION; TYPE-1 REPLICATION; PACKAGING CAPACITY; CODING CONTENT; IN-VITRO	Despite the use of retroviral vectors, efficiently introducing target genes into immunocytes such as T cells is difficult. In addition, retroviral vectors carry risks associated with the oncogenicity of the native virus and the potential for introducing malignancy in recipients due to genetic carryover from immortalized cells used during vector production. To address these issues, we have established a new virus vector that is based on human herpesvirus 6 (HHV-6), a non-oncogenic lymphotropic herpesvirus that infects CD4(+) T cells, macrophages, and dendritic cells. In the present study, we have altered the cell specificity of the resulting recombinant HHV-6 by knocking out the U2-U8 genes. The resulting virus proliferated only in activated cord blood cells and not in peripheral blood cells. Umbilical cord blood cells produced replication-defective recombinant virus in sufficiently high titer to omit the use of immortalized cells during vector production. HHV-6 vectors led to high rates (>90%) of gene transduction in both CD4(+) and CD8(+) T cells. These viruses showed low-level replication of viral DNA that supported greater expression of the induced genes than that of other methods but that was insufficient to support the production of replication-competent virus. Furthermore, HHV-6 vectors containing short hairpin RNAs against CD4 and HIV Gag remarkably inhibited the production of these proteins and HIV particles. Here we demonstrate the utility of HHV-6 as a new non-carcinogenic viral vector for immunologic diseases and immunotherapy.	[Shimizu, Akihiro; Kobayashi, Nobuyuki; Shimada, Kazuya; Kondo, Kazuhiro] Jikei Univ, Sch Med, Dept Virol, Tokyo, Japan; [Oura, Kuniaki; Tanaka, Tadao; Okamoto, Aikou] Jikei Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan	Jikei University; Jikei University	Kondo, K (corresponding author), Jikei Univ, Sch Med, Dept Virol, Tokyo, Japan.	kkondo@jikei.ac.jp	Kobayashi, Nobuyuki/AAS-9795-2021	Kobayashi, Nobuyuki/0000-0001-8627-515X; dao tian, he ye/0000-0003-1471-8067	Japanese Ministry of Health, Labor and Welfare	Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by grants from the Japanese Ministry of Health, Labor and Welfare. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], FIELDS VIROLOGY; Asada H, 1999, J VIROL, V73, P4019, DOI 10.1128/JVI.73.5.4019-4028.1999; BERNEMAN ZN, 1992, P NATL ACAD SCI USA, V89, P10552, DOI 10.1073/pnas.89.21.10552; BERNHEIM JL, 1977, P NATL ACAD SCI USA, V74, P2536, DOI 10.1073/pnas.74.6.2536; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; CARRIGAN DR, 1990, J INFECT DIS, V162, P844, DOI 10.1093/infdis/162.4.844; Daibata M, 1999, BLOOD, V94, P1545, DOI 10.1182/blood.V94.5.1545.417a25_1545_1549; Dhepakson P, 2002, J GEN VIROL, V83, P847, DOI 10.1099/0022-1317-83-4-847; Dominguez G, 1999, J VIROL, V73, P8040, DOI 10.1128/JVI.73.10.8040-8052.1999; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; EFSTATHIOU S, 1992, J GEN VIROL, V73, P1661, DOI 10.1099/0022-1317-73-7-1661; Fan H, 2011, VIRUSES-BASEL, V3, P398, DOI 10.3390/v3040398; Gama-Norton L, 2011, HUM GENE THER, V22, P1269, DOI 10.1089/hum.2010.143; GOMPELS UA, 1995, VIROLOGY, V209, P29, DOI 10.1006/viro.1995.1228; GRASSMANN R, 1989, J VIROL, V63, P1818, DOI 10.1128/JVI.63.4.1818-1821.1989; Hanson LK, 2009, J VIROL, V83, P7449, DOI 10.1128/JVI.00325-09; Hermonat PL, 1997, FEBS LETT, V407, P78, DOI 10.1016/S0014-5793(97)00311-6; Isegawa Y, 1999, J VIROL, V73, P8053, DOI 10.1128/JVI.73.10.8053-8063.1999; Kondo K, 2003, J VIROL, V77, P10719, DOI 10.1128/JVI.77.19.10719-10724.2003; KONDO K, 1991, J GEN VIROL, V72, P1401, DOI 10.1099/0022-1317-72-6-1401; KOTIN RM, 1990, P NATL ACAD SCI USA, V87, P2211, DOI 10.1073/pnas.87.6.2211; Lilja AE, 2008, J VIROL, V82, P2170, DOI 10.1128/JVI.02316-07; LUPPI M, 1993, J MED VIROL, V40, P44, DOI 10.1002/jmv.1890400110; LUSSO P, 1988, J EXP MED, V167, P1659, DOI 10.1084/jem.167.5.1659; Menard C, 2003, J VIROL, V77, P5557, DOI 10.1128/JVI.77.10.5557-5570.2003; Miyagishi M, 2004, J GENE MED, V6, P715, DOI 10.1002/jgm.556; Miyagishi M, 2003, OLIGONUCLEOTIDES, V13, P325, DOI 10.1089/154545703322617005; Mocarski ES, 1996, INTERVIROLOGY, V39, P320, DOI 10.1159/000150503; Mori Y, 2000, J VIROL, V74, P6096, DOI 10.1128/JVI.74.13.6096-6104.2000; Morissette G, 2010, J VIROL, V84, P12100, DOI 10.1128/JVI.01169-10; OKUNO T, 1990, VIROLOGY, V176, P625, DOI 10.1016/0042-6822(90)90033-N; OKUNO T, 1992, J GEN VIROL, V73, P443, DOI 10.1099/0022-1317-73-2-443; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Poeschla EM, 1998, NAT MED, V4, P354, DOI 10.1038/nm0398-354; Robertson ES, 1996, P NATL ACAD SCI USA, V93, P11334, DOI 10.1073/pnas.93.21.11334; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; SHELLING AN, 1994, GENE THER, V1, P165; Shen C, 2008, BIOLOGICALS, V36, P263, DOI 10.1016/j.biologicals.2008.02.002; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; TAKAHASHI K, 1989, J VIROL, V63, P3161, DOI 10.1128/JVI.63.7.3161-3163.1989; Takeda K, 1997, J GEN VIROL, V78, P2171, DOI 10.1099/0022-1317-78-9-2171; Tatalick LM, 2005, VACCINE, V23, P2628, DOI 10.1016/j.vaccine.2004.11.027; TORELLI G, 1995, J MED VIROL, V46, P178, DOI 10.1002/jmv.1890460303; YAMANISHI K, 1988, LANCET, V1, P1065; YAMANISHI K, 2007, FIELDS VIROLOGY, P2819; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; ZHOU SZ, 1994, J EXP MED, V179, P1867, DOI 10.1084/jem.179.6.1867; Zou P, 1999, J VIROL, V73, P5926, DOI 10.1128/JVI.73.7.5926-5933.1999	49	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56027	10.1371/journal.pone.0056027	http://dx.doi.org/10.1371/journal.pone.0056027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409116	Green Published, gold, Green Submitted			2022-12-27	WOS:000315100000042
J	Tamokou, JD; Chouna, JR; Fischer-Fodor, E; Chereches, G; Barbos, O; Damian, G; Benedec, D; Duma, M; Efouet, APN; Wabo, HK; Kuiate, JR; Mot, A; Silaghi-Dumitrescu, R				Tamokou, Jean de Dieu; Chouna, Jean Rodolphe; Fischer-Fodor, Eva; Chereches, Gabriela; Barbos, Otilia; Damian, Grigore; Benedec, Daniela; Duma, Mihaela; Efouet, Alango Pepin Nkeng; Wabo, Hippolyte Kamdem; Kuiate, Jules Roger; Mot, Augustin; Silaghi-Dumitrescu, Radu			Anticancer and Antimicrobial Activities of Some Antioxidant-Rich Cameroonian Medicinal Plants	PLOS ONE			English	Article							OVARIAN-CANCER CELLS; INDUCED APOPTOSIS; ANTILEUKEMIC XANTHONE; IN-VITRO; EXTRACTS; PSOROSPERMUM; PROLIFERATION; CONSTITUENTS; ASSAY; PEROXIDASE	Traditional remedies have a long-standing history in Cameroon and continue to provide useful and applicable tools for treating ailments. Here, the anticancer, antimicrobial and antioxidant activities of ten antioxidant-rich Cameroonian medicinal plants and of some of their isolated compounds are evaluated. The plant extracts were prepared by maceration in organic solvents. Fractionation of plant extract was performed by column chromatography and the structures of isolated compounds (emodin, 3-geranyloxyemodin, 2-geranylemodin) were confirmed spectroscopically. The antioxidant activity (AOA) was determined using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) bleaching method, the trolox equivalent antioxidant capacity (TEAC), and the hemoglobin ascorbate peroxidase activity inhibition (HAPX) assays. The anticancer activity was evaluated against A431 squamous epidermal carcinoma, WM35 melanoma, A2780 ovary carcinoma and cisplatin-resistant A2780cis cells, using a direct colorimetric assay. The total phenolic content in the extracts was determined spectrophotometrically by the Folin-Ciocalteu method. Rumex abyssinicus showed the best AOA among the three assays employed. The AOA of emodin was significantly higher than that of 3-geranyloxyemodin and 2-geranylemodin for both TEAC and HAPX methods. The lowest IC50 values (i.e., highest cytotoxicity) were found for the extracts of Vismia laurentii, Psorospermum febrifugum, Pentadesma butyracea and Ficus asperifolia. The Ficus asperifolia and Psorospermum febrifugum extracts are selective against A2780cis ovary cells, a cell line which is resistant to the standard anticancer drug cisplatin. Emodin is more toxic compared to the whole extract, 3-geranyloxyemodin and 2-geranylemodin. Its selectivity against the platinum-resistant A2780cis cell line is highest. All of the extracts display antimicrobial activity, in some cases comparable to that of gentamycin.	[Tamokou, Jean de Dieu; Chouna, Jean Rodolphe; Mot, Augustin; Silaghi-Dumitrescu, Radu] Univ Babes Bolyai, Dept Chem & Chem Engn, R-3400 Cluj Napoca, Romania; [Fischer-Fodor, Eva; Chereches, Gabriela; Barbos, Otilia] I Chiricuta Oncol Inst, Tumor Biol Lab, Cluj Napoca, Romania; [Damian, Grigore] Univ Babes Bolyai, Dept Phys, R-3400 Cluj Napoca, Romania; [Benedec, Daniela] Iuliu Hatieganu Univ Med & Pharm, Fac Pharm, Cluj Napoca, Romania; [Duma, Mihaela] State Vet Lab Anim Hlth & Safety, Cluj Napoca, Romania; [Tamokou, Jean de Dieu; Kuiate, Jules Roger] Univ Dschang, Dept Biochem, Dschang, Cameroon; [Chouna, Jean Rodolphe; Efouet, Alango Pepin Nkeng; Wabo, Hippolyte Kamdem] Univ Dschang, Dept Chem, Dschang, Cameroon	Babes Bolyai University from Cluj; Oncology Institute Prof. Dr. Ion Chiricuta; Babes Bolyai University from Cluj; Iuliu Hatieganu University of Medicine & Pharmacy	Mot, A (corresponding author), Univ Babes Bolyai, Dept Chem & Chem Engn, R-3400 Cluj Napoca, Romania.	augustinmot@chem.ubbcluj.ro; rsilaghi@chem.ubbcluj.ro	Silaghi-Dumitrescu, Radu/A-2883-2008; Mot, Augustin C./D-3017-2011; Mot, Augustin/AAP-4356-2021; DAMIAN, Grigore/B-6010-2011; Fischer-Fodor, Eva/C-4506-2011	Silaghi-Dumitrescu, Radu/0000-0003-3038-7747; Mot, Augustin C./0000-0002-1679-0487; Mot, Augustin/0000-0002-1679-0487; DAMIAN, Grigore/0000-0003-4127-8140; Fischer-Fodor, Eva/0000-0002-0898-0547; TAMOKOU, Jean de Dieu/0000-0002-8088-463X	Agence Universitaire de la Francophonie (AUF); Romanian Ministry of Education and Research; Romanian Ministry for Education and Research [PCCE 140/2008, POSDRU/88/1.5/S/60185]	Agence Universitaire de la Francophonie (AUF); Romanian Ministry of Education and Research(Ministry of Education and Research - Romania); Romanian Ministry for Education and Research(Ministry of Education and Research - Romania)	JDT acknowledges funding from the Agence Universitaire de la Francophonie (AUF) and the Romanian Ministry of Education and Research through their Eugen-Ionescu fellowship grant. Also acknowledged is funding from the Romanian Ministry for Education and Research grant PCCE 140/2008 (to RSD and EFF) and a PhD scholarship from Contract POSDRU/88/1.5/S/60185-"Innovative doctoral studies in a knowledge based society'' (to ACM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbiw D., 1990, USEFUL PLANTS GHANA, P182; Annan K, 2008, J ETHNOPHARMACOL, V119, P141, DOI 10.1016/j.jep.2008.06.017; Annan K, 2010, J PHARM PHARMACOL, V62, P663, DOI 10.1211/jpp.62.05.0016; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Bamps P, 1966, JARD BOT N AT BRUXEL, V36, P315; BEHRENS BC, 1987, CANCER RES, V47, P414; BOTTA B, 1985, PHYTOCHEMISTRY, V24, P827, DOI 10.1016/S0031-9422(00)84902-X; BOTTA B, 1983, PHYTOCHEMISTRY, V22, P539, DOI 10.1016/0031-9422(83)83041-6; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Cooper CE, 2008, BBA-PROTEINS PROTEOM, V1784, P1415, DOI 10.1016/j.bbapap.2008.03.019; Cos P, 2002, PHYTOMEDICINE, V9, P62, DOI 10.1078/0944-7113-00083; Fankam AG, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-104; Foyet HS, 2011, J ETHNOPHARMACOL, V133, P773, DOI 10.1016/j.jep.2010.11.011; Getie M, 2003, FITOTERAPIA, V74, P139, DOI 10.1016/S0367-326X(02)00315-5; Hritcu L, 2011, J ETHNOPHARMACOL, V137, P585, DOI 10.1016/j.jep.2011.06.008; ISO, 2005, 145021 ISO; Jagetia GC, 2004, J MED FOOD, V7, P343, DOI 10.1089/jmf.2004.7.343; Jimoh FO, 2007, J MED FOOD, V10, P707, DOI 10.1089/jmf.2006.253; Karasic TB, 2010, EXP CELL RES, V316, P1994, DOI 10.1016/j.yexcr.2010.04.014; Kerharo J., 1974, PHARMACOPEE SENEGALA; Khan RM, 1999, PHYTOCHEMISTRY, V50, P439, DOI 10.1016/S0031-9422(98)00478-6; Khare C, 2007, INDIAN MED PLANTS IL; Kisangau DP, 2007, AFR J TRADIT COMPLEM, V4, P510; Kofi A, 2009, PHARMACOGN MAG, V5, P119; KOUDOU J, 1994, PLANTA MED, V60, P96, DOI 10.1055/s-2006-959422; Koyama J, 2008, BIOORG MED CHEM LETT, V18, P4106, DOI 10.1016/j.bmcl.2008.05.109; Krishna M.S., 2010, INT J PHARM SCI DRUG, V2, P155; Kuete V, 2007, J ETHNOPHARMACOL, V109, P372, DOI 10.1016/j.jep.2006.07.044; Kuete V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021762; KUPCHAN SM, 1980, J NAT PROD, V43, P296, DOI 10.1021/np50008a010; Lacret R, 2011, J CHEM ECOL, V37, P1341, DOI 10.1007/s10886-011-0048-8; Lad L, 2002, EUR J BIOCHEM, V269, P3182, DOI 10.1046/j.1432-1033.2002.02998.x; Lazar-Molnar E, 2002, EUR J CLIN INVEST, V32, P743, DOI 10.1046/j.1365-2362.2002.01020.x; Lenta BN, 2011, PLANTA MED, V77, P377, DOI 10.1055/s-0030-1250384; Li J, 2009, ONCOL REP, V21, P1605, DOI 10.3892/or_00000394; Liu DL, 2012, INT J ONCOL, V40, P1049, DOI 10.3892/ijo.2011.1285; MAHATO SB, 1994, PHYTOCHEMISTRY, V37, P1517, DOI 10.1016/S0031-9422(00)89569-2; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mot AC, 2012, PROCESS BIOCHEM, V47, P968, DOI 10.1016/j.procbio.2012.03.006; Mot AC, 2011, J FOOD COMPOS ANAL, V24, P516, DOI 10.1016/j.jfca.2010.11.006; Mot AC, 2009, REDOX REP, V14, P267, DOI 10.1179/135100009X12525712409814; Muscolini M, 2011, J BIOL CHEM, V286, P39693, DOI 10.1074/jbc.M111.279539; Muscolini M, 2009, CELL CYCLE, V8, P3396, DOI 10.4161/cc.8.20.9910; Neamatallah A, 2005, LETT APPL MICROBIOL, V41, P94, DOI 10.1111/j.1472-765X.2005.01680.x; Nguemeving JR, 2006, PHYTOCHEMISTRY, V67, P1341, DOI 10.1016/j.phytochem.2006.03.018; Noungoue DT, 2009, Z NATURFORSCH C, V64, P210; Noungoue DT, 2008, PHYTOCHEMISTRY, V69, P1024, DOI 10.1016/j.phytochem.2007.10.026; Ok S, 2012, IMMUNOPHARM IMMUNOT, V34, P768, DOI 10.3109/08923973.2012.654494; Perde-Schrepler M, 2011, J ENVIRON PATHOL TOX, V30, P323, DOI 10.1615/JEnvironPatholToxicolOncol.v30.i4.50; PERMANA PA, 1994, CANCER RES, V54, P3191; Pietta P, 1998, J AGR FOOD CHEM, V46, P4487, DOI 10.1021/jf980310p; Rao K. N. V., 2011, Hygeia - Journal for Drugs and Medicine, V3, P76; REEVES DS, 1983, PRINCIPLES METHODS A, P140; RICEEVANS C, 1994, METHOD ENZYMOL, V234, P279; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Sinsin Brice, 2003, Cahiers Agricultures, V12, P75; Su YJ, 2010, MOL PHARMACOL, V77, P633, DOI 10.1124/mol.109.061887; Suboj P, 2012, PHARMACOLOGY, V89, P91, DOI 10.1159/000335659; Tchobo FP, 2007, J AM OIL CHEM SOC, V84, P755, DOI 10.1007/s11746-007-1102-0; Tsaffack M, 2009, CHEM PHARM BULL, V57, P1113, DOI 10.1248/cpb.57.1113; Uphof J.C.T, 1968, DICT EC PLANTS; Virag P, 2009, TOXICOL IND HEALTH, V25, P253, DOI 10.1177/0748233709103411; Vorauer K, 1996, J BIOCHEM BIOPH METH, V32, P85, DOI 10.1016/0165-022X(96)00002-4; Wabo HK, 2007, CHEM PHARM BULL, V55, P1640, DOI 10.1248/cpb.55.1640; Wang XD, 2007, BIOL PHARM BULL, V30, P1113, DOI 10.1248/bpb.30.1113; Watcho P, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep221; Watt JM, 1962, MED POISONOUS PLANTS, P494; Wright CW., 2007, J SCI TECHNOL GHANA, V27, P16; Yan XJ, 2006, GYNECOL ONCOL, V102, P348, DOI 10.1016/j.ygyno.2005.12.033; Zamble A, 2006, J CARDIOVASC PHARM, V47, P599, DOI 10.1097/01.fjc.0000211734.53798.1d; Zelefack F, 2009, J NAT PROD, V72, P954, DOI 10.1021/np8005953	75	44	44	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55880	10.1371/journal.pone.0055880	http://dx.doi.org/10.1371/journal.pone.0055880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409075	Green Published, gold			2022-12-27	WOS:000315100000029
J	Akash, MSH; Rehman, K; Sun, HY; Chen, SQ				Akash, Muhammad Sajid Hamid; Rehman, Kanwal; Sun, Hongying; Chen, Shuqing			Sustained Delivery of IL-1Ra from PF127-Gel Reduces Hyperglycemia in Diabetic GK-Rats	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; ISLET-ASSOCIATED MACROPHAGES; GOTO-KAKIZAKI RAT; IN-VITRO RELEASE; BETA-CELL; INSULIN-RESISTANCE; HIGH-FAT; TYPE-2; INFLAMMATION; MODEL	Interleukin-1beta (IL-1 beta) is a major cause for induction of various inflammatory mechanisms that are decisively involved to provoke pathogenesis of type 2 diabetes mellitus (T2DM). Interleukin-1 receptor antagonist (IL-1Ra) a naturally occurring anti-inflammatory antagonist of IL-1 beta has been recently approved for treatment of T2DM but due to its short half-life, higher doses and frequent dosing intervals are required. Pluronic F-127 (PF127) has previously shown to prolong the release of various proteinous drugs and their serum half-lives. Subsequently, in our previous work, we developed a new dosage form of IL-1Ra using PF127 and investigated its in-vitro and in-vivo effects. Here in present work, we have extended this approach using diabetic Goto-kakizaki (GK) rats. We administered IL-1Ra loaded in PF127 gel subcutaneously for one month into GK rats. IL-1Ra loaded in PF127 gel exhibited a sustained and prolonged hypoglycemic effects on treated animals. Intraperitoneal glucose tolerance test (IPGTT) results showed that IL-1Ra loaded in PF127 gel increased glucose tolerance along with increased insulin sensitivity and beta-cell's secretory function in treated rats. Moreover, significant reduction in pro-insulin/insulin ratio, lipid profiles and interleukin 6 (IL-6) were also observed. Immunohistochemical analysis showed slight macrophages infiltration in pancreatic islets. Histochemical analysis revealed no PF127-induced alteration in the normal physiology of skin and kidney of treated animals. Hence, we concluded that IL-1Ra loaded in PF127 gel has potential to exhibit broad spectrum anti-inflammatory effects alleviating the symptoms of T2DM.	[Akash, Muhammad Sajid Hamid; Rehman, Kanwal; Sun, Hongying; Chen, Shuqing] Zhejiang Univ, Inst Pharmacol Toxicol & Biochem Pharmaceut, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China; [Akash, Muhammad Sajid Hamid] Govt Coll Univ Faisalabad, Coll Pharm, Faisalabad, Pakistan	Zhejiang University; Government College University Faisalabad	Chen, SQ (corresponding author), Zhejiang Univ, Inst Pharmacol Toxicol & Biochem Pharmaceut, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China.	chenshuqing@zju.edu.cn	Akash, Muhammad Sajid Hamid/C-3477-2018; Rehman, Kanwal/P-7727-2014	Akash, Muhammad Sajid Hamid/0000-0002-9446-5233; Rehman, Kanwal/0000-0001-7873-6681; Chen, Shuqing/0000-0002-0792-3735	China Scholarship Council; Science and Technology Department of Zhejiang Province, China [2010C13006]	China Scholarship Council(China Scholarship Council); Science and Technology Department of Zhejiang Province, China	We acknowledge the China Scholarship Council to award full bright scholarship for PhD to Muhammad Sajid Hamid Akash and Kanwal Rehman. One of the authors would also like to admire her wife Mrs. Akash for her support and motivations. Without her, the writing of this manuscript would not have been possible.; This work was financially supported by the grant (No. 2010C13006) from the Science and Technology Department of Zhejiang Province, China. IL-1Ra was generously provided by Hisun Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggeli IK, 2011, ENDOCRINOLOGY, V152, P1274, DOI 10.1210/en.2010-1319; Akash MSH, 2011, J MED PLANTS RES, V5, P6885, DOI 10.5897/JMPR11.1425; Akash MSH, 2013, EUR J PHARMACOL, V701, P87, DOI 10.1016/j.ejphar.2013.01.008; Akash MSH, 2013, J CELL BIOCHEM, V114, P525, DOI 10.1002/jcb.24402; Akash MSH, 2012, PHARM RES-DORDR, V29, P3475, DOI 10.1007/s11095-012-0843-0; Akash MSH, 2012, J PHARM SCI-US, V101, P1647, DOI 10.1002/jps.23057; Antuna-Puente B, 2008, DIABETES METAB, V34, P294, DOI 10.1016/j.diabet.2008.02.001; Argoud K, 2006, DIABETOLOGIA, V49, P2679, DOI 10.1007/s00125-006-0396-z; Barichello JM, 1999, INT J PHARM, V184, P189, DOI 10.1016/S0378-5173(99)00119-2; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Boyko EJ, 2007, DIABETES CARE, V30, P2725, DOI 10.2337/dc07-1248; Briaud I, 2002, DIABETES, V51, P662, DOI 10.2337/diabetes.51.3.662; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; CARO JF, 1991, J CLIN ENDOCR METAB, V73, P691, DOI 10.1210/jcem-73-4-691; Chaibva FA, 2007, DISSOLUT TECHNOL, V14, P15, DOI 10.14227/DT140407P15; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Das N, 2012, PHARM DEV TECHNOL, V17, P363, DOI 10.3109/10837450.2010.542164; de Assis AM, 2009, EXP BIOL MED, V234, P1296, DOI 10.3181/0904-RM-126; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Dinarello CA, 2011, J INTERN MED, V269, P16, DOI 10.1111/j.1365-2796.2010.02313.x; Dinarello CA, 2000, NEW ENGL J MED, V343, P732, DOI 10.1056/NEJM200009073431011; Dinarello CA, 2004, CURR OPIN PHARMACOL, V4, P378, DOI 10.1016/j.coph.2004.03.010; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Ehses JA, 2010, DIABETOLOGIA, V53, P1795, DOI 10.1007/s00125-010-1747-3; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Fu JF, 2009, COMPARATIVE MED, V59, P557; Gaisano HY, 2002, ENDOCRINOLOGY, V143, P4218, DOI 10.1210/en.2002-220237; Gomes MB, 1997, BRAZ J MED BIOL RES, V30, P191, DOI 10.1590/S0100-879X1997000200006; Hiwale P, 2011, BIOMACROMOLECULES, V12, P3186, DOI 10.1021/bm200679w; Homo-Delarche F, 2006, DIABETES, V55, P1625, DOI 10.2337/db05-1526; JOHNSTON TP, 1992, PHARM RES-DORDR, V9, P425, DOI 10.1023/A:1015815624334; Kaleem M, 2008, SINGAP MED J, V49, P800; KATAKAM M, 1995, J PHARM SCI-US, V84, P713, DOI 10.1002/jps.2600840609; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Liu Y, 2007, J CONTROL RELEASE, V117, P387, DOI 10.1016/j.jconrel.2006.11.024; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2004, P NATL ACAD SCI USA, V101, P8138, DOI 10.1073/pnas.0305683101; Mansour H. A., 2000, J MED RES I, V21, P115; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Movassat J, 2008, AM J PHYSIOL-ENDOC M, V294, pE168, DOI 10.1152/ajpendo.00501.2007; Murugan P, 2007, BASIC CLIN PHARMACOL, V101, P241, DOI 10.1111/j.1742-7843.2007.00109.x; Navab M, 2008, CURR OPIN CLIN NUTR, V11, P459, DOI 10.1097/MCO.0b013e32830460c2; Ohta T, 2003, EUR J PHARMACOL, V476, P159, DOI 10.1016/S0014-2999(03)02120-4; Pawluczyk IZA, 1997, J AM SOC NEPHROL, V8, P1525; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Portha B, 2005, DIABETES-METAB RES, V21, P495, DOI 10.1002/dmrr.566; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Schrijvers BF, 2004, NEPHROL DIAL TRANSPL, V19, P1092, DOI 10.1093/ndt/gfh107; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Shinde UA, 2003, J CELL MOL MED, V7, P322, DOI 10.1111/j.1582-4934.2003.tb00233.x; Sohn EJ, 2007, LIFE SCI, V80, P468, DOI 10.1016/j.lfs.2006.09.037; Song YQ, 2007, DIABETES CARE, V30, P1747, DOI 10.2337/dc07-0358; Stratton LP, 1997, J PHARM SCI, V86, P1006, DOI 10.1021/js970034d; Wallis RH, 2004, DIABETOLOGIA, V47, P1096, DOI 10.1007/s00125-004-1416-5; WANG PL, 1993, J PARENT SCI TECHN, V47, P183; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102	65	40	41	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55925	10.1371/journal.pone.0055925	http://dx.doi.org/10.1371/journal.pone.0055925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409091	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300046
J	Gracia-Aznarez, FJ; Fernandez, V; Pita, G; Peterlongo, P; Dominguez, O; de la Hoya, M; Duran, M; Osorio, A; Moreno, L; Gonzalez-Neira, A; Rosa-Rosa, JM; Sinilnikova, O; Mazoyer, S; Hopper, J; Lazaro, C; Southey, M; Odefrey, F; Manoukian, S; Catucci, I; Caldes, T; Lynch, HT; Hilbers, FSM; van Asperen, CJ; Vasen, HFA; Goldgar, D; Radice, P; Devilee, P; Benitez, J				Javier Gracia-Aznarez, Francisco; Fernandez, Victoria; Pita, Guillermo; Peterlongo, Paolo; Dominguez, Orlando; de la Hoya, Miguel; Duran, Mercedes; Osorio, Ana; Moreno, Leticia; Gonzalez-Neira, Anna; Manuel Rosa-Rosa, Juan; Sinilnikova, Olga; Mazoyer, Sylvie; Hopper, John; Lazaro, Conchi; Southey, Melissa; Odefrey, Fabrice; Manoukian, Siranoush; Catucci, Irene; Caldes, Trinidad; Lynch, Henry T.; Hilbers, Florentine S. M.; van Asperen, Christi J.; Vasen, Hans F. A.; Goldgar, David; Radice, Paolo; Devilee, Peter; Benitez, Javier			Whole Exome Sequencing Suggests Much of Non-BRCA1/BRCA2 Familial Breast Cancer Is Due to Moderate and Low Penetrance Susceptibility Alleles	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OVARIAN-CANCER; CONFER SUSCEPTIBILITY; GERMLINE MUTATIONS; MISSENSE MUTATIONS; GENE; LOCI; VARIANTS; RISK; PROTEIN	The identification of the two most prevalent susceptibility genes in breast cancer, BRCA1 and BRCA2, was the beginning of a sustained effort to uncover new genes explaining the missing heritability in this disease. Today, additional high, moderate and low penetrance genes have been identified in breast cancer, such as P53, PTEN, STK11, PALB2 or ATM, globally accounting for around 35 percent of the familial cases. In the present study we used massively parallel sequencing to analyze 7 BRCA1/BRCA2 negative families, each having at least 6 affected women with breast cancer (between 6 and 10) diagnosed under the age of 60 across generations. After extensive filtering, Sanger sequencing validation and co-segregation studies, variants were prioritized through either control-population studies, including up to 750 healthy individuals, or case-control assays comprising approximately 5300 samples. As a result, a known moderate susceptibility indel variant (CHEK2 1100delC) and a catalogue of 11 rare variants presenting signs of association with breast cancer were identified. All the affected genes are involved in important cellular mechanisms like DNA repair, cell proliferation and survival or cell cycle regulation. This study highlights the need to investigate the role of rare variants in familial cancer development by means of novel high throughput analysis strategies optimized for genetically heterogeneous scenarios. Even considering the intrinsic limitations of exome resequencing studies, our findings support the hypothesis that the majority of non-BRCA1/BRCA2 breast cancer families might be explained by the action of moderate and/or low penetrance susceptibility alleles.	[Javier Gracia-Aznarez, Francisco; Fernandez, Victoria; Osorio, Ana; Benitez, Javier] Spanish Natl Canc Ctr CNIO, Human Genet Grp, Madrid, Spain; [Pita, Guillermo; Moreno, Leticia; Gonzalez-Neira, Anna; Benitez, Javier] Spanish Natl Canc Ctr CNIO, Human Genotyping Unit CEGEN, Madrid, Spain; [Peterlongo, Paolo; Catucci, Irene; Radice, Paolo] Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy; [Peterlongo, Paolo; Catucci, Irene; Radice, Paolo] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, Milan, Italy; [Dominguez, Orlando] Spanish Natl Canc Ctr CNIO, Genom Unit, Madrid, Spain; [de la Hoya, Miguel; Caldes, Trinidad] Inst Invest Sanitaria San Carlos IdISSC, Oncol Mol Lab, Madrid, Spain; [Duran, Mercedes] Inst Biol & Genet Mol IBGM UVA CSIC, Valladolid, Spain; [Manuel Rosa-Rosa, Juan] Sistemas Genom, Bioinformat Unit, Valencia, Spain; [Sinilnikova, Olga; Mazoyer, Sylvie] Univ Lyon 1, INSERM U1052, CNRS UMR5286, Canc Res Ctr Lyon,Ctr Leon Berard, Lyon, France; [Sinilnikova, Olga] Hosp Civils Lyon, Unite Mixte Genet Constitut Canc Ferquents, Ctr Leon Berard, Lyon, France; [Hopper, John] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3010, Australia; [Lazaro, Conchi] Inst Catala Oncol IDIBELL, Hereditary Canc Program, Mol Diagnost Unit, Barcelona, Spain; [Southey, Melissa; Odefrey, Fabrice] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Melbourne, Vic 3010, Australia; [Manoukian, Siranoush] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Unit Med Genet, Milan, Italy; [Lynch, Henry T.] Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, Omaha, NE USA; [Hilbers, Florentine S. M.; Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [van Asperen, Christi J.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Vasen, Hans F. A.] Fdn Detect Hereditary Tumors, Leiden, Netherlands; [Vasen, Hans F. A.] Leiden Univ, Med Ctr, Dept Gastroenterol, Leiden, Netherlands; [Goldgar, David; Devilee, Peter] Univ Utah, Sch Med, Dept Dermatol, Salt Lake City, UT USA; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Benitez, Javier] Biomed Network Rare Dis CIBERER, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); IFOM - FIRC Institute of Molecular Oncology; Fondazione IRCCS Istituto Nazionale Tumori Milan; Centro Nacional de Investigaciones Oncologicas (CNIO); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; CHU Lyon; UNICANCER; Centre Leon Berard; University of Melbourne; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Melbourne; Fondazione IRCCS Istituto Nazionale Tumori Milan; Creighton University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utah System of Higher Education; University of Utah; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Benitez, J (corresponding author), Spanish Natl Canc Ctr CNIO, Human Genet Grp, Madrid, Spain.	jbenitez@cnio.es	Mazoyer, Sylvie/N-7559-2017; Gonzalez-Neira, Anna/C-5791-2015; Hilbers, Florentine/AAB-8162-2019; Pinheiro, Maísa/E-7424-2012; Osorio, Ana/I-4324-2014; GARCIA, CONXI LAZARO/Q-2410-2016; Dominguez, Orlando/M-7515-2018; DEVILEE, PETER/ABR-2140-2022; Peterlongo, Paolo/Q-4717-2018; manoukian, siranoush/E-7132-2017; durán, mercedes/H-9240-2015; van Asperen, Christi J/D-3970-2012; Gracia Aznarez, Francisco Javier/AFV-2344-2022; Devilee, Peter/GXV-8005-2022; de la Hoya, MIguel/Z-2911-2019; Radice, Paolo/O-3119-2013	Gonzalez-Neira, Anna/0000-0002-5421-2020; Hilbers, Florentine/0000-0002-6764-3102; Osorio, Ana/0000-0001-8124-3984; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Peterlongo, Paolo/0000-0001-6951-6855; manoukian, siranoush/0000-0002-6034-7562; van Asperen, Christi J/0000-0002-1436-7650; Pita, Guillermo/0000-0003-2393-0510; Vasen, Hans/0000-0003-2682-2603; Radice, Paolo/0000-0001-6298-4111; Southey, Melissa/0000-0002-6313-9005; duran, Mercedes/0000-0002-6301-9732; de la Hoya, Miguel/0000-0002-8113-1410; Mazoyer, Sylvie/0000-0002-2135-0160; Devilee, Peter/0000-0002-8023-2009	Dutch Cancer Society [UL 2009-4388]; Australian NHMRC; New South Wales Cancer Council; Victorian Health Promotion Foundation (Australia); National Cancer Institute, National Institutes of Health under RFA [CA-06-503, U01 CA69467, U01 CA69398, U01 CA69631]; Asociacion Espanola Contra el Cancer, Spanish Health Research Fund; Carlos III Health Institute; Catalan Health Institute and Autonomous Government of Catalonia; Instituto de Salud Carlos III; Fondo de Investigacion Sanitaria (FIS) [09/00859]; Red Tematica de Investigacion Cooperativa en Cancer; Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional [RETICC 06/0020/0021]; Asociacion Espanola Contra el Cancer (AECC);  [ISCIIIRETIC RD06/0020/1051];  [PI10/01422];  [PI10/00748];  [2009SGR290]; NATIONAL CANCER INSTITUTE [U01CA069398, U01CA069446, U01CA069638, U01CA069467, U01CA069631, U01CA069417] Funding Source: NIH RePORTER	Dutch Cancer Society(KWF Kankerbestrijding); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Cancer Council(Cancer Council New South Wales); Victorian Health Promotion Foundation (Australia); National Cancer Institute, National Institutes of Health under RFA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Asociacion Espanola Contra el Cancer, Spanish Health Research Fund; Carlos III Health Institute(Instituto de Salud Carlos III); Catalan Health Institute and Autonomous Government of Catalonia(Generalitat de Catalunya); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Red Tematica de Investigacion Cooperativa en Cancer; Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional; Asociacion Espanola Contra el Cancer (AECC); ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	FSMH is supported by the Dutch Cancer Society (project UL 2009-4388). The Australian Breast Cancer Family Registry (ABCFR; 1992-1995) was supported by the Australian NHMRC, the New South Wales Cancer Council, the Victorian Health Promotion Foundation (Australia). The Breast Cancer Family Registry (BCFR) was supported by the National Cancer Institute, National Institutes of Health under RFA # CA-06-503, and through cooperative agreements with members of the BCFR and Principal Investigators, including Cancer Care Ontario (U01 CA69467), Columbia University (U01 CA69398), Fox Chase Cancer Center (U01 CA69631), Huntsman Cancer Institute (U01 CA69446), Cancer Prevention Institute of California (U01 CA69417), University of Melbourne (U01 CA69638) and Research Triangle Institute Informatics Support Center (RFP No. N02PC45022-46). MCS is a NHMRC Senior Research Fellow and Victorian Breast Cancer Research Consortium (VBCRC) Group Leader. JLH is a NHMRC Australia Fellow and VBCRC Group Leader. The Instituto Catalan de Oncologia (ICO) was granted by Asociacion Espanola Contra el Cancer, Spanish Health Research Fund; Carlos III Health Institute; Catalan Health Institute and Autonomous Government of Catalonia. Contract grant numbers: ISCIIIRETIC RD06/0020/1051, PI10/01422, PI10/00748 and 2009SGR290. The Hospital Clinico de San Carlos (HCSC) was supported by Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS) Research Grant 09/00859 to MdH. Red Tematica de Investigacion Cooperativa en Cancer; Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional (RETICC 06/0020/0021) supported TC, and MdH. The Spanish National Cancer Research Center (CNIO) was supported by Asociacion Espanola Contra el Cancer (AECC), Fondo de Investigaciones Sanitarias (FIS) Research Grant IP08-1120, RETICC RD06/0020/1106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; BORRESEN AL, 1992, CANCER RES, V52, P3234; Campeau PM, 2012, HUM MOL GENET, V21, P4904, DOI 10.1093/hmg/dds326; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fletcher O, 2010, NAT REV CANCER, V10, P353, DOI 10.1038/nrc2840; Garcia MJ, 2009, BREAST CANCER RES TR, V113, P545, DOI 10.1007/s10549-008-9945-0; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Heron SE, 2012, NAT GENET, V44, P1188, DOI 10.1038/ng.2440; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Lynch ED, 1997, AM J HUM GENET, V61, P1254, DOI 10.1086/301639; Rosa-Rosa JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009976; Rosa-Rosa JM, 2009, AM J HUM GENET, V84, P115, DOI 10.1016/j.ajhg.2008.12.013; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Orr N, 2012, NAT GENET, V44, P1182, DOI 10.1038/ng.2417; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Sawyer S, 2012, J CLIN ONCOL; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shamseldin HE, 2012, J MED GENET, V49, P184, DOI 10.1136/jmedgenet-2011-100585; Snape K, 2012, BREAST CANC RES TREA; Snape K, 2011, NAT GENET, V43, P527, DOI 10.1038/ng.822; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Thompson ER, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002894; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039	39	76	77	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55681	10.1371/journal.pone.0055681	http://dx.doi.org/10.1371/journal.pone.0055681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409019	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300028
J	Mac Donald, C; Johnson, A; Cooper, D; Malone, T; Sorrell, J; Shimony, J; Parsons, M; Snyder, A; Raichle, M; Fang, R; Flaherty, S; Russell, M; Brody, DL				Mac Donald, Christine; Johnson, Ann; Cooper, Dana; Malone, Thomas; Sorrell, James; Shimony, Joshua; Parsons, Matthew; Snyder, Abraham; Raichle, Marcus; Fang, Raymond; Flaherty, Stephen; Russell, Michael; Brody, David L.			Cerebellar White Matter Abnormalities following Primary Blast Injury in US Military Personnel	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; HEAD-INJURY; EXPOSURE; COMBAT; SCALE; IRAQI; DEPRESSION; VETERANS; SEQUELAE	Little is known about the effects of blast exposure on the human brain in the absence of head impact. Clinical reports, experimental animal studies, and computational modeling of blast exposure have suggested effects on the cerebellum and brainstem. In US military personnel with isolated, primary blast-related 'mild' traumatic brain injury and no other known insult, we found diffusion tensor MRI abnormalities consistent with cerebellar white matter injury in 3 of 4 subjects. No abnormalities in other brain regions were detected. These findings add to the evidence supporting the hypothesis that primary blast exposure contributes to brain injury in the absence of head impact and that the cerebellum may be particularly vulnerable. However, the clinical effects of these abnormalities cannot be determined with certainty; none of the subjects had ataxia or other detected evidence of cerebellar dysfunction. The details of the blast events themselves cannot be disclosed at this time, thus additional animal and computational modeling will be required to dissect the mechanisms underlying primary blast-related traumatic brain injury. Furthermore, the effects of possible subconcussive impacts and other military-related exposures cannot be determined from the data presented. Thus many aspects of topic will require further investigation.	[Mac Donald, Christine; Johnson, Ann; Cooper, Dana; Malone, Thomas; Sorrell, James; Brody, David L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Shimony, Joshua; Parsons, Matthew; Snyder, Abraham; Raichle, Marcus] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Fang, Raymond; Flaherty, Stephen] Landstuhl Reg Med Ctr, Dept Trauma Surg, Landstuhl, Germany; [Russell, Michael] USA, Rehabil & Reintegrat Div, San Antonio, TX USA	Washington University (WUSTL); Washington University (WUSTL); Landstuhl Regional Medical Center	Brody, DL (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	brodyd@neuro.wustl.edu			Congressionally Directed Medical Research Program [W81XWH-08-2-0061]; United States National Institutes of Health [F32NS062529, 5K23HD053212, P30NS048056, P50NS06833, 5K08NS49237]; U.S. Army Medical Research Acquisition Activity [W81XWH-09-2-0057]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD053212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS006833, P30NS048056, F32NS062529, K08NS049237] Funding Source: NIH RePORTER	Congressionally Directed Medical Research Program(United States Department of Defense); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Medical Research Acquisition Activity; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by grants from the Congressionally Directed Medical Research Program (W81XWH-08-2-0061, to Dr. Brody), the United States National Institutes of Health (F32NS062529, to Dr. Mac Donald; 5K23HD053212, to Dr. Shimony; P30NS048056, to Dr. Snyder; P50NS06833, to Drs. Raichle and Snyder; and 5K08NS49237, to Dr. Brody) and U.S. Army Medical Research Acquisition Activity (W81XWH-09-2-0057) to Dr. Russell, under a protocol approved by Brooke Army Medical Center, San Antonio, TX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Benton AL, 1983, MULTILINGUAL APHASIA; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Casscells S.W., 2007, TRAUMATIC BRAIN INJU; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Conners C.K., 2000, CONNERSCONTINUOUS PE; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Heaton R.K., 1993, WISCONSIN CARD SORTI; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Matthews C, 1964, INSTRUCTION MANUAL A; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Mott FW, 1916, LANCET, V1, P441; Mott FW, 1917, J ROY ARMY MED CORPS, V29, P662; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Peskind ER, 2010, NEUROIMAGE; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Reitan RM, 1992, TRAIL MAKING TEST MA; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Smith A., 1991, SYMBOL DIGIT MODALIT; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stoodley CJ, 2009, BRAIN LANG, V110, P149, DOI 10.1016/j.bandl.2009.07.006; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Talavage T. M., 2010, J NEUROTRAUMA; Taylor L, 1991, COMPENDIUM NEUROPSYC; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wechsler D., 2001, WECHSLER TEST ADULT; Wilkinson C, 2012, FRONT NEUROTRAUMA, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049	53	49	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55823	10.1371/journal.pone.0055823	http://dx.doi.org/10.1371/journal.pone.0055823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409052	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200070
J	Delamater, PL; Messina, JP; Grady, SC; WinklerPrins, V; Shortridge, AM				Delamater, Paul L.; Messina, Joseph P.; Grady, Sue C.; WinklerPrins, Vince; Shortridge, Ashton M.			Do More Hospital Beds Lead to Higher Hospitalization Rates? A Spatial Examination of Roemer's Law	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; SMALL-AREA VARIATIONS; LOW-BIRTH-WEIGHT; RESIDENTIAL SEGREGATION; MEDICAL-CARE; ACCESS; NEIGHBORHOOD; PHYSICIAN; ACCESSIBILITY; DETERMINANTS	Background: Roemer's Law, a widely cited principle in health care policy, states that hospital beds that are built tend to be used. This simple but powerful expression has been invoked to justify Certificate of Need regulation of hospital beds in an effort to contain health care costs. Despite its influence, a surprisingly small body of empirical evidence supports its content. Furthermore, known geographic factors influencing health services use and the spatial structure of the relationship between hospital bed availability and hospitalization rates have not been sufficiently explored in past examinations of Roemer's Law. We pose the question, "Accounting for space in health care access and use, is there an observable association between the availability of hospital beds and hospital utilization?'' Methods: We employ an ecological research design based upon the Anderson behavioral model of health care utilization. This conceptual model is implemented in an explicitly spatial context. The effect of hospital bed availability on the utilization of hospital services is evaluated, accounting for spatial structure and controlling for other known determinants of hospital utilization. The stability of this relationship is explored by testing across numerous geographic scales of analysis. The case study comprises an entire state system of hospitals and population, evaluating over one million inpatient admissions. Results: We find compelling evidence that a positive, statistically significant relationship exists between hospital bed availability and inpatient hospitalization rates. Additionally, the observed relationship is invariant with changes in the geographic scale of analysis. Conclusions: This study provides evidence for the effects of Roemer's Law, thus suggesting that variations in hospitalization rates have origins in the availability of hospital beds. This relationship is found to be robust across geographic scales of analysis. These findings suggest continued regulation of hospital bed supply to assist in controlling hospital utilization is justified.	[Delamater, Paul L.; Grady, Sue C.; Shortridge, Ashton M.] Michigan State Univ, Dept Geog, E Lansing, MI 48824 USA; [Messina, Joseph P.] Michigan State Univ, Dept Geog, Ctr Global Change & Earth Observat, Michigan AgBioRes, E Lansing, MI 48824 USA; [WinklerPrins, Vince] Georgetown Univ, Med Ctr, Washington, DC 20007 USA	Michigan State University; Michigan State University; Michigan State University AgBioResearch; Georgetown University	Delamater, PL (corresponding author), Michigan State Univ, Dept Geog, E Lansing, MI 48824 USA.	delamate@msu.edu		Delamater, Paul/0000-0003-3627-9739; Messina, Joseph/0000-0002-1978-0778	Michigan Department of Health, Certificate of Need Program	Michigan Department of Health, Certificate of Need Program	This research was funded by the Michigan Department of Health, Certificate of Need Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JA, 1999, MED CARE RES REV, V56, P94, DOI 10.1177/107755879905600106; Allen R. G., 1998, FAO Irrigation and Drainage Paper; ANDERSEN R, 1978, MED CARE, V16, P533, DOI 10.1097/00005650-197807000-00001; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; Anselin L, 2003, INT REGIONAL SCI REV, V26, P153, DOI 10.1177/0160017602250972; Berke E, 2009, INT J HEALTH GEOGR, V8, P1; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; Bivand RS, 2008, USE R, P1; Chi G, 2008, POPUL RES POLICY REV, V27, P17, DOI 10.1007/s11113-007-9051-8; CLARK JD, 1990, SOC SCI MED, V30, P67, DOI 10.1016/0277-9536(90)90330-U; Conover CJ, 2003, TECHNICAL REPORT; Darden J, 2010, ANN ASSOC AM GEOGR, V100, P137, DOI 10.1080/00045600903379042; Darden JT, 2007, STATE BLACK MICHIGAN; de Vries JJ, 2009, ENVIRON PLANN A, V41, P461, DOI 10.1068/a39369; Delamater PL, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-15; Delamater PL, BMC HLTH SE IN PRESS; DONABEDIAN A, 1972, MILBANK MEML FUND Q, V50, P103, DOI 10.2307/3349436; FELDSTEIN PJ, 1966, MILBANK FUND Q, V44, P128, DOI 10.2307/3348968; Ferrier GD, 2010, HEALTH CARE MANAG SC, V13, P84, DOI 10.1007/s10729-009-9113-z; FISHER ES, 1994, NEW ENGL J MED, V331, P989, DOI 10.1056/NEJM199410133311506; Folland S, 1990, Med Care Rev, V47, P419, DOI 10.1177/107755879004700403; FOTHERINGHAM AS, 1991, ENVIRON PLANN A, V23, P1025, DOI 10.1068/a231025; Ginsburg P B, 1983, Health Care Financ Rev, V5, P87; Grady SC, 2008, HEALTH PLACE, V14, P661, DOI 10.1016/j.healthplace.2007.10.011; Grady SC, 2006, SOC SCI MED, V63, P3013, DOI 10.1016/j.socscimed.2006.08.017; Grady SC, 2010, SPAT SPATIO-TEMPORAL, V1, P239, DOI 10.1016/j.sste.2010.09.006; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Green LA, 2001, NEW ENGL J MED, V344, P2021, DOI 10.1056/NEJM200106283442611; Griffith JR, 1972, QUANTITATIVE TECHNIQ; Guagliardo Mark F, 2004, Int J Health Geogr, V3, P3; Gujarati D, 2006, N BASIC ECONOMETRICS; Harrington DW, 2012, HEALTH PLACE, V18, P814, DOI 10.1016/j.healthplace.2012.03.011; HARRIS DM, 1975, J HEALTH SOC BEHAV, V16, P163, DOI 10.2307/2137157; Hewko J, 2002, ENVIRON PLANN A, V34, P1185, DOI 10.1068/a34171; Jolliffe Ian, 2011, PRINCIPAL COMPONENT; Jones SG, 2010, HEALTH SERV RES, V45, P316, DOI 10.1111/j.1475-6773.2009.01044.x; Joseph A., 1984, ACCESSIBILITY UTILIZ; Kaiser Family Foundation, 2009, 767002 KAIS FAM FDN; KHAN AA, 1992, SOCIO ECON PLAN SCI, V26, P275, DOI 10.1016/0038-0121(92)90004-O; Klein RJ, 2002, 24 NAT CTR HLTH STAT; Kravet SJ, 2008, AM J MED, V121, P142, DOI 10.1016/j.amjmed.2007.10.021; Kroneman M, 2004, SOC SCI MED, V59, P1731, DOI 10.1016/j.socscimed.2004.01.036; Langley SA, 2010, SOURCE CODE BIOL MED, V5, DOI 10.1186/1751-0473-5-4; LUGINAAH I, 2001, GEOJOURNAL, V53, P135, DOI DOI 10.1023/A:1015724619845; Luo W, 2009, HEALTH PLACE, V15, P1100, DOI 10.1016/j.healthplace.2009.06.002; MARSHALL RJ, 1991, J R STAT SOC C-APPL, V40, P283; McGrail MR, 2009, APPL GEOGR, V29, P533, DOI 10.1016/j.apgeog.2008.12.003; Meade M., 2010, MED GEOGRAPHY; Messina JP, 2006, INT J HEALTH GEOGR, V5, P1; MILLIGAN GW, 1980, PSYCHOMETRIKA, V45, P325, DOI 10.1007/BF02293907; Mobley LR, 2008, MED CARE RES REV, V65, P315, DOI 10.1177/1077558707312501; Mulley AG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4073; National Conference of State Legislatures, 2011, CON CERT NEED STAT L; Norris JC, 2003, HEALTH SERV RES, V38, P1791, DOI 10.1111/j.1475-6773.2003.00203.x; Oakes JM, 2004, SOC SCI MED, V58, P1929, DOI 10.1016/j.socscimed.2003.08.004; Odoi A, 2003, INT J HEALTH GEOGR, V2, P1; Oleske DM, 2009, EPIDEMIOLOGY AND THE DELIVERY OF HEALTH CARE SERVICES: METHODS AND APPLICATIONS, THIRD EDITION, P3, DOI 10.1007/978-1-4419-0164-4_1; Openshaw S., 1984, MODIFIABLE AREAL UNI; Paez A, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-52; PASLEY BH, 1995, HEALTH SERV RES, V30, P115; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Phillips KA, 1998, HEALTH SERV RES, V33, P571; R Development Core Team, 2011, TECHNICAL REPORT; Rey SJ, 2011, ECON DEV Q, V25, P54, DOI 10.1177/0891242410383414; Ricketts TC, 2001, HEALTH PLACE, V7, P27, DOI 10.1016/S1353-8292(00)00035-6; Rivers PA, 2007, HEALTH EDUC J, V66, P229, DOI 10.1177/0017896907080127; Rogerson P. A., 2006, STAT METHODS GEOGRAP; Rohrer J E, 1990, Health Serv Manage Res, V3, P41; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Schuurman N, 2010, CAN GEOGR-GEOGR CAN, V54, P29, DOI 10.1111/j.1541-0064.2009.00301.x; SHAIN M, 1959, Mod Hosp, V92, P71; Shwartz M, 2011, MED CARE, V49, P1062, DOI 10.1097/MLR.0b013e3182353907; Sparks PJ, 2010, POPUL SPACE PLACE, V16, P465, DOI 10.1002/psp.564; Swift A, 2008, COMPUT ENVIRON URBAN, V32, P134, DOI 10.1016/j.compenvurbsys.2008.01.002; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; US Federal Trade Commission, 2004, TECHNICAL REPORT; VANDOORSLAER EKA, 1989, SOC SCI MED, V28, P155, DOI 10.1016/0277-9536(89)90143-3; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; Wennberg J, 2005, 874 COMM FUND; WENNBERG JE, 1985, MED CARE, V23, P512, DOI 10.1097/00005650-198505000-00012; Wennberg JE, 1999, TECHNICAL REPORT; WHITE KL, 1961, NEW ENGL J MED, V265, P885, DOI 10.1056/NEJM196111022651805; Wright DB, 2010, SOC SCI MED, V70, P2006, DOI 10.1016/j.socscimed.2010.02.043; Young T. K., 2005, POPULATION HLTH CONC	85	81	82	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e54900	10.1371/journal.pone.0054900	http://dx.doi.org/10.1371/journal.pone.0054900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418432	Green Published, gold			2022-12-27	WOS:000315970300022
J	Lecomte, S; Reverdy, L; Le Quement, C; Le Masson, F; Amon, A; Le Goff, P; Michel, D; Christians, E; Le Drean, Y				Lecomte, Sylvain; Reverdy, Lea; Le Quement, Catherine; Le Masson, Florent; Amon, Axelle; Le Goff, Pascale; Michel, Denis; Christians, Elisabeth; Le Drean, Yves			Unraveling Complex Interplay between Heat Shock Factor 1 and 2 Splicing Isoforms	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; EXPRESSION; STRESS; ACTIVATION; GENE; DIFFERENTIATION; DISRUPTION; MEIOSIS; PATHWAY; CELLS	Chaperone synthesis in response to proteotoxic stress is dependent on a family of transcription factors named heat shock factors (HSFs). The two main factors in this family, HSF1 and HSF2, are co-expressed in numerous tissues where they can interact and form heterotrimers in response to proteasome inhibition. HSF1 and HSF2 exhibit two alternative splicing isoforms, called alpha and beta, which contribute to additional complexity in HSF transcriptional regulation, but remain poorly examined in the literature. In this work, we studied the transcriptional activity of HSF1 and HSF2 splicing isoforms transfected into immortalized Mouse Embryonic Fibroblasts (iMEFs) deleted for both Hsf1 and Hsf2, under normal conditions and after proteasome inhibition. We found that HSF1 alpha is significantly more active than the beta isoform after exposure to the proteasome inhibitor MG132. Furthermore, we clearly established that, while HSF2 had no transcriptional activity by itself, short beta isoform of HSF2 exerts a negative role on HSF1 beta-dependent transactivation. To further assess the impact of HSF2 beta inhibition on HSF1 activity, we developed a mathematical modelling approach which revealed that the balance between each HSF isoform in the cell regulated the strength of the transcriptional response. Moreover, we found that cellular stress such as proteasome inhibition could regulate the splicing of Hsf2 mRNA. All together, our results suggest that relative amounts of each HSF1 and HSF2 isoforms quantitatively determine the cellular level of the proteotoxic stress response.	[Lecomte, Sylvain; Reverdy, Lea; Le Quement, Catherine; Le Goff, Pascale; Michel, Denis; Le Drean, Yves] Univ Rennes 1, Transcript Environm & Canc Grp, Inst Rech Sante Environm & Travail, Inserm,U1085, Rennes, France; [Le Masson, Florent; Christians, Elisabeth] Univ Toulouse 3, CNRS, Ctr Dev Biol, UMR 5547, F-31062 Toulouse, France; [Amon, Axelle] Univ Rennes 1, CNRS, Inst Phys Rennes, UMR 6251, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Rennes	Le Drean, Y (corresponding author), Univ Rennes 1, Transcript Environm & Canc Grp, Inst Rech Sante Environm & Travail, Inserm,U1085, Rennes, France.	yves.le-drean@univ-rennes1.fr	LE GOFF, PASCALE/K-1842-2015; Amon, Axelle/N-7470-2014; Le Dréan, Yves/L-4822-2015; Lecomte, Sylvain/K-1745-2015	LE GOFF, PASCALE/0000-0002-3931-2197; Amon, Axelle/0000-0001-9475-4468; Michel, Denis/0000-0002-0643-8025	National Research Agency (ANR), France [10-CESA-017-01]	National Research Agency (ANR), France(French National Research Agency (ANR))	This study was supported by National Research Agency (ANR), France, under Grant No. 10-CESA-017-01 (BioREF project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; FIORENZA MT, 1995, NUCLEIC ACIDS RES, V23, P467, DOI 10.1093/nar/23.3.467; GOODSON ML, 1995, BIOCHEM BIOPH RES CO, V211, P943, DOI 10.1006/bbrc.1995.1903; GOODSON ML, 1995, MOL CELL BIOL, V15, P5288; He HY, 2003, J BIOL CHEM, V278, P35465, DOI 10.1074/jbc.M304663200; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Le Masson F, 2011, MOL CELL BIOL, V31, P3410, DOI 10.1128/MCB.05237-11; Le Masson F, 2011, CELL STRESS CHAPERON, V16, P275, DOI 10.1007/s12192-010-0239-1; Lecomte S, 2010, ONCOGENE, V29, P4216, DOI 10.1038/onc.2010.171; Leppa S, 1997, J BIOL CHEM, V272, P15293, DOI 10.1074/jbc.272.24.15293; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; Loison F, 2006, BIOCHEM J, V395, P223, DOI 10.1042/BJ20051190; Mathew A, 1998, MOL CELL BIOL, V18, P5091, DOI 10.1128/MCB.18.9.5091; Mathew A, 2001, MOL CELL BIOL, V21, P7163, DOI 10.1128/MCB.21.21.7163-7171.2001; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; McMillan DR, 2002, MOL CELL BIOL, V22, P8005, DOI 10.1128/MCB.22.22.8005-8014.2002; Metchat A, 2009, J BIOL CHEM, V284, P9521, DOI 10.1074/jbc.M808819200; MEZGER V, 1994, DEV BIOL, V166, P819, DOI 10.1006/dbio.1994.1361; Michel D, 2010, PROG BIOPHYS MOL BIO, V102, P16, DOI 10.1016/j.pbiomolbio.2009.12.007; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Paul S, 2008, BIOESSAYS, V30, P1172, DOI 10.1002/bies.20852; Petre I, 2011, NAT COMPUT, V10, P595, DOI 10.1007/s11047-010-9216-y; Pirkkala L, 2000, MOL CELL BIOL, V20, P2670, DOI 10.1128/MCB.20.8.2670-2675.2000; Rieger TR, 2005, BIOPHYS J, V88, P1646, DOI 10.1529/biophysj.104.055301; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; SISTONEN L, 1992, MOL CELL BIOL, V12, P4104, DOI 10.1128/MCB.12.9.4104; Szymanska Z, 2009, J THEOR BIOL, V259, P562, DOI 10.1016/j.jtbi.2009.03.021; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Yoshima T, 1998, NUCLEIC ACIDS RES, V26, P2580, DOI 10.1093/nar/26.11.2580	29	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56085	10.1371/journal.pone.0056085	http://dx.doi.org/10.1371/journal.pone.0056085			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418516	Green Published, gold			2022-12-27	WOS:000315970300108
J	Orsi, W; Biddle, JF; Edgcomb, V				Orsi, William; Biddle, Jennifer F.; Edgcomb, Virginia			Deep Sequencing of Subseafloor Eukaryotic rRNA Reveals Active Fungi across Marine Subsurface Provinces	PLOS ONE			English	Article							BACTERIAL-POPULATIONS; SEDIMENTS; DNA; COMMUNITY; ARCHAEA; PRESERVATION; DIVERSITY; ABUNDANCE; BIOMASS; GROWTH	The deep marine subsurface is a vast habitat for microbial life where cells may live on geologic timescales. Because DNA in sediments may be preserved on long timescales, ribosomal RNA ( rRNA) is suggested to be a proxy for the active fraction of a microbial community in the subsurface. During an investigation of eukaryotic 18S rRNA by amplicon pyrosequencing, unique profiles of Fungi were found across a range of marine subsurface provinces including ridge flanks, continental margins, and abyssal plains. Subseafloor fungal populations exhibit statistically significant correlations with total organic carbon (TOC), nitrate, sulfide, and dissolved inorganic carbon (DIC). These correlations are supported by terminal restriction length polymorphism (TRFLP) analyses of fungal rRNA. Geochemical correlations with fungal pyrosequencing and TRFLP data from this geographically broad sample set suggests environmental selection of active Fungi in the marine subsurface. Within the same dataset, ancient rRNA signatures were recovered from plants and diatoms in marine sediments ranging from 0.03 to 2.7 million years old, suggesting that rRNA from some eukaryotic taxa may be much more stable than previously considered in the marine subsurface.	[Orsi, William; Edgcomb, Virginia] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Biddle, Jennifer F.] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA	Woods Hole Oceanographic Institution; University of Delaware	Orsi, W (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	william.orsi@gmail.com	Biddle, Jennifer F/F-8323-2010; Edgcomb, Virginia/Q-2434-2019	Biddle, Jennifer F/0000-0002-4344-8724; Edgcomb, Virginia/0000-0001-6805-381X	Center for Dark Energy Biosphere Investigations (C-DEBI) [OCE-0939564]; Ocean Life Institute (WHOI) [OLI-27071359]; Office Of The Director [0814251] Funding Source: National Science Foundation	Center for Dark Energy Biosphere Investigations (C-DEBI); Ocean Life Institute (WHOI); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was performed with funding from the Center for Dark Energy Biosphere Investigations (C-DEBI) to William Orsi (OCE-0939564) and The Ocean Life Institute (WHOI) to Virginia Edgcomb (OLI-27071359). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Carpenter LL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-30; Biddle JF, 2005, GEOBIOLOGY, V3, P287, DOI 10.1111/j.1472-4669.2006.00062.x; Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; Boere AC, 2011, GEOBIOLOGY, V9, P377, DOI 10.1111/j.1472-4669.2011.00290.x; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Buckley DH, 2008, ENVIRON MICROBIOL, V10, P967, DOI 10.1111/j.1462-2920.2007.01517.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clement-Ziza M, 2008, RNA, V14, P2698, DOI 10.1261/rna.1261708; Cochrane V.W., 1958, PHYSL FUNGI; Coolen MJL, 2007, ENVIRON MICROBIOL, V9, P238, DOI 10.1111/j.1462-2920.2006.01134.x; Corinaldesi C, 2005, APPL ENVIRON MICROB, V71, P46, DOI 10.1128/AEM.71.1.46-50.2005; Corinaldesi C, 2011, MOL ECOL, V20, P642, DOI 10.1111/j.1365-294X.2010.04958.x; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; D'Hondt S, 2004, SCIENCE, V306, P2216, DOI 10.1126/science.1101155; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; D'Hondt S, 2009, P NATL ACAD SCI USA, V106, P11651, DOI 10.1073/pnas.0811793106; Dalpe Y, 1998, CAN J BOT, V76, P1930, DOI 10.1139/cjb-76-11-1930; Dell'Anno A, 2005, SCIENCE, V309, P2179, DOI 10.1126/science.1117475; Detrick R, 1990, P ODP INIT REPTS, V106/109; DHondt SL, 2003, P OCEAN DRILLING PRO, V201; Douillet P, 1998, J EXP MAR BIOL ECOL, V224, P183, DOI 10.1016/S0022-0981(97)00200-1; Edgcomb VP, 2011, ENVIRON MICROBIOL, V13, P172, DOI 10.1111/j.1462-2920.2010.02318.x; Gamper HA, 2009, NEW PHYTOL, V182, P495, DOI 10.1111/j.1469-8137.2008.02750.x; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Goldhammer T, 2011, GEOCHIM COSMOCHIM AC, V75, P3741, DOI 10.1016/j.gca.2011.04.006; Griffin DW, 2007, CLIN MICROBIOL REV, V20, P459, DOI 10.1128/CMR.00039-06; Gutierrez Juan Carlos, 2001, International Microbiology, V4, P151; HAMLETT NV, 1986, APPL ENVIRON MICROB, V52, P915, DOI 10.1128/AEM.52.4.915-923.1986; HOWES BL, 1994, MAR ECOL PROG SER, V114, P289, DOI 10.3354/meps114289; Inagaki F, 2005, ASTROBIOLOGY, V5, P141, DOI 10.1089/ast.2005.5.141; Inagaki F, 2006, PALEOME LETT ANCIENT; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Karasawa T, 2012, PLANT CELL ENVIRON, V35, P819, DOI 10.1111/j.1365-3040.2011.02455.x; Lipp JS, 2008, NATURE, V454, P991, DOI 10.1038/nature07174; Liu XL, 2011, ORG GEOCHEM, V42, P368, DOI 10.1016/j.orggeochem.2011.02.003; Lomstein BA, 2012, NATURE, V484, P101, DOI 10.1038/nature10905; Meister P, 2005, P ODP SCI RESULTS, P1; Mills HJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00113; Mills HJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00049; Mollenhauer G, 2003, GEOCHIM COSMOCHIM AC, V67, P2157, DOI 10.1016/S0016-7037(03)00168-6; Nebel ME, 2011, J BIOINF COMPUT BIOL, V9, P749, DOI 10.1142/S0219720011005781; Niitsuma S, 2006, P ODP SCI RESULTS; Pacini E, 2006, PROTOPLASMA, V228, P73, DOI 10.1007/s00709-006-0169-z; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; Schafer H, 2007, AQUAT MICROB ECOL, V50, P1, DOI 10.3354/ame01164; Schippers A, 2005, NATURE, V433, P861, DOI 10.1038/nature03302; Schippers A, 2006, ENVIRON MICROBIOL, V8, P1251, DOI 10.1111/j.1462-2920.2006.01019.x; Schippers A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00016; Schussler A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023333; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Suess E, 1986, P ODP INIT REPTS; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Tiquia SM, 2005, ENVIRON TECHNOL, V26, P1101, DOI 10.1080/09593332608618482; Trehu AM, 2002, P ODP INIT REPTS, V204; Webster G, 2006, FEMS MICROBIOL ECOL, V58, P65, DOI 10.1111/j.1574-6941.2006.00147.x; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Willerslev E, 2007, SCIENCE, V317, P111, DOI 10.1126/science.1141758; Ziebis W, 2012, EARTH PLANET SC LETT, V323, P79, DOI 10.1016/j.epsl.2012.01.018	60	173	176	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56335	10.1371/journal.pone.0056335	http://dx.doi.org/10.1371/journal.pone.0056335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418556	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300149
J	Pignatelli, A; Borin, M; Iseppe, AF; Gambardella, C; Belluzzi, O				Pignatelli, Angela; Borin, Mirta; Iseppe, Alex Fogli; Gambardella, Cristina; Belluzzi, Ottorino			The h-Current in Periglomerular Dopaminergic Neurons of the Mouse Olfactory Bulb	PLOS ONE			English	Article							HYPERPOLARIZATION-ACTIVATED CURRENT; RABBIT SINOATRIAL NODE; RECEPTOR MESSENGER-RNA; CURRENT I-H; RAT-BRAIN; TYROSINE-HYDROXYLASE; PACEMAKER CHANNELS; PURKINJE-FIBERS; CATION CURRENT; CYCLIC-AMP	The properties of the hyperpolarization-activated cation current (I-h) were investigated in rat periglomerular dopaminergic neurons using patch-clamp recordings in thin slices. A reliable identification of single dopaminergic neurons was made possible by use of a transgenic line of mice expressing eGFP under the tyrosine hydroxylase promoter. At 37 degrees C and minimizing the disturbance of the intracellular milieu with perforated patches, this current shows a midpoint of activation around -82.7 mV, with a significant level of opening already at rest, thereby giving a substantial contribution to the resting potential, and ultimately playing a relevant function in the control of the cell excitability. The blockage of I-h has a profound influence on the spontaneous firing of these neurons, which result as strongly depressed. However the effect is not due to a direct role of the current in the pacemaker process, but to the I-h influence on the resting membrane potential. I-h kinetics is sensitive to the intracellular levels of cAMP, whose increase promotes a shift of the activation curve towards more positive potentials. The direct application of DA and 5-HT neurotransmitters, physiologically released onto bulbar dopaminergic neurons and known to act on metabotropic receptors coupled to the cAMP pathway, do not modify the I-h amplitude. On the contrary, noradrenaline almost halves the I-h amplitude. Our data indicate that the HCN channels do not participate directly to the pacemaker activity of periglomerular dopaminergic neurons, but influence their resting membrane potential by controlling the excitability profile of these cells, and possibly affecting the processing of sensory information taking place at the entry of the bulbar circuitry.	[Belluzzi, Ottorino] Univ Ferrara, Dipartimento Sci Vita & Biotecnol, I-44100 Ferrara, Italy; Ist Nazl Neurosci, Ferrara, Italy	University of Ferrara	Belluzzi, O (corresponding author), Univ Ferrara, Dipartimento Sci Vita & Biotecnol, I-44100 Ferrara, Italy.	mk5@unife.it	Pignatelli, Angela/L-4490-2013	Pignatelli, Angela/0000-0002-7160-1597; Fogli Iseppe, Alex/0000-0003-4616-293X; Belluzzi, Ottorino/0000-0002-7543-3818	Ministero della Universita e della Ricerca Scientifica (MIUR) - PRIN	Ministero della Universita e della Ricerca Scientifica (MIUR) - PRIN(Ministry of Education, Universities and Research (MIUR))	The research was supported by a grant from the Ministero della Universita e della Ricerca Scientifica (MIUR) - PRIN 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARANEDA S, 1980, BRAIN RES, V196, P405, DOI 10.1016/0006-8993(80)90404-7; BAKER H, 1983, J NEUROSCI, V3, P69; BEAVO JA, 1970, MOL PHARMACOL, V6, P597; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; Brent R. P., 1973, ALGORITHMS MINIMIZAT; Bucchi A, 2002, J GEN PHYSIOL, V120, P1, DOI 10.1085/jgp.20028593; Bucchi A, 2006, J PHYSIOL-LONDON, V572, P335, DOI 10.1113/jphysiol.2005.100776; Cadetti L, 2001, NEUROREPORT, V12, P3117, DOI 10.1097/00001756-200110080-00027; Cathala L, 1999, EUR J NEUROSCI, V11, P398, DOI 10.1046/j.1460-9568.1999.00452.x; Cuevas J, 1997, J NEUROPHYSIOL, V78, P1890, DOI 10.1152/jn.1997.78.4.1890; Davila NG, 2003, J NEUROPHYSIOL, V90, P395, DOI 10.1152/jn.01058.2002; Day HEW, 1997, J CHEM NEUROANAT, V13, P115, DOI 10.1016/S0891-0618(97)00042-2; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61, DOI 10.1113/jphysiol.1986.sp016177; DIFRANCESCO D, 1980, J PHYSIOL-LONDON, V308, P353, DOI 10.1113/jphysiol.1980.sp013475; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DIFRANCESCO D, 1982, J PHYSIOL-LONDON, V329, P485, DOI 10.1113/jphysiol.1982.sp014315; Domyancic AV, 1997, J COMP NEUROL, V386, P358, DOI 10.1002/(SICI)1096-9861(19970929)386:3<358::AID-CNE3>3.0.CO;2-0; DOTY RL, 1989, PSYCHOPHARMACOLOGY, V98, P310, DOI 10.1007/BF00451680; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; Feigenspan A, 1998, J NEUROSCI, V18, P6776; Forsythe G.E., 1976, COMPUTER METHODS MAT; Fried HU, 2010, CELL TISSUE RES, V339, P463, DOI 10.1007/s00441-009-0904-9; GALL CM, 1987, J COMP NEUROL, V266, P307, DOI 10.1002/cne.902660302; Gambardella C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052329; GRACE AA, 1989, J NEUROSCI, V9, P3463; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; GUTHRIE KM, 1991, SYNAPSE, V8, P61, DOI 10.1002/syn.890080109; Gutierrez-Mecinas M, 2005, EUR J NEUROSCI, V22, P1357, DOI 10.1111/j.1460-9568.2005.04328.x; HAINSWORTH AH, 1991, NEUROSCIENCE, V43, P81, DOI 10.1016/0306-4522(91)90419-O; HALASZ N, 1990, VERTEBRATE OLFACTORY; HART G, 1983, J PHYSIOL-LONDON, V337, P401, DOI 10.1113/jphysiol.1983.sp014631; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Holderith NB, 2003, EUR J NEUROSCI, V18, P344, DOI 10.1046/j.1460-9568.2003.02756.x; Inyushin MU, 2010, NEUROSCIENCE, V167, P287, DOI 10.1016/j.neuroscience.2010.01.052; KAMONDI A, 1991, J NEUROPHYSIOL, V66, P1902, DOI 10.1152/jn.1991.66.6.1902; KOSAKA T, 1985, BRAIN RES, V343, P166, DOI 10.1016/0006-8993(85)91172-2; KRATSKIN I, 2003, HDB OLFACTION GUSTAT, P139; Linster C, 2011, J NEUROPHYSIOL, V105, P1432, DOI 10.1152/jn.00960.2010; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; Maher BJ, 2008, J NEUROPHYSIOL, V99, P1559, DOI 10.1152/jn.00636.2007; Matsushita N, 2002, J NEUROCHEM, V82, P295, DOI 10.1046/j.1471-4159.2002.00972.x; MCLEAN JH, 1988, J NEUROSCI, V8, P3658; MCLEAN JH, 1989, J COMP NEUROL, V285, P339, DOI 10.1002/cne.902850305; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Moosmang S, 1999, BIOL CHEM, V380, P975, DOI 10.1515/BC.1999.121; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; NOWYCKY MC, 1983, NEUROSCIENCE, V8, P717, DOI 10.1016/0306-4522(83)90005-2; PANULA P, 1989, NEUROSCIENCE, V28, P585, DOI 10.1016/0306-4522(89)90007-9; Panzanelli P, 2007, J COMP NEUROL, V502, P990, DOI 10.1002/cne.21356; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; PEDARZANI P, 1995, P NATL ACAD SCI USA, V92, P11716, DOI 10.1073/pnas.92.25.11716; Pena F, 2006, EXP BRAIN RES, V173, P282, DOI 10.1007/s00221-006-0473-z; Pignatelli A, 2005, J PHYSIOL-LONDON, V564, P501, DOI 10.1113/jphysiol.2005.084632; Pignatelli A, 2009, PFLUG ARCH EUR J PHY, V457, P899, DOI 10.1007/s00424-008-0535-0; Puopolo M, 2005, J NEUROPHYSIOL, V94, P3618, DOI 10.1152/jn.00225.2005; Saino-Saito S, 2004, J COMP NEUROL, V479, P389, DOI 10.1002/cne.20320; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Sawamoto K, 2001, J NEUROSCI, V21, P3895, DOI 10.1523/JNEUROSCI.21-11-03895.2001; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; SHIPLEY MT, 1985, BRAIN RES, V329, P294, DOI 10.1016/0006-8993(85)90537-2; Shipley MT, 1996, J NEUROBIOL, V30, P123; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; WinzerSerhan UH, 1997, NEUROSCIENCE, V76, P241; Yagi J, 1998, J NEUROPHYSIOL, V80, P1094, DOI 10.1152/jn.1998.80.3.1094; Yanagida H, 2000, AM J PHYSIOL-CELL PH, V278, pC40, DOI 10.1152/ajpcell.2000.278.1.C40; YOUNG WS, 1980, P NATL ACAD SCI-BIOL, V77, P1696, DOI 10.1073/pnas.77.3.1696; ZABORSZKY L, 1986, J COMP NEUROL, V243, P488, DOI 10.1002/cne.902430405	73	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56571	10.1371/journal.pone.0056571	http://dx.doi.org/10.1371/journal.pone.0056571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418585	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300178
J	Chen, IMA; Markowitz, VM; Chu, K; Anderson, I; Mavromatis, K; Kyrpides, NC; Ivanova, NN				Chen, I-Min A.; Markowitz, Victor M.; Chu, Ken; Anderson, Iain; Mavromatis, Konstantinos; Kyrpides, Nikos C.; Ivanova, Natalia N.			Improving Microbial Genome Annotations in an Integrated Database Context	PLOS ONE			English	Article							METABOLIC PATHWAYS	Effective comparative analysis of microbial genomes requires a consistent and complete view of biological data. Consistency regards the biological coherence of annotations, while completeness regards the extent and coverage of functional characterization for genomes. We have developed tools that allow scientists to assess and improve the consistency and completeness of microbial genome annotations in the context of the Integrated Microbial Genomes (IMG) family of systems. All publicly available microbial genomes are characterized in IMG using different functional annotation and pathway resources, thus providing a comprehensive framework for identifying and resolving annotation discrepancies. A rule based system for predicting phenotypes in IMG provides a powerful mechanism for validating functional annotations, whereby the phenotypic traits of an organism are inferred based on the presence of certain metabolic reactions and pathways and compared to experimentally observed phenotypes. The IMG family of systems are available at http://img.jgi.doe.gov/.	[Chen, I-Min A.; Markowitz, Victor M.; Chu, Ken] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Biol Data Management & Technol Ctr, Berkeley, CA 94720 USA; [Anderson, Iain; Mavromatis, Konstantinos; Kyrpides, Nikos C.; Ivanova, Natalia N.] Joint Genome Inst, Dept Energy, Microbial Genom & Metagenom Program, Walnut Creek, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Markowitz, VM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Biol Data Management & Technol Ctr, Berkeley, CA 94720 USA.	vmmarkowitz@lbl.gov	Kyrpides, Nikos C./A-6305-2014	Kyrpides, Nikos C./0000-0002-6131-0462; Mavrommatis, Konstantinos/0000-0003-4549-385X; Ivanova, Natalia/0000-0002-5802-9485	Office of Science, Office of Biological and Environmental Research, Life Sciences Division, U.S. Department of Energy [DE-AC02-05CH11231]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	Office of Science, Office of Biological and Environmental Research, Life Sciences Division, U.S. Department of Energy(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	The work presented in this paper was supported by the Director, Office of Science, Office of Biological and Environmental Research, Life Sciences Division, U.S. Department of Energy under Contract No. DE-AC02-05CH11231. This research used resources of the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Datta RS, 2009, NUCLEIC ACIDS RES, V37, pW84, DOI 10.1093/nar/gkp373; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; DeJongh M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-139; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Markowitz Victor M., 2007, V395, P35; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; Mavromatis K, 2009, STAND GENOMIC SCI, V1, P63, DOI 10.4056/sigs.632; Mavromatis K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007979; Mazin PV, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-29; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Selengut JD, 2007, NUCLEIC ACIDS RES, V35, pD260, DOI 10.1093/nar/gkl1043; Selkov E, 1998, NUCLEIC ACIDS RES, V26, P43, DOI 10.1093/nar/26.1.43; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; Vassoliou Y., 1979, P ACM SIGMOD INT C M, V35, P162; Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141	24	47	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e54859	10.1371/journal.pone.0054859	http://dx.doi.org/10.1371/journal.pone.0054859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424620	Green Submitted, Green Published, gold			2022-12-27	WOS:000315965100008
J	Fushing, H; Wang, H; VanderWaal, K; McCowan, B; Koehl, P				Fushing, Hsieh; Wang, Hui; VanderWaal, Kimberly; McCowan, Brenda; Koehl, Patrice			Multi-Scale Clustering by Building a Robust and Self Correcting Ultrametric Topology on Data Points	PLOS ONE			English	Article							GENE-EXPRESSION; ALGORITHMS; NETWORKS; CLASSIFICATION	The advent of high-throughput technologies and the concurrent advances in information sciences have led to an explosion in size and complexity of the data sets collected in biological sciences. The biggest challenge today is to assimilate this wealth of information into a conceptual framework that will help us decipher biological functions. A large and complex collection of data, usually called a data cloud, naturally embeds multi-scale characteristics and features, generically termed geometry. Understanding this geometry is the foundation for extracting knowledge from data. We have developed a new methodology, called data cloud geometry-tree (DCG-tree), to resolve this challenge. This new procedure has two main features that are keys to its success. Firstly, it derives from the empirical similarity measurements a hierarchy of clustering configurations that captures the geometric structure of the data. This hierarchy is then transformed into an ultrametric space, which is then represented via an ultrametric tree or a Parisi matrix. Secondly, it has a built-in mechanism for self-correcting clustering membership across different tree levels. We have compared the trees generated with this new algorithm to equivalent trees derived with the standard Hierarchical Clustering method on simulated as well as real data clouds from fMRI brain connectivity studies, cancer genomics, giraffe social networks, and Lewis Carroll's Doublets network. In each of these cases, we have shown that the DCG trees are more robust and less sensitive to measurement errors, and that they provide a better quantification of the multi-scale geometric structures of the data. As such, DCG-tree is an effective tool for analyzing complex biological data sets.	[Fushing, Hsieh; Wang, Hui] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [VanderWaal, Kimberly] Univ Calif Davis, Anim Behav Grad Grp, Davis, CA 95616 USA; [McCowan, Brenda] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [McCowan, Brenda] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Koehl, Patrice] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Koehl, Patrice] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Koehl, P (corresponding author), Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA.	koehl@cs.ucdavis.edu	Koehl, Patrice/K-5708-2013	Koehl, Patrice/0000-0002-0908-068X; VanderWaal, Kimberly/0000-0002-5764-6430	National Science Foundation [DMS-1007219]; National Institutes of Health (NIH) [GM080399]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080399] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107, R24OD011136] Funding Source: NIH RePORTER; Direct For Biological Sciences [1209338] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by the following: National Science Foundation Grant DMS-1007219 (http://www.nsf.gov) and National Institutes of Health (NIH) Grant GM080399 (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; BILBRO GL, 1991, J OPT SOC AM A, V8, P290, DOI 10.1364/JOSAA.8.000290; Blatt M, 1997, NEURAL COMPUT, V9, P1805, DOI 10.1162/neco.1997.9.8.1805; Blatt M, 1996, PHYS REV LETT, V76, P3251, DOI 10.1103/PhysRevLett.76.3251; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Chen C, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041120; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Cover T. M., 1991, ELEMENT INFORM THEOR; Croft DP, 2011, TRENDS ECOL EVOL, V26, P502, DOI 10.1016/j.tree.2011.05.012; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; DUBES R, 1976, PATTERN RECOGN, V8, P247, DOI 10.1016/0031-3203(76)90045-5; Fushing H, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061110; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Hofmann T, 1997, IEEE T PATTERN ANAL, V19, P1, DOI 10.1109/34.566806; Hui W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045502; Jain AK, 2004, INT C PATT RECOG, P260, DOI 10.1109/ICPR.2004.1334073; Jardine N., 1971, MATH TAXONOMY; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kleiner A., 2012, P 29 INT C MACH LEAR, V2, P1759; LANCE GN, 1966, NATURE, V212, P218, DOI 10.1038/212218a0; LANCE GN, 1967, COMPUT J, V9, P373, DOI 10.1093/comjnl/9.4.373; Mezard M., 2009, INFORM PHYS COMPUTAT, pp 584, DOI [10.1093/acprof:oso/9780198570837.001.0001, DOI 10.1093/ACPROF:OSO/9780198570837.001, DOI 10.1093/ACPROF:OSO/9780198570837.001.0001]; MILLIGAN GW, 1980, PATTERN RECOGN, V12, P41, DOI 10.1016/0031-3203(80)90001-1; MILLIGAN GW, 1979, PSYCHOMETRIKA, V44, P343, DOI 10.1007/BF02294699; OGIELSKI AT, 1985, PHYS REV LETT, V55, P1634, DOI 10.1103/PhysRevLett.55.1634; Puzicha J, 2000, PATTERN RECOGN, V33, P617, DOI 10.1016/S0031-3203(99)00076-X; Rose K, 1998, P IEEE, V86, P2210, DOI 10.1109/5.726788; ROSE K, 1990, PATTERN RECOGN LETT, V11, P589, DOI 10.1016/0167-8655(90)90010-Y; Sasik R, 2001, Pac Symp Biocomput, P335; SNEATH PHA, 1957, J GEN MICROBIOL, V17, P201, DOI 10.1099/00221287-17-1-201; Sokal RR, 1963, PRINCIPLES NUMERICAL; Solomon M, 2009, NEUROPSYCHOLOGIA, V47, P2515, DOI 10.1016/j.neuropsychologia.2009.04.019; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978	35	21	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56259	10.1371/journal.pone.0056259	http://dx.doi.org/10.1371/journal.pone.0056259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424653	Green Submitted, Green Published, gold			2022-12-27	WOS:000315965100041
J	Lotter, H; Helk, E; Bernin, H; Jacobs, T; Prehn, C; Adamski, J; Gonzalez-Roldan, N; Holst, O; Tannich, E				Lotter, Hannelore; Helk, Elena; Bernin, Hannah; Jacobs, Thomas; Prehn, Cornelia; Adamski, Jerzy; Gonzalez-Roldan, Nestor; Holst, Otto; Tannich, Egbert			Testosterone Increases Susceptibility to Amebic Liver Abscess in Mice and Mediates Inhibition of IFN gamma Secretion in Natural Killer T Cells	PLOS ONE			English	Article							LEISHMANIA-DONOVANI INFECTION; ENTAMOEBA-HISTOLYTICA TROPHOZOITES; PLASMODIUM-CHABAUDI MALARIA; INVARIANT NKT CELLS; SEXUAL-DIMORPHISM; MURINE MACROPHAGES; DENDRITIC CELLS; CUTTING EDGE; NITRIC-OXIDE; BONE-MARROW	Amebic liver abscess (ALA), a parasitic disease due to infection with the protozoan Entamoeba histolytica, occurs age and gender dependent with strong preferences for adult males. Using a mouse model for ALA with a similar male bias for the disease, we have investigated the role of female and male sexual hormones and provide evidence for a strong contribution of testosterone. Removal of testosterone by orchiectomy significantly reduced sizes of abscesses in male mice, while substitution of testosterone increased development of ALA in female mice. Activation of natural killer T (NKT) cells, which are known to be important for the control of ALA, is influenced by testosterone. Specifically activated NKT cells isolated from female mice produce more IFN gamma compared to NKT cells derived from male mice. This high level production of IFN gamma in female derived NKT cells was inhibited by testosterone substitution, while the IFN gamma production in male derived NKT cells was increased by orchiectomy. Gender dependent differences were not a result of differences in the total number of NKT cells, but a result of a higher activation potential for the CD4(-) NKT cell subpopulation in female mice. Taken together, we conclude that the hormone status of the host, in particular the testosterone level, determines susceptibility to ALA at least in a mouse model of the disease.	[Lotter, Hannelore; Helk, Elena; Bernin, Hannah; Jacobs, Thomas; Tannich, Egbert] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [Prehn, Cornelia; Adamski, Jerzy] Helmholtz Ctr Munich, Inst Expt Genet, Genome Anal Ctr, Neuherberg, Germany; [Gonzalez-Roldan, Nestor] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Immunobiol, Borstel, Germany; [Holst, Otto] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Struct Biochem, Borstel, Germany	Bernhard Nocht Institut fur Tropenmedizin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Forschungszentrum Borstel; Forschungszentrum Borstel	Lotter, H (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	lotter@bni-hamburg.de		Prehn, Cornelia/0000-0002-1274-4715; Adamski, Jerzy/0000-0001-9259-0199	Deutsche Forschungsgemeinschaft [TA110/8-1]; Collaborative Research Center, Germany [841]; German National Genome Research Network [NGFN2 : 01GR0430]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Collaborative Research Center, Germany; German National Genome Research Network	This work was supported by grants of the Deutsche Forschungsgemeinschaft (TA110/8-1) and the Collaborative Research Center 841, Germany. Part of this work was financed by the German National Genome Research Network (NGFN2 : 01GR0430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Soto R, 2000, AM J GASTROENTEROL, V95, P1277, DOI 10.1111/j.1572-0241.2000.01525.x; BARNES PF, 1987, MEDICINE, V66, P472, DOI 10.1097/00005792-198711000-00005; Bebo BF, 1999, J IMMUNOL, V162, P35; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Benten WPM, 1999, FASEB J, V13, P123, DOI 10.1096/fasebj.13.1.123; Benten WPM, 1997, J ENDOCRINOL, V153, P275, DOI 10.1677/joe.0.1530275; Benten WPM, 1998, FEBS LETT, V422, P349, DOI 10.1016/S0014-5793(98)00039-8; Blessmann J, 2003, J CLIN MICROBIOL, V41, P4745, DOI 10.1128/JCM.41.10.4745-4750.2003; Blessmann J, 2002, AM J TROP MED HYG, V66, P578, DOI 10.4269/ajtmh.2002.66.578; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; CHANDLER VL, 1983, CELL, V33, P489, DOI 10.1016/0092-8674(83)90430-0; CUTOLO A, 1995, APPL OPTICS, V34, P7974, DOI 10.1364/AO.34.007974; DENIS M, 1989, INFECT IMMUN, V57, P1750, DOI 10.1128/IAI.57.6.1750-1756.1989; Doisne JM, 2011, J IMMUNOL, V186, P662, DOI 10.4049/jimmunol.1002725; Filipin MD, 2008, EXP PARASITOL, V120, P249, DOI 10.1016/j.exppara.2008.07.012; Friedl R, 2000, LIFE SCI, V68, P417, DOI 10.1016/S0024-3205(00)00953-X; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gourdy P, 2005, BLOOD, V105, P2415, DOI 10.1182/blood-2004-07-2819; He YL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000915; Kanda N, 1996, CLIN EXP IMMUNOL, V106, P410, DOI 10.1046/j.1365-2249.1996.d01-842.x; Kee SJ, 2012, HUM IMMUNOL, V73, P1011, DOI 10.1016/j.humimm.2012.07.335; Kenna T, 2003, J IMMUNOL, V171, P1775, DOI 10.4049/jimmunol.171.4.1775; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Krucken J, 2005, INFECT IMMUN, V73, P436, DOI 10.1128/IAI.73.1.436-443.2005; Liu LM, 2006, PARASITOL RES, V99, P189, DOI 10.1007/s00436-006-0168-1; Liu LM, 2005, STEROIDS, V70, P604, DOI 10.1016/j.steroids.2005.02.020; Lotter H, 2006, INFECT IMMUN, V74, P118, DOI 10.1128/IAI.74.1.118-124.2006; Lotter H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000434; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mannik LA, 2011, IMMUNOLOGY, V132, P361, DOI 10.1111/j.1365-2567.2010.03369.x; Marriott I, 2006, IMMUNOL RES, V34, P177, DOI 10.1385/IR:34:3:177; MOCK BA, 1988, INFECT IMMUN, V56, P3316, DOI 10.1128/IAI.56.12.3316-3319.1988; Molling JW, 2005, INT J CANCER, V116, P87, DOI 10.1002/ijc.20998; Montoya CJ, 2007, IMMUNOLOGY, V122, P1, DOI 10.1111/j.1365-2567.2007.02647.x; Morales-Montor J, 2004, J PARASITOL, V90, P531, DOI 10.1645/GE-113R3; Mossmann H, 1997, LIFE SCI, V60, P839, DOI 10.1016/S0024-3205(97)00012-X; Nakazawa M, 1997, EXP PARASITOL, V85, P233, DOI 10.1006/expr.1997.4148; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Roberts CW, 2001, CLIN MICROBIOL REV, V14, P476, DOI 10.1128/CMR.14.3.476-488.2001; SALATA RA, 1987, AM J TROP MED HYG, V37, P72, DOI 10.4269/ajtmh.1987.37.72; Sandberg JK, 2003, EUR J IMMUNOL, V33, P588, DOI 10.1002/eji.200323707; Seydel KB, 2000, INFECT IMMUN, V68, P400, DOI 10.1128/IAI.68.1.400-402.2000; Shandera WX, 1998, SOUTH MED J, V91, P829, DOI 10.1097/00007611-199809000-00005; Snyder-Cappione JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015412; Subleski JJ, 2009, J LEUKOCYTE BIOL, V86, P751, DOI 10.1189/jlb.0309118; Takahashi T, 2002, J IMMUNOL, V168, P3140, DOI 10.4049/jimmunol.168.7.3140; Travi B, 2002, MEM I OSWALDO CRUZ, V97, P887, DOI 10.1590/S0074-02762002000600025; Travison TG, 2007, J CLIN ENDOCR METAB, V92, P196, DOI 10.1210/jc.2006-1375; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Volkmann A, 1996, EUR J IMMUNOL, V26, P2565, DOI 10.1002/eji.1830261105; Walderich B, 1997, AM J TROP MED HYG, V57, P70, DOI 10.4269/ajtmh.1997.57.70; Watanabe K, 1999, PARASITOL RES, V85, P522, DOI 10.1007/s004360050591; WESTPHAL O, 1983, PROG ALLERGY, V33, P9; Wingender G, 2010, J IMMUNOL, V185, P2721, DOI 10.4049/jimmunol.1001018; Wunderlich F, 2002, STEROIDS, V67, P535, DOI 10.1016/S0039-128X(01)00175-1; YAMAMOTO Y, 1991, INFECT IMMUN, V59, P4089, DOI 10.1128/IAI.59.11.4089-4096.1991; Zhang HP, 2001, PARASITOL RES, V87, P674, DOI 10.1007/s004360000354	59	50	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55694	10.1371/journal.pone.0055694	http://dx.doi.org/10.1371/journal.pone.0055694			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424637	Green Published, Green Submitted, gold			2022-12-27	WOS:000315965100025
J	Palumbo, L; Jellema, T				Palumbo, Letizia; Jellema, Tjeerd			Beyond Face Value: Does Involuntary Emotional Anticipation Shape the Perception of Dynamic Facial Expressions?	PLOS ONE			English	Article							EMBODIED SIMULATION; NEURAL SYSTEMS; GAZE DIRECTION; ADAPTATION; MIND; REPRESENTATION; RECOGNITION; IMITATION; JUDGMENTS; IDENTITY	Emotional facial expressions are immediate indicators of the affective dispositions of others. Recently it has been shown that early stages of social perception can already be influenced by (implicit) attributions made by the observer about the agent's mental state and intentions. In the current study possible mechanisms underpinning distortions in the perception of dynamic, ecologically-valid, facial expressions were explored. In four experiments we examined to what extent basic perceptual processes such as contrast/context effects, adaptation and representational momentum underpinned the perceptual distortions, and to what extent 'emotional anticipation', i.e. the involuntary anticipation of the other's emotional state of mind on the basis of the immediate perceptual history, might have played a role. Neutral facial expressions displayed at the end of short video-clips, in which an initial facial expression of joy or anger gradually morphed into a neutral expression, were misjudged as being slightly angry or slightly happy, respectively (Experiment 1). This response bias disappeared when the actor's identity changed in the final neutral expression (Experiment 2). Videos depicting neutral-to-joy-to-neutral and neutral-to-anger-to-neutral sequences again produced biases but in opposite direction (Experiment 3). The bias survived insertion of a 400 ms blank (Experiment 4). These results suggested that the perceptual distortions were not caused by any of the low-level perceptual mechanisms (adaptation, representational momentum and contrast effects). We speculate that especially when presented with dynamic, facial expressions, perceptual distortions occur that reflect 'emotional anticipation' (a low-level mindreading mechanism), which overrules low-level visual mechanisms. Underpinning neural mechanisms are discussed in relation to the current debate on action and emotion understanding.	[Palumbo, Letizia; Jellema, Tjeerd] Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Hull	Jellema, T (corresponding author), Univ Hull, Dept Psychol, Kingston Upon Hull HU6 7RX, N Humberside, England.	T.Jellema@hull.ac.uk			Hull University	Hull University	Funding by Hull University 80th Anniversary Studentship Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; [Anonymous], 1980, REMARKS PHILOS PSYCH; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; Botvinick M, 2005, NEUROIMAGE, V25, P312, DOI 10.1016/j.neuroimage.2004.11.043; Calvo MG, 2009, COGNITION EMOTION, V23, P782, DOI 10.1080/02699930802151654; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Cattaneo L, 2007, P NATL ACAD SCI USA, V104, P17825, DOI 10.1073/pnas.0706273104; Clark A, BEHAV BRAIN IN PRESS; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Davidson RJ, 1995, BRAIN ASYMMETRY; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; EKMAN P, 1988, J EXP PSYCHOL GEN, V117, P86, DOI 10.1037/0096-3445.117.1.86; Ekman P., 1975, UNMASKING FACE; Ekman P., 2003, EMOTIONS REVEALED RE, Vsecond; Ekman P., 1976, PICTURES FACIAL AFFE; Ellamil M, 2008, COGN AFFECT BEHAV NE, V8, P273, DOI 10.3758/CABN.8.3.273; Enns J., 2010, SPACE TIME PERCEPTIO, P503, DOI [DOI 10.1017/CBO9780511750540.028, 10.1017/CBO9780511750540.028]; FINKE RA, 1985, J EXP PSYCHOL LEARN, V11, P780, DOI 10.1037/0278-7393.11.1-4.780; FODOR JA, 1968, J PHILOS, V65, P627, DOI 10.2307/2024316; Fox CJ, 2007, BRAIN RES, V1127, P80, DOI 10.1016/j.brainres.2006.09.104; FREYD JJ, 1983, PERCEPT PSYCHOPHYS, V33, P575, DOI 10.3758/BF03202940; FREYD JJ, 1984, J EXP PSYCHOL LEARN, V10, P126, DOI 10.1037/0278-7393.10.1.126; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Gallagher Shaun., 2021, PHENOMENOLOGICAL MIN, V3rd ed., DOI 10.4324/9780203086599; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Goldman AI, 2005, COGNITION, V94, P193, DOI 10.1016/j.cognition.2004.01.005; Goldman AI, 2006, SIMULATING MINDS; Gordon R. M., 2004, STANFORD ENCY PHILOS; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Hess U, 2007, MOTIV EMOTION, V31, P137, DOI 10.1007/s11031-007-9057-x; Hsu SM, 2004, VIS COGN, V11, P871, DOI 10.1080/13506280444000030; Hubbard TL, 2005, PSYCHON B REV, V12, P822, DOI 10.3758/BF03196775; Hudson M, 2011, EMOTION, V11, P681, DOI 10.1037/a0023264; Hudson M, 2009, COGNITION, V112, P423, DOI 10.1016/j.cognition.2009.06.011; Jellema T, 2000, BRAIN COGNITION, V44, P280, DOI 10.1006/brcg.2000.1231; Jellema T, 2003, J COGNITIVE NEUROSCI, V15, P961, DOI 10.1162/089892903770007353; Jellema T, 2002, ATTENTION PERFORM, V19, P356; Jellema T, 2005, COGNITIVE NEUROSCIENCE OF SOCIAL BEHAVIOUR, P81, DOI 10.4324/9780203311875_chapter_4; Jellema T, 2011, VIS COGN, V19, P616, DOI 10.1080/13506285.2011.569775; Jones BC, 2006, PSYCHOL SCI, V17, P588, DOI 10.1111/j.1467-9280.2006.01749.x; Kerzel D, 2000, VISION RES, V40, P3703, DOI 10.1016/S0042-6989(00)00226-1; Kovacs G, 2008, NEUROIMAGE, V43, P156, DOI 10.1016/j.neuroimage.2008.06.042; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; LESLIE AM, 1994, COGNITION, V50, P211, DOI 10.1016/0010-0277(94)90029-9; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Likowski KU, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00214; Merleau-Ponty Maurice, 1964, PRIMACY PERCEPTION O; Muhlberger A, 2011, SOC COGN AFFECT NEUR, V6, P321, DOI 10.1093/scan/nsq039; Neta M, 2010, PSYCHOL SCI, V21, P901, DOI 10.1177/0956797610373934; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 2010, BEHAV BRAIN SCI, V33, P417, DOI 10.1017/S0140525X10000865; NIEDENTHAL PM, 2005, EMOTION CONSCIOUSNES, P21; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Perrett DI, 2009, Q J EXP PSYCHOL, V62, P2081, DOI 10.1080/17470210902959279; PERRETT DI, 1994, NATURE, V368, P239, DOI 10.1038/368239a0; Pitcher D, 2008, J NEUROSCI, V28, P8929, DOI 10.1523/JNEUROSCI.1450-08.2008; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sato W, 2004, COGNITION EMOTION, V18, P701, DOI 10.1080/02699930341000176; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2004, NEUROPSYCHOLOGIA, V42, P1435, DOI 10.1016/j.neuropsychologia.2004.04.015; Stich S., 1992, MIND LANG, V7, P35, DOI [DOI 10.1111/J.1468-0017.1992.TB00196, DOI 10.1111/J.1468-0017.1992.TB00196.X]; Suzuki S, 1998, J EXP PSYCHOL HUMAN, V24, P1315, DOI 10.1037/0096-1523.24.5.1315; TANAKAMATSUMI J, 1995, MOTIV EMOTION, V19, P139, DOI 10.1007/BF02250567; Teufel C, 2010, TRENDS COGN SCI, V14, P376, DOI 10.1016/j.tics.2010.05.005; Teufel C, 2010, ATTEN PERCEPT PSYCHO, V72, P695, DOI 10.3758/APP.72.3.695; THAYER S, 1980, J NONVERBAL BEHAV, V5, P71, DOI 10.1007/BF00986510; Vinson NG, 2002, VIS COGN, V9, P41, DOI 10.1080/13506280143000313; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; WEINER B, 1985, DEV PSYCHOL, V21, P102, DOI 10.1037/0012-1649.21.1.102; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Yoshikawa S, 2008, COGN AFFECT BEHAV NE, V8, P25, DOI 10.3758/CABN.8.1.25	77	17	19	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56003	10.1371/journal.pone.0056003	http://dx.doi.org/10.1371/journal.pone.0056003			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092DU	23409112	gold, Green Published, Green Submitted			2022-12-27	WOS:000315100000038
J	Lee, EH; Lee, EJ; Kim, HJ; Jang, AS; Koh, ES; Uh, ST; Kim, YH; Park, SW; Park, CS				Lee, Eun Hee; Lee, Eun-ju; Kim, Hee Jeong; Jang, An Soo; Koh, Eun Suk; Uh, Soo-taek; Kim, Yong Hoon; Park, Sung-woo; Park, Choon-sik			Overexpression of Apolipoprotein A1 in the Lung Abrogates Fibrosis in Experimental Silicosis	PLOS ONE			English	Article							PULMONARY-FIBROSIS; LIPOXIN A(4); APOPTOTIC NEUTROPHILS; INFLAMMATION; BLEOMYCIN; MICE; RESOLUTION; PEPTIDES; ANALOGS; PHAGOCYTOSIS	The inhalation of silica particles induces silicosis, an inflammatory and fibrotic lung disease characterized by the early accumulation of macrophages and neutrophils in the airspace and subsequent appearance of silicotic nodules as a result of progressive fibrosis. This study evaluated whether apolipoprotein A1 (ApoA1) protects against ongoing fibrosis and promotes the resolution of established experimental lung silicosis. Crystallized silica was intratracheally administered to 6- to 8-week-old transgenic mice expressing human ApoA1 in their alveolar epithelial cells (day 0). ApoA1 was overexpressed beginning on day 7 (ApoA1_D7 group) or day 15 (ApoA1_D15 group). The mice were sacrificed on day 30 for an evaluation of lung histology; the measurement of collagen, transforming growth factor-b1 and lipoxin A4; and a TUNEL assay for apoptotic cells. The ApoA1_D7 and D15 groups showed significant reductions in the silica-induced increase in inflammatory cells, silicotic nodule area, and collagen deposition compared with the silica-treated ApoA1 non-overexpressing mice. The level of transforming growth factor-b1 decreased in the bronchoalveolar lavage fluid, whereas lipoxin A4 was increased in the ApoA1_D7 and D15 groups compared with the silica-treated ApoA1 non-overexpressing mice. The silica-induced increase in the number of apoptotic cells was significantly reduced in the lungs of mice overexpressing ApoA1. Overexpression of ApoA1 decreased silica-induced lung inflammation and fibrotic nodule formation. The restoration of lipoxin A4 may contribute to the protective effect of ApoA1 overexpression against silica-induced lung fibrosis.	[Lee, Eun Hee; Lee, Eun-ju; Kim, Hee Jeong; Jang, An Soo; Park, Sung-woo; Park, Choon-sik] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Div Allergy & Resp Med, Puchon, Gyeonggi Do, South Korea; [Koh, Eun Suk] Soonchunhyang Univ, Bucheon Hosp, Dept Pathol, Puchon, Gyeonggi Do, South Korea; [Uh, Soo-taek] Soonchunhyang Univ, Seoul Hosp, Div Allergy & Resp Med, Seoul, South Korea; [Kim, Yong Hoon] Soonchunhyang Univ, Cheonan Hosp, Div Allergy & Resp Med, Cheonan, Chungcheongnam, South Korea	Soonchunhyang University; Soonchunhyang University; Soonchunhyang University; Soonchunhyang University	Park, SW (corresponding author), Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Div Allergy & Resp Med, Puchon, Gyeonggi Do, South Korea.	swpark@schmc.ac.kr		Park, Choon-Sik/0000-0003-2977-0255	Korea Health 21 R&D Project Ministry of Health & Welfare Republic of Korea [A090548]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0010584]	Korea Health 21 R&D Project Ministry of Health & Welfare Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant of the Korea Health 21 R&D Project Ministry of Health & Welfare Republic of Korea [Grant A090548]. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology [Grant 2010-0010584]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett EG, 1999, TOXICOL APPL PHARM, V161, P111, DOI 10.1006/taap.1999.8793; Blake TL, 1996, EXP LUNG RES, V22, P113, DOI 10.3109/01902149609074021; Borgeson E, 2011, FASEB J, V25, P2967, DOI 10.1096/fj.11-185017; Bonnans C, 2004, ALLERGY, V59, P1027, DOI 10.1111/j.1398-9995.2004.00617.x; Borges VM, 2001, J EXP MED, V194, P155, DOI 10.1084/jem.194.2.155; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Faffe DS, 2001, J APPL PHYSIOL, V90, P1400, DOI 10.1152/jappl.2001.90.4.1400; Fujita M, 2006, ANTIMICROB AGENTS CH, V50, P739, DOI 10.1128/AAC.50.2.739-743.2006; Gewirtz AT, 1998, J CLIN INVEST, V101, P1860, DOI 10.1172/JCI1339; Gharaee-Kermani M, 2005, AM J PATHOL, V166, P1593, DOI 10.1016/S0002-9440(10)62470-4; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Hachicha M, 1999, J EXP MED, V189, P1923, DOI 10.1084/jem.189.12.1923; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Hnizdo E, 2003, OCCUP ENVIRON MED, V60, P237, DOI 10.1136/oem.60.4.237; Huaux F, 1998, AM J RESP CELL MOL, V18, P51, DOI 10.1165/ajrcmb.18.1.2911; Iyer R, 1996, TOXICOL APPL PHARM, V141, P84, DOI 10.1006/taap.1996.0263; Jagirdar J, 1996, AM J RESP CRIT CARE, V154, P1076, DOI 10.1164/ajrccm.154.4.8887610; Kim TH, 2010, AM J RESP CRIT CARE, V182, P633, DOI 10.1164/rccm.200905-0659OC; Kuwano K, 1999, J CLIN INVEST, V104, P13, DOI 10.1172/JCI5628; Lardot CG, 1998, AM J RESP CRIT CARE, V157, P617, DOI 10.1164/ajrccm.157.2.9707052; Lassance RM, 2009, RESP PHYSIOL NEUROBI, V169, P227, DOI 10.1016/j.resp.2009.09.004; Lawson WE, 2005, AM J PATHOL, V167, P1267, DOI 10.1016/S0002-9440(10)61214-X; Levy BD, 2005, PROSTAG LEUKOTR ESS, V73, P231, DOI 10.1016/j.plefa.2005.05.010; Lo Re S, 2010, J IMMUNOL, V184, P6367, DOI 10.4049/jimmunol.0900459; Maron-Gutierrez T, 2011, EUR RESP J; Mitchell S, 2002, J AM SOC NEPHROL, V13, P2497, DOI 10.1097/01.ASN.0000032417.73640.72; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; Nandedkar SD, 2011, J LIPID RES, V52, P499, DOI 10.1194/jlr.M012724; Navab M, 2005, CIRC RES, V97, P524, DOI 10.1161/01.RES.0000181229.69508.2f; Ortiz LA, 2001, AM J RESP CRIT CARE, V163, P244, DOI 10.1164/ajrccm.163.1.2002123; Papayianni A, 1996, J IMMUNOL, V156, P2264; Park SW, 2009, AM J RESP CRIT CARE, V180, P603, DOI 10.1164/rccm.200811-1768OC; Park SW LE, 2011, INT C AM THOR SOC AT; PHAN SH, 1983, CHEST, V83, pS44; Reddy ST, 2006, EXPERT OPIN INV DRUG, V15, P13, DOI 10.1517/13543784.15.1.13; Sato T, 2008, J IMMUNOL, V180, P7648, DOI 10.4049/jimmunol.180.11.7648; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Tsuchiya Kimitake, 2007, Journal of Medical and Dental Sciences, V54, P9; Van Lenten BJ, 2008, CURR OPIN INVEST DR, V9, P1157; Wang LY, 2005, AM J PHYSIOL-LUNG C, V288, pL488, DOI 10.1152/ajplung.00123.2003; Weibel ER, 1990, MODELS LUNG DIS MICR, V47, P199	41	24	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55827	10.1371/journal.pone.0055827	http://dx.doi.org/10.1371/journal.pone.0055827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409054	gold, Green Submitted, Green Published			2022-12-27	WOS:000314660300036
J	Pereira, F; Moreira, C; Fonseca, L; van Asch, B; Mota, M; Abrantes, I; Amorim, A				Pereira, Filipe; Moreira, Claudia; Fonseca, Luis; van Asch, Barbara; Mota, Manuel; Abrantes, Isabel; Amorim, Antonio			New Insights into the Phylogeny and Worldwide Dispersion of Two Closely Related Nematode Species, Bursaphelenchus xylophilus and Bursaphelenchus mucronatus	PLOS ONE			English	Article							PINE WILT DISEASE; B-MUCRONATUS; DNA; PORTUGAL; STEINER; WOOD; APHELENCHOIDIDAE; ALGORITHM; INFERENCE; MRBAYES	The pinewood nematode, Bursaphelenchus xylophilus, is one of the greatest threats to coniferous forests worldwide, causing severe ecological damage and economic loss. The biology of B. xylophilus is similar to that of its closest relative, B. mucronatus, as both species share food resources and insect vectors, and have very similar morphological characteristics, although little pathogenicity to conifers has been associated with B. mucronatus. Using both nuclear and mitochondrial DNA markers, we show that B. xylophilus and B. mucronatus form distinct phylogenetic groups with contrasting phylogeographic patterns. B. xylophilus presents lower levels of intraspecific diversity than B. mucronatus, as expected for a species that evolved relatively recently through geographical or reproductive isolation. Genetic diversity was particularly low in recently colonised areas, such as in southwestern Europe. By contrast, B. mucronatus displays high levels of genetic diversity and two well-differentiated clades in both mitochondrial and nuclear DNA phylogenies. The lack of correlation between genetic and geographic distances in B. mucronatus suggests intense gene flow among distant regions, a phenomenon that may have remained unnoticed due to the reduced pathogenicity of the species. Overall, our findings suggest that B. xylophilus and B. mucronatus have different demographic histories despite their morphological resemblance and ecological overlap. These results suggest that Bursaphelenchus species are a valuable model for understanding the dispersion of invasive species and the risks posed to native biodiversity and ecosystems.	[Pereira, Filipe; Moreira, Claudia; van Asch, Barbara; Amorim, Antonio] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Fonseca, Luis; Abrantes, Isabel] Univ Coimbra, Dept Life Sci, IMAR CMA, Coimbra, Portugal; [Mota, Manuel] Univ Evora, ICAAM, Nucleo Mitra, Evora, Portugal; [Amorim, Antonio] Univ Porto, Fac Sci, P-4100 Oporto, Portugal	Universidade do Porto; Universidade de Coimbra; University of Evora; Universidade do Porto	Pereira, F (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.	fpereirapt@gmail.com	van Asch, Barbara/AAW-5154-2021; van Asch, Barbara/J-3622-2013; Abrantes, Isabel/CAG-1426-2022; Amorim, Antonio/A-7938-2008; Pereira, Filipe/F-6391-2010; van Asch, Barbara/HDN-5674-2022; Mota, Manuel/G-6031-2019	van Asch, Barbara/0000-0002-0171-879X; van Asch, Barbara/0000-0002-0171-879X; Abrantes, Isabel/0000-0002-8761-2151; Amorim, Antonio/0000-0002-7518-6247; Pereira, Filipe/0000-0001-8950-1036; van Asch, Barbara/0000-0002-0171-879X; Mota, Manuel/0000-0002-4145-5031; Fonseca, Luis/0000-0001-7405-8916	Portuguese national project 'O nemaode-da-madeira-do-pinheiro (NMP), Bursaphelenchus xylophilus' (Fundo Florestal Permanente); Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/44637/2008, SFRH/BPD/73108/2010]; EC 7th Framework project REPHRAME [KBBE.2010.1.4-09]; FCT	Portuguese national project 'O nemaode-da-madeira-do-pinheiro (NMP), Bursaphelenchus xylophilus' (Fundo Florestal Permanente); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); EC 7th Framework project REPHRAME; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was partially supported by the Portuguese national project 'O nemaode-da-madeira-do-pinheiro (NMP), Bursaphelenchus xylophilus' (Fundo Florestal Permanente) and by research grants to FP (SFRH/BPD/44637/2008) and BA (SFRH/BPD/73108/2010) from the Portuguese Foundation for Science and Technology (FCT). MM was partially supported by the EC 7th Framework project REPHRAME (KBBE.2010.1.4-09, 'Analysis of the potential of the pine wood nematode (Bursaphelenchus xylophilus) to spread, survive and cause pine wilt in European coniferous forests in support of EU plant health policy'). The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelleira A, 2011, PLANT DIS, V95, P776, DOI 10.1094/PDIS-12-10-0902; [Anonymous], 2009, B OEPP EPPO, V31, P61; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beckenbach K, 1999, NEMATOLOGY, V1, P539, DOI 10.1163/156854199508531; BOLLA RI, 1993, J NEMATOL, V25, P227; Braasch H., 2004, Nematologia Mediterranea, V32, P71; Cardoso J, 2011, 4 INT C MED PIN AV F, P180; Cheng XY, 2008, HEREDITY, V100, P356, DOI 10.1038/sj.hdy.6801082; Cheng XY, 2009, BIOL INVASIONS, V11, P205, DOI 10.1007/s10530-008-9225-2; Drummond A, 2009, GENEIOUS V 5 4; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fonseca L, 2012, HELMINTHOLOGIA, V49, P96, DOI 10.2478/s11687-012-0020-3; Fonseca L, 2008, PHYTOPATHOL MEDITERR, V47, P223; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iwahori H, 1998, FUND APPL NEMATOL, V21, P655; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; Jung J, 2010, GENES GENOM, V32, P151, DOI 10.1007/s13258-009-0842-7; Kang JS, 2004, NEMATOLOGY, V6, P279, DOI 10.1163/1568541041217915; Kanzaki N, 2002, NEMATOLOGY, V4, P35, DOI 10.1163/156854102760082186; Kanzaki N, 2006, NEMATOLOGY, V8, P485, DOI 10.1163/156854106778613994; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Li HM, 2009, NEMATOLOGY, V11, P375, DOI 10.1163/156854109X446971; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maehara N, 2011, FOREST PATHOL, V41, P477, DOI 10.1111/j.1439-0329.2010.00707.x; MAMIYA Y, 1979, NEMATOLOGICA, V25, P353, DOI 10.1163/187529279X00091; MARUYAMA T, 1991, GENETICS, V127, P449; Metge K, 2006, J PLANT DIS PROTECT, V113, P275, DOI 10.1007/BF03356193; Mota M, 2008, PINE WILT DIS WORLDI; Mota MM, 2006, J NEMATOL, V38, P429; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Nye TMW, 2006, BIOINFORMATICS, V22, P117, DOI 10.1093/bioinformatics/bti720; Pereira F, 2009, MOL BIOL EVOL, V26, P2765, DOI 10.1093/molbev/msp200; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; RIGA E, 1992, FUND APPL NEMATOL, V15, P391; Robertson L, 2011, NEMATOLOGY, V13, P755, DOI 10.1163/138855411X578888; Robinet C, 2011, BIOL INVASIONS, V13, P2981, DOI 10.1007/s10530-011-9983-0; Robinet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004646; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; RUTHERFORD TA, 1990, FOREST SCI, V36, P145; RUTHERFORD TA, 1992, J NEMATOL, V24, P40; Taga Y, 2011, NEMATOLOGY, V13, P701, DOI 10.1163/138855410X543166; Tamura K, 2002, MOL BIOL EVOL, V19, P1727, DOI 10.1093/oxfordjournals.molbev.a003995; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Togashi K, 2006, POPUL ECOL, V48, P271, DOI 10.1007/s10144-006-0011-7; Tsai YHE, 2011, MOL ECOL RESOUR, V11, P557, DOI 10.1111/j.1755-0998.2010.02964.x; Valadas V, 2012, NEMATOLOGY, V14, P899, DOI 10.1163/156854112X632673; Vieira P, 2007, J NEMATOL, V39, P118; WEBSTER J M, 1990, Revue de Nematologie, V13, P255; WHITEHEAD AG, 1965, ANN APPL BIOL, V55, P25, DOI 10.1111/j.1744-7348.1965.tb07864.x; Ye WM, 2007, MOL PHYLOGENET EVOL, V43, P1185, DOI 10.1016/j.ympev.2007.02.006	55	39	43	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56288	10.1371/journal.pone.0056288	http://dx.doi.org/10.1371/journal.pone.0056288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409167	Green Published, Green Submitted, gold			2022-12-27	WOS:000314660300071
J	Silvestro, D; Andersen, TG; Schaller, H; Jensen, PE				Silvestro, Daniele; Andersen, Tonni Grube; Schaller, Hubert; Jensen, Poul Erik			Plant Sterol Metabolism. Delta(7)-Sterol-C-5-Desaturase (STE1/DWARF7), Delta(5,7)-Sterol-Delta(7)-Reductase (DWARF5) and Delta(24)-Sterol-Delta(24)-Reductase (DIMINUTO/DWARF1) Show Multiple Subcellular Localizations in Arabidopsis thaliana (Heynh) L	PLOS ONE			English	Article							OXIDOSQUALENE CYCLASE ERG7P; ENDOPLASMIC-RETICULUM; LIPID PARTICLES; CELL-CYCLE; YEAST; BIOSYNTHESIS; GENE; IDENTIFICATION; BINDING; CHOLESTEROL	Sterols are crucial lipid components that regulate membrane permeability and fluidity and are the precursors of bioactive steroids. The plant sterols exist as three major forms, free sterols, steryl glycosides and steryl esters. The storage of steryl esters in lipid droplets has been shown to contribute to cellular sterol homeostasis. To further document cellular aspects of sterol biosynthesis in plants, we addressed the question of the subcellular localization of the enzymes implicated in the final steps of the post-squalene biosynthetic pathway. In order to create a clear localization map of steroidogenic enzymes in cells, the coding regions of Delta(7)-sterol-C-5-desaturase (STE1/DWARF7), Delta(24)-sterol-Delta(24)-reductase (DIMINUTO/DWARF1) and Delta(5,7)-sterol-Delta(7)-reductase (DWARF5) were fused to the yellow fluorescent protein (YFP) and transformed into Arabidopsis thaliana mutant lines deficient in the corresponding enzymes. All fusion proteins were found to localize in the endoplasmic reticulum in functionally complemented plants. The results show that both Delta(5,7)-sterol-Delta(7)-reductase and Delta(24)-sterol-Delta(24)-reductase are in addition localized to the plasma membrane, whereas Delta(7)-sterol-C-5-desaturase was clearly detected in lipid particles. These findings raise new challenging questions about the spatial and dynamic cellular organization of sterol biosynthesis in plants.	[Silvestro, Daniele; Jensen, Poul Erik] Univ Copenhagen, VKR Res Ctr Proact Plants, Villum Kann Rasmussen Fdn, Dept Plant & Environm Sci, Frederiksberg C, Denmark; [Silvestro, Daniele; Jensen, Poul Erik] Univ Copenhagen, Ctr Synthet Biol, Fac Sci, Frederiksberg C, Denmark; [Andersen, Tonni Grube] Univ Copenhagen, Fac Sci, Ctr Dynam Mol Interact DynaMo, Dept Plant & Environm Sci, Frederiksberg C, Denmark; [Schaller, Hubert] Univ Strasbourg, Inst Biol Mol Plantes CNRS, Dept Reseaux Metab Vegetaux, Strasbourg, France	University of Copenhagen; Villum Fonden; University of Copenhagen; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Silvestro, D (corresponding author), Univ Copenhagen, VKR Res Ctr Proact Plants, Villum Kann Rasmussen Fdn, Dept Plant & Environm Sci, Frederiksberg C, Denmark.	dasi@life.ku.dk	Jensen, Poul Erik/A-4862-2014	Jensen, Poul Erik/0000-0001-6524-7723; Schaller, Hubert/0000-0002-4099-4447; Andersen, Tonni/0000-0002-8905-0850	Danish Ministry of Food, Agriculture and Fisheries [3304-FVFP-07-774-01]; Villum Kann Rasmussen Foundation (VKR) research centre "Pro-Active Plants"	Danish Ministry of Food, Agriculture and Fisheries; Villum Kann Rasmussen Foundation (VKR) research centre "Pro-Active Plants"	This research was supported by The Danish Ministry of Food, Agriculture and Fisheries (3304-FVFP-07-774-01) and supported by the Villum Kann Rasmussen Foundation (VKR) research centre "Pro-Active Plants". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ArthingtonSkaggs BA, 1996, FEBS LETT, V392, P161, DOI 10.1016/0014-5793(96)00807-1; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Athenstaedt K, 2011, EUR J LIPID SCI TECH, V113, P1188, DOI 10.1002/ejlt.201100051; Banas A, 2005, J BIOL CHEM, V280, P34626, DOI 10.1074/jbc.M504459200; Beck JG, 2007, FASEB J, V21, P1714, DOI 10.1096/fj.06-7809com; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; Bouvier-Nave P, 2010, PLANT PHYSIOL, V152, P107, DOI 10.1104/pp.109.145672; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Burgers PMJ, 1999, METHODS, V18, P349, DOI 10.1006/meth.1999.0796; Chen Q, 2007, PLANT PHYSIOL, V145, P974, DOI 10.1104/pp.107.106278; Choe S, 2000, PLANT J, V21, P431, DOI 10.1046/j.1365-313x.2000.00693.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DAHL C, 1987, P NATL ACAD SCI USA, V84, P4012, DOI 10.1073/pnas.84.12.4012; DeBolt S, 2009, PLANT PHYSIOL, V151, P78, DOI 10.1104/pp.109.140582; DEMEL RA, 1976, BIOCHIM BIOPHYS ACTA, V457, P109, DOI 10.1016/0304-4157(76)90008-3; Diener AC, 2000, PLANT CELL, V12, P853, DOI 10.1105/tpc.12.6.853; DYAS L, 1993, PHYTOCHEMISTRY, V34, P17, DOI 10.1016/S0031-9422(00)90777-5; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; GACHOTTE D, 1995, PLANT J, V8, P407, DOI 10.1046/j.1365-313X.1995.08030407.x; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; GONDET L, 1994, PLANT PHYSIOL, V105, P509, DOI 10.1104/pp.105.2.509; Greeve I, 2000, J NEUROSCI, V20, P7345; Griebel T, 2010, PLANT J, V63, P254, DOI 10.1111/j.1365-313X.2010.04235.x; HABENICHT AJR, 1980, J BIOL CHEM, V255, P5134; HAMILTON JA, 1982, J BIOL CHEM, V257, P7318; HARTMANN MA, 2004, LIPID METABOLISM MEM, P57; Holmer L, 1998, GENOMICS, V54, P469, DOI 10.1006/geno.1998.5615; Husselstein T, 1999, PLANT MOL BIOL, V39, P891, DOI 10.1023/A:1006113919172; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Klahre U, 1998, PLANT CELL, V10, P1677, DOI 10.1105/tpc.10.10.1677; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; Lecain E, 1996, J BIOL CHEM, V271, P10866, DOI 10.1074/jbc.271.18.10866; Lin LJ, 2002, PLANT PHYSIOL, V128, P1200, DOI 10.1104/pp.010928; Lucas ME, 2003, MOL GENET METAB, V80, P227, DOI 10.1016/S1096-7192(03)00137-9; Men SZ, 2008, NAT CELL BIOL, V10, P237, DOI 10.1038/ncb1686; Milla P, 2002, J BIOL CHEM, V277, P2406, DOI 10.1074/jbc.M104195200; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; Mo C, 2003, BBA-MOL CELL BIOL L, V1633, P68, DOI 10.1016/S1388-1981(03)00088-X; Mongrand S, 2004, J BIOL CHEM, V279, P36277, DOI 10.1074/jbc.M403440200; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Ott RG, 2005, BBA-MOL CELL BIOL L, V1735, P111, DOI 10.1016/j.bbalip.2005.05.003; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pose D, 2009, PLANT J, V59, P63, DOI 10.1111/j.1365-313X.2009.03849.x; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Sambrookand Joseph, 2001, MOL CLONING LAB MANU; SATIATJEUNEMAITRE B, 1992, BIOL CELL, V74, P325, DOI 10.1016/0248-4900(92)90044-2; Schaeffer A, 2001, PLANT J, V25, P605, DOI 10.1046/j.1365-313x.2001.00994.x; Schaller H, 2003, PROG LIPID RES, V42, P163, DOI 10.1016/S0163-7827(02)00047-4; SCHALLER H, 1995, PLANT PHYSIOL, V109, P761, DOI 10.1104/pp.109.3.761; Schaller H, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 1: NATURAL PRODUCTS STRUCTURAL DIVERSITY-I: SECONDARY METABOLITES: ORGANIZATION AND BIOSYNTHESIS, P755; Schrick K, 2000, GENE DEV, V14, P1471; Schrick K, 2011, PHYTOCHEMISTRY, V72, P465, DOI 10.1016/j.phytochem.2011.01.009; Schulz TA, 2007, BBA-MOL CELL BIOL L, V1771, P769, DOI 10.1016/j.bbalip.2007.03.003; Sharma M, 2010, J VIROL, V84, P2270, DOI 10.1128/JVI.02003-09; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Spanova M, 2010, J BIOL CHEM, V285, P6127, DOI 10.1074/jbc.M109.074229; TAKAHASHI T, 1995, GENE DEV, V9, P97, DOI 10.1101/gad.9.1.97; Valitova JN, 2011, PHYTOCHEMISTRY, V72, P1751, DOI 10.1016/j.phytochem.2011.06.004; Vincill ED, 2012, PLANT PHYSIOL, V159, P40, DOI 10.1104/pp.112.197509; Wahlroos T, 2003, GENESIS, V35, P125, DOI 10.1002/gene.10172; Wewer V, 2011, J LIPID RES, V52, P1039, DOI 10.1194/jlr.D013987; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	69	43	43	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56429	10.1371/journal.pone.0056429	http://dx.doi.org/10.1371/journal.pone.0056429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409184	Green Published, Green Submitted, gold			2022-12-27	WOS:000314660300074
J	Cook, TR; Lescroel, A; Cherel, Y; Kato, A; Bost, CA				Cook, Timothee R.; Lescroel, Amelie; Cherel, Yves; Kato, Akiko; Bost, Charles-Andre			Can Foraging Ecology Drive the Evolution of Body Size in a Diving Endotherm?	PLOS ONE			English	Article							SHAG PHALACROCORAX NIVALIS; SOUTH-GEORGIAN SHAGS; REARING CROZET SHAGS; SEXUAL-DIMORPHISM; KING CORMORANTS; DIET; BEHAVIOR; PATTERNS; ALLOMETRY; ISLAND	Within a single animal species, different morphs can allow for differential exploitation of foraging niches between populations, while sexual size dimorphism can provide each sex with access to different resources. Despite being potentially important agents of evolution, resource polymorphisms, and the way they operate in wild populations, remain poorly understood. In this study, we examine how trophic factors can select for different body sizes between populations and sexes in a diving endotherm. Dive depth and duration are positively related to body size in diving birds and mammals, a relationship explained by a lower mass-specific metabolic rate and greater oxygen stores in larger individuals. Based on this allometry, we predict that selection for exploiting resources situated at different depths can drive the evolution of body size in species of diving endotherms at the population and sexual level. To test this prediction, we studied the foraging ecology of Blue-eyed Shags, a group of cormorants with male-biased sexual size dimorphism from across the Southern Ocean. We found that mean body mass and relative difference in body mass between sexes varied by up to 77% and 107% between neighbouring colonies, respectively. Birds from colonies with larger individuals dived deeper than birds from colonies with smaller individuals, when accounting for sex. In parallel, males dived further offshore and deeper than females and the sexual difference in dive depth reflected the level of sexual size dimorphism at each colony. We argue that body size in this group of birds is under intense selection for diving to depths of profitable benthic prey patches and that, locally, sexual niche divergence selection can exaggerate the sexual size dimorphism of Blue-eyed Shags initially set up by sexual selection. Our findings suggest that trophic resources can select for important geographic micro-variability in body size between populations and sexes.	[Cook, Timothee R.] Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, Dept Sci & Technol,Natl Res Fdn, Ctr Excellence, ZA-7700 Rondebosch, South Africa; [Cook, Timothee R.; Lescroel, Amelie; Cherel, Yves; Bost, Charles-Andre] CNRS, Ctr Etud Biol Chize, Unite Propre Rech 1934, Villiers En Bois, France; [Lescroel, Amelie] CNRS, Ctr Ecol Fonct & Evolut, Unite Mixte Rech 5175, F-34033 Montpellier, France; [Kato, Akiko] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Kato, Akiko] CNRS, Unite Mixte Rech 7178, Strasbourg, France; [Kato, Akiko] Natl Inst Polar Res, Itabashi Ku, Tokyo 1738515, Japan	National Research Foundation - South Africa; University of Cape Town; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan	Cook, TR (corresponding author), Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, Dept Sci & Technol,Natl Res Fdn, Ctr Excellence, ZA-7700 Rondebosch, South Africa.	timothee.cook@gmail.com	Kato, Akiko/W-2447-2019	Kato, Akiko/0000-0002-8947-3634; Cook, Timothee/0000-0003-2354-824X	French polar institute (Institut Paul Emile Victor-IPEV) [394]	French polar institute (Institut Paul Emile Victor-IPEV)	This research was funded by program number 394 of the French polar institute (Institut Paul Emile Victor-IPEV, URL: http://www.institut-polaire.fr/), with the logistical help of the Terres Australes et Antarctiques Francaises (TAAF, URL: http://www.taaf.fr/spip/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1997, AM NAT, V149, P540, DOI 10.1086/286004; ANDERSSON M, 1981, BIOL J LINN SOC, V15, P105, DOI 10.1111/j.1095-8312.1981.tb00752.x; Andersson Malte, 1994; Bergmann C., 1847, GOTT STUD, P1595; BERNSTEIN NP, 1984, CONDOR, V86, P151, DOI 10.2307/1367031; Bevan RM, 1997, J EXP BIOL, V200, P661; BIRT VL, 1987, MAR ECOL PROG SER, V40, P205, DOI 10.3354/meps040205; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; BOAG PT, 1981, SCIENCE, V214, P82, DOI 10.1126/science.214.4516.82; BOAG PT, 1983, EVOLUTION, V37, P877, DOI 10.1111/j.1558-5646.1983.tb05618.x; BOST CA, 1992, J ZOOL, V226, P135, DOI 10.1111/j.1469-7998.1992.tb06132.x; Bost CA, 2002, MAR ECOL PROG SER, V227, P51, DOI 10.3354/meps227051; Brischoux F, 2008, J EVOLUTION BIOL, V21, P324, DOI 10.1111/j.1420-9101.2007.01438.x; BROWN CR, 1990, TRENDS ECOL EVOL, V5, P398, DOI 10.1016/0169-5347(90)90023-7; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; BURGER AE, 1978, ZOOL AFR, V13, P81, DOI 10.1080/00445096.1978.11447608; BUTLER PJ, 1982, ADV COMP PHYSIOL BIO, V8, P179; CAMPO JJ, 1993, J FIELD ORNITHOL, V64, P135; Casaux R, 2006, ANTARCT SCI, V18, P3, DOI 10.1017/S0954102006000010; Casaux R, 2001, J FIELD ORNITHOL, V72, P22, DOI 10.1648/0273-8570-72.1.22; Casaux R, 2000, WATERBIRDS, V23, P489, DOI 10.2307/1522188; Childress RB, 2002, J AVIAN BIOL, V33, P23, DOI 10.1034/j.1600-048X.2002.330105.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cook TR, 2008, ANIM BEHAV, V76, P565, DOI 10.1016/j.anbehav.2008.02.010; Cook TR, 2007, ANTARCT SCI, V19, P55, DOI 10.1017/S0954102007000089; Cook TR, 2007, ANIM BEHAV, V74, P649, DOI 10.1016/j.anbehav.2006.11.024; Cook TR, 2012, MAR BIOL, V159, P373, DOI 10.1007/s00227-011-1815-3; Cook TR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009839; Cook TR, 2006, POLAR BIOL, V29, P562, DOI 10.1007/s00300-005-0089-y; COOPER J, 1986, IBIS, V128, P562, DOI 10.1111/j.1474-919X.1986.tb02707.x; Croll DA, 2001, ANIM CONSERV, V4, P13, DOI 10.1017/S1367943001001020; Danchin E, 1997, TRENDS ECOL EVOL, V12, P342, DOI 10.1016/S0169-5347(97)01124-5; Darwin C., 1874, DESCENT MAN SELECTIO; Daunt F, 2003, IBIS, V145, P54, DOI 10.1046/j.1474-919X.2003.00120.x; Duhamel G., 2005, POISSONS ILES KERGUE; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; FAIRBAIRN J, 1993, OIKOS, V68, P139, DOI 10.2307/3545319; Favero M, 1998, CONDOR, V100, P112, DOI 10.2307/1369902; Fonteneau F, 2009, IBIS, V151, P286, DOI 10.1111/j.1474-919X.2009.00909.x; Laich AG, 2012, J ORNITHOL, V153, P139, DOI 10.1007/s10336-011-0714-1; Grant P. R., 1986, ECOLOGY EVOLUTION DA; Green K, 1997, EMU, V97, P76, DOI 10.1071/MU97008; Green K, 1997, EMU, V97, P60, DOI 10.1071/MU97006; Halsey LG, 2006, AM NAT, V167, P276, DOI 10.1086/499439; Kato A, 2006, MAR ECOL PROG SER, V308, P293, DOI 10.3354/meps308293; Kato A, 1999, CR ACAD SCI III-VIE, V322, P557, DOI 10.1016/S0764-4469(00)88525-X; Kato A, 1996, POLAR BIOL, V16, P75, DOI 10.1007/BF02388738; Kato A, 2000, AUK, V117, P718, DOI 10.1642/0004-8038(2000)117[0718:VIFAPB]2.0.CO;2; Kennedy M, 2000, MOL PHYLOGENET EVOL, V17, P345, DOI 10.1006/mpev.2000.0840; KOFFIJBERG K, 1995, ARDEA, V83, P37; Kooyman GL, 1998, ANNU REV PHYSIOL, V60, P19, DOI 10.1146/annurev.physiol.60.1.19; Koubbi P, 1992, THESIS U PIERRE MARI; Lescroel A, 2004, POLAR BIOL, V27, P206, DOI 10.1007/s00300-003-0571-3; Lescroel A, 2005, THESIS U L PASTEUR S; MALACALAZA VE, 1988, COLON WATERBIRD, V11, P32, DOI 10.2307/1521167; Martinez I., 1992, P140; Moe B, 2004, J EXP BIOL, V207, P4067, DOI 10.1242/jeb.01226; Moorhouse Ron J., 1996, Notornis, V43, P19; Mori Y, 2002, J EVOLUTION BIOL, V15, P269, DOI 10.1046/j.1420-9101.2002.00382.x; Nelson JB, 2005, PELICANS CORMORANTS; Orta J., 1992, P326; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Quillfeldt P, 2011, MAR ECOL PROG SER, V428, P271, DOI 10.3354/meps09058; Quintana F, 2011, OIKOS, V120, P350, DOI 10.1111/j.1600-0706.2010.18387.x; Radford AN, 2004, AUK, V121, P178, DOI 10.1642/0004-8038(2004)121[0178:ESDIGW]2.0.CO;2; Randall DJ, 2002, ECKERT ANIMAL PHYSL, V5; Rensch B., 1960, EVOLUTION SPECIES LE; Ropert-Coudert Y, 2009, P ROY SOC B-BIOL SCI, V276, P4105, DOI 10.1098/rspb.2009.1399; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Schew William A., 1998, Oxford Ornithology Series, V8, P288; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schreer JF, 1997, CAN J ZOOL, V75, P339, DOI 10.1139/z97-044; Schreiber Elizabeth, 2002, BIOL MARINE BIRDS, DOI 10.1201/9781420036305; Selander R.K., 1972, SEXUAL SELECTION DES, P180, DOI DOI 10.4324/9781315129266-8; SELANDER RK, 1966, CONDOR, V68, P113, DOI 10.2307/1365712; SHINE R, 1988, AM NAT, V131, P124, DOI 10.1086/284778; SHINE R, 1991, AM NAT, V138, P103, DOI 10.1086/285207; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; SKULASON S, 1995, TRENDS ECOL EVOL, V10, P366, DOI 10.1016/S0169-5347(00)89135-1; SLATKIN M, 1984, EVOLUTION, V38, P622, DOI 10.1111/j.1558-5646.1984.tb00327.x; Szekely T, 2004, P NATL ACAD SCI USA, V101, P12224, DOI 10.1073/pnas.0404503101; Taylor SS, 2002, CAN J ZOOL, V80, P700, DOI 10.1139/Z02-046; Temeles EJ, 2000, SCIENCE, V289, P441, DOI 10.1126/science.289.5478.441; Walton P, 1998, ANIM BEHAV, V56, P165, DOI 10.1006/anbe.1998.0759; WANLESS S, 1995, CONDOR, V97, P550, DOI 10.2307/1369040; Watanabe Y, 2003, MAR ECOL PROG SER, V252, P283, DOI 10.3354/meps252283; Watanuki Y, 1999, CAN J ZOOL, V77, P1838, DOI 10.1139/cjz-77-11-1838; Watanuki Y, 1996, CAN J ZOOL, V74, P1098, DOI 10.1139/z96-122; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Wilson RP, 1991, ACT 20 C INT ORN CHR, P1852; YDENBERG RC, 1989, J THEOR BIOL, V139, P437, DOI 10.1016/S0022-5193(89)80064-5	92	31	31	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56297	10.1371/journal.pone.0056297	http://dx.doi.org/10.1371/journal.pone.0056297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409169	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200129
J	Hesketh, A; Conti-Ramsden, G				Hesketh, Anne; Conti-Ramsden, Gina			Memory and Language in Middle Childhood in Individuals with a History of Specific Language Impairment	PLOS ONE			English	Article							NON-WORD REPETITION; SHORT-TERM-MEMORY; NONWORD REPETITION; WORKING-MEMORY; READING IMPAIRMENT; CHILDREN; SLI; TENSE; LITERACY; MARKERS	This study reports on the sensitivity of sentence repetition as a marker of specific language impairment (SLI) in different subgroups of children in middle childhood and examines the role of memory and grammatical knowledge in the performance of children with and without language difficulties on this task. Eleven year old children, 197 with a history of SLI and 75 typically developing (TD) peers were administered sentence repetition, phonological short term memory (PSTM) and grammatical morphology tasks. Children with a history of SLI were divided into four subgroups: specific language impairment, non-specific language impairment, low cognition with resolved language and resolved. Performance on the sentence repetition task was significantly impaired in all four subgroups of children with a history of SLI when compared to their age peers. Regression analyses revealed grammatical knowledge was predictive of performance for TD children and children with a history of SLI. However, memory abilities were significantly predictive of sentence repetition task performance for children with a history of SLI only. Processes involved in sentence repetition are more taxing of PSTM for individuals with a history of SLI in middle childhood in a way that does not appear to be the case for TD children.	[Hesketh, Anne; Conti-Ramsden, Gina] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England	University of Manchester	Conti-Ramsden, G (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.	gina.conti-ramsden@manchester.ac.uk		Hesketh, Anne/0000-0003-0583-0217	Nuffield Foundation [DIR/28]; Economic and Social Research Council [RES-062-23-2745]; Economic and Social Research Council [ES/I00064X/1] Funding Source: researchfish; ESRC [ES/I00064X/1] Funding Source: UKRI	Nuffield Foundation; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The sources of funding that have supported the work are the Nuffield Foundation(www.nuffieldfoundation.org) grant number DIR/28 and the Economic and Social Research Council (www.esrc.ac.uk) grant number RES-062-23-2745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald LMD, 2006, J SPEECH LANG HEAR R, V49, P970, DOI 10.1044/1092-4388(2006/070); Archibald LMD, 2006, INT J LANG COMM DIS, V41, P675, DOI 10.1080/13682820500442602; Archibald LMD, 2009, J SPEECH LANG HEAR R, V52, P899, DOI 10.1044/1092-4388(2009/08-0099); Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A. D, 1986, WORKING MEMORY; Baird G, 2011, DEV MED CHILD NEUROL, V53, P711, DOI 10.1111/j.1469-8749.2011.03936.x; Bedore LM, 1998, J SPEECH LANG HEAR R, V41, P1185, DOI 10.1044/jslhr.4105.1185; Bishop D. V. M, 1982, TEST RECEPTION GRAMM; Bishop DVM, 2006, CURR DIR PSYCHOL SCI, V15, P217, DOI 10.1111/j.1467-8721.2006.00439.x; Bishop DVM, 2009, CHILD DEV, V80, P593, DOI 10.1111/j.1467-8624.2009.01281.x; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; Botting N, 2005, J CHILD PSYCHOL PSYC, V46, P317, DOI 10.1111/j.1469-7610.2004.00355.x; Botting N, 2001, INT J LANG COMM DIS, V36, P421, DOI 10.1080/13682820110074971; Bowyer-Crane C, 2008, J CHILD PSYCHOL PSYC, V49, P422, DOI 10.1111/j.1469-7610.2007.01849.x; Coady JA, 2008, INT J LANG COMM DIS, V43, P1, DOI 10.1080/13682820601116485; Conti-Ramsden G, 2003, INT J LANG COMM DIS, V38, P251, DOI 10.1080/1368282031000092339; Conti-Ramsden G, 2001, J CHILD PSYCHOL PSYC, V42, P741, DOI 10.1111/1469-7610.00770; Conti-Ramsden G, 1999, INT J LANG COMM DIS, V34, P359; Conti-Ramsden G, 2007, J CHILD PSYCHOL PSYC, V48, P147, DOI 10.1111/j.1469-7610.2006.01703.x; Conti-Ramsden G, 2012, J SPEECH LANG HEAR R, V55, P1716, DOI 10.1044/1092-4388(2012/10-0182); ContiRamsden G, 1997, J SPEECH LANG HEAR R, V40, P765, DOI 10.1044/jslhr.4004.765; Gathercole S. E., 1996, CHILDRENS TEST NONWO; GATHERCOLE SE, 1989, J MEM LANG, V28, P200, DOI 10.1016/0749-596X(89)90044-2; GATHERCOLE SE, 1990, J MEM LANG, V29, P336, DOI 10.1016/0749-596X(90)90004-J; Gathercole SE, 2006, APPL PSYCHOLINGUIST, V27, P513, DOI 10.1017/S0142716406060383; Leonard L.B., 1998, CHILDREN SPECIFIC LA; Leonard LB, 2007, J SPEECH LANG HEAR R, V50, P408, DOI 10.1044/1092-4388(2007/029); Leonard LB, 2004, J SPEECH LANG HEAR R, V47, P1363, DOI 10.1044/1092-4388(2004/102); Lum JAG, 2012, CORTEX, V48, P1138, DOI 10.1016/j.cortex.2011.06.001; Marchman VA, 1999, J SPEECH LANG HEAR R, V42, P206, DOI 10.1044/jslhr.4201.206; Marshall C. M., 2003, ED CHILD PSYCHOL, V20, P7; Melby-Lervag M, 2012, DEV PSYCHOL, DOI [10.1037/a0020228, DOI 10.1037/A0020228]; Miller CA, 2001, J SPEECH LANG HEAR R, V44, P416, DOI 10.1044/1092-4388(2001/034); Miller CA, 2008, INT J LANG COMM DIS, V43, P346, DOI 10.1080/13682820701546813; Newbury DF, 2005, TRENDS COGN SCI, V9, P528, DOI 10.1016/j.tics.2005.09.002; Poll GH, 2010, J SPEECH LANG HEAR R, V53, P414, DOI 10.1044/1092-4388(2009/08-0016); RAVEN JC, 1986, COLOURED PROGR MATRI; Rice ML, 2004, J SPEECH LANG HEAR R, V47, P816, DOI 10.1044/1092-4388(2004/061); RICE ML, 1995, J SPEECH HEAR RES, V38, P850, DOI 10.1044/jshr.3804.850; Rice ML, 1996, J SPEECH HEAR RES, V39, P1239, DOI 10.1044/jshr.3906.1239; Rice ML, 1998, J SPEECH HEAR RES, V47, P816; Riches NG, 2010, INT J LANG COMM DIS, V45, P47, DOI 10.3109/13682820802647676; Riches NG, 2012, INT J LANG COMM DIS, V47, P499, DOI 10.1111/j.1460-6984.2012.00158.x; Rispens J, 2012, J SPEECH LANG HEAR R, V55, P683, DOI 10.1044/1092-4388(2011/10-0263); Semel E., 1994, CLIN EVALUATION LANG; Tallal P, 2004, NAT REV NEUROSCI, V5, P721, DOI 10.1038/nrn1499; van der Lely HKJ, 2003, LANGUAGE, V79, P153, DOI 10.1353/lan.2003.0089; Wechsler D., 1992, WECHSLER INTELLIGENC; Weismer SE, 2000, J SPEECH LANG HEAR R, V43, P865, DOI 10.1044/jslhr.4304.865	49	28	28	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56314	10.1371/journal.pone.0056314	http://dx.doi.org/10.1371/journal.pone.0056314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092XV	23409172	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200132
J	Roche, S; El Garch, H; Brunet, S; Poulet, H; Iwaz, J; Ecochard, R; Vanhems, P				Roche, Sylvain; El Garch, Hanane; Brunet, Sylvie; Poulet, Herve; Iwaz, Jean; Ecochard, Rene; Vanhems, Philippe			Diversity of Trends of Viremia and T-Cell Markers in Experimental Acute Feline Immunodeficiency Virus Infection	PLOS ONE			English	Article							HIV-1 DISEASE PROGRESSION; VIRAL LOAD; DEVELOPMENTAL TRAJECTORIES; IMMUNE ACTIVATION; DOSE-RESPONSE; CATS; TRANSMISSION; MODEL; FIV; RNA	Objective: The early events of human immunodeficiency virus infection seem critical for progression toward disease and antiretroviral therapy initiation. We wanted to clarify some still unknown prognostic relationships between inoculum size and changes in various immunological and virological markers. Feline immunodeficiency virus infection could be a helpful model. Methods: Viremia and T-cell markers (number of CD4, CD8, CD8 beta(low)CD62L(neg) T-cells, CD4/CD8 ratio, and percentage of CD8 beta(low)CD62L(neg) cells among CD8 T-cells) were measured over 12 weeks in 102 cats infected with different feline immunodeficiency virus strains and doses. Viremia and T-cell markers trajectory groups were determined and the dose-response relationships between inoculum titres and trajectory groups investigated. Results: Cats given the same inoculum showed different patterns of changes in viremia and T-cell markers. A statistically significant positive dose-response relationship was observed between inoculum titre and i) viremia trajectory-groups (r = 0.80, p<0.01), ii) CD8 beta(low)CD62L(neg) cell-fraction trajectory-groups (r = 0.56, p<0.01). Significant correlations were also found between viremia and the CD4/CD8 ratio and between seven out of ten T-cell markers. Conclusions: In cats, the infectious dose determines early kinetics of viremia and initial CD8+ T-cell activation. An expansion of the CD8 beta(low)CD62L(neg) T-cells might be an early predictor of progression toward disease. The same might be expected in humans but needs confirmation.	[Roche, Sylvain; Iwaz, Jean; Ecochard, Rene] Hosp Civils Lyon, Serv Biostat, Lyon, France; [Roche, Sylvain; Iwaz, Jean; Ecochard, Rene; Vanhems, Philippe] Univ Lyon, Lyon, France; [Roche, Sylvain; Iwaz, Jean; Ecochard, Rene; Vanhems, Philippe] Univ Lyon 1, F-69622 Villeurbanne, France; [Roche, Sylvain; Iwaz, Jean; Ecochard, Rene] Ctr Natl Rech Sci, Unite Mixte Rech 5558, Equipe Biotat Sante, Villeurbanne, France; [El Garch, Hanane; Brunet, Sylvie; Poulet, Herve] Merial SAS, Discovery Res, Lyon, France; [Vanhems, Philippe] Hosp Civils Lyon, Serv Hyg Epidemiol & Prevent, Lyon, France; [Vanhems, Philippe] Ctr Natl Rech Sci, Unite Mixte Rech 5558, Equipe Epidemiol & Sante Publ, Villeurbanne, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Merial SASU; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup	Roche, S (corresponding author), Hosp Civils Lyon, Serv Biostat, Lyon, France.	sylvain.roche02@chu-lyon.fr			Merial; Direction Generale de la Competitivite de l'Industrie et des Services; Le Grand Lyon; Conseil General de l'Isere; Conseil General du Rhone; Lyon Biopole	Merial; Direction Generale de la Competitivite de l'Industrie et des Services; Le Grand Lyon(Region Auvergne-Rhone-Alpes); Conseil General de l'Isere(Region Auvergne-Rhone-Alpes); Conseil General du Rhone(Region Auvergne-Rhone-Alpes); Lyon Biopole	This study was financially supported by Merial (fr.merial.com), the Direction Generale de la Competitivite de l'Industrie et des Services, Le Grand Lyon, the Conseil General de l'Isere, and the Conseil General du Rhone. The financial coordination was handled by Lyon Biopole (www.lyonbiopole.org), as the FIV-Vax project. Researchers of Merial were responsible for the study design and data collection. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2002, J IMMUNOL, V168, P3660, DOI 10.4049/jimmunol.168.7.3660; Asabe S, 2009, J VIROL, V83, P9652, DOI 10.1128/JVI.00867-09; Bajaria SH, 2002, J ACQ IMMUN DEF SYND, V30, P41, DOI 10.1097/00042560-200205010-00006; Buchacz K, 2004, JAIDS-J ACQ IMM DEF, V36, P853, DOI 10.1097/00126334-200407010-00013; Burkhard MJ, 2003, CURR HIV RES, V1, P15, DOI 10.2174/1570162033352101; Davenport MP, 2006, JAIDS-J ACQ IMM DEF, V41, P259, DOI 10.1097/01.qai.0000199232.31340.d3; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Elder JH, 2010, CURR HIV RES, V8, P73, DOI 10.2174/157016210790416389; Ganesan A, 2010, J INFECT DIS, V201, P272, DOI 10.1086/649430; Gebhard DH, 1999, J INFECT DIS, V180, P1503, DOI 10.1086/315089; Geskus RB, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-65; Hecht FM, 2010, AIDS, V24, P941, DOI 10.1097/QAD.0b013e328337b12e; Ho DD, 1996, SCIENCE, V272, P1124, DOI 10.1126/science.272.5265.1124; Hokanson RM, 2000, VET MICROBIOL, V76, P311, DOI 10.1016/S0378-1135(00)00263-7; Hosie MJ, 2007, AUST VET J, V85, P5, DOI 10.1111/j.1751-0813.2006.00071.x; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kassutto S, 2004, CLIN INFECT DIS, V38, P1452, DOI 10.1086/420745; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Nagin DS, 2005, CRIMINOLOGY, V43, P873, DOI 10.1111/j.1745-9125.2005.00026.x; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Paillot R, 2005, VET IMMUNOL IMMUNOP, V106, P1, DOI 10.1016/j.vetimm.2004.12.023; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Pilcher CD, 2004, J CLIN INVEST, V113, P937, DOI [10.1172/JCI200421540, 10.1172/JCI21540]; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Regoes RR, 2005, PLOS MED, V2, P798, DOI 10.1371/journal.pmed.0020249; Rychert J, 2010, AIDS RES HUM RETROV, V26, P1139, DOI 10.1089/aid.2009.0290; Schacker TW, 1998, ANN INTERN MED, V128, P613, DOI 10.7326/0003-4819-128-8-199804150-00001; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sparger E, 2006, INFECT AGENTS PATHOG, P189; Sprague WS, 2010, VET IMMUNOL IMMUNOP, V134, P115, DOI 10.1016/j.vetimm.2009.10.016; Thiebaut R, 2002, COMPUT METH PROG BIO, V69, P249, DOI 10.1016/S0169-2607(02)00017-2; Tompkins MB, 2008, VET IMMUNOL IMMUNOP, V123, P45, DOI 10.1016/j.vetimm.2008.01.011; TOMPKINS MB, 1991, J AM VET MED ASSOC, V199, P1311; Vanhems P, 1998, CLIN INFECT DIS, V26, P323, DOI 10.1086/516289; Vanhems P, 2000, J INFECT DIS, V182, P334, DOI 10.1086/315687; WILLETT BJ, 1993, IMMUNOLOGY, V78, P1	37	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56135	10.1371/journal.pone.0056135	http://dx.doi.org/10.1371/journal.pone.0056135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409138	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200112
J	Goulart, CP; Mahmudi, M; Crona, KA; Jacobs, SD; Kallmann, M; Hall, BG; Greene, DC; Barlow, M				Goulart, Christiane P.; Mahmudi, Mentar; Crona, Kristina A.; Jacobs, Stephen D.; Kallmann, Marcelo; Hall, Barry G.; Greene, Devin C.; Barlow, Miriam			Designing Antibiotic Cycling Strategies by Determining and Understanding Local Adaptive Landscapes	PLOS ONE			English	Article							ANTIMICROBIAL SURVEILLANCE PROGRAM; BETA-LACTAMASE; EUROPEAN SURVEILLANCE; CONSUMPTION ESAC; ESCHERICHIA-COLI; PACIFIC REGION; LATIN-AMERICA; SOUTH-AFRICA; RESISTANCE; EVOLUTION	The evolution of antibiotic resistance among bacteria threatens our continued ability to treat infectious diseases. The need for sustainable strategies to cure bacterial infections has never been greater. So far, all attempts to restore susceptibility after resistance has arisen have been unsuccessful, including restrictions on prescribing [1] and antibiotic cycling [2,3]. Part of the problem may be that those efforts have implemented different classes of unrelated antibiotics, and relied on removal of resistance by random loss of resistance genes from bacterial populations (drift). Here, we show that alternating structurally similar antibiotics can restore susceptibility to antibiotics after resistance has evolved. We found that the resistance phenotypes conferred by variant alleles of the resistance gene encoding the TEM beta-lactamase (bla(TEM)) varied greatly among 15 different beta-lactam antibiotics. We captured those differences by characterizing complete adaptive landscapes for the resistance alleles bla(TEM-50) and bla(TEM-85), each of which differs from its ancestor bla(TEM-1) by four mutations. We identified pathways through those landscapes where selection for increased resistance moved in a repeating cycle among a limited set of alleles as antibiotics were alternated. Our results showed that susceptibility to antibiotics can be sustainably renewed by cycling structurally similar antibiotics. We anticipate that these results may provide a conceptual framework for managing antibiotic resistance. This approach may also guide sustainable cycling of the drugs used to treat malaria and HIV.	[Goulart, Christiane P.; Crona, Kristina A.; Jacobs, Stephen D.; Greene, Devin C.; Barlow, Miriam] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Mahmudi, Mentar; Kallmann, Marcelo] Univ Calif Merced, Sch Engn, Merced, CA USA; [Hall, Barry G.] Bellingham Res Inst, Bellingham, WA USA	University of California System; University of California Merced; University of California System; University of California Merced	Barlow, M (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA USA.	miriam.barlow@gmail.com			NIH [1R15GM090164-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM090164] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH Grant 1R15GM090164-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 2011, FEMS MICROBIOL REV, V35, P901, DOI 10.1111/j.1574-6976.2011.00289.x; Baraniak A, 2005, ANTIMICROB AGENTS CH, V49, P1872, DOI 10.1128/AAC.49.5.1872-1880.2005; Barlow M, 2002, GENETICS, V160, P823; Beardmore RE, 2010, MATH BIOSCI ENG, V7, P923, DOI 10.3934/mbe.2010.7.923; Beardmore RE, 2010, MATH BIOSCI ENG, V7, P527, DOI 10.3934/mbe.2010.7.527; Beerenwinkel N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-60; Bell JM, 2007, J CLIN MICROBIOL, V45, P1478, DOI 10.1128/JCM.02470-06; Bell JM, 2002, INT J ANTIMICROB AG, V19, P125, DOI 10.1016/S0924-8579(01)00475-7; Bell JM, 2002, DIAGN MICR INFEC DIS, V42, P193, DOI 10.1016/S0732-8893(01)00353-4; Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Brown EM, 2005, J ANTIMICROB CHEMOTH, V55, P6, DOI 10.1093/jac/dkh482; Carneiro M, 2010, P NATL ACAD SCI USA, V107, P1747, DOI 10.1073/pnas.0906192106; Coenen S, 2006, J ANTIMICROB CHEMOTH, V58, P413, DOI 10.1093/jac/dkl185; Crona K, 2012, J THEORETICAL BIOL C, V317C, P1; Crona K, 2013, J THEOR BIOL, V317, P1, DOI 10.1016/j.jtbi.2012.09.028; de Visser JAGM, 2009, AM NAT, V174, pS15, DOI 10.1086/599081; DEAN AM, 1988, MOL BIOL EVOL, V5, P469; DEAN AM, 1995, GENETICS, V139, P19; DEAN AM, 1989, GENETICS, V123, P441; DEAN AM, 1986, GENET RES, V48, P1, DOI 10.1017/S0016672300024587; Dean CR, 2003, ANTIMICROB AGENTS CH, V47, P972, DOI 10.1128/AAC.47.3.972-978.2003; DEAN JLE, 1994, BIOCHEM J, V301, P13, DOI 10.1042/bj3010013; Dykhuizen DE, 2004, GENETICS, V167, P2015, DOI 10.1534/genetics.103.025205; DYKHUIZEN DE, 1987, GENETICS, V115, P25; DYKHUIZEN DE, 1994, EVOL ECOL, V8, P524, DOI 10.1007/BF01238256; Fedler KA, 2006, DIAGN MICR INFEC DIS, V56, P427, DOI 10.1016/j.diagmicrobio.2006.07.003; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P408, DOI 10.1093/jac/dkl186; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P401, DOI 10.1093/jac/dkl188; Ferech M, 2006, J ANTIMICROB CHEMOTH, V58, P423, DOI 10.1093/jac/dkl183; Franke J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002134; Fridkin SK, 1999, CLIN INFECT DIS, V29, P245, DOI 10.1086/520193; GILLESPIE JH, 1978, THEOR POPUL BIOL, V14, P1, DOI 10.1016/0040-5809(78)90002-3; HARTL DL, 1985, GENETICS, V111, P655; Institute CaLS, 2008, PERF STAND ANT SUSC; KIMURA M, 1971, NATURE, V229, P467, DOI 10.1038/229467a0; KIMURA M, 1969, GENETICS, V61, P763; KIMURA M, 1962, GENETICS, V47, P713; Kimura M., 1983, NEUTRAL THEORY MOL E; Kimura M., 1983, EVOLUTION GENES PROT; Livermore DM, 2005, LANCET INFECT DIS, V5, P450, DOI 10.1016/S1473-3099(05)70166-3; Livermore DM, 1996, SCAND J INFECT DIS, P33; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; Medeiros AA, 1997, CLIN INFECT DIS, V24, pS19, DOI 10.1093/clinids/24.Supplement_1.S19; Mendes RE, 2004, ANTIMICROB AGENTS CH, V48, P1433, DOI 10.1128/AAC.48.4.1433-1434.2004; Moet GJ, 2007, DIAGN MICR INFEC DIS, V57, P7, DOI 10.1016/j.diagmicrobio.2006.05.009; Mroczkowska JE, 2008, ANTIMICROB AGENTS CH; Mroczkowska JE, 2008, ANTIMICROB AGENTS CH, V52, P3408, DOI 10.1128/AAC.00501-08; Perron GG, 2012, P ROY SOC B-BIOL SCI, V279, P1477, DOI 10.1098/rspb.2011.1933; Sarraf-Yazdi S, 2012, J SURG RES, V176, pE73, DOI 10.1016/j.jss.2011.12.014; Shahid M, 2009, CRIT REV MICROBIOL, V35, P81, DOI 10.1080/10408410902733979; Sirot D, 1997, ANTIMICROB AGENTS CH, V41, P1322, DOI 10.1128/AAC.41.6.1322; Solomon S, 2003, AM J INFECT CONTROL, V31, P481; Steward CD, 2000, DIAGN MICR INFEC DIS, V38, P59, DOI 10.1016/S0732-8893(00)00161-9; Tenover FC, 2003, J CLIN MICROBIOL, V41, P3142, DOI 10.1128/JCM.41.7.3142-3146.2003; Walsh TR, 2003, J ANTIMICROB CHEMOTH, V52, P116, DOI 10.1093/jac/dkg299; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539	56	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56040	10.1371/journal.pone.0056040	http://dx.doi.org/10.1371/journal.pone.0056040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418506	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300098
J	Landey, RB; Cenci, A; Georget, F; Bertrand, B; Camayo, G; Dechamp, E; Herrera, JC; Santoni, S; Lashermes, P; Simpson, J; Etienne, H				Landey, Roberto Bobadilla; Cenci, Alberto; Georget, Frederic; Bertrand, Benoit; Camayo, Gloria; Dechamp, Eveline; Carlos Herrera, Juan; Santoni, Sylvain; Lashermes, Philippe; Simpson, June; Etienne, Herve			High Genetic and Epigenetic Stability in Coffea arabica Plants Derived from Embryogenic Suspensions and Secondary Embryogenesis as Revealed by AFLP, MSAP and the Phenotypic Variation Rate	PLOS ONE			English	Article							CULTURE-INDUCED VARIATION; NUCLEAR-DNA CONTENT; TISSUE-CULTURE; SOMACLONAL VARIATION; SOMATIC EMBRYOGENESIS; CALLUS INDUCTION; CHROMOSOMAL VARIATIONS; TRANSPOSABLE ELEMENTS; METHYLATION PATTERNS; CELL-CULTURES	Embryogenic suspensions that involve extensive cell division are risky in respect to genome and epigenome instability. Elevated frequencies of somaclonal variation in embryogenic suspension-derived plants were reported in many species, including coffee. This problem could be overcome by using culture conditions that allow moderate cell proliferation. In view of true-to-type large-scale propagation of C. arabica hybrids, suspension protocols based on low 2,4-D concentrations and short proliferation periods were developed. As mechanisms leading to somaclonal variation are often complex, the phenotypic, genetic and epigenetic changes were jointly assessed so as to accurately evaluate the conformity of suspension-derived plants. The effects of embryogenic suspensions and secondary embryogenesis, used as proliferation systems, on the genetic conformity of somatic embryogenesis-derived plants (emblings) were assessed in two hybrids. When applied over a 6 month period, both systems ensured very low somaclonal variation rates, as observed through massive phenotypic observations in field plots (0.74% from 200 000 plant). Molecular AFLP and MSAP analyses performed on 145 three year-old emblings showed that polymorphism between mother plants and emblings was extremely low, i.e. ranges of 0-0.003% and 0.07-0.18% respectively, with no significant difference between the proliferation systems for the two hybrids. No embling was found to cumulate more than three methylation polymorphisms. No relation was established between the variant phenotype (27 variants studied) and a particular MSAP pattern. Chromosome counting showed that 7 of the 11 variant emblings analyzed were characterized by the loss of 1-3 chromosomes. This work showed that both embryogenic suspensions and secondary embryogenesis are reliable for true-to-type propagation of elite material. Molecular analyses revealed that genetic and epigenetic alterations are particularly limited during coffee somatic embryogenesis. The main change in most of the rare phenotypic variants was aneuploidy, indicating that mitotic aberrations play a major role in somaclonal variation in coffee.	[Landey, Roberto Bobadilla; Georget, Frederic; Bertrand, Benoit; Dechamp, Eveline; Etienne, Herve] Ctr Cooperat Int Rech Agron Dev, Unite Mixte Rech Resistance Plantes Bioagresseurs, Montpellier, France; [Cenci, Alberto; Lashermes, Philippe] Inst Rech Dev, Unite Mixte Rech Resistance Plantes Bioagresseurs, Montpellier, France; [Camayo, Gloria; Carlos Herrera, Juan] Ctr Nacl Invest Cafe, Manizales, Colombia; [Santoni, Sylvain] INRA, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France; [Simpson, June] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Plant Genet Engn, Guanajuato, Mexico	CIRAD; Institut de Recherche pour le Developpement (IRD); INRAE; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Etienne, H (corresponding author), Ctr Cooperat Int Rech Agron Dev, Unite Mixte Rech Resistance Plantes Bioagresseurs, Montpellier, France.	herve.etienne@cirad.fr	Simpson, June/I-1057-2012; Cenci, Alberto/H-2823-2019; Lashermes, Philippe/J-5295-2016	Simpson, June/0000-0002-1891-4914; Cenci, Alberto/0000-0002-4390-5948; Etienne, Herve/0000-0002-6208-9982; Bobadilla Landey, Roberto/0000-0002-6372-5354	Mexican Government through Consejo Nacional de Ciencia y Tecnologia (CONACyT) program [CVU:1623391]; PCP France-Mexico; CIRAD funds	Mexican Government through Consejo Nacional de Ciencia y Tecnologia (CONACyT) program; PCP France-Mexico; CIRAD funds	Financial support for this study was provided by the Mexican Government through a grant to Roberto Bobadilla Landey by the Consejo Nacional de Ciencia y Tecnologia (CONACyT) (CVU:1623391) program (http://www.conacyt.mx/), by another grant from the PCP France-Mexico (http://www.pcp-mexique.com/) and by the CIRAD funds for doctoral support (http://www.cirad.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula A, 2000, PLANT CELL REP, V19, P1140, DOI 10.1007/s002990000239; Al-Zahim MA, 1999, PLANT CELL REP, V18, P473, DOI 10.1007/s002990050606; Anthony F, 2001, EUPHYTICA, V118, P53, DOI 10.1023/A:1004013815166; Bairu MW, 2011, PLANT GROWTH REGUL, V63, P147, DOI 10.1007/s10725-010-9554-x; Baranek M, 2010, PLANT CELL TISS ORG, V101, P11, DOI 10.1007/s11240-009-9656-1; Bednarek PT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-10; Bertrand B, 2011, EUPHYTICA, V181, P147, DOI 10.1007/s10681-011-0372-7; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Bukowska B, 2006, POL J ENVIRON STUD, V15, P365; Cenci A, 2012, PLANT MOL BIOL, V78, P135, DOI 10.1007/s11103-011-9852-3; de la Puente R, 2008, IN VITRO CELL DEV-PL, V44, P419, DOI 10.1007/s11627-008-9152-z; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Diaz-Martinez M, 2012, PLANT SCI, V185, P321, DOI 10.1016/j.plantsci.2012.01.004; Ducos JP, 2003, EUPHYTICA, V131, P215, DOI 10.1023/A:1023915613158; Duncan RR, 1997, ADV AGRON, V58, P201; Etienne H., 2005, V77, P167; Etienne H, 2003, TREE PHYSIOL, V23, P419, DOI 10.1093/treephys/23.6.419; Etienne H, 2001, TREE PHYSIOL, V21, P1031, DOI 10.1093/treephys/21.14.1031; Etienne Hervé, 2006, Braz. J. Plant Physiol., V18, P45, DOI 10.1590/S1677-04202006000100005; Etienne H, 2012, CAH AGRIC, V21, P115, DOI 10.1684/agr.2012.0553; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Fiuk A, 2010, PLANT MOL BIOL REP, V28, P413, DOI 10.1007/s11105-009-0167-3; FUKUOKA H, 1994, PLANT MOL BIOL, V26, P899, DOI 10.1007/BF00028857; Gao XA, 2010, J PLANT GROWTH REGUL, V29, P257, DOI 10.1007/s00344-009-9133-4; Gillis K, 2007, PLANT CELL TISS ORG, V91, P115, DOI 10.1007/s11240-007-9236-1; GOZUKIRMIZI N, 1990, ACTA BOT NEERL, V39, P379; Guo WL, 2007, PLANT CELL REP, V26, P1297, DOI 10.1007/s00299-007-0320-0; Hao YJ, 2002, IN VITRO CELL DEV-PL, V38, P472, DOI [10.1079/IVP2002317, 10.1079/IVP200231]; HEINZE B, 1995, EUPHYTICA, V85, P341, DOI 10.1007/BF00023965; Henry IM, 2010, GENETICS, V186, P1231, DOI 10.1534/genetics.110.121079; Herrera JC, 2007, GENOME, V50, P619, DOI 10.1139/G07-034; Hornero J, 2001, INT J PLANT SCI, V162, P827, DOI 10.1086/320784; Hua YW, 2010, PLANT BREEDING, V129, P202, DOI 10.1111/j.1439-0523.2009.01663.x; JAHNE A, 1991, THEOR APPL GENET, V82, P74, DOI 10.1007/BF00231280; Jaligot E, 2004, GENOME, V47, P224, DOI 10.1139/G03-085; Jin SX, 2008, PLANT CELL REP, V27, P1303, DOI 10.1007/s00299-008-0557-2; KAEPPLER SM, 1993, IN VITRO CELL DEV-PL, V29P, P125, DOI 10.1007/BF02632283; Kaeppler SM, 2000, PLANT MOL BIOL, V43, P179, DOI 10.1023/A:1006423110134; Karp A., 1991, OXFORD SURVEYS PLANT, V7, P1; Karp A, 1994, PLANT CELL TISSUE CU, P139; KRUG CA, 1951, ADV GENET, V4, P127, DOI 10.1016/S0065-2660(08)60233-3; Lambe P, 1997, IN VITRO CELL DEV-PL, V33, P155, DOI 10.1007/s11627-997-0015-9; LARKIN PJ, 1987, IOWA STATE J RES, V61, P393; LARKIN PJ, 1981, THEOR APPL GENET, V60, P197, DOI 10.1007/BF02342540; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Leal F, 2006, PLANT CELL REP, V25, P978, DOI 10.1007/s00299-006-0162-1; Li XL, 2007, PLANT CELL TISS ORG, V90, P153, DOI 10.1007/s11240-007-9224-5; LOSCHIAVO F, 1989, THEOR APPL GENET, V77, P325, DOI 10.1007/BF00305823; Lu SY, 2006, PLANT CELL TISS ORG, V87, P77, DOI 10.1007/s11240-006-9138-7; Makarevitch I, 2010, PLANT PHYSIOL, V152, P927, DOI 10.1104/pp.109.150466; Mallon R, 2012, TREES-STRUCT FUNCT, V26, P731, DOI 10.1007/s00468-011-0639-6; Mckenzie N, 2002, THEOR APPL GENET, V105, P23, DOI 10.1007/s00122-002-0882-8; Menendez Yuffa A, 2000, ELECTRON J BIOTECHN, V3, P0; Miguel C, 2011, J EXP BOT, V62, P3713, DOI 10.1093/jxb/err155; Mujib A, 2007, PROPAG ORNAM PLANTS, V7, P169; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neelakandan AK, 2012, PLANT CELL REP, V31, P597, DOI 10.1007/s00299-011-1202-z; Peraza-Echeverria S, 2001, PLANT SCI, V161, P359, DOI 10.1016/S0168-9452(01)00421-6; PESCHKE VM, 1992, ADV GENET, V30, P41, DOI 10.1016/S0065-2660(08)60318-1; PESCHKE VM, 1987, SCIENCE, V238, P804, DOI 10.1126/science.238.4828.804; Rani V, 2000, PLANT CELL REP, V19, P1013, DOI 10.1007/s002990000228; Rani V, 2000, IN VITRO CELL DEV-PL, V36, P319, DOI 10.1007/s11627-000-0059-6; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Ribas AF, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-92; Rival A, 1997, PLANT CELL REP, V16, P884, DOI 10.1007/s002990050339; Sahijram L, 2003, IN VITRO CELL DEV-PL, V39, P551, DOI 10.1079/IVP2003467; Sanchez-Teyer LF, 2003, MOL BIOTECHNOL, V23, P107, DOI 10.1385/MB:23:2:107; Saze H, 2008, SEMIN CELL DEV BIOL, V19, P527, DOI 10.1016/j.semcdb.2008.07.017; Schellenbaum P, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-78; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smulders MJM, 2011, PLANT GROWTH REGUL, V63, P137, DOI 10.1007/s10725-010-9531-4; Sondahl M. R., 1992, V8, P401; Teisson C, 1995, CURR PLANT SCI BIOT, V22, P105; Vanyushin BF, 2011, BBA-GENE REGUL MECH, V1809, P360, DOI 10.1016/j.bbagrm.2011.04.006; Von Aderkas P, 2000, TREE PHYSIOL, V20, P921; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; YASUDA T, 1985, PLANT CELL PHYSIOL, V26, P595, DOI 10.1093/oxfordjournals.pcp.a076946; Yu X, 2011, ANN APPL BIOL, V158, P237, DOI 10.1111/j.1744-7348.2011.00458.x; Zhang MS, 2010, J GENET GENOMICS, V37, P1, DOI 10.1016/S1673-8527(09)60020-5; Zoriniants SE, 2003, PLANT SCI, V164, P141, DOI 10.1016/S0168-9452(02)00322-9	80	47	49	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56372	10.1371/journal.pone.0056372	http://dx.doi.org/10.1371/journal.pone.0056372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418563	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300156
J	Ma, Z; Yang, HX; Liu, HH; Xu, MF; Runyan, RB; Eisenberg, CA; Markwald, RR; Borg, TK; Gao, BZ				Ma, Zhen; Yang, Huaxiao; Liu, Honghai; Xu, Meifeng; Runyan, Raymond B.; Eisenberg, Carol A.; Markwald, Roger R.; Borg, Thomas K.; Gao, Bruce Z.			Mesenchymal Stem Cell-Cardiomyocyte Interactions under Defined Contact Modes on Laser-Patterned Biochips	PLOS ONE			English	Article							MEMBRANE NANOTUBES; IN-VIVO; TUNNELING NANOTUBES; ANIMAL-CELLS; FUSION; MYOCYTES; TRANSDIFFERENTIATION; FIBROBLASTS; DIFFERENTIATION; COMMUNICATION	Understanding how stem cells interact with cardiomyocytes is crucial for cell-based therapies to restore the cardiomyocyte loss that occurs during myocardial infarction and other cardiac diseases. It has been thought that functional myocardial repair and regeneration could be regulated by stem cell-cardiomyocyte contact. However, because various contact modes (junction formation, cell fusion, partial cell fusion, and tunneling nanotube formation) occur randomly in a conventional coculture system, the particular regulation corresponding to a specific contact mode could not be analyzed. In this study, we used laser-patterned biochips to define cell-cell contact modes for systematic study of contact-mediated cellular interactions at the single-cell level. The results showed that the biochip design allows defined stem cell-cardiomyocyte contact-mode formation, which can be used to determine specific cellular interactions, including electrical coupling, mechanical coupling, and mitochondria transfer. The biochips will help us gain knowledge of contact-mediated interactions between stem cells and cardiomyocytes, which are fundamental for formulating a strategy to achieve stem cell-based cardiac tissue regeneration.	[Ma, Zhen; Yang, Huaxiao; Liu, Honghai; Gao, Bruce Z.] Clemson Univ, Dept Bioengn, Clemson, SC 29631 USA; [Xu, Meifeng] Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; [Runyan, Raymond B.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA; [Eisenberg, Carol A.] New York Med Coll, Westchester Med Ctr, Stem Cell Lab, Valhalla, NY 10595 USA; [Markwald, Roger R.; Borg, Thomas K.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA	Clemson University; University System of Ohio; University of Cincinnati; University of Arizona; New York Medical College; Westchester Medical Center; Medical University of South Carolina	Gao, BZ (corresponding author), Clemson Univ, Dept Bioengn, Clemson, SC 29631 USA.	zgao@clemson.edu	Yang, Huaxiao/AAV-2636-2021; Runyan, Raymond B/B-6977-2012; Yang, Huaxiao/ABA-8620-2020	Runyan, Raymond B/0000-0002-7410-916X; Ma, Zhen/0000-0001-5228-105X	National Institutes of Health (NIH) [P20RR021949, 5k25hl088262-04, 5R01 HL085847]; National Science Foundation (NSF) (MRI through SC GEAR program) [CBET-0923311]; Guangdong Provincial Department of Science and Technology, China [2011B050400011]; State Key Laboratory of Precision Measuring Technology and Instruments (Tianjin University); Siebel Institute Postdoctoral Fellowship [41523-31595-44-OYZHMA-IQKEH]; National Science Foundation (NSF) (SC EPSCoR RII through SC GEAR program) [EPS-0903795]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021949] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL088262, R01HL085847] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) (MRI through SC GEAR program)(National Science Foundation (NSF)); Guangdong Provincial Department of Science and Technology, China; State Key Laboratory of Precision Measuring Technology and Instruments (Tianjin University); Siebel Institute Postdoctoral Fellowship; National Science Foundation (NSF) (SC EPSCoR RII through SC GEAR program)(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was partially supported by National Institutes of Health (NIH) (SC COBRE P20RR021949, Career Award 5k25hl088262-04, and 5R01 HL085847); National Science Foundation (NSF) (MRI, CBET-0923311and SC EPSCoR RII EPS-0903795 through SC GEAR program); and Guangdong Provincial Department of Science and Technology, China (2011B050400011). BZG would also like to acknowledge the support from the grant established by the State Key Laboratory of Precision Measuring Technology and Instruments (Tianjin University). ZM would like to acknowledge his Siebel Institute Postdoctoral Fellowship (41523-31595-44-OYZHMA-IQKEH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanell AM, 2009, ANN THORAC SURG, V88, P1036, DOI 10.1016/j.athoracsur.2009.02.093; Abel MP, 2011, BIOINTERPHASES, V6, P22, DOI 10.1116/1.3567416; Acquistapace A, 2011, STEM CELLS, V29, P812, DOI 10.1002/stem.632; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Alvarez-Dolado M, 2007, FRONT BIOSCI-LANDMRK, V12, P1, DOI 10.2741/2044; Alvarez-Dolado M, 2011, ADV EXP MED BIOL, V713, P161, DOI 10.1007/978-94-007-0763-4_10; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Avitabile D, 2011, AM J PHYSIOL-HEART C, V300, pH1875, DOI 10.1152/ajpheart.00523.2010; Bereiter-Hahn J., 1990, International Review of Cytology, V122, P1, DOI 10.1016/S0074-7696(08)61205-X; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Cselenyak A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-29; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; Driesen RB, 2005, CARDIOVASC RES, V68, P37, DOI 10.1016/j.cardiores.2005.05.020; Garbade J, 2005, EUR J CARDIO-THORAC, V28, P685, DOI 10.1016/j.ejcts.2005.06.047; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; He KM, 2011, CARDIOVASC RES, V92, P39, DOI 10.1093/cvr/cvr189; He KM, 2010, ACS NANO, V4, P3015, DOI 10.1021/nn1002198; He XQ, 2010, MOL CELL BIOCHEM, V339, P89, DOI 10.1007/s11010-009-0372-2; Hosoda T, 2009, P NATL ACAD SCI USA, V106, P17169, DOI 10.1073/pnas.0903089106; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60; Kieken F, 2009, CIRC RES, V104, P1103, DOI 10.1161/CIRCRESAHA.108.190454; Lindstrom S, 2011, BBA-GEN SUBJECTS, V1810, P308, DOI 10.1016/j.bbagen.2010.04.009; Liu HH, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3662457; Ma Z, 2012, CELL MOL BIOENG, V5, P327, DOI 10.1007/s12195-012-0240-0; Ma Z, 2012, BIOTECHNOL LETT, V34, P1385, DOI 10.1007/s10529-012-0906-7; Ma Z, 2012, LAB CHIP, V12, P566, DOI 10.1039/c2lc20699d; Ma Z, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034107; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Oettgen P, 2006, CIRCULATION, V114, P353, DOI 10.1161/CIRCULATIONAHA.106.639385; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Orlic D, 2003, PEDIATR TRANSPLANT, V7, P86, DOI 10.1034/j.1399-3046.7.s3.13.x; Pedrotty DM, 2008, AM J PHYSIOL-HEART C, V295, pH390, DOI 10.1152/ajpheart.91531.2007; Pijnappels DA, 2008, CIRC RES, V103, P167, DOI 10.1161/CIRCRESAHA.108.176131; Pirlo RK, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3529919; Plotnikov EY, 2008, J CELL MOL MED, V12, P1622, DOI 10.1111/j.1582-4934.2007.00205.x; Prochiantz A, 2003, NAT REV MOL CELL BIO, V4, P814, DOI 10.1038/nrm1227; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Rogers TB, 2011, J MOL CELL CARDIOL, V50, P346, DOI 10.1016/j.yjmcc.2010.09.001; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Song YH, 2011, CELL CYCLE, V10, P2281, DOI 10.4161/cc.10.14.16513; Valarmathi MT, 2011, BIOMATERIALS, V32, P2834, DOI 10.1016/j.biomaterials.2011.01.012; Wang TZ, 2006, INT J CARDIOL, V109, P74, DOI 10.1016/j.ijcard.2005.05.072; Wang X, 2012, BBA-BIOMEMBRANES, V1818, P2082, DOI 10.1016/j.bbamem.2011.09.002; Wang X, 2010, P NATL ACAD SCI USA, V107, P17194, DOI 10.1073/pnas.1006785107; Xu MF, 2004, CIRCULATION, V110, P2658, DOI 10.1161/01.CIR.0000145609.20435.36; Zhang S, 2004, CIRCULATION, V110, P3803, DOI 10.1161/01.CIR.0000150796.18473.8E	48	28	30	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56554	10.1371/journal.pone.0056554	http://dx.doi.org/10.1371/journal.pone.0056554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418583	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300176
J	Munch, EM; Harris, RA; Mohammad, M; Benham, AL; Pejerrey, SM; Showalter, L; Hu, M; Shope, CD; Maningat, PD; Gunaratne, PH; Haymond, M; Aagaard, K				Munch, Erika M.; Harris, R. Alan; Mohammad, Mahmoud; Benham, Ashley L.; Pejerrey, Sasha M.; Showalter, Lori; Hu, Min; Shope, Cynthia D.; Maningat, Patricia D.; Gunaratne, Preethi H.; Haymond, Morey; Aagaard, Kjersti			Transcriptome Profiling of microRNA by Next-Gen Deep Sequencing Reveals Known and Novel miRNA Species in the Lipid Fraction of Human Breast Milk	PLOS ONE			English	Article							CIRCULATING MICRORNAS; EXPRESSION; LACTATION; EVOLUTION; MACRONUTRIENT; DETERMINANTS; MAMMALS; MARKERS	While breast milk has unique health advantages for infants, the mechanisms by which it regulates the physiology of newborns are incompletely understood. miRNAs have been described as functioning transcellularly, and have been previously isolated in cell-free and exosomal form from bodily liquids (serum, saliva, urine) and tissues, including mammary tissue. We hypothesized that breast milk in general, and milk fat globules in particular, contain significant numbers of known and limited novel miRNA species detectable with massively parallel sequencing. Extracted RNA from lactating mothers before and following short-term treatment with recombinant human growth hormone (rhGH) was smRNA-enriched. smRNA-Seq was performed to generate 124,110,646 36-nt reads. Of these, 31,102,927 (25%) exactly matched known human miRNAs; with relaxing of stringency, 74,716,151 (60%) matched known miRNAs including 308 of the 1018 (29%) mature miRNAs (miRBase 16.0). These miRNAs are predicted to target 9074 genes; the 10 most abundant of these predicted to target 2691 genes with enrichment for transcriptional regulation of metabolic and immune responses. We identified 21 putative novel miRNAs, of which 12 were confirmed in a large validation set that included cohorts of lactating women consuming enriched diets. Of particular interest, we observed that expression of several novel miRNAs were altered by the perturbed maternal diet, notably following a high-fat intake (p<0.05). Our findings suggest that known and novel miRNAs are enriched in breast milk fat globules, and expression of several novel miRNA species is regulated by maternal diet. Based on robust pathway mapping, our data supports the notion that these maternally secreted miRNAs (stable in the milk fat globules) play a regulatory role in the infant and account in part for the health benefits of breast milk. We further speculate that regulation of these miRNA by a high fat maternal diet enables modulation of fetal metabolism to accommodate significant dietary challenges.	[Munch, Erika M.; Harris, R. Alan; Showalter, Lori; Hu, Min; Shope, Cynthia D.; Aagaard, Kjersti] Baylor Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Houston, TX 77030 USA; [Harris, R. Alan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Mohammad, Mahmoud; Maningat, Patricia D.; Haymond, Morey] Texas Childrens Hosp, Baylor Coll Med, Div Pediat Endocrinol & Metab, Dept Pediat,Childrens Nutr Res Ctr,USDA,ARS, Houston, TX 77030 USA; [Benham, Ashley L.; Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Pejerrey, Sasha M.; Aagaard, Kjersti] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Gunaratne, Preethi H.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA); University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine	Aagaard, K (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Houston, TX 77030 USA.	aagaardt@bcm.edu	Harris, R. Alan/AAI-2784-2020; Mohammad, Mahmoud/GNO-9940-2022	Harris, R. Alan/0000-0002-7333-4752; Mohammad, Mahmoud/0000-0002-6535-5529	National Institutes of Health (NIH) Director New Innovator Award [DP2120OD001500-01]; National Institute of Child Health and Human Development (NICHD)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK080558-01]; NIH Common Fund Human Microbiome-HMP [NIHU54HG004969]; Burroughs Welcome Fund (Burroughs Welcome Fund Preterm Birth Initiative); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001500] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Director New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development (NICHD)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH Common Fund Human Microbiome-HMP; Burroughs Welcome Fund (Burroughs Welcome Fund Preterm Birth Initiative); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health (NIH) Director New Innovator Award (DP2120OD001500-01 KA with funded support to RH), National Institute of Child Health and Human Development (NICHD)/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) # R01DK080558-01 (KA), the NIH Common Fund Human Microbiome-HMP (KA (NIHU54HG004969)), and the Burroughs Welcome Fund (Burroughs Welcome Fund Preterm Birth Initiative (KA)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard-Tillery KM, 2008, J MOL ENDOCRINOL, V41, P91, DOI 10.1677/JME-08-0025; Carissimi C, 2009, AUTOIMMUN REV, V8, P520, DOI 10.1016/j.autrev.2009.01.008; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Dall SRX, 2004, P ROY SOC B-BIOL SCI, V271, P2049, DOI 10.1098/rspb.2004.2830; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Enright AJ, 2004, GENOME BIOL, V5; Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171; Gartner LM, 2005, PEDIATRICS, V115, P496, DOI 10.1542/peds.2004-2491; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Goldman AS, 2002, J MAMMARY GLAND BIOL, V7, P277, DOI 10.1023/A:1022852700266; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hata T, 2010, BIOCHEM BIOPH RES CO, V396, P528, DOI 10.1016/j.bbrc.2010.04.135; Hinde K, 2010, AM J PRIMATOLOGY, V9999; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Lemay DG, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r43; Liao YL, 2010, J NUTR, V140, P1552, DOI 10.3945/jn.110.124289; Maningat PD, 2011, PHYSIOL GENOMICS, V43, P381, DOI 10.1152/physiolgenomics.00079.2010; Maningat PD, 2009, PHYSIOL GENOMICS, V37, P12, DOI 10.1152/physiolgenomics.90341.2008; Meiri E, 2010, NUCLEIC ACIDS RES, V38, P6234, DOI 10.1093/nar/gkq376; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Mohammad MA, 2011, AM J CLIN NUTR, V93, P374, DOI 10.3945/ajcn.110.005785; Mohammad MA, 2009, AM J CLIN NUTR, V89, P1821, DOI 10.3945/ajcn.2008.26877; Neville MC, 2005, J MAMMARY GLAND BIOL, V10, P119, DOI 10.1007/s10911-005-5395-z; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Oohashi T, 1999, J CELL BIOL, V145, P563, DOI 10.1083/jcb.145.3.563; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Saarela T, 2005, ACTA PAEDIATR, V94, P1176, DOI 10.1080/08035250510036499; Smit AFA, 2010, REPEATMASKER OPEN 3; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Stuebe A, 2009, REV OBSTET GYNECOL, V2, P65; Stuebe AM, 2010, J PERINATOL, V30, P155, DOI 10.1038/jp.2009.107; Stuebe AM, 2009, AM J PERINAT, V4, P522; Suter M, 2011, EPIGENETICS-US, V6, P1284, DOI 10.4161/epi.6.11.17819; Suter M, 2011, FASEB J, V25, P714, DOI 10.1096/fj.10-172080; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; Wickramasinghe S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018895; Zhang R, 2008, MOL BIOL EVOL, V25, P1493, DOI 10.1093/molbev/msn094; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118; Zhu HY, 2011, AM J CARDIOVASC DIS, V1, P138	48	126	133	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e50564	10.1371/journal.pone.0050564	http://dx.doi.org/10.1371/journal.pone.0050564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418415	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300005
J	Tempesta, D; Curcio, G; De Gennaro, L; Ferrara, M				Tempesta, Daniela; Curcio, Giuseppe; De Gennaro, Luigi; Ferrara, Michele			Long-Term Impact of Earthquakes on Sleep Quality	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; FOLLOW-UP; SURVIVORS; DEPRESSION; PTSD; INDEX; DISTURBANCES; PREVALENCE; NIGHTMARES; VETERANS	Purpose: We investigated the impact of the 6.3 magnitude 2009 L'Aquila (Italy) earthquake on standardized self-report measures of sleep quality (Pittsburgh Sleep Quality Index, PSQI) and frequency of disruptive nocturnal behaviours (Pittsburgh Sleep Quality Index-Addendum, PSQI-A) two years after the natural disaster. Methods: Self-reported sleep quality was assessed in 665 L'Aquila citizens exposed to the earthquake compared with a different sample (n = 754) of L'Aquila citizens tested 24 months before the earthquake. In addition, sleep quality and disruptive nocturnal behaviours (DNB) of people exposed to the traumatic experience were compared with people that in the same period lived in different areas ranging between 40 and 115 km from the earthquake epicenter (n = 3574). Results: The comparison between L'Aquila citizens before and after the earthquake showed a significant deterioration of sleep quality after the exposure to the trauma. In addition, two years after the earthquake L'Aquila citizens showed the highest PSQI scores and the highest incidence of DNB compared to subjects living in the surroundings. Interestingly, above-the-threshold PSQI scores were found in the participants living within 70 km from the epicenter, while trauma-related DNBs were found in people living in a range of 40 km. Multiple regressions confirmed that proximity to the epicenter is predictive of sleep disturbances and DNB, also suggesting a possible mediating effect of depression on PSQI scores. Conclusions: The psychological effects of an earthquake may be much more pervasive and long-lasting of its building destruction, lasting for years and involving a much larger population. A reduced sleep quality and an increased frequency of DNB after two years may be a risk factor for the development of depression and posttraumatic stress disorder.	[Tempesta, Daniela; Curcio, Giuseppe; Ferrara, Michele] Univ Laquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Curcio, Giuseppe] IRCCS S Raffaele, Cassino, FR, Italy; [De Gennaro, Luigi] Univ Roma La Sapienza, Dept Psychol, Rome, Italy	University of L'Aquila; Sapienza University Rome	Ferrara, M (corresponding author), Univ Laquila, Dept Life Hlth & Environm Sci, Laquila, Italy.	michele.ferrara@cc.univaq.it	Ferrara, Michele/AAB-7574-2022; Tempesta, Daniela/AAB-7539-2022; Kılıç, Cengiz/I-9145-2013; Curcio, Giuseppe/M-1635-2014; De Gennaro, Luigi/L-8711-2015	Ferrara, Michele/0000-0003-2304-7576; Tempesta, Daniela/0000-0002-6942-5336; De Gennaro, Luigi/0000-0003-3613-6631; Curcio, Giuseppe/0000-0003-2248-781X				Applewhite L, 2012, MIL MED, V177, P501, DOI 10.7205/MILMED-D-11-00142; ARCHIBALD HC, 1962, AM J PSYCHIAT, V119, P317, DOI 10.1176/ajp.119.4.317; Babson KA, 2010, J ANXIETY DISORD, V24, P1, DOI 10.1016/j.janxdis.2009.08.002; Basoglu M, 2004, J TRAUMA STRESS, V17, P133, DOI 10.1023/B:JOTS.0000022619.31615.e8; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chou FHC, 2004, QUAL LIFE RES, V13, P1089, DOI 10.1023/B:QURE.0000031337.73269.64; Curcio G, 2012, NEUROL SCI; Doi Y, 2000, PSYCHIAT RES, V97, P165, DOI 10.1016/S0165-1781(00)00232-8; Germain A, 2004, J TRAUMA STRESS, V17, P477, DOI 10.1007/s10960-004-5796-6; Germain A, 2005, J ANXIETY DISORD, V19, P233, DOI 10.1016/j.janxdis.2004.02.001; HEFEZ A, 1987, AM J PSYCHIAT, V144, P344; Jackson M, 2011, HUMAN SLEEP COGNITIO, V2; Koren D, 2002, AM J PSYCHIAT, V159, P855, DOI 10.1176/appi.ajp.159.5.855; Krakow B, 2001, JAMA-J AM MED ASSOC, V286, P537, DOI 10.1001/jama.286.5.537; Krystal AD, 2008, SLEEP MED, V9, pS10, DOI 10.1016/S1389-9457(08)70011-X; Kuwabara H, 2008, PSYCHIAT CLIN NEUROS, V62, P503, DOI 10.1111/j.1440-1819.2008.01842.x; Lai TJ, 2004, J PSYCHIATR RES, V38, P313, DOI 10.1016/j.jpsychires.2003.08.005; Lau EYY, 2011, J INT NEUROPSYCH SOC, V17, P382, DOI 10.1017/S1355617711000269; LAVIE P, 1979, AM J PSYCHIAT, V136, P175; LEOPOLD RL, 1963, AM J PSYCHIAT, V119, P913, DOI 10.1176/ajp.119.10.913; Mellman TA, 2001, J TRAUMA STRESS, V14, P241, DOI 10.1023/A:1007812321136; MELLMAN TA, 1995, AM J PSYCHIAT, V152, P110; Mellman TA, 1997, ANN NY ACAD SCI, V821, P142, DOI 10.1111/j.1749-6632.1997.tb48275.x; Neylan TC, 1998, AM J PSYCHIAT, V155, P929, DOI 10.1176/ajp.155.7.929; POLNER M, 1968, TRANS-ACT-SOC SCI MO, V6, P8; Qu ZY, 2012, ARCH WOMEN MENT HLTH, V15, P49, DOI 10.1007/s00737-011-0255-x; REYNOLDS CF, 1992, BIOL PSYCHIAT, V31, P69, DOI 10.1016/0006-3223(92)90007-M; Simor P, 2012, BRAIN COGNITION, V78, P274, DOI 10.1016/j.bandc.2012.01.006; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Stickgold R, 2002, J CLIN PSYCHOL, V58, P61, DOI 10.1002/jclp.1129; Stickgold R, 2007, NAT NEUROSCI, V10, P540, DOI 10.1038/nn0507-540; Tempesta D, 2012, HIPPOCAMPUS, V22, P1154, DOI 10.1002/hipo.20961; Vingilis E, 1996, ACCIDENT ANAL PREV, V28, P637, DOI 10.1016/0001-4575(96)00036-X; Wang S., 2012, CONFL HEALTH, V6, P1, DOI DOI 10.1186/1752-1505-6-4; Wang XD, 2000, AM J PSYCHIAT, V157, P1260, DOI 10.1176/appi.ajp.157.8.1260; Xu JP, 2011, COMPR PSYCHIAT, V52, P431, DOI 10.1016/j.comppsych.2010.08.002; Zhang Liping, 2011, Wei Sheng Yan Jiu, V40, P744	38	52	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55936	10.1371/journal.pone.0055936	http://dx.doi.org/10.1371/journal.pone.0055936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418478	gold, Green Published			2022-12-27	WOS:000315970300070
J	Uchida, F; Uzawa, K; Kasamatsu, A; Takatori, H; Sakamoto, Y; Ogawara, K; Shiiba, M; Bukawa, H; Tanzawa, H				Uchida, Fumihiko; Uzawa, Katsuhiro; Kasamatsu, Atsushi; Takatori, Hiroaki; Sakamoto, Yosuke; Ogawara, Katsunori; Shiiba, Masashi; Bukawa, Hiroki; Tanzawa, Hideki			Overexpression of CDCA2 in Human Squamous Cell Carcinoma: Correlation with Prevention of G1 Phase Arrest and Apoptosis	PLOS ONE			English	Article							DNA-DAMAGE; IONIZING-RADIATION; CANCER; EXPRESSION; CYCLE; ATM; P53; PROGRESSION; INHIBITION; ALCOHOL	Cell division cycle associated 2 (CDCA2) recruits protein phosphatase 1 to chromatin to antagonize activation of ataxia telangiectasia mutated (ATM)-dependent signal transduction. ATM kinase plays a critical role in the DNA damage response and its phosphorylation cascade to inhibit the p53-MDM2 interaction, which releases p53 to induce p21 and G1 cell-cycle arrest. However, the relevance of CDCA2 to human malignancy including oral squamous cell carcinoma (OSCC) is unknown. In the current study, we found that CDCA2 expression was up-regulated in OSCC cell lines. Functional studies with shRNA system showed that knockdown of CDCA2 significantly (P<0.05) inhibited cellular proliferation compared with the control cells by arresting cell-cycle progression at the G1 phase and up-regulating the cyclin-dependent kinase inhibitors (p21(Cip1), p27(Kip1), p15(INK4B), and p16(INK4A)). CDCA2 knockdown also promoted apoptosis after treatment with the DNA damage reagent, cisplatin. In clinical samples, the CDCA2 protein expression level in primary OSCCs was significantly (P<0.05) greater than in matched normal oral tissues (67/85, 79%). Furthermore, CDCA2-positive cases were correlated significantly (P<0.05) with high cancer progression. Our results showed for the first time that CDCA2 frequently is overexpressed in OSCCs and might be associated closely with OSCC progression by preventing cell-cycle arrest and apoptosis.	[Uchida, Fumihiko; Bukawa, Hiroki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Oral & Maxillofacial Surg, Tsukuba, Ibaraki, Japan; [Uzawa, Katsuhiro; Tanzawa, Hideki] Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chuo Ku, Chiba, Japan; [Uzawa, Katsuhiro; Kasamatsu, Atsushi; Sakamoto, Yosuke; Ogawara, Katsunori; Shiiba, Masashi; Tanzawa, Hideki] Chiba Univ Hosp, Div Dent & Oral Maxillofacial Surg, Chuo Ku, Chiba, Japan; [Takatori, Hiroaki] Chiba Univ, Grad Sch Med, Dept Mol Genet, Chuo Ku, Chiba, Japan; [Bukawa, Hiroki] Univ Tsukuba, Fac Med, Dept Oral & Maxillofacial Surg, Tsukuba, Ibaraki, Japan	University of Tsukuba; Chiba University; Chiba University; University of Tsukuba	Uzawa, K (corresponding author), Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chuo Ku, Chiba, Japan.	uzawak@faculty.chiba-u.jp		Uzawa, Katsuhiro/0000-0002-7036-0859	Ministry of Education, Culture, Sports, Science and Technology of Japan [23792317]; Grants-in-Aid for Scientific Research [24790989] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid Scientific Research (No. 23792317) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Brew CT, 2006, INT J CANCER, V118, P857, DOI 10.1002/ijc.21445; Decker Patrice, 2002, Current Pharmaceutical Biotechnology, V3, P275, DOI 10.2174/1389201023378265; Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Ishiwata J, 2012, INT J ONCOL, V40, P47, DOI 10.3892/ijo.2011.1178; Iyoda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014082; Kasamatsu A, 2005, INT J MOL MED, V16, P269; KAWAMATA N, 1995, CANCER RES, V55, P2266; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Krasnoselsky AL, 2005, ONCOGENE, V24, P1533, DOI 10.1038/sj.onc.1208341; Lombardi DP, 1999, CANCER RES, V59, P5724; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Maude SL, 2005, CANCER RES, V65, P780; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; Ogoshi K, 2011, INT J ONCOL, V39, P329, DOI 10.3892/ijo.2011.1046; Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Qian JB, 2011, CURR BIOL, V21, P766, DOI 10.1016/j.cub.2011.03.047; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Tvrdik D, 2002, J STRUCT BIOL, V140, P49, DOI 10.1016/S1047-8477(02)00535-X; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Vagnarelli P, 2011, DEV CELL, V21, P328, DOI 10.1016/j.devcel.2011.06.020; Walker MG, 2001, CURR CANCER DRUG TAR, V1, P73, DOI 10.2174/1568009013334241; Ward JF, 2000, COLD SPRING HARB SYM, V65, P377, DOI 10.1101/sqb.2000.65.377; Werbrouck J, 2008, MUTAT RES-GEN TOX EN, V656, P74, DOI 10.1016/j.mrgentox.2008.07.013; Yamano Y, 2008, INT J ONCOL, V32, P1001; Yamano Y, 2011, HEAD NECK-J SCI SPEC, V33, P309, DOI 10.1002/hed.21445; Yamatoji M, 2010, INT J CANCER, V130, P2903	37	61	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56381	10.1371/journal.pone.0056381	http://dx.doi.org/10.1371/journal.pone.0056381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418564	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300157
J	Wang, JP; Li, ZX; Feng, M; Ren, KM; Shen, GX; Zhao, CY; Jin, XM; Jiang, KW				Wang, Jiangping; Li, Zhongxia; Feng, Mei; Ren, Keming; Shen, Guoxia; Zhao, Congying; Jin, Xiaoming; Jiang, Kewen			Opening of Astrocytic Mitochondrial ATP-Sensitive Potassium Channels Upregulates Electrical Coupling between Hippocampal Astrocytes in Rat Brain Slices	PLOS ONE			English	Article							GAP-JUNCTION PERMEABILITY; GLIAL-CELLS; K+-CHANNEL; DEPENDENT MECHANISM; CATION CHANNEL; NERVOUS-SYSTEM; NEURONS; OPENERS; MEMBRANE; OLIGODENDROCYTES	Astrocytes form extensive intercellular networks through gap junctions to support both biochemical and electrical coupling between adjacent cells. ATP-sensitive K+ (K-ATP) channels couple cell metabolic state to membrane excitability and are enriched in glial cells. Activation of astrocytic mitochondrial K-ATP (mitoK(ATP)) channel regulates certain astrocytic functions. However, less is known about its impact on electrical coupling between directly coupled astrocytes ex vivo. By using dual patch clamp recording, we found that activation of mitoK(ATP) channel increased the electrical coupling ratio in brain slices. The electrical coupling ratio started to increase 3 min after exposure to Diazoxide, a mitoK(ATP) channel activator, peaked at 5 min, and maintained its level with little adaptation until the end of the 10-min treatment. Blocking the mitoK(ATP) channel with 5-hydroxydecanoate, inhibited electrical coupling immediately, and by 10-min, the ratio dropped by 71% of the initial level. Activation of mitoK(ATP) channel also decreased the latency time of the transjunctional currents by 50%. The increase in the coupling ratio resulting from the activation of the mitoK(ATP) channel in a single astrocyte was further potentiated by the concurrent inhibiting of the channel on the recipient astrocyte. Furthermore, Meclofenamic acid, a gap-junction inhibitor which completely blocked the tracer coupling, hardly reversed the impact of mitoK(ATP) channel's activation on electrical coupling (by 7%). The level of mitochondrial Connexin43, a gap junctional subunit, significantly increased by 70% in astrocytes after 10-min Diazoxide treatment. Phospho-ERK signals were detected in Connexin43 immunoprecipitates in the Diazoxide-treated astrocytes, but not untreated control samples. Finally, inhibiting ERK could attenuate the effects of Diazoxide on electrical coupling by 61%. These findings demonstrate that activation of astrocytic mitoK(ATP) channel upregulates electrical coupling between hippocampal astrocytes ex vivo. In addition, this effect is mainly via up-regulation of the Connexin43-constituted gap junction coupling by an ERK-dependent mechanism in the mitochondria.	[Wang, Jiangping; Li, Zhongxia; Feng, Mei; Ren, Keming; Shen, Guoxia; Zhao, Congying; Jiang, Kewen] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Jiangping] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Rehabil, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Xiaoming] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN USA; [Jiang, Kewen] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Lab, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Indiana University System; Indiana University Bloomington; Zhejiang University	Jiang, KW (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China.	kewenjiang@gmail.com	Jin, Xiaoming/AAH-3555-2020		National Natural Science Foundation of China [30471840, 30570644]; Natural Science Foundation of Zhejiang Province [Y205127, Y2080272, R2090266]; Qianjiang talents project of technology office in Zhejiang province [2010R10G2010055]; Fundamental Research Funds for the Central Universities; Key Laboratory of Medical Neurobiology of Ministry of Health at Zhejiang University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Qianjiang talents project of technology office in Zhejiang province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Laboratory of Medical Neurobiology of Ministry of Health at Zhejiang University	This publication was supported by the National Natural Science Foundation of China (30471840 and 30570644), Natural Science Foundation of Zhejiang Province (Y205127, Y2080272 and R2090266), Qianjiang talents project of technology office in Zhejiang province (2010R10G2010055), by the Fundamental Research Funds for the Central Universities, and by the Key Laboratory of Medical Neurobiology of Ministry of Health at Zhejiang University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Bahi-Buisson N, 2007, J CHILD NEUROL, V22, P1147, DOI 10.1177/0883073807306272; Bajgar R, 2001, J BIOL CHEM, V276, P33369, DOI 10.1074/jbc.M103320200; BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648; Brockhaus J, 2000, GLIA, V32, P205, DOI 10.1002/1098-1136(200012)32:3<205::AID-GLIA10>3.0.CO;2-6; Bushong EA, 2004, INT J DEV NEUROSCI, V22, P73, DOI 10.1016/j.ijdevneu.2003.12.008; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cavalheiro RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010666; Chen MK, 2003, J NEUROSCI, V23, P8568; D'Ascenzo M, 2007, P NATL ACAD SCI USA, V104, P1995, DOI 10.1073/pnas.0609408104; Downey JM, 2000, BASIC RES CARDIOL, V95, P272, DOI 10.1007/s003950070045; GANDOLFO G, 1989, EUR J PHARMACOL, V167, P181, DOI 10.1016/0014-2999(89)90762-0; Giaume C, 1997, GLIA, V21, P114; Gosejacob D, 2011, GLIA, V59, P511, DOI 10.1002/glia.21120; Hinterkeuser S, 2000, EUR J NEUROSCI, V12, P2087, DOI 10.1046/j.1460-9568.2000.00104.x; INOUE I, 1991, NATURE, V352, P244, DOI 10.1038/352244a0; Jiang K, 2011, NEUROSIGNALS, V19, P63, DOI 10.1159/000323575; Jiang KW, 2004, NEUROSCI RES, V50, P319, DOI 10.1016/j.neures.2004.08.001; Jiang KW, 2004, MOL BRAIN RES, V128, P83, DOI 10.1016/j.molbrainres.2004.06.005; Koulakoff A, 2008, GLIA, V56, P1299, DOI 10.1002/glia.20698; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; MCLAINE PN, 1971, J PEDIATR-US, V79, P829, DOI 10.1016/S0022-3476(71)80402-X; Mebazaa A, 2003, INT J CLIN PRACT, V57, P410; Meme W, 2009, NEUROSCI RES, V63, P236, DOI 10.1016/j.neures.2008.12.008; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Minami K, 2004, DIABETES, V53, pS176, DOI 10.2337/diabetes.53.suppl_3.S176; Nagy JI, 2004, BRAIN RES REV, V47, P191, DOI 10.1016/j.brainresrev.2004.05.005; Naitoh K, 2006, CARDIOVASC RES, V70, P374, DOI 10.1016/j.cardiores.2006.01.023; ORKAND RK, 1966, J NEUROPHYSIOL, V29, P788, DOI 10.1152/jn.1966.29.4.788; Proulx E, 2006, EUR J NEUROSCI, V23, P489, DOI 10.1111/j.1460-9568.2005.04558.x; RANSOM BR, 1990, GLIA, V3, P258, DOI 10.1002/glia.440030405; Rash JE, 2001, CELL COMMUN ADHES, V8, P315, DOI 10.3109/15419060109080745; Riess ML, 2008, J CARDIOVASC PHARM, V51, P483, DOI 10.1097/FJC.0b013e31816bf4a4; Rocheleau JV, 2006, PLOS BIOL, V4, P221, DOI 10.1371/journal.pbio.0040026; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Samavati L, 2002, AM J PHYSIOL-CELL PH, V283, pC273, DOI 10.1152/ajpcell.00514.2001; Santos DOC, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046019; SARGENT CA, 1993, J CARDIOVASC PHARM, V22, P564, DOI 10.1097/00005344-199310000-00009; Schools GP, 2006, J NEUROPHYSIOL, V96, P1383, DOI 10.1152/jn.00449.2006; Schwanstecher M, 1999, Methods Enzymol, V294, P445; Sershen H, 2012, BRIT J PHARMACOL, V167, P1000, DOI 10.1111/j.1476-5381.2012.02072.x; Strohschein S, 2011, GLIA, V59, P973, DOI 10.1002/glia.21169; Sun XL, 2008, NEUROPSYCHOPHARMACOL, V33, P1336, DOI 10.1038/sj.npp.1301501; Szewczyk A, 1997, BIOCHEM PHARMACOL, V54, P961, DOI 10.1016/S0006-2952(97)00136-6; Velasco A, 2000, J NEUROCHEM, V74, P1249; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wallraff A, 2006, J NEUROSCI, V26, P5438, DOI 10.1523/JNEUROSCI.0037-06.2006; WALZ W, 1994, J NEUROSCI RES, V38, P12, DOI 10.1002/jnr.490380104; Xu GJ, 2010, GLIA, V58, P481, DOI 10.1002/glia.20939; Xue J, 2008, AM J PHYSIOL-REG I, V294, pR451, DOI 10.1152/ajpregu.00528.2007; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Yang MK, 2009, J PHARMACOL SCI, V109, P222, DOI 10.1254/jphs.08132FP; Zahs KR, 1997, GLIA, V20, P10, DOI 10.1002/(SICI)1098-1136(199705)20:1<10::AID-GLIA2>3.3.CO;2-2; Zhang S, 2011, CELL MOL NEUROBIOL, V31, P111, DOI 10.1007/s10571-010-9560-6; Zhang S, 2009, J NEUROSCI RES, V87, P1230, DOI 10.1002/jnr.21931; Zhou F, 2008, J CELL MOL MED, V12, P1559, DOI 10.1111/j.1582-4934.2007.00144.x; Zhou M, 2002, MOL BRAIN RES, V101, P23, DOI 10.1016/S0169-328X(02)00137-7; Zhou M, 2009, J NEUROSCI, V29, P8551, DOI 10.1523/JNEUROSCI.5784-08.2009	59	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56605	10.1371/journal.pone.0056605	http://dx.doi.org/10.1371/journal.pone.0056605			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418587	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300180
J	Kampylafka, EI; Alexopoulos, H; Kosmidis, ML; Panagiotakos, DB; Vlachoyiannopoulos, PG; Dalakas, MC; Moutsopoulos, HM; Tzioufas, AG				Kampylafka, Eleni I.; Alexopoulos, Haralampos; Kosmidis, Michalis L.; Panagiotakos, Demosthenes B.; Vlachoyiannopoulos, Panayiotis G.; Dalakas, Marinos C.; Moutsopoulos, Haralampos M.; Tzioufas, Athanasios G.			Incidence and Prevalence of Major Central Nervous System Involvement in Systemic Lupus Erythematosus: A 3-Year Prospective Study of 370 Patients	PLOS ONE			English	Article							NEUROPSYCHIATRIC SYNDROMES; ANTIPHOSPHOLIPID SYNDROME; NEUROMYELITIS-OPTICA; RISK-FACTORS; CRITERIA; DISEASE; CLASSIFICATION; EVENTS; COHORT; DAMAGE	Background: The incidence and prevalence of CNS involvement in SLE remains unclear owing to conflicting results in the published studies. The aim of the study was to evaluate the incidence and prevalence of major definite CNS events in SLE patients. Methods: 370 SLE patients with no previous history of CNS involvement were prospectively evaluated in a tertiary hospital referral center for 3 years. Major CNS manifestations were codified according to ACR definitions, including chorea, aseptic meningitis, psychosis, seizures, myelopathy, demyelinating syndrome, acute confusional state and strokes. Minor CNS events were excluded. ECLAM and SLEDAI-SELENA Modification scores were used to evaluate disease activity and SLICC/ACR Damage Index was used to assess accumulated damage. Results: 16/370 (4.3%) patients presented with a total of 23 major CNS events. These included seizures (35%), strokes (26%), myelopathy (22%), optic neuritis (8.7%), aseptic meningitis (4.3%) and acute psychosis (4.3%). Incidence was 7.8/100 person years. Among hospitalizations for SLE, 13% were due to CNS manifestations. Epileptic seizures were associated with high disease activity, while myelopathy correlated with lower disease activity and NMO-IgG antibodies (P <= 0.05). Stroke incidence correlated with APS coexistence (P = 0.06). Overall, CNS involvement correlated with high ECLAM and SLEDAI scores (P<0.001). Conclusions: Clinically severe CNS involvement is rare in SLE patients, accounting for 7.8/100 person years. CNS involvement correlates with high disease activity and coexistence of specific features that define the respective CNS syndromes.	[Kampylafka, Eleni I.; Alexopoulos, Haralampos; Kosmidis, Michalis L.; Vlachoyiannopoulos, Panayiotis G.; Dalakas, Marinos C.; Moutsopoulos, Haralampos M.; Tzioufas, Athanasios G.] Univ Athens, Sch Med, Dept Pathophysiol, Athens 11528, Greece; [Panagiotakos, Demosthenes B.] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; Harokopio University Athens	Tzioufas, AG (corresponding author), Univ Athens, Sch Med, Dept Pathophysiol, Athens 11528, Greece.	agtzi@med.uoa.gr	Panagiotakos, Demosthenes/C-9776-2013; Panagiotakos, Demosthenes/M-9167-2019; TZIOUFAS, ATHANASIOS G/A-1690-2008; Panagiotakos, Demosthenes/K-8294-2019	Panagiotakos, Demosthenes/0000-0001-8583-153X; Panagiotakos, Demosthenes/0000-0001-8583-153X; Tzioufas, Athanasios/0000-0001-6666-8642; Alexopoulos, Harry/0000-0002-8672-7619	European Social Fund (ESF) fund through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) Research Funding Program: Heracleitus II; Greek National fund through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) Research Funding Program: Heracleitus II	European Social Fund (ESF) fund through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) Research Funding Program: Heracleitus II; Greek National fund through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) Research Funding Program: Heracleitus II	The present study has been co-financed by the European Social Fund (ESF) and Greek National funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) Research Funding Program: Heracleitus II. http://www.elke.uoa.gr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainiala H, 2001, NEUROLOGY, V57, P496, DOI 10.1212/WNL.57.3.496; Ainiala H, 2001, ARTHRIT RHEUM-ARTHR, V45, P419, DOI 10.1002/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-X; Andrade RM, 2008, ANN RHEUM DIS, V67, P829, DOI 10.1136/ard.2007.077594; Bernatsky S, 2006, LUPUS, V15, P835, DOI 10.1177/0961203306073133; Bertsias GK, 2010, ANN RHEUM DIS, V69, P2074, DOI 10.1136/ard.2010.130476; Bertsias GK, 2010, NAT REV RHEUMATOL, V6, P358, DOI 10.1038/nrrheum.2010.62; Birnbaum J, 2009, ARTHRITIS RHEUM-US, V60, P3378, DOI 10.1002/art.24937; Bosnic Dubravka, 2008, Lijec Vjesn, V130, P136; Brey RL, 2002, NEUROLOGY, V58, P1214, DOI 10.1212/WNL.58.8.1214; Carlomagno S, 2000, J NEUROL, V247, P273, DOI 10.1007/s004150050583; Chambers SA, 2009, RHEUMATOLOGY, V48, P673, DOI 10.1093/rheumatology/kep062; COSTALLAT LTL, 1994, CLIN EXP RHEUMATOL, V12, P603; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujieda Y, 2011, MOD RHEUMATOL, V21, P276, DOI 10.1007/s10165-010-0386-3; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Govoni M, 2011, RHEUMATOLOGY OXFORD; Hanly JG, 2007, ARTHRITIS RHEUM-US, V56, P265, DOI 10.1002/art.22305; Hanly JG, 2010, ANN RHEUM DIS, V69, P529, DOI 10.1136/ard.2008.106351; Hanly JG, 2004, J RHEUMATOL, V31, P2156; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Joseph FG, 2007, NEUROLOGY, V69, P644, DOI 10.1212/01.wnl.0000267320.48939.d0; Karassa FB, 2000, QJM-MON J ASSOC PHYS, V93, P169, DOI 10.1093/qjmed/93.3.169; Kasitanon N, 2002, ASIAN PAC J ALLERGY, V20, P85; Kozora E, 2008, ARTHRIT RHEUM-ARTHR, V59, P1639, DOI 10.1002/art.24189; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; McCaffrey LM, 2011, HEART LUNG; Mikdashi J, 2004, RHEUMATOLOGY, V43, P1555, DOI 10.1093/rheumatology/keh384; Mitsikostas DD, 2004, BRAIN, V127, P1200, DOI 10.1093/brain/awh146; MIYACHI K, 1979, ARTHRITIS RHEUM, V22, P87, DOI 10.1002/art.1780220114; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mosca M, 2000, LUPUS, V9, P445, DOI 10.1191/096120300678828640; Padovan M, 2010, RHEUMATOL INT; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; PETRI M, 1992, J RHEUMATOL, V19, P1559; Petri M, 2008, J RHEUMATOL, V35, P1776; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Sfikakis PP, 1998, BRIT J RHEUMATOL, V37, P300; Tektonidou MG, 2006, ARCH INTERN MED, V166, P2278, DOI 10.1001/archinte.166.20.2278; Tzioufas AG, 2000, ANN RHEUM DIS, V59, P99, DOI 10.1136/ard.59.2.99; Unterman A, 2011, SEMIN ARTHRITIS RHEU, V41, P1, DOI 10.1016/j.semarthrit.2010.08.001; Valentinov Monov Simeon, 2007, Med Pregl, V60 Suppl 2, P70; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8	47	51	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55843	10.1371/journal.pone.0055843	http://dx.doi.org/10.1371/journal.pone.0055843			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424638	Green Published, gold, Green Submitted			2022-12-27	WOS:000315965100026
J	Kunz, BR; Creem-Regehr, SH; Thompson, WB				Kunz, Benjamin R.; Creem-Regehr, Sarah H.; Thompson, William B.			Does Perceptual-Motor Calibration Generalize across Two Different Forms of Locomotion? Investigations of Walking and Wheelchairs	PLOS ONE			English	Article							PRISM ADAPTATION; RECALIBRATION; INTEGRATION; INFORMATION; AFFORDANCE; DEPENDS	The relationship between biomechanical action and perception of self-motion during walking is typically consistent and well-learned but also adaptable. This perceptual-motor coupling can be recalibrated by creating a mismatch between the visual information for self-motion and walking speed. Perceptual-motor recalibration of locomotion has been demonstrated through effects on subsequent walking without vision, showing that learned perceptual-motor coupling influences a dynamic representation of one's spatial position during walking. Our present studies test whether recalibration of wheelchair locomotion, a novel form of locomotion for typically walking individuals, similarly influences subsequent wheelchair locomotion. Furthermore, we test whether adaptation to the pairing of visual information for self-motion during one form of locomotion transfers to a different locomotion modality. We find strong effects of perceptual-motor recalibration for matched locomotion modalities - walking/walking and wheeling/wheeling. Transfer across incongruent locomotion modalities showed weak recalibration effects. The results have implications both for theories of perceptualmotor calibration mechanisms and their effects on spatial orientation, as well as for practical applications in training and rehabilitation.	[Kunz, Benjamin R.] Univ Dayton, Dept Psychol, Dayton, OH 45469 USA; [Creem-Regehr, Sarah H.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA; [Thompson, William B.] Univ Utah, Sch Comp, Salt Lake City, UT USA	University of Dayton; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kunz, BR (corresponding author), Univ Dayton, Dept Psychol, Dayton, OH 45469 USA.	bkunz1@udayton.edu			National Science Foundation (NSF) [IIS-0745131]	National Science Foundation (NSF)(National Science Foundation (NSF))	This research was supported in part by National Science Foundation (NSF) Grant IIS-0745131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adolph KE, 2000, J EXP PSYCHOL HUMAN, V26, P1148, DOI 10.1037/0096-1523.26.3.1148; Baraduc P, 2002, J NEUROPHYSIOL, V88, P973, DOI 10.1152/jn.2002.88.2.973; Bruggeman H, 2010, PSYCHOL SCI, V21, P1006, DOI 10.1177/0956797610372635; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; Durgin FH, 2005, J EXP PSYCHOL HUMAN, V31, P398, DOI 10.1037/0096-1523.31.3.398; Durgin FH, 2003, PSYCHOL SCI, V14, P567, DOI 10.1046/j.0956-7976.2003.psci_1466.x; Durgin FH, 1999, EXP BRAIN RES, V127, P12, DOI 10.1007/s002210050769; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fajen BR, 2007, ECOL PSYCHOL, V19, P383, DOI 10.1080/10407410701557877; Fajen BR, 2007, EXP BRAIN RES, V183, P61, DOI 10.1007/s00221-007-1021-1; Field DP, 1999, PERCEPT PSYCHOPHYS, V61, P161, DOI 10.3758/BF03211957; Higuchi T, 2004, J EXP PSYCHOL-APPL, V10, P55, DOI 10.1037/1076-898X.10.1.55; Interrante V, 2007, 7 LEAGUE BOOTS NEW M, P169; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kuhl SA, 2008, HMD CALIBRATION ITS; Kuhl SA, 2008, ACM T APPL PERCEPT, V5, DOI 10.1145/1402236.1402241; Kunz BR, 2009, J EXP PSYCHOL HUMAN, V35, P1458, DOI 10.1037/a0015786; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Loomis J.M., 2008, MEASURING SPATIAL PE; LOOMIS JM, 1992, J EXP PSYCHOL HUMAN, V18, P906, DOI 10.1037/0096-1523.18.4.906; Martin TA, 1996, BRAIN, V119, P1199, DOI 10.1093/brain/119.4.1199; Michel C, 2008, EXP BRAIN RES, V185, P259, DOI 10.1007/s00221-007-1152-4; Mohler BJ, 2007, ACM T APPL PERCEPT, V4, DOI 10.1145/1227134/1227138; Mohler BJ, 2004, P 1 S APPL PERC GRAP; Mohler BJ, 2007, THESIS U UTAH; Mohler BJ, 2006, P 3 SIGGRAPH S APPL; Morton SM, 2004, J NEUROPHYSIOL, V92, P2497, DOI 10.1152/jn.00129.2004; Mulavara AP, 2010, EXP BRAIN RES, V202, P649, DOI 10.1007/s00221-010-2171-0; Philbeck JW, 2008, PERCEPT PSYCHOPHYS, V70, P1459, DOI 10.3758/PP.70.8.1459; Pick HL, 1999, J EXP PSYCHOL HUMAN, V25, P1179, DOI 10.1037/0096-1523.25.5.1179; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Richardson AR, 2007, HUM FACTORS, V49, P507, DOI 10.1518/001872007X200139; RIESER JJ, 1995, J EXP PSYCHOL HUMAN, V21, P480, DOI 10.1037/0096-1523.21.3.480; Rieser JJ, 1999, WAYFINDING BEHAVIOR, P168; Savelsbergh G J, 1998, Pediatr Rehabil, V2, P5; Schrater PR, 2000, INT J COMPUT VISION, V40, P73, DOI 10.1023/A:1026557704054; Stoffregen TA, 2009, ECOL PSYCHOL, V21, P1, DOI 10.1080/10407410802626001; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Waller D, 2008, J EXP PSYCHOL-APPL, V14, P61, DOI 10.1037/1076-898X.14.1.61; WELCH RB, 1986, HDB PERCEPTION HUMAN; Williams BW, 2006, UPDATING ORIENTATION; Withagen R, 2002, ECOL PSYCHOL, V14, P223, DOI 10.1207/S15326969ECO1404_2; Yuille A, 2006, TRENDS COGN SCI, V10, P301, DOI 10.1016/j.tics.2006.05.002	44	21	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e54446	10.1371/journal.pone.0054446	http://dx.doi.org/10.1371/journal.pone.0054446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104BU	23424615	Green Published, Green Submitted, gold			2022-12-27	WOS:000315965100003
J	Papaix, J; David, O; Lannou, C; Monod, H				Papaix, Julien; David, Olivier; Lannou, Christian; Monod, Herve			Dynamics of Adaptation in Spatially Heterogeneous Metapopulations	PLOS ONE			English	Article							SENSITIVITY-ANALYSIS; EVOLUTION; AGGRESSIVENESS; SPECIALIZATION; COEVOLUTION; STRATEGIES; RESISTANCE; SPECIATION; DISPERSAL; SELECTION	The selection pressure experienced by organisms often varies across the species range. It is hence crucial to characterise the link between environmental spatial heterogeneity and the adaptive dynamics of species or populations. We address this issue by studying the phenotypic evolution of a spatial metapopulation using an adaptive dynamics approach. The singular strategy is found to be the mean of the optimal phenotypes in each habitat with larger weights for habitats present in large and well connected patches. The presence of spatial clusters of habitats in the metapopulation is found to facilitate specialisation and to increase both the level of adaptation and the evolutionary speed of the population when dispersal is limited. By showing that spatial structures are crucial in determining the specialisation level and the evolutionary speed of a population, our results give insight into the influence of spatial heterogeneity on the niche breadth of species.	[Papaix, Julien; Lannou, Christian] INRA, Plant Hlth & Environm Div, Biol & GEst Risques Agr Grp UR BIOGER CPP, Thiverval Grignon, France; [Papaix, Julien; David, Olivier; Monod, Herve] INRA, Appl Math & Informat Div, Math & Informat Appl Grp UR MIAJ, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Papaix, J (corresponding author), INRA, Plant Hlth & Environm Div, Biol & GEst Risques Agr Grp UR BIOGER CPP, Thiverval Grignon, France.	julien.papaix@jouy.inra.fr	Papaïx, Julien/S-3431-2016	David, Olivier/0000-0002-1389-7158	French National Institute for Agricultural Research	French National Institute for Agricultural Research	This study was supported by the French National Institute for Agricultural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnagaud JY, 2011, GLOBAL ECOL BIOGEOGR, V20, P630, DOI 10.1111/j.1466-8238.2010.00629.x; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bouvier A, 2009, ENVIRON MODELL SOFTW, V24, P843, DOI 10.1016/j.envsoft.2008.11.006; Burdon JJ, 2000, EVOL ECOL, V14, P261, DOI 10.1023/A:1011042721274; Caswell, 2000, MATRIX POPULATION MO; Champagnat N, 2006, THEOR POPUL BIOL, V69, P297, DOI 10.1016/j.tpb.2005.10.004; Champagnat N, 2007, ANN APPL PROBAB, V17, P102, DOI 10.1214/105051606000000628; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Claessen D, 2007, EVOL ECOL RES, V9, P51; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; DEAKIN MAB, 1966, AM NAT, V100, P690, DOI 10.1086/282462; Debarre F, 2010, J EVOLUTION BIOL, V23, P1090, DOI 10.1111/j.1420-9101.2010.01966.x; Debarre F, 2011, ECOL LETT, V14, P260, DOI 10.1111/j.1461-0248.2010.01580.x; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Dieckmann U, 1996, J MATH BIOL, V34, P579, DOI 10.1007/BF02409751; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; Durinx M, 2008, J MATH BIOL, V56, P673, DOI 10.1007/s00285-007-0134-2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Gandon S, 2000, P ROY SOC B-BIOL SCI, V267, P985, DOI 10.1098/rspb.2000.1100; Gautier M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-550; Geritz SAH, 2005, J EVOLUTION BIOL, V18, P1174, DOI 10.1111/j.1420-9101.2004.00841.x; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Hanski I, 2011, AM NAT, V177, P29, DOI 10.1086/657625; He HS, 2000, LANDSCAPE ECOL, V15, P591, DOI 10.1023/A:1008102521322; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; Johnson MTJ, 2007, J EVOLUTION BIOL, V20, P190, DOI 10.1111/j.1420-9101.2006.01201.x; JOHNSON R, 1981, PHYTOPATHOLOGY, V71, P567, DOI 10.1094/Phyto-71-567; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Meszena Geza, 1997, Journal of Biological Systems, V5, P265, DOI 10.1142/S0218339097000175; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Nagylaki T, 2008, LECT NOTES MATH, V1922, P117; Ovaskainen O, 2003, THEOR POPUL BIOL, V64, P481, DOI 10.1016/S0040-5809(03)00102-3; Pariaud B, 2009, PLANT PATHOL, V58, P409, DOI 10.1111/j.1365-3059.2009.02039.x; Pariaud B, 2009, PHYTOPATHOLOGY, V99, P869, DOI 10.1094/PHYTO-99-7-0869; Parnell S, 2009, PHYTOPATHOLOGY, V99, P1370, DOI 10.1094/PHYTO-99-12-1370; Parvinen K, 2004, THEOR POPUL BIOL, V66, P233, DOI 10.1016/j.tpb.2004.06.002; Plantegenest M, 2007, J R SOC INTERFACE, V4, P963, DOI 10.1098/rsif.2007.1114; Ravigne V, 2009, AM NAT, V174, pE141, DOI 10.1086/605369; Rhone B, 2008, MOL ECOL, V17, P930, DOI 10.1111/j.1365-294X.2007.03619.x; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Saltelli A, 2000, STAT SCI, V15, P377, DOI 10.1214/ss/1009213004; Skelsey P, 2010, PHYTOPATHOLOGY, V100, P1146, DOI 10.1094/PHYTO-06-09-0148; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Sobol I.M., 1993, MATH MODEL COMPUT EX, V1, P407, DOI DOI 10.18287/0134-2452-2015-39-4-459-461; Soubeyrand S, 2009, AM NAT, V174, P308, DOI 10.1086/603624; Sudret B, 2008, RELIAB ENG SYST SAFE, V93, P964, DOI 10.1016/j.ress.2007.04.002; van den Berg F, 2011, EVOL ECOL, V25, P121, DOI 10.1007/s10682-010-9387-0; Waxman D, 2005, J EVOLUTION BIOL, V18, P1139, DOI 10.1111/j.1420-9101.2005.00948.x; With KA, 1997, OIKOS, V78, P151, DOI 10.2307/3545811; Xu XM, 2011, PLANT PATHOL, V60, P857, DOI 10.1111/j.1365-3059.2011.02441.x	56	23	23	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e54697	10.1371/journal.pone.0054697	http://dx.doi.org/10.1371/journal.pone.0054697			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424618	gold, Green Submitted, Green Published			2022-12-27	WOS:000315965100006
J	Sabin, LR; Zheng, Q; Thekkat, P; Yang, J; Hannon, GJ; Gregory, BD; Tudor, M; Cherry, S				Sabin, Leah R.; Zheng, Qi; Thekkat, Pramod; Yang, Jamie; Hannon, Gregory J.; Gregory, Brian D.; Tudor, Matthew; Cherry, Sara			Dicer-2 Processes Diverse Viral RNA Species	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; ANTIVIRAL IMMUNITY; DROSOPHILA; INTERFERENCE; INFECTION; REPLICATION; SUPPRESSION; POLYMERASE; ALPHAVIRUS; INSECT	RNA silencing pathways play critical roles in gene regulation, virus infection, and transposon control. RNA interference (RNAi) is mediated by small interfering RNAs (siRNAs), which are liberated from double-stranded (ds)RNA precursors by Dicer and guide the RNA-induced silencing complex (RISC) to targets. Although principles governing small RNA sorting into RISC have been uncovered, the spectrum of RNA species that can be targeted by Dicer proteins, particularly the viral RNAs present during an infection, are poorly understood. Dicer-2 potently restricts viral infection in insects by generating virus-derived siRNAs from viral RNA. To better characterize the substrates of Dicer-2, we examined the virus-derived siRNAs produced during the Drosophila antiviral RNAi response to four different viruses using high-throughput sequencing. We found that each virus was uniquely targeted by the RNAi pathway; dicing substrates included dsRNA replication intermediates and intramolecular RNA stem loops. For instance, a putative intergenic RNA hairpin encoded by Rift Valley Fever virus generates abundant small RNAs in both Drosophila and mosquito cells, while repetitive sequences within the genomic termini of Vaccinia virus, which give rise to abundant small RNAs in Drosophila, were found to be transcribed in both insect and mammalian cells. Moreover, we provide evidence that the RNA species targeted by Dicer-2 can be modulated by the presence of a viral suppressor of RNAi. This study uncovered several novel, heavily targeted features within viral genomes, offering insight into viral replication, viral immune evasion strategies, and the mechanism of antiviral RNAi.	[Sabin, Leah R.; Cherry, Sara] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Sabin, Leah R.; Zheng, Qi; Yang, Jamie; Gregory, Brian D.; Cherry, Sara] Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA; [Zheng, Qi; Yang, Jamie; Gregory, Brian D.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Tudor, Matthew] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Thekkat, Pramod; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Gregory, BD (corresponding author), Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA.	bdgregor@sas.upenn.edu; mtudor@gmail.com; cherrys@mail.med.upenn.edu	Gregory, Brian D/G-2890-2010; Hannon, Gregory/AAB-3568-2019; Zheng, Qi/A-9208-2015	Zheng, Qi/0000-0002-2582-1222; cherry, sara/0000-0003-3956-6610; Tudor, Matthew/0000-0001-8766-195X; Sabin, Leah/0000-0003-1757-7415	Penn Genome Frontiers Institute; National Institutes of Health (NIH) [R01AI074951, U54AI057168]; NIH [T32GM007229, T32AI007324]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074951, T32AI007324, U54AI057168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062534, T32GM007229] Funding Source: NIH RePORTER	Penn Genome Frontiers Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Penn Genome Frontiers Institute to BG; from National Institutes of Health (NIH) (R01AI074951, U54AI057168) to SC; and from NIH (T32GM007229, T32AI007324) to LRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER WA, 1992, J VIROL, V66, P2934, DOI 10.1128/JVI.66.5.2934-2942.1992; Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; ARIF BM, 1995, J GEN VIROL, V76, P1, DOI 10.1099/0022-1317-76-1-1; Backes S, 2012, CELL HOST MICROBE, V12, P200, DOI 10.1016/j.chom.2012.05.019; Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; CAPLEN H, 1985, J GEN VIROL, V66, P2271, DOI 10.1099/0022-1317-66-10-2271; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; EMERY VC, 1987, VIROLOGY, V156, P1, DOI 10.1016/0042-6822(87)90430-2; Filone CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015483; Flynt A, 2009, P NATL ACAD SCI USA, V106, P5270, DOI 10.1073/pnas.0813412106; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11; Johnson KN, 1998, J GEN VIROL, V79, P191, DOI 10.1099/0022-1317-79-1-191; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Kim K, 2006, COLD SPRING HARB SYM, V71, P39, DOI 10.1101/sqb.2006.71.008; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; LAZZARINI RA, 1981, CELL, V26, P145, DOI 10.1016/0092-8674(81)90298-1; Lyles D., 2006, FIELDS VIROLOGY, P1363; Moser TS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000954; Moss B, 2006, FIELDS VIROLOGY, P2905; Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107; Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; R Development Core Team, R LANG ENV STAT COMP; Ramsburg E, 2005, J VIROL, V79, P15043, DOI 10.1128/JVI.79.24.15043-15053.2005; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; Sanchez-Vargas I, 2004, VIRUS RES, V102, P65, DOI 10.1016/j.virusres.2004.01.017; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12; Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848; Shin SW, 2005, J BIOL CHEM, V280, P16499, DOI 10.1074/jbc.M500711200; Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Venables WN., 2002, MODERN APPL STAT S 4; Vodovar N, 2011, J VIROL, V85, P11016, DOI 10.1128/JVI.05647-11	40	84	84	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55458	10.1371/journal.pone.0055458	http://dx.doi.org/10.1371/journal.pone.0055458			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424633	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000315965100021
J	Xu, DQ; Fu, HH; Obar, JJ; Park, JJ; Tamada, K; Yagita, H; Lefrancois, L				Xu, Daqi; Fu, Han-Hsuan; Obar, Joshua J.; Park, Jang-June; Tamada, Koji; Yagita, Hideo; Lefrancois, Leo			A Potential New Pathway for PD-L1 Costimulation of the CD8-T Cell Response to Listeria monocytogenes Infection	PLOS ONE			English	Article							T-CELLS; VIRAL-INFECTION; BLOCKADE; DIFFERENTIATION; EXPRESSION; EXPANSION; TOLERANCE; IMMUNITY; EFFECTOR; OX40	Programmed death ligand-1 (PD-L1) is an important negative regulator of T cell immune responses via interactions with PD-1 and CD80. However, PD-L1 can also act as a positive costimulator, but the relevant counterreceptor is not known. We analyzed the role of PD-L1 in CD8-T cell responses to infection with Listeria monocytogenes (LM) or vesicular stomatitis virus (VSV). PD-L1 blockade impaired antigen-specific CD8 effector T cell expansion in response to LM, but not to VSV infection, particularly limiting short-lived effector cell differentiation. Simultaneous CD4-T cell depletion and anti-PD-L1 blockade revealed that PD-L1 provided costimulation even in the absence of CD4-T cells. Most importantly, specific blockade of PD-L1 binding to CD80 or to PD-1 did not recapitulate PDL-1 blockade. The results suggested that PD-L1 plays an important costimulatory role for antigen-specific CD8 T cells during LM infection perhaps through a distinct receptor or interaction epitope.	[Xu, Daqi; Fu, Han-Hsuan; Obar, Joshua J.; Lefrancois, Leo] Univ Connecticut, Ctr Hlth, Dept Immunol, Ctr Integrated Immunol & Vaccine Res, Farmington, CT 06030 USA; [Park, Jang-June; Tamada, Koji] Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Obar, Joshua J.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA	University of Connecticut; University System of Maryland; University of Maryland Baltimore; Juntendo University; Montana State University System; Montana State University Bozeman	Lefrancois, L (corresponding author), Univ Connecticut, Ctr Hlth, Dept Immunol, Ctr Integrated Immunol & Vaccine Res, Farmington, CT 06030 USA.	llefranc@neuron.uchc.edu		Obar, Joshua/0000-0003-4068-7911	National Institutes of Health [AI41576, AI76457]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI074277, R01AI041576, R01AI076457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health AI41576, AI76457. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Croft M, 2003, CYTOKINE GROWTH F R, V14, P265, DOI 10.1016/S1359-6101(03)00025-X; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Gough MJ, 2009, ADV EXP MED BIOL, V647, P94, DOI 10.1007/978-0-387-89520-8_6; Kaech SM, 2007, IMMUNITY, V27, P393, DOI 10.1016/j.immuni.2007.08.007; Kanai T, 2003, J IMMUNOL, V171, P4156, DOI 10.4049/jimmunol.171.8.4156; Keir ME, 2007, J IMMUNOL, V179, P5064, DOI 10.4049/jimmunol.179.8.5064; Lee SJ, 2010, J IMMUNOL, V185, P2442, DOI 10.4049/jimmunol.1000743; Marzo AL, 2004, J IMMUNOL, V173, P969, DOI 10.4049/jimmunol.173.2.969; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Nurieva RI, 2009, IMMUNOL REV, V229, P88, DOI 10.1111/j.1600-065X.2009.00769.x; Obar JJ, 2010, INT IMMUNOL, V22, P619, DOI 10.1093/intimm/dxq053; Obar JJ, 2010, ANN NY ACAD SCI, V1183, P251, DOI 10.1111/j.1749-6632.2009.05126.x; Park JJ, 2010, BLOOD, V116, P1291, DOI 10.1182/blood-2010-01-265975; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Rowe JH, 2008, J IMMUNOL, V180, P7553, DOI 10.4049/jimmunol.180.11.7553; Rowe JH, 2012, J IMMUNOL, V189, P876, DOI 10.4049/jimmunol.1103227; Seo SK, 2008, IMMUNOLOGY, V123, P90, DOI 10.1111/j.1365-2567.2007.02708.x; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; Yamazaki H, 2005, J IMMUNOL, V175, P1586, DOI 10.4049/jimmunol.175.3.1586; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538	24	17	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56539	10.1371/journal.pone.0056539	http://dx.doi.org/10.1371/journal.pone.0056539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409193	Green Submitted, Green Published, gold			2022-12-27	WOS:000315100000058
J	Liv, N; Zonnevylle, AC; Narvaez, AC; Effting, APJ; Voorneveld, PW; Lucas, MS; Hardwick, JC; Wepf, RA; Kruit, P; Hoogenboom, JP				Liv, Nalan; Zonnevylle, A. Christiaan; Narvaez, Angela C.; Effting, Andries P. J.; Voorneveld, Philip W.; Lucas, Miriam S.; Hardwick, James C.; Wepf, Roger A.; Kruit, Pieter; Hoogenboom, Jacob P.			Simultaneous Correlative Scanning Electron and High-NA Fluorescence Microscopy	PLOS ONE			English	Article							TOMOGRAPHY; LIGHT; ULTRASTRUCTURE; TISSUES; CELLS; TOOL	Correlative light and electron microscopy (CLEM) is a unique method for investigating biological structure-function relations. With CLEM protein distributions visualized in fluorescence can be mapped onto the cellular ultrastructure measured with electron microscopy. Widespread application of correlative microscopy is hampered by elaborate experimental procedures related foremost to retrieving regions of interest in both modalities and/or compromises in integrated approaches. We present a novel approach to correlative microscopy, in which a high numerical aperture epi-fluorescence microscope and a scanning electron microscope illuminate the same area of a sample at the same time. This removes the need for retrieval of regions of interest leading to a drastic reduction of inspection times and the possibility for quantitative investigations of large areas and datasets with correlative microscopy. We demonstrate Simultaneous CLEM (SCLEM) analyzing cell-cell connections and membrane protrusions in whole uncoated colon adenocarcinoma cell line cells stained for actin and cortactin with AlexaFluor488. SCLEM imaging of coverglass-mounted tissue sections with both electron-dense and fluorescence staining is also shown.	[Liv, Nalan; Zonnevylle, A. Christiaan; Narvaez, Angela C.; Kruit, Pieter; Hoogenboom, Jacob P.] Delft Univ Technol, Fac Sci Appl, Dept Imaging Sci & Technol, Delft, Netherlands; [Effting, Andries P. J.] DELMIC BV, Delft, Netherlands; [Voorneveld, Philip W.; Hardwick, James C.] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands; [Lucas, Miriam S.; Wepf, Roger A.] Swiss Fed Inst Technol, Electron Microscopy ETH Zurich EMEZ, Zurich, Switzerland	Delft University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hoogenboom, JP (corresponding author), Delft Univ Technol, Fac Sci Appl, Dept Imaging Sci & Technol, Delft, Netherlands.	j.p.hoogenboom@tudelft.nl	Liv, Nalan/AAK-8588-2021; Hoogenboom, Jacob/F-4444-2014; Hardwick, James/J-4862-2013	Liv, Nalan/0000-0003-2654-9117; Hoogenboom, Jacob/0000-0003-4539-8772; Hardwick, James/0000-0002-9575-5099; /0000-0001-9998-6372; Voorneveld, Philip/0000-0002-3881-4435; Wepf, Roger/0000-0003-2203-3674	STW Valorisation Grant; NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands; 130 partners NanoNextNL	STW Valorisation Grant; NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands; 130 partners NanoNextNL	A.P.J.E. acknowledges support from a STW Valorisation Grant. A.C.N. is supported by NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners NanoNextNL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agronskaia AV, 2008, J STRUCT BIOL, V164, P183, DOI 10.1016/j.jsb.2008.07.003; Biel SS, 2003, J MICROSC-OXFORD, V212, P91, DOI 10.1046/j.1365-2818.2003.01227.x; Caplan J, 2011, CURR OPIN STRUC BIOL, V21, P686, DOI 10.1016/j.sbi.2011.06.010; de Jonge N, 2009, P NATL ACAD SCI USA, V106, P2159, DOI 10.1073/pnas.0809567106; Gaietta GM, 2006, P NATL ACAD SCI USA, V103, P17777, DOI 10.1073/pnas.0608509103; Giepmans BNG, 2005, NAT METHODS, V2, P743, DOI 10.1038/NMETH791; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Grabenbauer M, 2005, NAT METHODS, V2, P857, DOI 10.1038/nmeth806; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Kanemaru T, 2009, ULTRAMICROSCOPY, V109, P344, DOI 10.1016/j.ultramic.2009.01.002; Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Lucas MS, 2012, METHOD CELL BIOL, V111, P325, DOI 10.1016/B978-0-12-416026-2.00017-0; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mironov AA, 2009, J MICROSC-OXFORD, V235, P308, DOI 10.1111/j.1365-2818.2009.03222.x; Niitsuma J, 2005, J ELECTRON MICROSC, V54, P325, DOI 10.1093/jmicro/dfi043; Nishiyama H, 2010, J STRUCT BIOL, V169, P438, DOI 10.1016/j.jsb.2010.01.005; Plitzko JM, 2009, CURR OPIN BIOTECH, V20, P83, DOI 10.1016/j.copbio.2009.03.008; Pluk H, 2009, J MICROSC-OXFORD, V233, P353, DOI 10.1111/j.1365-2818.2009.03140.x; Rushe N, 2005, J MATER SCI-MATER M, V16, P247, DOI 10.1007/s10856-005-6686-z; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Spiegelhalter C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009014; Thiberge S, 2004, P NATL ACAD SCI USA, V101, P3346, DOI 10.1073/pnas.0400088101; Watanabe S, 2011, NAT METHODS, V8, P80, DOI 10.1038/NMETH.1537; WOUTERS CH, 1987, J MICROSC-OXFORD, V145, P237; Zhou SB, 1998, P NATL ACAD SCI USA, V95, P2412, DOI 10.1073/pnas.95.5.2412	26	60	65	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55707	10.1371/journal.pone.0055707	http://dx.doi.org/10.1371/journal.pone.0055707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409024	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300030
J	Rice, ES; Silverman, J				Rice, Eleanor Spicer; Silverman, Jules			Propagule Pressure and Climate Contribute to the Displacement of Linepithema humile by Pachycondyla chinensis	PLOS ONE			English	Article							INVASIVE ARGENTINE ANT; IMPORTED FIRE ANT; NATIVE ANTS; ESTABLISHMENT SUCCESS; ABIOTIC FACTORS; PONERINE ANT; SOLENOPSIS-INVICTA; FORAGING ACTIVITY; SPECIES RICHNESS; WORLDWIDE SPREAD	Identifying mechanisms governing the establishment and spread of invasive species is a fundamental challenge in invasion biology. Because species invasions are frequently observed only after the species presents an environmental threat, research identifying the contributing agents to dispersal and subsequent spread are confined to retrograde observations. Here, we use a combination of seasonal surveys and experimental approaches to test the relative importance of behavioral and abiotic factors in determining the local co-occurrence of two invasive ant species, the established Argentine ant (Linepithema humile Mayr) and the newly invasive Asian needle ant (Pachycondyla chinensis Emery). We show that the broader climatic envelope of P. chinensis enables it to establish earlier in the year than L. humile. We also demonstrate that increased P. chinensis propagule pressure during periods of L. humile scarcity contributes to successful P. chinensis early season establishment. Furthermore, we show that, although L. humile is the numerically superior and behaviorally dominant species at baits, P. chinensis is currently displacing L. humile across the invaded landscape. By identifying the features promoting the displacement of one invasive ant by another we can better understand both early determinants in the invasion process and factors limiting colony expansion and survival.	[Rice, Eleanor Spicer; Silverman, Jules] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Silverman, J (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	jules_silverman@gmail.com			Blanton J. Whitmire endowment at North Carolina State University	Blanton J. Whitmire endowment at North Carolina State University	This work was supported by the Blanton J. Whitmire endowment at North Carolina State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril S, 2007, ENVIRON ENTOMOL, V36, P1166, DOI 10.1603/0046-225X(2007)36[1166:FAADSO]2.0.CO;2; Alder P, 2005, J ECON ENTOMOL, V98, P493, DOI 10.1603/0022-0493-98.2.493; Bednar DM, 2011, INSECT SOC, V58, P459, DOI 10.1007/s00040-011-0163-0; Blackburn TM, 2011, BIODIVERS CONSERV, V20, P2189, DOI 10.1007/s10531-011-0081-5; Blackburn TM, 2001, NATURE, V414, P195, DOI 10.1038/35102557; Bomford M, 2010, BIOL INVASIONS, V12, P2559, DOI 10.1007/s10530-009-9665-3; Bomford M, 2009, WILDLIFE RES, V36, P192, DOI 10.1071/WR08055; Bomford M, 2009, BIOL INVASIONS, V11, P713, DOI 10.1007/s10530-008-9285-3; Brenneis VEF, 2011, OECOLOGIA, V167, P169, DOI 10.1007/s00442-011-1962-8; Brightwell RJ, 2010, J ECON ENTOMOL, V103, P1790, DOI 10.1603/EC10150; Brightwell RJ, 2010, ENVIRON ENTOMOL, V39, P1659, DOI 10.1603/EN09345; Brightwell RJ, 2011, ENVIRON ENTOMOL, V40, P1019, DOI 10.1603/EN11038; Brightwell RJ, 2010, BIOL INVASIONS, V12, P2051, DOI 10.1007/s10530-009-9607-0; Campos RBF, 2001, SOCIOBIOLOGY, V38, P539; Carrillo-Gavilan A, 2012, FUNCT ECOL, V26, P283, DOI 10.1111/j.1365-2435.2011.01931.x; Catford JA, 2011, DIVERS DISTRIB, V17, P1099, DOI 10.1111/j.1472-4642.2011.00794.x; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Dejean A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019837; Dietrich B, 2003, OECOLOGIA, V136, P63, DOI 10.1007/s00442-003-1245-0; Eschtruth AK, 2011, ECOLOGY, V92, P1314, DOI 10.1890/10-0857.1; Goodenough AE, 2010, COMMUNITY ECOL, V11, P13, DOI 10.1556/ComEc.11.2010.1.3; Green PT, 2011, ECOLOGY, V92, P1758, DOI 10.1890/11-0050.1; Grey EK, 2011, OECOLOGIA, V166, P935, DOI 10.1007/s00442-011-1931-2; Griffen BD, 2011, J EXP MAR BIOL ECOL, V406, P6, DOI 10.1016/j.jembe.2011.06.005; Guenard B, 2011, NATURWISSENSCHAFTEN, V98, P651, DOI 10.1007/s00114-011-0814-z; Guenard B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011614; Hartley S, 2006, ECOL LETT, V9, P1068, DOI 10.1111/j.1461-0248.2006.00954.x; Hartley S, 2010, ECOGRAPHY, V33, P83, DOI 10.1111/j.1600-0587.2009.06037.x; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Hee JJ, 2000, CONSERV BIOL, V14, P559, DOI 10.1046/j.1523-1739.2000.99040.x; Heller NE, 2008, OECOLOGIA, V155, P385, DOI 10.1007/s00442-007-0911-z; Heterick B, 1997, AUST J ECOL, V22, P218, DOI 10.1111/j.1442-9993.1997.tb00661.x; Holway DA, 2002, ECOLOGY, V83, P1610, DOI 10.1890/0012-9658(2002)083[1610:ROAFIG]2.0.CO;2; Holway DA, 1998, SCIENCE, V282, P949, DOI 10.1126/science.282.5390.949; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; Hooper-Bui LM, 2002, J ECON ENTOMOL, V95, P1222, DOI 10.1603/0022-0493-95.6.1222; Human KG, 1996, OECOLOGIA, V105, P405, DOI 10.1007/BF00328744; Human KG, 1999, INSECT SOC, V46, P159, DOI 10.1007/s000400050127; Human KG, 1998, ENVIRON ENTOMOL, V27, P822, DOI 10.1093/ee/27.4.822; Ito F, 1997, ETHOL ECOL EVOL, V9, P335, DOI 10.1080/08927014.1997.9522876; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; King JR, 2007, FLA ENTOMOL, V90, P435, DOI 10.1653/0015-4040(2007)90[435:REALPI]2.0.CO;2; King JR, 2006, J ANIM ECOL, V75, P1370, DOI 10.1111/j.1365-2656.2006.01161.x; Kirschenbaum R, 2008, SOCIOBIOLOGY, V51, P543; Kirschenbaum R, 2007, SOCIOBIOLOGY, V50, P1069; Krushelnycky PD, 2005, DIVERS DISTRIB, V11, P319, DOI 10.1111/j.1366-9516.2005.00151.x; Lach L, 2009, ANT ECOLOGY, P257; Lach L, 2008, ECOL ENTOMOL, V33, P155, DOI 10.1111/j.1365-2311.2007.00969.x; Leibold MA, 1997, ANNU REV ECOL SYST, V28, P467, DOI 10.1146/annurev.ecolsys.28.1.467; Lessard JP, 2009, ECOLOGY, V90, P2664, DOI 10.1890/09-0503.1; Llewelyn J, 2010, OECOLOGIA, V162, P343, DOI 10.1007/s00442-009-1471-1; Lockwood BL, 2011, J EXP MAR BIOL ECOL, V400, P167, DOI 10.1016/j.jembe.2011.02.022; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; Maschwitz U, 2004, NATURWISSENSCHAFTEN, V91, P40, DOI 10.1007/s00114-003-0487-3; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; Meissner HE, 2003, J ECON ENTOMOL, V96, P850, DOI 10.1603/0022-0493-96.3.850; Menke SB, 2007, ECOLOGY, V88, P3164, DOI 10.1890/07-0122.1; Menke SB, 2006, J ANIM ECOL, V75, P368, DOI 10.1111/j.1365-2656.2006.01056.x; Mikheyev AS, 2008, DIVERS DISTRIB, V14, P301, DOI 10.1111/j.1472-4642.2007.00463.x; Moller H, 1996, BIOL CONSERV, V78, P125, DOI 10.1016/0006-3207(96)00022-5; Morrison LW, 2003, ENVIRON ENTOMOL, V32, P548, DOI 10.1603/0046-225X-32.3.548; Nathan R, 2011, ECOL LETT, V14, P211, DOI 10.1111/j.1461-0248.2010.01573.x; Nelder MP, 2006, J MED ENTOMOL, V43, P1094, DOI 10.1603/0022-2585(2006)43[1094:EOTIAP]2.0.CO;2; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; Oliveras J, 2005, SOCIOBIOLOGY, V45, P643; Orivel J, 1998, BIOTROPICA, V30, P487, DOI 10.1111/j.1744-7429.1998.tb00085.x; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; PASSERA L, 1992, J ZOOL, V228, P141, DOI 10.1111/j.1469-7998.1992.tb04438.x; Plowes RM, 2007, BIOL INVASIONS, V9, P825, DOI 10.1007/s10530-006-9084-7; Polo-Cavia N, 2011, BIOL INVASIONS, V13, P1387, DOI 10.1007/s10530-010-9897-2; PORTER SD, 1990, ECOLOGY, V71, P2095, DOI 10.2307/1938623; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; Raimundo RLG, 2009, ANN ENTOMOL SOC AM, V102, P1151, DOI 10.1603/008.102.0625; Rauschert ESJ, 2010, BIOL INVASIONS, V12, P563, DOI 10.1007/s10530-009-9463-y; Rice ES, 2012, J ECON ENTOMOL, V105, P1751, DOI 10.1603/EC12207; Roche CT, 2003, WEED RES, V43, P177, DOI 10.1046/j.1365-3180.2003.00331.x; Rodriguez-Cabal MA, 2012, BIOL INVASIONS, V14, P557, DOI 10.1007/s10530-011-0097-5; Roura-Pascual N, 2011, P NATL ACAD SCI USA, V108, P220, DOI 10.1073/pnas.1011723108; Rowles AD, 2009, AUSTRAL ECOL, V34, P239, DOI 10.1111/j.1442-9993.2008.01922.x; Sagata K, 2009, J APPL ECOL, V46, P19, DOI 10.1111/j.1365-2664.2008.01523.x; Sanders NJ, 2003, GLOBAL ECOL BIOGEOGR, V12, P93, DOI 10.1046/j.1466-822X.2003.00324.x; Sanders NJ, 2003, P NATL ACAD SCI USA, V100, P2474, DOI 10.1073/pnas.0437913100; Sanders NJ, 2001, OECOLOGIA, V127, P123, DOI 10.1007/s004420000572; Sarty M, 2007, INSECT SOC, V54, P166, DOI 10.1007/s00040-007-0927-8; Sarty M, 2006, OECOLOGIA, V149, P465, DOI 10.1007/s00442-006-0453-9; Short KH, 2008, ANIM BEHAV, V76, P429, DOI 10.1016/j.anbehav.2008.04.008; Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Souza L, 2011, J PLANT ECOL, V4, P123, DOI 10.1093/jpe/rtq027; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Strongin K, 2011, AM MIDL NAT, V166, P224, DOI 10.1674/0003-0031-166.1.224; Stuble KL, 2009, ECOL ENTOMOL, V34, P520, DOI 10.1111/j.1365-2311.2009.01098.x; Suarez AV, 2002, ECOL APPL, V12, P291, DOI 10.2307/3061153; Suarez AV, 2005, P NATL ACAD SCI USA, V102, P17032, DOI 10.1073/pnas.0506119102; Suarez AV, 2005, INSECT SOC, V52, P378, DOI 10.1007/s00040-005-0824-y; Suwabe M, 2009, ECOL RES, V24, P637, DOI 10.1007/s11284-008-0534-9; de Albuquerque FS, 2011, PLANT ECOL, V212, P1901, DOI 10.1007/s11258-011-9962-7; Thomas ML, 2003, NATURWISSENSCHAFTEN, V90, P88, DOI 10.1007/s00114-002-0396-x; Von Holle B, 2005, ECOLOGY, V86, P3212, DOI 10.1890/05-0427; Wetterer JK, 2006, ECOL ENTOMOL, V31, P358, DOI 10.1111/j.1365-2311.2006.00790.x; Wetterer JK, 2011, FLA ENTOMOL, V94, P582, DOI 10.1653/024.094.0323; Wetterer JK, 2009, MYRMECOL NEWS, V12, P187; Wetterer JK, 2001, SOCIOBIOLOGY, V38, P709; Wilkins KJ, 2006, AFR ENTOMOL, V14, P367; Witte V, 2002, INSECT SOC, V49, P301, DOI 10.1007/PL00012646; Wittmann MJ, 2011, BIOL INVASIONS, V13, P2477, DOI 10.1007/s10530-011-0074-z; Yashiro T, 2010, ZOOTAXA, P39; Zepeda-Paulo FA, 2010, MOL ECOL, V19, P4738, DOI 10.1111/j.1365-294X.2010.04857.x; Zheng JH, 2008, J ENTOMOL SCI, V43, P331, DOI 10.18474/0749-8004-43.3.331	111	28	28	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56281	10.1371/journal.pone.0056281	http://dx.doi.org/10.1371/journal.pone.0056281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409164	Green Submitted, Green Published, gold			2022-12-27	WOS:000314660300070
J	Yokoyama, S; Takahashi, K; Kawashima, R				Yokoyama, Satoru; Takahashi, Kei; Kawashima, Ryuta			Use of Semantic Information to Interpret Thematic Information for Real-Time Sentence Comprehension in an SOV Language	PLOS ONE			English	Article							PASSIVE SENTENCES; JAPANESE; REANALYSIS	Recently, sentence comprehension in languages other than European languages has been investigated from a cross-linguistic perspective. In this paper, we examine whether and how animacy-related semantic information is used for real-time sentence comprehension in a SOV word order language (i.e., Japanese). Twenty-three Japanese native speakers participated in this study. They read semantically reversible and non-reversible sentences with canonical word order, and those with scrambled word order. In our results, the second argument position in reversible sentences took longer to read than that in non-reversible sentences, indicating that animacy information is used in second argument processing. In contrast, for the predicate position, there was no difference in reading times, suggesting that animacy information is NOT used in the predicate position. These results are discussed using the sentence comprehension models of an SOV word order language.	[Yokoyama, Satoru; Takahashi, Kei; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Yokoyama, Satoru] Tohoku Univ, Grad Sch Int Cultural Studies, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Yokoyama, S (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan.	yokoyama@idac.tohoku.ac.jp			JSPS KAKENHI [23720192]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant number 23720192. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornkessel I, 2006, PSYCHOL REV, V113, P787, DOI 10.1037/0033-295X.113.4.787; CHUJO K, 1983, JPN J PSYCHOL, V54, P250, DOI 10.4992/jjpsy.54.250; Ferreira F, 2003, COGNITIVE PSYCHOL, V47, P164, DOI 10.1016/S0010-0285(03)00005-7; HERRIOT P, 1969, J VERB LEARN VERB BE, V8, P166, DOI 10.1016/S0022-5371(69)80056-3; Ito T., 1993, BUN RIKAI HATASU ZYO; JUST MA, 1982, J EXP PSYCHOL GEN, V111, P228, DOI 10.1037/0096-3445.111.2.228; Kamide Y, 1999, LANG COGNITIVE PROC, V14, P631, DOI 10.1080/016909699386211; KEMPER S, 1979, LANG SPEECH, V22, P253, DOI 10.1177/002383097902200306; Kim J, 2009, J NEUROLINGUIST, V22, P151, DOI 10.1016/j.jneuroling.2008.07.005; Koizumi M., 2004, J LINGUIST SOC JPN, V125, P173; Mazuka R., 2002, SENTENCE PROCESSING, P167; Meltzer JA, 2010, CEREB CORTEX, V20, P1853, DOI 10.1093/cercor/bhp249; Miyamoto ET, 2003, LANG SPEECH, V46, P23, DOI 10.1177/00238309030460010301; Miyamoto ET, 2002, J PSYCHOLINGUIST RES, V31, P307, DOI 10.1023/A:1019540324040; Oishi Hiroaki, 2007, COMMUNICATING SKILLS, P367; Richardson FM, 2010, J COGNITIVE NEUROSCI, V22, P1283, DOI 10.1162/jocn.2009.21277; SLOBIN DI, 1966, J VERB LEARN VERB BE, V5, P219, DOI 10.1016/S0022-5371(66)80023-3; Suzuki T, 2008, IEICE TECHNICAL REPO, P17; Tamaoka K, 2005, J PSYCHOLINGUIST RES, V34, P281, DOI 10.1007/s10936-005-3641-6; Wolff S, 2008, BRAIN LANG, V107, P133, DOI 10.1016/j.bandl.2008.06.003; Yokoyama S, 2012, PARTIAL INCREMENTAL, P159; Yokoyama S, 2007, NEUROPSYCHOLOGIA, V45, P989, DOI 10.1016/j.neuropsychologia.2006.09.003	22	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56106	10.1371/journal.pone.0056106	http://dx.doi.org/10.1371/journal.pone.0056106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	086CJ	23409134	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300059
J	Dixon, LJ; Flask, CA; Papouchado, BG; Feldstein, AE; Nagy, LE				Dixon, Laura J.; Flask, Chris A.; Papouchado, Bettina G.; Feldstein, Ariel E.; Nagy, Laura E.			Caspase-1 as a Central Regulator of High Fat Diet-Induced Non-Alcoholic Steatohepatitis	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; LIVER-DISEASE; MICE DEFICIENT; STEATOSIS; INFLAMMASOME; PATHOGENESIS; POPULATION; FIBROSIS; OBESITY; ENZYME	Nonalcoholic steatohepatitis (NASH) is associated with caspase activation. However, a role for pro-inflammatory caspases or inflammasomes has not been explored in diet-induced liver injury. Our aims were to examine the role of caspase-1 in high fat-induced NASH. C57BL/6 wild-type and caspase 1-knockout (Casp1(-/-)) mice were placed on a 12-week high fat diet. Wildtype mice on the high fat diet increased hepatic expression of pro-caspase-1 and IL-1 beta. Both wild-type and Casp1(-/-) mice on the high fat diet gained more weight than mice on a control diet. Hepatic steatosis and TG levels were increased in wildtype mice on high fat diet, but were attenuated in the absence of caspase-1. Plasma cholesterol and free fatty acids were elevated in wild-type, but not Casp1(-/-) mice, on high fat diet. ALT levels were elevated in both wild-type and Casp1(-/-) mice on high fat diet compared to control. Hepatic mRNA expression for genes associated with lipogenesis was lower in Casp1(-/-) mice on high fat diet compared to wild-type mice on high fat diet, while genes associated with fatty acid oxidation were not affected by diet or genotype. Hepatic Tnf alpha and Mcp-1 mRNA expression was increased in wild-type mice on high fat diet, but not in Casp1(-/-) mice on high fat diet. alpha SMA positive cells, Sirius red staining, and Col1 alpha 1 mRNA were increased in wildtype mice on high fat diet compared to control. Deficiency of caspase-1 prevented those increases. In summary, the absence of caspase-1 ameliorates the injurious effects of high fat diet-induced obesity on the liver. Specifically, mice deficient in caspase-1 are protected from high fat-induced hepatic steatosis, inflammation and early fibrogenesis. These data point to the inflammasome as an important therapeutic target for NASH.	[Dixon, Laura J.; Nagy, Laura E.] Case Western Reserve Univ, Dept Mol Med, Cleveland, OH 44106 USA; [Flask, Chris A.] Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44106 USA; [Flask, Chris A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Papouchado, Bettina G.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Feldstein, Ariel E.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nagy, Laura E.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44106 USA; [Nagy, Laura E.] Cleveland Clin, Dept Gastroenterol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of California System; University of California San Diego; University of California System; University of California San Diego; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Nagy, LE (corresponding author), Case Western Reserve Univ, Dept Mol Med, Cleveland, OH 44106 USA.	nagyL3@ccf.org		Flask, Chris/0000-0002-1066-333X	NIH [P20 AA017837, R37 AA011876, RO1 DK082451, CTSA UL1RR024989]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017837, R37AA011876] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH Grants (P20 AA017837) and (R37 AA011876) to LEN, (RO1 DK082451) to AEF and (CTSA UL1RR024989). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunt EM, 2004, HUM PATHOL, V35, P1070, DOI 10.1016/j.humpath.2004.04.017; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Diehl AM, 2005, GUT, V54, P303, DOI 10.1136/gut.2003.024935; Dixon LJ, 2012, LAB INVEST, V92, P713, DOI 10.1038/labinvest.2012.45; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Endo M, 2007, EXP BIOL MED, V232, P614; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; FOSSATI P, 1982, CLIN CHEM, V28, P2077; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Ganz M, 2011, WORLD J GASTROENTERO, V17, P4772, DOI 10.3748/wjg.v17.i43.4772; Hill-Baskin AE, 2009, HUM MOL GENET, V18, P2975, DOI 10.1093/hmg/ddp236; Johnson DH, 2012, J MAGN RESON IMAGING, V35, P837, DOI 10.1002/jmri.23508; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Larter CZ, 2007, J GASTROEN HEPATOL, V22, P1353, DOI 10.1111/j.1440-1746.2007.05004.x; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; London Roslyn M, 2007, Clin Liver Dis, V11, P55, DOI 10.1016/j.cld.2007.02.010; Mandrekar P, 2010, HEPATOLOGY; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Miura K, 2012, AM J PHYSL GASTROINT; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Nanji Amin A, 2004, Clin Liver Dis, V8, P559, DOI 10.1016/j.cld.2004.04.002; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Paschos P, 2009, HIPPOKRATIA, V13, P128; Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Roychowdhury S, 2012, ALCOHOL CLIN EXP RES; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Siebler Jurgen, 2008, J Hepatol, V48, P1032, DOI 10.1016/j.jhep.2008.03.007; Watanabe A, 2009, AM J PHYSIOL-GASTR L, V296, pG1248, DOI 10.1152/ajpgi.90223.2008; Wieckowska A, 2005, CURR OPIN PEDIATR, V17, P636, DOI 10.1097/01.mop.0000172816.79637.c5; Witek RP, 2009, HEPATOLOGY, V50, P1421, DOI 10.1002/hep.23167	42	123	125	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56100	10.1371/journal.pone.0056100	http://dx.doi.org/10.1371/journal.pone.0056100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409132	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200108
J	Kamiyama, N; Yamamoto, M; Saiga, H; Ma, JS; Ohshima, J; Machimura, S; Sasai, M; Kimura, T; Ueda, Y; Kayama, H; Takeda, K				Kamiyama, Naganori; Yamamoto, Masahiro; Saiga, Hiroyuki; Ma, Ji Su; Ohshima, Jun; Machimura, Sakaaki; Sasai, Miwa; Kimura, Taishi; Ueda, Yoshiyasu; Kayama, Hisako; Takeda, Kiyoshi			CREBH Determines the Severity of Sulpyrine-Induced Fatal Shock	PLOS ONE			English	Article							NUCLEAR RECEPTOR CAR; RETICULUM STRESS-RESPONSE; TRANSCRIPTION FACTOR; DIPYRONE METABOLITES; TERMINAL KINASE; ACTIVATION; INDUCTION; ELEMENT; BIOTRANSFORMATION; METAMIZOL	Although the pyrazolone derivative sulpyrine is widely used as an antipyretic analgesic drug, side effects, including fatal shock, have been reported. However, the molecular mechanism underlying such a severe side effect is largely unclear. Here, we report that the transcription factor CREBH that is highly expressed in the liver plays an important role in fatal shock induced by sulpyrine in mice. CREBH-deficient mice were resistant to experimental fatal sulpyrine shock. We found that sulpyrine-induced expression of cytochrome P450 2B (CYP2B) family genes, which are involved in sulpyrine metabolism, in the liver was severely impaired in CREBH-deficient mice. Moreover, introduction of CYP2B in CREBH-deficient liver restored susceptibility to sulpyrine. Furthermore, ectopic expression of CREBH up-regulated CYP2B10 promoter activity, and in vivo knockdown of CREBH in wild-type mice conferred a significant resistance to fatal sulpyrine shock. These data demonstrate that CREBH is a positive regulator of CYP2B in response to sulpyrine administration, which possibly results in fatal shock.	[Kamiyama, Naganori; Yamamoto, Masahiro; Saiga, Hiroyuki; Ma, Ji Su; Ohshima, Jun; Machimura, Sakaaki; Kimura, Taishi; Ueda, Yoshiyasu; Kayama, Hisako; Takeda, Kiyoshi] Osaka Univ, Dept Microbiol & Immunol, Grad Sch Med, Suita, Osaka, Japan; [Kamiyama, Naganori; Yamamoto, Masahiro; Saiga, Hiroyuki; Ma, Ji Su; Ohshima, Jun; Machimura, Sakaaki; Kimura, Taishi; Ueda, Yoshiyasu; Kayama, Hisako; Takeda, Kiyoshi] Osaka Univ, Lab Mucosal Immunol, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Kamiyama, Naganori; Yamamoto, Masahiro; Ma, Ji Su; Ohshima, Jun; Machimura, Sakaaki; Sasai, Miwa] Osaka Univ, Lab Immunoparasitol, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Kamiyama, Naganori; Yamamoto, Masahiro; Ma, Ji Su; Ohshima, Jun; Machimura, Sakaaki; Sasai, Miwa] Osaka Univ, Microbial Dis Res Inst, Dept Immunoparasitol, Suita, Osaka 565, Japan; [Yamamoto, Masahiro; Kayama, Hisako; Takeda, Kiyoshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Yamamoto, M (corresponding author), Osaka Univ, Dept Microbiol & Immunol, Grad Sch Med, Suita, Osaka, Japan.	myamamoto@biken.osaka-u.ac.jp; ktakeda@ongene.med.osaka-u.ac.jp	Takeda, Kiyoshi/C-9331-2009	Sasai, Miwa/0000-0001-6440-3958; Takeda, Kiyoshi/0000-0002-1778-6332	Ministry of Education, Culture, Sports, Science and Technology; Strategic International Cooperative Program (Research Exchange Type); Japan Science and Technology Agency (JST); Kato Memorial Bioscience Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Waksman Foundation of Japan INC; Senri Life Science Foundation; Tokyo Biochemical Research Foundation; Research Foundation for Microbial Diseases of Osaka University; NAKAJIMA FOUNDATION; ASAHI GLASS FOUNDATION; Osaka Foundation for Promotion of Clinical Immunology; Sumitomo Foundation; Sagawa Foundation of Promotion of Cancer Research; Suzuken Memorial Foundation; Osaka Cancer Research Foundation	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic International Cooperative Program (Research Exchange Type); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Kato Memorial Bioscience Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Waksman Foundation of Japan INC(Waksman Foundation of Japan Inc.); Senri Life Science Foundation; Tokyo Biochemical Research Foundation; Research Foundation for Microbial Diseases of Osaka University; NAKAJIMA FOUNDATION; ASAHI GLASS FOUNDATION; Osaka Foundation for Promotion of Clinical Immunology; Sumitomo Foundation; Sagawa Foundation of Promotion of Cancer Research; Suzuken Memorial Foundation; Osaka Cancer Research Foundation	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology, the Strategic International Cooperative Program (Research Exchange Type), the Japan Science and Technology Agency (JST), and; Kato Memorial Bioscience Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; The Waksman Foundation of Japan INC, Senri Life Science Foundation; The Tokyo Biochemical Research Foundation; The Research Foundation for Microbial Diseases of Osaka University; THE NAKAJIMA FOUNDATION; THE ASAHI GLASS FOUNDATION; The Osaka Foundation for Promotion of Clinical Immunology; The Sumitomo Foundation; The Sagawa Foundation of Promotion of Cancer Research; Suzuken Memorial Foundation; Osaka Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Chin KT, 2005, NUCLEIC ACIDS RES, V33, P1859, DOI 10.1093/nar/gki332; Cohen SD, 1997, DRUG METAB REV, V29, P59, DOI 10.3109/03602539709037573; Din FVN, 2010, GUT, V59, P1670, DOI 10.1136/gut.2009.203000; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Fendrich Z, 2000, Cas Lek Cesk, V139, P440; Geisslinger G, 1996, PHARMACEUT RES, V13, P1272, DOI 10.1023/A:1016088925786; GLADTKE E, 1983, AM J MED, V75, P121, DOI 10.1016/0002-9343(83)90243-7; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Henderson NC, 2007, GUT, V56, P982, DOI 10.1136/gut.2006.104372; HENSCHEL L, 1991, Z GASTROENTEROL, V29, P645; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Hur KY, 2012, J EXP MED, V209, P307, DOI 10.1084/jem.20111298; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; Janke C, 2003, ANAESTHESIST, V52, P321, DOI 10.1007/s00101-003-0455-5; Jaszczuk E, 1999, Przegl Lek, V56, P175; Johannesdottir SA, 2012, CANCER; KATZ EZ, 1984, J CHROMATOGR, V305, P477; KRAUL H, 1991, EUR J CLIN PHARMACOL, V41, P475, DOI 10.1007/BF00626373; Lautenschlager MT, 1996, PHARMAZIE, V51, P750; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Liska D J, 1998, Altern Med Rev, V3, P187; Luebke-Wheeler J, 2008, HEPATOLOGY, V48, P1242, DOI 10.1002/hep.22439; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Mizushima T, 2008, YAKUGAKU ZASSHI, V128, P255, DOI 10.1248/yakushi.128.255; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Mori K, 2010, MOL BIOL CELL, V21, P1435, DOI 10.1091/mbc.E09-07-0600; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nagamori I, 2006, GENES CELLS, V11, P1161, DOI 10.1111/j.1365-2443.2006.01013.x; Namba T, 2009, J BIOL CHEM, V284, P4158, DOI 10.1074/jbc.M806051200; Okamura M, 2008, AM J PHYSIOL-RENAL, V295, pF1495, DOI 10.1152/ajprenal.00602.2007; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Pavitt GD, 2012, COLD SPRING HARB PER; Pierre SC, 2007, BRIT J PHARMACOL, V151, P494, DOI 10.1038/sj.bjp.0707239; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; RAUCY JL, 1989, ARCH BIOCHEM BIOPHYS, V271, P270, DOI 10.1016/0003-9861(89)90278-6; Reznik N D, 1972, Klin Med (Mosk), V50, P133; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Singh Gurkirpal, 1998, American Journal of Medicine, V105, p31S, DOI 10.1016/S0002-9343(98)00072-2; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Swales K, 2005, J BIOL CHEM, V280, P3458, DOI 10.1074/jbc.M411318200; Swaminathan J, 2009, SPECTROCHIM ACTA A, V73, P593, DOI 10.1016/j.saa.2009.03.009; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Tanaka K, 2005, J BIOL CHEM, V280, P31059, DOI 10.1074/jbc.M502956200; Tekkok IH, 2011, TURK NEUROSURG, V21, P116; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; VOLZ M, 1980, BRIT J CLIN PHARMACO, V10, pS299, DOI 10.1111/j.1365-2125.1980.tb01813.x; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Wessel JC, 2006, EUR J PHARM SCI, V28, P15, DOI 10.1016/j.ejps.2005.11.010; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang H, 2010, CARCINOGENESIS, V31, P703, DOI 10.1093/carcin/bgq008; Zaher H, 1998, TOXICOL APPL PHARM, V152, P193, DOI 10.1006/taap.1998.8501; Zelko I, 2000, BIOCHEM BIOPH RES CO, V277, P1, DOI 10.1006/bbrc.2000.3557; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	59	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55800	10.1371/journal.pone.0055800	http://dx.doi.org/10.1371/journal.pone.0055800			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409047	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200067
J	Phong, WY; Lin, WW; Rao, SPS; Dick, T; Alonso, S; Pethe, K				Phong, Wai Yee; Lin, Wenwei; Rao, Srinivasa P. S.; Dick, Thomas; Alonso, Sylvie; Pethe, Kevin			Characterization of Phosphofructokinase Activity in Mycobacterium tuberculosis Reveals That a Functional Glycolytic Carbon Flow Is Necessary to Limit the Accumulation of Toxic Metabolic Intermediates under Hypoxia	PLOS ONE			English	Article							ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; GROWTH; GENE; GLUCOSE-6-PHOSPHATE; GLUCOSE; MICE; PURIFICATION; MACROPHAGES; PERSISTENCE	Metabolic versatility has been increasingly recognized as a major virulence mechanism that enables Mycobacterium tuberculosis to persist in many microenvironments encountered in its host. Glucose is one of the most abundant carbon sources that is exploited by many pathogenic bacteria in the human host. M. tuberculosis has an intact glycolytic pathway that is highly conserved in all clinical isolates sequenced to date suggesting that glucose may represent a non-negligible source of carbon and energy for this pathogen in vivo. Fructose-6-phosphate phosphorylation represents the key-committing step in glycolysis and is catalyzed by a phosphofructokinase (PFK) activity. Two genes, pfkA and pfkB have been annotated to encode putative PFK in M. tuberculosis. Here, we show that PFKA is the sole PFK enzyme in M. tuberculosis with no functional redundancy with PFKB. PFKA is required for growth on glucose as sole carbon source. In co-metabolism experiments, we report that disruption of the glycolytic pathway at the PFK step results in intracellular accumulation of sugar-phosphates that correlated with significant impairment of the cell viability. Concomitantly, we found that the presence of glucose is highly toxic for the long-term survival of hypoxic non-replicating mycobacteria, suggesting that accumulation of glucose-derived toxic metabolites does occur in the absence of sustained aerobic respiration. The culture medium traditionally used to study the physiology of hypoxic mycobacteria is supplemented with glucose. In this medium, M. tuberculosis can survive for only 7-10 days in a true non-replicating state before death is observed. By omitting glucose in the medium this period could be extended for up to at least 40 days without significant viability loss. Therefore, our study suggests that glycolysis leads to accumulation of glucose-derived toxic metabolites that limits long-term survival of hypoxic mycobacteria. Such toxic effect is exacerbated when the glycolytic pathway is disrupted at the PKF step.	[Phong, Wai Yee; Rao, Srinivasa P. S.; Dick, Thomas; Pethe, Kevin] Novartis Inst Trop Dis, Singapore, Singapore; [Phong, Wai Yee; Lin, Wenwei; Alonso, Sylvie] Natl Univ Singapore, Yong Loo Lin Sch Med, Inst Life Sci, Dept Microbiol,Immunol Programme, Singapore 117595, Singapore; [Lin, Wenwei; Alonso, Sylvie] Singapore Massachusetts Inst Technol Alliance Res, Singapore, Singapore	Novartis; National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Alonso, S (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Inst Life Sci, Dept Microbiol,Immunol Programme, Singapore 117595, Singapore.	micas@nus.edu.sg	Pethe, Kevin/F-9495-2015; Dick, Thomas/AAB-4109-2019; Pethe, Kevin/L-1199-2013; Dick, Thomas/AAC-4824-2019	Dick, Thomas/0000-0002-9604-9452; Pethe, Kevin/0000-0003-0297-0150; Pethe, Kevin/0000-0003-0916-8873	Novartis Institute of Tropical Diseases; Singapore National Research Foundation under the Singapore-MIT Alliance for Research and Technology (SMART)	Novartis Institute of Tropical Diseases; Singapore National Research Foundation under the Singapore-MIT Alliance for Research and Technology (SMART)(Singapore-MIT Alliance for Research & Technology Centre (SMART)National Research Foundation, Singapore)	This work was funded by the Novartis Institute of Tropical Diseases and the Singapore National Research Foundation under the Singapore-MIT Alliance for Research and Technology (SMART). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alice AF, 2002, APPL ENVIRON MICROB, V68, P6410, DOI 10.1128/aem.68.12.6410-6415.2002; Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; [Anonymous], 2011, GLOB TUB CONTR; BABUL J, 1978, J BIOL CHEM, V253, P4350; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; BUSCHMEIER B, 1985, FEMS MICROBIOL LETT, V29, P231, DOI 10.1111/j.1574-6968.1985.tb00868.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daldal F, 1982, EUR J BIOCHEM, V379, P373; de Carvalho LPS, 2010, CHEM BIOL, V17, P1122, DOI 10.1016/j.chembiol.2010.08.009; DUBOS RJ, 1947, AM REV TUBERC PULM, V56, P334; FOUFELLE F, 1992, J BIOL CHEM, V267, P20543; FRAENKEL DG, 1986, ANNU REV BIOCHEM, V55, P317, DOI 10.1146/annurev.biochem.55.1.317; Hasan MR, 2010, J BIOL CHEM, V285, P19135, DOI 10.1074/jbc.M109.074310; Hsieh PC, 1996, J BIOL CHEM, V271, P4909; Jayanthi Bai N, 1975, Can J Microbiol, V21, P1688; Kalscheuer R, 2010, NAT CHEM BIOL, V6, P376, DOI 10.1038/nchembio.340; KAPOOR R, 1981, BIOCHEM J, V193, P435, DOI 10.1042/bj1930435; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lovingshimer MR, 2006, PROTEIN EXPRES PURIF, V46, P475, DOI 10.1016/j.pep.2005.09.015; Malaga W, 2003, FEMS MICROBIOL LETT, V219, P261, DOI 10.1016/S0378-1097(03)00003-X; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Miallau L, 2007, J BIOL CHEM, V282, P19948, DOI 10.1074/jbc.M701480200; Morita T, 2003, J BIOL CHEM, V278, P15608, DOI 10.1074/jbc.M300177200; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; ORCHARD LMD, 1990, P ROY SOC B-BIOL SCI, V242, P87, DOI 10.1098/rspb.1990.0108; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Paterson GK, 2009, MICROB PATHOGENESIS, V46, P261, DOI 10.1016/j.micpath.2009.01.008; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schumacher MA, 2000, J MOL BIOL, V296, P549, DOI 10.1006/jmbi.1999.3474; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344	43	39	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56037	10.1371/journal.pone.0056037	http://dx.doi.org/10.1371/journal.pone.0056037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409118	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200103
J	Buckley, DM; Burroughs-Garcia, J; Lewandoski, M; Waters, ST				Buckley, Desire M.; Burroughs-Garcia, Jessica; Lewandoski, Mark; Waters, Samuel T.			Characterization of the Gbx1(-/-) Mouse Mutant: A Requirement for Gbx1 in Normal Locomotion and Sensorimotor Circuit Development	PLOS ONE			English	Article							DORSAL SPINAL-CORD; MOTOR-NEURON IDENTITY; ROOT GANGLION NEURONS; MID/HINDBRAIN ORGANIZER; TRANSCRIPTIONAL CODES; SUBTYPE IDENTITY; NERVOUS-SYSTEM; GENE-FUNCTION; SPECIFICATION; EXPRESSION	The Gbx class of homeobox genes encodes DNA binding transcription factors involved in regulation of embryonic central nervous system (CNS) development. Gbx1 is dynamically expressed within spinal neuron progenitor pools and becomes restricted to the dorsal mantle zone by embryonic day (E) 12.5. Here, we provide the first functional analysis of Gbx1. We generated mice containing a conditional Gbx1 allele in which exon 2 that contains the functional homeodomain is flanked with loxP sites (Gbx1(flox)); Cre-mediated recombination of this allele results in a Gbx1 null allele. In contrast to mice homozygous for a loss-of-function allele of Gbx2, mice homozygous for the Gbx1 null allele, Gbx1(-/-), are viable and reproductively competent. However, Gbx1(-/-) mice display a gross locomotive defect that specifically affects hindlimb gait. Analysis of embryos homozygous for the Gbx1 null allele reveals disrupted assembly of the proprioceptive sensorimotor circuit within the spinal cord, and a reduction in ISL1(+) ventral motor neurons. These data suggest a functional requirement for Gbx1 in normal development of the neural networks that contribute to locomotion. The generation of this null allele has enabled us to functionally characterize a novel role for Gbx1 in development of the spinal cord.	[Buckley, Desire M.; Burroughs-Garcia, Jessica; Waters, Samuel T.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Buckley, Desire M.; Burroughs-Garcia, Jessica; Waters, Samuel T.] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO USA; [Lewandoski, Mark] NCI, Canc & Dev Biol Lab, NIH, Frederick, MD 21701 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Waters, ST (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	waterssa@missouri.edu		Lewandoski, Mark/0000-0002-1066-3735	University of Missouri; National Science Foundation [1021288]; NATIONAL CANCER INSTITUTE [ZIABC011321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056901] Funding Source: NIH RePORTER	University of Missouri; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by startup funds from the University of Missouri (STW) and by the National Science Foundation award 1021288. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; BRODY BA, 1989, J NEUROSCI, V9, P2391; Brown A. G., 1981, ORG SPINAL CORD, P154; Burek MJ, 1996, BRAIN PATHOL, V6, P427, DOI 10.1111/j.1750-3639.1996.tb00874.x; Burroughs-Garcia J, 2011, DEV DYNAM, V240, P828, DOI 10.1002/dvdy.22589; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Chen HH, 2003, CURR OPIN NEUROBIOL, V13, P96, DOI 10.1016/S0959-4388(03)00006-0; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; ESCURAT M, 1990, J NEUROSCI, V10, P764; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Hollyday M., 1980, Current Topics in Developmental Biology, V15, P181; Hutchinson SA, 2006, DEVELOPMENT, V133, P2137, DOI 10.1242/dev.02355; Inoue K, 2003, BLOOD CELL MOL DIS, V30, P157, DOI 10.1016/S1079-9796(03)00032-9; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; John A, 2005, DEV DYNAM, V234, P767, DOI 10.1002/dvdy.20568; Jungbluth S, 1999, DEVELOPMENT, V126, P2751; KILBY NJ, 1993, TRENDS GENET, V9, P413, DOI 10.1016/0168-9525(93)90104-P; Klein C, 2005, J INHERIT METAB DIS, V28, P425, DOI 10.1007/s10545-005-7495-8; Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li B, 2009, DEVELOPMENT, V136, P3267, DOI 10.1242/dev.036954; Li JYH, 2002, NEURON, V36, P31, DOI 10.1016/S0896-6273(02)00935-2; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Lin ZS, 2005, DEVELOPMENT, V132, P2309, DOI 10.1242/dev.01804; Liu AM, 2001, DEVELOPMENT, V128, P181; Luu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020940; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; NORNES HO, 1978, BRAIN RES, V159, P1, DOI 10.1016/0006-8993(78)90105-1; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Ozaki S, 1997, J COMP NEUROL, V380, P215; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Portier Marie-Madeleine, 1993, Comptes Rendus de l'Academie des Sciences Serie III Sciences de la Vie, V316, P1124; Posada A, 1999, BIOL CYBERN, V81, P239, DOI 10.1007/s004220050559; Rhinn M, 2004, DEV DYNAM, V229, P334, DOI 10.1002/dvdy.10435; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Siembab VC, 2010, J COMP NEUROL, V518, P4675, DOI 10.1002/cne.22441; Song MR, 2009, DEVELOPMENT, V136, P2923, DOI 10.1242/dev.037986; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Vidal PP, 2004, J PHYSIOL-LONDON, V559, P625, DOI 10.1113/jphysiol.2004.063883; Wassarman KM, 1997, DEVELOPMENT, V124, P2923; Waters ST, 2006, DEVELOPMENT, V133, P1991, DOI 10.1242/dev.02364; Waters ST, 2003, GENE EXPR PATTERNS, V3, P313, DOI 10.1016/S1567-133X(03)00041-3; Zhuang BQ, 2006, CURR OPIN NEUROBIOL, V16, P20, DOI 10.1016/j.conb.2005.11.001	59	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56214	10.1371/journal.pone.0056214	http://dx.doi.org/10.1371/journal.pone.0056214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418536	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300128
J	Dale, NM; Myatt, M; Prudhon, C; Briend, A				Dale, Nancy M.; Myatt, Mark; Prudhon, Claudine; Briend, Andre			Using Mid-Upper Arm Circumference to End Treatment of Severe Acute Malnutrition Leads to Higher Weight Gains in the Most Malnourished Children	PLOS ONE			English	Article								Objective: The World Health Organization recommends discharging children admitted to nutrition programs treating severe acute malnutrition, with a low mid-upper arm circumference (MUAC <115 mm) when weight gain is >15%. When this recommendation is followed, the most severely malnourished children receive a shorter treatment compared to children that are less severely malnourished. This study assesses whether using MUAC >125 mm as discharge criteria eliminates this effect. Methods and Findings: Data from 753 children cured from a Medecins Sans Frontieres outpatient nutrition program in Gedaref, North Sudan were analyzed. MUAC >125 mm was used as discharge criteria. Length of stay and percent weight gain of children were compared in relation to nutritional status on admission. Children with low MUAC on admission had a longer duration of treatment (p = 0.000) and also a higher percent weight gain (p = 0.000) than children with higher MUAC. Similar results with weight-for-height z-scores categories were shown with both duration of treatment (p = 0.000) and percent weight gain (p = 0.000). Conclusion: This study shows that using MUAC as the discharge criteria eliminates the effect of shorter treatment in most severely malnourished children compared to least severely malnourished, as is observed with percent weight gain. The findings directly address the main concern that has been identified with the current WHO recommendation of using percent weight gain. MUAC could be used as discharge criteria, instead of percent weight gain, as having a longer duration of treatment and a higher percent weight gain for the most malnourished is highly desirable.	[Dale, Nancy M.; Briend, Andre] Univ Tampere, Dept Int Hlth, Sch Med, FIN-33101 Tampere, Finland; [Dale, Nancy M.] Med Sans Frontieres, Geneva, Switzerland; [Myatt, Mark] Brixton Hlth, Llawryglyn, Wales; [Prudhon, Claudine] Hlth & Nutr Tracking Serv, Geneva, Switzerland	Tampere University; Doctors Without Borders	Dale, NM (corresponding author), Univ Tampere, Dept Int Hlth, Sch Med, FIN-33101 Tampere, Finland.	dalenmca@yahoo.com			Medecins sans Frontieres Switzerland; Ministry of Health, Gedaref	Medecins sans Frontieres Switzerland; Ministry of Health, Gedaref	This study was funded by Medecins sans Frontieres Switzerland. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Medecins sans Frontieres teams in Gedaref for their hard work with special attention to Dr. Khalid Ahmed (medical coordinator) and Dr. Philippa Boulle (field coordinator) for their commitment to the program and collection of data. The authors would also like to thank Dr Phil Humphris and Bruno Jochum of Medecins Sans Frontieres Switzerland for their operational guidance throughout the program and their support for this study. We also thank the Ministry of Health, Gedaref, for their support.	[Anonymous], [No title captured]; [Anonymous], 2008, INT WORKSH INT COMM; COLLINS S, 2004, 48 OV DEV I HUM PRAC; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Diop EHI, 2003, AM J CLIN NUTR, V78, P302, DOI 10.1093/ajcn/78.2.302; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; Goossens S, 2012, PLOS ONE IN PRESS; Guerrero S, 2010, DISASTERS, V34, P571, DOI 10.1111/j.1467-7717.2009.01144.x; Medecins Sans Frontieres Switzerland, 2010, PROT PAED NUTR CAS M; Mwangome MK, 2012, TROP MED INT HEALTH, V17, P622, DOI 10.1111/j.1365-3156.2012.02959.x; Myatt M, 2006, FOOD NUTR B S, V27; Sphere Standards, 2011, HUM CHART MIN STAND; VELZEBOER MI, 1983, J TROP PEDIATRICS, V29, P159, DOI 10.1093/tropej/29.3.159; Waterlow JC, 1992, PROTEIN ENERGY MALNU, P173; World Health Organization United Nations Children's Fund, 2002, IMCI AD GUID GUID C; World Health Organization World Food Program United Nations Standing Committee on Nutrition United Nations Children's Fund, 2007, COMM BAS MAN MALN	16	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55404	10.1371/journal.pone.0055404	http://dx.doi.org/10.1371/journal.pone.0055404			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418442	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300033
J	Daschkey, S; Rottgers, S; Giri, A; Bradtke, J; Teigler-Schlegel, A; Meister, G; Borkhardt, A; Landgraf, P				Daschkey, Svenja; Roettgers, Silja; Giri, Anamika; Bradtke, Jutta; Teigler-Schlegel, Andrea; Meister, Gunter; Borkhardt, Arndt; Landgraf, Pablo			MicroRNAs Distinguish Cytogenetic Subgroups in Pediatric AML and Contribute to Complex Regulatory Networks in AML-Relevant Pathways	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; RIBONUCLEOPROTEIN COMPLEXES; WIDE IDENTIFICATION; C/EBP-ALPHA; RIP-CHIP; PROTEIN; DIFFERENTIATION; PATTERNS; ASSOCIATION	Background: The role of microRNAs (miRNAs), important post-transcriptional regulators, in the pathogenesis of acute myeloid leukemia (AML) is just emerging and has been mainly studied in adults. First studies in children investigate single selected miRNAs, however, a comprehensive overview of miRNA expression and function in children and young adults is missing so far. Methodology/Principal Findings: We here globally identified differentially expressed miRNAs between AML subtypes in a survey of 102 children and adolescent. Pediatric samples with core-binding factor AML and promyelocytic leukemia could be distinguished from each other and from MLL-rearranged AML subtypes by differentially expressed miRNAs including miR-126, -146a, -181a/b, -100, and miR-125b. Subsequently, we established a newly devised immunoprecipitation assay followed by rapid microarray detection for the isolation of Argonaute proteins, the hallmark of miRNA targeting complexes, from cell line models resembling core-binding factor and promyelocytic leukemia. Applying this method, we were able to identify Ago-associated miRNAs and their targeted mRNAs. Conclusions/Significance: miRNAs as well as their mRNA-targets showed binding preferences for the different Argonaute proteins in a cell context-dependent manner. Bioinformatically-derived pathway analysis suggested a concerted action of all four Argonaute complexes in the regulation of AML-relevant pathways. For the first time, to our knowledge, a complete AML data set resulting from carefully devised biochemical isolation experiments and analysis of Ago-associated miRNAs and their target-mRNAs is now available.	[Daschkey, Svenja; Giri, Anamika; Borkhardt, Arndt; Landgraf, Pablo] Univ Dusseldorf, Fac Med, Clin Pediat Oncol Hematol & Clin Immunol, D-40225 Dusseldorf, Germany; [Roettgers, Silja; Bradtke, Jutta; Teigler-Schlegel, Andrea] Univ Giessen, Dept Pediat Hematol & Oncol, Oncogenet Lab, D-35390 Giessen, Germany; [Meister, Gunter] Univ Regensburg, Dept Biochem, Lab RNA Biol, D-93053 Regensburg, Germany	Heinrich Heine University Dusseldorf; Justus Liebig University Giessen; University of Regensburg	Landgraf, P (corresponding author), Univ Dusseldorf, Fac Med, Clin Pediat Oncol Hematol & Clin Immunol, D-40225 Dusseldorf, Germany.	pablo.landgraf@uni-duesseldorf.de			Research Commission of the Medical Faculty of the University of Dusseldorf; German Research Foundation (DFG) [LA 2983/2-1]; Bavarian Genome Research Network (BayGene); European Research Council (ERC); Giessen Parents Foundation; German-Israeli-Foundation (GIF)	Research Commission of the Medical Faculty of the University of Dusseldorf; German Research Foundation (DFG)(German Research Foundation (DFG)); Bavarian Genome Research Network (BayGene); European Research Council (ERC)(European Research Council (ERC)); Giessen Parents Foundation; German-Israeli-Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development)	This work was supported by the Research Commission of the Medical Faculty of the University of Dusseldorf (http://forschungskommission.uniduesseldorf.de/), by the German Research Foundation (DFG http://www.dfg.de, grant LA 2983/2-1), the Bavarian Genome Research Network (BayGene, http://www.baygene.genzentrum.lmu.de/), the European Research Council (ERC, http://erc.europa.eu/), by the Giessen Parents Foundation, and by the German-Israeli-Foundation (GIF, http://www.gif.org.il/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beghini A, 2004, HAEMATOLOGICA, V89, P920; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; Bissels U, 2012, HAEMATOL-HEMATOL J, V97, P160, DOI 10.3324/haematol.2011.051730; Bissels U, 2009, RNA, V15, P2375, DOI 10.1261/rna.1754109; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bousquet M, 2010, P NATL ACAD SCI USA, V107, P21558, DOI 10.1073/pnas.1016611107; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Creutzig U, 2005, LEUKEMIA, V19, P2030, DOI 10.1038/sj.leu.2403920; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Danen-van Oorschot AA, 2012, PEDIATR BLOOD CANCER, V58, P715, DOI 10.1002/pbc.23279; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Debernardi S, 2007, LEUKEMIA, V21, P912, DOI 10.1038/sj.leu.2404605; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Eyholzer M, 2010, LEUKEMIA RES, V34, P672, DOI 10.1016/j.leukres.2009.11.019; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Isken F, 2008, BRIT J HAEMATOL, V140, P153, DOI 10.1111/j.1365-2141.2007.06915.x; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724; OCARROLL D, 2007, GENES DEV; Pabst T, 2001, NAT MED, V7, P444, DOI 10.1038/86515; Paquette J, 2010, BIOINFORMATICS, V26, P285, DOI 10.1093/bioinformatics/btp656; Park S, 2010, HAEMATOL-HEMATOL J, V95, P819, DOI 10.3324/haematol.2009.013797; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Schoch C, 2004, HAEMATOLOGICA, V89, P1082; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shaham L, 2012, LEUKEMIA, V26, P2011, DOI 10.1038/leu.2012.90; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; Simon M, 2005, ONCOGENE, V24, P2410, DOI 10.1038/sj.onc.1208431; Starczynowski DT, 2011, EXP HEMATOL, V39, P167, DOI 10.1016/j.exphem.2010.09.011; Starczynowski DT, 2011, BLOOD, V117, P595, DOI 10.1182/blood-2010-03-277012; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Steiner FA, 2007, NAT STRUCT MOL BIOL, V14, P927, DOI 10.1038/nsmb1308; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; von Neuhoff C, 2010, J CLIN ONCOL, V28, P2682, DOI 10.1200/JCO.2009.25.6321; Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Zaidi SK, 2009, CANCER RES, V69, P8249, DOI 10.1158/0008-5472.CAN-09-1567; Zhang H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-108; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007826	72	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56334	10.1371/journal.pone.0056334	http://dx.doi.org/10.1371/journal.pone.0056334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418555	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300148
J	Turingan, RS; Thomann, HU; Zolotova, A; Tan, E; Selden, RF				Turingan, Rosemary S.; Thomann, Hans-Ulrich; Zolotova, Anna; Tan, Eugene; Selden, Richard F.			Rapid Focused Sequencing: A Multiplexed Assay for Simultaneous Detection and Strain Typing of Bacillus anthracis, Francisella tularensis, and Yersinia pestis	PLOS ONE			English	Article							NUMBER TANDEM REPEAT; FRAGMENT LENGTH POLYMORPHISM; CLOSELY-RELATED BACTERIA; IN-SITU HYBRIDIZATION; 23S RIBOSOMAL-RNA; TIME PCR ASSAY; NEXT-GENERATION; CEREUS GROUP; GENETIC-VARIABILITY; PLASMID	Background: The intentional release of Bacillus anthracis in the United States in 2001 has heightened concern about the use of pathogenic microorganisms in bioterrorism attacks. Many of the deadliest bacteria, including the Class A Select Agents Bacillus anthracis, Francisella tularensis, and Yersinia pestis, are highly infectious via the pulmonary route when released in aerosolized form. Hence, rapid, sensitive, and reliable methods for detection of these biothreats and characterization of their potential impact on the exposed population are of critical importance to initiate and support rapid military, public health, and clinical responses. Methodology/Principal Findings: We have developed microfluidic multiplexed PCR and sequencing assays based on the simultaneous interrogation of three pathogens per assay and ten loci per pathogen. Microfluidic separation of amplified fluorescently labeled fragments generated characteristic electrophoretic signatures for identification of each agent. The three sets of primers allowed significant strain typing and discrimination from non-pathogenic closely-related species and environmental background strains based on amplicon sizes alone. Furthermore, sequencing of the 10 amplicons per pathogen, termed "Rapid Focused Sequencing," allowed an even greater degree of strain discrimination and, in some cases, can be used to determine virulence. Both amplification and sequencing assays were performed in microfluidic biochips developed for fast thermal cycling and requiring 7 mu L per reaction. The 30-plex sequencing assay resulted in genotypic resolution of 84 representative strains belonging to each of the three biothreat species. Conclusions/Significance: The microfluidic multiplexed assays allowed identification and strain differentiation of the biothreat agents Bacillus anthracis, Francisella tularensis, and Yersinia pestis and clear discrimination from closely-related species and several environmental background strains. The assays may be extended to detect a large number of pathogens, are applicable to the evaluation of both environmental and clinical samples, and have the potential to be applied in military, public health, and clinical diagnostic settings.	[Turingan, Rosemary S.; Thomann, Hans-Ulrich; Zolotova, Anna; Tan, Eugene; Selden, Richard F.] NetBio, Waltham, MA USA		Selden, RF (corresponding author), NetBio, Waltham, MA USA.	richard.selden@netbio.com			Department of Homeland Security Science and Technology Directorate [HSHQDC-09-C-0082]	Department of Homeland Security Science and Technology Directorate(United States Department of Homeland Security (DHS))	This work was supported by an award from the Department of Homeland Security Science and Technology Directorate (contract HSHQDC-09-C-0082) (http://www.dhs.gov/xabout/structure/editorial_0530.shtm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Adair DM, 2000, J CLIN MICROBIOL, V38, P1516, DOI 10.1128/JCM.38.4.1516-1519.2000; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bavykin SG, 2004, J CLIN MICROBIOL, V42, P3711, DOI 10.1128/jcm.42.8.3711-3730.2004; Bhaduri S, 2008, J FOOD SAFETY, V28, P453, DOI 10.1111/j.1745-4565.2008.00123.x; Bode E, 2004, J CLIN MICROBIOL, V42, P5825, DOI 10.1128/JCM.42.12.5825-5831.2004; CDC. [Date unknown.] National Center for Emerging and Zoonotic Diseases, ANTHR STERN STRAIN 3; CROSS JT, 2000, PRINCIPLES PRACTICE, P2393; Daffonchio D, 2006, APPL ENVIRON MICROB, V72, P1295, DOI 10.1128/AEM.72.2.1295-1301.2006; Drancourt M, 2004, EMERG INFECT DIS, V10, P1585, DOI 10.3201/eid1009.030933; Eubanks LM, 2007, CHEM SOC REV, V36, P458, DOI 10.1039/b615227a; Farlow J, 2001, J CLIN MICROBIOL, V39, P3186, DOI 10.1128/JCM.39.9.3186-3192.2001; FORSMAN M, 1994, INT J SYST BACTERIOL, V44, P38, DOI 10.1099/00207713-44-1-38; Giese H, 2009, J FORENSIC SCI, V54, P1287, DOI 10.1111/j.1556-4029.2009.01200.x; Girard JM, 2004, P NATL ACAD SCI USA, V101, P8408, DOI 10.1073/pnas.0401561101; Graham Bob, 2008, WORLD RISK REPORT CO; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; HARRELL LJ, 1995, J CLIN MICROBIOL, V33, P1847, DOI 10.1128/JCM.33.7.1847-1850.1995; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Helgason E, 2004, APPL ENVIRON MICROB, V70, P191, DOI 10.1128/AEM.70.1.191-201.2004; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Huang XZ, 2006, CLIN MED RES, V4, P189, DOI 10.3121/cmr.4.3.189; Ingmar J, 2010, RELIABLE DETECTION B; Jackson PJ, 1999, J APPL MICROBIOL, V87, P263, DOI 10.1046/j.1365-2672.1999.00884.x; Janse I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031958; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Johansson A, 2001, J CLIN MICROBIOL, V39, P3140, DOI 10.1128/JCM.39.9.3140-3146.2001; Keim P, 1997, J BACTERIOL, V179, P818, DOI 10.1128/jb.179.3.818-824.1997; Keim P, 2009, MOL ASPECTS MED, V30, P397, DOI 10.1016/j.mam.2009.08.005; Klee SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010986; La Scola B, 2008, GENOME RES, V18, P742, DOI 10.1101/gr.071266.107; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsson P, 2007, EMERG INFECT DIS, V13, P1725, DOI 10.3201/eid1311.070603; Lim DV, 2005, CLIN MICROBIOL REV, V18, P583, DOI 10.1128/CMR.18.4.583-607.2005; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Motin VL, 2002, J BACTERIOL, V184, P1019, DOI 10.1128/jb.184.4.1019-1027.2002; Nubel U, 2006, J BACTERIOL, V188, P5319, DOI 10.1128/JB.01662-05; O'Toole T, 2009, BIOSECUR BIOTERROR, V7, P25, DOI 10.1089/bsp.2009.1001; Page R, DIVISION ECOLOGY EVO; Pandya GA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-213; Pannucci J, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-34; Pannucci J, 2002, J BACTERIOL, V184, P134, DOI 10.1128/JB.184.1.134-141.2002; Price LB, 1999, J BACTERIOL, V181, P2358, DOI 10.1128/JB.181.8.2358-2362.1999; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Read TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010595; Schumm J, 2012, J FORENSIC IN PRESS; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sjostedt A, 2003, BERGEYS MANUAL SYSTE, P111; Splettstoesser WD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-72; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Stewart A, 2008, J MED MICROBIOL, V57, P324, DOI 10.1099/jmm.0.47485-0; Svensson K, 2005, J BACTERIOL, V187, P3903, DOI 10.1128/JB.187.11.3903-3908.2005; Tomaso H, 2003, FEMS IMMUNOL MED MIC, V38, P117, DOI 10.1016/S0928-8244(03)00184-6; Tomioka K, 2005, J MOL DIAGN, V7, P486, DOI 10.1016/S1525-1578(10)60579-X; Trebesius K, 1998, J CLIN MICROBIOL, V36, P2557, DOI 10.1128/JCM.36.9.2557-2564.1998; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Wilson WJ, 2005, MOL CELL PROBE, V19, P137, DOI 10.1016/j.mcp.2004.10.005	61	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56093	10.1371/journal.pone.0056093	http://dx.doi.org/10.1371/journal.pone.0056093			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418519	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300111
J	Xia, YS; Li, RH; Ning, ZX; Bai, GH; Siddique, KHM; Yan, GJ; Baum, M; Varshney, RK; Guo, PG				Xia, Yanshi; Li, Ronghua; Ning, Zhengxiang; Bai, Guihua; Siddique, Kadambot H. M.; Yan, Guijun; Baum, Michael; Varshney, Rajeev K.; Guo, Peiguo			Single Nucleotide Polymorphisms in HSP17.8 and Their Association with Agronomic Traits in Barley	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR DIVERSITY; WILD BARLEY; POPULATION-STRUCTURE; QUANTITATIVE TRAITS; DROUGHT TOLERANCE; ABIOTIC STRESSES; GENES; DISCOVERY; VULGARE	Small heat shock protein 17.8 (HSP17.8) is produced abundantly in plant cells under heat and other stress conditions and may play an important role in plant tolerance to stress environments. However, HSP17.8 may be differentially expressed in different accessions of a crop species exposed to identical stress conditions. The ability of different genotypes to adapt to various stress conditions resides in their genetic diversity. Allelic variations are the most common forms of genetic variation in natural populations. In this study, single nucleotide polymorphisms (SNPs) of the HSP17.8 gene were investigated across 210 barley accessions collected from 30 countries using EcoTILLING technology. Eleven SNPs including 10 from the coding region of HSP17.8 were detected, which form nine distinguishable haplotypes in the barley collection. Among the 10 SNPs in the coding region, six are missense mutations and four are synonymous nucleotide changes. Five of the six missense changes are predicted to be deleterious to HSP17.8 function. The accessions from Middle East Asia showed the higher nucleotide diversity of HSP17.8 than those from other regions and wild barley (H. spontaneum) accessions exhibited greater diversity than the cultivated barley (H. vulgare) accessions. Four SNPs in HSP17.8 were found associated with at least one of the agronomic traits evaluated except for spike length, namely number of grains per spike, thousand kernel weight, plant height, flag leaf area and leaf color. The association between SNP and these agronomic traits may provide new insight for study of the gene's potential contribution to drought tolerance of barley.	[Xia, Yanshi; Li, Ronghua; Guo, Peiguo] Guangzhou Univ, Coll Life Sci, Int Crop Res Ctr Stress Resistance, Guangzhou, Guangdong, Peoples R China; [Xia, Yanshi; Ning, Zhengxiang] S China Univ Technol, Coll Light Ind & Food Sci, Guangzhou, Guangdong, Peoples R China; [Bai, Guihua] ARS, Hard Winter Wheat Genet Res Unit, USDA, Manhattan, KS USA; [Siddique, Kadambot H. M.; Yan, Guijun] Univ Western Australia, Inst Agr, Perth, WA 6009, Australia; [Baum, Michael] Int Ctr Agr Res Dry Areas, Aleppo, Syria; [Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Patancheru 502324, Greater Hyderab, India	Guangzhou University; South China University of Technology; United States Department of Agriculture (USDA); University of Western Australia; CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Guo, PG (corresponding author), Guangzhou Univ, Coll Life Sci, Int Crop Res Ctr Stress Resistance, Guangzhou, Guangdong, Peoples R China.	guopg@yahoo.com	bai, guihua/L-6374-2019; Siddique, Kadambot H.M./B-3462-2011; Li, Ronghua/AAP-8236-2021; Yan, Guijun/A-9809-2011; Varshney, Rajeev K/C-5295-2014	bai, guihua/0000-0002-1194-319X; Siddique, Kadambot H.M./0000-0001-6097-4235; Yan, Guijun/0000-0001-9628-1211; Varshney, Rajeev K/0000-0002-4562-9131; Baum, Michael/0000-0002-8248-6088	National Natural Science Foundation of China [30871526]; Guangdong Province the Technology Plan in China [2008B050300003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province the Technology Plan in China	This work was funded by the National Natural Science Foundation of China (30871526) (http://www.nsfc.gov.cn) and Guangdong Province the Technology Plan in China (2008B050300003) (http://www.gdstc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellaoui Raoudha, 2007, Asian Journal of Plant Sciences, V6, P261; Andras C, 2011, EUPHYTICA, V181, P341, DOI 10.1007/s10681-011-0445-7; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Bundock PC, 2004, THEOR APPL GENET, V109, P543, DOI 10.1007/s00122-004-1675-z; Ceccarelli S., 1995, Diversity, V11, P112; Chen GY, 2009, AGR SCI CHINA, V8, P1440, DOI 10.1016/S1671-2927(08)60357-0; Chung JD, 2010, BOT STUD, V51, P27; Comai L, 2004, PLANT J, V37, P778, DOI 10.1111/j.0960-7412.2003.01999.x; Duran C, 2009, PLANT BIOTECHNOL J, V7, P326, DOI 10.1111/j.1467-7652.2009.00407.x; Ellis RP, 2000, J EXP BOT, V51, P9, DOI 10.1093/jexbot/51.342.9; Gilchrist EJ, 2006, MOL ECOL, V15, P1367, DOI 10.1111/j.1365-294X.2006.02885.x; Grigorova B, 2011, ACTA PHYSIOL PLANT, V33, P2041, DOI 10.1007/s11738-011-0733-9; Guo P., 2007, J GUANGZHOU U NATURA, V6, P32; Guo P, 2007, AGR SCI CHINA, V5, P522; Guo PG, 2008, EUPHYTICA, V163, P203, DOI 10.1007/s10681-007-9629-6; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Guo PG, 2010, Chinese Patent, Patent No. [ZL200910038725.9, 2009100387259]; Gupta R, 2011, RES J AGR SCI, V2, P87; Hu WH, 2009, PLANT SCI, V176, P583, DOI 10.1016/j.plantsci.2009.01.016; Inostroza L, 2009, MOL BREEDING, V23, P365, DOI 10.1007/s11032-008-9239-6; Kant P, 2008, PLANT CELL ENVIRON, V31, P697, DOI 10.1111/j.1365-3040.2008.01779.x; Kilian B, 2006, MOL GENET GENOMICS, V276, P230, DOI 10.1007/s00438-006-0136-6; Kim DH, 2011, PLANT PHYSIOL, V157, P132, DOI 10.1104/pp.111.178681; Lakew B, 2011, FIELD CROP RES, V120, P161, DOI 10.1016/j.fcr.2010.09.011; Li JZ, 2006, GENOME, V49, P454, DOI 10.1139/G05-128; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu XG, 2005, IUBMB LIFE, V57, P449, DOI 10.1080/15216540500138402; Malysheva-Otto LV, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-6; Mohammed KAH, 2004, THESIS BONN U GERMAN; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nevo E., 1992, Barley: genetics, biochemistry, molecular biology and biotechnology., P19; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nieto C, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-34; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Peng JH, 2009, GENETICA, V135, P95, DOI 10.1007/s10709-008-9262-x; Peter-Schmid MKI, 2008, PLANT BREEDING, V127, P510, DOI 10.1111/j.1439-0523.2007.01478.x; Pritchard JK, 2000, GENETICS, V155, P945; Raghavan C, 2007, MOL BREEDING, V19, P87, DOI 10.1007/s11032-006-9046-x; Rostoks N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r54; Russell J, 2004, GENOME, V47, P389, DOI [10.1139/G03-125, 10.1139/g03-125]; Sato Y, 2008, PLANT CELL REP, V27, P329, DOI 10.1007/s00299-007-0470-0; Schmalenbach I, 2009, THEOR APPL GENET, V118, P483, DOI 10.1007/s00122-008-0915-z; Shou HX, 2004, P NATL ACAD SCI USA, V101, P3298, DOI 10.1073/pnas.0308095100; Song NH, 2011, NEW BIOTECHNOL, V28, P698, DOI 10.1016/j.nbt.2011.04.002; Stein N, 2007, THEOR APPL GENET, V114, P823, DOI 10.1007/s00122-006-0480-2; Sun DF, 2011, EUPHYTICA, V178, P31, DOI 10.1007/s10681-010-0260-6; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Szalma SJ, 2005, THEOR APPL GENET, V110, P1324, DOI 10.1007/s00122-005-1973-0; TAJIMA F, 1989, GENETICS, V123, P585; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Taylor NE, 2003, NUCLEIC ACIDS RES, V31, P3808, DOI 10.1093/nar/gkg574; Teulat B, 2001, THEOR APPL GENET, V103, P774, DOI 10.1007/s001220100619; Thornton KR, 2007, HEREDITY, V98, P340, DOI 10.1038/sj.hdy.6800967; Till BJ, 2006, NAT PROTOC, V1, P2465, DOI 10.1038/nprot.2006.329; Timperio AM, 2008, J PROTEOMICS, V71, P391, DOI 10.1016/j.jprot.2008.07.005; Varshney RK, 2012, FIELD CROP RES, V126, P171, DOI 10.1016/j.fcr.2011.10.008; Varshney RK, 2010, MOL BREEDING, V26, P229, DOI 10.1007/s11032-009-9373-9; Wang GX, 2007, PESTIC BIOCHEM PHYS, V88, P143, DOI 10.1016/j.pestbp.2006.10.006; Wang NA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-137; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Witkin SS, 2010, HEAT SHOCK PROTEINS, V4, P241, DOI 10.1007/978-90-481-2976-8_13; Wu DZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022938; Xia Yanshi, 2012, PLoS One, V7, pe37573, DOI 10.1371/journal.pone.0037573; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030765; Zeng XH, 2009, AGR SCI CHINA, V8, P8, DOI 10.1016/S1671-2927(09)60003-1; Zerr T, 2005, NUCLEIC ACIDS RES, V33, P2806, DOI 10.1093/nar/gki580; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	69	17	22	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56816	10.1371/journal.pone.0056816	http://dx.doi.org/10.1371/journal.pone.0056816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418603	gold, Green Published			2022-12-27	WOS:000315970300196
J	Zhou, J; Mo, YF; Li, H; Ran, XW; Yang, WY; Li, Q; Peng, YD; Li, YB; Gao, X; Luan, XJ; Wang, WQ; Jia, WP				Zhou, Jian; Mo, Yifei; Li, Hong; Ran, Xingwu; Yang, Wenying; Li, Qiang; Peng, Yongde; Li, Yanbing; Gao, Xin; Luan, Xiaojun; Wang, Weiqing; Jia, Weiping			Alanine Aminotransferase Is Associated with an Adverse Nocturnal Blood Glucose Profile in Individuals with Normal Glucose Regulation	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; INSULIN-RESISTANCE; METABOLIC SYNDROME; RISK; DISEASE; SENSITIVITY; PREDICTS; OBESITY; MEN; DETERMINANTS	Objective: Although the association between alanine aminotransferase (ALT) levels and risk of type 2 diabetes is well-studied, the effects of slightly increased ALT levels within the normal range on the temporal normal glucose profile remains poorly understood. Methods: A total of 322 Chinese subjects without impaired glucose tolerance or previous diagnoses of diabetes were recruited for study from 10 hospitals in urban areas across China. All subjects wore a continuous glucose monitoring (CGM) system for three consecutive days. The diurnal (06:00-20:00) and nocturnal (20:00-06:00) mean blood glucose (MBG) levels were calculated. Subjects were stratified by ALT quartile level and correlation analyses were performed. Results: The median ALT level was 17 IU/L, and subjects with ALT >= 17 IU/L had higher nocturnal MBG level than those with ALT < 17 IU/L (P<0.05). Nocturnal MBG was positively correlated with ALT levels (Pearson correlation analysis: r = 0.187, P = 0.001), and the correlation remained significant after correction for the homeostatic model assessment of insulin resistance index (HOMA-IR) (r = 0.105, P = 0.041). No correlations were found between diurnal MBG and ALT, and nocturnal or diurnal MBG and aspartate aminotransferase or gamma-glutamyltransferase (all, P>0.05). Multivariate stepwise regression analysis of elevated nocturnal MBG identified increased HOMA-IR, elevated ALT levels, and decreased homeostatic model assessment of beta-cell function as independent factors (all, P<0.05). Conclusions: Mildly elevated ALT levels, within the normal range, are associated with unfavorable nocturnal glucose profiles in Chinese subjects with normal glucose regulation.	[Zhou, Jian; Mo, Yifei; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet, Dept Endocrinol & Metab,Shanghai Diabet Inst, Shanghai 200030, Peoples R China; [Li, Hong] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Endocrinol & Metab, Hangzhou 310003, Zhejiang, Peoples R China; [Ran, Xingwu] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu 610064, Peoples R China; [Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China; [Li, Qiang] Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol & Metab, Harbin, Peoples R China; [Peng, Yongde] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Endocrinol & Metab, Shanghai 200030, Peoples R China; [Li, Yanbing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Guangzhou 510275, Guangdong, Peoples R China; [Gao, Xin] Fudan Univ, Affiliated Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Luan, Xiaojun] First Peoples Hosp Foshan, Dept Endocrinol & Metab, Foshan, Peoples R China; [Wang, Weiqing] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Endocrinol & Metab, Shanghai Clin Ctr Endocrine & Metab Dis,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Zhejiang University; Sichuan University; China-Japan Friendship Hospital; Harbin Medical University; Shanghai Jiao Tong University; Sun Yat Sen University; Fudan University; Shanghai Jiao Tong University	Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Clin Ctr Diabet, Dept Endocrinol & Metab,Shanghai Diabet Inst, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	Jia, Weiping/B-7483-2012; li, yan/GTI-4638-2022		National Natural Science Foundation of China [81100590]; Shanghai Rising-Star Program [12QA1402500]; Shanghai United Developing Technology Project of Municipal Hospitals [SHDC12010115]; Shanghai Medical Program for Outstanding Young Talent [XYQ2011013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Shanghai United Developing Technology Project of Municipal Hospitals; Shanghai Medical Program for Outstanding Young Talent	This work was funded by the National Natural Science Foundation of China (81100590), http://www.nsfc.gov.cn; the Shanghai Rising-Star Program (12QA1402500), http://www.stcsm.gov.cn; the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010115), http://www.shdc.org.cn; and Shanghai Medical Program for Outstanding Young Talent (XYQ2011013), http://wsj.sh.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4; Angelico F, 2005, J CLIN ENDOCR METAB, V90, P1578, DOI 10.1210/jc.2004-1024; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Bhatia LS, 2012, EUR HEART J, V33, P1190, DOI 10.1093/eurheartj/ehr453; Bian H, 2011, DIABETES TECHNOL THE, V13, P149, DOI 10.1089/dia.2010.0101; Bonnet F, 2011, DIABETES, V60, P1660, DOI 10.2337/db10-1806; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; CEDERHOLM J, 1990, DIABETES RES CLIN PR, V10, P167, DOI 10.1016/0168-8227(90)90040-Z; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Daniel S, 1999, AM J GASTROENTEROL, V94, P3010, DOI 10.1111/j.1572-0241.1999.01451.x; Goessling W, 2008, GASTROENTEROLOGY, V135, P1935, DOI 10.1053/j.gastro.2008.09.018; Gronbaek Henning, 2008, Expert Rev Gastroenterol Hepatol, V2, P705, DOI 10.1586/17474124.2.5.705; Hanley AJG, 2004, DIABETES, V53, P2623, DOI 10.2337/diabetes.53.10.2623; Hsiao TJ, 2004, INT J OBESITY, V28, P167, DOI 10.1038/sj.ijo.0802519; Lee DH, 2004, J CLIN ENDOCR METAB, V89, P5410, DOI 10.1210/jc.2004-0505; Marchesini G, 2005, J ENDOCRINOL INVEST, V28, P333, DOI 10.1007/BF03347199; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Musso G, 2008, DIABETES CARE, V31, P562, DOI 10.2337/dc07-1526; Nannipieri M, 2005, DIABETES CARE, V28, P1757, DOI 10.2337/diacare.28.7.1757; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Ruhl CE, 2003, GASTROENTEROLOGY, V124, P71, DOI 10.1053/gast.2003.50004; Sattar N, 2004, DIABETES, V53, P2855, DOI 10.2337/diabetes.53.11.2855; Schindhelm RK, 2007, DIABETIC MED, V24, P430, DOI 10.1111/j.1464-5491.2007.02100.x; Schindhelm RK, 2007, ATHEROSCLEROSIS, V191, P391, DOI 10.1016/j.atherosclerosis.2006.04.006; Schindhelm RK, 2006, DIABETES-METAB RES, V22, P437, DOI 10.1002/dmrr.666; SELTZER HS, 1967, J CLIN INVEST, V46, P323, DOI 10.1172/JCI105534; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Shibata M, 2007, DIABETES CARE, V30, P2940, DOI 10.2337/dc07-0792; Suh SY, 2009, METABOLISM, V58, P1731, DOI 10.1016/j.metabol.2009.05.028; Targher G, 2007, DIABETES CARE, V30, P2119, DOI 10.2337/dc07-0349; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Wang CC, 2009, J GASTROEN HEPATOL, V24, P1411, DOI 10.1111/j.1440-1746.2009.05872.x; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Xia MF, 2011, CLIN EXP PHARMACOL P, V38, P373, DOI 10.1111/j.1440-1681.2011.05519.x; Zhou J, 2009, DIABETES CARE, V32, P1188, DOI 10.2337/dc09-0076	40	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56072	10.1371/journal.pone.0056072	http://dx.doi.org/10.1371/journal.pone.0056072			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424646	Green Submitted, Green Published, gold			2022-12-27	WOS:000315965100034
J	Silden, E; Hjelle, SM; Wergeland, L; Sulen, A; Andresen, V; Bourdon, JC; Micklem, DR; McCormack, E; Gjertsen, BT				Silden, Elisabeth; Hjelle, Sigrun M.; Wergeland, Line; Sulen, Andre; Andresen, Vibeke; Bourdon, Jean-Christophe; Micklem, David R.; McCormack, Emmet; Gjertsen, Bjorn Tore			Expression of TP53 Isoforms p53 beta or p53 gamma Enhances Chemosensitivity in TP53(null) Cell Lines	PLOS ONE			English	Article							P53 ISOFORMS; DNA-DAMAGE; LEUKEMIA	The carboxy-terminal truncated p53 alternative spliced isoforms, p53 beta and p53 gamma, are expressed at disparate levels in cancer and are suggested to influence treatment response and therapy outcome. However, their functional role in cancer remains to be elucidated. We investigated their individual functionality in the p53(null) background of cell lines H1299 and SAOS-2 by stable retroviral transduction or transient transfection. Expression status of p53 beta and p53 gamma protein was found to correlate with increased response to camptothecin and doxorubicin chemotherapy. Decreased DNA synthesis and clonogenicity in p53 beta and p53 gamma congenic H1299 was accompanied by increased p21((CIP1/WAF1)), Bax and Mdm2 proteins. Chemotherapy induced p53 isoform degradation, most prominent for p53 gamma. The proteasome inhibitor bortezomib substantially increased basal p53 gamma protein level, while the level of p53 beta protein was unaffected. Treatment with dicoumarol, a putative blocker of the proteasome-related NAD(P)H quinone oxidoreductase NQO1, effectively attenuated basal p53 gamma protein level in spite of bortezomib treatment. Although in vitro proliferation and clonogenicity assays indicated a weak suppressive effect by p53 beta and p53 gamma expression, studies of in vivo subcutaneous H1299 tumor growth demonstrated a significantly increased growth by expression of either p53 isoforms. This study suggests that p53 beta and p53 gamma share functionality in chemosensitizing and tumor growth enhancement but comprise distinct regulation at the protein level.	[Silden, Elisabeth; Hjelle, Sigrun M.; Wergeland, Line; Sulen, Andre; Andresen, Vibeke; McCormack, Emmet; Gjertsen, Bjorn Tore] Univ Bergen, Inst Med, Hematol Sect, Bergen, Norway; [Bourdon, Jean-Christophe] Univ Dundee, Sch Med, Dept Surg & Mol Oncol, INSERM,European Associated Lab,U858, Dundee, Scotland; [Micklem, David R.] Univ Bergen, Inst Biomed, Bergen, Norway; [Gjertsen, Bjorn Tore] Haukeland Hosp, Dept Internal Med, Hematol Sect, N-5021 Bergen, Norway	University of Bergen; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Dundee; University of Bergen; University of Bergen; Haukeland University Hospital	Gjertsen, BT (corresponding author), Univ Bergen, Inst Med, Hematol Sect, Bergen, Norway.	bjorn.gjertsen@med.uib.no	Sulen, André/GSD-5586-2022; Gjertsen, Bjorn T/O-1542-2015; JC, Bourdon/A-4439-2008; Andresen, Vibeke/I-9482-2018; Hjelle, Sigrun M./AAZ-5585-2020; Cormack, Emmet Mc/D-2922-2012; Gjertsen, Bjørn T/AAP-3281-2020	Gjertsen, Bjorn T/0000-0001-9358-9704; JC, Bourdon/0000-0003-4623-9386; Andresen, Vibeke/0000-0002-2368-2978; Cormack, Emmet Mc/0000-0002-7621-4625; Gjertsen, Bjørn T/0000-0001-9358-9704; Micklem, David/0000-0003-2756-2591; Sulen, Andre/0000-0002-2053-1760	Norwegian Cancer Society; Solveig og Ove Lund's legacy; Western Norway Regional Health Authority	Norwegian Cancer Society(Norwegian Cancer Society); Solveig og Ove Lund's legacy; Western Norway Regional Health Authority	This work was supported by grants from the Norwegian Cancer Society with Solveig og Ove Lund's legacy and the Western Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Anensen N, 2012, ONCOGENE, V31, P1533, DOI 10.1038/onc.2011.348; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Boldrup L, 2007, EUR J CANCER, V43, P617, DOI 10.1016/j.ejca.2006.10.019; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Bourdon JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2811; Braun F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023577; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Camus S, 2012, CELL CYCLE, V11, P1646, DOI 10.4161/cc.20119; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Gartel AL, 2005, LEUKEMIA RES, V29, P1237, DOI 10.1016/j.leukres.2005.04.023; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; Graupner V, 2009, CELL CYCLE, V8, P1238, DOI 10.4161/cc.8.8.8251; Hofstetter G, 2010, ONCOGENE, V29, P1997, DOI 10.1038/onc.2009.482; Khoury Marie P, 2011, Genes Cancer, V2, P453, DOI 10.1177/1947601911408893; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Marcel V, 2011, CELL DEATH DIFFER, V18, P1815, DOI 10.1038/cdd.2011.120; Marcel V, 2010, FEBS LETT, V584, P4463, DOI 10.1016/j.febslet.2010.10.005; Mc Cormack E, 2005, LEUKEMIA, V19, P687, DOI 10.1038/sj.leu.2403670; Peltonen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012996; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Sellmann L, 2012, LEUKEMIA LYMPHOMA, V53, P1282, DOI 10.3109/10428194.2011.654115; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Song W, 2009, CHINESE MED J-PEKING, V122, P921, DOI 10.3760/cma.j.issn.0366-6999.2009.08.008; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Tronstad KJ, 2001, LIPIDS, V36, P305, DOI 10.1007/s11745-001-0722-8; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Wei JX, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/687359; Wergeland L, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-33	35	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56276	10.1371/journal.pone.0056276	http://dx.doi.org/10.1371/journal.pone.0056276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409163	Green Submitted, Green Published, gold			2022-12-27	WOS:000315100000047
J	Gorkiewicz, G; Thallinger, GG; Trajanoski, S; Lackner, S; Stocker, G; Hinterleitner, T; Gully, C; Hogenauer, C				Gorkiewicz, Gregor; Thallinger, Gerhard G.; Trajanoski, Slave; Lackner, Stefan; Stocker, Gernot; Hinterleitner, Thomas; Guelly, Christian; Hoegenauer, Christoph			Alterations in the Colonic Microbiota in Response to Osmotic Diarrhea	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; INTESTINAL MICROBIOTA; PSEUDOMONAS-PUTIDA; GUT MICROBIOME; GASTROINTESTINAL-TRACT; SPATIAL-ORGANIZATION; ESCHERICHIA-COLI; BACTERIAL; DIVERSITY; COMMUNITIES	Background & Aims: Diseases of the human gastrointestinal (GI) tract are often accompanied by diarrhea with profound alterations in the GI microbiota termed dysbiosis. Whether dysbiosis is due to the disease itself or to the accompanying diarrhea remains elusive. With this study we characterized the net effects of osmotic diarrhea on the composition of the GI microbiota in the absence of disease. Methods: We induced osmotic diarrhea in four healthy adults by oral administration of polyethylene glycol 4000 (PEG). Stool as well as mucosa specimens were collected before, during and after diarrhea and 16S rDNA-based microbial community profiling was used to assess the microbial community structure. Results: Stool and mucosal microbiotas were strikingly different, with Firmicutes dominating the mucosa and Bacteroidetes the stools. Osmotic diarrhea decreased phylotype richness and showed a strong tendency to equalize the otherwise individualized microbiotas on the mucosa. Moreover, diarrhea led to significant relative shifts in the phyla Bacteroidetes and Firmicutes and to a relative increase in the abundance of Proteobacteria on the mucosa, a phenomenon also noted in several inflammatory and diarrheal GI diseases. Conclusions: Changes in microbial community structure induced by osmotic diarrhea are profound and show similarities to changes observed in other GI diseases including IBD. These effects so must be considered when specimens from diarrheal diseases (i.e. obtained by stratification of samples according to diarrheal status) or conditions wherein bowel preparations like PEG (i.e. specimens obtained during endoscopy) are used.	[Gorkiewicz, Gregor; Lackner, Stefan] Med Univ Graz, Inst Pathol, Graz, Austria; [Thallinger, Gerhard G.; Stocker, Gernot] Graz Univ Technol, Inst Genom & Bioinformat, A-8010 Graz, Austria; [Trajanoski, Slave; Lackner, Stefan; Guelly, Christian] Med Univ Graz, Med Res Ctr, Graz, Austria; [Hinterleitner, Thomas; Hoegenauer, Christoph] Med Univ Graz, Dept Internal Med, Div Gastroenterol & Hepatol, Graz, Austria	Medical University of Graz; Graz University of Technology; Medical University of Graz; Medical University of Graz	Gorkiewicz, G (corresponding author), Med Univ Graz, Inst Pathol, Graz, Austria.	gregor.gorkiewicz@medunigraz.at; christoph.hoegenauer@medunigraz.at	Gorkiewicz, Gregor/ABF-1602-2021; Stocker, Gernot/Q-2461-2019	Gorkiewicz, Gregor/0000-0003-1149-4782; Thallinger, Gerhard G./0000-0002-2864-5404; Stocker, Gernot/0000-0001-8326-1852; Hogenauer, Christoph/0000-0003-4566-0806	Austrian Ministry of Science and Research, GEN AU Bioinformatics Integration Network	Austrian Ministry of Science and Research, GEN AU Bioinformatics Integration Network	GGT and GS were supported by the Austrian Ministry of Science and Research, GEN AU Bioinformatics Integration Network; http://www.gen-au.at/index.jsp?lang=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bakker MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044357; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouhnik Y, 2004, ALIMENT PHARM THER, V19, P889, DOI 10.1111/j.1365-2036.2004.01918.x; Bounaix MS, 2010, FEMS MICROBIOL LETT, V311, P18, DOI 10.1111/j.1574-6968.2010.02067.x; Britton RA, 2012, TRENDS MICROBIOL, V20, P313, DOI 10.1016/j.tim.2012.04.001; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; CHAO A, 1984, SCAND J STAT, V11, P265; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/B978-0-12-381300-8.00008-3, 10.1016/S0065-2776(10)07001-X]; Codling C, 2010, DIGEST DIS SCI, V55, P392, DOI 10.1007/s10620-009-0934-x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cremon C, 2010, EXPERT REV MOL DIAGN, V10, P389, DOI 10.1586/ERM.10.33; Cuiv PO, 2011, MICROB ECOL, V61, P353, DOI 10.1007/s00248-010-9771-x; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Durban A, 2011, MICROB ECOL, V61, P123, DOI 10.1007/s00248-010-9738-y; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FINE KD, 1992, GASTROENTEROLOGY, V102, P1936, DOI 10.1016/0016-5085(92)90316-Q; Foell D, 2009, GUT, V58, P859, DOI 10.1136/gut.2008.170019; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gonzalez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029973; Guirl MJ, 2003, AM J GASTROENTEROL, V98, P2219, DOI 10.1016/S0002-9270(03)00701-9; HAMMER HF, 1989, J CLIN INVEST, V84, P1056, DOI 10.1172/JCI114267; Harrell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032545; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Kindt R., 2005, WORLD; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Lee KW, 2012, ANAEROBE, V18, P96, DOI 10.1016/j.anaerobe.2011.12.015; Levin SA, 1998, ECOSYSTEMS, V1, P431, DOI 10.1007/s100219900037; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Macfarlane S, 2007, J APPL MICROBIOL, V102, P1187, DOI 10.1111/j.1365-2672.2007.03287.x; Macfarlane S, 2008, J CLIN GASTROENTEROL, V42, pS142, DOI 10.1097/MCG.0b013e31816207df; Mai V, 2006, GUT, V55, P1822, DOI 10.1136/gut.2006.108266; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Nava GM, 2011, ISME J, V5, P627, DOI 10.1038/ismej.2010.161; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Papa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039242; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; READ NW, 1986, CLIN GASTROENTEROL, V15, P657; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Schiller LR, 1987, GASTROENTEROLOGY, V92, P151, DOI 10.1016/0016-5085(87)90852-3; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Sergeant MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038094; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sonnenburg JL, 2004, NAT IMMUNOL, V5, P569, DOI 10.1038/ni1079; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; Stocker G, 2010, P 110 ASM GEN M 23 5; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Walker AW, 2008, ENVIRON MICROBIOL, V10, P3275, DOI 10.1111/j.1462-2920.2008.01717.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watts RE, 2012, INFECT IMMUN, V80, P333, DOI 10.1128/IAI.05594-11; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu JY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-255; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; Yang CH, 1996, J FORMOS MED ASSOC, V95, P754; Yoshino Y, 2011, J INFECT CHEMOTHER, V17, P278, DOI 10.1007/s10156-010-0114-0; Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004; Yuan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033865; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	82	83	85	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55817	10.1371/journal.pone.0055817	http://dx.doi.org/10.1371/journal.pone.0055817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409050	Green Submitted, gold, Green Published			2022-12-27	WOS:000314660300035
J	Patterson, JEH; Neuhaus, P; Kutz, SJ; Ruckstuhl, KE				Patterson, Jesse E. H.; Neuhaus, Peter; Kutz, Susan J.; Ruckstuhl, Kathreen E.			Parasite Removal Improves Reproductive Success of Female North American Red Squirrels (Tamiasciurus hudsonicus)	PLOS ONE			English	Article							LIFE-HISTORY; TROGLODYTES-AEDON; ENERGETIC COST; GREAT TIT; ECTOPARASITE; MITE; CONSEQUENCES; EVOLUTION; SURVIVAL; ECOLOGY	In order to evaluate potential reproductive costs associated with parasitism, we experimentally removed ectoparasites from reproductive female North American red squirrels (Tamiasciurus hudsonicus). Body mass and overwinter survival of mothers, days to juvenile emergence, juvenile survival from birth to emergence, and body mass of juveniles at emergence were all compared to those of untreated (control) animals. Ectoparasite removal did not affect the body mass of mothers throughout the lactation period and overwinter survival of mothers did not differ between treatments and controls. Likewise, there was no effect of treatment on the number of days to juvenile emergence. However, treated mothers raised offspring that were significantly heavier (11%) than controls at emergence. Juveniles from treated mothers were also 24% more likely to survive from birth to emergence. Our results indicate that ectoparasites impose costs on the reproductive success of female red squirrels and that ectoparasites have the potential to influence red squirrel life-histories and population dynamics.	[Patterson, Jesse E. H.; Neuhaus, Peter; Ruckstuhl, Kathreen E.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Kutz, Susan J.] Univ Calgary, Fac Vet Med, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Patterson, JEH (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	jesse.patterson@ucalgary.ca	Ruckstuhl, Kathreen Eva/B-4469-2013	kutz, susan/0000-0003-2352-8687; Ruckstuhl, Kathreen/0000-0002-2949-242X	Natural Sciences and Engineering Research Council of Canada; American Society of Mammalogists; University of Calgary	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); American Society of Mammalogists; University of Calgary	Funding for this project was provided by the Natural Sciences and Engineering Research Council of Canada (Graduate Scholarship), American Society of Mammalogists (Grants-in-Aid of Research), and the University of Calgary (Thesis Dissertation Grant, Graduate Scholarships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander K, 1998, CAN J ZOOL, V76, P19, DOI 10.1139/cjz-76-1-19; [Anonymous], 2010, R LANG ENV STAT COMP; ARNOLD W, 1993, BEHAV ECOL, V4, P36, DOI 10.1093/beheco/4.1.36; Berteaux D, 2000, ECOLOGY, V81, P1311, DOI 10.1890/0012-9658(2000)081[1311:BDIFNA]2.0.CO;2; BOOTH DT, 1993, P ROY SOC B-BIOL SCI, V253, P125, DOI 10.1098/rspb.1993.0091; BOUTIN S, 1993, J ANIM ECOL, V62, P364, DOI 10.2307/5367; BROWN CR, 1986, ECOLOGY, V67, P1206, DOI 10.2307/1938676; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Careau V, 2010, OECOLOGIA, V162, P303, DOI 10.1007/s00442-009-1466-y; Chadwick W, 2005, P ROY SOC B-BIOL SCI, V272, P505, DOI 10.1098/rspb.2004.2959; Colegrave N, 2003, BEHAV ECOL, V14, P446, DOI 10.1093/beheco/14.3.446; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Lope F, 1998, OECOLOGIA, V114, P188, DOI 10.1007/s004420050435; DELOPE F, 1993, OIKOS, V67, P557, DOI 10.2307/3545368; Descamps S, 2007, J ANIM ECOL, V76, P1192, DOI 10.1111/j.1365-2656.2007.01301.x; Fitze PS, 2004, J ANIM ECOL, V73, P216, DOI 10.1111/j.0021-8790.2004.00799.x; Giorgi MS, 2001, P ROY SOC B-BIOL SCI, V268, P2071, DOI 10.1098/rspb.2001.1686; Gooderham K, 2011, BEHAV ECOL, V22, P1195, DOI 10.1093/beheco/arr112; Harriman VB, 2010, J AVIAN BIOL, V41, P573, DOI 10.1111/j.1600-048X.2010.05013.x; Hillegass MA, 2010, BEHAV ECOL, V21, P696, DOI 10.1093/beheco/arq041; HIRSHFIELD MF, 1975, P NATL ACAD SCI USA, V72, P2227, DOI 10.1073/pnas.72.6.2227; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; Humphries MM, 2000, ECOLOGY, V81, P2867, DOI 10.2307/177347; JOHNSON LS, 1993, OIKOS, V66, P255, DOI 10.2307/3544812; Kerr TD, 2007, BIOLOGY LETT, V3, P289, DOI 10.1098/rsbl.2006.0615; Khokhlova IS, 2002, J ZOOL, V258, P349, DOI 10.1017/S0952836902001498; Kutz SJ, 2005, P ROY SOC B-BIOL SCI, V272, P2571, DOI 10.1098/rspb.2005.3285; Larsen K S, 2005, Parasitol Res, V97 Suppl 1, pS107, DOI 10.1007/s00436-005-1453-0; LARSEN KW, 1995, CAN J ZOOL, V73, P1115, DOI 10.1139/z95-133; MAHRT JL, 1972, J PARASITOL, V58, P639, DOI 10.2307/3278230; Mcadam AG, 2007, ECOSCIENCE, V14, P362, DOI 10.2980/1195-6860(2007)14[362:LHOFRS]2.0.CO;2; McFarlane SE, 2011, BIOL LETTERS, V7, P368, DOI 10.1098/rsbl.2010.1003; Metzger ME, 2002, J MED ENTOMOL, V39, P152, DOI 10.1603/0022-2585-39.1.152; MOLLER AP, 1993, J ANIM ECOL, V62, P309, DOI 10.2307/5362; MOLLER AP, 1990, ECOLOGY, V71, P2345, DOI 10.2307/1938645; MOSS WW, 1970, SCIENCE, V168, P1000, DOI 10.1126/science.168.3934.1000; Ohlberger J, 2011, P ROY SOC B-BIOL SCI, V278, P35, DOI 10.1098/rspb.2010.0960; OPPLIGER A, 1994, BEHAV ECOL, V5, P130, DOI 10.1093/beheco/5.2.130; Pacejka AJ, 1998, ECOLOGY, V79, P1797, DOI 10.1890/0012-9658(1998)079[1797:DPVMAH]2.0.CO;2; Prendergast JA, 2011, WEST N AM NATURALIST, V71, P516, DOI 10.3398/064.071.0409; PRICE K, 1993, BEHAV ECOL, V4, P144, DOI 10.1093/beheco/4.2.144; RICHNER H, 1993, J ANIM ECOL, V62, P703, DOI 10.2307/5390; RITTER RC, 1974, BEHAV BIOL, V11, P581, DOI 10.1016/S0091-6773(74)90935-3; Rogmann JJ, 2012, ORDINAL DOMINANCE ST; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Scantlebury M, 2007, P ROY SOC B-BIOL SCI, V274, P2169, DOI 10.1098/rspb.2007.0690; SMITH CC, 1968, ECOL MONOGR, V38, P31, DOI 10.2307/1948536; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Stearns S., 1992, EVOLUTION LIFE HIST; Steele Michael A., 1998, Mammalian Species, V586, P1; TRIVERS RL, 1974, AM ZOOL, V14, P249; [No title captured]	52	24	24	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55779	10.1371/journal.pone.0055779	http://dx.doi.org/10.1371/journal.pone.0055779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409041	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300034
J	Qi, WX; Wang, Q; Jiang, YL; Sun, YJ; Tang, LN; He, AN; Min, DL; Lin, F; Shen, Z; Yao, Y				Qi, Wei-Xiang; Wang, Qiong; Jiang, Yan-Ling; Sun, Yuan-Jue; Tang, Li-na; He, Ai-na; Min, Da-liu; Lin, Feng; Shen, Zan; Yao, Yang			Overall Survival Benefits for Combining Targeted Therapy as Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Published Data	PLOS ONE			English	Article							RANDOMIZED PHASE-II; TYROSINE KINASE INHIBITORS; GROWTH-FACTOR RECEPTOR; PLUS ERLOTINIB; DOUBLE-BLIND; PLACEBO; CHEMOTHERAPY; COMBINATION; MULTICENTER; GEFITINIB	Background: Combining targeted therapy has been extensively investigated in previously treated advanced non-small-cell lung cancer (NSCLC), but it is still unclear whether combining targeted therapy might offer any benefits against standard monotherapy with erlotinib. We thus performed a meta-analysis of randomized controlled trials to compare the efficacy and safety of combining targeted therapy versus erlotinib alone as second-line treatment for advanced NSCLC. Methods: Several databases were searched, including Pubmed, Embase and Cochrane databases. The endpoints were overall survival (OS), progression-free survival (PFS), overall response rate (ORR) and grade 3 or 4 adverse event (AEs). The pooled hazard ratio (HR) or odds ratio (OR), and 95% confidence intervals (CI) were calculated employing fixed- or random-effects models depending on the heterogeneity of the included trials. Results: Eight eligible trials involved 2417 patients were ultimately identified. The intention to treatment (ITT) analysis demonstrated that combining targeted therapy significantly improved OS (HR 0.90, 95% CI: 0.82-0.99, p = 0.024), PFS (HR 0.83, 95% CI: 0.72-0.97, p = 0.018), and ORR (OR 1.35, 95% CI 1.01-1.80, P = 0.04). Sub-group analysis based on phases of trials, EGFR-status and KRAS status also showed that there was a tendency to improve PFS and OS in combining targeted therapy, except that PFS for patients with EGFR-mutation or wild type KRAS favored erlotinib monotherapy. Additionally, more incidence of grade 3 or 4 rash, fatigue and hypertension were observed in combining targeted therapy. Conclusions: With the available evidence, combining targeted therapy seems superior over erlotinib monotherapy as second-line treatment for advanced NSCLC. More studies are still needed to identify patients who will most likely benefit from the appropriate combining targeted therapy.	[Qi, Wei-Xiang; Wang, Qiong; Sun, Yuan-Jue; Tang, Li-na; He, Ai-na; Min, Da-liu; Lin, Feng; Shen, Zan; Yao, Yang] Shanghai Jiao Tong Univ, Dept Oncol, Peoples Hosp 6, Shanghai 200030, Peoples R China; [Jiang, Yan-Ling] Kunming Med Univ, Dept Oncol, Kunming, Yunnan, Peoples R China	Shanghai Jiao Tong University; Kunming Medical University	Yao, Y (corresponding author), Shanghai Jiao Tong Univ, Dept Oncol, Peoples Hosp 6, Shanghai 200030, Peoples R China.	shenzanok@yahoo.com; qwxzlk@163.com		Qi, wei-xiang/0000-0001-5484-3343	National Natural Science Foundation of China [81001191]; Science and Technology Commission of Shanghai [10PJ1408300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM))	The study was supported by grants from the National Natural Science Foundation of China (81001191) and Science and Technology Commission of Shanghai (10PJ1408300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belani CP, 2012, CANCER TREAT REV, V38, P173, DOI 10.1016/j.ctrv.2011.05.009; Bennouna J, 2010, ANN ONCOLOGY S21; Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0; Custodio A, 2012, CANCER TREAT REV, V38, P36, DOI 10.1016/j.ctrv.2011.04.001; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang H, 2009, JPN J CLIN ONCOL, V39, P137, DOI 10.1093/jjco/hyn139; KURITZ SJ, 1988, ANNU REV PUBL HEALTH, V9, P123, DOI 10.1146/annurev.pu.09.050188.001011; Lin H, 2010, LUNG CANCER, V70, P57, DOI 10.1016/j.lungcan.2010.01.009; Lynch TJ, 2009, J THORAC ONCOL, V4, P1002, DOI 10.1097/JTO.0b013e3181aba89f; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mortenson MM, 2004, CANCER CHEMOTH PHARM, V54, P343, DOI 10.1007/s00280-004-0811-4; Natale RB, 2011, J CLIN ONCOL, V29, P1059, DOI 10.1200/JCO.2010.28.5981; NCI Cancer Therapy Evaluation Program, 2006, CTC V 2 0 COMM TERM; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Passaro A, 2011, EXPERT REV ANTICANC, V11, P1587, DOI [10.1586/ERA.11.120, 10.1586/era.11.120]; Pennell NA, 2009, ONCOLOGIST, V14, P399, DOI 10.1634/theoncologist.2008-0276; Qi WX, 2012, CURR MED RES OPIN, V28, P643, DOI 10.1185/03007995.2012.675880; Qi WX, 2011, LUNG, V189, P437, DOI 10.1007/s00408-011-9332-1; Ramalingam SS, 2011, J CLIN ONCOL, V29, P4574, DOI 10.1200/JCO.2011.36.6799; Rubin BP, 2006, LAB INVEST, V86, P981, DOI 10.1038/labinvest.3700466; Scagliotti GV, 2012, J CLIN ONCOL, V30, P2070, DOI 10.1200/JCO.2011.39.2993; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Spigel DR, 2011, J CLIN ONCOL, V29, P2582, DOI 10.1200/JCO.2010.30.7678; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tiwari D, 2012, THER ADV RESPIR DIS, V6, P41, DOI 10.1177/1753465811404590; Tortora G, 2003, CLIN CANCER RES, V9, P1566; Uhm JE, 2009, J THORAC ONCOL, V4, P1136, DOI 10.1097/JTO.0b013e3181b270a7; van der Kuip H, 2005, AM J PHARMACOGENOMIC, V5, P101, DOI 10.2165/00129785-200505020-00003; Witta SE, 2012, J CLIN ONCOL, V30, P2248, DOI 10.1200/JCO.2011.38.9411; Yang CH, 2008, LUNG CANCER, V60, pS23, DOI 10.1016/S0169-5002(08)70102-8; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	41	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55637	10.1371/journal.pone.0055637	http://dx.doi.org/10.1371/journal.pone.0055637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409011	Green Published, Green Submitted, gold			2022-12-27	WOS:000314660300026
J	Yan, D; Luo, JY; Han, YM; Peng, C; Dong, XP; Chen, SL; Sun, LG; Xiao, XH				Yan, Dan; Luo, Jiao Y.; Han, Yu M.; Peng, Cheng; Dong, Xiao P.; Chen, Shi L.; Sun, Li G.; Xiao, Xiao H.			Forensic DNA Barcoding and Bio-Response Studies of Animal Horn Products Used in Traditional Medicine	PLOS ONE			English	Article							COMPLEMENTARY MEDICINE; RIBOSOMAL-RNA; CONSERVATION; REMEDIES; IDENTIFICATION; COMMERCIALIZATION; PHYLOGENY; REGION; FAUNA; GENE	Background: Animal horns (AHs) have been applied to traditional medicine for more than thousands of years, of which clinical effects have been confirmed by the history. But now parts of AHs have been listed in the items of wildlife conservation, which limits the use for traditional medicine. The contradiction between the development of traditional medicine and the protection of wild resources has already become the common concern of zoophilists, traditional medical professionals, economists, sociologists. We believe that to strengthen the identification for threatened animals, to prevent the circulation of them, and to seek fertile animals of corresponding bioactivities as substitutes are effective strategies to solve this problem. Methodology/Principal Findings: A powerful technique of DNA barcoding based on the mitochondrial gene cytochrome c oxidase I (COI) was used to identify threatened animals of Bovidae and Cervidae, as well as their illegal adulterants (including 10 species and 47 specimens). Meanwhile, the microcalorimetric technique was used to characterize the differences of bio-responses when those animal specimens acted on model organism (Escherichia coli). We found that the COI gene could be used as a universal primer to identify threatened animals and illegal adulterants mentioned above. By analyzing 223 mitochondrial COI sequences, a 100% identification success rate was achieved. We further found that the horns of Mongolian Gazelle and Red Deer could be exploited as a substitute for some functions of endangered Saiga Antelope and Sika Deer in traditional medicine, respectively. Conclusion/Significance: Although it needs a more comprehensive evaluation of bioequivalence in order to completely solve the problem of substitutes for threatened animals, we believe that the identification (DNA barcoding) of threatened animals combined with seeking substitutions (bio-response) can yet be regarded as a valid strategy for establishing a balance between the protection of threatened animals and the development of traditional medicine.	[Yan, Dan; Luo, Jiao Y.; Xiao, Xiao H.] Mil 302 Hosp, China Mil Inst Chinese Mat Med, Beijing, Peoples R China; [Luo, Jiao Y.; Chen, Shi L.] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Han, Yu M.; Peng, Cheng; Dong, Xiao P.] Chengdu Univ Chinese Tradit Med, Coll Pharm, Chengdu, Peoples R China; [Sun, Li G.] Beijing Phys Examinat Ctr, Beijing, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chengdu University of Traditional Chinese Medicine	Chen, SL (corresponding author), Mil 302 Hosp, China Mil Inst Chinese Mat Med, Beijing, Peoples R China.	medplant@163.com; pharmsci@126.com	xiao, xiang/GWU-6035-2022	Peng, Cheng/0000-0003-3303-906X	National Natural Science Foundation of China [30873385, 81274078]; Beijing Natural Science Foundation [7112128]; Open Research Fund of State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicinal Resources	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Open Research Fund of State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicinal Resources	This work was supported by the National Natural Science Foundation of China (Grants No. 30873385 and No. 81274078), the Beijing Natural Science Foundation (Grants No. 7112128) and the Open Research Fund of State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicinal Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves RRN, 2007, BIOSCIENCE, V57, P949, DOI 10.1641/B571107; Alves RRN, 2007, J ETHNOPHARMACOL, V113, P541, DOI 10.1016/j.jep.2007.07.015; Alves RRN, 2006, J ETHNOPHARMACOL, V107, P259, DOI 10.1016/j.jep.2006.03.007; Alves RRN, 2011, J ETHNOBIOL ETHNOMED, V7, DOI [10.1186/1746-4269-7-9, 10.1186/1746-4269-7-22]; Alves RRN, 2010, MAMMAL REV, V40, P155, DOI 10.1111/j.1365-2907.2010.00158.x; Alves RRN, 2009, J ETHNOPHARMACOL, V124, P600, DOI 10.1016/j.jep.2009.04.049; Alves RRN, 2008, BIODIVERS CONSERV, V17, P2037, DOI 10.1007/s10531-007-9305-0; Arif IA, 2012, EVOL BIOINFORM, V8, P139, DOI 10.4137/EBO.S8897; Ben-Nun IF, 2011, NAT METHODS, V8, P829, DOI [10.1038/NMETH.1706, 10.1038/nmeth.1706]; Benitez G, 2011, J ETHNOPHARMACOL, V137, P1113, DOI 10.1016/j.jep.2011.07.036; Bitanyi S, 2011, MOL ECOL RESOUR, V11, P442, DOI 10.1111/j.1755-0998.2011.02980.x; Bruce SJ, 2009, ANAL CHEM, V81, P3285, DOI 10.1021/ac8024569; Cleland LG, 2003, DRUGS, V63, P845, DOI 10.2165/00003495-200363090-00001; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; Alves RRD, 2007, BIODIVERS CONSERV, V16, P969, DOI 10.1007/s10531-006-9036-7; Jacobo-Salcedo MD, 2011, J ETHNOPHARMACOL, V133, P902, DOI 10.1016/j.jep.2010.10.005; Feng YB, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-2; Guha S, 2007, MOL PHYLOGENET EVOL, V42, P585, DOI 10.1016/j.ympev.2006.06.020; Haddad NM, 2012, NAT METHODS, V9, P794, DOI 10.1038/nmeth.2107; Hassanin A, 2003, SYST BIOL, V52, P206, DOI 10.1080/10635150390192726; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Koo I, 2011, ANAL CHEM, V83, P5631, DOI 10.1021/ac200740w; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lam W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001270; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Leal IR, 2005, CONSERV BIOL, V19, P701, DOI 10.1111/j.1523-1739.2005.00703.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luo JY, 2011, J PHARM PHARM SCI, V14, P358, DOI 10.18433/J3N017; Magnacca KN, 2012, MOL ECOL RESOUR, V12, P990, DOI 10.1111/1755-0998.12001; Marschall J, 2012, CLIN INFECT DIS, V16, P11; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mishra N, 2011, AFR J PHARM PHARMACO, V5, P6; Nei M, 2000, MOL EVOLUTION PHYLOG; Alves RRN, 2010, HUM ECOL, V38, P691, DOI 10.1007/s10745-010-9352-0; Alves RRN, 2010, BIODIVERS CONSERV, V19, P1513, DOI 10.1007/s10531-010-9805-1; Oliveira ES, 2010, J ETHNOPHARMACOL, V130, P54, DOI 10.1016/j.jep.2010.04.010; Reid BN, 2011, MOL ECOL RESOUR, V11, P956, DOI 10.1111/j.1755-0998.2011.03032.x; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Taglietti A, 2012, LANGMUIR, V16, P11; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; United States Food and Drug Administration Public Health Service, 1973, GRAS MON SER FISH OI, P3; Wang F, 2010, CHEMOSPHERE, V78, P319, DOI 10.1016/j.chemosphere.2009.10.030; Whiting MJ, 2011, J ZOOL, V284, P84, DOI 10.1111/j.1469-7998.2010.00784.x	49	32	40	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55854	10.1371/journal.pone.0055854	http://dx.doi.org/10.1371/journal.pone.0055854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409064	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300040
J	Kondrychyn, I; Teh, C; Sin, M; Korzh, V				Kondrychyn, Igor; Teh, Cathleen; Sin, Melvin; Korzh, Vladimir			Stretching Morphogenesis of the Roof Plate and Formation of the Central Canal	PLOS ONE			English	Article							NEURAL-TUBE MORPHOGENESIS; CELL-SHAPE CHANGE; SPINAL-CORD; EMBRYONIC-DEVELOPMENT; ZIC GENES; ZEBRAFISH; SPECIFICATION; NEURULATION; ACTIN; MECHANISMS	Background: Neurulation is driven by apical constriction of actomyosin cytoskeleton resulting in conversion of the primitive lumen into the central canal in a mechanism driven by F-actin constriction, cell overcrowding and buildup of axonal tracts. The roof plate of the neural tube acts as the dorsal morphogenetic center and boundary preventing midline crossing by neural cells and axons. Methodology/Principal Findings: The roof plate zebrafish transgenics expressing cytosolic GFP were used to study and describe development of this structure in vivo for a first time ever. The conversion of the primitive lumen into the central canal causes significant morphogenetic changes of neuroepithelial cells in the dorsal neural tube. We demonstrated that the roof plate cells stretch along the D-V axis in parallel with conversion of the primitive lumen into central canal and its ventral displacement. Importantly, the stretching of the roof plate is well-coordinated along the whole spinal cord and the roof plate cells extend 3x in length to cover 2/3 of the neural tube diameter. This process involves the visco-elastic extension of the roof place cytoskeleton and depends on activity of Zic6 and the Rho-associated kinase (Rock). In contrast, stretching of the floor plate is much less extensive. Conclusions/Significance: The extension of the roof plate requires its attachment to the apical complex of proteins at the surface of the central canal, which depends on activity of Zic6 and Rock. The D-V extension of the roof plate may change a range and distribution of morphogens it produces. The resistance of the roof plate cytoskeleton attenuates ventral displacement of the central canal in illustration of the novel mechanical role of the roof plate during development of the body axis.	[Kondrychyn, Igor; Teh, Cathleen; Sin, Melvin; Korzh, Vladimir] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Korzh, Vladimir] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Korzh, V (corresponding author), ASTAR, Inst Mol & Cell Biol, Singapore, Singapore.	vlad@imcb.a-star.edu.sg	Korzh, Vladimir P/H-1596-2011; Kondrychyn, Igor/AAC-6237-2022; Kondrychyn, Igor/C-2621-2016	Korzh, Vladimir P/0000-0002-6580-7986; Kondrychyn, Igor/0000-0002-2268-7291; Kondrychyn, Igor/0000-0002-2268-7291	Agency for Science, Technology and Research (A-STAR) of Singapore	Agency for Science, Technology and Research (A-STAR) of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the grant of the Agency for Science, Technology and Research (A-STAR) of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Appel B, 2001, BMC Dev Biol, V1, P13, DOI 10.1186/1471-213X-1-13; Aruga J, 2004, MOL CELL NEUROSCI, V26, P205, DOI 10.1016/j.mcn.2004.01.004; Blank MC, 2011, DEVELOPMENT, V138, P1207, DOI 10.1242/dev.054114; BOHME G, 1988, J ANAT, V159, P37; Brand M, 1996, DEVELOPMENT, V123, P129; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Chizhikov VV, 2004, DEVELOPMENT, V131, P2693, DOI 10.1242/dev.01139; Colas JF, 2001, DEV DYNAM, V221, P117, DOI 10.1002/dvdy.1144; Copp AJ, 2005, J ANAT, V207, P623, DOI 10.1111/j.1469-7580.2005.00476.x; Cui WW, 2005, J NEUROSCI, V25, P6610, DOI 10.1523/JNEUROSCI.5009-04.2005; Elmonem MEA, 2007, ANAT HISTOL EMBRYOL, V36, P43, DOI 10.1111/j.1439-0264.2006.00716.x; Elsen GE, 2008, DEV BIOL, V314, P376, DOI 10.1016/j.ydbio.2007.12.006; Garcia-Lecea M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003090; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Grinberg I, 2004, NAT GENET, V36, P1053, DOI 10.1038/ng1420; Grinberg I, 2005, CLIN GENET, V67, P290, DOI 10.1111/j.1399-0004.2005.00418.x; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Harris MJ, 2001, TERATOLOGY, V63, P165, DOI 10.1002/tera.1030; Harris MJ, 2007, BIRTH DEFECTS RES A, V79, P187, DOI 10.1002/bdra.20333; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jiang YJ, 1996, DEVELOPMENT, V123, P205; KARFUNKEL P, 1974, INT REV CYTOL, V38, P245, DOI 10.1016/S0074-7696(08)60927-4; Keller MJ, 2007, DEV GENES EVOL, V217, P541, DOI 10.1007/s00427-007-0161-4; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinoshita N, 2008, MOL BIOL CELL, V19, P2289, DOI 10.1091/mbc.E07-12-1286; Kondrychyn I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-418; KORZH V, 1993, DEVELOPMENT, V118, P417; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Li YC, 2009, J HISTOCHEM CYTOCHEM, V57, P741, DOI 10.1369/jhc.2009.953646; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791; Lyons DA, 2003, DEVELOPMENT, V130, P3427, DOI 10.1242/dev.00569; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; McMahon Ariel R, 2010, BMC Res Notes, V3, P167, DOI 10.1186/1756-0500-3-167; Merzdorf CS, 2007, DEV DYNAM, V236, P922, DOI 10.1002/dvdy.21098; MESTRES P, 1980, Scanning Electron Microscopy, P465; Millen KJ, 2004, DEV BIOL, V270, P382, DOI 10.1016/j.ydbio.2004.03.008; MORRISSKAY G, 1985, J EMBRYOL EXP MORPH, V88, P333; Munson C, 2008, DEV BIOL, V324, P41, DOI 10.1016/j.ydbio.2008.08.033; Muroyama Y, 2002, GENE DEV, V16, P548, DOI 10.1101/gad.937102; NAGELE RG, 1987, J EXP ZOOL, V244, P425, DOI 10.1002/jez.1402440309; Nakano Y, 2004, DEV BIOL, V269, P381, DOI 10.1016/j.ydbio.2004.01.022; Nyholm MK, 2009, J CELL SCI, V122, P2137, DOI 10.1242/jcs.043471; Papan C, 1999, DEV GENES EVOL, V209, P135, DOI 10.1007/s004270050237; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Parisi MA, 2003, MOL GENET METAB, V80, P36, DOI 10.1016/j.ymgme.2003.08.010; Pogoda HM, 2000, CURR BIOL, V10, P1041, DOI 10.1016/S0960-9822(00)00669-2; SADLER TW, 1982, SCIENCE, V215, P172, DOI 10.1126/science.7031898; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Sevc J, 2009, CELL MOL NEUROBIOL, V29, P927, DOI 10.1007/s10571-009-9377-3; SHIMAMURA K, 1994, DEVELOPMENT, V120, P2225; SMEDLEY MJ, 1986, J EMBRYOL EXP MORPH, V93, P167; SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; STURROCK RR, 1981, J ANAT, V132, P119; Teh C, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-110; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wolff C, 2004, GENE DEV, V18, P1565, DOI 10.1101/gad.296004; Wu M, 1996, P NATL ACAD SCI USA, V93, P2110, DOI 10.1073/pnas.93.5.2110; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638	70	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56219	10.1371/journal.pone.0056219	http://dx.doi.org/10.1371/journal.pone.0056219			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409159	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200123
J	Kumari, J; Bogwald, J; Dalmo, RA				Kumari, Jaya; Bogwald, Jarl; Dalmo, Roy A.			Eomesodermin of Atlantic Salmon: An Important Regulator of Cytolytic Gene and Interferon Gamma Expression in Spleen Lymphocytes	PLOS ONE			English	Article							CELL-MEDIATED CYTOTOXICITY; BOX TRANSCRIPTION FACTOR; T-BET; RAINBOW-TROUT; EFFECTOR; PROMOTER; PROTEIN; PERFORIN; TH1	Eomesodermin (Eomes), a T-bet homologue expressed in activated CD8+T cells was recently proposed to act as a master regulator of cytotoxic CD8+T cell effector function and offers an exciting avenue for future exploration. Here, we have identified and characterized the full-length Atlantic salmon Eomes cDNA (2477 bp). Promoter analysis of the salmon Eomes showed the presence of important putative transcription binding sites like SP1, FOXO, Oct-1, SMAD, STAT, IRF, and Ets-1. The basal core region responsible for the promoter activity was located between base 2199 and +59. Quantitative PCR analysis revealed that the Atlantic salmon Eomes was ubiquitously expressed in all the tissues studied but strongly expressed in the ovary, spleen, brain, and the head kidney. Moreover, the involvement of Eomes in Atlantic salmon immune response and its relation with the cytolytic activity was demonstrated by investigating the early time dependent expression profile of Eomes and CD8 alpha followed by high interferon gamma (IFN-gamma) and granzyme A expression during challenge with live Aeromonas salmonicida and Infectious Pancreatic Necrosis (IPN) virus. Therefore, we further analyzed the regulated expression and function of this transcription factor in spleen lymphocytes. Overexpression of Eomes induced IFN-gamma, and granzyme A expression but not perforin expression, whereas small interfering RNA (siRNA) mediated suppression of Eomes expression led to significantly reduced IFN-gamma production. Thus, Eomes may be critical in cytolytic gene expression and function in fish similar to mammals. Furthermore, IFN-alpha, and mitogens induced Eomes expression. Taken together, this is the first study on the promoter activity and regulatory role of Eomes in fish.	[Kumari, Jaya; Bogwald, Jarl; Dalmo, Roy A.] Univ Tromso, Norwegian Coll Fishery Sci, Fac Biosci Fisheries & Econ, Tromso, Norway	UiT The Arctic University of Tromso	Kumari, J (corresponding author), Univ Tromso, Norwegian Coll Fishery Sci, Fac Biosci Fisheries & Econ, Tromso, Norway.	jaya.kumari@uit.no; roy.dalmo@uit.no	Swain, Jaya Kumari/AAT-1102-2020; Dalmo, Roy Ambli/B-8437-2011; Dalmo, Roy Ambli/AAN-5157-2021; Bøgwald, Jarl/AAH-2515-2019	Swain, Jaya Kumari/0000-0003-1787-5498; Dalmo, Roy Ambli/0000-0002-6181-9859; Dalmo, Roy Ambli/0000-0002-6181-9859; 	University of Tromso; European Commission [007103]; Research Council of Norway [183204/S40]; Tromso Research Foundation	University of Tromso; European Commission(European CommissionEuropean Commission Joint Research Centre); Research Council of Norway(Research Council of Norway); Tromso Research Foundation	This work was supported by the University of Tromso, the European Commission grant IMAQUANIM (contract no. 007103), the Research Council of Norway (contract no. 183204/S40) and the Tromso Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya I, 2007, GUT, V56, P1572, DOI 10.1136/gut.2006.117812; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bjornson CRR, 2005, DEV CELL, V9, P523, DOI 10.1016/j.devcel.2005.08.010; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Bruce AEE, 2005, DEV DYNAM, V233, P105, DOI 10.1002/dvdy.20305; Bruce AEE, 2003, DEVELOPMENT, V130, P5503, DOI 10.1242/dev.00763; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Eshima K, 2012, IMMUNOL LETT, V144, P7, DOI 10.1016/j.imlet.2012.02.013; Fischer U, 2003, DEV COMP IMMUNOL, V27, P323, DOI 10.1016/S0145-305X(02)00100-3; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; He WF, 2010, J IMMUNOL, V185, P126, DOI 10.4049/jimmunol.0903767; HERRMANN BG, 1992, CIBA F SYMP, V165, P78; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Kim MK, 1996, MOL CELL BIOL, V16, P4366; KLIMPEL GR, 1990, CELL IMMUNOL, V128, P603, DOI 10.1016/0008-8749(90)90052-S; Kumari J, 2009, MOL IMMUNOL, V46, P3099, DOI 10.1016/j.molimm.2009.06.008; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Narayanan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010636; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pipkin ME, 2010, IMMUNOL REV, V235, P55, DOI 10.1111/j.0105-2896.2010.00905.x; Rao RR, 2012, IMMUNITY, V36, P374, DOI 10.1016/j.immuni.2012.01.015; Robertsen B, 2003, J INTERF CYTOK RES, V23, P601, DOI 10.1089/107999003322485107; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Ryan K, 2000, MECH DEVELOP, V94, P133, DOI 10.1016/S0925-4773(00)00300-2; Sever-Chroneos Z, 1999, AM J PHYSIOL-LUNG C, V277, pL79, DOI 10.1152/ajplung.1999.277.1.L79; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; TAKIMOTO M, 1989, J BIOL CHEM, V264, P8992; Takizawa F, 2007, MOL IMMUNOL, V44, P2324, DOI 10.1016/j.molimm.2006.11.018; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Toda H, 2009, DEV COMP IMMUNOL, V33, P646, DOI 10.1016/j.dci.2008.11.008; Utke K, 2007, FISH SHELLFISH IMMUN, V22, P182, DOI 10.1016/j.fsi.2006.04.008; Wyllie DH, 2000, J IMMUNOL, V165, P7125, DOI 10.4049/jimmunol.165.12.7125; Zhou H, 2001, J IMMUNOL, V167, P1325, DOI 10.4049/jimmunol.167.3.1325; Zhu YB, 2010, J IMMUNOL, V184; Zhu YB, 2010, J IMMUNOL, V185, P3174, DOI 10.4049/jimmunol.1000749	37	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55893	10.1371/journal.pone.0055893	http://dx.doi.org/10.1371/journal.pone.0055893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409078	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200083
J	Biswas, S; Sharma, S; Saroha, A; Bhakuni, DS; Malhotra, R; Zahur, M; Oellerich, M; Das, HR; Asif, AR				Biswas, Sagarika; Sharma, Saurabh; Saroha, Ashish; Bhakuni, D. S.; Malhotra, Rajesh; Zahur, Muzna; Oellerich, Michael; Das, Hasi R.; Asif, Abdul R.			Identification of Novel Autoantigen in the Synovial Fluid of Rheumatoid Arthritis Patients Using an Immunoproteomics Approach	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; CITRULLINATED PROTEIN; IMMUNE-RESPONSE; ANTIBODIES; AUTOANTIBODIES; SPECIFICITY; DIAGNOSIS; VIMENTIN; ISOFORMS; SERUM	Rheumatoid arthritis (RA) is a chronic, autoimmune and inflammatory joint disease with a poorly understood etiology. Despite widespread diagnostic use of anti-citrullinated protein antibodies and rheumatoid factor proteins there is a strong demand for novel serological biomarkers to improve the diagnosis this disease. The present study was aimed to identify novel autoantigens involved in rheumatoid arthritis (RA) pathogenesis through immune-proteomic strategy. Synovial fluid samples from clinically diagnosed RA patients were separated on two-dimensional gel electrophoresis (2-DE). Samples from patients with non-RA rheumatisms (osteoarthritis and trauma) were used as controls. Immunoreactive proteins were spotted by Western blotting followed by identification through Q-TOF mass spectrometer analysis. Forty Western blots were generated using plasma from ten individual RA patients and 33 reactive spots were identified, 20 from the high molecular weight (HMW) gel and 13 from the low molecular weight (LMW) gel. Among the 33 common immunogenic spots, 18 distinct autoantigens were identified, out of which 14 are novel proteins in this context. Expression analysis of five important proteins, vimentin, gelsolin, alpha 2 HS glycoprotein (AHSG), glial fibrillary acidic protein (GFAP), and alpha 1 beta-glycoprotein (A1BG) by Western blot analysis using their specific antibodies revealed their higher expression in RA synovial fluid as compared to non-RA samples. Recombinantly expressed GFAP and A1BG protein were used to develop an in-house ELISA to quantify the amount of autoantibodies in the RA patients. RA patients revealed an increase in the expression of GFAP and A1BG in the plasma as compared to osteoarthritis patients. Therefore, GFAP and A1BG can be proposed as potential new autoantigens of diagnostic importance for RA subjects. Further characterization of these proteins in rheumatoid arthritis will be helpful in understanding the role of these proteins in the disease pathogenesis providing new diagnostic tool with better specificity and accurate detection of the disease.	[Biswas, Sagarika; Sharma, Saurabh; Saroha, Ashish; Das, Hasi R.] Inst Genom & Integrat Biol, Dept Genom & Mol Med, New Delhi, India; [Biswas, Sagarika; Oellerich, Michael; Asif, Abdul R.] Univ Med Ctr Goettingen, Dept Clin Chem, Gottingen, Germany; [Bhakuni, D. S.] Army Hosp Res & Referral, Dept Clin Immunol & Rheumatol, New Delhi, India; [Malhotra, Rajesh] All India Inst Med Sci, Dept Orthopaed, New Delhi, India; [Zahur, Muzna] Univ Gujrat, Dept Biochem & Mol Biol, Gujrat, Pakistan	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Gottingen; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Gujrat	Asif, AR (corresponding author), Univ Med Ctr Goettingen, Dept Clin Chem, Gottingen, Germany.	asif@med.uni-goettingen.de	Asif, Abdul R./A-9432-2016; Saroha, Ashish/A-3208-2019	Asif, Abdul R./0000-0002-8581-3187; Saroha, Ashish/0000-0001-6787-8633	Indian Council of Medical Research; Council of Scientific and Industrial Research, New Delhi, India; Department of Clinical Chemistry, University Medical Center, Goettingen, Germany	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Clinical Chemistry, University Medical Center, Goettingen, Germany	Financial assistance has been provided partly by Indian Council of Medical Research, Council of Scientific and Industrial Research, New Delhi, India, and Department of Clinical Chemistry, University Medical Center, Goettingen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal N, 2011, CLIN LAB, V57, P895; Alam M, 2010, J SEP SCI, V33, P1723, DOI 10.1002/jssc.200900756; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Asif AR, 2006, J PROTEOME RES, V5, P954, DOI 10.1021/pr0504586; Biswas S, 2009, BIOCHEMISTRY-MOSCOW+, V74, P329, DOI 10.1134/S0006297909030122; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burkhardt H, 2005, EUR J IMMUNOL, V35, P1643, DOI 10.1002/eji.200526000; CHAMBERS RE, 1983, ANN RHEUM DIS, V42, P665, DOI 10.1136/ard.42.6.665; Chang X, 2005, RHEUMATOLOGY, V44, P40, DOI 10.1093/rheumatology/keh414; Friese MA, 2000, CLIN EXP IMMUNOL, V121, P406, DOI 10.1046/j.1365-2249.2000.01285.x; Goldbach-Mansky R, 2000, ARTHRITIS RES, V2, P236, DOI 10.1186/ar93; Gupta B, 2006, J AUTOIMMUN, V27, P125, DOI 10.1016/j.jaut.2006.07.002; Hoffmann MH, 2007, J IMMUNOL, V179, P7568, DOI 10.4049/jimmunol.179.11.7568; Hong SH, 2004, CANCER RES, V64, P5504, DOI 10.1158/0008-5472.CAN-04-0077; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Lernmark A, 2001, J CLIN INVEST, V108, P1091, DOI 10.1172/JCI200114234; Li GH, 2012, MED RES REV, V32, P999, DOI 10.1002/med.20231; Liao H, 2004, ARTHRITIS RHEUM-US, V50, P3792, DOI 10.1002/art.20720; Lopez-Avila V, 2009, HEALTH, V1, P104, DOI [10.4236/health.2009.12017, DOI 10.4236/HEALTH.2009.12017]; Moore AR, 1999, ANN RHEUM DIS, V58, P109, DOI 10.1136/ard.58.2.109; Ohmura K, 2010, RHEUMATOLOGY, V49, P2298, DOI 10.1093/rheumatology/keq273; Osborn TM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2520; Poulsom H, 2008, CLIN REV ALLERG IMMU, V34, P4, DOI 10.1007/s12016-007-8016-3; Sato H, 2007, INTERNAL MED, V46, P1685, DOI 10.2169/internalmedicine.46.6269; SHADFORTH MF, 1978, ANN RHEUM DIS, V37, P18, DOI 10.1136/ard.37.1.18; Snir O, 2010, ARTHRITIS RHEUM-US, V62, P44, DOI 10.1002/art.25036; Takemura M, 2002, GENES CELLS, V7, P295, DOI 10.1046/j.1365-2443.2002.00513.x; Takizawa Y, 2006, ANN RHEUM DIS, V65, P1013, DOI 10.1136/ard.2005.044743; Tilleman K, 2008, RHEUMATOLOGY, V47, P597, DOI 10.1093/rheumatology/ken077; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; Trouw LA, 2012, AUTOIMMUN REV, V12, P318, DOI 10.1016/j.autrev.2012.05.007; Udby L, 2004, BIOCHEMISTRY-US, V43, P12877, DOI 10.1021/bi048823e; van Boekel MAM, 2002, ARTHRITIS RES, V4, P87, DOI 10.1186/ar395; Verpoort KN, 2007, ARTHRITIS RHEUM, V56, P3949, DOI 10.1002/art.23127; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, P107, DOI 10.1186/ar1184; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1149	36	64	66	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56246	10.1371/journal.pone.0056246	http://dx.doi.org/10.1371/journal.pone.0056246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418544	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300137
J	Holiga, S; Mueller, K; Moller, HE; Sieger, T; Schroeter, ML; Vymazal, J; Ruzicka, E; Jech, R				Holiga, Stefan; Mueller, Karsten; Moeller, Harald E.; Sieger, Tomas; Schroeter, Matthias L.; Vymazal, Josef; Ruzicka, Evzen; Jech, Robert			Motor Matters: Tackling Heterogeneity of Parkinson's Disease in Functional MRI Studies	PLOS ONE			English	Article							LEVODOPA; FMRI; MOVEMENTS; REORGANIZATION; CONNECTIVITY; PERFORMANCE; ACTIVATION; MECHANISMS; AMPLITUDE; TASK	To tackle the heterogeneity of Parkinson's disease symptoms, most functional imaging studies tend to select a uniform group of subjects. We hypothesize that more profound considerations are needed to account for intra/inter-subject clinical variability and possibly for differing pathophysiological processes. Twelve patients were investigated using functional magnetic resonance imaging during visually-guided finger tapping. To account for disease heterogeneity, the motor score and individual symptom scores from the Unified Parkinson's Disease Rating Scale (UPDRS-III) were utilized in the group-level model using two approaches either as the explanatory variable or as the effect of interest. Employment of the UPDRS-III score and symptom scores was systematically tested on the resulting group response to the levodopa challenge, which further accentuated the diversity of the diseased state of participants. Statistics revealed a bilateral group response to levodopa in the basal ganglia. Interestingly, systematic incorporation of individual motor aspects of the disease in the modelling amended the resulting activity patterns conspicuously, evidencing a manifold amount of explained variability by the particular score. In conclusion, the severity of clinical symptoms expressed in the UPDRS-III scores should be considered in the analysis to attain unbiased statistics, draw reliable conclusions and allow for comparisons between research groups studying Parkinson's disease using functional magnetic resonance imaging.	[Holiga, Stefan; Mueller, Karsten; Moeller, Harald E.; Schroeter, Matthias L.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Sieger, Tomas; Ruzicka, Evzen; Jech, Robert] Charles Univ Prague, Dept Neurol, Prague, Czech Republic; [Sieger, Tomas; Ruzicka, Evzen; Jech, Robert] Charles Univ Prague, Ctr Clin Neurosci, Prague, Czech Republic; [Sieger, Tomas] Czech Tech Univ, Fac Elect Engn, Dept Cybernet, CR-16635 Prague, Czech Republic; [Schroeter, Matthias L.] Univ Leipzig, Clin Cognit Neurol, D-04109 Leipzig, Germany; [Schroeter, Matthias L.] Univ Leipzig, Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany; [Schroeter, Matthias L.] FTLD Consortium, Leipzig, Germany; [Vymazal, Josef] Homolce Hosp, Dept Radiol, Prague, Czech Republic	Max Planck Society; Charles University Prague; Charles University Prague; Czech Technical University Prague; Leipzig University; Leipzig University; Na Homolce Hospital	Jech, R (corresponding author), Charles Univ Prague, Dept Neurol, Prague, Czech Republic.	jech@cesnet.cz	Möller, Harald/AAB-4679-2019; Moller, Harald E/A-1565-2008; Růžička, Evžen/F-9299-2017; Sieger, Tomas/AAD-9342-2019; Jech, Robert/HHY-7342-2022	Möller, Harald/0000-0002-5659-1925; Moller, Harald E/0000-0002-5659-1925; Růžička, Evžen/0000-0002-4893-9661; Jech, Robert/0000-0002-9732-8947; Sieger, Tomas/0000-0003-4960-1934	Czech Science Foundation [309/09/1145]; Czech Ministry of Health [IGA MZ CR NT12282-5/2011, IGA MZ CR NT12288-5/2011, IGA MZ CR NT 11331-6/2010]; Czech Ministry of Education [MSM 0021620849]; Charles University in Prague [PRVOUK-P26/LF1/4]; Czech Technical University in Prague [SGS10/279/OHK3/3T/13]; International Max Planck Research School on Neuroscience of Communication: Function, Structure, and Plasticity (IMPRS NeuroCom); LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig; European Union, European Regional Development Fund; Free State of Saxony within the framework of the excellence initiative; German Consortium for Frontotemporal Lobar Degeneration; German Federal Ministry of Education and Research	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Health(Ministry of Health, Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague; Czech Technical University in Prague; International Max Planck Research School on Neuroscience of Communication: Function, Structure, and Plasticity (IMPRS NeuroCom); LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig; European Union, European Regional Development Fund; Free State of Saxony within the framework of the excellence initiative; German Consortium for Frontotemporal Lobar Degeneration; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Czech Science Foundation, grant project 309/09/1145; by the Czech Ministry of Health, IGA MZ CR NT12282-5/2011, IGA MZ CR NT12288-5/2011, IGA MZ CR NT 11331-6/2010; by the Czech Ministry of Education, research project MSM 0021620849; by the Charles University in Prague, research project PRVOUK-P26/LF1/4; and by the Czech Technical University in Prague, grant project SGS10/279/OHK3/3T/13. Stefan Holiga has been supported by a stipend from the International Max Planck Research School on Neuroscience of Communication: Function, Structure, and Plasticity (IMPRS NeuroCom). Matthias Schroeter has been supported by LIFE - Leipzig Research Center for Civilization Diseases at the University of Leipzig - funded by European Union, European Regional Development Fund and by Free State of Saxony within the framework of the excellence initiative, and by the German Consortium for Frontotemporal Lobar Degeneration, funded by the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin RL, 2012, NEUROLOGY, V79, P202, DOI 10.1212/WNL.0b013e31825dd3d0; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Buhmann C, 2003, BRAIN, V126, P451, DOI 10.1093/brain/awg033; Cerasa A, 2012, MOVEMENT DISORD, V27, P364, DOI 10.1002/mds.24017; Fahn S., 1987, RECENT DEV PARKINSON, P153; Feigin A, 2001, NEUROLOGY, V57, P2083, DOI 10.1212/WNL.57.11.2083; Foltynie T, 2002, J NEUROL, V249, P138, DOI 10.1007/PL00007856; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Gonzalez-Garcia N, 2011, J NEUROL, V258, P1268, DOI 10.1007/s00415-011-5923-2; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; Helmich RC, 2011, HUM BRAIN MAPP; Holden A, 2006, PARKINSONISM RELAT D, V12, P73, DOI 10.1016/j.parkreldis.2005.11.001; Holiga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036271; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Jech R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049056; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Kalmar Z, 2011, EUR NEUROL, V66, P220, DOI 10.1159/000330658; Kraft E, 2009, PARKINSONISM RELAT D, V15, P558, DOI 10.1016/j.parkreldis.2009.02.005; Macri MA, 2006, MAGN RESON IMAGING, V24, P419, DOI 10.1016/j.mri.2005.12.035; Mallol R, 2007, BRAIN RES, V1147, P265, DOI 10.1016/j.brainres.2007.02.046; Martinu K, 2012, EUR J NEUROSCI, V35, P572, DOI 10.1111/j.1460-9568.2011.07979.x; Moraschi M, 2010, MAGN RESON IMAGING, V28, P1152, DOI 10.1016/j.mri.2010.03.025; Ng B, 2010, HUM BRAIN MAPP, V31, P88, DOI 10.1002/hbm.20847; Palmer SJ, 2010, NEUROSCIENCE, V166, P1110, DOI 10.1016/j.neuroscience.2010.01.012; Palmer SJ, 2009, NEUROSCIENCE, V158, P693, DOI 10.1016/j.neuroscience.2008.06.053; Palmer SJ, 2009, EUR J NEUROSCI, V29, P2187, DOI 10.1111/j.1460-9568.2009.06753.x; Pinto S, 2011, MOVEMENT DISORD, V26, P2212, DOI 10.1002/mds.23799; Prodoehl J, 2010, MOVEMENT DISORD, V25, P2035, DOI 10.1002/mds.23360; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Schiess MC, 2000, PARKINSONISM RELAT D, V6, P69, DOI 10.1016/S1353-8020(99)00051-6; Sen S, 2010, NEUROSCIENCE, V166, P712, DOI 10.1016/j.neuroscience.2009.12.036; Spraker MB, 2010, HUM BRAIN MAPP, V31, P1928, DOI 10.1002/hbm.20987; Tedroff J, 1996, NEUROLOGY, V46, P1430, DOI 10.1212/WNL.46.5.1430; Tessa C, 2012, NEURORADIOLOGY, V54, P261, DOI 10.1007/s00234-011-0955-y; Tessa C, 2010, EXP NEUROL, V224, P299, DOI 10.1016/j.expneurol.2010.04.005; Wu T, 2008, J NEUROL NEUROSUR PS, V79, P760, DOI 10.1136/jnnp.2007.126599; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Wu T, 2011, NEUROIMAGE, V55, P204, DOI 10.1016/j.neuroimage.2010.11.074; Wu T, 2010, BRAIN, V133, P2394, DOI 10.1093/brain/awq151	41	9	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56133	10.1371/journal.pone.0056133	http://dx.doi.org/10.1371/journal.pone.0056133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418522	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300114
J	Liu, F; Guo, FQ				Liu, Fang; Guo, Fang-Qing			Nitric Oxide Deficiency Accelerates Chlorophyll Breakdown and Stability Loss of Thylakoid Membranes during Dark-Induced Leaf Senescence in Arabidopsis	PLOS ONE			English	Article							HARVESTING COMPLEX-II; STAY-GREEN PROTEIN; METHYL JASMONATE; CELL-DEATH; FUNCTIONAL EXPRESSION; REGULATES CHLOROPHYLL; CATABOLITE REDUCTASE; MOLECULAR-CLONING; HIGHER-PLANTS; DEGRADATION	Nitric oxide (NO) has been known to preserve the level of chlorophyll (Chl) during leaf senescence. However, the mechanism by which NO regulates Chl breakdown remains unknown. Here we report that NO negatively regulates the activities of Chl catabolic enzymes during dark-induced leaf senescence. The transcriptional levels of the major enzyme genes involving Chl breakdown pathway except for RED CHL CATABOLITE REDUCTASE (RCCR) were dramatically up-regulated during dark-induced Chl degradation in the leaves of Arabidopsis NO-deficient mutant nos1/noa1 that exhibited an early-senescence phenotype. The activity of pheide a oxygenase (PAO) was higher in the dark-induced senescent leaves of nos1/noa1 compared with wild type. Furthermore, the knockout of PAO in nos1/noa1 background led to pheide a accumulation in the double mutant pao1 nos1/noa1, which retained the level of Chl during dark-induced leaf senescence. The accumulated pheide a in darkened leaves of pao1 nos1/noa1 was likely to inhibit the senescence-activated transcriptional levels of Chl catabolic genes as a feed-back inhibitory effect. We also found that NO deficiency led to decrease in the stability of photosynthetic complexes in thylakoid membranes. Importantly, the accumulation of pheide a caused by PAO mutations in combination with NO deficiency had a synergistic effect on the stability loss of thylakoid membrane complexes in the double mutant pao1 nos1/noa1 during dark-induced leaf senescence. Taken together, our findings have demonstrated that NO is a novel negative regulator of Chl catabolic pathway and positively functions in maintaining the stability of thylakoid membranes during leaf senescence.	[Liu, Fang; Guo, Fang-Qing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Liu, Fang; Guo, Fang-Qing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Plant Gene Res Shanghai, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Guo, FQ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China.	fqguo@sibs.ac.cn		Guo, Fang-Qing/0000-0001-6889-394X	Ministry of Science and Technology of China [2012CB944802, 2012AA101103]; Ministry of Agriculture of China [2011ZX08009-003-002]; National Natural Science Foundation of China [31170244, 30770198]; CAS/SAFEA International Partnership Program for Creative Research Teams	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences)	This research was supported in parts by the Ministry of Science and Technology of China (2012CB944802 and 2012AA101103), the Ministry of Agriculture of China (2011ZX08009-003-002), the National Natural Science Foundation of China (31170244 and 30770198) and the CAS/SAFEA International Partnership Program for Creative Research Teams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Armstead I, 2007, SCIENCE, V315, P73, DOI 10.1126/science.1132912; Armstead I, 2006, NEW PHYTOL, V172, P592, DOI 10.1111/j.1469-8137.2006.01922.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Aubry S, 2008, PLANT MOL BIOL, V67, P243, DOI 10.1007/s11103-008-9314-8; Barry CS, 2008, PLANT PHYSIOL, V147, P179, DOI 10.1104/pp.108.118430; Barry CS, 2009, PLANT SCI, V176, P325, DOI 10.1016/j.plantsci.2008.12.013; Benedetti CE, 1998, PLANT PHYSIOL, V116, P1037, DOI 10.1104/pp.116.3.1037; Borovsky Y, 2008, THEOR APPL GENET, V117, P235, DOI 10.1007/s00122-008-0768-5; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Corpas FJ, 2004, PLANT PHYSIOL, V136, P2722, DOI 10.1104/pp.104.042812; Crawford NM, 2006, TRENDS PLANT SCI, V11, P526, DOI 10.1016/j.tplants.2006.09.007; Del Rio LA, 2004, PHYTOCHEMISTRY, V65, P783, DOI 10.1016/j.phytochem.2004.02.001; DRAZKIEWICZ M, 1994, PHOTOSYNTHETICA, V30, P321; Eum HL, 2007, HORTSCIENCE, V42, P927; Eum HL, 2009, FOOD SCI TECHNOL INT, V15, P223, DOI 10.1177/1082013208339706; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Gas E, 2009, PLANT CELL, V21, P18, DOI 10.1105/tpc.108.065243; GRBIC V, 1995, PLANT J, V8, P595, DOI 10.1046/j.1365-313X.1995.8040595.x; Guo FG, 2006, TRENDS PLANT SCI, V11, P527, DOI 10.1016/j.tplants.2006.09.006; Guo FQ, 2005, PLANT CELL, V17, P3436, DOI 10.1105/tpc.105.037770; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Guo YF, 2005, CURR TOP DEV BIOL, V71, P83, DOI 10.1016/S0070-2153(05)71003-6; He YK, 2004, SCIENCE, V305, P1968, DOI 10.1126/science.1098837; HENSEL LL, 1993, PLANT CELL, V5, P553, DOI 10.1105/tpc.5.5.553; Hinder B, 1996, J BIOL CHEM, V271, P27233, DOI 10.1074/jbc.271.44.27233; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Hortensteiner S, 2009, TRENDS PLANT SCI, V14, P155, DOI 10.1016/j.tplants.2009.01.002; HORTENSTEINER S, 1995, NEW PHYTOL, V129, P237, DOI 10.1111/j.1469-8137.1995.tb04293.x; Hortensteiner S, 2002, J EXP BOT, V53, P927, DOI 10.1093/jexbot/53.370.927; Hung KT, 2004, J PLANT PHYSIOL, V161, P43, DOI 10.1078/0176-1617-01178; Jacob-Wilk D, 1999, PLANT J, V20, P653, DOI 10.1046/j.1365-313X.1999.00637.x; Jasid S, 2009, PLANT SCI, V176, P662, DOI 10.1016/j.plantsci.2009.02.007; Jiang HW, 2007, PLANT J, V52, P197, DOI 10.1111/j.1365-313X.2007.03221.x; Jing HC, 2003, PLANT BIOLOGY, V5, P455, DOI 10.1055/s-2003-44779; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; LANGMEIER M, 1993, PHYSIOL PLANTARUM, V89, P347, DOI 10.1111/j.1399-3054.1993.tb00165.x; Laxalt AM, 1997, EUR J PLANT PATHOL, V103, P643, DOI 10.1023/A:1008604410875; Leshem YY, 2000, J EXP BOT, V51, P1471, DOI 10.1093/jexbot/51.349.1471; Leshem YY, 1998, PLANT PHYSIOL BIOCH, V36, P825, DOI 10.1016/S0981-9428(99)80020-5; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Liu HJ, 2010, NEW PHYTOL, V187, P83, DOI 10.1111/j.1469-8137.2010.03264.x; Mach JM, 2001, P NATL ACAD SCI USA, V98, P771, DOI 10.1073/pnas.021465298; Matile P, 1999, ANNU REV PLANT PHYS, V50, P67, DOI 10.1146/annurev.arplant.50.1.67; Mishina TE, 2007, PLANT CELL ENVIRON, V30, P39, DOI 10.1111/j.1365-3040.2006.01604.x; Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Pruzinska A, 2005, PLANT PHYSIOL, V139, P52, DOI 10.1104/pp.105.065870; Pruzinska A, 2003, P NATL ACAD SCI USA, V100, P15259, DOI 10.1073/pnas.2036571100; Pruzinska A, 2007, PLANT CELL, V19, P369, DOI 10.1105/tpc.106.044404; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Ren GD, 2007, PLANT PHYSIOL, V144, P1429, DOI 10.1104/pp.107.100172; Rodoni S, 1997, PLANT PHYSIOL, V115, P669, DOI 10.1104/pp.115.2.669; Sato Y, 2009, PLANT J, V57, P120, DOI 10.1111/j.1365-313X.2008.03670.x; Sato Y, 2007, P NATL ACAD SCI USA, V104, P14169, DOI 10.1073/pnas.0705521104; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Schenk N, 2007, FEBS LETT, V581, P5517, DOI 10.1016/j.febslet.2007.10.060; Sudhamsu J, 2008, J BIOL CHEM, V283, P32968, DOI 10.1074/jbc.M804837200; Tanaka R, 2003, PLANT CELL PHYSIOL, V44, P1266, DOI 10.1093/pcp/pcg172; THOMAS H, 1987, THEOR APPL GENET, V73, P551, DOI 10.1007/BF00289193; Tommasini R, 1998, PLANT J, V13, P773, DOI 10.1046/j.1365-313X.1998.00076.x; Tsuchiya T, 1999, P NATL ACAD SCI USA, V96, P15362, DOI 10.1073/pnas.96.26.15362; Van Ree K, 2011, PLANT J, V68, P225, DOI 10.1111/j.1365-313X.2011.04680.x; Wuthrich KL, 2000, PLANT J, V21, P189, DOI 10.1046/j.1365-313x.2000.00667.x; Yang ML, 2004, PLANT MOL BIOL, V54, P175, DOI 10.1023/B:PLAN.0000028789.51807.6a; Yao N, 2006, PLANT CELL, V18, P397, DOI 10.1105/tpc.105.036251; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zemojtel T, 2006, TRENDS PLANT SCI, V11, P524, DOI 10.1016/j.tplants.2006.09.008; Zhao MG, 2007, PLANT PHYSIOL, V144, P206, DOI 10.1104/pp.107.096842; Zottini M, 2007, J EXP BOT, V58, P1397, DOI 10.1093/jxb/erm001	74	60	62	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56345	10.1371/journal.pone.0056345	http://dx.doi.org/10.1371/journal.pone.0056345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418559	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300152
J	Mito, T; Kikkawa, Y; Shimizu, A; Hashizume, O; Katada, S; Imanishi, H; Ota, A; Kato, Y; Nakada, K; Hayashi, JI				Mito, Takayuki; Kikkawa, Yoshiaki; Shimizu, Akinori; Hashizume, Osamu; Katada, Shun; Imanishi, Hirotake; Ota, Azusa; Kato, Yukina; Nakada, Kazuto; Hayashi, Jun-Ichi			Mitochondrial DNA Mutations in Mutator Mice Confer Respiration Defects and B-Cell Lymphoma Development	PLOS ONE			English	Article							OXIDATIVE STRESS; POINT MUTATIONS; MITO-MICE; MTDNA; PHENOTYPES; GENERATION; COMPLEMENTATION; DYSFUNCTION; DAMAGE; GENES	Mitochondrial DNA (mtDNA) mutator mice are proposed to express premature aging phenotypes including kyphosis and hair loss (alopecia) due to their carrying a nuclear-encoded mtDNA polymerase with a defective proofreading function, which causes accelerated accumulation of random mutations in mtDNA, resulting in expression of respiration defects. On the contrary, transmitochondrial mito-mice Delta carrying mtDNA with a large-scale deletion mutation (Delta mtDNA) also express respiration defects, but not express premature aging phenotypes. Here, we resolved this discrepancy by generating mtDNA mutator mice sharing the same C57BL/6J (B6J) nuclear background with that of mito-mice Delta. Expression patterns of premature aging phenotypes are very close, when we compared between homozygous mtDNA mutator mice carrying a B6J nuclear background and selected mito-mice Delta only carrying predominant amounts of Delta mtDNA, in their expression of significant respiration defects, kyphosis, and a short lifespan, but not the alopecia. Therefore, the apparent discrepancy in the presence and absence of premature aging phenotypes in mtDNA mutator mice and mito-mice Delta, respectively, is partly the result of differences in the nuclear background of mtDNA mutator mice and of the broad range of Delta mtDNA proportions of mito-mice Delta used in previous studies. We also provided direct evidence that mtDNA abnormalities in homozygous mtDNA mutator mice are responsible for respiration defects by demonstrating the co-transfer of mtDNA and respiration defects from mtDNA mutator mice into mtDNA-less (rho(0)) mouse cells. Moreover, heterozygous mtDNA mutator mice had a normal lifespan, but frequently developed B-cell lymphoma, suggesting that the mtDNA abnormalities in heterozygous mutator mice are not sufficient to induce a short lifespan and aging phenotypes, but are able to contribute to the B-cell lymphoma development during their prolonged lifespan.	[Mito, Takayuki; Shimizu, Akinori; Hashizume, Osamu; Katada, Shun; Imanishi, Hirotake; Ota, Azusa; Kato, Yukina; Nakada, Kazuto; Hayashi, Jun-Ichi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Kikkawa, Yoshiaki] Tokyo Metropolitan Inst Med Sci, Mammalian Genet Project, Tokyo 113, Japan	University of Tsukuba; Tokyo Metropolitan Institute of Medical Science	Hayashi, JI (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	jih45@biol.tsukuba.ac.jp	Kikkawa, Yoshiaki/AAI-7229-2020	Kikkawa, Yoshiaki/0000-0001-8859-4998	Scientific Research on Innovative Areas from Japan Society for the Promotion of Science (JSPS) [24117503]; Scientific Research A from Japan Society for the Promotion of Science (JSPS) [23240058]; Grants-in-Aid for Scientific Research [23240058] Funding Source: KAKEN	Scientific Research on Innovative Areas from Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Scientific Research A from Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Scientific Research on Innovative Areas 24117503 (to JIH) and Scientific Research A 23240058 (to KN) from Japan Society for the Promotion of Science (JSPS http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey LJ, 2009, NUCLEIC ACIDS RES, V37, P2327, DOI 10.1093/nar/gkp091; Balmain A, 1998, TRENDS GENET, V14, P139, DOI 10.1016/S0168-9525(98)01422-X; Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Hashizume O, 2012, P NATL ACAD SCI USA, V109, P10528, DOI 10.1073/pnas.1202367109; HAYASHI JI, 1994, J CELL BIOL, V125, P43, DOI 10.1083/jcb.125.1.43; Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x; Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005; Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007; Klaunig JE, 2010, TOXICOL PATHOL, V38, P96, DOI 10.1177/0192623309356453; Krupke DM, 2008, NAT REV CANCER, V8, P459, DOI 10.1038/nrc2390; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; Nakada K, 2004, BIOCHEM BIOPH RES CO, V323, P175, DOI 10.1016/j.bbrc.2004.08.073; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Ross JM, 2010, P NATL ACAD SCI USA, V107, P20087, DOI 10.1073/pnas.1008189107; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Sun Hong, 2007, V383, P303, DOI 10.1007/978-1-59745-335-6_19; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Yokota M, 2010, FEBS LETT, V584, P3943, DOI 10.1016/j.febslet.2010.07.048	32	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55789	10.1371/journal.pone.0055789	http://dx.doi.org/10.1371/journal.pone.0055789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418460	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300051
J	Munoz, M; Camargo, M; Soto-De Leon, SC; Sanchez, R; Parra, D; Pineda, AC; Sussmann, O; Perez-Prados, A; Patarroyo, ME; Patarroyo, MA				Munoz, Marina; Camargo, Milena; Soto-De Leon, Sara C.; Sanchez, Ricardo; Parra, Diana; Pineda, Andrea C.; Sussmann, Otto; Perez-Prados, Antonio; Patarroyo, Manuel E.; Patarroyo, Manuel A.			Human Papillomavirus Detection from Human Immunodeficiency Virus-Infected Colombian Women's Paired Urine and Cervical Samples	PLOS ONE			English	Article							POSITIVE WOMEN; HPV INFECTION; DNA DETECTION; PRIMER SETS; PCR; CANCER; HIV; MY09/11; AMPLIFICATION; COINFECTION	Infection, coinfection and type-specific human papillomavirus (HPV) distribution was evaluated in human immunodeficiency virus (HIV)-positive women from paired cervical and urine samples. Paired cervical and urine samples (n = 204) were taken from HIV-positive women for identifying HPV-DNA presence by using polymerase chain reaction (PCR) with three generic primer sets (GP5+/6+, MY09/11 and pU1M/2R). HPV-positive samples were typed for six high-risk HPV (HR-HPV) (HPV-16, -18, -31, -33, -45 and -58) and two low-risk (LR-HPV) (HPV-6/11) types. Agreement between paired sample results and diagnostic performance was evaluated. HPV infection prevalence was 70.6% in cervical and 63.2% in urine samples. HPV-16 was the most prevalent HPV type in both types of sample (66.7% in cervical samples and 62.0% in urine) followed by HPV-31(47.2%) in cervical samples and HPV-58 (35.7%) in urine samples. There was 55.4% coinfection (infection by more than one type of HPV) in cervical samples and 40.2% in urine samples. Abnormal Papanicolau smears were observed in 25.3% of the women, presenting significant association with HPV-DNA being identified in urine samples. There was poor agreement of cervical and urine sample results in generic and type-specific detection of HPV. Urine samples provided the best diagnosis when taking cytological findings as reference. In conclusion including urine samples could be a good strategy for ensuring adherence to screening programs aimed at reducing the impact of cervical cancer, since this sample is easy to obtain and showed good diagnostic performance.	[Munoz, Marina; Camargo, Milena; Soto-De Leon, Sara C.; Sanchez, Ricardo; Patarroyo, Manuel E.; Patarroyo, Manuel A.] Fdn Inst Inmunol Colombia FIDIC, Bogota, Colombia; [Munoz, Marina; Camargo, Milena; Soto-De Leon, Sara C.; Pineda, Andrea C.; Patarroyo, Manuel A.] Univ Nacl Rosario, Sch Med & Hlth Sci, Bogota, Colombia; [Munoz, Marina; Sanchez, Ricardo; Patarroyo, Manuel E.] Univ Nacl Colombia, Bogota, Colombia; [Parra, Diana; Sussmann, Otto] Asistencia Cient Alta Complejidad SAS, Bogota, Colombia; [Perez-Prados, Antonio] Univ Publ Navarra, Pamplona, Spain	Universidad Nacional de Colombia; Universidad Publica de Navarra	Patarroyo, MA (corresponding author), Fdn Inst Inmunol Colombia FIDIC, Bogota, Colombia.	mapatarr.fidic@gmail.com	Leon, Sara Cecilia Soto-De/ABD-3186-2020; Pineda-Peña, Andrea-Clemencia/N-9809-2015; Patarroyo, Manuel A/I-8046-2016; De León, Sara Cecilia Soto/AAF-6301-2021; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017; Sanchez, Ricardo/K-8254-2015	Pineda-Peña, Andrea-Clemencia/0000-0003-1937-0506; Patarroyo, Manuel A/0000-0002-4751-2500; De León, Sara Cecilia Soto/0000-0003-4515-6749; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; Camargo, Milena/0000-0003-0246-0716; Perez Prados, Antonio/0000-0002-6496-4242; Sanchez, Ricardo/0000-0002-7540-4734	Basque Cooperation Agency Development; Spanish Agency for International Development Cooperation (AECID)	Basque Cooperation Agency Development; Spanish Agency for International Development Cooperation (AECID)	This project was funded by the Basque Cooperation Agency Development and by the Spanish Agency for International Development Cooperation (AECID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GLOBAL HIV AIDS RESP; Brinkman JA, 2002, J CLIN MICROBIOL, V40, P3155, DOI 10.1128/JCM.40.9.3155-3161.2002; Camargo M, 2011, J VIROL METHODS, V178, P68, DOI 10.1016/j.jviromet.2011.08.014; Camargo M, 2011, ANN EPIDEMIOL, V21, P204, DOI 10.1016/j.annepidem.2010.11.003; Castellsague X, 2002, VIRUS RES, V89, P191, DOI 10.1016/S0168-1702(02)00188-0; Castle PE, 2007, SEX TRANSM DIS, V34, P849, DOI 10.1097/OLQ.0b013e318064c8c5; Cervantes Jorge, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P131, DOI 10.1590/S0036-46652003000300003; Chirenje ZM, 2005, BEST PRACT RES CL OB, V19, P269, DOI 10.1016/j.bpobgyn.2004.10.002; Clarke B, 2002, J CLIN PATHOL-MOL PA, V55, P19, DOI 10.1136/mp.55.1.19; Cuschieri K, 2011, J MED VIROL, V83, P1983, DOI 10.1002/jmv.22183; D'Hauwers K, 2007, ASIAN J ANDROL, V9, P705, DOI 10.1111/j.1745-7262.2007.00287.x; de Sanjose S, 2002, VIRUS RES, V89, P201, DOI 10.1016/S0168-1702(02)00189-2; Del Mistro A, 2001, EUR J CANCER, V37, P1227, DOI 10.1016/S0959-8049(01)00107-1; Denny L, 2012, BEST PRACT RES CL OB, V26, P189, DOI 10.1016/j.bpobgyn.2011.08.001; Depuydt CE, 2007, J CELL MOL MED, V11, P881, DOI 10.1111/j.1582-4934.2007.00073.x; Feller L, 2007, SADJ, V62, P432; Ferenczy A, 2003, CAN MED ASSOC J, V169, P431; FUJINAGA Y, 1991, J GEN VIROL, V72, P1039, DOI 10.1099/0022-1317-72-5-1039; Gillison Maura L, 2003, J Natl Cancer Inst Monogr, P57; Heard I, 2009, CURR OPIN HIV AIDS, V4, P68, DOI 10.1097/COH.0b013e328319bcbe; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Iftner Thomas, 2003, J Natl Cancer Inst Monogr, P80; Jong EE, 2008, J CLIN VIROL, V41, P111, DOI 10.1016/j.jcv.2007.10.007; Karlsen F, 1996, J CLIN MICROBIOL, V34, P2095, DOI 10.1128/JCM.34.9.2095-2100.1996; Lee Yuan-Ming, 2001, Journal of Microbiology Immunology and Infection, V34, P87; Moscicki AB, 2005, J ADOLESCENT HEALTH, V37, pS3, DOI 10.1016/j.jadohealth.2005.09.011; Moscicki AB, 2006, VACCINE, V24, P42, DOI 10.1016/j.vaccine.2006.06.018; Munoz M, 2012, J VIROL METHODS, V185, P32, DOI 10.1016/j.jviromet.2012.05.023; OLMOS M, 2007, RECOMENDACIONES TAMI, P64; Posso HJ, 2005, ACCIONES PLAN OBLIGA, P190; Remmerbach TW, 2004, J CLIN VIROL, V30, P302, DOI 10.1016/j.jcv.2003.12.011; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; Sehgal A, 2009, J OBSTET GYNAECOL, V29, P583, DOI 10.1080/01443610903061736; Sellors JW, 2000, CAN MED ASSOC J, V163, P513; Song ES, 2007, J KOREAN MED SCI, V22, P99, DOI 10.3346/jkms.2007.22.1.99; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Szostek S, 2006, ACTA BIOCHIM POL, V53, P603; Vorsters A, 2012, EUR J CLIN MICROBIOL, V31, P627, DOI 10.1007/s10096-011-1358-z; WHO/ICO, 2010, HUM PAP REL CANC COL	41	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56509	10.1371/journal.pone.0056509	http://dx.doi.org/10.1371/journal.pone.0056509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418581	Green Published, gold, Green Accepted			2022-12-27	WOS:000315970300174
J	Schreiber, D; Fonzo, G; Simmons, AN; Dawes, CT; Flagan, T; Fowler, JH; Paulus, MP				Schreiber, Darren; Fonzo, Greg; Simmons, Alan N.; Dawes, Christopher T.; Flagan, Taru; Fowler, James H.; Paulus, Martin P.			Red Brain, Blue Brain: Evaluative Processes Differ in Democrats and Republicans	PLOS ONE			English	Article							DECISION-MAKING; POLITICAL ORIENTATIONS; ACTIVATION; AMYGDALA; INSULA; MECHANISMS; COGNITION; EMOTION; HUMANS	Liberals and conservatives exhibit different cognitive styles and converging lines of evidence suggest that biology influences differences in their political attitudes and beliefs. In particular, a recent study of young adults suggests that liberals and conservatives have significantly different brain structure, with liberals showing increased gray matter volume in the anterior cingulate cortex, and conservatives showing increased gray matter volume in the in the amygdala. Here, we explore differences in brain function in liberals and conservatives by matching publicly-available voter records to 82 subjects who performed a risk-taking task during functional imaging. Although the risk-taking behavior of Democrats (liberals) and Republicans (conservatives) did not differ, their brain activity did. Democrats showed significantly greater activity in the left insula, while Republicans showed significantly greater activity in the right amygdala. In fact, a two parameter model of partisanship based on amygdala and insula activations yields a better fitting model of partisanship than a well-established model based on parental socialization of party identification long thought to be one of the core findings of political science. These results suggest that liberals and conservatives engage different cognitive processes when they think about risk, and they support recent evidence that conservatives show greater sensitivity to threatening stimuli.	[Schreiber, Darren] Univ Exeter, Dept Polit, Exeter, Devon, England; [Schreiber, Darren] Cent European Univ, Dept Polit Sci, Budapest, Hungary; [Fonzo, Greg] Univ Calif San Diego, San Diego State Univ, Joint Doctoral Program Clin Psychol, San Diego, CA 92103 USA; [Simmons, Alan N.; Flagan, Taru; Paulus, Martin P.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Simmons, Alan N.; Paulus, Martin P.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Dawes, Christopher T.] NYU, Dept Polit, New York, NY USA; [Flagan, Taru; Paulus, Martin P.] Univ Calif San Diego, Lab Biol Dynam & Theoret Med, La Jolla, CA 92093 USA; [Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA; [Fowler, James H.] Univ Calif San Diego, Div Med Genet, La Jolla, CA 92093 USA	University of Exeter; Central European University; California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; New York University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Schreiber, D (corresponding author), Univ Exeter, Dept Polit, Exeter, Devon, England.	darren.schreiber@gmail.com	Fonzo, Gregory/AAG-8824-2020; Simmons, Alan N/A-9815-2008; Fowler, James H/C-2750-2008	Simmons, Alan N/0000-0003-3963-2112; Fowler, James H/0000-0001-7795-1638; Fonzo, Gregory/0000-0002-0213-1034	Collaboratories Grant from the University of California, San Diego	Collaboratories Grant from the University of California, San Diego	Funding was provided by a Collaboratories Grant from the University of California, San Diego. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz AI, 1998, J POLIT, V60, P634, DOI 10.2307/2647642; Abramowitz AI, 2008, J POLIT, V70, P542, DOI 10.1017/S0022381608080493; Achen CH, 2002, POLIT BEHAV, V24, P151, DOI 10.1023/A:1021278208671; Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Arce E, 2006, PSYCHOPHARMACOLOGY, V189, P105, DOI 10.1007/s00213-006-0519-8; Bechara A, 2003, ANN NY ACAD SCI, V985, P356, DOI 10.1111/j.1749-6632.2003.tb07094.x; Bechara A, 2001, Semin Clin Neuropsychiatry, V6, P205, DOI 10.1053/scnp.2001.22927; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Canli T, 2000, J NEUROSCI, V20; CONVERSE PE, 1964, IDEOLOGY DISCONTENT; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Ernst M, 2002, NEUROPSYCHOPHARMACOL, V26, P682, DOI 10.1016/S0893-133X(01)00414-6; Fellows Lesley K, 2004, Behav Cogn Neurosci Rev, V3, P159; Fowler JH, 2008, SCIENCE, V322, P912, DOI 10.1126/science.1158188; GALLAGHER M, 1994, P NATL ACAD SCI USA, V91, P11771, DOI 10.1073/pnas.91.25.11771; Garavan H, 2001, NEUROREPORT, V12, P2779, DOI 10.1097/00001756-200108280-00036; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Huettel SA, 2004, BRAIN RES, V1000, P78, DOI 10.1016/j.brainres.2003.11.041; JACOBSON GC, 2004, STATE POLITICS POLIC, V0004; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kam CD, 2010, J POLIT, V72, P381, DOI 10.1017/S0022381609990806; Kanai R, 2011, CURR BIOL, V21, P677, DOI 10.1016/j.cub.2011.03.017; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LANG PJ, 1984, J BEHAV ASSESS, V6, P369, DOI 10.1007/BF01321326; LeDoux J E, 1992, Curr Opin Neurobiol, V2, P191, DOI 10.1016/0959-4388(92)90011-9; Levine DS, 2009, NEURAL NETWORKS, V22, P286, DOI 10.1016/j.neunet.2009.03.003; Lieberman MD, 2003, POLIT PSYCHOL, V24, P681, DOI 10.1046/j.1467-9221.2003.00347.x; MOGG K, 1989, BEHAV RES THER, V27, P317, DOI 10.1016/0005-7967(89)90001-6; Morrison SE, 2010, CURR OPIN NEUROBIOL, V20, P221, DOI 10.1016/j.conb.2010.02.007; Oxley DR, 2008, SCIENCE, V321, P1667, DOI 10.1126/science.1157627; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Paulus MP, 2003, BIOL PSYCHIAT, V53, P65, DOI 10.1016/S0006-3223(02)01442-7; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Poole KT, 2005, SPATIAL MODELS PARLI, Vxviii; Sarinopoulos I, 2010, CEREB CORTEX, V20, P929, DOI 10.1093/cercor/bhp155; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Scholz J., 2009, NAT NEUROSCI; Schonberg T, 2011, TRENDS COGN SCI, V15, P11, DOI 10.1016/j.tics.2010.10.002; Settle JE, 2009, POLIT RES QUART, V62, P601, DOI 10.1177/1065912908327607; Slovic P, 2000, PERCEPTION RISK, Vxxxvii; Tracey I, 2000, NEUROSCI LETT, V288, P159, DOI 10.1016/S0304-3940(00)01224-6; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vorhold V, 2008, ANN NY ACAD SCI, V1128, P41, DOI 10.1196/annals.1399.006; Woollett K, 2011, CURRENT BIOL	57	86	87	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e52970	10.1371/journal.pone.0052970	http://dx.doi.org/10.1371/journal.pone.0052970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418419	gold, Green Published			2022-12-27	WOS:000315970300009
J	van de Weijer, T; Sparks, LM; Phielix, E; Meex, RC; van Herpen, NA; Hesselink, MKC; Schrauwen, P; Schrauwen-Hinderling, VB				van de Weijer, Tineke; Sparks, Lauren Marie; Phielix, Esther; Meex, Ruth Carla; van Herpen, Noud Antonius; Hesselink, Matthijs Karel C.; Schrauwen, Patrick; Schrauwen-Hinderling, Vera Bettina			Relationships between Mitochondrial Function and Metabolic Flexibility in Type 2 Diabetes Mellitus	PLOS ONE			English	Article							INTRAMYOCELLULAR LIPID-CONTENT; FATTY-ACID-METABOLISM; INSULIN-RESISTANCE; SKELETAL-MUSCLE; GLUCOSE-METABOLISM; RESPIRATION; EXERCISE; OBESE; ASSOCIATION; DYSFUNCTION	Introduction: Mitochondrial dysfunction, lipid accumulation, insulin resistance and metabolic inflexibility have been implicated in the etiology of type 2 diabetes (T2D), yet their interrelationship remains speculative. We investigated these interrelationships in a group of T2D and obese normoglycemic control subjects. Methods: 49 non-insulin dependent male T2D patients and 54 male control subjects were enrolled, and a hyperinsulinemic-euglycemic clamp and indirect calorimetry were performed. A muscle biopsy was taken and intramyocellular lipid (IMCL) was measured. In vivo mitochondrial function was measured by PCr recovery in 30 T2D patients and 31 control subjects. Results: Fasting NEFA levels were significantly elevated in T2D patients compared with controls, but IMCL was not different. Mitochondrial function in T2D patients was compromised by 12.5% (p<0.01). Whole body glucose disposal (WGD) was higher at baseline and lower after insulin stimulation. Metabolic flexibility (Delta RER) was lower in the type 2 diabetic patients (0.050 +/- 0.033 vs. 0.093 +/- 0.050, p<0.01). Mitochondrial function was the sole predictor of basal respiratory exchange ratio (RER) (R-2 = 0.18, p<0.05); whereas WGD predicted both insulin-stimulated RER (R-2 = 0.29, p<0.001) and metabolic flexibility (R-2 = 0.40, p<0.001). Conclusions: These results indicate that defects in skeletal muscle in vivo mitochondrial function in type 2 diabetic patients are only reflected in basal substrate oxidation and highlight the importance of glucose disposal rate as a determinant of substrate utilization in response to insulin.	[van de Weijer, Tineke; Sparks, Lauren Marie; Phielix, Esther; van Herpen, Noud Antonius; Schrauwen, Patrick] Maastricht Univ Med Ctr, Dept Human Biol, Maastricht, Netherlands; [van de Weijer, Tineke; Sparks, Lauren Marie; Phielix, Esther; Meex, Ruth Carla; van Herpen, Noud Antonius; Hesselink, Matthijs Karel C.; Schrauwen, Patrick; Schrauwen-Hinderling, Vera Bettina] Maastricht Univ Med Ctr, Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Meex, Ruth Carla; Hesselink, Matthijs Karel C.] Maastricht Univ Med Ctr, Dept Human Movement Sci, Maastricht, Netherlands; [Schrauwen-Hinderling, Vera Bettina] Maastricht Univ Med Ctr, Dept Radiol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Schrauwen-Hinderling, VB (corresponding author), Maastricht Univ Med Ctr, Sch Nutr Toxicol & Metab, Maastricht, Netherlands.	v.schrauwen@maastrichtuniversity.nl		schrauwen, patrick/0000-0002-0973-847X; Sparks, Lauren/0000-0002-9257-5666	Center for Translational Molecular Medicine; Netherlands Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation (PREDICCt); VENI grant [916.11.136]; VICI grant from the Netherlands Organization for Scientific Research (NWO) [918.96.618]	Center for Translational Molecular Medicine; Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation (PREDICCt); VENI grant; VICI grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Center for Translational Molecular Medicine and the Netherlands Heart Foundation, Dutch Diabetes Research Foundation and Dutch Kidney Foundation (PREDICCt); see URL: http://www.ctmm.nl/pro1/general/home.asp. Also V. S. is supported by a VENI grant (Grant 916.11.136) and P.S. is supported by a VICI grant (Grant 918.96.618) from the Netherlands Organization for Scientific Research (NWO); also see URL: http://www.nwo.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x; DeFronzo RA, 2004, INT J CLIN PRACT, V58, P9, DOI 10.1111/j.1368-504X.2004.00389.x; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Galgani JE, 2008, DIABETES, V57, P841, DOI 10.2337/db08-0043; Galgani JE, 2012, OBESITY, V20, P1387, DOI 10.1038/oby.2011.166; GOLAY A, 1988, DIABETOLOGIA, V31, P585, DOI 10.1007/BF00264764; GOLAY A, 1988, DIABETES METAB, V14, P443; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Han DH, 2004, AM J PHYSIOL-ENDOC M, V286, pE347, DOI 10.1152/ajpendo.00434.2003; Hoeks J, 2006, DIABETOLOGIA, V49, P2419, DOI 10.1007/s00125-006-0369-2; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; KELLEY DE, 1993, J CLIN INVEST, V92, P91, DOI 10.1172/JCI116603; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Meex RCR, 2010, DIABETES, V59, P572, DOI 10.2337/db09-1322; Mensink M, 2001, DIABETES, V50, P2548, DOI 10.2337/diabetes.50.11.2548; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391; Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/h06-071; Rabol R, 2009, METABOLISM, V58, P1145, DOI 10.1016/j.metabol.2009.03.014; RANDLE PJ, 1963, LANCET, V1, P785; Schrauwen P, 2010, BBA-MOL CELL BIOL L, V1801, P266, DOI 10.1016/j.bbalip.2009.09.011; Schrauwen-Hinderling VB, 2007, DIABETOLOGIA, V50, P113, DOI 10.1007/s00125-006-0475-1; Schrauwen-Hinderling VB, 2008, J CLIN ENDOCR METAB, V93, P2917, DOI 10.1210/jc.2008-0267; SIRI W E, 1956, Adv Biol Med Phys, V4, P239; Snel M, 2012, J CLIN ENDOCR METAB, V97, P2512, DOI 10.1210/jc.2011-3178; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; van Herpen NA, 2011, J CLIN ENDOCR METAB, V96, pE691, DOI 10.1210/jc.2010-2243	39	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e51648	10.1371/journal.pone.0051648	http://dx.doi.org/10.1371/journal.pone.0051648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418416	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300006
J	Wang, CM; Zhang, YY; Wu, B; Liu, SL; Xu, P; Lu, YM; Luo, J; Nolte, DL; Deliberto, TJ; Duan, MX; Zhang, H; He, HX				Wang, Chengmin; Zhang, Yanyu; Wu, Bin; Liu, Shelan; Xu, Ping; Lu, Yanmin; Luo, Jing; Nolte, Dale Louis; Deliberto, Thomas Jude; Duan, Mingxing; Zhang, Hong; He, Hongxuan			Evolutionary Characterization of the Pandemic H1N1/2009 Influenza Virus in Humans Based on Non-Structural Genes	PLOS ONE			English	Article							AMINO-ACID SITES; H1N1 INFLUENZA; REPLICATION; SELECTION; PROTEIN; NUCLEOPROTEIN	The 2009 influenza pandemic had a tremendous social and economic impact. To study the genetic diversity and evolution of the 2009 H1N1 virus, a mutation network for the non-structural (NS) gene of the virus was constructed. Strains of the 2009 H1N1 pandemic influenza A virus could be divided into two categories based on the V123I mutation in the NS1 gene: G1 (characterized as 123 Val) and G2 (characterized as 123 Ile). Sequence homology analysis indicated that one type of NS sequence, primarily isolated from Mexico, was likely the original type in this pandemic. The two genotypes of the virus presented distinctive clustering features in their geographic distributions. These results provide additional insight into the genetics and evolution of human pandemic influenza H1N1.	[Wang, Chengmin; Wu, Bin; Xu, Ping; Lu, Yanmin; Luo, Jing; Zhang, Hong; He, Hongxuan] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Natl Res Ctr Wildlife Born Dis, Beijing, Peoples R China; [Nolte, Dale Louis; Deliberto, Thomas Jude] Wildlife Serv, Natl Wildlife Res Ctr, USDA, APHIS, Ft Collins, CO USA; [Duan, Mingxing] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Liu, Shelan] Zhejiang Ctr Dis Control & Prevent, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yanyu] Acad Mil Med Sci, Beijing Inst Transfus Med, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; United States Department of Agriculture (USDA); Tsinghua University; Academy of Military Medical Sciences - China	He, HX (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Natl Res Ctr Wildlife Born Dis, Beijing, Peoples R China.	hehx@ioz.ac.cn		Zhang, Hong/0000-0002-3930-6731	Chinese academy of sciences [KSCX2-EW-J-2]; National Science and Technology Ministry [2009BAI83B01]; National Natural Sciences Foundation of China [31101806]; USDA/APHIS/WS-IOZ CAS joint project [0760621234]	Chinese academy of sciences(Chinese Academy of Sciences); National Science and Technology Ministry; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); USDA/APHIS/WS-IOZ CAS joint project	This study was supported by the knowledge innovation program of the Chinese academy of sciences (KSCX2-EW-J-2), the National Science and Technology Ministry (2009BAI83B01), National Natural Sciences Foundation of China (31101806) and USDA/APHIS/WS-IOZ CAS joint project (0760621234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Campo DS, 2008, P NATL ACAD SCI USA, V105, P9685, DOI 10.1073/pnas.0801774105; Christopher FB, 2001, P NATL ACAD SCI USA, V98, P2746; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghedin E, 2011, J INFECT DIS, V203, P168, DOI 10.1093/infdis/jiq040; Hans-Jurgen B, 1999, MOL BIOL EVOL, V16, P37; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; LAMB RA, 1980, P NATL ACAD SCI-BIOL, V77, P1857, DOI 10.1073/pnas.77.4.1857; Newcomb LL, 2009, J VIROL, V83, P29, DOI 10.1128/JVI.02293-07; Nielsen R, 1998, GENETICS, V148, P929; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2007, PHYLOGENETIC HDB PRA, P1; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Rolland M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012463; Schmitt AP, 2005, ADV VIRUS RES, V64, P383, DOI 10.1016/S0065-3527(05)64012-2; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Thomas MA, 2003, MOL BIOL EVOL, V20, P964, DOI 10.1093/molbev/msg110; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	24	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56201	10.1371/journal.pone.0056201	http://dx.doi.org/10.1371/journal.pone.0056201			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418535	Green Published, gold			2022-12-27	WOS:000315970300127
J	Zhu, JP; Luo, Z; Wang, J; Xu, ZG; Chen, H; Fan, DY; Gao, N; Ping, GL; Zhou, Z; Zhang, Y; An, J				Zhu, Junping; Luo, Zhen; Wang, Juan; Xu, Zigang; Chen, Hui; Fan, Dongying; Gao, Na; Ping, Guoling; Zhou, Zhen; Zhang, Yan; An, Jing			Phylogenetic Analysis of Enterovirus 71 Circulating in Beijing, China from 2007 to 2009	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; MOUTH-DISEASE; COMPLETE GENOME; STRAINS; EVOLUTION; OUTBREAK; HAND; FOOT; VP1; INFECTION	The major pathogens of hand, foot and mouth disease (HFMD) in Beijing, China from 2007 to 2009 were identified in this study. A total of 186 HFMD cases were included, and 136 cases (73%) were positive for enterovirus (EV). In 2007, 75% (27/36) were Coxsackievirus A16 (CA16) positive and 19% (7/36) were Enterovirus 71 (EV71) positive cases. However, EV71 was the predominant virus in 2008, when 56% (31/55) of the cases were positive for EV71 and 22% (12/55) were positive for CA16. In 2009, EV71 and CA16, with positive rates of 36% (16/45) and 29% (13/45), respectively, were still the major pathogens of HFMD. Phylogenetic analysis revealed that the dominant genotype of EV71 was C4, with co-circulation of genotype A in 2009. The prevalent cluster of the EV71 subgenotype C4 changed over time. A proposed new sublineage of EV71, C4a-2, was the predominant virus associated with the Beijing and nationwide HFMD outbreaks since 2008 and amino acid substitution, which possibly link to the central nervous system tropism of EV71, was found in genotype A viruses. Persistent surveillance of HFMD-associated pathogens is required for predicting potential emerging viruses and related disease outbreaks.	[Zhu, Junping; Wang, Juan; Chen, Hui; Fan, Dongying; Gao, Na; Ping, Guoling; An, Jing] Capital Med Univ, Sch Basic Med Sci, Dept Pathogen Biol, Beijing, Peoples R China; [Luo, Zhen; Xu, Zigang] Capital Med Univ, Dept Dermatol, Beijing Childrens Hosp, Beijing, Peoples R China; [Zhou, Zhen] Capital Med Univ, Dept Biomed Engn, Sch Biomed Engn, Beijing, Peoples R China; [Zhang, Yan] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	An, J (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Pathogen Biol, Beijing, Peoples R China.	anjing@ccmu.edu.cn			Beijing Nature Science Foundation [7072009]; National Key Programs on Basic Research of China [2011CB504703]; National Natural Science Foundation of China [81271839, 30901259]	Beijing Nature Science Foundation(Beijing Natural Science Foundation); National Key Programs on Basic Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Beijing Nature Science Foundation (Grant No. 7072009, http://www.nsfc.gov.cn/), the National Key Programs on Basic Research of China (Grant No. 2011CB504703, http://www.973.gov.cn/English/Index.aspx) and the National Natural Science Foundation of China (Grant No. 81271839 and 30901259, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2008, J VIROL, V82, P1787, DOI 10.1128/JVI.01798-07; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chen TC, 2008, J BIOMED SCI, V15, P291, DOI 10.1007/s11373-007-9228-5; Chua BH, 2008, J GEN VIROL, V89, P1622, DOI 10.1099/vir.0.83676-0; Guan DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044386; Hafliger D, 1997, INT J FOOD MICROBIOL, V37, P27, DOI 10.1016/S0168-1605(97)00041-X; Ho Monto, 2000, Journal of Microbiology Immunology and Infection, V33, P205; Hu YF, 2011, J CLIN MICROBIOL, V49, P2426, DOI 10.1128/JCM.00007-11; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026237; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; McMinn PC, 2012, CURR OPIN VIROL, V2, P199, DOI 10.1016/j.coviro.2012.02.009; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Sun LM, 2011, JPN J INFECT DIS, V64, P13; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Tao ZX, 2012, J CLIN MICROBIOL, V50, P1823, DOI 10.1128/JCM.06850-11; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Yang F, 2001, SCI CHINA SER C, V44, P178, DOI 10.1007/BF02879323; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yu HY, 2010, VIRUS GENES, V41, P1, DOI 10.1007/s11262-010-0472-9; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300	34	32	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56318	10.1371/journal.pone.0056318	http://dx.doi.org/10.1371/journal.pone.0056318			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418551	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300144
J	Fowler, MS; Ruokolainen, L				Fowler, Mike S.; Ruokolainen, Lasse			Confounding Environmental Colour and Distribution Shape Leads to Underestimation of Population Extinction Risk	PLOS ONE			English	Article							SPECTRAL COLOR; NOISE COLOR; DYNAMICS; VARIABILITY; FLUCTUATIONS; TERRESTRIAL; UNCERTAINTY; EVOLUTION; SYNCHRONY; PATTERNS	The colour of environmental variability influences the size of population fluctuations when filtered through density dependent dynamics, driving extinction risk through dynamical resonance. Slow fluctuations (low frequencies) dominate in red environments, rapid fluctuations (high frequencies) in blue environments and white environments are purely random (no frequencies dominate). Two methods are commonly employed to generate the coloured spatial and/or temporal stochastic (environmental) series used in combination with population (dynamical feedback) models: autoregressive [AR(1)] and sinusoidal (1/f) models. We show that changing environmental colour from white to red with 1/f models, and from white to red or blue with AR(1) models, generates coloured environmental series that are not normally distributed at finite time-scales, potentially confounding comparison with normally distributed white noise models. Increasing variability of sample Skewness and Kurtosis and decreasing mean Kurtosis of these series alter the frequency distribution shape of the realised values of the coloured stochastic processes. These changes in distribution shape alter patterns in the probability of single and series of extreme conditions. We show that the reduced extinction risk for undercompensating (slow growing) populations in red environments previously predicted with traditional 1/f methods is an artefact of changes in the distribution shapes of the environmental series. This is demonstrated by comparison with coloured series controlled to be normally distributed using spectral mimicry. Changes in the distribution shape that arise using traditional methods lead to underestimation of extinction risk in normally distributed, red 1/f environments. AR(1) methods also underestimate extinction risks in traditionally generated red environments. This work synthesises previous results and provides further insight into the processes driving extinction risk in model populations. We must let the characteristics of known natural environmental covariates (e. g., colour and distribution shape) guide us in our choice of how to best model the impact of coloured environmental variation on population dynamics.	[Fowler, Mike S.] Inst Mediterrani Estudis Avancats UIB CSIC, Populat Ecol Grp, Esporles, Illes Balears, Spain; [Fowler, Mike S.] Swansea Univ, Dept Biosci, Swansea, W Glam, Wales; [Ruokolainen, Lasse] Univ Helsinki, Dept Biosci, Helsinki, Finland	Consejo Superior de Investigaciones Cientificas (CSIC); Swansea University; University of Helsinki	Fowler, MS (corresponding author), Univ Illes Balears, Consejo Super Invest Cient CSIC, Palma De Mallorca, Spain.	m.s.fowler@swansea.ac.uk	Fowler, Mike/H-5092-2013	Fowler, Mike/0000-0003-1544-0407; Ruokolainen, Lasse/0000-0003-0951-9100	JAE-Doc fellowship; Spanish Ministry of Science Innovation [CGL2006-04325/BOS]; Finnish Academy	JAE-Doc fellowship; Spanish Ministry of Science Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Finnish Academy(Academy of Finland)	Financial support came from a JAE-Doc fellowship and grant ref. CGL2006-04325/BOS from the Spanish Ministry of Science & Innovation to MSF and the Finnish Academy to LR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bocedi G, 2012, AM NAT, V179, P606, DOI 10.1086/665004; Caughley G., 1996, CONSERVATION BIOL TH; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cohen JE, 1999, CIRC SYST SIGNAL PR, V18, P431, DOI 10.1007/BF01200792; Cuddington KM, 1999, P ROY SOC B-BIOL SCI, V266, P969, DOI 10.1098/rspb.1999.0731; Gonzalez A, 2002, P NATL ACAD SCI USA, V99, P14872, DOI 10.1073/pnas.232589299; Greenman JV, 2005, THEOR POPUL BIOL, V68, P217, DOI 10.1016/j.tpb.2005.06.007; Halley JM, 2005, MAR ECOL PROG SER, V304, P274; Halley JM, 2004, FLUCT NOISE LETT, V4, pR1, DOI 10.1142/S0219477504001884; Halley JM, 2004, ECOL LETT, V7, P254, DOI 10.1111/j.1461-0248.2004.00568.x; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; Halley JM, 1999, THEOR POPUL BIOL, V56, P215, DOI 10.1006/tpbi.1999.1424; Heino M, 2000, ECOGRAPHY, V23, P177, DOI 10.1111/j.1600-0587.2000.tb00273.x; Inchausti P, 2002, EVOL ECOL RES, V4, P1033; Knape J, 2012, ECOL LETT, V15, P17, DOI 10.1111/j.1461-0248.2011.01702.x; Knape J, 2011, P ROY SOC B-BIOL SCI, V278, P985, DOI 10.1098/rspb.2010.1333; Laakso J, 2004, OIKOS, V104, P142, DOI 10.1111/j.0030-1299.2004.12197.x; Laakso J, 2003, OIKOS, V102, P663, DOI 10.1034/j.1600-0706.2003.12319.x; Li W, 2011, BIBLIO GENE GENOME D; Logdberg F, 2012, THEOR ECOL-NETH, V5, P545, DOI 10.1007/s12080-011-0145-x; Ovaskainen O, 2010, TRENDS ECOL EVOL, V25, P643, DOI 10.1016/j.tree.2010.07.009; Petchey OL, 1997, P ROY SOC B-BIOL SCI, V264, P1841, DOI 10.1098/rspb.1997.0254; Petchey OL, 2000, P ROY SOC B-BIOL SCI, V267, P747, DOI 10.1098/rspb.2000.1066; Reed DH, 2003, ANIM CONSERV, V6, P109, DOI 10.1017/S1367943003003147; Ripa J, 1999, ECOL LETT, V2, P219; Ripa J, 1996, P ROY SOC B-BIOL SCI, V263, P1751, DOI 10.1098/rspb.1996.0256; ROUGHGARDEN J, 1975, AM NAT, V109, P713, DOI 10.1086/283039; Ruokolainen L, 2008, P ROY SOC B-BIOL SCI, V275, P1775, DOI 10.1098/rspb.2008.0193; Ruokolainen L, 2007, OIKOS, V116, P439, DOI 10.1111/j.2006.0030-1299.15586.x; Ruokolainen L, 2009, J THEOR BIOL, V261, P379, DOI 10.1016/j.jtbi.2009.08.010; Ruokolainen L, 2009, TRENDS ECOL EVOL, V24, P555, DOI 10.1016/j.tree.2009.04.009; Ruokolainen L, 2009, ECOL LETT, V12, P909, DOI 10.1111/j.1461-0248.2009.01346.x; SAUPE D, 1988, SCI FRACTAL IMAGES, P71; Schwager M, 2006, AM NAT, V167, P879, DOI 10.1086/503609; Simons AM, 2011, P ROY SOC B-BIOL SCI, V278, P1601, DOI 10.1098/rspb.2011.0176; SMITH JM, 1973, ECOLOGY, V54, P384, DOI 10.2307/1934346; Starrfelt J, 2012, BIOL REV, V87, P742, DOI 10.1111/j.1469-185X.2012.00225.x; STEELE JH, 1985, NATURE, V313, P355, DOI 10.1038/313355a0; Stumpf MPH, 2012, SCIENCE, V335, P665, DOI 10.1126/science.1216142; Vasseur DA, 2004, ECOLOGY, V85, P1146, DOI 10.1890/02-3122; Vasseur DA, 2007, OIKOS, V116, P1726, DOI 10.1111/j.2007.0030-1299.16101.x; Vasseur DA, 2007, THEOR POPUL BIOL, V72, P186, DOI 10.1016/j.tpb.2007.06.002; Vucetich JA, 2000, CONSERV BIOL, V14, P1704, DOI 10.1111/j.1523-1739.2000.99359.x; Ward L. M., 2007, SCHOLARPEDIA, V2, P1537, DOI [DOI 10.4249/SCH0LARPEDIA.1537, 10.4249/scholarpedia.1537, DOI 10.4249/SCHOLARPEDIA.1537]; WEST BJ, 1994, PHYS REP, V246, P2; Wichmann MC, 2005, THEOR POPUL BIOL, V68, P29, DOI 10.1016/j.tpb.2005.03.001; Yaari G, 2012, ECOLOGY, V93, P1214, DOI 10.1890/11-1077.1	48	11	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55855	10.1371/journal.pone.0055855	http://dx.doi.org/10.1371/journal.pone.0055855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409065	gold, Green Published, Green Submitted			2022-12-27	WOS:000315100000026
J	Knoll, N; Jarick, I; Volckmar, AL; Klingenspor, M; Illig, T; Grallert, H; Gieger, C; Wichmann, HE; Peters, A; Hebebrand, J; Scherag, A; Hinney, A				Knoll, Nadja; Jarick, Ivonne; Volckmar, Anna-Lena; Klingenspor, Martin; Illig, Thomas; Grallert, Harald; Gieger, Christian; Wichmann, Heinz-Erich; Peters, Annette; Hebebrand, Johannes; Scherag, Andre; Hinney, Anke			Gene Set of Nuclear-Encoded Mitochondrial Regulators Is Enriched for Common Inherited Variation in Obesity	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MISSING HERITABILITY; RECEPTOR-ALPHA; FAT MASS; HOMEOSTASIS; BIOGENESIS; EXPRESSION; DISEASE	There are hints of an altered mitochondrial function in obesity. Nuclear-encoded genes are relevant for mitochondrial function (3 gene sets of known relevant pathways: (1) 16 nuclear regulators of mitochondrial genes, (2) 91 genes for oxidative phosphorylation and (3) 966 nuclear-encoded mitochondrial genes). Gene set enrichment analysis (GSEA) showed no association with type 2 diabetes mellitus in these gene sets. Here we performed a GSEA for the same gene sets for obesity. Genome wide association study (GWAS) data from a case-control approach on 453 extremely obese children and adolescents and 435 lean adult controls were used for GSEA. For independent confirmation, we analyzed 705 obesity GWAS trios (extremely obese child and both biological parents) and a population-based GWAS sample (KORA F4, n = 1,743). A meta-analysis was performed on all three samples. In each sample, the distribution of significance levels between the respective gene set and those of all genes was compared using the leading-edge-fraction-comparison test (cut-offs between the 50th and 95th percentile of the set of all gene-wise corrected p-values) as implemented in the MAGENTA software. In the case-control sample, significant enrichment of associations with obesity was observed above the 50th percentile for the set of the 16 nuclear regulators of mitochondrial genes (p(GSEA,50) = 0.0103). This finding was not confirmed in the trios (p(GSEA,50) = 0.5991), but in KORA (p(GSEA,50) = 0.0398). The meta-analysis again indicated a trend for enrichment (p(MAGENTA,50) = 0.1052, p(MAGENTA,75) = 0.0251). The GSEA revealed that weak association signals for obesity might be enriched in the gene set of 16 nuclear regulators of mitochondrial genes.	[Knoll, Nadja; Volckmar, Anna-Lena; Hebebrand, Johannes; Hinney, Anke] Univ Duisburg Essen, Dept Child & Adolescent Psychiat, Essen, Germany; [Jarick, Ivonne] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; [Klingenspor, Martin] Tech Univ Munich, Else Kroner Fresenius Ctr, Freising Weihenstephan, Germany; [Illig, Thomas; Grallert, Harald] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Res Unit Mol Epidemiol, Neuherberg, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Gieger, Christian] Helmholtz Ctr Munich, Inst Genet Epidemiol, German Res Ctr Environm Hlth, Neuherberg, Germany; [Wichmann, Heinz-Erich] Helmholtz Ctr Munich, Inst Epidemiol 1, German Res Ctr Environm Hlth, Neuherberg, Germany; [Wichmann, Heinz-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, Munich, Germany; [Wichmann, Heinz-Erich] Munich Univ Hosp, Munich, Germany; [Peters, Annette] Helmholtz Ctr Munich, Inst Epidemiol 2, German Res Ctr Environm Hlth, Neuherberg, Germany; [Scherag, Andre] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany	University of Duisburg Essen; Philipps University Marburg; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Duisburg Essen	Hinney, A (corresponding author), Univ Duisburg Essen, Dept Child & Adolescent Psychiat, Essen, Germany.	Anke.Hinney@uni-due.de	Scherag, Andre/B-3805-2014; Klingenspor, Martin/D-6930-2011; Grallert, Harald/B-3424-2013; Peters, Annette/A-6117-2011; Wichmann, Heinz Erich/AAA-5695-2022; Volckmar, Anna-Lena/ABE-3676-2021; Hinney, Anke/D-6953-2011; Klingenspor, Martin/K-5033-2019	Klingenspor, Martin/0000-0002-4502-6664; Peters, Annette/0000-0001-6645-0985; Hinney, Anke/0000-0001-5659-0706; Gieger, Christian/0000-0001-6986-9554; Scherag, Andre/0000-0002-9406-4704	German Federal Ministry of Education and Research (BMBF); NGFNplus [01KU0903, 01GS0830, 01GS0820]; European Community [245009]; FORES program of the University of Duisburg-Essen; Helmholtz Zentrum Munchen - German Research Center for Environmental Health; German Federal Ministry of Education and Research; State of Bavaria	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); NGFNplus; European Community(European Commission); FORES program of the University of Duisburg-Essen; Helmholtz Zentrum Munchen - German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria	This work was supported by grants of the German Federal Ministry of Education and Research (BMBF and NGFNplus, grant numbers 01KU0903, 01GS0830, and 01GS0820), the European Community's Seventh Framework Program (FP7/2007-2013, grant number 245009) and the IFORES program of the University of Duisburg-Essen. The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen - German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research and by the State of Bavaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama TE, 2001, J BIOL CHEM, V276, P39088, DOI 10.1074/jbc.M107073200; Bar-Yaacov D, 2012, BBA-GENE REGUL MECH, V1819, P1107, DOI 10.1016/j.bbagrm.2011.10.008; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Day N, 1999, BRIT J CANCER, V80, P95; Evangelou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041018; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500; Hebebrand J, 2000, INT J OBESITY, V24, P345, DOI 10.1038/sj.ijo.0801135; Hebebrand J, 1994, AKTUELLE ERNAHRUNGSM, V19, P259; Hebebrand J, 2010, OBESITY FACTS, V3, P294, DOI 10.1159/000321537; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Liu YJ, 2010, OBESITY, V18, P2339, DOI 10.1038/oby.2010.83; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Niemann B, 2011, J AM COLL CARDIOL, V57, P577, DOI 10.1016/j.jacc.2010.09.040; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pennisi E, 1998, SCIENCE, V281, P1787, DOI 10.1126/science.281.5384.1787; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Pi JB, 2010, J BIOL CHEM, V285, P9292, DOI 10.1074/jbc.M109.093955; Putter C, 2011, HUM HERED, V72, P173, DOI 10.1159/000332824; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Riu E, 2003, FASEB J, V17, P1715, DOI 10.1096/fj.02-1163fje; Ruckert IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022932; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Vimaleswaran KS, 2012, HUM MOL GENET, V21, P4537, DOI 10.1093/hmg/dds283; Wan J, 2010, BIOCHEM BIOPH RES CO, V391, P1567, DOI 10.1016/j.bbrc.2009.12.127; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; White R, 2000, NAT MED, V6, P1368, DOI 10.1038/82183; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yu JJ, 2009, ANN NY ACAD SCI, V1173, pE10, DOI 10.1111/j.1749-6632.2009.04952.x	44	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55884	10.1371/journal.pone.0055884	http://dx.doi.org/10.1371/journal.pone.0055884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409076	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000314660300043
J	Lindsley, DL; Roote, J; Kennison, JA				Lindsley, Dan L.; Roote, John; Kennison, James A.			Anent the Genomics of Spermatogenesis in Drosophila melanogaster	PLOS ONE			English	Article							BIASED GENE-EXPRESSION; STERILE MUTATIONS; MALE-FERTILITY; X-CHROMOSOME; DEMASCULINIZATION; REGION; LETHAL	An appreciable fraction of the Drosophila melanogaster genome is dedicated to male fertility. One approach to characterizing this subset of the genome is through the study of male-sterile mutations. We studied the relation between vital and male-fertility genes in three large autosomal regions that were saturated for lethal and male-sterile mutations. The majority of male-sterile mutations affect genes that are exclusively expressed in males. These genes are required only for male fertility, and several mutant alleles of each such gene were encountered. A few male-sterile mutations were alleles of vital genes that are expressed in both males and females. About one-fifth of the genes in Drosophila melanogaster show male-specific expression in adults. Although some earlier studies found a paucity of genes on the X chromosome showing male-biased expression, we did not find any significant differences between the X chromosome and the autosomes either in the relative frequencies of mutations to male sterility or in the frequencies of genes with male-specific expression in adults. Our results suggest that as much as 25% of the Drosophila genome may be dedicated to male fertility.	[Lindsley, Dan L.] Univ Calif San Diego, Dept Cell & Dev Biol, La Jolla, CA 92093 USA; [Roote, John] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Kennison, James A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Diego; University of Cambridge; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kennison, JA (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA.	Jim_Kennison@nih.gov			Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Department of Genetics, University of Cambridge; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001005] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Department of Genetics, University of Cambridge(University of Cambridge); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the Department of Genetics, University of Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 1999, GENETICS, V153, P179; Belote JM, 2009, HEREDITY, V103, P23, DOI 10.1038/hdy.2009.23; Cooper MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023509; Cooper MT, 2010, GENETICS, V185, P811, DOI 10.1534/genetics.110.115121; EPLER JL, 1966, GENETICS, V54, P31; GANS M, 1975, GENETICS, V81, P683; GEER BW, 1983, J EXP ZOOL, V225, P107, DOI 10.1002/jez.1402250113; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hahn MW, 2005, CURR BIOL, V15, pR192, DOI 10.1016/j.cub.2005.03.005; Hense W, 2007, PLOS BIOL, V5, P2288, DOI 10.1371/journal.pbio.0050273; Hiller M, 2004, DEVELOPMENT, V131, P5297, DOI 10.1242/dev.01314; Joslyn GL, 1988, THESIS U CALIFORNIA; Kemkemer C, 2011, MOL BIOL EVOL, V28, P1561, DOI 10.1093/molbev/msq355; KENNISON JA, 1983, GENETICS, V103, P219; Koundakjian EJ, 2004, GENETICS, V167, P203, DOI 10.1534/genetics.167.1.203; LIFSCHYTZ E, 1978, MOL GEN GENET, V161, P275, DOI 10.1007/BF00331001; Lindsley D.L., 1980, Genetics and Biology of Drosophila, V2d, P225; Lindsley D. L., 1972, The genetics of the spermatozoon. Proceedings, International Symposium, Edinburgh, 16-20 August, 1971., P203; Meiklejohn CD, 2012, GENOME BIOL EVOL, V4, P1007, DOI 10.1093/gbe/evs077; Meiklejohn CD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001126; Meisel RP, 2012, GENOME RES, V22, P1255, DOI 10.1101/gr.132100.111; MOHLER JD, 1977, GENETICS, V85, P259; NASH D, 1983, GENETICS, V105, P957; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; SCHUPBACH T, 1989, GENETICS, V121, P101; Sturgill D, 2007, NATURE, V450, P238, DOI 10.1038/nature06330; Wakimoto BT, 2004, GENETICS, V167, P207, DOI 10.1534/genetics.167.1.207; Wasbrough ER, 2010, J PROTEOMICS, V73, P2171, DOI 10.1016/j.jprot.2010.09.002	29	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55915	10.1371/journal.pone.0055915	http://dx.doi.org/10.1371/journal.pone.0055915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409089	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200089
J	Narne, VK				Narne, Vijaya Kumar			Temporal Processing and Speech Perception in Noise by Listeners with Auditory Neuropathy	PLOS ONE			English	Article							FINE-STRUCTURE CUES; FREQUENCY DISCRIMINATION; CARRIER FREQUENCY; MODULATION RATE; ENVELOPE; INDIVIDUALS; INTELLIGIBILITY; CONSEQUENCES; CHILDREN	Aim: The present study evaluated the relation between speech perception in the presence of background noise and temporal processing ability in listeners with Auditory Neuropathy (AN). Method: The study included two experiments. In the first experiment, temporal resolution of listeners with normal hearing and those with AN was evaluated using measures of temporal modulation transfer function and frequency modulation detection at modulation rates of 2 and 10 Hz. In the second experiment, speech perception in quiet and noise was evaluated at three signal to noise ratios (SNR) (0, 5, and 10 dB). Results: Results demonstrated that listeners with AN performed significantly poorer than normal hearing listeners in both amplitude modulation and frequency modulation detection, indicating significant impairment in extracting envelope as well as fine structure cues from the signal. Furthermore, there was significant correlation seen between measures of temporal resolution and speech perception in noise. Conclusion: Results suggested that an impaired ability to efficiently process envelope and fine structure cues of the speech signal may be the cause of the extreme difficulties faced during speech perception in noise by listeners with AN.	All India Inst Speech & Hearing, Mysore, Karnataka, India		Narne, VK (corresponding author), All India Inst Speech & Hearing, Mysore, Karnataka, India.	vijaynarne@gmail.com	Narne, Vijaya K/AAS-7643-2020; Narne, Vijaya/AAU-9326-2020	Narne, Vijaya/0000-0002-6531-8015				American National Standards Institute, 1996, S361996 ANSI; ANSI, 2018, S311999 ANSI; Berlin CI, 2003, PEDIATR CLIN N AM, V50, P331, DOI 10.1016/S0031-3955(03)00031-2; Buss E, 2004, EAR HEARING, V25, P242, DOI 10.1097/01.AUD.0000130796.73809.09; DRULLMAN R, 1995, J ACOUST SOC AM, V97, P585, DOI 10.1121/1.413112; DRULLMAN R, 1995, J ACOUST SOC AM, V98, P1796, DOI 10.1121/1.413378; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P2670, DOI 10.1121/1.409836; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P1053, DOI 10.1121/1.408467; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; HALL JW, 1994, J ACOUST SOC AM, V96, P150, DOI 10.1121/1.410474; Hopkins K, 2008, J ACOUST SOC AM, V123, P1140, DOI 10.1121/1.2824018; Hopkins K, 2009, J ACOUST SOC AM, V125, P442, DOI 10.1121/1.3037233; HOUTGAST T, 1985, J ACOUST SOC AM, V77, P1069, DOI 10.1121/1.392224; International Standards Organization, 1994, 3983 ISO; Kraus N, 2000, JARO-J ASSOC RES OTO, V1, P33, DOI 10.1007/s101620010004; Kumar AU, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-21; Lacher-Fougere S, 1998, AUDIOLOGY, V37, P109; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Liu S, 2004, J ACOUST SOC AM, V116, P2374, DOI 10.1121/1.1787528; Lorenzi C, 2000, NEUROCASE, V6, P231; Lorenzi C, 2006, P NATL ACAD SCI USA, V103, P18866, DOI 10.1073/pnas.0607364103; Moore BCJ, 2002, J ACOUST SOC AM, V111, P327, DOI 10.1121/1.1424871; MOORE BCJ, 1995, J ACOUST SOC AM, V97, P2468, DOI 10.1121/1.411967; Moore BCJ, 2003, SPEECH COMMUN, V41, P81, DOI 10.1016/S0167-6393(02)00095-X; MOORE BCJ, 1989, J ACOUST SOC AM, V86, P1722, DOI 10.1121/1.398603; Narne VK, 2009, INT J AUDIOL, V48, P700, DOI 10.1080/14992020902931574; Narne VK, 2009, EAR HEARING, V30, P136, DOI 10.1097/AUD.0b013e3181926545; Narne VK, 2007, FRONT RES SPEECH MUS, P130; Rance G, 2004, EAR HEARING, V25, P34, DOI 10.1097/01.AUD.0000111259.59690.B8; Rance G, 2007, EAR HEARING, V28, P351, DOI 10.1097/AUD.0b013e3180479404; Rance Gary, 2005, Trends Amplif, V9, P1, DOI 10.1177/108471380500900102; SEK A, 1995, J ACOUST SOC AM, V97, P2479, DOI 10.1121/1.411968; SININGER Y, 2001, AUDITORY NEUROPATHY, P15; Starr A, 2003, BRAIN, V126, P1604, DOI 10.1093/brain/awg156; Starr A, 1996, BRAIN, V119, P741, DOI 10.1093/brain/119.3.741; Stickney GS, 2004, J ACOUST SOC AM, V116, P1081, DOI 10.1121/1.1772399; VIEMEISTER NF, 1979, J ACOUST SOC AM, V66, P1364, DOI 10.1121/1.383531; Vinay, 2007, INT J AUDIOL, V46, P39, DOI 10.1080/14992020601077992; Yathiraj A, 2005, AUDITORY MEMORY TEST; Zeng FG, 2006, J SPEECH LANG HEAR R, V49, P367, DOI 10.1044/1092-4388(2006/029); Zeng FG, 2005, J NEUROPHYSIOL, V93, P3050, DOI 10.1152/jn.00985.2004; Zeng FG, 1999, NEUROREPORT, V10, P3429, DOI 10.1097/00001756-199911080-00031; Zeng FG, 2001, AUDITORY NEUROPATHY, P141; Zwicker E., 1956, ACUSTICA, V6, P356	44	13	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55995	10.1371/journal.pone.0055995	http://dx.doi.org/10.1371/journal.pone.0055995			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409105	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200099
J	Ballarin-Gonzalez, B; Lassen, LB; Jessen, R; Fuchtbauer, A; Fuchtbauer, EM; Pedersen, FS				Ballarin-Gonzalez, Borja; Lassen, Louise Berkhoudt; Jessen, Randi; Fuchtbauer, Annette; Fuchtbauer, Ernst-Martin; Pedersen, Finn Skou			Deregulated Nras Expression in Knock-In Animals Harboring a Gammaretroviral Long Terminal Repeat at the Nras/Csde1 Locus	PLOS ONE			English	Article							INSERTIONAL MUTAGENESIS; RETROVIRAL INTEGRATIONS; PROTEIN ISOFORMS; CELL LYMPHOMAS; MICE; DNA; ACTIVATION; REVEALS; GENES; SITE	To investigate mechanisms and phenotypic effects of insertional mutagenesis by gammaretroviruses, we have developed mouse lines containing a single Akv 1-99 long terminal repeat (LTR) and a floxed PGK/Tn5 neomycin cassette at the Nras proto-oncogene at positions previously identified as viral integration sites in Akv 1-99 induced tumors. The insert did not compromise the embryonic development, however, the cassette had an effect on Nras expression in all tissues analyzed. Cre-mediated excision of the PGK/Tn5 neomycin cassette in two of the lines caused upregulation of Nras. Altogether, the knock-in alleles are characterized by modulation of expression of the target gene from more than ten-fold upregulation to three-fold downregulation and exemplify various mechanisms of deregulation by insertional mutagenesis. LTR knock-in mice may serve as a tool to investigate mechanisms of retroviral insertional mutagenesis and as a way of constitutive or induced modulation of expression of a target gene.	[Ballarin-Gonzalez, Borja; Lassen, Louise Berkhoudt; Jessen, Randi; Fuchtbauer, Annette; Fuchtbauer, Ernst-Martin; Pedersen, Finn Skou] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	Aarhus University	Pedersen, FS (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	fsp@mb.au.dk			Danish Cancer Society; Danish Medical Research Council; Danish Genetically Modified Animal Resource (DAGMAR); Danish Agency for Science, Technology, and Innovation	Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Genetically Modified Animal Resource (DAGMAR); Danish Agency for Science, Technology, and Innovation	This study was supported in part by grants from the Danish Cancer Society, the Danish Medical Research Council and the Danish Genetically Modified Animal Resource (DAGMAR) funded by the Danish Agency for Science, Technology, and Innovation. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biasco L, 2012, MOL THER, V20, P709, DOI 10.1038/mt.2011.289; Blyth K, 2006, CANCER RES, V66, P2195, DOI 10.1158/0008-5472.CAN-05-3558; Haldar M, 2008, DEV CELL, V14, P437, DOI 10.1016/j.devcel.2008.01.002; Kool J, 2010, CANCER RES, V70, P520, DOI 10.1158/0008-5472.CAN-09-2736; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Lassen LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042216; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu JH, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-2; Martin-Hernandez J, 2001, J VIROL, V75, P11907, DOI 10.1128/JVI.75.23.11907-11912.2001; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Pyrz M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-86; Rasmussen MH, 2010, J VIROL, V84, P3780, DOI 10.1128/JVI.02088-09; Rasmussen MH, 2009, NUCLEIC ACIDS RES, V37, P4657, DOI 10.1093/nar/gkp469; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Uren AG, 2005, ONCOGENE, V24, P7656, DOI 10.1038/sj.onc.1209043; WERTZ K, 1994, TRANSGENICS, V1, P277; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844	23	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56029	10.1371/journal.pone.0056029	http://dx.doi.org/10.1371/journal.pone.0056029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418499	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300091
J	Chen, YL; Zhang, H; Wang, HT; Yu, LC; Chen, Y				Chen, Yueling; Zhang, Hui; Wang, Hengtong; Yu, Lianchun; Chen, Yong			The Role of Coincidence-Detector Neurons in the Reliability and Precision of Subthreshold Signal Detection in Noise	PLOS ONE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; CORTICAL NEURAL-NETWORKS; SYNAPTIC INPUT; SOMATOSENSORY CORTEX; TEMPORAL INTEGRATION; SYNCHRONOUS SPIKING; SOUND LOCALIZATION; CURRENT TRANSIENTS; AUDITORY-SYSTEM; PSTH RESPONSE	Subthreshold signal detection is an important task for animal survival in complex environments, where noise increases both the external signal response and the spontaneous spiking of neurons. The mechanism by which neurons process the coding of signals is not well understood. Here, we propose that coincidence detection, one of the ways to describe the functionality of a single neural cell, can improve the reliability and the precision of signal detection through detection of presynaptic input synchrony. Using a simplified neuronal network model composed of dozens of integrate-and-fire neurons and a single coincidence-detector neuron, we show how the network reads out the subthreshold noisy signals reliably and precisely. We find suitable pairing parameters, the threshold and the detection time window of the coincidence-detector neuron, that optimize the precision and reliability of the neuron. Furthermore, it is observed that the refractory period induces an oscillation in the spontaneous firing, but the neuron can inhibit this activity and improve the reliability and precision further. In the case of intermediate intrinsic states of the input neuron, the network responds to the input more efficiently. These results present the critical link between spiking synchrony and noisy signal transfer, which is utilized in coincidence detection, resulting in enhancement of temporally sensitive coding scheme.	[Chen, Yueling; Zhang, Hui; Wang, Hengtong; Yu, Lianchun; Chen, Yong] Lanzhou Univ, Inst Theoret Phys, Lanzhou 730000, Peoples R China; [Chen, Yueling] Gansu Coll Tradit Chinese Med, Dept Phys, Lanzhou, Peoples R China; [Chen, Yong] Kings Coll London, Dept Math, London WC2R 2LS, England	Lanzhou University; Gansu University of Chinese Medicine; University of London; King's College London	Chen, Y (corresponding author), Lanzhou Univ, Inst Theoret Phys, Lanzhou 730000, Peoples R China.	ychen@lzu.edu.cn	Chen, Yong/B-9051-2008; Wang, Hengtong/O-6772-2015	Chen, Yong/0000-0003-2580-5895; Wang, Hengtong/0000-0001-6876-4769	National Natural Science Foundation of China [10975063, 11105062]; Fundamental Research Funds for the Central Universities [lzujbky-2012-17]; Program for New Century Excellent Talents in University [NCET-11-0206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (Grants No. 10975063 and 11105062), the Fundamental Research Funds for the Central Universities (Grant No. lzujbky-2012-17), and the Program for New Century Excellent Talents in University (Grant No. NCET-11-0206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1982, ISRAEL J MED SCI, V18, P83; Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Berry MJ, 1998, J NEUROSCI, V18, P2200; Burkitt AN, 2006, BIOL CYBERN, V95, P97, DOI 10.1007/s00422-006-0082-8; Burkitt AN, 2006, BIOL CYBERN, V95, P1, DOI 10.1007/s00422-006-0068-6; Carr CE, 1999, NEURAL COMPUT, V11, P1, DOI 10.1162/089976699300016773; Chen Y, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051909; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; Diesmann M, 2001, NEUROCOMPUTING, V38, P565, DOI 10.1016/S0925-2312(01)00409-X; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Grande LA, 2004, J NEUROSCI, V24, P1839, DOI 10.1523/JNEUROSCI.3500-03.2004; Grothe B, 2003, NAT REV NEUROSCI, V4, P540, DOI 10.1038/nrn1136; Herrmann A, 2002, J COMPUT NEUROSCI, V12, P83, DOI 10.1023/A:1015739523224; Herrmann A, 2001, J COMPUT NEUROSCI, V11, P135, DOI 10.1023/A:1012841516004; Joris P, 2007, TRENDS NEUROSCI, V30, P70, DOI 10.1016/j.tins.2006.12.004; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; Kandler K, 2004, CURR OPIN NEUROBIOL, V14, P96, DOI 10.1016/j.conb.2004.01.017; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Katz Y, 2007, PLOS COMPUT BIOL, V3, P2432, DOI 10.1371/journal.pcbi.0030234; Kempter R, 1998, NEURAL COMPUT, V10, P1987, DOI 10.1162/089976698300016945; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Kostal L, 2010, CHINESE J PHYSIOL, V53, P454, DOI 10.4077/CJP.2010.AMM031; Kreuz T, 2007, J NEUROSCI METH, V165, P151, DOI 10.1016/j.jneumeth.2007.05.031; Krips R, 2009, NEURAL COMPUT, V21, P2524, DOI 10.1162/neco.2009.07-07-563; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Marsalek P, 2005, BIOL CYBERN, V92, P445, DOI 10.1007/s00422-005-0571-1; Marsalek P, 2000, BIOSYSTEMS, V58, P83, DOI 10.1016/S0303-2647(00)00110-6; McAlpine D, 2003, TRENDS NEUROSCI, V26, P347, DOI 10.1016/S0166-2236(03)00140-1; Mejias JF, 2008, J COMPUT NEUROSCI, V24, P222, DOI 10.1007/s10827-007-0052-8; MILLER MI, 1992, J ACOUST SOC AM, V92, P202, DOI 10.1121/1.404284; Oertel D, 2000, P NATL ACAD SCI USA, V97, P11773, DOI 10.1073/pnas.97.22.11773; Pantic L, 2003, NETWORK-COMP NEURAL, V14, P17, DOI 10.1088/0954-898X/14/1/302; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rodriguez-Molina VM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000319; Roy SA, 2001, J NEUROSCI, V21, P2462, DOI 10.1523/JNEUROSCI.21-07-02462.2001; Rudolph M, 2003, J COMPUT NEUROSCI, V14, P239, DOI 10.1023/A:1023245625896; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sherrington C, 1923, INTEGRATIVE ACTION N; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Tollin DJ, 2002, J NEUROSCI, V22, P1454, DOI 10.1523/JNEUROSCI.22-04-01454.2002; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; Wang HP, 2010, SCIENCE, V328, P106, DOI 10.1126/science.1183108	53	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56822	10.1371/journal.pone.0056822	http://dx.doi.org/10.1371/journal.pone.0056822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418604	Green Published, gold			2022-12-27	WOS:000315970300198
J	Gaughan, AE; Stevens, FR; Linard, C; Jia, P; Tatem, AJ				Gaughan, Andrea E.; Stevens, Forrest R.; Linard, Catherine; Jia, Peng; Tatem, Andrew J.			High Resolution Population Distribution Maps for Southeast Asia in 2010 and 2015	PLOS ONE			English	Article							LAND-COVER; ACCURACY; CENSUS; HEALTH	Spatially accurate, contemporary data on human population distributions are vitally important to many applied and theoretical researchers. The Southeast Asia region has undergone rapid urbanization and population growth over the past decade, yet existing spatial population distribution datasets covering the region are based principally on population count data from censuses circa 2000, with often insufficient spatial resolution or input data to map settlements precisely. Here we outline approaches to construct a database of GIS-linked circa 2010 census data and methods used to construct fine-scale (similar to 100 meters spatial resolution) population distribution datasets for each country in the Southeast Asia region. Landsat-derived settlement maps and land cover information were combined with ancillary datasets on infrastructure to model population distributions for 2010 and 2015. These products were compared with those from two other methods used to construct commonly used global population datasets. Results indicate mapping accuracies are consistently higher when incorporating land cover and settlement information into the AsiaPop modelling process. Using existing data, it is possible to produce detailed, contemporary and easily updatable population distribution datasets for Southeast Asia. The 2010 and 2015 datasets produced are freely available as a product of the AsiaPop Project and can be downloaded from: www.asiapop.org.	[Gaughan, Andrea E.; Stevens, Forrest R.; Jia, Peng; Tatem, Andrew J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Gaughan, Andrea E.; Stevens, Forrest R.; Jia, Peng; Tatem, Andrew J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Gaughan, Andrea E.; Stevens, Forrest R.] Univ Florida, Land Use Environm Change Inst, Gainesville, FL USA; [Tatem, Andrew J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Linard, Catherine] Fonds Natl Rech Sci, B-1050 Brussels, Belgium; [Linard, Catherine] Univ Libre Bruxelles, Brussels, Belgium	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Fonds de la Recherche Scientifique - FNRS; Universite Libre de Bruxelles	Gaughan, AE (corresponding author), Univ Florida, Dept Geog, Gainesville, FL 32611 USA.	aegaughan@gmail.com	Stevens, Forrest/B-1673-2013; Jia, Peng/K-1446-2017; Linard, Catherine/AAF-1670-2021	Stevens, Forrest/0000-0002-9328-3753; Jia, Peng/0000-0003-0110-3637; Tatem, Andrew/0000-0002-7270-941X; Linard, Catherine/0000-0002-0819-7755	RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Bill and Melinda Gates Foundation [49446, 1032350]; Fogarty International Center, National Institutes of Health	RAPIDD program of the Science and Technology Directorate, Department of Homeland Security; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	AJT acknowledges funding support from the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health, and is also supported by grants from the Bill and Melinda Gates Foundation (#49446 and #1032350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, TRANSFORMING POPULAT; Balk D., 2005, P INT SOC PHOT REM S, P14; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Bhaduri B, 2007, GEOJOURNAL, V69, P103, DOI 10.1007/s10708-007-9105-9; Central Intelligence Agency, 2010, WORLD FACTB; Centro Internacional de Agricultura Tropical (CIAT) United Nations Environment Program (UNEP) Center for International Earth Science Information Network (CIESIN) Columbia University The World Bank, 2005, LAT AM CAR POP DAT V; Cheriyadat A, 2007, GEOJOURNAL, V69, P119, DOI 10.1007/s10708-007-9101-0; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Deichmann U, 1996, 963 NCGIA U CAL; Dobson JE, 2000, PHOTOGRAMM ENG REM S, V66, P849; ERDAS, 2010, ERDAS IM 2011 PROD S; ESRI, 2008, ARCMAP 10 0; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Giraudoux P., 2012, PGIRMESS DATA ANAL E; Gregory I. N., 2002, Computers, Environment and Urban Systems, V26, P293, DOI 10.1016/S0198-9715(01)00013-8; Haklay M, 2008, IEEE PERVAS COMPUT, V7, P12, DOI 10.1109/MPRV.2008.80; Hay SI, 2005, TROP MED INT HEALTH, V10, P1073, DOI 10.1111/j.1365-3156.2005.01487.x; Kampstra P, 2008, J STAT SOFTWARE, V28; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Lambin EF, 2003, ANNU REV ENV RESOUR, V28, P205, DOI 10.1146/annurev.energy.28.050302.105459; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Linard C, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-7; Linard C, 2011, GEOJOURNAL, V76, P525, DOI 10.1007/s10708-010-9364-8; McDonald J.H., 2009, HDB BIOL STAT; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; MDA Federal Inc, 1995, EARTHSAT GEOCOVER LC; Mennis J., 2006, CARTOGR GEOGR INF SC, V33, P179, DOI [10.1559/152304006779077309, DOI 10.1559/152304006779077309]; Mertz O, 2009, HUM ECOL, V37, P281, DOI 10.1007/s10745-009-9249-y; Nakaya T, 2000, ENVIRON PLANN A, V32, P91, DOI 10.1068/a31145; Nelson A., 2004, AFRICAN POPULATION D; OPENSHAW S, 1984, ENVIRON PLANN A, V16, P17, DOI 10.1068/a160017; OpenStreetMap, 2012, OPENSTREETMAP FREE W; Pacific Distaster Center, 2012, GLOB HAZ INF NETW GH; Potere D, 2007, GEOJOURNAL, V69, P55, DOI 10.1007/s10708-007-9102-z; Potereand D, 2009, GLOBAL MAPPING HUMAN; R Core Team, 2020, R LANG ENV STAT COMP; Rasul G, 2003, LAND DEGRAD DEV, V14, P495, DOI 10.1002/ldr.570; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Sumilo D, 2008, VACCINE, V26, P2580, DOI 10.1016/j.vaccine.2008.03.029; Tatem AJ, 2005, REMOTE SENS ENVIRON, V96, P87, DOI 10.1016/j.rse.2005.02.001; Tatem A, 2011, NATURE, V474, P36, DOI 10.1038/474036d; Tatem AJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-8; Tatem AJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001298; Tatem AJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-218; Tobler W, 1997, Int J Popul Geogr, V3, P203; United Nations Population Division, 2011, WORLD POP PROSP; Yetman G., 2004, GLOBAL DISTRIBUTION; [No title captured]	48	158	166	9	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55882	10.1371/journal.pone.0055882	http://dx.doi.org/10.1371/journal.pone.0055882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418469	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000315970300060
J	Goutte, A; Cherel, Y; Houssais, MN; Klein, V; Ozouf-Costaz, C; Raccurt, M; Robineau, C; Masse, G				Goutte, Aurelie; Cherel, Yves; Houssais, Marie-Noelle; Klein, Vincent; Ozouf-Costaz, Catherine; Raccurt, Mireille; Robineau, Camille; Masse, Guillaume			Diatom-Specific Highly Branched Isoprenoids as Biomarkers in Antarctic Consumers	PLOS ONE			English	Article							POLAR MARINE ECOSYSTEMS; SEA-ICE CONDITIONS; EUPHAUSIA-SUPERBA; ADELIE PENGUINS; FOOD-WEB; TERRE-ADELIE; SOUTHERN; VARIABILITY; SEABIRD; KRILL	The structure, functioning and dynamics of polar marine ecosystems are strongly influenced by the extent of sea ice. Ice algae and pelagic phytoplankton represent the primary sources of nutrition for higher trophic-level organisms in seasonally ice-covered areas, but their relative contributions to polar marine consumers remain largely unexplored. Here, we investigated the potential of diatom-specific lipid markers and highly branched isoprenoids (HBIs) for estimating the importance of these two carbon pools in an Antarctic pelagic ecosystem. Using GC-MS analysis, we studied HBI biomarkers in key marine species over three years in Adelie Land, Antarctica: euphausiids (ice krill Euphausia crystallorophias and Antarctic krill E. superba), fish (bald notothens Pagothenia borchgrevinki and Antarctic silverfish Pleuragramma antarcticum) and seabirds (Adelie penguins Pygoscelis adeliae, snow petrels Pagodroma nivea and cape petrels Daption capense). This study provides the first evidence of the incorporation of HBI lipids in Antarctic pelagic consumers. Specifically, a di-unsaturated HBI (diene) of sea ice origin was more abundant in ice-associated species than in pelagic species, whereas a tri-unsaturated HBI (triene) of phytoplanktonic origin was more abundant in pelagic species than in ice-associated species. Moreover, the relative abundances of diene and triene in seabird tissues and eggs were higher during a year of good sea ice conditions than in a year of poor ice conditions. In turn, the higher contribution of ice algal derived organic matter to the diet of seabirds was related to earlier breeding and higher breeding success. HBI biomarkers are a promising tool for estimating the contribution of organic matter derived from ice algae in pelagic consumers from Antarctica.	[Goutte, Aurelie; Houssais, Marie-Noelle; Klein, Vincent; Robineau, Camille; Masse, Guillaume] Univ Paris 06, UMR CNRS 7159, Lab Oceanog & Climat Experimentat & Approches Num, Paris, France; [Cherel, Yves] Ctr Etud Biol Chize, UPR 1934 CNRS, Beauvoir Sur Niort, France; [Ozouf-Costaz, Catherine] Museum Natl Hist Nat, UMR CNRS 7138, F-75231 Paris, France; [Raccurt, Mireille] Univ Lyon, UMR CNRS 5023, Villeurbanne, France; [Masse, Guillaume] CNRS, Takuvik, PQ, Canada; [Masse, Guillaume] Univ Laval, UMI 3376, Takuvik, PQ, Canada	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Laval University	Goutte, A (corresponding author), Univ Paris 06, UMR CNRS 7159, Lab Oceanog & Climat Experimentat & Approches Num, Paris, France.	agoutte@gmail.com	Goutte, Aurelie/F-7572-2017	Goutte, Aurelie/0000-0001-8322-5843; Chiaradia, Andre/0000-0002-6178-4211	European Research Council (ICEPROXY) [203441]; French Insitut Paul-Emile Victor (IPEV) [1010, 1124, 131, 1039, 109]	European Research Council (ICEPROXY); French Insitut Paul-Emile Victor (IPEV)	This work was funded by the European Research Council (ICEPROXY, project number 203441) and the French Insitut Paul-Emile Victor (IPEV projects No 1010, G. Masse; No1124, G. Lecointre; No 131, C. Duchamp; No 1039, J-Y. Toullec and No109, H. Weimerskirch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 1998, POLAR BIOL, V20, P311, DOI 10.1007/s003000050308; Arrigo KR, 2004, ANTARCT SCI, V16, P471, DOI 10.1017/S0954102004002263; Arrigo KR, 1997, SCIENCE, V276, P394, DOI 10.1126/science.276.5311.394; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Barbara L, 2010, QUATERNARY SCI REV, V29, P2731, DOI 10.1016/j.quascirev.2010.06.027; Barbraud C, 2006, P NATL ACAD SCI USA, V103, P6248, DOI 10.1073/pnas.0510397103; Barbraud C, 2001, J AVIAN BIOL, V32, P297, DOI 10.1111/j.0908-8857.2001.320402.x; Beaman RJ, 2011, ANTARCT SCI, V23, P95, DOI 10.1017/S095410201000074X; Bec A, 2011, METHODS ECOL EVOL, V2, P651, DOI 10.1111/j.2041-210X.2011.00111.x; Belt ST, 2007, ORG GEOCHEM, V38, P16, DOI 10.1016/j.orggeochem.2006.09.013; Brown TA, 2012, POLAR BIOL, V35, P1281, DOI 10.1007/s00300-012-1164-9; Brown TA, 2012, J PLANKTON RES, V34, P647, DOI 10.1093/plankt/fbs045; Brown TA, 2012, POLAR BIOL, V35, P131, DOI 10.1007/s00300-011-1045-7; Budge SM, 2008, OECOLOGIA, V157, P117, DOI 10.1007/s00442-008-1053-7; CHASTEL O, 1993, OECOLOGIA, V94, P278, DOI 10.1007/BF00341328; Cherel Y, 2008, MAR BIOL, V154, P813, DOI 10.1007/s00227-008-0974-3; Clarke A, 2003, ENVIRON CONSERV, V30, P1, DOI 10.1017/S0376892903000018; Cottin M, 2012, MAR BIOL, V159, P1843, DOI 10.1007/s00227-012-1974-x; Croxall JP, 2002, SCIENCE, V297, P1510, DOI 10.1126/science.1071987; Damste JSS, 2004, SCIENCE, V304, P584, DOI 10.1126/science.1096806; EICKEN H, 1992, POLAR BIOL, V12, P3; Flores H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031775; GARRISON DL, 1991, AM ZOOL, V31, P17; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; HOSHIAI T, 1989, P NIPR S POLAR BIOL, V2, P61; HUBOLD G, 1985, POLAR BIOL, V5, P43, DOI 10.1007/BF00446044; Johns L, 1999, ORG GEOCHEM, V30, P1471, DOI 10.1016/S0146-6380(99)00112-6; Kattner G, 1998, MAR ECOL PROG SER, V170, P203, DOI 10.3354/meps170203; La Mesa M, 2004, POLAR BIOL, V27, P321, DOI 10.1007/s00300-004-0599-z; La Mesa M, 2012, FISH FISH, V13, P241, DOI 10.1111/j.1467-2979.2011.00427.x; Lizotte MP, 2001, AM ZOOL, V41, P57, DOI 10.1668/0003-1569(2001)041[0057:TCOSIA]2.0.CO;2; Masse G, 2011, ANTARCT SCI, V23, P487, DOI 10.1017/S0954102011000381; Masse G, 2008, EARTH PLANET SC LETT, V269, P565, DOI 10.1016/j.epsl.2008.03.017; Micol T, 2001, POLAR BIOL, V24, P175, DOI 10.1007/s003000000193; Moline MA, 2004, GLOBAL CHANGE BIOL, V10, P1973, DOI 10.1111/j.1365-2486.2004.00825.x; Montes-Hugo MA, 2008, DEEP-SEA RES PT II, V55, P2106, DOI 10.1016/j.dsr2.2008.04.036; Muller J, 2009, NAT GEOSCI, V2, P772, DOI 10.1038/NGEO665; Nicol S, 2006, BIOSCIENCE, V56, P111, DOI 10.1641/0006-3568(2006)056[0111:KCASIE]2.0.CO;2; Ono A, 2011, POLAR SCI, V5, P146, DOI 10.1016/j.polar.2011.04.006; Quetin LB, 2001, AM ZOOL, V41, P74, DOI 10.1668/0003-1569(2001)041[0074:EVAIIO]2.0.CO;2; RIDOUX V, 1989, POLAR BIOL, V9, P137, DOI 10.1007/BF00297168; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; SIEGEL V, 1995, MAR ECOL PROG SER, V123, P45, DOI 10.3354/meps123045; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Spreen G, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2005JC003384; VEIT RR, 1991, AUK, V108, P790; Williams CT, 2010, J ORNITHOL, V151, P531, DOI 10.1007/s10336-010-0513-0	47	13	13	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56504	10.1371/journal.pone.0056504	http://dx.doi.org/10.1371/journal.pone.0056504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418580	Green Published, gold			2022-12-27	WOS:000315970300173
J	Kempuraj, D; Twait, EC; Williard, DE; Yuan, ZB; Meyerholz, DK; Samuel, I				Kempuraj, Duraisamy; Twait, Erik C.; Williard, Deborah E.; Yuan, Zuobiao; Meyerholz, David K.; Samuel, Isaac			The Novel Cytokine Interleukin-33 Activates Acinar Cell Proinflammatory Pathways and Induces Acute Pancreatic Inflammation in Mice	PLOS ONE			English	Article							SUBSTANCE-P; MAST-CELLS; SYSTEMIC INFLAMMATION; CHEMOKINE SYNTHESIS; ADHESION MOLECULES; HYDROGEN-SULFIDE; ORGAN FAILURE; IL-33; LIGATION; EXPRESSION	Background: Acute pancreatitis is potentially fatal but treatment options are limited as disease pathogenesis is poorly understood. IL-33, a novel IL-1 cytokine family member, plays a role in various inflammatory conditions but its role in acute pancreatitis is not well understood. Specifically, whether pancreatic acinar cells produce IL-33 when stressed or respond to IL-33 stimulation, and whether IL-33 exacerbates acute pancreatic inflammation is unknown. Methods/Results: In duct ligation-induced acute pancreatitis in mice and rats, we found that (a) IL-33 concentration was increased in the pancreas; (b) mast cells, which secrete and also respond to IL-33, showed degranulation in the pancreas and lung; (c) plasma histamine and pancreatic substance P concentrations were increased; and (d) pancreatic and pulmonary proinflammatory cytokine concentrations were increased. In isolated mouse pancreatic acinar cells, TNF-alpha stimulation increased IL-33 release while IL-33 stimulation increased proinflammatory cytokine release, both involving the ERK MAP kinase pathway; the flavonoid luteolin inhibited IL-33-stimulated IL-6 and CCL2/MCP-1 release. In mice without duct ligation, exogenous IL-33 administration induced pancreatic inflammation without mast cell degranulation or jejunal inflammation; pancreatic changes included multifocal edema and perivascular infiltration by neutrophils and some macrophages. ERK MAP kinase (but not p38 or JNK) and NF-kB subunit p65 were activated in the pancreas of mice receiving exogenous IL-33, and acinar cells isolated from the pancreas of these mice showed increased spontaneous cytokine release (IL-6, CXCL2/MIP-2 alpha). Also, IL-33 activated ERK in human pancreatic tissue. Significance: As exogenous IL-33 does not induce jejunal inflammation in the same mice in which it induces pancreatic inflammation, we have discovered a potential role for an IL-33/acinar cell axis in the recruitment of neutrophils and macrophages and the exacerbation of acute pancreatic inflammation. Conclusion: IL-33 is induced in acute pancreatitis, activates acinar cell proinflammatory pathways and exacerbates acute pancreatic inflammation.	[Kempuraj, Duraisamy; Twait, Erik C.; Williard, Deborah E.; Yuan, Zuobiao; Samuel, Isaac] Univ Iowa, Dept Surg, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Meyerholz, David K.] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Samuel, I (corresponding author), Univ Iowa, Dept Surg, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	Isaac-Samuel@uiowa.edu	duraisamy, kempuraj/R-3043-2019; Meyerholz, David/J-8131-2019; Duraisamy, Kempuraj/AAC-5638-2022	Meyerholz, David/0000-0003-1552-3253; Samuel, Isaac/0000-0003-2538-121X	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD [R01 DK-071731]; American Recovery and Reinvestment Act [NIH R01 DK-071731]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071731] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Recovery and Reinvestment Act; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following research awards to I. Samuel: (a) Grant R01 DK-071731, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health, Bethesda, MD., and b) American Recovery and Reinvestment Act of 2009 - Supplemental Award to NIH R01 DK-071731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltran CJ, 2010, INFLAMM BOWEL DIS, V16, P1097, DOI 10.1002/ibd.21175; Benoist C, 2002, NATURE, V420, P875, DOI 10.1038/nature01324; Bhatia M, 2000, J PATHOL, V190, P117; Bhatia M, 1998, P NATL ACAD SCI USA, V95, P4760, DOI 10.1073/pnas.95.8.4760; Bhatia M, 2010, ANTIOXID REDOX SIGN, V12, P1191, DOI 10.1089/ars.2009.2927; Bi Y, 2005, AM J PHYSIOL-GASTR L, V289, pG561, DOI 10.1152/ajpgi.00508.2004; CHURG A, 1971, AM J PATHOL, V63, P521; Demyanets S, 2011, ARTERIOSCL THROM VAS, V31, P2080, DOI 10.1161/ATVBAHA.111.231431; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dib H, 2002, BRIT J SURG, V89, P172, DOI 10.1046/j.0007-1323.2001.01991.x; Enoksson M, 2011, J IMMUNOL, V186, P2523, DOI 10.4049/jimmunol.1003383; Hsu CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011944; Hueber AJ, 2011, EUR J IMMUNOL, V41, P2229, DOI 10.1002/eji.201041360; Isenmann R, 2001, PANCREAS, V22, P274, DOI 10.1097/00006676-200104000-00008; Johnson CD, 2004, GUT, V53, P1340, DOI 10.1136/gut.2004.039883; Kandere-Grzybowska K, 2003, J IMMUNOL, V171, P4830, DOI 10.4049/jimmunol.171.9.4830; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kobori A, 2010, J GASTROENTEROL, V45, P999, DOI 10.1007/s00535-010-0245-1; Lee JP, 2010, ACTA PHARMACOL SIN, V31, P831, DOI 10.1038/aps.2010.62; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Liu XJ, 2009, BIOCHEM BIOPH RES CO, V386, P181, DOI 10.1016/j.bbrc.2009.06.008; Lopez-Font I, 2010, WORLD J GASTROENTERO, V16, P3411, DOI 10.3748/wjg.v16.i27.3411; Lopez-Lazaro M, 2009, MINI-REV MED CHEM, V9, P31, DOI 10.2174/138955709787001712; Lunderius-Andersson C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00082; Carvalho KMMB, 2010, BIOL PHARM BULL, V33, P1534, DOI 10.1248/bpb.33.1534; Masamune A, 2010, AM J PHYSIOL-GASTR L, V299, pG821, DOI 10.1152/ajpgi.00178.2010; McKay CJ, 1999, BRIT J SURG, V86, P1302, DOI 10.1046/j.1365-2168.1999.01246.x; Meyerholz DK, 2007, AM J SURG, V194, P652, DOI 10.1016/j.amjsurg.2007.07.014; Meyerhotz DK, 2008, AM J SURG, V196, P675, DOI 10.1016/j.amjsurg.2008.07.009; Miller AM, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-22; Milovanovic M, 2012, IMMUNOL RES, V52, P89, DOI 10.1007/s12026-012-8283-9; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Norman J, 1998, AM J SURG, V175, P76, DOI 10.1016/S0002-9610(97)00240-7; Norman JG, 1996, SURGERY, V120, P515, DOI 10.1016/S0039-6060(96)80072-9; Ouziel R, 2012, AM J PATHOL, V180, DOI [10.1016/j.aj-path.2012.03.009, DOI 10.1016/J.AJ-PATH.2012.03.009]; Palmer G, 2009, ARTHRITIS RHEUM-US, V60, P738, DOI 10.1002/art.24305; Pastorelli Luca, 2011, Therap Adv Gastroenterol, V4, P311, DOI 10.1177/1756283X11410770; Pastorelli L, 2010, P NATL ACAD SCI USA, V107, P8017, DOI 10.1073/pnas.0912678107; Ramnath RD, 2008, BRIT J PHARMACOL, V154, P1339, DOI 10.1038/bjp.2008.188; Ramnath RD, 2007, J CELL MOL MED, V11, P1326, DOI 10.1111/j.1582-4934.2007.00086.x; RANSON JHC, 1974, SURG GYNECOL OBSTET, V139, P69; Samuel I, 2010, PANCREATOLOGY, V10, P536, DOI 10.1159/000320776; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seidelin JB, 2010, IMMUNOL LETT, V128, P80, DOI 10.1016/j.imlet.2009.11.001; Silver MR, 2010, INFLAMM RES, V59, P207, DOI 10.1007/s00011-009-0088-5; Tamizhselvi R, 2007, J CELL MOL MED, V11, P315, DOI 10.1111/j.1582-4934.2007.00024.x; Tenner S, 1997, GASTROENTEROLOGY, V113, P899, DOI 10.1016/S0016-5085(97)70185-9; Theoharides TC, 2010, P NATL ACAD SCI USA, V107, P4448, DOI 10.1073/pnas.1000803107; Verri WA, 2010, ANN RHEUM DIS, V69, P1697, DOI 10.1136/ard.2009.122655; Williard DE, 2010, AM J SURG, V200, P283, DOI 10.1016/j.amjsurg.2009.12.004; Xiang ZG, 2010, IMMUNOL LETT, V131, P159, DOI 10.1016/j.imlet.2010.04.005; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006; Yagami A, 2010, J IMMUNOL, V185, P5743, DOI 10.4049/jimmunol.0903818; Yonetci N, 2001, INT J PANCREATOL, V29, P163, DOI 10.1385/IJGC:29:3:163; Yuan Z, 2011, J GASTROINTEST SURG, V15, P1670, DOI 10.1007/s11605-011-1643-2; Zhao WH, 2010, CELL MOL IMMUNOL, V7, P260, DOI 10.1038/cmi.2010.3; Zhao X, 2005, LUNG, V183, P253, DOI 10.1007/s00408-004-2538-8	59	46	50	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56866	10.1371/journal.pone.0056866	http://dx.doi.org/10.1371/journal.pone.0056866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418608	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300202
J	Khan, FS; Lotia-Farrukh, I; Khan, AJ; Siddiqui, ST; Sajun, SZ; Malik, AA; Burfat, A; Arshad, MH; Codlin, AJ; Reininger, BM; McCormick, JB; Afridi, N; Fisher-Hoch, SP				Khan, Faisal S.; Lotia-Farrukh, Ismat; Khan, Aamir J.; Siddiqui, Saad Tariq; Sajun, Sana Zehra; Malik, Amyn Abdul; Burfat, Aziza; Arshad, Mohammad Hussham; Codlin, Andrew J.; Reininger, Belinda M.; McCormick, Joseph B.; Afridi, Nadeem; Fisher-Hoch, Susan P.			The Burden of Non-Communicable Disease in Transition Communities in an Asian Megacity: Baseline Findings from a Cohort Study in Karachi, Pakistan	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; SMOKELESS TOBACCO USE; BODY-MASS INDEX; DEVELOPING-COUNTRIES; INSULIN-RESISTANCE; ETHNIC-DIFFERENCES; DIABETES-MELLITUS; SOUTH ASIANS; RISK-FACTORS; PREVALENCE	Background: The demographic transition in South Asia coupled with unplanned urbanization and lifestyle changes are increasing the burden of non-communicable disease (NCD) where infectious diseases are still highly prevalent. The true magnitude and impact of this double burden of disease, although predicted to be immense, is largely unknown due to the absence of recent, population-based longitudinal data. The present study was designed as a unique 'Framingham-like' Pakistan cohort with the objective of measuring the prevalence and risk factors for hypertension, obesity, diabetes, coronary artery disease and hepatitis B and C infection in a multi-ethnic, middle to low income population of Karachi, Pakistan. Methods: We selected two administrative areas from a private charitable hospital's catchment population for enrolment of a random selection of cohort households in Karachi, Pakistan. A baseline survey measured the prevalence and risk factors for hypertension, obesity, diabetes, coronary artery disease and hepatitis B and C infection. Results: Six hundred and sixty-seven households were enrolled between March 2010 and August 2011. A majority of households lived in permanent structures (85%) with access to basic utilities (77%) and sanitation facilities (98%) but limited access to clean drinking water (68%). Households had high ownership of communication technologies in the form of cable television (69%) and mobile phones (83%). Risk factors for NCD, such as tobacco use (45%), overweight (20%), abdominal obesity (53%), hypertension (18%), diabetes (8%) and pre-diabetes (40%) were high. At the same time, infectious diseases such as hepatitis B (24%) and hepatitis C (8%) were prevalent in this population. Conclusion: Our findings highlight the need to monitor risk factors and disease trends through longitudinal research in high-burden transition communities in the context of rapid urbanization and changing lifestyles. They also demonstrate the urgency of public health intervention programs tailored for these transition communities.	[Khan, Faisal S.; Lotia-Farrukh, Ismat; Khan, Aamir J.] Indus Hosp Res Ctr, Karachi, Pakistan; [Khan, Faisal S.; Lotia-Farrukh, Ismat; Khan, Aamir J.; Siddiqui, Saad Tariq; Sajun, Sana Zehra; Malik, Amyn Abdul; Burfat, Aziza; Arshad, Mohammad Hussham; Codlin, Andrew J.] Interact Res & Dev, Karachi, Pakistan; [Reininger, Belinda M.; McCormick, Joseph B.; Fisher-Hoch, Susan P.] Univ Texas Sch Publ Hlth, Brownsville, TX USA; [Afridi, Nadeem] Assoc Pakistani Descent Cardiologists North Amer, Wellington, FL USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Khan, FS (corresponding author), Indus Hosp Res Ctr, Karachi, Pakistan.	faisal.khan@irdresearch.org	Fazli, Ghazal/AAE-8320-2022; Malik, Amyn A./AAF-4883-2021	Malik, Amyn A./0000-0003-4875-9916; Siddiqui, Saad/0000-0003-3018-3445; McCormick, Joseph/0000-0002-5844-8102	Interactive Research & Development (IRD); Association of Pakistani-Descent Cardiologists of North America (APCNA); International Society of Nephrology (ISN); NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	Interactive Research & Development (IRD); Association of Pakistani-Descent Cardiologists of North America (APCNA); International Society of Nephrology (ISN); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by separate grants from Interactive Research & Development (IRD), the Association of Pakistani-Descent Cardiologists of North America (APCNA) and the International Society of Nephrology (ISN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi M, 2004, EUR J CARDIOV PREV R, V11, P389, DOI 10.1097/00149831-200410000-00005; Akhter P, 2001, HEALTH PHYS, V80, P274, DOI 10.1097/00004032-200103000-00011; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Ali NS, 2009, J ORAL PATHOL MED, V38, P416, DOI 10.1111/j.1600-0714.2009.00754.x; Allender S, 2008, J URBAN HEALTH, V85, P938, DOI 10.1007/s11524-008-9325-4; Allender S, 2010, B WORLD HEALTH ORGAN, V88, P297, DOI 10.2471/BLT.09.065847; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; [Anonymous], 2011, NCD COUNTR PROF 2011; [Anonymous], 2011, HYPERTENSION FACT SH; Azim W., 2010, INT J PATHOL, V8, P59; Bloom DE, 2011, GLOBAL EC BURDEN NON; Bonita R, 2001, SURVEILLANCE RISK FA; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chadha SL, 1997, B WORLD HEALTH ORGAN, V75, P31; Cox W, 2012, PAKISTAN POPULATION; DAgostino RB, 1996, STROKE, V27, P1744, DOI 10.1161/01.STR.27.10.1744; Deurenberg-Yap M, 2000, INT J OBESITY, V24, P1011, DOI 10.1038/sj.ijo.0801353; Federal Bureau of Statistics-Pakistan, 2005, PAK DEM SURV; Federal Bureau of Statistics-Pakistan, 2011, PAK SOC LIV STAND ME; Fisher-Hoch SP, 2010, PREV CHRONIC DIS, V7; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Global Adult Tobacco Survey Collaborative Group, 2011, TOB QUEST SURV SUBS; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hajat C, 2010, PROG CARDIOVASC DIS, V53, P28, DOI 10.1016/j.pcad.2010.05.002; HAM E, 1973, ANN AM ACAD POLIT SS, P104; Hasan A, 2003, CASE KARACHI; Hoang Van Minh, 2007, Prev Chronic Dis, V4, pA22; Hyder AA, 2000, AM J PUBLIC HEALTH, V90, P1235, DOI 10.2105/AJPH.90.8.1235; Jafar TH, 2006, CAN MED ASSOC J, V175, P1071, DOI 10.1503/cmaj.060464; Jafar TH, 2004, DIABETIC MED, V21, P716, DOI 10.1111/j.1464-5491.2004.01140.x; Jafar TH, 2003, J HYPERTENSION, P21; Kannel W B, 2000, J Atheroscler Thromb, V6, P60; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Khan AN, 2012, INT ARAB J INF TECHN, V9, P9; Khowaja K, 2010, J PAK MED ASSOC, V60, P1035; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Lorenzo C, 2012, J CLIN ENDOCR METAB, V97, P793, DOI 10.1210/jc.2011-2272; Mahsud AZK, 2010, HUMAN SETTLEMENTS FO, P53; Mazahir S, 2006, SUBST ABUSE TREAT PR, V1, DOI 10.1186/1747-597X-1-10; McGee T, 2001, POPULATION TODAY, V29, P1; Ministry of Health, 1994, PAK NAT PLAN PREV BL; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Nanan D J, 2002, J Pak Med Assoc, V52, P342; National Institute of Population Studies Pakistan Macro International Inc., 2008, PAK DEM HLTH SURV 20; Ng N, 2006, B WORLD HEALTH ORGAN, V84, P305, DOI 10.2471/BLT.05.023721; Nishtar S, 2004, CURR MED RES OPIN, V20, P55, DOI 10.1185/030079903125002595; Nishtar S, 2010, J PAKISTAN MED ASS, P60; Nishtar S, 2011, LANCET, V378, P648, DOI 10.1016/S0140-6736(11)60606-5; Novak NL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-530; Organization WH, 2016, GLOBAL STATUS REPORT; ROSENBAUM PA, 1987, PEDIATRICS, V80, P807; Sayeed MA, 2003, DIABETES CARE, V26, P1034, DOI 10.2337/diacare.26.4.1034; Shera AS, 2007, DIABETES RES CLIN PR, V76, P219, DOI 10.1016/j.diabres.2006.08.011; Shetty PS, 2002, PUBLIC HEALTH NUTR, V5, P175, DOI 10.1079/PHN2001291; Singh RB, 1998, INT J CARDIOL, V66, P65, DOI 10.1016/S0167-5273(98)00141-7; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Thankappan KR, 2010, INDIAN J MED RES, V131, P53; World Health Organization, 2005, WHO STEPS SURV MAN W; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]; World Heath Organisation, 2003, WORLD HLTH SURV PAK	61	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56008	10.1371/journal.pone.0056008	http://dx.doi.org/10.1371/journal.pone.0056008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418493	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300085
J	Leonard, AS; Brent, J; Papaj, DR; Dornhaus, A				Leonard, Anne S.; Brent, Joshua; Papaj, Daniel R.; Dornhaus, Anna			Floral Nectar Guide Patterns Discourage Nectar Robbing by Bumble Bees	PLOS ONE			English	Article							IPOMOPSIS-AGGREGATA; EVOLUTION; POLLINATION; BEHAVIOR; PREFERENCE; SUCCESS; REDUCE; BIAS	Floral displays are under selection to both attract pollinators and deter antagonists. Here we show that a common floral trait, a nectar guide pattern, alters the behavior of bees that can act opportunistically as both pollinators and as antagonists. Generally, bees access nectar via the floral limb, transporting pollen through contact with the plant's reproductive structures; however bees sometimes extract nectar from a hole in the side of the flower that they or other floral visitors create. This behavior is called "nectar robbing" because bees may acquire the nectar without transporting pollen. We asked whether the presence of a symmetric floral nectar guide pattern on artificial flowers affected bumble bees' (Bombus impatiens) propensity to rob or access nectar "legitimately." We discovered that nectar guides made legitimate visits more efficient for bees than robbing, and increased the relative frequency of legitimate visits, compared to flowers lacking nectar guides. This study is the first to show that beyond speeding nectar discovery, a nectar guide pattern can influence bees' flower handling in a way that could benefit the plant.	[Leonard, Anne S.] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Brent, Joshua; Papaj, Daniel R.; Dornhaus, Anna] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Arizona	Leonard, AS (corresponding author), Univ Nevada, Dept Biol, Reno, NV 89557 USA.	anneleonard@unr.edu			University of Arizona Center for Insect Science through National Institutes of Health (NIH) [1K12 GM000708]; National Science Foundation (NSF) Grant [IOS-0921280]; University of Arizona Undergraduate Biology Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	University of Arizona Center for Insect Science through National Institutes of Health (NIH); National Science Foundation (NSF) Grant(National Science Foundation (NSF)); University of Arizona Undergraduate Biology Research Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Arizona Center for Insect Science through National Institutes of Health (NIH) Training Grant # 1K12 GM000708 and by National Science Foundation (NSF) Grant # IOS-0921280. J. Brent was supported by the University of Arizona Undergraduate Biology Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2005, ECOLOGY, V86, P2968, DOI 10.1890/05-0118; Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; [Anonymous], 2012, EVOLUTION PLANT POLL; Barth F. G., 1991, INSECTS FLOWERS BIOL; Biesmeijer JC, 2005, NATURWISSENSCHAFTEN, V92, P444, DOI 10.1007/s00114-005-0017-6; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Castro S, 2009, ECOL RES, V24, P47, DOI 10.1007/s11284-008-0481-5; Dafni A, 1997, BIOL REV, V72, P239, DOI 10.1017/S0006323196005002; Darwin C, 1892, EFFECTS CROSS SELF F; DAUMER K, 1958, Z VERGL PHYSIOL, V41, P49; Dedej S, 2005, BEHAV ECOL SOCIOBIOL, V57, P398, DOI 10.1007/s00265-004-0852-z; FREE J B, 1970, Behaviour, V37, P269, DOI 10.1163/156853970X00376; FREE JB, 1968, J APPL ECOL, V5, P631, DOI 10.2307/2401637; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; Goulson D., 2003, BUMBLEBEES BEHAV ECO; Gronquist M, 2001, P NATL ACAD SCI USA, V98, P13745, DOI 10.1073/pnas.231471698; Hansen DM, 2012, P ROY SOC B-BIOL SCI, V279, P634, DOI 10.1098/rspb.2011.1349; HEINRICH B, 1976, ECOL MONOGR, V46, P105, DOI 10.2307/1942246; Inouye D.W., 1983, P153; INOUYE DW, 1980, ECOLOGY, V61, P1251, DOI 10.2307/1936841; Irwin RE, 2004, ECOLOGY, V85, P1503, DOI 10.1890/03-0390; Irwin RE, 1999, ECOLOGY, V80, P1703; Irwin RE, 1998, OECOLOGIA, V116, P519, DOI 10.1007/s004420050617; Irwin RE, 2010, ANNU REV ECOL EVOL S, V41, P271, DOI 10.1146/annurev.ecolsys.110308.120330; Jersakova J, 2006, BIOL REV, V81, P219, DOI 10.1017/S1464793105006986; Kevan P. G., 1998, COLOR VISION PERSPEC, P163; Knuth P, 1893, BOTANISCHE CENTRALBL, V48, P160; LAVERTY TM, 1988, ANIM BEHAV, V36, P733, DOI 10.1016/S0003-3472(88)80156-8; Leadbeater E, 2008, P ROY SOC B-BIOL SCI, V275, P1669, DOI 10.1098/rspb.2008.0270; LEHRER M, 1995, PHILOS T R SOC B, V347, P123, DOI DOI 10.1098/rstb.1995.0017; Leonard AS, 2011, FUNCT ECOL, V25, P1293, DOI 10.1111/j.1365-2435.2011.01885.x; Lunau K, 2006, NATURWISSENSCHAFTEN, V93, P325, DOI 10.1007/s00114-006-0105-2; Lunau K, 2000, PLANT SYST EVOL, V222, P89, DOI 10.1007/BF00984097; Morris WF, 1996, ECOLOGY, V77, P1451, DOI 10.2307/2265542; Naug D, 2007, BIOL LETTERS, V3, P635, DOI 10.1098/rsbl.2007.0436; Navarro L, 2009, BIOL J LINN SOC, V96, P392, DOI 10.1111/j.1095-8312.2008.01146.x; Newman DA, 2005, OIKOS, V110, P309, DOI 10.1111/j.0030-1299.2005.13884.x; PENNY JHJ, 1983, NEW PHYTOL, V95, P707, DOI 10.1111/j.1469-8137.1983.tb03534.x; PYKE GH, 1981, BIOTROPICA, V13, P260, DOI 10.2307/2387804; Raine NE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000556; Raine NE, 2007, NATURWISSENSCHAFTEN, V94, P459, DOI 10.1007/s00114-006-0184-0; Richardson SC, 2004, OECOLOGIA, V139, P246, DOI 10.1007/s00442-004-1504-8; Schaefer HM, 2009, TRENDS ECOL EVOL, V24, P676, DOI 10.1016/j.tree.2009.06.006; Schiestl FP, 2010, TRENDS ECOL EVOL, V25, P382, DOI 10.1016/j.tree.2010.03.004; Schiestl FP, 2005, NATURWISSENSCHAFTEN, V92, P255, DOI 10.1007/s00114-005-0636-y; Shang YJ, 2011, NEW PHYTOL, V189, P602, DOI 10.1111/j.1469-8137.2010.03498.x; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Sprengel CK, 1793, ENTDECKE GEHEIMNISS; Stout JC, 2000, ACTA OECOL, V21, P277, DOI 10.1016/S1146-609X(00)01085-7; Strauss S.Y., 2006, ECOLOGY EVOLUTION FL, P120; WASER NM, 1985, OECOLOGIA, V67, P121, DOI 10.1007/BF00378462; Willmer P., 2011, POLLINATION FLORAL E; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	54	28	32	3	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55914	10.1371/journal.pone.0055914	http://dx.doi.org/10.1371/journal.pone.0055914			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418475	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300066
J	Pick, M; Azzola, L; Osborne, E; Stanley, EG; Elefanty, AG				Pick, Marjorie; Azzola, Lisa; Osborne, Elissa; Stanley, Edouard G.; Elefanty, Andrew G.			Generation of Megakaryocytic Progenitors from Human Embryonic Stem Cells in a Feeder- and Serum-Free Medium	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITORS; IN-VITRO; DIFFERENTIATION CULTURES; DEFINITIVE HEMATOPOIESIS; FUNCTIONAL PLATELETS; PERIPHERAL-BLOOD; MOUSE EMBRYO; CORD BLOOD; EXPRESSION; GROWTH	Background: The production of human platelets from embryonic stem cells in a defined culture system is a prerequisite for the generation of platelets for therapeutic use. As an important step towards this goal, we report the differentiation of human embryonic stem cells (hESCs) towards the megakaryocyte (Mk) lineage using a 'spin embryoid body' method in serum-free differentiation medium. Methodology and Principal Findings: Immunophenotypic analyses of differentiating hESC identified a subpopulation of cells expressing high levels of CD41a that expressed other markers associated with the Mk lineage, including CD110, CD42b and CD61. Differentiated cells were sorted on the basis of their expression of CD41a, CD34 and CD45 and assessed for Mk colony formation, expression of myeloid and Mk genes and ability to endoreplicate DNA. In a collagen-based colony assay, the CD41a(+) cells sorted from these differentiation cultures produced 100-800 Mk progenitors at day 13 and 25-160 Mk progenitors at day 20 of differentiation per 100,000 cells assayed. Differentiated Mk cells produced platelet-like particles which expressed CD42b and were activated by ADP, similar to platelets generated from precursors in cord blood. These studies were complemented by real time PCR analyses showing that subsets of cells enriched for CD41a(+) Mk precursors expressed high levels of Mk associated genes such as PF4 and MPL. Conversely, high levels of myeloid and erythroid related transcripts, such as GATA1, TAL1/SCL and PU.1, were detected in sorted fractions containing CD34(+) and CD45(+) cells. Conclusions: We describe a serum- and feeder-free culture system that enabled the generation of Mk progenitors from human embryonic stem cells. These cells formed colonies that included differentiated Mks that fragmented to form platelet-like particles. This protocol represents an important step towards the generation of human platelets for therapeutic use.	[Pick, Marjorie; Azzola, Lisa; Stanley, Edouard G.; Elefanty, Andrew G.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia; [Osborne, Elissa] Monash IVF, Monash Reprod Pathol & Genet, Clayton, Vic, Australia	Monash University	Pick, M (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Hematol, Jerusalem, Israel.	Marjorie@cc.huji.ac.il	Stanley, Ed G/A-2985-2013; Elefanty, Andrew G/A-6066-2008	Stanley, Ed G/0000-0002-6389-3665; Elefanty, Andrew/0000-0001-6448-8314	Australian Stem Cell Centre; Juvenile Diabetes Research Foundation; National Health and Medical Research Council (NHMRC) of Australia; Israel Cancer Research Fund (NY, USA); Stem Cells Australia	Australian Stem Cell Centre; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Israel Cancer Research Fund (NY, USA); Stem Cells Australia	This work was supported by research grants from the Australian Stem Cell Centre, Stem Cells Australia, the Juvenile Diabetes Research Foundation, the National Health and Medical Research Council (NHMRC) of Australia and by a Research Fellowship from the Israel Cancer Research Fund (NY, USA) to MP. AGE and EGS are Senior Research Fellows of the NHMRC. The funders had no role in study design, data collection and analysis, decision to publlsh or preparation of the manuscript.	Basch RS, 1999, BRIT J HAEMATOL, V105, P1044, DOI 10.1046/j.1365-2141.1999.01446.x; Berthier R, 1997, EXP HEMATOL, V25, P481; Costa M, 2005, NAT METHODS, V2, P259, DOI 10.1038/NMETH748; Costa Magdaline, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01c01s5; DEBILI N, 1995, BLOOD, V86, P2516; Dumon S, 2006, EXP HEMATOL, V34, P654, DOI 10.1016/j.exphem.2006.01.014; Elefanty AG, 1999, BLOOD, V94, P3754, DOI 10.1182/blood.V94.11.3754.423k05_3754_3763; Eto K, 2002, P NATL ACAD SCI USA, V99, P12819, DOI 10.1073/pnas.202380099; Feng R, 1998, BONE MARROW TRANSPL, V21, P1217, DOI 10.1038/sj.bmt.1701273; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Fujimoto TT, 2003, BLOOD, V102, P4044, DOI 10.1182/blood-2003-06-1773; Gaur M, 2006, J THROMB HAEMOST, V4, P436, DOI 10.1111/j.1538-7836.2006.01744.x; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Klimchenko O, 2009, BLOOD, V114, P1506, DOI 10.1182/blood-2008-09-178863; Lu SJ, 2011, CELL RES, V21, P530, DOI 10.1038/cr.2011.8; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Ng ES, 2008, NAT PROTOC, V3, P768, DOI 10.1038/nprot.2008.42; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Ruf A, 1997, BRIT J HAEMATOL, V98, P51, DOI 10.1046/j.1365-2141.1997.1502965.x; RYO R, 1980, THROMB RES, V17, P645, DOI 10.1016/0049-3848(80)90367-9; Schipper LF, 2012, STEM CELLS, V30, P988, DOI 10.1002/stem.1071; Schipper LF, 2003, EXP HEMATOL, V31, P324, DOI 10.1016/S0301-472X(03)00004-3; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Takayama N, 2010, J EXP MED, V207, P2817, DOI 10.1084/jem.20100844; Uzan G, 1996, Stem Cells, V14 Suppl 1, P194; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Yu QC, 2012, BLOOD, V119, P6243, DOI 10.1182/blood-2011-12-396093; Zambidis ET, 2008, BLOOD, V112, P3601, DOI 10.1182/blood-2008-03-144766; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	35	35	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55530	10.1371/journal.pone.0055530	http://dx.doi.org/10.1371/journal.pone.0055530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424635	Green Published, gold			2022-12-27	WOS:000315965100023
J	Fox, EJ; Baweja, HS; Kim, C; Kennedy, DM; Vaillancourt, DE; Christou, EA				Fox, Emily J.; Baweja, Harsimran S.; Kim, Changki; Kennedy, Deanna M.; Vaillancourt, David E.; Christou, Evangelos A.			Modulation of Force below 1 Hz: Age-Associated Differences and the Effect of Magnified Visual Feedback	PLOS ONE			English	Article							MOTOR UNIT DISCHARGE; CONSTANT ISOMETRIC CONTRACTIONS; OLDER-ADULTS; PARKINSONS-DISEASE; HAND MUSCLE; OUTPUT VARIABILITY; SYNAPTIC NOISE; GREATER AMOUNT; LOW-FREQUENCY; FLUCTUATIONS	Oscillations in force output change in specific frequency bins and have important implications for understanding aging and pathological motor control. Although previous studies have demonstrated that oscillations from 0-1 Hz can be influenced by aging and visuomotor processing, these studies have averaged power within this bandwidth and not examined power in specific frequencies below 1 Hz. The purpose was to determine whether a differential modulation of force below 1 Hz contributes to changes in force control related to manipulation of visual feedback and aging. Ten young adults (25+/-4 yrs, 5 men) and ten older adults (71+/-5 yrs, 4 men) were instructed to accurately match a target force at 2% of their maximal isometric force for 35 s with abduction of the index finger. Visual feedback was manipulated by changing the visual angle (0.05 degrees, 0.5 degrees, 1.5 degrees) or removing it after 15 s. Modulation of force below 1 Hz was quantified by examining the absolute and normalized power in seven frequency bins. Removal of visual feedback increased normalized power from 0-0.33 Hz and decreased normalized power from 0.66-1.0 Hz. In contrast, magnification of visual feedback (visual angles of 0.5 degrees and 1.5 degrees) decreased normalized power from 0-0.16 Hz and increased normalized power from 0.66-1.0 Hz. Older adults demonstrated a greater increase in the variability of force with magnification of visual feedback compared with young adults (P = 0.05). Furthermore, older adults exhibited differential force modulation of frequencies below 1 Hz compared with young adults (P<0.05). Specifically, older adults exhibited greater normalized power from 0-0.16 Hz and lesser normalized power from 0.66-0.83 Hz. The changes in force modulation predicted the changes in the variability of force with magnification of visual feedback (R-2=0.80). Our findings indicate that force oscillations below 1 Hz are associated with force control and are modified by aging and visual feedback.	[Fox, Emily J.; Baweja, Harsimran S.; Kim, Changki; Kennedy, Deanna M.; Vaillancourt, David E.; Christou, Evangelos A.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Christou, EA (corresponding author), Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA.	eachristou@hhp.ufl.edu		Fox, Emily/0000-0003-0142-3497	National Institutes of Health [R01-NS-058487, R01-NS-052318, R01-AG-031769]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052318, R01NS058487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health Grants R01-NS-058487 and R01-NS-052318 to DE Vaillancourt and R01-AG-031769 to EA Christou. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; AMZICA F, 1995, J NEUROPHYSIOL, V73, P20, DOI 10.1152/jn.1995.73.1.20; Baweja HS, 2011, HUM MOVEMENT SCI, V30, P1022, DOI 10.1016/j.humov.2010.09.007; Baweja HS, 2010, EUR J APPL PHYSIOL, V108, P935, DOI 10.1007/s00421-009-1301-5; Baweja HS, 2009, EXP BRAIN RES, V197, P35, DOI 10.1007/s00221-009-1883-5; CALVIN WH, 1968, J NEUROPHYSIOL, V31, P574, DOI 10.1152/jn.1968.31.4.574; Chao E.Y., 1989, BIOMECHANICS HAND BA; Christou EA, 2001, J GERONTOL A-BIOL, V56, pB524, DOI 10.1093/gerona/56.12.B524; Christou EA, 2005, MED SCI SPORT EXER, V37, P2126, DOI 10.1249/01.mss.0000178103.72988.cd; Christou EA, 2004, J APPL PHYSIOL, V97, P225, DOI 10.1152/japplphysiol.00066.2004; Christou EA, 2005, MOVEMENT SYSTEM VARI, P199; Christou EA, 2007, EXP BRAIN RES, V178, P285, DOI 10.1007/s00221-006-0739-5; Christou EA, 2011, EXERC SPORT SCI REV, V39, P77, DOI 10.1097/JES.0b013e31820b85ab; Coombes SA, 2010, J NEUROPHYSIOL, V103, P2114, DOI 10.1152/jn.00920.2009; Elble R, 2011, MOVEMENT DISORD, V26, P1096, DOI 10.1002/mds.23579; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hyngstrom AS, 2012, AM J PHYS MED REHAB, V91, P33, DOI 10.1097/PHM.0b013e31823caac0; Kennedy DM, 2011, EXP BRAIN RES, V213, P351, DOI 10.1007/s00221-011-2777-x; Keogh J, 2006, EUR J APPL PHYSIOL, V97, P76, DOI 10.1007/s00421-006-0151-7; Kim CK, 2011, NEUR M PLANN WASH DC; Kornatz KW, 2005, J APPL PHYSIOL, V98, P2072, DOI 10.1152/japplphysiol.01149.2004; Kouzaki M, 2010, MUSCLE NERVE, V42, P78, DOI 10.1002/mus.21599; Laidlaw DH, 2000, MUSCLE NERVE, V23, P600, DOI 10.1002/(SICI)1097-4598(200004)23:4<600::AID-MUS20>3.3.CO;2-4; Li S, 2007, NEUROSCI LETT, V412, P243, DOI 10.1016/j.neulet.2006.11.013; Matthews PBC, 1996, J PHYSIOL-LONDON, V492, P597, DOI 10.1113/jphysiol.1996.sp021332; Milham MP, 2002, BRAIN COGNITION, V49, P277, DOI 10.1006/brcg.2001.1501; Moritz CT, 2005, J NEUROPHYSIOL, V93, P2449, DOI 10.1152/jn.01122.2004; Mottram CJ, 2005, J NEUROPHYSIOL, V94, P2878, DOI 10.1152/jn.00390.2005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prakash RS, 2009, BRAIN COGNITION, V71, P328, DOI 10.1016/j.bandc.2009.07.005; Prodoehl J, 2006, J NEUROL NEUROSUR PS, V77, P909, DOI 10.1136/jnnp.2006.091363; Rassler B, 2000, CLIN NEUROPHYSIOL, V111, P2180, DOI 10.1016/S1388-2457(00)00483-1; Robichaud JA, 2005, MOVEMENT DISORD, V20, P441, DOI 10.1002/mds.20350; Salkind Neil J., 2002, USING SPSS WINDOWS M; Schmied A, 2000, EXP BRAIN RES, V133, P377, DOI 10.1007/s002210000421; Semmler JG, 2003, J NEUROPHYSIOL, V90, P1346, DOI 10.1152/jn.00941.2002; Slifkin AB, 2000, J NEUROPHYSIOL, V84, P1708, DOI 10.1152/jn.2000.84.4.1708; Sosnoff JJ, 2007, EXP AGING RES, V33, P399, DOI 10.1080/03610730701525311; Sosnoff JJ, 2006, EXP BRAIN RES, V170, P423, DOI 10.1007/s00221-005-0225-5; Taylor AM, 2003, J NEUROPHYSIOL, V90, P1350, DOI 10.1152/jn.00056.2003; Taylor AM, 2004, J COMPUT NEUROSCI, V16, P139, DOI 10.1023/B:JCNS.0000014107.16610.2e; Tracy BL, 2005, MUSCLE NERVE, V32, P533, DOI 10.1002/mus.20392; Tracy BL., 2009, ADV NEUROMUSCULAR PH, P39; Tracy BL, 2007, MED SCI SPORT EXER, V39, P469, DOI 10.1249/mss.0b013e31802d3ad3; Vaillancourt DE, 2006, EXP BRAIN RES, V173, P742, DOI 10.1007/s00221-006-0454-2; Vaillancourt DE, 2003, J APPL PHYSIOL, V94, P903, DOI 10.1152/japplphysiol.00166.2002; Vaillancourt DE, 2001, CLIN NEUROPHYSIOL, V112, P1594, DOI 10.1016/S1388-2457(01)00593-4; Vaillancourt DE, 2001, NEUROPSYCHOLOGIA, V39, P1410, DOI 10.1016/S0028-3932(01)00061-6; Westgaard RH, 2002, J NEUROPHYSIOL, V88, P1177, DOI 10.1152/jn.2002.88.3.1177	50	35	35	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55970	10.1371/journal.pone.0055970	http://dx.doi.org/10.1371/journal.pone.0055970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409099	Green Submitted, Green Published, gold			2022-12-27	WOS:000315100000035
J	Nicolo, C; Di Sante, G; Procoli, A; Migliara, G; Piermattei, A; Valentini, M; Delogu, G; Cittadini, A; Constantin, G; Ria, F				Nicolo, Chiara; Di Sante, Gabriele; Procoli, Annabella; Migliara, Giuseppe; Piermattei, Alessia; Valentini, Mariagrazia; Delogu, Giovanni; Cittadini, Achille; Constantin, Gabriela; Ria, Francesco			M tuberculosis in the Adjuvant Modulates Time of Appearance of CNS-Specific Effector T Cells in the Spleen through a Polymorphic Site of TLR2	PLOS ONE			English	Article							DENDRITIC CELLS; TOXOPLASMA-GONDII; RECEPTOR; ANTIGEN; LYMPHOCYTES; EXPRESSION; RESPONSES; DISTINCT; DISEASE; MICE	DC deliver information regulating trafficking of effector T cells along T-cell priming. However, the role of pathogen-derived motives in the regulation of movement of T cells has not been studied. We hereinafter report that amount of M tuberculosis in the adjuvant modulates relocation of PLP139-151 specific T cells. In the presence of a low dose of M tuberculosis in the adjuvant, T cells (detected by CDR3 BV-BJ spectratyping, the so-called "immunoscope'') mostly reach the spleen by day 28 after immunization ("late relocation'') in the SJL strain, whereas T cells reach the spleen by d 14 with a high dose of M tuberculosis ("early relocation''). The C57Bl/6 background confers a dominant "early relocation'' phenotype to F1 (SJLxC57Bl/6) mice, allowing early relocation of T cells in the presence of low dose M tuberculosis. A single non-synonymous polymorphism of TLR2 is responsible for "early/late'' relocation phenotype. Egress of T lymphocytes is regulated by TLR2 expressed on T cells. Thus, pathogens engaging TLR2 on T cells regulate directly T-cell trafficking, and polymorphisms of TLR2 condition T-cell trafficking upon a limiting concentration of ligand.	[Nicolo, Chiara; Di Sante, Gabriele; Migliara, Giuseppe; Piermattei, Alessia; Valentini, Mariagrazia; Cittadini, Achille; Ria, Francesco] Univ Cattolica Sacro Cuore, Inst Gen Pathol, Rome, Italy; [Delogu, Giovanni] Univ Cattolica Sacro Cuore, Inst Microbiol, Rome, Italy; [Procoli, Annabella] Univ Cattolica Sacro Cuore, Inst Gynecol, Rome, Italy; [Constantin, Gabriela] Univ Verona, Dept Pathol & Diagnost, Sect Gen Pathol, I-37100 Verona, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Verona	Ria, F (corresponding author), Univ Cattolica Sacro Cuore, Inst Gen Pathol, Rome, Italy.	fria@rm.unicatt.it	Delogu, Giovanni/I-3701-2012; Ria, Francesco/AAD-1174-2022; Di Sante, Gabriele/K-8629-2016; Di Sante, Gabriele/AHD-9850-2022; Di Sante, Gabriele/N-5294-2018; Di Sante, Gabriele/N-5280-2018; Migliara, Giuseppe/AAN-2138-2021	Delogu, Giovanni/0000-0003-0182-8267; Ria, Francesco/0000-0001-7455-4290; Di Sante, Gabriele/0000-0001-6608-3388; Di Sante, Gabriele/0000-0001-6608-3388; Di Sante, Gabriele/0000-0001-6608-3388; Di Sante, Gabriele/0000-0001-6608-3388; Constantin, Gabriela/0000-0001-8978-3539; Migliara, Giuseppe/0000-0002-4573-6025; piermattei, alessia/0000-0001-7164-4952	Fondazione Italiana Sclerosi Multipla (FISM) [28/2010/R]; PRIN from the Ministry of Education and Research (MIUR) [70103553]; European Research Council [261079]; Fondazione Cariverona	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); PRIN from the Ministry of Education and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); European Research Council(European Research Council (ERC)European Commission); Fondazione Cariverona(Fondazione Cariverona)	This work was supported by: Fondazione Italiana Sclerosi Multipla (FISM) grant Nr. 28/2010/R (FR); PRIN grant from the Ministry of Education and Research (MIUR) Nr. 70103553 (FR and GD); FP7 Program, European Research Council Grant 261079 "Neurotrafficking'' (GC); PRIN grant from the Ministry of Education and Research (MIUR) and Fondazione Cariverona (GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caetano BC, 2011, EUR J IMMUNOL, V41, P3627, DOI 10.1002/eji.201141876; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Cottalorda A, 2006, EUR J IMMUNOL, V36, P1684, DOI 10.1002/eji.200636181; Dudda JC, 2004, J IMMUNOL, V172, P857, DOI 10.4049/jimmunol.172.2.857; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; Guery JC, 1997, INT IMMUNOL, V9, P9, DOI 10.1093/intimm/9.1.9; Holley MM, 2012, J IMMUNOL, V188, P1360, DOI 10.4049/jimmunol.1101660; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Lech M, 2010, INT IMMUNOL, V22, P717, DOI 10.1093/intimm/dxq058; Ley K, 2005, NAT IMMUNOL, V6, P1215, DOI 10.1038/ni1205-1215; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Macagno A, 2007, TRENDS IMMUNOL, V28, P227, DOI 10.1016/j.it.2007.03.008; Mercier BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042170; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Morrison VL, 2010, J IMMUNOL, V185, P2737, DOI 10.4049/jimmunol.1000758; Nicolo C, 2006, INT IMMUNOL, V18, P363, DOI 10.1093/intimm/dxh376; Nyirenda MH, 2011, J IMMUNOL, V187, P2278, DOI 10.4049/jimmunol.1003715; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Penitente R, 2008, J IMMUNOL, V180, P6611, DOI 10.4049/jimmunol.180.10.6611; Petterson T, 2011, IMMUNOLOGY, V133, P84, DOI 10.1111/j.1365-2567.2011.03414.x; PIRCHER H, 1987, EUR J IMMUNOL, V17, P1843, DOI 10.1002/eji.1830171226; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Ria F, 2004, J IMMUNOL, V172, P3447, DOI 10.4049/jimmunol.172.6.3447; Ria F., 2001, Current Molecular Medicine (Hilversum), V1, P297, DOI 10.2174/1566524013363690; Ria F, 1998, EUR J IMMUNOL, V28, P2003, DOI 10.1002/(SICI)1521-4141(199806)28:06<2003::AID-IMMU2003>3.0.CO;2-S; Ria F, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2553; Rolla S, 2006, J IMMUNOL, V177, P7626, DOI 10.4049/jimmunol.177.11.7626; Shaw MH, 2009, NAT IMMUNOL, V10, P1267, DOI 10.1038/ni.1816; Stagg AJ, 2002, EUR J IMMUNOL, V32, P1445, DOI 10.1002/1521-4141(200205)32:5<1445::AID-IMMU1445>3.0.CO;2-E; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; TUOHY VK, 1989, J IMMUNOL, V142, P1523; Wrenshall L, 2003, SPRINGER SEMIN IMMUN, V25, P199, DOI 10.1007/s00281-003-0138-y; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	36	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55819	10.1371/journal.pone.0055819	http://dx.doi.org/10.1371/journal.pone.0055819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409051	Green Published, Green Submitted, gold			2022-12-27	WOS:000315100000024
J	Pruss, H; Rosche, B; Sullivan, AB; Brommer, B; Wengert, O; Gronert, K; Schwab, JM				Pruess, Harald; Rosche, Berit; Sullivan, Aaron B.; Brommer, Benedikt; Wengert, Oliver; Gronert, Karsten; Schwab, Jan M.			Proresolution Lipid Mediators in Multiple Sclerosis - Differential, Disease Severity-Dependent Synthesis - A Clinical Pilot Trial	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; INFLAMMATION; RESOLUTION	Background: The severity and longevity of inflammation is controlled by endogenous counter-regulatory signals. Among them are long-chain polyunsaturated fatty acid (PUFA)-derived lipid mediators, which promote the resolution of inflammation, an active process for returning to tissue homeostasis. Objective: To determine whether endogenous production of lipid-derived resolution agonists is regulated differentially in patients with highly active and less active multiple sclerosis (MS). Design: Matched-pairs study in University hospital Neurology department. Patients: Based on clinical (relapse frequency) and paraclinical (MRI lesions, contrast enhancement) criteria, 10 pairs of age- and sex-matched patients with relapsing-remitting MS were assigned either to a group with highly active or less active MS. Lipid mediators were quantified in serum and cerebrospinal fluid using LC-MS/MS-based lipidomics. Results: Levels of the key arachidonic (omega-6) and docosahexaenoic acid (omega-6)-derived mediators prostaglandins (PG), leukotrienes, hydroxyeicosatetraenoic acids (HETE) and resolution agonists lipoxin A(4) (LXA(4)), resolvin D1 (RvD1) and neuroprotectin D1 (NPD1) were quantified. In the patient group with highly active MS, 15-HETE and PGE(2) were increased, which are products of the 15-lipoxygenase and cyclooxygenase pathways. The proresolution mediator RvD1 was significantly upregulated and NPD1 was detected in the highly active group only. LXA(4) levels were not increased in patients with highly active MS. Conclusions: Lipid mediator pathways are regulated differentially in the cerebrospinal fluid of MS patients, depending on disease severity. Non-exhaustive or possibly 'delayed' resolution pathways may suggest a defective resolution program in patients with highly active MS. Longitudinal analyses are required to hetero-typify this differential resolution capacity, which may be associated with disease progression, longevity and eventual termination.	[Pruess, Harald; Rosche, Berit; Brommer, Benedikt; Wengert, Oliver; Schwab, Jan M.] Charite, Dept Neurol & Expt Neurol, D-13353 Berlin, Germany; [Sullivan, Aaron B.; Gronert, Karsten] Univ Calif Berkeley, Sch Optometry, Vis Sci Program, Berkeley, CA 94720 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Berkeley	Pruss, H (corresponding author), Charite, Dept Neurol & Expt Neurol, D-13353 Berlin, Germany.	harald.pruess@charite.de; jan.schwab@charite.de		Schwab, Jan/0000-0001-6784-4919	Berlin-Brandenburg Center for Regenerative Therapies (BCRT) [81717034]; Wings for Life Spinal Cord Research Foundation, Austria; National Institutes of Health [EY022208, EY016136]; Bayer-Schering; NATIONAL EYE INSTITUTE [R01EY022208, R01EY016136] Funding Source: NIH RePORTER	Berlin-Brandenburg Center for Regenerative Therapies (BCRT); Wings for Life Spinal Cord Research Foundation, Austria; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bayer-Schering(Bayer AG); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	JS is supported by the Berlin-Brandenburg Center for Regenerative Therapies (BCRT, #81717034) and the Wings for Life Spinal Cord Research Foundation, Austria (travel grant). The authors also acknowledge support from the National Institutes of Health (EY022208 and EY016136) to KG and from a restricted research grant covering some costs for laboratory material from "Bayer-Schering" to BR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad A, 2010, J NEUROIMMUNOL, V219, P1, DOI 10.1016/j.jneuroim.2009.09.002; BATES D, 1978, BMJ-BRIT MED J, V2, P1390, DOI 10.1136/bmj.2.6149.1390; Chiang N, 2004, P NATL ACAD SCI USA, V101, P15178, DOI 10.1073/pnas.0405445101; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Greco A, 1999, NEUROLOGY, V53, P1876, DOI 10.1212/WNL.53.8.1876; Hassan IR, 2009, J IMMUNOL, V182, P3223, DOI 10.4049/jimmunol.0802064; Leedom AJ, 2010, AM J PATHOL, V176, P74, DOI 10.2353/ajpath.2010.090678; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Morris T, 2010, P NATL ACAD SCI USA, V107, P8842, DOI 10.1073/pnas.1000373107; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Spite M, 2009, BRIT J PHARMACOL, V158, P1062, DOI 10.1111/j.1476-5381.2009.00234.x; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968	19	67	67	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55859	10.1371/journal.pone.0055859	http://dx.doi.org/10.1371/journal.pone.0055859			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409068	gold, Green Published, Green Submitted			2022-12-27	WOS:000314660300041
J	Papadakos, KS; Sougleri, IS; Mentis, AF; Hatziloukas, E; Sgouras, DN				Papadakos, Konstantinos S.; Sougleri, Ioanna S.; Mentis, Andreas F.; Hatziloukas, Efstathios; Sgouras, Dionyssios N.			Presence of Terminal EPIYA Phosphorylation Motifs in Helicobacter pylori CagA Contributes to IL-8 Secretion, Irrespective of the Number of Repeats	PLOS ONE			English	Article							NF-KAPPA-B; GASTRIC EPITHELIAL-CELLS; VIRULENCE FACTOR CAGA; PEPTIC-ULCER DISEASE; TYROSINE PHOSPHORYLATION; PATHOGENICITY ISLAND; VACA POLYMORPHISMS; EFFECTOR PROTEIN; IN-VITRO; KINASE	CagA protein contributes to pro-inflammatory responses during H. pylori infection, following its intracellular delivery to gastric epithelial cells. Here, we report for the first time in an isogenic background, on the subtle role of CagA phosphorylation on terminal EPIYA-C motifs in the transcriptional activation and expression of IL-8. We utilized isogenic H. pylori mutants of P12 reference strain, expressing CagA with varying number of EPIYA-C motifs and the corresponding phosphorylation defective EPIFA-C motifs while preserving intact the CM multimerization motifs. These mutants had been previously closely scrutinized in terms of type IV secretion system functionality, CagA translocation and its subsequent phosphorylation. Following infection of gastric epithelial cell lines, transcriptional activation of IL-8 gene and secreted IL-8 levels were found to be strictly dependent upon the functionality of the EPIYA-C phosphorylation motifs, as EPIFA-C phosphorylation-deficient CagA expression failed to induce full IL-8 transcriptional activity. Interestingly, levels of IL-8 gene activation and of secreted IL-8 were the same, irrespective of the number of EPIYA-C terminal repeats. We monitored IkB alpha phosphorylation and confirmed CagA involvement in NF-kB activation. Furthermore, we observed that presence of EPIYA-C functional phosphorylation motifs contributed to NF-kB activation. NF-kB upstream signaling events, such as early ERK1/2 and AKT activation were confirmed to be independent of EPIYA-C phosphorylation. On the contrary, use of TAK1 specific inhibitor 5Z-7-Oxozeaenol resulted in complete arrest of IL-8 secretion, in a dose-dependent manner, irrespective of CagA status. H. pylori-infected TAK1(-/-) mouse embryonic fibroblasts (MEFs) failed to induce NF-kB activity, unlike the respective control MEFs. CagA and TAK1 were found to immunoprecipitate together, irrespective of CagA EPIYA-C status, thus confirming earlier reports of TAK1 and CagA protein interaction. Our data suggest that CagA may potentially interfere with TAK1 activity during NF-kB activation for IL-8 induction in early H. pylori infection.	[Papadakos, Konstantinos S.; Sougleri, Ioanna S.; Mentis, Andreas F.; Sgouras, Dionyssios N.] Hellenic Pasteur Inst, Lab Med Microbiol, Athens, Greece; [Hatziloukas, Efstathios] Univ Ioannina, Dept Biol Applicat & Technol, Mol Biol Lab, GR-45110 Ioannina, Greece	University of Ioannina	Sgouras, DN (corresponding author), Hellenic Pasteur Inst, Lab Med Microbiol, Athens, Greece.	sgouras@pasteur.gr	Papadakos, Konstantinos/AAD-7417-2020; Sgouras, Dionyssios Nicholas/D-9943-2012	Sgouras, Dionyssios Nicholas/0000-0003-0975-2607; Papadakos, Konstantinos/0000-0001-5834-1447	Hellenic Pasteur Institute [HPI-922616]; ANR ERANET Pathogenomics [ANR-06-PATHO-007-01]	Hellenic Pasteur Institute; ANR ERANET Pathogenomics(French National Research Agency (ANR))	Study was supported mainly by a Hellenic Pasteur Institute grant (HPI-922616) and in part by ANR 2006 ERANET Pathogenomics ANR-06-PATHO-007-01. KSP was supported throughout his studies by a Hellenic Pasteur Institute Ph.D. studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Ando T, 1996, AM J GASTROENTEROL, V91, P1150; Argent RH, 2004, GASTROENTEROLOGY, V127, P514, DOI 10.1053/j.gastro.2004.06.006; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Ayers S, 2011, J NAT PROD, V74, P1126, DOI 10.1021/np200062x; Backert S, 2001, MOL MICROBIOL, V42, P631, DOI 10.1046/j.1365-2958.2001.02649.x; Backert S, 2010, TRENDS MICROBIOL, V18, P479, DOI 10.1016/j.tim.2010.08.003; Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; BLASER MJ, 1995, CANCER RES, V55, P2111; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; CRABTREE JE, 1994, J CLIN PATHOL, V47, P61, DOI 10.1136/jcp.47.1.61; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; GIONCHETTI P, 1994, AM J GASTROENTEROL, V89, P883; Gobert AP, 2013, CELL MICROBIOL, V15, P145, DOI 10.1111/cmi.12039; Gorrell RJ, 2013, CELL MICROBIOL, V15, P554, DOI 10.1111/cmi.12055; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2008, ONCOGENE, V27, P7047, DOI 10.1038/onc.2008.353; Hatakeyama M, 2006, INT J HEMATOL, V84, P301, DOI 10.1532/IJH97.06166; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lamb A, 2010, GUT MICROBES, V1, P109, DOI 10.4161/gmic.1.2.11587; Lamb A, 2009, EMBO REP, V10, P1242, DOI 10.1038/embor.2009.210; Lesouhaitier O, 2001, ENDOCRINOLOGY, V142, P4320, DOI 10.1210/en.142.10.4320; Maeda S, 2001, J BIOL CHEM, V276, P44856, DOI 10.1074/jbc.M105381200; Merlin J, 2010, CELL SIGNAL, V22, P1104, DOI 10.1016/j.cellsig.2010.03.004; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Mueller D, 2012, J CLIN INVEST, V122, P1553, DOI 10.1172/JCI61143; Nagy TA, 2009, J INFECT DIS, V199, P641, DOI 10.1086/596660; Nesic D, 2010, NAT STRUCT MOL BIOL, V17, P130, DOI 10.1038/nsmb.1705; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Nomura AMY, 2002, AM J EPIDEMIOL, V155, P1054, DOI 10.1093/aje/155.11.1054; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Pachathundikandi SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019614; Panayotopoulou EG, 2010, J CLIN MICROBIOL, V48, P2237, DOI 10.1128/JCM.00662-10; Papadakos KS, 2013, HELICOBACTER, V18, P229, DOI 10.1111/hel.12029; Peek RM, 1995, LAB INVEST, V73, P760; Pera T, 2011, AM J PHYSIOL-LUNG C, V301, pL822, DOI 10.1152/ajplung.00017.2011; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Sgouras DN, 2009, J CLIN MICROBIOL, V47, P2426, DOI 10.1128/JCM.00159-09; SHARMA SA, 1995, INFECT IMMUN, V63, P1681, DOI 10.1128/IAI.63.5.1681-1687.1995; SOBALA GM, 1991, GUT, V32, P1415, DOI 10.1136/gut.32.11.1415; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; van Vliet AHM, 1998, J BACTERIOL, V180, P5291, DOI 10.1128/JB.180.20.5291-5298.1998; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Wang Z, 2011, MOL VIS, V17, P3137; Wei JX, 2010, GASTROENTEROLOGY, V139, P1333, DOI 10.1053/j.gastro.2010.06.018; Witherell HL, 1997, J INFECT DIS, V176, P1641, DOI 10.1086/517346	60	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56291	10.1371/journal.pone.0056291	http://dx.doi.org/10.1371/journal.pone.0056291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409168	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200128
J	Plovanich, M; Bogorad, RL; Sancak, Y; Kamer, KJ; Strittmatter, L; Li, AA; Girgis, HS; Kuchimanchi, S; De Groot, J; Speciner, L; Taneja, N; Oshea, J; Koteliansky, V; Mootha, VK				Plovanich, Molly; Bogorad, Roman L.; Sancak, Yasemin; Kamer, Kimberli J.; Strittmatter, Laura; Li, Andrew A.; Girgis, Hany S.; Kuchimanchi, Satya; De Groot, Jack; Speciner, Lauren; Taneja, Nathan; Oshea, Jonathan; Koteliansky, Victor; Mootha, Vamsi K.			MICU2, a Paralog of MICU1, Resides within the Mitochondrial Uniporter Complex to Regulate Calcium Handling	PLOS ONE			English	Article							RAT KIDNEY MITOCHONDRIA; CA2+ UPTAKE; ESSENTIAL COMPONENT; RNAI THERAPEUTICS; RESPIRATION; METABOLISM; DELIVERY; PROTEIN; MCU; OSCILLATIONS	Mitochondrial calcium uptake is present in nearly all vertebrate tissues and is believed to be critical in shaping calcium signaling, regulating ATP synthesis and controlling cell death. Calcium uptake occurs through a channel called the uniporter that resides in the inner mitochondrial membrane. Recently, we used comparative genomics to identify MICU1 and MCU as the key regulatory and putative pore-forming subunits of this channel, respectively. Using bioinformatics, we now report that the human genome encodes two additional paralogs of MICU1, which we call MICU2 and MICU3, each of which likely arose by gene duplication and exhibits distinct patterns of organ expression. We demonstrate that MICU1 and MICU2 are expressed in HeLa and HEK293T cells, and provide multiple lines of biochemical evidence that MCU, MICU1 and MICU2 reside within a complex and cross-stabilize each other's protein expression in a cell-type dependent manner. Using in vivo RNAi technology to silence MICU1, MICU2 or both proteins in mouse liver, we observe an additive impairment in calcium handling without adversely impacting mitochondrial respiration or membrane potential. The results identify MICU2 as a new component of the uniporter complex that may contribute to the tissue-specific regulation of this channel.	[Plovanich, Molly; Sancak, Yasemin; Kamer, Kimberli J.; Strittmatter, Laura; Li, Andrew A.; Girgis, Hany S.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Plovanich, Molly; Sancak, Yasemin; Kamer, Kimberli J.; Strittmatter, Laura; Li, Andrew A.; Girgis, Hany S.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Plovanich, Molly; Sancak, Yasemin; Kamer, Kimberli J.; Strittmatter, Laura; Li, Andrew A.; Girgis, Hany S.; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Plovanich, Molly; Sancak, Yasemin; Kamer, Kimberli J.; Strittmatter, Laura; Li, Andrew A.; Girgis, Hany S.; Mootha, Vamsi K.] Broad Inst, Cambridge, MA USA; [Bogorad, Roman L.; Koteliansky, Victor] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Kuchimanchi, Satya; De Groot, Jack; Speciner, Lauren; Taneja, Nathan; Oshea, Jonathan] Alnylam Pharmaceut Inc, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Mootha, VK (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	vamsi@hms.harvard.edu		Kamer, Kimberli/0000-0001-8728-7793; Li, Andrew/0000-0002-1295-8115	National Institutes of Health [GM0077465, DK080261]; Alnylam; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alnylam; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM0077465, DK080261) awarded to VKM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Please note that in this paper, the authors' academic laboratory (based at Massachusetts General Hospital/Harvard Medical School) collaborated with Alnylam Pharmaceuticals (co-authors include JDG, L. Speciner, NT, JO, VK). As employees, they received compensation/stock from Alnylam. The authors do not believe that the fact that they are employees of a company, receiving salary/equity from this company, represents a competing interest that compromises the objectivity of the work. This does not alter the authors' adherence to all the PLOS ONE policies on data sharing and materials.	Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Alam MR, 2012, J BIOL CHEM, V287, P34445, DOI 10.1074/jbc.M112.392084; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bick AG, 2012, SCIENCE, V336, P886, DOI 10.1126/science.1214977; Brini M, 1999, MICROSC RES TECHNIQ, V46, P380, DOI 10.1002/(SICI)1097-0029(19990915)46:6<380::AID-JEMT6>3.0.CO;2-Y; CARAFOLI E, 1971, BIOCHEM J, V122, P681, DOI 10.1042/bj1220681; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; DENTON R M, 1980, Biochemical Society Transactions, V8, P266; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; Kaftan EJ, 2000, J BIOL CHEM, V275, P25465, DOI 10.1074/jbc.M000903200; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; VASINGTON FD, 1972, BIOCHIM BIOPHYS ACTA, V256, P43, DOI 10.1016/0005-2728(72)90161-2	32	302	312	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55785	10.1371/journal.pone.0055785	http://dx.doi.org/10.1371/journal.pone.0055785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409044	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200064
J	Blansky, D; Kavanaugh, C; Boothroyd, C; Benson, B; Gallagher, J; Endress, J; Sayama, H				Blansky, Deanna; Kavanaugh, Christina; Boothroyd, Cara; Benson, Brianna; Gallagher, Julie; Endress, John; Sayama, Hiroki			Spread of Academic Success in a High School Social Network	PLOS ONE			English	Article								Application of social network analysis to education has revealed how social network positions of K-12 students correlate with their behavior and academic achievements. However, no study has been conducted on how their social network influences their academic progress over time. Here we investigated correlations between high school students' academic progress over one year and the social environment that surrounds them in their friendship network. We found that students whose friends' average GPA (Grade Point Average) was greater (or less) than their own had a higher tendency toward increasing (or decreasing) their academic ranking over time, indicating social contagion of academic success taking place in their social network.	[Blansky, Deanna; Kavanaugh, Christina; Boothroyd, Cara; Benson, Brianna; Gallagher, Julie; Endress, John] Maine Endwell High Sch, Endwell, NY USA; [Sayama, Hiroki] SUNY Binghamton, Binghamton, NY 13902 USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Sayama, H (corresponding author), SUNY Binghamton, Binghamton, NY 13902 USA.	sayama@binghamton.edu	Sayama, Hiroki/GQH-1782-2022	Sayama, Hiroki/0000-0002-2670-5864; Blansky, Deanna/0000-0003-2633-7667	US National Science Foundation [1027752]; Direct For Education and Human Resources [1139478] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Direct For Education and Human Resources(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	This material is based upon work supported by the US National Science Foundation under Grant No. 1027752. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Add Health Data, 1994, ADD HLTH DATA; [Anonymous], [No title captured]; Bishop N, 2009, 2009 ANN M AM SOC AS; Boothroyd C, 2011, NETSCI 2011 INT SCH; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Coronges K, 2011, ADDICT BEHAV, V36, P1305, DOI 10.1016/j.addbeh.2011.07.008; Eagle N, 2011, HDB EMERGENT TECHNOL; Farmer TW, 1996, SOC DEV, V5, P174, DOI 10.1111/j.1467-9507.1996.tb00079.x; Fryer RG, 2010, J PUBLIC ECON, V94, P380, DOI 10.1016/j.jpubeco.2009.10.011; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Iyengar R, 2011, MARKET SCI, V30, P195, DOI 10.1287/mksc.1100.0566; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478	15	23	25	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55944	10.1371/journal.pone.0055944	http://dx.doi.org/10.1371/journal.pone.0055944			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418483	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300075
J	Li, YR; Ma, WX; Che, YZ; Zou, LF; Zakria, M; Zou, HS; Chen, GY				Li, Yu-Rong; Ma, Wen-Xiu; Che, Yi-Zhou; Zou, Li-Fang; Zakria, Muhammad; Zou, Hua-Song; Chen, Gong-You			A Highly-Conserved Single-Stranded DNA-Binding Protein in Xanthomonas Functions as a Harpin-Like Protein to Trigger Plant Immunity	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; SYRINGAE PV. PHASEOLICOLA; HYPERSENSITIVE RESPONSE; INNATE IMMUNITY; GENOME SEQUENCE; SALICYLIC-ACID; CELL-DEATH; TRANSCRIPTION FACTORS; DISEASE RESISTANCE; ERWINIA-AMYLOVORA	Harpins are produced by Gram-negative phytopathogenic bacteria and typically elicit hypersensitive response (HR) in non-host plants. The characterization of harpins in Xanthomonas species is largely unexplored. Here we demonstrate that Xanthomonas produce a highly conserved single-stranded DNA-binding protein (SSBX) that elicits HR in tobacco as by harpin Hpa1. SSBX, like Hpa1, is an acidic, glycine-rich, heat-stable protein that lacks cysteine residues. SSBX-triggered HR in tobacco, as by Hpa1, is characterized by the oxidative burst, the expression of HR markers (HIN1, HSR203J), pathogenesis-related genes, and callose deposition. Both SSBX-and Hpa1-induced HRs can be inhibited by general metabolism inhibitors actinomycin D, cycloheximide, and lanthanum chloride. Furthermore, those HRs activate the expression of BAK1 and BIK1 genes that are essential for induction of mitogen-activated protein kinase (MAPK) and salicylic acid pathways. Once applied to plants, SSBX induces resistance to the fungal pathogen Alternaria alternata and enhances plant growth. When ssb(X) was deleted in X. oryzae pv. oryzicola, the causal agent of bacterial leaf streak in rice, the resulting ssb(Xoc) mutant was reduced in virulence and bacterial growth in planta, but retained its ability to trigger HR in tobacco. Interestingly, ssbXoc contains an imperfect PIP-box (plant-inducible promoter) and the expression of ssb(Xoc) is regulated by HrpX, which belongs to the AraC family of transcriptional activators. Immunoblotting evidence showed that SSBx secretion requires a functional type-III secretion system as Hpa1 does. This is the first report demonstrating that Xanthomonas produce a highly-conserved SSBX that functions as a harpin-like protein for plant immunity.	[Li, Yu-Rong; Ma, Wen-Xiu; Che, Yi-Zhou; Zou, Li-Fang; Zakria, Muhammad; Zou, Hua-Song; Chen, Gong-You] Shanghai Jiao Tong Univ, Key Lab Urban South, Minist Agr China, Sch Agr & Biol, Shanghai 200030, Peoples R China	Ministry of Agriculture & Rural Affairs; Shanghai Jiao Tong University	Zou, HS (corresponding author), Shanghai Jiao Tong Univ, Key Lab Urban South, Minist Agr China, Sch Agr & Biol, Shanghai 200030, Peoples R China.	hszou@sjtu.edu.cn; gyouchen@sjtu.edu.cn	CHEN, Gongyou/AAA-9694-2019; Zou, Huasong/GLN-3569-2022	CHEN, Gongyou/0000-0003-1979-2880; Zou, Huasong/0000-0001-5758-1975	National Natural Science Foundation of China [31230059, 31071656, 31171832]; State Key Basic Research and Development Project of China [2012CB114003]; Key Basic Research Project of the Shanghai Committee of Science and Technology [11JC1406300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research and Development Project of China(State Key Development Program for Basic Research of China); Key Basic Research Project of the Shanghai Committee of Science and Technology	This work was supported by grants from the National Natural Science Foundation of China (31230059 and 31071656 to GC and 31171832 to HZ), the State Key Basic Research and Development Project of China (2012CB114003), and the Key Basic Research Project of the Shanghai Committee of Science and Technology (11JC1406300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu ME, 2009, J EXP BOT, V60, P1261, DOI 10.1093/jxb/ern363; Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; Ahmad M, 2001, MOL PLANT MICROBE IN, V14, P1223, DOI 10.1094/MPMI.2001.14.10.1223; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Altenbach D, 2007, MOL PLANT MICROBE IN, V20, P1031, DOI 10.1094/MPMI-20-9-1031; ARLAT M, 1994, EMBO J, V13, P543, DOI 10.1002/j.1460-2075.1994.tb06292.x; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Block A, 2011, CURR OPIN MICROBIOL, V14, P39, DOI 10.1016/j.mib.2010.12.011; Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; Charkowski AO, 1998, J BACTERIOL, V180, P5211, DOI 10.1128/JB.180.19.5211-5217.1998; Che Yi-Zhou, 2011, Microb Biotechnol, V4, P777, DOI 10.1111/j.1751-7915.2011.00281.x; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Collmer A, 2002, TRENDS MICROBIOL, V10, P462, DOI 10.1016/S0966-842X(02)02451-4; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Danna CH, 2011, P NATL ACAD SCI USA, V108, P9286, DOI 10.1073/pnas.1106366108; Danon A, 2000, PLANT PHYSIOL BIOCH, V38, P647, DOI 10.1016/S0981-9428(00)01178-5; DEFEYTER R, 1990, GENE, V88, P65, DOI 10.1016/0378-1119(90)90060-5; Dong HP, 2004, PLANT PHYSIOL, V136, P3628, DOI 10.1104/pp.104.048900; Dong HS, 1999, PLANT J, V20, P207, DOI 10.1046/j.1365-313x.1999.00595.x; DOW JM, 1990, APPL ENVIRON MICROB, V56, P2994, DOI 10.1128/AEM.56.10.2994-2998.1990; Durner J, 1997, TRENDS PLANT SCI, V2, P266, DOI 10.1016/S1360-1385(97)86349-2; Engelhardt S, 2009, PLANT J, V57, P706, DOI 10.1111/j.1365-313X.2008.03723.x; Fedorov R, 2006, NUCLEIC ACIDS RES, V34, P6708, DOI 10.1093/nar/gkl1002; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FELIX G, 1993, PLANT J, V4, P307, DOI 10.1046/j.1365-313X.1993.04020307.x; Furutani A, 2006, FEMS MICROBIOL LETT, V259, P133, DOI 10.1111/j.1574-6968.2006.00265.x; Furutani A, 2009, MOL PLANT MICROBE IN, V22, P96, DOI 10.1094/MPMI-22-1-0096; Gimenez-Ibanez S, 2010, MICROBES INFECT, V12, P428, DOI 10.1016/j.micinf.2010.03.002; Gopalan S, 1996, PLANT J, V10, P591, DOI 10.1046/j.1365-313X.1996.10040591.x; Haapalainen M, 2011, MOL PLANT PATHOL, V12, P151, DOI 10.1111/j.1364-3703.2010.00655.x; HE SY, 1993, CELL, V73, P1255, DOI 10.1016/0092-8674(93)90354-S; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; JEFFERSON RA, 1987, EMBO J, V6, P3901; Johnsen K, 1999, FEMS MICROBIOL LETT, V173, P155, DOI 10.1111/j.1574-6968.1999.tb13497.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kim CY, 2004, PLANT J, V38, P142, DOI 10.1111/j.1365-313X.2004.02033.x; Kim JF, 1998, J BACTERIOL, V180, P5203, DOI 10.1128/JB.180.19.5203-5210.1998; Kim JG, 2003, J BACTERIOL, V185, P3155, DOI 10.1128/JB.185.10.3155-3166.2003; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kvitko BH, 2007, J BACTERIOL, V189, P8059, DOI 10.1128/JB.01146-07; Tondo ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010803; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JG, 2010, MOL PLANT PATHOL, V11, P371, DOI [10.1111/j.1364-3703.2010.00610.x, 10.1111/J.1364-3703.2010.00610.X]; Li YR, 2011, MOL PLANT MICROBE IN, V24, P1086, DOI 10.1094/MPMI-09-10-0205; Li YR, 2011, APPL ENVIRON MICROB, V77, P3809, DOI 10.1128/AEM.02849-10; Li YR, 2012, ARCH MICROBIOL, V194, P281, DOI 10.1007/s00203-011-0758-x; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Mei CS, 2006, MOL PLANT MICROBE IN, V19, P1127, DOI 10.1094/MPMI-19-1127; Menke FLH, 2005, MOL PLANT MICROBE IN, V18, P1027, DOI 10.1094/MPMI-18-1027; Mersmann S, 2010, PLANT PHYSIOL, V154, P391, DOI 10.1104/pp.110.154567; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Oh CS, 2007, PLANT PHYSIOL, V145, P426, DOI 10.1104/pp.107.103432; Oh J, 2007, J BIOL CHEM, V282, P13601, DOI 10.1074/jbc.M602576200; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Pontier D, 1998, MOL PLANT MICROBE IN, V11, P544, DOI 10.1094/MPMI.1998.11.6.544; Postel S, 2009, SEMIN CELL DEV BIOL, V20, P1025, DOI 10.1016/j.semcdb.2009.06.002; PRESTON G, 1995, MOL PLANT MICROBE IN, V8, P717, DOI 10.1094/MPMI-8-0717; Reboutier D, 2007, MOL PLANT MICROBE IN, V20, P94, DOI 10.1094/MPMI-20-0094; Reboutier D, 2008, PLANT SIGNAL BEHAV, V3, P314, DOI 10.4161/psb.3.5.5304; Robatzek S, 2007, PLANT MOL BIOL, V64, P539, DOI 10.1007/s11103-007-9173-8; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Sambrook J., 2001, MOL CLONING LAB MANU; Samuel MA, 2005, PLANT J, V42, P406, DOI 10.1111/j.1365-313X.2005.02382.x; Schwessinger B, 2012, ANNU REV PLANT BIOL, V63, P451, DOI 10.1146/annurev-arplant-042811-105518; Sharma PC, 2003, MOL GENET GENOMICS, V269, P583, DOI 10.1007/s00438-003-0872-9; Studholme DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-395; Taguchi F, 2003, PLANT CELL PHYSIOL, V44, P342, DOI 10.1093/pcp/pcg042; Taguchi F, 2006, CELL MICROBIOL, V8, P923, DOI 10.1111/j.1462-5822.2005.00674.x; Taguchi F, 2010, MICROBIOL-SGM, V156, P72, DOI 10.1099/mic.0.030700-0; Takahashi Y, 2004, PLANT J, V40, P586, DOI 10.1111/j.1365-313X.2004.02234.x; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Tsuge S, 2005, J BACTERIOL, V187, P2308, DOI 10.1128/JB.187.7.2308-2314.2005; Upton JP, 2007, CELL DEATH DIFFER, V14, P932, DOI 10.1038/sj.cdd.4402092; van Wees SCM, 2003, PLANT J, V33, P733, DOI 10.1046/j.1365-313X.2003.01665.x; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang YinPeng, 2009, Acta Phytopathologica Sinica, V39, P392; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Xiao You-lun, 2007, Weishengwu Xuebao, V47, P396; Yang SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013472; Yap MN, 2006, J BACTERIOL, V188, P2280, DOI 10.1128/JB.188.6.2280-2284.2006; Yeam I, 2010, PLANT J, V61, P16, DOI 10.1111/j.1365-313X.2009.04028.x; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zou LF, 2006, APPL ENVIRON MICROB, V72, P6212, DOI 10.1128/AEM.00511-06; Zou LF, 2011, AGR SCI CHINA, V10, P1139, DOI 10.1016/S1671-2927(11)60104-1	99	10	14	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56240	10.1371/journal.pone.0056240	http://dx.doi.org/10.1371/journal.pone.0056240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418541	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300134
J	Lightwood, J; Glantz, SA				Lightwood, James; Glantz, Stanton A.			The Effect of the California Tobacco Control Program on Smoking Prevalence, Cigarette Consumption, and Healthcare Costs: 1989-2008	PLOS ONE			English	Article							INTERMITTENT SMOKING; UNITED-STATES; CONSEQUENCES; DEMAND; MEDIA; LIGHT	Background: Previous research has shown that tobacco control funding in California has reduced per capita cigarette consumption and per capita healthcare expenditures. This paper refines our earlier model by estimating the effect of California tobacco control funding on current smoking prevalence and cigarette consumption per smoker and the effect of prevalence and consumption on per capita healthcare expenditures. The results are used to calculate new estimates of the effect of the California Tobacco Program. Methodology/Principal Findings: Using state-specific aggregate data, current smoking prevalence and cigarette consumption per smoker are modeled as functions of cumulative California and control states' per capita tobacco control funding, cigarette price, and per capita income. Per capita healthcare expenditures are modeled as a function of prevalence of current smoking, cigarette consumption per smoker, and per capita income. One additional dollar of cumulative per capita tobacco control funding is associated with reduction in current smoking prevalence of 0.0497 (SE.00347) percentage points and current smoker cigarette consumption of 1.39 (SE.132) packs per smoker per year. Reductions of one percentage point in current smoking prevalence and one pack smoked per smoker are associated with $35.4 (SE $9.85) and $3.14 (SE.786) reductions in per capita healthcare expenditure, respectively (2010 dollars), using the National Income and Product Accounts (NIPA) measure of healthcare spending. Conclusions/Significance: Between FY 1989 and 2008 the California Tobacco Program cost $2.4 billion and led to cumulative NIPA healthcare expenditure savings of $134 (SE $30.5) billion.	[Lightwood, James] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA; [Lightwood, James] Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA; [Glantz, Stanton A.] Univ Calif San Francisco, Dept Med Cardiol, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA; [Glantz, Stanton A.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lightwood, J (corresponding author), Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA.	lightwoodj@pharmacy.ucsf.edu			California Tobacco-Related Disease Research Program [18ST-0201]; National Cancer Institute Grant [CA-61021]; NATIONAL CANCER INSTITUTE [R01CA061021] Funding Source: NIH RePORTER	California Tobacco-Related Disease Research Program(University of California System); National Cancer Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by California Tobacco-Related Disease Research Program. Grant 18ST-0201 and National Cancer Institute Grant CA-61021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746; Bala M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004704.pub2; Baltagi BH, 2010, ECON MODEL, V27, P804, DOI 10.1016/j.econmod.2009.12.001; Bjartveit K, 2005, TOB CONTROL, V14, P315, DOI 10.1136/tc.2005.011932; Bureau of Labor Statistics, 2011, CONS PRIC IND ALL UR; Burton A, 2011, ENVIRON HEALTH PERSP, V119, pA71; Centers for Medicare and Medicaid Services, 2011, HLTH EXP STAT PROV 1; Centers for Medicare and Medicaid Services, 2011, STAT HLTH EXP ACC ST; Centers for Medicare and Medicaid Services (CMS), 2011, HLTH SPEND STAT RES; Chattopahdyay S, 2011, CONTEMP ECON POLICY, V30, P430; Crystal Ball, 2010, CRYST BALL REL 11 1; Doornik J, 2009, EMPIRICAL ECONOMETRI, VI; Durkin S, 2012, TOB CONTROL, V21, P127, DOI 10.1136/tobaccocontrol-2011-050345; Enders W, 2008, APPL ECONOMETRIC TIM; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Gallet CA, 2003, HEALTH ECON, V12, P821, DOI 10.1002/hec.765; Gallet CA, 2004, J EC FINANCE, V28, P404; HU TW, 1995, HEALTH ECON, V4, P7, DOI 10.1002/hec.4730040102; KEELER TE, 1993, J HEALTH ECON, V12, P1, DOI 10.1016/0167-6296(93)90037-F; Korhonen T, 2009, NICOTINE TOB RES, V11, P148, DOI 10.1093/ntr/ntn023; Kornfeld R, 2011, NAT EC ACC DAT US C, P1; Kourogenis K, 2005, IRRELEVANT HIGHLY PE; Lightwood J, 2011, SOC SCI MED, V72, P166, DOI 10.1016/j.socscimed.2010.11.015; Lightwood JM, 2008, PLOS MED, V5, P1214, DOI 10.1371/journal.pmed.0050178; Luoto R, 2000, Nicotine Tob Res, V2, P133, DOI 10.1080/713688127; Maddala GS, 1998, UNIT ROOTS COINTEGRA, DOI 10.1017/CBO9780511751974; Marlow ML, 2008, APPL ECON, V40, P831, DOI 10.1080/00036840600771098; Max W, 2012, TOB CONTROL IN PRESS; McAlister A, 2004, J HEALTH COMMUN, V9, P95, DOI 10.1080/10810730490425231; Oxmetrics, 2010, OXM 6 10; PHILLIPS PCB, 1990, REV ECON STUD, V57, P99, DOI 10.2307/2297545; Phillips PCB, 2006, OPTIMAL ESTIMATION C; Pierce JP, 2011, JAMA-J AM MED ASSOC, V305, P1106, DOI 10.1001/jama.2011.334; Pierce JP, 1998, JAMA-J AM MED ASSOC, V280, P893, DOI 10.1001/jama.280.10.893; ROSENGREN A, 1992, J INTERN MED, V231, P357, DOI 10.1111/j.1365-2796.1992.tb00944.x; Schane RE, 2010, CIRCULATION, V121, P1518, DOI 10.1161/CIRCULATIONAHA.109.904235; Siegel M, 2002, ANNU REV PUBL HEALTH, V23, P45, DOI 10.1146/annurev.publhealth.23.092601.095916; Simmons MS, 2005, EUR RESPIR J, V25, P1011, DOI 10.1183/09031936.05.00086804; StataCorp LP, 2011, STAT VERS 12; Tan CE, 2012, CIRCULATION, V126, P2177, DOI 10.1161/CIRCULATIONAHA.112.121301; Tverdal A, 2006, TOB CONTROL, V15, P472, DOI 10.1136/tc.2006.016246; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; Warner KE, 1999, TOB CONTROL, V8, P290, DOI 10.1136/tc.8.3.290	43	45	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e47145	10.1371/journal.pone.0047145	http://dx.doi.org/10.1371/journal.pone.0047145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418411	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300001
J	Nestorov, P; Battke, F; Levesque, MP; Gerberding, M				Nestorov, Peter; Battke, Florian; Levesque, Mitchell P.; Gerberding, Matthias			The Maternal Transcriptome of the Crustacean Parhyale hawaiensis Is Inherited Asymmetrically to Invariant Cell Lineages of the Ectoderm and Mesoderm	PLOS ONE			English	Article							AMPHIPOD CRUSTACEAN; EARLY EMBRYOS; EXPRESSION; LOCALIZATION; AXIS; ARTHROPODS; EVOLUTION; PROTEINS; REVEALS; PATTERN	Background: The embryo of the crustacean Parhyale hawaiensis has a total, unequal and invariant early cleavage pattern. It specifies cell fates earlier than other arthropods, including Drosophila, as individual blastomeres of the 8-cell stage are allocated to the germ layers and the germline. Furthermore, the 8-cell stage is amenable to embryological manipulations. These unique features make Parhyale a suitable system for elucidating germ layer specification in arthropods. Since asymmetric localization of maternally provided RNA is a widespread mechanism to specify early cell fates, we asked whether this is also true for Parhyale. A candidate gene approach did not find RNAs that are asymmetrically distributed at the 8-cell stage. Therefore, we designed a high-density microarray from 9400 recently sequenced ESTs (1) to identify maternally provided RNAs and (2) to find RNAs that are differentially distributed among cells of the 8-cell stage. Results: Maternal-zygotic transition takes place around the 32-cell stage, i.e. after the specification of germ layers. By comparing a pool of RNAs from early embryos without zygotic transcription to zygotic RNAs of the germband, we found that more than 10% of the targets on the array were enriched in the maternal transcript pool. A screen for asymmetrically distributed RNAs at the 8-cell stage revealed 129 transcripts, from which 50% are predominantly expressed in the early embryonic stages. Finally, we performed knockdown experiments for two of these genes and observed cell-fate-related defects of embryonic development. Conclusions: In contrast to Drosophila, the four primary germ layer cell lineages in Parhyale are specified during the maternal control phase of the embryo. A key step in this process is the asymmetric distribution of a large number of maternal RNAs to the germ layer progenitor cells.	[Nestorov, Peter; Levesque, Mitchell P.; Gerberding, Matthias] Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany; [Battke, Florian] Univ Tubingen, Ctr Bioinformat, Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen	Gerberding, M (corresponding author), Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany.	matthias.gerberding@medizin.uni-tuebingen.de		Battke, Florian/0000-0001-6021-5837	Max Planck Society (Max Planck Gesellschaft)	Max Planck Society (Max Planck Gesellschaft)(Max Planck Society)	This work was funded by project grants from the Max Planck Society (Max Planck Gesellschaft). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Nadine Heckmann for her excellent support regarding molecular biology and animal care and for her spirit and willingness to help in many situations. Kerstin Miller is thanked for great animal care as well. Gunes Ozhan Kizil and Johanna Havemann helped to bring this project about by developing and sharing protocols and by discussing our and their own results. We thank Claas aufm Kampe for the data administration and Vikram Alva for help with data processing and analysis. Christa Lanz and Nadine Heckmann, Tubingen and Vertis, Munich, were instrumental in our EST project. In Hohenheim, we would like to thank Sandra Reineke for help with molecular biology and Martin Blum for space, equipment and discussions. We would like to thank Nipam Patel for his generous support in access to EST reads. Tom Gingeras, Jan Lohmann, Bettina Harr and Michael Kohn all gave encouraging input to this project. We thank Andrei Lupas for support for the GBM (Gesellschaft fur Biochemie und Molekularbiologie) diploma thesis award and the GBM and Bernd Hamprecht for the diploma thesis award. This work was supported by the Max Planck Society.	Abzhanov A, 2008, TRENDS GENET, V24, P353, DOI 10.1016/j.tig.2008.04.002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON KV, 1984, NATURE, V311, P223, DOI 10.1038/311223a0; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Baroux C, 2009, COLD SPRING HARB S Q; Battke F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-121; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Blythe MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033784; Browne WE, 2005, GENESIS, V42, P124, DOI 10.1002/gene.20145; Browne WE, 2006, DEV GENES EVOL, V216, P581, DOI 10.1007/s00427-006-0074-7; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuykendall TN, 2009, DEVELOPMENT, V136, P3057, DOI 10.1242/dev.036855; da Fonseca RN, 2009, CURR OPIN GENET DEV, V19, P404, DOI 10.1016/j.gde.2009.04.009; Extavour CG, 2005, DEV BIOL, V277, P387, DOI 10.1016/j.ydbio.2004.09.030; Gerberding M, 2002, DEVELOPMENT, V129, P5789, DOI 10.1242/dev.00155; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kizil GO, 2008, DEV BIOL; Kofron M, 2007, DEVELOPMENT, V134, P503, DOI 10.1242/dev.02739; Lawrence PA, 2006, CURR BIOL, V16, pR236, DOI 10.1016/j.cub.2006.03.016; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lorenzini DM, 2003, DEV COMP IMMUNOL, V27, P781, DOI 10.1016/S0145-305X(03)00058-2; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; McClintock TS, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-312; McGregor AP, 2008, BIOESSAYS, V30, P487, DOI 10.1002/bies.20744; Parchem RJ, 2010, GENOMICS, V95, P261, DOI 10.1016/j.ygeno.2010.03.005; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Price AL, 2009, DEV BIOL; Price AL, 2008, J EXP ZOOL PART B, V310B, P24, DOI 10.1002/jez.b.21135; Richter S, 2001, J ZOOL SYST EVOL RES, V39, P113; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; SAMBROOK J, 2000, MOL CLONING LAB MANU; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; Weese D, 2009, GENOME RES, V19, P1646, DOI 10.1101/gr.088823.108; Wilson MJ, 2011, EVOL DEV, V13, P127, DOI 10.1111/j.1525-142X.2011.00463.x; Yamada L, 2005, DEV BIOL, V284, P536, DOI 10.1016/j.ydbio.2005.05.027; Yatsu J, 2008, INT J DEV BIOL, V52, P913, DOI 10.1387/ijdb.082576jy; Zeng V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-581; Zhang C, 2007, DIFFERENTIATION, V75, P536, DOI 10.1111/j.1432-0436.2007.00190.x	42	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56049	10.1371/journal.pone.0056049	http://dx.doi.org/10.1371/journal.pone.0056049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418507	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300099
J	Ramirez, SH; Fan, SS; Dykstra, H; Rom, S; Mercer, A; Reichenbach, NL; Gofman, L; Persidsky, Y				Ramirez, Servio H.; Fan, Shongshan; Dykstra, Holly; Rom, Slava; Mercer, Aaron; Reichenbach, Nancy L.; Gofman, Larisa; Persidsky, Yuri			Inhibition of Glycogen Synthase Kinase 3 beta Promotes Tight Junction Stability in Brain Endothelial Cells by Half-Life Extension of Occludin and Claudin-5	PLOS ONE			English	Article							PROTEIN OCCLUDIN; BARRIER FUNCTION; BETA-CATENIN; MDCK CELLS; ACTIVATION; EXPRESSION; PHOSPHORYLATION; PERMEABILITY; IMPEDANCE; ATROGIN-1	Neuroinflammatory conditions often involve dysfunction of the Blood-Brain Barrier (BBB). Therefore, identifying molecular targets that can maintain barrier fidelity is of clinical importance. We have previously reported on the anti-inflammatory effects that glycogen synthase kinase 3 beta (GSK3 beta) inhibition has on primary human brain endothelial cells. Here we show that GSK3 beta inhibitors also promote barrier tightness by affecting tight junction (TJ) protein stability. Transendothelial electrical resistance (TEER) was used to evaluate barrier integrity with both pharmacological inhibitors and mutants of GSK3 beta. Inhibition of GSK3 beta produced a gradual and sustained increase in TEER (as much as 22% over baseline). Analysis of subcellular membrane fractions revealed an increase in the amount of essential tight junction proteins, occludin and claudin-5, but not claudin-3. This phenomenon was attributed to a decrease in TJ protein turnover and not transcriptional regulation. Using a novel cell-based assay, inactivation of GSK3 beta significantly increased the half-life of occludin and claudin-5 by 32% and 43%, respectively. A correlation was also established between the enhanced association of beta-catenin with ZO-1 as a function of GSK3 beta inhibition. Collectively, our findings suggest the possibility of using GSK3 beta inhibitors as a means to extend the half-life of key tight junction proteins to promote re-sealing of the BBB during neuroinflammation.	[Ramirez, Servio H.; Fan, Shongshan; Dykstra, Holly; Rom, Slava; Reichenbach, Nancy L.; Gofman, Larisa; Persidsky, Yuri] Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA; [Ramirez, Servio H.; Persidsky, Yuri] Temple Univ, Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19122 USA; [Mercer, Aaron] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Michigan System; University of Michigan	Ramirez, SH (corresponding author), Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA.	servio@temple.edu	Ramirez, Servio/F-8277-2014; Rom, Slava/AAF-6872-2020	ramirez, servio/0000-0002-4609-5653	National Institutes of Health [RO1MH065151, R37AA015913]; Temple University development grant; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA015913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Temple University development grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported (in part) by research funding from the National Institutes of Health: RO1MH065151 and R37AA015913 (YP) and a Temple University development grant (SHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2005, CELL MOL NEUROBIOL, V25, P5, DOI 10.1007/s10571-004-1374-y; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bernas MJ, 2010, NAT PROTOC, V5, P1265, DOI 10.1038/nprot.2010.76; Coisne C, 2011, ANTIOXID REDOX SIGN, V15, P1285, DOI 10.1089/ars.2011.3929; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DeBellefeuille S, 2003, ENDOCRINOLOGY, V144, P5040, DOI 10.1210/en.2002-0139; Dehoux M, 2007, AM J PHYSIOL-ENDOC M, V292, pE145, DOI 10.1152/ajpendo.00085.2006; DePaola N, 2001, ANN BIOMED ENG, V29, P648, DOI 10.1114/1.1385811; Escribano C, 2009, J IMMUNOL, V183, P6282, DOI 10.4049/jimmunol.0804093; Failor KL, 2007, MOL ENDOCRINOL, V21, P2403, DOI 10.1210/me.2007-0143; Fan SS, 2004, MOL BRAIN RES, V132, P38, DOI 10.1016/j.molbrainres.2004.09.003; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; Herve JC, 2007, J MEMBRANE BIOL, V217, P21, DOI 10.1007/s00232-007-9054-8; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Klamer G, 2010, CURR MED CHEM, V17, P2873, DOI 10.2174/092986710792065090; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Liu F, 2002, FASEB J, V16, P950, DOI 10.1096/fj.01-0870com; Lo CM, 1995, BIOPHYS J, V69, P2800, DOI 10.1016/S0006-3495(95)80153-0; Mandel I, 2012, J CELL BIOCH; Mankertz J, 2004, BIOCHEM BIOPH RES CO, V314, P1001, DOI 10.1016/j.bbrc.2003.12.185; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; Miwa N, 2001, ONCOL RES, V12, P469, DOI 10.3727/096504001108747477; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Raikwar NS, 2010, AM J PHYSIOL-RENAL, V299, pF436, DOI 10.1152/ajprenal.00674.2009; Rajasekaran AK, 1996, J CELL BIOL, V132, P451, DOI 10.1083/jcb.132.3.451; Ramirez SH, 2010, AM J PATHOL, V176, P881, DOI 10.2353/ajpath.2010.090671; Severson EA, 2010, BIOCHEM BIOPH RES CO, V397, P592, DOI 10.1016/j.bbrc.2010.05.164; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Traweger A, 2002, J BIOL CHEM, V277, P10201, DOI 10.1074/jbc.M111384200; Wakatsuki S, 2011, NAT CELL BIOL, V13, P1415, DOI 10.1038/ncb2373; Wang Z, 2007, ONCOGENE, V26, P1222, DOI 10.1038/sj.onc.1209902; Watanabe K, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002436; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang L, 2011, J BIOL CHEM, V286, P16879, DOI 10.1074/jbc.M110.186932; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	41	78	80	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55972	10.1371/journal.pone.0055972	http://dx.doi.org/10.1371/journal.pone.0055972			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418486	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300078
J	Samusik, N; Krukovskaya, L; Meln, I; Shilov, E; Kozlov, AP				Samusik, Nikolay; Krukovskaya, Larisa; Meln, Irina; Shilov, Evgeny; Kozlov, Andrey P.			PBOV1 Is a Human De Novo Gene with Tumor-Specific Expression That Is Associated with a Positive Clinical Outcome of Cancer	PLOS ONE			English	Article							BREAST-CANCER; HUMAN GENOME; STRUCTURE PREDICTION; ANTIGENS; PATHWAY; IDENTIFICATION; TRANSCRIPTION; RESOLUTION; EVOLUTION; PROSTATE	PBOV1 is a known human protein-coding gene with an uncharacterized function. We have previously found that PBOV1 lacks orthologs in non-primate genomes and is expressed in a wide range of tumor types. Here we report that PBOV1 protein-coding sequence is human-specific and has originated de novo in the primate evolution through a series of frame shift and stop codon mutations. We profiled PBOV1 expression in multiple cancer and normal tissue samples and found that it was expressed in 19 out of 34 tumors of various origins but completely lacked expression in any of the normal adult or fetal human tissues. We found that, unlike the cancer/testis antigens that are typically controlled by CpG island-containing promoters, PBOV1 was expressed from a GC-poor TATA-containing promoter which was not influenced by CpG demethylation and was inactive in testis. Our analysis of public microarray data suggests that PBOV1 activation in tumors could be dependent on the Hedgehog signaling pathway. Despite the recent de novo origin and the lack of identifiable functional signatures, a missense SNP in the PBOV1 coding sequence has been previously associated with an increased risk of breast cancer. Using publicly available microarray datasets, we found that high levels of PBOV1 expression in breast cancer and glioma samples were significantly associated with a positive outcome of the cancer disease. We also found that PBOV1 was highly expressed in primary but not in recurrent high-grade gliomas, suggesting the presence of a negative selection against PBOV1-expressing cancer cells. Our findings could contribute to the understanding of the mechanisms behind de novo gene origin and the possible role of tumors in this process.	[Samusik, Nikolay] Max Planck Inst Cell Biol & Genet, Dresden, Germany; [Krukovskaya, Larisa; Shilov, Evgeny; Kozlov, Andrey P.] Biomed Ctr, St Petersburg 197110, Russia; [Meln, Irina] VA Almazov Fed Heart Blood & Endocrinol Ctr, Inst Haematol, St Petersburg, Russia; [Kozlov, Andrey P.] St Petersburg State Univ, Dept Biochem, St Petersburg, Russia	Max Planck Society; Almazov National Medical Research Centre; Saint Petersburg State University	Samusik, N (corresponding author), Max Planck Inst Cell Biol & Genet, Dresden, Germany.	samusik@mpi-cbg.de	Kozlov, Andrei P/H-2117-2016; Shilov, Evgeny/ABG-3200-2021	Kozlov, Andrei P/0000-0003-4611-1534; Meln, Irina/0000-0001-5737-4167; Shilov, Evgeny/0000-0002-8933-7843	Russian-Belorussian program [K-32-NIR/111-3]; Biomedical Centre	Russian-Belorussian program; Biomedical Centre	This work was funded by the Biomedical Centre and by the Russian-Belorussian program #K-32-NIR/111-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except for Prof. Andrey P. Kozlov who, being the head of the Biomedical Centre, simultaneously authorized the funding and supervised this work.	An G, 2000, CANCER RES, V60, P7014; Augello MA, 2011, EMBO J, V30, P3885, DOI 10.1038/emboj.2011.340; Aydin Z, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-178; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Cai J, 2008, GENETICS, V179, P487, DOI 10.1534/genetics.107.084491; Chomez P, 2001, CANCER RES, V61, P5544; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Coggin JH, 2005, ANTICANCER RES, V25, P2345; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; de Magalhaes JP, 2007, MECH AGEING DEV, V128, P355, DOI 10.1016/j.mad.2007.03.004; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; FALKMER S, 1976, PROG EXP TUMOR RES, V20, P217; Ferre F, 2006, NUCLEIC ACIDS RES, V34, pW182, DOI 10.1093/nar/gkl189; Fisher MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015364; Guigo R., 1999, GENETIC DATABASES; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kamagata C, 2002, ANTICANCER RES, V22, P4087; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Katsura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020365; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Kozlov AP, 2010, MED HYPOTHESES, V74, P177, DOI 10.1016/j.mehy.2009.07.027; Kozlov Andrei P, 2006, Infect Agent Cancer, V1, P8, DOI 10.1186/1750-9378-1-8; Kozlov AP, 1996, MED HYPOTHESES, V46, P81, DOI 10.1016/S0306-9877(96)90005-5; Krukovskaja L. L., 2010, Voprosy Onkologii (St. Petersburg), V56, P327; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li CY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000734; Li D, 2010, CELL RES, V20, P408, DOI 10.1038/cr.2010.31; Loizidou MA, 2010, BREAST CANCER RES TR, V121, P147, DOI 10.1007/s10549-009-0518-7; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Mansour AA, 2011, MOL CELL NEUROSCI, V46, P187, DOI 10.1016/j.mcn.2010.09.002; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Nanni S, 2006, MOL CANCER RES, V4, P79, DOI 10.1158/1541-7786.MCR-05-0098; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nuber N, 2010, P NATL ACAD SCI USA, V107, P15187, DOI 10.1073/pnas.1002155107; Ortmann CA, 2008, ANN HEMATOL, V87, P809, DOI 10.1007/s00277-008-0514-8; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Plotkin JB, 2004, P NATL ACAD SCI USA, V101, P12588, DOI 10.1073/pnas.0404957101; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Sambrook J, 2001, MOL CLONING LAB MANU, P130; Samusik N. A., 2011, RUSS J GENET APPL RE, V1, P138; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schlom J, 2012, JNCI-J NATL CANCER I, V104, P599, DOI 10.1093/jnci/djs033; SCHREIBER H, 1988, ANNU REV IMMUNOL, V6, P465; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Stauffer Yves, 2004, Cancer Immun, V4, P2; Toll-Riera M, 2009, MOL BIOL EVOL, V26, P603, DOI 10.1093/molbev/msn281; Valen E, 2011, TRENDS GENET, V27, P475, DOI 10.1016/j.tig.2011.08.001; Vasudevan S, 2002, BIOESSAYS, V24, P785, DOI 10.1002/bies.10153; Wischnewski F, 2006, MOL CANCER RES, V4, P339, DOI 10.1158/1541-7786.MCR-05-0229; Wu DD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002379; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	57	25	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56162	10.1371/journal.pone.0056162	http://dx.doi.org/10.1371/journal.pone.0056162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418531	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300123
J	Uhart, M; Bustos, DM				Uhart, Marina; Bustos, Diego M.			Human 14-3-3 Paralogs Differences Uncovered by Cross-Talk of Phosphorylation and Lysine Acetylation	PLOS ONE			English	Article							INTRINSIC DISORDER; PROTEIN DISORDER; IN-VIVO; NETWORK; COMPLEXES; CYTOSCAPE; RESIDUES; CANCER; FOCUS; MOTIF	The 14-3-3 protein family interacts with more than 700 different proteins in mammals, in part as a result of its specific phospho-serine/phospho-threonine binding activity. Upon binding to 14-3-3, the stability, subcellular localization and/or catalytic activity of the ligands are modified. Seven paralogs are strictly conserved in mammalian species. Although initially thought as redundant, the number of studies showing specialization is growing. We created a protein-protein interaction network for 14-3-3, kinases and their substrates signaling in human cells. We included information of phosphorylation, acetylation and other PTM sites, obtaining a complete representation of the 14-3-3 binding partners and their modifications. Using a computational system approach we found that networks of each 14-3-3 isoform are statistically different. It was remarkable to find that Tyr was the most phosphorylatable amino acid in domains of 14-3-3 epsilon partners. This, together with the over-representation of SH3 and Tyr_Kinase domains, suggest that epsilon could be involved in growth factors receptors signaling pathways particularly. We also found that within zeta's network, the number of acetylated partners (and the number of modify lysines) is significantly higher compared with each of the other isoforms. Our results imply previously unreported hidden differences of the 14-3-3 isoforms interaction networks. The phosphoproteome and lysine acetylome within each network revealed post-transcriptional regulation intertwining phosphorylation and lysine acetylation. A global understanding of these networks will contribute to predict what could occur when regulatory circuits become dysfunctional or are modified in response to external stimuli.	[Uhart, Marina; Bustos, Diego M.] Univ Nacl San Martin UNSAM, Lab Biol Estruct & Celular Modificac Posttraducc, Inst Invest Biotecnol, Inst Tecnol Chascomus IIB INTECH,Consejo Nacl Inv, Chascomus, Argentina		Bustos, DM (corresponding author), Univ Nacl San Martin UNSAM, Lab Biol Estruct & Celular Modificac Posttraducc, Inst Invest Biotecnol, Inst Tecnol Chascomus IIB INTECH,Consejo Nacl Inv, Int Marino Km 8-2, Chascomus, Argentina.	dbustos@intech.gov.ar			ANPCyT [PICT-1495]; CONICET [PIP 0304, 2519]	ANPCyT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	ANPCyT (PICT-1495) and CONICET (PIP 0304 and 2519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; BURNETT G, 1954, J BIOL CHEM, V211, P969; Bustos DM, 2012, MOL BIOSYST, V8, P178, DOI 10.1039/c1mb05216k; Bustos DM, 2006, PROTEINS, V63, P35, DOI 10.1002/prot.20888; Caetano-Anolles G., 2010, EVOLUTIONARY GENOMIC; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Dunker A K, 1998, Pac Symp Biocomput, P473; Fernandez A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-604; Fernandez A, 2011, NATURE, V474, P502, DOI 10.1038/nature09992; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Gough NR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3137eg6; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Jin J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000546; Johnson C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005751; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kjarland E, 2006, CURR PHARM BIOTECHNO, V7, P217, DOI 10.2174/138920106777549777; Lu ZK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028228; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mathivanan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S19; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Minguez P, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.31; Mogk A, 2010, SCIENCE, V327, P966, DOI 10.1126/science.1187274; Moore B. W., 1967, PHYSL BIOCH ASPECTS, P343; Moreira JMA, 2008, MOL CELL PROTEOMICS, V7, P1225, DOI 10.1074/mcp.M700439-MCP200; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Norris KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe76; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Panni S, 2011, PROTEOMICS, V11, P128, DOI 10.1002/pmic.201000030; Paul AL, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00190; Rajamani D, 2004, P NATL ACAD SCI USA, V101, P11287, DOI 10.1073/pnas.0401942101; Sadoul K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/970382; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sun SY, 2009, J ENDOCRINOL, V202, P327, DOI 10.1677/JOE-09-0041; Tinti M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120103; Uhart M, 2011, J MOL BIOL, V406, P552, DOI 10.1016/j.jmb.2010.12.043; van Noort V, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.4; Vinayagam A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001699; Walsh I, 2011, NUCLEIC ACIDS RES, V39, pW190, DOI 10.1093/nar/gkr411; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Wu JM, 2009, NAT METHODS, V6, P75, DOI [10.1038/nmeth.1282, 10.1038/NMETH.1282]; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101	53	37	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55703	10.1371/journal.pone.0055703	http://dx.doi.org/10.1371/journal.pone.0055703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418452	Green Published, gold			2022-12-27	WOS:000315970300043
J	Umene-Nakano, W; Kato, TA; Kikuchi, S; Tateno, M; Fujisawa, D; Hoshuyama, T; Nakamura, J				Umene-Nakano, Wakako; Kato, Takahiro A.; Kikuchi, Saya; Tateno, Masaru; Fujisawa, Daisuke; Hoshuyama, Tsutomu; Nakamura, Jun			Nationwide Survey of Work Environment, Work-Life Balance and Burnout among Psychiatrists in Japan	PLOS ONE			English	Article							MENTAL-HEALTH PROFESSIONALS; JOB-SATISFACTION; STRESS; PREDICTORS; STAFF; PHYSICIANS; CONFLICT; NURSES; CARE; SWITZERLAND	Background: Psychiatry has been consistently shown to be a profession characterised by 'high-burnout'; however, no nationwide surveys on this topic have been conducted in Japan. Aims: The objective of this study was to estimate the prevalence of burnout and to ascertain the relationship between work environment satisfaction, work-life balance satisfaction and burnout among psychiatrists working in medical schools in Japan. Method: We mailed anonymous questionnaires to all 80 psychiatry departments in medical schools throughout Japan. Work-life satisfaction, work-environment satisfaction and social support assessments, as well as the Maslach Burnout Inventory (MBI), were used. Results: Sixty psychiatric departments (75.0%) responded, and 704 psychiatrists provided answers to the assessments and MBI. Half of the respondents (n = 311, 46.0%) experienced difficulty with their work-life balance. Based on the responses to the MBI, 21.0% of the respondents had a high level of emotional exhaustion, 12.0% had a high level of depersonalisation, and 72.0% had a low level of personal accomplishment. Receiving little support, experiencing difficulty with work-life balance, and having less work-environment satisfaction were significantly associated with higher emotional exhaustion. A higher number of nights worked per month was significantly associated with higher depersonalisation. Conclusions: A low level of personal accomplishment was quite prevalent among Japanese psychiatrists compared with the results of previous studies. Poor work-life balance was related to burnout, and social support was noted to mitigate the impact of burnout.	[Umene-Nakano, Wakako; Nakamura, Jun] Univ Occupat & Environm Hlth, Dept Psychiat, Kitakyushu, Fukuoka 807, Japan; [Kato, Takahiro A.] Kyushu Univ, Dept Neuropsychiat, Grad Sch Med Sci, Fukuoka 812, Japan; [Kato, Takahiro A.] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka 812, Japan; [Kikuchi, Saya] Tohoku Univ, Grad Sch Med, Dept Psychiat, Sendai, Miyagi 980, Japan; [Tateno, Masaru] Sapporo Med Univ, Dept Neuropsychiat, Sapporo, Hokkaido, Japan; [Fujisawa, Daisuke] Natl Canc Ctr Hosp East, Psychooncol Div, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan; [Hoshuyama, Tsutomu] Univ Occupat & Environm Hlth, Dept Environm Epidemiol, Kitakyushu, Fukuoka 807, Japan; [Hoshuyama, Tsutomu] Ushibuka City Hosp, Ushibuka, Amakusa, Japan	University of Occupational & Environmental Health - Japan; Kyushu University; Kyushu University; Tohoku University; Sapporo Medical University; National Cancer Center - Japan; University of Occupational & Environmental Health - Japan	Umene-Nakano, W (corresponding author), Univ Occupat & Environm Hlth, Dept Psychiat, Kitakyushu, Fukuoka 807, Japan.	wakako-u@med.uoeh-u.ac.jp	Fujisawa, Daisuke/AAR-5808-2021; Kato, Takahiro/R-7665-2019; kikuchi, saya/E-3755-2017	Kato, Takahiro/0000-0001-5169-2930; 				Alexander H., 2008, AAMC ANAL BRIEF, V8, P1; Allen T D, 2000, J Occup Health Psychol, V5, P278, DOI 10.1037/1076-8998.5.2.278; Asai M, 2007, PSYCHO-ONCOLOGY, V16, P421, DOI 10.1002/pon.1066; Barkil-Oteo A, 2012, LANCET, V379, P2428, DOI 10.1016/S0140-6736(12)61067-8; Bressi C, 2009, PSYCHIAT SERV, V60, P985, DOI 10.1176/appi.ps.60.7.985; Brown G T, 1992, Can J Occup Ther, V59, P258; Bryson L, 2007, SOC SCI MED, V65, P1142, DOI 10.1016/j.socscimed.2007.04.027; Bunton SA, 2012, ACAD MED, V87, P574, DOI 10.1097/ACM.0b013e31824d2b37; CHEMTOB CM, 1988, AM J PSYCHIAT, V145, P224; Chung KC, 2010, MED EDUC, V44, P985, DOI 10.1111/j.1365-2923.2010.03766.x; Dallender J, 1999, J ADV NURS, V29, P36, DOI 10.1046/j.1365-2648.1999.00858.x; Deahl M, 1997, BRIT J PSYCHIAT, V171, P6, DOI 10.1192/bjp.171.1.6; Fereday J, 2010, MIDWIFERY, V26, P311, DOI 10.1016/j.midw.2008.06.004; Fothergill A, 2004, INT J SOC PSYCHIATR, V50, P54, DOI 10.1177/0020764004040953; Fujiwara K, 2003, J OCCUP HEALTH, V45, P313, DOI 10.1539/joh.45.313; Fuyuno I, 2012, NATURE INT WEEKLY J; Garfinkel PE, 2001, CAN J PSYCHIAT, V46, P835, DOI 10.1177/070674370104600907; Hammig O, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13577; Hammig O, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-435; Hammer TH, 2004, J OCCUP HEALTH PSYCH, V9, P83, DOI 10.1037/1076-8998.9.1.83; Hammig O, 2009, INT J PUBLIC HEALTH, V54, P88, DOI 10.1007/s00038-009-8031-7; Hawton K, 2001, J EPIDEMIOL COMMUN H, V55, P296, DOI 10.1136/jech.55.5.296; Higashiguchi K, 1998, Nihon Eiseigaku Zasshi, V53, P447; HISCOTT RD, 1990, CAN J PUBLIC HEALTH, V81, P422; Keeton K, 2007, OBSTET GYNECOL, V109, P949, DOI 10.1097/01.AOG.0000258299.45979.37; Komaki K., 1994, JAPANESE J HLTH PSYC, V7, P2, DOI 10.11560/jahp.7.2_2; Kumar S, 2007, WORLD PSYCHIATRY, V6, P186; Kumar S, 2007, INT J SOC PSYCHIATR, V53, P306, DOI 10.1177/0020764006074534; Lasalvia A, 2009, BRIT J PSYCHIAT, V195, P537, DOI 10.1192/bjp.bp.108.060871; Leiter MP, 1996, INT J SOC PSYCHIATR, V42, P90, DOI 10.1177/002076409604200203; LOONEY JG, 1980, AM J PSYCHIAT, V137, P32; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C., 1996, MASLACH BURNOUT INVE; Montgomery D. C., 2021, INTRO LINEAR REGRESS, P12; Narumoto J, 2008, PSYCHIAT CLIN NEUROS, V62, P174, DOI 10.1111/j.1440-1819.2008.01751.x; Nomura K, 2008, J GEN INTERN MED, V23, P1105, DOI 10.1007/s11606-008-0644-7; Nomura Kyoko, 2011, Nihon Eiseigaku Zasshi, V66, P22, DOI 10.1265/jjh.66.22; PINES A, 1978, HOSP COMMUNITY PSYCH, V29, P233; Poghosyan L, 2009, INT J NURS STUD, V46, P894, DOI 10.1016/j.ijnurstu.2009.03.004; Portenoy RK, 1997, PSYCHOSOMATICS, V38, P277, DOI 10.1016/S0033-3182(97)71465-8; Prosser D, 1999, SOC PSYCH PSYCH EPID, V34, P295, DOI 10.1007/s001270050147; Ramirez AJ, 1996, LANCET, V347, P724, DOI 10.1016/S0140-6736(96)90077-X; Sano Akira, 2009, Seishin Shinkeigaku Zasshi, V111, P1303; Sasaki M, 2009, J NURS MANAGE, V17, P359, DOI 10.1111/j.1365-2834.2008.00960.x; Shitara S, 2009, JAPANESE J ADM SCI, V22, P223; SNIBBE JR, 1989, PSYCHOL REP, V65, P775, DOI 10.2466/pr0.1989.65.3.775; Tang CS, 1998, J CLIN PSYCHOL, V54, P55, DOI 10.1002/(SICI)1097-4679(199801)54:1<55::AID-JCLP6>3.0.CO;2-T; Teo A, 2007, MED EDUC, V41, P302, DOI 10.1111/j.1365-2929.2007.02691.x; Thomsen S, 1999, PSYCHOTHER PSYCHOSOM, V68, P157, DOI 10.1159/000012325; Umene-Nakano Wakako, 2011, Seishin Shinkeigaku Zasshi, V113, P271; Webster L, 1999, ADM POLICY MENT HLTH, V26, P387, DOI 10.1023/A:1021382806009	51	44	44	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55189	10.1371/journal.pone.0055189	http://dx.doi.org/10.1371/journal.pone.0055189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418435	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300025
J	Wang, AY; Du, Y; He, QC; Zhou, CX				Wang, Anyou; Du, Ying; He, Qianchuan; Zhou, Chunxiao			A Quantitative System for Discriminating Induced Pluripotent Stem Cells, Embryonic Stem Cells and Somatic Cells	PLOS ONE			English	Article							DNA METHYLATION; MICROARRAY; NETWORKS	Induced pluripotent stem cells (iPSCs) derived from somatic cells (SCs) and embryonic stem cells (ESCs) provide promising resources for regenerative medicine and medical research, leading to a daily identification of new cell lines. However, an efficient system to discriminate the different types of cell lines is lacking. Here, we develop a quantitative system to discriminate the three cell types, iPSCs, ESCs, and SCs. The system consists of DNA-methylation biomarkers and mathematical models, including an artificial neural network and support vector machines. All biomarkers were unbiasedly selected by calculating an eigengene score derived from analysis of genome-wide DNA methylations. With 30 biomarkers, or even with as few as 3 top biomarkers, this system can discriminate SCs from pluripotent cells (PCs, including ESCs and iPSCs) with almost 100% accuracy. With approximately 100 biomarkers, the system can distinguish ESCs from iPSCs with an accuracy of 95%. This robust system performs precisely with raw data without normalization as well as with converted data in which the continuous methylation levels are accounted. Strikingly, this system can even accurately predict new samples generated from different microarray platforms and the next-generation sequencing. The subtypes of cells, such as female and male iPSCs and fetal and adult SCs, can also be discriminated with this method. Thus, this novel quantitative system works as an accurate framework for discriminating the three cell types, iPSCs, ESCs, and SCs. This strategy also supports the notion that DNA-methylation generally varies among the three cell types.	[Wang, Anyou; Du, Ying] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [He, Qianchuan] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Zhou, Chunxiao] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Fred Hutchinson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill	Wang, AY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	anyou.wang@alumni.ucr.edu	W, Andrew/ABE-8298-2020	W, Andrew/0000-0002-4981-3606; He, Qianchuan/0000-0001-7044-6591				Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; DAVIS S, 2012, METHYLUMI HANDLE ILL; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Goldman B, 2008, NATURE REPORTS STEM, DOI [10.1038/stemcells.2008.26, DOI 10.1038/STEMCELLS.2008.26]; Goldstein DR, 2002, STAT SINICA, V12, P219; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Han MY, 2012, ONCOL REP, V28, P2233, DOI 10.3892/or.2012.2037; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones R, 2010, NATURE, V466, pS11, DOI 10.1038/466S11a; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lancashire LJ, 2009, BRIEF BIOINFORM, V10, P315, DOI 10.1093/bib/bbp012; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Oshima Y, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3316296; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rolston DW, 1988, PRINCIPLES ARTIFICIA; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Shen RL, 2006, BIOINFORMATICS, V22, P2635, DOI 10.1093/bioinformatics/btl442; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang AY, 2011, STEM CELLS DEV, V20, P1937, DOI 10.1089/scd.2010.0574; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	31	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56095	10.1371/journal.pone.0056095	http://dx.doi.org/10.1371/journal.pone.0056095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418520	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300112
J	Wang, XY; Wong, A				Wang, Xiao Yu; Wong, Alexander			Multi-Parametric Clustering for Sensor Node Coordination in Cognitive Wireless Sensor Networks	PLOS ONE			English	Article								The deployment of wireless sensor networks for healthcare applications have been motivated and driven by the increasing demand for real-time monitoring of patients in hospital and large disaster response environments. A major challenge in developing such sensor networks is the need for coordinating a large number of randomly deployed sensor nodes. In this study, we propose a multi-parametric clustering scheme designed to aid in the coordination of sensor nodes within cognitive wireless sensor networks. In the proposed scheme, sensor nodes are clustered together based on similar network behaviour across multiple network parameters, such as channel availability, interference characteristics, and topological characteristics, followed by mechanisms for forming, joining and switching clusters. Extensive performance evaluation is conducted to study the impact on important factors such as clustering overhead, cluster joining estimation error, interference probability, as well as probability of reclustering. Results show that the proposed clustering scheme can be an excellent candidate for use in large scale cognitive wireless sensor network deployments with high dynamics.	[Wang, Xiao Yu; Wong, Alexander] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Wong, A (corresponding author), Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada.	a28wong@uwaterloo.ca	Wong, Alexander/GZM-2929-2022	Wong, Alexander/0000-0002-5295-2797	Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Economic Development and Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Economic Development and Innovation	This research is funded by the Natural Sciences and Engineering Research Council of Canada and the Ontario Ministry of Economic Development and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker D, 1984, IEEE J SEL AREA COMM, P2; Baker D, 1981, IEEE T COMMUN COM; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Chatterjee M, 2002, CLUSTER COMPUT, P5; Chen T., 2007, P IEEE DYSPAN; Chintalapudi K, 1998, P IEEE INT C FUZZ SY; Deosarkar B, 2008, P IEEE ICCCN; Digham F, 2007, IEEE T COMMUN, P15; Gao T, 2008, 2008 IEEE CONFERENCE ON TECHNOLOGIES FOR HOMELAND SECURITY, VOLS 1 AND 2, P187, DOI 10.1109/THS.2008.4534447; Gardner W, 1994, CYCLOSTATIONARITY CO; Ghasemi A, 2008, IEEE J-STSP, V2, P41, DOI 10.1109/JSTSP.2007.914897; Haenggi M., 2009, IEEE J SEL AREAS COM, V27; Huang S, 2008, P IEEE INFOCOM; Kim M, 2009, P IEEE WIMOB; Ko J, 2010, P IEEE, V98, P1947, DOI 10.1109/JPROC.2010.2065210; Kumarawadu P, 2008, P IEEE ICIAF; Lazos L, 2009, P IEEE SECON; Malan D., 2004, INT WORKSH WEAR IMPL, P12; Rabbachin A, 2011, IEEE JSAC, P29; Rappaport T. S., 1996, WIRELESS COMMUNICATI; Shellhammer S. J., 2009, P INF THEOR APPL WOR; Vijay G, 2011, IEEE SENS J, V11, P582, DOI 10.1109/JSEN.2010.2052033; Yu J, 2005, IEEE COMMUNICATIONS, P7; Zahmati AS, 2009, IEEE TIC-STH 09: 2009 IEEE TORONTO INTERNATIONAL CONFERENCE: SCIENCE AND TECHNOLOGY FOR HUMANITY, P593, DOI 10.1109/TIC-STH.2009.5444432; Zhao J, 2007, WIRELESS COMMUNICATI, P7; Zhao J, 2005, P IEEE DYSPAN	26	1	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e53434	10.1371/journal.pone.0053434	http://dx.doi.org/10.1371/journal.pone.0053434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418421	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300011
J	Wu, M; Wang, ZW; Meng, CS; Wang, KL; Hu, YN; Wang, LZ; Wang, QM				Wu, Meng; Wang, Ziwen; Meng, Chuisong; Wang, Kailiang; Hu, Yanna; Wang, Lizhong; Wang, Qingmin			Discovery and SARs of Trans-3-Aryl Acrylic Acids and Their Analogs as Novel Anti- Tobacco Mosaic Virus (TMV) Agents	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITIES; DERIVATIVES; IDENTIFICATION; INHIBITION; FERULATE; EXTRACTS; GROWTH; DESIGN; RICE	A series of trans-3-aryl acrylic acids 1-27 and their derivatives 28-34 were prepared and evaluated for their antiviral activity against tobacco mosaic virus (TMV) for the first time. The bioassay results showed that most of these compounds exhibited good antiviral activity against TMV, of which compounds 1, 5, 6, 20, 27 and 34 exhibited significantly higher activity against TMV than commercial Ribavirin both in vitro and in vivo. Furthermore, these compounds have more simple structure than commercial Ribavirin, and can be synthesized more efficiently. These new findings demonstrate that trans-3-aryl acrylic acids and their derivatives represent a new template for antiviral studies and could be considered for novel therapy against plant virus infection.	[Wu, Meng; Wang, Ziwen; Meng, Chuisong; Wang, Kailiang; Hu, Yanna; Wang, Lizhong; Wang, Qingmin] Nankai Univ, Res Inst Elementoorgan Chem, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China	Nankai University	Wang, QM (corresponding author), Nankai Univ, Res Inst Elementoorgan Chem, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China.	wangqm@nankai.edu.cn			National Key Project for Basic Research [2010CB126106]; National Natural Science Foundation of China [21132003, 21121002]; China Postdoctoral Science Foundation [20090460057, 2011M500519, 2012T50207]; National Key Technology Research and Development Program [2012BAK25B03]	National Key Project for Basic Research(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Key Technology Research and Development Program(National Key Technology R&D Program)	The authors gratefully acknowledge the National Key Project for Basic Research (2010CB126106) and the National Natural Science Foundation of China (21132003, 21121002) and China Postdoctoral Science Foundation (20090460057, 2011M500519, 2012T50207) for financial support. The authors thank China Agricultural University to supply some of chemical reagents and the National Key Technology Research and Development Program (2012BAK25B03-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An TY, 2001, PHYTOCHEMISTRY, V58, P1267, DOI 10.1016/S0031-9422(01)00382-X; Bos L., 1982, Crop Protection, V1, P263, DOI 10.1016/0261-2194(82)90002-3; Cardenas M, 2006, BIOORGAN MED CHEM, V14, P2966, DOI 10.1016/j.bmc.2005.12.021; CHAN RIM, 1986, CANCER LETT, V31, P27, DOI 10.1016/0304-3835(86)90163-1; Chaves N, 2001, J CHEM ECOL, V27, P611, DOI 10.1023/A:1010336921853; Chen HM, 1996, J AGR FOOD CHEM, V44, P2619, DOI 10.1021/jf950833m; Creager Angela N. H., 1999, Plant Cell, V11, P301; Guardiola F, 1996, FOOD CHEM TOXICOL, V34, P193, DOI 10.1016/0278-6915(95)00094-1; Han CK, 2000, BIOORG MED CHEM LETT, V10, P39, DOI 10.1016/S0960-894X(99)00577-6; Hu DY, 2008, J AGR FOOD CHEM, V56, P998, DOI 10.1021/jf072394k; Hudson EA, 2000, CANCER EPIDEM BIOMAR, V9, P1163; Lam A, 2008, J AGR FOOD CHEM, V56, P11407, DOI 10.1021/jf8021942; Laranjinha J, 1996, BIOCHEM PHARMACOL, V51, P395, DOI 10.1016/0006-2952(95)02171-X; Li DD, 2011, BIOORGAN MED CHEM, V19, P5012, DOI 10.1016/j.bmc.2011.06.044; Long N, 2008, J AGR FOOD CHEM, V56, P5242, DOI 10.1021/jf800405m; Luo Y, 2011, BIOORGAN MED CHEM, V19, P4730, DOI 10.1016/j.bmc.2011.06.088; Nystrom L, 2005, J AGR FOOD CHEM, V53, P2503, DOI 10.1021/jf048051t; Park IK, 2000, J AGR FOOD CHEM, V48, P2528, DOI 10.1021/jf9904160; Qian XH, 2010, J AGR FOOD CHEM, V58, P2613, DOI 10.1021/jf904098w; Ren YP, 2010, PHARM RES-DORDR, V27, P2509, DOI 10.1007/s11095-010-0251-2; Ritzenthaler C, 2005, CURR OPIN BIOTECH, V16, P118, DOI 10.1016/j.copbio.2005.02.009; Seiber JN, 2011, J AGR FOOD CHEM, V59, P1, DOI 10.1021/jf1046078; TANAKA A, 1971, YUKAGAKU, V20, P792; van der Watt E, 2001, J ETHNOPHARMACOL, V76, P87, DOI 10.1016/S0378-8741(01)00197-0; Walker TS, 2003, J AGR FOOD CHEM, V51, P2548, DOI 10.1021/jf021166h; Wang KL, 2010, J AGR FOOD CHEM, V58, P2703, DOI 10.1021/jf902543r; Wei L. Z., 2010, Antiviral composition containing fucoidan and ribavirin for preventing and treating plant viral diseases, Patent No. [CN 101869111 A, 101869111]; Wu M, 2011, ORG BIOMOL CHEM, V9, P141, DOI 10.1039/c0ob00287a; Yamashita S, 2009, EUR J ORG CHEM, V2009, P1173, DOI 10.1002/ejoc.200801047; Yasukawa K, 1998, BIOL PHARM BULL, V21, P1072, DOI 10.1248/bpb.21.1072; [钟江春 Zhong Jiangchun], 2005, [化学试剂, Chemical Reagents], V27, P241; Zou HB, 2006, BIOORGAN MED CHEM, V14, P2060, DOI 10.1016/j.bmc.2005.10.056; Zou HB, 2010, BIOORGAN MED CHEM, V18, P6351, DOI 10.1016/j.bmc.2010.07.016; 胡益勇, 2006, [中成药, Chinese Traditional Patent Medicine], V28, P253	34	11	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56475	10.1371/journal.pone.0056475	http://dx.doi.org/10.1371/journal.pone.0056475			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418574	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300167
J	Siemens, N; Kreikemeyer, B				Siemens, Nikolai; Kreikemeyer, Bernd			Heterologous Expression of Ralp3 in Streptococcus pyogenes M2 and M6 Strains Affects the Virulence Characteristics	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; SEROTYPE M49; PATHOGENICITY REGION; PROTEIN F1; BINDING; FIBRONECTIN; STREPTOKINASE; INVASION; CELLS; TRANSCRIPTION	Background: Ralp3 is a transcriptional regulator present in a serotype specific fashion on the chromosome of the human pathogen Streptococcus pyogenes (group A streptococci, GAS). In serotypes harbouring the ralp3 gene either positive or negative effects on important metabolic and virulence genes involved in colonization and immune evasion in the human host were observed. A previous study revealed that deletion of ralp3 in a GAS M49 serotype significantly attenuated many virulence traits and caused metabolic disadvantages. This leads to two questions: (i) which kind of consequences could Ralp3 expression have in GAS serotypes naturally lacking this gene, and (ii) is Ralp3 actively lost during evolution in these serotypes. Methodology/Principal Findings: We investigated the role of Ralp3 in GAS M2 and M6 pathogenesis. Both serotypes lack ralp3 on their chromosome. The heterologous expression of ralp3 in both serotypes resulted in reduced attachment to and internalization into the majority of tested epithelial cells. Both ralp3 expression strains showed a decreased ability to survive in human blood and exclusively M2:: ralp3 showed decreased survival in human serum. Both mutants secreted more active SpeB in the supernatant, resulting in a higher activity compared to wild type strains. The respective M2 and M6 wild type strains outcompeted the ralp3 expression strains in direct metabolic competition assays. The phenotypic changes observed in the M2: ralp3 and M6: ralp3 were verified on the transcriptional level. Consistent with the virulence data, tested genes showed transcript level changes in the same direction. Conclusions/Significance: Together these data suggest that Ralp3 can take over transcriptional control of virulence genes in serotypes lacking the ralp3 gene. Those serotypes most likely lost Ralp3 during evolution since obviously expression of this gene is disadvantageous for metabolism and pathogenesis.	[Siemens, Nikolai; Kreikemeyer, Bernd] Univ Rostock, Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, D-18055 Rostock, Germany	University of Rostock	Kreikemeyer, B (corresponding author), Univ Rostock, Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, D-18055 Rostock, Germany.	bernd.kreikemeyer@med.uni-rostock.de		Kreikemeyer, Bernd/0000-0001-9527-5098; Siemens, Nikolai/0000-0003-0657-3822	Federal Ministry of Education and Research (BMBF): BMBF ERANet "Pathogenomics" II; Rostock University Medical Faculty FORUN program; BMBF ERANet "SysMO" II	Federal Ministry of Education and Research (BMBF): BMBF ERANet "Pathogenomics" II; Rostock University Medical Faculty FORUN program; BMBF ERANet "SysMO" II	The work of NS and BK was supported by the following grants awarded from the Federal Ministry of Education and Research (BMBF): BMBF ERANet "Pathogenomics" II and BMBF ERANet "SysMO" II. The authors further acknowledge funds from the Rostock University Medical Faculty FORUN program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckert S, 2001, INFECT IMMUN, V69, P534, DOI 10.1128/IAI.69.1.534-537.2001; Boyle MDP, 1997, THROMB HAEMOSTASIS, V77, P1; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carroll RK, 2011, MOL MICROBIOL, V81, P588, DOI 10.1111/j.1365-2958.2011.07709.x; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fiedler T, 2010, INT J MED MICROBIOL, V300, P248, DOI 10.1016/j.ijmm.2009.07.004; Granok AB, 2000, J BACTERIOL, V182, P1529, DOI 10.1128/JB.182.6.1529-1540.2000; HANSKI E, 1992, P NATL ACAD SCI USA, V89, P6172, DOI 10.1073/pnas.89.13.6172; Hytonen J, 2001, MOL MICROBIOL, V39, P512, DOI 10.1046/j.1365-2958.2001.02269.x; Jadoun J, 1998, J INFECT DIS, V178, P147, DOI 10.1086/515589; Kreikemeyer B, 2004, J BIOL CHEM, V279, P15850, DOI 10.1074/jbc.M313613200; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kreikemeyer B, 1999, FEMS MICROBIOL LETT, V178, P305, DOI 10.1016/S0378-1097(99)00373-0; Kreikemeyer B, 2001, MOL MICROBIOL, V39, P392, DOI 10.1046/j.1365-2958.2001.02226.x; Kreikemeyer B, 2007, INFECT IMMUN, V75, P5698, DOI 10.1128/IAI.00175-07; Kwinn LA, 2007, J BACTERIOL, V189, P1322, DOI 10.1128/JB.01256-06; Loughman JA, 2007, MOL MICROBIOL, V64, P269, DOI 10.1111/j.1365-2958.2007.05663.x; Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263; Nakata M, 2009, INFECT IMMUN, V77, P32, DOI 10.1128/IAI.00772-08; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004; Rezcallah MS, 2004, MICROBIOL-SGM, V150, P365, DOI 10.1099/mic.0.26826-0; Ribardo DA, 2006, MOL MICROBIOL, V62, P491, DOI 10.1111/j.1365-2958.2006.05381.x; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; ROSEY EL, 1991, J BACTERIOL, V173, P5992, DOI 10.1128/jb.173.19.5992-5998.1991; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Siemens N, 2012, J BACTERIOL, V194, P3618, DOI 10.1128/JB.00227-12; Siemens N, 2011, J BIOL CHEM, V286, P21612, DOI 10.1074/jbc.M110.202671; Sun HM, 2012, P NATL ACAD SCI USA, V109, P3469, DOI 10.1073/pnas.1201031109	31	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55109	10.1371/journal.pone.0055109	http://dx.doi.org/10.1371/journal.pone.0055109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424622	Green Published, Green Submitted, gold			2022-12-27	WOS:000315965100010
J	Agarwal, A; Boettcher, A; Kneuer, R; Sari-Sarraf, F; Donovan, A; Woelcke, J; Simic, O; Brandl, T; Krucker, T				Agarwal, Abhiruchi; Boettcher, Andreas; Kneuer, Rainer; Sari-Sarraf, Farid; Donovan, Adriana; Woelcke, Julian; Simic, Oliver; Brandl, Trixi; Krucker, Thomas			In Vivo Imaging with Fluorescent Smart Probes to Assess Treatment Strategies for Acute Pancreatitis	PLOS ONE			English	Article							IDIOPATHIC CHRONIC-PANCREATITIS; HUMAN CATHEPSIN-L; HEREDITARY PANCREATITIS; TRYPSINOGEN; SECRETAGOGUE; MUTATIONS; MICE; ACTIVATION; DIAGNOSIS; TUMORS	Background and Aims: Endoprotease activation is a key step in acute pancreatitis and early inhibition of these enzymes may protect from organ damage. In vivo models commonly used to evaluate protease inhibitors require animal sacrifice and therefore limit the assessment of dynamic processes. Here, we established a non-invasive fluorescence imaging-based biomarker assay to assess real-time protease inhibition and disease progression in a preclinical model of experimental pancreatitis. Methods: Edema development and trypsin activation were imaged in a rat caerulein-injection pancreatitis model. A fluorescent "smart'' probe, selectively activated by trypsin, was synthesized by labeling with Cy5.5 of a pegylated poly-L-lysine copolymer. Following injection of the probe, trypsin activation was monitored in the presence or absence of inhibitors by in vivo and ex vivo imaging. Results: We established the trypsin-selectivity of the fluorescent probe in vitro using a panel of endopeptidases and specific inhibitor. In vivo, the probe accumulated in the liver and a region attributed to the pancreas by necropsy. A dose dependent decrease of total pancreatic fluorescence signal occurred upon administration of known trypsin inhibitors. The fluorescence-based method was a better predictor of trypsin inhibition than pancreatic to body weight ratio. Conclusions: We established a fluorescence imaging assay to access trypsin inhibition in real-time in vivo. This method is more sensitive and dynamic than classic tissue sample readouts and could be applied to preclinically optimize trypsin inhibitors towards intrapancreatic target inhibition.	[Agarwal, Abhiruchi; Sari-Sarraf, Farid; Donovan, Adriana; Krucker, Thomas] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Boettcher, Andreas; Kneuer, Rainer; Woelcke, Julian; Simic, Oliver; Brandl, Trixi] Novartis Inst BioMed Res, Basel, Switzerland; [Krucker, Thomas] Novartis Inst BioMed Res, Emeryville, CA USA	Novartis; Novartis; Novartis	Krucker, T (corresponding author), Novartis Inst BioMed Res, Cambridge, MA 02139 USA.	thomas.krucker@novartis.com			Novartis organization	Novartis organization	Funding of this research was provided solely within the Novartis organization as per standard research activities. The funders (NIBR) had no role in study design, data collection and analysis, or preparation of the manuscript. The manuscript was assessed by the Novartis legal department as well as senior management in chemistry and biology (Infectious diseases and Center for Proteomic Chemistry) to ascertain that release of this manuscript did not contravene Novartis policy regarding release of proprietary information, but this was limited only to approval for release of the material and was not related to the results or interpretations/conclusions contained in the manuscript.	Bhoomagoud M, 2009, GASTROENTEROLOGY, V137, P1083, DOI 10.1053/j.gastro.2009.05.041; Bouchard MB, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2799188; Bremer C, 2001, RADIOLOGY, V221, P523, DOI 10.1148/radiol.2212010368; Carroll JK, 2007, AM FAM PHYSICIAN, V75, P1513; Chan YC, 2007, PANCREAS, V34, P1, DOI 10.1097/01.mpa.0000246658.38375.04; Chen CC, 2007, J PANCREAS, V8, P488; Festugato M, 2008, J PANCREAS, V9, P275; Fujishima A, 1997, FEBS LETT, V407, P47, DOI 10.1016/S0014-5793(97)00216-0; Hohenblum H, 2004, J BIOTECHNOL, V109, P3, DOI 10.1016/j.jbiotec.2003.10.022; Ishikura H, 2007, LIFE SCI, V80, P1999, DOI 10.1016/j.lfs.2007.02.044; Kobayashi H, 2011, ACCOUNTS CHEM RES, V44, P83, DOI 10.1021/ar1000633; Kobayashi H, 2010, LANCET ONCOL, V11, P589, DOI 10.1016/S1470-2045(10)70009-7; Kylanpaa-Back Marja Leena, 2002, JOP, V3, P34; LAMPEL M, 1977, VIRCHOWS ARCH A, V373, P97, DOI 10.1007/BF00432156; Law B, 2004, CHEM BIOL, V11, P99, DOI 10.1016/j.chembiol.2003.12.017; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Levenson RM, 2008, ILAR J, V49, P78, DOI 10.1093/ilar.49.1.78; Mansfield JR, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032458; Marten K, 2002, GASTROENTEROLOGY, V122, P406, DOI 10.1053/gast.2002.30990; Masson E, 2008, CLIN GASTROENTEROL H, V6, P82, DOI 10.1016/j.cgh.2007.10.004; Nomura T, 1997, BIOCHEM BIOPH RES CO, V230, P143, DOI 10.1006/bbrc.1996.5905; Nomura T, 1996, BIOCHEM BIOPH RES CO, V228, P792, DOI 10.1006/bbrc.1996.1733; Ohmuraya M, 2005, GASTROENTEROLOGY, V129, P696, DOI 10.1053/j.gastro.2005.05.057; Rickes S, 2009, POSTGRAD MED J, V85, P208, DOI 10.1136/pgmj.2008.070615; Sah RP, 2011, GUT; Saluja AK, 2007, ANNU REV PHYSIOL, V69, P249, DOI 10.1146/annurev.physiol.69.031905.161253; Schneider A, 2004, SCAND J GASTROENTERO, V39, P903, DOI 10.1080/00365520410006710; Shah AU, 2009, AM J PHYSIOL-GASTR L, V297, pG967, DOI 10.1152/ajpgi.00181.2009; Spanier BWM, 2008, BEST PRACT RES CL GA, V22, P45, DOI 10.1016/j.bpg.2007.10.007; SWEIRY JH, 1991, AM J PHYSIOL, V261, pG685, DOI 10.1152/ajpgi.1991.261.4.G685; TANI S, 1987, INT J PANCREATOL, V2, P337; Teich N, 2006, HUM MUTAT, V27, P721, DOI 10.1002/humu.20343; Tung CH, 1999, BIOCONJUGATE CHEM, V10, P892, DOI 10.1021/bc990052h; Urano Y, 2009, NAT MED, V15, P104, DOI 10.1038/nm.1854; Van Acker GJD, 2007, AM J PHYSIOL-GASTR L, V292, pG1738, DOI 10.1152/ajpgi.00543.2006; Warzecha Z, 2010, J PHYSIOL PHARMACOL, V61, P419; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Whitcomb DC, 2007, DIGEST DIS SCI, V52, P1, DOI 10.1007/s10620-006-9589-z; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; WILLEMER S, 1992, EUR SURG RES, V24, P29, DOI 10.1159/000129237; WISNER JR, 1989, INT J PANCREATOL, V4, P383	43	5	5	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55959	10.1371/journal.pone.0055959	http://dx.doi.org/10.1371/journal.pone.0055959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409095	gold, Green Published, Green Submitted			2022-12-27	WOS:000315100000034
J	Cao, GJ; Meng, JH; Strain, E; Stones, R; Pettengill, J; Zhao, SH; McDermott, P; Brown, E; Allard, M				Cao, Guojie; Meng, Jianghong; Strain, Errol; Stones, Robert; Pettengill, James; Zhao, Shaohua; McDermott, Patrick; Brown, Eric; Allard, Marc			Phylogenetics and Differentiation of Salmonella Newport Lineages by Whole Genome Sequencing	PLOS ONE			English	Article							PROVIDES ACQUIRED-RESISTANCE; FIELD GEL-ELECTROPHORESIS; ESCHERICHIA-COLI; POSITIVE SELECTION; ENTERICA; RECOMBINATION; EVOLUTION; CRISPR; ALIGNMENT; STRAINS	Salmonella Newport has ranked in the top three Salmonella serotypes associated with foodborne outbreaks from 1995 to 2011 in the United States. In the current study, we selected 26 S. Newport strains isolated from diverse sources and geographic locations and then conducted 454 shotgun pyrosequencing procedures to obtain 16-24 x coverage of high quality draft genomes for each strain. Comparative genomic analysis of 28 S. Newport strains (including 2 reference genomes) and 15 outgroup genomes identified more than 140,000 informative SNPs. A resulting phylogenetic tree consisted of four sublineages and indicated that S. Newport had a clear geographic structure. Strains from Asia were divergent from those from the Americas. Our findings demonstrated that analysis using whole genome sequencing data resulted in a more accurate picture of phylogeny compared to that using single genes or small sets of genes. We selected loci around the mutS gene of S. Newport to differentiate distinct lineages, including those between invH and mutS genes at the 39 end of Salmonella Pathogenicity Island 1 (SPI-1), ste fimbrial operon, and Clustered, Regularly Interspaced, Short Palindromic Repeats (CRISPR) associated-proteins (cas). These genes in the outgroup genomes held high similarity with either S. Newport Lineage II or III at the same loci. S. Newport Lineages II and III have different evolutionary histories in this region and our data demonstrated genetic flow and homologous recombination events around mutS. The findings suggested that S. Newport Lineages II and III diverged early in the serotype evolution and have evolved largely independently. Moreover, we identified genes that could delineate sublineages within the phylogenetic tree and that could be used as potential biomarkers for trace-back investigations during outbreaks. Thus, whole genome sequencing data enabled us to better understand the genetic background of pathogenicity and evolutionary history of S. Newport and also provided additional markers for epidemiological response.	[Cao, Guojie; Meng, Jianghong] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Strain, Errol] US FDA, Biostat Branch, Ctr Food Safety & Appl Nutr, College Pk, MD USA; [Stones, Robert] Food & Environm Res Agcy, York, N Yorkshire, England; [Pettengill, James; Brown, Eric; Allard, Marc] US FDA, Div Microbiol, Off Regular Sci, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA; [Zhao, Shaohua; McDermott, Patrick] US FDA, Div Anim & Food Microbiol, Res Off, Ctr Vet Med, Laurel, MD USA	University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA); Food & Environment Research Agency; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Allard, M (corresponding author), US FDA, Div Microbiol, Off Regular Sci, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.	marc.allard@fda.hhs.gov	McDermott, Patrick F./ABE-4374-2021	McDermott, Patrick F./0000-0003-1868-8096	U.S. Food and Drug Administration	U.S. Food and Drug Administration	Research funds were provided by the U.S. Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-32; [Anonymous], 2007, ANTIGENIC FORMULAE S; Attorney S, 2011, SPROUT SALMONELLA NE; Attorney S, 2009, MULTISTATE SALMONELL; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bell RL, 2012, SALMONELLA IN PRESS; BELTRAN P, 1988, P NATL ACAD SCI USA, V85, P7753, DOI 10.1073/pnas.85.20.7753; Brown EW, 2003, P NATL ACAD SCI USA, V100, P15676, DOI 10.1073/pnas.2634406100; Brown EW, 2002, MOL PHYLOGENET EVOL, V24, P102, DOI 10.1016/S1055-7903(02)00222-1; *CDC, 2010, INV UPD MULT OUTBR H; *CDC, 2006, SALM SURV ANN SUMM; Chang G, 2003, FEBS LETT, V555, P102, DOI 10.1016/S0014-5793(03)01085-8; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; den Bakker HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-425; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Didelot X, 2007, GENOME RES, V17, P61, DOI 10.1101/gr.5512906; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Didelot X, 2010, TRENDS MICROBIOL, V18, P315, DOI 10.1016/j.tim.2010.04.002; Dunne EF, 2000, JAMA-J AM MED ASSOC, V284, P3151, DOI 10.1001/jama.284.24.3151; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fey PD, 2000, NEW ENGL J MED, V342, P1242, DOI 10.1056/NEJM200004273421703; Fookes M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002191; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Fricke WF, 2009, J BACTERIOL, V191, P4750, DOI 10.1128/JB.00189-09; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Groisman EA, 1997, TRENDS MICROBIOL, V5, P343, DOI 10.1016/S0966-842X(97)01099-8; Harbottle H, 2006, J CLIN MICROBIOL, V44, P2449, DOI 10.1128/JCM.00019-06; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hu QH, 2008, J CLIN MICROBIOL, V46, P1330, DOI 10.1128/JCM.01255-07; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Klimke W, 2009, NUCLEIC ACIDS RES, V37, pD216, DOI 10.1093/nar/gkn734; Lama A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034037; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Lienau EK, 2011, NEW ENGL J MED, V364, P981, DOI 10.1056/NEJMc1100443; Maki DG, 2009, NEW ENGL J MED, V360, P949, DOI 10.1056/NEJMp0806575; Matsumura K, 2011, BIOCONTROL SCI, V16, P69, DOI 10.4265/bio.16.69; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; MILLS DM, 1995, MOL MICROBIOL, V15, P749, DOI 10.1111/j.1365-2958.1995.tb02382.x; Orsi RH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-233; Osborne SE, 2012, J BIOL CHEM; Park AK, 2010, FEMS MICROBIOL LETT, V309, P151, DOI 10.1111/j.1574-6968.2010.02031.x; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Porwollik S, 2011, SALMONELLA: FROM GENOME TO FUNCTION, P1; Sangal V, 2010, J BACTERIOL, V192, P6465, DOI 10.1128/JB.00969-10; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; SELANDER RK, 1990, INFECT IMMUN, V58, P2262, DOI 10.1128/IAI.58.7.2262-2275.1990; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Sukhnanand S, 2005, J CLIN MICROBIOL, V43, P3688, DOI 10.1128/JCM.43.8.3688-3698.2005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torpdahl M, 2005, J MICROBIOL METH, V63, P173, DOI 10.1016/j.mimet.2005.03.006; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Vale PF, 2010, P ROY SOC B-BIOL SCI, V277, P2097, DOI 10.1098/rspb.2010.0055; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yamasaki S, 2011, J ANTIBIOT, V64, P433, DOI 10.1038/ja.2011.28	62	48	48	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55687	10.1371/journal.pone.0055687	http://dx.doi.org/10.1371/journal.pone.0055687			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409020	gold, Green Published, Green Submitted			2022-12-27	WOS:000315100000020
J	Mori, T; Koyama, N; Guillot-Sestier, MV; Tan, J; Town, T				Mori, Takashi; Koyama, Naoki; Guillot-Sestier, Marie-Victoire; Tan, Jun; Town, Terrence			Ferulic Acid Is a Nutraceutical beta-Secretase Modulator That Improves Behavioral Impairment and Alzheimer-like Pathology in Transgenic Mice	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; MOUSE MODEL; OXIDATIVE STRESS; A-BETA; COGNITIVE IMPAIRMENT; CEREBRAL AMYLOIDOSIS; ASPARTYL PROTEASE; MEMORY DEFICITS; IN-VITRO; DISEASE	Amyloid precursor protein (APP) proteolysis is required for production of amyloid-beta (A beta) peptides that comprise beta-amyloid plaques in brains of Alzheimer's disease (AD) patients. Recent AD therapeutic interest has been directed toward a group of anti-amyloidogenic compounds extracted from plants. We orally administered the brain penetrant, small molecule phenolic compound ferulic acid (FA) to the transgenic PSAPP mouse model of cerebral amyloidosis (bearing mutant human APP and presenilin-1 transgenes) and evaluated behavioral impairment and AD-like pathology. Oral FA treatment for 6 months reversed transgene-associated behavioral deficits including defective: hyperactivity, object recognition, and spatial working and reference memory, but did not alter wild-type mouse behavior. Furthermore, brain parenchymal and cerebral vascular beta-amyloid deposits as well as abundance of various A beta species including oligomers were decreased in FA-treated PSAPP mice. These effects occurred with decreased cleavage of the beta-carboxyl-terminal APP fragment, reduced beta-site APP cleaving enzyme 1 protein stability and activity, attenuated neuroinflammation, and stabilized oxidative stress. As in vitro validation, we treated well-characterized mutant human APP-overexpressing murine neuron-like cells with FA and found significantly decreased A beta production and reduced amyloidogenic APP proteolysis. Collectively, these results highlight that FA is a beta-secretase modulator with therapeutic potential against AD.	[Mori, Takashi; Koyama, Naoki] Saitama Med Ctr & Univ, Dept Biomed Sci, Kawagoe, Saitama, Japan; [Mori, Takashi] Saitama Med Ctr & Univ, Dept Pathol, Kawagoe, Saitama, Japan; [Guillot-Sestier, Marie-Victoire; Town, Terrence] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Tan, Jun] Univ S Florida, Morsoni Coll Med, Dept Psychiat & Behav Neurosci, Silver Child Dev Ctr,Rashid Lab Dev Neurobiol, Tampa, FL USA; [Tan, Jun] Univ S Florida, Morsoni Coll Med, Dept Psychiat & Behav Neurosci, Neuroimmunol Lab, Tampa, FL USA; [Town, Terrence] Cedars Sinai Med Ctr, Regenerat Med Inst, Neural Program, Los Angeles, CA 90048 USA; [Town, Terrence] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	Saitama Medical University; Saitama Medical University; Cedars Sinai Medical Center; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mori, T (corresponding author), Saitama Med Ctr & Univ, Dept Biomed Sci, Kawagoe, Saitama, Japan.	t_mori@saitama-med.ac.jp; terrence.town@csmc.edu		Guillot-Sestier, Marie-Victoire/0000-0001-9674-7114	National Institute of Neurological Disorders and Stroke [5R00AG029726-04, 3R00AG029726-04S1, 1R01NS076794-01]; Japan Society for the Promotion of Science [22500320]; Alzheimer's Association Zenith Fellows Award [ZEN-10-174633]; American Federation of Aging Research/Ellison, and Medical Foundation Julie Martin Mid-Career Award in Aging Research [M11472]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032432, R00AG029726] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Alzheimer's Association Zenith Fellows Award(Alzheimer's Association); American Federation of Aging Research/Ellison, and Medical Foundation Julie Martin Mid-Career Award in Aging Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute of Neurological Disorders and Stroke(5R00AG029726-04, 3R00AG029726-04S1, and 1R01NS076794-01) to T. T., Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (22500320) to T. M., Alzheimer's Association Zenith Fellows Award (ZEN-10-174633) to T. T., and an American Federation of Aging Research/Ellison, and Medical Foundation Julie Martin Mid-Career Award in Aging Research (M11472) to T. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; Balasubashini MS, 2004, PHYTOTHER RES, V18, P310, DOI 10.1002/ptr.1440; BARNES DG, 1988, REGUL TOXICOL PHARM, V8, P471, DOI 10.1016/0273-2300(88)90047-5; Benzing WC, 1999, NEUROBIOL AGING, V20, P581, DOI 10.1016/S0197-4580(99)00065-2; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Breitner J, 2007, AM J MED, V120, pE3, DOI 10.1016/j.amjmed.2006.09.022; Brookmeyer R, 2000, STAT MED, V19, P1481, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1481::AID-SIM440>3.0.CO;2-U; Cheng CY, 2008, BRAIN RES, V1209, P136, DOI 10.1016/j.brainres.2008.02.090; Cheng CY, 2010, ACTA PHARMACOL SIN, V31, P889, DOI 10.1038/aps.2010.66; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; De Rosa R, 2005, P NATL ACAD SCI USA, V102, P3811, DOI 10.1073/pnas.0500195102; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; Dourson ML, 1996, REGUL TOXICOL PHARM, V24, P108, DOI 10.1006/rtph.1996.0116; Ellis RJ, 1996, NEUROLOGY, V46, P1592, DOI 10.1212/WNL.46.6.1592; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Gandhi S, 2004, J MOL NEUROSCI, V24, P137, DOI 10.1385/JMN:24:1:137; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Georgiou NA, 2011, EUR J PHARMACOL, V651, P1, DOI 10.1016/j.ejphar.2010.11.007; Goldsbury C, 2008, AGING CELL, V7, P771, DOI 10.1111/j.1474-9726.2008.00423.x; Good M, 1997, BEHAV NEUROSCI, V111, P487, DOI 10.1037/0735-7044.111.3.487; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Kanski J, 2002, J NUTR BIOCHEM, V13, P273, DOI 10.1016/S0955-2863(01)00215-7; Kawabata K, 2000, CANCER LETT, V157, P15, DOI 10.1016/S0304-3835(00)00461-4; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim KS, 2006, J NEUROSCI RES, V83, P497, DOI 10.1002/jnr.20754; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; Koh PO, 2012, NEUROSCI LETT, V507, P156, DOI 10.1016/j.neulet.2011.12.012; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Laghmouch A, 1997, BEHAV GENET, V27, P67, DOI 10.1023/A:1025667426222; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Montine TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009340; Mori T, 2006, J PHARMACOL EXP THER, V318, P571, DOI 10.1124/jpet.106.105171; Mori T, 2012, J BIOL CHEM, V287, P6912, DOI 10.1074/jbc.M111.294025; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Obregon DF, 2006, J BIOL CHEM, V281, P16419, DOI 10.1074/jbc.M600617200; Oddo S, 2006, J BIOL CHEM, V281, P39413, DOI 10.1074/jbc.M608485200; Pappolla MA, 1998, AM J PATHOL, V152, P871; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; Qin J, 2008, DRUG DEV IND PHARM, V34, P602, DOI [10.1080/03639040701833559, 10.1080/03639040701833559 ]; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; Rezai-Zadeh K, 2009, J CELL MOL MED, V13, P574, DOI 10.1111/j.1582-4934.2008.00344.x; ROZEMULLER JM, 1989, J NEUROPATH EXP NEUR, V48, P674, DOI 10.1097/00005072-198911000-00009; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023; Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; Sultana R, 2005, J NEUROCHEM, V92, P749, DOI 10.1111/j.1471-4159.2004.02899.x; Tan J, 2002, NAT NEUROSCI, V5, P1288, DOI 10.1038/nn968; Tan J, 2000, J NEUROSCI, V20, P7587; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565; Yabe T, 2010, NEUROSCIENCE, V165, P515, DOI 10.1016/j.neuroscience.2009.10.023; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Zhao ZH, 2004, J NUTR, V134, P3083, DOI 10.1093/jn/134.11.3083; Zhu YY, 2011, J NEUROSCI, V31, P1355, DOI 10.1523/JNEUROSCI.3268-10.2011	84	119	125	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55774	10.1371/journal.pone.0055774	http://dx.doi.org/10.1371/journal.pone.0055774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409038	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300033
J	Chakrabarti, M; Banik, NL; Ray, SK				Chakrabarti, Mrinmay; Banik, Naren L.; Ray, Swapan K.			Photofrin Based Photodynamic Therapy and miR-99a Transfection Inhibited FGFR3 and PI3K/Akt Signaling Mechanisms to Control Growth of Human Glioblastoma In Vitro and In Vivo	PLOS ONE			English	Article							MALIGNANT BRAIN-TUMORS; ANTITUMOR IMMUNITY; ENDOTHELIAL-CELLS; GENE-EXPRESSION; GLIOMA-CELLS; HUMAN CANCER; MICRORNAS; APOPTOSIS; SURVIVAL; RADIOTHERAPY	Glioblastoma is the most common malignant brain tumor in humans. We explored the molecular mechanisms how the efficacy of photofrin based photodynamic therapy (PDT) was enhanced by miR-99a transfection in human glioblastoma cells. Our results showed almost similar uptake of photofrin after 24 h in different glioblastoma cells, but p53 wild-type cells were more sensitive to radiation and photofrin doses than p53 mutant cells. Photofrin based PDT induced apoptosis, inhibited cell invasion, prevented angiogenic network formation, and promoted DNA fragmentation and laddering in U87MG and U118MG cells harvoring p53 wild-type. Western blotting showed that photofrin based PDT was efficient to block the angiogenesis and cell survival pathways. Further, photofrin based PDT followed by miR-99a transfection dramatically increased miR-99a expression and also increased apoptosis in glioblastoma cell cultures and drastically reduced tumor growth in athymic nude mice, due to down regulation of fibroblast growth factor receptor 3 (FGFR3) and PI3K/Akt signaling mechanisms leading to inhibition of cell proliferation and induction of molecular mechanisms of apoptosis. Therefore, our results indicated that the anti-tumor effects of photofrin based PDT was strongly augmented by miR-99a overexpression and this novel combination therapeutic strategy could be used for controlling growth of human p53 wildtype glioblastomas both in vitro and in vivo.	[Chakrabarti, Mrinmay; Ray, Swapan K.] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Banik, Naren L.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina	Ray, SK (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	swapan.ray@uscmed.sc.edu	CHAKRABARTI, MRINMAY/M-5652-2019					Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Au CM, 2006, J PHOTOCH PHOTOBIO B, V85, P92, DOI 10.1016/j.jphotobiol.2006.06.002; Bonauer A, 2010, CURR DRUG TARGETS, V11, P943, DOI 10.2174/138945010791591313; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Eljamel MS, 2008, LASER MED SCI, V23, P361, DOI 10.1007/s10103-007-0494-2; Eljamel MS, 2003, TECHNOL CANCER RES T, V2, P303, DOI 10.1177/153303460300200404; Eljamel S, 2010, PHOTODIAGN PHOTODYN, V7, P76, DOI 10.1016/j.pdpdt.2010.02.002; Engbrecht BW, 1999, CANCER RES, V59, P4334; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fowler A, 2011, EUR J CANCER, V47, P953, DOI 10.1016/j.ejca.2010.11.026; Garg AD, 2010, APOPTOSIS, V15, P1050, DOI 10.1007/s10495-010-0479-7; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gollnick SO, 2010, IMMUNOL RES, V46, P216, DOI 10.1007/s12026-009-8119-4; Goodell T T, 2001, J Neurosci Nurs, V33, P296; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Gupta AK, 2002, CLIN CANCER RES, V8, P885; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; HERRMANN M, 1994, NUCLEIC ACIDS RES, V22, P5506, DOI 10.1093/nar/22.24.5506; Hirschberg H, 2008, LASER SURG MED, V40, P535, DOI 10.1002/lsm.20670; Hsieh YJ, 2003, J CELL PHYSIOL, V194, P363, DOI 10.1002/jcp.10273; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kabingu E, 2009, CLIN CANCER RES, V15, P4460, DOI 10.1158/1078-0432.CCR-09-0400; Karmakar S, 2008, CANCER, V112, P596, DOI 10.1002/cncr.23223; Karmakar Surajit, 2010, J Cancer Sci Ther, V2, P107; Krishnamurthy S, 2000, LASER SURG MED, V27, P224, DOI 10.1002/1096-9101(2000)27:3<224::AID-LSM4>3.0.CO;2-#; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Marcu LG, 2010, CANCER TREAT REV, V36, P606, DOI 10.1016/j.ctrv.2010.04.004; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Mueller AC, 2013, ONCOGENE, V32, P1164, DOI 10.1038/onc.2012.131; O'Gorman DM, 2001, LEUKEMIA, V15, P21, DOI 10.1038/sj.leu.2401998; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Silbergeld DL, 1997, J NEUROSURG, V86, P525, DOI 10.3171/jns.1997.86.3.0525; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stylli SS, 2004, J CLIN NEUROSCI, V11, P584, DOI 10.1016/j.jocn.2004.02.001; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Takeshita F, 2005, P NATL ACAD SCI USA, V102, P12177, DOI 10.1073/pnas.0501753102; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Yang VXD, 2003, LASER SURG MED, V32, P224, DOI 10.1002/lsm.10131; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zimmermann A, 2001, PHOTOCHEM PHOTOBIOL, V74, P611, DOI 10.1562/0031-8655(2001)074<0611:MMPDOM>2.0.CO;2	54	41	42	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55652	10.1371/journal.pone.0055652	http://dx.doi.org/10.1371/journal.pone.0055652			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409016	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200048
J	Green, NS; Ender, KL; Pashankar, F; Driscoll, C; Giardina, PJ; Mullen, CA; Clark, LN; Manwani, D; Crotty, J; Kisselev, S; Neville, KA; Hoppe, C; Barral, S				Green, Nancy S.; Ender, Katherine L.; Pashankar, Farzana; Driscoll, Catherine; Giardina, Patricia J.; Mullen, Craig A.; Clark, Lorraine N.; Manwani, Deepa; Crotty, Jennifer; Kisselev, Sergey; Neville, Kathleen A.; Hoppe, Carolyn; Barral, Sandra			Candidate Sequence Variants and Fetal Hemoglobin in Children with Sickle Cell Disease Treated with Hydroxyurea	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ANEMIA; HBF; BCL11A; POLYMORPHISMS; DETERMINANTS; MODIFIERS; HBS1L-MYB	Background: Fetal hemoglobin level is a heritable complex trait that strongly correlates swith the clinical severity of sickle cell disease. Only few genetic loci have been identified as robustly associated with fetal hemoglobin in patients with sickle cell disease, primarily adults. The sole approved pharmacologic therapy for this disease is hydroxyurea, with effects largely attributable to induction of fetal hemoglobin. Methodology/Principal Findings: In a multi-site observational analysis of children with sickle cell disease, candidate single nucleotide polymorphisms associated with baseline fetal hemoglobin levels in adult sickle cell disease were examined in children at baseline and induced by hydroxyurea therapy. For baseline levels, single marker analysis demonstrated significant association with BCL11A and the beta and epsilon globin loci (HBB and HBE, respectively), with an additive attributable variance from these loci of 23%. Among a subset of children on hydroxyurea, baseline fetal hemoglobin levels explained 33% of the variance in induced levels. The variant in HBE accounted for an additional 13% of the variance in induced levels, while variants in the HBB and BCL11A loci did not contribute beyond baseline levels. Conclusions/Significance: These findings clarify the overlap between baseline and hydroxyurea-induced fetal hemoglobin levels in pediatric disease. Studies assessing influences of specific sequence variants in these and other genetic loci in larger populations and in unusual hydroxyurea responders are needed to further understand the maintenance and therapeutic induction of fetal hemoglobin in pediatric sickle cell disease.	[Green, Nancy S.; Ender, Katherine L.; Crotty, Jennifer] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Pashankar, Farzana] Yale Univ, Dept Pediat, New Haven, CT 06520 USA; [Driscoll, Catherine; Manwani, Deepa] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Giardina, Patricia J.] Weill Cornell Univ, Sch Med, Dept Pediat, New York, NY USA; [Mullen, Craig A.] Univ Rochester, Dept Pediat, Rochester, NY USA; [Clark, Lorraine N.; Kisselev, Sergey] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Neville, Kathleen A.] Childrens Mercy Hosp & Clin, Dept Pediat, Kansas City, MO USA; [Hoppe, Carolyn] Childrens Hosp & Res Ctr Oakland, Dept Hematol Oncol, Oakland, CA USA; [Barral, Sandra] Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA	Columbia University; Yale University; Yeshiva University; Albert Einstein College of Medicine; Cornell University; University of Rochester; Columbia University; Children's Mercy Hospital; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Columbia University	Green, NS (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10027 USA.	nsg11@columbia.edu		Green, Nancy S./0000-0002-9877-1561	National Institutes of Health (NIH) from the Best Pharmaceutical for Children's Act [3UL1RR024156-04S4]; St. Giles Foundation; NIH Clinical Translational Science Awards (CTSAs) at Columbia University [5UL1RR024156]; Albert Einstein College of Medicine [5UL1RR025750]; Weill-Cornell School of Medicine [5UL1RR024996]; University of Rochester [5UL1RR024160]; Oakland Children's-UCSF [5UL1RR024131];  [5UL1RR024139]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139, UL1RR024156, UL1RR025750, UL1RR024131, UL1RR024160, UL1RR024996] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the Best Pharmaceutical for Children's Act(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Giles Foundation; NIH Clinical Translational Science Awards (CTSAs) at Columbia University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine; Weill-Cornell School of Medicine; University of Rochester; Oakland Children's-UCSF; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the National Institutes of Health (NIH) to Columbia University from the Best Pharmaceutical for Children's Act (3UL1RR024156-04S4 to NSG), the St. Giles Foundation (to Gary M. Brittenham) and a gift from Henry Taub (to NSG). Additional support was provided by NIH Clinical Translational Science Awards (CTSAs) at Columbia University (5UL1RR024156), Albert Einstein College of Medicine (5UL1RR025750), Weill-Cornell School of Medicine (5UL1RR024996), University of Rochester (5UL1RR024160), Yale (5UL1RR024139) and Oakland Children's-UCSF (5UL1RR024131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae HT, 2012, BLOOD, V120, P1961, DOI 10.1182/blood-2012-06-432849; Bhatnagar P, 2011, J HUM GENET, V56, P316, DOI 10.1038/jhg.2011.12; BUNN HF, 1987, BLOOD, V69, P1; Charache S, 1997, SEMIN HEMATOL, V34, P15; Ender KL, 2011, J PEDIAT HEMATOL ONC, V33, P496, DOI 10.1097/MPH.0b013e31822dcc21; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Green NS, 2011, PEDIATR BLOOD CANCER, V56, P177, DOI 10.1002/pbc.22754; GREEN NS, 1993, AM J HEMATOL, V44, P145, DOI 10.1002/ajh.2830440214; Kumkhaek C, 2008, BRIT J HAEMATOL, V141, P254, DOI 10.1111/j.1365-2141.2008.07045.x; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Ma Q, 2007, PHARMACOGENOMICS J, V7, P386, DOI 10.1038/sj.tpj.6500433; Makani J, 2011, BLOOD, V117, P1390, DOI 10.1182/blood-2010-08-302703; Meier ER, 2011, PEDIATR BLOOD CANCER, V56, P103, DOI 10.1002/pbc.22643; Platt OS, 2008, NEW ENGL J MED, V358, P1362, DOI 10.1056/NEJMct0708272; POWARS DR, 1984, BLOOD, V63, P921, DOI 10.1182/blood.V63.4.921.921; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sebastiani P, 2008, AM J HEMATOL, V83, P189, DOI 10.1002/ajh.21048; Sedgewick AE, 2008, BLOOD CELL MOL DIS, V41, P255, DOI 10.1016/j.bcmd.2008.06.007; Solovieff N, 2010, BLOOD, V115, P1815, DOI 10.1182/blood-2009-08-239517; Steinberg MH, 1997, BLOOD, V89, P1078, DOI 10.1182/blood.V89.3.1078; Steinberg MH, 2003, AM J HEMATOL, V72, P121, DOI 10.1002/ajh.10264; Thein SL, 2009, HUM MOL GENET, V18, pR216, DOI 10.1093/hmg/ddp401; Ware RE, 2002, BLOOD, V99, P10, DOI 10.1182/blood.V99.1.10; Ware RE, 2011, BLOOD, V118, P4985, DOI 10.1182/blood-2011-07-364190; Zimmerman SA, 2004, BLOOD, V103, P2039, DOI 10.1182/blood-2003-07-2475	26	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55709	10.1371/journal.pone.0055709	http://dx.doi.org/10.1371/journal.pone.0055709			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409025	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200051
J	Laperchia, C; Mascaro, ALA; Sacconi, L; Andrioli, A; Matte, A; De Franceschi, L; Grassi-Zucconi, G; Bentivoglio, M; Buffelli, M; Pavone, FS				Laperchia, Claudia; Mascaro, Anna L. Allegra; Sacconi, Leonardo; Andrioli, Anna; Matte, Alessandro; De Franceschi, Lucia; Grassi-Zucconi, Gigliola; Bentivoglio, Marina; Buffelli, Mario; Pavone, Francesco S.			Two-Photon Microscopy Imaging of thy1GFP-M Transgenic Mice: A Novel Animal Model to Investigate Brain Dendritic Cell Subsets In Vivo	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CHOROID-PLEXUS; FLUORESCENT PROTEIN; CRANIAL WINDOW; LONG-TERM; MACROPHAGES; NEOCORTEX; MENINGES; MARKER	Transgenic mice expressing fluorescent proteins in specific cell populations are widely used for in vivo brain studies with two-photon fluorescence (TPF) microscopy. Mice of the thy1GFP-M line have been engineered for selective expression of green fluorescent protein (GFP) in neuronal populations. Here, we report that TPF microscopy reveals, at the brain surface of these mice, also motile non-neuronal GFP+ cells. We have analyzed the behavior of these cells in vivo and characterized in brain sections their immunophenotype. With TPF imaging, motile GFP+ cells were found in the meninges, subarachnoid space and upper cortical layers. The striking feature of these cells was their ability to move across the brain parenchyma, exhibiting evident shape changes during their scanning-like motion. In brain sections, GFP+ cells were immunonegative to antigens recognizing motile cells such as migratory neuroblasts, neuronal and glial precursors, mast cells, and fibroblasts. GFP+ non-neuronal cells exhibited instead the characteristic features and immunophenotype (CD11c and major histocompatibility complex molecule class II immunopositivity) of dendritic cells (DCs), and were immunonegative to the microglial marker Iba-1. GFP+ cells were also identified in lymph nodes and blood of thy1GFP-M mice, supporting their identity as DCs. Thus, TPF microscopy has here allowed the visualization for the first time of the motile behavior of brain DCs in situ. The results indicate that the thy1GFP-M mouse line provides a novel animal model for the study of subsets of these professional antigen-presenting cells in the brain. Information on brain DCs is still very limited and imaging in thy1GFP-M mice has a great potential for analyses of DC-neuron interaction in normal and pathological conditions.	[Laperchia, Claudia; Andrioli, Anna; Grassi-Zucconi, Gigliola; Bentivoglio, Marina; Buffelli, Mario] Univ Verona, Dept Neurol Sci, I-37100 Verona, Italy; [Laperchia, Claudia; Andrioli, Anna; Grassi-Zucconi, Gigliola; Bentivoglio, Marina; Buffelli, Mario] Natl Inst Neurosci, Verona, Italy; [Mascaro, Anna L. Allegra; Sacconi, Leonardo; Pavone, Francesco S.] Univ Florence, European Lab Nonlinear Spect, Sesto Fiorentino, Italy; [Sacconi, Leonardo; Pavone, Francesco S.] CNR, Natl Inst Opt, Florence, Italy; [Matte, Alessandro; De Franceschi, Lucia] Univ Verona, Dept Med, I-37100 Verona, Italy; [Buffelli, Mario] Univ Verona, Ctr Biomed Comp, I-37100 Verona, Italy; [Pavone, Francesco S.] Univ Florence, Dept Phys, Sesto Fiorentino, Italy; [Pavone, Francesco S.] Int Ctr Computat Neurophoton, Sesto Fiorentino, Italy	University of Verona; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University of Verona; University of Verona; University of Florence	Buffelli, M (corresponding author), Univ Verona, Dept Neurol Sci, I-37100 Verona, Italy.	mario.buffelli@univr.it	pavone, francesco s/F-4945-2015; DE FRANCESCHI, Lucia/AAB-8652-2022; Bentivoglio, Marina/K-1008-2016; Matte, Alessandro/AAB-3496-2022; Sacconi, Leonardo/B-8904-2015; ALLEGRA MASCARO, ANNA LETIZIA/L-3229-2018; Buffelli, Mario/C-6953-2018	DE FRANCESCHI, Lucia/0000-0001-7093-777X; Bentivoglio, Marina/0000-0003-4958-9795; Sacconi, Leonardo/0000-0002-9320-5085; ALLEGRA MASCARO, ANNA LETIZIA/0000-0002-8489-0076; Buffelli, Mario/0000-0002-3709-013X; pavone, francesco saverio/0000-0002-0675-3981	University of Verona; Fondazione Cariverona; Verona Nanomedicine Initiative; European Union [228334]; Human Frontier Science Program Research Grant [RGP0027/2009]; Ente Cassa di Risparmio di Firenze; Flagship Nanomax Project	University of Verona; Fondazione Cariverona(Fondazione Cariverona); Verona Nanomedicine Initiative; European Union(European Commission); Human Frontier Science Program Research Grant(Human Frontier Science Program); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Flagship Nanomax Project	This work was supported by funds of University of Verona, "Fondazione Cariverona" project 2007 and "Verona Nanomedicine Initiative". The research leading to these results received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement 228334. This research project was also supported by Human Frontier Science Program Research Grant RGP0027/2009, by the "Ente Cassa di Risparmio di Firenze" and the Flagship Nanomax Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra Mascaro AL, 2010, FRONT NEUROENERGETIC, P2; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Bobryshev YV, 2010, LAB INVEST, V90, P970, DOI 10.1038/labinvest.2010.94; Bulloch K, 2008, J COMP NEUROL, V508, P687, DOI 10.1002/cne.21668; Chinnery HR, 2010, J NEUROPATH EXP NEUR, V69, P896, DOI 10.1097/NEN.0b013e3181edbc1a; Comabella M, 2010, NAT REV NEUROL, V6, P499, DOI 10.1038/nrneurol.2010.112; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Gommet C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001421; Haeryfar SMM, 2004, J IMMUNOL, V173, P3581, DOI 10.4049/jimmunol.173.6.3581; Hatterer E, 2006, BLOOD, V107, P806, DOI 10.1182/blood-2005-01-0154; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Ishifune C, 2011, EUR J IMMUNOL, V41, P1309, DOI 10.1002/eji.201041159; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Lai L, 1998, J IMMUNOL, V160, P3861; Leon B, 2004, BLOOD, V103, P2668, DOI 10.1182/blood-2003-01-0286; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Matyszak MK, 1996, NEUROSCIENCE, V74, P599, DOI 10.1016/0306-4522(96)00160-1; McMenamin PG, 1999, J COMP NEUROL, V405, P553, DOI 10.1002/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6; McMenamin PG, 2003, CELL TISSUE RES, V313, P259, DOI 10.1007/s00441-003-0779-0; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; Misgeld T, 2006, NAT REV NEUROSCI, V7, P449, DOI 10.1038/nrn1905; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pashenkov M, 2002, TRENDS IMMUNOL, V23, P69, DOI 10.1016/S1471-4906(01)02114-7; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peters JH, 1996, IMMUNOL TODAY, V17, P273, DOI 10.1016/0167-5699(96)80544-5; Prodinger C, 2011, ACTA NEUROPATHOL, V121, P445, DOI 10.1007/s00401-010-0774-y; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Sacconi L, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2798723; Sagar D, 2012, J NEUROIMMUNE PHARM, V7, P74, DOI 10.1007/s11481-011-9302-7; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Sigler A, 2010, STROKE, V41, pS117, DOI 10.1161/STROKEAHA.110.594648; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Tomomura M, 2001, EUR J NEUROSCI, V14, P57, DOI 10.1046/j.0953-816x.2001.01624.x; VIDAL J, 1994, J GEN PSYCHOL, V121, P85, DOI 10.1080/00221309.1994.9711175; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577	46	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56144	10.1371/journal.pone.0056144	http://dx.doi.org/10.1371/journal.pone.0056144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409142	gold, Green Submitted, Green Published			2022-12-27	WOS:000315157200116
J	Marchocki, Z; Collins, K; Lehane, E; O' Reilly, P; O'Donoghue, K				Marchocki, Zbigniew; Collins, Kevin; Lehane, Eimear; O' Reilly, Paddy; O'Donoghue, Keelin			Staphylococcus lugdunensis Cultured from the Amniotic Fluid at Caesarean Section	PLOS ONE			English	Article								Staphylococcus lugdunensis is a virulent coagulase-negative staphylococcus. It behaves like and can be mistaken in culture for Staphylococcus aureus. While originally thought to be a skin commensal rarely responsible for opportunistic infection, it was rapidly established as a significant human pathogen. It has been mainly associated with native and prosthetic valve endocarditis, osteomyelitis, and skin and soft tissue cellulitis, but has also been reported as a cause of fasciitis as well as peritonitis. Staphylococcus lugdunensis has been reported as a cause of endometritis but has not been previously isolated from amniotic fluid. Here, amniotic fluid samples were collected in the course of a larger study on amniotic fluid bacteriology, with prior ethical approval and informed patient consent. Amniotic fluid was obtained at Caesarean Section by direct needle aspiration from the intact amnion. Analysis with Staphylococcal API test kits led to identification of Staphylococcus lugdunensis in two cases. The clinical significance of the finding in these reported cases is undetermined. Staphylococcus lugdunensis has been shown to be a cause of serious and potentially fatal morbidities, but this is the first report of its culture from amniotic fluid. As caesarean delivery is accepted as the single most important factor associated with post-partum infectious complications in both mother and neonate, the identification of this pathogen is a new concern.	[Marchocki, Zbigniew; O'Donoghue, Keelin] Natl Univ Ireland Univ Coll Cork, Cork Univ Matern Hosp, Dept Obstet & Gynaecol, Anu Res Ctr, Cork, Ireland; [Collins, Kevin; Lehane, Eimear; O' Reilly, Paddy] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland	University College Cork; University College Cork	O'Donoghue, K (corresponding author), Natl Univ Ireland Univ Coll Cork, Cork Univ Matern Hosp, Dept Obstet & Gynaecol, Anu Res Ctr, Cork, Ireland.	k.odonoghue@ucc.ie		O'Donoghue, Keelin/0000-0002-4616-2887				Babu E, 2011, EXPERT REV ANTI-INFE, V9, P901, DOI [10.1586/eri.11.110, 10.1586/ERI.11.110]; Bello C, 2007, West Afr J Med, V26, P243; Bouziri Asma, 2011, Tunis Med, V89, P206; Frank KL, 2008, CLIN MICROBIOL REV, V21, P111, DOI 10.1128/CMR.00036-07; FRENEY J, 1988, INT J SYST BACTERIOL, V38, P168, DOI 10.1099/00207713-38-2-168; Harris JW, 1927, AM J OBSTET GYNECOL, V13, P133, DOI 10.1016/S0002-9378(27)90506-7; Hung T, 2012, CASE REP INFECT DIS, V2012, DOI 10.1155/2012/453685; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P193, DOI 10.1111/j.1471-0528.2010.02729.x; National Institute for Clinical Excellence, 2011, NICE CLIN GUID; Shaaban HS, 2011, J GLOB INFECT DIS, V3, P101, DOI 10.4103/0974-777X.77311; van der Mee-Marquet N, 2003, J CLIN MICROBIOL, V41, P1404, DOI 10.1128/JCM.41.4.1404-1409.2003	11	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56373	10.1371/journal.pone.0056373	http://dx.doi.org/10.1371/journal.pone.0056373			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409177	gold, Green Submitted, Green Published			2022-12-27	WOS:000315157200134
J	van der Hoek, Y; Renfrew, R; Manne, LL				van der Hoek, Yntze; Renfrew, Rosalind; Manne, Lisa L.			Assessing Regional and Interspecific Variation in Threshold Responses of Forest Breeding Birds through Broad Scale Analyses	PLOS ONE			English	Article							HABITAT FRAGMENTATION; EXTINCTION THRESHOLDS; SPATIAL AUTOCORRELATION; ECOLOGICAL THRESHOLDS; RELATIVE IMPORTANCE; SPECIES RESPONSES; LANDSCAPE; MANAGEMENT; OCCUPANCY; COVER	Background: Identifying persistence and extinction thresholds in species-habitat relationships is a major focal point of ecological research and conservation. However, one major concern regarding the incorporation of threshold analyses in conservation is the lack of knowledge on the generality and transferability of results across species and regions. We present a multi-region, multi-species approach of modeling threshold responses, which we use to investigate whether threshold effects are similar across species and regions. Methodology/Principal Findings: We modeled local persistence and extinction dynamics of 25 forest-associated breeding birds based on detection/non-detection data, which were derived from repeated breeding bird atlases for the state of Vermont. We did not find threshold responses to be particularly well-supported, with 9 species supporting extinction thresholds and 5 supporting persistence thresholds. This contrasts with a previous study based on breeding bird atlas data from adjacent New York State, which showed that most species support persistence and extinction threshold models (15 and 22 of 25 study species respectively). In addition, species that supported a threshold model in both states had associated average threshold estimates of 61.41% (SE = 6.11, persistence) and 66.45% (SE = 9.15, extinction) in New York, compared to 51.08% (SE = 10.60, persistence) and 73.67% (SE = 5.70, extinction) in Vermont. Across species, thresholds were found at 19.45-87.96% forest cover for persistence and 50.82-91.02% for extinction dynamics. Conclusions/Significance: Through an approach that allows for broad-scale comparisons of threshold responses, we show that species vary in their threshold responses with regard to habitat amount, and that differences between even nearby regions can be pronounced. We present both ecological and methodological factors that may contribute to the different model results, but propose that regardless of the reasons behind these differences, our results merit a warning that threshold values cannot simply be transferred across regions or interpreted as clear-cut targets for ecosystem management and conservation.	[van der Hoek, Yntze; Manne, Lisa L.] CUNY Coll Staten Isl, Dept Biol Sci, New York, NY 10314 USA; [van der Hoek, Yntze] CUNY, Grad Ctr, New York, NY USA; [Renfrew, Rosalind] Vermont Ctr Ecostudies, White River Jct, VT USA	City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System	van der Hoek, Y (corresponding author), CUNY Coll Staten Isl, Dept Biol Sci, New York, NY 10314 USA.	yvan_der_hoek@gc.cuny.edu			Graduate Center and College of Staten Island of the City University of New York; USGS Patuxent Wildlife Research Center; Vermont Center for Ecostudies; Vermont Fish and Wildlife Department	Graduate Center and College of Staten Island of the City University of New York; USGS Patuxent Wildlife Research Center(United States Geological Survey); Vermont Center for Ecostudies; Vermont Fish and Wildlife Department	This research has received support from the Graduate Center and College of Staten Island of the City University of New York, the USGS Patuxent Wildlife Research Center, the Vermont Center for Ecostudies, and the Vermont Fish and Wildlife Department's Nongame Wildlife Fund and State Wildlife Grants (SWG) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren H, 1997, OIKOS, V80, P193, DOI 10.2307/3546534; Andren H, 1996, OIKOS, V76, P235, DOI 10.2307/3546195; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], 2010, R LANG ENV STAT COMP; Augustin NH, 1996, J APPL ECOL, V33, P339, DOI 10.2307/2404755; Bascompte J, 1996, J ANIM ECOL, V65, P465, DOI 10.2307/5781; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Betts MG, 2010, ECOL APPL, V20, P2116, DOI 10.1890/09-1305.1; Betts MG, 2007, CONSERV BIOL, V21, P1046, DOI 10.1111/j.1523-1739.2007.00723.x; Betts MG, 2006, ECOL APPL, V16, P1076, DOI 10.1890/1051-0761(2006)016[1076:IEOFOF]2.0.CO;2; Betts MG, 2006, ECOL MODEL, V191, P197, DOI 10.1016/j.ecolmodel.2005.04.027; Blanchet S, 2010, EVOL APPL, V3, P291, DOI 10.1111/j.1752-4571.2009.00110.x; Boyle SA, 2010, BIOL CONSERV, V143, P1134, DOI 10.1016/j.biocon.2010.02.008; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Davies KF, 2000, ECOLOGY, V81, P1450, DOI 10.2307/177221; Desrochers A, 2010, ECOGRAPHY, V33, P921, DOI 10.1111/j.1600-0587.2009.06061.x; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Digiovinazzo P, 2010, FOREST ECOL MANAG, V259, P343, DOI 10.1016/j.foreco.2009.10.027; Donovan TM, 1997, ECOLOGY, V78, P2064, DOI 10.1890/0012-9658(1997)078[2064:VILSEE]2.0.CO;2; dos Anjos L, 2011, BIOL CONSERV, V144, P2213, DOI 10.1016/j.biocon.2011.05.013; Drummond MA, 2010, BIOSCIENCE, V60, P286, DOI 10.1525/bio.2010.60.4.7; Eastman J. R., 2009, IDRISI TAIGA; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fahrig L, 1998, ECOL MODEL, V105, P273, DOI 10.1016/S0304-3800(97)00163-4; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Ficetola GF, 2009, ECOGRAPHY, V32, P1075, DOI 10.1111/j.1600-0587.2009.05571.x; Flather CH, 2002, AM NAT, V159, P40, DOI 10.1086/324120; Groffman PM, 2006, ECOSYSTEMS, V9, P1289, DOI 10.1007/s10021-006-0177-z; Hill MF, 1999, ECOL LETT, V2, P121, DOI 10.1046/j.1461-0248.1999.22061.x; Holland JD, 2004, BIOSCIENCE, V54, P227, DOI 10.1641/0006-3568(2004)054[0227:DTSSOS]2.0.CO;2; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jones JE, 2011, ECOLOGY, V92, P2299, DOI 10.1890/10-2403.1; Juutinen A, 2008, ENVIRON SCI POLICY, V11, P613, DOI 10.1016/j.envsci.2008.05.004; Kato S, 2011, LANDSC ECOL ENG, V7, P275, DOI 10.1007/s11355-010-0135-y; Kennedy CM, 2010, BIOL CONSERV, V143, P2136, DOI 10.1016/j.biocon.2010.05.025; LANDE R, 1987, AM NAT, V130, P624, DOI 10.1086/284734; Laughlin SB, 1985, ATLAS BREEDING BIRDS; Lees AC, 2009, OIKOS, V118, P280, DOI 10.1111/j.1600-0706.2008.16842.x; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; MCGARIGAL K, 1995, ECOL MONOGR, V65, P235, DOI 10.2307/2937059; Monkkonen M, 1999, OIKOS, V84, P302, DOI 10.2307/3546725; Muller J, 2010, EUR J FOREST RES, V129, P981, DOI 10.1007/s10342-010-0400-5; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; MUGGEO VMR, 2008, SEGMENTED PACKAGE R; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Radford JQ, 2004, BIOL CONSERV, V117, P375, DOI 10.1016/j.biocon.2003.08.002; Renfrew RB, 2 ATLAS BREEDING BIR; Rhodes JR, 2008, J APPL ECOL, V45, P549, DOI 10.1111/j.1365-2664.2007.01407.x; Richmond M. E., 2008, 2 ATLAS BREEDING BIR, P258; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Rompre G, 2010, FOREST CHRON, V86, P572, DOI 10.5558/tfc86572-5; Schooley RL, 2011, BIODIVERS CONSERV, V20, P1611, DOI 10.1007/s10531-011-0049-5; Shanahan DF, 2009, J APPL ECOL, V46, P1026, DOI 10.1111/j.1365-2664.2009.01694.x; SIMBERLOFF D, 1995, IBIS, V137, pS105, DOI 10.1111/j.1474-919X.1995.tb08430.x; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Smith AC, 2011, ECOGRAPHY, V34, P103, DOI 10.1111/j.1600-0587.2010.06201.x; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Stehman SV, 2003, REMOTE SENS ENVIRON, V86, P500, DOI 10.1016/S0034-4257(03)00128-7; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Thornton DH, 2011, LANDSCAPE ECOL, V26, P7, DOI 10.1007/s10980-010-9549-z; Tischendorf L, 2005, ECOL SOC, V10; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Vance MD, 2003, ECOLOGY, V84, P2643, DOI 10.1890/02-0159; Venier LA, 1999, J BIOGEOGR, V26, P315, DOI 10.1046/j.1365-2699.1999.00273.x; Villard MA, 1999, CONSERV BIOL, V13, P774, DOI 10.1046/j.1523-1739.1999.98059.x; WENNY DG, 1993, CONDOR, V95, P968, DOI 10.2307/1369432; With KA, 1999, CONSERV BIOL, V13, P314, DOI 10.1046/j.1523-1739.1999.013002314.x; Zitske BP, 2011, CONSERV BIOL, V25, P993, DOI 10.1111/j.1523-1739.2011.01709.x; Zuckerberg B, 2010, BIOL CONSERV, V143, P952, DOI 10.1016/j.biocon.2010.01.004	75	9	10	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55996	10.1371/journal.pone.0055996	http://dx.doi.org/10.1371/journal.pone.0055996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409106	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200100
J	Yoo, HJ; Hwang, SY; Hong, HC; Choi, HY; Yang, SJ; Choi, DS; Baik, SH; Bluher, M; Youn, BS; Choi, KM				Yoo, Hye Jin; Hwang, Soon Young; Hong, Ho Cheol; Choi, Hae Yoon; Yang, Sae Jeong; Choi, Dong Seop; Baik, Sei Hyun; Blueher, Matthias; Youn, Byung-Soo; Choi, Kyung Mook			Implication of Progranulin and C1q/TNF-Related Protein-3 (CTRP3) on Inflammation and Atherosclerosis in Subjects with or without Metabolic Syndrome	PLOS ONE			English	Article							GROWTH-FACTOR; EPITHELIN PRECURSOR; INSULIN-RESISTANCE; SERUM PROGRANULIN; ADIPOKINE; OBESITY; GLUCOSE; PLASMA; TISSUE; BINDS	Objective: Progranulin and C1q/TNF-related protein-3 (CTRP3) were recently discovered as novel adipokines which may link obesity with altered regulation of glucose metabolism, chronic inflammation and insulin resistance. Research Design and Methods: We examined circulating progranulin and CTRP3 concentrations in 127 subjects with (n = 44) or without metabolic syndrome (n = 83). Furthermore, we evaluated the relationship of progranulin and CTRP3 levels with inflammatory markers and cardiometabolic risk factors, including high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), estimated glomerular filtration rate (eGFR), and adiponectin serum concentrations, as well as carotid intima-media thickness (CIMT). Results: Circulating progranulin levels are significantly related with inflammatory markers, hsCRP (r = 0.30, P = 0.001) and IL-6 (r = 0.30, P = 0.001), whereas CTRP3 concentrations exhibit a significant association with cardiometabolic risk factors, including waist circumference (r = -0.21), diastolic blood pressure (r = -0.21), fasting glucose (r = -0.20), triglyceride (r = -0.34), total cholesterol (r = -0.25), eGFR (r = 0.39) and adiponectin (r = 0.26) levels. Serum progranulin concentrations were higher in patients with metabolic syndrome than those of the control group (199.55 [179.33, 215.53] vs. 185.10 [160.30, 204.90], P = 0.051) and the number of metabolic syndrome components had a significant positive correlation with progranulin levels (r = 0.227, P = 0.010). In multiple regression analysis, IL-6 and triglyceride levels were significant predictors of serum progranulin levels (R-2 = 0.251). Furthermore, serum progranulin level was an independent predictor for increased CIMT in subjects without metabolic syndrome after adjusting for other cardiovascular risk factors (R-2 = 0.365). Conclusions: Serum progranulin levels are significantly associated with systemic inflammatory markers and were an independent predictor for atherosclerosis in subjects without metabolic syndrome.	[Yoo, Hye Jin; Hong, Ho Cheol; Choi, Hae Yoon; Yang, Sae Jeong; Choi, Dong Seop; Baik, Sei Hyun; Choi, Kyung Mook] Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea; [Hwang, Soon Young] Korea Univ, Coll Med, Dept Biostat, Seoul 136705, South Korea; [Blueher, Matthias] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany; [Youn, Byung-Soo] AdipoGen Inc, Inchon, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Leipzig University	Choi, KM (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea.	bsyoun@gmail.com; medica7@gmail.com	Choi, Kyung Mook/C-4195-2018	Choi, Kyung Mook/0000-0001-6175-0225; Hwang, Soon Young/0000-0001-7474-1803; Yoo, Hye Jin/0000-0003-0600-0266	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012006363, 2012R1A1A1005257]; Ministry of Education and Human Resources Development, Republic of Korea [A102065-1011-1070100]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education and Human Resources Development, Republic of Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	Dr. KMC was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012006363) and Drs. SHB and KMC were supported by the Brain Korea 21 Project of the Ministry of Education and Human Resources Development, Republic of Korea (A102065-1011-1070100). Dr. HJY was also supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A1005257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Caro JF, 1996, LANCET, V348, P159, DOI 10.1016/S0140-6736(96)03173-X; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Choi KM, 2012, DIABETES, V61, P2932, DOI 10.2337/db12-0217; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Kojima Y, 2009, ATHEROSCLEROSIS, V206, P102, DOI 10.1016/j.atherosclerosis.2009.02.017; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Liu CJ, 2012, PHARMACOL THERAPEUT, V133, P124, DOI 10.1016/j.pharmthera.2011.10.003; Liu CJ, 2011, FEBS LETT, V585, P3675, DOI 10.1016/j.febslet.2011.04.065; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Okura H, 2010, J ATHEROSCLER THROMB, V17, P568, DOI 10.5551/jat.3921; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Svestak M, 2010, BIOMED PAP, V154, P199, DOI 10.5507/bp.2010.030; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Weigert J, 2005, FEBS LETT, V579, P5565, DOI 10.1016/j.febslet.2005.09.022; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Wu H, 2011, SCIENCE, V332, P427, DOI 10.1126/science.1205992; Yilmaz Y, 2011, DIS MARKERS, V31, P205, DOI [10.1155/2011/126240, 10.3233/DMA-2011-0815]; Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147; ZHOU J, 1993, J BIOL CHEM, V268, P10863	28	74	82	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55744	10.1371/journal.pone.0055744	http://dx.doi.org/10.1371/journal.pone.0055744			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409033	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200058
J	Berger, C; Berger, M; Beard, BC; Kiem, HP; Gooley, TA; Riddell, SR				Berger, Carolina; Berger, Michael; Beard, Brian C.; Kiem, Hans-Peter; Gooley, Theodore A.; Riddell, Stanley R.			Proliferation-Linked Apoptosis of Adoptively Transferred T Cells after IL-15 Administration in Macaques	PLOS ONE			English	Article							IN-VIVO PERSISTENCE; METASTATIC MELANOMA; MEDIATED REJECTION; MEMORY; CANCER; IMMUNOTHERAPY; INTERLEUKIN-15; LYMPHOCYTES; IMMUNITY; THERAPY	The adoptive transfer of antigen-specific effector T cells is being used to treat human infections and malignancy. T cell persistence is a prerequisite for therapeutic efficacy, but reliably establishing a high-level and durable T cell response by transferring cultured CD8(+) T cells remains challenging. Thus, strategies that promote a transferred high-level T cell response may improve the efficacy of T cell therapy. Lymphodepletion enhances persistence of transferred T cells in mice in part by reducing competition for IL-15, a common gamma-chain cytokine that promotes T cell memory, but lymphodepleting regimens have toxicity. IL-15 can be safely administered and has minimal effects on CD4(+) regulatory T cells at low doses, making it an attractive adjunct in adoptive T cell therapy. Here, we show in lymphoreplete macaca nemestrina, that proliferation of adoptively transferred central memory-derived CD8(+) effector T (T-CM/E) cells is enhanced in vivo by administering IL-15. TCM/E cells migrated to memory niches, persisted, and acquired both central memory and effector memory phenotypes regardless of the cytokine treatment. Unexpectedly, despite maintaining T cell proliferation, IL-15 did not augment the magnitude of the transferred T cell response in blood, bone marrow, or lymph nodes. T cells induced to proliferate by IL-15 displayed increased apoptosis demonstrating that enhanced cycling was balanced by cell death. These results suggest that homeostatic mechanisms that regulate T cell numbers may interfere with strategies to augment a high-level T cell response by adoptive transfer of CD8(+) T-CM/E cells in lymphoreplete hosts.	[Berger, Carolina; Berger, Michael; Beard, Brian C.; Kiem, Hans-Peter; Gooley, Theodore A.; Riddell, Stanley R.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Berger, Carolina; Beard, Brian C.; Kiem, Hans-Peter; Riddell, Stanley R.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Riddell, Stanley R.] Tech Univ Munich, Inst Adv Study, Focus Grp Clin Cell Proc & Purificat, D-80290 Munich, Germany	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Technical University of Munich	Berger, C (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	cberger@fhcrc.org			National Institutes of Health [CA114536, AI053193, P51-RR000166-48S2]; NATIONAL CANCER INSTITUTE [R01CA114536] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants CA114536 (SRR), AI053193 (SRR), and P51-RR000166-48S2 (CB, SRR) (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair JE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003425; Baerlocher GM, 2003, CYTOM PART A, V55A, P1, DOI 10.1002/cyto.a.10064; Beard BC, 2007, MOL THER, V15, P1356, DOI 10.1038/sj.mt.6300159; Berger C, 2011, J MED PRIMATOL, V40, P88, DOI 10.1111/j.1600-0684.2010.00451.x; Berger C, 2001, J VIROL, V75, P799, DOI 10.1128/JVI.75.2.799-808.2001; Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Berger C, 2009, BLOOD, V114, P2417, DOI 10.1182/blood-2008-12-189266; Berger C, 2009, CURR OPIN IMMUNOL, V21, P224, DOI 10.1016/j.coi.2009.02.010; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Brenner MK, 2010, CURR OPIN IMMUNOL, V22, P251, DOI 10.1016/j.coi.2010.01.020; Chapuis AG, 2012, P NATL ACAD SCI USA, V109, P4592, DOI 10.1073/pnas.1113748109; Chapuis AG, 2011, BLOOD, V117, P5391, DOI 10.1182/blood-2010-11-320226; Dudley ME, 2001, J IMMUNOTHER, V24, P363, DOI 10.1097/00002371-200107000-00012; Eisenman J, 2002, CYTOKINE, V20, P121, DOI 10.1006/cyto.2002.1989; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Lugli E, 2010, BLOOD, V116, P3238, DOI 10.1182/blood-2010-03-275438; Markley JC, 2010, BLOOD, V115, P3508, DOI 10.1182/blood-2009-09-241398; Nolz JC, 2012, P NATL ACAD SCI USA, V109, P6199, DOI 10.1073/pnas.1118868109; Picker LJ, 2006, J CLIN INVEST, V116, P1514, DOI 10.1172/JCI27564; Powell DJ, 2005, BLOOD, V105, P241, DOI 10.1182/blood-2004-06-2482; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Riddell SR, 2004, J EXP MED, V200, P1533, DOI 10.1084/jem.20042004; RIDDELL SR, 1992, SCIENCE, V257, P238; Riddell SR, 1996, NAT MED, V2, P216, DOI 10.1038/nm0296-216; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; Robbins PF, 2004, J IMMUNOL, V173, P7125, DOI 10.4049/jimmunol.173.12.7125; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Roychowdhury S, 2004, CANCER RES, V64, P8062, DOI 10.1158/0008-5472.CAN-04-1860; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sato N, 2007, P NATL ACAD SCI USA, V104, P588, DOI 10.1073/pnas.0610115104; Teague RM, 2006, NAT MED, V12, P335, DOI 10.1038/nm1359; Unsoeld H, 2005, J VIROL, V79, P4510, DOI 10.1128/JVI.79.7.4510-4513.2005; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Wang AR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004306; Wang XL, 2011, BLOOD, V117, P1888, DOI 10.1182/blood-2010-10-310599; Wei Xunbin, 2005, Mol Imaging, V4, P415; Yang SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022560; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099	48	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56268	10.1371/journal.pone.0056268	http://dx.doi.org/10.1371/journal.pone.0056268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418547	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300140
J	Chang, B; Kustra, R; Tian, WD				Chang, Billy; Kustra, Rafal; Tian, Weidong			Functional-Network-Based Gene Set Analysis Using Gene-Ontology	PLOS ONE			English	Article							P53; EXPRESSION; AMPLIFICATION; BIOLOGY; ARREST; CELLS	To account for the functional non-equivalence among a set of genes within a biological pathway when performing gene set analysis, we introduce GOGANPA, a network-based gene set analysis method, which up-weights genes with functions relevant to the gene set of interest. The genes are weighted according to its degree within a genome-scale functional network constructed using the functional annotations available from the gene ontology database. By benchmarking GOGANPA using a well-studied P53 data set and three breast cancer data sets, we will demonstrate the power and reproducibility of our proposed method over traditional unweighted approaches and a competing network-based approach that involves a complex integrated network. GOGANPA's sole reliance on gene ontology further allows GOGANPA to be widely applicable to the analysis of any gene-ontology-annotated genome.	[Chang, Billy; Tian, Weidong] Fudan Univ, State Key Lab Genet Engn, Inst Biostat, Shanghai 200433, Peoples R China; [Chang, Billy; Kustra, Rafal] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON, Canada	Fudan University; University of Toronto	Tian, WD (corresponding author), Fudan Univ, State Key Lab Genet Engn, Inst Biostat, Shanghai 200433, Peoples R China.	weidong.tian@fudan.edu.cn			National Basic Research Program of China [2010CB529505, 2012CB316505]; National Natural Science Foundation of China [30971643, 31071113]; Ontario Graduate Scholarship	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by the National Basic Research Program of China (Grant No. 2010CB529505, 2012CB316505); the National Natural Science Foundation of China (Grant No. 30971643, 31071113); and the Ontario Graduate Scholarship [to BC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Dbaibo GS, 1998, J CLIN INVEST, V102, P329, DOI 10.1172/JCI1180; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Fang ZY, 2012, CELL RES, V22, P565, DOI 10.1038/cr.2011.149; Guzzi PH, 2012, BRIEF BIOINFORM, V13, P569, DOI 10.1093/bib/bbr066; Hoshino M, 2001, J ALLERGY CLIN IMMUN, V107, P1034, DOI 10.1067/mai.2001.115626; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hung JH, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r23; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kicic A, 2010, AM J RESP CRIT CARE, V181, P889, DOI 10.1164/rccm.200907-1071OC; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; O'Callaghan-Sunol C, 2007, CANCER RES, V67, P11779, DOI 10.1158/0008-5472.CAN-07-2441; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ovaska K, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-11; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thomas R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r44; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	29	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55635	10.1371/journal.pone.0055635	http://dx.doi.org/10.1371/journal.pone.0055635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418449	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300040
J	Durussel, J; Daskalaki, E; Anderson, M; Chatterji, T; Wondimu, DH; Padmanabhan, N; Patel, RK; McClure, JD; Pitsiladis, YP				Durussel, Jerome; Daskalaki, Evangelia; Anderson, Martin; Chatterji, Tushar; Wondimu, Diresibachew H.; Padmanabhan, Neal; Patel, Rajan K.; McClure, John D.; Pitsiladis, Yannis P.			Haemoglobin Mass and Running Time Trial Performance after Recombinant Human Erythropoietin Administration in Trained Men	PLOS ONE			English	Article							EXERCISE CAPACITY; UPTAKE KINETICS; NEOCYTOLYSIS; MECHANISM; ALTITUDE; MARKERS; VOLUME; MODEL	Recombinant human erythropoietin (rHuEpo) increases haemoglobin mass (Hb(mass)) and maximal oxygen uptake ((v) over dot O-2 max). Purpose: This study defined the time course of changes in Hb(mass), (v) over dot O-2 (max) as well as running time trial performance following 4 weeks of rHuEpo administration to determine whether the laboratory observations would translate into actual improvements in running performance in the field. Methods: 19 trained men received rHuEpo injections of 50 IU.kg(-1) body mass every two days for 4 weeks. Hb(mass) was determined weekly using the optimized carbon monoxide rebreathing method until 4 weeks after administration. (v) over dot O-2 max and 3,000 m time trial performance were measured pre, post administration and at the end of the study. Results: Relative to baseline, running performance significantly improved by similar to 6% after administration (10:30 +/- 1:07 min: sec vs. 11:08 +/- 1:15 min: sec, p<0.001) and remained significantly enhanced by similar to 3% 4 weeks after administration (10:46 +/- 1:13 min: sec, p<0.001), while (v) over dot O-2 max was also significantly increased post administration (60.7 +/- 5.8 mL.min(-1).kg(-1) vs. 56.0 +/- 6.2 mL.min(-1).kg(-1), p<0.001) and remained significantly increased 4 weeks after rHuEpo (58.0 +/- 5.6 mL.min(-1).kg(-1), p = 0.021). Hb(mass) was significantly increased at the end of administration compared to baseline (15.2 +/- 1.5 g.kg(-1) vs. 12.7 +/- 1.2 g.kg(-1), p<0.001). The rate of decrease in Hb(mass) toward baseline values post rHuEpo was similar to that of the increase during administration (-0.53 g.kg(-1).wk(-1), 95% confidence interval (CI) (-0.68, -0.38) vs. 0.54 g.kg(-1).wk(-1), CI (0.46, 0.63)) but Hb(mass) was still significantly elevated 4 weeks after administration compared to baseline (13.7 +/- 1.1 g.kg(-1), p<0.001). Conclusion: Running performance was improved following 4 weeks of rHuEpo and remained elevated 4 weeks after administration compared to baseline. These field performance effects coincided with rHuEpo-induced elevated (v) over dot O-2 (max) and Hb(mass).	[Durussel, Jerome; Anderson, Martin; Chatterji, Tushar; Wondimu, Diresibachew H.; Padmanabhan, Neal; Patel, Rajan K.; McClure, John D.; Pitsiladis, Yannis P.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Daskalaki, Evangelia] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Wondimu, Diresibachew H.] Univ Addis Ababa, Dept Med Physiol, Addis Ababa, Ethiopia	University of Glasgow; University of Strathclyde; Addis Ababa University	Pitsiladis, YP (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	Yannis.Pitsiladis@glasgow.ac.uk		Pitsiladis, Yannis/0000-0001-6210-2449; Daskalaki, Evangelia/0000-0002-0313-3226	World Anti-Doping Agency [08C19YP]	World Anti-Doping Agency	This study was part of a larger research project supported and funded by World Anti-Doping Agency (08C19YP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgrim C, 2010, INT J LAB HEMATOL, V32, P506, DOI 10.1111/j.1751-553X.2009.01213.x; Alfrey CP, 1997, LANCET, V349, P1389, DOI 10.1016/S0140-6736(96)09208-2; Audran M, 1999, MED SCI SPORT EXER, V31, P639, DOI 10.1097/00005768-199905000-00003; Banfi G, 2008, SPORTS MED, V38, P187, DOI 10.2165/00007256-200838030-00002; Belcher JD, 2010, ANTIOXID REDOX SIGN, V12, P233, DOI 10.1089/ars.2009.2822; BERGLUND B, 1991, J INTERN MED, V229, P125, DOI 10.1111/j.1365-2796.1991.tb00319.x; Birkeland KI, 2000, MED SCI SPORT EXER, V32, P1238, DOI 10.1097/00005768-200007000-00009; Boning D, 2011, INT J SPORTS MED, V32, P242, DOI 10.1055/s-0030-1255063; Boning D, 2008, J APPL PHYSIOL, V105, P1988, DOI 10.1152/japplphysiol.91142.2008; BRIEN AJ, 1987, JAMA-J AM MED ASSOC, V257, P2761, DOI 10.1001/jama.257.20.2761; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Chang CC, 2009, J INVEST MED, V57, P650, DOI 10.2310/JIM.0b013e3181a3914e; Connes P, 2003, PFLUG ARCH EUR J PHY, V447, P231, DOI 10.1007/s00424-003-1174-0; COSTILL DL, 1973, MED SCI SPORT EXER, V5, P248; Durussel J, 2011, EUR J SPORT SCI; Ehrenreich H, 2008, J RENAL NUTR, V18, P146, DOI 10.1053/j.jrn.2007.10.029; ENGEL RR, 1971, PEDIATRICS, V47, P723; Franco RS, 2009, AM J HEMATOL, V84, P109, DOI 10.1002/ajh.21298; Heinicke K, 2001, INT J SPORTS MED, V22, P504, DOI 10.1055/s-2001-17613; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Jelkmann Wolfgang, 2009, P299, DOI 10.1007/978-3-7643-8698-6_16; Kirkeberg JM, 2011, INT J SPORTS MED, V32, P266, DOI 10.1055/s-0030-1269914; Laursen PB, 2007, MED SCI SPORT EXER, V39, P1374, DOI 10.1249/mss.0b013e31806010f5; LEVINE BD, 1992, INT J SPORTS MED, V13, pS209, DOI 10.1055/s-2007-1024642; Lipetzky A, 2012, J STRENGTH COND RES; Lucia A, 2002, MED SCI SPORT EXER, V34, P2079, DOI 10.1249/01.MSS.0000039306.92778.DF; Lundby C, 2008, J APPL PHYSIOL, V105, P581, DOI 10.1152/japplphysiol.90484.2008; Lundby C, 2007, J PHYSIOL-LONDON, V578, P309, DOI 10.1113/jphysiol.2006.122689; Lundby C, 2011, J PHYSIOL-LONDON, V589, P1265, DOI 10.1113/jphysiol.2010.195917; Millet GP, 2010, SPORTS MED, V40, P1, DOI 10.2165/11317920-000000000-00000; Miskowiak K, 2008, NEUROPSYCHOPHARMACOL, V33, P611, DOI 10.1038/sj.npp.1301439; Morkeberg J, 2009, SCAND J MED SCI SPOR, P1; Mujika I, 2001, SPORTS MED, V31, P479, DOI 10.2165/00007256-200131070-00003; Ninot G, 2006, J SPORT SCI, V24, P383, DOI 10.1080/02640410500131340; Noakes TD, 2008, BRIT J SPORT MED, V42, P551, DOI 10.1136/bjsm.2008.046821; Noakes TD, 2008, EUR J APPL PHYSIOL, V103, P485, DOI 10.1007/s00421-008-0712-z; Olsen NV, 2011, J PHYSIOL-LONDON, V589, P1273, DOI 10.1113/jphysiol.2010.194241; Parisotto R, 2000, HAEMATOLOGICA, V85, P564; Rasmussen P, 2010, J APPL PHYSIOL, V109, P476, DOI 10.1152/japplphysiol.00234.2010; Rice L, 2005, CELL PHYSIOL BIOCHEM, V15, P245, DOI 10.1159/000087234; Rice L, 2001, ANN INTERN MED, V134, P652, DOI 10.7326/0003-4819-134-8-200104170-00010; Russell G, 2002, EUR J APPL PHYSIOL, V86, P442, DOI 10.1007/s00421-001-0560-6; Ryter SW, 2004, BIOESSAYS, V26, P270, DOI 10.1002/bies.20005; Schmidt W, 2005, EUR J APPL PHYSIOL, V95, P486, DOI 10.1007/s00421-005-0050-3; Shephard RJ, 2009, BRIT J SPORT MED, V43, P83, DOI 10.1136/bjsm.2008.052506; Thomsen JJ, 2007, EUR J APPL PHYSIOL, V101, P481, DOI 10.1007/s00421-007-0522-8; Wilkerson DP, 2005, J PHYSIOL-LONDON, V568, P639, DOI 10.1113/jphysiol.2005.089920	47	37	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56151	10.1371/journal.pone.0056151	http://dx.doi.org/10.1371/journal.pone.0056151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418527	Green Accepted, Green Published, gold			2022-12-27	WOS:000315970300119
J	Lucci, G; Berchicci, M; Spinelli, D; Taddei, F; Di Russo, F				Lucci, Giuliana; Berchicci, Marika; Spinelli, Donatella; Taddei, Francesco; Di Russo, Francesco			The Effects of Aging on Conflict Detection	PLOS ONE			English	Article							RESPONSE-INHIBITION; ANTERIOR CINGULATE; COGNITIVE CONTROL; ERP COMPONENTS; GO/NOGO TASK; STOP-SIGNAL; AGE; P300; GO; N2	Several cognitive changes characterize normal aging; one change regards inhibitory processing and includes both conflict monitoring and response suppression. We attempted to segregate these two aspects within a Go/No-go task, investigating three age categories. Accuracy, response times and event-related potentials (ERPs) were recorded. The ERP data were analyzed, and the Go and No-go trials were separated; in addition, the trials were organized in repeat trials (in which the subjects repeated the action delivered in the previous trial) and switch trials (in which the subjects produced a response opposite to the previous response). We assumed that the switch trials conveyed more conflict than the repeat trials. In general, the behavioral data and slower P3 latencies confirmed the well-known age-related speed/accuracy trade-off. The novel analyses of the repeat vs. switch trials indicated that the age-related P3 slowing was significant only for the high conflict condition; the switch-P3 amplitude increased only in the two older groups. The 'aging switch effect' on the P3 component suggests a failure in the conflict conditions and likely contributes to a generalized dysfunction. The absence of either a switch effect in the young group and the P3 slowing in middle-aged group indicate that switching was not particularly demanding for these participants. The N2 component was less sensitive to the repeat/switch manipulation; however, the subtractive waves also enhanced the age effects in this earlier time window. The topographic maps showed other notable age effects: the frontal No-go N2 was nearly undetectable in the elderly; in the identical time window, a large activity in the posterior and prefrontal scalp regions was observed. Moreover, the prefrontal activity showed a negative correlation with false alarms. These results suggest that the frontal involvement during action suppression becomes progressively dysfunctional with aging, and additional activity was required to reach a good level of accuracy.	[Lucci, Giuliana; Berchicci, Marika; Spinelli, Donatella; Taddei, Francesco; Di Russo, Francesco] Univ Rome Foro Italico, Dept Human Movement Social & Hlth Sci, Rome, Italy; [Lucci, Giuliana; Spinelli, Donatella; Di Russo, Francesco] Santa Lucia Fdn IRCCS, Neuropsychol Unit, Rome, Italy	Foro Italico University of Rome; IRCCS Santa Lucia	Lucci, G (corresponding author), Univ Rome Foro Italico, Dept Human Movement Social & Hlth Sci, Rome, Italy.	giuliana.lucci@libero.it	Di Russo, Francesco/N-6686-2015	Di Russo, Francesco/0000-0002-3127-9433; Lucci, Giuliana/0000-0003-3118-2989; , Marika/0000-0001-8470-191X; SPINELLI, Donatella/0000-0002-4890-6931	University of Rome [RIC1152012]	University of Rome	This research was supported by University of Rome grant code RIC1152012. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Astle DE, 2006, BRAIN RES, V1125, P94, DOI 10.1016/j.brainres.2006.09.092; Azizian A, 2006, PSYCHOPHYSIOLOGY, V43, P253, DOI 10.1111/j.1469-8986.2006.00409.x; Bekker EM, 2004, CLIN NEUROPHYSIOL, V115, P2001, DOI 10.1016/j.clinph.2004.04.008; Berchicci M, 2012, NEUROIMAGE, V62, P1750, DOI 10.1016/j.neuroimage.2012.06.031; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Bokura H., 2002, INT C SERIES, V1232, P17, DOI DOI 10.1016/S0531-5131(01)00677-X; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Daffner KR, 2011, NEUROIMAGE, V54, P427, DOI 10.1016/j.neuroimage.2010.08.006; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; DiGirolamo GJ, 2001, NEUROREPORT, V12, P2065, DOI 10.1097/00001756-200107030-00054; Dirnberger G, 2010, AGE, V32, P323, DOI 10.1007/s11357-010-9134-z; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Enriquez-Geppert S, 2010, NEUROIMAGE, V51, P877, DOI 10.1016/j.neuroimage.2010.02.043; Falkenstein M, 2002, J PSYCHOPHYSIOL, V16, P167, DOI 10.1027//0269-8803.16.3.167; Fjell AM, 2001, BRAIN TOPOGR, V14, P25, DOI 10.1023/A:1012563605837; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gazzaley A, 2007, ANN NY ACAD SCI, V1097, P67, DOI 10.1196/annals.1379.010; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; Hammerer D, 2010, NEUROPSYCHOLOGIA, V48, P3305, DOI 10.1016/j.neuropsychologia.2010.07.014; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Hasher L., 2008, VARIATION WORKING ME, P227, DOI [10.1093/acprof:oso/9780195168648.001.0001, DOI 10.1093/ACPROF:OSO/9780195168648.001.0001, DOI 10.1093/ACPROF:OSO/9780195168648.003.0009]; Jamadar S, 2010, NEUROIMAGE, V51, P432, DOI 10.1016/j.neuroimage.2010.01.090; JODO E, 1992, ELECTROEN CLIN NEURO, V82, P477, DOI 10.1016/0013-4694(92)90054-L; JOHNSON R, 1980, PSYCHOPHYSIOLOGY, V17, P167, DOI 10.1111/j.1469-8986.1980.tb00131.x; Johnstone SJ, 2007, INT J PSYCHOPHYSIOL, V63, P25, DOI 10.1016/j.ijpsycho.2006.07.001; Jonkman LM, 2006, BRAIN RES, V1097, P181, DOI 10.1016/j.brainres.2006.04.064; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; KUTAS M, 1994, ELECTROEN CLIN NEURO, V92, P126, DOI 10.1016/0168-5597(94)90053-1; Lavric A, 2004, EUR J NEUROSCI, V20, P2483, DOI 10.1111/j.1460-9568.2004.03683.x; MAGLIERO A, 1984, PSYCHOPHYSIOLOGY, V21, P171, DOI 10.1111/j.1469-8986.1984.tb00201.x; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Nielson KA, 2002, PSYCHOL AGING, V17, P56, DOI 10.1037//0882-7974.17.1.56; Nielson KA, 2001, BRAIN COGNITION, V47, P169; Nieuwenhuis S, 2004, PSYCHOPHYSIOLOGY, V41, P157, DOI 10.1046/j.1469-8986.2003.00128.x; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; O'Connell RG, 2012, NEUROBIOL AGING, V33, P2448, DOI 10.1016/j.neurobiolaging.2011.12.021; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; PFEFFERBAUM A, 1988, ELECTROEN CLIN NEURO, V71, P55, DOI 10.1016/0168-5597(88)90019-6; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; PICTON TW, 1984, PSYCHOPHYSIOLOGY, V21, P312, DOI 10.1111/j.1469-8986.1984.tb02941.x; POLICH J, 1991, ELECTROEN CLIN NEURO, P304; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Potter LM, 2006, EXP BRAIN RES, V171, P56, DOI 10.1007/s00221-005-0244-2; Randall WM, 2011, CLIN NEUROPHYSIOL, V122, P2400, DOI 10.1016/j.clinph.2011.05.012; Ratcliff R, 2007, PSYCHOL AGING, V22, P56, DOI 10.1037/0882-7974.22.1.56; Reuter-Lorenz PA, 2002, TRENDS COGN SCI, V6, P394, DOI 10.1016/S1364-6613(02)01957-5; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Smith JL, 2008, CLIN NEUROPHYSIOL, V119, P704, DOI 10.1016/j.clinph.2007.11.042; Smith JL, 2007, CLIN NEUROPHYSIOL, V118, P343, DOI 10.1016/j.clinph.2006.09.027; Smith JL, 2010, INT J PSYCHOPHYSIOL, V75, P217, DOI 10.1016/j.ijpsycho.2009.11.002; Tachibana H, 1996, EVOKED POTENTIAL, V100, P299, DOI 10.1016/0168-5597(96)95108-4; Taddei F, 2012, MED SCI SPORT EXER, V44, P1057, DOI 10.1249/MSS.0b013e31824529c2; Vallesi A, 2011, NEUROSCI LETT, V487, P313, DOI 10.1016/j.neulet.2010.10.046; Vallesi A, 2010, NEUROIMAGE, V50, P1251, DOI 10.1016/j.neuroimage.2010.01.022; Vallesi A, 2009, NEUROPSYCHOLOGIA, V47, P577, DOI 10.1016/j.neuropsychologia.2008.10.018; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; Wascher E, 2011, NEUROSCI LETT, V487, P66, DOI 10.1016/j.neulet.2010.09.075; Willemssen R, 2011, NEUROBIOL AGING, V32, P327, DOI 10.1016/j.neurobiolaging.2009.02.002; Zhang BW, 2007, NEUROSCI LETT, V419, P225, DOI 10.1016/j.neulet.2007.04.013; Zimmermann P., 1992, TESTBATTERIE AUFMERK	67	48	50	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56566	10.1371/journal.pone.0056566	http://dx.doi.org/10.1371/journal.pone.0056566			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418584	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300177
J	Zhang, XZ; Daucher, M; Armistead, D; Russell, R; Kottilil, S				Zhang, Xiaozhen; Daucher, Marybeth; Armistead, David; Russell, Rodney; Kottilil, Shyam			MicroRNA Expression Profiling in HCV-Infected Human Hepatoma Cells Identifies Potential Anti-Viral Targets Induced by Interferon-alpha	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; CELLULAR MICRORNAS; PLUS RIBAVIRIN; LIVER-DISEASES; GENE; MET; MODULATION; MECHANISM	Objective: Increasing evidence suggests that miRNAs have a profound impact on host defense to Hepatitis C virus (HCV) infection and clinical outcome of standard HCV therapy. In this study, we investigated modulation of miRNA expression in Huh7.5 hepatoma cells by HCV infection and in vitro interferon-alpha treatment. Methods: MiRNA expression profiling was determined using Human miRNA TaqMan (R) Arrays followed by rigorous pairwise statistical analysis. MiRNA inhibitors assessed the functional effects of miRNAs on HCV replication. Computational analysis predicted anti-correlated mRNA targets and their involvement in host cellular pathways. Quantitative RTPCR confirmed the expression of predicted miRNA-mRNA correlated pairs in HCV-infected Huh7.5 cells with and without interferon-alpha. Results: Seven miRNAs (miR-30b, miR-30c, miR-130a, miR-192, miR-301, miR-324-5p, and miR-565) were down-regulated in HCV-infected Huh7.5 cells (p<0.05) and subsequently up-regulated following interferon-alpha treatment (p<0.01). The miR-30(a-d) cluster and miR-130a/301 and their putative mRNA targets were predicted to be associated with cellular pathways that involve Hepatitis C virus entry, propagation and host response to viral infection. Conclusions: HCV differentially modulates miRNAs to facilitate entry and early establishment of infection in vitro. Interferon-alpha appears to neutralize the effect of HCV replication on miRNA regulation thus providing a potential mechanism of action in eradicating HCV from hepatocytes.	[Zhang, Xiaozhen; Daucher, Marybeth; Kottilil, Shyam] NIAID, Immunopathogenesis Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Armistead, David] Life Technol Inc, Gaithersburg, MD USA; [Russell, Rodney] Mem Univ Newfoundland, Fac Med, Hlth Sci Ctr, St John, NF, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Thermo Fisher Scientific; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba	Kottilil, S (corresponding author), NIAID, Immunopathogenesis Sect, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	skottilil@niaid.nih.gov	Russell, Rod/AAU-3109-2021; Kottilil, Shyam/ABF-7605-2021		Intramural Research Program of the NIH, [National Institute of Allergy and Infectious Diseases]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000390] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, [National Institute of Allergy and Infectious Diseases](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors declare that they do not have anything to disclose regarding the funding or conflict of interest with respect to this manuscript. The content of this publication does not necessarily reflect the views of policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the U.S. Government. This research was supported in whole by the Intramural Research Program of the NIH, [National Institute of Allergy and Infectious Diseases]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Bala S, 2009, WORLD J GASTROENTERO, V15, P5633, DOI 10.3748/wjg.15.5633; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen LM, 2010, J GEN VIROL, V91, P382, DOI 10.1099/vir.0.015388-0; Chen QY, 1997, HEPATOLOGY, V26, P59; Chowdhury JB, 2012, J VIROL, V86, P10221, DOI 10.1128/JVI.00882-12; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Hou X, 2009, HEPATOLOGY, V49, P940, DOI 10.1002/hep.22725; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lempicki RA, 2006, J INFECT DIS, V193, P1172, DOI 10.1086/501365; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Murakami Y, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-48; Patsenker E, 2011, AM J PHYSIOL-GASTR L, V301, pG425, DOI 10.1152/ajpgi.00050.2011; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; Roubelakis MG, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S20; Saito T, 2010, NEW BIOTECHNOL, V27, P243, DOI 10.1016/j.nbt.2010.02.016; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Scagnolari C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-311; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Sidorkiewicz M, 2010, ACTA VIROL, V54, P75, DOI 10.4149/av_2010_01_75; Ueki T, 1997, HEPATOLOGY, V25, P862, DOI 10.1002/hep.510250413; Wang Y, 2007, FRONT BIOSCI-LANDMRK, V12, P2316, DOI 10.2741/2234; Yoshimura A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00020; Zeuzem S, 2006, J HEPATOL, V44, P97, DOI 10.1016/j.jhep.2005.10.003; ZHANG ZX, 1994, BIOCHEM BIOPH RES CO, V202, P1352, DOI 10.1006/bbrc.1994.2079	35	55	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55733	10.1371/journal.pone.0055733	http://dx.doi.org/10.1371/journal.pone.0055733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418453	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300044
J	Reiner, T; Parrondo, R; de las Pozas, A; Palenzuela, D; Perez-Stable, C				Reiner, Teresita; Parrondo, Ricardo; de las Pozas, Alicia; Palenzuela, Deanna; Perez-Stable, Carlos			Betulinic Acid Selectively Increases Protein Degradation and Enhances Prostate Cancer-Specific Apoptosis: Possible Role for Inhibition of Deubiquitinase Activity	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; NF-KAPPA-B; CELL-LINES; TRANSGENIC MOUSE; CYCLIN D1; IN-VITRO; PROTEASOME; THERAPY; TUMOR; ENZYMES	Inhibition of the ubiquitin-proteasome system (UPS) of protein degradation is a valid anti-cancer strategy and has led to the approval of bortezomib for the treatment of multiple myeloma. However, the alternative approach of enhancing the degradation of oncoproteins that are frequently overexpressed in cancers is less developed. Betulinic acid (BA) is a plant-derived small molecule that can increase apoptosis specifically in cancer but not in normal cells, making it an attractive anti-cancer agent. Our results in prostate cancer suggested that BA inhibited multiple deubiquitinases (DUBs), which resulted in the accumulation of poly-ubiquitinated proteins, decreased levels of oncoproteins, and increased apoptotic cell death. In normal fibroblasts, however, BA did not inhibit DUB activity nor increased total poly-ubiquitinated proteins, which was associated with a lack of effect on cell death. In the TRAMP transgenic mouse model of prostate cancer, treatment with BA (10 mg/kg) inhibited primary tumors, increased apoptosis, decreased angiogenesis and proliferation, and lowered androgen receptor and cyclin D1 protein. BA treatment also inhibited DUB activity and increased ubiquitinated proteins in TRAMP prostate cancer but had no effect on apoptosis or ubiquitination in normal mouse tissues. Overall, our data suggests that BA-mediated inhibition of DUBs and induction of apoptotic cell death specifically in prostate cancer but not in normal cells and tissues may provide an effective non-toxic and clinically selective agent for chemotherapy.	[Reiner, Teresita; Parrondo, Ricardo; de las Pozas, Alicia; Palenzuela, Deanna; Perez-Stable, Carlos] Bruce W Carter Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Miami, FL USA; [Reiner, Teresita; Parrondo, Ricardo; de las Pozas, Alicia; Palenzuela, Deanna; Perez-Stable, Carlos] Bruce W Carter Vet Affairs Med Ctr, Res Serv, Miami, FL USA; [Perez-Stable, Carlos] Univ Miami, Miller Sch Med, Dept Med, Div Gerontol & Geriatr Med, Miami, FL 33136 USA; [Perez-Stable, Carlos] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	Geriatric Research Education & Clinical Center; University of Miami; University of Miami	Perez-Stable, C (corresponding author), Bruce W Carter Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Miami, FL USA.	cperez@med.miami.edu			Veterans Affairs Merit Review [6996.06 MR]	Veterans Affairs Merit Review(US Department of Veterans Affairs)	Veterans Affairs Merit Review 6996.06 MR http://www.research.va.gov/programs/blrd/merit_review.cfm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Colland F, 2010, BIOCHEM SOC T, V38, P137, DOI 10.1042/BST0380137; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Comstock CES, 2011, J BIOL CHEM, V286, P8117, DOI 10.1074/jbc.M110.170720; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Draker R, 2011, NUCLEIC ACIDS RES, V39, P3529, DOI 10.1093/nar/gkq1352; Drobnjak M, 2000, CLIN CANCER RES, V6, P1891; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Faus H, 2005, MOL CELL ENDOCRINOL, V245, P138, DOI 10.1016/j.mce.2005.11.011; Fulda S, 2009, DRUG DISCOV TODAY, V14, P885, DOI 10.1016/j.drudis.2009.05.015; Gao Y, 2011, CANCER RES, V71, P5182, DOI 10.1158/0008-5472.CAN-10-2016; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gomez LA, 2006, MOL CANCER THER, V5, P1216, DOI 10.1158/1535-7163.MCT-05-0467; Gottlieb RA, 2002, METHODS, V26, P341, DOI 10.1016/S1046-2023(02)00040-3; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Huang L, 2007, FEBS LETT, V581, P4955, DOI 10.1016/j.febslet.2007.09.031; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Kapuria V, 2010, CANCER RES, V70, P9265, DOI 10.1158/0008-5472.CAN-10-1530; Kasperczyk H, 2005, ONCOGENE, V24, P6945, DOI 10.1038/sj.onc.1208842; Katsiki M, 2007, REJUV RES, V10, P157, DOI 10.1089/rej.2006.0513; Kessler JH, 2007, CANCER LETT, V251, P132, DOI 10.1016/j.canlet.2006.11.003; Kon N, 2010, ONCOGENE, V29, P1270, DOI 10.1038/onc.2009.427; Krishan A, 1990, Methods Cell Biol, V33, P121; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Morris MJ, 2007, J UROLOGY, V178, P2378, DOI 10.1016/j.juro.2007.08.015; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Parrondo R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-182; Perez-Stable C, 2006, CANCER LETT, V231, P49, DOI 10.1016/j.canlet.2005.01.018; PISHA E, 1995, NAT MED, V1, P1046, DOI 10.1038/nm1095-1046; Reiner T, 2009, CANCER LETT, V276, P21, DOI 10.1016/j.canlet.2008.10.026; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Shin YG, 1999, J CHROMATOGR B, V732, P331, DOI 10.1016/S0378-4347(99)00291-1; Soldatenkov VA, 1997, CANCER RES, V57, P3881; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; Zuco V, 2002, CANCER LETT, V175, P17, DOI 10.1016/S0304-3835(01)00718-2	48	56	60	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56234	10.1371/journal.pone.0056234	http://dx.doi.org/10.1371/journal.pone.0056234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424652	gold, Green Published, Green Submitted			2022-12-27	WOS:000315965100040
J	Hambolu, D; Freeman, J; Taddese, HB				Hambolu, Dupe; Freeman, Jenny; Taddese, Henock B.			Predictors of Bovine TB Risk Behaviour amongst Meat Handlers in Nigeria: A Cross-Sectional Study Guided by the Health Belief Model	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; TUBERCULOSIS; INFECTION; ETHIOPIA; GENDER	Background: Bovine Tuberculosis (bTB) is still a serious public health threat in developing countries. The aim of this study is to determine the social and cognitive factors predicting one of the risk behaviours amongst meat handlers in Nigeria, namely, eating Fuku Elegusi. This is the practice of eating the visibly infected parts of the lung in-order to convince customers to buy meat. The study is guided by the health belief model (HBM). Methods: This is a cross-sectional study of 349 randomly selected meat handlers in Oko-Oba Abattoir, in Lagos State. Descriptive statistics and multiple logistic regression analysis were employed to determine perceptions and prevalence of risk behaviours and to identify predictors of eating Fuku Elegusi. Results: Just over a quarter (28.1%) of the study participants knew that eating Fuku Elegusi could be a source of bTB in humans. The prevalence of eating Fuku Elegusi was found to be 22%. Across all knowledge indicators related to bTB, those who don't eat Fuku Elegusi exhibited better knowledge. Strong predictors of eating Fuku Elegusi were: being male (OR: 2.39, 95% CI: 1.10 to 5.19; p = 0.03), not knowing that eating Fuku Elegusi exposes to bTB (OR: 3.72, 95% CI: 1.69 to 8.22; p = 0.001), and the perception that one cannot sell meat without tasting it (perceived barrier) (OR: 1.35, 95% CI: 1.13 to 1.60; p = 0.001). Lower risk of eating Fuku Elegusi was predicted by perceived susceptibility to bTB due to another risk behaviour, namely, not washing hands after handling meat (OR: 0.78, 95% CI: 0.64 to 0.96; p-value = 0.021). Television and radio were the most acceptable media for TB prevention messages (78.5% and 75.6% respectively). Conclusion: Meat handlers in developing countries bear high risk to bTB owing to prevailing social and cognition determinants. Findings were largely consistent with the propositions of HBM.	[Hambolu, Dupe] Fed Minist Agr & Water Resources, Fed Dept Livestock & Pest Control Serv, Abuja, Nigeria; [Freeman, Jenny; Taddese, Henock B.] Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England	University of Sheffield	Taddese, HB (corresponding author), Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England.	h.taddese@sheffield.ac.uk						Abubakar U. B., 2011, Veterinary Research (Pakistan), V4, P24; Ademola A. I., 2010, Veterinary Research (Pakistan), V3, P54; Adesokan HK, 2012, INT J TUBERC LUNG D, V16, P1388, DOI 10.5588/ijtld.12.0109; Amenu K., 2010, Tropicultura, V28, P205; Anaelom N. J., 2010, Journal of Public Health and Epidemiology, V2, P118; [Anonymous], 1994, B WORLD HEALTH ORGAN, V72, P851; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Bowling A., 2014, RES METHODS HLTH INV; Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006; Cadmus S.I.B., 2008, NIG VET J, V45, P150; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Creswell J. W.., 2018, SAGE PUBLICATIONS; Daborn CJ, 1996, J APPL BACTERIOL, V81, pS27; Davidson KW, 2006, HEALTH EDUC BEHAV, V33, P731, DOI 10.1177/1090198106288043; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Glanz K., 2008, HLTH BEHAV HLTH ED T; Grange JM, 2001, TUBERCULOSIS, V81, P71, DOI 10.1054/tube.2000.0263; Ibironke AA, 2010, EUR J TRANSL MYOL, V20, P13, DOI 10.4081/ejtm.2010.1871; IDIGBE EO, 1986, J TROP MED HYG, V89, P143; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Mfinanga SG, 2003, INT J TUBERC LUNG D, V7, P933; Moda G, 1996, TUBERCLE LUNG DIS, V77, P103, DOI 10.1016/S0962-8479(96)90022-2; OKOLO MIO, 1992, MICROBIOS, V69, P105; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Rosenstock IM, 1994, HLTH BELIEF MODEL HI; Shitaye JE, 2007, VET MED-CZECH, V52, P317, DOI 10.17221/1872-VETMED; Strecher VJ, 1997, HLTH BELIEF MODEL; Swai E. S., 2010, Tanzania Journal of Health Research, V12, P272; Taylor D., 2007, REV USE HLTH BELIEF; WHO, 2011, WHO GLOBAL TUBERCULO	31	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56091	10.1371/journal.pone.0056091	http://dx.doi.org/10.1371/journal.pone.0056091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409127	Green Published, gold, Green Accepted			2022-12-27	WOS:000315100000044
J	Dunnick, WA; Shi, J; Fontaine, C; Collins, JT				Dunnick, Wesley A.; Shi, Jian; Fontaine, Clinton; Collins, John T.			Transgenes of the Mouse Immunoglobulin Heavy Chain Locus, Lacking Distal Elements in the 3 ' Regulatory Region, Are Impaired for Class Switch Recombination	PLOS ONE			English	Article							B-CELL DIFFERENTIATION; IGH LOCUS; CONSTANT-REGION; ENHANCER; EXPRESSION; DELETION; END; DNA; IDENTIFICATION; TRANSCRIPTION	The immunoglobulin heavy (H) chain class switch is mediated by a deletional recombination event between mu and gamma, alpha, or epsilon constant region genes. This recombination event is upregulated during immune responses by a regulatory region that lies 3' of the constant region genes. We study switch recombination using a transgene of the entire murine H chain constant region locus. We isolated two lines of mice in which the H chain transgenes were truncated at their 3' ends. The truncation in both transgenic lines results in deletion of the 3'-most enhancer (HS4) and a region with insulator-like structure and activities. Even though both truncated transgenes express the mu H chain gene well, they undergo very low or undetectable switch recombination to transgenic gamma and alpha constant region genes. For both transgenic lines, germline transcription of some H chain constant regions genes is severely impaired. However, the germline transcription of the gamma 1 and gamma 2a genes is at wild type levels for the transgenic line with the larger truncation, but at reduced levels for the transgenic line with the smaller truncation. The dramatic reduction in class switch recombination for all H chain genes and the varied reduction in germline transcription for some H chain genes could be caused by (i) insertion site effects or (ii) deletion of enhancer elements for class switch recombination and transcription, or (iii) a combination of both effects.	[Dunnick, Wesley A.; Shi, Jian; Fontaine, Clinton; Collins, John T.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Dunnick, WA (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	wesadunn@umich.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [AI076057]; National Institutes of Health [CA46592]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076057] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (AI076057)(http://www.niaid.nih.gov) Core support for the production of transgenic mice was provided by a grant from the National Institutes of Health to the University of Michigan Cancer Center (CA46592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arulampalam V, 1996, INT IMMUNOL, V8, P1149; Bebin AG, 2010, J IMMUNOL, V184, P3710, DOI 10.4049/jimmunol.0901978; BISHOP GA, 1995, EUR J IMMUNOL, V25, P1230, DOI 10.1002/eji.1830250515; Chauveau C, 1999, J IMMUNOL, V163, P4637; Chauveau C, 1998, EUR J IMMUNOL, V28, P3048, DOI 10.1002/(SICI)1521-4141(199810)28:10<3048::AID-IMMU3048>3.0.CO;2-V; CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978; COFFMAN RL, 1986, J IMMUNOL, V136, P949; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; Cogne M, 2004, MOL BIOL B CELLS, P289; DARIAVACH P, 1991, EUR J IMMUNOL, V21, P1499, DOI 10.1002/eji.1830210625; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Dunnick WA, 2004, J IMMUNOL, V173, P5531, DOI 10.4049/jimmunol.173.9.5531; Dunnick WA, 2011, J IMMUNOL, V187, P4733, DOI 10.4049/jimmunol.1101808; Dunnick WA, 2009, J EXP MED, V206, P2613, DOI 10.1084/jem.20091280; DURDIK J, 1989, P NATL ACAD SCI USA, V86, P2346, DOI 10.1073/pnas.86.7.2346; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; GERSTEIN RM, 1990, CELL, V63, P537, DOI 10.1016/0092-8674(90)90450-S; GIANNINI SL, 1993, J IMMUNOL, V150, P1772; GIUSTI AM, 1993, J EXP MED, V177, P797, DOI 10.1084/jem.177.3.797; LI SC, 1994, INT IMMUNOL, V6, P491, DOI 10.1093/intimm/6.4.491; Lieberson R, 1995, EMBO J, V14, P6229, DOI 10.1002/j.1460-2075.1995.tb00313.x; LIEBERSON R, 1991, NUCLEIC ACIDS RES, V19, P933, DOI 10.1093/nar/19.4.933; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; Manis JP, 2003, MOL IMMUNOL, V39, P753, DOI 10.1016/S0161-5890(02)00256-0; MATTHIAS P, 1993, MOL CELL BIOL, V13, P1547, DOI 10.1128/MCB.13.3.1547; MICHAELSON JS, 1995, NUCLEIC ACIDS RES, V23, P975, DOI 10.1093/nar/23.6.975; Ong J, 1998, J IMMUNOL, V160, P4896; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; Saitoh N, 2000, EMBO J, V19, P2315, DOI 10.1093/emboj/19.10.2315; Seidl KJ, 1999, P NATL ACAD SCI USA, V96, P3000, DOI 10.1073/pnas.96.6.3000; Shansab M, 2011, EUR J IMMUNOL, V41, P1456, DOI 10.1002/eji.201041077; Shi XR, 2001, INT IMMUNOL, V13, P1003, DOI 10.1093/intimm/13.8.1003; Vincent-Fabert C, 2010, BLOOD, V116, P1895, DOI 10.1182/blood-2010-01-264689; Vincent-Fabert C, 2009, J IMMUNOL, V182, P6926, DOI 10.4049/jimmunol.0900214; Volpi SA, 2012, J IMMUNOL, V188, P2556, DOI 10.4049/jimmunol.1102763; Yan Y, 2011, J BIOL CHEM, V286, P27123, DOI 10.1074/jbc.M111.230995	37	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55842	10.1371/journal.pone.0055842	http://dx.doi.org/10.1371/journal.pone.0055842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409061	Green Published, gold, Green Submitted			2022-12-27	WOS:000314660300039
J	Cignetti, F; Zedka, M; Vaugoyeau, M; Assaiante, C				Cignetti, Fabien; Zedka, Milan; Vaugoyeau, Marianne; Assaiante, Christine			Independent Walking as a Major Skill for the Development of Anticipatory Postural Control: Evidence from Adjustments to Predictable Perturbations	PLOS ONE			English	Article							LATERAL BALANCE CONTROL; MUSCLE-ACTIVITY; GAIT INITIATION; INFANTS; STABILIZATION; MOVEMENTS; ORGANIZATION; SPECIFICITY; PARAMETERS; PATTERNS	Although there is suggestive evidence that a link exists between independent walking and the ability to establish anticipatory strategy to stabilize posture, the extent to which this skill facilitates the development of anticipatory postural control remains largely unknown. Here, we examined the role of independent walking on the infants' ability to anticipate predictable external perturbations. Non-walking infants, walking infants and adults were sitting on a platform that produced continuous rotation in the frontal plane. Surface electromyography (EMG) of neck and lower back muscles and the positions of markers located on the platform, the upper body and the head were recorded. Results from cross-correlation analysis between rectified and filtered EMGs and platform movement indicated that although muscle activation already occurred before platform movement in non-walking infants, only walking infants demonstrated an adult-like ability for anticipation. Moreover, results from further cross-correlation analysis between segmental angular displacement and platform movement together with measures of balance control at the end-points of rotation of the platform evidenced two sorts of behaviour. The adults behaved as a non-rigid non-inverted pendulum, rather stabilizing head in space, while both the walking and non-walking infants followed the platform, behaving as a rigid inverted pendulum. These results suggest that the acquisition of independent walking plays a role in the development of anticipatory postural control, likely improving the internal model for the sensorimotor control of posture. However, despite such improvement, integrating the dynamics of an external object, here the platform, within the model to maintain balance still remains challenging in infants.	[Cignetti, Fabien; Vaugoyeau, Marianne; Assaiante, Christine] CNRS, LNC, UMR 7291, Marseille, France; [Cignetti, Fabien; Vaugoyeau, Marianne; Assaiante, Christine] Aix Marseille Univ, Marseille, France; [Cignetti, Fabien; Vaugoyeau, Marianne; Assaiante, Christine] Comportement Cerveau Cognit, Federat Rech N3512, Marseille, France; [Zedka, Milan] Univ Bern, Inselspital, Dept Paediat, Div Paediat Nephrol, CH-3010 Bern, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Bern; University Hospital of Bern	Assaiante, C (corresponding author), CNRS, LNC, UMR 7291, Marseille, France.	christine.assaiante@univ-provence.fr	Cignetti, Fabien/P-4551-2015	Cignetti, Fabien/0000-0002-9050-8056	French National Center for Scientific Research (CNRS)	French National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This research was supported by funding from the French National Center for Scientific Research (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph K., 2006, HDB CHILD DEV COGNIT, P161, DOI [10.1002/9780470147658.chpsy0204, DOI 10.1002/9780470147658.CHPSY0204]; Adolph KE, 2000, PSYCHOL SCI, V11, P290, DOI 10.1111/1467-9280.00258; Adolph KE, 1997, MONOGR SOC RES CHILD, V62, pR5; ARUIN AS, 1995, EXP BRAIN RES, V103, P323; ASSAIANTE C, 1993, NEUROREPORT, V4, P875, DOI 10.1097/00001756-199307000-00009; ASSAIANTE C, 1995, HUM MOVEMENT SCI, V14, P13, DOI 10.1016/0167-9457(94)00048-J; Assaiante C, 2000, J MOTOR BEHAV, V32, P211, DOI 10.1080/00222890009601373; Assaiante C, 1998, J MOTOR BEHAV, V30, P114, DOI 10.1080/00222899809601329; ASSAIANTE C, 1993, EXP BRAIN RES, V93, P499; Assaiante Christine, 2005, Neural Plasticity, V12, P109, DOI 10.1155/NP.2005.109; Barela JA, 1999, INFANT BEHAV DEV, V22, P87, DOI 10.1016/S0163-6383(99)80007-1; Bertenthal BI, 1997, J EXP PSYCHOL HUMAN, V23, P1631, DOI 10.1037/0096-1523.23.6.1631; Bertenthal BI, 2000, INFANT BEHAV DEV, V23, P299, DOI 10.1016/S0163-6383(01)00046-7; Bloomfield P., 2000, FOURIER ANAL TIME SE, P261; Brogren E, 1996, DEV MED CHILD NEUROL, V38, P379; Buchanan JJ, 1999, J NEUROPHYSIOL, V81, P2325, DOI 10.1152/jn.1999.81.5.2325; Campos JJ, 2000, INFANCY, V1, P149, DOI 10.1207/S15327078IN0102_1; Chen LC, 2007, INFANT BEHAV DEV, V30, P16, DOI 10.1016/j.infbeh.2006.07.005; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Corna S, 1999, EXP BRAIN RES, V124, P331, DOI 10.1007/s002210050630; de Graaf-Peters VB, 2007, EXP BRAIN RES, V181, P647, DOI 10.1007/s00221-007-0964-6; De Luca CJ, 1997, J APPL BIOMECH, V13, P135, DOI 10.1123/jab.13.2.135; De Nunzio AM, 2007, EXP BRAIN RES, V178, P18, DOI 10.1007/s00221-006-0708-z; Dingwell JB, 2008, IEEE T BIO-MED ENG, V55, P2666, DOI 10.1109/TBME.2008.2001130; Flanagan JR, 1997, J NEUROSCI, V17, P1519; FORSSBERG H, 1994, EXP BRAIN RES, V97, P515; HaddersAlgra M, 1996, J PHYSIOL-LONDON, V493, P289, DOI 10.1113/jphysiol.1996.sp021383; HaddersAlgra M, 1996, J PHYSIOL-LONDON, V493, P273, DOI 10.1113/jphysiol.1996.sp021382; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Hore J, 1999, J NEUROPHYSIOL, V82, P1187, DOI 10.1152/jn.1999.82.3.1187; Isableu B, 2003, EXP BRAIN RES, V150, P208, DOI 10.1007/s00221-003-1446-0; Mallau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013078; Malouin F, 2000, GAIT POSTURE, V11, P239, DOI 10.1016/S0966-6362(00)00051-5; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; NARDONE A, 1988, EXP BRAIN RES, V69, P469; OMalley MJ, 1996, J BIOMECH, V29, P619, DOI 10.1016/0021-9290(95)00088-7; Orfanidis S. J., 1996, OPTIMUM SIGNAL PROCE; Ornitz EM, 1983, DEV AUDITORY VESTIBU, P479; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Santos MJ, 2010, J ELECTROMYOGR KINES, V20, P388, DOI 10.1016/j.jelekin.2009.06.006; Schieppati M, 2002, EXP BRAIN RES, V144, P200, DOI 10.1007/s00221-002-1028-6; Shiratori T, 2001, CLIN NEUROPHYSIOL, V112, P1250, DOI 10.1016/S1388-2457(01)00553-3; van Balen LC, 2012, EXP BRAIN RES, V220, P109, DOI 10.1007/s00221-012-3121-9; van der Fits IBM, 1998, EXP BRAIN RES, V120, P202, DOI 10.1007/s002210050394; Van der Fits IBM, 1999, EXP BRAIN RES, V126, P517, DOI 10.1007/s002210050760; Van Der Fits IBM, 1998, NEUROSCI BIOBEHAV R, V22, P521, DOI 10.1016/S0149-7634(97)00039-0; von Hofsten C, 2004, TRENDS COGN SCI, V8, P266, DOI 10.1016/j.tics.2004.04.002; VONHOFSTEN C, 1993, HUM DEV, V36, P253, DOI 10.1159/000278212; Witherington DC, 2002, INFANCY, V3, P495, DOI 10.1207/S15327078IN0304_05	49	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56313	10.1371/journal.pone.0056313	http://dx.doi.org/10.1371/journal.pone.0056313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092XV	23409171	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200131
J	Stergiou, L; Bauer, M; Mair, W; Bausch-Fluck, D; Drayman, N; Wollscheid, B; Oppenheim, A; Pelkmans, L				Stergiou, Lilli; Bauer, Manuel; Mair, Waltraud; Bausch-Fluck, Damaris; Drayman, Nir; Wollscheid, Bernd; Oppenheim, Ariella; Pelkmans, Lucas			Integrin-Mediated Signaling Induced by Simian Virus 40 Leads to Transient Uncoupling of Cortical Actin and the Plasma Membrane	PLOS ONE			English	Article							ERM PROTEINS; EXTRACELLULAR-MATRIX; CAVEOLAR ENDOCYTOSIS; LINKED KINASE; CELLS; CYTOSKELETON; EZRIN/RADIXIN/MOESIN; PHOSPHORYLATION; DOMAINS; VIRUS	Simian Virus 40 (SV40) is a paradigm pathogen with multivalent binding sites for the sphingolipid GM1, via which it induces its endocytosis for infection. Here we report that SV40 also utilizes cell surface integrins to activate signaling networks required for infection, even in the absence of the previously implicated glycosphingolipids. We identify ILK, PDK1, the RhoGAP GRAF1 and RhoA as core nodes of the signaling network activated upon SV40 engagement of integrins. We show that integrin-mediated signaling through host SV40 engagement induces the de-phosphorylation of Ezrin leading to uncoupling of the plasma membrane and cortical actin. Our results provide functional evidence for a mechanism by which SV40 activates signal transduction in human epithelial cells via integrins in the context of clathrin-independent endocytosis.	[Stergiou, Lilli; Bauer, Manuel; Mair, Waltraud; Bausch-Fluck, Damaris; Wollscheid, Bernd; Pelkmans, Lucas] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Pelkmans, Lucas] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Bausch-Fluck, Damaris; Wollscheid, Bernd] UZH ETH Zurich, NCCR, Neuro Ctr Prote, Zurich, Switzerland; [Drayman, Nir; Oppenheim, Ariella] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Hematol, IL-91010 Jerusalem, Israel	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Hebrew University of Jerusalem	Pelkmans, L (corresponding author), ETH, Inst Mol Syst Biol, Zurich, Switzerland.	lucas.pelkmans@imls.uzh.ch	Wollscheid, Bernd/E-8909-2010	Wollscheid, Bernd/0000-0002-3923-1610; Pelkmans, Lucas/0000-0002-6754-9730	Bonizzi-Theler Foundation; Swiss National Science Foundation; National Center of Competence in Research (NCCR) Neural Plasticity and Repair; InfectX project within the Swiss Initiative in Systems Biology	Bonizzi-Theler Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); InfectX project within the Swiss Initiative in Systems Biology	This work was supported by the Bonizzi-Theler Foundation (LS), the Swiss National Science Foundation (LP), the National Center of Competence in Research (NCCR) Neural Plasticity and Repair (BW), and the InfectX project within the Swiss Initiative in Systems Biology (BW, LP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Butin-Israeli V, 2010, J VIROL, V84, P3431, DOI 10.1128/JVI.01735-09; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chen YZ, 1999, EXP CELL RES, V246, P83, DOI 10.1006/excr.1998.4301; Cheng ZJ, 2006, MOL MEMBR BIOL, V23, P101, DOI 10.1080/09687860500460041; Chu JJH, 2004, J BIOL CHEM, V279, P54533, DOI 10.1074/jbc.M410208200; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Hansen CG, 2009, J CELL SCI, V122, P1713, DOI 10.1242/jcs.033951; Hofmann A, 2010, BLOOD, V116, pE26, DOI 10.1182/blood-2010-02-271270; ICHIKAWA S, 1994, P NATL ACAD SCI USA, V91, P2703, DOI 10.1073/pnas.91.7.2703; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Pelkmans L, 2005, BBA-MOL CELL RES, V1746, P295, DOI 10.1016/j.bbamcr.2005.06.009; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Ramo P, 2009, BIOINFORMATICS, V25, P3028, DOI 10.1093/bioinformatics/btp524; Sandalon Z, 1997, VIROLOGY, V237, P414, DOI 10.1006/viro.1997.8796; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; Shaw RJ, 1998, MOL BIOL CELL, V9, P403, DOI 10.1091/mbc.9.2.403; Shibata H, 2001, J BIOCHEM, V130, P23, DOI 10.1093/oxfordjournals.jbchem.a002958; Siebers MC, 2008, J MATER SCI-MATER M, V19, P861, DOI 10.1007/s10856-007-0166-6; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Smith AE, 2003, FEBS LETT, V555, P199, DOI 10.1016/S0014-5793(03)01220-1; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Weinreb PH, 2004, J BIOL CHEM, V279, P17875, DOI 10.1074/jbc.M312103200; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Wu CY, 2001, J CELL BIOL, V155, P505, DOI 10.1083/jcb.200108077; Zoppi N, 2004, J BIOL CHEM, V279, P18157, DOI 10.1074/jbc.M312609200	50	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55799	10.1371/journal.pone.0055799	http://dx.doi.org/10.1371/journal.pone.0055799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409046	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000315157200066
J	Su, HM; Lin, TH; Hsu, PC; Chu, CY; Lee, WH; Chen, SC; Lee, CS; Voon, WC; Lai, WT; Sheu, SH				Su, Ho-Ming; Lin, Tsung-Hsien; Hsu, Po-Chao; Chu, Chun-Yuan; Lee, Wen-Hsien; Chen, Szu-Chia; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung			A Comparison between Brachial and Echocardiographic Systolic Time Intervals	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; PREEJECTION PERIOD; EJECTION TIME; CLINICAL-SIGNIFICANCE; HEART-FAILURE; PARAMETER; RATIO; FRACTION; PREDICTS; INDEX	Systolic time interval (STI) is an established noninvasive technique for the assessment of cardiac function. Brachial STIs can be automatically determined by an ankle-brachial index (ABI)-form device. The aims of this study are to evaluate whether the STIs measured from ABI-form device can represent those measured from echocardiography and to compare the diagnostic values of brachial and echocardiographic STIs in the prediction of left ventricular ejection fraction (LVEF) <50%. A total of 849 patients were included in the study. Brachial pre-ejection period (bPEP) and brachial ejection time (bET) were measured using an ABI-form device and pre-ejection period (PEP) and ejection time (ET) were measured from echocardiography. Agreement was assessed by correlation coefficient and Bland-Altman plot. Brachial STIs had a significant correlation with echocardiographic STIs (r = 0.644, P<0.001 for bPEP and PEP; r = 0.850, P<0.001 for bET and ET; r = 0.708, P<0.001 for bPEP/bET and PEP/ET). The disagreement between brachial and echocardiographic STIs (brachial STIs minus echocardiographic STIs) was 28.55 ms for bPEP and PEP, -4.15 ms for bET and ET and -0.11 for bPEP/bET and PEP/ET. The areas under the curve for bPEP/bET and PEP/ET in the prediction of LVEF <50% were 0.771 and 0.765, respectively. Brachial STIs were good alternatives to STIs obtained from echocardiography and also helpful in prediction of LVEF <50%. Brachial STIs automatically obtained from an ABI-form device may be helpful for evaluation of left ventricular systolic dysfunction.	[Su, Ho-Ming; Lin, Tsung-Hsien; Hsu, Po-Chao; Chu, Chun-Yuan; Lee, Wen-Hsien; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Cardiol, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Szu-Chia] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Su, Ho-Ming; Chen, Szu-Chia] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Su, Ho-Ming; Lin, Tsung-Hsien; Chen, Szu-Chia; Lee, Chee-Siong; Voon, Wen-Chol; Lai, Wen-Ter; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Coll Med, Fac Mecicine, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University	Chen, SC (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan.	scarchenone@yahoo.com.tw	蘇, 河名/AAE-9843-2019	Chu, Chun-Yuan/0000-0001-5550-102X; Lin, Tsung-Hsien/0000-0002-7226-8730; Su, Ho-Ming/0000-0003-0247-3250	Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung [kmhk-101, kmhk-101-002]	Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung	The research presented in this article is supported by the grant from Kaohsiung Municipal Hsiao-Kang Hospital (kmhk-101), Kaohsiung Medical University, Kaohsiung, and the statistical work by the department of Research Education and Training at Kaohsiung Municipal Hsiao-Kang Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research presented in this article is supported by the grant from Kaohsiung Municipal Hsiao-Kang Hospital (kmhk-101-002), Kaohsiung Medical University, Kaohsiung, and the statistical work by the department of Research Education and Training at Kaohsiung Municipal Hsiao-Kang Hospital.	Chen SC, 2011, NEPHROL DIAL TRANSPL, V26, P1895, DOI 10.1093/ndt/gfq639; Chen SC, 2010, CIRC J, V74, P2206, DOI 10.1253/circj.CJ-10-0273; Chen SC, 2010, HYPERTENS RES, V33, P492, DOI 10.1038/hr.2010.24; Correale M, 2012, ECHOCARDIOGR-J CARD, V29, P906, DOI 10.1111/j.1540-8175.2012.01729.x; Cybulski G, 1993, J Physiol Pharmacol, V44, P251; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; GARRARD CL, 1970, CIRCULATION, V42, P455, DOI 10.1161/01.CIR.42.3.455; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEWIS RP, 1977, CIRCULATION, V56, P146, DOI 10.1161/01.CIR.56.2.146; LEWIS SJ, 1991, AM HEART J, V121, P1088, DOI 10.1016/0002-8703(91)90666-6; Munakata M, 2003, AM J HYPERTENS, V16, P653, DOI 10.1016/S0895-7061(03)00918-X; Paiva RP, 2012, PHYSIOL MEAS, V33, P177, DOI 10.1088/0967-3334/33/2/177; ROSS J, 1991, CIRCULATION, V83, P1076, DOI 10.1161/01.CIR.83.3.1076; Su HM, 2012, ATHEROSCLEROSIS, V223, P171, DOI 10.1016/j.atherosclerosis.2012.04.022; Su HM, 2009, AM J HYPERTENS, V22, P871, DOI 10.1038/ajh.2009.94; Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5; Veyrat C, 2005, AM J CARDIOL, V96, P1022, DOI 10.1016/j.amjcard.2005.05.067; WEISSLER AM, 1968, CIRCULATION, V37, P149, DOI 10.1161/01.CIR.37.2.149; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359	20	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55840	10.1371/journal.pone.0055840	http://dx.doi.org/10.1371/journal.pone.0055840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409059	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200075
J	Romero-Silva, MJ; Mendez, V; Agullo, L; Seeger, M				Jose Romero-Silva, Maria; Mendez, Valentina; Agullo, Loreine; Seeger, Michael			Genomic and Functional Analyses of the Gentisate and Protocatechuate Ring-Cleavage Pathways and Related 3-Hydroxybenzoate and 4-Hydroxybenzoate Peripheral Pathways in Burkholderia xenovorans LB400	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE M5A1; SP STRAIN LB400; PSEUDOMONAS-PUTIDA; AROMATIC-COMPOUNDS; ACINETOBACTER-CALCOACETICUS; EVOLUTIONARY DIVERGENCE; BETA-KETOADIPATE; ACTIVE-SITE; DEGRADATION; PURIFICATION	In this study, the gentisate and protocatechuate pathways in Burkholderia xenovorans LB400 were analyzed by genomic and functional approaches, and their role in 3-hydroxybenzoate (3-HBA) and 4-hydroxybenzoate (4-HBA) degradation was proposed. The LB400 genome possesses two identical mhbRTDHI gene clusters encoding the gentisate pathway and one mhbM gene encoding a 3-HBA 6-hydroxylase that converts 3-HBA into gentisate. The pca genes encoding the protocatechuate pathway and the pobA gene encoding the 4-HBA 3-monooxygenase that oxidizes 4-HBA into protocatechuate are arranged in gene clusters and single genes mainly at the minor chromosome, but also at the major chromosome and the megaplasmid. Strain LB400 was able to grow on gentisate, protocatechuate, 3-HBA and 4-HBA. Transcriptional analyses showed that the mhbD gene encoding the gentisate 1,2-dioxygenase was expressed during growth on 3-HBA, 4-HBA and gentisate, whereas the pcaG gene encoding the protocatechuate 3,4-dioxygenase was expressed only during growth on 4-HBA and protocatechuate. The mhbM gene encoding the 3-HBA 6-hydroxylase was transcribed in strain LB400 during growth on HBAs, gentisate, protocatechuate and glucose. The pobA gene encoding the 4-HBA 3-monooxygenase was expressed during growth on HBAs and glucose. 3-HBA- and 4-HBA-grown LB400 cells showed gentisate 1,2-dioxygenase activity, whereas protocatechuate 3,4-dioxygenase activity was observed only in 4-HBA-grown cells. The mhbR gene encoding a MarR-type transcriptional regulator that probably regulates the expression of the MhbT transporter, and the pcaQ and pcaR genes encoding LysR-type transcriptional regulators that regulate pcaHG and pcaIJBDC genes, respectively, were transcribed during growth on both HBAs, gentisate, protocatechuate and glucose, suggesting a basal constitutive expression. The results indicate active gentisate, protocatechuate, 3-HBA and 4-HBA catabolic pathways in B. xenovorans LB400 and suggest that 3-HBA is channeled exclusively through the gentisate route, whereas 4-HBA is funneled into the protocatechuate central pathway and potentially into the gentisate pathway.	[Seeger, Michael] Univ Tecn Federico Santa Maria, Dept Quim, Lab Microbiol Mol & Biotecnol Ambiental, Valparaiso, Chile; Univ Tecn Federico Santa Maria, Ctr Nanotechnol & Syst Biol, Valparaiso, Chile	Universidad Tecnica Federico Santa Maria; Universidad Tecnica Federico Santa Maria	Seeger, M (corresponding author), Univ Tecn Federico Santa Maria, Dept Quim, Lab Microbiol Mol & Biotecnol Ambiental, Valparaiso, Chile.	michael.seeger@usm.cl	Agullo, Loreine/AAH-2424-2019; Seeger, Michael/AFK-3436-2022	Agullo Carvajal, Loreine Joselyn/0000-0003-4789-2686	FONDECYT [1110992, 1070507]; Center for Nanotechnology and Systems Biology; USM [131109, 130948]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Center for Nanotechnology and Systems Biology; USM	M.S. acknowledges financial support from FONDECYT (1110992 and 1070507) (http://www.fondecyt.cl), Center for Nanotechnology and Systems Biology (http://www.usm.cl) and USM (131109, 130948) (http://www.usm.cl) grants. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Agullo L, 2007, FEMS MICROBIOL LETT, V267, P167, DOI 10.1111/j.1574-6968.2006.00554.x; Buchan A, 2000, APPL ENVIRON MICROB, V66, P4662, DOI 10.1128/AEM.66.11.4662-4672.2000; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; CRAWFORD RL, 1976, J BACTERIOL, V127, P204, DOI 10.1128/JB.127.1.204-210.1976; Fairley DJ, 2002, APPL ENVIRON MICROB, V68, P6246, DOI 10.1128/AEM.68.12.6246-6255.2002; GOETZ FE, 1992, FEMS MICROBIOL LETT, V97, P45; HARELAND WA, 1975, J BACTERIOL, V121, P272, DOI 10.1128/JB.121.1.272-285.1975; HARPEL MR, 1990, J BIOL CHEM, V265, P22187; HARTNETT C, 1990, J BACTERIOL, V172, P956, DOI 10.1128/jb.172.2.956-966.1990; HARTNETT GB, 1994, GENE, V142, P23, DOI 10.1016/0378-1119(94)90350-6; HARWOOD CS, 1994, J BACTERIOL, V176, P6479, DOI 10.1128/JB.176.21.6479-6488.1994; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Hiromoto T, 2006, J MOL BIOL, V364, P878, DOI 10.1016/j.jmb.2006.09.031; Ishiyama D, 2004, APPL ENVIRON MICROB, V70, P1297, DOI 10.1128/AEM.70.3.1297-1306.2004; Jimenez JI, 2002, ENVIRON MICROBIOL, V4, P824, DOI 10.1046/j.1462-2920.2002.00370.x; JONES DCN, 1990, ARCH MICROBIOL, V154, P489, DOI 10.1007/BF00245233; Khang HY, 2002, BIOCHEM BIOPH RES CO, V295, P903; Lin LX, 2010, MICROBIOL RES, V165, P66, DOI 10.1016/j.micres.2008.08.001; Liu TT, 2011, APPL MICROBIOL BIOT, V90, P671, DOI 10.1007/s00253-010-3033-1; Ma YF, 2009, APPL ENVIRON MICROB, V75, P6812, DOI 10.1128/AEM.00933-09; MacLean AM, 2011, MICROBIOL-SGM, V157, P2522, DOI 10.1099/mic.0.050542-0; Mendez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017583; MICHALOVER JL, 1973, BIOCHEM BIOPH RES CO, V55, P888, DOI 10.1016/0006-291X(73)91227-8; Nichols NN, 1997, J BACTERIOL, V179, P5056, DOI 10.1128/jb.179.16.5056-5061.1997; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; PARALES RE, 1992, J BACTERIOL, V174, P4657, DOI 10.1128/JB.174.14.4657-4666.1992; Parke D, 1996, J BACTERIOL, V178, P266, DOI 10.1128/jb.178.1.266-272.1996; Perera IC, 2011, PROTEIN SCI, V20, P621, DOI 10.1002/pro.588; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Perez-Pantoja D, 2012, ENVIRON MICROBIOL, V14, P1091, DOI 10.1111/j.1462-2920.2011.02613.x; POH C L, 1980, Journal of Bacteriology, V143, P59; Ponce BL, 2011, ENZYME MICROB TECH, V49, P509, DOI 10.1016/j.enzmictec.2011.04.021; Robson ND, 1996, MICROBIOL-SGM, V142, P2115, DOI 10.1099/13500872-142-8-2115; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Seeger M, 2001, J BACTERIOL, V183, P3548, DOI 10.1128/JB.183.12.3548-3555.2001; Seeger M, 1999, APPL ENVIRON MICROB, V65, P3614; SEEGER M, 1995, APPL ENVIRON MICROB, V61, P2654, DOI 10.1128/AEM.61.7.2654-2658.1995; Seibold B, 1996, EUR J BIOCHEM, V239, P469, DOI 10.1111/j.1432-1033.1996.0469u.x; Shen XH, 2005, APPL ENVIRON MICROB, V71, P3442, DOI 10.1128/AEM.71.7.3442-3452.2005; Suarez M, 1996, FEMS MICROBIOL LETT, V143, P89, DOI 10.1016/0378-1097(96)00299-6; SUAREZ M, 1995, ARCH MICROBIOL, V164, P70; VANBERKEL W, 1992, EUR J BIOCHEM, V210, P411; Vanelli T, 1995, BIOCHEMISTRY-US, V34, P11743; WANG LH, 1987, BIOCHEMISTRY-US, V26, P1099, DOI 10.1021/bi00378a017; Weilharter A, 2011, J BACTERIOL, V193, P3383, DOI 10.1128/JB.05055-11; WHEELIS ML, 1967, ARCH MIKROBIOL, V59, P302, DOI 10.1007/BF00406344; WILLIAMS SE, 1992, BIOCHEMISTRY-US, V31, P9768, DOI 10.1021/bi00155a033; WRIGHT JD, 1991, APPL MICROBIOL BIOT, V35, P94, DOI 10.1007/BF00180643; Yagi JM, 2009, ENVIRON MICROBIOL, V11, P2253, DOI 10.1111/j.1462-2920.2009.01947.x	49	44	45	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56038	10.1371/journal.pone.0056038	http://dx.doi.org/10.1371/journal.pone.0056038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418504	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300096
J	Loutfy, MR; Wu, W; Letchumanan, M; Bondy, L; Antoniou, T; Margolese, S; Zhang, YM; Rueda, S; McGee, F; Peck, R; Binder, L; Allard, P; Rourke, SB; Rochon, PA				Loutfy, Mona R.; Wu, Wei; Letchumanan, Michelle; Bondy, Lise; Antoniou, Tony; Margolese, Shari; Zhang, Yimeng; Rueda, Sergio; McGee, Frank; Peck, Ryan; Binder, Louise; Allard, Patricia; Rourke, Sean B.; Rochon, Paula A.			Systematic Review of HIV Transmission between Heterosexual Serodiscordant Couples where the HIV-Positive Partner Is Fully Suppressed on Antiretroviral Therapy	PLOS ONE			English	Review							SEXUAL RISK BEHAVIOR; VIRAL LOAD; DISCORDANT COUPLES; COITAL ACT; PREVENTION; INFECTION; WOMEN; INITIATION; RAKAI; RNA	Background: The risk of sexual HIV transmission in serodiscordant couples when the HIV-positive partner has full virologic suppression on combination antiretroviral therapy (cART) is debated. This study aims to systematically review observational studies and randomized controlled trials (RCTs), evaluating rates of sexual HIV transmission between heterosexual serodiscordant couples when the HIV-positive partner has full suppression on cART. Methods and Findings: We searched major bibliographic databases to November 2012 for relevant observational studies and RCTs without language restrictions. Conference proceedings, key journals and bibliographies were also searched. Studies reporting HIV transmission rates, cART histories and viral loads of the HIV-positive partners were included. Two reviewers extracted methodologic characteristics and outcomes. Of 20,252 citations, 3 studies met all eligibility criteria with confirmed full virologic suppression in the HIV-positive partner. We included 3 additional studies (2 cohort studies, 1 RCT) that did not confirm viral suppression in the HIV-positive partner at transmission in a secondary meta-analysis. Methodologic quality was reasonable. The rate of transmission in the 3 studies confirming virologic suppression was 0 per 100 person-years (95% CI = 0-0.05), with low heterogeneity (I-2 = 0%). When we included the 3 studies that did not confirm virologic suppression, the rate of transmission was 0.14 per 100 person-years (95%CI = 0.04-0.31) (I-2 = 0%). In a sensitivity analysis including all 6 studies, the rate of transmission was 0 per 100 person-years (95%CI = 0-0.01) after omitting all transmissions with known detectable or unconfirmed viral loads, as full suppression in these cases was unlikely. Limitations included lack of data on same-sex couples, type of sexual intercourse (vaginal vs. anal), direction of HIV transmission, exact viral load at the time of transmission, sexually transmitted infections (STI) rates, and extent of condom use. Conclusions: Our findings suggest minimal risk of sexual HIV transmission for heterosexual serodiscordant couples when the HIV-positive partner has full viral suppression on cART with caveats regarding information on sexual intercourse type, STIs, and condom use. These findings have implications when counseling heterosexual serodiscordant couples on sexual and reproductive health. More research is needed to explore HIV transmission risk between same-sex couples.	[Loutfy, Mona R.; Wu, Wei; Letchumanan, Michelle; Margolese, Shari; Rochon, Paula A.] Univ Toronto, Womens Coll Hosp, Womens Coll, Res Inst, Toronto, ON, Canada; [Loutfy, Mona R.; Bondy, Lise; Zhang, Yimeng; Rochon, Paula A.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Loutfy, Mona R.; Letchumanan, Michelle; Antoniou, Tony; Rochon, Paula A.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Loutfy, Mona R.; Antoniou, Tony; Rourke, Sean B.] Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Rueda, Sergio; Rourke, Sean B.] Ontario HIV Treatment Network, Toronto, ON, Canada; [McGee, Frank] Ontario Minist Hlth & Long Term Care, AIDS Bur, Toronto, ON, Canada; [Peck, Ryan] HIV & AIDS Legal Clin Ontario, Toronto, ON, Canada; [Binder, Louise] Canadian Treatment Act Council, Toronto, ON, Canada; [Allard, Patricia] Canadian HIV AIDS Legal Network, Toronto, ON, Canada; [Rourke, Sean B.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; Women's College Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Loutfy, MR (corresponding author), Univ Toronto, Womens Coll Hosp, Womens Coll, Res Inst, Toronto, ON, Canada.	mona.loutfy@wchospital.ca	Rochon, Paula A/J-2918-2016	Rochon, Paula A/0000-0002-5973-4151	 [KRS-102081]		This work was supported by grant # KRS-102081 (www.cihr-irsc.gc.ca.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2011, GLOB PUBLIC HEALTH, V6, pS357, DOI 10.1080/17441692.2011.623136; Anglemyer A, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009153, 10.1002/14651858.CD009153.pub2]; Apondi R, 2011, AIDS, V25, P1317, DOI 10.1097/QAD.0b013e328347f775; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baggaley RF, 2010, CURR OPIN HIV AIDS, V5, P269, DOI 10.1097/COH.0b013e32833a51b2; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Borenstein M, 2000, COMPREHENSIVE METAAN, P25; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2012, CURR OPIN HIV AIDS, V7, P99, DOI 10.1097/COH.0b013e32834f5cf2; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Dieffenbach CW, 2012, CURR OPIN HIV AIDS, V7, P106, DOI 10.1097/COH.0b013e32834f3f13; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; El-Sadr WM, 2011, AIDS, V25, P2295, DOI 10.1097/QAD.0b013e32834c4c22; Eshleman SH, 2011, J INFECT DIS, V204, P1918, DOI 10.1093/infdis/jir651; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gupta G R, 2000, Can HIV AIDS Policy Law Rev, V5, P86; Guthrie BL, 2011, JAIDS-J ACQ IMM DEF, V58, pE87, DOI 10.1097/QAI.0b013e31822f064e; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hogg RS, 2012, 19 C RETR OPP INF CR; Kravcik S, 1998, J ACQ IMMUN DEF SYND, V19, P124, DOI 10.1097/00042560-199810010-00004; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Loutfy MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007925; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mantell JE, 2009, J PUBLIC HEALTH POL, V30, P367, DOI 10.1057/jphp.2009.35; Marcelin AG, 2008, AIDS, V22, P1677, DOI 10.1097/QAD.0b013e32830abdc8; Mastro TD, 2011, AIDS, V25, P2049, DOI 10.1097/QAD.0b013e32834c4c62; Melo MG, 2008, SEX TRANSM DIS, V35, P912, DOI 10.1097/OLQ.0b013e31817e2491; Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, 2005, REC US ANT DRUGS PRE; Peters J, 2008, EVAL HEALTH PROF, V31, P370, DOI 10.1177/0163278708324438; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; REMIEN RH, 1995, AIDS CARE, V7, P429, DOI 10.1080/09540129550126380; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Ruzagira E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024037; Sheth PM, 2012, MUCOSAL IMMUNOL, V5, P248, DOI 10.1038/mi.2012.1; Sheth PM, 2009, AIDS, V23, P2050, DOI 10.1097/QAD.0b013e3283303e04; Spiegelhalter DJ, 1999, BRIT MED J, V319, P508, DOI 10.1136/bmj.319.7208.508; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suarez TP, 2001, J ACQ IMMUN DEF SYND, V28, P471, DOI 10.1097/00042560-200112150-00011; Vernazza P, 2008, B MED SUISSES, V89, P165; Wang L.-S, COMMUNICATION; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	44	115	120	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55747	10.1371/journal.pone.0055747	http://dx.doi.org/10.1371/journal.pone.0055747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418455	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300046
J	Matthews, LJ; DeWan, P; Rula, EY				Matthews, Luke J.; DeWan, Peter; Rula, Elizabeth Y.			Methods for Inferring Health-Related Social Networks among Coworkers from Online Communication Patterns	PLOS ONE			English	Article							SPREAD; AUTOCORRELATION; COMMUNITY; BEHAVIOR; SMOKING	Studies of social networks, mapped using self-reported contacts, have demonstrated the strong influence of social connections on the propensity for individuals to adopt or maintain healthy behaviors and on their likelihood to adopt health risks such as obesity. Social network analysis may prove useful for businesses and organizations that wish to improve the health of their populations by identifying key network positions. Health traits have been shown to correlate across friendship ties, but evaluating network effects in large coworker populations presents the challenge of obtaining sufficiently comprehensive network data. The purpose of this study was to evaluate methods for using online communication data to generate comprehensive network maps that reproduce the health-associated properties of an offline social network. In this study, we examined three techniques for inferring social relationships from email traffic data in an employee population using thresholds based on: (1) the absolute number of emails exchanged, (2) logistic regression probability of an offline relationship, and (3) the highest ranked email exchange partners. As a model of the offline social network in the same population, a network map was created using social ties reported in a survey instrument. The email networks were evaluated based on the proportion of survey ties captured, comparisons of common network metrics, and autocorrelation of body mass index (BMI) across social ties. Results demonstrated that logistic regression predicted the greatest proportion of offline social ties, thresholding on number of emails exchanged produced the best match to offline network metrics, and ranked email partners demonstrated the strongest autocorrelation of BMI. Since each method had unique strengths, researchers should choose a method based on the aspects of offline behavior of interest. Ranked email partners may be particularly useful for purposes related to health traits in a social network.	[Matthews, Luke J.; DeWan, Peter] Activate Networks Inc, Newton, MA USA; [Rula, Elizabeth Y.] Healthways Inc, Healthways Ctr Hlth Res, Franklin, TN USA		Matthews, LJ (corresponding author), Activate Networks Inc, Newton, MA USA.	lmatthews@activatenetworks.net		Rula, Elizabeth/0000-0003-2188-1102				Adamic L, 2005, SOC NETWORKS, V27, P187, DOI 10.1016/j.socnet.2005.01.007; Butts, 2020, SNA TOOLS SOCIAL NET; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cobb NK, 2010, AM J PUBLIC HEALTH, V100, P1282, DOI 10.2105/AJPH.2009.165449; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; De Choudhury M, 2010, P 19 INT C WORLD WID; DOW MM, 1984, AM ETHNOL, V11, P754, DOI 10.1525/ae.1984.11.4.02a00080; DOW MM, 1982, SOC NETWORKS, V4, P169, DOI 10.1016/0378-8733(82)90031-4; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; Leenders RTAJ, 2002, SOC NETWORKS, V24, P21, DOI 10.1016/S0378-8733(01)00049-1; Lyons R, 2011, POLITICS POLICY, V2; Marsden PV, 2003, SOC NETWORKS, V25, P1, DOI 10.1016/S0378-8733(02)00009-6; McCulloh I, 2007, 1218 US ARM RES I; Mizruchi MS, 2008, SOC NETWORKS, V30, P190, DOI 10.1016/j.socnet.2008.02.002; Neuman EJ, 2010, SOC NETWORKS, V32, P290, DOI 10.1016/j.socnet.2010.04.003; O'Malley AJ, 2008, HEALTH SERV OUTCOME, V8, P222, DOI 10.1007/s10742-008-0041-z; Quintane E., 2011, CONNECTIONS, V31; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richardson CR, 2010, J MED INTERNET RES, V12, P138, DOI 10.2196/jmir.1338; Rosenquist JN, 2011, MOL PSYCHIATR, V16, P273, DOI 10.1038/mp.2010.13; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Smith TE, 2004, SPATIAL ECONOMETRICS, P53; Sundquist J, 1998, INT J EPIDEMIOL, V27, P57, DOI 10.1093/ije/27.1.57; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Whitfield J B, 2001, Twin Res, V4, P365, DOI 10.1375/twin.4.5.365; Wuchty S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026972	29	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55234	10.1371/journal.pone.0055234	http://dx.doi.org/10.1371/journal.pone.0055234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418436	gold, Green Published			2022-12-27	WOS:000315970300026
J	Mehendale, S; Thakar, M; Sahay, S; Kumar, M; Shete, A; Sathyamurthi, P; Verma, A; Kurle, S; Shrotri, A; Gilmour, J; Goyal, R; Dally, L; Sayeed, E; Zachariah, D; Ackland, J; Kochhar, S; Cox, JH; Excler, JL; Kumaraswami, V; Paranjape, R; Ramanathan, VD				Mehendale, Sanjay; Thakar, Madhuri; Sahay, Seema; Kumar, Makesh; Shete, Ashwini; Sathyamurthi, Pattabiraman; Verma, Amita; Kurle, Swarali; Shrotri, Aparna; Gilmour, Jill; Goyal, Rajat; Dally, Len; Sayeed, Eddy; Zachariah, Devika; Ackland, James; Kochhar, Sonali; Cox, Josephine H.; Excler, Jean-Louis; Kumaraswami, Vasanthapuram; Paranjape, Ramesh; Ramanathan, Vadakkuppatu Devasenapathi			Safety and Immunogenicity of DNA and MVA HIV-1 Subtype C Vaccine Prime-Boost Regimens: A Phase I Randomised Trial in HIV-Uninfected Indian Volunteers	PLOS ONE			English	Article							T-CELL RESPONSES; IMMUNODEFICIENCY VIRUS SIVMAC239; IMMUNE-RESPONSES; HEALTHY-ADULTS; EFFICACY TRIAL; TYPE-1 CLADE; PLASMID DNA; ANKARA MVA; CHALLENGE; PROTEIN	Study Design: A randomized, double-blind, placebo controlled phase I trial. Methods: The trial was conducted in 32 HIV-uninfected healthy volunteers to assess the safety and immunogenicity of prime-boost vaccination regimens with either 2 doses of ADVAX, a DNA vaccine containing Chinese HIV-1 subtype C env gp160, gag, pol and nef/tat genes, as a prime and 2 doses of TBC-M4, a recombinant MVA encoding Indian HIV-1 subtype C env gp160, gag, RT, rev, tat, and nef genes, as a boost in Group A or 3 doses of TBC-M4 alone in Group B participants. Out of 16 participants in each group, 12 received vaccine candidates and 4 received placebos. Results: Both vaccine regimens were found to be generally safe and well tolerated. The breadth of anti-HIV binding antibodies and the titres of anti-HIV neutralizing antibodies were significantly higher (p<0.05) in Group B volunteers at 14 days post last vaccination. Neutralizing antibodies were detected mainly against Tier-1 subtype B and C viruses. HIV-specific IFN-gamma ELISPOT responses were directed mostly to Env and Gag proteins. Although the IFN-gamma ELISPOT responses were infrequent after ADVAX vaccinations, the response rate was significantly higher in group A after 1st and 2nd MVA doses as compared to the responses in group B volunteers. However, the priming effect was short lasting leading to no difference in the frequency, breadth and magnitude of IFN-gamma ELISPOT responses between the groups at 3, 6 and 9 months post-last vaccination. Conclusions: Although DNA priming resulted in enhancement of immune responses after 1st MVA boosting, the overall DNA prime MVA boost was not found to be immunologically superior to homologous MVA boosting.	[Mehendale, Sanjay] Natl Inst Epidemiol, Madras, Tamil Nadu, India; [Thakar, Madhuri; Sahay, Seema; Shete, Ashwini; Verma, Amita; Kurle, Swarali; Shrotri, Aparna; Paranjape, Ramesh] Natl AIDS Res Inst, Pune, Maharashtra, India; [Kumar, Makesh; Sathyamurthi, Pattabiraman; Kumaraswami, Vasanthapuram; Ramanathan, Vadakkuppatu Devasenapathi] Natl Inst Res TB, Madras, Tamil Nadu, India; [Goyal, Rajat] Int AIDS Vaccine Initiat, Delhi, India; [Gilmour, Jill] Univ London Imperial Coll Sci Technol & Med, IAVI Human Immunol Labs, London, England; [Dally, Len] EMMES Corp, Rockville, MD USA; [Sayeed, Eddy; Zachariah, Devika; Cox, Josephine H.; Excler, Jean-Louis] InternationalAIDS Vaccine Initiat, New York, NY USA; [Ackland, James] Global BioSolut, Melbourne, Vic, Australia; [Kochhar, Sonali] OneWorldHealth, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); International AIDS Vaccine Initiative; Imperial College London; International AIDS Vaccine Initiative; Emmes Corporation	Mehendale, S (corresponding author), Natl Inst Epidemiol, Madras, Tamil Nadu, India.	sanjaymehendale@icmr.org.in	Kochhar, Sonali/H-4036-2012	Kochhar, Sonali/0000-0002-1150-5691; Paranjape, Ramesh/0000-0003-2948-9148; Cox, Josephine/0000-0003-1301-7373; Sahay, Seema/0000-0001-6064-827X	Indian Council of Medical Research; National AIDS Control Organisation in India	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); National AIDS Control Organisation in India	We express our gratitude to all the study participants, to the research staff at both the clinical sites for their outstanding work and dedication, to the Indian Council of Medical Research and the National AIDS Control Organisation in India for their support and guidance, and to the Safety Review Board for overseeing the study. We are very grateful to David Ho and Sandhya Vasan from the Aaron Diamond AIDS Research Center for providing the ADVAX DNA vaccine and necessary support for this clinical trial. We would like to thank Patricia Fast, IAVI Chief Medical Officer, for her constant support, guidance and helpful comments as well as the members of the IAVI Human Immunology Laboratory, especially Gwynn Stevens, Paramesh Chetty and Tony Tarragona for technical and logistic support throughout the trial. We are also thankful to David Montefiori, Marcella Sarzotti-Kelsoe and the CAVD group for their guidance in conduct of neutralization assays and GHRC for providing pseudoviruses for the study. We are thankful to Dr. Jayanta Bhattacharya, NARI, for providing pseudo virus from recent HIV infection.	Amara RR, 2002, J VIROL, V76, P7625, DOI 10.1128/JVI.76.15.7625-7631.2002; Bakari M, 2011, VACCINE, V29, P8417, DOI 10.1016/j.vaccine.2011.08.001; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Boaz MJ, 2009, CLIN VACCINE IMMUNOL, V16, P147, DOI 10.1128/CVI.00326-08; Bot A, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-132; Cebere I, 2006, VACCINE, V24, P417, DOI 10.1016/j.vaccine.2005.08.041; Cohen J, 2011, SCIENCE, V333, P1560, DOI 10.1126/science.333.6049.1560; Cosma A, 2003, VACCINE, V22, P21, DOI 10.1016/S0264-410X(03)00538-3; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; De Rosa SC, 2011, J IMMUNOL, V187, P3391, DOI 10.4049/jimmunol.1101421; Dunachie SJ, 2006, INFECT IMMUN, V74, P5933, DOI 10.1128/IAI.00590-06; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Frey SE, 2007, VACCINE, V25, P8562, DOI 10.1016/j.vaccine.2007.10.017; Gilbert SC, 2006, VACCINE, V24, P4554, DOI 10.1016/j.vaccine.2005.08.048; Gill DK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014330; Goepfert PA, 2007, VACCINE, V25, P510, DOI 10.1016/j.vaccine.2006.07.050; Gudmundsdotter L, 2009, VACCINE, V27, P4468, DOI 10.1016/j.vaccine.2009.05.018; Gurunathan S, 2000, CURR OPIN IMMUNOL, V12, P442, DOI 10.1016/S0952-7915(00)00118-7; Hanke T, 2007, J GEN VIROL, V88, P1, DOI 10.1099/vir.0.82493-0; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Huang TX, 2008, JAIDS-J ACQ IMM DEF, V47, P403, DOI 10.1097/QAI.0b013e3181651b9d; Hutchings CL, 2005, J IMMUNOL, V175, P599, DOI 10.4049/jimmunol.175.1.599; Jaoko W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012873; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kong WP, 2003, J VIROL, V77, P12764, DOI 10.1128/JVI.77.23.12764-12772.2003; Koopman G, 2008, J GEN VIROL, V89, P540, DOI 10.1099/vir.0.83384-0; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; Krupa M, 2011, VACCINE, V29, P1504, DOI 10.1016/j.vaccine.2010.12.016; Lai L, 2012, VACCINE; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; Mehendale S, 2008, AIDS RES HUM RETROV, V24, P873, DOI [10.1089/aid.2007.0292, 10.1089/aid.2008.0292]; Mehendale S, 2010, INDIAN J MED RES, V132, P168; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; National AIDS Control Programme, 2011, RESP HIV EP IND; Nayak S, 2010, GENE THER, V17, P295, DOI 10.1038/gt.2009.148; Ozaki DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030963; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Ramanathan VD, 2009, AIDS RES HUM RETROV, V25, P1107, DOI 10.1089/aid.2009.0096; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rollman E, 2005, MICROBES INFECT, V7, P1414, DOI 10.1016/j.micinf.2005.07.017; Rosati M, 2005, J VIROL, V79, P8480, DOI 10.1128/JVI.79.13.8480-8492.2005; Russell ND, 2007, JAIDS-J ACQ IMM DEF, V44, P203, DOI 10.1097/01.qai.0000248356.48501.ff; Sadagopal S, 2005, J VIROL, V79, P3243, DOI 10.1128/JVI.79.6.3243-3253.2005; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shete AV, 2011, J GLOB INFECT DIS, V3, P246, DOI 10.4103/0974-777X.83530; Smith JM, 2004, AIDS RES HUM RETROV, V20, P654, DOI 10.1089/0889222041217419; Vasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019252; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008617; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Winstone N, 2011, J VIROL, V85, P9578, DOI 10.1128/JVI.05060-11; Wu L, 2005, J VIROL, V79, P8024, DOI 10.1128/JVI.79.13.8024-8031.2005; Yang ZY, 2003, J VIROL, V77, P799, DOI 10.1128/JVI.77.1.799-803.2003	56	33	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55831	10.1371/journal.pone.0055831	http://dx.doi.org/10.1371/journal.pone.0055831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418465	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000315970300056
J	Reimold, FR; Braun, N; Zsengeller, ZK; Stillman, IE; Karumanchi, SA; Toka, HR; Latus, J; Fritz, P; Biegger, D; Segerer, S; Alscher, MD; Bhasin, MK; Alper, SL				Reimold, Fabian R.; Braun, Niko; Zsengeller, Zsuzsanna K.; Stillman, Isaac E.; Karumanchi, S. Ananth; Toka, Hakan R.; Latus, Joerg; Fritz, Peter; Biegger, Dagmar; Segerer, Stephan; Alscher, M. Dominik; Bhasin, Manoj K.; Alper, Seth L.			Transcriptional Patterns in Peritoneal Tissue of Encapsulating Peritoneal Sclerosis, a Complication of Chronic Peritoneal Dialysis	PLOS ONE			English	Article							FLUID-FLOW STRESS; MESENCHYMAL TRANSITION; GENE-EXPRESSION; FIBRONECTIN; CELLS; PATHOGENESIS; MORTALITY; MEMBRANE; EPIDEMIOLOGY; INFLAMMATION	Encapsulating peritoneal sclerosis (EPS) is a devastating complication of peritoneal dialysis (PD), characterized by marked inflammation and severe fibrosis of the peritoneum, and associated with high morbidity and mortality. EPS can occur years after termination of PD and, in severe cases, leads to intestinal obstruction and ileus requiring surgical intervention. Despite ongoing research, the pathogenesis of EPS remains unclear. We performed a global transcriptome analysis of peritoneal tissue specimens from EPS patients, PD patients without EPS, and uremic patients without history of PD or EPS (Uremic). Unsupervised and supervised bioinformatics analysis revealed distinct transcriptional patterns that discriminated these three clinical groups. The analysis identified a signature of 219 genes expressed differentially in EPS as compared to PD and Uremic groups. Canonical pathway analysis of differentially expressed genes showed enrichment in several pathways, including antigen presentation, dendritic cell maturation, B cell development, chemokine signaling and humoral and cellular immunity (P value<0.05). Further interactive network analysis depicted effects of EPS-associated genes on networks linked to inflammation, immunological response, and cell proliferation. Gene expression changes were confirmed by qRT-PCR for a subset of the differentially expressed genes. EPS patient tissues exhibited elevated expression of genes encoding sulfatase1, thrombospondin 1, fibronectin 1 and alpha smooth muscle actin, among many others, while in EPS and PD tissues mRNAs encoding leptin and retinol-binding protein 4 were markedly down-regulated, compared to Uremic group patients. Immunolocalization of Collagen 1 alpha 1 revealed that Col1a1 protein was predominantly expressed in the submesothelial compact zone of EPS patient peritoneal samples, whereas PD patient peritoneal samples exhibited homogenous Col1a1 staining throughout the tissue samples. The results are compatible with the hypothesis that encapsulating peritoneal sclerosis is a distinct pathological process from the simple peritoneal fibrosis that accompanies all PD treatment.	[Reimold, Fabian R.; Stillman, Isaac E.; Karumanchi, S. Ananth; Toka, Hakan R.; Alper, Seth L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Renal, Boston, MA 02215 USA; [Reimold, Fabian R.; Karumanchi, S. Ananth; Bhasin, Manoj K.; Alper, Seth L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Reimold, Fabian R.; Braun, Niko; Latus, Joerg; Alscher, M. Dominik] Robert Bosch Krankenhaus, Dept Gen Internal Med & Nephrol, Stuttgart, Germany; [Braun, Niko; Latus, Joerg; Alscher, M. Dominik] Inst Digital Med, Stuttgart, Germany; [Zsengeller, Zsuzsanna K.; Stillman, Isaac E.] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Zsengeller, Zsuzsanna K.; Stillman, Isaac E.; Karumanchi, S. Ananth; Toka, Hakan R.; Bhasin, Manoj K.; Alper, Seth L.] Harvard Univ, Sch Med, Boston, MA USA; [Karumanchi, S. Ananth; Alper, Seth L.] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Toka, Hakan R.] Brigham & Womens Hosp, Div Nephrol, Boston, MA 02115 USA; [Toka, Hakan R.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Fritz, Peter; Biegger, Dagmar] Robert Bosch Krankenhaus, Dept Diagnost Med, Div Pathol, Stuttgart, Germany; [Biegger, Dagmar] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Segerer, Stephan] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Bhasin, Manoj K.] Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Bhasin, Manoj K.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Bosch; Robert Bosch Krankenhaus; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Zurich; University Zurich Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Alper, SL (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Renal, Boston, MA 02215 USA.	salper@bidmc.harvard.edu	Stillman, Isaac E/ABC-7278-2020; Karumanchi, Subbian Ananth/AAI-1694-2021; Toka, Hakan/AAQ-2162-2021	Latus, Joerg/0000-0003-0584-4870; Segerer, Stephan/0000-0002-1936-9719; Alscher, Mark Dominik/0000-0002-9658-1211; Zsengeller, Zsuzsanna/0000-0002-4540-5728; Bhasin, Manoj/0000-0001-5172-420X	Baxter International, Inc.; Howard Hughes Medical Institute; NIH [DK34854]; Swiss National Science Foundation [32003B-129710]; Robert Bosch Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	Baxter International, Inc.; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Robert Bosch Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Baxter International, Inc. (NB, SS and MDA), the Howard Hughes Medical Institute (SAK) and NIH DK34854 (Harvard Digestive Diseases Center to SLA). FRR was supported by a Fellowship of the Robert Bosch Foundation. SS is supported by the Swiss National Science Foundation (32003B-129710). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher DM, 2007, AM J KIDNEY DIS, V49, P452, DOI 10.1053/j.ajkd.2006.11.040; Aoki S, 2011, BIOCHEM BIOPH RES CO, V416, P391, DOI 10.1016/j.bbrc.2011.11.051; Aoki S, 2011, PERITON DIALYSIS INT, V31, P466, DOI 10.3747/pdi.2010.00157; Augustine T, 2009, NEPHRON CLIN PRACT, V111, pC149, DOI 10.1159/000191214; Ayuzawa N, 2012, PERITON DIALYSIS INT, V32, P159, DOI 10.3747/pdi.2010.00234; Baroni G, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/912595; Bhasin M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-342; Bige N, 2012, KIDNEY INT, V81, P1226, DOI 10.1038/ki.2012.21; Braun N, 2012, PLOS ONE IN PRESS; Braun N, 2010, NEPHROLOGE, V5, P531; Braun N, 2011, NEPHROL THER, V7, P162, DOI 10.1016/j.nephro.2010.12.011; Braun N, 2011, PERITON DIALYSIS INT, V31, P291, DOI 10.3747/pdi.2010.00118; Braun N, 2011, NEPHROL DIAL TRANSPL, V26, P1033, DOI 10.1093/ndt/gfq488; Brown MC, 2009, CLIN J AM SOC NEPHRO, V4, P1222, DOI 10.2215/CJN.01260209; Coral K, 2012, CURR EYE RES; Doerner AM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-100; El-Haibi CP, 2012, P NATL ACAD SCI US; Fieren MWJA, 2007, PERITON DIALYSIS INT, V27, P619; Fieren MWJA, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/976241; Garcia-Lopez E, 2012, NAT REV NEPHROL, V8, P224, DOI 10.1038/nrneph.2012.13; Garibotto G, 2012, NUTR METAB CARDIOVAS; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; GRINNELL F, 1984, J CELL BIOCHEM, V26, P107, DOI 10.1002/jcb.240260206; Guo H, 2007, J AM SOC NEPHROL, V18, P2689, DOI 10.1681/ASN.2007010121; Han ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039520; Herranz N, 2012, MOL CELL, V46, P369, DOI 10.1016/j.molcel.2012.03.002; Honda Kazuho, 2003, Adv Perit Dial, V19, P169; Imai Toshimi, 2011, Adv Perit Dial, V27, P11; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Johnson DW, 2010, KIDNEY INT, V77, P904, DOI 10.1038/ki.2010.16; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kawanishi H, 2005, PERITON DIALYSIS INT, V25, pS14; Kawanishi H, 2004, AM J KIDNEY DIS, V44, P729, DOI 10.1053/j.ajkd.2004.06.020; Kawanishi H, 2001, Adv Perit Dial, V17, P200; Kawanishi Hideki, 2011, Adv Perit Dial, V27, P53; Kawanishi Hideki, 2008, Adv Perit Dial, V24, P51; Koak Y, 2008, EUR J GASTROEN HEPAT, V20, P148, DOI 10.1097/MEG.0b013e3282cf4d98; Korte MR, 2011, AM J TRANSPLANT, V11, P599, DOI 10.1111/j.1600-6143.2010.03434.x; Korte MR, 2011, NEPHROL DIAL TRANSPL, V26, P691, DOI 10.1093/ndt/gfq362; Lai KN, 2012, PERITON DIALYSIS INT, V32, P280, DOI 10.3747/pdi.2010.00176; Lameire N, 2010, NAT REV NEPHROL, V6, P75, DOI 10.1038/nrneph.2009.210; Latus J, 2012, NEPHROL DIAL TRANSPL; Le SJ, 2010, DIFFERENTIATION, V79, P232, DOI 10.1016/j.diff.2010.03.001; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lorkova L, 2012, ONCOL REP, V27, P318, DOI 10.3892/or.2011.1513; Lugassy J, 2012, J BIOL CHEM, V287, P3541, DOI 10.1074/jbc.M111.261016; Margetts PJ, 2005, J AM SOC NEPHROL, V16, P425, DOI 10.1681/ASN.2004060436; Margetts PJ, 2012, NEPHROL DIAL TRANSPL; Matsubara K, 2004, NEPHROLOGY, V9, P256, DOI 10.1111/j.1440-1797.2004.00271.x; Mehrotra R, 2011, AM J KIDNEY DIS, V58, P418, DOI 10.1053/j.ajkd.2011.03.018; Minutolo V, 2008, G CHIR, V29, P173; Mizuno M, 2012, AM J PHYSIOL-RENAL, V302, pF1245, DOI 10.1152/ajprenal.00652.2011; Mizuno T, 2011, NEPHROL DIAL TRANSPL, V26, P1821, DOI 10.1093/ndt/gfq683; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Nakamoto H, 2005, PERITON DIALYSIS INT, V25, pS30; Nakamoto H, 2008, PERITON DIALYSIS INT, V28, pS83; Nakamura S, 2004, SEMIN NEPHROL, V24, P502, DOI 10.1016/j.semnephrol.2004.06.027; Park SH, 2008, PERITON DIALYSIS INT, V28, pS21; da Luz MMP, 2011, SURG TODAY, V41, P1644, DOI 10.1007/s00595-010-4493-8; Sagara A, 2011, J AM SOC NEPHROL, p36A; Schwenger V, 2006, J AM SOC NEPHROL, V17, P199, DOI 10.1681/ASN.2005020155; Sweetwyne MT, 2012, MATRIX BIOL, V31, P178, DOI 10.1016/j.matbio.2012.01.006; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Teta D, 2005, NEPHROL DIAL TRANSPL, V20, P1329, DOI 10.1093/ndt/gfh812; Toyohara T, 2011, INTERNAL MED, V50, P2519, DOI 10.2169/internalmedicine.50.5810; Ulmer C, 2012, SURGERY; Valenick LV, 2005, EXP CELL RES, V309, P48, DOI 10.1016/j.yexcr.2005.05.024; Van Vliet AI, 2001, J PATHOL, V193, P256; Vlijm A, 2009, PERITON DIALYSIS INT, V29, P517; Wang Chengxiong, 2007, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V24, P736; Wang HR, 2012, KIDNEY BLOOD PRESS R, V35, P211, DOI 10.1159/000332402; Wang WJ, 2012, KIDNEY INT, V81, P1002, DOI 10.1038/ki.2011.457; Weigle DS, 1997, J CLIN ENDOCR METAB, V82, P561, DOI 10.1210/jc.82.2.561; Wojcik Katarina, 2007, Med Pregl, V60 Suppl 2, P114; Wong CF, 2005, PERITON DIALYSIS INT, V25, P285; Yamamoto Hiroyasu, 2002, Adv Perit Dial, V18, P135; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yerlikaya FH, 2011, RENAL FAILURE, V33, P819, DOI 10.3109/0886022X.2011.601831; Yokoi H, 2012, KIDNEY INT, V81, P160, DOI 10.1038/ki.2011.305	82	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56389	10.1371/journal.pone.0056389	http://dx.doi.org/10.1371/journal.pone.0056389			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418565	Green Published, Green Accepted, gold			2022-12-27	WOS:000315970300158
J	Ridgers, ND; Timperio, A; Crawford, D; Salmon, J				Ridgers, Nicola D.; Timperio, Anna; Crawford, David; Salmon, Jo			What Factors Are Associated with Adolescents' School Break Time Physical Activity and Sedentary Time?	PLOS ONE			English	Article							CHILDREN; RECESS; LUNCHTIME	Purpose: Adolescents' physical activity levels during school break time are low and understanding correlates of physical activity and sedentary time in this context is important. This study investigated cross-sectional and longitudinal associations between a range of individual, behavioural, social and policy/organisational correlates and objectively measured school break time physical activity and sedentary time. Methods: In 2006, 146 adolescents (50% males; mean age = 14.1 +/- 0.6 years) completed a questionnaire and wore an accelerometer for >= 3 school days. Time spent engaged in sedentary, light (LPA) and moderate-to-vigorous physical activity (MVPA) during school break times (recess and lunchtime) were calculated using existing cut-points. Measures were repeated in 2008 among 111 adolescents. Multilevel models examined cross-sectional and longitudinal associations. Results: Bringing in equipment was cross-sectionally associated with 3.2% more MVPA during break times. Females engaged in 5.1% more sedentary time than males, whilst older adolescents engaged in less MVPA than younger adolescents. Few longitudinal associations were observed. Adolescents who brought sports equipment to school engaged in 7.2% less LPA during break times two years later compared to those who did not bring equipment to school. Conclusion: These data suggest that providing equipment and reducing restrictions on bringing in sports equipment to school may promote physical activity during school recess. Strategies targeting females' and older adolescents', in particular, are warranted.	[Ridgers, Nicola D.; Timperio, Anna; Crawford, David; Salmon, Jo] Deakin Univ, Ctr Phys Act & Nutr Res C PAN, Melbourne, Vic, Australia	Deakin University	Ridgers, ND (corresponding author), Deakin Univ, Ctr Phys Act & Nutr Res C PAN, Melbourne, Vic, Australia.	nicky.ridgers@deakin.edu.au	Salmon, Jo/C-1226-2009; Timperio, Anna F/A-3086-2013; Ridgers, Nicola/AGN-1339-2022; Crawford, David A/K-6301-2015; Salmon, Jo/X-2630-2019; Ridgers, Nicola/B-2092-2013	Salmon, Jo/0000-0002-4734-6354; Timperio, Anna F/0000-0002-8773-5012; Crawford, David A/0000-0002-2467-7556; Salmon, Jo/0000-0002-4734-6354; Ridgers, Nicola/0000-0001-5713-3515	Australian Research Council [DP0664206]; Australian Research Council Discovery Early Career Researcher Award [DE120101173]; Victorian Health Promotion Foundation Public Health Fellowship; National Health and Medical Research Council Principal Research Fellowship [APP1026216]	Australian Research Council(Australian Research Council); Australian Research Council Discovery Early Career Researcher Award(Australian Research Council); Victorian Health Promotion Foundation Public Health Fellowship; National Health and Medical Research Council Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding from the Australian Research Council (HEAPS T2 and T3; ID DP0664206). NDR is supported by an Australian Research Council Discovery Early Career Researcher Award (DE120101173), AT is supported by a Victorian Health Promotion Foundation Public Health Fellowship, and JS is supported by a National Health and Medical Research Council Principal Research Fellowship (APP1026216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Cardon G, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-11; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Crawford D, 2010, INT J OBESITY, V34, P1177, DOI 10.1038/ijo.2010.57; Department of Health, 2004, LEAST 5 WEEK EV IMP; Department of Health and Ageing, 2005, AUSTR PHYS ACT REC C; Department of Health Western Australia & Edith Cowan University, 2015, REFRSH ED FOOD NUTR; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Haug E, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-47; Haug E, 2010, HEALTH EDUC RES, V25, P248, DOI 10.1093/her/cyn050; Haug E, 2010, HEALTH PROMOT INT, V25, P63, DOI 10.1093/heapro/dap040; Hohepa M, 2006, J ADOLESCENT HEALTH, V39, P328, DOI 10.1016/j.jadohealth.2005.12.024; Hohepa M, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-54; Hohepa M, 2009, J SCI MED SPORT, V12, P284, DOI 10.1016/j.jsams.2007.11.005; Kimm SYS, 2000, MED SCI SPORT EXER, V32, P1445, DOI 10.1097/00005768-200008000-00013; Kirby J, 2011, J PHYS ACT HEALTH, V8, P785, DOI 10.1123/jpah.8.6.785; Kriemler S, 2011, BRIT J SPORT MED, V45, P923, DOI 10.1136/bjsports-2011-090186; Leggett C, 2012, INT J PUBLIC HEALTH, V57, P315, DOI 10.1007/s00038-011-0306-0; Martinez-Gomez D, 2010, PEDIATR EXERC SCI, V22, P218, DOI 10.1123/pes.22.2.218; Mo Frank, 2005, Int J Adolesc Med Health, V17, P49; Mulhall P, 2011, J PHYS ACT HEALTH, V8, P244, DOI 10.1123/jpah.8.2.244; Ommundsen Y, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-32; Plewis I, 2003, BRIT J EDUC STUD, V51, P408, DOI 10.1046/j.1467-8527.2003.00246.x; Ridgers ND, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-74; Ridgers ND, 2012, AM J PREV MED, V43, P320, DOI 10.1016/j.amepre.2012.05.019; Ridgers ND, 2012, BRIT J SPORT MED, V46, P741, DOI 10.1136/bjsm.2011.084921; Ridgers ND, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-15; Ridgers ND, 2011, HEALTH EDUC RES, V26, P586, DOI 10.1093/her/cyr014; Rothon C, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-32; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sallis JF, 2002, HLTH BEHAV HLTH ED T, V3, P462; Stanley RM, 2012, J SCI MED SPORT, V15, P44, DOI 10.1016/j.jsams.2011.08.002; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; Timperio A, 2012, J SCI MED SPORT, V15, P122, DOI 10.1016/j.jsams.2011.07.010; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; U.S. Department of Health and Human Services, 2008, PHYS ACT GUID AM, P15; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Wilson DK, 2005, J PEDIATR PSYCHOL, V30, P293, DOI 10.1093/jpepsy/jsi039	38	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56838	10.1371/journal.pone.0056838	http://dx.doi.org/10.1371/journal.pone.0056838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418606	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300200
J	Szczepaniak, EW; Malliaras, K; Nelson, MD; Szczepaniak, LS				Szczepaniak, Edward W.; Malliaras, Konstantinos; Nelson, Michael D.; Szczepaniak, Lidia S.			Measurement of Pancreatic Volume by Abdominal MRI: A Validation Study	PLOS ONE			English	Article							RESONANCE; LIVER	Objective: To develop abdominal magnetic resonance imaging (MRI) protocol to measure pancreatic volume in humans and to validate it in large animals. Materials and Methods: We performed abdominal MRI in eight mini-pigs using a clinical 3T MRI system. We used consecutive parallel abdominal slices, covering the entire pancreas to calculate pancreatic volume. Following MRI, animals were sacrificed, the pancreas was removed, and the volume of the pancreas was measured by water displacement. We used the same MRI protocol to measure pancreatic volume in 21 humans. To assess reproducibility of in vivo measurement we repeated MRI pancreas volume evaluation within 24 hours in additional five humans. Results: In mini-pigs the measurements of pancreatic volume by MRI and by water displacement were almost identical (R-2 = 0.9867; p<0.0001). In humans the average pancreas volume was 72.7+/-24.5 ml, range from 35.0 to 105.5 ml. This result is in strong agreement with results of previous large postmortem and computed tomography (CT) studies. Repeated measurements of pancreatic volume in humans were highly reproducible. Pancreatic volume measured in vivo was negatively correlated with age, body fat mass, pancreatic TG levels, and visceral fat mass. Conclusions: These initial results are highly encouraging and our protocol for pancreatic volume estimation in vivo may prove useful in obesity research to follow in vivo changes of pancreatic volume and structure during time course of obesity and type 2 diabetes development.	[Szczepaniak, Edward W.; Malliaras, Konstantinos; Nelson, Michael D.; Szczepaniak, Lidia S.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Szczepaniak, LS (corresponding author), Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.	lidia.szczepaniak@cshs.org	Nelson, Michael Shawn/GXF-4934-2022	Nelson, Michael/0000-0002-3232-8639	National Institute of Health [RO1DK081524, UL1TR000124]; Lincy Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081524] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lincy Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health grants RO1DK081524, UL1TR000124, and by grant from Lincy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 1997, AM J CLIN NUTR, V65, P403, DOI 10.1093/ajcn/65.2.403; Bergman RN, 2007, DIABETES, V56, P1489, DOI 10.2337/db07-9903; Caglar V, 2012, SURG RADIOL ANAT, V34, P935, DOI 10.1007/s00276-012-0988-x; Djuric-Stefanovic A, 2012, SURG RADIOL ANAT, V34, P811, DOI 10.1007/s00276-012-0962-7; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Genuth S, 2003, DIABETES CARE, V26, P3160; Geraghty EM, 2004, ABDOM IMAGING, V29, P482, DOI 10.1007/s00261-003-0139-2; Kaplan LA, 1987, METHODS CLIN CHEM; KASALES CJ, 1994, CRIT REV DIAGN IMAG, V35, P485; Lee Jung Pil, 2011, Korean J Ophthalmol, V25, P37, DOI 10.3341/kjo.2011.25.1.37; Lingvay I, 2009, J CLIN ENDOCR METAB, V94, P4070, DOI 10.1210/jc.2009-0584; Mathur Abhishek, 2007, HPB (Oxford), V9, P312, DOI 10.1080/13651820701504157; Meier JM, 2007, SEMIN NUCL MED, V37, P154, DOI 10.1053/j.semnuclmed.2007.02.001; Meng K, 2010, ACAD RADIOL, V17, P1302, DOI 10.1016/j.acra.2010.03.019; PESHOCK RM, 1990, AM J CARDIOL, V66, pF41, DOI 10.1016/0002-9149(90)90641-D; Sahin B, 2003, EUR J RADIOL, V47, P164, DOI 10.1016/S0720-048X(02)00152-3; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Sequeiros IM, 2010, BRIT J RADIOL, V83, P921, DOI 10.1259/bjr/24009651; Swindle MM, 1998, SCAND J LAB ANIM SCI, V25, P11; Szczepaniak LS, 2012, DIABETES CARE, V35, P2377, DOI 10.2337/dc12-0701; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Williams AJK, 2007, DIABETIC MED, V24, P35, DOI 10.1111/j.1464-5491.2007.02027.x	23	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55991	10.1371/journal.pone.0055991	http://dx.doi.org/10.1371/journal.pone.0055991			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418491	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300083
J	Hjelholt, A; Carlsen, T; Deleuran, B; Jurik, AG; Schiottz-Christensen, B; Christiansen, G; Birkelund, S				Hjelholt, Astrid; Carlsen, Thomas; Deleuran, Bent; Jurik, Anne Grethe; Schiottz-Christensen, Berit; Christiansen, Gunna; Birkelund, Svend			Increased Levels of IgG Antibodies against Human HSP60 in Patients with Spondyloarthritis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ANKYLOSING-SPONDYLITIS PATIENTS; HEAT-SHOCK-PROTEIN-60 HSP60; RHEUMATOID-ARTHRITIS; REACTIVE ARTHRITIS; 60 KDA; HLA-B27; CELLS; SERA; SUBCLASSES	Spondyloarthritis (SpA) comprises a heterogeneous group of inflammatory diseases, with strong association to human leukocyte antigen (HLA)-B27. A triggering bacterial infection has been considered as the cause of SpA, and bacterial heat shock protein (HSP) seems to be a strong T cell antigen. Since bacterial and human HSP60, also named HSPD1, are highly homologous, cross-reactivity has been suggested in disease initiation. In this study, levels of antibodies against bacterial and human HSP60 were analysed in SpA patients and healthy controls, and the association between such antibodies and disease severity in relation to HLA-B27 was evaluated. Serum samples from 82 patients and 50 controls were analysed by enzyme-linked immunosorbent assay (ELISA) for immunoglobulin (Ig)G1, IgG2, IgG3 and IgG4 antibodies against human HSP60 and HSP60 from Chlamydia trachomatis, Salmonella enteritidis and Campylobacter jejuni. Disease severity was assessed by the clinical scorings Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Metrology Index (BASMI). Levels of IgG1 and IgG3 antibodies against human HSP60, but not antibodies against bacterial HSP60, were elevated in the SpA group compared with the control group. Association between IgG3 antibodies against human HSP60 and BASMI was shown in HLA-B27(+) patients. Only weak correlation between antibodies against bacterial and human HSP60 was seen, and there was no indication of cross-reaction. These results suggest that antibodies against human HSP60 is associated with SpA, however, the theory that antibodies against human HSP60 is a specific part of the aetiology, through cross-reaction to bacterial HSP60, cannot be supported by results from this study. We suggest that the association between elevated levels of antibodies against human HSP60 and disease may reflect a general activation of the immune system and an increased expression of human HSP60 in the synovium of patients with SpA.	[Hjelholt, Astrid; Deleuran, Bent; Christiansen, Gunna] Aarhus Univ, Dept Biomed Med Microbiol & Immunol, Aarhus, Denmark; [Carlsen, Thomas; Birkelund, Svend] Aarhus Univ, Dept Hlth Sci & Technol, Aarhus, Denmark; [Deleuran, Bent] Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark; [Jurik, Anne Grethe] Aarhus Univ Hosp, Dept Radiol, DK-8000 Aarhus, Denmark; [Schiottz-Christensen, Berit] Aarhus Clin Rheumat Dis, Aarhus, Denmark; [Christiansen, Gunna; Birkelund, Svend] Loke Diagnost, Risskov, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Hjelholt, A (corresponding author), Aarhus Univ, Dept Biomed Med Microbiol & Immunol, Aarhus, Denmark.	astrid.hjelholt@studmed.au.dk		Hjelholt, Astrid Johannesson/0000-0002-3114-4176; Schiottz-Christensen, Berit/0000-0003-3866-856X; Jurik, Anne Grethe/0000-0003-2571-0466; Deleuran, Bent/0000-0002-7079-1587; Birkelund, Svend/0000-0001-6171-5606; Christiansen, Gunna/0000-0003-0540-1367	EuroPathoGenomics -'EPG' [LSHB-CT-2005-512061]; Lundbeck Foundation [R19-A2023]; Danish Rheumatism Association [R80-A1287]; Institute of Clinical Medicine Aarhus University; Jens Aage Sorensens and wife Edit Sorensens Foundation	EuroPathoGenomics -'EPG'; Lundbeck Foundation(Lundbeckfonden); Danish Rheumatism Association; Institute of Clinical Medicine Aarhus University; Jens Aage Sorensens and wife Edit Sorensens Foundation	The study was supported by the EuroPathoGenomics -'EPG' (contract no. LSHB-CT-2005-512061), The Lundbeck Foundation (contract no. R19-A2023), Danish Rheumatism Association (contract no. R80-A1287), The Institute of Clinical Medicine Aarhus University and Jens Aage Sorensens and wife Edit Sorensens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERSBERG JB, 1975, P NATL ACAD SCI USA, V72, P723, DOI 10.1073/pnas.72.2.723; Avery DT, 2008, J IMMUNOL, V181, P1767, DOI 10.4049/jimmunol.181.3.1767; Barr A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3178; Bax CJ, 2004, SEX TRANSM INFECT, V80, P415, DOI 10.1136/sti.2004.009167; BENJAMIN R, 1990, IMMUNOL TODAY, V11, P137, DOI 10.1016/0167-5699(90)90051-A; Bowness P, 2002, RHEUMATOLOGY, V41, P857, DOI 10.1093/rheumatology/41.8.857; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; CAMBRIDGE G, 1994, ANN RHEUM DIS, V53, P24, DOI 10.1136/ard.53.1.24; Cancino-Diaz JC, 2004, BRIT J OPHTHALMOL, V88, P247, DOI 10.1136/bjo.2003.023390; De Maio A, 2011, CELL STRESS CHAPERON, V16, P235, DOI 10.1007/s12192-010-0236-4; Dominguez-Lopez ML, 2009, CLIN EXP RHEUMATOL, V27, P626; Dominguez-Lopez ML, 2002, SCAND J RHEUMATOL, V31, P260, DOI 10.1080/030097402760375133; DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218, DOI 10.1002/art.1780341003; Drasbek M, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-7; FitzGerald O, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2580; Garraud O, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-63; Gaston JSH, 1998, BIOTHERAPY, V10, P197, DOI 10.1007/BF02678297; Handley HH, 1996, CLIN EXP IMMUNOL, V103, P429; Hjelholt A, 2011, HUM REPROD, V26, P2069, DOI 10.1093/humrep/der167; Huang MN, 2010, SEMIN ARTHRITIS RHEU, V40, P164, DOI 10.1016/j.semarthrit.2009.10.002; Huhtinen M, 2001, INVEST OPHTH VIS SCI, V42, P1816; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Liu YD, 2011, INT J NEUROSCI, V121, P570, DOI 10.3109/00207454.2011.596293; Locht H, 2002, J RHEUMATOL, V29, P767; Manolova I, 2002, RHEUMATOL INT, V21, P227, DOI 10.1007/s00296-002-0174-2; McMichael A, 2002, ARTHRITIS RES THER, V4, pS153, DOI 10.1186/ar571; Merendino AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009247; MORELL A, 1972, J IMMUNOL, V108, P195; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pfister G, 2005, J CELL SCI, V118, P1587, DOI 10.1242/jcs.02292; Pockley AG, 1999, CELL STRESS CHAPERON, V4, P29, DOI 10.1054/csac.1998.0121; Rashid T, 2011, DISCOV MED, V12, P187; Raska Milan, 2005, Biomedical Papers (Olomouc), V149, P243; Schett G, 2001, ARTHRITIS RES, V3, P80, DOI 10.1186/ar144; SCHMITT J, 1993, MOL BIOL REP, V18, P223, DOI 10.1007/BF01674434; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; SHARIF M, 1992, ARTHRITIS RHEUM, V35, P1427, DOI 10.1002/art.1780351205; Sieper J, 2000, ARTHRITIS RHEUM, V43, P720, DOI 10.1002/1529-0131(200004)43:4<720::AID-ANR2>3.0.CO;2-8; Spiegelberg H L, 1974, Adv Immunol, V19, P259, DOI 10.1016/S0065-2776(08)60254-0; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Thiel A, 2000, ARTHRITIS RHEUM-US, V43, P2834, DOI 10.1002/1529-0131(200012)43:12<2834::AID-ANR25>3.0.CO;2-7; Townes JM, 2010, CLIN INFECT DIS, V50, P247, DOI 10.1086/649540; Wegener HC, 2003, EMERG INFECT DIS, V9, P774; Zeidler H, 2004, CURR OPIN RHEUMATOL, V16, P380, DOI 10.1097/01.bor.0000126150.04251.f9; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	47	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56210	10.1371/journal.pone.0056210	http://dx.doi.org/10.1371/journal.pone.0056210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424650	Green Published, Green Submitted, gold			2022-12-27	WOS:000315965100038
J	Yang, Z; Xu, BH; Lu, JL; Tian, XG; Li, MA; Sun, K; Huang, F; Liu, Y; Xu, M; Bi, YF; Wang, WQ				Yang, Zhi; Xu, Baihui; Lu, Jieli; Tian, Xiaoguang; Li, Mian; Sun, Kan; Huang, Fei; Liu, Yu; Xu, Min; Bi, Yufang; Wang, Weiqing			Autonomic Test by EZSCAN in the Screening for Prediabetes and Diabetes	PLOS ONE			English	Article							NEUROPATHY; PREVALENCE; ACCURACY; SKIN	Background: Autonomic neuropathy is common in diabetics and may occur in prediabetes. A new and noninvasive autonomic test-EZSCAN evaluates sudomotor function precisely. No generally accepted EZSCAN thresholds to screen for prediabetes and diabetes have been defined. Methodology and Principal Findings: Cross-sectional study of 5, 824 Chinese adults aged 40 and older was conducted in Shanghai, China. We used EZSCAN to evaluate autonomic function in different glucose status and screen for prediabetes and diabetes. The prevalence of prediabetes and diabetes were 21.9% and 17.5% respectively. Compared with the lowest quintile, the highest quintile of EZSCAN value had odds ratios for having dysglycemia (prediabetes or diabetes) of 2.08 (95% CI 1.67-2.58) in total population, 2.89 (95% CI 2.06-4.05) in men and 1.70 (95% CI 1.28-2.25) in women after adjustment for confounding factors. EZSCAN value improved the areas under ROC curve for detection of dysglycemia or diabetes beyond the contribution of conventional risk factors by 0.8% and 12.9%. The cut-off point of EZSCAN value higher than 30% provided reasonable sensitivities (70.3-83.7%) to detect dysglycemia not only in total population regardless of sex but also in individuals with high risk of developing diabetes. Conclusions and Significance: EZSCAN value higher than 30% indicate an increased risk of prevalent prediabetes and diabetes, suggesting that subjects with EZSCAN >= 30% should be further evaluated by oral glucose tolerance test. The improvement of EZSCAN for diabetes detection was still of limited clinical relevance. Thus the clinical application value of EZSCAN is needed to be explored in future studies.	[Yang, Zhi; Xu, Baihui; Lu, Jieli; Tian, Xiaoguang; Li, Mian; Sun, Kan; Huang, Fei; Liu, Yu; Xu, Min; Bi, Yufang; Wang, Weiqing] E Inst Shanghai Univ, Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp,Minist Hlth,Key Lab Endocrine & Meta, Shanghai, Peoples R China; [Yang, Zhi; Xu, Baihui; Lu, Jieli; Tian, Xiaoguang; Li, Mian; Sun, Kan; Huang, Fei; Liu, Yu; Xu, Min; Bi, Yufang; Wang, Weiqing] Shanghai Jiao Tong Univ, Rui Jin Hosp, Dept Endocrinol & Metab,Shanghai Inst Endocrine &, Shanghai Clin Ctr Endocrine & Metab Dis,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, WQ (corresponding author), E Inst Shanghai Univ, Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp,Minist Hlth,Key Lab Endocrine & Meta, Shanghai, Peoples R China.	wqingw@hotmail.com			Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health [1994DP131044]; National Natural Science Foundation of China [81222008, 81100564, 30911120493, 81170739, 81130016]; Shanghai Natural Science Foundation [10ZR1426400]; Shanghai Committee of Science and Technology [10X1403000]	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This study was supported by the grants from the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044), the National Natural Science Foundation of China (numbers 81222008, 81100564, 30911120493, 81170739 and 81130016), the Shanghai Natural Science Foundation (number 10ZR1426400) and Shanghai Committee of Science and Technology (10X1403000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Bossuyt PM, 2003, CROAT MED J, V44, P639; Brunswick P, 2007, P ANN INT IEEE EMBS, P4544, DOI 10.1109/IEMBS.2007.4353350; Calvet J. H., 2011, BR J DIABETES VASC D, V11, P204, DOI DOI 10.1177/1474651411402629; Chizmadzhev YA, 1998, BIOPHYS J, V74, P843, DOI 10.1016/S0006-3495(98)74008-1; Dyck PJ, 2006, DIABETES CARE, V29, P2282, DOI 10.2337/dc06-0525; Edwards JL, 2008, PHARMACOL THERAPEUT, V120, P1, DOI 10.1016/j.pharmthera.2008.05.005; England JD, 2009, NEUROLOGY, V72, P177, DOI 10.1212/01.wnl.0000336345.70511.0f; Gallop RJ, 2003, UNDERSTAND STAT, V2, P219, DOI DOI 10.1207/S15328031US0204_01; Illigens BMW, 2009, CLIN AUTON RES, V19, P79, DOI 10.1007/s10286-008-0506-8; Isak B, 2008, DIABETES-METAB RES, V24, P563, DOI 10.1002/dmrr.859; Licht CMM, 2010, J CLIN ENDOCR METAB, V95, P2458, DOI 10.1210/jc.2009-2801; Mayaudon H, 2010, DIABETES METAB, V36, P450, DOI 10.1016/j.diabet.2010.05.004; Ozaki R, 2011, DIABETES TECHNOL THE, V13, P937, DOI 10.1089/dia.2011.0023; Pacher P, 2002, DIABETES, V51, P514, DOI 10.2337/diabetes.51.2.514; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pop-Busui R, 2010, DIABETES CARE, V33, P434, DOI 10.2337/dc09-1294; Rajabally YA, 2011, ACTA NEUROL SCAND, V124, P1, DOI 10.1111/j.1600-0404.2010.01425.x; Ramachandran A, 2010, DIABETES RES CLIN PR, V88, P302, DOI 10.1016/j.diabres.2010.01.023; Sheng CS, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-36; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043449; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Vinik AI, 2011, DIABETIC MED, V28, P643, DOI 10.1111/j.1464-5491.2010.03184.x; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; Watkins LL, 2000, DIABETES CARE, V23, P826, DOI 10.2337/diacare.23.6.826; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	29	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56480	10.1371/journal.pone.0056480	http://dx.doi.org/10.1371/journal.pone.0056480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424665	Green Published, Green Submitted, gold			2022-12-27	WOS:000315965100053
J	Komarova, NL; Jameson, KA				Komarova, Natalia L.; Jameson, Kimberly A.			A Quantitative Theory of Human Color Choices	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; EVOLUTIONARY MODELS; CATEGORIZATION; UNIVERSALITY; VISION	The system for colorimetry adopted by the Commission Internationale de l'Eclairage (CIE) in 1931, along with its subsequent improvements, represents a family of light mixture models that has served well for many decades for stimulus specification and reproduction when highly controlled color standards are important. Still, with regard to color appearance many perceptual and cognitive factors are known to contribute to color similarity, and, in general, to all cognitive judgments of color. Using experimentally obtained odd-one-out triad similarity judgments from 52 observers, we demonstrate that CIE-based models can explain a good portion (but not all) of the color similarity data. Color difference quantified by CIELAB Delta E explained behavior at levels of 81% (across all colors), 79% (across red colors), and 66% (across blue colors). We show that the unexplained variation cannot be ascribed to inter-or intra-individual variations among the observers, and points to the presence of additional factors shared by the majority of responders. Based on this, we create a quantitative model of a lexicographic semiorder type, which shows how different perceptual and cognitive influences can trade-off when making color similarity judgments. We show that by incorporating additional influences related to categorical and lightness and saturation factors, the model explains more of the triad similarity behavior, namely, 91% (all colors), 90% (reds), and 87% (blues). We conclude that distance in a CIE model is but the first of several layers in a hierarchy of higher-order cognitive influences that shape color triad choices. We further discuss additional mitigating influences outside the scope of CIE modeling, which can be incorporated in this framework, including well-known influences from language, stimulus set effects, and color preference bias. We also discuss universal and cultural aspects of the model as well as non-uniformity of the color space with respect to different cultural biases.	[Komarova, Natalia L.] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA; [Jameson, Kimberly A.] Univ Calif Irvine, Inst Math & Behav Sci, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Komarova, NL (corresponding author), Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA.	komarova@uci.edu			National Science Foundation (NSF) from the Methodology, Measurement, and Statistics (MMS) Program of the Division of Social and Economic Sciences (SES) [NSF 07724228]	National Science Foundation (NSF) from the Methodology, Measurement, and Statistics (MMS) Program of the Division of Social and Economic Sciences (SES)(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Partial support was provided by National Science Foundation (NSF) grant NSF 07724228 from the Methodology, Measurement, and Statistics (MMS) Program of the Division of Social and Economic Sciences (SES). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baronchelli A, 2010, P NATL ACAD SCI USA, V107, P2403, DOI 10.1073/pnas.0908533107; Barratt L. B., 1996, INT J LEXICOGR, V9, P102, DOI DOI 10.1093/IJL/9.2.102; Bartleson C.J., 1976, COLOR RES APPL, V1, P181; Battistella EL., 1996, LOGIC MARKEDNESS; Berlin B., 1969, BASIC COLOR TERMS TH; Bimler D, 2004, BEHAV RES METH INS C, V36, P69, DOI 10.3758/BF03195550; Bostock J., 1855, NATURAL HIST PLINY E; Brown AM, 2011, J VISION, V11, DOI 10.1167/11.12.2; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Davidoff J, 1999, NATURE, V398, P203, DOI 10.1038/18335; Diaz JA, 1998, COLOR RES APPL, V23, P379, DOI 10.1002/(SICI)1520-6378(199812)23:6<379::AID-COL6>3.0.CO;2-E; Fairchild M. D., 2005, COLOR APPEARANCE MOD; FAIRCHILD MD, 1993, COLOR RES APPL, V18, P178, DOI 10.1002/col.5080180308; Fernandez-Maloigne C., 2013, ADV COLOR IMAGE PROC; Gilbert AL, 2006, P NATL ACAD SCI USA, V103, P489, DOI 10.1073/pnas.0509868103; GOLDSTONE R, 1994, J EXP PSYCHOL GEN, V123, P178, DOI 10.1037/0096-3445.123.2.178; HELM CE, 1962, AM J PSYCHOL, V75, P437, DOI 10.2307/1419867; Jameson K., 1997, COLOR CATEGORIES THO, P295, DOI DOI 10.1017/CBO9780511519819.014; Jameson KA, 2003, COLOR RES APPL, V28, P113, DOI 10.1002/col.10131; Jameson KA, 2005, J COGN CULT, V5, P293, DOI 10.1163/156853705774648527; Jameson KA, 2009, J OPT SOC AM A, V26, P1424, DOI 10.1364/JOSAA.26.001424; Jameson KA, 2009, J OPT SOC AM A, V26, P1414, DOI 10.1364/JOSAA.26.001414; Komarova NI, 2008, J THEOR BIOL, V253, P680, DOI 10.1016/j.jtbi.2008.03.030; Lindsey DT, 2006, P NATL ACAD SCI USA, V103, P16608, DOI 10.1073/pnas.0607708103; MacLaury RE, 2007, ANTHROPOLOGY OF COLOR: INTERDISCIPLINARY MULTILEVEL MODELING, P1; MACLAURY RE, 1992, CURR ANTHROPOL, V33, P137, DOI 10.1086/204049; Moore CC, 2000, P NATL ACAD SCI USA, V97, P5007, DOI 10.1073/pnas.97.9.5007; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Paramei GV, 2005, CROSS-CULT RES, V39, P10, DOI 10.1177/1069397104267888; Paramei GV, 1998, VISION RES, V38, P3397, DOI 10.1016/S0042-6989(97)00454-9; Regier T, 2005, P NATL ACAD SCI USA, V102, P8386, DOI 10.1073/pnas.0503281102; Roberson D, 2000, J EXP PSYCHOL GEN, V129, P369, DOI 10.1037//0096-3445.129.3.369; Sayim B, 1988, J COGNITION CULTURE, V5, P427; TVERSKY A, 1969, PSYCHOL REV, V76, P31, DOI 10.1037/h0026750; Webster MA, 2000, J OPT SOC AM A, V17, P1545, DOI 10.1364/JOSAA.17.001545; WEBSTER MA, 1988, J OPT SOC AM A, V5, P1722, DOI 10.1364/JOSAA.5.001722; WYSECKI G, 1982, COLOR SCI CONCEPTS M; Xiao YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024994; Zhang XM, 1997, COMPCON IEEE, P44, DOI 10.1109/CMPCON.1997.584669	39	9	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55986	10.1371/journal.pone.0055986	http://dx.doi.org/10.1371/journal.pone.0055986			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092DU	23409103	gold, Green Published, Green Submitted			2022-12-27	WOS:000315100000036
J	Cloward, JM; Shafer, WM				Cloward, Jason M.; Shafer, William M.			MtrR Control of a Transcriptional Regulatory Pathway in Neisseria meningitidis That Influences Expression of a Gene (nadA) Encoding a Vaccine Candidate	PLOS ONE			English	Article							EFFLUX PUMP; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; CORREIA ELEMENT; PHASE VARIATION; DNA-SEQUENCE; HUMAN SALIVA; GONORRHOEAE; RESISTANCE; PROTEIN	The surface-exposed NadA adhesin produced by a subset of capsular serogroup B strains of Neisseria meningitidis is currently being considered as a vaccine candidate to prevent invasive disease caused by a hypervirulent lineage of meningococci. Levels of NadA are known to be controlled by both transcriptional regulatory factors and a component of human saliva, 4-hydroxyphenylacetic acid. Herein, we confirmed the capacity of a DNA-binding protein termed FarR to negatively control nadA expression. We also found that a known transcriptional regulator of farR in N. gonorrhoeae termed MtrR can have a negative regulatory impact on farR and nadA expression, especially when over-expressed. MtrR-mediated repression of nadA was found to be direct, and its binding to a target DNA sequence containing the nadA promoter influenced formation and/or stability of FarR:: nadA complexes. The complexity of the multi-layered regulation of nadA uncovered during this investigation suggests that N. meningitidis modulates NadA adhesin protein levels for the purpose of interacting with host cells yet avoiding antibody directed against surface exposed epitopes.	[Cloward, Jason M.; Shafer, William M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Cloward, Jason M.; Shafer, William M.] Vet Affairs Med Ctr Atlanta, Labs Bacterial Pathogenesis, Decatur, GA USA	Emory University	Shafer, WM (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	wshafer@emory.edu			NIH [AI021150-28]; VA Merit award; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021150, R37AI021150] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit award(US Department of Veterans Affairs); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI021150-28 and a VA Merit award to W. M. S. W. M. S. is the recipient of a Senior Research Career Scientist Award from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; Cartwright K., 1995, MENINGOCOCCAL DIS, P115; CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Enriquez R, 2010, J MED MICROBIOL, V59, P1055, DOI 10.1099/jmm.0.021220-0; Fagnocchi L, 2012, J BACTERIOL, V194, P460, DOI 10.1128/JB.06161-11; Folster JP, 2007, J BACTERIOL, V189, P4569, DOI 10.1128/JB.00286-07; Folster JP, 2009, J BACTERIOL, V191, P287, DOI 10.1128/JB.01165-08; HAGMAN KE, 1995, J BACTERIOL, V177, P4162, DOI 10.1128/jb.177.14.4162-4165.1995; HAGMAN KE, 1995, MICROBIOL-SGM, V141, P611, DOI 10.1099/13500872-141-3-611; Johnson PJT, 2011, ANTIMICROB AGENTS CH, V55, P2559, DOI 10.1128/AAC.00010-11; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee EH, 2003, J BACTERIOL, V185, P7145, DOI 10.1128/JB.185.24.7145-7152.2003; Lee EH, 1999, MOL MICROBIOL, V33, P839, DOI 10.1046/j.1365-2958.1999.01530.x; Lucas CE, 1997, J BACTERIOL, V179, P4123, DOI 10.1128/jb.179.13.4123-4128.1997; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; Martin P, 2003, MOL MICROBIOL, V50, P245, DOI 10.1046/j.1365-2958.2003.03678.x; MENARD R, 1993, J BACTERIOL, V175, P5899; Metruccio MME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000710; MURPHY GL, 1989, CELL, V56, P539, DOI 10.1016/0092-8674(89)90577-1; NASSIF X, 1994, P NATL ACAD SCI USA, V91, P3769, DOI 10.1073/pnas.91.9.3769; Ohneck EA, 2011, MBIO, V2; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Rouquette-Loughlin CE, 2004, MOL MICROBIOL, V54, P731, DOI 10.1111/j.1365-2958.2004.04299.x; Sambrook J., 2002, MOL CLONING LAB MANU; Scheuerpflug I, 1999, INFECT IMMUN, V67, P834, DOI 10.1128/IAI.67.2.834-843.1999; Schielke S, 2011, INT J MED MICROBIOL, V301, P325, DOI 10.1016/j.ijmm.2010.11.007; Schielke S, 2010, APPL ENVIRON MICROB, V76, P3160, DOI 10.1128/AEM.02833-09; Schielke S, 2009, MOL MICROBIOL, V72, P1054, DOI 10.1111/j.1365-2958.2009.06710.x; SHAFER WM, 1984, ANTIMICROB AGENTS CH, V25, P767, DOI 10.1128/AAC.25.6.767; SHAFER WM, 1995, MICROBIOL-UK, V141, P907, DOI 10.1099/13500872-141-4-907; Sharip A, 2006, PEDIATR INFECT DIS J, V25, P191, DOI 10.1097/01.inf.0000202065.03366.0c; SILVER LE, 1995, GENE, V166, P101, DOI 10.1016/0378-1119(95)00605-6; SIMON D, 1992, P NATL ACAD SCI USA, V89, P5512, DOI 10.1073/pnas.89.12.5512; Skaar EP, 2002, J BACTERIOL, V184, P919, DOI 10.1128/jb.184.4.919-927.2002; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; STEPHENS DS, 1991, INFECT IMMUN, V59, P4097, DOI 10.1128/IAI.59.11.4097-4102.1991; Takahama U, 2002, FEBS LETT, V518, P116, DOI 10.1016/S0014-5793(02)02659-5; VIRJI M, 1993, MOL MICROBIOL, V10, P1013, DOI 10.1111/j.1365-2958.1993.tb00972.x; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Zalucki YM, 2011, FUNCTION REGULATION	42	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56097	10.1371/journal.pone.0056097	http://dx.doi.org/10.1371/journal.pone.0056097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409129	Green Submitted, Green Published, gold			2022-12-27	WOS:000314660300056
J	Alvarez-Castelao, B; Losada, F; Ahicart, P; Castano, JG				Alvarez-Castelao, Beatriz; Losada, Fernando; Ahicart, Patricia; Castano, Jose G.			The N-Terminal Region of Nurr1 (a.a 1-31) Is Essential for Its Efficient Degradation by the Ubiquitin Proteasome Pathway	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTOR; MIDBRAIN DOPAMINERGIC-NEURONS; TYROSINE-HYDROXYLASE GENE; PARKINSONS-DISEASE; TRANSCRIPTION FACTOR; PROGENITOR CELLS; ALPHA-SYNUCLEIN; IN-VITRO; EXPRESSION; MUTANT	NURR1/NR4A2 is an orphan nuclear receptor that is critical for the development and maintenance of mesencephalic dopaminergic neurons and regulates transcription of genes involved in the function of dopaminergic neurons directly via specific NGFI-B response elements (NBRE). and substantial data support a possible role of Nurr1 in the pathogenesis of Parkinson's disease (PD). Here we show that Nurr1 is degraded by the ubiquitin-proteasome pathway and determined that N-terminal region (a. a 1-31) of Nurr1 is essential for an efficient targeting of Nurr1 to degradation in the cell. Nurr1 Delta 1-31 has a much longer half-life, and as a consequence its steady-state protein levels were higher, than full-length Nurr1 in the cell. Nurr1 Delta 1-31 was as potent as Nurr1 full length in transcriptional luciferase reporter assays after normalization with the corresponding steady-state protein expression levels, either in trans-activation of NBRE or trans-repression of iNOS (inducible NO synthase) reporters. These results suggest that Nurr1 Delta 1-31, because of longer persistence in the cell, can be a good candidate for gene and cell therapies in the treatment of PD.	[Alvarez-Castelao, Beatriz; Losada, Fernando; Ahicart, Patricia; Castano, Jose G.] Univ Autonoma Madrid, Fac Med,Inst Invest Biomed Alberto Sols, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Consejo Super Invest Cient,Dept Bioquim, Madrid, Spain	Autonomous University of Madrid; CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Castano, JG (corresponding author), Univ Autonoma Madrid, Fac Med,Inst Invest Biomed Alberto Sols, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Consejo Super Invest Cient,Dept Bioquim, Madrid, Spain.	joseg.castano@uam.es	Alvarez-castelao, Beatriz/ABG-8826-2021; alvarez-castelao, beatriz/W-1707-2018	alvarez-castelao, beatriz/0000-0001-7505-1855; G. Castano, Jose/0000-0002-6579-8442	MINECO [SAF-2011-22643]; Fundacion Mutua Madrilena; Comunidad de Madrid [P2010_BMD-2331]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas	MINECO(Spanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas	This work was supported by grants from MINECO SAF-2011-22643, Fundacion Mutua Madrilena, Comunidad de Madrid P2010_BMD-2331 & Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas to JGC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castro DS, 1999, J BIOL CHEM, V274, P37483, DOI 10.1074/jbc.274.52.37483; Chu YP, 2006, J COMP NEUROL, V494, P495, DOI 10.1002/cne.20828; Decressac M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004676; Eells JB, 2002, BEHAV BRAIN RES, V136, P267, DOI 10.1016/S0166-4328(02)00185-7; Grimes DA, 2006, MOVEMENT DISORD, V21, P906, DOI 10.1002/mds.20820; Jacobsen KX, 2008, NEUROBIOL DIS, V29, P117, DOI 10.1016/j.nbd.2007.08.003; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; Jo AY, 2009, STEM CELLS, V27, P2238, DOI 10.1002/stem.146; Jorgensen JR, 2006, EXP NEUROL, V198, P427, DOI 10.1016/j.expneurol.2005.12.023; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Kessler MA, 2003, MOL BRAIN RES, V112, P8, DOI 10.1016/S0169-328X(02)00694-0; Kim KS, 2003, J NEUROCHEM, V85, P622, DOI 10.1046/j.1471-4159.2003.01671.x; Kim SJ, 2006, NEUROREPORT, V17, P1729, DOI 10.1097/01.wnr.0000239951.14954.10; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Le WD, 2008, J NEUROL SCI, V273, P29, DOI 10.1016/j.jns.2008.06.007; Lin X, 2012, J NEUROSCI, V32, P9248, DOI 10.1523/JNEUROSCI.1731-12.2012; MAGES HW, 1994, MOL ENDOCRINOL, V8, P1583, DOI 10.1210/me.8.11.1583; Martin-Clemente B, 2004, J BIOL CHEM, V279, P52984, DOI 10.1074/jbc.M409028200; Martinez-Gonzalez J, 2005, CARDIOVASC RES, V65, P609, DOI 10.1016/j.cardiores.2004.10.002; Nordzell M, 2004, BIOCHEM BIOPH RES CO, V313, P205, DOI 10.1016/j.bbrc.2003.11.079; Park CH, 2012, DEVELOPMENT, V139, P2447, DOI 10.1242/dev.075978; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sacchetti P, 2006, NUCLEIC ACIDS RES, V34, P5515, DOI 10.1093/nar/gkl712; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Sakurada K, 1999, DEVELOPMENT, V126, P4017; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; SaucedoCardenas O, 1996, J MOL NEUROSCI, V7, P51, DOI 10.1007/BF02736848; Sleiman PMA, 2009, NEUROSCI LETT, V457, P75, DOI 10.1016/j.neulet.2009.03.021; Smits SM, 2003, EUR J NEUROSCI, V18, P1731, DOI 10.1046/j.1460-9568.2003.02885.x; Vila-Del Sol V, 2007, J LEUKOCYTE BIOL, V81, P272, DOI 10.1189/jlb.0905529; Wallen A, 1999, EXP CELL RES, V253, P737, DOI 10.1006/excr.1999.4691; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Witta J, 2000, MOL BRAIN RES, V84, P67, DOI 10.1016/S0169-328X(00)00211-4; Xu PY, 2002, NEUROLOGY, V58, P881, DOI 10.1212/WNL.58.6.881; Zetterstrom RH, 1996, MOL BRAIN RES, V41, P111, DOI 10.1016/0169-328X(96)00074-5; Zhang T, 2007, NEUROSCI LETT, V423, P118, DOI 10.1016/j.neulet.2007.06.041	38	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55999	10.1371/journal.pone.0055999	http://dx.doi.org/10.1371/journal.pone.0055999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409108	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200101
J	Dumitru, CA; Bankfalvi, A; Gu, X; Zeidler, R; Brandau, S; Lang, S				Dumitru, Claudia A.; Bankfalvi, Agnes; Gu, Xiang; Zeidler, Reinhard; Brandau, Sven; Lang, Stephan			AHNAK and Inflammatory Markers Predict Poor Survival in Laryngeal Carcinoma	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; NECK-CANCER; DESMOYOKIN/AHNAK PROTEIN; CELL; NEUTROPHILS; IDENTIFICATION; HEAD; BIOLOGY; TARGET; LINK	AHNAK/Desmoyokin is a giant protein which has been recently linked to reorganization of the actin cytoskeleton, cellular migration and invasion. Here, we investigated the role of AHNAK in the pathophysiology of larynx carcinoma-one of the major subtypes of head and neck cancer. To this end, we analysed AHNAK expression in tumor tissues from 83 larynx carcinoma patients in relation to overall survival. We found that tumoral AHNAK overexpression significantly associated with poor survival of these patients both in univariate and multivariate analysis. In further studies, we combined the prognostic value of AHNAK with selected markers of inflammation, such as macrophage migration inhibitory factor (MIF) and tumor-infiltrating neutrophils (CD66b-positive cells). Both MIF and neutrophils have been linked to enhanced tumoral migration and poor clinical outcome in patients with orohypopharynx carcinoma-another major subtype of head and neck cancer. Interestingly, we found that synchronous high levels of AHNAK and MIF or AHNAK and neutrophils, respectively, were stronger predictors of poor survival than AHNAK alone. Synchronous high levels of all three markers were the strongest predictors of poor survival in our patient cohort. Taken together, our findings propose novel strategies for an accurate prognosis in larynx carcinoma and suggest potential mechanisms of inflammation-mediated tumor progression.	[Dumitru, Claudia A.; Gu, Xiang; Brandau, Sven; Lang, Stephan] Univ Duisburg Essen, Dept Otorhinolaryngol, Essen, Germany; [Bankfalvi, Agnes] Univ Duisburg Essen, Dept Pathol Neuropathol, Essen, Germany; [Zeidler, Reinhard] Univ Munich, Dept Otorhinolaryngol, Munich, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Munich	Dumitru, CA (corresponding author), Univ Duisburg Essen, Dept Otorhinolaryngol, Essen, Germany.	claudia.dumitru@uni-due.de	Zeidler, Reinhard/M-9837-2014	Zeidler, Reinhard/0000-0002-3357-4954; Brandau, Sven/0000-0002-2702-4163	Bundesministerium fA1/4Jr Bildung und Forschung (BMBF)	Bundesministerium fA1/4Jr Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was in part supported by the Bundesministerium fA1/4Jr Bildung und Forschung (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bekes EM, 2011, AM J PATHOL, V179, P1455, DOI 10.1016/j.ajpath.2011.05.031; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Borgonovo B, 2002, NAT CELL BIOL, V4, P955, DOI 10.1038/ncb888; Brandau S, 2013, SEMIN IMMUNOPATHOL, V35, P163, DOI 10.1007/s00281-012-0344-6; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Choong N, 2008, CA-CANCER J CLIN, V58, P32, DOI 10.3322/CA.2007.0004; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dumitru CA, 2012, CANCER IMMUNOL IMMUN, V61, P1155, DOI 10.1007/s00262-012-1294-5; Dumitru CA, 2012, J LEUKOCYTE BIOL, V91, P591, DOI 10.1189/jlb.0411193; Dumitru CA, 2011, INT J CANCER, V129, P859, DOI 10.1002/ijc.25991; Gentil BJ, 2001, J BIOL CHEM, V276, P23253, DOI 10.1074/jbc.M010655200; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Grieb G, 2010, DRUG NEWS PERSPECT, V23, P257, DOI 10.1358/dnp.2010.23.4.1453629; Haase H, 1999, FASEB J, V13, P2161, DOI 10.1096/fasebj.13.15.2161; HASHIMOTO T, 1995, EXP CELL RES, V217, P258, DOI 10.1006/excr.1995.1085; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Leong S, 2012, J PROTEOME RES, V11, P3561, DOI 10.1021/pr2012335; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; MASUNAGA T, 1995, J INVEST DERMATOL, V104, P941, DOI 10.1111/1523-1747.ep12606213; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Rauch J, 2004, BIOCHEM BIOPH RES CO, V323, P156, DOI 10.1016/j.bbrc.2004.08.071; Shankar J, 2010, CANCER RES, V70, P3780, DOI 10.1158/0008-5472.CAN-09-4439; SHTIVELMAN E, 1993, J CELL BIOL, V120, P625, DOI 10.1083/jcb.120.3.625; SHTIVELMAN E, 1992, P NATL ACAD SCI USA, V89, P5472, DOI 10.1073/pnas.89.12.5472; Sussman J, 2001, J CELL BIOL, V154, P1019, DOI 10.1083/jcb.200105121; Tanaka M, 2008, CANCER SCI, V99, P979, DOI 10.1111/j.1349-7006.2008.00757.x; Trellakis S, 2011, INT J CANCER, V129, P2183, DOI 10.1002/ijc.25892	29	43	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56420	10.1371/journal.pone.0056420	http://dx.doi.org/10.1371/journal.pone.0056420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409183	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200135
J	Turner, JW; Paranjpye, RN; Landis, ED; Biryukov, SV; Gonzalez-Escalona, N; Nilsson, WB; Strom, MS				Turner, Jeffrey W.; Paranjpye, Rohinee N.; Landis, Eric D.; Biryukov, Stanley V.; Gonzalez-Escalona, Narjol; Nilsson, William B.; Strom, Mark S.			Population Structure of Clinical and Environmental Vibrio parahaemolyticus from the Pacific Northwest Coast of the United States	PLOS ONE			English	Article							SEROVARS O3-K6; SEQUENCE; STRAINS; DIVERSITY; HEMOLYSIN; OYSTERS; SPREAD; PCR; GASTROENTERITIS; DISSEMINATION	Vibrio parahaemolyticus is a common marine bacterium and a leading cause of seafood-borne bacterial gastroenteritis worldwide. Although this bacterium has been the subject of much research, the population structure of cold-water populations remains largely undescribed. We present a broad phylogenetic analysis of clinical and environmental V. parahaemolyticus originating largely from the Pacific Northwest coast of the United States. Repetitive extragenic palindromic PCR (REP-PCR) separated 167 isolates into 39 groups and subsequent multilocus sequence typing (MLST) separated a subset of 77 isolates into 24 sequence types. The Pacific Northwest population exhibited a semi-clonal structure attributed to an environmental clade (ST3, N = 17 isolates) clonally related to the pandemic O3:K6 complex and a clinical clade (ST36, N = 20 isolates) genetically related to a regionally endemic O4:K12 complex. Further, the identification of at least five additional clinical sequence types (i.e., ST43, 50, 65, 135 and 417) demonstrates that V. parahaemolyticus gastroenteritis in the Pacific Northwest is polyphyletic in nature. Recombination was evident as a significant source of genetic diversity and in particular, the recA and dtdS alleles showed strong support for frequent recombination. Although pandemic-related illnesses were not documented during the study, the environmental occurrence of the pandemic clone may present a significant threat to human health and warrants continued monitoring. It is evident that V. parahaemolyticus population structure in the Pacific Northwest is semi-clonal and it would appear that multiple sequence types are contributing to the burden of disease in this region.	[Turner, Jeffrey W.; Paranjpye, Rohinee N.; Biryukov, Stanley V.; Nilsson, William B.; Strom, Mark S.] NOAA, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA; [Turner, Jeffrey W.] Univ Washington, Sch Oceanog, Ctr Environm Genom, Seattle, WA 98195 USA; [Landis, Eric D.] US FDA, Ctr Vet Med, Rockville, MD 20857 USA; [Gonzalez-Escalona, Narjol] US FDA, Ctr Food Safety & Appl Nutr, College Pk, MD USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Turner, JW (corresponding author), NOAA, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA 98115 USA.	jeff.turner@noaa.gov	Gonzalez-Escalona, Narjol/A-7598-2009; Gonzalez-Escalona, Narjol/H-6161-2019	Gonzalez-Escalona, Narjol/0000-0003-4568-0022	National Oceanic and Atmospheric Administration's (NOAA) Oceans and Human Health Initiative (OHHI); NOAA's National Marine Fisheries Service (NMFS); National Research Council's Research Associateship Program (NRC-RAP)	National Oceanic and Atmospheric Administration's (NOAA) Oceans and Human Health Initiative (OHHI); NOAA's National Marine Fisheries Service (NMFS); National Research Council's Research Associateship Program (NRC-RAP)	Funding sources for this study include National Oceanic and Atmospheric Administration's (NOAA) Oceans and Human Health Initiative (OHHI) (http://oceansandhumanhealth.noaa.gov), NOAA's National Marine Fisheries Service (NMFS) (http://www.nmfs.noaa.gov) and the National Research Council's Research Associateship Program (NRC-RAP) (http://sites.nationalacademies.org/pga/rap/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT SL, 1989, J CLIN MICROBIOL, V27, P2891, DOI 10.1128/JCM.27.12.2891-2893.1989; Ansaruzzaman M, 2008, J MED MICROBIOL, V57, P1502, DOI 10.1099/jmm.0.2008/004275-0; Ansaruzzaman M, 2005, J CLIN MICROBIOL, V43, P2559, DOI 10.1128/JCM.43.6.2559-2562.2005; Bag PK, 1999, J CLIN MICROBIOL, V37, P2354, DOI 10.1128/JCM.37.7.2354-2357.1999; Balter S., 2006, Morbidity and Mortality Weekly Report, V55, P854; Bej AK, 1999, J MICROBIOL METH, V36, P215, DOI 10.1016/S0167-7012(99)00037-8; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chowdhury NR, 2000, EPIDEMIOL INFECT, V125, P17, DOI 10.1017/S0950268899004070; Chowdhury NR, 2004, J CLIN MICROBIOL, V42, P1280, DOI 10.1128/JCM.42.3.1280-1282.2004; Chowdhury NR, 2000, EMERG INFECT DIS, V6, P631, DOI 10.3201/eid0606.000612; Cook DW, 2003, J FOOD PROTECT, V66, P2276, DOI 10.4315/0362-028X-66.12.2276; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; DePaola A, 2003, APPL ENVIRON MICROB, V69, P3999, DOI 10.1128/AEM.69.7.3999-4005.2003; DePaola A, 2000, APPL ENVIRON MICROB, V66, P4649, DOI 10.1128/AEM.66.11.4649-4654.2000; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellis CN, 2012, APPL ENVIRON MICROB, V78, P3778, DOI 10.1128/AEM.07794-11; Feil EJ, 2000, RES MICROBIOL, V151, P465, DOI 10.1016/S0923-2508(00)00168-6; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gonzalez-Escalona N, 2008, J BACTERIOL, V190, P2831, DOI 10.1128/JB.01808-07; Harth E, 2009, EMERG INFECT DIS, V15, P163, DOI 10.3201/eid1502.071269; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hazen TH, 2009, ENVIRON MICROBIOL, V11, P1254, DOI 10.1111/j.1462-2920.2008.01853.x; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Iwamoto M, 2010, CLIN MICROBIOL REV, V23, P399, DOI 10.1128/CMR.00059-09; Johnson CN, 2009, MICROB ECOL, V57, P437, DOI 10.1007/s00248-008-9418-3; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; JOSEPH SW, 1982, CRC CR REV MICROBIOL, V10, P77, DOI 10.3109/10408418209113506; JUKES T H, 1969, P21; KANEKO T, 1978, MICROBIAL ECOL, V4, P135, DOI 10.1007/BF02014284; KANEKO T, 1973, J BACTERIOL, V113, P24, DOI 10.1128/JB.113.1.24-32.1973; KAYSNER CA, 1994, APPL ENVIRON MICROB, V60, P3020, DOI 10.1128/AEM.60.8.3020-3022.1994; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Matsumoto C, 2000, J CLIN MICROBIOL, V38, P578, DOI 10.1128/JCM.38.2.578-585.2000; McLaughlin JB, 2005, NEW ENGL J MED, V353, P1463, DOI 10.1056/NEJMoa051594; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; NEI M, 1986, MOL BIOL EVOL, V3, P418; Okuda N, 1997, J CLIN MICROBIOL, V35, P3150, DOI 10.1128/JCM.35.12.3150-3155.1997; Paranjpye R, 2012, APPL ENVIRON MICROB, V78, P8631, DOI 10.1128/AEM.01531-12; Parvathi A, 2006, ENVIRON MICROBIOL, V8, P997, DOI 10.1111/j.1462-2920.2006.00990.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quilici ML, 2005, EMERG INFECT DIS, V11, P1148; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; SHIRAI H, 1990, INFECT IMMUN, V58, P3568, DOI 10.1128/IAI.58.11.3568-3573.1990; Sloan E, 2003, J RAPID METH AUT MIC, V11, P297, DOI 10.1111/j.1745-4581.2003.tb00269.x; Su YC, 2007, FOOD MICROBIOL, V24, P549, DOI 10.1016/j.fm.2007.01.005; Velazquez-Roman J, 2012, APPL ENVIRON MICROB, V78, P1794, DOI 10.1128/AEM.06953-11; Wilkes JG, 2005, ANTON LEEUW INT J G, V88, P151, DOI 10.1007/s10482-005-3990-z; Wong HC, 2001, J CLIN MICROBIOL, V39, P4233, DOI 10.1128/JCM.39.12.4233-4240.2001; Yan YF, 2011, INT J FOOD MICROBIOL, V145, P106, DOI 10.1016/j.ijfoodmicro.2010.11.038; Yeung PSM, 2002, APPL ENVIRON MICROB, V68, P2901, DOI 10.1128/AEM.68.6.2901-2909.2002; Yu Y, 2011, FOODBORNE PATHOG DIS, V8, P1169, DOI 10.1089/fpd.2011.0865	56	82	86	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55726	10.1371/journal.pone.0055726	http://dx.doi.org/10.1371/journal.pone.0055726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409028	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200053
J	Zhou, CX; Steplowski, TA; Dickens, HK; Malloy, KM; Gehrig, PA; Boggess, JF; Bae-Jump, VL				Zhou, Chunxiao; Steplowski, Tara A.; Dickens, Hallum K.; Malloy, Kimberly M.; Gehrig, Paola A.; Boggess, John F.; Bae-Jump, Victoria L.			Estrogen Induction of Telomerase Activity through Regulation of the Mitogen-Activated Protein Kinase (MAPK) Dependent Pathway in Human Endometrial Cancer Cells	PLOS ONE			English	Article; Proceedings Paper	43rd Annual Meeting of the Society-of-Gynecologic-Oncology	MAR 24-27, 2012	Austin, TX	Soc Gynecol Oncol			REVERSE-TRANSCRIPTASE GENE; CATALYTIC SUBUNIT HTERT; RECEPTOR-ALPHA; EXPRESSION; PROMOTER; PHOSPHORYLATION; PROLIFERATION; IDENTIFICATION; STIMULATION; SENESCENCE	Given that prolonged exposure to estrogen and increased telomerase activity are associated with endometrial carcinogenesis, our objective was to evaluate the interaction between the MAPK pathway and estrogen induction of telomerase activity in endometrial cancer cells. Estradiol (E2) induced telomerase activity and hTERT mRNA expression in the estrogen receptor (ER)-alpha positive, Ishikawa endometrial cancer cell line. UO126, a highly selective inhibitor of MEK1/MEK2, inhibited telomerase activity and hTERT mRNA expression induced by E2. Similar results were also found after transfection with ERK 1/2-specific siRNA. Treatment with E2 resulted in rapid phosphorylation of p44/42 MAPK and increased MAPK activity which was abolished by UO126. The hTERT promoter contains two estrogen response elements (EREs), and luciferase assays demonstrate that these EREs are activated by E2. Exposure to UO126 or ERK 1/2-specific siRNA in combination with E2 counteracted the stimulatory effect of E2 on luciferase activity from these EREs. These findings suggest that E2-induction of telomerase activity is mediated via the MAPK pathway in human endometrial cancer cells.	[Zhou, Chunxiao; Dickens, Hallum K.; Malloy, Kimberly M.; Gehrig, Paola A.; Boggess, John F.; Bae-Jump, Victoria L.] Univ N Carolina, Dept Obstet & Gynecol, Div Gynecol Oncol, Chapel Hill, NC 27515 USA; [Steplowski, Tara A.] Univ N Carolina, Dept Otolaryngol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Bae-Jump, VL (corresponding author), Univ N Carolina, Dept Obstet & Gynecol, Div Gynecol Oncol, Chapel Hill, NC 27515 USA.	vbae@unch.unc.edu			NATIONAL CANCER INSTITUTE [K23CA143154] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025746] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Baykal A, 2004, ADV ANAT PATHOL, V11, P262, DOI 10.1097/01.pap.0000138145.19258.64; Bieche I, 2000, CLIN CANCER RES, V6, P452; Boggess JF, 2006, GYNECOL ONCOL, V103, P417, DOI 10.1016/j.ygyno.2006.03.032; Braunstein I, 2001, CANCER RES, V61, P5529; Cheskis BJ, 2007, J CELL PHYSIOL, V213, P610, DOI 10.1002/jcp.21253; Cong YS, 1999, HUM MOL GENET, V8, P137, DOI 10.1093/hmg/8.1.137; Cruzalegui FH, 1999, ONCOGENE, V18, P7948, DOI 10.1038/sj.onc.1203362; Deng YB, 2007, LAB INVEST, V87, P1071, DOI 10.1038/labinvest.3700673; Ebina Y, 1999, INT J CANCER, V84, P529, DOI 10.1002/(SICI)1097-0215(19991022)84:5<529::AID-IJC15>3.0.CO;2-J; Gao H, 2011, MOL CELL ENDOCRINOL, V334, P83, DOI 10.1016/j.mce.2010.09.002; Ge Z, 2006, MOL CELL BIOL, V26, P230, DOI 10.1128/MCB.26.1.230-237.2006; Horikawa I, 1999, CANCER RES, V59, P826; Kato  S, 2001, Breast Cancer, V8, P3, DOI 10.1007/BF02967472; Kimura A, 2004, ONCOGENE, V23, P4505, DOI 10.1038/sj.onc.1207582; Kondoh K, 2007, EXP CELL RES, V313, P3486, DOI 10.1016/j.yexcr.2007.06.028; Kurarmoto Hiroyuki, 2002, Hum Cell, V15, P81, DOI 10.1111/j.1749-0774.2002.tb00103.x; Kyo S, 1999, INT J CANCER, V80, P60, DOI 10.1002/(SICI)1097-0215(19990105)80:1<60::AID-IJC12>3.3.CO;2-5; Kyo S, 1999, CANCER RES, V59, P5917; Lee H, 2000, MOL ENDOCRINOL, V14, P1882, DOI 10.1210/me.14.11.1882; Lehner R, 2002, GYNECOL ONCOL, V84, P120, DOI 10.1006/gyno.2001.6474; Lessey BA, 2003, CELL AND MOLECULAR BIOLOGY OF ENDOMETRIAL CARCINOMA, P267; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; Madak-Erdogan Z, 2011, MOL CELL BIOL, V31, P226, DOI 10.1128/MCB.00821-10; Marino M, 2001, J CELL PHYSIOL, V188, P170, DOI 10.1002/jcp.1105; Menon Malini M, 2003, Indian J Pathol Microbiol, V46, P394; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; Misiti S, 2000, MOL CELL BIOL, V20, P3764, DOI 10.1128/MCB.20.11.3764-3771.2000; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakayama JI, 1997, CELL, V88, P875, DOI 10.1016/S0092-8674(00)81933-9; Nishida M, 1985, Nihon Sanka Fujinka Gakkai Zasshi, V37, P1103; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Takakura M, 1999, CANCER RES, V59, P551; Tanaka M, 1998, AM J PATHOL, V153, P1985, DOI 10.1016/S0002-9440(10)65712-4; Tzukerman M, 2000, MOL BIOL CELL, V11, P4381, DOI 10.1091/mbc.11.12.4381; Wang Z, 2000, CANCER RES, V60, P5376; Williams CD, 2001, J CLIN ENDOCR METAB, V86, P3912, DOI 10.1210/jc.86.8.3912; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0	38	28	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55730	10.1371/journal.pone.0055730	http://dx.doi.org/10.1371/journal.pone.0055730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Science & Technology - Other Topics	092XV	23409030	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200055
J	Abraham, MC; Metheetrairut, C; Irish, VF				Abraham, Mary C.; Metheetrairut, Chanatip; Irish, Vivian F.			Natural Variation Identifies Multiple Loci Controlling Petal Shape and Size in Arabidopsis thaliana	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BHLH TRANSCRIPTION FACTOR; RECOMBINANT INBRED LINES; ZINC-FINGER PROTEIN; PLANT ORGAN SIZE; CELL-PROLIFERATION; FLOWER DEVELOPMENT; FLORAL DEVELOPMENT; DEVELOPING LEAVES; LEAF DEVELOPMENT	Natural variation in organ morphologies can have adaptive significance and contribute to speciation. However, the underlying allelic differences responsible for variation in organ size and shape remain poorly understood. We have utilized natural phenotypic variation in three Arabidopsis thaliana ecotypes to examine the genetic basis for quantitative variation in petal length, width, area, and shape. We identified 23 loci responsible for such variation, many of which appear to correspond to genes not previously implicated in controlling organ morphology. These analyses also demonstrated that allelic differences at distinct loci can independently affect petal length, width, area or shape, suggesting that these traits behave as independent modules. We also showed that ERECTA (ER), encoding a leucine-rich repeat (LRR) receptor-like serine-threonine kinase, is a major effect locus determining petal shape. Allelic variation at the ER locus was associated with differences in petal cell proliferation and concomitant effects on petal shape. ER has been previously shown to be required for regulating cell division and expansion in other contexts; the ER receptor-like kinase functioning to also control organ-specific proliferation patterns suggests that allelic variation in common signaling components may nonetheless have been a key factor in morphological diversification.	[Abraham, Mary C.; Metheetrairut, Chanatip; Irish, Vivian F.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Irish, Vivian F.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	Yale University; Yale University	Irish, VF (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	Vivian.irish@yale.edu		Metheetrairut, Chanatip/0000-0002-4394-5085	NSF [IOS-0817744]; Yale University	NSF(National Science Foundation (NSF)); Yale University	Funding support from NSF (http://www.nsf.gov/) grant # IOS-0817744 (to V.F.I.) and from a Yale University (http://www.yale.edu/) Brown Fellowship (to M.C.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Anastasiou E, 2007, DEV CELL, V13, P843, DOI 10.1016/j.devcel.2007.10.001; Balasubramanian S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004318; Borevitz JO, 2002, GENETICS, V160, P683; Breuninger H, 2010, CURR TOP DEV BIOL, V91, P185, DOI 10.1016/S0070-2153(10)91007-7; Brewer MT, 2006, PLANT PHYSIOL, V141, P15, DOI 10.1104/pp.106.077867; Brioudes F, 2009, PLANT J, V60, P1070, DOI 10.1111/j.1365-313X.2009.04023.x; Brock MT, 2007, EVOLUTION, V61, P2913, DOI 10.1111/j.1558-5646.2007.00240.x; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Carles CC, 2005, DEVELOPMENT, V132, P897, DOI 10.1242/dev.01642; CHURCHILL GA, 1994, GENETICS, V138, P963; Coen E, 2004, P NATL ACAD SCI USA, V101, P4728, DOI 10.1073/pnas.0306308101; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Dinneny JR, 2004, DEVELOPMENT, V131, P1101, DOI 10.1242/dev.00949; Disch S, 2006, CURR BIOL, V16, P272, DOI 10.1016/j.cub.2005.12.026; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Eriksson S, 2010, CURR BIOL, V20, P527, DOI 10.1016/j.cub.2010.01.039; Fletcher JC, 2001, DEVELOPMENT, V128, P1323; Fowlkes CC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002346; Frary A, 2004, THEOR APPL GENET, V109, P523, DOI 10.1007/s00122-004-1669-x; Fu J, 2009, NAT GENET, V41, P166, DOI 10.1038/ng.308; Green AA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000537; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hamant O, 2010, CURR OPIN GENET DEV, V20, P454, DOI 10.1016/j.gde.2010.04.009; HILL JP, 1989, CAN J BOT, V67, P2922, DOI 10.1139/b89-375; Ingram GC, 2006, CURR OPIN PLANT BIOL, V9, P12, DOI 10.1016/j.pbi.2005.11.007; Ingram GC, 2005, CURR BIOL, V15, pR663, DOI 10.1016/j.cub.2005.08.026; Irish VF, 2008, TRENDS PLANT SCI, V13, P430, DOI 10.1016/j.tplants.2008.05.006; JANSEN RC, 1993, GENETICS, V135, P205; Jenik PD, 2000, DEVELOPMENT, V127, P1267; Juenger T, 2000, GENETICS, V156, P1379; Juenger T, 2005, EVOL DEV, V7, P259, DOI 10.1111/j.1525-142X.2005.05028.x; Kawade K, 2010, DEVELOPMENT, V137, P4221, DOI 10.1242/dev.057117; Kazama T, 2010, PLANT CELL PHYSIOL, V51, P1046, DOI 10.1093/pcp/pcq051; Keurentjes JJB, 2007, P NATL ACAD SCI USA, V104, P1708, DOI 10.1073/pnas.0610429104; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Koumproglou R, 2002, PLANT J, V31, P355, DOI 10.1046/j.1365-313X.2002.01353.x; Krizek BA, 1999, DEV GENET, V25, P224, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;224::AID-DVG5&gt;3.0.CO;2-Y; Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304; Li YH, 2008, GENE DEV, V22, P1331, DOI 10.1101/gad.463608; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Massonnet C, 2010, PLANT PHYSIOL, V152, P2142, DOI 10.1104/pp.109.148338; Millenaar FF, 2005, PLANT PHYSIOL, V137, P998, DOI 10.1104/pp.104.053967; Mizukami Y, 2000, P NATL ACAD SCI USA, V97, P942, DOI 10.1073/pnas.97.2.942; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Ohno CK, 2004, DEVELOPMENT, V131, P1111, DOI 10.1242/dev.00991; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pyke KA, 1998, PLANT PHYSIOL, V116, P797, DOI 10.1104/pp.116.2.797; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; REDEI GP, 1962, GENETICS, V47, P443; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Sicard A, 2011, PLANT CELL, V23, P3156, DOI 10.1105/tpc.111.088237; Singer T, 2006, PLOS GENET, V2, P1352, DOI 10.1371/journal.pgen.0020144; Sloan J, 2009, PLANT PHYSIOL, V151, P1844, DOI 10.1104/pp.109.144683; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Strange A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019949; Szecsi J, 2006, EMBO J, V25, P3912, DOI 10.1038/sj.emboj.7601270; Takeda S, 2004, DEVELOPMENT, V131, P425, DOI 10.1242/dev.00938; Terpstra IR, 2010, PLANT PHYSIOL, V154, P1067, DOI 10.1104/pp.110.159996; Tisne S, 2008, PLANT PHYSIOL, V148, P1117, DOI 10.1104/pp.108.124271; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Tsukaya H, 2002, PLANT CELL PHYSIOL, V43, P372, DOI 10.1093/pcp/pcf051; Van Ooijen JW, 1999, HEREDITY, V83, P613, DOI 10.1038/sj.hdy.6886230; van Zanten M, 2010, PLANT J, V61, P83, DOI 10.1111/j.1365-313X.2009.04035.x; van Zanten M, 2009, TRENDS PLANT SCI, V14, P214, DOI 10.1016/j.tplants.2009.01.010; Varaud E, 2011, PLANT CELL, V23, P973, DOI 10.1105/tpc.110.081653; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Whitney HM, 2009, CURR BIOL, V19, P948, DOI 10.1016/j.cub.2009.04.051; Wricke G., 1986, QUANTITATIVE GENETIC; ZENG ZB, 1994, GENETICS, V136, P1457	72	19	22	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56743	10.1371/journal.pone.0056743	http://dx.doi.org/10.1371/journal.pone.0056743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418598	gold, Green Submitted, Green Published			2022-12-27	WOS:000315970300191
J	Gagliano, M; Depczynski, M				Gagliano, Monica; Depczynski, Martial			Spot the Difference: Mimicry in a Coral Reef Fish	PLOS ONE			English	Article							EYESPOT PLASTICITY; SEXUAL SELECTION; MATURATION; HISTORIES; MALES; EYE	Eyespots on the body of many animals have long been assumed to confer protection against predators, but empirical evidence has recently demonstrated that this may not always be the case and suggested that such markings may also serve other purposes. Clearly, this raises the unresolved question of what functions do these markings have and do they contribute to an individual's evolutionary fitness in the wild. Here, we examined the occurrence of eyespots on the dorsal fin of a coral reef damselfish (Pomacentrus amboinensis), where these markings are typical of the juvenile stage and fade away as the fish approaches sexual maturation to then disappear completely in the vast majority of, but not all, adult individuals. By exploring differences in body shape among age and gender groups, we found that individuals retaining the eyespot into adulthood are all sexually mature males, suggesting that these eyespots may be an adult deceptive signal. Interestingly, the body shape of these individuals resembled more closely that of immature females than mature dominant males. These results suggest that eyespots have multiple roles and their functional significance changes within the lifetime of an animal from being a juvenile advertisement to a deceptive adult signal. Male removal experiments or colour manipulations may be necessary to establish specific functions.	[Gagliano, Monica] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA, Australia; [Gagliano, Monica] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Crawley, WA, Australia; [Depczynski, Martial] Univ Western Australia, Australian Inst Marine Sci, Oceans Inst, Crawley, WA, Australia	University of Western Australia; University of Western Australia; Australian Institute of Marine Science; University of Western Australia	Gagliano, M (corresponding author), Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA, Australia.	monica.gagliano@uwa.edu.au	Gagliano, Monica/A-3129-2012; depczynski, martial/B-7689-2008	Gagliano, Monica/0000-0002-2414-6990; depczynski, martial/0000-0001-8723-0076	Research Fellowships from the University of Western Australia; Australian Research Council	Research Fellowships from the University of Western Australia; Australian Research Council(Australian Research Council)	MG was supported by Research Fellowships from the University of Western Australia and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo SH, 2000, AM NAT, V156, P266, DOI 10.1086/303391; Alonzo SH, 2000, BEHAV ECOL, V11, P56, DOI 10.1093/beheco/11.1.56; Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Breuker CJ, 2002, P ROY SOC B-BIOL SCI, V269, P1233, DOI 10.1098/rspb.2002.2005; Carter AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042440; Endler J.A., 1986, Monographs in Population Biology, pviii; Gagliano M, 2008, BEHAV ECOL, V19, P733, DOI 10.1093/beheco/arn013; Gagliano M, 2007, OIKOS, V116, P111, DOI 10.1111/j.2006.0030-1299.15418.x; GROSS MR, 1980, P NATL ACAD SCI-BIOL, V77, P6937, DOI 10.1073/pnas.77.11.6937; JONES GP, 1987, ECOLOGY, V68, P1534, DOI 10.2307/1939237; Kerrigan BA, 1995, THESIS J COOK U AUST; Klingenberg CP, 2003, BIOL J LINN SOC, V80, P397, DOI 10.1046/j.1095-8312.2003.00246.x; LYON BE, 1986, EVOLUTION, V40, P605, DOI 10.1111/j.1558-5646.1986.tb00511.x; Lyytinen A, 2004, P ROY SOC B-BIOL SCI, V271, P279, DOI 10.1098/rspb.2003.2571; Mank JE, 2006, EVOLUTION, V60, P1311; McCormick MI, 2007, ECOLOGY, V88, P1562, DOI 10.1890/06-0830; Monteiro A, 1997, EVOLUTION, V51, P1207, DOI 10.1111/j.1558-5646.1997.tb03968.x; Munday PL, 2006, P ROY SOC B-BIOL SCI, V273, P2845, DOI 10.1098/rspb.2006.3666; NEUDECKER S, 1989, ENVIRON BIOL FISH, V25, P142; Oliver JC, 2009, P ROY SOC B-BIOL SCI, V276, P2369, DOI 10.1098/rspb.2009.0182; Olofsson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010798; Robertson KA, 2005, P ROY SOC B-BIOL SCI, V272, P1541, DOI 10.1098/rspb.2005.3142; ROHWER S, 1980, AM NAT, V115, P400, DOI 10.1086/283569; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Siebeck U. E., 2002, THESIS U QUEENSLAND; Stevens M, 2005, BIOL REV, V80, P573, DOI 10.1017/S1464793105006810; Stevens M, 2008, BEHAV ECOL, V19, P525, DOI 10.1093/beheco/arm162; Stevens M, 2007, ANIM BEHAV, V74, P1215, DOI 10.1016/j.anbehav.2007.01.031; TABORSKY M, 1994, ADV STUD BEHAV, V23, P1, DOI 10.1016/S0065-3454(08)60351-4; Vallin A, 2005, P ROY SOC B-BIOL SCI, V272, P1203, DOI 10.1098/rspb.2004.3034; Vallin A, 2007, BEHAV ECOL SOCIOBIOL, V61, P1419, DOI 10.1007/s00265-007-0374-6; Vallin A, 2011, BEHAV ECOL SOCIOBIOL, V65, P1629, DOI 10.1007/s00265-011-1173-7; Van Buskirk J, 2004, COPEIA, P599, DOI 10.1643/CE-03-283R; Vlieger L, 2007, BIOL J LINN SOC, V92, P661, DOI 10.1111/j.1095-8312.2007.00863.x; Walker SPW, 2009, BIOL LETTERS, V5, P73, DOI 10.1098/rsbl.2008.0555; WARNER RR, 1984, EVOLUTION, V38, P148, DOI 10.1111/j.1558-5646.1984.tb00268.x; Wilson DT, 1997, MAR ECOL PROG SER, V153, P259, DOI 10.3354/meps153259	39	9	9	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55938	10.1371/journal.pone.0055938	http://dx.doi.org/10.1371/journal.pone.0055938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418480	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300072
J	Hamerton, I; Tedaldi, L; Eastaugh, N				Hamerton, Ian; Tedaldi, Lauren; Eastaugh, Nicholas			A Systematic Examination of Colour Development in Synthetic Ultramarine According to Historical Methods	PLOS ONE			English	Article							BLUE	A number of historical texts are investigated to ascertain the optimum conditions for the preparation of synthetic ultramarine, using preparative methods that would have been available to alchemists and colour chemists of the nineteenth century. The effect of varying the proportion of sulphur in the starting material on the colour of the final product is investigated. The optimum preparation involves heating a homogenised, pelletised mixture of kaolin (100 parts), sodium carbonate (100 parts), bitumen emulsion (or any 'sticky' carbon source) (12 parts) and sulphur (60 parts) at 750 degrees C for ca. 4 hours. At this stage the ingress of air should be limited. The sample is allowed to cool in the furnace to 500 degrees C, the ingress of air is permitted and additional sulphur (30 parts) is introduced before a second calcination step is undertaken at 500 degrees C for two hours. The products obtained from the optimum synthesis have CIE ranges of x = 0.2945-0.3125, y = 0.2219-0.2617, Y = 0.4257-0.4836, L* = 3.8455-4.3682, a* = 4.2763-7.6943, b* = -27.6772-(-)3.3033, L = 3.8455-4.3682, C = 5.3964-10.8693, h = 315.0636-322.2562. The values are calculated using UV/visible near infrared spectra using Lazurite [1], under D65 illumination, and the 1931 2 degrees observer.	[Hamerton, Ian; Tedaldi, Lauren] Univ Surrey, Dept Chem, Fac Engn & Phys Sci, Guildford GU2 5XH, Surrey, England; [Eastaugh, Nicholas] Art Access & Res, London, England	University of Surrey	Hamerton, I (corresponding author), Univ Surrey, Dept Chem, Fac Engn & Phys Sci, Guildford GU2 5XH, Surrey, England.	i.hamerton@surrey.ac.uk	Hamerton, Ian/AAV-8918-2021; Eastaugh, Nicholas/AAJ-6954-2021	Hamerton, Ian/0000-0003-3113-0345; 				Booth DG, 2003, DYES PIGMENTS, V58, P73, DOI 10.1016/S0143-7208(03)00037-8; BUTLER AR, 1993, CHEM BRIT, V29, P952; Buxbaum G., 1998, IND INORGANIC PIGMEN, V3rd; Chamberlin G. J., 1955, CIE INT COLOUR SYSTE; Chicken E, 1993, ULTRAMARINE CASE STU; CLARK RJH, 1975, CHEM PHYS LETT, V34, P69, DOI 10.1016/0009-2614(75)80202-8; Fabian J, 2006, J MOL STRUC-THEOCHEM, V801, P63, DOI 10.1016/j.theochem.2006.08.050; Heinz B, 2006, CHEM SOC REV, V36, P15; Hoeniger C., 1991, J AM INST CONSERV, V30, P115; HOFMANN U, 1969, Z ANORG ALLG CHEM, V367, P119, DOI 10.1002/zaac.19693670303; KLINOWSKI J, 1987, NATURE, V330, P56, DOI 10.1038/330056a0; Kuhn H, 1969, PIGMENTE GERMALDEN S; KUMINS CA, 1953, IND ENG CHEM, V45, P567, DOI 10.1021/ie50519a031; Lichtenberger GE, 1865, ULTRAMARIN FABRIKATI; McGonigle F, 1987, PIGMENT HDB, V1, P265; Moser F. H., 1973, PIGMENT HDB PROPERTI, P409; Riffault JRD, 1874, PRACTICAL TREATISE M; TARLING SE, 1988, ACTA CRYSTALLOGR B, V44, P128, DOI 10.1107/S0108768187011698; YAMAGUCH.G, 1968, B CHEM SOC JPN, V41, P2641, DOI 10.1246/bcsj.41.2641; Zerr G, 1908, TREATISE COLOUR MANU	20	2	2	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e50364	10.1371/journal.pone.0050364	http://dx.doi.org/10.1371/journal.pone.0050364			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418413	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300003
J	Saino, N; Romano, M; Rubolini, D; Caprioli, M; Ambrosini, R; Boncoraglio, G; Canova, L				Saino, Nicola; Romano, Maria; Rubolini, Diego; Caprioli, Manuela; Ambrosini, Roberto; Boncoraglio, Giuseppe; Canova, Luca			Population and Colony-Level Determinants of Tertiary Sex Ratio in the Declining Barn Swallow	PLOS ONE			English	Article							NATURAL-POPULATIONS; ORTOLAN BUNTINGS; HIRUNDO-RUSTICA; FARMLAND BIRDS; SELECTION; DISPERSAL; EVOLUTION; ABILITY; TRENDS; COSTS	Sex ratio of adults (tertiary sex ratio, TSR) is a major feature of animal populations with consequences for their behaviour, genetic structure and viability. Spatial and temporal variation in TSR occurs within species but the mechanisms behind it are poorly understood. In this long-term study of a declining population of a socially monogamous, colonial, migratory bird, the barn swallow (Hirundo rustica), we first analyzed population-level variation in TSR (= proportion of males) of yearlings at sexual maturation in relation to ecological conditions as gauged by annual survival rate of adults. TSR was male-biased both among yearlings and older individuals, but male bias of yearlings was more pronounced after years with larger decline in adult survival. Thus, male offspring were less susceptible to the adverse ecological conditions that cause increased mortality. Dispersal and settling site decisions can have major consequences on fitness via the effects of local TSR on mating and sperm competition. Breeding barn swallows are highly philopatric while natal dispersal is high and, together with mortality, is the main determinant of colony TSR. We thus also investigated the mechanisms of breeding colony choice by yearlings and found that TSR of new-settlers in a given colony and year was negatively predicted by TSR of returning, early arriving older individuals in that year, but not by overall TSR at the colony in the previous year. This suggests that in our male-biased population new-settler males respond to local TSR upon arrival to choose the sites with larger breeding opportunities. Hence, variation in ecological conditions as reflected by adult survival can shift the TSR of individuals recruiting into a local population, with potentially various demographic consequences. However, breeding site choice based on TSR tends to homogenize TSR at a population level likely by facilitating settling of dispersing males in colonies with less male-biased TSR.	[Saino, Nicola; Romano, Maria; Rubolini, Diego; Caprioli, Manuela; Boncoraglio, Giuseppe] Univ Milan, Dipartimento Biosci, Milan, Italy; [Ambrosini, Roberto] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Canova, Luca] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy	University of Milan; University of Milano-Bicocca; University of Pavia	Saino, N (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	nicola.saino@unimi.it	Ambrosini, Roberto/F-3188-2012; Canova, Luca/P-6066-2017; Rubolini, Diego/F-2851-2011	Ambrosini, Roberto/0000-0002-7148-1468; Canova, Luca/0000-0002-5011-7413; Rubolini, Diego/0000-0003-2703-5783; Saino, Nicola/0000-0002-0230-3967				Alatalo RV, 1995, LEKS; Ambrosini R, 2002, J APPL ECOL, V39, P524, DOI 10.1046/j.1365-2664.2002.00721.x; Ambrosini R, 2012, BIRD CONSERV INT, V22, P411, DOI 10.1017/S0959270912000056; Ambrosini R, 2011, BIRD STUDY, V58, P495, DOI 10.1080/00063657.2011.609883; Bani L, 2009, ETHOL ECOL EVOL, V21, P27, DOI 10.1080/08927014.2009.9522509; Bennett P. M., 2002, OX ECOL EV; Bensch S, 1999, J EVOLUTION BIOL, V12, P1104; BirdLife International, 2004, BIRDL CONSERV SER, V12; Boncoraglio G, 2008, BEHAV ECOL SOCIOBIOL, V62, P729, DOI 10.1007/s00265-007-0498-8; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; BULL J J, 1988, P96; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Dale S, 2001, OIKOS, V92, P344, DOI 10.1034/j.1600-0706.2001.920217.x; Dale S, 2011, J AVIAN BIOL, V42, P114, DOI 10.1111/j.1600-048X.2010.05147.x; Darwin C., 1871, P423; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fisher RA, 1930, GENETICAL THEORY NAT; Fuller RJ, 1995, CONSERV BIOL, V9, P1425, DOI 10.1046/j.1523-1739.1995.09061425.x; Hanski I., 1999, METAPOPULATION ECOLO; Hewison AJM, 1999, BEHAV ECOL SOCIOBIOL, V45, P339, DOI 10.1007/s002650050569; Ims Rolf A., 1997, P247, DOI 10.1016/B978-012323445-2/50015-8; Kokko H, 2006, PHILOS T R SOC B, V361, P319, DOI 10.1098/rstb.2005.1784; Kruuk LEB, 1999, NATURE, V399, P459, DOI 10.1038/20917; Liker A, 2005, EVOLUTION, V59, P890, DOI 10.1554/04-560; Moller AP, 1995, J EVOLUTION BIOL, V8, P671, DOI 10.1046/j.1420-9101.1995.8060671.x; Moller AP., 1994, SEXUAL SELECTION BAR; Nichols J., 2001, DISPERSAL; Nicolaus M, 2012, J ANIM ECOL, V81, P827, DOI 10.1111/j.1365-2656.2012.01959.x; Perrin N, 2000, AM NAT, V155, P116, DOI 10.1086/303296; Post E, 1999, AM NAT, V154, P194, DOI 10.1086/303224; PROMISLOW DEL, 1992, P ROY SOC B-BIOL SCI, V247, P203, DOI 10.1098/rspb.1992.0030; Saino N, 1999, J ANIM ECOL, V68, P999, DOI 10.1046/j.1365-2656.1999.00350.x; Saino N, 2006, BEHAV ECOL, V17, P172, DOI 10.1093/beheco/arj023; Saino N, 2004, ECOL LETT, V7, P21, DOI 10.1046/j.1461-0248.2003.00553.x; Saino N, 2013, J ORN IN PRESS; Saino N, 2008, EVOL ECOL, V22, P659, DOI 10.1007/s10682-007-9189-1; Saino N, 2012, J ANIM ECOL, V81, P1004, DOI 10.1111/j.1365-2656.2012.01989.x; Saino N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019593; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; Steifetten O, 2006, BIOL CONSERV, V132, P88, DOI 10.1016/j.biocon.2006.03.016; Tiainen J., 2000, LINNUT VUOSIKIRJA, V1999, P98; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Tschirren B, 2003, J ANIM ECOL, V72, P839, DOI 10.1046/j.1365-2656.2003.00755.x; Tucker GM, 1994, BIRDS EUROPE THEIR C, V3; Turner A., 2006, BARN SWALLOW; West SA, 2002, SCIENCE, V295, P1685, DOI 10.1126/science.1069043; Wilkinson NI, 2002, BIRD STUDY, V49, P177, DOI 10.1080/00063650209461263; Woolfenden BE, 2001, AUK, V118, P156, DOI 10.1642/0004-8038(2001)118[0156:DOBHCA]2.0.CO;2; Wretenberg J, 2007, J APPL ECOL, V44, P933, DOI 10.1111/j.1365-2664.2007.01349.x	51	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56493	10.1371/journal.pone.0056493	http://dx.doi.org/10.1371/journal.pone.0056493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418577	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300170
J	Zou, HC; Wu, ZY; Yu, JP; Li, M; Ablimit, M; Li, F; Poundstone, K				Zou, Huachun; Wu, Zunyou; Yu, Jianping; Li, Min; Ablimit, Muhtar; Li, Fan; Poundstone, Katharine			Internet-Facilitated, Voluntary Counseling and Testing (VCT) Clinic-Based HIV Testing among Men Who Have Sex with Men in China	PLOS ONE			English	Article							TARGETING RURAL MSM; RECRUITMENT TOOL; RISK BEHAVIOR; PREVALENCE; INTERVENTION; INFECTION; EFFICACY	Objective: To explore the feasibility of using Internet outreach to encourage men who have sex with men (MSM) to get tested for HIV at voluntary counseling and testing (VCT) clinics in Beijing and Urumqi, China. Methods: From June to August 2007, two volunteers contacted MSM using instant messaging, online chat rooms, mobile phone, and e-mail (active recruitment). Banners with study information were put at the front pages of three major Chinese gay websites (passive recruitment). Those contacted were offered a modest financial incentive to seek HIV testing at existing VCT clinics. Those who subsequently sought HIV testing services at VCT clinics and provided informed consent completed a questionnaire and a blood draw to test for HIV and syphilis. Results: A total of 3,332 MSM were contacted and 429 attended VCT clinics. One out of every 4 men that were recruited through instant messaging actually went for HIV testing, while the recruitment yields for online gay chat rooms, mobile phone contact, and email were 1:6, 1:10, and 1:140, respectively. The majority of participants (80%, 317/399) reported being motivated to seek HIV testing out of concern for their health, and only 3% (11/399) reported being motivated by the financial incentive. Active recruitment tend to recruit MSM who are younger (X-2 = 11.400, P = 0.001), never tested for HIV (X-2 = 4.281, P = 0.039), tested less often (X-2 = 5.638, P = 0.018). Conclusion: Internet outreach is a promising way to encourage MSM to seek HIV testing at existing VCT clinics. Active recruitment can target MSM who are younger, never tested for HIV and tested less often.	[Zou, Huachun; Wu, Zunyou; Poundstone, Katharine] Chinese Ctr Dis Control & Prevent, Div Hlth Educ & Behav Intervent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Zou, Huachun] Univ Melbourne, Sch Populat Hlth, Sexual Hlth Unit, Melbourne, Vic 3010, Australia; [Yu, Jianping; Li, Min] Xicheng Dist Ctr Dis Control & Prevent, Div AIDS STD, Beijing, Peoples R China; [Ablimit, Muhtar; Li, Fan] Xingjiang Uyghur Autonomous Reg Ctr Dis Control &, Ctr AIDS STD Control & Prevent, Urumqi, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; University of Melbourne	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent, Div Hlth Educ & Behav Intervent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wuzy@263.net	Zou, Huachun/AAU-6097-2020		Multidisciplinary HIV and TB Implementation Sciences Training in China [U2R TW 006918]; National Institutes of Health; Fogarty International Center; National Institute of Drug Abuse; FOGARTY INTERNATIONAL CENTER [U2RTW006918] Funding Source: NIH RePORTER	Multidisciplinary HIV and TB Implementation Sciences Training in China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The study was supported by the Multidisciplinary HIV and TB Implementation Sciences Training in China with grant number U2R TW 006918, funded by the National Institutes of Health, the Fogarty International Center and the National Institute of Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PCG, 2009, JAIDS-J ACQ IMM DEF, V52, pS143, DOI 10.1097/QAI.0b013e3181baf111; [Anonymous], 2007, NCAIDS PLAN HIV AIDS; [Anonymous], 2011, HIGH IMP HIV PREV CD; Blas MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010448; Bolding G, 2007, AIDS BEHAV, V11, P522, DOI 10.1007/s10461-007-9224-9; Bowen A, 2004, AIDS BEHAV, V8, P311, DOI 10.1023/B:AIBE.0000044078.43476.1f; Bowen AM, 2008, J BEHAV MED, V31, P463, DOI 10.1007/s10865-008-9171-6; Bowen AM, 2007, HEALTH EDUC RES, V22, P120, DOI 10.1093/her/cyl057; Carballo-Dieguez A, 2006, ARCH SEX BEHAV, V35, P473, DOI 10.1007/s10508-006-9078-7; Carpenter KM, 2010, AIDS BEHAV, V14, P549, DOI 10.1007/s10461-009-9578-2; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P129; Chen H, 2012, SEX TRANSM INFECT; Chen XS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-111; Chow EPF, 2012, HIV MED, V13, P255, DOI 10.1111/j.1468-1293.2011.00974.x; Feng Lian-gui, 2008, Zhonghua Yufang Yixue Zazhi, V42, P870; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Fernandez MI, 2004, AIDS CARE, V16, P953, DOI 10.1080/09540120412331292480; Graham AL, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1001; Koo Malcolm, 2005, J Med Internet Res, V7, pe6, DOI 10.2196/jmir.7.1.e6; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Mausbach BT, 2007, DRUG ALCOHOL DEPEN, V87, P249, DOI 10.1016/j.drugalcdep.2006.08.026; Ning Zhen, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P848; Ouyang Lin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1001; Rhodes SD, 2011, HEALTH EDUC BEHAV, V38, P311, DOI 10.1177/1090198110379572; United Nations General Assembly, 2010, UNGASS COUNTR PROGR; Zhang R, 2008, THESIS KUNMING MED U; ZHONG F, 2009, AIDS BEHAV; Zou H, 2012, AIDS BEHAV; Zou H, 2012, SEXUALLY TRANSMITTED; Zou HC, 2010, JAIDS-J ACQ IMM DEF, V53, pS81, DOI 10.1097/QAI.0b013e3181c7dd2b	30	47	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e51919	10.1371/journal.pone.0051919	http://dx.doi.org/10.1371/journal.pone.0051919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418417	gold, Green Published			2022-12-27	WOS:000315970300007
J	Villela, AD; Ducati, RG; Rosado, LA; Bloch, CJ; Prates, MV; Goncalves, DC; Ramos, CHI; Basso, LA; Santos, DS				Villela, Anne Drumond; Ducati, Rodrigo Gay; Rosado, Leonardo Astolfi; Bloch, Carlos Junior; Prates, Maura Vianna; Goncalves, Danieli Cristina; Inacio Ramos, Carlos Henrique; Basso, Luiz Augusto; Santos, Diogenes Santiago			Biochemical Characterization of Uracil Phosphoribosyltransferase from Mycobacterium tuberculosis	PLOS ONE			English	Article							PURINE NUCLEOSIDE PHOSPHORYLASE; DRUG-RESISTANT TUBERCULOSIS; SULFOLOBUS-SOLFATARICUS; ESCHERICHIA-COLI; BACILLUS-CALDOLYTICUS; KINETIC MECHANISM; SALVAGE PATHWAY; GENE-EXPRESSION; BINDING; PURIFICATION	Uracil phosphoribosyltransferase (UPRT) catalyzes the conversion of uracil and 5-phosphoribosyl-alpha-1-pyrophosphate (PRPP) to uridine 5'-monophosphate (UMP) and pyrophosphate (PPi). UPRT plays an important role in the pyrimidine salvage pathway since UMP is a common precursor of all pyrimidine nucleotides. Here we describe cloning, expression and purification to homogeneity of upp-encoded UPRT from Mycobacterium tuberculosis (MtUPRT). Mass spectrometry and N-terminal amino acid sequencing unambiguously identified the homogeneous protein as MtUPRT. Analytical ultracentrifugation showed that native MtUPRT follows a monomer-tetramer association model. MtUPRT is specific for uracil. GTP is not a modulator of MtUPRT ativity. MtUPRT was not significantly activated or inhibited by ATP, UTP, and CTP. Initial velocity and isothermal titration calorimetry studies suggest that catalysis follows a sequential ordered mechanism, in which PRPP binding is followed by uracil, and PPi product is released first followed by UMP. The pH-rate profiles indicated that groups with pK values of 5.7 and 8.1 are important for catalysis, and a group with a pK value of 9.5 is involved in PRPP binding. The results here described provide a solid foundation on which to base upp gene knockout aiming at the development of strategies to prevent tuberculosis.	[Villela, Anne Drumond; Ducati, Rodrigo Gay; Rosado, Leonardo Astolfi; Basso, Luiz Augusto; Santos, Diogenes Santiago] Pontificia Univ Catolica Rio Grande do Sul PUCRS, INCT TB, CPBMF, Porto Alegre, RS, Brazil; [Villela, Anne Drumond; Rosado, Leonardo Astolfi; Basso, Luiz Augusto; Santos, Diogenes Santiago] Pontificia Univ Catolica Rio Grande do Sul PUCRS, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil; [Rosado, Leonardo Astolfi] Pontificia Univ Catolica Rio Grande do Sul PUCRS, Programa Posgrad Med & Ciencias Saude, Porto Alegre, RS, Brazil; [Bloch, Carlos Junior; Prates, Maura Vianna] Empresa Brasileira Pesquisa Agr Recursos Genet &, Lab Espectrometria Massa, Estacao Parque Biol, Brasilia, DF, Brazil; [Goncalves, Danieli Cristina] Univ Estadual Campinas, UNICAMP, Inst Biol, Campinas, SP, Brazil; [Goncalves, Danieli Cristina; Inacio Ramos, Carlos Henrique] Univ Estadual Campinas, UNICAMP, Inst Quim, Campinas, SP, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Basso, LA (corresponding author), Pontificia Univ Catolica Rio Grande do Sul PUCRS, INCT TB, CPBMF, Porto Alegre, RS, Brazil.	luiz.basso@pucrs.br; diogenes@pucrs.br	Bloch, Carlos/S-8375-2019; Goncalves, Danieli C/H-2089-2019; Ramos, CH/C-1571-2012; Prates, Maura/S-8399-2019; Basso, Luiz Augusto/T-9308-2019; Ducati, Rodrigo/M-5286-2013	Goncalves, Danieli C/0000-0003-0429-204X; Ramos, CH/0000-0002-7246-9081; Prates, Maura/0000-0002-0206-5890; Basso, Luiz Augusto/0000-0003-0903-2407; Astolfi Rosado, Leonardo/0000-0002-4349-0244; Ducati, Rodrigo/0000-0002-8783-8847; Bloch Jr, Carlos/0000-0003-2799-6883	Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES; FAPERGS-CNPq-PRONEX (Fundacao de Amparoa Pesquisa do estado do Rio Grand do Sul); "Embrapa Recursos Geneticos e Biotecnologia", Brazil; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); National Research Council of Brazil (CNPq) [520182/99-5, 304051/1975-06, 304034/2008-8]; CNPq (The National Council for Scientific and Technological Development)	Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES; FAPERGS-CNPq-PRONEX (Fundacao de Amparoa Pesquisa do estado do Rio Grand do Sul); "Embrapa Recursos Geneticos e Biotecnologia", Brazil(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Research Council of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq (The National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by funds of Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES to National Institute of Science and Technology on Tuberculosis (INCT-TB) to DSS and LAB. LAB and DSS also acknowledge financial support awarded by FAPERGS-CNPq-PRONEX-2009 (Fundacao de Amparoa Pesquisa do estado do Rio Grand do Sul). CB acknowledges financial support from "Embrapa Recursos Geneticos e Biotecnologia", Brazil. CHIR acknowledges financial support from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). LAB (CNPq, 520182/99-5), DSS (CNPq, 304051/1975-06), CBJ (304034/2008-8), and CHIR are Research Career Awardees of the National Research Council of Brazil (CNPq). RGD was a post-doctoral fellow of CNPq (The National Council for Scientific and Technological Development). ADV and LAR acknowledge scholarships awarded by CNPq (The National Council for Scientific and Technological Development). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arent S, 2005, BIOCHEMISTRY-US, V44, P883, DOI 10.1021/bi048041l; Borges JC, 2011, CURR MED CHEM, V18, P1276; Martinelli LKB, 2011, MOL BIOSYST, V7, P1289, DOI 10.1039/c0mb00245c; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand GD, 2006, PEPTIDES, V27, P2137, DOI 10.1016/j.peptides.2006.04.020; Brown A, 2009, INT J MOL SCI, V10, P3457, DOI 10.3390/ijms10083457; Christoffersen S, 2009, J MOL BIOL, V393, P464, DOI 10.1016/j.jmb.2009.08.019; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cook P. F., 2007, ENZYME KINETICS MECH; Copeland R. A., 2005, EVALUATION ENZYME IN; DAI YP, 1995, INT J PARASITOL, V25, P207, DOI 10.1016/0020-7519(94)00090-B; De Brabandere H, 2008, ANAL CHEM, V80, P6689, DOI 10.1021/ac8006335; de Mendonca JD, 2011, MOL BIOSYST, V7, P119, DOI 10.1039/c0mb00085j; Ducati RG, 2007, CURR DRUG TARGETS, V8, P423, DOI 10.2174/138945007780059004; Ducati RG, 2011, CURR MED CHEM, V18, P1258; Ducati R.G., 2010, INT REV BIOPHYS CHEM, V1, P34; Ducati RG, 2010, BIOORGAN MED CHEM, V18, P4769, DOI 10.1016/j.bmc.2010.05.009; Ducati RG, 2009, ARCH BIOCHEM BIOPHYS, V486, P155, DOI 10.1016/j.abb.2009.04.011; Ducati RG, 2006, MEM I OSWALDO CRUZ, V101, P697, DOI 10.1590/S0074-02762006000700001; Grossman TH, 1998, GENE, V209, P95, DOI 10.1016/S0378-1119(98)00020-1; HENRI V, 1913, BIOCHEM Z, V49, P333; Ichikawa Wataru, 2006, Gastric Cancer, V9, P145, DOI 10.1007/s10120-006-0373-8; Jain A, 2008, FEMS IMMUNOL MED MIC, V53, P145, DOI 10.1111/j.1574-695X.2008.00400.x; Jensen HK, 1997, PROTEIN EXPRES PURIF, V10, P356, DOI 10.1006/prep.1997.0755; Jensen KF, 2005, FEBS J, V272, P1440, DOI 10.1111/j.1742-4658.2005.04576.x; Jensen KF, 1996, EUR J BIOCHEM, V240, P637, DOI 10.1111/j.1432-1033.1996.0637h.x; Kadziola A, 2002, ACTA CRYSTALLOGR D, V58, P936, DOI 10.1107/S0907444902005024; Kamath AT, 2005, VACCINE, V23, P3753, DOI 10.1016/j.vaccine.2005.03.001; Kantardjieff KA, 2005, ACTA CRYSTALLOGR D, V61, P355, DOI 10.1107/S090744490403389X; KELLEY KC, 1995, GENE, V156, P33, DOI 10.1016/0378-1119(95)00008-T; Kim S, 2009, FEBS J, V276, P4715, DOI 10.1111/j.1742-4658.2009.07168.x; LADBURY JE, 2004, BIOCALORIMETRY, V2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JX, 2007, J HUM GENET, V52, P415, DOI 10.1007/s10038-007-0129-2; Linde L, 1996, BBA-PROTEIN STRUCT M, V1296, P16, DOI 10.1016/0167-4838(96)00045-3; Lundegaard C, 1999, BIOCHEMISTRY-US, V38, P3327, DOI 10.1021/bi982279q; Moffatt Barbara A, 2002, Arabidopsis Book, V1, pe0018, DOI 10.1199/tab.0018; NATALINI P, 1979, J BIOL CHEM, V254, P1558; Nunes JES, 2011, ARCH BIOCHEM BIOPHYS, V512, P143, DOI 10.1016/j.abb.2011.05.020; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; RASMUSSEN UB, 1986, BIOCHIM BIOPHYS ACTA, V881, P268, DOI 10.1016/0304-4165(86)90013-9; Renck D, 2010, ARCH BIOCHEM BIOPHYS, V497, P35, DOI 10.1016/j.abb.2010.03.004; Rostirolla DC, 2011, ARCH BIOCHEM BIOPHYS, V505, P202, DOI 10.1016/j.abb.2010.10.019; Sambandamurthy VK, 2005, MICROBES INFECT, V7, P955, DOI 10.1016/j.micinf.2005.04.001; Sanchez-Quitian ZA, 2010, J STRUCT BIOL, V169, P413, DOI 10.1016/j.jsb.2009.12.019; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schumacher MA, 2002, P NATL ACAD SCI USA, V99, P78, DOI 10.1073/pnas.012399599; Schumacher MA, 1998, EMBO J, V17, P3219, DOI 10.1093/emboj/17.12.3219; Segel H.L., 1975, ENZYME KINETICS BEHA; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Suzuki NN, 2004, STRUCTURE, V12, P751, DOI 10.1016/j.str.2004.02.038; Velayati AA, 2009, EUR RESPIR J, V34, P1202, DOI 10.1183/09031936.00081909; Villela AD, 2011, CURR MED CHEM, V18, P1286; WHO, 2011, WHO GLOBAL TUBERCULO; Yablonski MJ, 1996, J BIOL CHEM, V271, P10704, DOI 10.1074/jbc.271.18.10704	55	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56445	10.1371/journal.pone.0056445	http://dx.doi.org/10.1371/journal.pone.0056445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424660	Green Published, gold, Green Submitted			2022-12-27	WOS:000315965100048
J	Bomholt, J; Helix-Nielsen, C; Scharff-Poulsen, P; Pedersen, PA				Bomholt, Julie; Helix-Nielsen, Claus; Scharff-Poulsen, Peter; Pedersen, Per Amstrup			Recombinant Production of Human Aquaporin-1 to an Exceptional High Membrane Density in Saccharomyces cerevisiae	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROTEIN OVEREXPRESSION; FUNCTIONAL EXPRESSION; WATER CHANNELS; PURIFICATION; OPTIMIZATION; RECEPTOR; FACILITATE; DIFFUSION	In the present paper we explored the capacity of yeast Saccharomyces cerevisiae as host for heterologous expression of human Aquaporin-1. Aquaporin-1 cDNA was expressed from a galactose inducible promoter situated on a plasmid with an adjustable copy number. Human Aquaporin-1 was C-terminally tagged with yeast enhanced GFP for quantification of functional expression, determination of sub-cellular localization, estimation of in vivo folding efficiency and establishment of a purification protocol. Aquaporin-1 was found to constitute 8.5 percent of total membrane protein content after expression at 15 degrees C in a yeast host over-producing the Gal4p transcriptional activator and growth in amino acid supplemented minimal medium. In-gel fluorescence combined with western blotting showed that low accumulation of correctly folded recombinant Aquaporin-1 at 30 degrees C was due to in vivo mal-folding. Reduction of the expression temperature to 15 degrees C almost completely prevented Aquaporin-1 mal-folding. Bioimaging of live yeast cells revealed that recombinant Aquaporin-1 accumulated in the yeast plasma membrane. A detergent screen for solubilization revealed that CYMAL-5 was superior in solubilizing recombinant Aquaporin-1 and generated a monodisperse protein preparation. A single Ni-affinity chromatography step was used to obtain almost pure Aquaporin-1. Recombinant Aquaporin-1 produced in S. cerevisiae was not N-glycosylated in contrast to the protein found in human erythrocytes.	[Bomholt, Julie; Helix-Nielsen, Claus] Aquaporin AS, Copenhagen, Denmark; [Helix-Nielsen, Claus] Tech Univ Denmark, Dept Phys, DK-2800 Lyngby, Denmark; [Scharff-Poulsen, Peter; Pedersen, Per Amstrup] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen	Pedersen, PA (corresponding author), Univ Copenhagen, Dept Biol, August Krogh Bldg, Copenhagen, Denmark.	PAPedersen@bio.ku.dk	Hélix-Nielsen, Claus/N-1054-2019; Helix-Nielsen, Claus/A-5979-2011; Scharff-Poulsen, Peter/A-3556-2014; Pedersen, Per Amstrup/M-4592-2014	Hélix-Nielsen, Claus/0000-0002-9392-7133; Scharff-Poulsen, Peter/0000-0002-5332-9331; Pedersen, Per Amstrup/0000-0001-8648-9748	Danish Research Council; Aquaporin A/S	Danish Research Council(Det Frie Forskningsrad (DFF)); Aquaporin A/S	The present work was supported by the Danish Research Council and Aquaporin A/S. The funders had no role on study design, data collection, decision to publish, or preparation of the manuscript.	Agre P, 1999, Methods Enzymol, V294, P550; AGRE P, 1993, AM J PHYSIOL, V265, pF461, DOI 10.1152/ajprenal.1993.265.3.F461; Arinaminpathy Y, 2009, DRUG DISCOV TODAY, V14, P1130, DOI 10.1016/j.drudis.2009.08.006; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Bienert GP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-26; Cesareni G, 1987, GENETIC ENG PRINCIPL, V9, P135, DOI DOI 10.1007/978-1-4684-5377-5_9; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Clark KM, 2010, PROTEIN EXPRES PURIF, V71, P207, DOI 10.1016/j.pep.2009.12.012; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Erhat E., 1983, J BACTERIOL, V156, P625; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; Hansen MK, 1999, RECEPTOR CHANNEL, V6, P271; Herrera M, 2006, HYPERTENSION, V48, P157, DOI 10.1161/01.HYP.0000223652.29338.77; Ikeda M, 2002, J BIOL CHEM, V277, P39873, DOI 10.1074/jbc.M207008200; Ishibashi K, 1997, J BIOL CHEM, V272, P20782, DOI 10.1074/jbc.272.33.20782; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jahn TP, 2004, FEBS LETT, V574, P31, DOI 10.1016/j.febslet.2004.08.004; Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102; Jorgensen JR, 2001, BIOCHEMISTRY-US, V40, P7301, DOI 10.1021/bi0029503; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; King LS, 2001, NEW ENGL J MED, V345, P175, DOI 10.1056/NEJM200107193450304; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laize V, 1997, PROTEIN EXPRES PURIF, V11, P284, DOI 10.1006/prep.1997.0798; Lohr C, 2009, METHOD ENZYMOL, V465, P143, DOI 10.1016/S0076-6879(09)65008-4; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Nyblom M, 2007, PROTEIN EXPRES PURIF, V56, P110, DOI 10.1016/j.pep.2007.07.007; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Pedersen PA, 1996, J BIOL CHEM, V271, P2514, DOI 10.1074/jbc.271.5.2514; Prasad GVR, 1998, J BIOL CHEM, V273, P33123, DOI 10.1074/jbc.273.50.33123; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Shiroishi M, 2011, METHODS, V55, P281, DOI 10.1016/j.ymeth.2011.08.015; Steffensen L, 2006, EUKARYOT CELL, V5, P248, DOI 10.1128/EC.5.2.248-261.2006; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Verkman AS, 2008, J MOL MED, V86, P523, DOI 10.1007/s00109-008-0303-9; Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467; Verkman AS, 2002, EXP NEPHROL, V10, P235; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Xu GY, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-68	48	24	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56431	10.1371/journal.pone.0056431	http://dx.doi.org/10.1371/journal.pone.0056431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409185	Green Submitted, Green Published, gold			2022-12-27	WOS:000315100000054
J	Kewitz, S; Staege, MS				Kewitz, Stefanie; Staege, Martin S.			Knock-Down of PRAME Increases Retinoic Acid Signaling and Cytotoxic Drug Sensitivity of Hodgkin Lymphoma Cells	PLOS ONE			English	Article							REED-STERNBERG CELLS; GENE-EXPRESSION; CISPLATIN SENSITIVITY; CLINICAL-IMPLICATIONS; ANTIGEN PRAME; CHEMOTHERAPY; DISEASE; LINES; HYPOMETHYLATION; ADENOCARCINOMA	The prognosis for patients with Hodgkin lymphoma (HL) has improved in recent decades. On the other hand, not all patients can be cured with the currently established therapy regimes and this therapy is associated with several adverse late effects. Therefore it is necessary to develop new therapy strategies. After treatment of L-540 HL cells with 5'-azacytidine (5AC), we observed increased expression of the preferentially expressed antigen in melanoma (PRAME). In addition, we detected an increased resistance of 5AC-treated cells against cytotoxic drugs. We analyzed the influence of PRAME on cell survival of HL cells by knocking down PRAME in the chemotherapy resistant cell line L-428, a cell line that express PRAME at a high level. After knock-down of PRAME using vector based RNA interference we observed increased sensitivity for cisplatin, etoposide and retinoic acid. DNA microarray analysis of HL cells after PRAME knock-down indicated regulation of several genes including down-regulation of known anti-apoptotic factors. Increased retinoic acid signaling in these cells was revealed by increased expression of the retinoic acid metabolizing cytochrome P450 (CYP26B1), a transcriptional target of retinoic acid signaling. Our data suggest that PRAME inhibits retinoic acid signaling in HL cells and that the knock-down of PRAME might be an interesting option for the development of new therapy strategies for patients with chemo-resistant HL.	[Kewitz, Stefanie; Staege, Martin S.] Univ Halle Wittenberg, Dept Pediat, D-06108 Halle, Germany	Martin Luther University Halle Wittenberg	Staege, MS (corresponding author), Univ Halle Wittenberg, Dept Pediat, D-06108 Halle, Germany.	martin.staege@medizin.uni-halle.de	Staege, Martin/AAX-8994-2021	Staege, Martin/0000-0003-3765-7068	Peter-Escher-Foundation for children with cancer	Peter-Escher-Foundation for children with cancer	This work was supported by grants from Peter-Escher-Foundation for children with cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi S, 1997, CLIN CANCER RES, V3, P2033; Affer M, 2001, J ONCOL, V2011; Birtle Zoe, 2005, BMC Genomics, V6, P120, DOI 10.1186/1471-2164-6-120; Bradley EW, 2008, J BIOL CHEM, V283, P8055, DOI 10.1074/jbc.M709500200; De Carvalho DD, 2011, ONCOGENE, V30, P223, DOI 10.1038/onc.2010.409; DIEHL V, 1982, CANCER TREAT REP, V66, P615; Drexler H G, 1992, Hum Cell, V5, P42; DREXLER HG, 1986, LEUKEMIA RES, V10, P487, DOI 10.1016/0145-2126(86)90084-6; Epping MT, 2006, CANCER RES, V66, P10639, DOI 10.1158/0008-5472.CAN-06-2522; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Foell JL, 2008, ANTICANCER RES, V28, P887; Grunt TW, 1998, BRIT J CANCER, V78, P79, DOI 10.1038/bjc.1998.446; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; Jozan S, 1998, ANTI-CANCER DRUG, V9, P229, DOI 10.1097/00001813-199803000-00005; KAMESAKI H, 1986, BLOOD, V68, P285; Kawano R, 2009, J CLIN EXP HEMATOP, V49, P1, DOI 10.3960/jslrt.49.1; Kewitz S., 2012, RETINOIC ACID STRUCT, P87; Kewitz S, 2012, LEUKEMIA RES, V36, P773, DOI 10.1016/j.leukres.2012.02.021; Korholz D, 2004, KLIN PADIATR, V216, P150, DOI 10.1055/s-2004-822627; Lin HMJ, 2005, J PEDIAT HEMATOL ONC, V27, P28, DOI 10.1097/01.mph.0000150740.80690.d4; Luetkens T, 2010, LEUKEMIA RES, V34, P1647, DOI 10.1016/j.leukres.2010.03.039; Mauz-Korholz C, 2010, J CLIN ONCOL, V28, P3680, DOI 10.1200/JCO.2009.26.9381; Metkar SS, 2001, CANCER BIOTHER RADIO, V16, P85, DOI 10.1089/108497801750096104; Monge M, 2009, CARCINOGENESIS, V30, P1288, DOI 10.1093/carcin/bgp119; Navarro A, 2009, BLOOD, V114, P2945, DOI 10.1182/blood-2009-02-204842; Neumann I, 2010, PEDIATR BLOOD CANCER, V55, P464, DOI 10.1002/pbc.22603; Ng AK, 2011, BRIT J HAEMATOL, V154, P23, DOI 10.1111/j.1365-2141.2011.08713.x; Oberthuer A, 2004, CLIN CANCER RES, V10, P4307, DOI 10.1158/1078-0432.CCR-03-0813; Ocaya PA, 2011, J VASC RES, V48, P23, DOI 10.1159/000317397; Oehler VG, 2009, BLOOD, V114, P3299, DOI 10.1182/blood-2008-07-170282; Ortmann CA, 2008, ANN HEMATOL, V87, P809, DOI 10.1007/s00277-008-0514-8; Passeron T, 2009, J CLIN INVEST, V119, P954, DOI 10.1172/JCI34015; Pettersson F, 2001, PANCREAS, V23, P273, DOI 10.1097/00006676-200110000-00008; Quintarelli C, 2011, BLOOD, V117, P3353, DOI 10.1182/blood-2010-08-300376; Roman-Gomez O, 2007, LEUKEMIA RES, V31, P1521, DOI 10.1016/j.leukres.2007.02.016; Sahin U, 2002, BLOOD, V100, P4139, DOI 10.1182/blood.V100.12.4139; SCHAADT M, 1979, BLUT, V38, P185, DOI 10.1007/BF01007965; Schenk T, 2007, GENE CHROMOSOME CANC, V46, P796, DOI 10.1002/gcc.20465; Schwering I, 2003, BLOOD, V101, P1505, DOI 10.1182/blood-2002-03-0839; Staege MS, 2008, EXP HEMATOL, V36, P886, DOI 10.1016/j.exphem.2008.02.014; Staege MS, 2004, CANCER RES, V64, P8213, DOI 10.1158/0008-5472.CAN-03-4059; Steidl C, 2012, BLOOD, V120, P3530, DOI 10.1182/blood-2012-06-439570; Steinbach D, 2002, CANCER GENET CYTOGEN, V133, P118, DOI 10.1016/S0165-4608(01)00570-2; Tzankov A, 2006, PATHOBIOLOGY, V73, P107, DOI 10.1159/000095558; van der Kaaij MAE, 2010, HEMATOL ONCOL, V28, P168, DOI 10.1002/hon.939; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wadelin F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-226; Winkler C, 2012, CANCER IMMUNOL IMMUN, V61, P1769, DOI 10.1007/s00262-012-1239-z; Wolf J, 1996, BLOOD, V87, P3418, DOI 10.1182/blood.V87.8.3418.bloodjournal8783418; Yan MY, 2011, CANCER IMMUNOL IMMUN, V60, P1243, DOI 10.1007/s00262-011-1024-4	50	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55897	10.1371/journal.pone.0055897	http://dx.doi.org/10.1371/journal.pone.0055897			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409080	Green Submitted, Green Published, gold			2022-12-27	WOS:000315100000031
J	Ni, Y; Song, L; Qian, XH; Sun, ZH				Ni, Ye; Song, Liang; Qian, Xiaohong; Sun, Zhihao			Proteomic Analysis of Pseudomonas putida Reveals an Organic Solvent Tolerance-Related Gene mmsB	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; EXPRESSION PROFILES; DNA MICROARRAYS; ACTIVE EFFLUX; DOT-T1E; TOLUENE; INVOLVEMENT; BACTERIUM; SYSTEM; S12	Organic solvents are toxic to most microorganisms. However, some organic-solvent-tolerant (OST) bacteria tolerate the destructive effects of organic solvent through various accommodative mechanisms. In this work, we developed an OST adapted strain Pseudomonas putida JUCT1 that could grow in the presence of 60% (v/v) cyclohexane. Two-dimensional gel electrophoresis was used to compare and analyze the total cellular protein of P. putida JUCT1 growing with or without 60% (v/v) cyclohexane. Under different solvent conditions, five high-abundance protein spots whose intensity values show over 60% discrepancies were identified by MALDI-TOF/TOF spectra. Specifically, they are arginine deiminase, carbon-nitrogen hydrolase family putative hydrolase, 3-hydroxyisobutyrate dehydrogenase, protein chain elongation factor EF-Ts, and isochorismatase superfamily hydrolase. The corresponding genes of the latter three proteins, mmsB, tsf, and PSEEN0851, were separately expressed in Escherichia coli to evaluate their effect on OST properties of the host strain. In the presence of 4% (v/v) cyclohexane, E. coli harboring mmsB could grow to 1.70 OD660, whereas cell growth of E. coli JM109 (the control) was completely inhibited by 2% (v/v) cyclohexane. Transformants carrying tsf or PSEEN0851 also showed an increased resistance to cyclohexane and other organic solvents compared with the control. Of these three genes, mmsB exhibited the most prominent effect on increasing OST of E. coli. Less oxidation product of cyclohexane was detected because mmsB transformants might help keep a lower intracellular cyclohexane level. This study demonstrates a feasible approach for elucidating OST mechanisms of microorganisms, and provides molecular basis to construct organic-solvent-tolerant strains for industrial applications.	[Ni, Ye; Song, Liang; Qian, Xiaohong; Sun, Zhihao] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China	Jiangnan University	Ni, Y (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Ind Biotechnol, Wuxi, Jiangsu, Peoples R China.	yni@jiangnan.edu.cn	NI, YE/P-3977-2019		Natural Science Foundation of China [21276112]; National High Technology Research and Development Program of China [2011CB710800]; New Century Excellent Talents in University [NCET-11-0658]; Natural Science Foundation of Jiangsu Province [BK2011150]; Program of Introducing Talents of Discipline to Universities [111-2-06]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); Priority Academic Program Development of Jiangsu Higher Education Institutions	The authors gratefully thank the financial support from the Natural Science Foundation of China (21276112), the National High Technology Research and Development Program of China (2011CB710800), New Century Excellent Talents in University (NCET-11-0658), Natural Science Foundation of Jiangsu Province (BK2011150), the Program of Introducing Talents of Discipline to Universities No. 111-2-06, and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MJ, 1994, STRUCTURE, V2, P651, DOI 10.1016/S0969-2126(00)00066-6; AONO R, 1994, BIOSCI BIOTECH BIOCH, V58, P2009, DOI 10.1271/bbb.58.2009; Aono R, 1997, APPL ENVIRON MICROB, V63, P3637, DOI 10.1128/AEM.63.9.3637-3642.1997; AONO R, 1991, AGR BIOL CHEM TOKYO, V55, P1935, DOI 10.1080/00021369.1991.10870883; Aono R, 1998, J BACTERIOL, V180, P938, DOI 10.1128/JB.180.4.938-944.1998; Bernal P, 2007, ENVIRON MICROBIOL, V9, P1658, DOI 10.1111/j.1462-2920.2007.01283.x; Cheng ZY, 2009, PROTEOMICS, V9, P4271, DOI 10.1002/pmic.200900142; Chowdhury EK, 2003, BIOSCI BIOTECH BIOCH, V67, P438, DOI 10.1271/bbb.67.438; de Carvalho CCCR, 2011, BIOTECHNOL ADV, V29, P75, DOI 10.1016/j.biotechadv.2010.09.001; Godoy P, 2001, J BACTERIOL, V183, P5285, DOI 10.1128/JB.183.18.5285-5292.2001; Hawes JW, 1996, FEBS LETT, V389, P263, DOI 10.1016/0014-5793(96)00597-2; Hayashi S, 2003, J BIOSCI BIOENG, V95, P379, DOI 10.1263/jbb.95.379; Heipieper HJ, 2007, APPL MICROBIOL BIOT, V74, P961, DOI 10.1007/s00253-006-0833-4; Husken LE, 2002, J BIOTECHNOL, V96, P281, DOI 10.1016/S0168-1656(02)00045-7; INOUE A, 1989, NATURE, V338, P264, DOI 10.1038/338264a0; Isken S, 1996, J BACTERIOL, V178, P6056, DOI 10.1128/jb.178.20.6056-6058.1996; Kawarai T, 2005, J BIOSCI BIOENG, V100, P613, DOI 10.1263/jbb.100.613; Kieboom J, 1998, J BACTERIOL, V180, P6769, DOI 10.1128/JB.180.24.6769-6772.1998; Kobayashi H, 1998, MICROBIOL-UK, V144, P353, DOI 10.1099/00221287-144-2-353; Okochi M, 2007, APPL MICROBIOL BIOT, V73, P1394, DOI 10.1007/s00253-006-0624-y; POOLE K, 1993, J BACTERIOL, V175, P7363, DOI 10.1128/JB.175.22.7363-7372.1993; Ramos JL, 1998, J BACTERIOL, V180, P3323, DOI 10.1128/JB.180.13.3323-3329.1998; Rojas A, 2003, J BACTERIOL, V185, P4755, DOI 10.1128/JB.185.16.4755-4763.2003; Rojas A, 2001, J BACTERIOL, V183, P3967, DOI 10.1128/JB.183.13.3967-3973.2001; Sardessai Y, 2002, RES MICROBIOL, V153, P263, DOI 10.1016/S0923-2508(02)01319-0; Segura A, 2005, J BACTERIOL, V187, P5937, DOI 10.1128/JB.187.17.5937-5945.2005; Segura A, 2004, J BACTERIOL, V186, P1905, DOI 10.1128/JB.186.6.1905-1909.2004; Shimizu K, 2005, J BIOSCI BIOENG, V99, P72, DOI 10.1263/jbb.99.72; Shimizu K, 2005, APPL ENVIRON MICROB, V71, P1093, DOI 10.1128/AEM.71.2.1093-1096.2005; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; Volkers RJM, 2006, ENVIRON MICROBIOL, V8, P1674, DOI 10.1111/j.1462-2920.2006.01056.x; Wierckx NJP, 2005, APPL ENVIRON MICROB, V71, P8221, DOI 10.1128/AEM.71.12.8221-8227.2005; Zhang W, 2009, PROCESS BIOCHEM, V44, P1270, DOI 10.1016/j.procbio.2009.07.011	33	13	15	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55858	10.1371/journal.pone.0055858	http://dx.doi.org/10.1371/journal.pone.0055858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409067	Green Submitted, Green Published, gold			2022-12-27	WOS:000315100000027
J	Iqbal, Z; Aleem, A; Iqbal, M; Naqvi, MI; Gill, A; Taj, AS; Qayyum, A; ur-Rehman, N; Khalid, AM; Shah, IH; Khalid, M; Haq, R; Khan, M; Baig, SM; Jamil, A; Abbas, MN; Absar, M; Mahmood, A; Rasool, M; Akhtar, T				Iqbal, Zafar; Aleem, Aamer; Iqbal, Mudassar; Naqvi, Mubashar Iqbal; Gill, Ammara; Taj, Abid Sohail; Qayyum, Abdul; ur-Rehman, Najeeb; Khalid, Ahmad Mukhtar; Shah, Ijaz Hussain; Khalid, Muhammad; Haq, Riazul; Khan, Mahwish; Baig, Shahid Mahmood; Jamil, Abid; Abbas, Muhammad Naeem; Absar, Muhammad; Mahmood, Amer; Rasool, Mahmood; Akhtar, Tanveer			Sensitive Detection of Pre-Existing BCR-ABL Kinase Domain Mutations in CD34+Cells of Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients Is Associated with Imatinib Resistance: Implications in the Post-Imatinib Era	PLOS ONE			English	Article							STEM-CELLS; IN-VITRO; THERAPY; CML; MESYLATE; GENE; INHIBITOR; QUIESCENT; TIME; MECHANISMS	Background: BCR-ABL kinase domain mutations are infrequently detected in newly diagnosed chronic-phase chronic myeloid leukemia (CML) patients. Recent studies indicate the presence of pre-existing BCR-ABL mutations in a higher percentage of CML patients when CD34+ stem/progenitor cells are investigated using sensitive techniques, and these mutations are associated with imatinib resistance and disease progression. However, such studies were limited to smaller number of patients. Methods: We investigated BCR-ABL kinase domain mutations in CD34+ cells from 100 chronic-phase CML patients by multiplex allele-specific PCR and sequencing at diagnosis. Mutations were re-investigated upon manifestation of imatinib resistance using allele-specific PCR and direct sequencing of BCR-ABL kinase domain. Results: Pre-existing BCR-ABL mutations were detected in 32/100 patients and included F311L, M351T, and T315I. After a median follow-up of 30 months (range 8-48), all patients with pre-existing BCR-ABL mutations exhibited imatinib resistance. Of the 68 patients without pre-existing BCR-ABL mutations, 24 developed imatinib resistance; allele-specific PCR and BCR-ABL kinase domain sequencing detected mutations in 22 of these patients. All 32 patients with pre-existing BCR-ABL mutations had the same mutations after manifestation of imatinib-resistance. In imatinib-resistant patients without preexisting BCR-ABL mutations, we detected F311L, M351T, Y253F, and T315I mutations. All imatinib-resistant patients except T315I and Y253F mutations responded to imatinib dose escalation. Conclusion: Pre-existing BCR-ABL mutations can be detected in a substantial number of chronic-phase CML patients by sensitive allele-specific PCR technique using CD34+ cells. These mutations are associated with imatinib resistance if affecting drug binding directly or indirectly. After the recent approval of nilotinib, dasatinib, bosutinib and ponatinib for treatment of chronic myeloid leukemia along with imatinib, all of which vary in their effectiveness against mutated BCR-ABL forms, detection of pre-existing BCR-ABL mutations can help in selection of appropriate first-line drug therapy. Thus, mutation testing using CD34+ cells may facilitate improved, patient-tailored treatment.	[Iqbal, Zafar] King Saud Bin Abdulaziz Univ Hlth Sci KSAU HS, Natl Guards Hlth Affairs, Coll Appl Med Sci, Riyadh, Saudi Arabia; [Aleem, Aamer] King Saud Univ, Coll Med, Dept Med, Div Hematol Oncol, Riyadh 11461, Saudi Arabia; [Aleem, Aamer] King Saud Univ, King Khalid Univ Hosp, Riyadh, Saudi Arabia; [Iqbal, Mudassar] Natl Surg Ctr, Asian Med Inst, Foreign Fac, Bishkek, Kyrgyzstan; [Naqvi, Mubashar Iqbal] Govt Elementary Sch Chak 19 SB, Comp Sci & Bioinformat Lab, Sargodha, Pakistan; [Taj, Abid Sohail] Inst Radiotherapy & Nucl Med, Peshawar, Pakistan; [Qayyum, Abdul] Pakistan Inst Med Sci, Dept Oncol, Islamabad, Pakistan; [ur-Rehman, Najeeb] Medilaser, Lahore, Pakistan; [Iqbal, Zafar; Khalid, Ahmad Mukhtar] Univ Sargodha, Sch Biol Sci, Sargodha, Pakistan; [Shah, Ijaz Hussain; Khalid, Muhammad] Allied Hosp, Dept Oncol, Faisalabad, Pakistan; [Shah, Ijaz Hussain; Khalid, Muhammad] Punjab Med Coll, Faisalabad, Pakistan; [Haq, Riazul] Univ Texas San Antonio, Ctr Hlth, San Antonio, TX USA; [Iqbal, Zafar; Haq, Riazul; Khan, Mahwish] Univ Lahore, Inst Mol Biol & Biotechnol, Lahore, Pakistan; [Iqbal, Zafar; Haq, Riazul; Khan, Mahwish] Univ Lahore, Ctr Res Mol Med, Lahore, Pakistan; [Baig, Shahid Mahmood] Natl Inst Biotechnol & Genet Engn, Hlth Biotechnol Div, Human Mol Genet Grp, Faisalabad, Pakistan; [Jamil, Abid] Postgrad Med Inst, Peshawar, Pakistan; [Iqbal, Zafar; Iqbal, Mudassar; Naqvi, Mubashar Iqbal; Gill, Ammara; Khan, Mahwish; Abbas, Muhammad Naeem; Absar, Muhammad; Akhtar, Tanveer] Univ Punjab, Dept Zool, Hlth Sci Res Labs,Program Hematol Oncol & Pharmac, HOPES Grp,Higher Educ Commiss, Lahore, Pakistan; [Mahmood, Amer] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia; [Rasool, Mahmood] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21413, Saudi Arabia	King Saud Bin Abdulaziz University for Health Sciences; King Saud University; King Saud University; King Khalid University Hospital; Asian Medical Institute; Ministry of Health - Kyrgyzstan; Pakistan Institute of Medical Sciences; University of Sargodha; Punjab Medical College; University of Texas System; University of Texas at San Antonio (UTSA); University of Lahore; University of Lahore; Pakistan Institute of Engineering & Applied Science; University of Punjab; King Saud University; King Abdulaziz University	Iqbal, Z (corresponding author), King Saud Bin Abdulaziz Univ Hlth Sci KSAU HS, Natl Guards Hlth Affairs, Coll Appl Med Sci, Riyadh, Saudi Arabia.	iqbalz@ksau-hs.edu.sa	Akhtar, Tanveer/N-9178-2013; Rasool, Mahmood/H-9475-2012; Khalid, Ahmad Mukhtar/I-6764-2015; BAig, Shahid Mahmood/AAS-8365-2020; Absar, Muhammad/W-5615-2019; Baig, Shahid Mahmood/I-7309-2015	Akhtar, Tanveer/0000-0002-7269-4684; Rasool, Mahmood/0000-0003-2997-5891; Absar, Muhammad/0000-0002-1284-2673; Iqbal, Zafar/0000-0002-1334-6372; Mahmood, Amer/0000-0002-9199-0120	College of Medicine Research Center, King Saud University, Riyadh, Saudi Arabia; Higher Education Commission Pakistan	College of Medicine Research Center, King Saud University, Riyadh, Saudi Arabia; Higher Education Commission Pakistan(Higher Education Commission of Pakistan)	This work was partially supported by the College of Medicine Research Center, Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia. Research funding provided by Higher Education Commission Pakistan is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperley JF, 2007, LANCET ONCOL, V8, P1018, DOI 10.1016/S1470-2045(07)70342-X; Baccarani M, 2006, BLOOD, V108, P1809, DOI 10.1182/blood-2006-02-005686; Baranska M, 2008, J APPL GENET, V49, P201, DOI 10.1007/BF03195613; Branford S, 2004, BLOOD, V104, P2926, DOI 10.1182/blood-2004-03-1134; Branford S, 2006, METH MOLEC MED, V125, P93; Carella AM, 2010, LEUKEMIA LYMPHOMA, V51, P275, DOI 10.3109/10428190903503446; Chu S, 2005, BLOOD, V105, P2093, DOI 10.1182/blood-2004-03-1114; Chu S, 2011, BLOOD, V118, P5565, DOI 10.1182/blood-2010-12-327437; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Cortes Jorge, 2008, J Natl Compr Canc Netw, V6 Suppl 2, pS22; Dolgin E, 2013, NAT MED, V19, P7, DOI 10.1038/nm0113-7; Dulucq S, 2008, BLOOD, V112, P2024, DOI 10.1182/blood-2008-03-147744; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Goldman JM, 2007, BLOOD, V110, P2828, DOI 10.1182/blood-2007-04-038943; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Hao QL, 1998, BLOOD, V91, P4145, DOI 10.1182/blood.V91.11.4145.411a10_4145_4151; Holyoake TL, 2001, BLOOD, V97, P720, DOI 10.1182/blood.V97.3.720; Hughes T, 2009, J CLIN ONCOL, V27, P4204, DOI 10.1200/JCO.2009.21.8230; Iqbal Z, 2004, THERAPY, V1, P249; Jiang X, 2007, LEUKEMIA, V21, P926, DOI 10.1038/sj.leu.2404609; Jiang XY, 2007, J NATL CANCER I, V99, P680, DOI 10.1093/jnci/djk150; Jiang XY, 2010, BLOOD, V116, P2112, DOI 10.1182/blood-2009-05-222471; Kang HY, 2006, HAEMATOLOGICA, V91, P659; Kantarjian Hagop, 2008, J Natl Compr Canc Netw, V6 Suppl 2, pS37; Kantarjian HM, 2003, BLOOD, V101, P473, DOI 10.1182/blood-2002-05-1451; Khorashad JS, 2008, J CLIN ONCOL, V26, P4806, DOI 10.1200/JCO.2008.16.9953; Kreuzer KA, 2003, ANN HEMATOL, V82, P284, DOI 10.1007/s00277-003-0644-y; Leder K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027682; Lucas CM, 2008, LEUKEMIA, V22, P1963, DOI 10.1038/leu.2008.225; Marin D, 2010, J CLIN ONCOL, V28, P2381, DOI 10.1200/JCO.2009.26.3087; Nicolini FE, 2006, LEUKEMIA, V20, P1061, DOI 10.1038/sj.leu.2404236; O'Brien S, 2011, J NATL COMPR CANC NE, V9, pS1; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; Pfeifer H, 2007, BLOOD, V110, P727, DOI 10.1182/blood-2006-11-052373; RADICH JP, 1995, BLOOD, V85, P2632, DOI 10.1182/blood.V85.9.2632.bloodjournal8592632; Roche-Lestienne C, 2002, BLOOD, V100, P1014, DOI 10.1182/blood.V100.3.1014; Roche-Lestienne C, 2003, NEW ENGL J MED, V348, P2265, DOI 10.1056/NEJMc035089; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Sherbenou DW, 2007, LEUKEMIA, V21, P489, DOI 10.1038/sj.leu.2404554; Sorel N, 2004, BIOCHEM BIOPH RES CO, V323, P728, DOI 10.1016/j.bbrc.2004.08.169; Soverini S, 2006, CLIN CANCER RES, V12, P7374, DOI 10.1158/1078-0432.CCR-06-1516; Soverini S, 2011, HAEMATOL-HEMATOL J, V96, P552, DOI 10.3324/haematol.2010.034173; Wang L, 2008, CLIN PHARMACOL THER, V83, P258, DOI 10.1038/sj.clpt.6100268; Willis SG, 2005, BLOOD, V106, P2128, DOI 10.1182/blood-2005-03-1036; Wongboonma W, 2012, EXP MOL PATHOL, V92, P259, DOI 10.1016/j.yexmp.2012.01.007	46	24	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55717	10.1371/journal.pone.0055717	http://dx.doi.org/10.1371/journal.pone.0055717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409026	Green Submitted, Green Published, gold			2022-12-27	WOS:000314660300031
J	Luijten, M; Singh, AV; Bastian, CA; Westerman, A; Pisano, MM; Pennings, JLA; Verhoef, A; Green, ML; Piersma, AH; de Vries, A; Knudsen, TB				Luijten, Mirjam; Singh, Amar V.; Bastian, Caleb A.; Westerman, Anja; Pisano, M. Michele; Pennings, Jeroen L. A.; Verhoef, Aart; Green, Maia L.; Piersma, Aldert H.; de Vries, Annemieke; Knudsen, Thomas B.			Lasting Effects on Body Weight and Mammary Gland Gene Expression in Female Mice upon Early Life Exposure to n-3 but Not n-6 High-Fat Diets	PLOS ONE			English	Article							BREAST-CANCER RISK; PREPUBERTAL LOW-FAT; INSULIN-RESISTANCE; METABOLIC SYNDROME; MATERNAL DIET; DEVELOPMENTAL ORIGINS; ADIPOSE-TISSUE; ACID DIETS; SEX-RATIO; OBESITY	Exposure to an imbalance of nutrients prior to conception and during critical developmental periods can have lasting consequences on physiological processes resulting in chronic diseases later in life. Developmental programming has been shown to involve structural and functional changes in important tissues. The aim of the present study was to investigate whether early life diet has a programming effect on the mammary gland. Wild-type mice were exposed from 2 weeks prior to conception to 6 weeks of age to a regular low-fat diet, or to high-fat diets based on either corn oil or flaxseed oil. At 6 weeks of age, all mice were shifted to the regular low-fat diet until termination at 10 weeks of age. Early life exposure to a high-fat diet, either high in n-6 (corn oil) or in n-3 (flaxseed oil) polyunsaturated fatty acids, did not affect birth weight, but resulted in an increased body weight at 10 weeks of age. Transcriptome analyses of the fourth abdominal mammary gland revealed differentially expressed genes between the different treatment groups. Exposure to high-fat diet based on flaxseed oil, but not on corn oil, resulted in regulation of pathways involved in energy metabolism, immune response and inflammation. Our findings suggest that diet during early life indeed has a lasting effect on the mammary gland and significantly influences postnatal body weight gain, metabolic status, and signaling networks in the mammary gland of female offspring.	[Luijten, Mirjam; Westerman, Anja; Pennings, Jeroen L. A.; Verhoef, Aart; Piersma, Aldert H.; de Vries, Annemieke] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands; [Singh, Amar V.; Bastian, Caleb A.; Pisano, M. Michele; Green, Maia L.; Knudsen, Thomas B.] Univ Louisville, Dept Mol Cellular & Craniofacial Biol, Birth Defects Ctr, Louisville, KY 40292 USA; [Knudsen, Thomas B.] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA	Netherlands National Institute for Public Health & the Environment; University of Louisville; United States Environmental Protection Agency	Knudsen, TB (corresponding author), Univ Louisville, Dept Mol Cellular & Craniofacial Biol, Birth Defects Ctr, Louisville, KY 40292 USA.	knudsen.thomas@epa.gov	Singh, Amar/K-4400-2013	Singh, Amar/0000-0003-3780-8233; Pennings, Jeroen L.A./0000-0002-9188-6358; Luijten, Mirjam/0000-0002-5277-1443; Green, Maia/0000-0002-8397-2299	NIH [R21 ES013821, R25 CA044789, P30 ES014443]; National Institute of Environmental Health Sciences; National Cancer Institute; Bioinformatics and Biostatistics Core, University of Louisville Center for Integrative Biology and Environmental Genomics; NATIONAL CANCER INSTITUTE [R25CA044789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES013821, P30ES014443] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bioinformatics and Biostatistics Core, University of Louisville Center for Integrative Biology and Environmental Genomics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by NIH grant R21 ES013821, National Institute of Environmental Health Sciences (http://www.niehs.nih.gov). C.B. was supported on a fellowship from NIH grant R25 CA044789, National Cancer Institute (http://www.cancer.gov) Additional support is acknowledged from Bioinformatics and Biostatistics Core, University of Louisville Center for Integrative Biology and Environmental Genomics, funded by NIH grant P30 ES014443, National Institute of Environmental Health Sciences (http://www.niehs.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexenko AP, 2007, BIOL REPROD, V77, P599, DOI 10.1095/biolreprod.107.062174; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Barker DJP, 2006, NAT CLIN PRACT NEPHR, V2, P700, DOI 10.1038/ncpneph0344; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; BARKER DJP, 1986, LANCET, V1, P1077; Bertram CE, 2001, BRIT MED BULL, V60, P103, DOI 10.1093/bmb/60.1.103; Bouret SG, 2009, J PEDIATR GASTR NUTR, V48, pS31, DOI 10.1097/MPG.0b013e3181977375; Boyd NF, 2003, BRIT J CANCER, V89, P1672, DOI 10.1038/sj.bjc.6601314; Bruins W, 2008, MOL CELL BIOL, V28, P1974, DOI 10.1128/MCB.01610-07; Bruins W, 2007, CARCINOGENESIS, V28, P1814, DOI 10.1093/carcin/bgm041; Burdge GC, 2009, BRIT J NUTR, V101, P619, DOI 10.1017/S0007114508145883; Clement K, 2004, FASEB J, V18, P1657, DOI 10.1096/fj.04-2204com; Cottam DR, 2004, OBES SURG, V14, P589, DOI 10.1381/096089204323093345; Cottrell EC, 2008, PHYSIOL BEHAV, V94, P17, DOI 10.1016/j.physbeh.2007.11.017; Das UN, 2002, NUTRITION, V18, P430, DOI 10.1016/S0899-9007(01)00747-X; De Assis S, 2006, ANN NY ACAD SCI, V1089, P14, DOI 10.1196/annals.1386.039; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Engstrom G, 2003, DIABETES, V52, P2097, DOI 10.2337/diabetes.52.8.2097; Eriksson JG, 2002, DIABETOLOGIA, V45, P342, DOI 10.1007/s00125-001-0757-6; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; FAIL CHD, 1995, ARCH DIS CHILD, V73, P287; Fata JE, 2001, BIOL REPROD, V65, P680, DOI 10.1095/biolreprod65.3.680; Fay MP, 1997, CANCER RES, V57, P3979; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; Gardner DS, 2007, CURR DRUG TARGETS, V8, P894; Grimble RF, 2002, CURR OPIN CLIN NUTR, V5, P551, DOI 10.1097/00075197-200209000-00015; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hilakivi-Clarke L, 2002, CLIN CANCER RES, V8, P3601; Hilakivi-Clarke L, 1999, BRIT J CANCER, V80, P1682, DOI 10.1038/sj.bjc.6690584; Hilakivi-Clarke L, 1999, NUTRITION, V15, P392, DOI 10.1016/S0899-9007(99)00029-5; Hilakivi-Clarke L, 1998, CANCER RES, V58, P654; Hilakivi-Clarke L, 2007, CURR CANCER DRUG TAR, V7, P465; HilakiviClarke L, 1997, P NATL ACAD SCI USA, V94, P9372, DOI 10.1073/pnas.94.17.9372; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; HOWE GR, 1990, JNCI-J NATL CANCER I, V82, P561, DOI 10.1093/jnci/82.7.561; Ion G, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-81; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kalupahana NS, 2011, OBESITY, V19, P245, DOI 10.1038/oby.2010.196; Kavanagh K, 2010, NUTR RES, V30, P418, DOI 10.1016/j.nutres.2010.06.006; Khalid S, 2010, BREAST CANCER RES TR, V122, P647, DOI 10.1007/s10549-009-0586-8; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Kopecky J, 2009, P NUTR SOC, V68, P361, DOI 10.1017/S0029665109990231; Luijten M, 2007, REPROD TOXICOL, V23, P407, DOI 10.1016/j.reprotox.2006.12.001; MacLennan M, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2646; Mamalakis G, 2006, EUR J CLIN NUTR, V60, P1016, DOI 10.1038/sj.ejcn.1602413; Martin-Gronert MS, 2005, EARLY HUM DEV, V81, P981, DOI 10.1016/j.earlhumdev.2005.10.006; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Michels KB, 2006, INT J CANCER, V119, P2007, DOI 10.1002/ijc.22004; Mora S, 2002, DIABETES-METAB RES, V18, P345, DOI 10.1002/dmrr.321; Moral R, 2011, NUTR CANCER, V63, P410, DOI 10.1080/01635581.2011.535956; Muhlhausler BS, 2007, J NEUROENDOCRINOL, V19, P67, DOI 10.1111/j.1365-2826.2006.01505.x; Olivo SE, 2005, CARCINOGENESIS, V26, P1563, DOI 10.1093/carcin/bgi118; Olivo-Marston SE, 2008, CANCER PREV RES, V1, P532, DOI 10.1158/1940-6207.CAPR-08-0030; Olson LK, 2010, INT J OBESITY, V34, P1415, DOI 10.1038/ijo.2010.51; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Reusens B, 2007, CURR DRUG TARGETS, V8, P935; Rondinone CM, 1997, P NATL ACAD SCI USA, V94, P4171, DOI 10.1073/pnas.94.8.4171; Rosenfeld CS, 2003, P NATL ACAD SCI USA, V100, P4628, DOI 10.1073/pnas.0330808100; Rossmeisl M, 2009, OBESITY, V17, P1023, DOI 10.1038/oby.2008.602; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Shankar K, 2010, ENDOCRINOLOGY, V151, P2577, DOI 10.1210/en.2010-0017; Sieri S, 2008, AM J CLIN NUTR, V88, P1304, DOI 10.3945/ajcn.2008.26090; Silberstein GB, 2006, J ENDOCRINOL, V190, P225, DOI 10.1677/joe.1.06725; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thiebaut ACM, 2007, JNCI-J NATL CANCER I, V99, P451, DOI 10.1093/jnci/djk094; van Dielen FMH, 2004, J CLIN ENDOCR METAB, V89, P4062, DOI 10.1210/jc.2003-032125; WELSCH CW, 1992, CANCER RES, V52, pS2040; White PJ, 2010, DIABETES; Xue F, 2007, LANCET ONCOL, V8, P1088, DOI 10.1016/S1470-2045(07)70377-7; YAJNIK CS, 1995, DIABETIC MED, V12, P330, DOI 10.1111/j.1464-5491.1995.tb00487.x; ZIEGLER RG, 1993, JNCI-J NATL CANCER I, V85, P1819, DOI 10.1093/jnci/85.22.1819	72	6	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55603	10.1371/journal.pone.0055603	http://dx.doi.org/10.1371/journal.pone.0055603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409006	gold, Green Submitted, Green Published			2022-12-27	WOS:000315157200043
J	Duffy, JE; Macdonald, KS; Hultgren, KM; Chak, TCS; Rubenstein, DR				Duffy, J. Emmett; Macdonald, Kenneth S., III; Hultgren, Kristin M.; Chak, Tin Chi Solomon; Rubenstein, Dustin R.			Decline and Local Extinction of Caribbean Eusocial Shrimp	PLOS ONE			English	Article							CLIMATE-CHANGE; CORAL-REEFS; SPONGE; BIODIVERSITY; DEMOSPONGIAE; ABUNDANCE; PORIFERA; SCALE	The tropical shrimp genus Synalpheus includes the only eusocial marine animals. In much of the Caribbean, eusocial species have dominated the diverse fauna of sponge-dwelling shrimp in coral rubble for at least the past two decades. Here we document a recent, dramatic decline and apparent local extinction of eusocial shrimp species on the Belize Barrier Reef. Our collections from shallow reefs in central Belize in 2012 failed to locate three of the four eusocial species formerly abundant in the area, and showed steep declines in colony size and increases in frequency of queenless colonies prior to their disappearance. Concordant with these declines, several nonsocial, pair-forming Synalpheus species increased in frequency. The decline in eusocial shrimp is explained in part by disappearance of two sponge species on which they specialize. Eusocial shrimp collections from Jamaica in 2012 showed similar patterns of decline in colony size and increased queenlessness compared with prior Jamaican collections. The decline and local extinction of eusocial shrimp happened against a backdrop of changes in coral assemblages during recent decades, and may reflect changes in abundance and quality of dead coral substratum and succession of the diverse cryptic organisms living within it. These changes document potentially worrisome declines in a unique taxon of eusocial marine animals.	[Duffy, J. Emmett; Chak, Tin Chi Solomon] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA; [Macdonald, Kenneth S., III] New Mexico State Univ, Dept Fish Wildlife & Conservat Ecol, Las Cruces, NM 88003 USA; [Hultgren, Kristin M.] Seattle Univ, Dept Biol, Seattle, WA 98122 USA; [Rubenstein, Dustin R.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA	William & Mary; Virginia Institute of Marine Science; New Mexico State University; Seattle University; Columbia University	Duffy, JE (corresponding author), Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA.	jeduffy@vims.edu	Macdonald, Kenneth/F-9822-2011; Rubenstein, Dustin R/A-3451-2015; Duffy, J. Emmett/ABF-9200-2020; Rubenstein, Dustin R./N-9302-2019	Rubenstein, Dustin R/0000-0002-4999-3723; Duffy, J. Emmett/0000-0001-8595-6391; Rubenstein, Dustin R./0000-0002-4999-3723; Chak, Tin Chi Solomon/0000-0002-6362-4414	Smithsonian Institution's Caribbean Coral Reef Ecosystem program; National Science Foundation [IOS-1121716, IOS-1121435]; Direct For Biological Sciences [1121716] Funding Source: National Science Foundation	Smithsonian Institution's Caribbean Coral Reef Ecosystem program; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors are grateful to the Smithsonian Institution's Caribbean Coral Reef Ecosystem program and to the National Science Foundation, most recently via grants IOS-1121716 (JED) and IOS-1121435 (DRR), for supporting the authors' research on sponge-dwelling Synalpheus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeier H, 2011, FEMS MICROBIOL ECOL, V75, P218, DOI 10.1111/j.1574-6941.2010.01001.x; Anker A, 2008, ZOOTAXA, P1; Aronson R, 2008, IUCN 2012 IUCN RED L; Aronson RB, 2000, NATURE, V405, P36, DOI 10.1038/35011132; Aronson RB, 2002, ECOL MONOGR, V72, P233, DOI 10.1890/0012-9615(2002)072[0233:TESOST]2.0.CO;2; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Butler MJ, 1995, MAR ECOL PROG SER, V129, P119, DOI 10.3354/meps129119; Campos M, 2005, ZOOTAXA, P1, DOI 10.11646/zootaxa.963.1.1; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; CORREDOR JE, 1988, LIMNOL OCEANOGR, V33, P114, DOI 10.4319/lo.1988.33.1.0114; De Grave S, 2009, RAFFLES B ZOOL, P1; Diaz MC, 1997, MAR ECOL PROG SER, V156, P97, DOI 10.3354/meps156097; Duffy J. Emmett, 2003, P217; Duffy JE, 2010, P ROY SOC B-BIOL SCI, V277, P575, DOI 10.1098/rspb.2009.1483; Duffy JE, 1996, NATURE, V381, P512, DOI 10.1038/381512a0; Duffy JE, 2002, BEHAV ECOL SOCIOBIOL, V51, P488, DOI 10.1007/s00265-002-0455-5; DUFFY JE, 1992, MAR ECOL PROG SER, V90, P127, DOI 10.3354/meps090127; Duffy JE, 1996, BIOL J LINN SOC, V58, P307, DOI 10.1111/j.1095-8312.1996.tb01437.x; Duffy JE, 2007, EVOLUTIONARY ECOLOGY, P388; Duris Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021987; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Hultgren KM, 2011, ZOOTAXA, P1; Hultgren KM, 2010, ZOOTAXA, P221; Hultgren KM, 2011, J CRUSTACEAN BIOL, V31, P352, DOI 10.1651/10-3382.1; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Locke JM, 2007, P BIOL SOC WASH, V120, P214, DOI 10.2988/0006-324X(2007)120[214:ANDSOM]2.0.CO;2; MacDonald KS, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3543[1:TNSOSS]2.0.CO;2; Macdonald KS, 2009, ZOOTAXA, P1; Macdonald KS, 2006, DIVERS DISTRIB, V12, P165, DOI 10.1111/j.1366-9516.2005.00213.x; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; PEARSE AS, 1950, ECOLOGY, V31, P149, DOI 10.2307/1931369; Pile AJ, 1997, LIMNOL OCEANOGR, V42, P178, DOI 10.4319/lo.1997.42.1.0178; Plaisance L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025026; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; REAKAKUDLA ML, 1997, BIODIVERSITY, V2, P83; Rios R, 2007, ZOOTAXA, P1; Rutzler K., 1976, Tethys, V7, P249; Toth E, 2005, BIOL LETT-UK, V1, P49, DOI 10.1098/rsbl.2004.0237; Wapnick CM, 2004, ECOL LETT, V7, P354, DOI 10.1111/j.1461-0248.2004.00586.x; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; WESTINGA E, 1981, MAR BIOL, V62, P139, DOI 10.1007/BF00388176; Wulff JL, 2006, CAN J ZOOL, V84, P146, DOI 10.1139/Z06-019; Wulff JL, 2006, BIOL CONSERV, V127, P167, DOI 10.1016/j.biocon.2005.08.007	45	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e54637	10.1371/journal.pone.0054637	http://dx.doi.org/10.1371/journal.pone.0054637			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418429	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300019
J	Duvivier, BMFM; Schaper, NC; Bremers, MA; van Crombrugge, G; Menheere, PPCA; Kars, M; Savelberg, HHCM				Duvivier, Bernard M. F. M.; Schaper, Nicolaas C.; Bremers, Michelle A.; van Crombrugge, Glenn; Menheere, Paul P. C. A.; Kars, Marleen; Savelberg, Hans H. C. M.			Minimal Intensity Physical Activity (Standing and Walking) of Longer Duration Improves Insulin Action and Plasma Lipids More than Shorter Periods of Moderate to Vigorous Exercise (Cycling) in Sedentary Subjects When Energy Expenditure Is Comparable	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; MENSTRUAL-CYCLE; PUBLIC-HEALTH; SITTING TIME; US ADULTS; BED-REST; INACTIVITY; MORTALITY; GLUCOSE	Background: Epidemiological studies suggest that excessive sitting time is associated with increased health risk, independent of the performance of exercise. We hypothesized that a daily bout of exercise cannot compensate the negative effects of inactivity during the rest of the day on insulin sensitivity and plasma lipids. Methodology/Principal Findings: Eighteen healthy subjects, age 21 +/- 2 year, BMI 22.6 +/- 2.6 kgm(-2) followed randomly three physical activity regimes for four days. Participants were instructed to sit 14 hr/day (sitting regime); to sit 13 hr/day and to substitute 1 hr of sitting with vigorous exercise 1 hr (exercise regime); to substitute 6 hrs sitting with 4 hr walking and 2 hr standing (minimal intensity physical activity (PA) regime). The sitting and exercise regime had comparable numbers of sitting hours; the exercise and minimal intensity PA regime had the same daily energy expenditure. PA was assessed continuously by an activity monitor (ActivPAL) and a diary. Measurements of insulin sensitivity (oral glucose tolerance test, OGTT) and plasma lipids were performed in the fasting state, the morning after the 4 days of each regime. In the sitting regime, daily energy expenditure was about 500 kcal lower than in both other regimes. Area under the curve for insulin during OGTT was significantly lower after the minimal intensity PA regime compared to both sitting and exercise regimes 6727.3 +/- 4329.4 vs 7752.0 +/- 3014.4 and 8320.4 +/- 5383.7 mU.min/ml, respectively. Triglycerides, non-HDL cholesterol and apolipoprotein B plasma levels improved significantly in the minimal intensity PA regime compared to sitting and showed non-significant trends for improvement compared to exercise. Conclusions: One hour of daily physical exercise cannot compensate the negative effects of inactivity on insulin level and plasma lipids if the rest of the day is spent sitting. Reducing inactivity by increasing the time spent walking/standing is more effective than one hour of physical exercise, when energy expenditure is kept constant.	[Duvivier, Bernard M. F. M.; Schaper, Nicolaas C.; Bremers, Michelle A.; van Crombrugge, Glenn; Kars, Marleen] Maastricht Univ Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Duvivier, Bernard M. F. M.; Savelberg, Hans H. C. M.] Maastricht Univ Med Ctr, Dept Human Movement Sci, Maastricht, Netherlands; [Menheere, Paul P. C. A.] Maastricht Univ Med Ctr, Cent Diagnost Lab, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Savelberg, HHCM (corresponding author), Maastricht Univ Med Ctr, Dept Human Movement Sci, Maastricht, Netherlands.	hans.savelberg@maastrichtuniversity.nl	Schaper, Nicolaas C/E-7112-2014; Savelberg, Hans/ABC-8946-2020	Savelberg, Hans/0000-0002-8864-2109; schaper, nicolaas/0000-0002-2128-8029				Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Bergouignan A, 2011, J APPL PHYSIOL, V111, P1201, DOI 10.1152/japplphysiol.00698.2011; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Blanc S, 2000, J CLIN ENDOCR METAB, V85, P2223, DOI 10.1210/jc.85.6.2223; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Ekblom-Bak E, 2010, BRIT J SPORT MED, V44, P834, DOI 10.1136/bjsm.2009.067702; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grant PM, 2006, BRIT J SPORT MED, V40, P992, DOI 10.1136/bjsm.2006.030262; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hawley JA, 2012, DIABETOLOGIA, V55, P535, DOI 10.1007/s00125-012-2460-1; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2008, MED SCI SPORT EXER, V40, P639, DOI 10.1249/MSS.0b013e3181607421; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Hiilloskorpi HK, 2003, INT J SPORTS MED, V24, P332; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Koster A, 2012, PLOS ONE IN PRESS; Krogh-Madsen R, 2010, J APPL PHYSIOL, V108, P1034, DOI 10.1152/japplphysiol.00977.2009; Magkos F, 2006, AM J PHYSIOL-ENDOC M, V291, pE1243, DOI 10.1152/ajpendo.00246.2006; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Meijer EP, 1999, EUR J APPL PHYSIOL O, V80, P16, DOI 10.1007/s004210050552; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Praet SFE, 2008, DIABETOLOGIA, V51, P736, DOI 10.1007/s00125-008-0950-y; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Stephens BR, 2011, METABOLISM, V60, P941, DOI 10.1016/j.metabol.2010.08.014; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; van Sloten TT, 2011, DIABETES RES CLIN PR, V91, P32, DOI 10.1016/j.diabres.2010.09.030; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; YANAGIBORI R, 1994, ACTA PHYSIOL SCAND, V150, P51; Yanagibori R, 1997, J Gravit Physiol, V4, pS82; Yeung EH, 2010, J CLIN ENDOCR METAB, V95, P5435, DOI 10.1210/jc.2010-0702	35	216	219	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55542	10.1371/journal.pone.0055542	http://dx.doi.org/10.1371/journal.pone.0055542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418444	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300035
J	Frobert, O; Sarno, G; James, SK; Saleh, N; Lagerqvist, B				Frobert, Ole; Sarno, Giovanna; James, Stefan K.; Saleh, Nawsad; Lagerqvist, Bo			Effect of Stent Inflation Pressure and Post-Dilatation on the Outcome of Coronary Artery Intervention. A Report of More than 90 000 Stent Implantations	PLOS ONE			English	Article							DRUG-ELUTING STENTS; INTIMAL HYPERPLASIA; BALLOON PRESSURE; ULTRASOUND; DEPLOYMENT; ANGIOPLASTY; MULTICENTER; THROMBOSIS; IMPACT; TRIAL	Background: Percutaneous coronary intervention (PCI) stent inflation pressure correlates to angiographic lumen improvement and stent expansion but the relation to outcome is not clarified. Using comprehensive registry data our aim was to evaluate how stent inflation pressure influences restenosis, stent thrombosis and death following PCI. Methods: We evaluated all consecutive coronary stent implantations in Sweden during 46 months from 2008 using data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). We used logistic regression and Cox proportional hazard modeling to estimate risk of outcomes with different balloon pressures. Results: In total, 93 697 stents were eligible for analysis and divided into five different pressure interval groups: <= 15 atm, 16-17 atm, 18-19 atm, 20-21 atm and >= 22 atm. The risks of stent thrombosis and restenosis were significantly higher in the <= 15 atm, 18-19 atm and >= 22 atm groups (but not in the 16-17 atm group) compared to the 20-21 atm group. There were no differences in mortality. Post-dilatation was associated with a higher restenosis risk ratio (RR) of 1.22 (95% confidence interval (CI) 1.14-1.32, P < 0.001) but stent thrombosis did not differ statistically between procedures with or without post-dilatation. The risk of death was lower following post-dilatation (RR 0.81 (CI 0.71-0.93) P = 0.003) and the difference compared to no post-dilatation was seen immediately after PCI. Conclusion: Our retrospective study of stent inflation pressure identified a possible biological pattern-the risks of stent thrombosis and of restenosis appeared to be higher with low and very high pressures. Post-dilatation might increase restenosis risk.	[Frobert, Ole] Orebro Univ Hosp, Dept Cardiol, Orebro, Sweden; [Sarno, Giovanna; James, Stefan K.; Lagerqvist, Bo] Uppsala Univ, Inst Med Sci, Uppsala, Sweden; [Saleh, Nawsad] Karolinska Hosp, Dept Cardiol, S-10401 Stockholm, Sweden	Orebro University; Uppsala University; Karolinska Institutet; Karolinska University Hospital	Frobert, O (corresponding author), Orebro Univ Hosp, Dept Cardiol, Orebro, Sweden.	ole.frobert@orebroll.se	James, Stefan K/J-4554-2014	Frobert, Ole/0000-0002-5846-345X				Blackman DJ, 2004, AM J CARDIOL, V94, P922, DOI 10.1016/j.amjcard.2004.06.029; Brasselet C, 2007, CLIN CHEM LAB MED, V45, P526, DOI 10.1515/CCLM.2007.088; Cheneau E, 2003, CIRCULATION, V108, P43, DOI 10.1161/01.CIR.0000078636.71728.40; Costa JD, 2005, AM J CARDIOL, V96, P74, DOI 10.1016/j.amjcard.2005.02.049; de Jaegere P, 1998, EUR HEART J, V19, P1214, DOI 10.1053/euhj.1998.1012; Dirschinger J, 1999, CIRCULATION, V100, P918, DOI 10.1161/01.CIR.100.9.918; Frobert O, 1997, INT J EXP PATHOL, V78, P421, DOI 10.1046/j.1365-2613.1997.470374.x; GOLDBERG SL, 1994, J AM COLL CARDIOL, V24, P996, DOI 10.1016/0735-1097(94)90861-3; Hoffmann R, 2005, CATHETER CARDIO INTE, V66, P499, DOI 10.1002/ccd.20542; Hoffmann R, 2001, EUR HEART J, V22, P2015, DOI 10.1053/euhj.2001.2609; Hovasse T, 2013, CATHETER CARDIO INTE, V81, P446, DOI 10.1002/ccd.23343; James SK, 2009, NEW ENGL J MED, V360, P1933, DOI 10.1056/NEJMoa0809902; Karabulut A, 2011, KARDIOL POL, V69, P183; Kim JS, 2008, AM J CARDIOL, V102, P304, DOI 10.1016/j.amjcard.2008.03.059; Lagerqvist B, 2009, CIRC-CARDIOVASC INTE, V2, P401, DOI 10.1161/CIRCINTERVENTIONS.108.844985; Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934; Muraoka Y, 2011, HEART VESSELS, V26, P565, DOI 10.1007/s00380-010-0094-0; Olbrich T, 2006, PHYSIOL MEAS, V27, P213, DOI 10.1088/0967-3334/27/3/001; Ozaki Y, 2010, EUR HEART J, V31, P1470, DOI 10.1093/eurheartj/ehq066; Romagnoli E, 2008, JACC-CARDIOVASC INTE, V1, P22, DOI 10.1016/j.jcin.2007.10.005; SAREMBOCK IJ, 1989, CIRCULATION, V80, P1029, DOI 10.1161/01.CIR.80.4.1029; Tahara S, 2011, CIRC J, V75, P2113, DOI 10.1253/circj.CJ-10-0647; van der Hoeven BL, 2008, JACC-CARDIOVASC INTE, V1, P192, DOI 10.1016/j.jcin.2008.02.003; Williams PD, 2012, EUROINTERVENTION, V8, P267, DOI 10.4244/EIJV8I2A41	24	25	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56348	10.1371/journal.pone.0056348	http://dx.doi.org/10.1371/journal.pone.0056348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418560	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300153
J	Hollingsworth, TN; Johnstone, JF; Bernhardt, EL; Chapin, FS				Hollingsworth, Teresa N.; Johnstone, Jill F.; Bernhardt, Emily L.; Chapin, F. Stuart, III			Fire Severity Filters Regeneration Traits to Shape Community Assembly in Alaska's Boreal Forest	PLOS ONE			English	Article							PLANT FUNCTIONAL TRAITS; VEGETATION RESPONSE; SPECIES COMPOSITION; TREE RECRUITMENT; INTERIOR ALASKA; SCALE; ECOSYSTEMS; CLIMATE; BIOMASS; REGIME	Disturbance can both initiate and shape patterns of secondary succession by affecting processes of community assembly. Thus, understanding assembly rules is a key element of predicting ecological responses to changing disturbance regimes. We measured the composition and trait characteristics of plant communities early after widespread wildfires in Alaska to assess how variations in disturbance characteristics influenced the relative success of different plant regeneration strategies. We compared patterns of post-fire community composition and abundance of regeneration traits across a range of fire severities within a single pre-fire forest type-black spruce forests of Interior Alaska. Patterns of community composition, as captured by multivariate ordination with nonmetric multidimensional scaling, were primarily related to gradients in fire severity (biomass combustion and residual vegetation) and secondarily to gradients in soil pH and regional climate. This pattern was apparent in both the full dataset (n = 87 sites) and for a reduced subset of sites (n = 49) that minimized the correlation between site moisture and fire severity. Changes in community composition across the fire-severity gradient in Alaska were strongly correlated to variations in plant regeneration strategy and rooting depth. The tight coupling of fire severity with regeneration traits and vegetation composition after fire supports the hypothesis that disturbance characteristics influence patterns of community assembly by affecting the relative success of different regeneration strategies. This study further demonstrated that variations in disturbance characteristics can dominate over environmental constraints in determining early patterns of community assembly. By affecting the success of regeneration traits, changes in fire regime directly shape the outcomes of community assembly, and thus may override the effects of slower environmental change on boreal forest composition.	[Hollingsworth, Teresa N.] US Forest Serv, USDA, Pacific NW Res Stn, Fairbanks, AK USA; [Johnstone, Jill F.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Bernhardt, Emily L.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK USA; [Chapin, F. Stuart, III] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA	United States Department of Agriculture (USDA); United States Forest Service; University of Saskatchewan; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Hollingsworth, TN (corresponding author), US Forest Serv, USDA, Pacific NW Res Stn, Fairbanks, AK USA.	thollingsworth@fs.fed.us	Chapin, F Stuart/AAZ-3931-2020; Johnstone, Jill F./C-9204-2009	Chapin, F Stuart/0000-0002-2558-9910; Johnstone, Jill F./0000-0001-6131-9339	U. S. Joint Fire Science Program [05-1-2-06]; NSERC; Direct For Biological Sciences [1026415] Funding Source: National Science Foundation	U. S. Joint Fire Science Program; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by funding from the U. S. Joint Fire Science Program (project 05-1-2-06), a NSERC Discovery grant to JFJ, and in-kind support from the Bonanza Creek Long-Term Ecological Research site and U. S. Forest Service PNW Research Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ROLE FIRE NO CIRCUMP; Balshi MS, 2009, GLOBAL CHANGE BIOL, V15, P578, DOI 10.1111/j.1365-2486.2008.01679.x; BERGERON Y, 1993, J VEG SCI, V4, P827, DOI 10.2307/3235621; Bernhardt EL, 2011, J VEG SCI, V22, P32, DOI 10.1111/j.1654-1103.2010.01231.x; Boby LA, 2010, ECOL APPL, V20, P1633, DOI 10.1890/08-2295.1; Chapin FS, 2004, AMBIO, V33, P361, DOI 10.1639/0044-7447(2004)033[0361:GCATBF]2.0.CO;2; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Donato DC, 2009, J ECOL, V97, P142, DOI 10.1111/j.1365-2745.2008.01456.x; Elven R., 2011, ANNOTATED CHECKLIST; ESSLINGER TL, 1997, CUMULATIVE CHECKLIST; Fenton NJ, 2007, CAN J BOT, V85, P43, DOI 10.1139/B06-148; Greene DF, 2007, CAN J FOREST RES, V37, P1012, DOI 10.1139/X06-245; Hinzman L.D., 2006, ALASKAS CHANGING BOR, P39; Hollingsworth TN, 2006, CAN J FOREST RES, V36, P1781, DOI 10.1139/X06-061; HU FS, 1993, CAN J BOT, V71, P1133, DOI 10.1139/b93-133; Johnstone J, 2006, ECOSYSTEMS, V9, P14, DOI 10.1007/s10021-004-0042-x; Johnstone JF, 2010, GLOBAL CHANGE BIOL, V16, P1281, DOI 10.1111/j.1365-2486.2009.02051.x; Kane ES, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000458; Kasischke ES, 2010, CAN J FOREST RES, V40, P1313, DOI 10.1139/X10-098; Kasischke ES, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025677; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Keith DA, 2007, J ECOL, V95, P1324, DOI 10.1111/j.1365-2745.2007.01302.x; Key CH, 2005, FIREMON FIRE EFFECTS, P25; Kruskal J, 1978, MULTIDIMENSIONAL SCA; Lynch JA, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000332; Mack MC, 2008, ECOSYSTEMS, V11, P209, DOI 10.1007/s10021-007-9117-9; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; NOBLE IR, 1980, VEGETATIO, V43, P5, DOI 10.1007/BF00121013; Ozinga WA, 2005, OIKOS, V108, P555, DOI 10.1111/j.0030-1299.2005.13632.x; Pausas JG, 2004, ECOLOGY, V85, P1085, DOI 10.1890/02-4094; PAYETTE S, 1992, P144, DOI 10.1017/CBO9780511565489.006; Rydgren K, 2004, ECOLOGY, V85, P1906, DOI 10.1890/03-0276; Schimmel J, 1996, ECOLOGY, V77, P1436, DOI 10.2307/2265541; Siegwart-Collier L.C., 2010, OECOLOGIA, V164, P465, DOI [10.1007/s00442-010-1642-0, DOI 10.1007/S00442-010-1642-0]; Todd SK., 2006, FIRE ALASKA HIST ORG; Turetsky MR, 2011, NAT GEOSCI, V4, P27, DOI 10.1038/NGEO1027; Turner MG, 1999, INT J WILDLAND FIRE, V9, P21, DOI 10.1071/WF99003; VANCLEVE K, 1991, BIOSCIENCE, V41, P78, DOI 10.2307/1311560; Wang GG, 2005, CAN J FOREST RES, V35, P254, DOI [10.1139/x04-177, 10.1139/X04-177]; Webb CT, 2010, ECOL LETT, V13, P267, DOI 10.1111/j.1461-0248.2010.01444.x; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; Wolken JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00288.1	43	79	81	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56033	10.1371/journal.pone.0056033	http://dx.doi.org/10.1371/journal.pone.0056033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418503	Green Published, gold			2022-12-27	WOS:000315970300095
J	Malcolm, P; Derave, W; Galle, S; De Clercq, D				Malcolm, Philippe; Derave, Wim; Galle, Samuel; De Clercq, Dirk			A Simple Exoskeleton That Assists Plantarflexion Can Reduce the Metabolic Cost of Human Walking	PLOS ONE			English	Article							ENERGY-EXPENDITURE; MECHANICAL WORK; LEVEL WALKING; ANKLE; ENERGETICS; MASS; BIOMECHANICS; PERFORMANCE; LOCOMOTION; POWER	Background: Even though walking can be sustained for great distances, considerable energy is required for plantarflexion around the instant of opposite leg heel contact. Different groups attempted to reduce metabolic cost with exoskeletons but none could achieve a reduction beyond the level of walking without exoskeleton, possibly because there is no consensus on the optimal actuation timing. The main research question of our study was whether it is possible to obtain a higher reduction in metabolic cost by tuning the actuation timing. Methodology/Principal Findings: We measured metabolic cost by means of respiratory gas analysis. Test subjects walked with a simple pneumatic exoskeleton that assists plantarflexion with different actuation timings. We found that the exoskeleton can reduce metabolic cost by 0.18 +/- 0.06 W kg(-1) or 6 +/- 2% (standard error of the mean) (p = 0.019) below the cost of walking without exoskeleton if actuation starts just before opposite leg heel contact. Conclusions/Significance: The optimum timing that we found concurs with the prediction from a mathematical model of walking. While the present exoskeleton was not ambulant, measurements of joint kinetics reveal that the required power could be recycled from knee extension deceleration work that occurs naturally during walking. This demonstrates that it is theoretically possible to build future ambulant exoskeletons that reduce metabolic cost, without power supply restrictions.	[Malcolm, Philippe; Derave, Wim; Galle, Samuel; De Clercq, Dirk] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium	Ghent University	Malcolm, P (corresponding author), Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium.	philippe.malcolm@ugent.be	Derave, Wim/B-2554-2014	Derave, Wim/0000-0002-2225-5587; Galle, Samuel/0000-0002-1928-7764	Ghent University	Ghent University(Ghent University)	This research was funded by the Ghent University (it was conducted during the appointment of the corresponding author as an assistant/PhD student). There was no external funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au SK, 2006, IEEE INT CONF ROBOT, P2939, DOI 10.1109/ROBOT.2006.1642148; Bogue R, 2009, IND ROBOT, V36, P421, DOI 10.1108/01439910910980141; Bregman DJJ, 2011, CLIN BIOMECH, V26, P955, DOI 10.1016/j.clinbiomech.2011.05.007; BROCKWAY JM, 1987, HUM NUTR-CLIN NUTR, V41C, P463; Browning RC, 2007, MED SCI SPORT EXER, V39, P515, DOI 10.1249/mss.0b013e31802b3562; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; Collins SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009307; Dempster W.T., 1955, 55159 WADC, P55; Ferris DP, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-17; Fornaris E, 1998, Hist Sci Med, V32, P161; Galle S, 2013, GAIT POSTURE; GIVONI B, 1971, J APPL PHYSIOL, V30, P429, DOI 10.1152/jappl.1971.30.3.429; Gordon KE, 2006, J BIOMECH, V39, P1832, DOI 10.1016/j.jbiomech.2005.05.018; Grabowski A, 2005, J APPL PHYSIOL, V98, P579, DOI 10.1152/japplphysiol.00734.2004; Gregorczyk KN, 2010, ERGONOMICS, V53, P1263, DOI 10.1080/00140139.2010.512982; Herr H, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-21; HRELJAC A, 1993, MED SCI SPORT EXER, V25, P1158; Ishikawa M, 2005, J APPL PHYSIOL, V99, P603, DOI 10.1152/japplphysiol.00189.2005; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; Li QG, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-22; Malcolm P, 2009, GAIT POSTURE, V30, P322, DOI 10.1016/j.gaitpost.2009.06.002; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Norris JA, 2007, GAIT POSTURE, V25, P620, DOI 10.1016/j.gaitpost.2006.07.002; Perera S, 2006, J AM GERIATR SOC, V54, P743, DOI 10.1111/j.1532-5415.2006.00701.x; Ruina A, 2005, J THEOR BIOL, V237, P170, DOI 10.1016/j.jtbi.2005.04.004; Sawicki GS, 2008, J EXP BIOL, V211, P1402, DOI 10.1242/jeb.009241; Sawicki GS, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-3; Sawicki GS, 2009, J EXP BIOL, V212, P21, DOI 10.1242/jeb.017269; Smith AE, 1982, ORTHOTICS PROSTHET, V36, P49; Thirunarayan M.A., 1996, GAIT POSTURE, P306, DOI 10.1016/0966-6362(95)01058-0; van den Bogert AJ, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-17; van Dijk W., 2011, P 2011 IEEE INT C RE, P1, DOI [DOI 10.1109/ICORR.2011.5975470, 10.1109/ICORR.2011.5975470]; Walsh CJ, 2007, INT J HUM ROBOT, V4, P487, DOI 10.1142/S0219843607001126; Wiggin M. B., 2012, P 7 ANN DYN WALK C, P24; WINTER DA, 1983, CLIN ORTHOP RELAT R, P147	35	247	257	11	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56137	10.1371/journal.pone.0056137	http://dx.doi.org/10.1371/journal.pone.0056137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418524	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300116
J	Qin, AL; Wang, MM; Cun, YZ; Yang, FS; Wang, SS; Ran, JH; Wang, XQ				Qin, Ai-Li; Wang, Ming-Ming; Cun, Yu-Zhi; Yang, Fu-Sheng; Wang, Shan-Shan; Ran, Jin-Hua; Wang, Xiao-Quan			Phylogeographic Evidence for a Link of Species Divergence of Ephedra in the Qinghai-Tibetan Plateau and Adjacent Regions to the Miocene Asian Aridification	PLOS ONE			English	Article							PINUS-DENSATA; PHYLOGENETIC-RELATIONSHIPS; QUATERNARY CLIMATE; NONCODING REGIONS; UNIVERSAL PRIMERS; CHLOROPLAST DNA; EVOLUTION; GNETALES; SPECIATION; PINACEAE	The Qinghai-Tibetan Plateau (QTP) has become one of the hotspots for phylogeographical studies due to its high species diversity. However, most previous studies have focused on the effects of the Quaternary glaciations on phylogeographical structures and the locations of glacial refugia, and little is known about the effects of the aridization of interior Asia on plant population structure and speciation. Here the chloroplast DNA (cpDNA) trnT-trnF and trnS-trnfM sequences were used to investigate the differentiation and phylogeographical history of 14 Ephedra species from the QTP and northern China, based on a sampling of 107 populations. The phylogeographical analysis, together with phylogenetic reconstruction based on combined four cpDNA fragments (rbcL, rpl16, rps4, and trnS-trnfM), supports three main lineages (eastern QTP, southern QTP, and northern China) of these Ephedra species. Divergence of each lineage could be dated to the Middle or Late Miocene, and was very likely linked to the uplift of the QTP and the Asian aridification, given the high drought and/or cold tolerance of Ephedra. Most of the Ephedra species had low intraspecific variation and lacked a strong phylogeographical structure, which could be partially attributed to clonal reproduction and a relatively recent origin. In addition, ten of the detected 25 cpDNA haplotypes are shared among species, suggesting that a wide sampling of species is helpful to investigate the origin of observed haplotypes and make reliable phylogeographical inference. Moreover, the systematic positions of some Ephedra species are discussed.	[Qin, Ai-Li; Wang, Ming-Ming; Cun, Yu-Zhi; Yang, Fu-Sheng; Wang, Shan-Shan; Ran, Jin-Hua; Wang, Xiao-Quan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Qin, Ai-Li; Wang, Ming-Ming] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, XQ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	xiaoq_wang@ibcas.ac.cn		Wang, Xiao-Quan/0000-0003-3978-0828	National Natural Science Foundation of China [31170197, 30730010]; Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by by the National Natural Science Foundation of China (grants 31170197, 30730010) and the Chinese Academy of Sciences (the 100-Talent Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; CUTLER H. C., 1939, ANN MISSOURI BOT GARD, V26, P373, DOI 10.2307/2394299; DEMESURE B, 1995, MOL ECOL, V4, P129, DOI 10.1111/j.1365-294X.1995.tb00201.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupont-Nivet G, 2007, NATURE, V445, P635, DOI 10.1038/nature05516; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Fu LK, 1999, FLORA CHINA, P97; Gao J, 2012, MOL ECOL, V21, P4811, DOI 10.1111/j.1365-294X.2012.05712.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Huang JL, 2005, MOL PHYLOGENET EVOL, V35, P48, DOI 10.1016/j.ympev.2004.12.020; Huang JL, 2003, MOL BIOL EVOL, V20, P435, DOI 10.1093/molbev/msg049; Ickert-Bond SM, 2004, SYST BOT, V29, P834, DOI 10.1600/0363644042451143; Ickert-Bond SM, 2011, INT J PLANT SCI, V172, P36, DOI 10.1086/657299; Ickert-Bond SM, 2009, J SYST EVOL, V47, P444, DOI 10.1111/j.1759-6831.2009.00053.x; Jiang HC, 2008, PALAEOGEOGR PALAEOCL, V265, P30, DOI 10.1016/j.palaeo.2008.04.016; Li Xi-Wen, 1993, Acta Botanica Yunnanica, V15, P217; Li Y, 2011, MOL PHYLOGENET EVOL, V59, P412, DOI 10.1016/j.ympev.2011.01.009; Li Y, 2010, MOL BIOL EVOL, V27, P1001, DOI 10.1093/molbev/msp301; Liu JQ, 2012, J SYST EVOL, V50, P267, DOI 10.1111/j.1759-6831.2012.00214.x; Loera I, 2012, MOL PHYLOGENET EVOL, V65, P437, DOI 10.1016/j.ympev.2012.06.025; MANTEL N, 1967, CANCER RES, V27, P209; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; Mittermeier R, 2005, HOTSPOTS REVISITED E; Nei M., 1975, MOL POPULATION GENET; Nylander JAA., 2004, BIOINFORMATICS; Opgenoorth L, 2010, NEW PHYTOL, V185, P332, DOI 10.1111/j.1469-8137.2009.03007.x; Pons O, 1996, GENETICS, V144, P1237; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Rambaut A, 2007, TRACER V1 4 MOL EVOL; Ran JH, 2006, MOL PHYLOGENET EVOL, V41, P405, DOI 10.1016/j.ympev.2006.05.039; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Royden LH, 2008, SCIENCE, V321, P1054, DOI 10.1126/science.1155371; Rydin C, 2004, P NATL ACAD SCI USA, V101, P16571, DOI 10.1073/pnas.0407588101; Rydin C, 2010, BOT J LINN SOC, V163, P387, DOI 10.1111/j.1095-8339.2010.01066.x; Rydin C, 2009, INT J PLANT SCI, V170, P1031, DOI 10.1086/605116; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Shimono A, 2010, HEREDITY, V104, P534, DOI 10.1038/hdy.2009.158; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Song BH, 2003, MOL ECOL, V12, P2995, DOI 10.1046/j.1365-294X.2003.01962.x; Song BH, 2002, MOL ECOL, V11, P1057, DOI 10.1046/j.1365-294X.2002.01502.x; [宋之琛 SONG Zhichen], 2008, [古生物学报, Acta Palaeontologica Sinica], V47, P265; Spicer RA, 2003, NATURE, V421, P622, DOI 10.1038/nature01356; Sun JM, 2008, GLOBAL PLANET CHANGE, V64, P53, DOI 10.1016/j.gloplacha.2008.09.001; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang BS, 2011, MOL ECOL, V20, P3796, DOI 10.1111/j.1365-294X.2011.05157.x; Wang CS, 2008, P NATL ACAD SCI USA, V105, P4987, DOI 10.1073/pnas.0703595105; Wang H, 2010, MOL ECOL, V19, P2964, DOI 10.1111/j.1365-294X.2010.04729.x; Wang KF, 1975, CHINESE J GEOL, V4, P366; Wang X, 2010, CHINESE SCI BULL, V55, P1511, DOI 10.1007/s11434-010-3069-8; Wang XR, 2001, GENETICS, V159, P337; Wei XX, 2004, MOL ECOL, V13, P3115, DOI 10.1111/j.1365-294X.2004.02299.x; Wei XX, 2003, J MOL EVOL, V57, P623, DOI 10.1007/s00239-003-2512-8; Wendt Tom, 1993, Phytologia, V74, P141; Wu, 1988, J JPN BOT, V63, P297; Xu TT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-194; Yang FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037196; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yang Y, 2003, NOVON, V13, P153, DOI 10.2307/3393581; Yang Y, 2002, SYSTEMATICS EVOLUTIO; [张镱锂 Zhang Yili], 2002, [地理研究, Geographical Research], V21, P1	74	37	39	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56243	10.1371/journal.pone.0056243	http://dx.doi.org/10.1371/journal.pone.0056243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418542	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300135
J	Thompson, KA; Pappachan, JV; Bennett, AM; Mittal, H; Macken, S; Dove, BK; Nguyen-Van-Tam, JS; Copley, VR; O'Brien, S; Hoffman, P; Parks, S; Bentley, A; Isalska, B; Thomson, G				Thompson, Katy-Anne; Pappachan, John V.; Bennett, Allan M.; Mittal, Himanshu; Macken, Susan; Dove, Brian K.; Nguyen-Van-Tam, Jonathan S.; Copley, Vicky R.; O'Brien, Sarah; Hoffman, Peter; Parks, Simon; Bentley, Andrew; Isalska, Barbara; Thomson, Gail		EASE Study Consortium	Influenza Aerosols in UK Hospitals during the H1N1 (2009) Pandemic - The Risk of Aerosol Generation during Medical Procedures	PLOS ONE			English	Article							VIRAL LOAD; VIRUS; INFECTION; TRANSMISSION; TORONTO; SARS	Background: Nosocomial infection of health-care workers (HCWs) during outbreaks of respiratory infections (e. g. Influenza A H1N1 (2009)) is a significant concern for public health policy makers. World Health Organization (WHO)-defined 'aerosol generating procedures' (AGPs) are thought to increase the risk of aerosol transmission to HCWs, but there are presently insufficient data to quantify risk accurately or establish a hierarchy of risk-prone procedures. Methodology/Principal Findings: This study measured the amount of H1N1 (2009) RNA in aerosols in the vicinity of H1N1 positive patients undergoing AGPs to help quantify the potential risk of transmission to HCWs. There were 99 sampling occasions (windows) producing a total of 198 May stages for analysis in the size ranges 0.86-7.3 mu m. Considering stages 2 (4-7.3 mu m) and 3 (0.86-4 mu m) as comprising one sample, viral RNA was detected in 14 (14.1%) air samples from 10 (25.6%) patients. Twenty three air samples were collected while potential AGPs were being performed of which 6 (26.1%) contained viral RNA; in contrast, 76 May samples were collected when no WHO 2009 defined AGP was being performed of which 8 (10.5%) contained viral RNA (unadjusted OR = 2.84 (95% CI 1.11-7.24) adjusted OR = 4.31 (0.83-22.5)). Conclusions/Significance: With our small sample size we found that AGPs do not significantly increase the probability of sampling an H1N1 (2009) positive aerosol (OR (95% CI) = 4.31 (0.83-22.5). Although the probability of detecting positive H1N1 (2009) positive aerosols when performing various AGPs on intensive care patients above the baseline rate (i.e. in the absence of AGPs) did not reach significance, there was a trend towards hierarchy of AGPs, placing bronchoscopy and respiratory and airway suctioning above baseline (background) values. Further, larger studies are required but these preliminary findings may be of benefit to infection control teams.	[Thompson, Katy-Anne; Bennett, Allan M.; Macken, Susan; Parks, Simon] Hlth Protect Agcy, Biosafety Invest Unit, Porton Down, Wilts, England; [Pappachan, John V.] Univ Hosp Southampton NHS Fdn Trust, Paediat Intens Care Unit, Southampton, Hants, England; [Mittal, Himanshu] Hlth Protect Agcy, Biosafety Invest Unit, London, England; [Dove, Brian K.] Hlth Protect Agcy, Influenza Grp, Porton Down, Wilts, England; [Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Hlth Protect & Influenza Res Grp, Nottingham NG7 2RD, England; [Copley, Vicky R.] Hlth Protect Agcy, Microbial Risk Assessment Grp, Porton Down, Wilts, England; [O'Brien, Sarah] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Hoffman, Peter] Hlth Protect Agcy, Antimicrobial Resistance & Healthcare Associated, London, England; [Bentley, Andrew] Univ S Manchester Hosp, Acute Intens Care Unit, Manchester M20 8LR, Lancs, England; [Isalska, Barbara] Univ S Manchester Hosp, Dept Microbiol, Manchester M20 8LR, Lancs, England; [Thomson, Gail] Hlth Protect Agcy, Porton Down, Wilts, England	Health Protection Agency; University of Southampton; University Hospital Southampton NHS Foundation Trust; Health Protection Agency; Health Protection Agency; University of Nottingham; Health Protection Agency; University of Liverpool; Health Protection Agency; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Health Protection Agency	Thompson, KA (corresponding author), Hlth Protect Agcy, Biosafety Invest Unit, Porton Down, Wilts, England.	Katy-Anne.Thompson@hpa.org.uk	Nguyen-Van-Tam, Jonathan/I-2162-2019	Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Bentley, Andrew/0000-0002-6883-9246; O'Brien, Sarah Jane/0000-0003-2896-8999; Pappachan, John/0000-0002-3559-0595; Bennett, Allan/0000-0001-7448-8182	Health Protection Agency; GlaxoSmithKline plc (GSK)	Health Protection Agency; GlaxoSmithKline plc (GSK)	This study was funded by the Health Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KAT, BD, SM, SP, JP, GT, VC, HM, SO, PH, AB and BI have no conflict of interest. JVT: The University of Nottingham Health Protection Research Group is currently in receipt of research funds from GlaxoSmithKline plc (GSK), who are manufacturers/distributors of a virucidal respirator; this research funding is entirely unrelated to the performance or use of the virucidal respirator. Furthermore the research funding from GSK did not support any aspect of the work described in this manuscript. JVT has also received consultancy fees from GSK; but all forms of personal remuneration ceased in September, 2010. JVT is a former employee of SmithKline Beecham plc. (now GSK) prior to 2002, with no outstanding pecuniary interests in GSK by way of shareholdings, share options or accrued pension rights. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	ALFORD RH, 1967, AM J EPIDEMIOL, V86, P185, DOI 10.1093/oxfordjournals.aje.a120723; Almstrand AC, 2010, J APPL PHYSIOL, V108, P584, DOI 10.1152/japplphysiol.00873.2009; [Anonymous], 2008, PANDEMIC INFLUENZA G; [Anonymous], 2007, INFECT PREVENTION CO; [Anonymous], 2007, ISOTS169761; [Anonymous], 2009, NAT PLAN INFL PAND N; [Anonymous], 2009, INTERIM GUIDANCE INF; [Anonymous], 2009, PANDEMIC H1N1 2009 I; [Anonymous], 2009, INFECT PREVENTION CO; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P461; Cox CS., 1987, AEROBIOLOGICAL PATHW; Davies A., 2009, Journal of Infection Prevention, V10, P122, DOI 10.1177/1757177409106456; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; Fabian P, 2011, J AEROSOL MED PULM D, V24, P137, DOI 10.1089/jamp.2010.0815; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; HALL CB, 1979, J INFECT DIS, V140, P610, DOI 10.1093/infdis/140.4.610; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Johnson GR, 2011, J AEROSOL SCI, V42, P839, DOI 10.1016/j.jaerosci.2011.07.009; Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797; Killingley B, 2010, HEALTH TECHNOL ASSES, V14, P237, DOI 10.3310/hta14460-04; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; MAY KR, 1966, BACTERIOL REV, V30, P559, DOI 10.1128/MMBR.30.3.559-570.1966; McDonald LC, 2004, EMERG INFECT DIS, V10, P777, DOI 10.3201/eid1005.030791; Milton DK, 2010, AM J RESP CRIT CARE, V181; Nicas M, 2006, RISK ANAL, V26, P1085, DOI 10.1111/j.1539-6924.2006.00802.x; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; SODERHOLM SC, 1989, ANN OCCUP HYG, V33, P301, DOI 10.1093/annhyg/33.3.301; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Teunis PFM, 2010, EPIDEMICS-NETH, V2, P215, DOI 10.1016/j.epidem.2010.10.001; The Influenza Pandemic Preparedness Team, 2011, ROUT TRANSM INFL VIR; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664	38	90	94	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56278	10.1371/journal.pone.0056278	http://dx.doi.org/10.1371/journal.pone.0056278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418548	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000315970300141
J	Uchida, S; Itaka, K; Uchida, H; Hayakawa, K; Ogata, T; Ishii, T; Fukushima, S; Osada, K; Kataoka, K				Uchida, Satoshi; Itaka, Keiji; Uchida, Hirokuni; Hayakawa, Kentaro; Ogata, Toru; Ishii, Takehiko; Fukushima, Shigeto; Osada, Kensuke; Kataoka, Kazunori			In Vivo Messenger RNA Introduction into the Central Nervous System Using Polyplex Nanomicelle	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; GENE DELIVERY; VACCINATION TRIAL; DIRECT-INJECTION; LINKING INNATE; CELLS; PSEUDOURIDINE; TRANSFECTION; EXPRESSION; EFFICIENT	Messenger RNA (mRNA) introduction is a promising approach to produce therapeutic proteins and peptides without any risk of insertion mutagenesis into the host genome. However, it is difficult to introduce mRNA in vivo mainly because of the instability of mRNA under physiological conditions and its strong immunogenicity through the recognition by Toll-like receptors (TLRs). We used a novel carrier based on self-assembly of a polyethylene glycol (PEG)-polyamino acid block copolymer, polyplex nanomicelle, to administer mRNA into the central nervous system (CNS). The nanomicelle with 50 nm in diameter has a core-shell structure with mRNA-containing inner core surrounded by PEG layer, providing the high stability and stealth property to the nanomicelle. The functional polyamino acids possessing the capacity of pH-responsive membrane destabilization allows smooth endosomal escape of the nanomicelle into the cytoplasm. After introduction into CNS, the nanomicelle successfully provided the sustained protein expression in the cerebrospinal fluid for almost a week. Immune responses after mRNA administration into CNS were effectively suppressed by the use of the nanomicelle compared with naked mRNA introduction. In vitro analyses using specific TLR expressing HEK293 cells confirmed that the nanomicelle inclusion prevented mRNA from the recognition by TLRs. Thus, the polyplex nanomicelle is a promising system that simultaneously resolved the two major problems of in vivo mRNA introduction, the instability and immunogenicity, opening the door to various new therapeutic strategies using mRNA.	[Uchida, Satoshi; Itaka, Keiji; Kataoka, Kazunori] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Div Clin Biotechnol,Bunkyo Ku, Tokyo, Japan; [Uchida, Hirokuni; Ishii, Takehiko; Kataoka, Kazunori] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo, Japan; [Hayakawa, Kentaro; Ogata, Toru] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama, Japan; [Fukushima, Shigeto; Osada, Kensuke; Kataoka, Kazunori] Univ Tokyo, Grad Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Itaka, K (corresponding author), Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Div Clin Biotechnol,Bunkyo Ku, Tokyo, Japan.	itaka-ort@umin.net; kataoka@bmw.t.u-tokyo.ac.jp	Ogata, Toru/ADC-3560-2022; UCHIDA, SATOSHI/H-6112-2018; Osada, Kensuke/V-3322-2017; Kataoka, Kazunori/K-7108-2012	Ogata, Toru/0000-0001-9011-8640; UCHIDA, SATOSHI/0000-0001-8726-0478; Osada, Kensuke/0000-0001-9557-6851; Kataoka, Kazunori/0000-0002-8591-413X	Core Research Program for Evolutional Science and Technology (CREST) from Japan Science and Technology Corporation (JST); Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Global COE Program 'Medical System Innovation through Multidisciplinary Integration' from MEXT, Japan; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Japan Society for the Promotion of Science (JSPS)	Core Research Program for Evolutional Science and Technology (CREST) from Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program 'Medical System Innovation through Multidisciplinary Integration' from MEXT, Japan; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was financially supported in part by the Core Research Program for Evolutional Science and Technology (CREST) from Japan Science and Technology Corporation (JST) (K.K., http://www.jst.go.jp/kisoken/crest/en/index.html), Grants-in-Aid for Scientific Research form the Japanese Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) (K.I., http://www.jsps.go.jp/english/e-grants/index.html), Global COE Program 'Medical System Innovation through Multidisciplinary Integration' from MEXT, Japan(http://park.itc.u-tokyo.ac.jp/CMSI/e/index.html) and Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) from the Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Anderson BR, 2010, NUCLEIC ACIDS RES, V38, P5884, DOI 10.1093/nar/gkq347; Bettinger T, 2001, NUCLEIC ACIDS RES, V29, P3882, DOI 10.1093/nar/29.18.3882; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; CALLIS J, 1987, NUCLEIC ACIDS RES, V15, P5823; Charette M, 2000, IUBMB LIFE, V49, P341; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Itaka K, 2011, CURR GENE THER, V11, P457, DOI 10.2174/156652311798192879; Itaka K, 2010, BIOMATERIALS, V31, P3707, DOI 10.1016/j.biomaterials.2009.11.072; Itaka K, 2009, EUR J PHARM BIOPHARM, V71, P475, DOI 10.1016/j.ejpb.2008.09.019; Kanayama N, 2006, CHEMMEDCHEM, V1, P439, DOI 10.1002/cmdc.200600008; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kariko K, 2012, MOL THER, V20, P948, DOI 10.1038/mt.2012.7; Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Listvanova S, 2003, J IMMUNOL METHODS, V281, P27, DOI 10.1016/S0022-1759(03)00267-9; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; MALONE RW, 1989, P NATL ACAD SCI USA, V86, P6077, DOI 10.1073/pnas.86.16.6077; Masago K, 2007, BIOMATERIALS, V28, P5169, DOI 10.1016/j.biomaterials.2007.07.019; Mitchell DA, 2000, J CLIN INVEST, V106, P1065, DOI 10.1172/JCI11405; Miyata K, 2012, CHEM SOC REV, V41, P2562, DOI 10.1039/c1cs15258k; Miyata K, 2008, J AM CHEM SOC, V130, P16287, DOI 10.1021/ja804561g; Plews JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014397; Probst J, 2007, GENE THER, V14, P1175, DOI 10.1038/sj.gt.3302964; Qiu P, 1996, GENE THER, V3, P262; Reijneveld JC, 1999, J NEURO-ONCOL, V42, P137, DOI 10.1023/A:1006237917632; Rejman J, 2010, J CONTROL RELEASE, V147, P385, DOI 10.1016/j.jconrel.2010.07.124; Scheel B, 2005, EUR J IMMUNOL, V35, P1557, DOI 10.1002/eji.200425656; Su XF, 2011, MOL PHARMACEUT, V8, P774, DOI 10.1021/mp100390w; Tannous BA, 2009, NAT PROTOC, V4, P582, DOI 10.1038/nprot.2009.28; Tavernier G, 2011, BIOMATERIALS; Tavernier G, 2011, J CONTROL RELEASE, V150, P238, DOI 10.1016/j.jconrel.2010.10.020; Van Tendeloo VF, 2007, CURR OPIN MOL THER, V9, P423; Veening JG, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-1; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Weide B, 2008, J IMMUNOTHER, V31, P180, DOI 10.1097/CJI.0b013e31815ce501; Weide B, 2009, J IMMUNOTHER, V32, P498, DOI 10.1097/CJI.0b013e3181a00068; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Zou S, 2010, INT J PHARMACEUT, V389, P232, DOI 10.1016/j.ijpharm.2010.01.019	45	69	79	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56220	10.1371/journal.pone.0056220	http://dx.doi.org/10.1371/journal.pone.0056220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418537	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300129
J	Vignier, N; Amor, F; Fogel, P; Duvallet, A; Poupiot, J; Charrier, S; Arock, M; Montus, M; Nelson, I; Richard, I; Carrier, L; Servais, L; Voit, T; Bonne, G; Israeli, D				Vignier, Nicolas; Amor, Fatima; Fogel, Paul; Duvallet, Angelique; Poupiot, Jerome; Charrier, Sabine; Arock, Michel; Montus, Marie; Nelson, Isabelle; Richard, Isabelle; Carrier, Lucie; Servais, Laurent; Voit, Thomas; Bonne, Gisele; Israeli, David			Distinctive Serum miRNA Profile in Mouse Models of Striated Muscular Pathologies	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; CIRCULATING MICRORNAS; DYSTROPHY; MUSCLE; CANCER; CARDIOMYOPATHY; BIOMARKERS; DEFICIENCY; MUTATIONS; ALPHA	Biomarkers are critically important for disease diagnosis and monitoring. In particular, close monitoring of disease evolution is eminently required for the evaluation of therapeutic treatments. Classical monitoring methods in muscular dystrophies are largely based on histological and molecular analyses of muscle biopsies. Such biopsies are invasive and therefore difficult to obtain. The serum protein creatine kinase is a useful biomarker, which is however not specific for a given pathology and correlates poorly with the severity or course of the muscular pathology. The aim of the present study was the systematic evaluation of serum microRNAs )miRNAs) as biomarkers in striated muscle pathologies. Mouse models for five striated muscle pathologies were investigated: Duchenne muscular dystrophy (DMD), limb-girdle muscular dystrophy type 2D (LGMD2D), limb-girdle muscular dystrophy type 2C (LGMD2C), Emery-Dreifuss muscular dystrophy )EDMD) and hypertrophic cardiomyopathy (HCM). Two-step RT-qPCR methodology was elaborated, using two different RT-qPCR miRNA quantification technologies. We identified miRNA modulation in the serum of all the five mouse models. The most highly dysregulated serum miRNAs were found to be commonly upregulated in DMD, LGMD2D and LGMD2C mouse models, which all exhibit massive destruction of striated muscle tissues. Some of these miRNAs were down rather than upregulated in the EDMD mice, a model without massive myofiber destruction. The dysregulated miRNAs identified in the HCM model were different, with the exception of one dysregulated miRNA common to all pathologies. Importantly, a specific and distinctive circulating miRNA profile was identified for each studied pathological mouse model. The differential expression of a few dysregulated miRNAs in the DMD mice was further evaluated in DMD patients, providing new candidates of circulating miRNA biomarkers for DMD.	[Vignier, Nicolas; Nelson, Isabelle; Carrier, Lucie; Voit, Thomas; Bonne, Gisele] INSERM, UMRS 974, Paris, France; [Vignier, Nicolas; Nelson, Isabelle; Carrier, Lucie; Voit, Thomas; Bonne, Gisele] Univ Paris 06, CNRS, UM 76, UMR 7215,Inst Myol,IFR14, Paris, France; [Amor, Fatima; Duvallet, Angelique; Poupiot, Jerome; Charrier, Sabine; Montus, Marie; Richard, Isabelle; Israeli, David] Genethon, Evry, France; [Fogel, Paul] Stat Consulting, Paris, France; [Arock, Michel] Grp Hosp Pitie Salpetriere Charles Foix, AP HP, Unite Fonct Hematol & Hemostase, Paris, France; [Richard, Isabelle] CNRS, UMR8587, LAMBE, Evry, France; [Carrier, Lucie] Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Cardiovasc Res Ctr, Hamburg, Germany; [Servais, Laurent] Inst Myol, Dept Therapeut Trials & Databases, Paris, France; [Bonne, Gisele] Grp Hosp Pitie Salpetriere, AP HP, UF Cardiogenet & Myogenet, Serv Biochim Metab, F-75634 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; CEA; CY Cergy Paris Universite; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Israeli, D (corresponding author), Genethon, Evry, France.		Bonne, Gisèle/G-3121-2013; Richard, isabelle/J-8298-2013; Vignier, Nicolas/AAW-8289-2021; Servais, Laurent/AAL-7384-2020	Bonne, Gisèle/0000-0002-2516-3258; Vignier, Nicolas/0000-0003-2663-4864; nelson, isabelle/0000-0001-6390-622X; Fogel, Paul/0000-0002-5398-6622; CHARRIER, Sabine/0000-0001-9399-7492; Servais, Laurent/0000-0001-9270-4061	Association Francaise contre les Myopathies (AFM); ADNA (Advanced Diagnostics for New Therapeutic Approaches); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Pierre et Marie Curie Paris 06; Centre National de la Recherche Scientifique (CNRS); bi-national grant from the Agence Nationale de la Recherche (ANR, France); Bundesministerium fur Bildung und Forshung (BMBF, Germany) [ANR-BMBF-09-GENO-107]	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); ADNA (Advanced Diagnostics for New Therapeutic Approaches); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie Paris 06; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); bi-national grant from the Agence Nationale de la Recherche (ANR, France)(French National Research Agency (ANR)); Bundesministerium fur Bildung und Forshung (BMBF, Germany)(Federal Ministry of Education & Research (BMBF))	This study was financially supported by the Association Francaise contre les Myopathies (AFM); by ADNA (Advanced Diagnostics for New Therapeutic Approaches); the Institut National de la Sante et de la Recherche Medicale (INSERM); the Universite Pierre et Marie Curie Paris 06; the Centre National de la Recherche Scientifique (CNRS); the bi-national grant from the Agence Nationale de la Recherche (ANR, France) and the Bundesministerium fur Bildung und Forshung (BMBF, Germany) (ANR-BMBF-09-GENO-107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Cacchiarelli D, 2011, EMBO REP, V12, P136, DOI 10.1038/embor.2010.208; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; CHAPMAN VM, 1989, P NATL ACAD SCI USA, V86, P1292, DOI 10.1073/pnas.86.4.1292; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696; Fougerousse F, 1998, CIRC RES, V82, P130; Gagan J, 2011, J BIOL CHEM, V286, P19431, DOI 10.1074/jbc.M111.219006; Gasper Mason C, 2005, Med Health R I, V88, P400; Gasper MC, 2005, MED HLTH R I, V88, P400; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; Hermans MCE, 2010, NEUROMUSCULAR DISORD, V20, P479, DOI 10.1016/j.nmd.2010.04.008; Jacoby D, 2012, EUR HEART J, V33, P296, DOI 10.1093/eurheartj/ehr260; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lancioni A, 2011, HUM MOL GENET, V20, P4644, DOI 10.1093/hmg/ddr398; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; McCarthy JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC451, DOI 10.1152/ajpcell.00077.2007; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Meune C, 2011, INT J CARDIOL, V151, P160, DOI 10.1016/j.ijcard.2010.05.005; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mizuno H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018388; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Olivotto I, 2011, J AM COLL CARDIOL, V58, P839, DOI 10.1016/j.jacc.2011.05.018; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Sveen ML, 2008, ARCH NEUROL-CHICAGO, V65, P1196, DOI 10.1001/archneur.65.9.1196; Sylvius N, 2011, FASEB J, V25, P3966, DOI 10.1096/fj.11-182915; Towbin JA, 1998, CURR OPIN CELL BIOL, V10, P131, DOI 10.1016/S0955-0674(98)80096-3; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Vignier N, 2009, CIRC RES, V105, P239, DOI 10.1161/CIRCRESAHA.109.201251; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028	47	77	80	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55281	10.1371/journal.pone.0055281	http://dx.doi.org/10.1371/journal.pone.0055281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418438	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300028
J	Li, ZW; Li, CL; Du, LL; Zhou, Y; Wu, W				Li, Zongwen; Li, Chunliu; Du, Lianlian; Zhou, Yan; Wu, Wei			Human Chorionic Gonadotropin beta Induces Migration and Invasion via Activating ERK1/2 and MMP-2 in Human Prostate Cancer DU145 Cells	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH; HCG; EXTRACELLULAR-SIGNAL-REGULATED-KINASE-1/2; STEROIDOGENESIS; BINDING	We previously demonstrated that human chorionic gonadotropin beta (hCG beta) induced migration and invasion in human prostate cancer cells. However, the involved molecular mechanisms are unclear. Here, we established a stable prostate cancer cell line overexpressing hCG beta and tested hCG beta-triggered signaling pathways causing cell migration and invasion. ELISA showed that the hCG beta amount secreted into medium increased with culture time after the hCG beta-transfected cells were incubated for 3, 6, 9, 12 and 24 h. More, hCG beta standards promoted MAPK (ERK1/2) phosphorylation and increased MMP-2 expression and activity in both dose-and time-dependent manners in hCG beta non-transfected cells. In addition, hCG beta promoted ERK1/2 phosphorylation and increased MMP-2 expression and activity significantly in hCG beta transfected DU145 cells. Whereas ERK1/2 blocker PD98059 (25 mu M) significantly downregulated phosphorylated ERK1/2 and MMP-2. Particularly, hCG beta promoted cell migration and invasion, yet the PD98059 diminished the hCG beta-induced cell motility under those conditions. These results indicated that hCG beta induced cell motility via promoting ERK1/2 phosphorylation and MMP-2 upregulation in human prostate cancer DU145 cells.	[Li, Zongwen; Li, Chunliu; Du, Lianlian; Wu, Wei] Capital Med Univ, Sch Publ Hlth & Family Med, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Zhou, Yan; Wu, Wei] Capital Med Univ, Sch Basic Med Sci, Dept Biochem, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Wu, W (corresponding author), Capital Med Univ, Sch Publ Hlth & Family Med, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China.	weiwu207@ccmu.edu.cn			Science and Development Plan of Beijing Education Committee [KM200910025008]; National Natural Science Foundation of China [81272843]	Science and Development Plan of Beijing Education Committee; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by Science and Development Plan of Beijing Education Committee (grant number: KM200910025008) and National Natural Science Foundation of China (grant number: 81272843). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalinkeel R, 2011, IMMUNOL INVEST, V40, P447, DOI 10.3109/08820139.2011.557795; Armstrong AJ, 2008, UROL ONCOL-SEMIN ORI, V26, P430, DOI 10.1016/j.urolonc.2007.11.006; Babykutty S, 2012, CLIN EXP METASTAS, V29, P471, DOI 10.1007/s10585-012-9464-6; Bao BY, 2006, CARCINOGENESIS, V27, P32, DOI 10.1093/carcin/bgi170; Barqawi AB, 2012, ADV UROLOGY; Chen YY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/378415; Chiu HW, 2012, PLOS ONE; Cole LA, 2012, AM J CANCER RES, V2, P22; Cole LA, 2009, EXPERT REV MOL DIAGN, V9, P51, DOI 10.1586/14737159.9.1.51; Couvelard A, 2004, VIRCHOWS ARCH, V445, P279, DOI 10.1007/s00428-004-1078-1; Darwish OM, 2012, MANAGEMENT BIOCH REC; Dashevsky O, 2009, INT J CANCER, V124, P1773, DOI 10.1002/ijc.24016; de Medeiros SF, 2009, HUM REPROD UPDATE, V15, P69, DOI 10.1093/humupd/dmn036; Fluhr H, 2008, FERTIL STERIL, V90, P1384, DOI [10.1016/j.fertnstert.2007.07.1357, 10.1016/j.fertnstert.2007.08.023]; Fong Y, 2010, J FOOD SCI, V75, pH30, DOI 10.1111/j.1750-3841.2009.01438.x; Iles RK, 2010, MOL CELL ENDOCRINOL, V329, P62, DOI 10.1016/j.mce.2010.07.014; Ilic D, 2012, MATURITAS, V72, P269, DOI 10.1016/j.maturitas.2012.04.014; Jiang C, 2010, CANCER IMMUNOL IMMUN, V59, P1771, DOI 10.1007/s00262-010-0902-5; Khare P, 2012, INDIAN J BIOCHEM BIO, V49, P92; Kim Y, 2009, BMB REP, V42, P758, DOI 10.5483/BMBRep.2009.42.11.758; Leahy M, 2012, EUROPEAN J ONCOLOGY; Liu D, 2012, J UROLOGY, V187, P1241, DOI 10.1016/j.juro.2011.12.015; Manna PR, 2007, J ENDOCRINOL, V193, P53, DOI 10.1677/JOE-06-0201; Martinelle N, 2004, ENDOCRINOLOGY, V145, P4629, DOI 10.1210/en.2004-0496; Massart C, 2005, CLIN CHEM LAB MED, V43, P886, DOI 10.1515/CCLM.2005.150; Nishimura R, 2000, METH MOLEC MED, V39, P135; Prast J, 2008, ENDOCRINOLOGY, V149, P979, DOI 10.1210/en.2007-1282; Reis ST, 2011, INT J BIOL MARKER, V26, P255, DOI 10.5301/JBM.2011.8831; Song MO, 2012, TOXICOLOGY, V292, P23, DOI 10.1016/j.tox.2011.11.013; Stio M, 2011, ANTICANCER RES, V31, P4091; Tan CT, 2008, CARCINOGENESIS, V29, P1519, DOI 10.1093/carcin/bgn108; Tokar E, 2005, CLIN EXP METASTAS, V22, P275, DOI 10.1007/s10585-005-8393-z; Tsai EM, 2008, FERTIL STERIL, V89, P1522, DOI 10.1016/j.fertnstert.2007.05.053; Wilkins-Port CE, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/454368; Wu W, 2006, CANCER-AM CANCER SOC, V106, P68, DOI 10.1002/cncr.21549; Yu HS, 2013, PROSTATE, V73, P89, DOI 10.1002/pros.22544	36	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e54592	10.1371/journal.pone.0054592	http://dx.doi.org/10.1371/journal.pone.0054592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424616	Green Published, gold, Green Submitted			2022-12-27	WOS:000315965100004
J	Campioni, D; Zauli, G; Gambetti, S; Campo, G; Cuneo, A; Ferrari, R; Secchiero, P				Campioni, Diana; Zauli, Giorgio; Gambetti, Stefania; Campo, Gianluca; Cuneo, Antonio; Ferrari, Roberto; Secchiero, Paola			In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome	PLOS ONE			English	Article							PERIPHERAL-BLOOD; CFU-EN; ANGIOGENESIS; NEOVASCULARIZATION; VASCULOGENESIS; MARKERS	Background: The current understanding of the functional characteristics of circulating endothelial progenitor cells (EPC) is limited, especially in patients affected by cardiovascular diseases. In this study, we have analyzed the in vitro clonogenic capacity of circulating EPC, also known as endothelial colony-forming cells (ECFC), in patients with acute coronary syndrome (ACS), in comparison to the colony forming unit-endothelial-like cells (CFU-EC) of hematopoietic/monocytic origin. Methodology/Principal Findings: By culturing peripheral blood mononuclear cells (PBMC) of patients with ACS (n = 70), CFU-EC were frequently isolated (from 77% of ACS patients), while EPC/ECFC were obtained only in a small subset (13%) of PBMC samples, all harvested between 7-14 days after the acute cardiovascular event. Notably, ex-vivo generation of EPC/ECFC was correlated to a higher in vitro release of PDGF-AA by the corresponding ACS patient PBMC. By using specific endothelial culture media, EPC/ECFC displayed in vitro expansion capacity, allowing the phenotypic and functional characterization of the cells. Indeed, after expansion, EPC/ECFC exhibited a normal diploid chromosomal setting by FISH analysis and an immunophenotype characterized by: i) uniform positivity for the expression of CD105, CD31, CD146 and Factor VIII, i) variable expression of the CD34, CD106 and CD184 markers, and iii) negativity for CD45, CD90, CD117 and CD133. Of interest, in single-cell replanting assays EPC/ECFC exhibited clonogenic expansion capacity, forming secondary colonies characterized by variable proliferation capacities. Conclusion/Significance: Our data indicate that a careful characterization of true EPC is needed in order to design future studies in the clinical autologous setting of patients with ACS.	[Campioni, Diana; Cuneo, Antonio] Univ Ferrara, Azienda Osped Univ, Dept Med Sci, Sect Hematol, I-44100 Ferrara, Italy; [Zauli, Giorgio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Gambetti, Stefania; Campo, Gianluca; Ferrari, Roberto] Univ Ferrara, Azienda Osped Univ, Dept Med Sci, Cardiovasc Sect, I-44100 Ferrara, Italy; [Secchiero, Paola] Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy; [Secchiero, Paola] Univ Ferrara, LTTA Ctr, I-44100 Ferrara, Italy	University of Ferrara; Arcispedale Sant'Anna; IRCCS Burlo Garofolo; University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; University of Ferrara	Secchiero, P (corresponding author), Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy.	paola.secchiero@unife.it	Cuneo, Antonio/K-7617-2016; Zauli, Giorgio/ABE-8001-2020; secchiero, paola/G-9689-2015; FERRARI, ROBERTO/ABD-5169-2020; Campioni, Diana/O-4552-2015	secchiero, paola/0000-0003-4101-7987; Campioni, Diana/0000-0003-1650-8354; Campo, Gianluca/0000-0002-5150-188X; Zauli, Giorgio/0000-0002-3750-8698; Ferrari, Roberto/0000-0003-2046-9175	Regione Emilia Romagna- Programma di Ricerca Medicina Rigenerativa, Regione-Universita	Regione Emilia Romagna- Programma di Ricerca Medicina Rigenerativa, Regione-Universita	This work was supported by Regione Emilia Romagna- Programma di Ricerca Medicina Rigenerativa, Regione-Universita 2007/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anghelina M, 2006, AM J PATHOL, V168, P529, DOI 10.2353/ajpath.2006.050255; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Campioni D, 2004, LEUKEMIA RES, V28, P9, DOI 10.1016/S0145-2126(03)00123-1; Campioni D, 2008, HAEMATOL-HEMATOL J, V93, P1233, DOI 10.3324/haematol.12526; Cangiano E, 2011, J THROMB THROMBOLYS, V32, P1, DOI 10.1007/s11239-010-0543-8; Dignat-George F, 2003, PATHOPHYSIOL HAEMO T, V33, P495, DOI 10.1159/000083851; Dominici M, 2001, LEUKEMIA, V15, P171, DOI 10.1038/sj.leu.2401984; Goon PKY, 2007, CYTOM PART B-CLIN CY, V72B, P416, DOI 10.1002/cyto.b.20355; Heldin CH, 2012, UPSALA J MED SCI, V117, P83, DOI 10.3109/03009734.2012.658119; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Jujo K, 2008, J MOL CELL CARDIOL, V45, P530, DOI 10.1016/j.yjmcc.2008.08.003; Khan SS, 2005, CYTOM PART B-CLIN CY, V64B, P1, DOI 10.1002/cyto.b.20040; Lanza F, 2003, BONE MARROW TRANSPL, V32, P1165, DOI 10.1038/sj.bmt.1704279; Lee MJ, 2011, CYTOTHERAPY, V13, P165, DOI 10.3109/14653249.2010.512632; Luttun A, 2003, CARDIOVASC RES, V58, P378, DOI 10.1016/S0008-6363(03)00258-X; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Massa M, 2009, EXP HEMATOL, V37, P8, DOI 10.1016/j.exphem.2008.09.007; Meneveau N, 2011, BASIC RES CARDIOL, V106, P1397, DOI 10.1007/s00395-011-0220-x; Mund JA, 2009, CYTOTHERAPY, V11, P103, DOI 10.1080/14653240802714827; Pakala Rajbabu, 2002, Cardiovasc Radiat Med, V3, P95; Pearson JD, 2009, J THROMB HAEMOST, V7, P255, DOI 10.1111/j.1538-7836.2008.03214.x; Pujol BF, 2001, EUR J CELL BIOL, V80, P99, DOI 10.1078/0171-9335-00136; Rafii S, 2000, J CLIN INVEST, V105, P17, DOI 10.1172/JCI8774; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Schatteman GC, 2007, AM J PHYSIOL-HEART C, V292, pH1, DOI 10.1152/ajpheart.00662.2006; Schmeisser A, 2002, J HEMATOTH STEM CELL, V11, P69, DOI 10.1089/152581602753448540; Shah P, 2012, J ORAL IMPLANTOL; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Strijbos MH, 2007, CYTOM PART B-CLIN CY, V72B, P86, DOI 10.1002/cyto.b.20156; Strijbos MH, 2009, CLIN CANCER RES, V15, P3640, DOI 10.1158/1078-0432.CCR-09-0160; Valgimigli M, 2004, CIRCULATION, V110, P1209, DOI 10.1161/01.CIR.0000136813.89036.21; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	37	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56377	10.1371/journal.pone.0056377	http://dx.doi.org/10.1371/journal.pone.0056377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409178	Green Published, Green Submitted, gold			2022-12-27	WOS:000315100000050
J	Johannessen, LE; Spilsberg, B; Wiik-Nielsen, CR; Kristoffersen, AB; Holst-Jensen, A; Berdal, KG				Johannessen, Lene E.; Spilsberg, Bjorn; Wiik-Nielsen, Christer R.; Kristoffersen, Anja B.; Holst-Jensen, Arne; Berdal, Knut G.			DNA-Fragments Are Transcytosed across CaCo-2 Cells by Adsorptive Endocytosis and Vesicular Mediated Transport	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; NUCLEIC-ACID CHANNEL; COLONIC HOMEOSTASIS; MAMMALIAN-CELLS; TH1/TH2 BALANCE; BACTERIAL-DNA; DIETARY DNA; FOREIGN DNA; PROTEINS; IMMUNITY	Dietary DNA is degraded into shorter DNA-fragments and single nucleosides in the gastrointestinal tract. Dietary DNA is mainly taken up as single nucleosides and bases, but even dietary DNA-fragments of up to a few hundred bp are able to cross the intestinal barrier and enter the blood stream. The molecular mechanisms behind transport of DNA-fragments across the intestine and the effects of this transport on the organism are currently unknown. Here we investigate the transport of DNA-fragments across the intestinal barrier, focusing on transport mechanisms and rates. The human intestinal epithelial cell line CaCo-2 was used as a model. As DNA material a PCR-fragment of 633 bp was used and quantitative real time PCR was used as detection method. DNA-fragments were found to be transported across polarized CaCo-2 cells in the apical to basolateral direction (AB). After 90 min the difference in directionality AB vs. BA was >10(3) fold. Even undegraded DNA-fragments of 633 bp could be detected in the basolateral receiver compartment at this time point. Transport of DNA-fragments was sensitive to low temperature and inhibition of endosomal acidification. DNA-transport across CaCo-2 cells was not competed out with oligodeoxynucleotides, fucoidan, heparin, heparan sulphate and dextrane sulphate, while linearized plasmid DNA, on the other hand, reduced transcytosis of DNA-fragments by a factor of approximately 2. Our findings therefore suggest that vesicular transport is mediating transcytosis of dietary DNA-fragments across intestinal cells and that DNA binding proteins are involved in this process. If we extrapolate our findings to in vivo conditions it could be hypothesized that this transport mechanism has a function in the immune system.	[Johannessen, Lene E.; Spilsberg, Bjorn; Wiik-Nielsen, Christer R.; Kristoffersen, Anja B.; Holst-Jensen, Arne; Berdal, Knut G.] Norwegian Vet Inst, Oslo, Norway	Norwegian Veterinary Institute	Holst-Jensen, A (corresponding author), Norwegian Vet Inst, Oslo, Norway.	arne.holst-jensen@vetinst.no	Holst-Jensen, Arne/F-8531-2019	Holst-Jensen, Arne/0000-0002-5111-7765	Norwegian Research Council [172151/S40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was funded by the Norwegian Research Council (www.forskningsradet.no), grant number 172151/S40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADSON A, 1994, J PHARM SCI, V83, P1529, DOI 10.1002/jps.2600831103; Altschuler Y, 2003, CURR OPIN CELL BIOL, V15, P423, DOI 10.1016/S0955-0674(03)00084-X; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Basner-Tschakarjan E, 2004, GENE THER, V11, P765, DOI 10.1038/sj.gt.3302221; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Doerfler W, 2012, EPIGENOMICS-UK, V4, P41, DOI [10.2217/EPI.11.111, 10.2217/epi.11.111]; Einspanier R, 2001, EUR FOOD RES TECHNOL, V212, P129, DOI 10.1007/s002170000248; Forsman A, 2003, MOL GENET GENOMICS, V270, P362, DOI 10.1007/s00438-003-0930-3; Gil A, 2002, EUR J CLIN NUTR, V56, pS1, DOI 10.1038/sj.ejcn.1601475; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Gursel M, 2006, J IMMUNOL, V177, P1575, DOI 10.4049/jimmunol.177.3.1575; Hanss B, 1998, P NATL ACAD SCI USA, V95, P1921, DOI 10.1073/pnas.95.4.1921; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Incorporated C, 2002, CELL CULT PROT CLS A; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leal-Pinto E, 2005, AM J PHYSIOL-RENAL, V289, pF97, DOI 10.1152/ajprenal.00196.2004; Lee J, 2008, SEMIN IMMUNOPATHOL, V30, P3, DOI 10.1007/s00281-007-0099-7; Lee JD, 2007, CURR OPIN GASTROEN, V23, P27, DOI 10.1097/MOG.0b013e3280118272; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Lehmann MJ, 2005, GENE THER, V12, P446, DOI 10.1038/sj.gt.3302428; Liu JW, 2007, WORLD J GASTROENTERO, V13, P3847; Mazzara M, 2005, 21825ENJRC32103 EUR; Nielsen C, 2005, EUR FOOD RES TECHNOL, V221, P1, DOI 10.1007/s00217-005-1160-1; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Reuter T, 2003, EUR FOOD RES TECHNOL, V216, P185, DOI 10.1007/s00217-002-0642-7; Schubbert R, 1997, P NATL ACAD SCI USA, V94, P961, DOI 10.1073/pnas.94.3.961; Shi FX, 2007, OLIGONUCLEOTIDES, V17, P122, DOI 10.1089/oli.2007.0034; Sissener NH, 2010, BRIT J NUTR, V103, P3, DOI 10.1017/S0007114509991401; Sudo N, 2000, CLIN EXP ALLERGY, V30, P979, DOI 10.1046/j.1365-2222.2000.00811.x; Sudo N, 2004, INT ARCH ALLERGY IMM, V135, P132, DOI 10.1159/000080655; Wang HP, 2012, VIRUS RES, V167, P48, DOI 10.1016/j.virusres.2012.04.001; Watanabe T, 2010, BIOL PHARM BULL, V33, P796, DOI 10.1248/bpb.33.796; Wittrup A, 2007, J BIOL CHEM, V282, P27897, DOI 10.1074/jbc.M701611200; Wu-Pong S, 1999, BIOPHARM DRUG DISPOS, V20, P411, DOI 10.1002/1099-081X(199912)20:9<411::AID-BDD208>3.0.CO;2-4	35	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56671	10.1371/journal.pone.0056671	http://dx.doi.org/10.1371/journal.pone.0056671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409196	Green Published, Green Submitted, gold			2022-12-27	WOS:000315100000060
J	Jenke, AC; Postberg, J; Raine, T; Nayak, KM; Molitor, M; Wirth, S; Kaser, A; Parkes, M; Heuschkel, RB; Orth, V; Zilbauer, M				Jenke, Andreas C.; Postberg, Jan; Raine, Timothy; Nayak, Komal M.; Molitor, Malte; Wirth, Stefan; Kaser, Arthur; Parkes, Miles; Heuschkel, Robert B.; Orth, Valerie; Zilbauer, Matthias			DNA Methylation Analysis in the Intestinal Epithelium-Effect of Cell Separation on Gene Expression and Methylation Profile	PLOS ONE			English	Article							DITHIOTHREITOL; DISEASE	Background: Epigenetic signatures are highly cell type specific. Separation of distinct cell populations is therefore desirable for all epigenetic studies. However, to date little information is available on whether separation protocols might influence epigenetic and/or gene expression signatures and hence might be less beneficial. We investigated the influence of two frequently used protocols to isolate intestinal epithelium cells (IECs) from 6 healthy individuals. Materials and Methods: Epithelial cells were isolated from small bowel (i.e. terminal ileum) biopsies using EDTA/DTT and enzymatic release followed by magnetic bead sorting via EPCAM labeled microbeads. Effects on gene/mRNA expression were analyzed using a real time PCR based expression array. DNA methylation was assessed by pyrosequencing of bisulfite converted DNA and methylated DNA immunoprecipitation (MeDIP). Results: While cell purity was >95% using both cell separation approaches, gene expression analysis revealed significantly higher mRNA levels of several inflammatory genes in EDTA/DTT when compared to enzymatically released cells. In contrast, DNA methylation of selected genes was less variable and only revealed subtle differences. Comparison of DNA methylation of the epithelial cell marker EPCAM in unseparated whole biopsy samples with separated epithelium (i.e. EPCAM positive and negative fraction) demonstrated significant differences in DNA methylation between all three tissue fractions indicating cell type specific methylation patterns can be masked in unseparated tissue samples. Conclusions: Taken together, our data highlight the importance of considering the potential effect of cell separation on gene expression as well as DNA methylation signatures. The decision to separate tissue samples will therefore depend on study design and specific separation protocols.	[Jenke, Andreas C.; Nayak, Komal M.; Molitor, Malte; Heuschkel, Robert B.; Zilbauer, Matthias] Univ Cambridge, Addenbrookes Hosp, Dept Paediat Gastroenterol Hepatol & Nutr, Cambridge CB2 2QQ, England; [Jenke, Andreas C.; Postberg, Jan; Molitor, Malte; Wirth, Stefan; Orth, Valerie] Univ Witten Herdecke, HELIOS Childrens Hosp, Dept Neonatol, Wuppertal, Germany; [Raine, Timothy; Kaser, Arthur; Parkes, Miles] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Gastroenterol & Hepatol, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Witten Herdecke University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Zilbauer, M (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Paediat Gastroenterol Hepatol & Nutr, Cambridge CB2 2QQ, England.	mz304@medschl.cam.ac.uk	Jenke, Andreas/AAO-2291-2020; Zilbauer, Matthias/AAZ-2740-2020	Jenke, Andreas/0000-0002-4008-7185; Zilbauer, Matthias/0000-0002-7272-0547; Parkes, Miles/0000-0002-6467-0631; Postberg, Jan/0000-0002-8562-3316; Raine, Tim/0000-0002-5855-9873	CICRA (Crohn's in Childhood Research Association); 3Cs (Crohn's and Colitis in Childhood)	CICRA (Crohn's in Childhood Research Association); 3Cs (Crohn's and Colitis in Childhood)	This work was supported by CICRA (Crohn's in Childhood Research Association) and the 3Cs (Crohn's and Colitis in Childhood). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTNIK W, 1980, GASTROENTEROLOGY, V78, P976; Bocker MT, 2011, BLOOD, V117, pE182, DOI 10.1182/blood-2011-01-331926; BULL DM, 1977, J CLIN INVEST, V59, P966, DOI 10.1172/JCI108719; Cooke J, 2012, INFLAMM BOWEL DIS, V18, P2128, DOI 10.1002/ibd.22942; EVANS GS, 1992, J CELL SCI, V101, P219; GIBSON PR, 1989, GASTROENTEROLOGY, V96, P283, DOI 10.1016/0016-5085(89)91549-7; HELD KD, 1987, RADIAT RES, V112, P544, DOI 10.2307/3577106; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Mohn F, 2009, TRENDS GENET, V25, P129, DOI 10.1016/j.tig.2008.12.005; Nimmo ER, 2012, INFLAMM BOWEL DIS, V18, P889, DOI 10.1002/ibd.21912; Takahashi K, 2011, J BIOL CHEM, V286, P35755, DOI 10.1074/jbc.M111.271007; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; Uematsu S, 2010, MICROBIOL IMMUNOL, V54, P645, DOI 10.1111/j.1348-0421.2010.00267.x; VALETTI C, 1994, MOL BIOL CELL, V5, P1311, DOI 10.1091/mbc.5.12.1311; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	16	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55636	10.1371/journal.pone.0055636	http://dx.doi.org/10.1371/journal.pone.0055636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409010	gold, Green Submitted, Green Published			2022-12-27	WOS:000314660300025
J	Brzoska, AJ; Hassan, KA; de Leon, EJ; Paulsen, IT; Lewis, PJ				Brzoska, Anthony J.; Hassan, Karl A.; de Leon, Ellen J.; Paulsen, Ian T.; Lewis, Peter J.			Single-Step Selection of Drug Resistant Acinetobacter baylyi ADP1 Mutants Reveals a Functional Redundancy in the Recruitment of Multidrug Efflux Systems	PLOS ONE			English	Article							MESSENGER-RNA; BAUMANNII; PUMP; SUSCEPTIBILITY; TRANSPORTERS; ANTIBIOTICS; EXPRESSION; STABILITY; ADEIJK	Members of the genus Acinetobacter have been the focus recent attention due to both their clinical significance and application to molecular biology. The soil commensal bacterium Acinetobacter baylyi ADP1 has been proposed as a model system for molecular and genetic studies, whereas in a clinical environment, Acinetobacter spp. are of increasing importance due to their propensity to cause serious and intractable systemic infections. Clinically, a major factor in the success of Acinetobacter spp. as opportunistic pathogens can be attributed to their ability to rapidly evolve resistance to common antimicrobial compounds. Whole genome sequencing of clinical and environmental Acinetobacter spp. isolates has revealed the presence of numerous multidrug transporters within the core and accessory genomes, suggesting that efflux is an important host defense response in this genus. In this work, we used the drug-susceptible organism A. baylyi ADP1 as a model for studies into the evolution of efflux mediated resistance in genus Acinetobacter, due to the high level of conservation of efflux determinants across four diverse Acinetobacter strains, including clinical isolates. A single exposure of therapeutic concentrations of chloramphenicol to populations of A. baylyi ADP1 cells produced five individual colonies displaying multidrug resistance. The major facilitator superfamily pump craA was upregulated in one mutant strain, whereas the resistance nodulation division pump adeJ was upregulated in the remaining four. Within the adeJ upregulated population, two different levels of adeJ mRNA transcription were observed, suggesting at least three separate mutations were selected after single-step exposure to chloramphenicol. In the craA upregulated strain, a T to G substitution 12 nt upstream of the craA translation initiation codon was observed. Subsequent mRNA stability analyses using this strain revealed that the half-life of mutant craA mRNA was significantly greater than that of wild-type craA mRNA.	[Brzoska, Anthony J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Brzoska, Anthony J.; Hassan, Karl A.; Paulsen, Ian T.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Brzoska, Anthony J.; Lewis, Peter J.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [de Leon, Ellen J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia	University of Sydney; Macquarie University; University of Newcastle; University of Queensland	Brzoska, AJ (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	Anthony.Brzoska@sydney.edu.au	Paulsen, Ian/K-3832-2012; Hassan, Karl/B-2802-2013	Paulsen, Ian/0000-0001-9015-9418; Hassan, Karl/0000-0003-2031-9679	National Health and Medical Research Council (NHMRC) [APP1021479, 535053]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC; http://www.nhmrc.gov.au/) project grant APP1021479 to PJL and by NHMRC project grant 535053 to ITP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Beceiro A, 2007, J ANTIMICROB CHEMOTH, V59, P996, DOI 10.1093/jac/dkm070; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Chastre J, 2000, Semin Respir Infect, V15, P287; Coyne S, 2011, ANTIMICROB AGENTS CH, V55, P947, DOI 10.1128/AAC.01388-10; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P333, DOI 10.1128/AAC.01037-09; Damier-Piolle L, 2008, ANTIMICROB AGENTS CH, V52, P557, DOI 10.1128/AAC.00732-07; de Berardinis V, 2009, CURR OPIN MICROBIOL, V12, P568, DOI 10.1016/j.mib.2009.07.005; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Elliott KT, 2011, IUBMB LIFE, V63, P1075, DOI 10.1002/iub.530; Fournier B, 2001, J BACTERIOL, V183, P2367, DOI 10.1128/JB.183.7.2367-2371.2001; Lee A, 2000, J BACTERIOL, V182, P3142, DOI 10.1128/JB.182.11.3142-3150.2000; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Metzgar D, 2004, NUCLEIC ACIDS RES, V32, P5780, DOI 10.1093/nar/gkh881; Michalopoulos A, 2010, EXPERT OPIN PHARMACO, V11, P779, DOI 10.1517/14656561003596350; Nikaido Hiroshi, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P1; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ohki R, 2004, J BACTERIOL, V186, P7450, DOI 10.1128/JB.186.21.7450-7455.2004; Petersen C, 1993, CONTROL MESSENGER RN, P117; RAINEY FA, 1994, FEMS MICROBIOL LETT, V124, P349, DOI 10.1016/0378-1097(94)00453-6; Rajamohan G, 2010, J ANTIMICROB CHEMOTH, V65, P228, DOI 10.1093/jac/dkp427; Reams AB, 2003, MOL MICROBIOL, V47, P1291, DOI 10.1046/j.1365-2958.2003.03342.x; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Roca I, 2009, ANTIMICROB AGENTS CH, V53, P4013, DOI 10.1128/AAC.00584-09; Rosenfeld N, 2012, ANTIMICROB AGENTS CH, V56, P2504, DOI 10.1128/AAC.06422-11; Rozen S, 2000, Methods Mol Biol, V132, P365; Tal N, 2009, P NATL ACAD SCI USA, V106, P9051, DOI 10.1073/pnas.0902400106; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; VILA J, 1993, ANTIMICROB AGENTS CH, V37, P138, DOI 10.1128/AAC.37.1.138; Warner DM, 2008, MOL MICROBIOL, V70, P462, DOI 10.1111/j.1365-2958.2008.06424.x; Wieczorek P, 2008, FOLIA HISTOCHEM CYTO, V46, P257, DOI 10.2478/v10042-008-0056-x; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521	32	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56090	10.1371/journal.pone.0056090	http://dx.doi.org/10.1371/journal.pone.0056090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409126	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200106
J	Kim, MJ; Park, HS; Seo, KH; Yang, HJ; Kim, SK; Choi, JH				Kim, Min-Ji; Park, Hyun Soo; Seo, Kyung Hye; Yang, Hyo-Jin; Kim, Sook-Kyung; Choi, Jun-Hyuk			Complete Solubilization and Purification of Recombinant Human Growth Hormone Produced in Escherichia coli	PLOS ONE			English	Article							SECONDARY STRUCTURE; INCLUSION-BODIES; PROTEIN; EXPRESSION; QUANTIFICATION; AUTOINDUCTION; STRATEGIES; RETENTION; PROLACTIN; SECRETION	High-level expression of recombinant human growth hormone (hGH) in Escherichia coli (E. coli) leads to the formation of insoluble aggregates as inclusion bodies devoid of biological activity. Until recently, significant efforts have been made to improve the recovery of active hGH from inclusion bodies. Here, we developed an efficient procedure for the production of completely soluble hGH by minimizing the formation of inclusion bodies and optimizing protein purification conditions. Under the newly established conditions we were able to obtain most of the total hGH in the soluble fraction. We show that the soluble protein can be efficiently purified in high yield by a series of chromatographic procedures. We analyzed the resulting hGH using various analytical techniques such as reversed-phase high-performance liquid chromatography (RP-HPLC), size-exclusion chromatography (SEC), matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry, and circular dichroism (CD). These multiple analyses support the conclusion that we obtained highly pure hGH with the expected molecular mass and intact secondary structure. The biological activity of purified hGH was also confirmed by evaluating its growth-promoting effect using a cell proliferation assay. Taken together, we describe a straightforward strategy for the production of completely soluble and biologically active hGH in E. coli.	[Kim, Min-Ji; Park, Hyun Soo; Seo, Kyung Hye; Yang, Hyo-Jin; Kim, Sook-Kyung; Choi, Jun-Hyuk] Korea Res Inst Stand & Sci, Dept Metrol Qual Life, Ctr Bioanal, Taejon, South Korea; [Kim, Min-Ji; Yang, Hyo-Jin; Kim, Sook-Kyung] Univ Sci & Technol, Dept Bioanalyt Sci, Daejion, South Korea	Korea Research Institute of Standards & Science (KRISS)	Choi, JH (corresponding author), Korea Res Inst Stand & Sci, Dept Metrol Qual Life, Ctr Bioanal, 1 Doryong Dong, Taejon, South Korea.	junchoi@kriss.re.kr	kim, minji/GRX-9996-2022	Kim, Doeun/0000-0001-9579-3071	Korea Research Institute of Standards and Science [12011021]	Korea Research Institute of Standards and Science	This work was supported by the Korea Research Institute of Standards and Science under the project "Development of Protein Measurement Standards", Grant 12011021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; BECKER GW, 1986, FEBS LETT, V204, P145, DOI 10.1016/0014-5793(86)81403-X; BEWLEY TA, 1969, BIOCHEMISTRY-US, V8, P4701, DOI 10.1021/bi00840a007; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPBELL RM, 1990, P SOC EXP BIOL MED, V193, P269; CHANG CN, 1987, GENE, V55, P189, DOI 10.1016/0378-1119(87)90279-4; DATAR RV, 1993, BIO-TECHNOL, V11, P349, DOI 10.1038/nbt0393-349; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DIXON JS, 1966, SCIENCE, V154, P785, DOI 10.1126/science.154.3750.785; Fahnert B, 2004, ADV BIOCHEM ENG BIOT, V89, P93; Francis DM, 2010, CURR PROTOC PROTEIN, V24, P21; Garcia-Barros M, 2000, HORM RES, V53, P40, DOI 10.1159/000023512; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; GOEDDEL DV, 1979, NATURE, V281, P544, DOI 10.1038/281544a0; GRAY GL, 1985, GENE, V39, P247, DOI 10.1016/0378-1119(85)90319-1; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; IKEHARA M, 1984, P NATL ACAD SCI-BIOL, V81, P5956, DOI 10.1073/pnas.81.19.5956; ISAKSSON OGP, 1985, ANNU REV PHYSIOL, V47, P483, DOI 10.1146/annurev.ph.47.030185.002411; Jeong JS, 2011, J CHROMATOGR A, V1218, P6596, DOI 10.1016/j.chroma.2011.07.053; Khan RH, 1998, BIOTECHNOL PROGR, V14, P722, DOI 10.1021/bp980071q; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NECESSARY PC, 1985, MOL CELL ENDOCRINOL, V39, P247, DOI 10.1016/0303-7207(85)90068-1; Patra AK, 2000, PROTEIN EXPRES PURIF, V18, P182, DOI 10.1006/prep.1999.1179; Sadaf S, 2007, BIOTECHNOL APPL BIOC, V47, P21, DOI 10.1042/BA20060154; Shin NK, 1998, J BIOTECHNOL, V62, P143, DOI 10.1016/S0168-1656(98)00054-6; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Soares CRJ, 2003, PROTEIN ENG, V16, P1131, DOI 10.1093/protein/gzg114; Sonoda H, 2008, BIOSCI BIOTECH BIOCH, V72, P2675, DOI 10.1271/bbb.80332; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; St John RJ, 2001, J BIOL CHEM, V276, P46856, DOI 10.1074/jbc.M107671200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TANAKA T, 1980, J CLIN ENDOCR METAB, V51, P1058, DOI 10.1210/jcem-51-5-1058	35	35	41	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56168	10.1371/journal.pone.0056168	http://dx.doi.org/10.1371/journal.pone.0056168			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409149	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200120
J	Boutin, H; Prenant, C; Maroy, R; Galea, J; Greenhalgh, AD; Smigova, A; Cawthorne, C; Julyan, P; Wilkinson, SM; Banister, SD; Brown, G; Herholz, K; Kassiou, M; Rothwell, NJ				Boutin, Herve; Prenant, Christian; Maroy, Renaud; Galea, James; Greenhalgh, Andrew D.; Smigova, Alison; Cawthorne, Christopher; Julyan, Peter; Wilkinson, Shane M.; Banister, Samuel D.; Brown, Gavin; Herholz, Karl; Kassiou, Michael; Rothwell, Nancy J.			[(18) F]DPA-714: Direct Comparison with [C-11]PK11195 in a Model of Cerebral Ischemia in Rats	PLOS ONE			English	Article							BENZODIAZEPINE BINDING-SITES; PROTEIN 18 KDA; POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE; ARTERY OCCLUSION; FOCAL ISCHEMIA; IN-VIVO; MICROGLIAL ACTIVATION; <PK-H-3 11195; PLASMA INPUT	Purpose: Neuroinflammation is involved in several brain disorders and can be monitored through expression of the translocator protein 18 kDa (TSPO) on activated microglia. In recent years, several new PET radioligands for TSPO have been evaluated in disease models. [F-18]DPA-714 is a TSPO radiotracer with great promise; however results vary between different experimental models of neuroinflammation. To further examine the potential of [F-18]DPA-714, it was compared directly to [C-11]PK11195 in experimental cerebral ischaemia in rats. Methods: Under anaesthesia, the middle cerebral artery of adult rats was occluded for 60 min using the filament model. Rats were allowed recovery for 5 to 7 days before one hour dynamic PET scans with [C-11]PK11195 and/or [F-18]DPA-714 under anaesthesia. Results: Uptake of [C-11]PK11195 vs [F-18]DPA-714 in the ischemic lesion was similar (core/contralateral ratio: 2.84 +/- 0.67 vs 2.28 +/- 0.34 respectively), but severity of the brain ischemia and hence ligand uptake in the lesion appeared to vary greatly between animals scanned with [C-11]PK11195 or with [F-18]DPA-714. To solve this issue of inter-individual variability, we performed a direct comparison of [C-11]PK11195 and [F-18]DPA-714 by scanning the same animals sequentially with both tracers within 24 h. In this direct comparison, the core/contralateral ratio (3.35 +/- 1.21 vs 4.6 +/- 62.50 for [C-11]PK11195 vs [F-18]DPA-714 respectively) showed a significantly better signal-to-noise ratio (1.6 (1.3-1.9, 95% CI) fold by linear regression) for [F-18]DPA-714. Conclusions: In a clinically relevant model of neuroinflammation, uptake for both radiotracers appeared to be similar at first, but a high variability was observed in our model. Therefore, to truly compare tracers in such models, we performed scans with both tracers in the same animals. By doing so, our result demonstrated that [F-18]DPA-714 displayed a higher signal-tonoise ratio than [C-11]PK11195. Our results suggest that, with the longer half-life of [F-18]which facilitates distribution of the tracer across PET centre, [F-18]DPA-714 is a good alternative for TSPO imaging.	[Boutin, Herve] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Boutin, Herve; Prenant, Christian; Smigova, Alison; Cawthorne, Christopher; Brown, Gavin; Herholz, Karl] Univ Manchester, Wolfson Mol Imaging Ctr, Manchester, Lancs, England; [Maroy, Renaud] Commissariat Energie Atom, Serv Hosp Frederic Joliot, Orsay, France; [Galea, James; Greenhalgh, Andrew D.; Rothwell, Nancy J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Galea, James] Salford Royal NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Brain Injury Res Grp, Salford, Lancs, England; [Julyan, Peter] Christie Hosp, Manchester, Lancs, England; [Wilkinson, Shane M.; Banister, Samuel D.; Kassiou, Michael] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Kassiou, Michael] Univ Sydney, Discipline Med Radiat Sci, Sydney, NSW 2006, Australia; [Kassiou, Michael] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia	University of Manchester; University of Manchester; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; University of Manchester; Salford Royal NHS Foundation Trust; Christie NHS Foundation Trust; Christie Hospital; University of Sydney; University of Sydney; University of Sydney	Boutin, H (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England.	herve.boutin@manchester.ac.uk	Boutin, Herve/C-4532-2011; Cawthorne, Christopher/AAC-1018-2022; Cawthorne, Christopher J/Q-5512-2018; Banister, Samuel/G-8501-2012	Cawthorne, Christopher/0000-0002-5975-0354; Cawthorne, Christopher J/0000-0002-5975-0354; Banister, Samuel/0000-0002-4690-4318; Kassiou, Michael/0000-0002-6655-0529; Boutin, Herve/0000-0002-0029-5246; Herholz, Karl/0000-0002-8658-0151	Wolfson Molecular Imaging Centre, Manchester; MRC, UK; European Union [HEALTH-F2-2011-278850 (INMiND)]; Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust; University of Manchester Strategic Fund; MRC [G19/41] Funding Source: UKRI; Medical Research Council [G19/41] Funding Source: researchfish	Wolfson Molecular Imaging Centre, Manchester; MRC, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Manchester Strategic Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wolfson Molecular Imaging Centre, Manchester; Prof. N. Rothwell is funded by MRC, UK; Dr H. Boutin was funded by MRC, UK and is now funded by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no HEALTH-F2-2011-278850 (INMiND). The Bioimaging Facility microscopes used in this study were purchased with grants from Biotechnology and Biological Sciences Research Council (BBSRC), Wellcome Trust and the University of Manchester Strategic Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspey BS, 2000, NEUROPATH APPL NEURO, V26, P232, DOI 10.1046/j.1365-2990.2000.00221.x; BENAVIDES J, 1984, EUR J PHARMACOL, V99, P1, DOI 10.1016/0014-2999(84)90425-4; BENAVIDES J, 1990, BRAIN RES, V522, P275, DOI 10.1016/0006-8993(90)91472-S; BENAVIDES J, 1983, J NEUROCHEM, V41, P1744, DOI 10.1111/j.1471-4159.1983.tb00888.x; Boutin H, 2007, J NUCL MED, V48, P573, DOI 10.2967/jnumed.106.036764; CAMSONNE R, 1984, J LABELLED COMPD RAD, V21, P985, DOI 10.1002/jlcr.2580211012; Cawthorne C, 2011, BRIT J PHARMACOL, V162, P659, DOI 10.1111/j.1476-5381.2010.01068.x; Chauveau F, 2011, EUR J NUCL MED MOL I, V38, P509, DOI 10.1007/s00259-010-1628-5; Chauveau F, 2009, J NUCL MED, V50, P468, DOI 10.2967/jnumed.108.058669; Chauveau F, 2008, EUR J NUCL MED MOL I, V35, P2304, DOI 10.1007/s00259-008-0908-9; CREMER JE, 1992, NUCL MED BIOL, V19, P159; Damont A, 2011, BIOORG MED CHEM LETT, V21, P4819, DOI 10.1016/j.bmcl.2011.06.048; Dolle F, 2009, CURR MED CHEM, V16, P2899, DOI 10.2174/092986709788803150; Doorduin J, 2009, MOL IMAGING BIOL, V11, P386, DOI 10.1007/s11307-009-0211-6; Gerhard A, 2005, NEUROIMAGE, V24, P591, DOI 10.1016/j.neuroimage.2004.09.034; Gildersleeve DL, 1996, NUCL MED BIOL, V23, P23, DOI 10.1016/0969-8051(95)02007-1; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; GROOM GN, 1995, J NUCL MED, V36, P2207; Hastings DL, 2007, NUCL INSTRUM METH A, V573, P80, DOI 10.1016/j.nima.2006.11.037; Imaizumi M, 2007, NEUROSCI LETT, V411, P200, DOI 10.1016/j.neulet.2006.09.093; James ML, 2008, J NUCL MED, V49, P814, DOI 10.2967/jnumed.107.046151; JUNCK L, 1989, ANN NEUROL, V26, P752, DOI 10.1002/ana.410260611; Kropholler MA, 2005, J CEREBR BLOOD F MET, V25, P842, DOI 10.1038/sj.jcbfm.9600092; Kropholler MA, 2007, J CEREBR BLOOD F MET, V27, P1965, DOI 10.1038/sj.jcbfm.9600488; Kropholler MA, 2006, J CEREBR BLOOD F MET, V26, P1431, DOI 10.1038/sj.jcbfm.9600289; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; LEFUR G, 1983, LIFE SCI, V33, P449, DOI 10.1016/0024-3205(83)90794-4; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Luus C, 2010, J LABELLED COMPD RAD, V53, P501, DOI 10.1002/jlcr.1752; Maroy R, 2010, MED PHYS, V37, P1507, DOI 10.1118/1.3327454; Maroy R, 2008, IEEE T MED IMAGING, V27, P342, DOI 10.1109/TMI.2007.905106; Martin A, 2010, J CEREBR BLOOD F MET, V30, P230, DOI 10.1038/jcbfm.2009.205; Mrak RE, 2001, NEUROBIOL AGING, V22, P903, DOI 10.1016/S0197-4580(01)00287-1; OLIFF HS, 1995, BRAIN RES, V675, P20, DOI 10.1016/0006-8993(95)00033-M; Owen D.R., 2010, J CEREB BLOOD FLOW M; Owen DRJ, 2011, J NUCL MED, V52, P24, DOI 10.2967/jnumed.110.079459; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Pappata S, 2000, NEUROLOGY, V55, P1052, DOI 10.1212/WNL.55.7.1052; PAPPATA S, 1991, J NUCL MED, V32, P1608; Reader AJ, 2002, IEEE T NUCL SCI, V49, P693, DOI 10.1109/TNS.2002.1039550; Rojas S, 2007, J CEREBR BLOOD F MET, V27, P1975, DOI 10.1038/sj.jcbfm.9600500; Schuitemaker A, 2007, NEUROIMAGE, V35, P1473, DOI 10.1016/j.neuroimage.2007.02.013; Schuiternaker A, 2007, J CEREBR BLOOD F MET, V27, P1603, DOI 10.1038/sj.jcbfm.9600459; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; SETTE G, 1993, STROKE, V24, P2046, DOI 10.1161/01.STR.24.12.2046; Shaftel SS, 2008, J NEUROINFLAMM, V5, P1742; Thominiaux C, 2010, J LABELLED COMPD RAD, V53, P767, DOI 10.1002/jlcr.1794; Touzani O, 1999, J NEUROIMMUNOL, V100, P203, DOI 10.1016/S0165-5728(99)00202-7; Welsh P, 2008, STROKE, V39, P2226, DOI 10.1161/STROKEAHA.107.504498	50	70	70	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56441	10.1371/journal.pone.0056441	http://dx.doi.org/10.1371/journal.pone.0056441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418569	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300162
J	Capocasa, M; Battaggia, C; Anagnostou, P; Montinaro, F; Boschi, I; Ferri, G; Alu, M; Coia, V; Crivellaro, F; Bisol, GD				Capocasa, Marco; Battaggia, Cinzia; Anagnostou, Paolo; Montinaro, Francesco; Boschi, Ilaria; Ferri, Gianmarco; Alu, Milena; Coia, Valentina; Crivellaro, Federica; Bisol, Giovanni Destro			Detecting Genetic Isolation in Human Populations: A Study of European Language Minorities	PLOS ONE			English	Article							Y-CHROMOSOME; LINKAGE DISEQUILIBRIUM; MITOCHONDRIAL; GENOME; MTDNA; SHOW; LANDSCAPE; MIGRATION; TOOLS; RATES	The identification of isolation signatures is fundamental to better understand the genetic structure of human populations and to test the relations between cultural factors and genetic variation. However, with current approaches, it is not possible to distinguish between the consequences of long-term isolation and the effects of reduced sample size, selection and differential gene flow. To overcome these limitations, we have integrated the analysis of classical genetic diversity measures with a Bayesian method to estimate gene flow and have carried out simulations based on the coalescent. Combining these approaches, we first tested whether the relatively short history of cultural and geographical isolation of four "linguistic islands'' of the Eastern Alps (Lessinia, Sauris, Sappada and Timau) had left detectable signatures in their genetic structure. We then compared our findings to previous studies of European population isolates. Finally, we explored the importance of demographic and cultural factors in shaping genetic diversity among the groups under study. A combination of small initial effective size and continued genetic isolation from surrounding populations seems to provide a coherent explanation for the diversity observed among Sauris, Sappada and Timau, which was found to be substantially greater than in other groups of European isolated populations. Simulations of micro-evolutionary scenarios indicate that ethnicity might have been important in increasing genetic diversity among these culturally related and spatially close populations.	[Battaggia, Cinzia; Anagnostou, Paolo; Bisol, Giovanni Destro] Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy; [Capocasa, Marco; Bisol, Giovanni Destro] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, Rome, Italy; [Capocasa, Marco; Anagnostou, Paolo] Ist Italiano Antropol, Rome, Italy; [Montinaro, Francesco; Boschi, Ilaria] Univ Cattolica, Fac Med, Ist Med Legale, Rome, Italy; [Ferri, Gianmarco; Alu, Milena] Univ Modena & Reggio Emilia, Dipartimento ad Attivita Integrata Lab, Modena, Italy; [Coia, Valentina] Univ Trento, Dipartimento Filosofia Storia & Beni Culturali, Trento, Italy; [Crivellaro, Federica] Leverhulme Ctr Human Evolutionary Studies, Div Biol Anthropol, Cambridge, England	Sapienza University Rome; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Universita di Modena e Reggio Emilia; University of Trento; University of Cambridge	Bisol, GD (corresponding author), Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy.	destrobisol@uniroma1.it	Capocasa, Marco/AAF-8315-2021; Montinaro, Francesco/HDM-8551-2022	Destro Bisol, Giovanni/0000-0002-4232-9715; Crivellaro, Federica/0000-0003-1656-8605; Anagnostou, Paolo/0000-0003-0768-4612; Montinaro, Francesco/0000-0002-4506-963X	Ministero dell'Istruzione, dell'Universita e della Ricerca [2007TYXE3X, 200975T9EW]; Istituto Italiano di Antropologia	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Istituto Italiano di Antropologia	The authors' research was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN 2007-2009, prot n. 2007TYXE3X; PRIN 2009-2011, prot. n. 200975T9EW) and the Istituto Italiano di Antropologia (project Atlante bioculturale Italiano). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Ballantyne KN, 2010, AM J HUM GENET, V87, P341, DOI 10.1016/j.ajhg.2010.08.006; Barbujani G, 2010, TRENDS GENET, V26, P285, DOI 10.1016/j.tig.2010.04.002; Boattini A, 2011, J ANTHROPOL SCI, V89, P161, DOI 10.4436/jass.89014; Bosch E, 2006, ANN HUM GENET, V70, P459, DOI 10.1111/j.1469-1809.2005.00251.x; Bosch E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-338; Brandstatter A, 2007, ANN HUM GENET, V71, P791, DOI 10.1111/j.1469-1809.2007.00371.x; Brunettin G., 1998, SAURIS ZAHRE COMUNIT, P43; Cavalli Sforza LL, 1993, HIST GEOGRAPHY HUMAN; CHAKRABORTY R, 1991, AM J PHYS ANTHROPOL, V86, P497, DOI 10.1002/ajpa.1330860405; Coelho M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-80; Coia V, 2012, J HUM GENET, V57, P254, DOI 10.1038/jhg.2012.14; Congiu A, 2012, J ANTHROPOL SCI, V90, P201, DOI 10.4436/jass.90020; De Concini W, 1997, ALTRI ALPI MINORANZE; Delfin F, 2011, EUR J HUM GENET, V19, P224, DOI 10.1038/ejhg.2010.162; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2011, BIOINFORMATICS, V27, P1332, DOI 10.1093/bioinformatics/btr124; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; Garrigan D, 2007, GENETICS, V177, P2195, DOI 10.1534/genetics.107.077495; Gri GP, 1998, SAURIS ZAHRE COMUNIT, P9; HARPENDING HC, 1994, HUM BIOL, V66, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Heutink P, 2002, HUM MOL GENET, V11, P2507, DOI 10.1093/hmg/11.20.2507; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hoban S, 2012, NAT REV GENET, V13, P110, DOI 10.1038/nrg3130; ISTAT, 2010, BIL DEM POP RES SESS; Kramer J, 2004, ARCH AKTO ADIGE, V98, P277; Kristiansson K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-109; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Loose R, 1996, TIROLER HEIMAT, V60, P5; Maurer-Lausegger Herta., 2004, TIDSSKRIFT SPROGFORS, V2, P5; Nasidze I, 2006, ANN HUM GENET, V71, P379; Navarra E., 2002, UOMINI COMUNITA MONT, P113; Navarra E, 1998, RICERCA FOLKLORICA, V38, P49; Neel J, 1992, MINORITY POPULATIONS; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2001, GENETICS, V158, P885; Ottoni C, 2011, EUR J HUM GENET, V19, P571, DOI 10.1038/ejhg.2010.230; Pellegrini Giovan Battista, 1991, GENESI RETOROMANZO O; Peratoner A., 2002, SAPPADA PLODN STORIA; Petris B., 1980, TISCHLBONG TAMAU TIM; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; Rapelli G, 2004, ISOLE CULTURA SAGGI, P243; REYNOLDS J, 1983, GENETICS, V105, P767; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; SLATKIN M, 1995, GENETICS, V139, P457; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Steinicke E., 2011, J ALPINE RES, V99, P2, DOI DOI 10.4000/RGA.1469; Steinicke E, 2002, TISCHLBONGARA PIACHL, V6, P300; Steinicke E, 2001, ANNALES, V11, P259; TAJIMA F, 1989, GENETICS, V123, P585; Templeton AR, 1998, AM ANTHROPOL, V100, P632, DOI 10.1525/aa.1998.100.3.632; Thomas MG, 2008, EUR J HUM GENET, V16, P124, DOI 10.1038/sj.ejhg.5201906; Tishkoff SA, 2004, NAT GENET, V36, pS21, DOI 10.1038/ng1438; Tofanelli S, 2011, J ANTHROPOL SCI, V89, P201, DOI 10.4436/jass.89017; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Toso Fiorenzo, 2008, MINORANZE LINGUISTIC; van Oven M, 2011, MOL BIOL EVOL, V28, P1349, DOI 10.1093/molbev/msq300; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Varilo T, 2004, CURR OPIN GENET DEV, V14, P316, DOI 10.1016/j.gde.2004.04.008; Viazzo P.P., 1989, UPLAND COMMUNITIES E; Volpato G, 1988, RICERCA FOLKLORICA, V18, P117	67	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56371	10.1371/journal.pone.0056371	http://dx.doi.org/10.1371/journal.pone.0056371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418562	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300155
J	Jeruschke, S; Buscher, AK; Oh, J; Saleem, MA; Hoyer, PF; Weber, S; Nalbant, P				Jeruschke, Stefanie; Buescher, Anja Katrin; Oh, Jun; Saleem, Moin Ahson; Hoyer, Peter Friedrich; Weber, Stefanie; Nalbant, Perihan			Protective Effects of the mTOR Inhibitor Everolimus on Cytoskeletal Injury in Human Podocytes Are Mediated by RhoA Signaling	PLOS ONE			English	Article							ACTIN STRESS FIBERS; KIDNEY-TRANSPLANT RECIPIENTS; FOCAL ADHESIONS; NEPHROTIC SYNDROME; CALCINEURIN-INHIBITOR; DIABETIC-NEPHROPATHY; BASEMENT-MEMBRANE; SLIT DIAPHRAGM; CELL-MIGRATION; SIROLIMUS	Podocytes are highly differentiated kidney cells playing an important role in maintaining the glomerular filtration barrier. Particularly, the integrity of the actin cytoskeleton is crucial as cytoskeletal damage associated with foot process effacement and loss of slit diaphragms constitutes a major aspect of proteinuria. Previously, the mammalian target of rapamycin (mTOR) was linked to actin regulation and aberrant activity of the kinase was associated with renal disease. In this study, actin-related effects of mTOR inhibition by the immunosuppressant everolimus (EV) were investigated in human podocytes using an in vitro model of puromycin aminonucleoside (PAN) induced proteinuria. EV substantially recovered aberrant podocyte behavior by re-establishing a stationary phenotype with decreased migration efficiency, enhanced cell adhesion and recovery of actin stress fibers. Biochemical studies revealed substantial increase in the activity of RhoA and the effector pathway Rho-associated protein kinase (ROCK) and myosin light chain (MLC) by EV, all known regulators of stress fiber generation. Taken together, we show for the first time cytoskeleton stabilizing effects of the mTOR inhibitor EV and establish RhoA signaling as a key mediator in this process.	[Jeruschke, Stefanie; Buescher, Anja Katrin; Hoyer, Peter Friedrich; Weber, Stefanie] Univ Duisburg Essen, Essen, Germany; [Oh, Jun] Univ Bristol, Bristol Royal Hosp Children, Childrens Renal Unit, Bristol, Avon, England; [Saleem, Moin Ahson] Univ Med Ctr, Childrens Hosp, Dept Pediat Nephrol, Hamburg, Germany; [Nalbant, Perihan] Univ Duisburg Essen, Ctr Med Biotechnol, Essen, Germany	University of Duisburg Essen; Bristol Royal Hospital For Children; University of Bristol; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Duisburg Essen	Nalbant, P (corresponding author), Univ Duisburg Essen, Ctr Med Biotechnol, Essen, Germany.	perihan.nalbant@uni-due.de		Saleem, Moin/0000-0002-9808-4518	Deutsche Forschungsgemeinschaft [BU 2602/3-1]; Forschungsunterstutzungskreis Kindernephrologie e.V; Novartis Pharmaceuticals Corporation; Novartis Pharmaceuticals (Basic Research Grant)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungsunterstutzungskreis Kindernephrologie e.V; Novartis Pharmaceuticals Corporation(Novartis); Novartis Pharmaceuticals (Basic Research Grant)	Anja Buescher and Stefanie Weber received financial support from the Deutsche Forschungsgemeinschaft (BU 2602/3-1) and the Forschungsunterstutzungskreis Kindernephrologie e.V. Jun Oh has received research funding from Novartis Pharmaceuticals Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare they have received financial support from Novartis Pharmaceuticals (Basic Research Grant). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. No other commercial funding was acquired. No other relevant agreements relating to employment, consultancy, patents, products in development or marketed products etc. have been stipulated with Novartis or any other pharmaceutical company.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Budde K, 2011, LANCET, V377, P837, DOI 10.1016/S0140-6736(10)62318-5; Buchler M, 2007, AM J TRANSPLANT, V7, P2522, DOI 10.1111/j.1600-6143.2007.01976.x; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Butani L, 2004, TRANSPLANTATION, V78, P1362, DOI 10.1097/01.TP.0000140868.88149.63; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Daniel C, 2005, AM J TRANSPLANT, V5, P2849, DOI 10.1111/j.1600-6143.2005.01120.x; Daniel C, 2000, EXP NEPHROL, V8, P52; Dantal J, 2010, TRANSPL INT, V23, P1084, DOI 10.1111/j.1432-2277.2010.01094.x; Diekmann F, 2004, AM J TRANSPLANT, V4, P1869, DOI 10.1111/j.1600-6143.2004.00590.x; Dittrich E, 2004, TRANSPL INT, V17, P215, DOI 10.1007/s00147-004-0700-0; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Eto N, 2007, KIDNEY INT, V72, P455, DOI 10.1038/sj.ki.5002311; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Fuchshofer R, 2011, HISTOCHEM CELL BIOL, V136, P301, DOI 10.1007/s00418-011-0844-9; Gallegos L, 2011, NAT CELL BIOL, V13, P344, DOI [10.1038/ncb0411-344, 10.1038/ncb2230]; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Ichimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P1589, DOI 10.1177/002215540305101203; Inoki K, 2008, DIABETES RES CLIN PR, V82, pS59, DOI 10.1016/j.diabres.2008.09.028; Ito N, 2011, LAB INVEST, V91, P1584, DOI 10.1038/labinvest.2011.135; Ivanov AI, 2008, FRONT BIOSCI-LANDMRK, V13, P6662, DOI 10.2741/3180; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kretzler M, 2002, MICROSC RES TECHNIQ, V57, P247, DOI 10.1002/jemt.10083; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Kummer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027457; Lebranchu Y, 2009, AM J TRANSPLANT, V9, P1115, DOI 10.1111/j.1600-6143.2009.02615.x; Mancini M, 2010, J CELL BIOCHEM, V109, P320, DOI 10.1002/jcb.22380; Markova B, 2012, J CANCER RES CLIN, V138, P545, DOI 10.1007/s00432-011-1123-9; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Ransom RF, 2005, KIDNEY INT, V68, P2473, DOI 10.1111/j.1523-1755.2005.00723.x; Reiser J, 2004, J BIOL CHEM, V279, P34827, DOI 10.1074/jbc.M401973200; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Roodnat JL, 2001, TRANSPLANTATION, V72, P438, DOI 10.1097/00007890-200108150-00014; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schena FP, 2009, TRANSPLANTATION, V87, P233, DOI 10.1097/TP.0b013e3181927a41; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008; Wang LM, 2012, KIDNEY INT, V81, P1075, DOI 10.1038/ki.2011.472; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; WHITESIDE CI, 1993, AM J PATHOL, V142, P1641; Yan K, 2012, CELL CYCLE, V11, P1504, DOI 10.4161/cc.19825; Yost SE, 2011, NAT REV NEPHROL, V7, P553, DOI 10.1038/nrneph.2011.125; Zhou HY, 2010, CURR PROTEIN PEPT SC, V11, P409, DOI 10.2174/138920310791824093	59	33	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55980	10.1371/journal.pone.0055980	http://dx.doi.org/10.1371/journal.pone.0055980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418489	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300081
J	Reveiz, L; Sangalang, S; Glujovsky, D; Pinzon, CE; Lobos, CA; Cortes, M; Canon, M; Bardach, A; Bonfill, X				Reveiz, Ludovic; Sangalang, Stephanie; Glujovsky, Demian; Pinzon, Carlos E.; Asenjo Lobos, Claudia; Cortes, Marcela; Canon, Martin; Bardach, Ariel; Bonfill, Xavier			Characteristics of Randomized Trials Published in Latin America and the Caribbean According to Funding Source	PLOS ONE			English	Article							CLINICAL-TRIALS; MORTALITY; QUALITY; THERAPY; SCIENCE	Introduction: Few studies have assessed the nature and quality of randomized controlled trials (RCTs) in Latin America and the Caribbean (LAC). Methods and Findings: The aims of this systematic review are to evaluate the characteristics (including the risk of bias assessment) of RCT conducted in LAC according to funding source. A review of RCTs published in 2010 in which the author's affiliation was from LAC was performed in PubMed and LILACS. Two reviewers independently extracted data and assessed the risk of bias. The primary outcomes were risk of bias assessment and funding source. A total of 1,695 references were found in PubMed and LILACS databases, of which 526 were RCTs (N = 73.513 participants). English was the dominant publication language (93%) and most of the RCTs were published in non-LAC journals (84.2%). Only five of the 19 identified countries accounted for nearly 95% of all RCTs conducted in the region (Brazil 70.9%, Mexico 10.1%, Argentina 5.9%, Colombia 3.8%, and Chile 3.4%). Few RCTs covered priority areas related with Millennium Development Goals like maternal health (6.7%) or high priority infectious diseases (3.8%). Regarding children, 3.6% and 0.4% RCT evaluated nutrition and diarrhea interventions respectively but none pneumonia. As a comparison, aesthetic and sport related interventions account for 4.6% of all trials. A random sample of RCTs (n = 358) was assessed for funding source: exclusively public (33.8%); private (e.g. pharmaceutical company) (15.3%); other (e.g. mixed, NGO) (15.1%); no funding (35.8%). Overall assessments for risk of bias showed no statistically significant differences between RCTs and type of funding source. Statistically significant differences favoring private and others type of funding was found when assessing trial registration and conflict of interest reporting. Conclusion: Findings of this study could be used to provide more direction for future research to facilitate innovation, improve health outcomes or address priority health problems.	[Reveiz, Ludovic; Sangalang, Stephanie] PAHO, Hlth Syst Based Primary Hlth Care, Washington, DC USA; [Glujovsky, Demian; Bardach, Ariel] Argentine Cochrane Ctr, Inst Clin Effectiveness & Hlth Policy IECS, Buenos Aires, DF, Argentina; [Pinzon, Carlos E.] Fdn Univ Sanitas, Inst Invest, Bogota, Colombia; [Asenjo Lobos, Claudia] Univ Concepcion, Ctr Adherido Chileno Red Cochrane Iberoamer, Ctr Rehabil Oral Avanzada & Implantol CRAI, Santiago, Chile; [Cortes, Marcela] Univ Catolica Santisima Concepcion, Iberoamer Cochrane Network, Chilean Branch, Santiago, Chile; [Canon, Martin] Fdn Univ Sanitas, Fac Med, Bogota, Colombia; [Bonfill, Xavier] Univ Autonoma Barcelona, Biomed Res Ctr Network Epidemiol & Publ Hlth CIBE, St Pau Biomed Res Inst IIB St Pau, Iberoamer Cochrane Ctr, E-08193 Barcelona, Spain	Pan American Health Organization; Universidad de Concepcion; Universidad Catolica de la Santisima Concepcion; Autonomous University of Barcelona	Reveiz, L (corresponding author), PAHO, Hlth Syst Based Primary Hlth Care, Washington, DC USA.	reveizl@paho.org	Asenjo-Lobos, Claudia/AAO-6815-2020; Glujovsky, Demian/AAJ-5743-2021; Bardach, Ariel E/E-6153-2012; Bardach, Ariel/H-9566-2019	Glujovsky, Demian/0000-0002-0586-9341; Bardach, Ariel/0000-0003-4437-0073; Asenjo-Lobos, Claudia/0000-0002-8264-0524; Bonfill Cosp, Xavier/0000-0003-1530-3509				Alger J, 2009, REV PANAM SALUD PUBL, V26, P447; [Anonymous], MONITORING FINANCIAL; [Anonymous], MONITORING FINANCIAL; Bradley CJ, 2008, JNCI-J NATL CANCER I, V100, P1763, DOI 10.1093/jnci/djn384; Chapman E, 2013, J CLIN EPIDEMIOL, V66, P105, DOI 10.1016/j.jclinepi.2012.09.005; Chen YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011926; de Souza RF, 2010, J APPL ORAL SCI, V18, P104, DOI 10.1590/S1678-77572010000200002; DeMets DL, 2011, JAMA-J AM MED ASSOC, V305, P713, DOI 10.1001/jama.2011.175; Etter JF, 2007, ADDICTION, V102, P815, DOI 10.1111/j.1360-0443.2007.01822.x; Galandi Daniel, 2006, BMC Med Res Methodol, V6, P30, DOI 10.1186/1471-2288-6-30; Hermes-Lima M, 2007, COMP BIOCHEM PHYS C, V146, P1, DOI 10.1016/j.cbpc.2007.05.005; Hermes-Lima M, 2007, IUBMB LIFE, V59, P199, DOI 10.1080/15216540701258751; Higgins J., 2009, COCHRANE HDB SYSTEMA; HOLM S, 1979, SCAND J STAT, V6, P65; Isaakidis P, 2003, AM J EPIDEMIOL, V158, P921, DOI 10.1093/aje/kwg232; Jones R, 2010, J EVAL CLIN PRACT, V16, P1322, DOI 10.1111/j.1365-2753.2009.01335.x; Lemarchand G. A., 2010, SISTEMAS NACL CIENCI; Manriquez J, 2005, REV MED CHILE, V133, P439; Minaya Gabriela, 2012, Rev. perú. med. exp. salud publica, V29, P431, DOI 10.1590/s1726-46342012000400003; Montgomery JH, 2004, CONTROL CLIN TRIALS, V25, P598, DOI 10.1016/j.cct.2004.09.002; Moran M, 2009, PLOS MED, V6, P137, DOI 10.1371/journal.pmed.1000030; Pan American Health Organization, 2009, CD4910 OPS; Pan WKY, 2010, SOC SCI MED, V70, P401, DOI 10.1016/j.socscimed.2009.09.021; Perel P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001696; Reveiz L, 2012, J CLIN EPIDEMIOL, V65, P482, DOI 10.1016/j.jclinepi.2011.09.003; Reyes-Morales H, 2009, REV PANAM SALUD PUBL, V25, P328, DOI 10.1590/S1020-49892009000400007; Saad D, 2010, ANN ONCOL, V21, P627, DOI 10.1093/annonc/mdp350; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; The Pan American HealthOrganization (PAHO), 2007, AG SAL AM 2008 2017; The World Bank, 2010, LAT AM CAR POP TOT; Uetani K, 2009, INTERNAL MED, V48, P307, DOI 10.2169/internalmedicine.48.1358; United Nations, 2011, MILL DEV GOALS REP 2; Viergever RF, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-36; Wehby GL, 2011, HEALTH SERV RES, V46, P2119, DOI 10.1111/j.1475-6773.2010.01225.x	34	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56410	10.1371/journal.pone.0056410	http://dx.doi.org/10.1371/journal.pone.0056410			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418566	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300159
J	Singh, N; Chikara, S; Sundar, S				Singh, Neeloo; Chikara, Surendra; Sundar, Shyam			SOLiD (TM) Sequencing of Genomes of Clinical Isolates of Leishmania donovani from India Confirm Leptomonas Co-Infection and Raise Some Key Questions	PLOS ONE			English	Article							KALA-AZAR; VISCERAL LEISHMANIASIS; HIMACHAL-PRADESH; IN-VITRO; RESISTANCE; INFECTION; SANDFLIES; VALLEY; CATTLE	Background: Known as 'neglected disease' because relatively little effort has been applied to finding cures, leishmaniasis kills more than 150,000 people every year and debilitates millions more. Visceral leishmaniasis (VL), also called Kala Azar (KA) or black fever in India, claims around 20,000 lives every year. Whole genome analysis presents an excellent means to identify new targets for drugs, vaccine and diagnostics development, and also provide an avenue into the biological basis of parasite virulence in the L. donovani complex prevalent in India. Methodology/Principal Findings: In our presently described study, the next generation SOLiD (TM) platform was successfully utilized for the first time to carry out whole genome sequencing of L. donovani clinical isolates from India. We report the exceptional occurrence of insect trypanosomatids in clinical cases of visceral leishmaniasis (Kala Azar) patients in India. We confirm with whole genome sequencing analysis data that isolates which were sequenced from Kala Azar (visceral leishmaniasis) cases were genetically related to Leptomonas. The co-infection in splenic aspirate of these patients with a species of Leptomonas and how likely is it that the infection might be pathogenic, are key questions which need to be investigated. We discuss our results in the context of some important probable hypothesis in this article. Conclusions/Significance: Our intriguing results of unusual cases of Kala Azar found to be most similar to Leptomonas species put forth important clinical implications for the treatment of Kala Azar in India. Leptomonas have been shown to be highly susceptible to several standard leishmaniacides in vitro. There is very little divergence among these two species viz. Leishmania sp. and L. seymouri, in terms of genomic sequence and organization. A more extensive perception of the phenomenon of co-infection needs to be addressed from molecular pathogenesis and eco-epidemiological standpoint.	[Singh, Neeloo] Cent Drug Res Inst, CSIR, Lucknow 226001, Uttar Pradesh, India; [Chikara, Surendra] Xcelris Genom, Ahmadabad, Gujarat, India; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Banaras Hindu University (BHU)	Singh, N (corresponding author), Cent Drug Res Inst, CSIR, Lucknow 226001, Uttar Pradesh, India.	neeloo888@yahoo.com			Department of Biotechnology(DBT), India [BT/PR13384/MED/29/166/2009]	Department of Biotechnology(DBT), India(Department of Biotechnology (DBT) India)	This work was funded by the Department of Biotechnology(DBT), India, BT/PR13384/MED/29/166/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2009, SCIENCE, V324, P265, DOI 10.1126/science.1169464; Alam MS, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-27; BACCHI CJ, 1975, ANTIMICROB AGENTS CH, V8, P688, DOI 10.1128/AAC.8.6.688; Baker J. R., 1965, P1; Basile C., 1920, Parasitology Cambridge, V12, DOI 10.1017/S0031182000014359; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; Bhattarai NR, 2010, EMERG INFECT DIS, V16, P231, DOI 10.3201/eid1602.090623; Bhattarai NR, 2009, T ROY SOC TROP MED H, V103, P1087, DOI 10.1016/j.trstmh.2009.03.008; Chakravarty A.K., 1980, Journal of Communicable Diseases, V11, P219; Cheeran MM, 2010, REV CLIN TRIALS TREA; CHULAY JD, 1983, AM J TROP MED HYG, V32, P475, DOI 10.4269/ajtmh.1983.32.475; Deane M. P., 1954, Hospital, V45, P697; Dedet JP, 1995, T ROY SOC TROP MED H, V89, P644, DOI 10.1016/0035-9203(95)90427-1; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; Dube A, 2005, PARASITOL RES, V96, P216, DOI 10.1007/s00436-005-1339-1; DUJARDIN JC, 1995, ACTA TROP, V59, P293, DOI 10.1016/0001-706X(95)00094-U; Fantham HB, 1912, BRIT MED J, P1196; Garin YJF, 2001, J EUKARYOT MICROBIOL, V48, P170, DOI 10.1111/j.1550-7408.2001.tb00299.x; GARNHAM PCC, 1971, B WORLD HEALTH ORGAN, V44, P477; Ghosh S, 2012, J CLIN MICROBIOL, V50, P2774, DOI 10.1128/JCM.00966-12; Hamad S. H., 2011, Journal of Microbiology and Antimicrobials, V3, P142; Jimenez MI, 1996, LANCET, V347, P264, DOI 10.1016/S0140-6736(96)90441-9; KELLY JM, 1991, MOL BIOCHEM PARASIT, V46, P253, DOI 10.1016/0166-6851(91)90049-C; KILLICKKENDRICK R, 1975, PROC R SOC SER B-BIO, V188, P229, DOI 10.1098/rspb.1975.0015; KUTISH GF, 1981, J PARASITOL, V67, P457, DOI 10.2307/3280474; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Lynn MA, 2008, TRENDS PARASITOL, V24, P103, DOI 10.1016/j.pt.2007.11.006; Mauricio IL, 1999, PARASITOLOGY, V119, P237, DOI 10.1017/S0031182099004710; MCGHEE RB, 1980, MICROBIOL REV, V44, P140, DOI 10.1128/MMBR.44.1.140-173.1980; Mehta Vandana, 2009, Dermatol Online J, V15, P9; Morio F, 2008, J CLIN MICROBIOL, V46, P3845, DOI 10.1128/JCM.01098-08; MUKHOPADHYAY AK, 1987, INDIAN J MED RES, V86, P475; Pacheco RS, 1998, MEM I OSWALDO CRUZ, V93, P531, DOI 10.1590/S0074-02761998000400021; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Rastogi V, 2007, Indian J Med Microbiol, V25, P272; Rougeron V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001004; Sharma NL, 2009, J VECTOR DIS, V46, P136; Sharma NL, 2005, AM J TROP MED HYG, V72, P819, DOI 10.4269/ajtmh.2005.72.819; Sharma Umakant, 2007, Journal of Vector Borne Diseases, V44, P230; Singh N, 2003, J INFECT DIS, V188, P600, DOI 10.1086/377133; SRIVASTAVA L, 1984, ANN TROP MED PARASIT, V78, P501, DOI 10.1080/00034983.1984.11811855; Srivastava P, 2010, INFECT GENET EVOL, V10, P1145, DOI 10.1016/j.meegid.2010.07.009; Stevens JR, 2001, ADV PARASIT, V48, P1, DOI 10.1016/S0065-308X(01)48003-1; Sundar S, 2001, AM J TROP MED HYG, V65, P193, DOI 10.4269/ajtmh.2001.65.193; Sundar S, 2000, EXPERT OPINION PHARM, V6, P2821; Vickerman K., 1976, P35; Volf P, 2007, INT J PARASITOL, V37, P589, DOI 10.1016/j.ijpara.2007.02.002; Waki K, 2009, EUKARYOT CELL, V6, P198; WALLACE FG, 1983, J PROTOZOOL, V30, P308, DOI 10.1111/j.1550-7408.1983.tb02921.x; Weirather JL, 2011, J CLIN MICROBIOL, V49, P3892, DOI 10.1128/JCM.r00764-11	50	36	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55738	10.1371/journal.pone.0055738	http://dx.doi.org/10.1371/journal.pone.0055738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418454	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300045
J	Sreekar, R; Purushotham, CB; Saini, K; Rao, SN; Pelletier, S; Chaplod, S				Sreekar, Rachakonda; Purushotham, Chetana B.; Saini, Katya; Rao, Shyam N.; Pelletier, Simon; Chaplod, Saniya			Photographic Capture-Recapture Sampling for Assessing Populations of the Indian Gliding Lizard Draco dussumieri	PLOS ONE			English	Article							WESTERN-GHATS; FLYING LIZARDS; GENUS-DRACO; PHOTOIDENTIFICATION; IDENTIFICATION; AMPHIBIANS; REPTILES; WILD	The usage of invasive tagging methods to assess lizard populations has often been criticised, due to the potential negative effects of marking, which possibly cause increased mortality or altered behaviour. The development of safe, less invasive techniques is essential for improved ecological study and conservation of lizard populations. In this study, we describe a photographic capture-recapture (CR) technique for estimating Draco dussumieri (Agamidae) populations. We used photographs of the ventral surface of the patagium to identify individuals. To establish that the naturally occurring blotches remained constant through time, we compared capture and recapture photographs of 45 pen-marked individuals after a 30 day interval. No changes in blotches were observed and individual lizards could be identified with 100% accuracy. The population density of D. dussumieri in a two hectare areca-nut plantation was estimated using the CR technique with ten sampling occasions over a ten day period. The resulting recapture histories for 24 individuals were analysed using population models in the program CAPTURE. All models indicated that nearly all individuals were captured. The estimated probability for capturing D. dussumieri on at least one occasion was 0.92 and the estimated population density was 13 +/- 1.65 lizards/ha. Our results demonstrate the potential for applying CR to population studies in gliding lizards (Draco spp.) and other species with distinctive markings.	[Sreekar, Rachakonda] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China; [Sreekar, Rachakonda; Purushotham, Chetana B.; Saini, Katya; Rao, Shyam N.; Pelletier, Simon; Chaplod, Saniya] Agumbe Rainforest Res Stn, Agumbe, Karnataka, India; [Purushotham, Chetana B.; Saini, Katya] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Rao, Shyam N.] Colorado State Univ, Ft Collins, CO 80523 USA; [Sreekar, Rachakonda] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Colorado State University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sreekar, R (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China.	sreekar1988@gmail.com	Sreekar, Rachakonda/C-4377-2008	Sreekar, Rachakonda/0000-0001-5445-6589	Agumbe Rainforest Research Station; The Gerry Martin Project	Agumbe Rainforest Research Station; The Gerry Martin Project	This study was undertaken with the support of Agumbe Rainforest Research Station (http://www.agumberainforest.com) and The Gerry Martin Project (http://www.gerrymartin.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interest. This study was partly funded by The Gerry Martin Project. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 1991, USERS GUIDE INTERACT; Bloch N, 2005, J HERPETOL, V39, P288, DOI 10.1670/97-04N; Dahanukar N, 2004, J BIOGEOGR, V31, P123, DOI 10.1046/j.0305-0270.2003.01016.x; Daniel, 2002, BOOK INDIAN REPTILES; DANIELS RJR, 1992, J BIOGEOGR, V19, P521, DOI 10.2307/2845771; den Hartog J, 2008, I3S MANTA MANUAL VER; ELBIN SB, 1994, WILDLIFE SOC B, V22, P677; Ferner JW, 1979, HERPETOLOGICAL CIRCU; FISHER M, 1989, Herpetological Review, V20, P45; Funk WC, 2005, NATURE, V433, P193, DOI 10.1038/433193c; Golay Nils, 1994, Amphibia-Reptilia, V15, P81, DOI 10.1163/156853894X00560; Honda M, 1999, ZOOL SCI, V16, P535, DOI 10.2108/zsj.16.535; Ishwar N.M., 2003, CONSERV SOC, V1, P269; Jacobs GJ, 1983, 57 SMITHS HERP INF S; John K.O., 1962, Journal of the Bombay Natural History Society, V59, P298; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Karanth KU, 1998, ECOLOGY, V79, P2852; Lettink M, 2011, NEW ZEAL J ECOL, V35, P236; Martin-Smith KM, 2011, J FISH BIOL, V78, P1757, DOI 10.1111/j.1095-8649.2011.02966.x; McGuire JA, 2011, INTEGR COMP BIOL, V51, P983, DOI 10.1093/icb/icr090; MORI A, 1994, COPEIA, P124; MORI A, 1993, RAFFLES B ZOOL, V41, P83; Oosthuizen WC, 2010, MAR MAMMAL SCI, V26, P350, DOI 10.1111/j.1748-7692.2009.00328.x; OTIS DL, 1978, WILDLIFE MONOGR, P1; Ottenwalder J.A., 2000, W INDIAN IGUANAS STA, P51; Perry G, 2011, J HERPETOL, V45, P547, DOI 10.1670/11-037.1; Phillott AD, 2011, WILDLIFE RES, V38, P204, DOI 10.1071/WR10154; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Sacchi R, 2010, AMPHIBIA-REPTILIA, V31, P489, DOI 10.1163/017353710X521546; Smith M.A., 1935, FAUNA BRIT INDIA INC, VII; Speed CW, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-2; Venugopal PD, 2010, HERPETOL J, V20, P69; WOODBURY AM, 1948, COPEIA, P127	34	16	17	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55935	10.1371/journal.pone.0055935	http://dx.doi.org/10.1371/journal.pone.0055935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418477	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300069
J	Tanida, M; Yamamoto, N; Shibamoto, T; Rahmouni, K				Tanida, Mamoru; Yamamoto, Naoki; Shibamoto, Toshishige; Rahmouni, Kamal			Involvement of Hypothalamic AMP-Activated Protein Kinase in Leptin-Induced Sympathetic Nerve Activation	PLOS ONE			English	Article							BLOOD-PRESSURE; FOOD-INTAKE; MELANOCORTIN SYSTEM; ARTERIAL-PRESSURE; HYPERTENSIVE-RATS; ADIPOSE-TISSUE; RESISTANCE; NEURONS	In mammals, leptin released from the white adipose tissue acts on the central nervous system to control feeding behavior, cardiovascular function, and energy metabolism. Central leptin activates sympathetic nerves that innervate the kidney, adipose tissue, and some abdominal organs in rats. AMP-activated protein kinase (AMPK) is essential in the intracellular signaling pathway involving the activation of leptin receptors (ObRb). We investigated the potential of AMPK alpha 2 in the sympathetic effects of leptin using in vivo siRNA injection to knockdown AMPK alpha 2 in rats, to produce reduced hypothalamic AMPK alpha 2 expression. Leptin effects on body weight, food intake, and blood FFA levels were eliminated in AMPK alpha 2 siRNA-treated rats. Leptin-evoked enhancements of the sympathetic nerve outflows to the kidney, brown and white adipose tissues were attenuated in AMPK alpha 2 siRNA-treated rats. To check whether AMPK alpha 2 was specific to sympathetic changes induced by leptin, we examined the effects of injecting MT-II, a melanocortin-3 and -4 receptor agonist, on the sympathetic nerve outflows to the kidney and adipose tissue. MT-II-induced sympatho-excitation in the kidney was unchanged in AMPK alpha 2 siRNA-treated rats. However, responses of neural activities involving adipose tissue to MT-II were attenuated in AMPK alpha 2 siRNA-treated rats. These results suggest that hypothalamic AMPK alpha 2 is involved not only in appetite and body weight regulation but also in the regulation of sympathetic nerve discharges to the kidney and adipose tissue. Thus, AMPK might function not only as an energy sensor, but as a key molecule in the cardiovascular, thermogenic, and lipolytic effects of leptin through the sympathetic nervous system.	[Tanida, Mamoru; Shibamoto, Toshishige] Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 92002, Japan; [Tanida, Mamoru] Ritsumeikan Univ, Coll Life Sci, Dept Biomed Sci, Kusatsu, Shiga, Japan; [Yamamoto, Naoki] Ritsumeikan Univ, Coll Pharmacol, Kusatsu, Shiga, Japan; [Rahmouni, Kamal] Univ Iowa Carver, Coll Med, Dept Pharmacol, Iowa City, IA USA; [Rahmouni, Kamal] Univ Iowa Carver, Coll Med, Dept Internal Med, Iowa City, IA USA	Kanazawa Medical University; Ritsumeikan University; Ritsumeikan University; University of Iowa; University of Iowa	Tanida, M (corresponding author), Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 92002, Japan.	mtanida@kanazawa-med.ac.jp	Rahmouni, Kamal/Y-1788-2019	Rahmouni, Kamal/0000-0001-5136-6748	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23689008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL084207] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant-in-Aid for Young Scientists to MT, 23689008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato S, 2011, SCIENCE, V332, P247, DOI 10.1126/science.1201678; Breit A, 2011, MOL CELL ENDOCRINOL, V331, P232, DOI 10.1016/j.mce.2010.07.007; Brito MN, 2007, ENDOCRINOLOGY, V148, P5339, DOI 10.1210/en.2007-0621; Casto RM, 1998, NEUROSCI LETT, V246, P29, DOI 10.1016/S0304-3940(98)00223-7; Chikahisa S, 2009, NEUROPHARMACOLOGY, V57, P369, DOI 10.1016/j.neuropharm.2009.07.015; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Dhillon SS, 2011, ENDOCRINOLOGY, V152, P4138, DOI 10.1210/en.2011-0178; Ford RJ, 2012, J HYPERTENS, V30, P725, DOI 10.1097/HJH.0b013e32835050ca; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; Harlan SM, 2011, CIRC RES, V108, P808, DOI 10.1161/CIRCRESAHA.111.240226; Harlan SM, 2011, HYPERTENSION, V57, P627, DOI 10.1161/HYPERTENSIONAHA.110.166538; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; Kumagai H, 2012, HYPERTENS RES, V35, P132, DOI 10.1038/hr.2011.208; Kuo JJ, 2003, HYPERTENSION, V41, P768, DOI 10.1161/01.HYP.0000048194.97428.1A; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2008, NUTRITION, V24, P786, DOI 10.1016/j.nut.2008.06.002; Niijima A, 1999, NEUROSCI LETT, V262, P125, DOI 10.1016/S0304-3940(99)00054-3; Rahmouni K, 2003, HYPERTENSION, V41, P763, DOI 10.1161/01.HYP.0000048342.54392.40; Rahmouni K, 2005, DIABETES, V54, P2012, DOI 10.2337/diabetes.54.7.2012; Rahmouni K, 2007, HYPERTENSION, V49, P647, DOI 10.1161/01.HYP.0000254827.59792.b2; Rahmouni K, 2009, DIABETES, V58, P536, DOI 10.2337/db08-0822; Shen J, 2007, NEUROSCI LETT, V416, P193, DOI 10.1016/j.neulet.2007.02.003; Tanida M, 2006, LIFE SCI, V78, P1149, DOI 10.1016/j.lfs.2005.05.058; Tanida M, 2011, NEUROSCI LETT, V503, P167, DOI 10.1016/j.neulet.2011.08.013; Tanida M, 2011, NEUROSCI LETT, V491, P211, DOI 10.1016/j.neulet.2011.01.040; Toda C, 2009, DIABETES, V58, P2757, DOI 10.2337/db09-0638; Wang Q, 2009, STROKE, V40, P2157, DOI 10.1161/STROKEAHA.108.541490; Wang SX, 2011, HYPERTENSION, V57, P1010, DOI 10.1161/HYPERTENSIONAHA.110.168906; Yang CS, 2010, DIABETES, V59, P2435, DOI 10.2337/db10-0221; Yasuda T, 2004, EXP BIOL MED, V229, P235, DOI 10.1177/153537020422900303; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	32	69	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56660	10.1371/journal.pone.0056660	http://dx.doi.org/10.1371/journal.pone.0056660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418591	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300184
J	Witt, K; van Dorn, R; Fazel, S				Witt, Katrina; van Dorn, Richard; Fazel, Seena			Risk Factors for Violence in Psychosis: Systematic Review and Meta-Regression Analysis of 110 Studies	PLOS ONE			English	Article							PUBLICATION BIAS; SCHIZOPHRENIA; AGGRESSION; BEHAVIOR; METAANALYSIS; DISORDERS; ASSOCIATION; PREDICTION; INPATIENTS; OFFENDERS	Background: Previous reviews on risk and protective factors for violence in psychosis have produced contrasting findings. There is therefore a need to clarify the direction and strength of association of risk and protective factors for violent outcomes in individuals with psychosis. Method: We conducted a systematic review and meta-analysis using 6 electronic databases (CINAHL, EBSCO, EMBASE, Global Health, PsycINFO, PUBMED) and Google Scholar. Studies were identified that reported factors associated with violence in adults diagnosed, using DSM or ICD criteria, with schizophrenia and other psychoses. We considered non-English language studies and dissertations. Risk and protective factors were meta-analysed if reported in three or more primary studies. Meta-regression examined sources of heterogeneity. A novel meta-epidemiological approach was used to group similar risk factors into one of 10 domains. Sub-group analyses were then used to investigate whether risk domains differed for studies reporting severe violence (rather than aggression or hostility) and studies based in inpatient (rather than outpatient) settings. Findings: There were 110 eligible studies reporting on 45,533 individuals, 8,439 (18.5%) of whom were violent. A total of 39,995 (87.8%) were diagnosed with schizophrenia, 209 (0.4%) were diagnosed with bipolar disorder, and 5,329 (11.8%) were diagnosed with other psychoses. Dynamic (or modifiable) risk factors included hostile behaviour, recent drug misuse, non-adherence with psychological therapies (p values<0.001), higher poor impulse control scores, recent substance misuse, recent alcohol misuse (p values<0.01), and non-adherence with medication (p value <0.05). We also examined a number of static factors, the strongest of which were criminal history factors. When restricting outcomes to severe violence, these associations did not change materially. In studies investigating inpatient violence, associations differed in strength but not direction. Conclusion: Certain dynamic risk factors are strongly associated with increased violence risk in individuals with psychosis and their role in risk assessment and management warrants further examination.	[Witt, Katrina; Fazel, Seena] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England; [van Dorn, Richard] Res Triangle Inst Int, Durham, NC USA	University of Oxford; Research Triangle Institute	Fazel, S (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford, England.	seena.fazel@psych.ox.ac.uk	Fazel, Seena/B-5307-2008; Witt, Katrina/AAN-4554-2020	Fazel, Seena/0000-0002-5383-5365; Witt, Katrina/0000-0002-1489-4573	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	No current external funding sources for this study. SF is supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Altman D.G., 1991, SOME COMMON PROBLEMS; [Anonymous], 2010, LANCET, V375, P348, DOI 10.1016/S0140-6736(10)60148-1; Appelbaum PS, 2000, AM J PSYCHIAT, V157, P566, DOI 10.1176/appi.ajp.157.4.566; Arango C, 1999, SCHIZOPHRENIA BULL, V25, P493, DOI 10.1093/oxfordjournals.schbul.a033396; Baker WL, 2009, INT J CLIN PRACT, V63, P1426, DOI 10.1111/j.1742-1241.2009.02168.x; Barkataki I, 2006, BEHAV BRAIN RES, V169, P239, DOI 10.1016/j.bbr.2006.01.009; Bo S, 2011, CLIN PSYCHOL REV, V31, P711, DOI 10.1016/j.cpr.2011.03.002; Bonta J, 1998, PSYCHOL BULL, V123, P123, DOI 10.1037/0033-2909.123.2.123; Buckley P, 2011, SCHIZOPHRENIA BULL, V37, P930, DOI 10.1093/schbul/sbr104; Burton A, 2010, EPIDEMIOL PSICHIAT S, V19, P233; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805; Conner KR, 2003, AGGRESS VIOLENT BEH, V8, P413, DOI 10.1016/S1359-1789(02)00067-8; DeCoster J., 2009, METAANALYSIS NOTES; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Douglas KS, 2009, PSYCHOL BULL, V135, P679, DOI 10.1037/a0016311; Douglas KS, 2005, PSYCHOL PUBLIC POL L, V11, P347, DOI 10.1037/1076-8971.11.3.347; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Farrington D. P., 2012, OXFORD HDB CRIME PRE, P46; Fazel S, 2010, ARCH GEN PSYCHIAT, V67, P931, DOI 10.1001/archgenpsychiatry.2010.97; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; Fazel S, 2009, JAMA-J AM MED ASSOC, V301, P2016, DOI 10.1001/jama.2009.675; Geddes JR, 2005, EPIDEMIOL PSICHIAT S, V14, P122, DOI 10.1017/S1121189X00006357; Heaton R.K., 1993, WISCONSIN CARD SORTI; Hiday VA, 1999, PSYCHIATR SERV, V50, P62, DOI 10.1176/ps.50.1.62; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KHAN K, 2001, UNDERTAKING SYSTEMAT; Khiroya R, 2009, PSYCHIATR BULL, V33, P129, DOI 10.1192/pb.bp.108.019810; Kooyman I, 2007, BRIT J PSYCHIAT, V191, pS29, DOI 10.1192/bjp.191.50.s29; Large M, 2009, SCHIZOPHRENIA BULL, V35, P1012, DOI 10.1093/schbul/sbn040; Large MM, 2011, SCHIZOPHR RES, V125, P209, DOI 10.1016/j.schres.2010.11.026; Liberati A, 2009, PLOS MED, V6, DOI DOI 10.1186/s13643-016-0384-4; Link BG, 1998, SOC PSYCH PSYCH EPID, V33, pS55, DOI 10.1007/s001270050210; Mercado CC, 2007, INT J LAW PSYCHIAT, V30, P49, DOI 10.1016/j.ijlp.2006.02.001; Mullen P. E., 2006, ADV PSYCHIAT TREATME, V12, P239, DOI DOI 10.1192/APT.12.4.239; Nelson HE., 1982, NATL ADULT READING T; Nolan KA, 2005, J PSYCHIATR RES, V39, P109, DOI 10.1016/j.jpsychires.2004.04.010; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Raja Michele, 2005, Clin Pract Epidemiol Ment Health, V1, P11; Rosenberg MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010059; Rosenthal JA, 1996, J SOC SERV RES, V21, P37, DOI 10.1300/J079v21n04_02; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Schwarzer G, 2002, STAT MED, V21, P2465, DOI 10.1002/sim.1224; Singh JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031727; Singh JP, 2011, SCHIZOPHRENIA BULL, V37, P899, DOI 10.1093/schbul/sbr093; Singh JP, 2010, CRIM JUSTICE BEHAV, V37, P965, DOI 10.1177/0093854810374274; Soyka M, 2011, SCHIZOPHRENIA BULL, V37, P913, DOI 10.1093/schbul/sbr103; Steinert T, 2002, ACTA PSYCHIAT SCAND, V106, P133, DOI 10.1034/j.1600-0447.106.s412.29.x; Swanson JW, 2008, BRIT J PSYCHIAT, V193, P37, DOI 10.1192/bjp.bp.107.042630; Swanson JW, 2006, AM J PSYCHIAT, V163, P1404, DOI 10.1176/appi.ajp.163.8.1404; Swanson JW, 2004, SCHIZOPHRENIA BULL, V30, P3, DOI 10.1093/oxfordjournals.schbul.a007065; Swanson JW, 2002, AM J PUBLIC HEALTH, V92, P1523, DOI 10.2105/AJPH.92.9.1523; Swanson JW, 2006, ARCH GEN PSYCHIAT, V63, P490, DOI 10.1001/archpsyc.63.5.490; TAYLOR PJ, 1984, BRIT MED J, V288, P1945, DOI 10.1136/bmj.288.6435.1945; Topiwala A, 2011, EXPERT REV NEUROTHER, V11, P53, DOI [10.1586/ern.10.180, 10.1586/ERN.10.180]; Van Dorn R, 2011, P 7 EUR C VIOL CLIN; Van Dorn R, 2012, SOC PSYCH PSYCH EPID, V47, P487, DOI 10.1007/s00127-011-0356-x; Verma S, 2005, INT J SOC PSYCHIATR, V51, P365, DOI 10.1177/0020764005060852; Volavka J., 2002, NEUROBIOLOGY VIOLENC; Volavka J, 2011, SCHIZOPHRENIA BULL, V37, P921, DOI 10.1093/schbul/sbr041; Walsh E, 2002, BRIT J PSYCHIAT, V180, P490, DOI 10.1192/bjp.180.6.490; Webster C.D., 2004, SHORT TERM ASSESSMEN; Wechsler D, 2008, WAIS IV ADM SCORING; Wechsler D., 2008, WAIS IV TECHNICAL IN; Wehring HJ, 2011, SCHIZOPHRENIA BULL, V37, P877, DOI 10.1093/schbul/sbr094; Wobrock T, 2008, PROG NEURO-PSYCHOPH, V32, P1375, DOI 10.1016/j.pnpbp.2008.02.008; Wootton L, 2008, SCHIZOPHR RES, V101, P176, DOI 10.1016/j.schres.2007.12.490; Yiend J, 2011, PSYCHOL CRIME LAW, V17, P277, DOI 10.1080/10683160903203938; Yu RQ, 2012, J PERS DISORD, V26, P775, DOI 10.1521/pedi.2012.26.5.775; Zygmunt A, 2002, AM J PSYCHIAT, V159, P1653, DOI 10.1176/appi.ajp.159.10.1653	73	337	351	2	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55942	10.1371/journal.pone.0055942	http://dx.doi.org/10.1371/journal.pone.0055942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418482	Green Published, gold			2022-12-27	WOS:000315970300074
J	Yan, Q; Li, W; Tang, Q; Yao, SH; Lv, ZG; Feng, NH; Ma, XT; Bai, ZQ; Zeng, Y; Qin, D; Lu, C				Yan, Qin; Li, Wan; Tang, Qiao; Yao, Shuihong; Lv, Zhigang; Feng, Ninghan; Ma, Xinting; Bai, Zhiqiang; Zeng, Yi; Qin, Di; Lu, Chun			Cellular MicroRNAs 498 and 320d Regulate Herpes Simplex Virus 1 Induction of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Targeting RTA	PLOS ONE			English	Article							CYCLE REPLICATION; HUMAN CYTOMEGALOVIRUS; EXPRESSION PROFILE; ENDOTHELIAL-CELLS; INFECTION; TYPE-1; LATENCY; IDENTIFICATION; SUPPRESSION; ACTIVATION	Kaposi's sarcoma-associated herpesvirus (KSHV) infection was necessary but not sufficient for KS development without other cofactors. We have previously reported that herpes simplex virus (HSV)-1 was an important cofactor that reactivated KSHV from latency by inducing the expression of KSHV replication and transcription activator (RTA), the lytic switch protein. Here, we further investigated the possible cellular microRNAs (miRNAs) involved in regulation of RTA during HSV-1-induced KSHV replication. The differential profiles of miRNAs expression between Mock- and HSV-1-infected body cavity-based lymphoma (BCBL-1) cells were identified by miRNA microarray analysis. Bioinformatics and luciferase reporter analyses showed that two of the HSV-1-downregulated cellular miRNAs, miR-498 and miR-320d, directly targeted the 3' untranslated region (UTR) of KSHV RTA. As a result, overexpression of these two miRNAs significantly inhibited HSV-1-induced KSHV replication, whereas repression of these miRNAs with specific suppressors enhanced HSV-1-mediated KSHV replication. In addition, miR-498 or miR-320d alone, without HSV-1 infection, regulated KSHV replication in BCBL-1 cells. Finally, bioinformatics Gene Ontology (GO) analysis indicated that targets of HSV-1-regulated miRNAs were enriched for proteins, whose roles were involved in protein binding, enzyme activity, biological regulation, and several potential signaling pathways including transforming growth factor (TGF)-beta were likely to participate in HSV-1-induced KSHV replication. Collectively, these novel findings demonstrated that host-encoded miR-498 and miR-320d regulated HSV-1 induction of KSHV lytic replication by targeting RTA, which provided further insights into the molecular mechanisms controlling KSHV lytic replication.	[Yan, Qin; Qin, Di; Lu, Chun] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Yan, Qin; Qin, Di; Lu, Chun] Nanjing Med Univ, Key Lab Pathogen Biol Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Yan, Qin; Li, Wan; Tang, Qiao; Lv, Zhigang; Ma, Xinting; Bai, Zhiqiang; Qin, Di; Lu, Chun] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Tang, Qiao] Nanjing Med Univ, Nanjing Hosp 1, Dept Clin Lab, Nanjing, Jiangsu, Peoples R China; [Yao, Shuihong] Quzhou Coll, Dept Med, Quzhou, Peoples R China; [Lv, Zhigang] Jiangsu Prov Official Hosp, Dept Clin Lab, Nanjing, Jiangsu, Peoples R China; [Feng, Ninghan] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Zeng, Yi] Youjiang Med Coll Nationalities, Dept Microbiol & Immunol, Bose, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Quzhou University; Nanjing Medical University; Youjiang Medical University for Nationalities	Qin, D (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	diqin@njmu.edu.cn; clu@njmu.edu.cn	Feng, Ninghan/ABA-8996-2021; Feng, ninghan/ABB-3726-2021	Lu, Chun/0000-0002-6078-9352	National Basic Research Program of China (973 Program) [2011CB504803]; National Natural Science Foundation of China [81171552, 81210108028, 30972619, 30900064, 31270199, 81071345, 81272831]; Natural Science Foundation of Ministry of Education of Jiangsu Province [10KJA310032]; Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund) [20093234120004]; Natural Science Foundation of Jiangsu Province [BK2010577]; Jiangsu Province's Outstanding Medical Academic Leader Program [RC201178]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Ministry of Education of Jiangsu Province; Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Province's Outstanding Medical Academic Leader Program	This work was supported by grants from the National Basic Research Program of China (973 Program) (2011CB504803) (http://www.973.gov.cn/English/Index.aspx), National Natural Science Foundation of China (grants 81171552, 81210108028, and 30972619 to CL, 30900064 to DQ, 31270199 to ZB, 81071345 to YZ, and 81272831 to NF) (http://www.nsfc.gov.cn/Portal0/default152.htm), Natural Science Foundation of Ministry of Education of Jiangsu Province (great project 10KJA310032 to CL) (http://www.jsjyt.gov.cn/), Research Fund for the Doctoral Program of Higher Education of China (New Teacher Fund, grant 20093234120004 to DQ) (http://www.cutech.edu.cn/cn/index.htm), Natural Science Foundation of Jiangsu Province (BK2010577 to NF) (http://www.jsnsf.gov.cn/Index.aspx), and Jiangsu Province's Outstanding Medical Academic Leader Program (RC201178 to NF) (http://www.jswst.gov.cn/gb/jsswst/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellare P, 2009, CELL HOST MICROBE, V6, P570, DOI 10.1016/j.chom.2009.11.008; Berrington WR, 2009, CLIN INFECT DIS, V49, P1295, DOI 10.1086/606053; Birek Catalena, 2006, Curr Infect Dis Rep, V8, P181, DOI 10.1007/s11908-006-0057-x; Boivin G, 2009, CAN J INFECT DIS MED, V20, P122, DOI 10.1155/2009/482407; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Casper C, 2002, J INFECT DIS, V185, P990, DOI 10.1086/339605; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen L, 2009, J HEPATOL, V50, P358, DOI 10.1016/j.jhep.2008.09.015; Chen TS, 2006, MODERN PATHOL, V19, P726, DOI 10.1038/modpathol.3800584; Cheng B, 2009, J CLIN VIROL, V46, P244, DOI 10.1016/j.jcv.2009.07.025; Duan HH, 2010, TOXICOL IN VITRO, V24, P928, DOI 10.1016/j.tiv.2009.11.013; Ellis-Connell AL, 2010, J VIROL, V84, P10329, DOI 10.1128/JVI.00923-10; Gottwein E, 2010, J VIROL, V84, P5229, DOI 10.1128/JVI.00202-10; Greene Whitney, 2007, Cancer Treat Res, V133, P69; Gusev Y, 2008, METHODS, V44, P61, DOI 10.1016/j.ymeth.2007.10.005; Han ZB, 2012, MOL ONCOL, V6, P445, DOI 10.1016/j.molonc.2012.04.001; Hansen A, 2010, GENE DEV, V24, P195, DOI 10.1101/gad.553410; Harel L, 2004, CLIN INFECT DIS, V39, P636, DOI 10.1086/422643; Holzinger Dirk, 2010, J Pediatr Hematol Oncol, V32, pe19, DOI 10.1097/MPH.0b013e3181b79669; Ishida H, 2011, BIOCHEM BIOPH RES CO, V412, P92, DOI 10.1016/j.bbrc.2011.07.049; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; KEY NS, 1990, P NATL ACAD SCI USA, V87, P7095, DOI 10.1073/pnas.87.18.7095; Kumar N, 2007, J MED VIROL, V79, P52, DOI 10.1002/jmv.20728; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; LAMONTAGNE L, 1994, CLIN IMMUNOL IMMUNOP, V73, P38, DOI 10.1006/clin.1994.1167; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Liang DG, 2011, CELL RES, V21, P793, DOI 10.1038/cr.2011.5; Lin SS, 2005, MICROBES INFECT, V7, P635, DOI 10.1016/j.micinf.2004.12.023; Lin XZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016224; Lu C, 2005, AM J PATHOL, V166, P173, DOI 10.1016/S0002-9440(10)62242-0; Lu CC, 2010, EMBO REP, V11, P784, DOI 10.1038/embor.2010.132; Lu F, 2010, J VIROL, V84, P2697, DOI 10.1128/JVI.01997-09; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; Miller CS, 2005, J CLIN MICROBIOL, V43, P2173, DOI 10.1128/JCM.43.5.2173-2180.2005; Murphy EJ, 2008, LIPIDS, V43, P105, DOI 10.1007/s11745-008-3156-7; Qin D, 2008, CELL MICROBIOL, V10, P713, DOI 10.1111/j.1462-5822.2007.01079.x; Qin D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-240; Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Schaar DG, 2009, EXP HEMATOL, V37, P245, DOI 10.1016/j.exphem.2008.10.002; Scheglovitova Olga N., 2000, Russ J Immunol, V5, P133; Scheglovitova Olga N., 2001, Russ J Immunol, V6, P367; Scheglovitova Olga N, 2002, Russ J Immunol, V7, P115; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Shang YL, 2012, AMINO ACIDS, V42, P1879, DOI 10.1007/s00726-011-0907-1; Shaoqing Y, 2011, AM J RHINOL ALLERGY, V25, pe242, DOI DOI 10.2500/AJRA.2011.25.3682; Shen YL, 2009, BIOMED ENVIRON SCI, V22, P14, DOI 10.1016/S0895-3988(09)60016-7; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Tang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031652; Tang S, 2009, J VIROL, V83, P1433, DOI 10.1128/JVI.01723-08; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; van Benthem BHB, 2001, SEX TRANSM INFECT, V77, P120, DOI 10.1136/sti.77.2.120; Varthakavi V, 2002, VIROLOGY, V297, P270, DOI 10.1006/viro.2002.1434; Vieira J, 2001, J VIROL, V75, P1378, DOI 10.1128/JVI.75.3.1378-1386.2001; Wang FZ, 2008, J VIROL, V82, P9065, DOI 10.1128/JVI.00961-08; Wang XH, 2009, CLIN EXP PHARMACOL P, V36, P181, DOI 10.1111/j.1440-1681.2008.05057.x; Xu DS, 2007, J VIROL, V81, P6068, DOI 10.1128/JVI.02743-06; Ye FC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002054; Zeng Y, 2007, J VIROL, V81, P2401, DOI 10.1128/JVI.02024-06; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008; Zhang HL, 2011, BIOCHEM BIOPH RES CO, V404, P273, DOI 10.1016/j.bbrc.2010.11.106; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x; Zheng SQ, 2011, ANTIVIR RES, V89, P219, DOI 10.1016/j.antiviral.2011.01.008; Zhu XL, 2011, J MOL BIOL, V410, P1035, DOI 10.1016/j.jmb.2011.03.055	69	29	30	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55832	10.1371/journal.pone.0055832	http://dx.doi.org/10.1371/journal.pone.0055832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418466	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300057
J	Li, BH; Zhang, LL; Zhang, BB; Yin, YW; Dai, LM; Pi, Y; Guo, L; Gao, CY; Fang, CQ; Wang, JZ; Li, JC				Li, Bing-Hu; Zhang, Li-Li; Zhang, Bei-Bei; Yin, Yan-Wei; Dai, Li-Meng; Pi, Yan; Guo, Lu; Gao, Chang-Yue; Fang, Chuan-Qin; Wang, Jing-Zhou; Li, Jing-Cheng			Association between NADPH Oxidase p22(phox) C242T Polymorphism and Ischemic Cerebrovascular Disease: A Meta-Analysis	PLOS ONE			English	Article							CONJUGATED SUPEROXIDE-DISMUTASE; CORONARY-ARTERY-DISEASE; NAD(P)H OXIDASE; OXIDATIVE STRESS; P22PHOX GENE; CEREBRAL-ISCHEMIA; STROKE; RISK; POPULATION; FAMILY	Background: Epidemiological studies have evaluated the association between nicotinamide adenine dinucleotide phosphate (NADPH) oxidase p22(phox) C242T polymorphism and risk of ischemic cerebrovascular disease (ICVD), but the results remain inconclusive. This meta-analysis was therefore designed to clarify these controversies. Methodology/Principal Findings: Systematic searches of electronic databases Embase, PubMed and Web of Science, as well as hand searching of the references of identified articles and the meeting abstracts were performed. Statistical analyses were performed using software Review Manager (Version 5.1.7) and Stata (Version 11.0). The pooled odds ratios (ORs) with 95% confidence intervals (95% CIs) were performed. Fixed or random effects model was separately used depending on the heterogeneity between studies. Publication bias was tested by Begg's funnel plot and Egger's regression test. A total of 6 studies including 1,948 cases and 2,357 controls were combined showing no statistical evidence of association between NADPH oxidase p22(phox) C242T polymorphism and overall ICVD (allelic model: OR = 1.08, 95%CI = 0.93-1.26; additive model: OR = 1.33, 95%CI = 0.81-2.17; dominant model: OR = 1.00, 95%CI = 0.86-1.15; recessive model: OR = 1.06, 95%CI = 0.77-1.45). Significant association was found in large-artery atherosclerotic stroke subgroup (allelic model: OR = 1.12, 95%CI = 0.88-1.41; additive model: OR = 1.36, 95%CI = 0.60-3.09; dominant model: OR = 1.25, 95%CI = 0.74-2.11; recessive model: OR = 2.17, 95%CI = 1.11-4.23). No statistical evidence of significant association was observed for small-vessel occlusive stroke, as well as Asian subgroup and Caucasian subgroup. Statistical powers on the combined sample size (total and subgroup) were all lower than 80%. Conclusions/Significance: This meta-analysis indicates that NADPH oxidase p22(phox) C242T polymorphism is more associated with large-artery atherosclerotic stroke than small-vessel occlusive stroke. However, this conclusion should be interpreted with caution due to the small sample size. Larger sample-size studies with homogeneous ICVD patients and well-matched controls are required.	[Li, Bing-Hu; Zhang, Li-Li; Yin, Yan-Wei; Pi, Yan; Guo, Lu; Gao, Chang-Yue; Fang, Chuan-Qin; Wang, Jing-Zhou; Li, Jing-Cheng] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Neurol, Chongqing, Peoples R China; [Zhang, Bei-Bei] Gen Hosp PLA Chengdu Mil Area Command, Dept Med Affairs, Chengdu, Peoples R China; [Dai, Li-Meng] Third Mil Med Univ, Dept Med Genet, Coll Basic Med Sci, Chongqing, Peoples R China	Army Medical University; Army Medical University	Li, JC (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept Neurol, Chongqing, Peoples R China.	lijingcheng11@yahoo.com.cn			National Natural Science Foundation of China [30970998, 30800444]; Chongqing Key Project of Science and Technologies [CSTC2010GGC502]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Key Project of Science and Technologies	This study was supported by grants from the National Natural Science Foundation of China (30970998, 30800444), and a grant from the Chongqing Key Project of Science and Technologies (CSTC2010GGC502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Corsetti JP, 2008, ATHEROSCLEROSIS, V196, P461, DOI 10.1016/j.atherosclerosis.2006.12.007; Custodis F, 2008, CIRCULATION, V117, P2377, DOI 10.1161/CIRCULATIONAHA.107.746537; Dahabreh IJ, 2010, GENET MED, V12, P606, DOI 10.1097/GIM.0b013e3181ee81c6; DeLeo FR, 1998, J CLIN INVEST, V101, P455, DOI 10.1172/JCI949; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Edmondson D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038915; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fischer-Rosinsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003852; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Genius J, 2008, CEREBROVASC DIS, V26, P430, DOI 10.1159/000155639; Gorlach A, 2000, FASEB J, V14, P1518, DOI 10.1096/fj.14.11.1518; Griendling KK, 2004, HEART, V90, P491, DOI 10.1136/hrt.2003.029397; Guzik TJ, 2000, CIRCULATION, V102, P1744; Harrison R, 2004, DRUG METAB REV, V36, P363, DOI 10.1081/DMR-120037569; HE YY, 1993, AM J PHYSIOL, V265, pH252, DOI 10.1152/ajpheart.1993.265.1.H252; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang Xiao-song, 2007, Zhonghua Yixue Yichuanxue Zazhi, V24, P524; Huang Xiao-song, 2007, Zhonghua Yi Xue Za Zhi, V87, P2062; IMAIZUMI S, 1990, STROKE, V21, P1312, DOI 10.1161/01.STR.21.9.1312; Ito D, 2000, STROKE, V31, P936, DOI 10.1161/01.STR.31.4.936; Jerrard-Dunne P, 2003, STROKE, V34, P1364, DOI 10.1161/01.STR.0000069723.17984.FD; Jose GS, 2008, CLIN SCI, V114, P173, DOI 10.1042/CS20070130; Khan U, 2007, CEREBROVASC DIS, V24, P135, DOI 10.1159/000103615; Krex D, 2003, CEREBROVASC DIS, V16, P363, DOI 10.1159/000072558; Kuroda J, 2007, EUR J NEUROL, V14, P1091, DOI 10.1111/j.1468-1331.2007.01904.x; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Lim SC, 2006, DIABETIC MED, V23, P1037, DOI 10.1111/j.1464-5491.2006.01916.x; LIU TH, 1989, AM J PHYSIOL, V256, pH589, DOI 10.1152/ajpheart.1989.256.2.H589; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moreno MU, 2007, J HYPERTENS, V25, P1620, DOI 10.1097/HJH.0b013e3281ac211d; Moreno MU, 2006, J HYPERTENS, V24, P1299, DOI 10.1097/01.hjh.0000234110.54110.56; Moreno MU, 2003, FEBS LETT, V542, P27, DOI 10.1016/S0014-5793(03)00331-4; Nasti S, 2006, DIS MARKERS, V22, P167, DOI 10.1155/2006/458587; Niemiec P, 2010, NEUROL NEUROCHIR POL, V44, P453; Perianayagam MC, 2007, J AM SOC NEPHROL, V18, P255, DOI 10.1681/ASN.2006070806; Schulz UGR, 2004, STROKE, V35, P819, DOI 10.1161/01.STR.0000121646.23955.0f; Shi TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038606; Shimo-Nakanishi Y, 2004, ATHEROSCLEROSIS, V175, P109, DOI 10.1016/j.atherosclerosis.2004.01.043; Shimokata K, 2004, ATHEROSCLEROSIS, V172, P167, DOI 10.1016/j.atherosclerosis.2003.09.019; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; UshioFukai M, 1996, J BIOL CHEM, V271, P23317, DOI 10.1074/jbc.271.38.23317; Wells GA, 2011, NEWCASTLE OTTAWA SCA; Xu XW, 2010, NEUROGENETICS, V11, P327, DOI 10.1007/s10048-010-0235-8; Zafari AM, 2002, ANTIOXID REDOX SIGN, V4, P675, DOI 10.1089/15230860260220184	53	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56478	10.1371/journal.pone.0056478	http://dx.doi.org/10.1371/journal.pone.0056478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409188	Green Published, Green Submitted, gold			2022-12-27	WOS:000315100000056
J	Ataollahi, F; Mohri, M; Seifi, HA; Pingguan-Murphy, B; Abas, WAW; Abu Osman, NA				Ataollahi, Forough; Mohri, Mehrdad; Seifi, Hesam A.; Pingguan-Murphy, Belinda; Abas, Wan Abu Bakar Wan; Abu Osman, Noor Azuan			Evaluation of Copper Concentration in Subclinical Cases of White Muscle Disease and Its Relationship with Cardiac Troponin I	PLOS ONE			English	Article							TRACE-ELEMENTS; NITRIC-OXIDE; SELENIUM; STRESS; LAMBS; LIVER; ZINC	The present study aims to evaluate the serum level of copper (Cu) in lambs suffering from subclinical forms of white muscle disease (WMD) and its relationship with cardiac troponin I (cTn-I) as a novel biomarker of cardiovascular disorders. Ten milliliters of jugular blood were taken from 200 lambs less than one year old to measure serum concentrations of Cu, selenium (Se), and cTn-I. The subjects were divided into 2 groups, namely, the deficient group which included 36 lambs, and the control group which included 164 lambs according to the reference serum Se concentration (50 ng/mL). Serum Se levels in the deficient group were lower than 50 ng/mL. By contrast, the control group showed Se levels higher than 50 ng/mL. Differences among the serum Cu and cTn-I levels were determined in both groups. The mean +/- SD and median of serum Cu and cTn-I levels in the deficient group were lower and higher than those in the control group, respectively. A significant positive correlation was observed between serum Cu and Se levels, and also serum Cu and Se levels showed a negative correlation with serum cTn-I concentrations. Stepwise linear regression analysis showed that serum Cu levels were correlated positively with serum Se levels (p<0.05). Receiver operating characteristic (ROC) curve analysis indicated that the area under curve (AUC) of Cu was significantly higher than that of cTn-I based on the reference diagonal line. It is important to keep in mind that the value of AUC for the ROC curve is between 0.5 and 1.00, in which the lowest accuracy is related to the reference diagonal line with AUC of 0.5. A cut-off was determined to indicate which Cu level can discriminate between affected and healthy lambs. The cut-off level, sensitivity, and specificity of Cu in this study were 144.5 ng/mL, 74%, and 61%, respectively.	[Ataollahi, Forough; Mohri, Mehrdad; Seifi, Hesam A.] Ferdowsi Univ Mashhad, Dept Clin Sci, Sch Vet Med, Mashhad, Iran; [Mohri, Mehrdad; Seifi, Hesam A.] Ferdowsi Univ Mashhad, Ctr Excellence Ruminant Abort & Neonatal Mortal, Sch Vet Med, Mashhad, Iran; [Pingguan-Murphy, Belinda; Abas, Wan Abu Bakar Wan; Abu Osman, Noor Azuan] Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur, Malaysia	Ferdowsi University Mashhad; Ferdowsi University Mashhad; Universiti Malaya	Ataollahi, F (corresponding author), Ferdowsi Univ Mashhad, Dept Clin Sci, Sch Vet Med, Mashhad, Iran.	forough_at@yahoo.com	Ataollahi, Forough/S-7275-2017; Mohri, Mehrdad/B-2355-2009; Pingguan-Murphy, Belinda/B-8332-2010; ABU OSMAN, NOOR AZUAN/B-9265-2010; Ataollahi, Forough/AAM-4156-2020; Seifi, Hesam/B-2300-2015; Ataollahi, Forough/O-9254-2019	Ataollahi, Forough/0000-0002-6538-8566; Pingguan-Murphy, Belinda/0000-0001-5567-1141; ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Ataollahi, Forough/0000-0002-6538-8566; Mohri, Mehrdad/0000-0003-3756-8890; Seifi, Hesam A./0000-0003-3460-2301	Ministry of Higher Education (MOHE) of Malaysia [UM.C/HIR/MOHE/ENG/10 D000010-16001]; University of Malaya Faculty of Engineering	Ministry of Higher Education (MOHE) of Malaysia; University of Malaya Faculty of Engineering	This study was funded and will be funded by Ministry of Higher Education (MOHE) of Malaysia, grant number UM.C/HIR/MOHE/ENG/10 D000010-16001-"Biomechanical System for Hard Tissues of Normal and Disable Subjects" and supported by University of Malaya Faculty of Engineering. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Altekin E, 2005, J TRACE ELEM MED BIO, V18, P235, DOI 10.1016/j.jtemb.2004.12.002; Archer J, 2003, COMP CLIN PATH, V12, P121, DOI DOI 10.1007/S00580-003-0488-9; Blood DC, 2000, J EQUINE VET SCI; da Cunha Sergio, 2002, Arq Bras Cardiol, V79, P454; Fonfara S, 2010, VET J, V184, P334, DOI 10.1016/j.tvjl.2009.04.004; Gunes V, 2010, VET J, V184, P376, DOI 10.1016/j.tvjl.2009.03.001; Jihen EH, 2009, ECOTOX ENVIRON SAFE, V72, P1559, DOI 10.1016/j.ecoenv.2008.12.006; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Kosar Feridun, 2006, Anadolu Kardiyol Derg, V6, P216; Kozat S, 2011, KAFKAS UNIV VET FAK, V17, P441; Kutil B, 2010, MOL CELL BIOCHEM, V345, P23, DOI 10.1007/s11010-010-0555-x; Maggini S, 2007, BRIT J NUTR, V98, pS29, DOI 10.1017/S0007114507832971; Navarro-Alarcon M, 2000, SCI TOTAL ENVIRON, V249, P347, DOI 10.1016/S0048-9697(99)00526-4; Orun I, 2008, ECOTOX ENVIRON SAFE, V71, P71, DOI 10.1016/j.ecoenv.2007.07.008; Park SH, 2004, KOREAN J RADIOL, V5, P11, DOI 10.3348/kjr.2004.5.1.11; Pilarczyk B, 2009, EUR J WILDLIFE RES, V55, P279, DOI 10.1007/s10344-008-0247-y; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Sahin T, 2009, J ANIM VET ADV, V8, P2223; Shokrzadeh M, 2009, BIOL TRACE ELEM RES, V127, P116, DOI 10.1007/s12011-008-8237-1; Tekin S, 2009, J ANIM VET ADV; Tunca R, 2009, TURK J VET ANIM SCI, V33, P53; Whitley E, 2002, CRIT CARE, V6, P509, DOI 10.1186/cc1820	22	7	7	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56163	10.1371/journal.pone.0056163	http://dx.doi.org/10.1371/journal.pone.0056163			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409147	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000314660300061
J	Low, CG; Luk, ISU; Lin, D; Fazli, L; Yang, K; Xu, Y; Gleave, M; Gout, PW; Wang, YZ				Low, Christopher G.; Luk, Iris S. U.; Lin, Dong; Fazli, Ladan; Yang, Kuo; Xu, Yong; Gleave, Martin; Gout, Peter W.; Wang, Yuzhuo			BIRC6 Protein, an Inhibitor of Apoptosis: Role in Survival of Human Prostate Cancer Cells	PLOS ONE			English	Article							X-LINKED INHIBITOR; EMBRYONIC-DEVELOPMENT; TUMOR-SUPPRESSOR; GENE-EXPRESSION; AUTOPHAGY GENE; APOLLON; PATHWAY; BRUCE; IAP; BECLIN-1	Background: BIRC6 is a member of the Inhibitors of Apoptosis Protein (IAP) family which is thought to protect a variety of cancer cells from apoptosis. The main objective of the present study was to investigate whether BIRC6 plays a role in prostate cancer and could be useful as a novel therapeutic target. Methods: BIRC6 expression in cell lines was assessed using Western blot analysis and in clinical samples using immunohistochemistry of tissue microarrays. The biological significance of BIRC6 was determined by siRNA-induced reduction of BIRC6 expression in LNCaP cells followed by functional assays. Results: Elevated BIRC6 protein expression was found in prostate cancer cell lines and clinical specimens as distinct from their benign counterparts. Increased BIRC6 expression was associated with Gleason 6-8 cancers and castration resistance. Reduction of BIRC6 expression in LNCaP cells led to a marked reduction in cell proliferation which was associated with an increase in apoptosis and a decrease in autophagosome formation. Doxorubicin-induced apoptosis was found to be coupled to a reduction in BIRC6 protein expression. Conclusion: The data suggest a role for BIRC6 in prostate cancer progression and treatment resistance, and indicate for the first time that the BIRC6 gene and its product are potentially valuable targets for treatment of prostate cancers.	[Low, Christopher G.; Luk, Iris S. U.; Lin, Dong; Fazli, Ladan; Yang, Kuo; Gleave, Martin; Wang, Yuzhuo] Univ British Columbia, Vancouver Prostate Ctr, Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada; [Low, Christopher G.; Luk, Iris S. U.; Lin, Dong; Fazli, Ladan; Yang, Kuo; Gleave, Martin; Wang, Yuzhuo] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Low, Christopher G.; Luk, Iris S. U.; Lin, Dong; Gout, Peter W.; Wang, Yuzhuo] BC Canc Agcy, Dept Expt Therapeut, Vancouver, BC, Canada; [Yang, Kuo; Xu, Yong] Tianjin Med Univ, Hosp 2, Tianjin Inst Urol, Dept Urol, Tianjin, Peoples R China	University of British Columbia; University of British Columbia; British Columbia Cancer Agency; Tianjin Medical University	Wang, YZ (corresponding author), Univ British Columbia, Vancouver Prostate Ctr, Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada.	ywang@bccrc.ca		Wang, Yuzhuo/0000-0002-9749-8591; Gleave, Martin/0000-0003-4235-0167	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantana A, 2004, MOL CANCER THER, V3, P699; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Bianchini M, 2006, INT J ONCOL, V29, P83; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Chen N, 2010, FEBS LETT, V584, P1427, DOI 10.1016/j.febslet.2009.12.034; Chen ZH, 1999, BIOCHEM BIOPH RES CO, V264, P847, DOI 10.1006/bbrc.1999.1585; Chu L, 2008, GENE THER, V15, P484, DOI 10.1038/gt.2008.6; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Gleave M, 2005, CANCER CHEMOTH PHARM, V56, pS47, DOI 10.1007/s00280-005-0098-0; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Iqbal J, 2009, LEUKEMIA, V23, P1139, DOI 10.1038/leu.2009.3; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim RH, 2009, CANCER RES, V69, P700, DOI 10.1158/0008-5472.CAN-08-3157; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; LaCasse EC, 2006, CLIN CANCER RES, V12, P5231, DOI 10.1158/1078-0432.CCR-06-0608; Lee CH, 2005, GYNECOL ONCOL, V96, P48, DOI 10.1016/j.ygyno.2004.09.025; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lopergolo A, 2009, BRIT J CANCER, V100, P739, DOI 10.1038/sj.bjc.6604927; Lorenzo E, 2002, J BIOL CHEM, V277, P10883, DOI 10.1074/jbc.M107442200; Miyake H, 2000, ENDOCRINOLOGY, V141, P2257, DOI 10.1210/en.141.6.2257; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Parikh A, 2010, PROSTATE, V70, P971, DOI 10.1002/pros.21131; Petrioli R, 2008, CANCER TREAT REV, V34, P710, DOI 10.1016/j.ctrv.2008.05.004; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Qiu XB, 2004, EMBO J, V23, P800, DOI 10.1038/sj.emboj.7600075; Qiu XB, 2005, J BIOL CHEM, V280, P174, DOI 10.1074/jbc.M411430200; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ren JY, 2005, P NATL ACAD SCI USA, V102, P565, DOI 10.1073/pnas.0408744102; Rocchi P, 2004, CANCER RES, V64, P6595, DOI 10.1158/0008-5472.CAN-03-3998; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sekine K, 2005, BIOCHEM BIOPH RES CO, V330, P279, DOI 10.1016/j.bbrc.2005.02.165; Sowery RD, 2008, BJU INT, V102, P389, DOI 10.1111/j.1464-410X.2008.07618.x; Sung KW, 2007, CLIN CANCER RES, V13, P5109, DOI 10.1158/1078-0432.CCR-07-0693; van Houdt WJ, 2011, MOL CELLULAR PROTEOM; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	40	23	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55837	10.1371/journal.pone.0055837	http://dx.doi.org/10.1371/journal.pone.0055837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409057	Green Published, Green Submitted, gold			2022-12-27	WOS:000314660300037
J	Mathiharan, YK; Pappachan, A; Savithri, HS; Murthy, MRN				Mathiharan, Yamuna Kalyani; Pappachan, Anju; Savithri, H. S.; Murthy, Mathur R. N.			Dramatic Structural Changes Resulting from the Loss of a Crucial Hydrogen Bond in the Hinge Region Involved in C-Terminal Helix Swapping in SurE: A Survival Protein from Salmonella typhimurium	PLOS ONE			English	Article							STATIONARY-PHASE SURVIVAL; CRYSTAL-STRUCTURE; PHOSPHATASE; ALIGNMENT; SEQUENCE	Domain swapping is an interesting feature of some oligomeric proteins in which each protomer of the oligomer provides an identical surface for exclusive interaction with a segment or domain belonging to another protomer. Here we report results of mutagenesis experiments on the structure of C-terminal helix swapped dimer of a stationary phase survival protein from Salmonella typhimurium (StSurE). Wild type StSurE is a dimer in which a large helical segment at the C-terminus and a tetramerization loop comprising two beta strands are swapped between the protomers. Key residues in StSurE that might promote C-terminal helix swapping were identified by sequence and structural comparisons. Three mutants in which the helix swapping is likely to be avoided were constructed and expressed in E. coli. Three-dimensional X-ray crystal structures of the mutants H234A and D230A/H234A could be determined at 2.1 angstrom and 2.35 angstrom resolutions, respectively. Contrary to expectations, helix swapping was mostly retained in both the mutants. The loss of the crucial D230 OD2- H234 NE2 hydrogen bond (2.89 angstrom in the wild type structure) in the hinge region was compensated by new inter and intra-chain interactions. However, the two fold molecular symmetry was lost and there were large conformational changes throughout the polypeptide. In spite of these changes, the dimeric structure and an approximate tetrameric organization were retained, probably due to the interactions involving the tetramerization loop. Mutants were mostly functionally inactive, highlighting the importance of precise inter-subunit interactions for the symmetry and function of StSurE.	[Mathiharan, Yamuna Kalyani; Pappachan, Anju; Murthy, Mathur R. N.] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Savithri, H. S.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Murthy, MRN (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	mrn@mbu.iisc.ernet.in		Mathiharan, Yamuna Kalyani/0000-0003-4042-6199	DST, Government of India; DBT, Government of India; MHRD, Government of India	DST, Government of India(Department of Science & Technology (India)); DBT, Government of India(Department of Biotechnology (DBT) India); MHRD, Government of India(Ministry of Human Resource Development (MHRD), Government of India)	M.R.N. Murthy and H. S. Savithri thank DST and the DBT, Government of India for funding. Yamuna Kalyani Mathiharan thanks the MHRD, Government of India, for the award of a Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Antonyuk SV, 2009, ACTA CRYSTALLOGR F, V65, P1204, DOI 10.1107/S1744309109043814; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BENNETT MJ, 1994, PROTEIN SCI, V3, P1444, DOI 10.1002/pro.5560030911; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P5741, DOI 10.1073/pnas.77.10.5741; Iwasaki W, 2007, J MOL BIOL, V371, P123, DOI 10.1016/j.jmb.2007.05.007; Jaskolski M, 2001, ACTA BIOCHIM POL, V48, P807; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JY, 2001, NAT STRUCT BIOL, V8, P789, DOI 10.1038/nsb0901-789; Li C, 1997, MICROBIOL-UK, V143, P3513, DOI 10.1099/00221287-143-11-3513; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mura C, 2003, J MOL BIOL, V326, P1559, DOI 10.1016/S0022-2836(03)00056-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ostermeier M, 2001, ADV PROTEIN CHEM, V55, P29, DOI 10.1016/S0065-3233(01)55002-0; Pappachan A, 2008, FEBS J, V275, P5855, DOI 10.1111/j.1742-4658.2008.06715.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55978	10.1371/journal.pone.0055978	http://dx.doi.org/10.1371/journal.pone.0055978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409101	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200096
J	Oxborough, RM; Kitau, J; Matowo, J; Feston, E; Mndeme, R; Mosha, FW; Rowland, MW				Oxborough, Richard M.; Kitau, Jovin; Matowo, Johnson; Feston, Emmanuel; Mndeme, Rajab; Mosha, Franklin W.; Rowland, Mark W.			ITN Mixtures of Chlorfenapyr (Pyrrole) and Alphacypermethrin (Pyrethroid) for Control of Pyrethroid Resistant Anopheles arabiensis and Culex quinquefasciatus	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; HOUSE-FREQUENTING HABITS; MALARIA VECTOR CONTROL; VERANDAH-TRAP HUT; BED NETS; GAMBIAE; MOSQUITOS; DIPTERA; POPULATIONS; AREA	Pyrethroid resistant Anopheles gambiae malaria vectors are widespread throughout sub-Saharan Africa and continued efficacy of pyrethroid ITNs is under threat. Chlorfenapyr is a promising pyrrole insecticide with a unique mechanism of action conferring no cross-resistance to existing public health insecticides. Mixtures of chlorfenapyr (CFP) and alphacypermethrin (alpha) may provide additional benefits over chlorfenapyr or alphacypermethrin used alone. An ITN mixture of CFP 100 mg/m(2)+alpha 25 mg/m(2) was compared with CFP 100 mg/m(2) and alpha 25 mg/m(2) in a small-scale experimental hut trial in an area of wild An. arabiensis. The same treatments were evaluated in tunnel tests against insectary-reared pyrethroid susceptible and resistant Culex quinquefasciatus. Performance was measured in terms of insecticide-induced mortality, and blood-feeding inhibition. Tunnel tests showed that mixtures of CFP 100+ alpha 25 were 1.2 and 1.5 times more effective at killing susceptible Cx. quinquefasciatus than either Alpha 25 (P = 0.001) or CFP 100 (P = 0.001) ITNs. Mixtures of CFP100+ alpha 25 were 2.2 and 1.2 times more effective against resistant Cx. quinquefasciatus than either alpha 25 (P = 0.001) or CFP100 (P = 0.003) ITNs. CFP 100+ alpha 25 produced higher levels of blood-feeding inhibition than CFP alone for susceptible (94 vs 46%, P = 0.001) and resistant (84 vs 53%, P = 0.001) strains. In experimental huts the mixture of CFP 100+ Alpha 25 killed 58% of An. arabiensis, compared with 50% for alpha and 49% for CFP, though the differences were not significant. Blood-feeding inhibition was highest in the mixture with a 76% reduction compared to the untreated net (P = 0.001). ITN mixtures of chlorfenapyr and alphacypermethrin should restore effective control of resistant populations of An. gambiae malaria vectors, provide protection from blood-feeding, and may have benefits for resistance management, particularly in areas with low or moderate frequency of pyrethroid resistance. A wash-resistant mixture should be developed urgently.	[Oxborough, Richard M.; Rowland, Mark W.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Oxborough, Richard M.; Kitau, Jovin; Matowo, Johnson; Feston, Emmanuel; Mndeme, Rajab; Mosha, Franklin W.] Tumaini Univ, Kilimanjaro Christian Med Univ Coll KCMUCo, Dept Entomol & Parasitol, Moshi, Kilimanjaro, Tanzania; [Oxborough, Richard M.; Kitau, Jovin; Matowo, Johnson; Feston, Emmanuel; Mndeme, Rajab; Mosha, Franklin W.; Rowland, Mark W.] PAMVERC, Pan African Malaria Vector Res Consortium, Dept Entomol, Moshi, Kilimanjaro, Tanzania	University of London; London School of Hygiene & Tropical Medicine	Oxborough, RM (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	Richard.Oxborough@lshtm.ac.uk			Innovative Vector Control Consortium (IVCC), Liverpool, United Kingdom	Innovative Vector Control Consortium (IVCC), Liverpool, United Kingdom	This work was supported by Innovative Vector Control Consortium (IVCC), Liverpool, United Kingdom. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The funders were consulted regarding publication and approved submission.	[Anonymous], 2004, COCHRANE DB SYST REV; Asidi AN, 2004, MED VET ENTOMOL, V18, P134, DOI 10.1111/j.0269-283X.2004.00485.x; Beiersmann C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-296; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Curtis CF, 1996, MED VET ENTOMOL, V10, P1, DOI 10.1111/j.1365-2915.1996.tb00075.x; CURTIS CF, 1985, B ENTOMOL RES, V75, P259, DOI 10.1017/S0007485300014346; Czeher C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-189; DENHOLM I, 1992, ANNU REV ENTOMOL, V37, P91, DOI 10.1146/annurev.en.37.010192.000515; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Guglielmone AA, 2000, VET PARASITOL, V93, P77, DOI 10.1016/S0304-4017(00)00335-6; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Ijumba JN, 2002, MED VET ENTOMOL, V16, P28, DOI 10.1046/j.0269-283x.2002.00337.x; Irish SR, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-17; Jones CM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-24; Kitau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031481; Kulkarni MA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-56; LINES JD, 1988, PARASITOL TODAY, V4, pS17, DOI 10.1016/0169-4758(88)90083-X; Matowo J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-193; MILLER JE, 1994, J MED ENTOMOL, V31, P114, DOI 10.1093/jmedent/31.1.114; Mosha FW, 2008, TROP MED INT HEALTH, V13, P644, DOI 10.1111/j.1365-3156.2008.02058.x; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; N'Guessan R, 2007, ACTA TROP, V102, P69, DOI 10.1016/j.actatropica.2007.03.003; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; N'Guessan R, 2009, TROP MED INT HEALTH, V14, P389, DOI 10.1111/j.1365-3156.2009.02245.x; Ngufor C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-343; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Oliver SV, 2010, TROP MED INT HEALTH, V15, P127, DOI 10.1111/j.1365-3156.2009.02416.x; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Oxborough RM, 2010, T ROY SOC TROP MED H, V104, P639, DOI 10.1016/j.trstmh.2010.07.008; Raghavendra K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-16; Rajatileka S, 2011, T ROY SOC TROP MED H, V105, P247, DOI 10.1016/j.trstmh.2011.01.009; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; SMITH A, 1969, B ENTOMOL RES, V59, P33, DOI 10.1017/S000748530000300X; SMITH A, 1965, B ENTOMOL RES, V56, P161, DOI 10.1017/S0007485300057114; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1170, DOI 10.1093/jee/83.4.1170; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2007, WHO REC INS PROD TRE; WHO, 2005, WHOCDSWHOPESGCDPP200; World Health Organization, WHOCDSNTDWHOPESGCDPP; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6	43	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55781	10.1371/journal.pone.0055781	http://dx.doi.org/10.1371/journal.pone.0055781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409042	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000315157200062
J	Arai, Y; Totoki, Y; Takahashi, H; Nakamura, H; Hama, N; Kohno, T; Tsuta, K; Yoshida, A; Asamura, H; Mutoh, M; Hosoda, F; Tsuda, H; Shibata, T				Arai, Yasuhito; Totoki, Yasushi; Takahashi, Hiroyuki; Nakamura, Hiromi; Hama, Natsuko; Kohno, Takashi; Tsuta, Koji; Yoshida, Akihiko; Asamura, Hisao; Mutoh, Michihiro; Hosoda, Fumie; Tsuda, Hitoshi; Shibata, Tatsuhiro			Mouse Model for ROS1-Rearranged Lung Cancer	PLOS ONE			English	Article							TYROSINE KINASE; GENE FUSIONS; TARGETED THERAPY; ROS1; IDENTIFICATION; LANDSCAPE	Genetic rearrangement of the ROS1 receptor tyrosine kinase was recently identified as a distinct molecular signature for human non-small cell lung cancer (NSCLC). However, direct evidence of lung carcinogenesis induced by ROS1 fusion genes remains to be verified. The present study shows that EZR-ROS1 plays an essential role in the oncogenesis of NSCLC harboring the fusion gene. EZR-ROS1 was identified in four female patients of lung adenocarcinoma. Three of them were never smokers. Interstitial deletion of 6q22-q25 resulted in gene fusion. Expression of the fusion kinase in NIH3T3 cells induced anchorage-independent growth in vitro, and subcutaneous tumors in nude mice. This transforming ability was attributable to its kinase activity. The ALK/MET/ROS1 kinase inhibitor, crizotinib, suppressed fusion-induced anchorage-independent growth of NIH3T3 cells. Most importantly, established transgenic mouse lines specifically expressing EZR-ROS1 in lung alveolar epithelial cells developed multiple adenocarcinoma nodules in both lungs at an early age. These data suggest that the EZR-ROS1 is a pivotal oncogene in human NSCLC, and that this animal model could be valuable for exploring therapeutic agents against ROS1-rearranged lung cancer.	[Arai, Yasuhito; Totoki, Yasushi; Takahashi, Hiroyuki; Nakamura, Hiromi; Hama, Natsuko; Hosoda, Fumie; Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Canc Genom, Chuo Ku, Tokyo 104, Japan; [Kohno, Takashi] Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, Tokyo 104, Japan; [Tsuta, Koji; Yoshida, Akihiko; Tsuda, Hitoshi] Natl Canc Ctr, Div Pathol & Clin Labs, Chuo Ku, Tokyo, Japan; [Asamura, Hisao] Natl Canc Ctr, Thorac Surg Div, Chuo Ku, Tokyo, Japan; [Mutoh, Michihiro] Natl Canc Ctr, Res Inst, Div Canc Prevent Res, Chuo Ku, Tokyo 104, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Shibata, T (corresponding author), Natl Canc Ctr, Res Inst, Div Canc Genom, Chuo Ku, Tokyo 104, Japan.	tashibat@ncc.go.jp	Mutoh, Michihiro/AAB-1868-2022; Shibata, Tatsuhiro/AAO-1278-2021; Shibata, Tatsuhiro/ABA-8234-2020	Arai, Yasuhito/0000-0001-6306-9409	Program for Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation, National Cancer Center Research and Development Fund [23-A-7, 23-B-28]; Research Grant of the Princess Takamatsu Cancer Research Fund; Ministry of Health, Labour and Welfare for the 3rd-term Comprehensive 10-year Strategy for Cancer Control; National Cancer Center Research and Development Fund, Japan	Program for Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation, National Cancer Center Research and Development Fund; Research Grant of the Princess Takamatsu Cancer Research Fund; Ministry of Health, Labour and Welfare for the 3rd-term Comprehensive 10-year Strategy for Cancer Control; National Cancer Center Research and Development Fund, Japan	This study was supported by the Program for Promotion of Fundamental Studies in Health Sciences from the National Institute of Biomedical Innovation, National Cancer Center Research and Development Funds (23-A-7 and 23-B-28), Research Grant of the Princess Takamatsu Cancer Research Fund and Grants-in-Aid from the Ministry of Health, Labour and Welfare for the 3rd-term Comprehensive 10-year Strategy for Cancer Control. National Cancer Center Biobank is supported by the National Cancer Center Research and Development Fund, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Birch AH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028250; Charest A, 2003, GENE CHROMOSOME CANC, V37, P58, DOI 10.1002/gcc.10207; Charest A, 2003, P NATL ACAD SCI USA, V100, P916, DOI 10.1073/pnas.242741799; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Davies KD, 2012, CLIN CANCER RES, V18, P4570, DOI 10.1158/1078-0432.CCR-12-0550; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Gerber DE, 2010, CANCER CELL, V18, P548, DOI 10.1016/j.ccr.2010.11.033; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Inamura K, 2009, MODERN PATHOL, V22, P508, DOI 10.1038/modpathol.2009.2; Janku F, 2010, NAT REV CLIN ONCOL, V7, P401, DOI 10.1038/nrclinonc.2010.64; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Lovly CM, 2011, NAT REV CLIN ONCOL, V8, P68, DOI 10.1038/nrclinonc.2010.224; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Medves S, 2012, J CELL MOL MED, V16, P237, DOI 10.1111/j.1582-4934.2011.01415.x; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; Mishra A, 2001, J BIOL CHEM, V276, P8453, DOI 10.1074/jbc.M009481200; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Park BS, 2009, BIOORG MED CHEM LETT, V19, P4720, DOI 10.1016/j.bmcl.2009.06.066; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rimkunas VM, 2012, CLIN CANCER RES, V18, P4449, DOI 10.1158/1078-0432.CCR-11-3351; Sasaki T, 2011, CLIN CANCER RES, V17, P7213, DOI 10.1158/1078-0432.CCR-11-1404; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soda M, 2008, P NATL ACAD SCI USA, V105, P19893, DOI 10.1073/pnas.0805381105; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Yoshida A, AM J SURG P IN PRESS; Yoshida A, 2011, AM J SURG PATHOL, V35, P1226, DOI 10.1097/PAS.0b013e3182233e06; Yoshikawa D, 2009, BRIT J CANCER, V100, P1257, DOI 10.1038/sj.bjc.6604988	32	47	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56010	10.1371/journal.pone.0056010	http://dx.doi.org/10.1371/journal.pone.0056010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418494	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300086
J	Bohm, S; Buchberger, A				Boehm, Stefanie; Buchberger, Alexander			The Budding Yeast Cdc48(Shp1) Complex Promotes Cell Cycle Progression by Positive Regulation of Protein Phosphatase 1 (Glc7)	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; AAA-ATPASE CDC48/P97; AURORA B ACTIVITY; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; MITOTIC SPINDLE; UBX DOMAIN; ENDOPLASMIC-RETICULUM; NUCLEAR-LOCALIZATION; KINETOCHORE FUNCTION	The conserved, ubiquitin-selective AAA ATPase Cdc48 regulates numerous cellular processes including protein quality control, DNA repair and the cell cycle. Cdc48 function is tightly controlled by a multitude of cofactors mediating substrate specificity and processing. The UBX domain protein Shp1 is a bona fide substrate-recruiting cofactor of Cdc48 in the budding yeast S. cerevisiae. Even though Shp1 has been proposed to be a positive regulator of Glc7, the catalytic subunit of protein phosphatase 1 in S. cerevisiae, its cellular functions in complex with Cdc48 remain largely unknown. Here we show that deletion of the SHP1 gene results in severe growth defects and a cell cycle delay at the metaphase to anaphase transition caused by reduced Glc7 activity. Using an engineered Cdc48 binding-deficient variant of Shp1, we establish the Cdc48(Shp1) complex as a critical regulator of mitotic Glc7 activity. We demonstrate that shp1 mutants possess a perturbed balance of Glc7 phosphatase and Ipl1 (Aurora B) kinase activities and show that hyper-phosphorylation of the kinetochore protein Dam1, a key mitotic substrate of Glc7 and Ipl1, is a critical defect in shp1. We also show for the first time a physical interaction between Glc7 and Shp1 in vivo. Whereas loss of Shp1 does not significantly affect Glc7 protein levels or localization, it causes reduced binding of the activator protein Glc8 to Glc7. Our data suggest that the Cdc48(Shp1) complex controls Glc7 activity by regulating its interaction with Glc8 and possibly further regulatory subunits.	[Boehm, Stefanie; Buchberger, Alexander] Univ Wurzburg, Dept Biochem, Bioctr, D-97070 Wurzburg, Germany	University of Wurzburg	Buchberger, A (corresponding author), Univ Wurzburg, Dept Biochem, Bioctr, D-97070 Wurzburg, Germany.	alexander.buchberger@biozentrum.uni-wuerzburg.de	Buchberger, Alexander/AAF-4728-2019; Buchberger, Alexander/J-4070-2019	Buchberger, Alexander/0000-0002-2836-0820; Buchberger, Alexander/0000-0002-2836-0820	German Research Foundation (DFG) [BU951/3-1, BU951/3-2, BU951/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants BU951/3-1, BU951/3-2 and BU951/4-1 by the German Research Foundation (DFG) (http://www.dfg.de/en/index.jsp) to A.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi B, 2009, GENE DEV, V23, P2887, DOI 10.1101/gad.1865909; Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; AXTON JM, 1990, CELL, V63, P33, DOI 10.1016/0092-8674(90)90286-N; Baker SH, 1997, GENETICS, V145, P615; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Bharucha JP, 2008, MOL BIOL CELL, V19, P1032, DOI 10.1091/mbc.E07-05-0499; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; BLACK S, 1995, YEAST, V11, P747, DOI 10.1002/yea.320110806; Bloecher A, 2000, J CELL BIOL, V149, P125, DOI 10.1083/jcb.149.1.125; Bloecher A, 1999, GENE DEV, V13, P517, DOI 10.1101/gad.13.5.517; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Bohm S, 2011, MOL CELL BIOL, V31, P1528, DOI 10.1128/MCB.00962-10; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Buchberger A, 2002, TRENDS CELL BIOL, V12, P216, DOI 10.1016/S0962-8924(02)02269-9; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Buchberger A, SUBCELL BIO IN PRESS; Buchberger A, 2010, SUBCELL BIOCHEM, V54, P17, DOI 10.1007/978-1-4419-6676-6_2; CANNON JF, 1994, GENETICS, V136, P485; Cannon JF, 2010, ADV APPL MICROBIOL, V73, P27, DOI 10.1016/S0065-2164(10)73002-1; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Castermans D, 2012, CELL RES, V22, P1058, DOI 10.1038/cr.2012.20; CHAN CSM, 1993, GENETICS, V135, P677; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cheng YL, 2010, J CELL SCI, V123, P2024, DOI 10.1242/jcs.066043; Cohen PTW, 2002, J CELL SCI, V115, P241; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Cui DY, 2004, J BIOL CHEM, V279, P9713, DOI 10.1074/jbc.M310793200; Daniel JA, 2006, GENETICS, V172, P53, DOI 10.1534/genetics.105.046441; Dargemont C, 2012, BBA-MOL CELL RES, V1823, P138, DOI 10.1016/j.bbamcr.2011.07.011; Decottignies A, 2004, YEAST, V21, P127, DOI 10.1002/yea.1071; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; FERNANDEZ A, 1992, J CELL BIOL, V116, P1421, DOI 10.1083/jcb.116.6.1421; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; FRANCISCO L, 1994, CELL MOL BIOL RES, V40, P207; Fu XR, 2003, J CELL BIOL, V163, P21, DOI 10.1083/jcb.200307025; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Hardwick KG, 1999, GENETICS, V152, P509; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; HISAMOTO N, 1994, MOL CELL BIOL, V14, P3158, DOI 10.1128/MCB.14.5.3158; Hitt R, 2004, FEMS YEAST RES, V4, P721, DOI 10.1016/j.femsyr.2004.02.003; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hsieh MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018988; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Ishii K, 1996, EMBO J, V15, P6629, DOI 10.1002/j.1460-2075.1996.tb01053.x; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kaneko Y, 2010, FEBS LETT, V584, P3873, DOI 10.1016/j.febslet.2010.07.061; Kang JS, 2001, J CELL BIOL, V155, P763, DOI 10.1083/jcb.200105029; Keating P, 2009, J CELL SCI, V122, P4375, DOI 10.1242/jcs.055566; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kozubowski L, 2003, MOL BIOL CELL, V14, P26, DOI 10.1091/mbc.E02-06-0373; Krick R, 2010, J CELL BIOL, V190, P965, DOI 10.1083/jcb.201002075; Lampert F, 2010, J CELL BIOL, V189, P641, DOI 10.1083/jcb.200912021; Larson JR, 2008, MOL BIOL CELL, V19, P3040, DOI 10.1091/mbc.E08-02-0130; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; LIU HP, 1992, GENETICS, V132, P665; MACKELVIE SH, 1995, MOL CELL BIOL, V15, P3777; Meadows JC, 2011, DEV CELL, V20, P739, DOI 10.1016/j.devcel.2011.05.008; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer Hemmo H, 2005, Biochim Biophys Acta, V1744, P481; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; MOIR D, 1982, GENETICS, V100, P547; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; OHKURA H, 1989, CELL, V57, P997, DOI 10.1016/0092-8674(89)90338-3; Pedelini L, 2007, J BIOL CHEM, V282, P3282, DOI 10.1074/jbc.M607171200; Peggie MW, 2002, J CELL SCI, V115, P195; Peters C, 1999, SCIENCE, V285, P1084, DOI 10.1126/science.285.5430.1084; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Pinsky BA, 2006, MOL CELL BIOL, V26, P2648, DOI 10.1128/MCB.26.7.2648-2660.2006; Pinsky BA, 2009, CURR BIOL, V19, P1182, DOI 10.1016/j.cub.2009.06.043; Posch M, 2010, J CELL BIOL, V191, P61, DOI 10.1083/jcb.200912046; Rosenberg JS, 2011, CURR BIOL, V21, P942, DOI 10.1016/j.cub.2011.04.011; Sambade M, 2005, GENETICS, V170, P1539, DOI 10.1534/genetics.105.042812; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Schuberth C, 2006, THESIS LUDWIG MAXIMI; Shang C, 2003, MOL BIOL CELL, V14, P3342, DOI 10.1091/mbc.E02-11-0765; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Skibbens RV, 1998, ANNU REV GENET, V32, P307, DOI 10.1146/annurev.genet.32.1.307; Starita LM, 2012, PROTEOMICS, V12, P236, DOI 10.1002/pmic.201100166; Stark MJR, 1996, YEAST, V12, P1647, DOI 10.1002/(SICI)1097-0061(199612)12:16<1647::AID-YEA71>3.0.CO;2-Q; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Tan YSH, 2003, J BIOL CHEM, V278, P147, DOI 10.1074/jbc.M208058200; Tatchell K, 2011, P NATL ACAD SCI USA, V108, P3994, DOI 10.1073/pnas.1014406108; Tien JF, 2010, J CELL BIOL, V189, P713, DOI 10.1083/jcb.200910142; TUNG HYL, 1995, MOL CELL BIOL, V15, P6064; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Vanoosthuyse V, 2009, CURR BIOL, V19, P1176, DOI 10.1016/j.cub.2009.05.060; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Wang CW, 2012, J CELL SCI, V125, P2930, DOI 10.1242/jcs.100230; WANG YC, 1995, MOL CELL BIOL, V15, P6838; Wilcox AJ, 2009, NAT CELL BIOL, V11, P1481, DOI 10.1038/ncb1997; Wilson WA, 2005, BIOCHEM BIOPH RES CO, V329, P161, DOI 10.1016/j.bbrc.2005.01.106; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Wu XL, 2001, BIOCHEMISTRY-US, V40, P7410, DOI 10.1021/bi002796k; Wurzenberger C, 2012, J CELL BIOL, V198, P173, DOI 10.1083/jcb.201112112; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yuan XM, 2001, J MOL BIOL, V311, P255, DOI 10.1006/jmbi.2001.4864; ZHANG SR, 1995, MOL CELL BIOL, V15, P2037	123	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56486	10.1371/journal.pone.0056486	http://dx.doi.org/10.1371/journal.pone.0056486			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418575	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300168
J	Broch, O; Gruenewald, M; Renner, J; Meybohm, P; Schottler, J; Hess, K; Steinfath, M; Bein, B				Broch, Ole; Gruenewald, Matthias; Renner, Jochen; Meybohm, Patrick; Schoettler, Jan; Hess, Katharina; Steinfath, Markus; Bein, Berthold			Dynamic and Volumetric Variables Reliably Predict Fluid Responsiveness in a Porcine Model with Pleural Effusion	PLOS ONE			English	Article							PULSE PRESSURE VARIATION; CHEST-WALL MECHANICS; END-DIASTOLIC VOLUME; HIGH-RISK SURGERY; CARDIAC PRELOAD; HOSPITAL STAY; LUNG; ESOPHAGEAL; MANAGEMENT; EXPANSION	Background: The ability of stroke volume variation (SVV), pulse pressure variation (PPV) and global end-diastolic volume (GEDV) for prediction of fluid responsiveness in presence of pleural effusion is unknown. The aim of the present study was to challenge the ability of SVV, PPV and GEDV to predict fluid responsiveness in a porcine model with pleural effusions. Methods: Pigs were studied at baseline and after fluid loading with 8 ml kg(-1) 6% hydroxyethyl starch. After withdrawal of 8 ml kg(-1) blood and induction of pleural effusion up to 50 ml kg(-1) on either side, measurements at baseline and after fluid loading were repeated. Cardiac output, stroke volume, central venous pressure (CVP) and pulmonary occlusion pressure (PAOP) were obtained by pulmonary thermodilution, whereas GEDV was determined by transpulmonary thermodilution. SVV and PPV were monitored continuously by pulse contour analysis. Results: Pleural effusion was associated with significant changes in lung compliance, peak airway pressure and stroke volume in both responders and non-responders. At baseline, SVV, PPV and GEDV reliably predicted fluid responsiveness (area under the curve 0.85 (p<0.001), 0.88 (p<0.001), 0.77 (p=0.007). After induction of pleural effusion the ability of SVV, PPV and GEDV to predict fluid responsiveness was well preserved and also PAOP was predictive. Threshold values for SVV and PPV increased in presence of pleural effusion. Conclusions: In this porcine model, bilateral pleural effusion did not affect the ability of SVV, PPV and GEDV to predict fluid responsiveness.	[Broch, Ole; Gruenewald, Matthias; Renner, Jochen; Steinfath, Markus; Bein, Berthold] Univ Hosp Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Schleswig Holstein, Germany; [Meybohm, Patrick] Univ Hosp Frankfurt, Dept Anesthesiol Intens Care Med & Pain Therapy, Hessen, Germany; [Schoettler, Jan] Univ Hosp Schleswig Holstein, Dept Cardiothorac & Vasc Surg, Schleswig Holstein, Germany; [Hess, Katharina] Univ Kiel, Schleswig Holstein, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel	Broch, O (corresponding author), Univ Hosp Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Campus Kiel, Schleswig Holstein, Germany.	ole.broch@uksh.de	Gruenewald, Matthias/F-9485-2012; Meybohm, Patrick/K-4066-2017	Meybohm, Patrick/0000-0002-2666-8696; Hess, Katharina/0000-0003-3922-6413	Department of Anaesthesiology and Intensive Care Medicine, University Hospital Schleswig Holstein, Campus Kiel, Germany	Department of Anaesthesiology and Intensive Care Medicine, University Hospital Schleswig Holstein, Campus Kiel, Germany	The present study was supported by departmental funding only (Department of Anaesthesiology and Intensive Care Medicine, University Hospital Schleswig Holstein, Campus Kiel, Germany). There were no commercial funding sources supporting the submitted study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay E, 2003, CURR OPIN PULM MED, V9, P291, DOI 10.1097/00063198-200307000-00008; Balik M, 2006, INTENS CARE MED, V32, P318, DOI 10.1007/s00134-005-0024-2; Broch O, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.07.073; Cannesson M, 2011, CRIT CARE, V15, DOI 10.1186/cc10364; Cannesson M, 2011, ANESTHESIOLOGY, V115, P231, DOI 10.1097/ALN.0b013e318225b80a; De Backer D, 2005, INTENS CARE MED, V31, P517, DOI 10.1007/s00134-005-2586-4; De Backer D, 2009, ANESTHESIOLOGY, V110, P1092, DOI 10.1097/ALN.0b013e31819db2a1; de Waal EEC, 2009, CRIT CARE MED, V37, P510, DOI 10.1097/CCM.0b013e3181958bf7; DECHMAN G, 1993, EUR RESPIR J, V6, P219; Graf J, 2011, CRIT CARE MED, V39, P2294, DOI 10.1097/CCM.0b013e3182227bb5; Hadian M, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.08.018; Heenen S, 2006, CRIT CARE, V10, DOI 10.1186/cc4970; JACOB R, 1992, EUR HEART J, V13, P7, DOI 10.1093/eurheartj/13.suppl_E.7; Kumar A, 2004, CRIT CARE MED, V32, P691, DOI 10.1097/01.CCM.0000114996.68110.C9; Lopes MR, 2007, CRIT CARE, V11, DOI 10.1186/cc6117; Loring SH, 2010, J APPL PHYSIOL, V108, P515, DOI 10.1152/japplphysiol.00835.2009; Magder S, 2004, AM J RESP CRIT CARE, V169, P151, DOI 10.1164/rccm.200211-1360CC; Marik PE, 2009, CRIT CARE MED, V37, P2642, DOI 10.1097/CCM.0b013e3181a590da; Mayer J, 2010, CRIT CARE, V14, DOI 10.1186/cc8875; Michard F, 1999, AM J RESP CRIT CARE, V159, P935, DOI 10.1164/ajrccm.159.3.9805077; Michard F, 2003, CHEST, V124, P1900, DOI 10.1378/chest.124.5.1900; Nishida O, 1999, CRIT CARE MED, V27, P583, DOI 10.1097/00003246-199903000-00040; Osman D, 2007, CRIT CARE MED, V35, P64, DOI 10.1097/01.CCM.0000249851.94101.4F; Pearse R, 2005, CRIT CARE, V9, pR687, DOI 10.1186/cc3887; Pelosi P, 1996, CHEST, V109, P144, DOI 10.1378/chest.109.1.144; Peris A, 2010, ANESTH ANALG, V111, P687, DOI 10.1213/ANE.0b013e3181e7cc42; Pinsky MR, 2005, CHEST, V128, p592S, DOI 10.1378/chest.128.5_suppl_2.592S; Renner J, 2007, ANESTH ANALG, V105, P1243, DOI 10.1213/01.ane.0000281152.72734.d0; Renner J, 2009, CRIT CARE MED, V37, P650, DOI 10.1097/CCM.0b013e3181959864; Reuter DA, 2005, BRIT J ANAESTH, V94, P318, DOI 10.1093/bja/aei043; Rex S, 2007, ACTA ANAESTH SCAND, V51, P1258, DOI 10.1111/j.1399-6576.2007.01423.x; Rex S, 2004, BRIT J ANAESTH, V93, P782, DOI 10.1093/bja/aeh280; Rhodes A, 2010, INTENS CARE MED, V36, P1327, DOI 10.1007/s00134-010-1869-6; Sagrista-Sauleda J, 2008, CIRCULATION, V117, P1545, DOI 10.1161/CIRCULATIONAHA.107.737841; Sakka SG, 2000, INTENS CARE MED, V26, P180, DOI 10.1007/s001340050043; Talmor D, 2006, CRIT CARE MED, V34, P1389, DOI 10.1097/01.CCM.0000215515.49001.A2; Talmor D, 2008, NEW ENGL J MED, V359, P2095, DOI 10.1056/NEJMoa0708638; Trof RJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10062; VASKA K, 1992, CIRCULATION, V86, P609, DOI 10.1161/01.CIR.86.2.609	39	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56267	10.1371/journal.pone.0056267	http://dx.doi.org/10.1371/journal.pone.0056267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418546	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300139
J	Essabbani, A; Garcia, L; Zonetti, MJ; Fisco, T; Pucci, S; Chiocchia, G				Essabbani, Abdellatif; Garcia, Luis; Zonetti, Maria Jose; Fisco, Tommaso; Pucci, Sabina; Chiocchia, Gilles			Exon-Skipping Strategy by Ratio Modulation between Cytoprotective versus Pro-Apoptotic Clusterin Forms Increased Sensitivity of LNCaP to Cell Death	PLOS ONE			English	Article							INDUCED DNA-DAMAGE; PROSTATE-CANCER; IN-VITRO; CLUSTERIN/APOLIPOPROTEIN-J; SULFATED GLYCOPROTEIN-2; NUCLEAR CLUSTERIN; OXIDATIVE STRESS; OVEREXPRESSION; EXPRESSION; PROTEIN	Background: In prostate cancer the secreted form of clusterin (sCLU) has been described as an anti-apoptotic protein whose expression is increased after therapeutic intervention, whereas, the nuclear protein form nCLU was reported to have pro-apoptotic properties. Methodology: In order to provide new therapeutic approaches targeting CLU, we developed a strategy based on exon skipping by using a lentiviral construct to preferentially induce the nuclear spliced form of the protein. The molecular construct was transduced in LNCaP cells for testing the modulation of sensitivity of the transduced cells to pro-apoptotic stress. Results and Conclusions: We showed an increase of nCLU/sCLU expression ratio in the prostate cancer cell line "LNCaP'' after lentiviral vector-U7 nCLU transduction. Moreover, we showed a significant inhibition of cell proliferation in nCLU-U7 LNCaP cells after treatment with cisplatin and after exposure to ionizing radiation compared to control cells. Finally, we showed that nCLU-U7 LNCaP cells exposure to UV-C significantly reduced an increase of cell death compared to control. Finally, we showed that modulating nCLU expression had profound impact on Ku70/Bax interaction as well as Rad17 expression which could be a key mechanism in sensitizing cells to cell death. In conclusion, this is the first report showing that increasing of nCLU/sCLU expression ratio by using an "on demand alternative splicing'' strategy successfully increased sensitivity to radiotherapy and chemotherapy of prostate cancer cells.	[Essabbani, Abdellatif; Chiocchia, Gilles] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Essabbani, Abdellatif; Chiocchia, Gilles] Univ Paris 05, CNRS, UMR 8104, Lab Excellence INFLAMEX, Paris, France; [Essabbani, Abdellatif; Garcia, Luis; Chiocchia, Gilles] Univ Versailles, F-78000 Versailles, France; [Garcia, Luis] Univ Paris 06, INSERM, Grp Hosp Pitie Salpetriere, UMR S 974,CNRS,UMR 7215,Inst Myol, Paris, France; [Zonetti, Maria Jose; Fisco, Tommaso; Pucci, Sabina] Univ Rome Tor Vergata Policlin, Dept Biopathol, Rome, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Rome Tor Vergata	Chiocchia, G (corresponding author), Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France.	gilles.chiocchia@inserm.fr	García, Luis V/GQA-9712-2022; CHIOCCHIA, Gilles R/F-6287-2013	CHIOCCHIA, Gilles R/0000-0001-9973-0940; Pucci, Sabina/0000-0002-2418-6482; Zonetti, Maria Jose/0000-0002-5451-0626; Fisco, Tommaso/0000-0002-6687-3264	Inserm; CNRS; Societe Francaise de Rhumatologie; Arthritis Fondation Courtin; Association pour la Recherche sur le Cancer (ARC)	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Societe Francaise de Rhumatologie; Arthritis Fondation Courtin; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	The work was supported by Inserm and CNRS. This work was supported by grants from Societe Francaise de Rhumatologie, and Arthritis Fondation Courtin. A.E. was supported by Association pour la Recherche sur le Cancer (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benchaouir R, 2007, CELL STEM CELL, V1, P646, DOI 10.1016/j.stem.2007.09.016; Caccamo AE, 2005, CELL DEATH DIFFER, V12, P101, DOI 10.1038/sj.cdd.4401491; Caccamo AE, 2003, ANN NY ACAD SCI, V1010, P514, DOI 10.1196/annals.1299.095; Cagnard N, 2005, EUR CYTOKINE NETW, V16, P289; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chung J, 2004, CANCER LETT, V203, P155, DOI 10.1016/j.canlet.2003.07.008; Essabbani A, 2010, J BIOL CHEM, V285, P4273, DOI 10.1074/jbc.C109.057133; Falgarone G, 2009, ADV CANCER RES, V104, P139, DOI 10.1016/S0065-230X(09)04008-1; FRENCH LE, 1994, J CLIN INVEST, V93, P877, DOI 10.1172/JCI117043; Gentile M, 2003, NUCLEIC ACIDS RES, V31, P4779, DOI 10.1093/nar/gkg675; Gleave M, 2005, WORLD J UROL, V23, P38, DOI 10.1007/s00345-004-0474-0; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Humphreys D, 1997, BIOCHEMISTRY-US, V36, P15233, DOI 10.1021/bi9703507; Jones SE, 2002, INT J BIOCHEM CELL B, V34, P427, DOI 10.1016/S1357-2725(01)00155-8; Lee CH, 2002, UROLOGY, V60, P516, DOI 10.1016/S0090-4295(02)01806-X; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Markopoulou S, 2009, FEBS J, V276, P4208, DOI 10.1111/j.1742-4658.2009.07093.x; Miyake H, 2004, PROSTATE, V61, P318, DOI 10.1002/pros.20087; Park IS, 1999, J ENDOCRINOL, V162, P57, DOI 10.1677/joe.0.1620057; Rizzi F, 2008, J PHYSIOL PHARMACOL, V59, P265; SENSIBAR JA, 1995, CANCER RES, V55, P2431; Trougakos IP, 2004, CANCER RES, V64, P1834, DOI 10.1158/0008-5472.CAN-03-2664; Trougakos IP, 2004, ANN NY ACAD SCI, V1019, P206, DOI 10.1196/annals.1297.033; Yang CR, 1999, NUCLEIC ACIDS RES, V27, P2165, DOI 10.1093/nar/27.10.2165; Zellweger T, 2002, CLIN CANCER RES, V8, P3276; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291	26	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e54920	10.1371/journal.pone.0054920	http://dx.doi.org/10.1371/journal.pone.0054920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418433	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300023
J	Fernandez-Silva, I; Whitney, J; Wainwright, B; Andrews, KR; Ylitalo-Ward, H; Bowen, BW; Toonen, RJ; Goetze, E; Karl, SA				Fernandez-Silva, Iria; Whitney, Jonathan; Wainwright, Benjamin; Andrews, Kimberly R.; Ylitalo-Ward, Heather; Bowen, Brian W.; Toonen, Robert J.; Goetze, Erica; Karl, Stephen A.			Microsatellites for Next-Generation Ecologists: A Post-Sequencing Bioinformatics Pipeline	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; REPETITIVE ELEMENTS; DNA; IDENTIFICATION; POPULATIONS; MARKERS	Microsatellites are the markers of choice for a variety of population genetic studies. The recent advent of next-generation pyrosequencing has drastically accelerated microsatellite locus discovery by providing a greater amount of DNA sequencing reads at lower costs compared to other techniques. However, laboratory testing of PCR primers targeting potential microsatellite markers remains time consuming and costly. Here we show how to reduce this workload by screening microsatellite loci via bioinformatic analyses prior to primer design. Our method emphasizes the importance of sequence quality, and we avoid loci associated with repetitive elements by screening with repetitive sequence databases available for a growing number of taxa. Testing with the Yellowstripe Goatfish Mulloidichthys flavolineatus and the marine planktonic copepod Pleuromamma xiphias we show higher success rate of primers selected by our pipeline in comparison to previous in silico microsatellite detection methodologies. Following the same pipeline, we discover and select microsatellite loci in nine additional species including fishes, sea stars, copepods and octopuses.	[Fernandez-Silva, Iria; Whitney, Jonathan; Wainwright, Benjamin; Andrews, Kimberly R.; Ylitalo-Ward, Heather; Bowen, Brian W.; Toonen, Robert J.; Karl, Stephen A.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Andrews, Kimberly R.; Goetze, Erica] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii System	Fernandez-Silva, I (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA.	iriafernandezsilva@gmail.com	Fernandez-Silva, Iria/AAA-8996-2020; Toonen, Rob/V-6230-2019	Toonen, Rob/0000-0001-6339-4340	National Oceanic and Atmospheric Administration (NOAA) National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies grant [NA07NOS4780187, NA07NOS478190, NA07NOS4780189]; NOAA Coral Reef Conservation Program; Hawaii Undersea Research Laboratory [NA05OAR4301108, HC07-11, HC08-06]; NOAA Pacific Island Fisheries Science Center grant [NA10NMF4520121]; NOAA National Marine Sanctuaries Program MOA grant [2005-008/66882]; University of Hawai'i College of Arts Sciences; American Society for Ichthyologists Herpetologists; National Science Foundation (NSF) [OCE-1029478]; Fulbright - Spanish Ministry of Science and Technology fellowship; University of Hawaii NSF EPSCoR program (Investing in Multidisciplinary University Activities) [EPS-0903833]; Society for Integrative & Comparative Biology	National Oceanic and Atmospheric Administration (NOAA) National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies grant; NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); Hawaii Undersea Research Laboratory; NOAA Pacific Island Fisheries Science Center grant; NOAA National Marine Sanctuaries Program MOA grant; University of Hawai'i College of Arts Sciences; American Society for Ichthyologists Herpetologists; National Science Foundation (NSF)(National Science Foundation (NSF)); Fulbright - Spanish Ministry of Science and Technology fellowship; University of Hawaii NSF EPSCoR program (Investing in Multidisciplinary University Activities); Society for Integrative & Comparative Biology	This research was supported by the National Oceanic and Atmospheric Administration (NOAA) National Centers for Coastal Ocean Science Coral Reef Ecosystem Studies grant NA07NOS4780187 to the Bishop Museum, NA07NOS478190 to the University of Hawaii, NA07NOS4780189 to the State of Hawaii; the NOAA Coral Reef Conservation Program research grants program administered by Hawaii Undersea Research Laboratory under award NA05OAR4301108, project numbers HC07-11 and HC08-06; NOAA Pacific Island Fisheries Science Center grant NA10NMF4520121 to B.W.B.; NOAA National Marine Sanctuaries Program (http://sanctuaries.noaa.gov/) MOA grant 2005-008/66882 to R.J.T.; the University of Hawai'i College of Arts & Sciences, Society for Integrative & Comparative Biology Grant-in-Aid of Research, and the American Society for Ichthyologists & Herpetologists to JLW; the National Science Foundation (NSF) under award OCE-1029478 to E.G. and K.R.A; and a Fulbright - Spanish Ministry of Science and Technology fellowship to I.F.S. This work was further supported by the University of Hawaii NSF EPSCoR program (Investing in Multidisciplinary University Activities, EPS-0903833, J. Gaines, PI) in support of the core functional genomics facility at the Hawaii Institute of Marine Biology, SOEST, UH-Manoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allentoft ME, 2009, BIOTECHNIQUES, V46, P195, DOI 10.2144/000113086; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; Carreras-Carbonell J, 2006, MOL ECOL, V15, P3527, DOI 10.1111/j.1365-294X.2006.03003.x; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; Concepcion GT, 2010, CONSERV GENET RESOUR, V2, P11, DOI 10.1007/s12686-009-9118-4; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; ESTOUP A, 1996, MICROSATELLITE MARKE; Fernandez-Silva I, 2008, THEOR APPL GENET, V118, P139, DOI 10.1007/s00122-008-0883-3; Ferreira Daniela Cristina, 2011, Mob Genet Elements, V1, P112; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Gaffney PM, 2003, J MOL EVOL, V56, P308, DOI 10.1007/s00239-002-2402-5; Gaither MR, 2010, CONSERV GENET RESOUR, V2, P169, DOI 10.1007/s12686-009-9119-3; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; GLENN T, 1996, MICROSATELLITE MANUA; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Gu WJ, 2008, ANAL BIOCHEM, V380, P77, DOI 10.1016/j.ab.2008.05.015; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Malausa T, 2011, MOL ECOL RESOUR, V11, P638, DOI 10.1111/j.1755-0998.2011.02992.x; McInerney CE, 2011, HEREDITY, V106, P78, DOI 10.1038/hdy.2010.36; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Neff BD, 2001, EVOLUTION, V55, P1717, DOI 10.1111/j.0014-3820.2001.tb00822.x; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Ramsay L, 1999, PLANT J, V17, P415, DOI 10.1046/j.1365-313X.1999.00392.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sinama M, 2011, EUR J ENTOMOL, V108, P261, DOI 10.14411/eje.2011.035; Smith S, 2009, B ENTOMOL RES, V101, P551; TOONEN RJ, 1997, MICROSATELLITE UNPUB; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x; Zhang DX, 2004, TRENDS ECOL EVOL, V19, P507, DOI 10.1016/j.tree.2004.07.020	38	39	44	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55990	10.1371/journal.pone.0055990	http://dx.doi.org/10.1371/journal.pone.0055990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424642	Green Published, gold			2022-12-27	WOS:000315965100030
J	Hu, D; Fukuhara, A; Miyata, Y; Yokoyama, C; Otsuki, M; Kihara, S; Shimomura, I				Hu, Di; Fukuhara, Atsunori; Miyata, Yugo; Yokoyama, Chieko; Otsuki, Michio; Kihara, Shinji; Shimomura, Iichiro			Adiponectin Regulates Vascular Endothelial Growth Factor-C Expression in Macrophages via Syk-ERK Pathway	PLOS ONE			English	Article							METABOLIC SYNDROME; TYROSINE KINASE; CELL APOPTOSIS; HYPERTENSION; ACTIVATION; OBESITY; FAMILY; HYPOADIPONECTINEMIA; LYMPHANGIOGENESIS; MECHANISM	Adiponectin is exclusively expressed in adipose tissues and exhibits protective effects against cardiovascular and metabolic diseases. It enhances AMP-activated kinase (AMPK) and peroxisome proliferator-activated receptor alpha (PPAR alpha) signaling in the liver and skeletal muscles, however, its signaling pathways in macrophages remain to be elucidated. Here, we show that adiponectin upregulated the expression of vascular endothelial growth factor (VEGF)-C, and induced phosphorylation of extracellular signal-regulated kinase (ERK) in macrophages. Inhibition of Syk abrogated adiponectin-induced VEGF-C expression and ERK phosphorylation. Furthermore, inhibition of ERK blocked the induction of VEGF-C gene. Inhibition of Syk, but not that of ERK, abrogated adiponectin-induced expression of cyclooxygenase (COX)-2, tissue inhibitor of metalloproteinase (TIMP)-1, and interleukin (IL)-6. These results indicate that adiponectin regulates VEGF-C expression via Syk-ERK pathway in macrophages.	[Hu, Di; Fukuhara, Atsunori; Miyata, Yugo; Yokoyama, Chieko; Otsuki, Michio; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan; [Kihara, Shinji] Osaka Univ, Grad Sch Med, Dept Biomed Informat, Div Hlth Sci, Suita, Osaka, Japan	Osaka University; Osaka University	Fukuhara, A (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2 Yamadaoka, Suita, Osaka, Japan.	fukuhara@endmet.med.osaka-u.ac.jp	Fukuhara, Atsunori/A-9601-2018	Fukuhara, Atsunori/0000-0002-6289-3778; Miyata, Yugo/0000-0002-3245-4600	Ministry of Health, Labor and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation; Grants-in-Aid for Scientific Research [22590978] Funding Source: KAKEN	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for JSPS fellowship. This work was supported by a grant from the Ministry of Health, Labor and Welfare, Japan, a grant from the Ministry of Education, Culture, Sports, Science and Technology, and a grant from Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Bohmer R, 2010, DEV CELL, V18, P437, DOI 10.1016/j.devcel.2010.01.009; Brakenhielm E, 2004, P NATL ACAD SCI USA, V101, P2476, DOI 10.1073/pnas.0308671100; Chow WS, 2007, HYPERTENSION, V49, P1455, DOI 10.1161/HYPERTENSIONAHA.107.086835; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; KUROSAKI T, 1994, J EXP MED, V179, P1725, DOI 10.1084/jem.179.5.1725; Kusunoki N, 2010, ARTHRITIS RHEUM-US, V62, P1641, DOI 10.1002/art.27450; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Okamoto Y, 2008, CIRC RES, V102, P218, DOI 10.1161/CIRCRESAHA.107.164988; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Riba R, 2008, J THROMB HAEMOST, V6, P1012, DOI 10.1111/j.1538-7836.2008.02982.x; Shibata S, 2012, J IMMUNOL, V189, P3231, DOI 10.4049/jimmunol.1101739; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Tsubakio-Yamamoto K, 2008, BIOCHEM BIOPH RES CO, V375, P390, DOI 10.1016/j.bbrc.2008.08.009; Wijesekara N, 2010, J BIOL CHEM, V285, P33623, DOI 10.1074/jbc.M109.085084; Yamaguchi N, 2005, FEBS LETT, V579, P6821, DOI 10.1016/j.febslet.2005.11.019; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723	28	13	15	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56071	10.1371/journal.pone.0056071	http://dx.doi.org/10.1371/journal.pone.0056071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424645	Green Published, Green Submitted, gold			2022-12-27	WOS:000315965100033
J	Lee, TT; Zhang, XD; Chuang, CC; Chen, JJ; Chen, YA; Chen, SC; Chen, TY; Tang, CY				Lee, Ting-Ting; Zhang, Xiao-Dong; Chuang, Chao-Chin; Chen, Jing-Jer; Chen, Yi-An; Chen, Shu-Ching; Chen, Tsung-Yu; Tang, Chih-Yung			Myotonia Congenita Mutation Enhances the Degradation of Human CLC-1 Chloride Channels	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; QUALITY-CONTROL; SKELETAL-MUSCLE; INTRACELLULAR-TRANSPORT; PROTEASOME INHIBITORS; TORPEDO ELECTROPLAX; RAPID DEGRADATION; CLCN1 MUTATIONS; HUMAN-DISEASES	Myotonia congenita is a hereditary muscle disorder caused by mutations in the human voltage-gated chloride (Cl-) channel CLC-1. Myotonia congenita can be inherited in an autosomal recessive (Becker type) or dominant (Thomsen type) fashion. One hypothesis for myotonia congenita is that the inheritance pattern of the disease is determined by the functional consequence of the mutation on the gating of CLC-1 channels. Several disease-related mutations, however, have been shown to yield functional CLC-1 channels with no detectable gating defects. In this study, we have functionally and biochemically characterized a myotonia mutant: A531V. Despite a gating property similar to that of wild-type (WT) channels, the mutant CLC-1 channel displayed a diminished whole-cell current density and a reduction in the total protein expression level. Our biochemical analyses further demonstrated that the reduced expression of A531V can be largely attributed to an enhanced proteasomal degradation as well as a defect in protein trafficking to surface membranes. Moreover, the A531V mutant protein also appeared to be associated with excessive endosomal-lysosomal degradation. Neither the reduced protein expression nor the diminished current density was rescued by incubating A531V-expressing cells at 27 degrees C. These results demonstrate that the molecular pathophysiology of A531V does not involve anomalous channel gating, but rather a disruption of the balance between the synthesis and degradation of the CLC-1 channel protein.	[Lee, Ting-Ting; Chuang, Chao-Chin; Chen, Jing-Jer; Chen, Yi-An; Tang, Chih-Yung] Natl Taiwan Univ, Coll Med, Dept Physiol, Taipei 10764, Taiwan; [Zhang, Xiao-Dong; Chen, Tsung-Yu] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Chen, Shu-Ching] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Tang, Chih-Yung] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan	National Taiwan University; University of California System; University of California Davis; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Tang, CY (corresponding author), Natl Taiwan Univ, Coll Med, Dept Physiol, Taipei 10764, Taiwan.	tang@ntu.edu.tw		TANG, CHIH-YUNG/0000-0003-1065-2865; Chen, Shu-Ching/0000-0001-9112-1526	National Science Council, Taiwan [NSC 96-2320-B-002-069-MY3]; National Institutes of Health, USA [R01GM065447]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065447] Funding Source: NIH RePORTER	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research grants from National Science Council, Taiwan (NSC 96-2320-B-002-069-MY3) to CYT, and from National Institutes of Health, USA (R01GM065447) to TYC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Aridor M, 1999, NAT MED, V5, P745, DOI 10.1038/10466; Aridor M, 2002, TRAFFIC, V3, P781, DOI 10.1034/j.1600-0854.2002.31103.x; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BRETAG AH, 1987, PHYSIOL REV, V67, P618, DOI 10.1152/physrev.1987.67.2.618; BRYANT SH, 1971, J PHYSIOL-LONDON, V219, P367, DOI 10.1113/jphysiol.1971.sp009667; Cai ZW, 2011, ACTA PHARMACOL SIN, V32, P693, DOI 10.1038/aps.2011.71; Chen TY, 2005, ANNU REV PHYSIOL, V67, P809, DOI 10.1146/annurev.physiol.67.032003.153012; Cheng J, 2004, J BIOL CHEM, V279, P1892, DOI 10.1074/jbc.M308640200; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Colding-Jorgensen E, 2005, MUSCLE NERVE, V32, P19, DOI 10.1002/mus.20295; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Duffield M, 2003, J GEN PHYSIOL, V121, P149, DOI 10.1085/jgp.20028741; DULHUNTY AF, 1979, J MEMBRANE BIOL, V45, P293, DOI 10.1007/BF01869290; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; French PJ, 1996, J CLIN INVEST, V98, P1304, DOI 10.1172/JCI118917; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893; Jurkat-Rott K, 2002, J NEUROL, V249, P1493, DOI 10.1007/s00415-002-0871-5; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Kubisch C, 1998, HUM MOL GENET, V7, P1753, DOI 10.1093/hmg/7.11.1753; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Ling H, 1996, J AM SOC NEPHROL, V7, P73; Lossin C, 2008, ADV GENET, V63, P25, DOI 10.1016/S0065-2660(08)01002-X; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Macias MJ, 2007, BIOCHEM J, V403, P79, DOI 10.1042/BJ20061230; Mihic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018273; Miki H, 2010, J BIOL CHEM, V285, P19967, DOI 10.1074/jbc.M109.092684; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Nufer O, 2002, J CELL SCI, V115, P619; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Papponen H, 1999, NEUROLOGY, V53, P297, DOI 10.1212/WNL.53.2.297; Papponen H, 2008, MUSCLE NERVE, V37, P317, DOI 10.1002/mus.20922; PTACEK LJ, 1993, NEW ENGL J MED, V328, P482; Pusch M, 2002, HUM MUTAT, V19, P423, DOI 10.1002/humu.10063; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Skovronsky DM, 2000, BIOCHEMISTRY-US, V39, P810, DOI 10.1021/bi991728z; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; Sun C, 2001, EUR J HUM GENET, V9, P903, DOI 10.1038/sj.ejhg.5200736; Tseng PY, 2007, J GEN PHYSIOL, V130, P217, DOI 10.1085/jgp.200709817; Vandenberghe W, 2004, CURR OPIN CELL BIOL, V16, P134, DOI 10.1016/j.ceb.2004.01.003; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wan J, 2005, NEUROLOGY, V64, P2090, DOI 10.1212/01.WNL.0000167409.59089.C0; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; WARD CL, 1994, J BIOL CHEM, V269, P25710; Weinberger S, 2012, J PHYSIOL-LONDON, V590, P3449, DOI 10.1113/jphysiol.2012.232785; Wong W, 2002, J BIOL CHEM, V277, P20423, DOI 10.1074/jbc.M109412200; Wu FF, 2002, BRAIN, V125, P2392, DOI 10.1093/brain/awf246	60	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55930	10.1371/journal.pone.0055930	http://dx.doi.org/10.1371/journal.pone.0055930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424641	gold, Green Submitted, Green Published			2022-12-27	WOS:000315965100029
J	Mamidala, P; Wijeratne, AJ; Wijeratne, S; Poland, T; Qazi, SS; Doucet, D; Cusson, M; Beliveau, C; Mittapalli, O				Mamidala, Praveen; Wijeratne, Asela J.; Wijeratne, Saranga; Poland, Therese; Qazi, Sohail S.; Doucet, Daniel; Cusson, Michel; Beliveau, Catherine; Mittapalli, Omprakash			Identification of Odor-Processing Genes in the Emerald Ash Borer, Agrilus planipennis	PLOS ONE			English	Article							SEX-PHEROMONE COMPONENT; DROSOPHILA-MELANOGASTER; OLFACTORY RECEPTORS; BINDING-PROTEINS; APIS-MELLIFERA; CHEMOSENSORY PROTEINS; ANOPHELES-GAMBIAE; DEGRADING ENZYME; BOMBYX-MORI; P450 ENZYME	Background: Insects rely on olfaction to locate food, mates, and suitable oviposition sites for successful completion of their life cycle. Agrilus planipennis Fairmaire (emerald ash borer) is a serious invasive insect pest that has killed tens of millions of North American ash (Fraxinus spp) trees and threatens the very existence of the genus Fraxinus. Adult A. planipennis are attracted to host volatiles and conspecifics; however, to date no molecular knowledge exists on olfaction in A. planipennis. Hence, we undertook an antennae-specific transcriptomic study to identify the repertoire of odor processing genes involved in A. planipennis olfaction. Methodology and Principal Findings: We acquired 139,085 Roche/454 GS FLX transcriptomic reads that were assembled into 30,615 high quality expressed sequence tags (ESTs), including 3,249 isotigs and 27,366 non-isotigs (contigs and singletons). Intriguingly, the majority of the A. planipennis antennal transcripts (59.72%) did not show similarity with sequences deposited in the non-redundant database of GenBank, potentially representing novel genes. Functional annotation and KEGG analysis revealed pathways associated with signaling and detoxification. Several odor processing genes (9 odorant binding proteins, 2 odorant receptors, 1 sensory neuron membrane protein and 134 odorant/xenobiotic degradation enzymes, including cytochrome P450s, glutathione-S-transferases; esterases, etc.) putatively involved in olfaction processes were identified. Quantitative PCR of candidate genes in male and female A. planipennis in different developmental stages revealed developmental- and sex-biased expression patterns. Conclusions and Significance: The antennal ESTs derived from A. planipennis constitute a rich molecular resource for the identification of genes potentially involved in the olfaction process of A. planipennis. These findings should help in understanding the processing of antennally-active compounds (e.g. 7-epi-sesquithujene) previously identified in this serious invasive pest.	[Mamidala, Praveen; Mittapalli, Omprakash] Ohio State Univ, Ohio Agr & Res Dev Ctr, Dept Entomol, Wooster, OH USA; [Wijeratne, Asela J.; Wijeratne, Saranga] Ohio State Univ, Ohio Agr & Res Dev Ctr, Dept Mol & Cellular Imaging Ctr, Wooster, OH USA; [Poland, Therese] Michigan State Univ, USDA, US Forest Serv, No Res Stn, E Lansing, MI 48824 USA; [Qazi, Sohail S.; Doucet, Daniel] Nat Resources Canada, Sault Ste Marie, ON, Canada; [Cusson, Michel; Beliveau, Catherine] Nat Resources Canada, Quebec City, PQ, Canada	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Michigan State University; United States Department of Agriculture (USDA); United States Forest Service; Natural Resources Canada; Natural Resources Canada	Mittapalli, O (corresponding author), Ohio State Univ, Ohio Agr & Res Dev Ctr, Dept Entomol, Wooster, OH USA.	mittapalli.1@osu.edu	Wijeratne, Saranga/I-5341-2016; Poland, Therese/AAZ-9272-2021; Qazi, Sohail/AAH-5106-2019; Cusson, Michel/AAG-9036-2019	Wijeratne, Saranga/0000-0002-9782-4406; Poland, Therese/0000-0001-7684-1306; Qazi, Sohail/0000-0003-1317-6657; Mamidala, Praveen/0000-0001-8587-0635	USDA APHIS/USDA Forest Service Accelerated Emerald Ash Borer Research Program [GRT00011769/60016270]; State and Federal funds appropriated to the Ohio Agricultural Research and Development Center; The Ohio State University; Genomic Research and Development Initiative grant from Natural Resources Canada	USDA APHIS/USDA Forest Service Accelerated Emerald Ash Borer Research Program; State and Federal funds appropriated to the Ohio Agricultural Research and Development Center; The Ohio State University(Ohio State University); Genomic Research and Development Initiative grant from Natural Resources Canada(Natural Resources Canada)	This research was supported by a grant from the USDA APHIS (GRT00011769/60016270)/USDA Forest Service Accelerated Emerald Ash Borer Research Program, by State and Federal funds appropriated to the Ohio Agricultural Research and Development Center, The Ohio State University and by a Genomic Research and Development Initiative grant from Natural Resources Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Angelini DR, 2009, DEV BIOL, V327, P240, DOI 10.1016/j.ydbio.2008.10.047; Anulewicz Andrea C., 2007, Arboriculture & Urban Forestry, V33, P338; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Briand L, 2002, EUR J BIOCHEM, V269, P4586, DOI 10.1046/j.1432-1033.2002.03156.x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cappaert David, 2005, American Entomologist, V51, P152; Chinkers M, 2001, TRENDS ENDOCRIN MET, V12, P28, DOI 10.1016/S1043-2760(00)00335-0; Chung HR, 2007, MOL BIOL EVOL, V24, P1934, DOI 10.1093/molbev/msm121; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crook DJ, 2008, ANN ENTOMOL SOC AM, V101, P1103, DOI 10.1603/0013-8746-101.6.1103; Crook DJ, 2008, ENVIRON ENTOMOL, V37, P356, DOI 10.1603/0046-225X(2008)37[356:DOAHSL]2.0.CO;2; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dani FR, 2010, J PROTEOME RES, V9, P1822, DOI 10.1021/pr900969k; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; de Groot P, 2008, J CHEM ECOL, V34, P1170, DOI 10.1007/s10886-008-9514-3; Durand N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015026; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Harada E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029710; Hattori D, 2009, NATURE, V461, P644, DOI 10.1038/nature08431; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; He P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028921; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huber DPW, 2007, INSECT MOL BIOL, V16, P335, DOI 10.1111/j.1365-2583.2007.00731.x; Ishida Y, 2002, INSECT BIOCHEM MOLEC, V32, P1775, DOI 10.1016/S0965-1748(02)00136-4; Ishida Y, 2008, P NATL ACAD SCI USA, V105, P9076, DOI 10.1073/pnas.0802610105; Jacquin-Joly E, 2004, J CHEM ECOL, V30, P2359, DOI 10.1007/s10886-004-7941-3; Jacquin-Joly E, 2012, INT J BIOL SCI, V8, P1036, DOI 10.7150/ijbs.4469; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Landolt Peter J., 1997, American Entomologist, V43, P12; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Leal WS, 2005, SEMIOCHEMICALS PEST, P45; Lelito JP, 2007, J INSECT BEHAV, V20, P537, DOI 10.1007/s10905-007-9097-9; Lelito JP, 2009, J CHEM ECOL, V35, P104, DOI 10.1007/s10886-008-9583-3; Liu R, 2012, INSECT MOL BIOL, V21, P41, DOI 10.1111/j.1365-2583.2011.01114.x; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Maibeche-Coisne M, 2004, P NATL ACAD SCI USA, V101, P11459, DOI 10.1073/pnas.0403537101; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; Matz Mikhail V, 2003, Methods Mol Biol, V221, P41; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Nichols Z, 2008, INSECT BIOCHEM MOLEC, V38, P398, DOI 10.1016/j.ibmb.2007.11.003; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Poland TM, 2006, J FOREST, V104, P118; Pureswaran DS, 2009, J INSECT BEHAV, V22, P205, DOI 10.1007/s10905-008-9166-8; Rajarapu SP, 2012, INSECT SCI, V19, P41, DOI 10.1111/j.1744-7917.2011.01447.x; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rodriguez-Saona C, 2006, CHEMOECOLOGY, V16, P75, DOI 10.1007/s00049-005-0329-1; Rodriguez-Saona Cesar R., 2007, Great Lakes Entomologist, V40, P1; Rogers ME, 1999, J EXP BIOL, V202, P1625; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Ryall KL, 2012, ENVIRON ENTOMOL, V41, P648, DOI 10.1603/EN11312; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sato K, 2009, RESULTS PROBL CELL D, V47, P121, DOI 10.1007/400_2008_10; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seaver EC, 1996, DEVELOPMENT, V122, P567; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Shen Jian-Mei, 2011, Acta Entomologica Sinica, V54, P265; Silk PJ, 2009, NATURWISSENSCHAFTEN, V96, P601, DOI 10.1007/s00114-009-0513-1; Small GJ, 2000, INSECT MOL BIOL, V9, P647, DOI 10.1046/j.1365-2583.2000.00229.x; Smith A, 2006, EFFECTS COMMUNITY ST, V122; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Smyth RR, 2003, J INSECT BEHAV, V16, P347, DOI 10.1023/A:1024824025210; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; Vogt RG, 2002, J EXP BIOL, V205, P719; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Vosshall LB, 2001, CHEM SENSES, V26, P207, DOI 10.1093/chemse/26.2.207; Vosshall Leslie B., 2003, P567, DOI 10.1016/B978-012107151-6/50021-9; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang Q, 1999, J BIOL CHEM, V274, P10309, DOI 10.1074/jbc.274.15.10309; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Wojtasek H, 1999, FEBS LETT, V458, P333, DOI 10.1016/S0014-5793(99)01178-3; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Yin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033589; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhi-Liang H, 2007, PLANT AN GEN 15 C SA; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JJ, 2009, J MOL BIOL, V389, P529, DOI 10.1016/j.jmb.2009.04.015; Zhu JY, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/491748	110	41	47	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56555	10.1371/journal.pone.0056555	http://dx.doi.org/10.1371/journal.pone.0056555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424668	gold, Green Published			2022-12-27	WOS:000315965100056
J	Ballarini, A; Segata, N; Huttenhower, C; Jousson, O				Ballarini, Annalisa; Segata, Nicola; Huttenhower, Curtis; Jousson, Olivier			Simultaneous Quantification of Multiple Bacteria by the BactoChip Microarray Designed to Target Species-Specific Marker Genes	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; PHYLOGENETIC MICROARRAY; DIVERSITY; IDENTIFICATION; MICROBIOTA; VIRULENCE; DATABASE; EVOLUTION; SURFACES; STRAINS	Bacteria are ubiquitous throughout the environment, the most abundant inhabitants of the healthy human microbiome, and causal pathogens in a variety of diseases. Their identification in disease is often an essential step in rapid diagnosis and targeted intervention, particularly in clinical settings. At present, clinical bacterial detection and discrimination is primarily culture-based, requiring both time and microbiological expertise, especially for bacteria that are not easily cultivated. Higher-throughput molecular methods based on PCR amplification or, recently, microarrays are reaching the clinic as well. However, these methods are currently restricted to a small set of microbes or based on conserved phylogenetic markers such as the 16S rRNA gene, which are difficult to resolve at the species or strain levels. Here, we designed and experimentally validated the BactoChip, an oligonucleotide microarray for bacterial detection and quantification. The chip allows the culture-independent identification of bacterial species, also determining their relative abundances in complex communities as occur in the commensal microbiota or in clinical settings. The microarray successfully distinguished among bacterial species from 21 different genera using 60-mer probes targeting a novel set of in silico identified high-resolution marker genes. The BactoChip additionally proved accurate in determining species-level relative abundances over a 100-fold dynamic range in complex bacterial communities and with a low limit of detection (0.1%). In combination with the continually increasing number of sequenced bacterial genomes, future iterations of the technology could enable to highly accurate clinically-oriented tools for rapid assessment of bacterial community composition and relative abundances.	[Ballarini, Annalisa; Segata, Nicola; Jousson, Olivier] Univ Trento, Ctr Integrat Biol, Trento, Italy; [Segata, Nicola; Huttenhower, Curtis] Harvard Univ, Dept Biostat, Boston, MA 02115 USA	University of Trento; Harvard University	Ballarini, A (corresponding author), Univ Trento, Ctr Integrat Biol, Trento, Italy.	ballarini@science.unitn.it	Segata, Nicola/AAB-2980-2019; Jousson, Olivier/S-4397-2019; Jousson, Olivier/N-7000-2013; Segata, Nicola/K-7240-2016	Jousson, Olivier/0000-0003-3344-7194; Segata, Nicola/0000-0002-1583-5794; Huttenhower, Curtis/0000-0002-1110-0096	Autonomous Province of Trento; Centre for Integrative Biology of the University of Trento; National Institutes of Health (NIH) [1RO1HG005969]; National Science Foundation (NSF) [DBI-1053486]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005969] Funding Source: NIH RePORTER	Autonomous Province of Trento(Autonomous Province of Trento); Centre for Integrative Biology of the University of Trento; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Progetti speciali PAT-CRS 2007" from the Autonomous Province of Trento (AB), by a startup grant from the Centre for Integrative Biology of the University of Trento (AB), and by National Institutes of Health (NIH) 1RO1HG005969 and National Science Foundation (NSF) DBI-1053486 (CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022788; Andam CP, 2011, NAT REV MICROBIOL, V9, P543, DOI 10.1038/nrmicro2593; Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; Brenner D. J., 2005, PROTEOBACTERIA B; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Funke G, 2004, J CLIN MICROBIOL, V42, P4067, DOI 10.1128/JCM.42.9.4067-4071.2004; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Jackson DA, 1997, ECOLOGY, V78, P929; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Janse I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031958; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Lin S, 2010, LANCET, V375, P178, DOI 10.1016/S0140-6736(09)61791-8; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Lukjancenko O, 2010, COMM COM INF SC, V115, P165, DOI 10.1007/978-3-642-16750-8_15; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; McLoughlin KS, 2011, BRIEF FUNCT GENOMICS, V10, P342, DOI 10.1093/bfgp/elr027; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; Murray PR, 2003, STORAGE SHELF LIFE S, V30, P2; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Pallen MJ, 2010, CURR OPIN MICROBIOL, V13, P625, DOI 10.1016/j.mib.2010.08.003; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Relogio A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.11.e51; Rigsbee L, 2011, FEMS MICROBIOL ECOL, V75, P332, DOI 10.1111/j.1574-6941.2010.01009.x; Sakamoto M, 2004, J MED MICROBIOL, V53, P563, DOI 10.1099/jmm.0.45576-0; Schutzer SE, 2005, PLOS MED, V2, P1242, DOI 10.1371/journal.pmed.0020337; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Sharma R, 2005, CURR SCI INDIA, V89, P72; Slany M, 2010, CAN J MICROBIOL, V56, P1040, DOI 10.1139/W10-091; Takahashi T, 1999, INT J SYST BACTERIOL, V49, P725, DOI 10.1099/00207713-49-2-725; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Valdezate S, 2004, J CLIN MICROBIOL, V42, P693, DOI 10.1128/JCM.42.2.693-699.2003; Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x; Wilson KH, 2002, APPL ENVIRON MICROB, V68, P2535, DOI 10.1128/AEM.68.5.2535-2541.2002; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151	54	14	15	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55764	10.1371/journal.pone.0055764	http://dx.doi.org/10.1371/journal.pone.0055764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409037	gold, Green Published, Green Submitted			2022-12-27	WOS:000315100000022
J	Boon, CM; Ng, MH; Choo, YM; Mok, SL				Boon, Chee-Meng; Ng, Mei-Han; Choo, Yuen-May; Mok, Shiueh-Lian			Super, Red Palm and Palm Oleins Improve the Blood Pressure, Heart Size, Aortic Media Thickness and Lipid Profile in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							OXIDATIVE STRESS; FATTY-ACIDS; OLIVE OIL; SODIUM; MEMBRANE; DIETS; SALT; ATHEROSCLEROSIS; CONSUMPTION; ACTIVATION	Background: Oleic acid has been shown to lower high blood pressure and provide cardiovascular protection. Curiosity arises as to whether super olein (SO), red palm olein (RPO) and palm olein (PO), which have high oleic acid content, are able to prevent the development of hypertension. Methodology/Principal Findings: Four-week-old male spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats were fed 15% SO, RPO or PO supplemented diet for 15 weeks. After 15 weeks of treatment, the systolic blood pressure (SBP) of SHR treated with SO, RPO and PO were 158.4+/-5.0 mmHg (p<0.001), 178.9+/-2.7 mmHg (p<0.001) and 167.7+/-2.1 mmHg (p<0.001), respectively, compared with SHR controls (220.9+/-1.5 mmHg). Bradycardia was observed with SO and PO. In contrast, the SBP and heart rate of treated WKY rats were not different from those of WKY controls. The SO and PO significantly reduced the increased heart size and thoracic aortic media thickness observed in untreated SHR but RPO reduced only the latter. No such differences, however, were observed between the treated and untreated WKY rats. Oil Red O enface staining of thoracic-abdominal aorta did not show any lipid deposition in all treated rats. The SO and RPO significantly raised serum alkaline phosphatase levels in the SHR while body weight and renal biochemical indices were unaltered in both strains. Serum lipid profiles of treated SHR and WKY rats were unchanged, with the exception of a significant reduction in LDL-C level and total cholesterol/HDL ratio (atherogenic index) in SO and RPO treated SHR compared with untreated SHR. Conclusion: The SO, RPO and PO attenuate the rise in blood pressure in SHR, accompanied by bradycardia and heart size reduction with SO and PO, and aortic media thickness reduction with SO, RPO and PO. The SO and RPO are antiatherogenic in nature by improving blood lipid profiles in SHR.	[Boon, Chee-Meng; Mok, Shiueh-Lian] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Ng, Mei-Han; Choo, Yuen-May] Malaysian Palm Oil Board, Kajang, Selangor, Malaysia	Universiti Malaya; Malaysian Palm Oil Board	Mok, SL (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.	josephinemok@um.edu.my	MOK, SHIUEH LIAN/B-9146-2010		University of Malaya [RG061/11BIO, PV059/2011B, PS188/2010B]	University of Malaya(Universiti Malaya)	This research was supported by the University of Malaya with research grants (RG061/11BIO, PV059/2011B and PS188/2010B) and a Fellowship Scheme (CMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2010, BIOCHEM PHARMACOL, V80, P1613, DOI 10.1016/j.bcp.2010.07.043; Aguila MB, 2005, INT J CARDIOL, V100, P461, DOI 10.1016/j.ijcard.2004.12.008; Al-Saqer JM, 2004, FOOD CHEM, V85, P579, DOI 10.1016/j.foodchem.2003.08.003; Annuk M, 2001, J AM SOC NEPHROL, V12, P2747, DOI 10.1681/ASN.V12122747; AOKI K, 1972, JPN CIRCULATION J, V36, P539, DOI 10.1253/jcj.36.539; Bartolomucci F, 2011, AM J HYPERTENS, V24, P750, DOI 10.1038/ajh.2011.66; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Bott-Flugel L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018048; Brodde OE, 1999, PHARMACOL REV, V51, P651; Carmosino M, 2011, PFLUG ARCH EUR J PHY, V462, P281, DOI 10.1007/s00424-011-0967-9; Choo YM, 1993, PALM OIL DEV, V19, P30; COTTRELL RC, 1991, AM J CLIN NUTR, V53, pS989, DOI 10.1093/ajcn/53.4.989Sb; DEEMS RO, 1994, J CLIN GASTROENTEROL, V18, P304, DOI 10.1097/00004836-199406000-00009; DINICOLANTONIO R, 1988, CLIN EXP PHARMACOL P, V15, P741; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; EDEM DO, 2002, PLANT FOOD HUM NUTR, V57, P319, DOI DOI 10.1023/A:1021828132707; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Fife B, 2007, PALM OIL MIRACLE DIS, P73; FOLKOW B, 1982, PHYSIOL REV, V62, P347, DOI 10.1152/physrev.1982.62.2.347; Frenoux JMR, 2001, J NUTR, V131, P39, DOI 10.1093/jn/131.1.39; Grassi G, 1998, J HYPERTENS, V16, P1979, DOI 10.1097/00004872-199816121-00019; Grundtman C., 2012, INFLAMMATION ATHEROS, VVol. 1, P133, DOI [10.1007/978-3-7091-0338-8_8, DOI 10.1007/978-3-7091-0338-8_8]; GRUNDY SM, 1990, J LIPID RES, V31, P1149; GRUNERT RR, 1950, J NUTR, V42, P609, DOI 10.1093/jn/42.4.609; Grynberg A, 2005, J HUM HYPERTENS, V19, pS25, DOI 10.1038/sj.jhh.1001957; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hozawa A, 2009, J HYPERTENS, V27, P237, DOI 10.1097/HJH.0b013e32832258c9; JESPERSEN LT, 1985, HYPERTENSION, V7, P734, DOI 10.1161/01.HYP.7.5.734; Kokkinos Peter, 2005, J Clin Hypertens (Greenwich), V7, P165, DOI 10.1111/j.1524-6175.2005.04079.x; KRISETHERTON PM, 1984, J NUTR, V114, P1675, DOI 10.1093/jn/114.9.1675; Loganathan R, 2008, PALM OIL DEV, V50, P16; Magoori K, 2003, J BIOL CHEM, V278, P11331, DOI 10.1074/jbc.M211987200; Mancia G, 1999, HYPERTENSION, V34, P724, DOI 10.1161/01.HYP.34.4.724; Marque V, 1999, HYPERTENSION, V34, P415, DOI 10.1161/01.HYP.34.3.415; Martus W, 2005, AM J PHYSIOL-RENAL, V288, pF428, DOI 10.1152/ajprenal.00310.2004; Medeiros FJ, 2005, PROSTAG OTH LIPID M, V78, P231, DOI 10.1016/j.prostaglandins.2005.09.001; MENSINK RP, 1988, AM J CLIN NUTR, V47, P976, DOI 10.1093/ajcn/47.6.976; Mukherjee Sutapa, 2009, Journal of Human Ecology, V26, P197; Owu DU, 1998, ACTA TROP, V69, P65, DOI 10.1016/S0001-706X(97)00115-0; Perona JS, 2007, J GERONTOL A-BIOL, V62, P256, DOI 10.1093/gerona/62.3.256; Psaltopoulou T, 2004, AM J CLIN NUTR, V80, P1012, DOI 10.1093/ajcn/80.4.1012; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; ROMAN RJ, 1985, AM J PHYSIOL, V248, pF199, DOI 10.1152/ajprenal.1985.248.2.F199; RuizGutierrez V, 1997, J NUTR BIOCHEM, V8, P689, DOI 10.1016/S0955-2863(97)00120-4; Saleh FH, 2001, J PATHOL, V193, P415; Sambanthamurthi R, 2000, PROG LIPID RES, V39, P507, DOI 10.1016/S0163-7827(00)00015-1; Sarafidis P, 2010, J HYPERTENS, V28, pE508; Sarikonda KV, 2009, J AM SOC HYPERTENS, V3, P158, DOI 10.1016/j.jash.2009.02.003; Simon A, 2002, J HYPERTENS, V20, P159, DOI 10.1097/00004872-200202000-00001; SUNDRAM K, 1990, LIPIDS, V25, P187, DOI 10.1007/BF02535746; Takishita S, 1996, HYPERTENSION, V27, P90, DOI 10.1161/01.HYP.27.1.90; Teres S, 2008, P NATL ACAD SCI USA, V105, P13811, DOI 10.1073/pnas.0807500105; Thapa BR, 2007, INDIAN J PEDIATR, V74, P663, DOI 10.1007/s12098-007-0118-7; Thijssen MA, 2005, HANDB EXP PHARM, V170, P165; TOAL CB, 1983, AM J PHYSIOL, V245, P1081; TOBIAN L, 1991, HYPERTENSION, V17, pI52, DOI 10.1161/01.HYP.17.1_Suppl.I52; Udenfriend S., 1976, ILAR News, V19, pG1; Ward NC, 2004, FREE RADICAL BIO MED, V36, P226, DOI 10.1016/j.freeradbiomed.2003.10.021; WINTERNITZ SR, 1982, CLIN EXP HYPERTENS, V4, P751, DOI 10.3109/10641968209061611; Yang Q, 2005, MOL PHARMACOL, V68, P210, DOI 10.1124/mol.105.011692; Yen PL, 2010, NUTRITION, V26, P331, DOI 10.1016/j.nut.2009.04.020	61	19	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55908	10.1371/journal.pone.0055908	http://dx.doi.org/10.1371/journal.pone.0055908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409085	Green Submitted, gold, Green Published			2022-12-27	WOS:000315100000033
J	Rahman, S; Yamato, I; Saijo, S; Mizutani, K; Ishizuka-Katsura, Y; Ohsawa, N; Terada, T; Shirouzu, M; Yokoyama, S; Iwata, S; Murata, T				Rahman, Suhaila; Yamato, Ichiro; Saijo, Shinya; Mizutani, Kenji; Ishizuka-Katsura, Yoshiko; Ohsawa, Noboru; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki; Iwata, So; Murata, Takeshi			Biochemical and Biophysical Properties of Interactions between Subunits of the Peripheral Stalk Region of Human V-ATPase	PLOS ONE			English	Article							YEAST VACUOLAR ATPASE; N-TERMINAL DOMAIN; H+-ATPASE; A(1)A(0)-ATP SYNTHASE; STATOR COMPLEX; STOICHIOMETRY; LOCALIZATION; ACIDIFICATION; PURIFICATION; MUTATIONS	Peripheral stalk subunits of eukaryotic or mammalian vacuolar ATPases (V-ATPases) play key roles in regulating its assembly and disassembly. In a previous study, we purified several subunits and their isoforms of the peripheral stalk region of Homo sapiens (human) V-ATPase; such as C1, E1G1, H, and the N-terminal cytoplasmic region of V-o, a1. Here, we investigated the in vitro binding interactions of the subunits at the stalk region and measured their specific affinities. Surface plasmon resonance experiments revealed that the subunit C1 binds the E1G1 heterodimer with both high and low affinities (2.8 nM and 1.9 mu M, respectively). In addition, an E1G1-H complex can be formed with high affinity (48 nM), whereas affinities of other subunit pairs appeared to be low (similar to 0.21-23.0 mu M). The putative ternary complex of C1-H-E1G1 was not much strong on co-incubation of these subunits, indicating that the two strong complexes of C1-E1G1 and H-E1G1 in cooperation with many other weak interactions may be sufficiently strong enough to withstand the torque of rotation during catalysis. We observed a partially stable quaternary complex (consisting of E1G1, C1, a1(NT), and H subunits) resulting from discrete peripheral subunit interactions stabilizing the complex through their intrinsic affinities. No binding was observed in the absence of E1G1 (using only H, C1, and a1(NT)); therefore, it is likely that, in vivo, the E1G1 heterodimer has a significant role in the initiation of subunit assembly. Multiple interactions of variable affinity in the stalk region may be important to the mechanism of reversible dissociation of the intact V-ATPase.	[Rahman, Suhaila; Yamato, Ichiro; Saijo, Shinya; Mizutani, Kenji] Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba, Japan; [Saijo, Shinya] RIKEN SPring 8, Harima Science City, Hyogo, Japan; [Mizutani, Kenji; Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba, Japan; [Ishizuka-Katsura, Yoshiko; Ohsawa, Noboru; Terada, Takaho; Shirouzu, Mikako; Yokoyama, Shigeyuki; Iwata, So; Murata, Takeshi] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan; [Iwata, So] Kyoto Univ, Fac Med, Dept Cell Biol, Kyoto, Japan; [Murata, Takeshi] JST, PRESTO, Chiba, Japan	Tokyo University of Science; RIKEN; Chiba University; RIKEN; University of Tokyo; Kyoto University; Japan Science & Technology Agency (JST)	Rahman, S (corresponding author), Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba, Japan.	srahman@rs.tus.ac.jp	Murata, Takeshi/J-6181-2017; Yokoyama, Shigeyuki/N-6911-2015; Shirouzu, Mikako/A-6521-2016	Murata, Takeshi/0000-0002-5748-4670; Yokoyama, Shigeyuki/0000-0003-3133-7338; 	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); MEXT; Biotechnology and Biological Sciences Research Council [BBS/B/06458] Funding Source: researchfish	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Targeted Proteins Research Program (T. M., S. I. and S.Y.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and by Special Coordination Funds for Promoting Science and Technology (T. M.) from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster A, 2004, FEBS LETT, V570, P119, DOI 10.1016/j.febslet.2004.06.029; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; Esteban O, 2008, J BIOL CHEM, V283, P2595, DOI 10.1074/jbc.M704941200; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Hahn H, 2003, AM J KIDNEY DIS, V41, P238, DOI 10.1053/ajkd.2003.50014; Hildenbrand ZL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012588; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kish-Trier E, 2008, J MOL BIOL, V375, P673, DOI 10.1016/j.jmb.2007.10.063; Kish-Trier E, 2009, J BIOL CHEM, V284, P12031, DOI 10.1074/jbc.M808962200; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; Lokanath NK, 2007, J MOL BIOL, V366, P933, DOI 10.1016/j.jmb.2006.11.088; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; Oot RA, 2012, J BIOL CHEM, V287, P13396, DOI 10.1074/jbc.M112.343962; Oot RA, 2010, J BIOL CHEM, V285, P24654, DOI 10.1074/jbc.M110.136960; Qi J, 2008, J BIOL CHEM, V283, P19274, DOI 10.1074/jbc.M802442200; Rahman S, 2011, ANAL BIOCHEM, V418, P301, DOI 10.1016/j.ab.2011.07.009; Rahman S, 2011, PROTEIN EXPRES PURIF, V78, P181, DOI 10.1016/j.pep.2011.02.012; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Sennoune SR, 2007, J BIOENERG BIOMEMBR, V39, P427, DOI 10.1007/s10863-007-9108-8; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Yamamoto M, 2008, J BIOL CHEM, V283, P19422, DOI 10.1074/jbc.M801772200; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhang ZY, 2006, FEBS LETT, V580, P2006, DOI 10.1016/j.febslet.2006.03.001; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200	38	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e55704	10.1371/journal.pone.0055704	http://dx.doi.org/10.1371/journal.pone.0055704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409023	Green Published, Green Submitted, gold			2022-12-27	WOS:000315100000021
J	Rao, SS; Mohan, KVK; Atreya, CD				Rao, Shilpakala Sainath; Mohan, Ketha V. K.; Atreya, Chintamani D.			A Peptide Derived from Phage Display Library Exhibits Antibacterial Activity against E. coli and Pseudomonas aeruginosa	PLOS ONE			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; POSITIVELY CHARGED RESIDUES; ESCHERICHIA-COLI; BIOLOGICAL-ACTIVITY; PROTEIN DOCKING; NET CHARGE; HYDROPHOBICITY; ANTIBIOTICS; DISCOVERY; MEMBRANE	Emergence of drug resistant strains to currently available antibiotics has resulted in the quest for novel antimicrobial agents. Antimicrobial peptides (AMPs) are receiving attention as alternatives to antibiotics. In this study, we used phage-display random peptide library to identify peptides binding to the cell surface of E. coli. The peptide with sequence RLLFRKIRRLKR (EC5) bound to the cell surface of E. coli and exhibited certain features common to AMPs and was rich in Arginine and Lysine residues. Antimicrobial activity of the peptide was tested in vitro by growth inhibition assays and the bacterial membrane permeabilization assay. The peptide was highly active against Gram-negative organisms and showed significant bactericidal activity against E. coli and P. aeruginosa resulting in a reduction of 5 log(10) CFU/ml. In homologous plasma and platelets, incubation of EC5 with the bacteria resulted in significant reduction of E. coli and P. aeruginosa, compared to the peptide-free controls. The peptide was non-hemolytic and non-cytotoxic when tested on eukaryotic cells in culture. EC5 was able to permeabilize the outer membrane of E. coli and P. aeruginosa causing rapid depolarization of cytoplasmic membrane resulting in killing of the cells at 5 minutes of exposure. The secondary structure of the peptide showed a a-helical conformation in the presence of aqueous environment. The bacterial lipid interaction with the peptide was also investigated using Molecular Dynamic Simulations. Thus this study demonstrates that peptides identified to bind to bacterial cell surface through phage-display screening may additionally aid in identifying and developing novel antimicrobial peptides.	[Rao, Shilpakala Sainath; Mohan, Ketha V. K.; Atreya, Chintamani D.] US FDA, Sect Cell Biol, Lab Cellular Hematol, Div Hematol,Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Mohan, KVK (corresponding author), US FDA, Sect Cell Biol, Lab Cellular Hematol, Div Hematol,Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	krishna.ketha@fda.hhs.gov; chintamani.atreya@fda.hhs.gov	Rao, Shilpakala Sainath/AAQ-8394-2021		Center for Biologics Evaluation and Research (CBER)	Center for Biologics Evaluation and Research (CBER)	SSR is a recipient of a postdoctoral fellowship at the Center for Biologics Evaluation and Research (CBER) administered by the Oak Ridge Institute for Science and Education (ORISE) through an intra -agency agreement between the U. S. Department of Energy and the U. S. Food and Drug Administration. Review of the manuscript by Drs. Salim Haddad and Xuan Chi, CBER is highly appreciated. The findings and conclusions in this report have not been formally disseminated by the Food and Drug Administration and should not be construed to represent any Agency determination or policy.	ADEY NB, 1995, GENE, V156, P27, DOI 10.1016/0378-1119(95)00058-E; Avrahami D, 2002, BIOCHEMISTRY-US, V41, P2254, DOI 10.1021/bi011549t; Azad MA, 2011, ANTIMICROB AGENTS CH, V55, P2137, DOI 10.1128/AAC.01148-10; Bishop-Hurley SL, 2010, PROTEIN ENG DES SEL, V23, P751, DOI 10.1093/protein/gzq050; Bishop-Hurley SL, 2005, ANTIMICROB AGENTS CH, V49, P2972, DOI 10.1128/AAC.49.7.2972-2978.2005; Bishop-Hurley SL, 2002, APPL ENVIRON MICROB, V68, P3315, DOI 10.1128/AEM.68.7.3315-3320.2002; Chen CC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-366; Chen PW, 2003, AM J VET RES, V64, P1088, DOI 10.2460/ajvr.2003.64.1088; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Daugelavicius R, 2000, ANTIMICROB AGENTS CH, V44, P2969, DOI 10.1128/AAC.44.11.2969-2978.2000; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; Fang ZD, 2006, P NATL ACAD SCI USA, V103, P18444, DOI 10.1073/pnas.0605542103; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Hadley EB, 2010, CURR TOP MED CHEM, V10, P1872; Hancock R E, 1995, Adv Microb Physiol, V37, P135, DOI 10.1016/S0065-2911(08)60145-9; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jiang ZQ, 2008, CHEM BIOL DRUG DES, V72, P483, DOI 10.1111/j.1747-0285.2008.00728.x; Jiang ZQ, 2008, BIOPOLYMERS, V90, P369, DOI 10.1002/bip.20911; Jiang ZQ, 2009, ADV EXP MED BIOL, V611, P561, DOI 10.1007/978-0-387-73657-0_246; Kay BK, 2001, METHODS, V24, P240, DOI 10.1006/meth.2001.1185; Kay Brian K, 2003, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1704s17; Knurr J, 2003, APPL ENVIRON MICROB, V69, P6841, DOI 10.1128/AEM.69.11.6841-6847.2003; Lin KC, 2012, APPL MICROBIOL BIOT, V94, P755, DOI 10.1007/s00253-011-3857-3; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; Loose C, 2006, NATURE, V443, P867, DOI 10.1038/nature05233; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Mohan KVK, 2010, TRANSFUSION, V50, P166, DOI 10.1111/j.1537-2995.2009.02376.x; Mukhija S, 1997, MOL MICROBIOL, V25, P1159, DOI 10.1046/j.1365-2958.1997.5501910.x; Pathak S, 2011, ANTIMICROB AGENTS CH, V55, P2178, DOI 10.1128/AAC.01493-10; Pini A, 2005, ANTIMICROB AGENTS CH, V49, P2665, DOI 10.1128/AAC.49.7.2665-2672.2005; Rao SS, 2013, MICROBIOL RES, V168, P106, DOI 10.1016/j.micres.2012.07.004; Rao SS, 2010, BIOCHEM BIOPH RES CO, V395, P93, DOI 10.1016/j.bbrc.2010.03.145; Rathinakumar R, 2010, FASEB J, V24, P3232, DOI 10.1096/fj.10-157040; Rathinakumar R, 2009, J AM CHEM SOC, V131, P7609, DOI 10.1021/ja8093247; Rishi P, 2011, ANTIMICROB AGENTS CH, V55, P4176, DOI 10.1128/AAC.00273-11; Sainathrao S, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-67; Sergeeva A, 2006, ADV DRUG DELIVER REV, V58, P1622, DOI 10.1016/j.addr.2006.09.018; Shepherd CM, 2001, BIOPHYS J, V80, P579, DOI 10.1016/S0006-3495(01)76039-0; SIMS PJ, 1974, BIOCHEMISTRY-US, V13, P3315, DOI 10.1021/bi00713a022; Tachi T, 2002, BIOCHEMISTRY-US, V41, P10723, DOI 10.1021/bi0256983; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaara M, 2008, ANTIMICROB AGENTS CH, V52, P3229, DOI 10.1128/AAC.00405-08; Velkov T, 2010, J MED CHEM, V53, P1898, DOI 10.1021/jm900999h; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yount NY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026727; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200	57	27	33	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56081	10.1371/journal.pone.0056081	http://dx.doi.org/10.1371/journal.pone.0056081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409125	Green Submitted, Green Published, gold			2022-12-27	WOS:000315100000043
J	Seyedarabi, A; Cheng, LL; Zachary, I; Djordjevic, S				Seyedarabi, Arefeh; Cheng, Lili; Zachary, Ian; Djordjevic, Snezana			Production of Soluble Human Vascular Endothelial Growth Factor VEGF-A(165)-Heparin Binding Domain in Escherichia coli	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; GENE-PRODUCT; NEUROPILIN-1; RECEPTOR; HEPARIN; OVEREXPRESSION; CYTOPLASM; VEGF(165); PROTEINS; AFFINITY	We report a method for production of soluble heparin binding domain (HBD) of human vascular endothelial growth factor VEGF-A(165). Recombinant VEGF-A(165)-HBD that contains four disulphide bridges was expressed in specialised E. coli SHuffle cells and its activity has been confirmed through interactions with neuropilin and heparin. The ability to produce significant quantities of a soluble active form of VEGF-A(165)-HBD will enable further studies addressing the role of VEGF-A in essential processes such as angiogenesis, vasculogenesis and vascular permeability.	[Seyedarabi, Arefeh; Djordjevic, Snezana] UCL, Inst Struct & Mol Biol, London, England; [Cheng, Lili] Ark Therapeut Ltd, London, England; [Cheng, Lili; Zachary, Ian] UCL, British Heart Fdn Labs, Ctr Cardiovasc Biol & Med, London, England	University of London; Birkbeck University London; University College London; University of London; University College London	Djordjevic, S (corresponding author), UCL, Inst Struct & Mol Biol, London, England.	s.djordjevic@ucl.ac.uk			British Heart Foundation [PG/10/52/28448]; British Heart Foundation [RG/11/11/29050, RG/06/003/21131] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by funding from the British Heart Foundation (AS, SD, IZ) PG/10/52/28448. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baca AM, 2000, INT J PARASITOL, V30, P113, DOI 10.1016/S0020-7519(00)00019-9; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; BRINKMANN U, 1989, GENE, V85, P109, DOI 10.1016/0378-1119(89)90470-8; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Christinger HW, 1996, PROTEINS, V26, P353, DOI 10.1002/(SICI)1097-0134(199611)26:3<353::AID-PROT9>3.0.CO;2-E; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Fairbrother WJ, 1998, STRUCT FOLD DES, V6, P637, DOI 10.1016/S0969-2126(98)00065-3; Fuh G, 2000, J BIOL CHEM, V275, P26690; Geretti E, 2007, J BIOL CHEM, V282, P25698, DOI 10.1074/jbc.M702942200; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; Jarvis A, 2010, J MED CHEM, V53, P2215, DOI 10.1021/jm901755g; Jeong KW, 2011, BIOCHEMISTRY-US, V50, P4843, DOI 10.1021/bi2000752; Jia H, 2010, BRIT J CANCER, V102, P541, DOI 10.1038/sj.bjc.6605539; Jia HY, 2006, J BIOL CHEM, V281, P13493, DOI 10.1074/jbc.M512121200; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kong JS, 2010, ARTHRITIS RHEUM-US, V62, P179, DOI 10.1002/art.27243; Kurland C, 1996, CURR OPIN BIOTECH, V7, P489, DOI 10.1016/S0958-1669(96)80050-4; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Levy R, 2001, PROTEIN EXPRES PURIF, V23, P338, DOI 10.1006/prep.2001.1520; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; Pace N. C., 1995, PROTEIN SCI, V4, P2411; Parker MW, 2012, J BIOL CHEM, V287, P11082, DOI 10.1074/jbc.M111.331140; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Poltorak Z, 1997, J BIOL CHEM, V272, P7151, DOI 10.1074/jbc.272.11.7151; SEIDEL HM, 1992, BIOCHEMISTRY-US, V31, P2598, DOI 10.1021/bi00124a021; TISCHER E, 1991, J BIOL CHEM, V266, P11947	29	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55690	10.1371/journal.pone.0055690	http://dx.doi.org/10.1371/journal.pone.0055690			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409021	Green Submitted, Green Published, gold			2022-12-27	WOS:000314660300029
J	Zhang, QB; Sun, HC; Zhang, KZ; Jia, QA; Bu, Y; Wang, M; Chai, ZT; Zhang, QB; Wang, WQ; Kong, LQ; Zhu, XD; Lu, L; Wu, WZ; Wang, L; Tang, ZY				Zhang, Qiang-Bo; Sun, Hui-Chuan; Zhang, Ke-Zhi; Jia, Qing-An; Bu, Yang; Wang, Miao; Chai, Zong-Tao; Zhang, Quan-Bao; Wang, Wen-Quan; Kong, Ling-Qun; Zhu, Xiao-dong; Lu, Lu; Wu, Wei-Zhong; Wang, Lu; Tang, Zhao-You			Suppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular Carcinoma	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; LIVER-CANCER; LYMPHOCYTES; ACTIVATION; SUNITINIB; RECEPTOR; MOBILIZATION; PROGRESSION; PATHWAY; TRIGGER	Sorafenib, a multi-tyrosine kinase inhibitor, is a standard treatment for advanced hepatocellular carcinoma (HCC). The present study was undertaken to determine whether the growth and metastasis of HCC were influenced in mice receiving sorafenib prior to implantation with tumors, and to investigate the in-vivo and in-vitro effect of sorafenib on natural killer (NK) cells. In sorafenib-pretreated BALB/c nu/nu mice and C57BL/6 mice, tumor growth was accelerated, mouse survival was decreased, and lung metastasis was increased. However, the depletion of NK1.1(+) cells in C57BL/6 mice eliminated sorafenib-mediated pro-metastatic effects. Sorafenib significantly reduced the number of NK cells and inhibited reactivity of NK cells against tumor cells, in both tumor-bearing and tumor-free C57BL/6 mice. Sorafenib down-regulated the stimulatory receptor CD69 in NK cells of tumor-bearing mice, but not in tumor-free mice, and inhibited proliferation of NK92-MI cells, which is associated with the blocking of the PI3K/AKT pathway, and inhibited cytotoxicity of NK cells in response to tumor targets, which was due to impaired ERK phosphorylation. These results suggest immunotherapeutic approaches activating NK cells may enhance the therapeutic efficacy of sorafenib in HCC patients.	[Tang, Zhao-You] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Liver Canc Inst, Shanghai, Peoples R China; Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Zhongshan Hosp, Shanghai, Peoples R China	Fudan University; Fudan University	Tang, ZY (corresponding author), Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Chinese Minist Educ, Liver Canc Inst, Shanghai, Peoples R China.	zytang88@163.com	Zhu, Xiao-Dong/A-8197-2010	Zhu, Xiao-Dong/0000-0001-9864-6763; Sun, Hui-Chuan/0000-0003-3761-7058	National Natural Science Foundation of China [8102010802, 811018715, 81020108025, 81101871, 81101564]; National Key Project for Infectious Diseases [2012ZX10002012-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project for Infectious Diseases	This work was supported jointly by the National Natural Science Foundation of China (No. 8102010802, 811018715, 81020108025, 81101871, 81101564), the National Key Project for Infectious Diseases (2012ZX10002012-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro C, 2009, BRIT J CANCER, V100, P1111, DOI 10.1038/sj.bjc.6604965; Andrews P, 2008, CANCER CHEMOTH PHARM, V61, P203, DOI 10.1007/s00280-007-0462-3; Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Cao M, 2011, LAB INVEST; Carr BI, 2004, GASTROENTEROLOGY, V127, pS218, DOI 10.1053/j.gastro.2004.09.036; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chiu TL, 2009, INT J ONCOL, V35, P1361, DOI 10.3892/ijo_00000454; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Dennehy KM, 2011, J IMMUNOL, V186, P657, DOI 10.4049/jimmunol.0904117; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Hipp MM, 2008, BLOOD, V111, P5610, DOI 10.1182/blood-2007-02-075945; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson P, 2009, LANCET ONCOL, V10, P4, DOI 10.1016/S1470-2045(08)70317-6; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Krusch M, 2009, J IMMUNOL, V183, P8286, DOI 10.4049/jimmunol.0902404; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Levy EM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/676198; MORETTA A, 1991, J EXP MED, V174, P1393, DOI 10.1084/jem.174.6.1393; Nokihara H, 2000, CANCER RES, V60, P7002; Oh SJ, 2012, ENDOCR-RELAT CANCER, V19, P305, DOI 10.1530/ERC-11-0298; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Palmer DH, 2008, NEW ENGL J MED, V359, P2498; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shao YY, 2011, ONCOLOGIST, V16, P82, DOI 10.1634/theoncologist.2010-0272; Strumberg D, 2007, ONCOLOGIST, V12, P426, DOI 10.1634/theoncologist.12-4-426; Taguchi Y, 2004, BLOOD, V104, P3285, DOI 10.1182/blood-2004-03-0900; Tai WT, 2011, J HEPATOL, V55, P1041, DOI 10.1016/j.jhep.2011.06.005; Trotta R, 1998, J IMMUNOL, V161, P6648; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wai LE, 2008, TRANSPLANTATION, V85, P145, DOI 10.1097/01.tp.0000296817.28053.7b; Wang YY, 2005, P NATL ACAD SCI USA, V102, P1104, DOI 10.1073/pnas.0408831102; Wei S, 2000, J IMMUNOL, V165, P3811, DOI 10.4049/jimmunol.165.7.3811; Wei S, 1998, J EXP MED, V187, P1753, DOI 10.1084/jem.187.11.1753; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yang BW, 2008, EUR J GASTROEN HEPAT, V20, P1077, DOI 10.1097/MEG.0b013e3283050a67; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904; Zhao W, 2008, LEUKEMIA, V22, P1226, DOI 10.1038/leu.2008.58; Zimmer J, 2005, LEUKEMIA, V19, P1849, DOI 10.1038/sj.leu.2403906	40	38	40	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e55945	10.1371/journal.pone.0055945	http://dx.doi.org/10.1371/journal.pone.0055945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409093	gold, Green Published, Green Submitted			2022-12-27	WOS:000314660300047
J	Cuerrier, CM; Chen, YX; Tremblay, D; Rayner, K; McNulty, M; Zhao, XL; Kennedy, CRJ; de BelleRoche, J; Pelling, AE; O'Brien, ER				Cuerrier, Charles M.; Chen, Yong-Xiang; Tremblay, Dominique; Rayner, Katey; McNulty, Melissa; Zhao, XiaoLing; Kennedy, Christopher R. J.; de BelleRoche, Jacqueline; Pelling, Andrew E.; O'Brien, Edward R.			Chronic Over-Expression of Heat Shock Protein 27 Attenuates Atherogenesis and Enhances Plaque Remodeling: A Combined Histological and Mechanical Assessment of Aortic Lesions	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; HEAT-SHOCK-PROTEIN-27; ATHEROSCLEROSIS; APOPTOSIS; ARTERIES; HSP27	Aims: Expression of Heat Shock Protein-27 (HSP27) is reduced in human coronary atherosclerosis. Over-expression of HSP27 is protective against the early formation of lesions in atherosclerosis-prone apoE(-/-) mice (apoE(-/-) HSP27(o/e)) - however, only in females. We now seek to determine if chronic HSP27 over-expression is protective in a model of advanced atherosclerosis in both male and female apoE(-/-) mice. Methods and Results: After 12 weeks on a high fat diet, serum HSP27 levels rose more than 16-fold in male and female apoE(-/-) HSP27(o/e) mice, although females had higher levels than males. Relative to apoE(-/-) mice, female apoE(-/-) HSP27(o/e) mice showed reductions in aortic lesion area of 35% for en face and 30% for cross-sectional sinus tissue sections - with the same parameters reduced by 21% and 24% in male cohorts; respectively. Aortic plaques from apoE(-/-) HSP27(o/e) mice showed almost 50% reductions in the area occupied by cholesterol clefts and free cholesterol, with fewer macrophages and reduced apoptosis but greater intimal smooth muscle cell and collagen content. The analysis of the aortic mechanical properties showed increased vessel stiffness in apoE(-/-) HSP27(o/e) mice (41% in female, 34% in male) compare to apoE(-/-) counterparts. Conclusions: Chronic over-expression of HSP27 is atheroprotective in both sexes and coincides with reductions in lesion cholesterol accumulation as well as favorable plaque remodeling. These data provide new clues as to how HSP27 may improve not only the composition of atherosclerotic lesions but potentially their stability and resilience to plaque rupture.	[Cuerrier, Charles M.; Chen, Yong-Xiang; Rayner, Katey; McNulty, Melissa; Zhao, XiaoLing; O'Brien, Edward R.] Univ Ottawa, Inst Heart, Ottawa, ON, Canada; [Cuerrier, Charles M.; Tremblay, Dominique; Pelling, Andrew E.] Univ Ottawa, Dept Phys, Ctr Interdisciplinary NanoPhys, Ottawa, ON K1N 6N5, Canada; [Kennedy, Christopher R. J.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Kennedy, Christopher R. J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [de BelleRoche, Jacqueline] Univ London Imperial Coll Sci Technol & Med, London, England; [Pelling, Andrew E.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Pelling, Andrew E.] Univ Ottawa, Inst Sci Soc & Policy, Ottawa, ON, Canada; [O'Brien, Edward R.] Libin Cardiovasc Inst Alberta, Calgary, AB, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa; University of Ottawa; Imperial College London; University of Ottawa; University of Ottawa; Libin Cardiovascular Institute Of Alberta	O'Brien, ER (corresponding author), Univ Ottawa, Inst Heart, Ottawa, ON, Canada.	ed.obrien@albertahealthservices.ca	O'Brien, Edward R/J-6621-2013	O'Brien, Edward R/0000-0003-1039-9425; Rayner, Katey/0000-0001-6230-426X; Pelling, Andrew/0000-0003-3732-7472	Canadian Institute for Health Research (CIHR) [MOP80204]; Heart and Stroke Foundation of Ontario [T6335]; Fonds de Recherche en Sante du Quebec (FRSQ); Ernest and Margaret Ford cardiology endowed research fellowship from the University of Ottawa Heart Institute; Fonds de Recherche du Quebec- Nature et Technologies (FQRNT); MITACS Elevate Strategic Fellowship; Heart and Stroke Foundation of Ontario; CIHR's Institute of Gender and Health; Ontario Women's Health Council; Natural Sciences and Engineering Research Council (NSERC) Discovery Grant, an NSERC Discovery Accelerator Supplement; Canada Research Chairs (CRC) program; Early Researcher Award from the Province of Ontario	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Ernest and Margaret Ford cardiology endowed research fellowship from the University of Ottawa Heart Institute; Fonds de Recherche du Quebec- Nature et Technologies (FQRNT)(FQRNT); MITACS Elevate Strategic Fellowship; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); CIHR's Institute of Gender and Health(Canadian Institutes of Health Research (CIHR)); Ontario Women's Health Council; Natural Sciences and Engineering Research Council (NSERC) Discovery Grant, an NSERC Discovery Accelerator Supplement(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs (CRC) program(Canada Research Chairs); Early Researcher Award from the Province of Ontario	This work was supported by operating grants MOP80204 from the Canadian Institute for Health Research (CIHR) and T6335 from the Heart and Stroke Foundation of Ontario. CMC was supported by a postdoctoral studentship from le Fonds de Recherche en Sante du Quebec (FRSQ) and the Ernest and Margaret Ford cardiology endowed research fellowship from the University of Ottawa Heart Institute. DT was supported by a postdoctoral studentship from le Fonds de Recherche du Quebec- Nature et Technologies (FQRNT) and a MITACS Elevate Strategic Fellowship. KR was supported by studentships from both the Heart and Stroke Foundation of Ontario and the CIHR's Institute of Gender and Health in collaboration with the Ontario Women's Health Council. AEP is funded by the Natural Sciences and Engineering Research Council (NSERC) Discovery Grant, an NSERC Discovery Accelerator Supplement and gratefully acknowledges the support of the Canada Research Chairs (CRC) program and an Early Researcher Award from the Province of Ontario. The CIHR and Medtronic collectively provide EOB with a peer-reviewed Research Chair (URC #57093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Chen YX, 2004, CIRCULATION, V110, P3721, DOI 10.1161/01.CIR.0000146790.51331.BA; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Harrington SC, 2007, CIRC RES, V100, P1696, DOI 10.1161/CIRCRESAHA.106.146183; Henderson B, 2009, CELL STRESS CHAPERON, V14, P329, DOI 10.1007/s12192-008-0087-4; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; KRUTH HS, 1984, AM J PATHOL, V114, P201; Labinaz M, 1999, CARDIOVASC RES, V41, P255, DOI 10.1016/S0008-6363(98)00203-X; Martin-Ventura JL, 2004, CIRCULATION, V110, P2216, DOI 10.1161/01.CIR.0000136814.87170.B1; Miller H, 2005, ARTERIOSCL THROM VAS, V25, pE10, DOI 10.1161/01.ATV.0000156536.89752.8e; Park HK, 2006, CIRCULATION, V114, P886, DOI 10.1161/CIRCULATIONAHA.105.541219; Raizman JE, 2012, ARTERIOSCLER THROMB, V32, pA544; Rayner K, 2008, CIRC RES, V103, P133, DOI 10.1161/CIRCRESAHA.108.172155; Rayner K, 2008, J STEROID BIOCHEM, V108, P72, DOI 10.1016/j.jsbmb.2007.07.006; Rayner K, 2009, ARTERIOSCL THROM VAS, V29, P1751, DOI 10.1161/ATVBAHA.109.193656; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; Rekhter MD, 1996, CARDIOVASC RES, V32, P496, DOI 10.1016/S0008-6363(96)00097-1; Rippstein P, 2006, J HISTOCHEM CYTOCHEM, V54, P673, DOI 10.1369/jhc.5A6824.2006; Salari S, 2012, CELL STRESS IN PRESS; Sharp P, 2006, EXP NEUROL, V198, P511, DOI 10.1016/j.expneurol.2005.12.031; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tremblay D, 2009, ANN THORAC SURG, V88, P1484, DOI 10.1016/j.athoracsur.2009.07.023	23	28	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55867	10.1371/journal.pone.0055867	http://dx.doi.org/10.1371/journal.pone.0055867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409070	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200079
J	Jiang, J; Bailey, K; Chen, AT; Cui, Q; Zhang, QL				Jiang, Jun; Bailey, Kira; Chen, Antao; Cui, Qian; Zhang, Qinglin			Unconsciously Triggered Emotional Conflict by Emotional Facial Expressions	PLOS ONE			English	Article							ANTERIOR CINGULATE ACTIVATION; SEQUENTIAL MODULATIONS; STROOP TASK; FACES; AWARENESS; MECHANISMS; COGNITION; AMYGDALA; ANXIETY	The present study investigated whether emotional conflict and emotional conflict adaptation could be triggered by unconscious emotional information as assessed in a backward-masked affective priming task. Participants were instructed to identify the valence of a face (e.g., happy or sad) preceded by a masked happy or sad face. The results of two experiments revealed the emotional conflict effect but no emotional conflict adaptation effect. This demonstrates that emotional conflict can be triggered by unconsciously presented emotional information, but participants may not adjust their subsequent performance trial-by trial to reduce this conflict.	[Jiang, Jun; Chen, Antao; Cui, Qian; Zhang, Qinglin] Southwest Univ, Fac Psychol, Chongqing, Peoples R China; [Jiang, Jun; Chen, Antao; Cui, Qian; Zhang, Qinglin] Southwest Univ, Key Lab Cognit & Personal, Minist Educ, Chongqing, Peoples R China; [Bailey, Kira] Univ Missouri, Dept Psychol Sci, Columbia, MO USA	Southwest University - China; Southwest University - China; University of Missouri System; University of Missouri Columbia	Zhang, QL (corresponding author), Southwest Univ, Fac Psychol, Chongqing, Peoples R China.	qlzhang.swu@gmail.com	Jiang, Jun/F-8577-2015	Jiang, Jun/0000-0002-0136-993X	National Natural Science Foundation of China [31170983, 31170980]; New Century Excellent Talents in University [NCET-11-0698]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This research was supported by National Natural Science Foundation of China (31170983, 31170980), and the New Century Excellent Talents in University (NCET-11-0698). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews V, 2011, MOTIV EMOTION, V35, P33, DOI 10.1007/s11031-010-9196-3; Ansorge U, 2011, PSYCHOL RES-PSYCH FO, V75, P351, DOI 10.1007/s00426-010-0313-4; Bodner GE, 2010, EXP PSYCHOL, V57, P360, DOI 10.1027/1618-3169/a000043; Chiew KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017635; Chiew KS, 2010, EMOTION, V10, P842, DOI 10.1037/a0019704; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Etkin A, 2010, AM J PSYCHIAT, V167, P545, DOI 10.1176/appi.ajp.2009.09070931; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Fenske MJ, 2003, EMOTION, V3, P327, DOI 10.1037/1528-3542.3.4.327; Francken JC, 2011, CONSCIOUS COGN, V20, P1793, DOI 10.1016/j.concog.2011.04.005; Frings C, 2008, ACTA PSYCHOL, V128, P318, DOI 10.1016/j.actpsy.2008.03.004; [龚栩 Gong Xu], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P40; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; Haas BW, 2007, BEHAV NEUROSCI, V121, P249, DOI 10.1037/0735-7044.121.2.249; Haas BW, 2006, COGN AFFECT BEHAV NE, V6, P152, DOI 10.3758/CABN.6.2.152; Heinemann A, 2011, THESIS TU DORTMUND D; Hughes G, 2009, PSYCHOPHYSIOLOGY, V46, P1258, DOI 10.1111/j.1469-8986.2009.00873.x; Kiefer M, 2000, NEUROREPORT, V11, P2401, DOI 10.1097/00001756-200008030-00013; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P318, DOI 10.1111/j.1469-8986.2007.00634.x; Kunde W, 2003, PSYCHON B REV, V10, P198, DOI 10.3758/BF03196485; Kunde W, 2008, EXP PSYCHOL, V55, P151, DOI 10.1027/1618-3169.55.3.151; Li W, 2008, J COGNITIVE NEUROSCI, V20, P95; Liddell BJ, 2004, J COGNITIVE NEUROSCI, V16, P479, DOI 10.1162/089892904322926809; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; Pegna AJ, 2008, INT J PSYCHOPHYSIOL, V70, P127, DOI 10.1016/j.ijpsycho.2008.08.007; Stenberg G, 1998, COGNITION EMOTION, V12, P755, DOI 10.1080/026999398379420; Straube T, 2011, BRIT J PSYCHOL, V102, P830, DOI 10.1111/j.2044-8295.2011.02056.x; van Gaal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011508; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Winkielman P, 2005, PERS SOC PSYCHOL B, V31, P121, DOI 10.1177/0146167204271309	32	9	10	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55907	10.1371/journal.pone.0055907	http://dx.doi.org/10.1371/journal.pone.0055907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092XV	23409084	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200087
J	Lan, YY; Yeh, TH; Lin, WH; Wu, SY; Lai, HC; Chang, FH; Takada, K; Chang, Y				Lan, Yu-Yan; Yeh, Tzu-Hao; Lin, Wei-Hung; Wu, Shih-Yi; Lai, Hsiao-Ching; Chang, Fang-Hsin; Takada, Kenzo; Chang, Yao			Epstein-Barr Virus Zta Upregulates Matrix Metalloproteinases 3 and 9 That Synergistically Promote Cell Invasion In Vitro	PLOS ONE			English	Article							NASOPHARYNGEAL CARCINOMA-CELLS; GENOME INSTABILITY; C-FOS; EXPRESSION; GENE; PROTEIN; MATRIX-METALLOPROTEINASE-9; BZLF1; EBV; INDUCTION	Zta is a lytic transactivator of Epstein-Barr virus (EBV) and has been shown to promote migration and invasion of epithelial cells. Although previous studies indicate that Zta induces expression of matrix metalloproteinase (MMP) 9 and MMP1, direct evidence linking the MMPs to Zta-induced cell migration and invasion is still lacking. Here we performed a series of in vitro studies to re-examine the expression profile and biologic functions of Zta-induced MMPs in epithelial cells derived from nasopharyngeal carcinoma. We found that, in addition to MMP9, MMP3 was a new target gene upregulated by Zta. Ectopic Zta expression in EBV-negative cells increased both mRNA and protein production of MMP3. Endogenous Zta also contributed to induction of MMP3 expression, migration and invasion of EBV-infected cells. Zta activated the MMP3 promoter through three AP-1 elements, and its DNA-binding domain was required for the promoter binding and MMP3 induction. We further tested the effects of MMP3 and MMP9 on cell motility and invasiveness in vitro. Zta-promoted cell migration required MMP3 but not MMP9. On the other hand, both MMP3 and MMP9 were essential for Zta-induced cell invasion, and co-expression of the two MMPs synergistically increased cell invasiveness. Therefore, this study provides integrated evidence demonstrating that, at least in the in vitro cell models, Zta drives cell migration and invasion through MMPs.	[Lan, Yu-Yan; Yeh, Tzu-Hao; Lin, Wei-Hung; Wu, Shih-Yi; Lai, Hsiao-Ching; Chang, Fang-Hsin; Chang, Yao] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan; [Lan, Yu-Yan; Lai, Hsiao-Ching; Chang, Yao] Natl Cheng Kung Univ, Med Coll & Hosp, Grad Inst Basic Med Sci, Tainan 70101, Taiwan; [Yeh, Tzu-Hao; Lin, Wei-Hung; Chang, Fang-Hsin; Chang, Yao] Natl Cheng Kung Univ, Med Coll & Hosp, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Takada, Kenzo] Hokkaido Univ, Inst Med Genet, Dept Tumor Virol, Sapporo, Hokkaido, Japan	National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University; Hokkaido University	Chang, Y (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Tainan, Taiwan.	yaochang@nhri.org.tw	Lin, Wei-Hung/ABE-1927-2021; Chang, Yao/B-2653-2010	Lan, Yu-Yan/0000-0003-4436-2057	National Health Research Institutes, Taiwan [ID-099-PP-16, ID-100-PP-16, IV-101-PP-18, IV-102-PP-19]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by the National Health Research Institutes, Taiwan (ID-099-PP-16, ID-100-PP-16, IV-101-PP-18 and IV-102-PP-19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRANCO SC, 1983, CANCER RES, V43, P1703; Belguise K, 2005, ONCOGENE, V24, P1434, DOI 10.1038/sj.onc.1208312; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bhende PM, 2004, NAT GENET, V36, P1099, DOI 10.1038/ng1424; BOUVIER G, 1995, CARCINOGENESIS, V16, P1879, DOI 10.1093/carcin/16.8.1879; Bu XM, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/214269; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chan ATC, 2002, ANN ONCOL, V13, P1007, DOI 10.1093/annonc/mdf179; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Chang Y, 2006, J VIROL, V80, P7748, DOI 10.1128/JVI.02608-05; Chicoine E, 2002, BIOCHEM BIOPH RES CO, V297, P765, DOI 10.1016/S0006-291X(02)02283-0; Chien YC, 2001, NEW ENGL J MED, V345, P1877, DOI 10.1056/NEJMoa011610; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; COCHET C, 1993, VIROLOGY, V197, P358, DOI 10.1006/viro.1993.1597; Couillard J, 2006, BIOCHEM BIOPH RES CO, V342, P1233, DOI 10.1016/j.bbrc.2006.02.068; DEVATHAIRE F, 1988, INT J CANCER, V42, P176, DOI 10.1002/ijc.2910420206; Dickerson SJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000356; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fang CY, 2009, INT J CANCER, V124, P2016, DOI 10.1002/ijc.24179; Fauquier L, 2008, FASEB J, V22, P3337, DOI 10.1096/fj.07-104604; FLEMINGTON E, 1990, J VIROL, V64, P4549, DOI 10.1128/JVI.64.9.4549-4552.1990; FLEMINGTON EK, 1994, MOL CELL BIOL, V14, P3041, DOI 10.1128/MCB.14.5.3041; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; GROGAN E, 1987, P NATL ACAD SCI USA, V84, P1332, DOI 10.1073/pnas.84.5.1332; HENLE W, 1977, INT J CANCER, V20, P663, DOI 10.1002/ijc.2910200504; HOLLEYGUTHRIE EA, 1990, J VIROL, V64, P3753, DOI 10.1128/JVI.64.8.3753-3759.1990; Hsu M, 2008, J VIROL, V82, P3679, DOI 10.1128/JVI.02301-07; Huang SY, 2012, J GEN VIROL, V93, P139, DOI 10.1099/vir.0.034405-0; Huang SY, 2010, CHEM-BIOL INTERACT, V188, P623, DOI 10.1016/j.cbi.2010.09.020; Hung WC, 2010, CANCER LETT, V288, P156, DOI 10.1016/j.canlet.2009.06.032; Inoue K, 2000, CANCER RES, V60, P2290; JOAB I, 1991, INT J CANCER, V48, P647, DOI 10.1002/ijc.2910480503; Johnson JL, 2012, CANCER RES, V72, P516, DOI 10.1158/0008-5472.CAN-11-2647; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; KOUZARIDES T, 1991, ONCOGENE, V6, P195; Lan YY, 2012, J VIROL, V86, P6656, DOI 10.1128/JVI.00174-12; Lee CH, 2011, J VIROL, V85, P7333, DOI 10.1128/JVI.00182-11; Lee DCW, 2007, BIOMED PHARMACOTHER, V61, P520, DOI 10.1016/j.biopha.2007.08.007; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Lu J, 2000, J VIROL, V74, P7391, DOI 10.1128/JVI.74.16.7391-7399.2000; Lu J, 2003, CANCER RES, V63, P256; Luo Y, 2009, BIOCHEMISTRY-US, V48, P1838, DOI 10.1021/bi8020789; Mahot S, 2003, J GEN VIROL, V84, P965, DOI 10.1099/vir.0.18845-0; MARTELRENOIR D, 1995, J GEN VIROL, V76, P1401, DOI 10.1099/0022-1317-76-6-1401; Maruo S, 2001, J GEN VIROL, V82, P2373, DOI 10.1099/0022-1317-82-10-2373; Mendes O, 2005, CLIN EXP METASTAS, V22, P237, DOI 10.1007/s10585-005-8115-6; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Ragoczy T, 1998, J VIROL, V72, P7978, DOI 10.1128/JVI.72.10.7978-7984.1998; RHEINWALD JG, 1981, CANCER RES, V41, P1657; ROONEY CM, 1989, J VIROL, V63, P3109, DOI 10.1128/JVI.63.7.3109-3116.1989; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; SHAO YM, 1988, CARCINOGENESIS, V9, P1455, DOI 10.1093/carcin/9.8.1455; Sheu BC, 2001, CANCER RES, V61, P237; Shih WL, 2008, CANCER LETT, V270, P202, DOI 10.1016/j.canlet.2008.05.005; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Song YH, 2008, MOL IMMUNOL, V45, P137, DOI 10.1016/j.molimm.2007.04.031; Westermarck J, 1997, ONCOGENE, V14, P2651, DOI 10.1038/sj.onc.1201111; YIP TTC, 1994, CANCER, V74, P2414, DOI 10.1002/1097-0142(19941101)74:9<2414::AID-CNCR2820740905>3.0.CO;2-8; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621; Yoshizaki T, 1999, CLIN EXP METASTAS, V17, P431, DOI 10.1023/A:1006699003525; Yu FL, 2005, J HEPATOL, V42, P520, DOI 10.1016/j.jhep.2004.11.031; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zang XP, 2006, ANTICANCER RES, V26, P961	67	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56121	10.1371/journal.pone.0056121	http://dx.doi.org/10.1371/journal.pone.0056121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409137	gold, Green Submitted, Green Published			2022-12-27	WOS:000315157200111
J	Loov, C; Shevchenko, G; Nadadhur, AG; Clausen, F; Hillered, L; Wetterhall, M; Erlandsson, A				Loov, Camilla; Shevchenko, Ganna; Nadadhur, Aishwarya Geeyarpuram; Clausen, Fredrik; Hillered, Lars; Wetterhall, Magnus; Erlandsson, Anna			Identification of Injury Specific Proteins in a Cell Culture Model of Traumatic Brain Injury	PLOS ONE			English	Article							IN-VITRO MODELS; MEMBRANE; ASSOCIATION; EXPRESSION; MIGRATION; CYTOKINES; PATHWAY; BINDING; FUSION; ACTIN	The complicated secondary molecular and cellular mechanisms following traumatic brain injury (TBI) are still not fully understood. In the present study, we have used mass spectrometry to identify injury specific proteins in an in vitro model of TBI. A standardized injury was induced by scalpel cuts through a mixed cell culture of astrocytes, oligodendrocytes and neurons. Twenty-four hours after the injury, cell culture medium and whole-cell fractions were collected for analysis. We found 53 medium proteins and 46 cell fraction proteins that were specifically expressed after injury and the known function of these proteins was elucidated by an extensive literature survey. By using time-lapse microscopy and immunostainings we could link a large proportion of the proteins to specific cellular processes that occur in response to trauma; including cell death, proliferation, lamellipodia formation, axonal regeneration, actin remodeling, migration and inflammation. A high percentage of the proteins uniquely expressed in the medium after injury were actin-related proteins, which normally are situated intracellularly. We show that two of these, ezrin and moesin, are expressed by astrocytes both in the cell culture model and in mouse brain subjected to experimental TBI. Interestingly, we found many inflammation-related proteins, despite the fact that cells were present in the culture. This study contributes with important knowledge about the cellular responses after trauma and identifies several potential cell-specific biomarkers.	[Loov, Camilla; Nadadhur, Aishwarya Geeyarpuram; Clausen, Fredrik; Hillered, Lars; Erlandsson, Anna] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Shevchenko, Ganna; Wetterhall, Magnus] Uppsala Univ, Dept Chem BMC, Uppsala, Sweden	Uppsala University; Uppsala University	Erlandsson, A (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	anna.erlandsson@neuro.uu.se		G Nadadhur, Aishwarya/0000-0003-0468-9135; Hillered, Lars/0000-0002-2808-9292; Clausen, Fredrik/0000-0003-3592-4417	Jeanssons Foundation; Tore Nilssons Foundation; Swedish Society of Medicine [SLS-251631]; Magnus Bergvall foundation [24942*1*2011]; Medical Faculty Foundation for Psychological and Neurological Research at Uppsala University; Uppsala University Hospital	Jeanssons Foundation; Tore Nilssons Foundation; Swedish Society of Medicine; Magnus Bergvall foundation; Medical Faculty Foundation for Psychological and Neurological Research at Uppsala University; Uppsala University Hospital	This study was supported by grants from Jeanssons Foundation, Tore Nilssons Foundation, the Swedish Society of Medicine (SLS-251631), Magnus Bergvall foundation (24942*1*2011) and the Medical Faculty Foundation for Psychological and Neurological Research at Uppsala University and Uppsala University Hospital. MW further acknowledges Lars Hiertas Minne Foundation (FO2009-0695) and Signe och Olof Wallenius Foundation (R103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell J.N., 2011, J NEUROTRAUMA; Castoreno AB, 2005, P NATL ACAD SCI USA, V102, P13129, DOI 10.1073/pnas.0506716102; Chastain EML, 2011, BBA-MOL BASIS DIS, V1812, P265, DOI 10.1016/j.bbadis.2010.07.008; Chen XQ, 2005, J CEREBR BLOOD F MET, V25, P338, DOI 10.1038/sj.jcbfm.9600032; Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Fiedler LR, 2009, BIOCHEM SOC T, V37, P1243, DOI 10.1042/BST0371243; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Kreipke CW, 2006, MICROVASC RES, V71, P197, DOI 10.1016/j.mvr.2006.02.002; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; Lee SH, 2010, MOL CELLS, V29, P311, DOI 10.1007/s10059-010-0053-8; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marion S, 2011, TRAFFIC, V12, P421, DOI 10.1111/j.1600-0854.2011.01158.x; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moalem G, 1999, FASEB J, V13, P1207, DOI 10.1096/fasebj.13.10.1207; Moon Y, 2011, NEUROREPORT, V22, P304, DOI 10.1097/WNR.0b013e3283460265; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Qi YX, 2008, CARDIOVASC RES, V80, P114, DOI 10.1093/cvr/cvn158; Rao MS, 1999, ANAT RECORD, V257, P137; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; Riddell JR, 2010, J IMMUNOL, V184, P1022, DOI 10.4049/jimmunol.0901945; Shevchenko G, 2012, J PROTEOME RES, V11, P2441, DOI 10.1021/pr201169q; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wojciak-Stothard B, 2007, J CELL SCI, V120, P929, DOI 10.1242/jcs.002212; Wolk K, 2005, GENES IMMUN, V6, P452, DOI 10.1038/sj.gene.6364224; Wright KT, 2010, BIOCHEM BIOPH RES CO, V398, P79, DOI 10.1016/j.bbrc.2010.06.039; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Yamaguchi H, 2009, J CELL PHYSIOL, V220, P748, DOI 10.1002/jcp.21822; Zhang W, 2011, P NATL ACAD SCI USA, V108, P4956, DOI 10.1073/pnas.1102527108	43	30	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55983	10.1371/journal.pone.0055983	http://dx.doi.org/10.1371/journal.pone.0055983			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409102	Green Submitted, gold, Green Published			2022-12-27	WOS:000315157200097
J	Marmamula, S; Narsaiah, S; Shekhar, K; Khanna, RC				Marmamula, Srinivas; Narsaiah, Saggam; Shekhar, Konegari; Khanna, Rohit C.			Visual Impairment among Weaving Communities in Prakasam District in South India	PLOS ONE			English	Article							CENTRAL SRI-LANKA; RAPID ASSESSMENT; AVOIDABLE BLINDNESS; CATARACT; PREVALENCE; SERVICES; BARRIERS	Purpose: To assess the prevalence and causes of visual impairment in weaving communities in Prakasam district in South India state of Andhra Pradesh. Methods: Using Rapid Assessment of Visual Impairment (RAVI) methodology, a population based cross-sectional study was conducted. A two-stage sampling strategy was used to select 3000 participants aged >= 40 years. Visual Acuity (VA) was assessed using a tumbling E chart and ocular examinations were performed by trained Para medical ophthalmic personnel. A questionnaire was used to collect personal and demographic information. Blindness and moderate Visual Impairment (VI) was defined as presenting VA <6/60 and <6/18 to 6/60 respectively. VI included blindness and moderate VI. Results: 2848 of 3000 enumerated subjects (94.0%) participated. 39% were in 40-49 years age group and 11.8% were aged >= 70 years, 55% were women and nearly half of them had no formal education. 400 (14%; 95% CI: 12.8-15.3) subjects had VI, including blindness in 131 (4.6%; 95% CI: 3.8-5.4) and moderate VI in 269 (9.4%; 95% CI: 8.3-10.5) individuals. On applying multiple logistic regression, VI was significantly associated with older age and no formal education. Though the odds of having VI were higher in females, it was of borderline statistical significance (p = 0.06). Refractive error was the leading cause of all VI followed by cataract (56%). However, refractive errors were the leading cause of moderate VI (73.2%) and cataract was the leading cause of blindness (62.6%). 'Cannot afford the cost of services' was the leading barrier for utilization of eye care services (47%). Conclusions: There is a significant burden of VI in weaving communities in Andhra Pradesh, India most of which is avoidable. With this information as baseline, services need to be streamlined to address this burden.	[Marmamula, Srinivas; Narsaiah, Saggam; Shekhar, Konegari; Khanna, Rohit C.] LV Prasad Eye Inst, Allen Foster Community Eye Hlth Res Ctr, Int Ctr Adv Rural Eye Care, Hyderabad, Andhra Pradesh, India; [Marmamula, Srinivas] LV Prasad Eye Inst, Bausch & Lomb Sch Optometry, Hyderabad, Andhra Pradesh, India; [Marmamula, Srinivas] Wilmer Eye Inst, Dana Ctr Prevent Ophthalmol, Baltimore, MD 21287 USA	L. V. Prasad Eye Institute; Bausch Health; Bausch + Lomb; L. V. Prasad Eye Institute; Johns Hopkins University; Johns Hopkins Medicine	Marmamula, S (corresponding author), LV Prasad Eye Inst, Allen Foster Community Eye Hlth Res Ctr, Int Ctr Adv Rural Eye Care, Hyderabad, Andhra Pradesh, India.	srioptom@lvpei.org			OneSight Luxottica Foundation; Hyderabad Eye Research Foundation	OneSight Luxottica Foundation; Hyderabad Eye Research Foundation	Financial support for this study was provided by OneSight Luxottica Foundation and Hyderabad Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiov PA, 2009, CLIN EXP OPHTHALMOL, V37, P780, DOI 10.1111/j.1442-9071.2009.02152.x; Census of India, 2001, PRIM CENS ABSTRACT G; Dandona L, 2001, INVEST OPHTH VIS SCI, V42, P908; Edussuriya K, 2009, OPHTHALMOLOGY, V116, P52, DOI 10.1016/j.ophtha.2008.08.034; Jadoon MZ, 2006, INVEST OPHTH VIS SCI, V47, P4749, DOI 10.1167/iovs.06-0374; Kovai Vilas, 2007, Indian Journal of Ophthalmology, V55, P365; Limburg H, 1997, INT J EPIDEMIOL, V26, P1049, DOI 10.1093/ije/26.5.1049; Marmamula S, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-26; Mohan M., 1989, NATL SURVEY BLINDNES; Murthy GVS, 2010, OPHTHAL EPIDEMIOL, V17, P185, DOI 10.3109/09286586.2010.483751; Narasaiah L, 1999, CRISIS HANDLOOM IND; Neena J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002867; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Polack S, 2012, OPHTHALMOLOGY, V119, P1033, DOI 10.1016/j.ophtha.2011.11.002; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Sapkota YD, 2006, BRIT J OPHTHALMOL, V90, P411, DOI 10.1136/bjo.2005.082503; Sapkota YD, 2012, OPHTHAL EPIDEMIOL, V17, P82; Sherchan A, 2010, BRIT J OPHTHALMOL, V94, P161, DOI 10.1136/bjo.2008.155408; Wadud Z, 2006, BRIT J OPHTHALMOL, V90, P1225, DOI 10.1136/bjo.2006.101287; *WHO, 1988, COD INSTR WHO PBL EY; World Health Organization, 1991, TRAIN MIDL MAN EPI C	21	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55924	10.1371/journal.pone.0055924	http://dx.doi.org/10.1371/journal.pone.0055924			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409090	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200090
J	Prestinicola, L; Boglione, C; Makridis, P; Spano, A; Rimatori, V; Palamara, E; Scardi, M; Cataudella, S				Prestinicola, Loredana; Boglione, Clara; Makridis, Pavlos; Spano, Attilio; Rimatori, Valentina; Palamara, Elisa; Scardi, Michele; Cataudella, Stefano			Environmental Conditioning of Skeletal Anomalies Typology and Frequency in Gilthead Seabream (Sparus aurata L., 1758) Juveniles	PLOS ONE			English	Article							BASS DICENTRARCHUS-LABRAX; DIPLODUS-PUNTAZZO CETTI; ZEBRAFISH DANIO-RERIO; EUROPEAN FISH LARVAE; BONE-RESORBING CELLS; SEA BREAM; CAUDAL FIN; OSTEOLOGICAL DEVELOPMENT; SADDLEBACK-SYNDROME; QUALITY ASSESSMENT	In this paper, 981 reared juveniles of gilthead seabream (Sparus aurata) were analysed, 721 of which were from a commercial hatchery located in Northern Italy (Venice, Italy) and 260 from the Hellenic Center for Marine Research (Crete, Greece). These individuals were from 4 different egg batches, for a total of 10 different lots. Each egg batch was split into two lots after hatching, and reared with two different methodologies: intensive and semi-intensive. All fish were subjected to processing for skeletal anomaly and meristic count analysis. The aims involved: (1) quantitatively and qualitatively analyzing whether differences in skeletal elements arise between siblings and, if so, what they are; (2) investigating if any skeletal bone tissue/ossification is specifically affected by changing environmental rearing conditions; and (3) contributing to the identification of the best practices for gilthead seabream larval rearing in order to lower the deformity rates, without selections. The results obtained in this study highlighted that: i) in all the semi-intensive lots, the bones having intramembranous ossification showed a consistently lower incidence of anomalies; ii) the same clear pattern was not observed in the skeletal elements whose ossification process requires a cartilaginous precursor. It is thus possible to ameliorate the morphological quality (by reducing the incidence of severe skeletal anomalies and the variability in meristic counts of dermal bones) of reared seabream juveniles by lowering the stocking densities (maximum 16 larvae/L) and increasing the volume of the hatchery rearing tanks (minimum 40 m(3)). Feeding larvae with a wide variety of live (wild) preys seems further to improve juvenile skeletal quality. Additionally, analysis of the morphological quality of juveniles reared under two different semi-intensive conditions, Mesocosm and Large Volumes, highlighted a somewhat greater capacity of Large Volumes to significantly augment the gap with siblings reared in intensive (conventional) modality.	[Prestinicola, Loredana; Boglione, Clara; Spano, Attilio; Rimatori, Valentina; Palamara, Elisa; Scardi, Michele; Cataudella, Stefano] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Makridis, Pavlos] Univ Patras, Dept Biol, Patras, Greece	University of Rome Tor Vergata; University of Patras	Boglione, C (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	boglione@uniroma2.it	Boglione, Clara/B-5633-2013	Boglione, Clara/0000-0002-8313-0542	Italian Ministry for Agriculture, Food and Forestry Policy [Law 41/82]; Commission of the European Communities [SSP-2005-44483]	Italian Ministry for Agriculture, Food and Forestry Policy; Commission of the European Communities(European Commission)	This study was funded by the Italian Ministry for Agriculture, Food and Forestry Policy (Law 41/82) and by the Commission of the European Communities (specific RTD programme "Specific Support to Policies", SSP-2005-44483 "SEACASE - Sustainable extensive and semi-intensive coastal aquaculture in Southern Europe"). It does not necessarily reflect the Italian Ministry for Agriculture, Food and Forestry Policy and the European Commission views. In no way anticipates the Commissions future policy in this area. This work benefits also from participation in LARVANET COST action FA0801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso JM, 2000, FISH PHYSIOL BIOCHEM, V22, P159, DOI 10.1023/A:1007811702624; Allaby M, 2004, OXFORD DICT ECOLOGY, P201; Almeida D, 2008, AQUACULTURE, V279, P120, DOI 10.1016/j.aquaculture.2008.04.003; Andrades JA, 1996, AQUACULTURE, V141, P1, DOI 10.1016/0044-8486(95)01226-5; Balbelona MC, 1993, B EUR ASSOC FISH PAT, V13, P33; Beer A-M, 2011, MMW Fortschr Med, V153 Suppl 1, P14, DOI 10.1007/BF03367581; Benzecri JP, 1973, ANAL DONNEES ANAL CO, V2, P628; Beyers R. J., 1993, ECOLOGICAL MICROCOSM; BIANCHI G, 1984, Cybium, V8, P31; Bird NC, 2009, ZOOLOGY, V112, P97, DOI 10.1016/j.zool.2008.05.003; Bird NC, 2003, DEV DYNAM, V228, P337, DOI 10.1002/dvdy.10387; Boglione C., 1993, EAS (European Aquaculture Society) Special Publication, V18, P189; Boglione C, 2001, AQUACULTURE, V192, P1, DOI 10.1016/S0044-8486(00)00446-4; Boglione C, 1995, ICES MAR SC, V201, P163; Boglione C, 2006, ECOL INDIC, V6, P712, DOI 10.1016/j.ecolind.2005.08.032; Boglione C, 2003, AQUACULTURE, V227, P373, DOI 10.1016/S0044-8486(03)00515-5; Boglione C, 2013, REV AQUACULT, V5, pS99, DOI 10.1111/raq.12015; Boglione C, 2013, REV AQUACULT, V5, pS121, DOI 10.1111/raq.12016; Boglione Clara, 2011, P233; Boglione C, 2009, AQUACULTURE, V291, P48, DOI 10.1016/j.aquaculture.2009.02.041; Cahu C, 2003, AQUACULTURE, V227, P245, DOI 10.1016/S0044-8486(03)00507-6; Castro J, 2008, AQUACULTURE, V279, P18, DOI 10.1016/j.aquaculture.2008.04.023; Cataudella S, 2002, SEAFARMING TODAY TOM, P177; Cataudella S, 2003, INT AQ C FISH FARM M; CHATAIN B, 1994, AQUACULTURE, V119, P371, DOI 10.1016/0044-8486(94)90301-8; Costa C, 2010, BIOL J LINN SOC, V101, P427, DOI 10.1111/j.1095-8312.2010.01512.x; Dhert P, 1998, REARING TECHNIQUES D, P48; DINGERKUS G, 1977, STAIN TECHNOL, V52, P229, DOI 10.3109/10520297709116780; Divanach P, 1997, AQUACULTURE, V156, P145, DOI 10.1016/S0044-8486(97)00072-0; Divanach P., 2000, Cahiers Options Mediterraneennes, V47, P75; Estevao MD, 2011, CELL TISSUE RES, V343, P619, DOI 10.1007/s00441-010-1109-y; Faustino M, 1999, J FISH BIOL, V54, P1094; Faustino M, 1998, J FISH BIOL, V52, P11, DOI 10.1111/j.1095-8649.1998.tb01548.x; Favaloro E, 2000, AQUACULT INT, V8, P417, DOI 10.1023/A:1009284421354; Favaloro E, 2003, FISH PHYSIOL BIOCHEM, V32, P159; Favaloro E, 2006, FISH PHYSIOL BIOCHEM, V32, P159, DOI 10.1007/s10695-006-0008-3; Fernandez I, 2010, J APPL ICHTHYOL, V26, P344, DOI 10.1111/j.1439-0426.2010.01432.x; Fernandez I, 2008, AQUACULTURE, V283, P102, DOI 10.1016/j.aquaculture.2008.06.037; Fischer W., 1987, MEDITERRANEE MER NOI, V37, P761; FOWLER JA, 1970, Q REV BIOL, V45, P148, DOI 10.1086/406492; Gavaia PJ, 2006, GENE EXPR PATTERNS, V6, P637, DOI 10.1016/j.modgep.2005.11.010; Georgalas V, 2007, AQUACULTURE, V264, P418, DOI 10.1016/j.aquaculture.2006.09.035; Haga Y, 2002, ZOOL SCI, V19, P1105, DOI 10.2108/zsj.19.1105; Hall B.K., 2015, BONES CARTILAGE DEV; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harder W, 1975, ANATOMY FISHES 1; HilomenGarcia GV, 1997, AQUACULTURE, V152, P155, DOI 10.1016/S0044-8486(96)01518-9; Hough C, 2009, MANUAL CONTROL MALFO, P150; Imsland AK, 2006, AQUAC RES, V37, P1015, DOI 10.1111/j.1365-2109.2006.01523.x; Izquierdo MS, 2012, BRIT J NUTR IN PRESS; Jofre J, 1988, PATOLOGIA ACUICULTUR, P1; Kause A, 2007, GENET SEL EVOL, V39, P529, DOI 10.1051/gse:2007019; Kentouri M, 1995, COMP STUDY COST EFFE; KITAJIMA C, 1981, B JPN SOC SCI FISH, V47, P1289; Koumoundouros G, 1997, AQUACULTURE, V149, P215, DOI 10.1016/S0044-8486(96)01443-3; Koumoundouros G, 2008, J FISH BIOL, V72, P737, DOI 10.1111/j.1095-8649.2007.01714.x; Koumoundouros G, 2002, AQUACULTURE, V209, P49, DOI 10.1016/S0044-8486(01)00821-3; Koumoundouros G, 2001, AQUACULTURE, V200, P285, DOI 10.1016/S0044-8486(01)00552-X; Koumoundouros G, 1997, AQUACULTURE, V156, P165, DOI 10.1016/S0044-8486(97)89294-0; Koumoundourous G, 1995, EUROPEAN AQUACULTURE, V23, p[16, 413]; Kouttouki S, 2006, AQUAC RES, V37, P655, DOI 10.1111/j.1365-2109.2006.01475.x; Lall SP, 2007, AQUACULTURE, V267, P3, DOI 10.1016/j.aquaculture.2007.02.053; Le Vay L, 2007, AQUACULTURE, V268, P169, DOI 10.1016/j.aquaculture.2007.04.041; Lewis LM, 2004, AQUACULTURE, V241, P47, DOI 10.1016/j.aquaculture.2004.08.018; Malavasi S, 2004, J FISH BIOL, V65, P143, DOI 10.1111/j.0022-1112.2004.00545.x; Marino G., 1993, Aquaculture and Fisheries Management, V24, P445, DOI 10.1111/j.1365-2109.1993.tb00568.x; Marino G, 1989, EUR ACQ SOC S BORD O, P313; Matsuoka M, 2003, JARQ-JPN AGR RES Q, V37, P21, DOI 10.6090/jarq.37.21; Matsuoka M., 1987, B SEIKAI REG FISH RE, V65, P1; Papandroulakis N, 2002, AQUACULTURE, V204, P45, DOI 10.1016/S0044-8486(01)00643-3; PAPERNA I, 1977, AQUACULTURE, V10, P195, DOI 10.1016/0044-8486(77)90001-1; PAPERNA I, 1978, J FISH BIOL, V12, P109, DOI 10.1111/j.1095-8649.1978.tb04157.x; Puvanendran V, 2009, AQUAC RES, V40, P1653, DOI 10.1111/j.1365-2109.2009.02268.x; Russo T, 2007, J FISH BIOL, V71, P629, DOI 10.1111/j.1095-8649.2007.01528.x; Russo T, 2011, AQUACULTURE, V315, P69, DOI 10.1016/j.aquaculture.2010.11.030; Russo T, 2010, J APPL ICHTHYOL, V26, P360, DOI 10.1111/j.1439-0426.2010.01435.x; Russo T, 2009, AQUACULTURE, V289, P289, DOI 10.1016/j.aquaculture.2009.01.021; SCHULTZE HP, 1989, ZOOL J LINN SOC-LOND, V97, P189, DOI 10.1111/j.1096-3642.1989.tb00547.x; Sfakianakis DG, 2005, AQUACULTURE, V250, P36, DOI 10.1016/j.aquaculture.2005.03.042; Shields RJ, 1999, J NUTR, V129, P1186, DOI 10.1093/jn/129.6.1186; Sire JY, 2003, BIOL REV, V78, P219, DOI 10.1017/S1464793102006073; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Spedicato M. T., 2000, Cahiers Options Mediterraneennes, V47, P227; TANING AV, 1952, BIOL REV, V27, P169, DOI 10.1111/j.1469-185X.1952.tb01392.x; Tesseyre C, 1979, THESIS U MONTPELLIER; Verhaegen Y, 2007, AQUACULTURE, V268, P156, DOI 10.1016/j.aquaculture.2007.04.037; Witten PE, 2010, J APPL ICHTHYOL, V26, P225, DOI 10.1111/j.1439-0426.2010.01410.x; Witten P. Eckhard, 2007, P79; Witten PE, 2001, J MORPHOL, V250, P197, DOI 10.1002/jmor.1065.abs	89	34	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55736	10.1371/journal.pone.0055736	http://dx.doi.org/10.1371/journal.pone.0055736			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409031	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200056
J	Kayser, G; Csanadi, A; Otto, C; Plones, T; Bittermann, N; Rawluk, J; Passlick, B; Werner, M				Kayser, Gian; Csanadi, Agnes; Otto, Claudia; Ploenes, Till; Bittermann, Nicola; Rawluk, Justyna; Passlick, Bernward; Werner, Martin			Simultaneous Multi-Antibody Staining in Non-Small Cell Lung Cancer Strengthens Diagnostic Accuracy Especially in Small Tissue Samples	PLOS ONE			English	Article							QUALITY-OF-LIFE; MARKERS; CLASSIFICATION; CHEMOTHERAPY; SURVIVAL; P63; SUBCLASSIFICATION; DIFFERENTIATION; ASSOCIATION; CARCINOMAS	Histological subclassification of non-small cell lung cancer (NSCLC) has growing therapeutic impact. In advanced cancer stages tissue specimens are usually bioptically collected. These small samples are of extraordinary value since molecular analyses are gaining importance for targeted therapies. We therefore studied the feasibility, diagnostic accuracy, economic and prognostic effects of a tissue sparing simultaneous multi-antibody assay for subclassification of NSCLC. Of 265 NSCLC patients tissue multi arrays (TMA) were constructed to simulate biopsy samples. TMAs were stained by a simultaneous bicolor multi-antibody assay consisting of TTF1, Vimentin, p63 and neuroendocrine markers (CD56, chromogranin A, synaptophysin). Classification was based mainly on the current proposal of the IASLC with a hierarchical decision tree for subclassification into adenocarcinoma (LAC), squamous cell carcinoma (SCC), large cell neuroendocrine carcinoma (LCNEC) and NSCLC not otherwise specified. Investigation of tumor heterogeneity showed an explicit lower variation for immunohistochemical analyses compared to conventional classification. Furthermore, survival analysis of our combined immunohistochemical classification revealed distinct separation of each entity's survival curve. This was statistically significant for therapeutically important subgroups (p = 0.045). As morphological and molecular cancer testing is emerging, our multi-antibody assay in combination with standardized classification delivers accurate and reliable separation of histomorphological diagnoses. Additionally, it permits clinically relevant subtyping of NSCLC including LCNEC. Our multi-antibody assay may therefore be of special value, especially in diagnosing small biopsies. It futher delivers substantial prognostic information with therapeutic consequences. Integration of immunohistochemical subtyping including investigation of neuroendocrine differentiation into standard histopathological classification of NSCLC must, therefore, be considered.	[Kayser, Gian; Csanadi, Agnes; Otto, Claudia; Bittermann, Nicola; Werner, Martin] Univ Hosp Freiburg, Inst Pathol, Freiburg, Germany; [Ploenes, Till; Passlick, Bernward] Univ Hosp Freiburg, Dept Thorac Surg, Freiburg, Germany; [Rawluk, Justyna] Univ Hosp Freiburg, Dept Hematol & Oncol, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Kayser, G (corresponding author), Univ Hosp Freiburg, Inst Pathol, Freiburg, Germany.	gian.kayser@uniklinik-freiburg.de	Plönes, Till/AAK-8208-2021	Plönes, Till/0000-0003-4839-2130	Deutsche Forschungsgemeinschaft [SFB 850]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study has been financially supported by the Deutsche Forschungsgemeinschaft, SFB 850. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aggarwal C, 2010, J NATL COMPR CANC NE, V8, P822, DOI 10.6004/jnccn.2010.0059; Andrews J, 2011, CANCER J, V17, P104, DOI 10.1097/PPO.0b013e318213f3cf; Azzoli CG, 2011, J CLIN ONCOL, V29, P3825, DOI 10.1200/JCO.2010.34.2774; Bishop JA, 2012, MODERN PATHOL, V25, P405, DOI 10.1038/modpathol.2011.173; Bryant AS, 2012, J THORAC CARDIOV SUR, V144, P1139, DOI 10.1016/j.jtcvs.2012.07.083; Chen Y, 2011, ONCOLOGY-BASEL, V80, P333, DOI 10.1159/000329098; Coate LE, 2009, LANCET ONCOL, V10, P1001, DOI 10.1016/S1470-2045(09)70155-X; Coghlin CL, 2010, J THORAC ONCOL, V5, P448, DOI 10.1097/JTO.0b013e3181ca12c4; de Marinis F, 2011, LUNG CANCER, V73, P1, DOI 10.1016/j.lungcan.2011.02.022; Goeckenjan G, 2010, Pneumologie, V64 Suppl 2, pe1, DOI 10.1055/s-0029-1243837; Gollard R, 2010, LUNG CANCER, V69, P13, DOI 10.1016/j.lungcan.2009.12.011; Husmann G, 2010, KREBS DEUTSCHLAND 20; Ionescu DN, 2007, AM J SURG PATHOL, V31, P26, DOI 10.1097/01.pas.0000213319.04919.97; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Konopa K, 2010, ANN ONCOL, V21, P199, DOI 10.1093/annonc/mdq452; La Rosa S, 2010, VIRCHOWS ARCH, V457, P497, DOI 10.1007/s00428-010-0954-0; Ureste MM, 2010, CLIN TRANSL ONCOL, V12, P92, DOI 10.1007/S12094-010-0475-y; Menna C, 2012, MINERVA CHIR, V67, P219; Mukhopadhyay S, 2011, AM J SURG PATHOL, V35, P15, DOI 10.1097/PAS.0b013e3182036d05; Noh S, 2012, LUNG CANCER, V76, P51, DOI 10.1016/j.lungcan.2011.09.008; Nonaka D, 2012, AM J SURG PATHOL, V36, P895, DOI 10.1097/PAS.0b013e3182498f2b; Pelosi G, 2011, J THORAC ONCOL, V6, P1039, DOI 10.1097/JTO.0b013e318211dd16; Rekhtman N, 2010, ARCH PATHOL LAB MED, V134, P1628, DOI 10.1043/2009-0583-RAR.1; Righi L, 2011, CANCER-AM CANCER SOC, V117, P3416, DOI 10.1002/cncr.25830; Rodriguez KA, 2012, ANN THORAC SURG; Rueth NM, 2011, ANN SURG, V254, P368, DOI 10.1097/SLA.0b013e31822150fe; Sangoi AR, 2011, AM J SURG PATHOL, V35, P678, DOI 10.1097/PAS.0b013e3182152629; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Sculier JP, 2008, J THORAC ONCOL, V3, P457, DOI 10.1097/JTO.0b013e31816de2b8; Sobin LHGM., 2009, TNM CLASSIFICATION M, V7th; Sterlacci W, 2012, AM J CLIN PATHOL, V137, P946, DOI 10.1309/AJCP77KMKJXNMPMS; Sun JM, 2012, LUNG CANC; Travis W, 2004, TUMOURS LUNG PLEURA; Travis WD, 2010, ANN ONCOL, V21, P65, DOI 10.1093/annonc/mdq380; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Perez JMT, 2010, CLIN TRANSL ONCOL, V12, P735, DOI 10.1007/s12094-010-0588-3; Wahidi MM, 2010, RESPIRATION, V79, P137, DOI 10.1159/000235818; Yanagita E, 2011, APPL IMMUNOHISTOCHEM	38	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56333	10.1371/journal.pone.0056333	http://dx.doi.org/10.1371/journal.pone.0056333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418554	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300147
J	Lundblom, K; Murungi, L; Nyaga, V; Olsson, D; Rono, J; Osier, F; Ogada, E; Montgomery, S; Scott, JAG; Marsh, K; Farnert, A				Lundblom, Klara; Murungi, Linda; Nyaga, Victoria; Olsson, Daniel; Rono, Josea; Osier, Faith; Ogada, Edna; Montgomery, Scott; Scott, J. Anthony G.; Marsh, Kevin; Farnert, Anna			Plasmodium falciparum Infection Patterns Since Birth and Risk of Severe Malaria: A Nested Case-Control Study in Children on the Coast of Kenya	PLOS ONE			English	Article							CLINICAL-PROTECTION; CEREBRAL MALARIA; AFRICAN INFANTS; REDUCED RISK; TRANSMISSION; IMMUNITY; INDICATORS; ANTIBODIES; MORBIDITY; DISEASE	Children in malaria endemic areas acquire immunity to severe malaria faster than to mild malaria. Only a minority of children suffers from severe malaria and it is not known what determines this. The aim of this study was to establish how P. falciparum infections during the first years of life affect the risk of severe malaria. A matched case-control study was nested within a large birth cohort set up to study the immunoepidemiology of pneumococci on the Kenyan coast. Infection patterns in three-monthly blood samples in cohort children admitted to hospital with severe malaria were compared to controls matched on age, residential location and time of sampling. P. falciparum detected at least once from birth conferred an increased risk of severe malaria and particularly if multiclonal infections, as characterized by genotyping of a polymorphic antigen gene, were ever detected. The results show for the first time that children with severe malaria have more infections early in life compared to community controls. These findings provide important insights on the immunity to severe disease, knowledge essential for the development of a vaccine against severe malaria.	[Lundblom, Klara; Rono, Josea; Farnert, Anna] Karolinska Inst, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden; [Murungi, Linda; Nyaga, Victoria; Rono, Josea; Osier, Faith; Ogada, Edna; Scott, J. Anthony G.; Marsh, Kevin] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Olsson, Daniel] Karolinska Inst, Inst Environm Med, Dept Epidemiol, Unit Biostat, S-10401 Stockholm, Sweden; [Montgomery, Scott] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Montgomery, Scott] Univ Orebro, Orebro Univ Hosp, Clin Epidemiol & Biostat Unit, Orebro, Sweden; [Montgomery, Scott] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Dept Primary Care & Publ Hlth, London, England; [Scott, J. Anthony G.; Marsh, Kevin] Univ Oxford, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England	Karolinska Institutet; Kenya Medical Research Institute; Karolinska Institutet; Karolinska Institutet; Orebro University; Imperial College London; University of Oxford	Lundblom, K (corresponding author), Karolinska Inst, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden.	klara.lundblom@ki.se	Montgomery, Scott/AAN-2546-2020	Montgomery, Scott/0000-0001-6328-5494; Ogada, Edna/0000-0003-0181-2505; Olsson, Daniel/0000-0003-0535-2729; Osier, Faith/0000-0001-7133-5375; NYAGA, Victoria/0000-0002-8381-9964; Farnert, Anna/0000-0001-7583-282X	Wellcome Trust; Swedish Research Council; Swedish International Development Agency; Swedish Society of Medicine; Karolinska Institutet Faculty	Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Agency; Swedish Society of Medicine; Karolinska Institutet Faculty(Karolinska Institutet)	Financial support has been granted from the Wellcome Trust, the Swedish Research Council, the Swedish International Development Agency and the Swedish Society of Medicine. K.L. was supported by Karolinska Institutet Faculty funding for doctoral studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlYaman F, 1997, T ROY SOC TROP MED H, V91, P602, DOI 10.1016/S0035-9203(97)90046-8; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bereczky S, 2007, MICROBES INFECT, V9, P103, DOI 10.1016/j.micinf.2006.10.014; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Branch OH, 2001, INFECT IMMUN, V69, P7783, DOI 10.1128/IAI.69.12.7783-7792.2001; Bruneel F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013236; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Culleton RL, 2011, PARASITE IMMUNOL, V33, P73, DOI 10.1111/j.1365-3024.2010.01251.x; English M, 1996, AM J TROP MED HYG, V55, P521, DOI 10.4269/ajtmh.1996.55.521; Farnert A, 2008, TRENDS PARASITOL, V24, P340, DOI 10.1016/j.pt.2008.04.008; Farnert A, 2009, J INFECT DIS, V200, P1166, DOI 10.1086/605652; Franks S, 2001, J INFECT DIS, V183, P796, DOI 10.1086/318834; Gupta S, 1999, P ROY SOC B-BIOL SCI, V266, P33, DOI 10.1098/rspb.1999.0600; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Henning L, 2004, T ROY SOC TROP MED H, V98, P687, DOI 10.1016/j.trstmh.2004.03.010; JEFFERY GM, 1966, B WORLD HEALTH ORGAN, V35, P873; Liljander A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-78; Lundblom K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-229; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; MOLYNEUX ME, 1989, Q J MED, V71, P441; Mueller I, 2012, P NATL ACAD SCI USA, V109, P10030, DOI 10.1073/pnas.1200841109; Ndungu FM, 2002, PARASITE IMMUNOL, V24, P77, DOI 10.1046/j.0141-9838.2001.00440.x; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Osier FHA, 2010, PARASITE IMMUNOL, V32, P193, DOI 10.1111/j.1365-3024.2009.01178.x; RAZANAMPARANY M, 1989, Parassitologia (Rome), V31, P89; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; SMYTHE JA, 1991, P NATL ACAD SCI USA, V88, P1751, DOI 10.1073/pnas.88.5.1751; Snow RW, 1998, J INFECT DIS, V177, P819, DOI 10.1086/517818; Wagner G, 1998, AM J TROP MED HYG, V59, P115, DOI 10.4269/ajtmh.1998.59.115; World Health Organization, WORLD MALARIA REPORT	31	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56032	10.1371/journal.pone.0056032	http://dx.doi.org/10.1371/journal.pone.0056032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418502	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000315970300094
J	Mallat, J; Barrailler, S; Lemyze, M; Pepy, F; Gasan, G; Tronchon, L; Thevenin, D				Mallat, Jihad; Barrailler, Stephanie; Lemyze, Malcolm; Pepy, Florent; Gasan, Gaelle; Tronchon, Laurent; Thevenin, Didier			Use of Sodium-Chloride Difference and Corrected Anion Gap as Surrogates of Stewart Variables in Critically Ill Patients	PLOS ONE			English	Article							CARBON DIOXIDE TENSION; ACID-BASE EQUILIBRIA; INTENSIVE-CARE-UNIT; METABOLIC-ACIDOSIS; SERUM-PROTEINS; DIAGNOSIS; EXCESS; BLOOD; BICARBONATE; CHEMISTRY	Introduction: To investigate whether the difference between sodium and chloride ([Na+] - [Cl-]) and anion gap corrected for albumin and lactate (AG(corr)) could be used as apparent strong ion difference (SIDapp) and strong ion gap (SIG) surrogates (respectively) in critically ill patients. Methods: A total of 341 patients were prospectively observed; 161 were allocated to the modeling group, and 180 to the validation group. Simple regression analysis was used to construct a mathematical model between SIDapp and [Na+] -[Cl-] and between SIG and AGcorr in the modeling group. Area under the receiver operating characteristic (ROC) curve was also measured. The mathematical models were tested in the validation group. Results: in the modeling group, SIDapp and SIG were well predicted by [Na+] -[Cl-] and AG(corr) (R-2 = 0.973 and 0.96, respectively). Accuracy values of [Na+] - [Cl-] for the identification of SIDapp acidosis (<42.7 mEq/L) and alkalosis (>47.5 mEq/L) were 0.992 (95% confidence interval [CI], 0.963-1) and 0.998 (95% CI, 0.972-1), respectively. The accuracy of AGcorr in revealing SIG acidosis (>8 mEq/L) was 0.974 (95% CI: 0.936-0.993). These results were validated by showing excellent correlations and good agreements between predicted and measured SIDapp and between predicted and measured SIG in the validation group (R-2 = 0.977; bias = 0 +/- 1.5 mEq/L and R-2 = 0.96; bias = 20.2 +/- 1.8 mEq/L, respectively). Conclusions: SIDapp and SIG can be substituted by [Na+] - [Cl-] and by AG(corr) respectively in the diagnosis and management of acid-base disorders in critically ill patients.	[Mallat, Jihad; Barrailler, Stephanie; Lemyze, Malcolm; Pepy, Florent; Gasan, Gaelle; Tronchon, Laurent; Thevenin, Didier] Ctr Hosp Dr Schaffner, Dept Intens Care Unit, Lens, France		Mallat, J (corresponding author), Ctr Hosp Dr Schaffner, Dept Intens Care Unit, Lens, France.	mallatjihad@gmail.com		Mallat, Jihad/0000-0001-6372-7360				Adrogue HJ, 2010, J AM SOC NEPHROL, V21, P920, DOI 10.1681/ASN.2009121211; ANDERSEN OS, 1960, SCAND J CLIN LAB INV, V12, P172, DOI 10.3109/00365516009062419; ASTRUP P, 1956, SCAND J CLIN LAB INV, V8, P33, DOI 10.3109/00365515609049241; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boniatti MM, 2009, INTENS CARE MED, V35, P1377, DOI 10.1007/s00134-009-1496-2; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Fencl V, 2000, AM J RESP CRIT CARE, V162, P2246, DOI 10.1164/ajrccm.162.6.9904099; FENCL V, 1993, RESP PHYSIOL, V91, P1, DOI 10.1016/0034-5687(93)90085-O; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Figge J, 1998, CRIT CARE MED, V26, P1807, DOI 10.1097/00003246-199811000-00019; FIGGE J, 1991, J LAB CLIN MED, V117, P453; FIGGE J, 1992, J LAB CLIN MED, V120, P713; Gauthier PM, 2002, CRIT CARE CLIN, V18, P289, DOI 10.1016/S0749-0704(01)00012-4; GILFIX BM, 1993, J CRIT CARE, V8, P187, DOI 10.1016/0883-9441(93)90001-2; Gunnerson Kyle J, 2003, Curr Opin Crit Care, V9, P468, DOI 10.1097/00075198-200312000-00002; Henderson LJ, 1908, AM J PHYSIOL, V21, P427, DOI 10.1152/ajplegacy.1908.21.4.427; KELLEHER SP, 1986, ARCH INTERN MED, V146, P1839, DOI 10.1001/archinte.146.9.1839; Maciel Alexandre Toledo, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.09.2008.1011; Mallat J, 2012, AM J EMERG MED, V30, P391, DOI 10.1016/j.ajem.2010.11.039; Mansoor S, 2007, CLIN BIOCHEM, V40, P226, DOI 10.1016/j.clinbiochem.2006.10.011; MCAULIFFE JJ, 1986, AM J MED, V81, P86, DOI 10.1016/0002-9343(86)90187-7; Moviat M, 2003, CRIT CARE, V7, pR41, DOI 10.1186/cc2184; Murray Deirdre M, 2004, Pediatr Crit Care Med, V5, P240, DOI 10.1097/01.PCC.0000112367.50051.3B; Nagaoka D, 2010, J CRIT CARE, V25, P525, DOI 10.1016/j.jcrc.2010.02.003; Nguyen BV, 2009, ANESTH ANALG, V109, P1517, DOI 10.1213/ANE.0b013e3181b62664; OH MS, 1977, NEW ENGL J MED, V297, P814, DOI 10.1056/NEJM197710132971507; Parikh C, 2001, RENAL FAILURE, V23, P91, DOI 10.1081/JDI-100001288; Park M, 2008, BRAZ J MED BIOL RES, V41, P241; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SIGGAARDANDERSEN O, 1977, SCAND J CLIN LAB INV, V37, P15, DOI 10.3109/00365517709098927; Sirker AA, 2002, ANAESTHESIA, V57, P348, DOI 10.1046/j.0003-2409.2001.02447.x; STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444, DOI 10.1139/y83-207; Story D A, 2004, Crit Care Resusc, V6, P188; Story DA, 2004, BRIT J ANAESTH, V92, P54, DOI 10.1093/bja/aeh018; Tabachnick B. G., 2007, USING MULTIVARIATE S, P117; Van Slyke DD, 1923, J BIOL CHEM, V56, P765; Yunos NM, 2010, CRIT CARE, V14, DOI 10.1186/cc9052	38	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56635	10.1371/journal.pone.0056635	http://dx.doi.org/10.1371/journal.pone.0056635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418590	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300183
J	Pizon, M; Zimon, DS; Pachmann, U; Pachmann, K				Pizon, Monika; Zimon, Dorothea Sonja; Pachmann, Ulrich; Pachmann, Katharina			Insulin-Like Growth Factor Receptor I (IGF-IR) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) Are Expressed on the Circulating Epithelial Tumor Cells of Breast Cancer Patients	PLOS ONE			English	Article							TRASTUZUMAB; THERAPY	Background: Circulating epithelial tumor cell (CETC) analysis is a promising diagnostic field for estimating the risk for metastatic relapse and progression in patients with malignant disease. CETCs characterization can be used as a liquid biopsy for prognostic and predictive purposes in breast and other cancers. IGF-IR and VEGFR-2 play an important role in tumor growth and the progression of cancer disease. The purpose of the current study was therefore to investigate their expression on CETCs. Methods: CETCs were determined from the blood of 50 patients suffering from breast cancer. The number of vital CETCs and the expression of IGF-IR and VEGFR-2 were investigated using the maintrac (R) method. Results: IGF-IR and VEGFR-2 expression on the surface of CETCs were detected in 84% of patients. A statistically high correlation was found between IGF-IR and VEGFR-2 (r = 0.745 and p<0.001) on the CETCs. The co-expression of both receptors was confirmed in some experiments and ranged between 70% and 100%. Statistically significant correlations were observed between the number of CETCs and IGF-IR (r = 0.315 and p<0.05) and VEGFR-2 (r = 0.310 and p<0.05) expression. The presence of CETCs and the level of IGF-IR and VEGFR-2 expression were not associated with tumor stage, hormone receptor status or nodal/distant metastasis. Summary: In this study, a parallel and co-expression of IGF-IR and VEGFR-2 was examined on the surface of CETCs in breast cancer patients for the first time. Characterization of CETCs may be a promising approach for the rational design of targeted anticancer therapies.	[Pizon, Monika; Zimon, Dorothea Sonja; Pachmann, Ulrich] Transfus Ctr Bayreuth, Bayreuth, Germany; [Pachmann, Katharina] Univ Jena, Oncol Res Lab, Clin Internal Med 2, Jena, Germany	Friedrich Schiller University of Jena	Pizon, M (corresponding author), Transfus Ctr Bayreuth, Bayreuth, Germany.	tzb.info@t-online.de	PIZON, Monika/AAT-3582-2021					Ashworth T. R, 1869, AUST MED J, V14, P146, DOI DOI 10.1038/SJ.BJC.6604218; Belfiore A, 2008, J MAMMARY GLAND BIOL, V13, P381, DOI 10.1007/s10911-008-9099-z; Browne BC, 2011, ANN ONCOL, V22, P68, DOI 10.1093/annonc/mdq349; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Davison Z, 2011, NEOPLASIA, V13, P504, DOI 10.1593/neo.101590; de Bono JS, 2007, CLIN CANCER RES, V13, P3611, DOI 10.1158/1078-0432.CCR-07-0268; Gajkowska A, 2006, FOLIA HISTOCHEM CYTO, V44, P53; Giatromanolaki A, 2007, EUR J CLIN INVEST, V37, P878, DOI 10.1111/j.1365-2362.2007.01866.x; Guo SC, 2010, BBA-REV CANCER, V1806, P108, DOI 10.1016/j.bbcan.2010.04.004; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Hicks DJ, 2006, BIOTECH HISTOCHEM, V81, P23, DOI 10.1080/10520290600725375; Ignatiadis M, 2008, CURR OPIN OBSTET GYN, V20, P55, DOI 10.1097/GCO.0b013e3282f22b2e; Kallergi G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2452; Kowanetz M, 2006, CLIN CANCER RES, V12, P5018, DOI 10.1158/1078-0432.CCR-06-1520; Lianidou ES, 2011, CLIN CHEM LAB MED, V49, P1579, DOI 10.1515/CCLM.2011.628; Munagala R, 2011, INDIAN J PHARMACOL, V43, P236, DOI 10.4103/0253-7613.81497; Nakopoulou L, 2002, HUM PATHOL, V33, P863, DOI 10.1053/hupa.2002.126879; Pachmann K, 2005, CLIN CHEM LAB MED, V43, P617, DOI 10.1515/CCLM.2005.107; Pachmann K, 2008, J CLIN ONCOL, V26, P1208, DOI 10.1200/JCO.2007.13.6523; Pachmann K, 2011, J CANCER RES CLIN, V137, P1317, DOI 10.1007/s00432-011-1000-6; Pachmann U, 2011, CANCER, V2; RAILO MJ, 1994, EUR J CANCER, V30A, P307, DOI 10.1016/0959-8049(94)90247-X; Ring A, 2004, LANCET ONCOL, V5, P79, DOI 10.1016/S1470-2045(04)01381-6; Ross JS, 2009, AM J CLIN PATHOL, V132, P237, DOI 10.1309/AJCPJI7DEOLKCS6F; Shimizu C, 2004, HUM PATHOL, V35, P1537, DOI 10.1016/j.humpath.2004.09.005; Strati A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-422; Wong ALA, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/415170	27	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56836	10.1371/journal.pone.0056836	http://dx.doi.org/10.1371/journal.pone.0056836			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418605	gold, Green Published			2022-12-27	WOS:000315970300199
J	Shafique, K; Morrison, DS				Shafique, Kashif; Morrison, David S.			Socio-Economic Inequalities in Survival of Patients with Prostate Cancer: Role of Age and Gleason Grade at Diagnosis	PLOS ONE			English	Article							NEW-ZEALAND; ENGLAND; POPULATION; WALES; MANAGEMENT; NORTHERN; TRENDS; IMPACT; STAGE; CARE	In the United Kingdom, survival of prostate cancer patients has improved since the 1990s. A deprivation gap in survival (better survival for the least deprived compared with the most deprived) has been reported but it is not known if differential distribution of earlier age or lower grade disease at diagnosis might explain such patterns. We therefore investigated the impact of age and Gleason grade at diagnosis on the deprivation gap in survival of prostate cancer patients over time. Incident cases of prostate cancer (ICD 10 C61) from the West of Scotland were extracted from the Scottish Cancer Registry from 1991 to 2007. Socio-economic circumstances were measured using the Scottish Index for Multiple Deprivation 2004 (SIMD). Age and deprivation specific mortality rates were obtained from the General Registrar Office for Scotland (GRO( S)). The survival gradient across the five deprivation categories was estimated with linear regression, weighted by the variance of the relative survival estimate. We examined the data for 15,292 adults diagnosed with prostate cancer between 1991 and 2007. Despite substantial improvements in survival of prostate cancer patients, a deprivation gap persists throughout the three periods of diagnoses. The deprivation gap in five year relative survival widened from 24.76 in 1991-1996 to 210.08 in 2003-2007. On age and grade-specific analyses, a significant deprivation gap in five year survival existed between all age groups except among patients' age >= 75 and both low and high grade disease. On multivariate analyses, deprivation was significantly associated with increased excess risk of death (RER 1.48, 95% CI 1.31-1.68, p-value, 0.001) independent of age, Gleason grade and period of diagnosis. The deprivation gap in survival from prostate cancer cannot be wholly explained by socio-economic differentials in early detection of disease. Further research is needed to understand whether differences in comorbidities or treatment explain inequalities in prostate cancer outcomes.	[Shafique, Kashif; Morrison, David S.] Univ Glasgow, Inst Hlth & Wellbeing, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Shafique, Kashif] Dow Univ Hlth Sci, Dow Med Coll, Dept Community Med, Karachi, Pakistan; [Morrison, David S.] West Scotland Canc Surveillance Unit, Glasgow, Lanark, Scotland	University of Glasgow; Dow University of Health Sciences	Shafique, K (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	k.shafique.1@research.gla.ac.uk		Morrison, David/0000-0002-0617-3047; Shafique, Kashif/0000-0001-7151-5122				Borre Michael, 2011, Clin Epidemiol, V3 Suppl 1, P41, DOI 10.2147/CLEP.S20625; Byers TE, 2008, CANCER-AM CANCER SOC, V113, P582, DOI 10.1002/cncr.23567; Coleman MP, 2004, BRIT J CANCER, V90, P1367, DOI 10.1038/sj.bjc.6601696; COX DR, 1972, J R STAT SOC B, V34, P187; Cremers RGHM, 2010, EUR J CANCER, V46, P2077, DOI 10.1016/j.ejca.2010.03.040; Drummond FJ, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-3; ESTEVE J, 1990, STAT MED, V9, P529, DOI 10.1002/sim.4780090506; Evans S, 2010, BRIT J CANCER, V102, P249, DOI 10.1038/sj.bjc.6605461; Fairley L, 2009, BRIT J CANCER, V101, P1839, DOI 10.1038/sj.bjc.6605424; Hall SE, 2005, BJU INT, V95, P51, DOI 10.1111/j.1464-410X.2005.05248.x; Haynes R, 2008, SOC SCI MED, V67, P928, DOI 10.1016/j.socscimed.2008.05.005; Jack RH, 2010, BJU INT, V105, P1226, DOI 10.1111/j.1464-410X.2009.08940.x; Jeffreys M, 2009, CANCER EPIDEM BIOMAR, V18, P915, DOI 10.1158/1055-9965.EPI-08-0685; Lawder R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-330; Lin DW, 2009, CANCER-AM CANCER SOC, V115, P2863, DOI 10.1002/cncr.24324; Lund L, 2007, SCAND J UROL NEPHROL, V41, P308, DOI 10.1080/00365590701365149; Lyratzopoulos G, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1928; Mokete M, 2006, BJU INT, V97, P266, DOI 10.1111/j.1464-410X.2005.06011.x; Moore AL, 2009, BJU INT, V104, P1592, DOI 10.1111/j.1464-410X.2009.08652.x; Rachet B, 2008, BRIT J CANCER, V99, pS2, DOI 10.1038/sj.bjc.6604571; Rachet B, 2010, BRIT J CANCER, V103, P446, DOI 10.1038/sj.bjc.6605752; Rowan S, 2008, BRIT J CANCER, V99, pS75, DOI 10.1038/sj.bjc.6604595; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Schwartz K, 2009, UROLOGY, V74, P1296, DOI 10.1016/j.urology.2009.02.058; Scottish Government, 2006, US SCOTT IND MULT DE; Shack LG, 2007, BRIT J CANCER, V97, P999, DOI 10.1038/sj.bjc.6603980; Shafique K, 2012, BRIT J CANCER, V107, P575, DOI 10.1038/bjc.2012.289; SOGANI PC, 1985, UROLOGY, V25, P223, DOI 10.1016/0090-4295(85)90316-4; White A, 2011, CANCER-AM CANCER SOC, V117, P1080, DOI 10.1002/cncr.25671	29	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56184	10.1371/journal.pone.0056184	http://dx.doi.org/10.1371/journal.pone.0056184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418534	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000315970300126
J	Care, MA; Barrans, S; Worrillow, L; Jack, A; Westhead, DR; Tooze, RM				Care, Matthew A.; Barrans, Sharon; Worrillow, Lisa; Jack, Andrew; Westhead, David R.; Tooze, Reuben M.			A Microarray Platform-Independent Classification Tool for Cell of Origin Class Allows Comparative Analysis of Gene Expression in Diffuse Large B-cell Lymphoma	PLOS ONE			English	Article							CLASS-II GENE; NF-KAPPA-B; MOLECULAR SUBTYPES; DISTINCT SUBGROUPS; FACTOR E2-2; SURVIVAL; GENOME; SIGNATURES; PREDICTS; TUMOR	Cell of origin classification of diffuse large B-cell lymphoma (DLBCL) identifies subsets with biological and clinical significance. Despite the established nature of the classification existing studies display variability in classifier implementation, and a comparative analysis across multiple data sets is lacking. Here we describe the validation of a cell of origin classifier for DLBCL, based on balanced voting between 4 machine-learning tools: the DLBCL automatic classifier (DAC). This shows superior survival separation for assigned Activated B-cell (ABC) and Germinal Center B-cell (GCB) DLBCL classes relative to a range of other classifiers. DAC is effective on data derived from multiple microarray platforms and formalin fixed paraffin embedded samples and is parsimonious, using 20 classifier genes. We use DAC to perform a comparative analysis of gene expression in 10 data sets (2030 cases). We generate ranked meta-profiles of genes showing consistent class-association using >= 6 data sets as a cut-off: ABC (414 genes) and GCB (415 genes). The transcription factor ZBTB32 emerges as the most consistent and differentially expressed gene in ABC-DLBCL while other transcription factors such as ARID3A, BATF, and TCF4 are also amongst the 24 genes associated with this class in all datasets. Analysis of enrichment of 12323 gene signatures against meta-profiles and all data sets individually confirms consistent associations with signatures of molecular pathways, chromosomal cytobands, and transcription factor binding sites. We provide DAC as an open access Windows application, and the accompanying meta-analyses as a resource.	[Care, Matthew A.; Tooze, Reuben M.] Univ Leeds, Leeds Inst Mol Med, Sect Expt Haematol, Leeds, W Yorkshire, England; [Care, Matthew A.; Westhead, David R.] Univ Leeds, Inst Mol & Cellular Biol, Bioinformat Grp, Leeds, W Yorkshire, England; [Barrans, Sharon; Worrillow, Lisa; Jack, Andrew; Tooze, Reuben M.] St Jamess Inst Oncol, HMDS, Leeds, W Yorkshire, England	University of Leeds; University of Leeds; Saint James's University Hospital	Westhead, DR (corresponding author), Univ Leeds, Inst Mol & Cellular Biol, Bioinformat Grp, Leeds, W Yorkshire, England.	D.R.Westhead@leeds.ac.uk; r.tooze@leeds.ac.uk	Care, Matthew A/I-4334-2014; Care, Matthew/P-2987-2019	Care, Matthew/0000-0001-6584-5889; Tooze, Reuben/0000-0003-2915-7119; Westhead, David/0000-0002-0519-3820	Cancer Research UK Senior Clinical Research Fellowship [C7845/A10066]; The Francis Crick Institute [10066] Funding Source: researchfish	Cancer Research UK Senior Clinical Research Fellowship; The Francis Crick Institute	This work was supported by a Cancer Research UK Senior Clinical Research Fellowship (R. Tooze), reference C7845/A10066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a Cancer Research UK Senior Clinical Fellowship (RMT) grant ref C7845/A10066. We thank Ming Du and Gina Doody for critical reading of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alizadeh AA, 2011, BLOOD, V118, P1350, DOI 10.1182/blood-2011-03-345272; Barrans SL, 2012, BRIT J HAEMATOL, V159, P441, DOI 10.1111/bjh.12045; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Choi WWL, 2009, CLIN CANCER RES, V15, P5494, DOI 10.1158/1078-0432.CCR-09-0113; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Cocco M, 2012, J IMMUNOLOGY; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Culhane AC, 2010, NUCLEIC ACIDS RES, V38, pD716, DOI 10.1093/nar/gkp1015; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Gutierrez-Garcia G, 2011, BLOOD, V117, P4836, DOI 10.1182/blood-2010-12-322362; Hall M., 2009, SIGKDD EXPLORATIONS, V11; Hamoudi RA, 2010, LEUKEMIA, V24, P1487, DOI 10.1038/leu.2010.118; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Jima DD, 2010, BLOOD, V116, pE118, DOI 10.1182/blood-2010-05-285403; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Malumbres R, 2008, BLOOD, V111, P5509, DOI 10.1182/blood-2008-02-136374; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Monti S, 2012, CANCER CELL, V22, P359, DOI 10.1016/j.ccr.2012.07.014; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Nagasawa M, 2008, EUR J IMMUNOL, V38, P2389, DOI 10.1002/eji.200838470; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Rimsza LM, 2008, BLOOD, V112, P3425, DOI 10.1182/blood-2008-02-137372; Rimsza LM, 2011, CLIN CANCER RES, V17, P3727, DOI 10.1158/1078-0432.CCR-10-2573; Rimsza LM, 2004, BLOOD, V103, P4251, DOI 10.1182/blood-2003-07-2365; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salaverria I, 2011, BLOOD, V118, P139, DOI 10.1182/blood-2011-01-330795; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tagawa H, 2005, BLOOD, V106, P1770, DOI 10.1182/blood-2005-02-0542; Team R, 2008, R LANG ENV STAT COMP; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Visco C, 2012, LEUKEMIA, V26, P2103, DOI 10.1038/leu.2012.83; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams PM, 2010, J MOL DIAGN, V12, P680, DOI 10.2353/jmoldx.2010.090164; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Wulff H, 2004, J IMMUNOL, V173, P776, DOI 10.4049/jimmunol.173.2.776; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang YB, 2012, CANCER CELL, V21, P723, DOI 10.1016/j.ccr.2012.05.024; Yin TF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r77; Yoon HS, 2012, J IMMUNOL, V189, P2393, DOI 10.4049/jimmunol.1103371	61	49	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e55895	10.1371/journal.pone.0055895	http://dx.doi.org/10.1371/journal.pone.0055895			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424639	Green Submitted, gold, Green Published			2022-12-27	WOS:000315965100027
J	Tahara, EB; Cunha, FM; Basso, TO; Della Bianca, BE; Gombert, AK; Kowaltowski, AJ				Tahara, Erich B.; Cunha, Fernanda M.; Basso, Thiago O.; Della Bianca, Bianca E.; Gombert, Andreas K.; Kowaltowski, Alicia J.			Calorie Restriction Hysteretically Primes Aging Saccharomyces cerevisiae toward More Effective Oxidative Metabolism	PLOS ONE			English	Article							REPLICATIVE LIFE-SPAN; MITOCHONDRIAL RESPIRATION; YEAST; SKELETAL; BIOGENESIS; EXPRESSION; LONGEVITY; MECHANISM; EXTENSION; CAPACITY	Calorie restriction (CR) is an intervention known to extend the lifespan of a wide variety of organisms. In S. cerevisiae, chronological lifespan is prolonged by decreasing glucose availability in the culture media, a model for CR. The mechanism has been proposed to involve an increase in the oxidative (versus fermentative) metabolism of glucose. Here, we measured wild-type and respiratory incompetent (rho(0)) S. cerevisiae biomass formation, pH, oxygen and glucose consumption, and the evolution of ethanol, glycerol, acetate, pyruvate and succinate levels during the course of 28 days of chronological aging, aiming to identify metabolic changes responsible for the effects of CR. The concomitant and quantitative measurements allowed for calculations of conversion factors between different pairs of substrates and products, maximum specific substrate consumption and product formation rates and maximum specific growth rates. Interestingly, we found that the limitation of glucose availability in CR S. cerevisiae cultures hysteretically increases oxygen consumption rates many hours after the complete exhaustion of glucose from the media. Surprisingly, glucose-to-ethanol conversion and cellular growth supported by glucose were not quantitatively altered by CR. Instead, we found that CR primed the cells for earlier, faster and more efficient metabolism of respiratory substrates, especially ethanol. Since lifespan-enhancing effects of CR are absent in respiratory incompetent rho(0) cells, we propose that the hysteretic effect of glucose limitation on oxidative metabolism is central toward chronological lifespan extension by CR in this yeast.	[Tahara, Erich B.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Cunha, Fernanda M.] Univ Sao Paulo, Escola deArtes Ciencias & Humanidades, Sao Paulo, Brazil; [Basso, Thiago O.; Della Bianca, Bianca E.; Gombert, Andreas K.] Univ Sao Paulo, Dept Engn Quim, Escola Politecn, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Gombert, AK (corresponding author), Univ Sao Paulo, Dept Engn Quim, Escola Politecn, Sao Paulo, Brazil.	andreas.gombert@poli.usp.br; alicia@iq.usp.br	Basso, Thiago Olitta/H-9312-2012; Gombert, Andreas K/F-3764-2010; Kowaltowski, Alicia J/H-8698-2012; Della-Bianca, Bianca E/E-6042-2018; DA CUNHA, FERNANDA MARQUES/AAY-4000-2020; da Cunha, Fernanda M/G-3575-2012	Basso, Thiago Olitta/0000-0001-7765-4297; Gombert, Andreas K/0000-0001-9557-3773; Della-Bianca, Bianca E/0000-0002-0169-1048; da Cunha, Fernanda M/0000-0002-1583-5380	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); Nucleo de Apoio a Pesquisa Redoxoma (NAP Redoxoma); John Simon Guggenheim Memorial Foundation	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); Nucleo de Apoio a Pesquisa Redoxoma (NAP Redoxoma); John Simon Guggenheim Memorial Foundation	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Pesquisa e Desenvolvimento (CNPq), Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma), Nucleo de Apoio a Pesquisa Redoxoma (NAP Redoxoma) and the John Simon Guggenheim Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DJ, 2006, J GERONTOL A-BIOL, V61, P675, DOI 10.1093/gerona/61.7.675; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barros MH, 2010, MECH AGEING DEV, V131, P494, DOI 10.1016/j.mad.2010.04.008; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Cerqueira FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031155; Cerqueira FM, 2012, FREE RADICAL BIO MED, V52, P1236, DOI 10.1016/j.freeradbiomed.2012.01.011; Cerqueira FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018433; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Crabtree HG, 1928, BIOCHEM J, V22, P1289, DOI 10.1042/bj0221289; Doran P.M., 1995, BIOPROCESS ENG PRINC; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Goldberg AA, 2009, EXP GERONTOL, V44, P555, DOI 10.1016/j.exger.2009.06.001; Hempenstall S, 2012, MECH AGEING DEV, V133, P37, DOI 10.1016/j.mad.2011.12.002; Hepple RT, 2006, REJUV RES, V9, P219, DOI 10.1089/rej.2006.9.219; Jazwinski SM, 2005, MECH AGEING DEV, V126, P243, DOI 10.1016/j.mad.2004.08.016; Kaeberlein M, 2005, PLOS GENET, V1, P614, DOI 10.1371/journal.pgen.0010069; Li Bin, 2011, J Aging Res, V2011, P673185, DOI 10.4061/2011/673185; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Maskell DL, 2003, FEMS YEAST RES, V3, P201, DOI 10.1016/S1567-1356(02)00199-X; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Murakami C, 2012, CELL CYCLE, V11, P3087, DOI 10.4161/cc.21465; Murakami CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024530; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Ocampo A, 2012, CELL METAB, V16, P55, DOI 10.1016/j.cmet.2012.05.013; Oliveira GA, 2008, J BIOENERG BIOMEMBR, V40, P381, DOI 10.1007/s10863-008-9159-5; Olsson L, 1997, APPL ENVIRON MICROB, V63, P2366, DOI 10.1128/AEM.63.6.2366-2371.1997; Piper PW, 2006, MECH AGEING DEV, V127, P733, DOI 10.1016/j.mad.2006.05.004; POLAKIS ES, 1965, BIOCHEM J, V97, P284, DOI 10.1042/bj0970284; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; POSTMA E, 1989, APPL ENVIRON MICROB, V55, P468, DOI 10.1128/AEM.55.2.468-477.1989; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Tahara EB, 2007, FASEB J, V21, P274, DOI 10.1096/fj.06-6686com; Tahara EB, 2011, J BIOENERG BIOMEMBR, V43, P483, DOI 10.1007/s10863-011-9377-0; Woo DK, 2009, EXP GERONTOL, V44, P390, DOI 10.1016/j.exger.2009.03.001; YOTSUYANAGI Y, 1962, J ULTRA MOL STRUCT R, V7, P141, DOI 10.1016/S0022-5320(62)80032-X; Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1	43	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56388	10.1371/journal.pone.0056388	http://dx.doi.org/10.1371/journal.pone.0056388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409181	gold, Green Published, Green Submitted			2022-12-27	WOS:000315100000053
J	Xu, XL; Zhang, YH; Meng, QC; Meng, K; Zhang, W; Zhou, XJ; Luo, HY; Chen, RM; Yang, PL; Yao, B				Xu, Xiaolu; Zhang, Yuhong; Meng, Qingchang; Meng, Kun; Zhang, Wei; Zhou, Xiaojin; Luo, Huiying; Chen, Rumei; Yang, Peilong; Yao, Bin			Overexpression of a Fungal beta-Mannanase from Bispora sp MEY-1 in Maize Seeds and Enzyme Characterization	PLOS ONE			English	Article							GENE CLONING; PICHIA-PASTORIS; EXPRESSION; PLANTS; BOMBARDMENT; PROGENY; PHYTASE; DIETS	Background: Mannans and heteromannans are widespread in plants cell walls and are well-known as anti-nutritional factors in animal feed. To remove these factors, it is common practice to incorporate endo-beta-mannanase into feed for efficient nutrition absorption. The objective of this study was to overexpress a beta-mannanase gene directly in maize, the main ingredient of animal feed, to simplify the process of feed production. Methodology/Principal Findings: The man5A gene encoding an excellent beta-mannanase from acidophilic Bispora sp. MEY-1 was selected for heterologous overexpression. Expression of the modified gene (man5As) was driven by the embryo-specific promoter ZM-leg1A, and the transgene was transferred to three generations by backcrossing with commercial inbred Zheng58. Its exogenous integration into the maize embryonic genome and tissue specific expression in seeds were confirmed by PCR and Southern blot and Western blot analysis, respectively. Transgenic plants at BC3 generation showed agronomic traits statistically similar to Zheng58 except for less plant height (154.0 cm vs 158.3 cm). The expression level of MAN5AS reached up to 26,860 units per kilogram of maize seeds. Compared with its counterpart produced in Pichia pastoris, seed-derived MAN5AS had higher temperature optimum (90 degrees C), and remained more beta-mannanase activities after pelleting at 80 degrees C, 100 degrees C or 120 degrees C. Conclusion/Significance: This study shows the genetically stable overexpression of a fungal beta-mannanase in maize and offers an effective and economic approach for transgene containment in maize for direct utilization without any purification or supplementation procedures.	[Xu, Xiaolu; Meng, Kun; Luo, Huiying; Yang, Peilong; Yao, Bin] Chinese Acad Agr Sci, Minist Agr, Feed Res Inst, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China; [Zhang, Yuhong; Zhang, Wei; Zhou, Xiaojin; Chen, Rumei] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Meng, Qingchang] Jiangsu Acad Agr Sci, Inst Food Crops, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Jiangsu Academy of Agricultural Sciences	Yang, PL (corresponding author), Chinese Acad Agr Sci, Minist Agr, Feed Res Inst, Key Lab Feed Biotechnol, Beijing 100193, Peoples R China.	yangpl@mail.caas.cn; binyao@caas.cn			Key Program of Transgenic Plant Breeding [2009ZX08003-020B]; China Modern Agriculture Research System [CARS-42]; National Natural Science Foundation of China [31172235]	Key Program of Transgenic Plant Breeding; China Modern Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Key Program of Transgenic Plant Breeding (2009ZX08003-020B) and the China Modern Agriculture Research System (CARS-42) and the National Natural Science Foundation of China (31172235). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029302; ARAUJO A, 1990, J APPL BACTERIOL, V68, P253, DOI 10.1111/j.1365-2672.1990.tb02572.x; Armstrong C. L., 1991, Maize Genetics Cooperation News Letter, P92; Bhat MK, 2000, BIOTECHNOL ADV, V18, P355, DOI 10.1016/S0734-9750(00)00041-0; Chen RM, 2008, TRANSGENIC RES, V17, P633, DOI 10.1007/s11248-007-9138-3; Cohen J. I., 2002, AgBiotechNet, V4, P1; Dale N, 1997, HEMICELL POULTRY SWI; Deng LF, 2009, CHIN AGR SCI B, V25, P7; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; DIRK LMA, 1995, PHYTOCHEMISTRY, V40, P1045, DOI 10.1016/0031-9422(95)00296-J; Do BC, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-59; GREEN CE, 1982, PLANT TISSUE CULTURE, P107; Hiwasa-Tanase K, 2011, PLANT CELL REP, V30, P113, DOI 10.1007/s00299-010-0949-y; Hoshikawa K, 2012, PLANT BIOTECHNOL REP, V6, P243, DOI 10.1007/s11816-012-0219-2; HUANG N, 1990, J CAASS, V1, P73; Jackson ME, 1999, POULTRY SCI, V78, P1737, DOI 10.1093/ps/78.12.1737; Jiang XR, 2011, BIOTECHNOL LETT, V33, P1797, DOI 10.1007/s10529-011-0642-4; Jiang ZQ, 2006, CARBOHYD POLYM, V66, P88, DOI 10.1016/j.carbpol.2006.02.030; Kim SW, 2003, PIG NEWS INFO, V24, p91N; KLEIN TM, 1988, P NATL ACAD SCI USA, V85, P4305, DOI 10.1073/pnas.85.12.4305; Li J, 1997, PLANT PHYSIOL, V114, P1103, DOI 10.1104/pp.114.3.1103; [李圣彦 Li Shengyan], 2011, [中国农业科技导报, Journal of Agricultural Science and Technology], V13, P20; Li YN, 2008, J MICROBIOL BIOTECHN, V18, P160; Li Z, 2011, FUNCT INTEGR GENOMIC, V11, P63, DOI 10.1007/s10142-011-0211-x; Liepman AH, 2007, PLANT PHYSIOL, V143, P1881, DOI 10.1104/pp.106.093989; Liu HM, 2010, MOL BIOL REP, V37, P677, DOI 10.1007/s11033-009-9521-7; Luo HY, 2009, APPL MICROBIOL BIOT, V82, P453, DOI 10.1007/s00253-008-1766-x; MATHESON NK, 1985, POLYSACCHARIDES, V3, P1; MCCLEARY BV, 1988, METHOD ENZYMOL, V160, P596; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Nandi S, 2002, PLANT SCI, V163, P713, DOI 10.1016/S0168-9452(02)00165-6; Odetallah NH, 2002, POULTRY SCI, V81, P1322, DOI 10.1093/ps/81.9.1322; Petkowicz CLD, 2001, CARBOHYD POLYM, V44, P107, DOI 10.1016/S0144-8617(00)00212-5; Qiao HY, 2010, J VET MED ANIM HUSB, V42, P15; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Song JM, 2008, COMP BIOCHEM PHYS B, V151, P32, DOI 10.1016/j.cbpb.2008.05.005; Songstad DD, 1996, IN VITRO CELL DEV-PL, V32, P179; Sun ZW, 2005, ACTA ZOONUTRIMENTA S, V17, P20; Tomes D. T., 1995, P197; TOMES DT, 1990, PLANT MOL BIOL, V14, P261, DOI 10.1007/BF00018566; Verma D, 2010, PLANT BIOTECHNOL J, V8, P332, DOI 10.1111/j.1467-7652.2009.00486.x; Whittle CA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-169; Yang PL, 2009, APPL BIOCHEM BIOTECH, V159, P85, DOI 10.1007/s12010-008-8364-3; Yao B, 1998, SCI CHINA SER C, V41, P330, DOI 10.1007/BF02895110; Yoon KH, 2008, J MICROBIOL, V46, P344, DOI 10.1007/s12275-008-0045-y; Ziegler MT, 2000, MOL BREEDING, V6, P37, DOI 10.1023/A:1009667524690	47	8	12	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 11	2013	8	2							e56146	10.1371/journal.pone.0056146	http://dx.doi.org/10.1371/journal.pone.0056146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092DU	23409143	Green Submitted, Green Published, gold			2022-12-27	WOS:000315100000045
J	Hill, TA; Ashrafi, H; Reyes-Chin-Wo, S; Yao, JQ; Stoffel, K; Truco, MJ; Kozik, A; Michelmore, RW; Van Deynze, A				Hill, Theresa A.; Ashrafi, Hamid; Reyes-Chin-Wo, Sebastian; Yao, JiQiang; Stoffel, Kevin; Truco, Maria-Jose; Kozik, Alexander; Michelmore, Richard W.; Van Deynze, Allen			Characterization of Capsicum annuum Genetic Diversity and Population Structure Based on Parallel Polymorphism Discovery with a 30K Unigene Pepper GeneChip	PLOS ONE			English	Article							SINGLE-FEATURE POLYMORPHISMS; GENOMIC SELECTION; L.; MARKERS; TOMATO; IDENTIFICATION; DOMESTICATION; TRANSCRIPTOME; EVOLUTIONARY; SOLANACEAE	The widely cultivated pepper, Capsicum spp., important as a vegetable and spice crop world-wide, is one of the most diverse crops. To enhance breeding programs, a detailed characterization of Capsicum diversity including morphological, geographical and molecular data is required. Currently, molecular data characterizing Capsicum genetic diversity is limited. The development and application of high-throughput genome-wide markers in Capsicum will facilitate more detailed molecular characterization of germplasm collections, genetic relationships, and the generation of ultra-high density maps. We have developed the Pepper GeneChip (R) array from Affymetrix for polymorphism detection and expression analysis in Capsicum. Probes on the array were designed from 30,815 unigenes assembled from expressed sequence tags (ESTs). Our array design provides a maximum redundancy of 13 probes per base pair position allowing integration of multiple hybridization values per position to detect single position polymorphism (SPP). Hybridization of genomic DNA from 40 diverse C. annuum lines, used in breeding and research programs, and a representative from three additional cultivated species (C. frutescens, C. chinense and C. pubescens) detected 33,401 SPP markers within 13,323 unigenes. Among the C. annuum lines, 6,426 SPPs covering 3,818 unigenes were identified. An estimated three-fold reduction in diversity was detected in non-pungent compared with pungent lines, however, we were able to detect 251 highly informative markers across these C. annuum lines. In addition, an 8.7 cM region without polymorphism was detected around Pun1 in non-pungent C. annuum. An analysis of genetic relatedness and diversity using the software Structure revealed clustering of the germplasm which was confirmed with statistical support by principle components analysis (PCA) and phylogenetic analysis. This research demonstrates the effectiveness of parallel high-throughput discovery and application of genome-wide transcript-based markers to assess genetic and genomic features among Capsicum annuum.	[Hill, Theresa A.; Ashrafi, Hamid; Reyes-Chin-Wo, Sebastian; Yao, JiQiang; Stoffel, Kevin; Van Deynze, Allen] Univ Calif Davis, Seed Biotechnol Ctr, Davis, CA 95616 USA; [Reyes-Chin-Wo, Sebastian; Truco, Maria-Jose; Kozik, Alexander; Michelmore, Richard W.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Hill, Theresa A.; Ashrafi, Hamid; Stoffel, Kevin; Michelmore, Richard W.; Van Deynze, Allen] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Van Deynze, A (corresponding author), Univ Calif Davis, Seed Biotechnol Ctr, Davis, CA 95616 USA.	avandeynze@ucdavis.edu		Ashrafi, Hamid/0000-0002-2094-2367	University of California [bio06-10565]; Rijk Zwaan BV; Enza Zaden BV; DeRuiter Seeds B.V.; Nunhems USA; Seminis Vegetable Seeds, Inc.; Syngenta Seeds, Inc.; Vilmorin Co.; University of California Davis	University of California(University of California System); Rijk Zwaan BV; Enza Zaden BV; DeRuiter Seeds B.V.; Nunhems USA; Seminis Vegetable Seeds, Inc.; Syngenta Seeds, Inc.(Syngenta); Vilmorin Co.; University of California Davis(University of California System)	This project was supported by an award from the University of California UC Discovery Program bio06-10565 with matching funds from Rijk Zwaan BV, Enza Zaden BV, DeRuiter Seeds B.V., Nunhems USA, Seminis Vegetable Seeds, Inc., Syngenta Seeds, Inc., and Vilmorin Co.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the University of California Davis, UC Discovery program, which received matching funds from these commercial entities: Rijk Zwaan BV, Enza Zaden BV, DeRuiter Seeds B. V., Nunhems USA, Seminis Vegetable Seeds, Inc., Syngenta Seeds, Inc., and Vilmorin Co.. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The role of the commercial entities was limited to providing funds for research. The funds were to the Regents of the University of California. The authors have not personally taken money from the funders.	Adetula OA, 2006, AFR J BIOTECHNOL, V5, P120; *AFF, 2007, QUAL ASS EX GEN ARR; Aguilar-Melendez A, 2009, AM J BOT, V96, P1190, DOI 10.3732/ajb.0800155; Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDREWS J, 1993, GEOGR REV, V83, P194, DOI 10.2307/215257; Andrews J., 1984, PEPPERS DOMESTICATED; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Ashrafi Hamid, 2012, BMC Genomics, V13, P571, DOI 10.1186/1471-2164-13-571; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Bosland P. W., 2012, Peppers: vegetable and spice capsicums, DOI 10.1079/9781845938253.0000; BOSLAND PW, 1991, PLANT DIS, V75, P1048, DOI 10.1094/PD-75-1048; Das S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-107; Eshbaugh W. H., 1993, New crops., P132; Falush D, 2003, GENETICS, V164, P1567; FAO, 1996, REP STAT WORLDS PLAN; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Greenleaf WH, 1986, BREEDING VEGETABLE C, P67; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hamilton JP, 2012, PLANT GENOME-US, V5, P17, DOI 10.3835/plantgenome2011.12.0033; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; HEISER C B JR, 1969, Taxon, V18, P277, DOI 10.2307/1218828; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; IPGRI AVRDC, 1995, DESCR CAPS CAPS SPP; Jeong HJ, 2010, GENOME, V53, P1029, DOI 10.1139/G10-094; Jung JK, 2010, EUPHYTICA, V175, P91, DOI 10.1007/s10681-010-0191-2; Kaeuffer R, 2007, HEREDITY, V99, P374, DOI 10.1038/sj.hdy.6801010; Kim H, 2008, I S MOD ANAL SIM COM, P181, DOI 10.1186/1471-2229-8-101; Kochieva EZ, 2003, RUSS J GENET+, V39, P1345, DOI 10.1023/B:RUGE.0000009146.54565.94; Kraft KH, 2009, DOMESTICATION CHILE; Kumar R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000284; Lane RP, 1997, HORTSCIENCE, V32, P333, DOI 10.21273/HORTSCI.32.2.333; LEFEBVRE V, 1993, EUPHYTICA, V71, P189, DOI 10.1007/BF00040408; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Moscone EA, 2003, ANN BOT-LONDON, V92, P21, DOI 10.1093/aob/mcg105; Nazia Akbar, 2010, Asian Journal of Agricultural Sciences, V2, P53; Neitzke RS, 2010, HORTIC BRAS, V28, P47, DOI 10.1590/S0102-05362010000100009; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Olmstead RG, 2008, TAXON, V57, P1159, DOI 10.1002/tax.574010; ORTEGA RG, 1992, PLANT BREEDING, V108, P118, DOI 10.1111/j.1439-0523.1992.tb00110.x; Paran I, 1998, EUPHYTICA, V99, P167, DOI 10.1023/A:1018301215945; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Perry L, 2007, SCIENCE, V315, P986, DOI 10.1126/science.1136914; PICKERSGILL B, 1971, EVOLUTION, V25, P683, DOI 10.1111/j.1558-5646.1971.tb01926.x; Pickersgill B, 1997, EUPHYTICA, V96, P129, DOI 10.1023/A:1002913228101; Powell ALT, 2012, SCIENCE, V336, P1711, DOI 10.1126/science.1222218; PRINCE JP, 1995, GENOME, V38, P224, DOI 10.1139/g95-027; Pritchard JK, 2000, GENETICS, V155, P945; Riztyan, 2011, POULTRY SCI, V90, P2471, DOI 10.3382/ps.2011-01450; Robbins MD, 2011, J EXP BOT, V62, P1831, DOI 10.1093/jxb/erq367; Rostoks N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r54; SMITH PG, 1951, AM J BOT, V38, P362, DOI 10.2307/2437824; SMITH PG, 1987, HORTSCIENCE, V22, P11; Souza MM, 2012, CROP BREED APPL BIOT, V12, P138, DOI 10.1590/S1984-70332012000200007; Stewart C, 2005, PLANT J, V42, P675, DOI 10.1111/j.1365-313X.2005.02410.x; Stoffel K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-185; Tam SM, 2009, THEOR APPL GENET, V119, P973, DOI 10.1007/s00122-009-1102-6; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tewksbury JJ, 2001, NATURE, V412, P403, DOI 10.1038/35086653; Todorovska E, 2010, GENETIKA-BELGRADE, V42, P177, DOI 10.2298/GENSR1001175T; USDA-ARS, 2011, GRIN SPEC REC CAPS; Van Deynze A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-465; Varshney RK, 2009, J PLANT BIOCHEM BIOT, V18, P127, DOI 10.1007/BF03263311; Votava EJ, 2005, ECON BOT, V59, P8, DOI 10.1663/0013-0001(2005)059[0008:GDOCCA]2.0.CO;2; West MAL, 2006, GENOME RES, V16, P787, DOI 10.1101/gr.5011206; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455; Xu Y. B., 2003, Rice science: innovations and impact for livelihood. Proceedings of the International Rice Research Conference, Beijing, China, 16-19 September 2002, P213; Zewdie Y, 2004, GENET RESOUR CROP EV, V51, P147, DOI 10.1023/B:GRES.0000020858.96226.38	72	71	75	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56200	10.1371/journal.pone.0056200	http://dx.doi.org/10.1371/journal.pone.0056200			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409153	Green Submitted, Green Published, gold			2022-12-27	WOS:000314660300065
J	Guillemot, L; Spadaro, D; Citi, S				Guillemot, Laurent; Spadaro, Domenica; Citi, Sandra			The Junctional Proteins Cingulin and Paracingulin Modulate the Expression of Tight Junction Protein Genes through GATA-4	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HEART TUBE FORMATION; SMALL GTPASE RHOA; CLAUDIN-2 EXPRESSION; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; VENTRAL MORPHOGENESIS; SEQUENCE SIMILARITY; ADHERENS JUNCTIONS; DIFFERENTIATION	The cytoplamic junctional proteins cingulin and paracingulin have been implicated in the regulation of gene expression in different cultured cell models. In renal epithelial MDCK cells, depletion of either protein results in a Rho-dependent increase in the expression of claudin-2. Here we examined MDCK cell clones depleted of both cingulin and paracingulin (double-KD cells), and we found that unexpectedly the expression of claudin-2, and also the expression of ZO-3 and claudin-3, were decreased, while RhoA activity was still higher than in control cells. The decreased expression of claudin-2 and other TJ proteins in double-KD cells correlated with reduced levels of the transcription factor GATA-4, and was rescued by overexpression of GATA-4, but not by inhibiting RhoA activity. These results indicate that in MDCK cells GATA-4 is required for the expression of claudin-2 and other TJ proteins, and that maintenance of GATA-4 expression requires either cingulin or paracingulin. These results and previous studies suggest a model whereby cingulin and paracingulin redundantly control the expression of specific TJ proteins through distinct GATA-4- and RhoA-dependent mechanisms, and that in the absence of sufficient levels of GATA-4 the RhoA-mediated upregulation of claudin-2 is inhibited.	[Guillemot, Laurent; Spadaro, Domenica; Citi, Sandra] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Spadaro, Domenica; Citi, Sandra] Univ Geneva, Dept Cell Biol, Geneva, Switzerland; [Citi, Sandra] Univ Geneva, Inst Genet & Genom Geneva, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Citi, S (corresponding author), Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland.	sandra.citi@unige.ch	Citi, Sandra/E-4514-2014	Citi, Sandra/0000-0002-6537-4818	Swiss National Science Foundation [31003A103637, 31003A116763]; State of Geneva; Section of Biology of the University of Geneva	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); State of Geneva; Section of Biology of the University of Geneva	This study was funded by the Swiss National Science Foundation (grants n. 31003A103637, 31003A116763), the State of Geneva, and the Section of Biology of the University of Geneva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Benoit YD, 2010, AM J PHYSIOL-GASTR L, V298, pG504, DOI 10.1152/ajpgi.00265.2009; Boyd M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-68; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buchert M, 2010, P NATL ACAD SCI USA, V107, P2628, DOI 10.1073/pnas.0903747107; Carrozzino F, 2005, AM J PHYSIOL-CELL PH, V289, pC1002, DOI 10.1152/ajpcell.00175.2005; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Chiba H, 2003, EXP CELL RES, V286, P288, DOI 10.1016/S0014-4827(03)00116-2; Citi S, 2001, CELL CELL INTERACTIO, P153; Escaffit F, 2005, J CELL PHYSIOL, V203, P15, DOI 10.1002/jcp.20189; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gao XP, 1998, MOL CELL BIOL, V18, P2901, DOI 10.1128/MCB.18.5.2901; Guillemot L, 2004, J CELL SCI, V117, P5245, DOI 10.1242/jcs.01399; Guillemot L, 2012, J CELL SCI IN PRESS; Guillemot L, 2008, MOL BIOL CELL, V19, P4442, DOI 10.1091/mbc.E08-06-0558; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; Guillemot L, 2006, MOL BIOL CELL, V17, P3569, DOI 10.1091/mbc.E06-02-0122; Guillemot Laurent, 2006, P54; Halbleib JM, 2007, MOL BIOL CELL, V18, P4261, DOI 10.1091/mbc.E07-04-0308; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Mankertz J, 2004, BIOCHEM BIOPH RES CO, V314, P1001, DOI 10.1016/j.bbrc.2003.12.185; McCrea PD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002923; Meng W, 2009, COLD SPRING HARBOR P, DOI [10.1101/cshper-spect.a002899, DOI 10.1101/CSHPER-SPECT.A002899]; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Muto S, 2010, P NATL ACAD SCI USA, V107, P8011, DOI 10.1073/pnas.0912901107; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Ohnishi H, 2004, J BIOL CHEM, V279, P46014, DOI 10.1074/jbc.M402616200; Paschoud S, 2008, MOL MEMBR BIOL, V25, P1, DOI 10.1080/09687680701474009; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Sakaguchi T, 2002, J BIOL CHEM, V4, P4; Snyder M, 2010, J BIOL CHEM, V285, P23639, DOI 10.1074/jbc.M110.101063; Spadaro D, 2012, ESSAYS BIOC IN PRESS; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Tsukita S, 2002, CURR OPIN CELL BIOL, V14, P531, DOI 10.1016/S0955-0674(02)00362-9; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; Yanazume T, 2002, J BIOL CHEM, V277, P8618, DOI 10.1074/jbc.M107924200; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	45	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55873	10.1371/journal.pone.0055873	http://dx.doi.org/10.1371/journal.pone.0055873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409073	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200081
J	Steidinger, TU; Slone, SR; Ding, HP; Standaert, DG; Yacoubian, TA				Steidinger, Trent U.; Slone, Sunny R.; Ding, Huiping; Standaert, David G.; Yacoubian, Talene A.			Angiogenin in Parkinson Disease Models: Role of Akt Phosphorylation and Evaluation of AAV-Mediated Angiogenin Expression in MPTP Treated Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NEUROBLASTOMA-CELLS; ENDOTHELIAL-CELLS; ANG GENE; MUTATIONS; VARIANTS; SURVIVAL; MOTONEURONS; ACTIVATION; MECHANISMS	The angiogenic factor, angiogenin, has been recently linked to both Amyotrophic Lateral Sclerosis (ALS) and Parkinson Disease (PD). We have recently shown that endogenous angiogenin levels are dramatically reduced in an alpha-synuclein mouse model of PD and that exogenous angiogenin protects against cell loss in neurotoxin-based cellular models of PD. Here, we extend our studies to examine whether activation of the prosurvival Akt pathway is required for angiogenin's neuroprotective effects against 1-methyl-4-phenylpyridinium (MPP+), as observed in ALS models, and to test the effect of virally-mediated overexpression of angiogenin in an in vivo PD model. Using a dominant negative Akt construct, we demonstrate that inhibition of the Akt pathway does not reduce the protective effect of angiogenin against MPP+ toxicity in the dopaminergic SH-SY5Y cell line. Furthermore, an ALS-associated mutant of angiogenin, K40I, which fails to induce Akt phosphorylation, was similar to wildtype angiogenin in protection against MPP+. These results confirm previous work showing neuroprotective effects of angiogenin against MPP+, and indicate that Akt is not required for this protective effect. We also investigated whether adeno-associated viral serotype 2 (AAV2)-mediated overexpression of angiogenin protects against dopaminergic neuron loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model. We found that angiogenin overexpression using this approach does not reduce the MPTP-induced degeneration of dopaminergic cells in the substantia nigra, nor limit the depletion of dopamine and its metabolites in the striatum. Together, these findings extend the evidence for protective effects of angiogenin in vitro, but also suggest that further study of in vivo models is required to translate these effects into meaningful therapies.	[Steidinger, Trent U.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA; [Slone, Sunny R.; Ding, Huiping; Standaert, David G.; Yacoubian, Talene A.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Yacoubian, TA (corresponding author), Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, UAB Stn, Birmingham, AL 35294 USA.	tyacoub@uab.edu		Ding, Huiping/0000-0001-5783-0759; Standaert, David/0000-0003-2921-8348	National Institutes of Health - National Institute of Neurological Disorders and Stroke [K08 (NS060948)]; American Parkinson Disease Association; Parkinson's Association of Alabama; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS060948] Funding Source: NIH RePORTER	National Institutes of Health - National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Parkinson Disease Association; Parkinson's Association of Alabama; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a National Institutes of Health - National Institute of Neurological Disorders and Stroke K08 (NS060948), by the American Parkinson Disease Association, and by the Parkinson's Association of Alabama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BICKNELL R, 1988, P NATL ACAD SCI USA, V85, P5961, DOI 10.1073/pnas.85.16.5961; Cho GW, 2010, MOL CELL BIOCHEM, V340, P133, DOI 10.1007/s11010-010-0410-0; Conforti FL, 2008, NEUROMUSCULAR DISORD, V18, P68, DOI 10.1016/j.nmd.2007.07.003; Crabtree B, 2007, BIOCHEMISTRY-US, V46, P11810, DOI 10.1021/bi701333h; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Gao XW, 2008, ACTA BIOCH BIOPH SIN, V40, P619, DOI 10.1111/j.1745-7270.2008.00442.x; Gellera C, 2008, NEUROGENETICS, V9, P33, DOI 10.1007/s10048-007-0111-3; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Greenway MJ, 2004, NEUROLOGY, V63, P1936, DOI 10.1212/01.WNL.0000144344.39103.F6; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Kang JQ, 2003, MOL PHARMACOL, V64, P557, DOI 10.1124/mol.64.3.557; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kim HM, 2007, BIOCHEM BIOPH RES CO, V352, P509, DOI 10.1016/j.bbrc.2006.11.047; Lambrechts D, 2006, TRENDS MOL MED, V12, P345, DOI 10.1016/j.molmed.2006.06.008; Li S, 2011, J CELL PHYSL, V227, P1639, DOI DOI 10.1002/JCP.22881; Li SP, 2010, FEBS J, V277, P3575, DOI 10.1111/j.1742-4658.2010.07766.x; Liu SM, 2001, BIOCHEM BIOPH RES CO, V287, P305, DOI 10.1006/bbrc.2001.5568; Paubel A, 2008, ARCH NEUROL-CHICAGO, V65, P1333, DOI 10.1001/archneur.65.10.1333; Rayaprolu S, 2012, ANN NEUROL, V71, P725, DOI 10.1002/ana.23586; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sebastia J, 2009, CELL DEATH DIFFER, V16, P1238, DOI 10.1038/cdd.2009.52; Skorupa A, 2012, J NEUROSCI, V32, P5024, DOI 10.1523/JNEUROSCI.6366-11.2012; St Martin JL, 2007, J NEUROCHEM, V100, P1449, DOI 10.1111/j.1471-4159.2006.04310.x; Steidinger TU, 2011, J NEUROCHEM, V116, P334, DOI 10.1111/j.1471-4159.2010.07112.x; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Subramanian V, 2007, HUM MOL GENET, V16, P1445, DOI 10.1093/hmg/ddm095; Tanno B, 2002, J BIOL CHEM, V277, P23172, DOI 10.1074/jbc.M200141200; van Es MA, 2009, NEUROLOGY, V72, P287, DOI 10.1212/01.wnl.0000339487.84908.00; van Es MA, 2011, ANN NEUROL, V70, P964, DOI 10.1002/ana.22611; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221; Xu ZP, 2002, BIOCHEM BIOPH RES CO, V294, P287, DOI 10.1016/S0006-291X(02)00479-5; Xu ZP, 2001, BIOCHEM BIOPH RES CO, V285, P909, DOI 10.1006/bbrc.2001.5255; Yacoubian TA, 2008, NEUROBIOL DIS, V29, P515, DOI 10.1016/j.nbd.2007.11.008	35	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56092	10.1371/journal.pone.0056092	http://dx.doi.org/10.1371/journal.pone.0056092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409128	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200107
J	Li, LL; Voullaire, L; Sandi, C; Pook, MA; Ioannou, PA; Delatycki, MB; Sarsero, JP				Li, Lingli; Voullaire, Lucille; Sandi, Chiranjeevi; Pook, Mark A.; Ioannou, Panos A.; Delatycki, Martin B.; Sarsero, Joseph P.			Pharmacological Screening Using an FXN-EGFP Cellular Genomic Reporter Assay for the Therapy of Friedreich Ataxia	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; GAA REPEAT LENGTH; YEAST FRATAXIN; SACCHAROMYCES-CEREVISIAE; TRANSGENIC MICE; TRIPLET-REPEAT; PPAR-GAMMA; EPIGENETIC CHANGES; GENE-EXPRESSION; UP-REGULATION	Friedreich ataxia (FRDA) is an autosomal recessive disorder characterized by neurodegeneration and cardiomyopathy. The presence of a GAA trinucleotide repeat expansion in the first intron of the FXN gene results in the inhibition of gene expression and an insufficiency of the mitochondrial protein frataxin. There is a correlation between expansion length, the amount of residual frataxin and the severity of disease. As the coding sequence is unaltered, pharmacological up-regulation of FXN expression may restore frataxin to therapeutic levels. To facilitate screening of compounds that modulate FXN expression in a physiologically relevant manner, we established a cellular genomic reporter assay consisting of a stable human cell line containing an FXN-EGFP fusion construct, in which the EGFP gene is fused in-frame with the entire normal human FXN gene present on a BAC clone. The cell line was used to establish a fluorometric cellular assay for use in high throughput screening (HTS) procedures. A small chemical library containing FDA-approved compounds and natural extracts was screened and analyzed. Compound hits identified by HTS were further evaluated by flow cytometry in the cellular genomic reporter assay. The effects on FXN mRNA and frataxin protein levels were measured in lymphoblast and fibroblast cell lines derived from individuals with FRDA and in a humanized GAA repeat expansion mouse model of FRDA. Compounds that were established to increase FXN gene expression and frataxin levels included several anti-cancer agents, the iron-chelator deferiprone and the phytoalexin resveratrol.	[Li, Lingli; Voullaire, Lucille; Ioannou, Panos A.; Sarsero, Joseph P.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Li, Lingli; Delatycki, Martin B.; Sarsero, Joseph P.] Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Parkville, Vic, Australia; [Ioannou, Panos A.; Delatycki, Martin B.; Sarsero, Joseph P.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Delatycki, Martin B.] Austin Hlth, Dept Clin Genet, Heidelberg, Vic, Australia; [Sandi, Chiranjeevi; Pook, Mark A.] Brunel Univ, Sch Hlth Sci & Social Care, Div Biosci, Uxbridge UB8 3PH, Middx, England	Murdoch Children's Research Institute; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Brunel University	Sarsero, JP (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.	joe@sarsero.com			Muscular Dystrophy Association (USA) [3657, 3725, 69033]; National Health and Medical Research Council (Australia) [491234]; Friedreich's Ataxia Research Alliance (USA); Brockhoff Foundation (Australia); Friedreich Ataxia Research Association (Australasia); Seek A Miracle (USA); Victorian Government's Operational Infrastructure Support Program	Muscular Dystrophy Association (USA)(Muscular Dystrophy Association); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Friedreich's Ataxia Research Alliance (USA); Brockhoff Foundation (Australia); Friedreich Ataxia Research Association (Australasia); Seek A Miracle (USA); Victorian Government's Operational Infrastructure Support Program	This work was supported by the Muscular Dystrophy Association (USA) (grants 3657, 3725, 69033), the National Health and Medical Research Council (Australia) (grant 491234), the Friedreich's Ataxia Research Alliance (USA), the Brockhoff Foundation (Australia), the Friedreich Ataxia Research Association (Australasia), Seek A Miracle (USA) and the Victorian Government's Operational Infrastructure Support Program. MBD is a National Health and Medical Research Council Practitioner Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva F, 2008, CEREBELLUM; Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003; Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Almeida L, 2009, MOL NUTR FOOD RES, V53, pS7, DOI 10.1002/mnfr.200800177; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Boddaert N, 2007, BLOOD, V110, P401, DOI 10.1182/blood-2006-12-065433; Boesch S, 2008, MOVEMENT DISORD, V23, P1940, DOI 10.1002/mds.22294; Boulikas T, 2003, ONCOL REP, V10, P1663; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Castaldo I, 2008, J MED GENET, V45, P808, DOI 10.1136/jmg.2008.058594; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Coppola G, 2009, HUM MOL GENET, V18, P2452, DOI 10.1093/hmg/ddp183; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Cucciolla V, 2007, CELL CYCLE, V6, P2495, DOI 10.4161/cc.6.20.4815; Dai H, 2010, J BIOL CHEM, V285, P32695, DOI 10.1074/jbc.M110.133892; De Michele G, 1998, J NEUROL, V245, P166, DOI 10.1007/s004150050198; Delatycki MB, 1999, AM J MED GENET, V87, P168, DOI 10.1002/(SICI)1096-8628(19991119)87:2<168::AID-AJMG8>3.0.CO;2-2; Delatycki MB, 1999, ANN NEUROL, V45, P673, DOI 10.1002/1531-8249(199905)45:5<673::AID-ANA20>3.3.CO;2-H; Evans-Galea MV, 2012, ANN NEUROL, V71, P487, DOI 10.1002/ana.22671; Filla A, 1996, AM J HUM GENET, V59, P554; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Ghazizadeh Mohammad, 2003, Journal of Nippon Medical School, V70, P367; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Iyer M, 2001, P NATL ACAD SCI USA, V98, P14595, DOI 10.1073/pnas.251551098; Koeppen AH, 2007, ACTA NEUROPATHOL, V114, P163, DOI 10.1007/s00401-007-0220-y; Koeppen AH, 2009, ACTA NEUROPATHOL, V118, P763, DOI 10.1007/s00401-009-0589-x; la Porte C, 2010, CLIN PHARMACOKINET, V49, P449, DOI 10.2165/11531820-000000000-00000; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Marmolino D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010025; Marmolino D, 2009, CEREBELLUM, V8, P98, DOI 10.1007/s12311-008-0087-z; Mokni M, 2007, NEUROCHEM RES, V32, P981, DOI 10.1007/s11064-006-9255-z; Monros E, 1997, AM J HUM GENET, V61, P101, DOI 10.1086/513887; Narayanan K, 1999, GENE THER, V6, P442, DOI 10.1038/sj.gt.3300901; O'Hagan KA, 2009, P NATL ACAD SCI USA, V106, P2188, DOI 10.1073/pnas.0808801106; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Pandolfo M, 2008, NAT CLIN PRACT NEURO, V4, P86, DOI 10.1038/ncpneuro0704; Pandolfo M, 2006, METH MOLEC MED, V126, P197; Park S, 2002, J BIOL CHEM, V277, P38589, DOI 10.1074/jbc.M206711200; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Pirola L, 2008, IUBMB LIFE, V60, P323, DOI 10.1002/iub.47; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Puspasari N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022001; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sacca F, 2011, MOVEMENT DISORD, V26, P739, DOI 10.1002/mds.23435; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; Santoro L, 2000, CLIN NEUROPHYSIOL, V111, P1023, DOI 10.1016/S1388-2457(00)00290-X; Sarsero JP, 2005, MAMM GENOME, V16, P228, DOI 10.1007/s00335-004-3021-9; Sarsero JP, 2004, MAMM GENOME, V15, P370, DOI 10.1007/s00335-004-3019-3; Sarsero JP, 2003, J GENE MED, V5, P72, DOI 10.1002/jgm.320; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Schulz JB, 2009, NAT REV NEUROL, V5, P222, DOI 10.1038/nrneurol.2009.26; Sohn YS, 2008, BLOOD, V111, P1690, DOI 10.1182/blood-2007-07-102335; Soragni E, 2011, METHODS MOL BIOL, V793, P495, DOI 10.1007/978-1-61779-328-8_32; Tomassini B, 2012, HUM MOL GENET, V21, P2855, DOI 10.1093/hmg/dds110; Ulukan H, 2002, DRUGS, V62, P2039, DOI 10.2165/00003495-200262140-00004; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wermuth CG, 2006, DRUG DISCOV TODAY, V11, P160, DOI 10.1016/S1359-6446(05)03686-X; Willis JH, 2008, MOL GENET METAB, V94, P491, DOI 10.1016/j.ymgme.2008.03.019; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010; Yang TL, 2006, TRENDS ENDOCRIN MET, V17, P186, DOI 10.1016/j.tem.2006.04.002; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i	78	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55940	10.1371/journal.pone.0055940	http://dx.doi.org/10.1371/journal.pone.0055940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418481	Green Published, gold			2022-12-27	WOS:000315970300073
J	Martin, M; Benzina, O; Szabo, V; Vegh, AG; Lucas, O; Cloitre, T; Scamps, F; Gergely, C				Martin, Marta; Benzina, Ouafa; Szabo, Vivien; Vegh, Attila-Gergely; Lucas, Olivier; Cloitre, Thierry; Scamps, Frederique; Gergely, Csilla			Morphology and Nanomechanics of Sensory Neurons Growth Cones following Peripheral Nerve Injury	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; GENE-EXPRESSION; SCIATIC-NERVE; NKCC1 PHOSPHORYLATION; MECHANICAL-PROPERTIES; ELASTIC PROPERTIES; LIVING CELLS; REGENERATION; ADULT; IDENTIFICATION	A prior peripheral nerve injury in vivo, promotes a rapid elongated mode of sensory neurons neurite regrowth in vitro. This in vitro model of conditioned axotomy allows analysis of the cellular and molecular mechanisms leading to an improved neurite re-growth. Our differential interference contrast microscopy and immunocytochemistry results show that conditioned axotomy, induced by sciatic nerve injury, did not increase somatic size of adult lumbar sensory neurons from mice dorsal root ganglia sensory neurons but promoted the appearance of larger neurites and growth cones. Using atomic force microscopy on live neurons, we investigated whether membrane mechanical properties of growth cones of axotomized neurons were modified following sciatic nerve injury. Our data revealed that neurons having a regenerative growth were characterized by softer growth cones, compared to control neurons. The increase of the growth cone membrane elasticity suggests a modification in the ratio and the inner framework of the main structural proteins.	[Martin, Marta; Benzina, Ouafa; Szabo, Vivien; Cloitre, Thierry; Gergely, Csilla] Univ Montpellier 2, Lab Charles Coulomb, UMR 5221, Montpellier, France; [Martin, Marta; Benzina, Ouafa; Szabo, Vivien; Cloitre, Thierry; Gergely, Csilla] CNRS, Lab Charles Coulomb, UMR 5221, Montpellier, France; [Benzina, Ouafa] Ctr Biotechnol Sfax, Lab LVBPPE, Sfax, Tunisia; [Vegh, Attila-Gergely] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary; [Lucas, Olivier; Scamps, Frederique] INM Hop St Eloi, INSERM, U1051, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Montpellier; Centre de Biotechnologie de Sfax; Universite de Sfax; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Scamps, F (corresponding author), INM Hop St Eloi, INSERM, U1051, Montpellier, France.	frederique.scamps@inserm.fr; csilla.gergely@univ-montp2.fr	Végh, Attila Gergely/A-4789-2011; Scamps, Frédérique/M-5268-2018; cloitre, thierry/M-1976-2018	Végh, Attila Gergely/0000-0003-0524-0946; Scamps, Frédérique/0000-0001-9545-407X; cloitre, thierry/0000-0001-6058-4050; Szabo, Vivien/0000-0002-0079-7596; Gergely, Csilla/0000-0003-1229-6761	COST-EU Action on "Applications of Atomic Force Microscopy to NanoMedecine and Life Sciences'' [TD1002-AFM4NanoMedBio]; Association francaise contre les myopathies (AFM)	COST-EU Action on "Applications of Atomic Force Microscopy to NanoMedecine and Life Sciences''; Association francaise contre les myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by the COST-EU Action on "Applications of Atomic Force Microscopy to NanoMedecine and Life Sciences'' (TD1002-AFM4NanoMed&Bio) and by the Association francaise contre les myopathies (AFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre S, 2003, J NEUROPHYSIOL, V90, P3764, DOI 10.1152/jn.00449.2003; Araki T, 2001, J BIOL CHEM, V276, P34131, DOI 10.1074/jbc.M104271200; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; Butt H. J., 2010, SURFACE INTERFACIAL; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; Charron F, 2007, ADV EXP MED BIOL, V621, P116, DOI 10.1007/978-0-387-76715-4_9; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Chumakova OV, 2000, B EXP BIOL MED+, V130, P921, DOI 10.1007/BF02682270; Costa KD, 2003, DIS MARKERS, V19, P139, DOI 10.1155/2004/482680; DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dickson TC, 2002, J CELL BIOL, V157, P1105, DOI 10.1083/jcb.200111076; Dupont-Gillain CC, 2004, J MATER SCI-MATER M, V15, P347, DOI 10.1023/B:JMSM.0000021100.71256.29; EVANS E, 1984, J CLIN INVEST, V73, P477, DOI 10.1172/JCI111234; Garcia R, 2007, NAT MATER, V6, P405, DOI 10.1038/nmat1925; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Goldberg JL, 2008, GENE DEV, V17, P941; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Heinrich V, 2001, BIOPHYS J, V81, P1452, DOI 10.1016/S0006-3495(01)75800-6; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; Hilaire C, 2005, NEUROSCI LETT, V380, P330, DOI 10.1016/j.neulet.2005.01.068; Hoffman PN, 2010, EXP NEUROL, V223, P11, DOI 10.1016/j.expneurol.2009.09.006; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Laishram J, 2009, J STRUCT BIOL, V168, P366, DOI 10.1016/j.jsb.2009.09.005; LAL R, 1995, AM J PHYSIOL-CELL PH, V269, pC275, DOI 10.1152/ajpcell.1995.269.1.C275; Lankford KL, 1998, J COMP NEUROL, V391, P11, DOI 10.1002/(SICI)1096-9861(19980202)391:1<11::AID-CNE2>3.0.CO;2-U; Lawson SN., 1992, SENSORY NEURONS DIVE, P27; Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X; McNally HA, 2004, J NEUROCYTOL, V33, P251, DOI 10.1023/B:NEUR.0000030700.48612.0b; McNally HA, 2005, J NEUROSCI METH, V142, P177, DOI 10.1016/j.jneumeth.2004.08.018; Mechaly I, 2006, MOL CELL NEUROSCI, V32, P217, DOI 10.1016/j.mcn.2006.04.004; Mustata M, 2010, J NEUROSCI METH, V186, P35, DOI 10.1016/j.jneumeth.2009.10.021; Nilsson A, 2005, MOL BRAIN RES, V136, P65, DOI 10.1016/j.molbrainres.2005.01.008; Pieraut S, 2007, J NEUROSCI, V27, P6751, DOI 10.1523/JNEUROSCI.1337-07.2007; Pieraut S, 2011, J NEUROSCI, V31, P13516, DOI 10.1523/JNEUROSCI.3382-11.2011; Radmacher M, 1996, BIOPHYS J, V70, P556, DOI 10.1016/S0006-3495(96)79602-9; Radmacher M, 1997, IEEE ENG MED BIOL, V16, P47, DOI 10.1109/51.582176; Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496; Sleep J, 1999, BIOPHYS J, V77, P3085, DOI 10.1016/S0006-3495(99)77139-0; Smith DS, 1997, J NEUROSCI, V17, P646; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Spedden E, 2012, BIOPHYS J, V103, P868, DOI 10.1016/j.bpj.2012.08.005; Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002; Svaldo Lanero T, 2006, J BIOTECHNOL, V124, P723, DOI 10.1016/j.jbiotec.2006.02.016; TANAKA K, 1992, EXP NEUROL, V118, P53, DOI 10.1016/0014-4886(92)90022-I; Tojima T, 2000, NEUROSCIENCE, V101, P471, DOI 10.1016/S0306-4522(00)00320-1; Vinckier A, 1998, FEBS LETT, V430, P12, DOI 10.1016/S0014-5793(98)00592-4; Weisenhorn A. L., 1993, Nanotechnology, V4, P106, DOI 10.1088/0957-4484/4/2/006; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Xiong Y, 2009, BIOPHYS J, V96, P5060, DOI 10.1016/j.bpj.2009.03.032	51	22	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56286	10.1371/journal.pone.0056286	http://dx.doi.org/10.1371/journal.pone.0056286			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418549	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000315970300142
J	Motomura, Y; Kitamura, S; Oba, K; Terasawa, Y; Enomoto, M; Katayose, Y; Hida, A; Moriguchi, Y; Higuchi, S; Mishima, K				Motomura, Yuki; Kitamura, Shingo; Oba, Kentaro; Terasawa, Yuri; Enomoto, Minori; Katayose, Yasuko; Hida, Akiko; Moriguchi, Yoshiya; Higuchi, Shigekazu; Mishima, Kazuo			Sleep Debt Elicits Negative Emotional Reaction through Diminished Amygdala-Anterior Cingulate Functional Connectivity	PLOS ONE			English	Article							SLOW-WAVE ACTIVITY; PREFRONTAL CORTEX; ANTIDEPRESSANT TREATMENT; DAYTIME SLEEPINESS; DEPRIVATION; BRAIN; RESTRICTION; HOMEOSTASIS; ADENOSINE; EEG	Objectives: Sleep debt reportedly increases emotional instability, such as anxiety and confusion, in addition to sleepiness and psychomotor impairment. However, the neural basis of emotional instability due to sleep debt has yet to be elucidated. This study investigated changes in emotional responses that are elicited by the simulation of short-term sleep loss and the brain regions responsible for these changes. Subjects and Methods: Fourteen healthy adult men aged 24.1 +/- 3.3 years (range, 20-32 years) participated in a within-subject crossover study consisting of 5-day sessions of both sleep debt (4 h for time in bed) and sleep control (8 h for time in bed). On the last day of each session, participants underwent polysomnography and completed the State-Trait Anxiety Inventory and Profile of Mood States questionnaires. In addition, functional magnetic resonance imaging was conducted while performing an emotional face viewing task. Results: Restricted sleep over the 5-day period increased the activity of the left amygdala in response to the facial expression of fear, whereas a happy facial expression did not change the activity. Restricted sleep also resulted in a significant decrease in the functional connectivity between the amygdala and the ventral anterior cingulate cortex (vACC) in proportion to the degree of sleep debt (as indicated by the percentage of slow wave sleep and delta wave power). This decrease was significantly correlated with activation of the left amygdala and deterioration of subjective mood state. Conclusion: The results of this study suggest that continuous and accumulating sleep debt that can be experienced in everyday life can downregulate the functional suppression of the amygdala by the vACC and consequently enhance the response of the amygdala to negative emotional stimuli. Such functional alteration in emotional control may, in part, be attributed to the neural basis of emotional instability during sleep debt.	[Motomura, Yuki; Kitamura, Shingo; Oba, Kentaro; Terasawa, Yuri; Enomoto, Minori; Katayose, Yasuko; Hida, Akiko; Moriguchi, Yoshiya; Mishima, Kazuo] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychophysiol, Kodaira, Tokyo, Japan; [Motomura, Yuki] Kyushu Univ, Grad Sch Integrated Frontier Sci, Higashi Ku, Fukuoka 812, Japan; [Higuchi, Shigekazu] Kyushu Univ, Fac Design, Minami Ku, Fukuoka 812, Japan	National Center for Neurology & Psychiatry - Japan; Kyushu University; Kyushu University	Mishima, K (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychophysiol, 4-1-1 Ogawa Higashi, Kodaira, Tokyo, Japan.	mishima@ncnp.go.jp	Terasawa, Yuri/HGA-1834-2022; HIGUCHI, Shigekazu/AAM-5800-2020; Kitamura, Shingo/G-6727-2013	Terasawa, Yuri/0000-0002-2812-0544; Kitamura, Shingo/0000-0001-9607-1812; higuchi, shigekazu/0000-0001-7131-0792; , SHINGO/0000-0002-1928-0490; MISHIMA, KAZUO/0000-0003-1182-1181	Ministry of Education, Culture, Sports, Science and Technology of Japan; Intramural Research Grant for Neurological and Psychiatric Disorders from NCNP [23-3]; KAKENHI [21390335]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Intramural Research Grant for Neurological and Psychiatric Disorders from NCNP; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for the Strategic Research Program for Brain Sciences (Understanding of molecular and environmental bases for brain health) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (URL: http://brainprogram.mext.go.jp/), an Intramural Research Grant (23-3) for Neurological and Psychiatric Disorders from NCNP(URL:http://www.ncnp.go.jp/), and KAKENHI (21390335)(URL:http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHERMANN P, 1993, BRAIN RES BULL, V31, P97, DOI 10.1016/0361-9230(93)90016-5; Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; Akerstedt T, 2009, SLEEP, V32, P217, DOI 10.1093/sleep/32.2.217; BANKS S, 2010, SLEEP S, V33, pA104; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; Basner M, 2007, SLEEP, V30, P1085, DOI 10.1093/sleep/30.9.1085; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; BLISS EL, 1959, ARCH NEURO PSYCHIATR, V81, P348, DOI 10.1001/archneurpsyc.1959.02340150080009; Bonnet MH, 1995, SLEEP, V18, P908, DOI 10.1093/sleep/18.10.908; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; BORBELY AA, 1981, ELECTROEN CLIN NEURO, V51, P483, DOI 10.1016/0013-4694(81)90225-X; Breslau N, 1997, AM J PUBLIC HEALTH, V87, P1649, DOI 10.2105/AJPH.87.10.1649; BRUNNER DP, 1993, SLEEP, V16, P100, DOI 10.1093/sleep/16.2.100; CARSKADON MA, 1981, PSYCHOPHYSIOLOGY, V18, P107, DOI 10.1111/j.1469-8986.1981.tb02921.x; Chalupka S, 2012, WORKPLACE HEALTH SAF, V60, P192, DOI 10.3928/21650799-20120328-26; Chuah LYM, 2008, ANN ACAD MED SINGAP, V37, P689; Chuah LYM, 2010, SLEEP, V33, P1305, DOI 10.1093/sleep/33.10.1305; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P292, DOI 10.1196/annals.1308.033; Dannlowski U, 2007, GENES BRAIN BEHAV, V6, P672, DOI 10.1111/j.1601-183X.2006.00297.x; DIJK DJ, 1993, BRAIN RES, V626, P190, DOI 10.1016/0006-8993(93)90579-C; Dinges DF, 1997, SLEEP, V20, P267; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Elmenhorst D, 2007, J NEUROSCI, V27, P2410, DOI 10.1523/JNEUROSCI.5066-06.2007; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Fitzgerald DA, 2006, NEUROIMAGE, V30, P1441, DOI 10.1016/j.neuroimage.2005.11.003; Franzen PL, 2009, BIOL PSYCHOL, V80, P300, DOI 10.1016/j.biopsycho.2008.10.010; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Gillin JC, 2001, DEPRESS ANXIETY, V14, P37, DOI 10.1002/da.1045; GLOOR P, 1982, ANN NEUROL, V12, P129, DOI 10.1002/ana.410120203; Gujar N, 2011, J NEUROSCI, V31, P4466, DOI 10.1523/JNEUROSCI.3220-10.2011; HALGREN E, 1978, BRAIN, V101, P83, DOI 10.1093/brain/101.1.83; Hampton AN, 2007, NEURON, V55, P545, DOI 10.1016/j.neuron.2007.07.022; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; HORNE JA, 1993, BRIT J PSYCHIAT, V162, P413, DOI 10.1192/bjp.162.3.413; Hublin C, 2001, SLEEP, V24, P392, DOI 10.1093/sleep/24.4.392; Jones BE, 2009, NEURON, V61, P156, DOI 10.1016/j.neuron.2009.01.005; Kaneita Y, 2005, J EPIDEMIOL, V15, P1, DOI 10.2188/jea.15.1; Killgore WDS, 2004, NEUROIMAGE, V21, P1215, DOI 10.1016/j.neuroimage.2003.12.033; Killgore WDS, 2012, NEUROREPORT, V23, P741, DOI 10.1097/WNR.0b013e3283565056; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; Kitamura S, 2010, CHRONOBIOL INT, V27, P1797, DOI 10.3109/07420528.2010.516705; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; Landolt HP, 2008, BIOCHEM PHARMACOL, V75, P2070, DOI 10.1016/j.bcp.2008.02.024; Lu J, 2011, J NEUROSCI, V31, P15065, DOI 10.1523/JNEUROSCI.2364-11.2011; McClure EB, 2007, ARCH GEN PSYCHIAT, V64, P97, DOI 10.1001/archpsyc.64.1.97; McNair D., 1971, MANUAL PROFILE MOOD; Minkel JD, 2012, EMOTION, V12, P1015, DOI 10.1037/a0026871; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Murray EA, 2007, TRENDS COGN SCI, V11, P489, DOI 10.1016/j.tics.2007.08.013; Nomura M, 2004, NEUROIMAGE, V21, P352, DOI 10.1016/j.neuroimage.2003.09.021; Norbury R, 2009, PSYCHOPHARMACOLOGY, V206, P197, DOI 10.1007/s00213-009-1597-1; Ogawa T., 1997, TECHNICAL REPORT I E, V97, P47; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Scott, 1997, Int J Occup Environ Health, V3, pS2; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; SPIELBERGER CD, 1970, STAI MANUAL STAIT TR; Swann CE, 2006, J SLEEP RES, V15, P23, DOI 10.1111/j.1365-2869.2006.00495.x; Urade Y, 2011, SLEEP MED REV, V15, P411, DOI 10.1016/j.smrv.2011.08.003; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2004, SLEEP, V27, P423; Virtanen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030719; Whalen PJ, 1998, J NEUROSCI, V18, P411; Williams LM, 2006, J NEUROSCI, V26, P9264, DOI 10.1523/JNEUROSCI.1016-06.2006; Wirz-Justice A, 1999, BIOL PSYCHIAT, V46, P445, DOI 10.1016/S0006-3223(99)00125-0; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007; Zhong X, 2005, J APPL PHYSIOL, V98, P2024, DOI 10.1152/japplphysiol.00620.2004; Zohar D, 2005, SLEEP, V28, P47, DOI 10.1093/sleep/28.1.47	78	117	122	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56578	10.1371/journal.pone.0056578	http://dx.doi.org/10.1371/journal.pone.0056578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418586	Green Published, gold			2022-12-27	WOS:000315970300179
J	Nye, MD; Hoyo, C; Huang, ZQ; Vidal, AC; Wang, F; Overcash, F; Smith, JS; Vasquez, B; Hernandez, B; Swai, B; Oneko, O; Mlay, P; Obure, J; Gammon, MD; Bartlett, JA; Murphy, SK				Nye, Monica D.; Hoyo, Cathrine; Huang, Zhiqing; Vidal, Adriana C.; Wang, Frances; Overcash, Francine; Smith, Jennifer S.; Vasquez, Brandi; Hernandez, Brenda; Swai, Britta; Oneko, Olola; Mlay, Pendo; Obure, Joseph; Gammon, Marilie D.; Bartlett, John A.; Murphy, Susan K.			Associations between Methylation of Paternally Expressed Gene 3 (PEG3), Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; WOMEN; RISK; BAX	Cytology-based screening for invasive cervical cancer (ICC) lacks sensitivity and specificity to discriminate between cervical intraepithelial neoplasia (CIN) likely to persist or progress from cases likely to resolve. Genome-wide approaches have been used to identify DNA methylation marks associated with CIN persistence or progression. However, associations between DNA methylation marks and CIN or ICC remain weak and inconsistent. Between 2008-2009, we conducted a hospital-based, case-control study among 213 Tanzania women with CIN 1/2/3 or ICC. We collected questionnaire data, biopsies, peripheral blood, cervical scrapes, Human papillomavirus (HPV) and HIV-1 infection status. We assessed PEG3 methylation status by bisulfite pyrosequencing. Multinomial logistic regression was used to estimate odds ratios (OR) and confidence intervals (CI 95%) for associations between PEG3 methylation status and CIN or ICC. After adjusting for age, gravidity, hormonal contraceptive use and HPV infection, a 5% increase in PEG3 DNA methylation was associated with increased risk for ICC (OR = 1.6; 95% CI 1.2-2.1). HPV infection was associated with a higher risk of CIN1-3 (OR = 15.7; 95% CI 5.7-48.6) and ICC (OR = 29.5, 95% CI 6.3-38.4). Infection with high risk HPV was correlated with mean PEG3 differentially methylated regions (DMRs) methylation (r = 0.34 p<0.0001), while the correlation with low risk HPV infection was weaker (r = 0.16 p = 0.047). Although small sample size limits inference, these data support that PEG3 methylation status has potential as a molecular target for inclusion in CIN screening to improve prediction of progression. Impact statement: We present the first evidence that aberrant methylation of the PEG3 DMR is an important co-factor in the development of Invasive cervical carcinoma (ICC), especially among women infected with high risk HPV. Our results show that a five percent increase in DNA methylation of PEG3 is associated with a 1.6-fold increase ICC risk. Suggesting PEG3 methylation status may be useful as a molecular marker for CIN screening to improve prediction of cases likely to progress.	[Nye, Monica D.; Huang, Zhiqing; Overcash, Francine; Murphy, Susan K.] Duke Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Durham, NC 27706 USA; [Hoyo, Cathrine; Vidal, Adriana C.] Duke Univ, Sch Med, Dept Obstet & Gynecol, Program Canc Detect, Durham, NC USA; [Wang, Frances] Duke Univ, Med Ctr, Duke Comprehens Canc Ctr, Durham, NC 27710 USA; [Smith, Jennifer S.; Gammon, Marilie D.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Vasquez, Brandi] Kilmanjaro Christian Med Ctr, Moshi, Tanzania; [Hernandez, Brenda] Univ Hawaii, Canc Res Ctr Hawaii, Honolulu, HI 96813 USA; [Swai, Britta] Tumaini Univ, Kilimanjaro Christian Med Ctr, Dept Pathol, Moshi, Tanzania; [Oneko, Olola; Mlay, Pendo; Obure, Joseph] Tumaini Univ, Kilimanjaro Christian Med Ctr, Dept Obstet & Gynecol, Moshi, Tanzania; [Bartlett, John A.] Duke Univ, Sch Med, Dept Med, Div Infect Dis, Durham, NC 27706 USA; [Bartlett, John A.] Duke Univ, Sch Med, Duke Global Hlth Inst, Durham, NC USA; [Nye, Monica D.] Univ N Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Vasquez, Brandi] Duke Womens Hlth Collaborat, Durham, NC USA	Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Cancer Research Center of Hawaii; University of Hawaii System; Kilimanjaro Christian Medical Centre; Kilimanjaro Christian Medical Centre; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Murphy, SK (corresponding author), Duke Univ, Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Durham, NC 27706 USA.	susan.murphy@duke.edu	Vidal, Adriana/AAG-8944-2021; Murphy, Susan/R-3903-2019	Murphy, Susan/0000-0001-8298-7272	Duke CFAR [P30 AI 064518, R01CA142983, R01CA142983S1, R25CA057726];  [K01104517]; NATIONAL CANCER INSTITUTE [R25CA057726, R01CA142983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085173] Funding Source: NIH RePORTER	Duke CFAR; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants K01104517, Duke CFAR P30 AI 064518, R01CA142983, R01CA142983S1 and R25CA057726. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boonen SE, 2008, EUR J HUM GENET, V16, P453, DOI 10.1038/sj.ejhg.5201993; Crum CP, 1995, J CELL BIOCHEM, P71; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Dong SM, 2001, CLIN CANCER RES, V7, P1982; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Duenas-Gonzalez A, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-38; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Franco EL, 2010, JNCI-J NATL CANCER I, V102, P1451, DOI 10.1093/jnci/djq357; Gloss BS, 2011, CANC LETT; Gravitt PE, 2002, INT J CANCER, V100, P729, DOI 10.1002/ijc.10538; Johnson MD, 2002, J BIOL CHEM, V277, P23000, DOI 10.1074/jbc.M201907200; Lehoux M, 2009, PUBLIC HEALTH GENOM, V12, P268, DOI 10.1159/000214918; Maegawa S, 2001, MOL CARCINOGEN, V31, P1, DOI 10.1002/mc.1034; Marsit CJ, 2009, CARCINOGENESIS, V30, P416, DOI 10.1093/carcin/bgp006; Narayan Gopeshwar, 2003, Mol Cancer, V2, P24, DOI 10.1186/1476-4598-2-24; Otsuka S, 2009, P JPN ACAD B-PHYS, V85, P157, DOI 10.2183/pjab.85.157; Paskett ED, 2010, PREV MED, V50, P74, DOI 10.1016/j.ypmed.2009.09.001; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Vidal AC, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-20; Virmani AK, 2001, CLIN CANCER RES, V7, P584; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wentzensen N, 2009, GYNECOL ONCOL, V112, P293, DOI 10.1016/j.ygyno.2008.10.012	23	68	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56325	10.1371/journal.pone.0056325	http://dx.doi.org/10.1371/journal.pone.0056325			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418553	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300146
J	Wei, HB; Zhou, B; Zhang, F; Tu, YY; Hu, YN; Zhang, BG; Zhai, QW				Wei, Haibin; Zhou, Ben; Zhang, Fang; Tu, Yanyang; Hu, Yanan; Zhang, Baoguo; Zhai, Qiwei			Profiling and Identification of Small rDNA-Derived RNAs and Their Potential Biological Functions	PLOS ONE			English	Article							RIBOSOMAL DNA REPEAT; COMPLETE SEQUENCE; GENE; MICRORNAS; BIOGENESIS; ORGANIZATION; EXPRESSION; GERMLINE; PATHWAY; TRANSCRIPTOME	Small non-coding RNAs constitute a large family of regulatory molecules with diverse functions. Notably, some small non-coding RNAs matched to rDNA have been identified as qiRNAs and small guide RNAs involved in various biological processes. However, a large number of small rDNA-derived RNAs (srRNAs) are usually neglected and yet to be investigated. We systematically investigated srRNAs using small RNA datasets generated by high-throughput sequencing, and found srRNAs are mainly mapped to rRNA coding regions in sense direction. The datasets from immunoprecipitation and high-throughput sequencing demonstrate that srRNAs are co-immunoprecipitated with Argonaute (AGO) proteins. Furthermore, the srRNA expression profile in mouse liver is affected by diabetes. Overexpression or inhibition of srRNAs in cultured cells shows that srRNAs are involved in various signaling pathways. This study presents a global view of srRNAs in total small RNA and AGO protein complex from different species, and demonstrates that srRNAs are correlated with diabetes, and involved in some biological processes. These findings provide new insights into srRNAs and their functions in various physiological and pathological processes.	[Wei, Haibin; Zhou, Ben; Zhang, Fang; Tu, Yanyang; Hu, Yanan; Zhang, Baoguo; Zhai, Qiwei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhai, QW (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	qwzhai@sibs.ac.cn	Zhou, Ben/AAB-5808-2020; Zhou, Ben/G-1850-2017; Zhou, Ben/R-9844-2019	Zhou, Ben/0000-0001-7177-2882; Zhou, Ben/0000-0001-7177-2882; Zhai, Qiwei/0000-0002-9617-7403; Zhang, Fang/0000-0002-7000-554X; zhang, bao guo/0000-0002-0800-0342	National Natural Science Foundation of China [30825009, 30970619, 31030022, 81021002, 31200591]; National Basic Research Program of China (973 Program) [2009CB918403]; Program of Shanghai Subject Chief Scientist [11XD1405800]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-R-09]; Postdoctoral Fellowship Program of Shanghai Institutes for Biological Sciences [2011KIP511]; SA-SIBS Scholarship Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Program of Shanghai Subject Chief Scientist; Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Postdoctoral Fellowship Program of Shanghai Institutes for Biological Sciences; SA-SIBS Scholarship Program	This research was supported by grants from National Natural Science Foundation of China (30825009, 30970619, 31030022, 81021002 and 31200591), National Basic Research Program of China (973 Program, 2009CB918403), Program of Shanghai Subject Chief Scientist (11XD1405800), Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-R-09), Postdoctoral Fellowship Program of Shanghai Institutes for Biological Sciences (2011KIP511) and SA-SIBS Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius L, 2007, BEST PRACT RES CL EN, V21, P587, DOI 10.1016/j.beem.2007.09.001; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basturea GN, 2011, RNA, V17, P338, DOI 10.1261/rna.2448911; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOWMAN LH, 1983, MOL CELL BIOL, V3, P1501, DOI 10.1128/MCB.3.8.1501; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Choudhuri S, 2009, BIOCHEM BIOPH RES CO, V388, P177, DOI 10.1016/j.bbrc.2009.08.039; CHU S, 1994, P NATL ACAD SCI USA, V91, P659, DOI 10.1073/pnas.91.2.659; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Deng W, 2006, GENOME RES, V16, P20, DOI 10.1101/gr.4139206; Elbarbary RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005908; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; GONZALEZ IL, 1995, GENOMICS, V27, P320, DOI 10.1006/geno.1995.1049; Grozdanov P, 2003, GENOMICS, V82, P637, DOI 10.1016/S0888-7543(03)00199-X; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008206; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jin QH, 2010, CELL RES, V20, P470, DOI 10.1038/cr.2010.24; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5; KAPLAN R, 1975, J BIOL CHEM, V250, P1854; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Nemeth A, 2008, EPIGENETICS-US, V3, P243, DOI 10.4161/epi.3.5.6913; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Rederstorff M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq057; SAKAI K, 1995, GENOMICS, V26, P521, DOI 10.1016/0888-7543(95)80170-Q; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076; Sim S, 2011, WIRES RNA, V2, P686, DOI 10.1002/wrna.85; SRIVASTAVA AK, 1993, MAMM GENOME, V4, P445, DOI 10.1007/BF00296819; Stadler PF, 2009, MOL BIOL EVOL, V26, P1975, DOI 10.1093/molbev/msp112; Swaminathan K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r12; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tseng H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001843; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Zentner GE, 2011, NUCLEIC ACIDS RES, V39, P4949, DOI 10.1093/nar/gkq1326; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921; Zundel MA, 2009, RNA, V15, P977, DOI 10.1261/rna.1381309	62	37	39	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56842	10.1371/journal.pone.0056842	http://dx.doi.org/10.1371/journal.pone.0056842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418607	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300201
J	Woodfield, SE; Graves, HK; Hernandez, JA; Bergmann, A				Woodfield, Sarah E.; Graves, Hillary K.; Hernandez, Jacob A.; Bergmann, Andreas			De-Regulation of JNK and JAK/STAT Signaling in ESCRT-II Mutant Tissues Cooperatively Contributes to Neoplastic Tumorigenesis	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; TUMOR-SUPPRESSOR GENE; DROSOPHILA-MELANOGASTER; ENDOCYTIC CONTROL; ENDOSOMAL ENTRY; APAF-1 HOMOLOG; PATHWAY; GROWTH; ACTIVATION; TSG101	Multiple genes involved in endocytosis and endosomal protein trafficking in Drosophila have been shown to function as neoplastic tumor suppressor genes (nTSGs), including Endosomal Sorting Complex Required for Transport-II (ESCRT-II) components vacuolar protein sorting 22 (vps22), vps25, and vps36. However, most studies of endocytic nTSGs have been done in mosaic tissues containing both mutant and non-mutant populations of cells, and interactions among mutant and non-mutant cells greatly influence the final phenotype. Thus, the true autonomous phenotype of tissues mutant for endocytic nTSGs remains unclear. Here, we show that tissues predominantly mutant for ESCRT-II components display characteristics of neoplastic transformation and then undergo apoptosis. These neoplastic tissues show upregulation of c-Jun N-terminal Kinase (JNK), Notch, and Janus Kinase (JAK)/Signal Transducer and Activator of Transcription (STAT) signaling. Significantly, while inhibition of JNK signaling in mutant tissues partially inhibits proliferation, inhibition of JAK/STAT signaling rescues other aspects of the neoplastic phenotype. This is the first rigorous study of tissues predominantly mutant for endocytic nTSGs and provides clear evidence for cooperation among de-regulated signaling pathways leading to tumorigenesis.	[Woodfield, Sarah E.; Bergmann, Andreas] Baylor Coll Med, Grad Program Dev Biol, Houston, TX 77030 USA; [Woodfield, Sarah E.; Graves, Hillary K.; Hernandez, Jacob A.; Bergmann, Andreas] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Bergmann, Andreas] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Massachusetts System; University of Massachusetts Worcester	Bergmann, A (corresponding author), Baylor Coll Med, Grad Program Dev Biol, Houston, TX 77030 USA.	Andreas.Bergmann@umassmed.edu	Woodfield, Sarah/AAG-9602-2022; Woodfield, Sarah/AEW-0563-2022		National Insitutes of Health [R01 GM068016]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068016] Funding Source: NIH RePORTER	National Insitutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01 GM068016 from the National Insitutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Bach EA, 2003, GENETICS, V165, P1149; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Bache KG, 2004, MOL BIOL CELL, V15, P4337, DOI 10.1091/mbc.E04-03-0250; Beaucher M, 2007, DEV BIOL, V303, P625, DOI 10.1016/j.ydbio.2006.12.001; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Chen CL, 2012, P NATL ACAD SCI USA, V109, P484, DOI 10.1073/pnas.1113882109; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; Devergne O, 2007, J CELL SCI, V120, P3457, DOI 10.1242/jcs.005926; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Ghiglione C, 2002, DEVELOPMENT, V129, P5437, DOI 10.1242/dev.00116; Gilbert MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007083; Graves HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037615; HANRATTY WP, 1993, MOL GEN GENET, V238, P33, DOI 10.1007/BF00279527; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Herz HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004165; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Irion U, 2007, NATURE, V445, P554, DOI 10.1038/nature05503; Kanuka H, 1999, MOL CELL, V4, P757, DOI 10.1016/S1097-2765(00)80386-X; Koon N, 2004, GUT, V53, P235, DOI 10.1136/gut.2003.021238; KRAMATSCHEK B, 1994, DEVELOPMENT, V120, P815; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Li J, 2008, CELL CYCLE, V7, P2886, DOI 10.4161/cc.7.18.6677; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Liu RT, 2002, ONCOGENE, V21, P4830, DOI 10.1038/sj.onc.1205612; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Luo H, 2002, MOL GENET GENOMICS, V267, P57, DOI 10.1007/s00438-001-0632-7; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Menut L, 2007, GENETICS, V177, P1667, DOI 10.1534/genetics.107.078360; Meyer CA, 2000, EMBO J, V19, P4533, DOI 10.1093/emboj/19.17.4533; Mills K, 2006, J CELL BIOL, V172, P809, DOI 10.1083/jcb.200512126; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Morrison HA, 2008, MOL BIOL CELL, V19, P4167, DOI 10.1091/mbc.E08-07-0716; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oh KB, 2007, ONCOGENE, V26, P5950, DOI 10.1038/sj.onc.1210401; Ohsawa S, 2011, DEV CELL, V20, P315, DOI 10.1016/j.devcel.2011.02.007; Ring JM, 1993, DEVELOPMENT S, V121, P251; Robinson BS, 2011, CELL CYCLE, V10, P4110, DOI 10.4161/cc.10.23.18243; Rodahl LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004354; Rodrigues AB, 2012, DEVELOPMENT, V139, P4051, DOI 10.1242/dev.076760; Rodriguez A, 2002, EMBO J, V21, P2189, DOI 10.1093/emboj/21.9.2189; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Shlevkov E, 2012, CELL DEATH DIFFER, V19, P451, DOI 10.1038/cdd.2011.113; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Srivastava M, 2007, CELL DEATH DIFFER, V14, P92, DOI 10.1038/sj.cdd.4401931; Stowers RS, 1999, GENETICS, V152, P1631; Suissa Y, 2011, J BIOL CHEM, V286, P15556, DOI 10.1074/jbc.M110.193235; Teis D, 2009, CELL, V137, DOI 10.1016/j.cell.2009.03.027; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Tsai YC, 2004, GENESIS, V39, P141, DOI 10.1002/gene.20035; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Vaccari T, 2009, J CELL SCI, V122, P2413, DOI 10.1242/jcs.046391; Wagner KU, 2003, MOL CELL BIOL, V23, P150, DOI 10.1128/MCB.23.1.150-162.2003; Walker GE, 2006, ONCOGENE, V25, P1943, DOI 10.1038/sj.onc.1209213; Xu ZH, 2003, BIOCHEM BIOPH RES CO, V311, P1057, DOI 10.1016/j.bbrc.2003.10.109; Young TW, 2007, MOL CELL PROTEOMICS, V6, P294, DOI 10.1074/mcp.M600305-MCP200; Zhou L, 1999, MOL CELL, V4, P745, DOI 10.1016/S1097-2765(00)80385-8	65	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56021	10.1371/journal.pone.0056021	http://dx.doi.org/10.1371/journal.pone.0056021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418496	gold, Green Submitted, Green Published			2022-12-27	WOS:000315970300088
J	Luo, WR; Li, SY; Peng, BL; Ye, YF; Deng, XB; Yao, KT				Luo, Weiren; Li, Siyi; Peng, Bailu; Ye, Yanfen; Deng, Xubin; Yao, Kaitai			Embryonic Stem Cells Markers SOX2, OCT4 and Nanog Expression and Their Correlations with Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							CYCLE ARREST; CANCER; PLURIPOTENCY; COEXPRESSION; NICHE	Expression of embryonic stem cells (ESCs) markers (SOX2, OCT4, Nanog and Nestin) is crucial for progression of various human malignancies. The purpose of this study was to investigate the expression and prognostic impact of these molecules in nasopharyngeal carcinoma (NPC) patients by immunohistochemistry and immunofluorescence. In the present study, we found that the expression levels of SOX2, OCT4 and Nanog were highly expressed in NPC compared with the non-tumorous tissues. Furthermore, these proteins correlated significantly with several clinicalpathological factors and epithelial-mesenchymal transition (EMT)-associated indicators (E-cadherin/N-cadherin and Snail). In multivariate analyses, high expression of OCT4 (P = 0.013) and Nanog (P = 0.040), but not that of SOX2, was associated with worse survival and had strongly independent prognostic effects. Of note, OCT4 and Nanog were more frequently located at the invasive front of tumors, and correlated significantly with various aggressive behaviors including T classification, N classification, M classification and clinical stage. Furthermore, patients with co-expression of OCT4 and Nanog in the invasive front had significantly worse survival (P = 0.005). Interestingly, at the invasive front, these molecules correlated significantly with Nestin expression in endothelial cells (P < 0.001). These findings provide evidence that ESCs biomarkers OCT4 and Nanog serves as independent prognostic factors for NPC. Additionally, cancer cells in the invasive front of NPC acquiring ESCs-like features should be maintained by vascular niches.	[Luo, Weiren; Li, Siyi] Guangdong Med Coll, Secondary Clin Coll, Dept Pathol, Dongguan, Peoples R China; [Luo, Weiren; Peng, Bailu; Ye, Yanfen; Deng, Xubin; Yao, Kaitai] Southern Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China	Guangdong Medical University; Southern Medical University - China	Yao, KT (corresponding author), Southern Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China.	yao.kaitai@yahoo.cn	Luo, Weiren/AAI-8364-2020	Luo, Weiren/0000-0002-2762-6332	National Natural Science Foundation of China [81202125]; National Natural Science Foundation of China - Guangdong Joint Fund [u0732006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China - Guangdong Joint Fund	This work was supported by National Natural Science Foundation of China (81202125) and National Natural Science Foundation of China - Guangdong Joint Fund (u0732006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Cabarcas SM, 2011, INT J CANCER, V129, P2315, DOI 10.1002/ijc.26312; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Ferletta M, 2011, INT J CANCER, V129, P45, DOI 10.1002/ijc.25647; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x; Han JH, 2012, CANCER LETT, V321, P80, DOI 10.1016/j.canlet.2012.02.021; Han X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041335; He H, 2012, J CLIN NEUROSCI, V19, P121, DOI 10.1016/j.jocn.2011.07.026; Hu JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045965; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Kong QL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000940; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Lee C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050501; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Li CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049693; Li JN, 2013, INT J CANCER, V133, P525, DOI 10.1002/ijc.27896; Li X, 2009, CURR MOL MED, V9, P751, DOI 10.2174/156652409788970698; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luo WR, 2012, ANN SURG ONCOL, V19, P2971, DOI 10.1245/s10434-012-2347-x; Luo WR, 2012, HISTOPATHOLOGY, V61, P237, DOI 10.1111/j.1365-2559.2012.04212.x; Luo WR, 2012, HISTOPATHOLOGY, V61, P113, DOI 10.1111/j.1365-2559.2012.04205.x; Luo WR, 2012, INT J CANCER, V131, P1863, DOI 10.1002/ijc.27467; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsuoka J, 2012, J SURG RES, V174, P130, DOI 10.1016/j.jss.2010.11.903; Mei YP, 2007, CELL CYCLE, V6, P1379, DOI 10.4161/cc.6.11.4274; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Saigusa S, 2009, ANN SURG ONCOL, V16, P3488, DOI 10.1245/s10434-009-0617-z; Sarkar D, 2012, INT J CANCER, V130, P328, DOI 10.1002/ijc.26029; Scheel C, 2011, INT J CANCER, V129, P2310, DOI 10.1002/ijc.26311; Sholl LM, 2010, AM J SURG PATHOL, V34, P1193, DOI 10.1097/PAS.0b013e3181e5e024; Sneddon JB, 2007, CELL STEM CELL, V1, P607, DOI 10.1016/j.stem.2007.11.009; Suzuki S, 2010, J HISTOCHEM CYTOCHEM, V58, P721, DOI 10.1369/jhc.2010.955609; Wang Pei, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P261; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Werling AM, 2011, HISTOPATHOLOGY, V58, P286, DOI 10.1111/j.1365-2559.2011.03748.x; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Yin X, 2012, ANN SURG ONCOL, V19, P2877, DOI 10.1245/s10434-012-2314-6; Zhang Y, 2010, J OTOLARYNGOL-HEAD N, V39, P157, DOI 10.2310/7070.2009.090150	50	133	141	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56324	10.1371/journal.pone.0056324	http://dx.doi.org/10.1371/journal.pone.0056324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424657	Green Published, Green Submitted, gold			2022-12-27	WOS:000315965100045
J	Betti, L; von Cramon-Taubadel, N; Manica, A; Lycett, SJ				Betti, Lia; von Cramon-Taubadel, Noreen; Manica, Andrea; Lycett, Stephen J.			Global Geometric Morphometric Analyses of the Human Pelvis Reveal Substantial Neutral Population History Effects, Even across Sexes	PLOS ONE			English	Article							HUMAN GENETIC DIVERSITY; BODY-SIZE; DIFFERENTIAL PRESERVATION; CRANIOMETRIC VARIATION; MULTIVARIATE-ANALYSIS; NATURAL-SELECTION; SEXUAL-DIMORPHISM; PATTERNS; EVOLUTION; DISTANCE	Recent applications of population genetic models to human craniodental traits have revealed a strong neutral component to patterns of global variation. However, little work has been undertaken to determine whether neutral processes might also be influencing the postcranium, perhaps due to substantial evidence for selection and plastic environmental responses in these regions. Recent work has provided evidence for neutral effects in the pelvis, but has been limited in regard to shape data (small numbers of linear measurements) and restricted only to males. Here, we use geometric morphometric methods to examine population variation in the human os coxae (pelvic bone) in both males and females. Neutrality is examined via apportionment of variance patterns and fit to an Out-of-Africa serial founder effect model, which is known to structure neutral genetic patterns. Moreover, we compare males and females directly, and the true versus false pelvis, in order to examine potential obstetrical effects. Our results indicate evidence for substantial neutral population history effects on pelvic shape variation. They also reveal evidence for the effect of obstetrical constraints, but these affect males and females to equivalent extents. Our results do not deny an important role for selection in regard to specific aspects of human pelvic variation, especially in terms of features associated with body size and proportions. However, our analyses demonstrate that at a global level, the shape of the os coxae reveals substantial evidence for neutral variation. Our analyses thus indicate that population variation in the human pelvis might be used to address important questions concerning population history, just as the human cranium has done.	[Betti, Lia; von Cramon-Taubadel, Noreen; Lycett, Stephen J.] Univ Kent, Dept Anthropol, Sch Anthropol & Conservat, Canterbury, Kent, England; [Betti, Lia] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England; [Manica, Andrea] Univ Cambridge, Dept Zool, Cambridge, England	University of Kent; University of Cambridge; University of Cambridge	Betti, L (corresponding author), Univ Kent, Dept Anthropol, Sch Anthropol & Conservat, Canterbury, Kent, England.	lb386@cam.ac.uk	Manica, Andrea/N-9013-2019; Manica, Andrea/B-5497-2008	Manica, Andrea/0000-0003-1895-450X; Manica, Andrea/0000-0003-1895-450X; Betti, Lia/0000-0003-2895-9718	Wenner-Gren Foundation for Anthropological Research; University of Kent; Sigma Xi [G20100315153260]; SYNTHESYS Project; European Community Research Infrastructure Action; American Museum of Natural History	Wenner-Gren Foundation for Anthropological Research; University of Kent; Sigma Xi; SYNTHESYS Project; European Community Research Infrastructure Action(European Commission); American Museum of Natural History	This study was funded by the Wenner-Gren Foundation for Anthropological Research (http://www.wennergren.org/, fieldwork dissertation grant #8289), a Ian and Christine Bolt scholarship from the University of Kent (http://www.kent.ac.uk/scholarships/postgraduate/christine_bolt.html), Sigma Xi (http://www.sigmaxi.org/, grant G20100315153260), two grants from the SYNTHESYS Project (http://www.synthesys.info/) which is financed by European Community Research Infrastructure Action under the FP7 "Capacities" Program, the American Museum of Natural History (http://www.amnh.org/, collection study grant), and a University of Kent Ph.D. research scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello L, 1990, INTRO HUMAN EVOLUTIO; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BERGE C, 1984, J HUM EVOL, V13, P555, DOI 10.1016/S0047-2484(84)80027-5; Betti L, 2012, HUM BIOL, V84, P139, DOI 10.3378/027.084.0203; Betti L, 2010, AM J PHYS ANTHROPOL, V141, P76, DOI 10.1002/ajpa.21115; Betti L, 2009, P ROY SOC B-BIOL SCI, V276, P809, DOI 10.1098/rspb.2008.1563; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Correia H, 2005, HOMO, V56, P153, DOI 10.1016/j.jchb.2005.05.003; COX M, 1992, AM J PHYS ANTHROPOL, V89, P431, DOI 10.1002/ajpa.1330890404; CURREY J, 1984, AM ZOOL, V24, P5; de Azevedo S, 2011, AM J PHYS ANTHROPOL, V146, P539, DOI 10.1002/ajpa.21564; DeSilva JM, 2011, P NATL ACAD SCI USA, V108, P1022, DOI 10.1073/pnas.1003865108; DEVOR EJ, 1987, J CRAN GENET DEV BIO, V7, P95; Dunsworth HM, 2012, P NATL ACAD SCI USA, V109, P15212, DOI 10.1073/pnas.1205282109; Edwards AWF, 2003, BIOESSAYS, V25, P798, DOI 10.1002/bies.10315; Eller E, 1999, AM J PHYS ANTHROPOL, V108, P147, DOI 10.1002/(SICI)1096-8644(199902)108:2<147::AID-AJPA2>3.0.CO;2-E; Franklin D, 2010, AM J HUM BIOL, V22, P23, DOI 10.1002/ajhb.20908; Gonzalez-Jose R, 2004, AM J PHYS ANTHROPOL, V123, P69, DOI 10.1002/ajpa.10302; Hanihara T, 2008, AM J PHYS ANTHROPOL, V136, P169, DOI 10.1002/ajpa.20792; HARPENDING HC, 1973, METHODS THEORIES ANT, P177; Harvati K, 2007, VERTEBR PALEOBIOL PA, P239; Harvati K, 2006, ANAT REC PART A, V288A, P1225, DOI 10.1002/ar.a.20395; Holliday TW, 2010, AM J PHYS ANTHROPOL, V142, P287, DOI 10.1002/ajpa.21226; Holliday TW, 1997, AM J PHYS ANTHROPOL, V104, P245, DOI 10.1002/(SICI)1096-8644(199710)104:2<245::AID-AJPA10>3.3.CO;2-8; Holliday TW, 1997, J HUM EVOL, V32, P423, DOI 10.1006/jhev.1996.0111; Hubbe M, 2011, AM J PHYS ANTHROPOL, V144, P442, DOI 10.1002/ajpa.21425; Hubbe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011105; ISCAN M Y, 1984, Florida Scientist, V47, P94; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Krogman WM, 1951, AM J PHYS ANTHROP-NE, V9, P211, DOI 10.1002/ajpa.1330090208; Kurki HK, 2007, AM J PHYS ANTHROPOL, V133, P1152, DOI 10.1002/ajpa.20636; Kurki HK, 2011, J HUM EVOL, V61, P631, DOI 10.1016/j.jhevol.2011.07.006; LATTER BDH, 1980, AM NAT, V116, P220, DOI 10.1086/283624; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lieberman DE, 1996, AM J PHYS ANTHROPOL, V101, P217, DOI 10.1002/(SICI)1096-8644(199610)101:2<217::AID-AJPA7>3.3.CO;2-7; Long JC, 2003, HUM BIOL, V75, P449, DOI 10.1353/hub.2003.0058; Long JC, 2009, HUM BIOL, V81, P799, DOI 10.3378/027.081.0622; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; Manica A, 2005, HUM GENET, V118, P366, DOI 10.1007/s00439-005-0039-3; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; MCHENRY HM, 1978, AM J PHYS ANTHROPOL, V48, P215, DOI 10.1002/ajpa.1330480216; O'Higgins P, 1998, J ANAT, V193, P251, DOI 10.1046/j.1469-7580.1998.19320251.x; PHENICE TW, 1969, AM J PHYS ANTHROPOL, V30, P297, DOI 10.1002/ajpa.1330300214; Pinhasi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006747; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Relethford JH, 1997, HUM BIOL, V69, P443; Relethford JH, 2002, AM J PHYS ANTHROPOL, V118, P393, DOI 10.1002/ajpa.10079; RELETHFORD JH, 1990, HUM BIOL, V62, P5; Relethford JH, 2004, HUM BIOL, V76, P499, DOI 10.1353/hub.2004.0060; Relethford JH, 2004, AM J HUM BIOL, V16, P379, DOI 10.1002/ajhb.20045; RELETHFORD JH, 1994, AM J PHYS ANTHROPOL, V95, P53, DOI 10.1002/ajpa.1330950105; Relethford JH, 2010, AM J PHYS ANTHROPOL, V142, P105, DOI 10.1002/ajpa.21207; Reynolds E, 1931, PAP PEABODY MUS AM A, V11, P255; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1990, ANNU REV ECOL SYST, V21, P299, DOI 10.1146/annurev.es.21.110190.001503; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Roseman CC, 2004, AM J PHYS ANTHROPOL, V125, P257, DOI 10.1002/ajpa.10424; Roseman CC, 2004, P NATL ACAD SCI USA, V101, P12824, DOI 10.1073/pnas.0402637101; Roseman CC, 2007, BIOESSAYS, V29, P1185, DOI 10.1002/bies.20678; Rosenberg Karen, 1995, Evolutionary Anthropology, V4, P161, DOI 10.1002/evan.1360040506; ROSENBERG KR, 1992, YEARB PHYS ANTHROPOL, V35, P89; Ruff C, 2002, ANNU REV ANTHROPOL, V31, P211, DOI 10.1146/annurev.anthro.31.040402.085407; RUFF CB, 1991, J HUM EVOL, V21, P81, DOI 10.1016/0047-2484(91)90001-C; Ruff C, 2010, J HUM EVOL, V58, P166, DOI 10.1016/j.jhevol.2009.10.003; Ruff Christopher B., 1994, Yearbook of Physical Anthropology, V37, P65; Ruff Christopher B., 1993, Evolutionary Anthropology, V2, P53, DOI 10.1002/evan.1360020207; RYMAN N, 1983, HUM HERED, V33, P93, DOI 10.1159/000153357; Schultz AH, 1936, Q REV BIOL, V11, P425, DOI 10.1086/394517; Slice DE, 1996, NATO ADV SCI INST SE, V284, P179; Smith HF, 2009, AM J HUM BIOL, V21, P36, DOI 10.1002/ajhb.20805; Smith HF, 2011, J EVOLUTION BIOL, V2011; STEUDEL K, 1978, J HUM EVOL, V7, P583, DOI 10.1016/S0047-2484(78)80044-X; Stock J, 2001, AM J PHYS ANTHROPOL, V115, P337, DOI 10.1002/ajpa.1090; Stock JT, 2006, AM J PHYS ANTHROPOL, V131, P194, DOI 10.1002/ajpa.20398; SUTHERLAND LD, 1991, J FORENSIC SCI, V36, P501; TAGUE RG, 1989, AM J PHYS ANTHROPOL, V80, P59, DOI 10.1002/ajpa.1330800108; TAGUE RG, 1995, AM J PHYS ANTHROPOL, V97, P213, DOI 10.1002/ajpa.1330970302; TAGUE RG, 1992, AM J PHYS ANTHROPOL, V88, P1, DOI 10.1002/ajpa.1330880102; Thomas H, 1939, AM J OBSTET GYNECOL, V38, P634, DOI 10.1016/S0002-9378(39)90362-5; von Cramon-Taubadel N, 2008, AM J PHYS ANTHROPOL, V136, P108, DOI 10.1002/ajpa.20775; von Cramon-Taubadel N, 2007, AM J PHYS ANTHROPOL, V134, P24, DOI 10.1002/ajpa.20616; von Cramon-Taubadel N, 2011, P NATL ACAD SCI USA, V108, P19546, DOI 10.1073/pnas.1113050108; von Cramon-Taubadel N, 2011, AM J PHYS ANTHROPOL, V146, P83, DOI 10.1002/ajpa.21550; von Cramon-Taubadel N, 2011, P ROY SOC B-BIOL SCI, V278, P2874, DOI 10.1098/rspb.2010.2678; von Cramon-Taubadel N, 2009, EVOL ANTHROPOL, V18, P237, DOI 10.1002/evan.20233; von Cramon-Taubadel N, 2009, AM J PHYS ANTHROPOL, V140, P205, DOI 10.1002/ajpa.21041; von Cramon-Taubadel N, 2009, J HUM EVOL, V57, P179, DOI 10.1016/j.jhevol.2009.05.009; Walker PL, 2005, AM J PHYS ANTHROPOL, V127, P385, DOI 10.1002/ajpa.10422; Ward CV, 2002, YEARB PHYS ANTHROPOL, V45, P185, DOI 10.1002/ajpa.10185; WASHBURN SL, 1960, SCI AM, V203, P63; Waterman HC, 1929, B AM MUS NAT HIST, V58, P585; Weaver TD, 2002, THESIS STANFORD U PA; Weaver TD, 2008, P NATL ACAD SCI USA, V105, P4645, DOI 10.1073/pnas.0709079105; Weaver TD, 2007, J HUM EVOL, V53, P135, DOI 10.1016/j.jhevol.2007.03.001; Weaver TD, 2009, P NATL ACAD SCI USA, V106, P8151, DOI 10.1073/pnas.0812554106; Wells JCK, 2012, AM J PHYS ANTHROPOL, V149, P40, DOI 10.1002/ajpa.22160; WILLIAMSBLANGERO S, 1992, HUM BIOL, V64, P35; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	104	53	53	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55909	10.1371/journal.pone.0055909	http://dx.doi.org/10.1371/journal.pone.0055909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409086	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200088
J	Borissoff, JI; Otten, JJT; Heeneman, S; Leenders, P; van Oerle, R; Soehnlein, O; Loubele, STBG; Hamulyak, K; Hackeng, TM; Daemen, MJAP; Degen, JL; Weiler, H; Esmon, CT; van Ryn, J; Biessen, EAL; Spronk, HMH; ten Cate, H				Borissoff, Julian I.; Otten, Jeroen J. T.; Heeneman, Sylvia; Leenders, Peter; van Oerle, Rene; Soehnlein, Oliver; Loubele, Sarah T. B. G.; Hamulyak, Karly; Hackeng, Tilman M.; Daemen, Mat J. A. P.; Degen, Jay L.; Weiler, Hartmut; Esmon, Charles T.; van Ryn, Joanne; Biessen, Erik A. L.; Spronk, Henri M. H.; ten Cate, Hugo			Genetic and Pharmacological Modifications of Thrombin Formation in Apolipoprotein E-deficient Mice Determine Atherosclerosis Severity and Atherothrombosis Onset in a Neutrophil-Dependent Manner	PLOS ONE			English	Article							SUDDEN CORONARY DEATH; COLONY-STIMULATING FACTOR; PLAQUE STABILITY; P-SELECTIN; INFLAMMATION; ATHEROGENESIS; COAGULATION; MECHANISMS; DISEASE; ACTIVATION	Background: Variations in the blood coagulation activity, determined genetically or by medication, may alter atherosclerotic plaque progression, by influencing pleiotropic effects of coagulation proteases. Published experimental studies have yielded contradictory findings on the role of hypercoagulability in atherogenesis. We therefore sought to address this matter by extensively investigating the in vivo significance of genetic alterations and pharmacologic inhibition of thrombin formation for the onset and progression of atherosclerosis, and plaque phenotype determination. Methodology/Principal Findings: We generated transgenic atherosclerosis-prone mice with diminished coagulant or hypercoagulable phenotype and employed two distinct models of atherosclerosis. Gene-targeted 50% reduction in prothrombin (FII-/WT:ApoE(-/-)) was remarkably effective in limiting disease compared to control ApoE(-/-) mice, associated with significant qualitative benefits, including diminished leukocyte infiltration, altered collagen and vascular smooth muscle cell content. Genetically-imposed hypercoagulability in TMPro/Pro:ApoE(-/-) mice resulted in severe atherosclerosis, plaque vulnerability and spontaneous atherothrombosis. Hypercoagulability was associated with a pronounced neutrophilia, neutrophil hyper-reactivity, markedly increased oxidative stress, neutrophil intraplaque infiltration and apoptosis. Administration of either the synthetic specific thrombin inhibitor Dabigatran etexilate, or recombinant activated protein C (APC), counteracted the pro-inflammatory and pro-atherogenic phenotype of pro-thrombotic TMPro/Pro:ApoE(-/-) mice. Conclusions/Significance: We provide new evidence highlighting the importance of neutrophils in the coagulation-inflammation interplay during atherogenesis. Our findings reveal that thrombin-mediated proteolysis is an unexpectedly powerful determinant of atherosclerosis in multiple distinct settings. These studies suggest that selective anticoagulants employed to prevent thrombotic events may also be remarkably effective in clinically impeding the onset and progression of cardiovascular disease.	[Borissoff, Julian I.; Leenders, Peter; van Oerle, Rene; Loubele, Sarah T. B. G.; Hamulyak, Karly; Spronk, Henri M. H.; ten Cate, Hugo] Maastricht Univ, Med Ctr, Lab Clin Thrombosis & Hemostasis, Dept Internal Med,Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Borissoff, Julian I.] Harvard Univ, Sch Med, Program Cellular & Mol Med, Boston Childrens Hosp, Boston, MA USA; [Borissoff, Julian I.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Otten, Jeroen J. T.; Heeneman, Sylvia; Daemen, Mat J. A. P.; Biessen, Erik A. L.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Expt Vasc Pathol Res Grp, Dept Pathol, Maastricht, Netherlands; [Soehnlein, Oliver] Rhein Westfal TH Aachen, Fac Med, Inst Cardiovasc Mol Res, Aachen, Germany; [Hackeng, Tilman M.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Med Ctr, Maastricht, Netherlands; [Degen, Jay L.] Univ Cincinnati, Coll Med, Childrens Hosp Res Fdn, Cincinnati, OH USA; [Weiler, Hartmut] Blood Ctr SE Wisconsin Inc, Blood Res Inst, Milwaukee, WI 53233 USA; [Esmon, Charles T.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Esmon, Charles T.] Howard Hughes Med Inst, Oklahoma City, OK USA; [van Ryn, Joanne] Boehringer Ingelheim Pharma GmbH & Co KG, Dept CardioMetab Dis Res, Biberach, Germany	Maastricht University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Maastricht University; RWTH Aachen University; Maastricht University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; Versiti Blood Center of Wisconsin; Oklahoma Medical Research Foundation; Howard Hughes Medical Institute; Boehringer Ingelheim	Borissoff, JI (corresponding author), Maastricht Univ, Med Ctr, Lab Clin Thrombosis & Hemostasis, Dept Internal Med,Cardiovasc Res Inst Maastricht, Maastricht, Netherlands.	j.ilcheff@maastrichtuniversity.nl	Cate, Hugo ten/AAM-4000-2021	Daemen, Mat/0000-0003-1076-199X; Spronk, Henri/0000-0002-3858-334X; Biessen, Erik/0000-0002-6454-8548; Hackeng, Tilman/0000-0003-0142-0843; ten Cate, Hugo/0000-0001-7796-4463	European Commission [MEST-CT-2005-020706]; SenterNovem grant; Maastricht University; Netherlands Organization for Scientific Research (NWO) [825.11.019]; Deutsche Forschungsgemeinschaft [SO876/3-1, SO876/4-1]; Gutenberg Research College Fellowship (Gutenberg University, Mainz, Germany); Bayer; Boehringer Ingelheim; GlaxoSmithKline; Leo Pharma	European Commission(European CommissionEuropean Commission Joint Research Centre); SenterNovem grant; Maastricht University; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gutenberg Research College Fellowship (Gutenberg University, Mainz, Germany); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Leo Pharma(LEO Pharma)	Boehringer Ingelheim GmbH provided Dabigatran etexilate-supplemented and placebo diets. This study was supported by a Marie Curie fellowship (MEST-CT-2005-020706) from the European Commission (to Dr. J.I. Borissoff) and a SenterNovem grant (to Cardiovascular Research Institute Maastricht (CARIM)). Dr. J.I. Borissoff is a recipient of a Kootstra Talent Fellowship (2011) from Maastricht University and is supported by a Rubicon fellowship (825.11.019), granted by the Netherlands Organization for Scientific Research (NWO). Dr. Oliver Soehnlein is supported by the Deutsche Forschungsgemeinschaft (SO876/3-1 and SO876/4-1). Dr. Hugo ten Cate is sponsored by a Gutenberg Research College Fellowship (Gutenberg University, Mainz, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. Boehringer Ingelheim GmbH provided Dabigatran etexilate-supplemented and placebo diets for this study and is the employer of Joanne van Ryn. Dr. ten Cate has received speaker fees from Bayer, Boehringer Ingelheim, GlaxoSmithKline and Leo Pharma. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; Baetta R, 2010, ATHEROSCLEROSIS, V210, P1, DOI 10.1016/j.atherosclerosis.2009.10.028; Bea F, 2006, ARTERIOSCL THROM VAS, V26, P2787, DOI 10.1161/01.ATV.0000246797.05781.ad; Borissoff JI, 2012, JACC-CARDIOVASC IMAG, V5, P1201, DOI 10.1016/j.jcmg.2012.01.023; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Borissoff JI, 2010, CIRCULATION, V122, P821, DOI 10.1161/CIRCULATIONAHA.109.907121; Borissoff JI, 2009, CARDIOVASC RES, V82, P392, DOI 10.1093/cvr/cvp066; Burke AP, 2001, CIRCULATION, V103, P934; Burns AR, 1999, J LEUKOCYTE BIOL, V65, P299, DOI 10.1002/jlb.65.3.299; Castellino FJ, 2006, THROMB HAEMOSTASIS, V96, P794, DOI 10.1160/TH06-08-0430; Cella G, 2006, LEUKEMIA, V20, P1430, DOI 10.1038/sj.leu.2404271; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Degen JL, 2007, J THROMB HAEMOST, V5, P24, DOI 10.1111/j.1538-7836.2007.02519.x; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Demers M, 2012, P NATL ACAD SCI USA, V109, P13076, DOI 10.1073/pnas.1200419109; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Drechsler M, 2011, THROMB HAEMOSTASIS, V106, P839, DOI 10.1160/TH11-07-0501; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Eitzman DT, 2005, CIRCULATION, V111, P1822, DOI 10.1161/01.CIR.0000160854.75779.E8; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Falanga A, 1999, BLOOD, V93, P2506, DOI 10.1182/blood.V93.8.2506.408k31_2506_2514; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Ionita MG, 2010, ARTERIOSCL THROM VAS, V30, P1842, DOI 10.1161/ATVBAHA.110.209296; Iwaki T, 2006, BLOOD, V107, P3883, DOI 10.1182/blood-2005-09-3780; Jackson CL, 2007, ARTERIOSCL THROM VAS, V27, P973, DOI 10.1161/01.ATV.0000261545.53586.f0; Johnston B, 1999, J CLIN INVEST, V103, P1269, DOI 10.1172/JCI5208; Kadoglou NP, 2012, CARDIOVASC DRUGS THE; Kisucka J, 2009, BLOOD, V113, P6015, DOI 10.1182/blood-2008-10-186650; Kramer MCA, 2010, J AM COLL CARDIOL, V55, P122, DOI 10.1016/j.jacc.2009.09.007; Lee IO, 2012, J PHARM EXP THER; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Mann J, 1999, HEART, V82, P265, DOI 10.1136/hrt.82.3.265; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; May AE, 2008, ARTERIOSCL THROM VAS, V28, pS5, DOI 10.1161/ATVBAHA.107.158915; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Nasr N, 2009, ATHEROSCLEROSIS, V207, P519, DOI 10.1016/j.atherosclerosis.2009.05.003; Rittersma SZH, 2005, CIRCULATION, V111, P1160, DOI 10.1161/01.CIR.0000157141.00778.AC; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rotzius P, 2010, AM J PATHOL, V177, P493, DOI 10.2353/ajpath.2010.090480; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Seehaus S, 2009, CIRCULATION, V120, P774, DOI 10.1161/CIRCULATIONAHA.109.849539; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Sun WY, 1998, P NATL ACAD SCI USA, V95, P7597, DOI 10.1073/pnas.95.13.7597; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Uchino K, 2012, ARCH INTERN MED, V172, P397, DOI 10.1001/archinternmed.2011.1666; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; Vicente CP, 2007, BLOOD, V110, P4261, DOI 10.1182/blood-2007-04-086611; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; von der Thusen JH, 2001, CIRCULATION, V103, P1164, DOI 10.1161/01.CIR.103.8.1164; Wei HJ, 2011, CARDIOVASC RES, V92, P317, DOI 10.1093/cvr/cvr220; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006; Westrick RJ, 2001, CIRCULATION, V103, P3044, DOI 10.1161/hc2501.092492; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391	55	99	102	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55784	10.1371/journal.pone.0055784	http://dx.doi.org/10.1371/journal.pone.0055784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409043	Green Submitted, gold, Green Published			2022-12-27	WOS:000315157200063
J	Luo, Z; Liu, HM; Sun, XM; Guo, R; Cui, RB; Ma, XX; Yan, M				Luo, Zheng; Liu, Huimin; Sun, Xiaomeng; Guo, Rong; Cui, Ruibing; Ma, Xiangxing; Yan, Ming			RNA Interference against Discoidin Domain Receptor 2 Ameliorates Alcoholic Liver Disease in Rats	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; FAT-STORING CELLS; MATRIX METALLOPROTEINASE-2; GENE-EXPRESSION; COLLAGEN I; EXTRACELLULAR-MATRIX; HSC-T6 CELLS; FIBROSIS; ACTIVATION; APOPTOSIS	Discoidin domain receptor 2 (DDR2) is involved in fibrotic disease. However, the exact pathogenic implications of the receptor in early alcoholic liver disease are still controversial. We constructed plasmid vectors encoding short-hairpin RNA against DDR2 to investigate its role in alcoholic liver disease in an immortalized rat hepatic stellate cell line, HSC-T6, and in rats by MTT, RT-PCR and western blot analyses; immunohistochemistry and electron microscopy. Alcohol-induced upregulation of DDR2 was associated with the expression of matrix metalloproteinase 2, the transforming growth factor beta 1 signaling pathway and tissue inhibitor of metalloproteinase 1; collagen deposition; and extracellular matrix remodeling. Inhibition of DDR2 decreased HSC-T6 cell proliferation and liver injury in rats with 10-week-induced alcoholic liver disease. DDR2 may have an important role in the pathogenesis of early-stage alcoholic liver disease. Silencing DDR2 may be effective in preventing early-stage alcoholic liver disease.	[Luo, Zheng; Sun, Xiaomeng; Guo, Rong; Cui, Ruibing; Yan, Ming] Shandong Univ, Dept Geriatr Gastroenterol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Luo, Zheng] Shandong Univ, Key Lab Cardiovasc Remodeling, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Liu, Huimin] Qingdao Univ, Dept Gastroenterol & Hepatol, Yantai Yuhuangding Hosp, Coll Med, Yantai, Shandong, Peoples R China; [Ma, Xiangxing] Shandong Univ, Dept Radiol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Qingdao University; Shandong University	Ma, XX (corresponding author), Shandong Univ, Dept Radiol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	maxiangxing@yahoo.com; ymylh@163.com	罗, 争/GYU-2181-2022		Science and Technology Planning Project of Shandong Province, China [2007GG30002002]	Science and Technology Planning Project of Shandong Province, China	This work was supported by Science and Technology Planning Project of Shandong Province, China (grant number 2007GG30002002). We declare that funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2005, DIGEST DIS, V23, P255, DOI 10.1159/000090173; Agarwal G, 2002, BIOCHEMISTRY-US, V41, P11091, DOI 10.1021/bi020087w; Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; Badiola I, 2011, ONCOL REP, V26, P971, DOI 10.3892/or.2011.1356; Bartalis J, 2011, BIOORGAN MED CHEM, V19, P2757, DOI 10.1016/j.bmc.2011.01.037; Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552; CASINI A, 1991, HEPATOLOGY, V13, P758, DOI 10.1016/0270-9139(91)92576-T; CASINI A, 1994, LIFE SCI, V55, P1311, DOI 10.1016/0024-3205(94)00763-2; Chen A, 2002, BIOCHEM J, V368, P683, DOI 10.1042/BJ20020949; Friedman SL, 1999, ALCOHOL CLIN EXP RES, V23, P904, DOI 10.1097/00000374-199905000-00020; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Gukovsky I, 2008, AM J PHYSIOL-GASTR L, V294, pG68, DOI 10.1152/ajpgi.00006.2007; Haas SL, 2012, CURR OPIN CLIN NUTR, V15, P457, DOI 10.1097/MCO.0b013e3283566699; Hartland SN, 2009, LIVER INT, V29, P966, DOI 10.1111/j.1478-3231.2009.02070.x; Huang ZS, 1999, WORLD J GASTROENTERO, V5, P362; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Issa R, 2001, GUT, V48, P548, DOI 10.1136/gut.48.4.548; Jeong WI, 2004, LIVER INT, V24, P658, DOI 10.1111/j.1478-3231.2004.0961.x; Jiang YA, 2005, WORLD J GASTROENTERO, V11, P6780, DOI 10.3748/wjg.v11.i43.6780; Kano K, 2010, MOL REPROD DEV, V77, P29, DOI 10.1002/mrd.21093; Kazuo I, 2003, CONNECT TISSUE, V35, P165; Lim CS, 2010, BIOSCI BIOTECH BIOCH, V74, P477, DOI 10.1271/bbb.90435; Liu Hui-min, 2008, Zhonghua Gan Zang Bing Za Zhi, V16, P425; Mihai C, 2006, J MOL BIOL, V361, P864, DOI 10.1016/j.jmb.2006.06.067; Morales MO, 2005, MICROSC MICROANAL, V11, P260, DOI 10.1017/S1431927605050518; Neuman MG, 2012, INT J HEPATOL, V2012, DOI DOI 10.1155/2012/231210; Nie QH, 2004, WORLD J GASTROENTERO, V10, P86; Nyblom H, 2004, ALCOHOL ALCOHOLISM, V39, P336, DOI 10.1093/alcalc/agh074; Olaso E, 2002, J BIOL CHEM, V277, P3606, DOI 10.1074/jbc.M107571200; Olaso E, 2001, J CLIN INVEST, V108, P1369, DOI 10.1172/JCI12373; Olaso E, 2011, AM J PATHOL, V179, P2894, DOI 10.1016/j.ajpath.2011.09.002; Plewka K, 2009, POSTEP HIG MED DOSW, V63, P303; Radbill BD, 2011, DIGEST DIS SCI, V56, P406, DOI 10.1007/s10620-010-1296-0; Rahn S B, 2001, J Insur Med, V33, P110; SAVOLAINEN V, 1995, J HEPATOL, V23, P524, DOI 10.1016/0168-8278(95)80057-3; Schindhelm RK, 2006, DIABETES-METAB RES, V22, P437, DOI 10.1002/dmrr.666; Sivakumar L, 2010, BIOMATERIALS, V31, P4802, DOI 10.1016/j.biomaterials.2010.02.070; Svegliati-Baroni G, 2001, HEPATOLOGY, V33, P1130, DOI 10.1053/jhep.2001.23788; Tang LX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031350; Theret N, 1999, HEPATOLOGY, V30, P462, DOI 10.1002/hep.510300236; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; URASHIMA S, 1993, ALCOHOL ALCOHOLISM, V28, P77, DOI 10.1093/alcalc/28.Supplement_1B.77; Vogel S, 2000, J LIPID RES, V41, P882; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel W, 1999, FASEB J, V13, pS77, DOI 10.1096/fasebj.13.9001.s77; Wall SJ, 2005, J BIOL CHEM, V280, P40187, DOI 10.1074/jbc.M508226200; Wang Lei, 2006, Zhong Xi Yi Jie He Xue Bao, V4, P281; WITTE MH, 1992, ALCOHOL, V9, P473, DOI 10.1016/0741-8329(92)90083-M; Yin M, 2000, HEPATOLOGY, V31, P117, DOI 10.1002/hep.510310119; Zhang XH, 2010, ARCH MED RES, V41, P586, DOI 10.1016/j.arcmed.2010.10.010	52	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55860	10.1371/journal.pone.0055860	http://dx.doi.org/10.1371/journal.pone.0055860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409069	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200078
J	Makela, SM; Dandona, R; Dilip, TR; Dandona, L				Makela, Susanna M.; Dandona, Rakhi; Dilip, T. R.; Dandona, Lalit			Social Sector Expenditure and Child Mortality in India: A State-Level Analysis from 1997 to 2009	PLOS ONE			English	Article							MATERNAL EDUCATION; INFANT-MORTALITY; SOCIOECONOMIC INEQUALITIES; DEVELOPING-COUNTRIES; HEALTH EXPENDITURE; DETERMINANTS; SURVIVAL	Background: India is unlikely to meet the Millennium Development Goal for child mortality. As public policy impacts child mortality, we assessed the association of social sector expenditure with child mortality in India. Methods and Findings: Mixed-effects regression models were used to assess the relationship of state-level overall social sector expenditure and its major components (health, health-related, education, and other) with mortality by sex among infants and children aged 1-4 years from 1997 to 2009, adjusting for potential confounders. Counterfactual models were constructed to estimate deaths averted due to overall social sector increases since 1997. Increases in per capita overall social sector expenditure were slightly higher in less developed than in more developed states from 1997 to 2009 (2.4-fold versus 2-fold), but the level of expenditure remained 36% lower in the former in 2009. Increase in public expenditure on health was not significantly associated with mortality reduction in infants or at ages 1-4 years, but a 10% increase in health-related public expenditure was associated with a 3.6% mortality reduction (95% confidence interval 0.2-6.9%) in 1-4 years old boys. A 10% increase in overall social sector expenditure was associated with a mortality reduction in both boys (6.8%, 3.5-10.0%) and girls (4.1%, 0.8-7.5%) aged 1-4 years. We estimated 119,807 (95% uncertainty interval 53,409 - 214,662) averted deaths in boys aged 1-4 years and 94,037 (14,725 - 206,684) in girls in India in 2009 that could be attributed to increases in overall social sector expenditure since 1997. Conclusions: Further reduction in child mortality in India would be facilitated if policymakers give high priority to the social sector as a whole for resource allocation in the country's 5-year plan for 2012-2017, as public expenditure on health alone has not had major impact on reducing child mortality.	[Makela, Susanna M.; Dandona, Rakhi; Dilip, T. R.; Dandona, Lalit] Publ Hlth Fdn India, New Delhi, India; [Dandona, Rakhi] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Public Health Foundation of India; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Dandona, R (corresponding author), Publ Hlth Fdn India, New Delhi, India.	rakhi.dandona@phfi.org		Dandona, Rakhi/0000-0003-0926-788X	BUPA Foundation, United Kingdom	BUPA Foundation, United Kingdom	This research was supported by a grant from the BUPA Foundation, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinkugbe O, 2009, SOC WORK PUBLIC HLTH, V24, P131, DOI 10.1080/19371910802569716; [Anonymous], 2009, COMB FIN REV ACC UN; [Anonymous], 2011, CENSUS INDIA 2011 PR, P1; Baldacci E., 2003, J INT DEV, V15, P709, DOI DOI 10.1002/JID.1025; Banister J, 2005, WORLD DEV, V33, P21, DOI 10.1016/j.worlddev.2004.09.003; Basu AM, 2005, SOC SCI MED, V60, P2011, DOI 10.1016/j.socscimed.2004.08.057; Bhalotra S, 2007, HEALTH ECON, V16, P911, DOI 10.1002/hec.1260; BICEGO GT, 1993, SOC SCI MED, V36, P1207, DOI 10.1016/0277-9536(93)90241-U; Chalasani S, 2010, CHANGING RELATIONSHI; CLELAND JG, 1988, SOC SCI MED, V27, P1357, DOI 10.1016/0277-9536(88)90201-8; Dandona L, 2012, BRIT MED J, V12, pe3140; Dev SM., 2002, ECON POLIT WEEKLY, V37, P853; Farahani M, 2010, HEALTH ECON, V19, P1361, DOI 10.1002/hec.1557; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; GBESEMETE KP, 1993, HEALTH POLICY, V24, P155, DOI 10.1016/0168-8510(93)90032-K; Government of India Planning Commission, 2011, FAST SUST MOR INCL G; High Level Expert Group, 2011, HIGH LEV EXP GROUP R; Hojman DE, 1996, APPL ECON, V28, P281, DOI 10.1080/000368496328641; Human Development Unit South Asia Region, 2004, ATT MILL DEV GOALS I, P2004; International Institute for Population Sciences, 2005, NAT FAM HLTH SURV NF; Joe W, 2010, GLOB PUBLIC HEALTH, V5, P493, DOI 10.1080/17441690903213774; Kravdal O, 2004, POP STUD-J DEMOG, V58, P177, DOI 10.1080/0032472042000213721; Kumar C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037515; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Luke N, 2011, DEMOGR RES, V24, P345, DOI 10.4054/DemRes.2011.24.15; Maitra P, 2004, J HEALTH ECON, V23, P259, DOI 10.1016/j.jhealeco.2003.09.002; Measham AR, 1999, ECON POLIT WEEKLY, V34, P1359; Nayar KR, 2007, INDIAN J MED RES, V126, P355; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Pradhan J, 2010, HEALTH POLICY, V98, P114, DOI 10.1016/j.healthpol.2010.05.010; Rao SR, 1997, SOC BIOL, V44, P101; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Registrar General of India, 1997, SAMPL REG SYST STAT; Reserve Bank of India, 2011, HDB STAT IND EC YEAR; United Nations Children's Fund (UNICEF), 2014, STATE WORLDS CHILDRE; Vajpayee AB, 2000, COMMUNICATION; Wagstaff A, 2003, SOC SCI MED, V57, P1529, DOI 10.1016/S0277-9536(02)00555-5; Wang LM, 2003, HEALTH POLICY, V65, P277, DOI 10.1016/S0168-8510(03)00039-3; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8	39	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56285	10.1371/journal.pone.0056285	http://dx.doi.org/10.1371/journal.pone.0056285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092XV	23409166	Green Submitted, Green Published, gold			2022-12-27	WOS:000315157200127
J	Sheikh, MA; Malik, YS; Yu, HL; Lai, MM; Wang, XZ; Zhu, XJ				Sheikh, Muhammad Abid; Malik, Yousra Saeed; Yu, Huali; Lai, Mingming; Wang, Xingzhi; Zhu, Xiaojuan			Epigenetic Regulation of Dpp6 Expression by Dnmt3b and Its Novel Role in the Inhibition of RA Induced Neuronal Differentiation of P19 Cells	PLOS ONE			English	Article							DNA METHYLTRANSFERASES DNMT3A; DIPEPTIDYL PEPTIDASE-IV; EMBRYONAL CARCINOMA-CELLS; RECEPTOR EXPRESSION; BINDING-PROTEINS; GENE-EXPRESSION; STEM-CELLS; METHYLATION; REPRESSOR; UNIQUE	DNA methylation is an important mechanism of gene silencing in mammals catalyzed by a group of DNA methyltransferases including Dnmt1, Dnmt3a, and Dnmt3b which are required for the establishment of genomic methylation patterns during development and differentiation. In this report, we studied the role of DNA methyltransferases during retinoic acid induced neuronal differentiation of P19 cells. We observed an increase in the mRNA and protein level of Dnmt3b, whereas the expression of Dnmt1 and Dnmt3a was decreased after RA treatment of P19 cells which indicated that Dnmt3b is more important during neuronal differentiation of P19 cells. Dnmt3b enriched chromatin library from RA treated P19 cells identified dipeptidyl peptidase 6 (Dpp6) gene as a novel target of Dnmt3b. Further, quantitative ChIP analysis showed that the amount of Dnmt3b recruited on Dpp6 promoter was equal in both RA treated as well as untreated p19 cells. Bisulfite genomic sequencing, COBRA, and methylation specific PCR analysis revealed that Dpp6 promoter was heavily methylated in both RA treated and untreated P19 cells. Dnmt3b was responsible for transcriptional silencing of Dpp6 gene as depletion of Dnmt3b resulted in increased mRNA and protein expression of Dpp6. Consequently, the average methylation of Dpp6 gene promoter was reduced to half in Dnmt3b knockdown cells. In the absence of Dnmt3b, Dnmt3a was associated with Dpp6 gene promoter and regulated its expression and methylation in P19 cells. RA induced neuronal differentiation was inhibited upon ectopic expression of Dpp6 in P19 cells. Taken together, the present study described epigenetic silencing of Dpp6 expression by DNA methylation and established that its ectopic expression can act as negative signal during RA induced neuronal differentiation of P19 cells.	[Sheikh, Muhammad Abid; Malik, Yousra Saeed; Yu, Huali; Lai, Mingming; Wang, Xingzhi; Zhu, Xiaojuan] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China	Northeast Normal University - China	Zhu, XJ (corresponding author), NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China.	zhuxj720@nenu.edu.cn		Zhu, Xiao-Juan/0000-0001-8386-8064	Program for New Century Excellent Talents in University [NCET-07-0173, 111496019]; National Natural Science Foundation of China [30670689, 30871302, 31171042]; Scientific Research Foundation from Northeast Normal University [09ZDQD04]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation from Northeast Normal University	This work was supported by the Program for New Century Excellent Talents in University (NCET-07-0173, 111496019), the National Natural Science Foundation of China (30670689, 30871302 and 31171042), and the Scientific Research Foundation from Northeast Normal University (09ZDQD04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Boatright JH, 2000, BRAIN RES, V887, P211, DOI 10.1016/S0006-8993(00)02990-5; Chedin F, 2011, PROG MOL BIOL TRANSL, V101, P255, DOI 10.1016/B978-0-12-387685-0.00007-X; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Clark BD, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.008.2008; D'Aiuto L, 2011, DIFFERENTIATION, V82, P9, DOI 10.1016/j.diff.2011.03.003; DELECEA L, 1994, MOL BRAIN RES, V25, P286, DOI 10.1016/0169-328X(94)90164-3; Deplus R, 2002, NUCLEIC ACIDS RES, V30, P3831, DOI 10.1093/nar/gkf509; Du J, 2011, ACTA HISTOCHEM, V113, P636, DOI 10.1016/j.acthis.2010.08.001; Fan GP, 2005, CELL RES, V15, P255, DOI 10.1038/sj.cr.7290294; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Hough RB, 1998, P NATL ACAD SCI USA, V95, P13800, DOI 10.1073/pnas.95.23.13800; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kotackova L, 2009, FOLIA BIOL-PRAGUE, V55, P77; Lan J, 2010, ACTA BIOCH BIOPH SIN, V42, P243, DOI 10.1093/abbs/gmq015; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Liu YL, 1996, NUCLEIC ACIDS RES, V24, P2718, DOI 10.1093/nar/24.14.2718; Nadal MS, 2006, BRAIN RES, V1094, P1, DOI 10.1016/j.brainres.2006.03.106; Nadin BM, 2010, J NEUROSCI, V30, P8551, DOI 10.1523/JNEUROSCI.5489-09.2010; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pachernik J, 2005, PHYSIOL RES, V54, P115, DOI 10.33549/physiolres.930526; Qi SY, 2003, BIOCHEM J, V373, P179, DOI 10.1042/BJ20021914; Resende RR, 2007, NEUROSCIENCE, V146, P1169, DOI 10.1016/j.neuroscience.2007.02.041; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Saied MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033213; Schroeder DI, 2011, GENOME RES, V21, P1583, DOI 10.1101/gr.119131.110; Sedo A, 1994, Sb Lek, V95, P285; SEDO A, 1991, PHYSIOL RES, V40, P359; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Singh RP, 2009, CELL TRANSPLANT, V18, P1197, DOI 10.3727/096368909X12483162197204; Stremenova J, 2007, INT J ONCOL, V31, P785; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; Sun W, 2011, NEURON, V71, P1102, DOI 10.1016/j.neuron.2011.08.008; Ulrich H, 2006, CELL PROLIFERAT, V39, P281, DOI 10.1111/j.1365-2184.2006.00385.x; WADA K, 1992, P NATL ACAD SCI USA, V89, P197, DOI 10.1073/pnas.89.1.197; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; Wu H, 2006, PEDIATR RES, V59, p21R, DOI 10.1203/01.pdr.0000203565.76028.2a; Yu HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036988	50	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55826	10.1371/journal.pone.0055826	http://dx.doi.org/10.1371/journal.pone.0055826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409053	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200071
J	Walker, KA; Sims-Lucas, S; Di Giovanni, VE; Schaefer, C; Sunseri, WM; Novitskaya, T; de Caestecker, MP; Chen, F; Bates, CM				Walker, Kenneth A.; Sims-Lucas, Sunder; Di Giovanni, Valeria E.; Schaefer, Caitlin; Sunseri, Whitney M.; Novitskaya, Tatiana; de Caestecker, Mark P.; Chen, Feng; Bates, Carlton M.			Deletion of Fibroblast Growth Factor Receptor 2 from the Peri-Wolffian Duct Stroma Leads to Ureteric Induction Abnormalities and Vesicoureteral Reflux	PLOS ONE			English	Article							BRANCHING MORPHOGENESIS; KIDNEY DEVELOPMENT; DUPLEX KIDNEYS; MUTANT MICE; EXPRESSION; MESENCHYME; PROTEIN; ORIFICE; BUD	Purpose: Pax3cre-mediated deletion of fibroblast growth factor receptor 2 (Fgfr2) broadly in renal and urinary tract mesenchyme led to ureteric bud (UB) induction defects and vesicoureteral reflux (VUR), although the mechanisms were unclear. Here, we investigated whether Fgfr2 acts specifically in peri Wolffian duct stroma (ST) to regulate UB induction and development of VUR and the mechanisms of Fgfr2 activity. Methods: We conditionally deleted Fgfr2 in ST (Fgfr2(ST-/-)) using Tbx18cre mice. To look for ureteric bud induction defects in young embryos, we assessed length and apoptosis of common nephric ducts (CNDs). We performed 3D reconstructions and histological analyses of urinary tracts of embryos and postnatal mice and cystograms in postnatal mice to test for VUR. We performed in situ hybridization and real-time PCR in young embryos to determine mechanisms underlying UB induction defects. Results: We confirmed that Fgfr2 is expressed in ST and that Fgfr2 was efficiently deleted in this tissue in Fgfr2(ST-/-) mice at embryonic day (E) 10.5. E11.5 Fgfr2(ST-/-) mice had randomized UB induction sites with approximately 1/3 arising too high and 1/3 too low from the Wolffian duct; however, apoptosis was unaltered in E12.5 mutant CNDs. While ureters were histologically normal, E15.5 Fgfr2(ST-/-) mice exhibit improper ureteral insertion sites into the bladder, consistent with the ureteric induction defects. While ureter and bladder histology appeared normal, postnatal day (P) 1 mutants had high rates of VUR versus controls (75% versus 3%, p = 0.001) and occasionally other defects including renal hypoplasia and duplex systems. P1 mutant mice also had improper ureteral bladder insertion sites and shortened intravesicular tunnel lengths that correlated with VUR. E10.5 Fgfr2(ST-/-) mice had decreases in Bmp4 mRNA in stromal tissues, suggesting a mechanism underlying the ureteric induction and VUR phenotypes. Conclusion: Mutations in FGFR2 could possibly cause VUR in humans.	[Walker, Kenneth A.; Sims-Lucas, Sunder; Di Giovanni, Valeria E.; Schaefer, Caitlin; Sunseri, Whitney M.] UPMC, Childrens Hosp Pittsburgh, Rangos Res Ctr, Pittsburgh, PA USA; [Novitskaya, Tatiana; de Caestecker, Mark P.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol, Nashville, TN USA; [Chen, Feng] Washington Univ, Sch Med, Dept Internal Med, Div Renal, St Louis, MO 63110 USA; [Bates, Carlton M.] Univ Pittsburgh, Sch Med, Dept Pediat, Div Nephrol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bates, CM (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Div Nephrol, Pittsburgh, PA 15261 USA.	batescm@upmc.edu		Sims-Lucas, Sunder/0000-0003-1908-4809	National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK081128]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081592, R01DK087960, R01DK104374, R01DK081128] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases Grant 1R01DK081128 (to CMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena S, 2007, BJU INT, V100, P407, DOI 10.1111/j.1464-410X.2007.06921.x; Bates CM, 2011, AM J PHYSIOL-RENAL, V301, pF245, DOI 10.1152/ajprenal.00186.2011; Cain JE, 2006, J ANAT, V209, P745, DOI 10.1111/j.1469-7580.2006.00655.x; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Hains D, 2008, PEDIATR RES, V64, P592, DOI 10.1203/PDR.0b013e318187cc12; Hains DS, 2010, J UROLOGY, V183, P2077, DOI 10.1016/j.juro.2009.12.095; Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172; Hoshino T, 2008, GENES CELLS, V13, P159, DOI 10.1111/j.1365-2443.2007.01158.x; LEBOWITZ RL, 1985, PEDIATR RADIOL, V15, P105, DOI 10.1007/BF02388714; Long JZ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-20; MACKIE GG, 1975, J UROLOGY, V114, P274, DOI 10.1016/S0022-5347(17)67007-1; MACKIE GG, 1975, J PEDIATR SURG, V10, P473, DOI 10.1016/0022-3468(75)90187-6; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Miyazaki Y, 2003, KIDNEY INT, V63, P835, DOI 10.1046/j.1523-1755.2003.00834.x; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Murawski IJ, 2006, CLIN GENET, V69, P105, DOI 10.1111/j.1399-0004.2005.00562.x; Poladia DP, 2006, DEV BIOL, V291, P325, DOI 10.1016/j.ydbio.2005.12.034; Sims-Lucas S, 2012, J AM SOC NEPHROLOGY; Sims-Lucas S, 2011, DEVELOPMENT, V138, P1275, DOI 10.1242/dev.062158; Sims-Lucas S, 2011, DEV DYNAM, V240, P240, DOI 10.1002/dvdy.22501; Sims-Lucas S, 2009, J AM SOC NEPHROL, V20, P2525, DOI 10.1681/ASN.2009050532; Sims-Lucas S, 2009, AM J PHYSIOL-RENAL, V297, pF1208, DOI 10.1152/ajprenal.00262.2009; Tabatabaeifar M, 2009, PEDIATR NEPHROL, V24, P2361, DOI 10.1007/s00467-009-1287-6; Walker KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018723; Wang Y, 2009, GENESIS; Weber S, 2008, J AM SOC NEPHROL, V19, P891, DOI 10.1681/ASN.2006111282; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002	28	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56062	10.1371/journal.pone.0056062	http://dx.doi.org/10.1371/journal.pone.0056062			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409123	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000315157200104
J	Wu, S; Tan, GG; Dong, X; Zhu, ZY; Li, WH; Lou, ZY; Chai, YF				Wu, Si; Tan, Guangguo; Dong, Xin; Zhu, Zhenyu; Li, Wuhong; Lou, Ziyang; Chai, Yifeng			Metabolic Profiling Provides a System Understanding of Hypothyroidism in Rats and Its Application	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; TRADITIONAL CHINESE MEDICINE; YANG DEFICIENCY SYNDROME; MASS-SPECTROMETRY; THYROID-HORMONES; TAURINE SUPPLEMENTATION; SINI DECOCTION; PLASMA; LIVER; IDENTIFICATION	Background: Hypothyroidism is a chronic condition of endocrine disorder and its precise molecular mechanism remains obscure. In spite of certain efficacy of thyroid hormone replacement therapy in treating hypothyroidism, it often results in other side effects because of its over-replacement, so it is still urgent to discover new modes of treatment for hypothyroidism. Sini decoction (SND) is a well-known formula of Traditional Chinese Medicine (TCM) and is considered as efficient agents against hypothyroidism. However, its holistic effect assessment and mechanistic understanding are still lacking due to its complex components. Methodology/Principal Findings: A urinary metabonomic method based on ultra performance liquid chromatography coupled to mass spectrometry was employed to explore global metabolic characters of hypothyroidism. Three typical hypothyroidism models (methimazole-, propylthiouracil-and thyroidectomy-induced hypothyroidism) were applied to elucidate the molecular mechanism of hypothyroidism. 17, 21, 19 potential biomarkers were identified with these three hypothyroidism models respectively, primarily involved in energy metabolism, amino acid metabolism, sphingolipid metabolism and purine metabolism. In order to avert the interference of drug interaction between the antithyroid drugs and SND, the thyroidectomy-induced hypothyroidism model was further used to systematically assess the therapeutic efficacy of SND on hypothyroidism. A time-dependent recovery tendency was observed in SND-treated group from the beginning of model to the end of treatment, suggesting that SND exerted a recovery effect on hypothyroidism in a time-dependent manner through partially regulating the perturbed metabolic pathways. Conclusions/Significance: Our results showed that the metabonomic approach is instrumental to understand the pathophysiology of hypothyroidism and offers a valuable tool for systematically studying the therapeutic effects of SND on hypothyroidism.	[Wu, Si; Tan, Guangguo; Dong, Xin; Zhu, Zhenyu; Li, Wuhong; Lou, Ziyang; Chai, Yifeng] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Wu, Si; Zhu, Zhenyu; Li, Wuhong; Chai, Yifeng] Shanghai Key Lab Pharmaceut Metabolite Res, Shanghai, Peoples R China; [Tan, Guangguo] Chinese Peoples Liberat Army, Hosp 22, Geermu, Peoples R China	Naval Medical University	Chai, YF (corresponding author), Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China.	yfchai@smmu.edu.cn			National Natural Science Foundation of China [30873196]; Project of Modernization of Traditional Chinese Medicine of Shanghai [09dZ1975100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Modernization of Traditional Chinese Medicine of Shanghai	The authors appreciate the financial support from the National Natural Science Foundation of China (NO. 30873196) and Project of Modernization of Traditional Chinese Medicine of Shanghai (NO. 09dZ1975100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzoubi KH, 2009, HIPPOCAMPUS, V19, P66, DOI 10.1002/hipo.20476; Babenko NA, 1999, BIOCHEMISTRY-MOSCOW+, V64, P912; Baliga MS, 2011, CRIT REV FOOD SCI, V51, P499, DOI 10.1080/10408391003698669; BECKETT GJ, 1985, BRIT MED J, V291, P427, DOI 10.1136/bmj.291.6493.427; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Briere JJ, 2006, AM J PHYSIOL-CELL PH, V291, pC1114, DOI 10.1152/ajpcell.00216.2006; Cai D, 1999, Zhongguo Zhong Xi Yi Jie He Za Zhi, V19, P415; CAREW LB, 1983, J NUTR, V113, P1756, DOI 10.1093/jn/113.9.1756; Chen J, 2009, ANAL CHIM ACTA, V650, P3, DOI 10.1016/j.aca.2009.03.039; Chinese Pharmacopoeia Commission, 2010, PHARM PEOPL REP CHIN; Clarke Nick, 2004, Treat Endocrinol, V3, P217, DOI 10.2165/00024677-200403040-00003; Constantinou C, 2011, J PROTEOME RES, V10, P869, DOI 10.1021/pr100699m; Ding WJ, 2009, AM J CHINESE MED, V37, P427, DOI 10.1142/S0192415X09006953; Dirican M, 2007, CLIN EXP PHARMACOL P, V34, P833, DOI 10.1111/j.1440-1681.2007.04615.x; Ermantas N, 2010, CLIN APPL THROMB-HEM, V16, P568, DOI 10.1177/1076029609350890; Fegert I, 2012, REPROD TOXICOL, V34, P331, DOI 10.1016/j.reprotox.2012.05.096; Fernstrom J.D., 2007, J NUTR S1, V137, p1548S; Fernstrom JD, 2007, J NUTR, V137, p1539S, DOI 10.1093/jn/137.6.1539S; Flynn RW, 2010, J CLIN ENDOCR METAB, V95, P186, DOI 10.1210/jc.2009-1625; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gorska M, 2003, J PHYSIOL PHARMACOL, V54, P89; He LP, 2009, J ANAL TOXICOL, V33, P588, DOI 10.1093/jat/33.9.588; Hulbert AJ, 2000, BIOL REV, V75, P519, DOI 10.1017/S146479310000556X; Jena S, 2012, MOL BIOL REP, V39, P1193, DOI 10.1007/s11033-011-0849-4; Koromilas C, 2010, METAB BRAIN DIS, V25, P339, DOI 10.1007/s11011-010-9208-8; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Kulikov A, 1999, NEUROENDOCRINOLOGY, V69, P453, DOI 10.1159/000054449; La Vignera S, 2008, Minerva Ginecol, V60, P475; Liang XP, 2011, J PROTEOME RES, V10, P790, DOI 10.1021/pr1009299; Liu Ying, 2006, Zhongguo Zhong Yao Za Zhi, V31, P1269; Liu Yong, 2006, Nan Fang Yi Ke Da Xue Xue Bao, V26, P1559; Lu XM, 2011, TALANTA, V83, P700, DOI 10.1016/j.talanta.2010.09.026; LYMAN EM, 1976, CAN J BIOCHEM CELL B, V54, P15, DOI 10.1139/o76-003; Ma T, 2010, MOL BIOSYST, V6, P613, DOI 10.1039/b914024g; MANNISTO PT, 1978, ACTA ENDOCRINOL-COP, V89, P100, DOI 10.1530/acta.0.0890100; Martinez B, 2009, ENDOCRINOLOGY, V150, P3953, DOI 10.1210/en.2008-1755; Miaorong P, 2010, CHINA J TRADITIONAL; Min Z., 2006, COMP STUDIES CHINESE, P75; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Puzianowska-Kuznicka M, 2006, ACTA BIOCHIM POL, V53, P641, DOI 10.18388/abp.2006_3292; Rahimpour S, 2012, J SURG RES; Sanchez-Huerta KB, 2012, J NEUROSCI RES, V90, P905, DOI 10.1002/jnr.22806; Sangster T, 2006, ANALYST, V131, P1075, DOI 10.1039/b604498k; Singhuber J, 2009, J ETHNOPHARMACOL, V126, P18, DOI 10.1016/j.jep.2009.07.031; Sjoberg S, 1998, EUR J ENDOCRINOL, V139, P493, DOI 10.1530/eje.0.1390493; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Stabouli S, 2010, EXPERT REV CARDIOVAS, V8, P1559, DOI [10.1586/erc.10.141, 10.1586/ERC.10.141]; Tan GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034157; Tan GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027683; Tan GG, 2011, BIOMED CHROMATOGR, V25, P913, DOI 10.1002/bmc.1544; Tas S, 2006, CELL BIOCHEM FUNCT, V24, P153, DOI 10.1002/cbf.1198; VACCARI A, 1990, NEUROSCIENCE, V35, P699, DOI 10.1016/0306-4522(90)90340-A; van Ravenzwaay B, 2007, TOXICOL LETT, V172, P21, DOI 10.1016/j.toxlet.2007.05.021; van Ravenzwaay B, 2012, MUTAT RES-GEN TOX EN, V746, P144, DOI 10.1016/j.mrgentox.2012.01.006; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang XY, 2009, J PROTEOME RES, V8, P2511, DOI 10.1021/pr801086k; Wei J, 2012, J PROTEOME RES, V11, P1302, DOI 10.1021/pr2009725; Wiersinga WM, 2001, HORM RES, V56, P74, DOI 10.1159/000048140; Williams GR, 2009, ENDOKRYNOL POL, V60, P380; Xiang N, 2005, HYPOTHYROIDISM; Xie GX, 2010, J PROTEOME RES, V9, P125, DOI 10.1021/pr900333h; Yao ZZ, 2011, MOL BIOSYST, V7, P2608, DOI 10.1039/c1mb05029j; Yu Z, 1996, HEILONGJIANG MED PHA, V19, P13; Zha LL, 1993, CHINESE J INTEGRATED, V13, P195; Zhang AH, 2010, PLANTA MED, V76, P2026, DOI 10.1055/s-0030-1250542; Zhao Dan-Yang, 2008, Zhong Yao Cai, V31, P1681; Zhao J, 2010, BRIEF BIOINFORM, V11, P417, DOI 10.1093/bib/bbp063; Zhao Ming-qi, 2009, Zhong Yao Cai, V32, P1860	68	150	153	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55599	10.1371/journal.pone.0055599	http://dx.doi.org/10.1371/journal.pone.0055599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409005	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200042
J	Bai, H; Wang, ZJ; Wang, YY; Zhuo, ML; Zhou, QH; Duan, JC; Yang, L; Wu, MN; An, TT; Zhao, J; Wang, J				Bai, Hua; Wang, Zhijie; Wang, Yuyan; Zhuo, Minglei; Zhou, Qinghua; Duan, Jianchun; Yang, Lu; Wu, Meina; An, Tongtong; Zhao, Jun; Wang, Jie			Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; ACQUIRED-RESISTANCE; GENETIC-HETEROGENEITY; KINASE INHIBITORS; GEFITINIB; TUMORS; ADENOCARCINOMAS; AMPLIFICATION; SENSITIVITY; EVOLUTION	Purpose: This study evaluated occurrence and potential clinical significance of intratumoral EGFR mutational heterogeneity in Chinese patients with non-small cell lung cancer (NSCLC). Materials and Methods: Eighty-five stage IIIa-IV NSCLC patients who had undergone palliative surgical resection were included in this study. Of these, 45 patients carried EGFR mutations (group-M) and 40 patients were wild-type (group-W). Each tumor sample was microdissected to yield 28-34 tumor foci and Intratumoral EGFR mutation were determined using Denaturing High Performance Liquid Chromatography (DHPLC) and Amplification Refractory Mutation System (ARMS). EGFR copy numbers were measured using fluorescence in situ hybridization (FISH). Results: Microdissection yielded 1,431 tumor foci from EGFR mutant patients (group-M) and 1,238 foci from wild-type patients (group-W). The EGFR mutant frequencies in group-M were 80.6% (1,154/1,431) and 87.1% (1,247/1,431) using DHPLC and ARMS, respectively. A combination of EGFR-mutated and wild-type cells was detected in 32.9% (28/85) of samples by DHPLC and 28.2% (24/85) by ARMS, supporting the occurrence of intratumoral heterogeneity. Thirty-one patients (36.5%) were identified as EGFR FISH-positive. Patients harboring intratumoral mutational heterogeneity possessed lower EGFR copy numbers than those tumors contained mutant cells alone (16.7% vs. 71.0%, P<0.05). Among 26 patients who had received EGFR-TKIs, the mean EGFR mutation content was higher in patients showing partial response (86.1%) or stable disease (48.7%) compared with patients experiencing progressive disease (6.0%) (P = 0.001). There also showed relationship between progression-free survival (PFS) and different content of EGFR mutation groups (pure wild type EGFR, EGFR mutation with heterogeneity and pure mutated EGFR) (P = 0.001). Conclusion: Approximately 30% of patients presented intratumoral EGFR mutational heterogeneity, accompanying with relatively low EGFR copy number. EGFR mutant content was correlated with the response and prognosis of EGFR-TKIs.	[Bai, Hua; Wang, Zhijie; Wang, Yuyan; Zhuo, Minglei; Duan, Jianchun; Yang, Lu; Wu, Meina; An, Tongtong; Zhao, Jun; Wang, Jie] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Thorac Med Oncol, Beijing 100871, Peoples R China; [Zhou, Qinghua] Tianjin Med Univ, Dept Thorac Surg, Gen Hosp, Tianjin, Peoples R China	Peking University; Tianjin Medical University	Wang, J (corresponding author), Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Dept Thorac Med Oncol, Beijing 100871, Peoples R China.	wangjie_cc@yahoo.com	Duan, Jianchun/AAM-5765-2020	zhuo, minglei/0000-0003-2489-7791	National Natural Sciences Foundation Distinguished Young Scholars [81025012]; National Natural Sciences Foundation General Program [81172235]; Beijing Health Systems Academic Leader [2011-2-22]	National Natural Sciences Foundation Distinguished Young Scholars; National Natural Sciences Foundation General Program; Beijing Health Systems Academic Leader	This work was supported by the National Natural Sciences Foundation Distinguished Young Scholars [81025012]; and the National Natural Sciences Foundation General Program [81172235]; and the Beijing Health Systems Academic Leader [2011-2-22]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2012, J CLIN ONCOL, V30, P3077, DOI 10.1200/JCO.2011.39.3744; Bai H, 2009, J CLIN ONCOL, V27, P2653, DOI 10.1200/JCO.2008.17.3930; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Cheng L, 1998, J NATL CANCER I, V90, P233, DOI 10.1093/jnci/90.3.233; Chin TM, 2007, CLIN CHEM, V53, P62, DOI 10.1373/clinchem.2006.074831; Cohen V, 2006, CANCER, V107, P2858, DOI 10.1002/cncr.22331; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Diaz-Cano SJ, 2000, LAB INVEST, V80, P279, DOI 10.1038/labinvest.3780033; Ellison G, 2012, J CLIN PATHOL; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gonzalez-Garcia I, 2002, P NATL ACAD SCI USA, V99, P13085, DOI 10.1073/pnas.202139299; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Janne PA, 2008, LUNG CANCER, V60, pS3, DOI 10.1016/S0169-5002(08)70099-0; Lichy JH, 2000, LAB INVEST, V80, P291, DOI 10.1038/labinvest.3780034; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Na II, 2012, J CANCER RES THER, V8, P373, DOI 10.4103/0973-1482.103515; NOWELL PC, 1986, CANCER RES, V46, P2203; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Puhringer-Oppermann FA, 2007, DIS ESOPHAGUS, V20, P9, DOI 10.1111/j.1442-2050.2007.00630.x; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Suda K, 2010, CLIN CANCER RES, V16, P5489, DOI 10.1158/1078-0432.CCR-10-1371; Taniguchi K, 2008, CANCER SCI, V99, P929, DOI 10.1111/j.1349-7006.2008.00782.x; Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7; Uramoto H, 2007, BRIT J CANCER, V96, P857, DOI 10.1038/sj.bjc.6603665; Wu KH, 2012, INT J MOL SCI, V13, P11471, DOI 10.3390/ijms130911471; Yatabe Y, 2011, J CLIN ONCOL, V29, P2972, DOI 10.1200/JCO.2010.33.3906	31	77	86	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e54170	10.1371/journal.pone.0054170	http://dx.doi.org/10.1371/journal.pone.0054170			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418425	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300015
J	Carmona, R; Cano, E; Mattiotti, A; Gaztambide, J; Munoz-Chapuli, R				Carmona, Rita; Cano, Elena; Mattiotti, Andrea; Gaztambide, Joaquin; Munoz-Chapuli, Ramon			Cells Derived from the Coelomic Epithelium Contribute to Multiple Gastrointestinal Tissues in Mouse Embryos	PLOS ONE			English	Article							INTERSTITIAL-CELLS; SMOOTH-MUSCLE; SMALL-INTESTINE; HUMAN GUT; CAJAL; TRACT; DIFFERENTIATION; MORPHOGENESIS; MESOTHELIUM; ALPHA	Gut mesodermal tissues originate from the splanchnopleural mesenchyme. However, the embryonic gastrointestinal coelomic epithelium gives rise to mesenchymal cells, whose significance and fate are little known. Our aim was to investigate the contribution of coelomic epithelium-derived cells to the intestinal development. We have used the transgenic mouse model mWt1/IRES/GFP-Cre (Wt1(cre)) crossed with the Rosa26R-EYFP reporter mouse. In the gastrointestinal duct Wt1, the Wilms' tumor suppressor gene, is specific and dynamically expressed in the coelomic epithelium. In the embryos obtained from the crossbreeding, the Wt1-expressing cell lineage produces the yellow fluorescent protein (YFP) allowing for colocalization with differentiation markers through confocal microscopy and flow cytometry. Wt1(cre-YFP) cells were very abundant throughout the intestine during midgestation, declining in neonates. Wt1(cre-YFP) cells were also transiently observed within the mucosa, being apparently released into the intestinal lumen. YFP was detected in cells contributing to intestinal vascularization (endothelium, pericytes and smooth muscle), visceral musculature (circular, longitudinal and submucosal) as well as in Cajal and Cajal-like interstitial cells. Wt1(cre-YFP) mesenchymal cells expressed FGF9, a critical growth factor for intestinal development, as well as PDGFR alpha, mainly within developing villi. Thus, a cell population derived from the coelomic epithelium incorporates to the gut mesenchyme and contribute to a variety of intestinal tissues, probably playing also a signaling role. Our results support the origin of interstitial cells of Cajal and visceral circular muscle from a common progenitor expressing anoctamin-1 and SMC alpha-actin. Coelomic-derived cells contribute to the differentiation of at least a part of the interstitial cells of Cajal.	[Carmona, Rita; Cano, Elena; Mattiotti, Andrea; Munoz-Chapuli, Ramon] Univ Malaga, Dept Anim Biol, Fac Sci, E-29071 Malaga, Spain; [Gaztambide, Joaquin] Reg Hosp Carlos Haya, Pediat Surg Unit, Matern & Children Hosp, Malaga, Spain	Universidad de Malaga	Munoz-Chapuli, R (corresponding author), Univ Malaga, Dept Anim Biol, Fac Sci, E-29071 Malaga, Spain.	chapuli@uma.es	Munoz-Chapuli, Ramon/K-7306-2014; Carmona, Rita/K-4217-2014; Cano, Elena/AAU-9715-2020	Munoz-Chapuli, Ramon/0000-0001-6392-6802; Carmona, Rita/0000-0002-9686-473X; 	Ministerio de Ciencia e Innovacion [BFU2008-02384, BFU2011-25304]; TerCel network, ISCIII [RD06/0010/0015]; Junta de Andalucia [P08-CTS-03618, P11-CTS-7564]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); TerCel network, ISCIII(Instituto de Salud Carlos III); Junta de Andalucia(Junta de Andalucia)	This study was supported by grants BFU2008-02384, BFU2011-25304 (Ministerio de Ciencia e Innovacion), RD06/0010/0015 (TerCel network, ISCIII), P08-CTS-03618 and P11-CTS-7564 (Junta de Andalucia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Guadix JA, 2011, DEVELOPMENT, V138, P1093, DOI 10.1242/dev.044594; BELL L, 1988, ANAT EMBRYOL, V177, P377, DOI 10.1007/BF00315847; Carmona IC, 2011, J CELL MOL MED, V15, P26, DOI 10.1111/j.1582-4934.2010.01207.x; del Monte G, 2011, CIRC RES, V108, P824, DOI 10.1161/CIRCRESAHA.110.229062; Faussone-Pellegrini MS, 2007, J CELL MOL MED, V11, P482, DOI 10.1111/j.1582-4934.2007.00043.x; Fu M, 2004, ANAT EMBRYOL, V208, P33, DOI 10.1007/s00429-003-0371-0; Geske MJ, 2008, DEVELOPMENT, V135, P2959, DOI 10.1242/dev.020453; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Ijpenberg A, 2007, DEV BIOL, V312, P157, DOI 10.1016/j.ydbio.2007.09.014; Karl J, 1998, DEV BIOL, V203, P323, DOI 10.1006/dbio.1998.9068; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Kluppel M, 1998, DEV DYNAM, V211, P60; Lavine KJ, 2005, DEV CELL, V8, P85, DOI 10.1016/j.devcel.2004.12.002; Lee JCF, 1999, AM J PHYSIOL-GASTR L, V277, pG409, DOI 10.1152/ajpgi.1999.277.2.G409; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Mclin VA, 2009, GASTROENTEROLOGY, V136, P2074, DOI 10.1053/j.gastro.2009.03.001; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Moore AW, 1998, MECH DEVELOP, V79, P169, DOI 10.1016/S0925-4773(98)00188-9; Pieri L, 2008, J CELL MOL MED, V12, P1944, DOI 10.1111/j.1582-4934.2008.00461.x; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Rolle U, 2007, PEDIATR SURG INT, V23, P1139, DOI 10.1007/s00383-007-2022-7; Sanders KM, 2012, EXP PHYSIOL, V97, P200, DOI 10.1113/expphysiol.2011.058248; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Streutker CJ, 2003, AM J SURG PATHOL, V27, P228, DOI 10.1097/00000478-200302000-00012; Su ZY, 2010, J ZHEJIANG UNIV-SC B, V11, P489, DOI 10.1631/jzus.B0900415; Torihashi S, 1997, GASTROENTEROLOGY, V112, P144, DOI 10.1016/S0016-5085(97)70229-4; Vanderwinden JM, 2000, CELL TISSUE RES, V302, P145, DOI 10.1007/s004410000264; Vanderwinden JM, 2002, CELL TISSUE RES, V309, P261, DOI 10.1007/s00441-002-0590-3; Wallace AS, 2005, CELL TISSUE RES, V319, P367, DOI 10.1007/s00441-004-1023-2; Wessels A, 2012, DEV BIOL, V366, P111, DOI 10.1016/j.ydbio.2012.04.020; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Zhang XQ, 2006, DEVELOPMENT, V133, P173, DOI 10.1242/dev.02175	32	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55890	10.1371/journal.pone.0055890	http://dx.doi.org/10.1371/journal.pone.0055890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418471	gold, Green Submitted, Green Published			2022-12-27	WOS:000315970300062
J	Chhibber, S; Kaur, T; Kaur, S				Chhibber, Sanjay; Kaur, Tarsem; Kaur, Sandeep			Co-Therapy Using Lytic Bacteriophage and Linezolid: Effective Treatment in Eliminating Methicillin Resistant Staphylococcus aureus (MRSA) from Diabetic Foot Infections	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; KLEBSIELLA-PNEUMONIAE; BACTERIAL-INFECTIONS; PHAGE THERAPY; COMPLICATED SKIN; VANCOMYCIN; MICE; PENETRATION; MELLITUS; PHARMACOKINETICS	Background: Staphylococcus aureus remains the predominant pathogen in diabetic foot infections and prevalence of methicillin resistant S. aureus (MRSA) strains further complicates the situation. The incidence of MRSA in infected foot ulcers is 15-30% and there is an alarming trend for its increase in many countries. Diabetes acts as an immunosuppressive state decreasing the overall immune functioning of body and to worsen the situation, wounds inflicted with drug resistant strains represent a morbid combination in diabetic patients. Foot infections caused by MRSA are associated with an increased risk of amputations, increased hospital stay, increased expenses and higher infection-related mortality. Hence, newer, safer and effective treatment strategies are required for treating MRSA mediated diabetic foot infections. The present study focuses on the use of lytic bacteriophage in combination with linezolid as an effective treatment strategy against foot infection in diabetic population. Methodology: Acute hindpaw infection with S. aureus ATCC 43300 was established in alloxan induced diabetic BALB/c mice. Therapeutic efficacy of a well characterized broad host range lytic bacteriophage, MR-10 was evaluated alone as well as in combination with linezolid in resolving the course of hindpaw foot infection in diabetic mice. The process of wound healing was also investigated. Results and Conclusions: A single administration of phage exhibited efficacy similar to linezolid in resolving the course of hindpaw infection in diabetic animals. However, combination therapy using both the agents was much more effective in arresting the entire infection process (bacterial load, lesion score, foot myeloperoxidase activity and histopathological analysis). The entire process of tissue healing was also hastened. Use of combined agents has been known to decrease the frequency of emergence of resistant mutants, hence this approach can serve as an effective strategy in treating MRSA mediated foot infections in diabetic individuals who do not respond to conventional antibiotic therapy.	[Chhibber, Sanjay; Kaur, Tarsem; Kaur, Sandeep] Panjab Univ, Dept Microbiol, Chandigarh 160014, India	Panjab University	Chhibber, S (corresponding author), Panjab Univ, Dept Microbiol, Chandigarh 160014, India.	sanjaychhibber8@gmail.com	Kaur, Sandeep/T-1863-2019	Kaur, Sandeep/0000-0003-3146-1611				Adam MH., 1959, BACTERIOPHAGES, P450, DOI 10.5962/bhl.title.6966; Bader MS, 2008, AM FAM PHYSICIAN, V78, P71; Bedi MS, 2009, WORLD J MICROB BIOT, V25, P1145, DOI 10.1007/s11274-009-9991-8; Biswas B, 2002, INFECT IMMUN, V70, P204, DOI 10.1128/IAI.70.1.204-210.2002; BOGOVAZOVA GG, 1991, ZH MIKROB EPID IMMUN, P5; Bowling FL, 2007, DIABETES CARE, V30, P370, DOI 10.2337/dc06-2348; Brans TA, 1994, BURNS, V20, P548; Bull JJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-35; Capparelli R, 2007, ANTIMICROB AGENTS CH, V51, P2765, DOI 10.1128/AAC.01513-06; Cerveny KE, 2002, INFECT IMMUN, V70, P6251, DOI 10.1128/IAI.70.11.6251-6262.2002; Chang HC, 2005, APPL ENVIRON MICROB, V71, P1387, DOI 10.1128/AEM.71.3.1387-1393.2005; Chhibber S, 2008, J MED MICROBIOL, V57, P1508, DOI 10.1099/jmm.0.2008/002873-0; CISLO M, 1987, ARCH IMMUNOL THER EX, V35, P175; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dang CN, 2003, DIABETIC MED, V20, P159, DOI 10.1046/j.1464-5491.2003.00860.x; Dryden MS, 2011, J ANTIMICROB CHEMOTH, V66, pIV7, DOI 10.1093/jac/dkr072; Duckworth DH, 2002, BIODRUGS, V16, P57, DOI 10.2165/00063030-200216010-00006; Falagas ME, 2008, LANCET INFECT DIS, V8, P53, DOI 10.1016/S1473-3099(07)70312-2; Goodridge L, 2003, APPL ENVIRON MICROB, V69, P5364, DOI 10.1128/AEM.69.9.5364-5371.2003; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Greenberger MJ, 1996, J INFECT DIS, V173, P159, DOI 10.1093/infdis/173.1.159; Gresham HD, 2000, J IMMUNOL, V164, P3713, DOI 10.4049/jimmunol.164.7.3713; Grimble SAJ, 2001, EUR J VASC ENDOVASC, V22, P215, DOI 10.1053/ejvs.2001.1436; Itani KMF, 2005, INT J ANTIMICROB AG, V26, P442, DOI 10.1016/j.ijantimicag.2005.09.003; Kochetkova VA, 1989, SOV MEDITISINA, V16, P23; Kumari S, 2009, J MICROBIOL BIOTECHN, V19, P622, DOI 10.4014/jmb.0808.493; Lazareva E. B., 2001, Antibiotiki i Khimioterapiya, V46, P10; Lipsky BA, 2004, CLIN INFECT DIS, V38, P17, DOI 10.1086/380449; Lipsky BA, 2004, CLIN INFECT DIS, V39, P885, DOI 10.1086/383271; Lipsky BA, 2004, DIABETES-METAB RES, V20, pS68, DOI 10.1002/dmrr.453; MARHOFFER W, 1993, DIABETES RES CLIN PR, V19, P183, DOI 10.1016/0168-8227(93)90112-I; Mathur M D, 2003, J Assoc Physicians India, V51, P593; MOUTSCHEN MP, 1992, DIABETES METAB, V18, P187; Murugan S, 2008, J CLIN DIAGN RES, V2, P979; Oladeinde FO, 2007, CELL MOL BIOL, V53, P34, DOI 10.1170/T794; Pan DD, 2008, AFR J BIOTECHNOL, V7, P4369; Park S, 2009, INFECT IMMUN, V77, P1008, DOI 10.1128/IAI.00976-08; REPINE JE, 1980, J INFECT DIS, V142, P869, DOI 10.1093/infdis/142.6.869; Rich J, 2005, DIABETES, V54, P2904, DOI 10.2337/diabetes.54.10.2904; Rogers LC, 2009, MRSA DIABETIC FOOT; RYBAK MJ, 1990, J ANTIMICROB CHEMOTH, V25, P679, DOI 10.1093/jac/25.4.679; SAKANDELIDZE VM, 1991, VRACHEBNOE DELO, P60; Sambrook J., 2002, MOL CLONING LAB MANU; Sharpe JN, 2005, AM J SURG, V189, P425, DOI 10.1016/j.amjsurg.2005.01.011; Stein GE, 2007, J ANTIMICROB CHEMOTH, V60, P819, DOI 10.1093/jac/dkm271; Stein GE, 2006, CLIN INFECT DIS, V43, P518, DOI 10.1086/505494; Stroj L, 1993, NEUROL NEUROCHIR POL, V3, P693; Sunagar R, 2010, RES MICROBIOL, V161, P854, DOI 10.1016/j.resmic.2010.09.011; Talon D, 2002, Eur J Intern Med, V13, P31, DOI 10.1016/S0953-6205(01)00189-3; TAN JS, 1975, J LAB CLIN MED, V85, P26; TATER D, 1987, HORM METAB RES, V19, P642, DOI 10.1055/s-2007-1011899; Turner JM, 2004, BRIT J DIABETES VASC, V4, P44; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; VinodKumar CS, 2011, INT J PHARM SCI DRUG, V3, P202; Wayne PA, 2006, M7A7 CLIN LAB STAND; WEBERDABROWSKA B, 1987, ARCH IMMUNOL THER EX, V35, P563; Weigelt J, 2004, AM J SURG, V188, P760, DOI 10.1016/j.amjsurg.2004.08.045; Weigelt J, 2005, ANTIMICROB AGENTS CH, V49, P2260, DOI 10.1128/AAC.49.6.2260-2266.2005; WILSON RM, 1986, CLIN EXP IMMUNOL, V63, P478; Wiskirchen DE, 2011, ANTIMICROB AGENTS CH, V55, P4170, DOI 10.1128/AAC.00445-11	60	118	120	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56022	10.1371/journal.pone.0056022	http://dx.doi.org/10.1371/journal.pone.0056022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418497	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300089
J	El-Shinawi, M; Mohamed, HT; El-Ghonaimy, EA; Tantawy, M; Younis, A; Schneider, RJ; Mohamed, MM				El-Shinawi, Mohamed; Mohamed, Hossam Taha; El-Ghonaimy, Eslam A.; Tantawy, Marwa; Younis, Amal; Schneider, Robert J.; Mohamed, Mona Mostafa			Human Cytomegalovirus Infection Enhances NF-kappa B/p65 Signaling in Inflammatory Breast Cancer Patients	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; NF-KAPPA-B; PROGRAMMED CELL-DEATH; DRUG-RESISTANCE; EXPRESSION; CARCINOMA; EPIDEMIOLOGY; ANGIOGENESIS; SIGNATURE; PROMOTES	Human Cytomegalovirus (HCMV) is an endemic herpes virus that re-emerges in cancer patients enhancing oncogenic potential. Recent studies have shown that HCMV infection is associated with certain types of cancer morbidity such as glioblastoma. Although HCMV has been detected in breast cancer tissues, its role, if any, in the etiology of specific forms of breast cancer has not been investigated. In the present study we investigated the presence of HCMV infection in inflammatory breast cancer (IBC), a rapidly progressing form of breast cancer characterized by specific molecular signature. We screened for anti-CMV IgG antibodies in peripheral blood of 49 non-IBC invasive ductal carcinoma (IDC) and 28 IBC patients. In addition, we screened for HCMV-DNA in postsurgical cancer and non-cancer breast tissues of non-IBC and IBC patients. We also tested whether HCMV infection can modulate the expression and activation of transcriptional factor NF-kappa B/p65, a hallmark of IBC. Our results reveal that IBC patients are characterized by a statistically significant increase in HCMV IgG antibody titers compared to non-IBC patients. HCMV-DNA was significantly detected in cancer tissues than in the adjacent non-carcinoma tissues of IBC and IDC, and IBC cancer tissues were significantly more infected with HCMV-DNA compared to IDC. Further, HCMV sequence analysis detected different HCMV strains in IBC patients tissues, but not in the IDC specimens. Moreover, HCMV-infected IBC cancer tissues were found to be enhanced in NF-kappa B/p65 signaling compared to non-IBC patients. The present results demonstrated a correlation between HCMV infection and IBC. Etiology and causality of HCMV infection with IBC now needs to be rigorously examined.	[El-Shinawi, Mohamed] Ain Shams Univ, Dept Gen Surg, Fac Med, Cairo, Egypt; [Mohamed, Hossam Taha; El-Ghonaimy, Eslam A.; Tantawy, Marwa; Younis, Amal; Mohamed, Mona Mostafa] Cairo Univ, Dept Zool, Fac Sci, Giza, Egypt; [Schneider, Robert J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Cairo University; New York University	Mohamed, MM (corresponding author), Cairo Univ, Dept Zool, Fac Sci, Giza, Egypt.	mmostafa@sci.cu.edu.eg	Mohamed, Hossam Taha/GPX-1362-2022; Mohamed, Hossam Taha/N-8045-2018	Mohamed, Hossam Taha/0000-0003-1989-5783; Schneider, Robert/0000-0001-5807-5564; El-Shinawi, Mohamed/0000-0003-3645-2343; Tantawy, Marwa/0000-0001-6767-1093	Cairo University Research Sector; Avon Foundation USA [02-2011-062]	Cairo University Research Sector(Cairo University); Avon Foundation USA	Author MMM is supported by Cairo University Research Sector. Authors RJS and MMM are supported by Avon Foundation USA (Grant number 02-2011-062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Al-Raawi D, 2011, INT J CLIN EXP MED, V4, P265; Allart S, 2002, J BIOL CHEM, V277, P29063, DOI 10.1074/jbc.M201974200; Amarante MK, 2009, J CANCER RES CLIN, V135, P329, DOI 10.1007/s00432-008-0511-2; Baryawno N, 2011, J CLIN INVEST, V121, P4043, DOI 10.1172/JCI57147; Blaheta RA, 2004, NEOPLASIA, V6, P323, DOI 10.1593/neo.03418; Blaheta RA, 2006, NEOPLASIA, V8, P807, DOI 10.1593/neo.06379; BONNIER P, 1995, INT J CANCER, V62, P382, DOI 10.1002/ijc.2910620404; Breathnach O, 1999, ANN ONCOL, V10, P461, DOI 10.1023/A:1008360927507; Chan G, 2009, VIRUS RES; Chan G, 2008, J VIROL, V82, P1040, DOI 10.1128/JVI.00864-07; Chang S, 1998, CANCER, V82, P2366; Cheeran MCJ, 2001, J NEUROVIROL, V7, P135; Cinatl J, 1998, CANCER RES, V58, P367; Cobbs Charles S, 2011, Herpesviridae, V2, P10, DOI 10.1186/2042-4280-2-10; Cobbs CS, 2002, CANCER RES, V62, P3347; Duke TJ, 2010, ONCOL REP, V24, P1277, DOI 10.3892/or_00000983; Dumortier J, 2008, J VIROL, V82, P6524, DOI 10.1128/JVI.00502-08; Fagundes CP, 2011, BRAIN BEHAV IMMUN; Fawzy S, 2008, CLIN BIOCHEM, V41, P486, DOI 10.1016/j.clinbiochem.2007.12.017; Fiorentini S, 2011, J GEN VIROL, V92, P650, DOI 10.1099/vir.0.025395-0; Gong Y, 2008, SEMIN ONCOL, V35, P33, DOI 10.1053/j.seminoncol.2007.11.014; Hachana M, 2011, PATHOL RES PRACT, V207, P695, DOI 10.1016/j.prp.2011.09.007; Harkins L, 2002, LANCET, V360, P1557, DOI 10.1016/S0140-6736(02)11524-8; Harkins Lualhati E, 2010, Herpesviridae, V1, P8, DOI 10.1186/2042-4280-1-8; Juckem LK, 2008, J IMMUNOL, V180, P4965, DOI 10.4049/jimmunol.180.7.4965; Labidi SI, 2008, ANN ONCOL, V19, P473, DOI 10.1093/annonc/mdm480; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Lo AC, 2009, BREAST, V18, P55, DOI 10.1016/j.breast.2008.11.002; Maussang D, 2006, P NATL ACAD SCI USA, V103, P13068, DOI 10.1073/pnas.0604433103; Melnick M, 2012, EXP MOL PATHOL, V92, P118, DOI 10.1016/j.yexmp.2011.10.011; Michaelis M, 2009, NEOPLASIA, V11, P1, DOI 10.1593/neo.81178; Niedobitek G, 2001, INT J EXP PATHOL, V82, P149, DOI 10.1111/j.1365-2613.2001.iep190.x; Nouh MA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-1; Retiere C, 1998, VIRUS RES, V57, P43, DOI 10.1016/S0168-1702(98)00083-5; Richardson AK, 2004, BRIT J CANCER, V90, P2149, DOI 10.1038/sj.bjc.6601822; Robertson FM, 2010, CA-CANCER J CLIN, V60, P351, DOI 10.3322/caac.20082; Samanta M, 2003, J UROLOGY, V170, P998, DOI 10.1097/01.ju.0000080263.46164.97; Shimamura M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001170; Smith MS, 2007, J VIROL, V81, P7683, DOI 10.1128/JVI.02839-06; Soderberg-Naucler C, 2008, J CLIN VIROL, V41, P218, DOI 10.1016/j.jcv.2007.11.009; Soderberg-Naucler C, 2012, ONCOIMMUNOLOGY, V1, P739, DOI 10.4161/onci.19441; Soliman AS, 2009, BREAST J, V15, P432, DOI 10.1111/j.1524-4741.2009.00755.x; Soroceanu L, 2011, CANCER RES, V71, P6643, DOI 10.1158/0008-5472.CAN-11-0744; Soroceanu L, 2011, VIRUS RES, V157, P193, DOI 10.1016/j.virusres.2010.10.026; Sowmya P, 2009, J MED VIROL, V81, P861, DOI 10.1002/jmv.21459; Toi M, 2010, JPN J CLIN ONCOL, V40, pi13, DOI 10.1093/jjco/hyq122; Tsai JH, 2007, J CANCER RES CLIN, V133, P13, DOI 10.1007/s00432-006-0141-5; Van Laere S, 2005, BREAST CANCER RES TR, V93, P237, DOI 10.1007/s10549-005-5157-z; Van Laere SJ, 2006, BREAST CANCER RES TR, V95, P243, DOI 10.1007/s10549-005-9015-9; Van Laere SJ, 2006, CLIN CANCER RES, V12, P3249, DOI 10.1158/1078-0432.CCR-05-2800; Vermeulen PB, 2010, CANCER-AM CANCER SOC, V116, P2748, DOI 10.1002/cncr.25169; YUROCHKO AD, 1995, J VIROL, V69, P5391, DOI 10.1128/JVI.69.9.5391-5400.1995; Zamora MR, 2011, SEMIN RESP CRIT CARE, V32, P454, DOI 10.1055/s-0031-1283285; Zhang S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-73; Zhang Y, 2009, TRANSPL P, V41, P1767, DOI 10.1016/j.transproceed.2009.03.064	55	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55755	10.1371/journal.pone.0055755	http://dx.doi.org/10.1371/journal.pone.0055755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418456	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300047
J	Fennell, JG; Baddeley, RJ				Fennell, John G.; Baddeley, Roland J.			Reward Is Assessed in Three Dimensions That Correspond to the Semantic Differential	PLOS ONE			English	Article							SEROTONIN; UNCERTAINTY; PREDICTION; CINGULATE; SIGNAL; RISK	If choices are to be made between alternatives like should I go for a walk or grab a coffee, a 'common currency' is needed to compare them. This quantity, often known as reward in psychology and utility in economics, is usually conceptualised as a single dimension. Here we propose that to make a comparison between different options it is important to know not only the average reward, but also both the risk and level of certainty (or control) associated with an option. Almost all objects can be the subject of choice, so if these dimensions are required in order to make a decision, they should be part of the meaning of those objects. We propose that this ubiquity is unique, so if we take an average over many concepts and domains these three dimensions (reward, risk, and uncertainty) should emerge as the three most important dimensions in the "meaning" of objects. We investigated this possibility by relating the three dimensions of reward to an old, robust and extensively studied factor analytic instrument known as the semantic differential. Across a very wide range of situations, concepts and cultures, factor analysis shows that 50% of the variance in rating scales is accounted for by just three dimensions, with these dimensions being Evaluation, Potency, and Activity [1]. Using a statistical analysis of internet blog entries and a betting experiment, we show that these three factors of the semantic differential are strongly correlated with the reward history associated with a given concept: Evaluation measures relative reward; Potency measures absolute risk; and Activity measures the uncertainty or lack of control associated with a concept. We argue that the 50% of meaning captured by the semantic differential is simply a summary of the reward history that allows decisions to be made between widely different options.	[Fennell, John G.; Baddeley, Roland J.] Univ Bristol, Bristol, Avon, England	University of Bristol	Fennell, JG (corresponding author), Univ Bristol, Bristol, Avon, England.	john.fennell@bristol.ac.uk	Fennell, John G/V-5947-2018	Fennell, John G/0000-0003-2991-3391				Bad, 2011, BAD RANDOLY CHOSEN B; Berry M, 2012, JOURNALISM; Boureau YL, 2010, NEUROPSYCHOPHARMACOL; COOLS R, 2010, NEUROPSYCHOPHARMACOL; Crockett MJ, 2008, SCIENCE, V320, P1739, DOI 10.1126/science.1155577; Crockett MJ, 2009, J NEUROSCI, V29, P11993, DOI 10.1523/JNEUROSCI.2513-09.2009; Dalton P, 2008, J SENS STUD, V23, P485, DOI 10.1111/j.1745-459X.2008.00167.x; Damasio A, 2000, FEELING WHAT HAPPENS; Damasio A.R., 2005, DESCARTES ERROR EMOT; Dayan P, 2006, NETWORK-COMP NEURAL, V17, P335, DOI 10.1080/09548980601004024; Dayan P, 2009, ANNU REV NEUROSCI, V32, P95, DOI 10.1146/annurev.neuro.051508.135607; ELLIOTT LL, 1963, AM J PSYCHOL, V76, P589, DOI 10.2307/1419708; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Francis C., 2006, MEAN AFFECTIVE RATIN; Good, 2011, GOOD RANDOMLY CHOSEN; Heise D, 2010, SURVEYING CULTURES D, DOI [10.1002/9780470575789, DOI 10.1002/9780470575789]; Heise David R, 2001, ELECT J SOCIOLOGY, V5; Houston AI, 2007, BIOLOGY LETT, V3, P365, DOI 10.1098/rsbl.2007.0111; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kim NH, 2009, KSCE J CIV ENG, V13, P65, DOI 10.1007/s12205-009-0065-0; Knight F. H., 1921, HART SCHAFFNER MARX, V31; Landis D, 1976, VARIATIONS BLACK WHI; MATLAB, 2008, MATLAB VERSION 7 6 0; MCNAMARA JM, 1986, AM NAT, V127, P358, DOI 10.1086/284489; McNeil A. J., 2005, QUANTITATIVE RISK MA; Miron M, 1969, WHAT IS IT IS BEING; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Osgood C.E., 1975, CROSS CULTURAL UNIVE; Osgood C.E., 1957, MEASUREMENT MEANING; OSGOOD CE, 1969, J PERS SOC PSYCHOL, V12, P194, DOI 10.1037/h0027715; OSGOOD CE, 1955, J EXP PSYCHOL, V50, P325, DOI 10.1037/h0043965; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Rushworth MFS, 2008, NAT NEUROSCI, V11, P389, DOI 10.1038/nn2066; SCHNEIDER Danieli D., 2010, ROBOT LEARNING, V17, P65; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Technorati, 2011, STAT BLOG 2011; TESAURO G, 1995, COMMUN ACM, V38, P58, DOI 10.1145/203330.203343; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Trimmer PC, 2011, ANIM COGN, V14, P465, DOI 10.1007/s10071-011-0387-4; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	46	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55588	10.1371/journal.pone.0055588	http://dx.doi.org/10.1371/journal.pone.0055588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418445	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300036
J	Geng, YS; Yang, J; Huang, WJ; Harrison, TJ; Zhou, Y; Wen, ZH; Wang, YC				Geng, Yansheng; Yang, Jun; Huang, Weijin; Harrison, Tim J.; Zhou, Yan; Wen, Zhiheng; Wang, Youchun			Virus Host Protein Interaction Network Analysis Reveals That the HEV ORF3 Protein May Interrupt the Blood Coagulation Process	PLOS ONE			English	Article							HEPATITIS-E-VIRUS; PHYLOGENETIC ANALYSIS; BETA-CHAIN; AVIAN HEV; INFECTION; CELLS; GENOTYPE; TRANSLOCATION; VITRONECTIN; HEPATOCYTE	Hepatitis E virus (HEV) is endemic worldwide and a major cause of acute liver disease in developing countries. However, the molecular mechanisms of liver pathology and clinical disease are not well understood for HEV infection. Open reading frame 3 (ORF3) of HEV encodes a small phosphoprotein, which is assumed to be involved in liver pathology and clinical disease. In this study, the interactions between the HEV ORF3 protein and human proteins were investigated using a stringent, high-throughput yeast two-hybrid (Y2H) analysis. Thirty two proteins were shown to interact with genotype 1 ORF3, 28 of which have not been reported previously. These novel interactions were evaluated by coimmunoprecipitation of protein complexes from transfected cells. We found also that the ORF3 proteins of genotype 4 and rabbit HEV interacted with all of the human proteins identified by the genotype 1 ORF3 protein. However, the putative ORF3 protein derived from avian HEV did not interact with the majority of these human proteins. The identified proteins were used to infer an overall interaction map linking the ORF3 protein with components of the host cellular networks. Analysis of this interaction map, based on functional annotation with the Gene Ontology features and KEGG pathways, revealed an enrichment of host proteins involved in complement coagulation, cellular iron ion homeostasis and oxidative stress. Additional canonical pathway analysis highlighted the enriched biological pathways relevant to blood coagulation and hemostasis. Consideration of the clinical manifestations of hepatitis E reported previously and the results of biological analysis from this study suggests that the ORF3 protein is likely to lead to an imbalance of coagulation and fibrinolysis by interacting with host proteins and triggering the corresponding pathological processes. These results suggest critical approaches to further study of the pathogenesis of the HEV ORF3 protein.	[Geng, Yansheng; Huang, Weijin; Zhou, Yan; Wen, Zhiheng; Wang, Youchun] Natl Inst Food & Drug Control, Dept Cell Biol, Beijing, Peoples R China; [Geng, Yansheng] Hebei Univ, Hlth Sci Ctr, Baoding, Peoples R China; [Yang, Jun] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA; [Harrison, Tim J.] UCL, Sch Med, Div Med, London W1N 8AA, England	National Institute of Food & Drug Control - China; Hebei University; St Jude Children's Research Hospital; University of London; University College London; UCL Medical School	Wang, YC (corresponding author), Natl Inst Food & Drug Control, Dept Cell Biol, 2 Tian Tan Xi Li, Beijing, Peoples R China.	wangyc@nifdc.org.cn	huang, weijin/AAY-5028-2020; Yang, Jun/N-2309-2018	huang, weijin/0000-0002-4246-8889; Yang, Jun/0000-0002-4233-3220; Meng, X.J./0000-0002-2739-1334	National Natural Science Foundation of China [81171549]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant: 81171549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam Shahinul, 2009, Saudi J Gastroenterol, V15, P229, DOI 10.4103/1319-3767.56094; BARABASI AL, 1991, PHYS REV A, V44, P2730, DOI 10.1103/PhysRevA.44.2730; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Chandra V, 2008, J VIROL, V82, P7100, DOI 10.1128/JVI.00403-08; Chandra V, 2010, J VIROL, V84, P3857, DOI 10.1128/JVI.01994-09; CRABTREE GR, 1982, J BIOL CHEM, V257, P7277; Emerson SU, 2003, REV MED VIROL, V13, P145, DOI 10.1002/rmv.384; Emerson SU, 2010, J VIROL, V84, P9059, DOI 10.1128/JVI.00593-10; Fields S, 2005, FEBS J, V272, P5391, DOI 10.1111/j.1742-4658.2005.04973.x; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Geng YS, 2011, INFECT GENET EVOL, V11, P476, DOI 10.1016/j.meegid.2010.12.012; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Huang FF, 2004, J GEN VIROL, V85, P1609, DOI 10.1099/vir.0.79841-0; Huang YW, 2007, J VIROL, V81, P3018, DOI 10.1128/JVI.02259-06; Huntoon KM, 2008, J LEUKOCYTE BIOL, V84, P170, DOI 10.1189/jlb.0208100; Ibrahim AS, 2009, J MED VIROL, V81, P1047, DOI 10.1002/jmv.21474; Jennewein C, 2011, MOL MED, V17, P568, DOI 10.2119/molmed.2010.00146; Jia ZS, 2003, WORLD J GASTROENTERO, V9, P631, DOI 10.3748/wjg.v9.i3.631; Kamar N, 2008, AM J TRANSPLANT, V8, P1744, DOI 10.1111/j.1600-6143.2008.02286.x; Kannan H, 2009, J VIROL, V83, P6375, DOI 10.1128/JVI.02571-08; Khadka S, 2011, MOL CELL PR IN PRESS; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P61, DOI 10.1046/j.1365-2893.2003.00398.x; Korkaya H, 2001, J BIOL CHEM, V276, P42389, DOI 10.1074/jbc.M101546200; Krawczynski K, 2007, NEW ENGL J MED, V356, P949, DOI 10.1056/NEJMe068311; Lu L, 2006, REV MED VIROL, V16, P5, DOI 10.1002/rmv.482; Ma HX, 2011, J MED VIROL, V83, P827, DOI 10.1002/jmv.22032; Marek A, 2010, VET MICROBIOL, V145, P54, DOI 10.1016/j.vetmic.2010.03.014; Meng X, 2011, VIRUS TAXONOMY CLASS, P991; Meng XJ, 2010, VET MICROBIOL, V140, P256, DOI 10.1016/j.vetmic.2009.03.017; Moin SM, 2009, CELL MICROBIOL, V11, P1409, DOI 10.1111/j.1462-5822.2009.01340.x; Moin SM, 2007, J BIOL CHEM, V282, P21124, DOI 10.1074/jbc.M701696200; Morgenstern E, 2001, EUR J CELL BIOL, V80, P87, DOI 10.1078/0171-9335-00138; Mushahwar IK, 2008, J MED VIROL, V80, P646, DOI 10.1002/jmv.21116; Okamoto H, 2007, VIRUS RES, V127, P216, DOI 10.1016/j.virusres.2007.02.002; OTTO JM, 1987, J CELL BIOL, V105, P1067, DOI 10.1083/jcb.105.3.1067; Patra S, 2007, ANN INTERN MED, V147, P28, DOI 10.7326/0003-4819-147-1-200707030-00005; Peralta B, 2009, VET MICROBIOL, V137, P31, DOI 10.1016/j.vetmic.2008.12.010; Peron JM, 2007, J VIRAL HEPATITIS, V14, P298, DOI 10.1111/j.1365-2893.2007.00858.x; Ratra R, 2008, BIOCHEMISTRY-US, V47, P1957, DOI 10.1021/bi7016552; Ratra R, 2009, J GEN VIROL, V90, P1359, DOI 10.1099/vir.0.009274-0; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Sheikh A, 2002, AM J TROP MED HYG, V66, P721, DOI 10.4269/ajtmh.2002.66.721; Smith JL, 2001, J FOOD PROTECT, V64, P572, DOI 10.4315/0362-028X-64.4.572; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Surjit M, 2006, J BIOL CHEM, V281, P8135, DOI 10.1074/jbc.M509568200; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Tyagi S, 2005, J VIROL, V79, P12081, DOI 10.1128/JVI.79.18.12081-12087.2005; Tyagi S, 2004, J BIOL CHEM, V279, P29308, DOI 10.1074/jbc.M402017200; Tyagi S, 2002, J BIOL CHEM, V277, P22759, DOI 10.1074/jbc.M200185200; Wang YC, 2000, J GEN VIROL, V81, P1675, DOI 10.1099/0022-1317-81-7-1675; Wu YP, 2004, BLOOD, V104, P1034, DOI 10.1182/blood-2003-12-4293; Zafrullah M, 1997, J VIROL, V71, P9045, DOI 10.1128/JVI.71.12.9045-9053.1997; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536; Zhao Q, 2010, EMERG INFECT DIS, V16, P1469, DOI 10.3201/eid1609.100626	55	23	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56320	10.1371/journal.pone.0056320	http://dx.doi.org/10.1371/journal.pone.0056320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418552	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300145
J	Jahchan, NS; Ouyang, GL; Luo, KX				Jahchan, Nadine S.; Ouyang, Gaoliang; Luo, Kunxin			Expression Profiles of SnoN in Normal and Cancerous Human Tissues Support Its Tumor Suppressor Role in Human Cancer	PLOS ONE			English	Article							TGF-BETA; CDNA-CLONES; SKI; OVEREXPRESSION; TUMORIGENESIS; GROWTH; MICROENVIRONMENT; ADENOCARCINOMA; AMPLIFICATION; CARCINOMAS	SnoN is a negative regulator of TGF-beta signaling and also an activator of the tumor suppressor p53 in response to cellular stress. Its role in human cancer is complex and controversial with both pro-oncogenic and anti-oncogenic activities reported. To clarify its role in human cancer and provide clinical relevance to its signaling activities, we examined SnoN expression in normal and cancerous human esophageal, ovarian, pancreatic and breast tissues. In normal tissues, SnoN is expressed in both the epithelium and the surrounding stroma at a moderate level and is predominantly cytoplasmic. SnoN levels in all tumor epithelia examined are lower than or similar to that in the matched normal samples, consistent with its anti-tumorigenic activity in epithelial cells. In contrast, SnoN expression in the stroma is highly upregulated in the infiltrating inflammatory cells in high-grade esophageal and ovarian tumor samples, suggesting that SnoN may potentially promote malignant progression through modulating the tumor microenvironment in these tumor types. The overall levels of SnoN expression in these cancer tissues do not correlate with the p53 status. However, in human cancer cell lines with amplification of the snoN gene, a strong correlation between increased SnoN copy number and inactivation of p53 was detected, suggesting that the tumor suppressor SnoN-p53 pathway must be inactivated, either through downregulation of SnoN or inactivation of p53, in order to allow cancer cell to proliferate and survive. These data strongly suggest that SnoN can function as a tumor suppressor at early stages of tumorigenesis in human cancer tissues.	[Jahchan, Nadine S.; Luo, Kunxin] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Ouyang, Gaoliang] Xiamen Univ, Coll Life Sci, Xiamen, Fujian, Peoples R China	University of California System; University of California Berkeley; Xiamen University	Luo, KX (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kluo@berkeley.edu			NIH [RO1 CA101891, RO1 DK090347]; DOD BCRP predoctoral fellowship; NATIONAL CANCER INSTITUTE [R01CA101891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090347] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD BCRP predoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by NIH RO1 CA101891 and RO1 DK090347 to K. Luo and DOD BCRP predoctoral fellowship to N. Jahchan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi I, 2008, ANN SURG ONCOL, V15, P2965, DOI 10.1245/s10434-008-9986-y; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bascom JL, 2005, CANCER RES, V65, P8617, DOI 10.1158/0008-5472.CAN-05-1985; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; BOYER PL, 1993, ONCOGENE, V8, P457; Chia JA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-252; Cianci R, 2010, J BIOL REG HOMEOS AG, V24, P239; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; Goh AM, 2010, J PATHOL; Imoto I, 2001, BIOCHEM BIOPH RES CO, V286, P559, DOI 10.1006/bbrc.2001.5428; Jahchan NS, 2010, CANCER RES, V70, P4204, DOI 10.1158/0008-5472.CAN-10-0135; Jahchan NS, 2010, CURR OPIN PHARM; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; McAllister SS, 2010, J CLIN ONCOL, V28, P4022, DOI 10.1200/JCO.2010.28.4257; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Nanjundan M, 2008, MOL ONCOL, V2, P164, DOI 10.1016/j.molonc.2008.05.001; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Pan D, 2009, EMBO J, V28, P3500, DOI 10.1038/emboj.2009.250; PEARSONWHITE S, 1993, NUCLEIC ACIDS RES, V21, P4632, DOI 10.1093/nar/21.19.4632; PearsonWhite S, 1997, NUCLEIC ACIDS RES, V25, P2930, DOI 10.1093/nar/25.14.2930; Pelzer T, 1996, DEV DYNAM, V205, P114; Shinagawa T, 2001, ONCOGENE, V20, P8100, DOI 10.1038/sj.onc.1204987; Truty MJ, 2007, PANCREATOLOGY, V7, P423, DOI 10.1159/000108959; Villanacci V, 2008, HUM PATHOL, V39, P403, DOI 10.1016/j.humpath.2007.07.009; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Zhang F, 2003, CANCER RES, V63, P5005; Zhang XY, 2009, INT J DERMATOL, V48, P579, DOI 10.1111/j.1365-4632.2009.03685.x; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06	31	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55794	10.1371/journal.pone.0055794	http://dx.doi.org/10.1371/journal.pone.0055794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418461	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300052
J	Kok, J; Blyth, CC; Foo, H; Bailey, MJ; Pilcher, DV; Webb, SA; Seppelt, IM; Dwyer, DE; Iredell, JR				Kok, Jen; Blyth, Christopher C.; Foo, Hong; Bailey, Michael J.; Pilcher, David V.; Webb, Steven A.; Seppelt, Ian M.; Dwyer, Dominic E.; Iredell, Jonathan R.			Viral Pneumonitis Is Increased in Obese Patients during the First Wave of Pandemic A(H1N1) 2009 Virus	PLOS ONE			English	Article							C-REACTIVE PROTEIN; EXTRACORPOREAL MEMBRANE-OXYGENATION; IMMUNIZATION PRACTICES ACIP; H1N1 INFLUENZA; VACCINES RECOMMENDATIONS; ADVISORY-COMMITTEE; MORTALITY; INFECTION; HOSPITALIZATION; INFLAMMATION	Introduction: There is conflicting data as to whether obesity is an independent risk factor for mortality in severe pandemic (H1N1) 2009 influenza (A(H1N1)pdm09). It is postulated that excess inflammation and cytokine production in obese patients following severe influenza infection leads to viral pneumonitis and/or acute respiratory distress syndrome. Methods: Demographic, laboratory and clinical data prospectively collected from obese and non-obese patients admitted to nine adult Australian intensive care units (ICU) during the first A(H1N1)pdm09 wave, supplemented with retrospectively collected data, were compared. Results: Of 173 patients, 100 (57.8%), 73 (42.2%) and 23 (13.3%) had body mass index (BMI) <30 kg/m(2), >= 30 kg/m(2) (obese) and >= 40 kg/m(2) (morbidly obese) respectively. Compared to non-obese patients, obese patients were younger (mean age 43.4 vs. 48.4 years, p = 0.035) and more likely to develop pneumonitis (61% vs. 44%, p = 0.029). Extracorporeal membrane oxygenation use was greater in morbidly obese compared to non-obese patients (17.4% vs. 4.7%, p = 0.04). Higher mortality rates were observed in non-obese compared to obese patients, but not after adjusting for severity of disease. C-reactive protein (CRP) levels and hospital length of stay (LOS) were similar. Amongst ICU survivors, obese patients had longer ICU LOS (median 11.9 vs. 6.8 days, p = 0.017). Similar trends were observed when only patients infected with A(H1N1)pdm09 were examined. Conclusions: Among patients admitted to ICU during the first wave of A(H1N1)pdm09, obese and morbidly obese patients with severe infection were more likely to develop pneumonitis compared to non-obese patients, but mortality rates were not increased. CRP is not an accurate marker of pneumonitis.	[Kok, Jen; Dwyer, Dominic E.; Iredell, Jonathan R.] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Inst Clin Pathol & Med Res,Sydney Inst Emerging I, Westmead, NSW 2145, Australia; [Kok, Jen; Dwyer, Dominic E.; Iredell, Jonathan R.] Univ Sydney, Westmead Hosp, Ctr Res Excellence Crit Infect, Westmead, NSW 2145, Australia; [Blyth, Christopher C.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Blyth, Christopher C.] Princess Margaret Hosp, Dept Paediat & Adolescent Med, Subiaco, WA, Australia; [Blyth, Christopher C.] Princess Margaret Hosp, PathWest Lab Med WA, Subiaco, WA, Australia; [Foo, Hong] Liverpool Hosp, Dept Microbiol & Infect Dis, Sydney South West Pathol Serv, Sydney, NSW, Australia; [Bailey, Michael J.; Pilcher, David V.] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Pilcher, David V.] Australian & New Zealand Intens Care Soc Ctr Outc, Carlton, Vic, Australia; [Pilcher, David V.] Alfred Hosp, Dept Intens Care Med, Phahran, Vic, Australia; [Webb, Steven A.] Royal Perth Hosp, Intens Care Unit, Perth, WA, Australia; [Webb, Steven A.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Webb, Steven A.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Seppelt, Ian M.] Nepean Hosp, Dept Intens Care Med, Penrith, NSW, Australia; [Seppelt, Ian M.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Western Australia; Liverpool Hospital; Monash University; Florey Institute of Neuroscience & Mental Health; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; Nepean Hospital; University of Sydney; University of Sydney	Kok, J (corresponding author), Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Inst Clin Pathol & Med Res,Sydney Inst Emerging I, Westmead, NSW 2145, Australia.	jen.kok@swahs.health.nsw.gov.au	Blyth, Christopher/ABG-8231-2020; Bailey, Michael J/A-4499-2012	Blyth, Christopher/0000-0003-2017-0683; Bailey, Michael J/0000-0002-5551-1401; Pilcher, David/0000-0002-8939-7985				Akinnusi ME, 2008, CRIT CARE MED, V36, P151, DOI 10.1097/01.CCM.0000297885.60037.6E; Australian Government Australian Institute of Health and Welfare, AUSTR HLTH 2010; Australian Government Department of Health and Ageing, 2010, 5 AUSTR GOV DEP HLTH; Australian Government Department of Health and Ageing, 2012, AUSTR PUBL ASS REP T; Blyth CC, 2013, INFLUENZA OTHER RESP, V7, P168, DOI 10.1111/j.1750-2659.2012.00360.x; Brun-Buisson C, 2011, AM J RESP CRIT CARE, V183, P1200, DOI 10.1164/rccm.201101-0135OC; Cohen S, 1999, ANN NY ACAD SCI, V896, P246, DOI 10.1111/j.1749-6632.1999.tb08119.x; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Department of Health, 2006, GREEN BOOK INFL UPD; Diaz E, 2011, CHEST, V139, P382, DOI 10.1378/chest.10-1160; Estenssoro E, 2010, AM J RESP CRIT CARE, V182, P41, DOI [10.1164/rccm.201001-0037OC, 10.1164/201001-0037OC]; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Fedson DS, 2006, CLIN INFECT DIS, V43, P199, DOI 10.1086/505116; Fedson DS, 2009, EMERG INFECT DIS, V15, P365, DOI 10.3201/eid1503.080857; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Galarce EM, 2011, VACCINE, V29, P5284, DOI 10.1016/j.vaccine.2011.05.014; Greenfield JR, 2004, CIRCULATION, V109, P3022, DOI 10.1161/01.CIR.0000130640.77501.79; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; Ho YC, 2009, J INFECTION, V58, P439, DOI 10.1016/j.jinf.2009.03.007; Hogue CW, 2009, INTENS CARE MED, V35, P1152, DOI 10.1007/s00134-009-1424-5; Ingram PR, 2010, INTENS CARE MED, V36, P528, DOI 10.1007/s00134-009-1746-3; Iwasenko JM, 2010, CLIN INFECT DIS, V51, P70, DOI 10.1086/653610; Kim SH, 2011, AM J RESP CRIT CARE, V183, P1207, DOI 10.1164/rccm.201101-0110OC; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Kwong JC, 2011, CLIN INFECT DIS, V53, P413, DOI 10.1093/cid/cir442; Lam YY, 2011, OBESITY, V19, P2113, DOI 10.1038/oby.2011.68; Lee N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026050; Louie JK, 2011, CLIN INFECT DIS, V52, P301, DOI 10.1093/cid/ciq152; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Louie JK, 2012, PLOS ONE, V6; Marti A, 2001, Obes Rev, V2, P131, DOI 10.1046/j.1467-789x.2001.00025.x; Martino JL, 2011, CHEST, V140, P1198, DOI 10.1378/chest.10-3023; Memoli B, 2007, AM J PHYSIOL-ENDOC M, V293, pE1030, DOI 10.1152/ajpendo.00697.2006; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; Myles PR, 2012, THORAX, V67, P709, DOI 10.1136/thoraxjnl-2011-200266; New Zealand Ministry of Health, PORTR HLTH KEY RES 2; Noah MA, 2011, JAMA-J AM MED ASSOC, V306, P1659, DOI 10.1001/jama.2011.1471; O'Dea JA, 2003, MED J AUSTRALIA, V179, P63, DOI 10.5694/j.1326-5377.2003.tb05430.x; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8044; Riscili BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018166; Rodriguez A, 2011, MED INTENSIVA, V35, P208, DOI 10.1016/j.medin.2011.03.001; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Tsatsanis C, 2010, J INFECT DIS, V202, P459, DOI 10.1086/653842; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481	50	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55631	10.1371/journal.pone.0055631	http://dx.doi.org/10.1371/journal.pone.0055631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418448	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300039
J	Liu, CY; Li, YH; Yu, JZ; Feng, L; Hou, SW; Liu, YT; Guo, MF; Xie, Y; Meng, J; Zhang, HF; Xiao, BG; Ma, CG				Liu, Chunyun; Li, Yanhua; Yu, Jiezhong; Feng, Ling; Hou, Shaowei; Liu, Yueting; Guo, Mingfang; Xie, Yong; Meng, Jian; Zhang, Haifei; Xiao, Baoguo; Ma, Cungen			Targeting the Shift from M1 to M2 Macrophages in Experimental Autoimmune Encephalomyelitis Mice Treated with Fasudil	PLOS ONE			English	Article							RHO-KINASE; T-CELLS; MULTIPLE-SCLEROSIS; ALTERNATIVE ACTIVATION; IFN-GAMMA; POLARIZATION; INHIBITION; MONOCYTES; MIGRATION; CROSSTALK	We observed the therapeutic effect of Fasudil and explored its mechanisms in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). Fasudil, a selective Rho kinase (ROCK) inhibitor, was injected intraperitoneally at 40 mg/kg/d in early and late stages of EAE induction. Fasudil ameliorated the clinical severity of EAE at different stages, and decreased the expression of ROCK-II in spleen, accompanied by an improvement in demyelination and inhibition of inflammatory cells. Fasudil mainly inhibited CD4(+)IL-17(+) T cells in early treatment, but also elevated CD4(+)IL-10(+) regulatory T cells and IL-10 production in late treatment. The treatment of Fasudil shifted inflammatory M1 to anti-inflammatory M2 macrophages in both early and late treatment, being shown by inhibiting CD16/32, iNOS, IL-12, TLR4 and CD40 and increasing CD206, Arg-1, IL-10 and CD14 in spleen. By using Western blot and immunohistochemistry, iNOS and Arg-1, as two most specific markers for M1 and M2, was inhibited or induced in splenic macrophages and spinal cords of EAE mice treated with Fasudil. In vitro experiments also indicate that Fasudil shifts M1 to M2 phenotype, which does not require the participation or auxiliary of other cells. The polarization of M2 macrophages was associated with the decrease of inflammatory cytokine IL-1 beta, TNF-alpha and MCP-1. These results demonstrate that Fasudil has therapeutic potential in EAE possibly through inducing the polarization of M2 macrophages and inhibiting inflammatory responses.	[Liu, Chunyun; Li, Yanhua; Yu, Jiezhong; Feng, Ling; Hou, Shaowei; Liu, Yueting; Guo, Mingfang; Xie, Yong; Meng, Jian; Zhang, Haifei; Ma, Cungen] Shanxi Datong Univ, Inst Brain Sci, Sch Med, Dept Neurol, Datong, Peoples R China; [Xiao, Baoguo] Fudan Univ, Inst Neurol, Huashan Hosp, Inst Brain Sci, Shanghai 200433, Peoples R China; [Xiao, Baoguo] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Ma, Cungen] Shanxi Univ Tradit Chinese Med, Dept Neurol, Taiyuan, Peoples R China	Shanxi Datong University; Fudan University; Fudan University	Xiao, BG (corresponding author), Fudan Univ, Inst Neurol, Huashan Hosp, Inst Brain Sci, Shanghai 200433, Peoples R China.	bgxiao@shmu.edu.cn; macungen2001@yahoo.com.cn			National Natural Science Foundation of China [81070957, 30972715, 81070956]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant from National Natural Science Foundation of China (No. 81070957, No. 30972715 and No. 81070956). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Bao WK, 2004, CARDIOVASC RES, V61, P548, DOI 10.1016/j.cardiores.2003.12.004; BAUER J, 1994, J NEUROSCI RES, V38, P365, DOI 10.1002/jnr.490380402; Becher B, 2011, CURR OPIN IMMUNOL, V23, P707, DOI 10.1016/j.coi.2011.08.005; Bennett J, 2010, J NEUROIMMUNOL, V229, P180, DOI 10.1016/j.jneuroim.2010.08.011; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; Bosurgi L, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00062; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Chan T, 2011, CELL IMMUNOL, V266, P180, DOI 10.1016/j.cellimm.2010.10.002; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Denkinger CM, 2003, J IMMUNOL, V170, P1274, DOI 10.4049/jimmunol.170.3.1274; Ding RY, 2011, J SURG RES, V171, pE209, DOI 10.1016/j.jss.2011.08.009; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Haas J, 2009, J NEUROIMMUNOL, V216, P113, DOI 10.1016/j.jneuroim.2009.06.011; Haegert DG, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/461304; Hara M, 2000, J NEUROSURG, V93, P94, DOI 10.3171/spi.2000.93.1.0094; Heasman Sarah J, 2010, Small GTPases, V1, P174, DOI 10.4161/sgtp.1.3.14724; Huang XN, 2011, J NEUROIMMUNOL, V239, P61, DOI 10.1016/j.jneuroim.2011.08.015; Jadidi-Niaragh F, 2011, IMMUNOPHARM IMMUNOT, V33, P545, DOI 10.3109/08923973.2010.513391; Pinto-Medel MJ, 2012, J NEUROIMMUNOL, V243, P1, DOI 10.1016/j.jneuroim.2011.11.008; Jiang HR, 2012, EUR J IMMUNOL, V42, P1804, DOI 10.1002/eji.201141947; Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; Li HM, 2009, J NEUROIMMUNOL, V208, P54, DOI 10.1016/j.jneuroim.2009.01.002; Liu GW, 2011, IMMUNOL CELL BIOL, V89, P130, DOI 10.1038/icb.2010.70; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lutterotti A, 2006, J NEUROIMMUNOL, V181, P145, DOI 10.1016/j.jneuroim.2006.09.002; Marchetti V, 2011, SCI REP-UK, V1, DOI 10.1038/srep00076; Martin R, 2012, CLIN IMMUNOL, V142, P9, DOI 10.1016/j.clim.2011.10.008; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mensah-Brown EP, 2011, J NEUROIMMUNOL, V232, P68, DOI 10.1016/j.jneuroim.2010.10.010; Michel L, 2008, J CLIN INVEST, V118, P3411, DOI 10.1172/JCI35365; Mikita J, 2011, MULT SCLER J, V17, P2, DOI 10.1177/1352458510379243; Pierot L, 2010, CURR OPIN CRIT CARE, V16, P110, DOI 10.1097/MCC.0b013e3283372ef2; Rikitake Y, 2005, STROKE, V36, P2251, DOI 10.1161/01.STR.0000181077.84981.11; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Segal BA, 2003, CURR ALLERGY ASTHM R, V3, P86, DOI 10.1007/s11882-003-0017-6; Sinha S, 2010, J NEUROIMMUNOL, V225, P52, DOI 10.1016/j.jneuroim.2010.04.013; Slotta JE, 2008, BRIT J SURG, V95, P976, DOI 10.1002/bjs.6082; Sosa RA, 2011, J INTERF CYTOK RES, V31, P753, DOI 10.1089/jir.2011.0052; Street CA, 2011, ANTICANCER RES, V31, P3645; Sun XJ, 2006, J NEUROIMMUNOL, V180, P126, DOI 10.1016/j.jneuroim.2006.06.027; Taylor BV, 2011, MULT SCLER J, V17, P1171, DOI 10.1177/1352458511421105; Tselis A, 2011, SEMIN NEUROL, V31, P307, DOI 10.1055/s-0031-1287656; Ukkonen M, 2007, MULT SCLER, V13, P701, DOI 10.1177/1352458506075378; Wang L, 2012, STEM CELLS DEV, V21, P1069, DOI 10.1089/scd.2011.0124; Wolf NA, 2007, J NEUROIMMUNOL, V185, P115, DOI 10.1016/j.jneuroim.2007.02.001; Yamamoto M, 2008, AM J PATHOL, V172, P521, DOI 10.2353/ajpath.2008.070076; Yu JZ, 2010, J NEUROSCI RES, V88, P1664, DOI 10.1002/jnr.22339	54	166	187	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e54841	10.1371/journal.pone.0054841	http://dx.doi.org/10.1371/journal.pone.0054841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418431	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300021
J	Muganyizi, PS; Kidanto, H				Muganyizi, Projestine S.; Kidanto, Hussein			Sickle Cell Disease in Pregnancy: Trend and Pregnancy Outcomes at a Tertiary Hospital in Tanzania	PLOS ONE			English	Article							MORTALITY; CHILDREN; COHORT; EXPERIENCE; MANAGEMENT; SURVIVAL; NIGERIA; MALARIA; ANEMIA	SCD in pregnancy is associated with increased adverse fetal and maternal outcomes. In Tanzania where the frequency of sickle cell trait is 13% there has been scanty data on SCD in pregnancy. With progressive improvement in childhood survival the burden of SCD in pregnancy will increase. We analyzed all deliveries at Muhimbili National Hospital (MNH) from 1999 to 2011. Fetal and maternal outcomes of SCD deliveries were compared with non-SCD. Data were analyzed using IBM SPSS statistics version 19. Chi square and Fisher Exact tests were used to compare proportions and the independent t-test for continuous data. To predict risks of adverse effects, odds ratios were determined using multivariate logistic regression. A p-value<0.05 was considered significant. In total, 157,473 deliveries occurred at MNH during the study period, of which 149 were SCD (incidence of 95 SCD per 100,000 deliveries). The incidence of SCD had increased from 76 per 100,000 deliveries in the 1999-2002 period to over 100 per 100, 000 deliveries in recent years. The mean maternal age at delivery was lower in SCD (24.0 +/- 5.5 years) than in non-SCD deliveries (26.2 +/- 6.0 years), p<0.001. Compared with non-SCD (2.9 +/- 0.7 Kg), SCD deliveries had less mean birth-weight (2.6 +/- 0.6 Kg), p<0.001. SCD were more likely than non-SCD to deliver low APGAR score at 5 minutes (34.5% Vs 15.0%, OR = 3.0, 95%CI: 2.1-4.2), stillbirths (25.7% Vs 7.5%, OR = 4.0, 95%CI: 2.8-5.8). There was excessive risk of maternal deaths in SCD compared to non-SCD (11.4% Vs 0.4%, OR = 29, 95%CI: 17.3-48.1). The leading cause of deaths in SCD was infections in wholly 82% in contrast to only 32% in non-SCD. In conclusion SCD in pregnancy is an emerging problem at MNH with increased adverse fetal outcomes and excessive maternal mortality mainly due to infections.	[Muganyizi, Projestine S.; Kidanto, Hussein] MUHAS, Sch Med, Dept Obstet & Gynecol, Dar Es Salaam, Tanzania	Muhimbili University of Health & Allied Sciences	Muganyizi, PS (corresponding author), MUHAS, Sch Med, Dept Obstet & Gynecol, Dar Es Salaam, Tanzania.	promuga@yahoo.com						Afolabi BB, 2009, J OBSTET GYNAECOL, V29, P104, DOI 10.1080/01443610802667112; Al Jama FE, 2009, ARCH GYNECOL OBSTET, V280, P793, DOI 10.1007/s00404-009-1002-7; ANGASTINIOTIS M, 1995, B WORLD HEALTH ORGAN, V73, P375; Asnani MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026281; Barfield WD, 2010, AM J PREV MED, V38, pS542, DOI 10.1016/j.amepre.2009.12.020; DARE FO, 1992, INT J GYNECOL OBSTET, V37, P163, DOI 10.1016/0020-7292(92)90376-T; Diallo D, 2002, CURR OPIN HEMATOL, V9, P111, DOI 10.1097/00062752-200203000-00005; ELSHAFEI AM, 1988, AUST NZ J OBSTET GYN, V28, P41; Makani J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014699; Makani J, 2010, BLOOD, V115, P215, DOI 10.1182/blood-2009-07-233528; McAuley CF, 2010, BLOOD, V116, P1663, DOI 10.1182/blood-2010-01-265249; [NHS S.C.a], 2009, NHD HDB LAB; Ogedengbe O K, 1993, West Afr J Med, V12, P96; Patra PK, 2011, J COMMUN GENET, V2, P147, DOI 10.1007/s12687-011-0050-4; Quinn CT, 2004, BLOOD, V103, P4023, DOI 10.1182/blood-2003-11-3758; Rahimy MC, 2000, BLOOD, V96, P1685, DOI 10.1182/blood.V96.5.1685.h8001685_1685_1689; Rajab KE, 2004, SAUDI MED J, V25, P265; Serjeant G R, 2005, East Afr Med J, V82, P367; Serjeant G R, 2003, East Afr Med J, V80, P384; Serjeant GR, 2005, BJOG-INT J OBSTET GY, V112, P1308, DOI 10.1111/j.1471-0528.2005.00678.x; Serjeant GR, 2004, OBSTET GYNECOL, V103, P1278, DOI 10.1097/01.AOG.0000127433.23611.54; Serjeant GR, 2001, ARCH DIS CHILD, V85, P375, DOI 10.1136/adc.85.5.375; Smith JA, 1996, OBSTET GYNECOL, V87, P199, DOI 10.1016/0029-7844(95)00367-3; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; Sun PM, 2001, AM J OBSTET GYNECOL, V184, P1127, DOI 10.1067/mob.2001.115477; Telfer P, 2007, HAEMATOLOGICA, V92, P905, DOI 10.3324/haematol.10937; United Republic of Tanzania. National Bureau of Statistics (NBS), 2011, TANZ DEM HLTH SURV 2; Wierenga KJJ, 2001, LANCET, V357, P680, DOI 10.1016/S0140-6736(00)04132-5	28	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56541	10.1371/journal.pone.0056541	http://dx.doi.org/10.1371/journal.pone.0056541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418582	Green Published, Green Submitted, gold			2022-12-27	WOS:000315970300175
J	Pope, RA; Parida, S; Bailey, D; Brownlie, J; Barrett, T; Banyard, AC				Pope, Robert A.; Parida, Satya; Bailey, Dalan; Brownlie, Joe; Barrett, Thomas; Banyard, Ashley C.			Early Events following Experimental Infection with Peste-Des-Petits Ruminants Virus Suggest Immune Cell Targeting	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; PATHOLOGICAL FINDINGS; RINDERPEST VIRUS; MEASLES-VIRUS; GOATS; CATTLE; OUTBREAK; MORBILLIVIRUS; SHEEP; PPR	Peste-des-petits ruminants virus (PPRV) is a viral pathogen that causes a devastating plague of small ruminants. PPRV is an economically significant disease that continues to be a major obstacle to the development of sustainable agriculture across the developing world. The current understanding of PPRV pathogenesis has been heavily assumed from the closely related rinderpest virus (RPV) and other morbillivirus infections alongside data derived from field outbreaks. There have been few studies reported that have focused on the pathogenesis of PPRV and very little is known about the processes underlying the early stages of infection. In the present study, 15 goats were challenged by the intranasal route with a virulent PPRV isolate, Cote d'Ivoire '89 (CI/89) and sacrificed at strategically defined time-points post infection to enable pre- and post-mortem sampling. This approach enabled precise monitoring of the progress and distribution of virus throughout the infection from the time of challenge, through peak viraemia and into a period of convalescence. Observations were then related to findings of previous field studies and experimental models of PPRV to develop a clinical scoring system for PPRV. Importantly, histopathological investigations demonstrated that the initial site for virus replication is not within the epithelial cells of the respiratory mucosa, as has been previously reported, but is within the tonsillar tissue and lymph nodes draining the site of inoculation. We propose that virus is taken up by immune cells within the respiratory mucosa which then transport virus to lymphoid tissues where primary virus replication occurs, and from where virus enters circulation. Based on these findings we propose a novel clinical scoring methodology for PPRV pathogenesis and suggest a fundamental shift away from the conventional model of PPRV pathogenesis.	[Pope, Robert A.; Parida, Satya; Bailey, Dalan; Barrett, Thomas; Banyard, Ashley C.] Pirbright Inst, Woking, Surrey, England; [Brownlie, Joe] Royal Vet Coll, Hatfield, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of London; University of London Royal Veterinary College	Parida, S (corresponding author), Pirbright Inst, Woking, Surrey, England.	satya.parida@pirbright.ac.uk; ashley.banyard@ahvla.gsi.gov.uk	Parida, Satya/E-5463-2015; Banyard, Ashley/C-7998-2011	Parida, Satya/0000-0001-8253-9461; Banyard, Ashley/0000-0002-1286-9825; Bailey, Dalan/0000-0002-5640-2266	BBSRC CIDLID Grant [BBH009485/1]; BBSRC [BB/H009485/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H009485/1] Funding Source: researchfish	BBSRC CIDLID Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AB and SP are part funded by BBSRC CIDLID Grant BBH009485/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar M, 2012, VIRUS RES, V167, P43, DOI 10.1016/j.virusres.2012.03.018; Abubakar M, 2011, TROP ANIM HEALTH PRO, V43, P745, DOI 10.1007/s11250-010-9776-y; ANDERSON J, 1994, EPIDEMIOL INFECT, V112, P225, DOI 10.1017/S0950268800057599; Anderson J., 1991, USE MONOCLONAL ANTIB; Anderson J, 1996, FAO ANIMAL HLTH MANU, P81; APPEL MJG, 1969, AM J VET RES, V30, P1167; Banyard AC, 2010, J GEN VIROLOGY; Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; Bao JY, 2011, RES VET SCI, V90, P238, DOI 10.1016/j.rvsc.2010.05.031; Barrett T., 2006, BIOL ANIMAL INFECT R, DOI [10.1016/B978-012088385-1/50033-2, DOI 10.1016/B978-012088385-1/50033-2]; Barrett T, 2008, ENCY VIROLOGY, P497; BORROW P, 1995, CURR TOP MICROBIOL, V191, P85; Brown CC, 1997, RES VET SCI, V63, P103, DOI 10.1016/S0034-5288(97)90000-X; BROWN CC, 1991, VET PATHOL, V28, P166, DOI 10.1177/030098589102800209; BROWN CC, 1994, VET PATHOL, V31, P194, DOI 10.1177/030098589403100206; BUNDZA A, 1988, CAN J VET RES, V52, P46; Chard LS, 2008, VIRUS RES, V136, P192, DOI 10.1016/j.virusres.2008.04.018; Couacy-Hymann E, 2007, VET J, V173, P178, DOI 10.1016/j.tvjl.2005.08.020; Couacy-Hymann E, 2007, PREV VET MED, V78, P85, DOI 10.1016/j.prevetmed.2006.09.003; Das SC, 2000, J VIROL, V74, P9039, DOI 10.1128/JVI.74.19.9039-9047.2000; De Nardi M, 2012, TRANSBOUND EMERG DIS, V59, P214, DOI 10.1111/j.1865-1682.2011.01260.x; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; Dhar P, 2002, VET MICROBIOL, V88, P153, DOI 10.1016/S0378-1135(02)00102-5; Diop M, 2005, EPIDEMIOL INFECT, V133, P711, DOI 10.1017/S0950268805003729; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; EMPRESS, 2008, PPRV MOR; ESOLEN LM, 1993, J INFECT DIS, V168, P47, DOI 10.1093/infdis/168.1.47; FAO, 2012, LIV EP CAUS HAV DEM; FAO, 2010, CAS DEF LIV DIS; Farina C, 2004, INT IMMUNOL, V16, P799, DOI 10.1093/intimm/dxh083; Forster R, 2012, TRENDS IMMUNOL, V33, P271, DOI 10.1016/j.it.2012.02.007; FURLEY CW, 1987, VET REC, V121, P443, DOI 10.1136/vr.121.19.443; Govindarajan R, 1997, VET REC, V141, P573, DOI 10.1136/vr.141.22.573; Heaney J, 2005, J GEN VIROL, V86, P3349, DOI 10.1099/vir.0.81370-0; Kennedy S, 1998, J COMP PATHOL, V119, P201, DOI 10.1016/S0021-9975(98)80045-5; Khan HA, 2008, TROP ANIM HEALTH PRO, V40, P521, DOI 10.1007/s11250-008-9129-2; Kinne J, 2010, EPIDEMIOL INFECT, V138, P1211, DOI 10.1017/S0950268809991592; Kul O, 2007, VET PATHOL, V44, P479, DOI 10.1354/vp.44-4-479; Kulkarni DD, 1996, VET REC, V138, P187, DOI 10.1136/vr.138.8.187; Kumar P, 2004, J VET MED B, V51, P153, DOI 10.1111/j.1439-0450.2004.00747.x; Kwiatek O, 2007, J COMP PATHOL, V136, P111, DOI 10.1016/j.jcpa.2006.12.002; Lefevre P C, 1990, Rev Sci Tech, V9, P935; Lemon K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001263; LIESS B, 1964, J HYG-CAMBRIDGE, V62, P81, DOI 10.1017/S0022172400039796; Mahapatra M, 2006, J GEN VIROL, V87, P2021, DOI 10.1099/vir.0.81721-0; Martin-Fontecha Alfonso, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-71029-5_2; McChesney MB, 1997, VIROLOGY, V233, P74, DOI 10.1006/viro.1997.8576; Merck, 2005, REF TABL RECT TEMP H, P2581; MORNET P., 1956, Revue de l'Elevage. Productions animales - Productions fourrageres, V9, P313; Mrkic B, 2000, J VIROL, V74, P1364, DOI 10.1128/JVI.74.3.1364-1372.2000; Munir M, 2012, EMERG INFECT DIS, V18, P193, DOI 10.3201/eid1801.111304; Nawathe DR, 1983, REV SCI TECH OIE, V2, P77; OBI TU, 1983, ZBL VET MED B, V30, P751; OIE, 2011, RIND ER; OIE, 2012, DIAGNOSTIC TESTS VAC, V1, P721; Osunkoya B O, 1990, West Afr J Med, V9, P35; PUGH DG, 2001, SHEEP GOAT MED; Radostits OM, 1994, VET MED A TXB DIS CA; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roeder P., 1999, FAO ANIM HLTH MAN, V5, P28; Russel A, 1984, In Pract, V6, P91; SHAILA MS, 1989, VET REC, V125, P602; Taylor W P, 1986, Rev Sci Tech, V5, P407, DOI 10.20506/rst.5.2.250; TAYLOR WP, 1984, PREV VET MED, V2, P157, DOI 10.1016/0167-5877(84)90059-X; Toplu N, 2004, J COMP PATHOL, V131, P135, DOI 10.1016/j.jcpa.2004.02.004; UGOCHUKWU EI, 1991, MICROBIOS, V65, P81; von Andrian UH, 1998, CELL ADHES COMMUN, V6, P85; von Messling V, 2004, P NATL ACAD SCI USA, V101, P14216, DOI 10.1073/pnas.0403597101; von Messling V, 2006, J VIROL, V80, P6084, DOI 10.1128/JVI.00357-06; WAFULA JS, 1987, TROP ANIM HEALTH PRO, V19, P173, DOI 10.1007/BF02239714; WAMWAYI HM, 1995, VET MICROBIOL, V44, P151, DOI 10.1016/0378-1135(95)00008-X; Wang ZL, 2009, EMERG INFECT DIS, V15, P299, DOI 10.3201/eid1502.080817; WOHLSEIN P, 1993, VET PATHOL, V30, P544, DOI 10.1177/030098589303000608; WOHLSEIN P, 1995, VET MICROBIOL, V44, P141, DOI 10.1016/0378-1135(95)00007-W; Woo PCY, 2012, P NATL ACAD SCI USA, V109, P5435, DOI 10.1073/pnas.1119972109; Yanagi Y, 2006, J GEN VIROL, V87, P2767, DOI 10.1099/vir.0.82221-0	76	60	62	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55830	10.1371/journal.pone.0055830	http://dx.doi.org/10.1371/journal.pone.0055830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418464	Green Published, gold, Green Submitted			2022-12-27	WOS:000315970300055
J	Schaible, B; McClean, S; Selfridge, A; Broquet, A; Asehnoune, K; Taylor, CT; Schaffer, K				Schaible, Bettina; McClean, Siobhan; Selfridge, Andrew; Broquet, Alexis; Asehnoune, Karim; Taylor, Cormac T.; Schaffer, Kirsten			Hypoxia Modulates Infection of Epithelial Cells by Pseudomonas aeruginosa	PLOS ONE			English	Article							NF-KAPPA-B; TRANSMEMBRANE CONDUCTANCE REGULATOR; INDUCIBLE FACTOR-I; CFTR EXPRESSION; GENE-EXPRESSION; UP-REGULATION; INTERNALIZATION; KINASE; SURVIVAL; HIF-1-ALPHA	Pseudomonas aeruginosa (P. aeruginosa) is an opportunistic pathogen commonly associated with lung and wound infections. Hypoxia is a frequent feature of the microenvironment of infected tissues which induces the expression of genes associated with innate immunity and inflammation in host cells primarily through the activation of the hypoxia-inducible factor (HIF) and Nuclear factor kappaB (NF-kappa B) pathways which are regulated by oxygen-dependent prolyl-hydroxylases. Hypoxia also affects virulence and antibiotic resistance in bacterial pathogens. However, less is known about the impact of hypoxia on host-pathogen interactions such as bacterial adhesion and infection. In the current study, we demonstrate that hypoxia decreases the internalization of P. aeruginosa into cultured epithelial cells resulting in decreased host cell death. This response can also be elicited by the hydroxylase inhibitor Dimethyloxallyl Glycine (DMOG). Reducing HIF-2 alpha expression or Rho kinase activity diminished the effects of hypoxia on P. aeruginosa infection. Furthermore, in an in vivo pneumonia infection model, application of DMOG 48 h before infection with P. aeruginosa significantly reduced mortality. Thus, hypoxia reduces P. aeruginosa internalization into epithelial cells and pharmacologic manipulation of the host pathways involved may represent new therapeutic targets in the treatment of P. aeruginosa infection.	[Schaible, Bettina; Selfridge, Andrew; Taylor, Cormac T.] Univ Coll Dublin, UCD Sch Med & Med Sci, Dublin 2, Ireland; [Schaible, Bettina; Selfridge, Andrew; Taylor, Cormac T.] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Schaible, Bettina] Queenss Univ, Sch Pharm, Belfast, Antrim, North Ireland; [McClean, Siobhan] Inst Technol Tallaght, Dublin, Ireland; [Broquet, Alexis; Asehnoune, Karim] Univ Nantes, Fac Med, Lab UPRES EA Therapeut Clin & Expt Infect 3826, Nantes, France; [Asehnoune, Karim] CHU Nantes, Hotel Dieu HME, Serv Anesthesie Reanimat Chirurg, F-44035 Nantes 01, France; [Schaffer, Kirsten] St Vincents Univ Hosp, Dept Microbiol, Dublin 4, Ireland	University College Dublin; University College Dublin; Technological University Dublin; Nantes Universite; Nantes Universite; CHU de Nantes; University College Dublin; Saint Vincent's University Hospital	Schaffer, K (corresponding author), St Vincents Univ Hosp, Dept Microbiol, Dublin 4, Ireland.	kirsten.e.schaffer@ucd.ie		McClean, Siobhan/0000-0001-6389-2542; Broquet, Alexis/0000-0002-6635-9601; Taylor, Cormac/0000-0002-0946-1247	Irish Research Council for Science, Engineering Technology; Science Foundation Ireland	Irish Research Council for Science, Engineering Technology(Irish Research Council for Science, Engineering and Technology); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by grants from the Irish Research Council for Science, Engineering & Technology, and Science Foundation Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajmoczi M, 2009, AM J PHYSIOL-CELL PH, V297, pC263, DOI 10.1152/ajpcell.00527.2008; Bruning U, 2011, MOL CELL BIOL, V31, P4087, DOI 10.1128/MCB.01276-10; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Evans DJ, 2002, MICROB PATHOGENESIS, V33, P135, DOI 10.1006/mpat.2002.0521; Fitzpatrick SF, 2011, J IMMUNOL, V186, P1091, DOI 10.4049/jimmunol.1002256; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Garrity-Ryan L, 2000, INFECT IMMUN, V68, P7100, DOI 10.1128/IAI.68.12.7100-7113.2000; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Guimbellot JS, 2008, AM J RESP CELL MOL, V39, P514, DOI 10.1165/rcmb.2007-0452OC; Ha U, 2001, INFECT IMMUN, V69, P4398, DOI 10.1128/IAI.69.7.4398-4406.2001; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hirakata Y, 2000, J INFECT DIS, V181, P765, DOI 10.1086/315276; Hirota SA, 2010, GASTROENTEROLOGY, V139, P259, DOI 10.1053/j.gastro.2010.03.045; Jacqueline C, 2012, J ANTIMICROB CHEMOTH; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Keely S, 2010, MOL BIOL CELL, V21, P538, DOI 10.1091/mbc.E09-07-0573; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Magret M, 2011, CRIT CARE, V15, DOI 10.1186/cc10036; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Marteyn B, 2010, NATURE, V465, P355, DOI 10.1038/nature08970; Maynard MA, 2007, CELL CYCLE, V6, P2810, DOI 10.4161/cc.6.22.4947; Naldini A, 2012, J CELL PHYSIOL, V227, P587, DOI 10.1002/jcp.22761; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Pielage JF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000031; Pier GB, 1997, P NATL ACAD SCI USA, V94, P12088, DOI 10.1073/pnas.94.22.12088; Sadikot RT, 2006, J IMMUNOL, V176, P4923, DOI 10.4049/jimmunol.176.8.4923; Schaible B, 2012, ANTIMICROB AGENTS CH, V56, P2114, DOI 10.1128/AAC.05574-11; Schaible B, 2010, RESP PHYSIOL NEUROBI, V174, P235, DOI 10.1016/j.resp.2010.08.006; Schmiedl A, 2010, CELL TISSUE RES, V342, P67, DOI 10.1007/s00441-010-1036-y; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Spilker T, 2004, J CLIN MICROBIOL, V42, P2074, DOI 10.1128/JCM.42.5.2074-2079.2004; Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Taylor CT, 2009, ANN NY ACAD SCI, V1177, P178, DOI 10.1111/j.1749-6632.2009.05024.x; Taylor CT, 1999, J BIOL CHEM, V274, P19447, DOI 10.1074/jbc.274.27.19447; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Turcotte S, 2003, J CELL SCI, V116, P2247, DOI 10.1242/jcs.00427; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vogel S, 2010, J BIOL CHEM, V285, P33756, DOI 10.1074/jbc.M110.132985; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Zaidi T, 2004, INVEST OPHTH VIS SCI, V45, P4066, DOI 10.1167/iovs.04-0627; Zheng W, 2009, FASEB J, V23, P204, DOI 10.1096/fj.08-110221	53	46	49	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56491	10.1371/journal.pone.0056491	http://dx.doi.org/10.1371/journal.pone.0056491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418576	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300169
J	Lamichhane, JR; Fabi, A; Ridolfi, R; Varvaro, L				Lamichhane, Jay Ram; Fabi, Alfredo; Ridolfi, Roberto; Varvaro, Leonardo			Epidemiological Study of Hazelnut Bacterial Blight in Central Italy by Using Laboratory Analysis and Geostatistics	PLOS ONE			English	Article							ARBORICOLA PV. CORYLINA; GEOGRAPHIC INFORMATION-SYSTEMS; CLIMATE-CHANGE; SPATIAL-ANALYSIS; PLANT-PATHOGENS; PHYSICAL-PROPERTIES; ELEVATED CO2; SOIL-PH; DISEASE; SPREAD	Incidence of Xanthomonas arboricola pv. corylina, the causal agent of hazelnut bacterial blight, was analyzed spatially in relation to the pedoclimatic factors. Hazelnut grown in twelve municipalities situated in the province of Viterbo, central Italy was studied. A consistent number of bacterial isolates were obtained from the infected tissues of hazelnut collected in three years (2010-2012). The isolates, characterized by phenotypic tests, did not show any difference among them. Spatial patterns of pedoclimatic data, analyzed by geostatistics showed a strong positive correlation of disease incidence with higher values of rainfall, thermal shock and soil nitrogen; a weak positive correlation with soil aluminium content and a strong negative correlation with the values of Mg/K ratio. No correlation of the disease incidence was found with soil pH. Disease incidence ranged from very low (<1%) to very high (almost 75%) across the orchards. Young plants (4-year old) were the most affected by the disease confirming a weak negative correlation of the disease incidence with plant age. Plant cultivars did not show any difference in susceptibility to the pathogen. Possible role of climate change on the epidemiology of the disease is discussed. Improved management practices are recommended for effective control of the disease.	[Lamichhane, Jay Ram; Fabi, Alfredo; Ridolfi, Roberto; Varvaro, Leonardo] Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy DAFN, Viterbo, Italy; [Lamichhane, Jay Ram; Fabi, Alfredo; Varvaro, Leonardo] Hazelnut Res Ctr, Viterbo, Italy	Tuscia University	Varvaro, L (corresponding author), Univ Tuscia, Dept Sci & Technol Agr Forestry Nat & Energy DAFN, Viterbo, Italy.	varvaro@unitus.it	Fabi, Alfredo/AAB-4073-2020	Lamichhane, Jay Ram/0000-0001-9780-0941				Agrios G. N., 2005, PLANT PATHOL; Aloj B, 1987, INF AGRARIO, V26, P55; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Ayers SH, 1919, USDA B; Balestra GM, 1997, PSEUDOMONAS SYRINGAE, P88; BARBIERI M, 1988, CONTRIB MINERAL PETR, V99, P485, DOI 10.1007/BF00371939; BARNETT HL, 1959, ANNU REV MICROBIOL, V13, P191, DOI 10.1146/annurev.mi.13.100159.001203; Barss HP, 1913, OREGON AGR EXPT STAT, V14, P213; Berry PM, 2002, GLOBAL ECOL BIOGEOGR, V11, P453, DOI 10.1111/j.1466-8238.2002.00304.x; Bianco M, 2002, P 2 NAT C HAZ GIFF V, P52; Boccacci P, 2009, ACTA HORTIC, V845, P127; Bradbury JF, 1987, CMI DESCRIPTIONS PAT; Brent K. J., 1998, FUNGICIDE RESISTANCE; Broders KD, 2009, PHYTOPATHOLOGY, V99, P957, DOI 10.1094/PHYTO-99-8-0957; BUTTERWORTH J, 1991, J APPL BACTERIOL, V71, P484, DOI 10.1111/j.1365-2672.1991.tb03822.x; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; CAMPBELL CL, 1985, ANNU REV PHYTOPATHOL, V23, P129; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; Chakraborty S, 2011, PLANT PATHOL, V60, P2, DOI 10.1111/j.1365-3059.2010.02411.x; Chakraborty S, 2003, NEW PHYTOL, V159, P733, DOI 10.1046/j.1469-8137.2003.00842.x; CHELLEMI DO, 1988, PHYTOPATHOLOGY, V78, P221, DOI 10.1094/Phyto-78-221; Clark I, 1979, PRATICAL GEOSTATISTI; Cliff AD, 1977, SPATIAL AUTOCORRELAT; Coakley SM, 1999, ANNU REV PHYTOPATHOL, V37, P399, DOI 10.1146/annurev.phyto.37.1.399; COOKSEY DA, 1990, ANNU REV PHYTOPATHOL, V28, P201, DOI 10.1146/annurev.py.28.090190.001221; CRESSIE N, 1988, MATH GEOL, V20, P405, DOI 10.1007/BF00892986; CRESSIE N, 1985, J INT ASS MATH GEOL, V17, P563, DOI 10.1007/BF01032109; Cristofori V, 2011, FRUTTICOL, V5, P44; DELHAIZE E, 1995, PLANT PHYSIOL, V107, P315, DOI 10.1104/pp.107.2.315; Deutsch C.V., 1992, GSLIB GEOSTATISTICAL; Dordas C, 2008, AGRON SUSTAIN DEV, V28, P33, DOI 10.1051/agro:2007051; Duffy BK, 1997, PHYTOPATHOLOGY, V87, P1118, DOI 10.1094/PHYTO.1997.87.11.1118; Eastman J. R, 1999, GUIDE GIS IMAGE PROC; Eastman JR, 2001, GUIDE GIS IMAGE PROC, VI; Fabi A, 2005, ACTA HORTIC, P427, DOI 10.17660/ActaHortic.2005.686.59; Fabi A, 2009, ACTA HORTIC, V845, P507, DOI 10.17660/ActaHortic.2009.845.78; Fabi A, 2006, P 12 C MED PHYT UN J, P217; FAO, 2010, FAO STAT; FERRIN DM, 1986, PHYTOPATHOLOGY, V76, P1153, DOI 10.1094/Phyto-76-1153; Fiori M, 2006, PETRIA, V16, P71; Fitt BDL, 2011, PLANT PATHOL, V60, P44, DOI 10.1111/j.1365-3059.2010.02413.x; FOY CD, 1978, ANNU REV PLANT PHYS, V29, P511, DOI 10.1146/annurev.pp.29.060178.002455; Franke J, 2009, PHYTOPATHOLOGY, V99, P974, DOI 10.1094/PHYTO-99-8-0974; Fuhrer J, 2003, AGR ECOSYST ENVIRON, V97, P1, DOI 10.1016/S0167-8809(03)00125-7; Gardan L, 1986, EPPO EPO B, V16, P13; Gardan L, 1983, P INT C HAZ AV IT, P443; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Gent DH, 2012, PLANT PATHOL, V61, P37, DOI 10.1111/j.1365-3059.2011.02491.x; Gisi U, 2007, PLANT PATHOL, V56, P199, DOI 10.1111/j.1365-3059.2006.01512.x; Goodchild MF, 1993, ENV MODELING GIS, P8; Goovaerts P., 1997, GEOSTATISTICS NATURA, DOI DOI 10.2307/1270969; GOTTWALD TR, 1995, PLANT DIS, V79, P266, DOI 10.1094/PD-79-0266; GRAY SM, 1986, PHYTOPATHOLOGY, V76, P243, DOI 10.1094/Phyto-76-243; Guo X.D., 2000, J APPL ECOL, V11, P557; HAAS JH, 1976, PHYTOPATHOLOGY, V66, P1219, DOI 10.1094/Phyto-66-1219; Hannan J.M., 2011, THESIS IOWA STATE U; Henne DC, 2012, PLANT DIS, V96, P948, DOI 10.1094/PDIS-09-11-0805-RE; HIRANO SS, 1990, ANNU REV PHYTOPATHOL, V28, P155, DOI 10.1146/annurev.py.28.090190.001103; Isaaks EH, 1989, APPL GEOSTATISTICS; Jaime-Garcia R, 2001, PHYTOPATHOLOGY, V91, P1156, DOI 10.1094/PHYTO.2001.91.12.1156; JAKOBSEN ST, 1993, ACTA AGR SCAND B-S P, V43, P1, DOI 10.1080/09064719309410223; Johansson O. A. H., 1977, Proceedings, International Seminar on Soil Environment and Fertility Management in Intensive Agriculture (SEFMIA), Japan 1977., P487; Kazempour MN, 2006, J PLANT PATHOL, V88, P341; KINRAIDE TB, 1992, PLANT PHYSIOL, V99, P1461, DOI 10.1104/pp.99.4.1461; KLEMENT Z, 1967, ANNU REV PHYTOPATHOL, V5, P17, DOI 10.1146/annurev.py.05.090167.000313; KLEMENT Z., 1961, Phytopathologische Zeitschrift, V41, P217, DOI 10.1111/j.1439-0434.1961.tb04050.x; Lamichhane JR, 2012, PLANT DIS, V96, P1577, DOI 10.1094/PDIS-04-12-0375-PDN; Lamichhane JR, 2012, J PHYTOPATHOL, V160, P752, DOI 10.1111/jph.12004; Lamichhane JR, 2012, ACTA HORT IN PRESS; LARKIN RP, 1995, PHYTOPATHOLOGY, V85, P191, DOI 10.1094/Phyto-85-191; LEBEN C, 1968, PHYTOPATHOLOGY, V58, P1143; LEE YA, 1992, PHYTOPATHOLOGY, V82, P971, DOI 10.1094/Phyto-82-971; Lelliot R.A., 1987, METHODS PLANT PATHOL, V2; Luck J, 2011, PLANT PATHOL, V60, P113, DOI 10.1111/j.1365-3059.2010.02414.x; MADDEN LV, 1982, PHYTOPATHOLOGY, V72, P195, DOI 10.1094/Phyto-72-195; Marschner H., 1995, MARSCHNERS MINERAL N, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; Martin HL, 2004, PLANT DIS, V88, P921, DOI 10.1094/PDIS.2004.88.9.921; Martins L, 2007, EUR J PLANT PATHOL, V119, P159, DOI 10.1007/s10658-007-9155-3; Martins LM, 2005, ACTA HORTIC, P621, DOI 10.17660/ActaHortic.2005.693.83; Martins LM, 1999, ACTA HORTIC, P447, DOI 10.17660/ActaHortic.1999.494.67; Martins Luis M., 2001, Forest Snow and Landscape Research, V76, P357; Mazzone P., 2006, PETRIA, V16, P19; Me G, 2006, PETRIA, V16, P7; MELAKEBERHAN H, 1995, PLANT DIS, V79, P886, DOI 10.1094/PD-79-0886; Melloy P, 2010, GLOBAL CHANGE BIOL, V16, P3363, DOI 10.1111/j.1365-2486.2010.02178.x; MILES WG, 1977, PHYTOPATHOLOGY, V67, P895, DOI 10.1094/Phyto-67-895; Miller PW, 1949, OREGON AGR EXPT STAT, V6; MOORE LW, 1974, PHYTOPATHOLOGY, V64, P1537, DOI 10.1094/Phyto-64-1537; Nelson Merritt R., 1997, AAAS Annual Meeting and Science Innovation Exposition, V163, pA22; Nelson MR, 1999, PLANT DIS, V83, P308, DOI 10.1094/PDIS.1999.83.4.308; NELSON MR, 1994, PHYTOPATHOLOGY, V84, P898, DOI 10.1094/Phyto-84-898; NICOT PC, 1984, PHYTOPATHOLOGY, V74, P1399, DOI 10.1094/Phyto-74-1399; NOE JP, 1985, J NEMATOL, V17, P86; Noviello C., 1968, LIEBIGS ANN CHEM, V4, P3; OEPP/EPPO, 1990, EPPO TECHN DOC; OEPP/EPPO, 2004, OEPP EPPO B, V34, P155; OEPP/EPPO, 1986, OEPP EPPO B, V16, P13; Oliver M. A., 1990, International Journal of Geographical Information Systems, V4, P313, DOI 10.1080/02693799008941549; OMAR MA, 1966, SOIL SCI, V101, P437, DOI 10.1097/00010694-196606000-00003; Orum TV, 1997, PLANT DIS, V81, P911, DOI 10.1094/PDIS.1997.81.8.911; Pangga IB, 2011, PLANT PATHOL, V60, P70, DOI 10.1111/j.1365-3059.2010.02408.x; PATHAK A N, 1971, Zeitschrift fuer Pflanzenernaehrung und Bodenkunde, V130, P118, DOI 10.1002/jpln.19711300204; Pedica A, 1997, ACTA HORTIC, P123, DOI 10.17660/ActaHortic.1997.445.17; PETRI L., 1932, BOLL R STAZ PATOL VEG [FLORENCE], V12, P1; PETRI L., 1933, BOLL R STAZ PATOL VEG, V13, P1; Pettiet J. V., 1988, Proceedings, Beltwide Cotton Production Research Conferences, 3-8 Jan. 1988, New Orleans, Louisiana, USA., P517; Pietrarelli L, 2006, J PLANT PATHOL, V88, P245; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Poschenrieder G, 2006, BAYERISCHE LANDESANS, P32; PRINCE AL, 1947, SOIL SCI, V63, P69, DOI 10.1097/00010694-194701000-00008; PROCTOR CH, 1984, COMMUN STAT-THEOR M, V13, P617, DOI 10.1080/03610928408828706; Pulawska J, 2010, J PLANT PATHOL, V92, P803; RAMIREZ BN, 1975, PHYTOPATHOLOGY, V65, P780, DOI 10.1094/Phyto-65-780; Ristaino JB, 2000, ANNU REV PHYTOPATHOL, V38, P541, DOI 10.1146/annurev.phyto.38.1.541; Roberts SJ, 1997, EUR J PLANT PATHOL, V103, P711, DOI 10.1023/A:1008609206778; Roberts SJ, 1985, THESIS U LEEDS; Schaad N. W., 2001, LAB GUIDE IDENTIFICA, V3rd, P1; Scortichini M, 2002, PLANT PATHOL, V51, P374, DOI 10.1046/j.1365-3059.2002.00691.x; Scortichini M, 1991, INF FITOPATOL, V41, P251; Scortichini M, 2001, INFORM AGRARIO, V21, P85; SEEM RC, 1984, ANNU REV PHYTOPATHOL, V22, P133, DOI 10.1146/annurev.py.22.090184.001025; Shear GM, 1944, PHYTOPATHOLOGY, V34, P603; Siscaro G, 2006, PETRIA, V16, P59; Snoeijers SS, 2000, EUR J PLANT PATHOL, V106, P493, DOI 10.1023/A:1008720704105; Star J, 1990, GEOGRAPHIC INFORM SY; STEIN A, 1994, PHYTOPATHOLOGY, V84, P1227, DOI 10.1094/Phyto-84-1227; Stein M.L., 1999, INTERPOLATION SPATIA; SUNDIN GW, 1993, APPL ENVIRON MICROB, V59, P1018, DOI 10.1128/AEM.59.4.1018-1024.1993; TEWARI S. N., 1971, Proceedings, International Symposium on Soil Fertility Evaluation, New Delhi, Indian Society of Soil Science, V1, P317; Tombesi A., 2002, 2 CONV NAZ NOCC, V296, P11; Tombesi A., 1991, AA VV FRUTTICOLTURA, P614; TRANGMAR BB, 1985, ADV AGRON, V38, P45; van Maanen A, 2003, EUR J PLANT PATHOL, V109, P669, DOI 10.1023/A:1026018005613; Vanneste J. L., 2005, New Zealand Plant Protection, V58, P101; Varvaro L, 1993, INF FITOPATOL, V2, P54; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Vigouroux A., 1993, ACTA HORTIC, V384, P607; Virdis S, 2008, THESIS U SASSARI SAR; Voisin A., 1963, GRASS TETANY; WEAVER DJ, 1975, PHYTOPATHOLOGY, V65, P984, DOI 10.1094/Phyto-65-984; White PJ, 2010, ANN BOT-LONDON, V105, P1073, DOI 10.1093/aob/mcq085; WILKINSON SR, 1990, MET IONS BIOL SYST, V26, P33; Wu BM, 2001, PHYTOPATHOLOGY, V91, P134, DOI 10.1094/PHYTO.2001.91.2.134; Yamamoto JK., 1999, NATURAL RESOURCES RE, V8, P153, DOI DOI 10.1023/A:1021894703729; Yang X B, 2001, GLOB CHANGE HUM HLTH, V2, P90, DOI [10.1023/A:1015086831467, DOI 10.1023/A:1015086831467]	145	25	26	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2013	8	2							e56298	10.1371/journal.pone.0056298	http://dx.doi.org/10.1371/journal.pone.0056298			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104BU	23424654	Green Published, gold, Green Submitted			2022-12-27	WOS:000315965100042
J	Bengtsson, F; Brasselet, R; Johansson, RS; Arleo, A; Jorntell, H				Bengtsson, Fredrik; Brasselet, Romain; Johansson, Roland S.; Arleo, Angelo; Jorntell, Henrik			Integration of Sensory Quanta in Cuneate Nucleus Neurons In Vivo	PLOS ONE			English	Article							DORSAL COLUMN NUCLEI; HUMAN TACTILE AFFERENTS; THALAMOCORTICAL NEURONS; MECHANICAL STIMULATION; ROOT FIBERS; TRANSMISSION; SINGLE; ORGANIZATION; PLASTICITY; RESPONSES	Discriminative touch relies on afferent information carried to the central nervous system by action potentials (spikes) in ensembles of primary afferents bundled in peripheral nerves. These sensory quanta are first processed by the cuneate nucleus before the afferent information is transmitted to brain networks serving specific perceptual and sensorimotor functions. Here we report data on the integration of primary afferent synaptic inputs obtained with in vivo whole cell patch clamp recordings from the neurons of this nucleus. We find that the synaptic integration in individual cuneate neurons is dominated by 4-8 primary afferent inputs with large synaptic weights. In a simulation we show that the arrangement with a low number of primary afferent inputs can maximize transfer over the cuneate nucleus of information encoded in the spatiotemporal patterns of spikes generated when a human fingertip contact objects. Hence, the observed distributions of synaptic weights support high fidelity transfer of signals from ensembles of tactile afferents. Various anatomical estimates suggest that a cuneate neuron may receive hundreds of primary afferents rather than 4-8. Therefore, we discuss the possibility that adaptation of synaptic weight distribution, possibly involving silent synapses, may function to maximize information transfer in somatosensory pathways.	[Bengtsson, Fredrik; Jorntell, Henrik] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Brasselet, Romain; Arleo, Angelo] Univ Paris 06, CNRS, Unit Neurobiol Adapt Proc, Paris, France; [Johansson, Roland S.] Umea Univ, Dept Integrat Med Biol, Physiol Sect, Umea, Sweden	Lund University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Umea University	Jorntell, H (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	henrik.jorntell@med.lu.se	Johansson, Roland S/A-5890-2009; Arleo, Angelo/N-9255-2019	Johansson, Roland S/0000-0003-3288-8326; Arleo, Angelo/0000-0002-1990-1971	SENSOPAC; EU [IST-028056-SENSOPAC, 248587]; Hand Embodied (THE); French Medical Research Foundation [FDT20090916556]; Swedish Research Council [08291, 08667]; LinnA(C) grant from the Swedish Research Council [60012701]; Knut and Alice Wallenberg Foundation [KAW 2004.0119]; Medical Faculty at Lund University	SENSOPAC; EU(European Commission); Hand Embodied (THE); French Medical Research Foundation(Fondation pour la Recherche Medicale); Swedish Research Council(Swedish Research CouncilEuropean Commission); LinnA(C) grant from the Swedish Research Council; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Medical Faculty at Lund University	The work was supported by SENSOPAC (an Integrated Project funded by the EU under FP6, IST-028056-SENSOPAC), The Hand Embodied (THE) (an Integrated Project funded by the EU under FP7, project number 248587), the French Medical Research Foundation (project number FDT20090916556), the Swedish Research Council (project number 08291, 08667), a LinnA (c) grant (project number 60012701) from the Swedish Research Council, The Knut and Alice Wallenberg Foundation (project number KAW 2004.0119) and the Medical Faculty at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN P, 1970, J PHYSIOL-LONDON, V210, P433, DOI 10.1113/jphysiol.1970.sp009219; ANDERSEN P, 1964, J NEUROPHYSIOL, V27, P1096, DOI 10.1152/jn.1964.27.6.1096; Arleo A, 2010, NEURAL COMPUT, V22, P2031, DOI 10.1162/NECO_a_00006-Arleo; Bagnall MW, 2011, NEURON, V71, P180, DOI 10.1016/j.neuron.2011.05.032; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bengtsson F, 2009, P NATL ACAD SCI USA, V106, P2389, DOI 10.1073/pnas.0808428106; Birznieks I, 2001, J NEUROSCI, V21, P8222, DOI 10.1523/JNEUROSCI.21-20-08222.2001; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Canedo A, 1998, NEUROSCIENCE, V84, P603, DOI 10.1016/S0306-4522(97)00554-X; Canedo A, 2000, EUR J NEUROSCI, V12, P2515, DOI 10.1046/j.1460-9568.2000.00107.x; CULBERSON JL, 1989, SOMATOSENS MOT RES, V6, P319, DOI 10.3109/08990228909144680; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; DYKES RW, 1982, J NEUROPHYSIOL, V47, P389, DOI 10.1152/jn.1982.47.3.389; FERRINGTON DG, 1987, J PHYSIOL-LONDON, V386, P293, DOI 10.1113/jphysiol.1987.sp016535; FLORENCE SL, 1989, J COMP NEUROL, V286, P48, DOI 10.1002/cne.902860104; Gerstner W, 2002, SPIKING NEURON MODEL; GOLOVCHINSKY V, 1980, J NEUROPHYSIOL, V43, P1673, DOI 10.1152/jn.1980.43.6.1673; Granseth B, 2003, J NEUROPHYSIOL, V89, P2952, DOI 10.1152/jn.01160.2002; HEINO R, 1991, ANAT EMBRYOL, V184, P181, DOI 10.1007/BF01673255; Hsiao S, 2008, CURR OPIN NEUROBIOL, V18, P418, DOI 10.1016/j.conb.2008.09.001; ISOMURA G, 1988, NEUROSCI RES, V5, P395, DOI 10.1016/0168-0102(88)90025-9; Jenmalm P, 2003, EUR J NEUROSCI, V18, P164, DOI 10.1046/j.1460-9568.2003.02721.x; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V297, P405, DOI 10.1113/jphysiol.1979.sp013048; Jones EG, 2000, ANNU REV NEUROSCI, V23, P1, DOI 10.1146/annurev.neuro.23.1.1; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; London M, 2002, NAT NEUROSCI, V5, P332, DOI 10.1038/nn826; Macefield VG, 1996, EXP BRAIN RES, V108, P155; MILLAR J, 1976, EXP NEUROL, V50, P658, DOI 10.1016/0014-4886(76)90035-2; Nadal JP, 1998, NETWORK-COMP NEURAL, V9, P207, DOI 10.1088/0954-898X/9/2/004; NADAL JP, 1994, NETWORK-COMP NEURAL, V5, P565, DOI 10.1088/0954-898X/5/4/008; Niedermayer E, 1993, ELECTROENCEPHALOGRAP; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; PETER G, 1986, J APPL PHYSIOL, V60, P1107, DOI 10.1152/jappl.1986.60.4.1107; PETTIT MJ, 1993, SCIENCE, V262, P2054, DOI 10.1126/science.8266104; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; PUBOLS BH, 1965, J NEUROPHYSIOL, V28, P312, DOI 10.1152/jn.1965.28.2.312; Reichova I, 2004, J NEUROPHYSIOL, V92, P2185, DOI 10.1152/jn.00322.2004; ROSEN I, 1969, J PHYSIOL-LONDON, V205, P209, DOI 10.1113/jphysiol.1969.sp008961; RUSTIONI A, 1968, J COMP NEUROL, V134, P113, DOI 10.1002/cne.901340107; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; TAKAHASHI T, 1992, J PHYSIOL-LONDON, V450, P593, DOI 10.1113/jphysiol.1992.sp019145; Toyoizumi T, 2005, P NATL ACAD SCI USA, V102, P5239, DOI 10.1073/pnas.0500495102; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; Verdu E, 2000, J PERIPHER NERV SYST, V5, P191, DOI 10.1046/j.1529-8027.2000.00026.x; WEINBERG RJ, 1990, J COMP NEUROL, V300, P113, DOI 10.1002/cne.903000108; WEN CY, 1978, J ANAT, V127, P169; Zachariah MK, 2001, J NEUROPHYSIOL, V86, P900, DOI 10.1152/jn.2001.86.2.900	57	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56630	10.1371/journal.pone.0056630	http://dx.doi.org/10.1371/journal.pone.0056630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409195	Green Submitted, Green Published, gold			2022-12-27	WOS:000314660300078
J	Ishii, A; Saito, Y; Mitsui, J; Ishiura, H; Yoshimura, J; Arai, H; Yamashita, S; Kimura, S; Oguni, H; Morishita, S; Tsuji, S; Sasaki, M; Hirose, S				Ishii, Atsushi; Saito, Yoshiaki; Mitsui, Jun; Ishiura, Hiroyuki; Yoshimura, Jun; Arai, Hidee; Yamashita, Sumimasa; Kimura, Sadami; Oguni, Hirokazu; Morishita, Shinichi; Tsuji, Shoji; Sasaki, Masayuki; Hirose, Shinichi			Identification of ATP1A3 Mutations by Exome Sequencing as the Cause of Alternating Hemiplegia of Childhood in Japanese Patients	PLOS ONE			English	Article							ONSET DYSTONIA-PARKINSONISM; DE-NOVO MUTATIONS; GENE MUTATION; MIGRAINE; NA,K-ATPASE; ATAXIA	Background: Alternating hemiplegia of childhood (AHC) is a rare disorder characterized by transient repeated attacks of paresis and cognitive impairment. Recent studies from the U. S. and Europe have described ATP1A3 mutations in AHC. However, the genotype-phenotype relationship remains unclear. The purpose of this study was to identify the genetic abnormality in a Japanese cohort of AHC using exome analysis. Principal Findings: A total of 712,558 genetic single nucleotide variations in 8 patients with sporadic AHC were found. After a series of exclusions, mutations of three genes were regarded as candidate causes of AHC. Each patient harbored a heterozygous missense mutation of ATP1A3, which included G755C, E815K, C927Y and D801N. All mutations were at highly conserved amino acid residues and deduced to affect ATPase activity of the corresponding ATP pump, the product of ATP1A3. They were de novo mutations and not identified in 96 healthy volunteers. Using Sanger sequencing, E815K was found in two other sporadic cases of AHC. In this study, E815K was found in 5 of 10 patients (50%), a prevalence higher than that reported in two recent studies [19 of 82 (23%) and 7 of 24 (29%)]. Furthermore, the clinical data of the affected individuals indicated that E815K resulted in a severer phenotype compared with other ATP1A3 mutations. Interpretation: Heterozygous de novo mutations of ATP1A3 were identified in all Japanese patients with AHC examined in this study, confirming that ATP1A3 mutation is the cause of AHC.	[Ishii, Atsushi; Hirose, Shinichi] Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 81401, Japan; [Ishii, Atsushi; Hirose, Shinichi] Fukuoka Univ, Cent Res Inst Mol Pathomech Epilepsy, Fukuoka 81401, Japan; [Saito, Yoshiaki; Sasaki, Masayuki] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Kodaira, Tokyo, Japan; [Mitsui, Jun; Ishiura, Hiroyuki; Tsuji, Shoji] Univ Tokyo, Dept Neurol, Grad Sch Med, Tokyo, Japan; [Yoshimura, Jun; Morishita, Shinichi] Univ Tokyo, Dept Computat Biol, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Arai, Hidee] Chiba Childrens Hosp, Dept Neurol, Chiba, Japan; [Yamashita, Sumimasa] Kanagawa Childrens Med Ctr, Div Child Neurol, Yokohama, Kanagawa, Japan; [Kimura, Sadami] Osaka Med Ctr, Div Child Neurol, Izumi, Japan; [Kimura, Sadami] Res Inst Maternal & Child Hlth, Izumi, Japan; [Oguni, Hirokazu] Tokyo Womens Med Univ, Dept Pediat, Tokyo, Japan	Fukuoka University; Fukuoka University; National Center for Neurology & Psychiatry - Japan; University of Tokyo; University of Tokyo; Chiba Children's Hospital; Osaka Medical Center for Cancer & Cardiovascular Diseases; Tokyo Women's Medical University	Hirose, S (corresponding author), Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 81401, Japan.	hirose@fukuoka-u.ac.jp	Mitsui, Jun/B-5455-2012	Mitsui, Jun/0000-0001-7425-4765; Morishita, Shinichi/0000-0002-6201-8885; HIROSE, Shinichi/0000-0001-6796-3790; Yoshimura, Jun/0000-0003-2988-1123	Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002]; Japan Society for the Promotion of Science (JSPS) [21249062, 23659529, 23791201]; Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) Exploratory Research, Japan Science and Technology Agency (JSP); Ministry of Health, Labor and Welfare of Japan [21B-5, 24-7]; "Central Research Institute for the Molecular Pathomechanisms of Epilepsy of Fukuoka University", Recommended Projects of Fukuoka University [117016]; Japan Foundation for Pediatric Research; Japan Epilepsy Research Foundation; Kaibara Morikazu Medical Science Promotion Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) Exploratory Research, Japan Science and Technology Agency (JSP); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); "Central Research Institute for the Molecular Pathomechanisms of Epilepsy of Fukuoka University", Recommended Projects of Fukuoka University; Japan Foundation for Pediatric Research; Japan Epilepsy Research Foundation; Kaibara Morikazu Medical Science Promotion Foundation(Kaibara Morikazu Medical Science Promotion Foundation)	This work was supported in part by a grant-in-aid for Scientific Research on Innovative Areas "Genome Science" from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#221S0002), a grant-in-aid for Scientific Research (A) (#21249062, to SH), a grant-in-aid for Challenging Exploratory Research (#23659529, to SH), a grant-in-aid for Young Scientists (B) (#23791201, to AI) from the Japan Society for the Promotion of Science (JSPS), grants from Adaptable and Seamless Technology Transfer Program through Target-driven R&D (A-STEP) Exploratory Research, Japan Science and Technology Agency (JSP), a research grant (#21B-5, #24-7, to MS, YS, and SH) for Nervous and Mental Disorders from the Ministry of Health, Labor and Welfare of Japan, "Central Research Institute for the Molecular Pathomechanisms of Epilepsy of Fukuoka University", Recommended Projects of Fukuoka University (#117016), a research grant from the Japan Foundation for Pediatric Research (to AI), a research grant from the Japan Epilepsy Research Foundation (to AI), and a research grant from Kaibara Morikazu Medical Science Promotion Foundation (to AI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Anselm IA, 2009, NEUROLOGY, V73, P400, DOI 10.1212/WNL.0b013e3181b04acd; Bassi MT, 2004, J MED GENET, V41, P621, DOI 10.1136/jmg.2003.017863; BOURGEOIS M, 1993, J PEDIATR-US, V122, P673, DOI 10.1016/S0022-3476(06)80003-X; Brashear A, 1997, NEUROLOGY, V48, P1066, DOI 10.1212/WNL.48.4.1066; Brashear A, 2012, DEV MED CHILD NEUROL, V54, P1065, DOI 10.1111/j.1469-8749.2012.04421.x; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; DOBYNS WB, 1993, NEUROLOGY, V43, P2596, DOI 10.1212/WNL.43.12.2596; Ducros A, 1999, AM J HUM GENET, V64, P89, DOI 10.1086/302192; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linazasoro G, 2002, MOVEMENT DISORD, V17, P608, DOI 10.1002/mds.10103; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Neville BGR, 2007, DEV MED CHILD NEUROL, V49, P777, DOI 10.1111/j.1469-8749.2007.00777.x; Pittock SJ, 2000, NEUROLOGY, V55, P991, DOI 10.1212/WNL.55.7.991; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Saito TL, 2009, BIOINFORMATICS, V25, P1856, DOI 10.1093/bioinformatics/btp350; Sweney MT, 2009, PEDIATRICS, V123, pe534, DOI 10.1542/peds.2008-2027; Vanmolkot KRJ, 2003, ANN NEUROL, V54, P360, DOI 10.1002/ana.10674	23	65	75	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56120	10.1371/journal.pone.0056120	http://dx.doi.org/10.1371/journal.pone.0056120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409136	Green Published, Green Submitted, gold			2022-12-27	WOS:000314660300060
J	Marchetti, M; Capela, D; Poincloux, R; Benmeradi, N; Auriac, MC; Le Ru, A; Maridonneau-Parini, I; Batut, J; Masson-Boivin, C				Marchetti, Marta; Capela, Delphine; Poincloux, Renaud; Benmeradi, Nacer; Auriac, Marie-Christine; Le Ru, Aurelie; Maridonneau-Parini, Isabelle; Batut, Jacques; Masson-Boivin, Catherine			Queuosine Biosynthesis Is Required for Sinorhizobium meliloti-Induced Cytoskeletal Modifications on HeLa Cells and Symbiosis with Medicago truncatula	PLOS ONE			English	Article							RNA-GUANINE TRANSGLYCOSYLASE; GENETIC-CHARACTERIZATION; BACTERIAL TOXINS; RHO GTPASES; RHIZOBIUM; INFECTION; ALFALFA; GENOME; DIFFERENTIATION; IDENTIFICATION	Rhizobia are symbiotic soil bacteria able to intracellularly colonize legume nodule cells and form nitrogen-fixing symbiosomes therein. How the plant cell cytoskeleton reorganizes in response to rhizobium colonization has remained poorly understood especially because of the lack of an in vitro infection assay. Here, we report on the use of the heterologous HeLa cell model to experimentally tackle this question. We observed that the model rhizobium Sinorhizobium meliloti, and other rhizobia as well, were able to trigger a major reorganization of actin cytoskeleton of cultured HeLa cells in vitro. Cell deformation was associated with an inhibition of the three major small RhoGTPases Cdc42, RhoA and Rac1. Bacterial entry, cytoskeleton rearrangements and modulation of RhoGTPase activity required an intact S. meliloti biosynthetic pathway for queuosine, a hypermodifed nucleoside regulating protein translation through tRNA, and possibly mRNA, modification. We showed that an intact bacterial queuosine biosynthetic pathway was also required for effective nitrogen-fixing symbiosis of S. meliloti with its host plant Medicago truncatula, thus indicating that one or several key symbiotic functions of S. meliloti are under queuosine control. We discuss whether the symbiotic defect of que mutants may originate, at least in part, from an altered capacity to modify plant cell actin cytoskeleton.	[Marchetti, Marta; Capela, Delphine; Auriac, Marie-Christine; Batut, Jacques; Masson-Boivin, Catherine] INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France; [Marchetti, Marta; Capela, Delphine; Auriac, Marie-Christine; Batut, Jacques; Masson-Boivin, Catherine] CNRS, LIPM, UMR2594, Castanet Tolosan, France; [Poincloux, Renaud; Maridonneau-Parini, Isabelle] CNRS, IPBS, Toulouse, France; [Poincloux, Renaud; Maridonneau-Parini, Isabelle] Univ Toulouse 3, Univ Toulouse, IPBS, F-31062 Toulouse, France; [Benmeradi, Nacer] Inst Biol Cellulaire & Genet IBCG CNRS, Toulouse, France; [Le Ru, Aurelie] Ctr Dev Biol, Plateforme Microscopie FRBT, Toulouse, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Batut, J (corresponding author), INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France.	Jacques.Batut@toulouse.inra.fr	Maridonneau-Parini, Isabelle/F-1985-2011; Poincloux, Renaud/AAD-4746-2019	Poincloux, Renaud/0000-0003-2884-1744; Auriac, Marie-Christine/0000-0002-1202-032X; Maridonneau-Parini, Isabelle/0000-0003-0189-0976; AURELIE, LE RU/0000-0002-0236-791X	SPE INRA	SPE INRA	This work is part of the "Laboratoire d'Excellence" (LABEX) entitled TULIP (ANR -10-LABX-41) and was supported by a grant from SPE INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadou C, 2008, GENOME RES, V18, P1472, DOI 10.1101/gr.076448.108; Barbieri JT, 2002, ANNU REV CELL DEV BI, V18, P315, DOI 10.1146/annurev.cellbio.18.012502.134748; Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; Becker A, 1995, MOL GEN GENET, V249, P487, DOI 10.1007/BF00290574; Bourzac KM, 2007, INFECT IMMUN, V75, P1203, DOI 10.1128/IAI.01702-06; Brembu T, 2006, CELL RES, V16, P435, DOI 10.1038/sj.cr.7310055; Campbell GRO, 2003, J BACTERIOL, V185, P3853, DOI 10.1128/JB.185.13.3853-3862.2003; CHARLES TC, 1991, GENETICS, V127, P5; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Costa A, 2004, J CHROMATOGR B, V801, P237, DOI 10.1016/j.jchromb.2003.11.022; Curak J, 2009, CURR OPIN MICROBIOL, V12, P18, DOI 10.1016/j.mib.2008.11.004; Darzynkiewicz Z., 1997, CURRENT PROTOCOLS CY; Davidson AL, 2001, CAN J BOT, V79, P767, DOI 10.1139/cjb-79-7-767; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; Gough C, 2011, MOL PLANT MICROBE IN, V24, P867, DOI 10.1094/MPMI-01-11-0019; Guillemin K, 2002, P NATL ACAD SCI USA, V99, P15136, DOI 10.1073/pnas.182558799; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARADA F, 1972, BIOCHEMISTRY-US, V11, P301, DOI 10.1021/bi00752a024; HIRSCH PR, 1979, J GEN MICROBIOL, V113, P219, DOI 10.1099/00221287-113-2-219; Hurt JK, 2007, NUCLEIC ACIDS RES, V35, P4905, DOI 10.1093/nar/gkm473; Ivanov S, 2010, CURR OPIN PLANT BIOL, V13, P372, DOI 10.1016/j.pbi.2010.04.005; Iwata-Reuyl D, 2003, BIOORG CHEM, V31, P24, DOI 10.1016/S0045-2068(02)00513-8; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Soto MJ, 2011, CENT EUR J BIOL, V6, P911, DOI 10.2478/s11535-011-0069-x; Ke DX, 2012, PLANT PHYSIOL, V159, P131, DOI 10.1104/pp.112.197269; Lagares A, 2001, J BACTERIOL, V183, P1248, DOI 10.1128/JB.183.4.1248-1258.2001; LANGGUT W, 1990, FEBS LETT, V265, P33, DOI 10.1016/0014-5793(90)80877-L; Lee KB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-271; Lemonnier M, 2007, FEMS MICROBIOL REV, V31, P515, DOI 10.1111/j.1574-6976.2007.00078.x; LeVier K, 2000, SCIENCE, V287, P2492, DOI 10.1126/science.287.5462.2492; Liu W, 2010, J INTEGR PLANT BIOL, V52, P639, DOI 10.1111/j.1744-7909.2010.00944.x; Marks ME, 2010, J BACTERIOL, V192, P3678, DOI 10.1128/JB.00255-10; Masson-Boivin C, 2009, TRENDS MICROBIOL, V17, P458, DOI 10.1016/j.tim.2009.07.004; MEADE HM, 1982, J BACTERIOL, V149, P114, DOI 10.1128/JB.149.1.114-122.1982; MEIER F, 1985, EMBO J, V4, P823, DOI 10.1002/j.1460-2075.1985.tb03704.x; Murray JD, 2011, MOL PLANT MICROBE IN, V24, P631, DOI 10.1094/MPMI-08-10-0181; NOGUCHI S, 1982, J BIOL CHEM, V257, P6544; Oke V, 1999, CURR OPIN MICROBIOL, V2, P641, DOI 10.1016/S1369-5274(99)00035-1; Reader JS, 2004, J BIOL CHEM, V279, P6280, DOI 10.1074/jbc.M310858200; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Shames SR, 2009, INT J BIOCHEM CELL B, V41, P380, DOI 10.1016/j.biocel.2008.08.013; Sprent JI, 2007, NEW PHYTOL, V174, P11, DOI 10.1111/j.1469-8137.2007.02015.x; Szucs A, 2006, BBA-GENE STRUCT EXPR, V1759, P108, DOI 10.1016/j.bbaexp.2006.03.001; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Timmers ACJ, 1998, DEVELOPMENT, V125, P339; Vandamme P, 2002, SYST APPL MICROBIOL, V25, P507, DOI 10.1078/07232020260517634; VASSE J, 1990, J BACTERIOL, V172, P4295, DOI 10.1128/jb.172.8.4295-4306.1990; Verma D P, 1998, Subcell Biochem, V29, P1; Vinayak M, 2010, BIOSCIENCE REP, V30, P135, DOI 10.1042/BSR20090057; Yokota K, 2009, PLANT CELL, V21, P267, DOI 10.1105/tpc.108.063693; Yuksel B, 2008, J EXP BOT, V59, P3831, DOI 10.1093/jxb/ern223	53	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56043	10.1371/journal.pone.0056043	http://dx.doi.org/10.1371/journal.pone.0056043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409119	gold, Green Published, Green Submitted			2022-12-27	WOS:000314660300052
J	Pang, Y; Zhang, XL				Pang, Yong; Zhang, Xiaoliang			Interpolated Compressed Sensing for 2D Multiple Slice Fast MR Imaging	PLOS ONE			English	Article							COIL DESIGN; RECONSTRUCTION	Sparse MRI has been introduced to reduce the acquisition time and raw data size by undersampling the k-space data. However, the image quality, particularly the contrast to noise ratio (CNR), decreases with the undersampling rate. In this work, we proposed an interpolated Compressed Sensing (iCS) method to further enhance the imaging speed or reduce data size without significant sacrifice of image quality and CNR for multi-slice two-dimensional sparse MR imaging in humans. This method utilizes the k-space data of the neighboring slice in the multi-slice acquisition. The missing k-space data of a highly undersampled slice are estimated by using the raw data of its neighboring slice multiplied by a weighting function generated from low resolution full k-space reference images. In-vivo MR imaging in human feet has been used to investigate the feasibility and the performance of the proposed iCS method. The results show that by using the proposed iCS reconstruction method, the average image error can be reduced and the average CNR can be improved, compared with the conventional sparse MRI reconstruction at the same undersampling rate.	[Pang, Yong; Zhang, Xiaoliang] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Zhang, Xiaoliang] Univ Calif San Francisco, Univ Calif Berkeley, Joint Grad Grp Bioengn, Berkeley, CA USA; [Zhang, Xiaoliang] Univ Calif San Francisco, Univ Calif Berkeley, Joint Grad Grp Bioengn, San Francisco, CA 94143 USA; [Zhang, Xiaoliang] Calif Inst Quantitat Biosci QB3, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California San Francisco; University of California System; University of California Berkeley; University of California San Francisco	Zhang, XL (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	xiaoliang.zhang@ucsf.edu	Pang, Yong/H-1589-2013	Pang, Yong/0000-0001-8938-8213	NIH [EB004453, EB008699, P41EB013598]; QB3 Research Award; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB013598, R01EB004453, R01EB008699] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); QB3 Research Award; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was partially supported by NIH grants EB004453, EB008699 and P41EB013598, and a QB3 Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajraoui S, 2010, MAGN RESON MED, V63, P1059, DOI 10.1002/mrm.22302; Chan RW, 2012, MAGN RESON MED, V67, P363, DOI 10.1002/mrm.23008; Chang CH, 2010, IEEE ENG MED BIO, P875, DOI 10.1109/IEMBS.2010.5627890; Cukur T, 2011, IEEE T MED IMAGING, V30, P1017, DOI 10.1109/TMI.2011.2116123; Cukur T, 2009, MAGN RESON MED, V61, P1122, DOI 10.1002/mrm.21907; Cunningham CH, 2007, J MAGN RESON, V187, P357, DOI 10.1016/j.jmr.2007.05.014; Doneva M, 2010, MAGN RESON MED, V64, P1749, DOI 10.1002/mrm.22563; Doneva M, 2010, MAGN RESON MED, V64, P1114, DOI 10.1002/mrm.22483; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Eslami R, 2010, IEEE T MED IMAGING, V29, P1297, DOI 10.1109/TMI.2010.2046673; Haldar JP, 2011, IEEE T MED IMAGING, V30, P893, DOI 10.1109/TMI.2010.2085084; Holland DJ, 2010, J MAGN RESON, V203, P236, DOI 10.1016/j.jmr.2010.01.001; Hu S, 2008, J MAGN RESON, V192, P258, DOI 10.1016/j.jmr.2008.03.003; Hu S, 2010, MAGN RESON MED, V63, P312, DOI 10.1002/mrm.22233; Huang C, 2011, MAGN RESON MED; Huang F, 2012, MAGN RESON MED, V68, P772, DOI 10.1002/mrm.23293; Ji JX, 2008, IEEE ENG MED BIO, P1671, DOI 10.1109/IEMBS.2008.4649496; Jung H, 2009, MAGN RESON MED, V61, P103, DOI 10.1002/mrm.21757; Kampf T, 2010, J MAGN RESON, V207, P262, DOI 10.1016/j.jmr.2010.09.006; Kazimierczuk K, 2011, ANGEW CHEM INT EDIT, V50, P5556, DOI 10.1002/anie.201100370; Kim D, 2012, MAGN RESON MED, V67, P1054, DOI 10.1002/mrm.23088; Kim YC, 2009, MAGN RESON MED, V61, P1434, DOI 10.1002/mrm.21953; Larson PEZ, 2011, MAGN RESON MED, V65, P610, DOI 10.1002/mrm.22650; Li W, 2012, MAGN RESON MED, V68, P1127, DOI 10.1002/mrm.23323; Liang D, 2012, MAGN RESON MED, V68, P41, DOI 10.1002/mrm.23197; Liang D, 2010, IEEE ENG MED BIO, P2829, DOI 10.1109/IEMBS.2010.5626077; Liang D, 2009, MAGN RESON MED, V62, P1574, DOI 10.1002/mrm.22161; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Madelin G, 2012, J MAGN RESON, V214, P360, DOI 10.1016/j.jmr.2011.12.005; Majumdar A, 2011, MAGN RESON IMAGING, V29, P408, DOI 10.1016/j.mri.2010.09.001; Menzel MI, 2011, MAGN RESON MED, V66, P1226, DOI 10.1002/mrm.23064; Michailovich O, 2011, IEEE T MED IMAGING, V30, P1100, DOI 10.1109/TMI.2011.2142189; Otazo R, 2010, MAGN RESON MED, V64, P767, DOI 10.1002/mrm.22463; Pang Y., P 20 ANN M ISMRM MEL, P2275; Stern AS, 2007, J MAGN RESON, V188, P295, DOI 10.1016/j.jmr.2007.07.008; Tsaig Y, 2006, SIGNAL PROCESS, V86, P549, DOI 10.1016/j.sigpro.2005.05.028; Vasanawala SS, 2010, RADIOLOGY, V256, P607, DOI 10.1148/radiol.10091218; Wu B, 2012, MAGN RESON MED, V67, P137, DOI 10.1002/mrm.23000; Wu B, 2011, MAGN RESON MED, V65, P83, DOI 10.1002/mrm.22545; Yu YY, 2011, IEEE ENG MED BIO, P5734, DOI 10.1109/IEMBS.2011.6091419; Yu YY, 2010, IEEE ENG MED BIO, P5661, DOI 10.1109/IEMBS.2010.5627897; Zhang XL, 2005, MAGN RESON MED, V53, P1234, DOI 10.1002/mrm.20462; Zhang XL, 2005, IEEE T BIO-MED ENG, V52, P495, DOI 10.1109/TBME.2004.842968; Zhang XL, 2003, J MAGN RESON, V161, P242, DOI 10.1016/S1090-7807(03)00004-1; Zhang XL, 2001, MAGNET RESON MED, V46, P443, DOI 10.1002/mrm.1212	45	15	20	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2013	8	2							e56098	10.1371/journal.pone.0056098	http://dx.doi.org/10.1371/journal.pone.0056098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086CJ	23409130	Green Published, Green Submitted, gold			2022-12-27	WOS:000314660300057
J	Aisemberg, J; Vercelli, CA; Bariani, MV; Billi, SC; Wolfson, ML; Franchi, AM				Aisemberg, Julieta; Vercelli, Claudia A.; Bariani, Maria V.; Billi, Silvia C.; Wolfson, Manuel L.; Franchi, Ana M.			Progesterone Is Essential for Protecting against LPS-Induced Pregnancy Loss. LIF as a Potential Mediator of the Anti-inflammatory Effect of Progesterone	PLOS ONE			English	Article							LEUKEMIA-INHIBITORY FACTOR; HUMAN MYOMETRIAL CELLS; HORMONAL-REGULATION; HUMAN ENDOMETRIUM; GENE-EXPRESSION; NITRIC-OXIDE; RAT UTERUS; EMBRYO IMPLANTATION; RECEPTOR EXPRESSION; MIFEPRISTONE RU486	Lipopolysaccharide (LPS) administration to mice on day 7 of gestation led to 100% embryonic resorption after 24 h. In this model, nitric oxide is fundamental for the resorption process. Progesterone may be responsible, at least in part, for a Th2 switch in the feto-maternal interface, inducing active immune tolerance against fetal antigens. Th2 cells promote the development of T cells, producing leukemia inhibitory factor (LIF), which seems to be important due to its immunomodulatory action during early pregnancy. Our aim was to evaluate the involvement of progesterone in the mechanism of LPS-induced embryonic resorption, and whether LIF can mediate hormonal action. Using in vivo and in vitro models, we provide evidence that circulating progesterone is an important component of the process by which infection causes embryonic resorption in mice. Also, LIF seems to be a mediator of the progesterone effect under inflammatory conditions. We found that serum progesterone fell to very low levels after 24 h of LPS exposure. Moreover, progesterone supplementation prevented embryonic resorption and LPS-induced increase of uterine nitric oxide levels in vivo. Results show that LPS diminished the expression of the nuclear progesterone receptor in the uterus after 6 and 12 h of treatment. We investigated the expression of LIF in uterine tissue from pregnant mice and found that progesterone up-regulates LIF mRNA expression in vitro. We observed that LIF was able to modulate the levels of nitric oxide induced by LPS in vitro, suggesting that it could be a potential mediator of the inflammatory action of progesterone. Our observations support the view that progesterone plays a critical role in a successful pregnancy as an anti-inflammatory agent, and that it could have possible therapeutic applications in the prevention of early reproductive failure associated with inflammatory disorders.	[Aisemberg, Julieta; Vercelli, Claudia A.; Bariani, Maria V.; Wolfson, Manuel L.; Franchi, Ana M.] Ctr Estudios Farmacol & Bot CONICET UBA, Buenos Aires, DF, Argentina; [Billi, Silvia C.] Univ San Martin, Inst Invest Biotecnol, Buenos Aires, DF, Argentina		Aisemberg, J (corresponding author), Ctr Estudios Farmacol & Bot CONICET UBA, Buenos Aires, DF, Argentina.	jaisemberg@yahoo.com.ar		Bariani, Maria Victoria/0000-0003-2675-7936; Wolfson, Manuel Luis/0000-0003-3433-1521	"Alberto J. Roemmers" Foundation; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-PICT) [10901]	"Alberto J. Roemmers" Foundation; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-PICT)(ANPCyT)	This work was supported by research grants from the "Alberto J. Roemmers" Foundation (2004-2005) and by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-PICT 2002/no10901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACE CI, 1995, MOL CELL ENDOCRINOL, V115, P95, DOI 10.1016/0303-7207(95)03674-V; ADASHI EY, 1990, AM J OBSTET GYNECOL, V162, P889, DOI 10.1016/0002-9378(90)91289-O; Agrawal V, 2012, ZYGOTE, P1; Agrawal V, 2011, FERTIL STERIL, V95, P1471, DOI 10.1016/j.fertnstert.2010.08.046; Aisemberg J, 2007, P NATL ACAD SCI USA, V104, P7534, DOI 10.1073/pnas.0702279104; ARICI A, 1995, J CLIN ENDOCR METAB, V80, P1908, DOI 10.1210/jc.80.6.1908; Auernhammer CJ, 2000, ENDOCR REV, V21, P313, DOI 10.1210/er.21.3.313; AVRECH OM, 1991, FERTIL STERIL, V56, P385; Bethea CL, 1998, ENDOCRINOLOGY, V139, P677, DOI 10.1210/en.139.2.677; Bowen JM, 2000, BIOL REPROD, V63, P1179, DOI 10.1095/biolreprod63.4.1179; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN MA, 1994, CYTOKINE, V6, P300, DOI 10.1016/1043-4666(94)90027-2; Burton GJ, 2002, J CLIN ENDOCR METAB, V87, P2954, DOI 10.1210/jc.87.6.2954; Cai LQ, 2000, CYTOKINE, V12, P1676, DOI 10.1006/cyto.2000.0758; Cervellati F, 2011, REPROD FERT DEVELOP, V23, P319, DOI 10.1071/RD10077; CHWALISZ K, 1995, ANN NY ACAD SCI, V761, P202, DOI 10.1111/j.1749-6632.1995.tb31380.x; Cullinan EB, 1996, P NATL ACAD SCI USA, V93, P3115, DOI 10.1073/pnas.93.7.3115; DEANESLY R, 1973, J REPROD FERTIL, V35, P183; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Diao HL, 2011, FERTIL STERIL, V95, P2087, DOI 10.1016/j.fertnstert.2011.01.160; Dong YL, 2000, BIOL REPROD, V62, P533, DOI 10.1095/biolreprod62.3.533; ELGER W, 1987, AM J OBSTET GYNECOL, V157, P1065, DOI 10.1016/S0002-9378(87)80134-5; Elovitz MA, 2006, PEDIATR RES, V59, P50, DOI 10.1203/01.pdr.0000191141.21932.b6; Fang X, 1997, ENDOCRINOLOGY, V138, P2763, DOI 10.1210/en.138.7.2763; Fidel P I Jr, 1998, J Matern Fetal Med, V7, P222; Friebe A, 2008, INT J BIOCHEM CELL B, V40, P2348, DOI 10.1016/j.biocel.2008.04.019; Goyeneche AA, 2003, BIOL REPROD, V68, P151, DOI 10.1095/biolreprod.102.007898; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Guo K, 1998, BIOL REPROD, V58, P739, DOI 10.1095/biolreprod58.3.739; Hambartsoumian E, 1998, AM J REPROD IMMUNOL, V39, P137; Hardy DB, 2006, MOL ENDOCRINOL, V20, P2724, DOI 10.1210/me.2006-0112; Heikinheimo O, 1997, CLIN PHARMACOKINET, V33, P7, DOI 10.2165/00003088-199733010-00002; Hirsch E, 2002, BIOL REPROD, V67, P1337, DOI 10.1095/biolreprod67.4.1337; Kholkute SD, 2000, MOL HUM REPROD, V6, P337, DOI 10.1093/molehr/6.4.337; Laird SM, 1997, HUM REPROD, V12, P569; Lee Y, 1996, P NATL ACAD SCI USA, V93, P15180, DOI 10.1073/pnas.93.26.15180; Mahajan DK, 1997, FERTIL STERIL, V68, P967, DOI 10.1016/S0015-0282(97)00189-1; Marriott LK, 2007, ENDOCRINE, V32, P317, DOI 10.1007/s12020-008-9038-1; McCormack JT, 1998, BIOL REPROD, V58, P255, DOI 10.1095/biolreprod58.1.255; Merlino AA, 2007, J CLIN ENDOCR METAB, V92, P1927, DOI 10.1210/jc.2007-0077; Mulac-Jericevic B, 2004, REPRODUCTION, V128, P139, DOI 10.1530/rep.1.00189; Murata T, 2003, J REPROD DEVELOP, V49, P425, DOI 10.1262/jrd.49.425; Nardo LG, 2006, REPROD BIOMED ONLINE, V13, P47, DOI 10.1016/S1472-6483(10)62015-9; Ogando DG, 2003, REPRODUCTION, V125, P95, DOI 10.1530/rep.0.1250095; OLSON NC, 1995, BRIT VET J, V151, P489, DOI 10.1016/S0007-1935(05)80023-5; Paiva P, 2009, CYTOKINE GROWTH F R, V20, P319, DOI 10.1016/j.cytogfr.2009.07.001; Piccinni MP, 1998, NAT MED, V4, P1020, DOI 10.1038/2006; Reinhart KC, 1998, MOL HUM REPROD, V4, P301, DOI 10.1093/molehr/4.3.301; Ribeiro ML, 2005, P NATL ACAD SCI USA, V102, P8048, DOI 10.1073/pnas.0502899102; Rodriguez A, 2007, THERIOGENOLOGY, V67, P1092, DOI 10.1016/j.theriogenology.2006.11.015; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruan HC, 2006, HUM REPROD, V21, P2521, DOI 10.1093/humrep/del215; Salamonsen LA, 2000, SEMIN REPROD MED, V18, P299, DOI 10.1055/s-2000-12567; SANCHOTELLO M, 1992, J ENDOCRINOL, V135, P571, DOI 10.1677/joe.0.1350571; Seli E, 2005, HUM REPROD, V20, P3012, DOI 10.1093/humrep/dei188; Shuya LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025288; Slayden OD, 2004, ARCH HISTOL CYTOL, V67, P393, DOI 10.1679/aohc.67.393; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Szekeres-Bartho J, 2005, CHEM IMMUNOL ALLERGY, V89, P118, DOI 10.1159/000087953; Tan HQ, 2012, J CLIN ENDOCR METAB, V97, pE719, DOI 10.1210/jc.2011-3251; Tan J, 1999, ENDOCRINOLOGY, V140, P5310, DOI 10.1210/en.140.11.5310; Toth B, 2009, GYNECOL OBSTET INVES, V67, P269, DOI 10.1159/000210373; Vercelli CA, 2009, REPROD BIOMED ONLINE, V18, P824, DOI 10.1016/S1472-6483(10)60033-8; WARING PM, 1995, P NATL ACAD SCI USA, V92, P1337, DOI 10.1073/pnas.92.5.1337; Weber MA, 2005, LAB INVEST, V85, P276, DOI 10.1038/labinvest.3700216; Winer N, 2009, EUR J OBSTET GYN R B, V145, P53, DOI 10.1016/j.ejogrb.2009.04.028; Xu DX, 2007, TOXICOLOGY, V234, P167, DOI 10.1016/j.tox.2007.02.010; YANG ZM, 1995, MOL REPROD DEV, V42, P407, DOI 10.1002/mrd.1080420406; Yang ZM, 1996, MOL REPROD DEV, V43, P470	69	69	72	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56161	10.1371/journal.pone.0056161	http://dx.doi.org/10.1371/journal.pone.0056161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409146	Green Published, gold, Green Submitted			2022-12-27	WOS:000315157200119
J	van Kesteren, MTR; Rijpkema, M; Ruiter, DJ; Fernandez, G				van Kesteren, Marlieke T. R.; Rijpkema, Mark; Ruiter, Dirk J.; Fernandez, Guillen			Consolidation Differentially Modulates Schema Effects on Memory for Items and Associations	PLOS ONE			English	Article							EPISODIC MEMORY; PRIOR KNOWLEDGE; SLEEP; INFORMATION; RECONSOLIDATION; CONNECTIVITY; EXPERIENCE; HUMANS	Newly learned information that is congruent with a preexisting schema is often better remembered than information that is incongruent. This schema effect on memory has previously been associated to more efficient encoding and consolidation mechanisms. However, this effect is not always consistently supported in the literature, with differential schema effects reported for different types of memory, different retrieval cues, and the possibility of time-dependent effects related to consolidation processes. To examine these effects more directly, we tested participants on two different types of memory (item recognition and associative memory) for newly encoded visuo-tactile associations at different study-test intervals, thus probing memory retrieval accuracy for schema-congruent and schema-incongruent items and associations at different time points (t = 0, t = 20, and t = 48 hours) after encoding. Results show that the schema effect on visual item recognition only arises after consolidation, while the schema effect on associative memory is already apparent immediately after encoding, persisting, but getting smaller over time. These findings give further insight into different factors influencing the schema effect on memory, and can inform future schema experiments by illustrating the value of considering effects of memory type and consolidation on schema-modulated retrieval.	[van Kesteren, Marlieke T. R.; Rijpkema, Mark; Fernandez, Guillen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [van Kesteren, Marlieke T. R.; Ruiter, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Dept Anat, NL-6525 ED Nijmegen, Netherlands; [Fernandez, Guillen] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van Kesteren, MTR (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	marlieke.vankesteren@donders.ru.nl	Ruiter, D.J./L-4617-2015; Rijpkema, Mark/D-1974-2010; van Kesteren, Marlieke/J-5809-2014; Fernandez, Guillen/B-3771-2009; van Kesteren, Marlieke/F-2723-2011	Rijpkema, Mark/0000-0002-8495-4703; van Kesteren, Marlieke/0000-0001-6765-7881; Fernandez, Guillen/0000-0002-5522-0604; 	RUNMC (Radboud University Nijmegen Medical Centre) [RG 000457]	RUNMC (Radboud University Nijmegen Medical Centre)	This research was supported by grants from the RUNMC (Radboud University Nijmegen Medical Centre) (RG 000457). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBA JW, 1983, PSYCHOL BULL, V93, P203, DOI 10.1037/0033-2909.93.2.203; ANDERSON JR, 1981, MEM COGNITION, V9, P237, DOI 10.3758/BF03196958; Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; BRANSFORD JD, 1972, J VERB LEARN VERB BE, V11, P717, DOI 10.1016/S0022-5371(72)80006-9; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Davis T, 2012, CEREB CORTEX, V22, P260, DOI 10.1093/cercor/bhr036; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dudai Y, 2012, ANNU REV NEUROSCI, V35, P227, DOI 10.1146/annurev-neuro-062111-150500; Fischer S, 2009, J EXP PSYCHOL LEARN, V35, P1586, DOI 10.1037/a0017256; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Lewis PA, 2011, TRENDS COGN SCI, V15, P343, DOI 10.1016/j.tics.2011.06.004; McKenzie S, 2011, NEURON, V71, P224, DOI 10.1016/j.neuron.2011.06.037; Neuschatz JS, 2002, APPL COGNITIVE PSYCH, V16, P687, DOI 10.1002/acp.824; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Payne JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033079; Payne JD, 2011, J COGNITIVE NEUROSCI, V23, P1285, DOI 10.1162/jocn.2010.21526; Peters RM, 2009, J NEUROSCI, V29, P15756, DOI 10.1523/JNEUROSCI.3684-09.2009; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; ROJAHN K, 1992, BRIT J SOC PSYCHOL, V31, P81, DOI 10.1111/j.2044-8309.1992.tb00958.x; Sakamoto Y, 2004, J EXP PSYCHOL GEN, V133, P534, DOI 10.1037/0096-3445.133.4.534; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Staresina BP, 2009, CEREB CORTEX, V19, P1198, DOI 10.1093/cercor/bhn165; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Tse D, 2011, SCIENCE, V333, P891, DOI 10.1126/science.1205274; TULVING E, 1995, PSYCHON B REV, V2, P387, DOI 10.3758/BF03210977; van Kesteren MTR, 2012, TRENDS NEUROSCI, V35, P211, DOI 10.1016/j.tins.2012.02.001; van Kesteren MTR, 2010, J NEUROSCI, V30, P15888, DOI 10.1523/JNEUROSCI.2674-10.2010; van Kesteren MTR, 2010, P NATL ACAD SCI USA, V107, P7550, DOI 10.1073/pnas.0914892107; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523	32	30	30	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56155	10.1371/journal.pone.0056155	http://dx.doi.org/10.1371/journal.pone.0056155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092XV	23409144	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200117
J	Wu, IC; Wu, CC; Lu, CY; Hsu, WH; Wu, MC; Lee, JY; Chou, SH; Lee, JM; Chou, YP; Wu, DC; Wu, MT				Wu, I-Chen; Wu, Chun-Chieh; Lu, Chien-Yu; Hsu, Wen-Hung; Wu, Meng-Chieh; Lee, Jui-Ying; Chou, Shah-Hwa; Lee, Jang-Ming; Chou, Yi-Ping; Wu, Deng-Chyang; Wu, Ming-Tsang			Substance Use (Alcohol, Areca Nut and Cigarette) Is Associated with Poor Prognosis of Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							TOBACCO SMOKING; CANCER; SURVIVAL; RISK; PREDICTORS; ARECOLINE; TAIWAN	Background: Few studies have reported the association between lifestyle factors and prognosis of esophageal squamous cell carcinoma (ESCC) and among these, the effects of habitual areca nut chewing have never been examined. Methodology/Principal Findings: Data from 718 pathology-proven ESCC patients recruited in a multicenter hospital-based case-control study between 2000 and 2008 in Taiwan were analyzed. Clinical and lifestyle information were obtained by chart review and questionnaire survey. Death was confirmed using the National Death Index. The mean age at diagnosis was 59.8 years and 506 (70.5%) patients presented with stage III or IV diseases. The overall 1- and 5-year survival rates were 41.8% and 9.75% respectively. In addition to clinical stage, habitual alcohol drinking was found to be the strongest predictor for ESCC survival, followed by areca chewing and smoking. Compared with non-users, patients who regularly used all three substances (alcohol, areca nut, and cigarette) had 1.52 times the risk of early death (adjusted hazard ratio = 1.52, 95% CI = 1.02- 2.27, p = 0.04). In addition, the more the number of substances used, the worse the prognosis of ESCC (adjusted p for trend = 0.01). Conclusions/Significance: Our study found that indulgence in more substances is a significant predictor of ESCC survival. Further mechanistic studies are necessary to elucidate how these substances lead to an adverse outcome.	[Wu, I-Chen; Lu, Chien-Yu; Hsu, Wen-Hung; Wu, Meng-Chieh; Wu, Deng-Chyang] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan; [Wu, I-Chen; Lu, Chien-Yu; Wu, Deng-Chyang] Kaohsiung Med Univ, Dept Med, Coll Med, Fac Med, Kaohsiung, Taiwan; [Wu, Chun-Chieh] Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Hsu, Wen-Hung; Wu, Meng-Chieh; Wu, Deng-Chyang] Kaohsiung Municipal Hsiaokang Hosp, Div Internal Med, Kaohsiung, Taiwan; [Lee, Jui-Ying; Chou, Shah-Hwa] Kaohsiung Med Univ Hosp, Div Chest Surg, Dept Surg, Kaohsiung, Taiwan; [Lee, Jang-Ming] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Chou, Yi-Ping] Kaohsiung Vet Gen Hosp, Dept Surg, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Municipal Hsiaokang Hosp, Ctr Environm & Occupat Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Kaohsiung Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Wu, MT (corresponding author), Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan.	960021@ms.kmuh.org.tw	Wu, Ming-Tsang/G-5637-2012	Wu, Ming-Tsang/0000-0001-7307-7816; LEE, JANG-MING/0000-0001-9727-227X; Wu, Chun-Chieh/0000-0003-0284-3784	Taiwan National Science Council [NSC 101-2314-B-037-043]; Kaohsiung Medical University Hospital [KMUH100-0R04]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital	This study was supported by the Taiwan National Science Council (NSC 101-2314-B-037-043) and Kaohsiung Medical University Hospital (KMUH100-0R04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 1988, IARC Monogr Eval Carcinog Risks Hum, V44, P1; [Anonymous], 2006, HLTH STAT TAIW; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Jeng JH, 2003, CARCINOGENESIS, V24, P1301, DOI 10.1093/carcin/bgg083; Lee CH, 2005, INT J CANCER, V113, P475, DOI 10.1002/ijc.20619; Lee CH, 2007, EUR J CANCER, V43, P1188, DOI 10.1016/j.ejca.2007.01.039; Li Y, 2009, DIS ESOPHAGUS, V22, P664, DOI 10.1111/j.1442-2050.2008.00928.x; Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025347; NAIR MPN, 1990, CLIN IMMUNOL IMMUNOP, V54, P395, DOI 10.1016/0090-1229(90)90053-S; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Shitara K, 2010, CANCER SCI, V101, P1001, DOI 10.1111/j.1349-7006.2009.01466.x; Sundelof M, 2008, EUR J CANCER, V44, P1566, DOI 10.1016/j.ejca.2008.04.002; Thrift AP, 2012, INT J CANCER, V131, pE759, DOI 10.1002/ijc.27420; Thrift AP, 2012, CANCER CAUSE CONTROL, V23, P555, DOI 10.1007/s10552-012-9913-1; Trivers KF, 2005, CLIN GASTROENTEROL H, V3, P225, DOI 10.1016/S1542-3565(04)00613-5; Wang YC, 2010, ORAL ONCOL, V46, P255, DOI 10.1016/j.oraloncology.2010.01.003; Wu IC, 2008, WORLD J SURG, V32, P1989, DOI 10.1007/s00268-008-9609-6; Wu IC, 2006, EUR J CLIN INVEST, V36, P236, DOI 10.1111/j.1365-2362.2006.01621.x; Zhang H, 2009, ALCOHOL CLIN EXP RES, V33, P419, DOI 10.1111/j.1530-0277.2008.00852.x; 2004, IARC MONOGR EVAL CAR, V83, P1	22	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55834	10.1371/journal.pone.0055834	http://dx.doi.org/10.1371/journal.pone.0055834			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409056	gold, Green Published, Green Submitted			2022-12-27	WOS:000315157200073
J	Liu, HP; Liu, ZH; Chen, JX; Chen, L; He, X; Zheng, RJ; Yang, H; Song, P; Weng, D; Hu, HL; Fan, L; Xiao, HP; Kaufmann, SHE; Ernst, J; Ge, BX				Liu, Haipeng; Liu, Zhonghua; Chen, Jianxia; Chen, Ling; He, Xin; Zheng, Ruijuan; Yang, Hong; Song, Peng; Weng, Dong; Hu, Haili; Fan, Lin; Xiao, Heping; Kaufmann, Stefan H. E.; Ernst, Joel; Ge, Baoxue			Induction of CCL8/MCP-2 by Mycobacteria through the Activation of TLR2/PI3K/Akt Signaling Pathway	PLOS ONE			English	Article							TUBERCULOUS PLEURAL EFFUSIONS; HELPER T-CELLS; INTERFERON-GAMMA; DIAGNOSTIC UTILITY; UP-REGULATION; HOST DISEASE; PLASMA CCL8; EXPRESSION; MCP-2; RECRUITMENT	Pleural tuberculosis (TB), together with lymphatic TB, constitutes more than half of all extrapulmonary cases. Pleural effusions (PEs) in TB are representative of lymphocytic PEs which are dominated by T cells. However, the mechanism underlying T lymphocytes homing and accumulation in PEs is still incompletely understood. Here we performed a comparative analysis of cytokine abundance in PEs from TB patients and non-TB patients by protein array analysis and observed that MCP-2/CCL8 is highly expressed in the TB-PEs as compared to peripheral blood. Meanwhile, we observed that CCR5, the primary receptor used by MCP-2/CCL8, is mostly expressed on pleural CD4(+) T lymphocytes. Furthermore, we found that infection with either Mycobacterium bovis Bacillus Calmette-Guerin (BCG) or Mycobacterium tuberculosis H37Rv induced production of MCP-2/CCL8 at both transcriptional and protein level in Raw264.7 and THP-1 macrophage cells, mouse peritoneal macrophages as well as human PBMC monocyte-derived macrophages (MDMs). The induction of MCP-2/CCL8 by mycobacteria is dependent on the activation of TLR2/PI3K/Akt and p38 signaling pathway. We conclude that accumulation of MCP-2/CCL8 in TB-PEs may function as a biomarker for TB diagnosis.	[Liu, Haipeng; Liu, Zhonghua; Chen, Jianxia; Zheng, Ruijuan; Ge, Baoxue] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai TB Key Lab, Shanghai 200092, Peoples R China; [Liu, Haipeng; Yang, Hong; Song, Peng; Weng, Dong; Ge, Baoxue] Tongji Univ, Sch Med, Dept Microbiol & Immunol, Shanghai 200092, Peoples R China; [Liu, Haipeng; Chen, Jianxia; Chen, Ling; He, Xin; Yang, Hong; Song, Peng; Weng, Dong; Ge, Baoxue] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Clin Translat Res Ctr, Shanghai 200092, Peoples R China; [Hu, Haili; Fan, Lin; Xiao, Heping] Tongji Univ, Sch Med, Shanghai Pulm Hosp, TB Dept, Shanghai 200092, Peoples R China; [Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Ernst, Joel] NYU, Sch Med, Div Infect Dis, New York, NY USA	Tongji University; Tongji University; Tongji University; Tongji University; Max Planck Society; New York University	Ge, BX (corresponding author), Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai TB Key Lab, Shanghai 200092, Peoples R China.	baoxue_ge@tongji.edu.cn	; Kaufmann, Stefan HE/I-5454-2014	Liu, Haipeng/0000-0002-3338-6291; Kaufmann, Stefan HE/0000-0001-9866-8268	National Natural Science Foundation of China [81200003]; National Basic Research Program of China (973 Program) [2012CB518700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported in part by a grant from the National Natural Science Foundation of China (81200003); in part by a grant from the National Basic Research Program of China (973 Program 2012CB518700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameglio F, 2005, INT J TUBERC LUNG D, V9, P98; ANTONY VB, 1985, J CLIN INVEST, V76, P1514, DOI 10.1172/JCI112131; ANTONY VB, 1983, ACTA CYTOL, V27, P355; Bandow K, 2012, FEBS LETT, V586, P1540, DOI 10.1016/j.febslet.2012.04.018; BARNES PF, 1989, J IMMUNOL, V142, P1114; Baumann MH, 2007, CHEST, V131, P1125, DOI 10.1378/chest.06-2352; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; BOSSINK AWJ, 1995, BLOOD, V86, P3841, DOI 10.1182/blood.V86.10.3841.bloodjournal86103841; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Dheda K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004689; Dietrich J, 2009, APMIS, V117, P440, DOI 10.1111/j.1600-0463.2009.02458.x; Flynn JL, 2011, MUCOSAL IMMUNOL, V4, P271, DOI 10.1038/mi.2011.14; Gong XQ, 1997, J BIOL CHEM, V272, P11682, DOI 10.1074/jbc.272.18.11682; Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063; Hamm H, 1997, EUR RESPIR J, V10, P1150, DOI 10.1183/09031936.97.10051150; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Huynh KK, 2011, CURR OPIN IMMUNOL, V23, P464, DOI 10.1016/j.coi.2011.06.002; Jiang J, 2007, CHEST, V131, P1133, DOI 10.1378/chest.06-2273; Kohmo S, 2012, TUBERCULOSIS, V92, P248, DOI 10.1016/j.tube.2012.01.001; Kong L, 2008, CELL RES, V18, P745, DOI 10.1038/cr.2008.65; Liang QL, 2008, RESP MED, V102, P744, DOI 10.1016/j.rmed.2007.12.007; Light RW, 2002, NEW ENGL J MED, V346, P1971, DOI 10.1056/NEJMcp010731; Maddocks S, 2009, TUBERCULOSIS, V89, P285, DOI 10.1016/j.tube.2009.05.003; Mege JL, 2011, CURR OPIN INFECT DIS, V24, P230, DOI 10.1097/QCO.0b013e328344b73e; Mitra DK, 2005, EUR J IMMUNOL, V35, P2367, DOI 10.1002/eji.200525977; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Ota A, 2009, EXP HEMATOL, V37, P525, DOI 10.1016/j.exphem.2008.12.006; Pierer M, 2004, J IMMUNOL, V172, P1256, DOI 10.4049/jimmunol.172.2.1256; Pokkali S, 2008, CYTOKINE, V41, P307, DOI 10.1016/j.cyto.2007.12.009; Porcel JM, 2009, LUNG, V187, P263, DOI 10.1007/s00408-009-9165-3; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Ruffing N, 1998, CELL IMMUNOL, V189, P160, DOI 10.1006/cimm.1998.1379; Ruhwald M, 2008, EUR RESPIR J, V32, P1607, DOI 10.1183/09031936.00055508; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Sun XG, 2006, INFECT IMMUN, V74, P5943, DOI 10.1128/IAI.00082-06; Supriya P, 2008, DIAGN MICR INFEC DIS, V62, P186, DOI 10.1016/j.diagmicrobio.2008.05.011; Trajman A, 2008, EUR RESPIR J, V31, P1098, DOI 10.1183/09031936.00147507; VANDAMME J, 1994, J IMMUNOL, V152, P5495; Villena V, 2002, ARCH BRONCONEUMOL, V38, P21, DOI 10.1016/S0300-2896(02)75142-9; Wang Ting-ting, 2011, Zhonghua Xue Ye Xue Za Zhi, V32, P592; WANGOO A, 1993, CLIN EXP IMMUNOL, V94, P43; Wu C, 2010, RESPIROLOGY, V15, P522, DOI 10.1111/j.1440-1843.2010.01719.x; Yamamoto M, 2011, EXP HEMATOL, V39, P1101, DOI 10.1016/j.exphem.2011.07.006; Yang WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040450; Ye ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031710; Ye ZJ, 2012, AM J RESP CRIT CARE, V185, P660, DOI 10.1164/rccm.201107-1198OC	46	58	61	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56815	10.1371/journal.pone.0056815	http://dx.doi.org/10.1371/journal.pone.0056815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418602	Green Published, gold			2022-12-27	WOS:000315970300195
J	Jiang, JQ; Zhou, ZW				Jiang, JiaQian; Zhou, Zhengwei			Removal of Pharmaceutical Residues by Ferrate(VI)	PLOS ONE			English	Article							WASTE-WATER TREATMENT; PERSONAL CARE PRODUCTS; DISRUPTING CHEMICALS EDCS; SEWAGE-TREATMENT PLANTS; POTASSIUM FERRATE(VI); ENDOCRINE DISRUPTORS; ACTIVE COMPOUNDS; RISK-ASSESSMENT; OXIDATION; CARBAMAZEPINE	Background: Pharmaceuticals and their metabolites are inevitably emitted into the waters. The adverse environmental and human health effects of pharmaceutical residues in water could take place under a very low concentration range; from several mu g/L to ng/L. These are challenges to the global water industries as there is no unit process specifically designed to remove these pollutants. An efficient technology is thus sought to treat these pollutants in water and waste water. Methodology/Major Results: A novel chemical, ferrate, was assessed using a standard jar test procedure for the removal of pharmaceuticals. The analytical protocols of pharmaceuticals were standard solid phase extraction together with various instrumentation methods including LC-MS, HPLC-UV and UV/Vis spectroscopy. Ferrate can remove more than 80% of ciprofloxacin (CIP) at ferrate dose of 1 mg Fe/L and 30% of ibuprofen (IBU) at ferrate dose of 2 mg Fe/L. Removal of pharmaceuticals by ferrate was pH dependant and this was in coordinate to the chemical/physical properties of pharmaceuticals. Ferrate has shown higher capability in the degradation of CIP than IBU; this is because CIP has electron-rich organic moieties (EOM) which can be readily degraded by ferrate oxidation and IBU has electron-withdrawing groups which has slow reaction rate with ferrate. Promising performance of ferrate in the treatment of real waste water effluent at both pH 6 and 8 and dose range of 1-5 mg Fe/L was observed. Removal efficiency of ciprofloxacin was the highest among the target compounds (63%), followed by naproxen (43%). On the other hand, n-acetyl sulphamethoxazole was the hardest to be removed by ferrate (8% only). Conclusions: Ferrate is a promising chemical to be used to treat pharmaceuticals in waste water. Adjusting operating conditions in terms of the properties of target pharmaceuticals can maximise the pharmaceutical removal efficiency.	[Jiang, JiaQian; Zhou, Zhengwei] Glasgow Caledonian Univ, Sch Engn & Built Environm, Glasgow G4 0BA, Lanark, Scotland	Glasgow Caledonian University	Jiang, JQ (corresponding author), Glasgow Caledonian Univ, Sch Engn & Built Environm, Glasgow G4 0BA, Lanark, Scotland.	jiaqian.jiang@gcu.ac.uk	Jiang, Jia-Qian/O-9493-2014; Zhou, Zhengwei/M-9957-2015	Jiang, Jia-Qian/0000-0003-3607-8910; Zhou, Zhengwei/0000-0001-9014-5139; Bines, Julie/0000-0002-5452-6601	Glasgow Caledonian University Research Committee	Glasgow Caledonian University Research Committee	The authors thank the Glasgow Caledonian University Research Committee for offering a research studentship to ZZ for his PhD study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anquandah GAK, 2011, ENVIRON SCI TECHNOL, V45, P10575, DOI 10.1021/es202237g; Castiglioni S, 2006, ENVIRON SCI TECHNOL, V40, P357, DOI 10.1021/es050991m; Comeau F, 2008, SCI TOTAL ENVIRON, V396, P132, DOI 10.1016/j.scitotenv.2008.02.031; Comerton AM, 2008, J MEMBRANE SCI, V313, P323, DOI 10.1016/j.memsci.2008.01.021; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Ferrari B, 2003, ECOTOX ENVIRON SAFE, V55, P359, DOI 10.1016/S0147-6513(02)00082-9; Filip J, 2011, CHEM-EUR J, V17, P10097, DOI 10.1002/chem.201100711; Grung M, 2008, ECOTOX ENVIRON SAFE, V71, P328, DOI 10.1016/j.ecoenv.2007.10.015; Hu L, 2009, ENVIRON SCI TECHNOL, V43, P509, DOI 10.1021/es8023513; Jiang JQ, 2007, J HAZARD MATER, V146, P617, DOI 10.1016/j.jhazmat.2007.04.075; Jiang JQ, 2012, GLOBAL NEST J, V14, P93; Jiang JQ, 2007, DESALINATION, V210, P266, DOI 10.1016/j.desal.2006.05.051; Jiang JQ, 2012, SEP PURIF TECHNOL, V88, P95, DOI 10.1016/j.seppur.2011.12.021; Jiang JQ, 2009, SEP PURIF TECHNOL, V68, P227, DOI 10.1016/j.seppur.2009.05.007; Jiang JQ, 2002, WATER RES, V36, P1397, DOI 10.1016/S0043-1354(01)00358-X; Jiang JQ, 2006, J ENVIRON MANAGE, V79, P215, DOI 10.1016/j.jenvman.2005.06.009; Jiang JQ, 2005, CHEMOSPHERE, V61, P544, DOI 10.1016/j.chemosphere.2005.02.029; Jiang JQ, 2001, ENVIRON ENG SCI, V18, P323, DOI 10.1089/10928750152726041; Jiang JQ, 2001, SEPAR PURIF METHOD, V30, P127, DOI 10.1081/SPM-100102986; Jjemba PK, 2006, ECOTOX ENVIRON SAFE, V63, P113, DOI 10.1016/j.ecoenv.2004.11.011; Lee HB, 2007, J CHROMATOGR A, V1139, P45, DOI 10.1016/j.chroma.2006.11.068; Lee Y, 2009, ENVIRON SCI TECHNOL, V43, P3831, DOI 10.1021/es803588k; Lishman L, 2006, SCI TOTAL ENVIRON, V367, P544, DOI 10.1016/j.scitotenv.2006.03.021; Nakada N, 2006, WATER RES, V40, P3297, DOI 10.1016/j.watres.2006.06.039; Okuda T, 2008, WATER SCI TECHNOL, V57, P65, DOI 10.2166/wst.2008.822; Paxeus N, 2004, WATER SCI TECHNOL, V50, P253, DOI 10.2166/wst.2004.0335; Santos JL, 2007, ENVIRON INT, V33, P596, DOI 10.1016/j.envint.2006.09.014; Seitz W, 2008, CHEMOSPHERE, V70, P1238, DOI 10.1016/j.chemosphere.2007.07.081; Sharma VK, 2008, J WATER SUPPLY RES T, V57, P419, DOI 10.2166/aqua.2008.077; Sharma VK, 2006, ENVIRON CHEM LETT, V3, P182, DOI 10.1007/s10311-005-0002-5; Sharma VK, 2012, CHEMOSPHERE, V87, P644, DOI 10.1016/j.chemosphere.2012.01.019; Sharma VK, 2011, CHEMOSPHERE, V82, P1083, DOI 10.1016/j.chemosphere.2010.12.053; Sharma VK, 2010, J ENVIRON SCI HEAL A, V45, P645, DOI 10.1080/10934521003648784; Sharma VK, 2002, ADV ENVIRON RES, V6, P143, DOI 10.1016/S1093-0191(01)00119-8; Sharma VK, 2001, PHYS CHEM CHEM PHYS, V3, P2059, DOI 10.1039/b101432n; Snyder SA, 2007, DESALINATION, V202, P156, DOI 10.1016/j.desal.2005.12.052; Stanford C, 2010, WATER AIR SOIL POLL, V209, P483, DOI 10.1007/s11270-009-0216-4; Ternes TA, 1998, WATER RES, V32, P3245, DOI 10.1016/S0043-1354(98)00099-2; Wang L, 2010, SCI TOTAL ENVIRON, V408, P3139, DOI 10.1016/j.scitotenv.2010.04.047; Westerhoff P, 2005, ENVIRON SCI TECHNOL, V39, P6649, DOI 10.1021/es0484799; Yang B, 2012, WATER RES, V46, P2194, DOI 10.1016/j.watres.2012.01.047; Zhou ZW, 2012, J APPL SPECTROSC+, V79, P459, DOI 10.1007/s10812-012-9623-1	42	182	186	14	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e55729	10.1371/journal.pone.0055729	http://dx.doi.org/10.1371/journal.pone.0055729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409029	Green Published, Green Submitted, gold			2022-12-27	WOS:000315157200054
J	Kumar, S; Kaur, G				Kumar, Sushil; Kaur, Gurcharan			Intermittent Fasting Dietary Restriction Regimen Negatively Influences Reproduction in Young Rats: A Study of Hypothalamo-Hypophysial-Gonadal Axis	PLOS ONE			English	Article							LUTEINIZING-HORMONE SECRETION; CHRONIC FOOD RESTRICTION; NEURON-GLIAL PLASTICITY; NEUROPEPTIDE-Y; METABOLIC HORMONES; BODY-WEIGHT; SEXUAL DEVELOPMENT; ANOREXIA-NERVOSA; FEED RESTRICTION; ENERGY-BALANCE	Nutritional infertility is very common in societies where women fail to eat enough to match their energy expenditure and such females often present as clinical cases of anorexia nervosa. The cellular and molecular mechanisms that link energy balance and central regulation of reproduction are still not well understood. Peripheral hormones such as estradiol, testosterone and leptin, as well as neuropeptides like kisspeptin and neuropeptides Y (NPY) play a potential role in regulation of reproduction and energy balance with their primary target converging on the hypothalamic median eminence-arcuate region. The present study was aimed to explore the effects of negative energy state resulting from intermittent fasting dietary restriction (IF-DR) regimen on complete hypothalamo-hypophysial-gonadal axis in Wistar strain young female and male rats. Significant changes in body weight, blood glucose, estrous cyclicity and serum estradiol, testosterone and LH level indicated the negative role of IF-DR regimen on reproduction in these young animals. Further, it was elucidated whether serum level of metabolic hormone, leptin plays a mechanistic role in suppressing hypothalamo-hypophysial-gonadal (HPG) axis via energy regulators, kisspeptin and NPY in rats on IF-DR regimen. We also studied the effect of IF-DR regimen on structural remodeling of GnRH axon terminals in median eminence region of hypothalamus along with the glial cell marker, GFAP and neuronal plasticity marker, PSA-NCAM using immunostaining, Western blotting and RT-PCR. Together these data suggest that IF-DR regimen negatively influences reproduction in young animals due to its adverse effects on complete hypothalamus-hypophysial-gonadal axis and may explain underlying mechanism(s) to understand the clinical basis of nutritional infertility.	[Kumar, Sushil; Kaur, Gurcharan] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India	Guru Nanak Dev University	Kaur, G (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.	kgurcharan.neuro@yahoo.com	Kaur, Gurcharan/V-6033-2019	Kaushik, Nutan/0000-0002-3870-8093	Indo-French Centre for Promotion of Advanced Research (IFCPAR); Indian Council of Medical Research (ICMR) under the National Task Force Program; IFCPAR, New Delhi	Indo-French Centre for Promotion of Advanced Research (IFCPAR)(French National Research Agency (ANR)); Indian Council of Medical Research (ICMR) under the National Task Force Program; IFCPAR, New Delhi	The study was supported by a Grant from the Indo-French Centre for Promotion of Advanced Research (IFCPAR) and Indian Council of Medical Research (ICMR) under the National Task Force Program. Mr. Sushil Kumar is thankful to the IFCPAR, New Delhi for the research fellowship provided during this research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, REGUL PEPTIDES, V92, P1, DOI 10.1016/S0167-0115(00)00142-7; ALMOND GW, 1990, J ANIM SCI, V68, P1077, DOI 10.2527/1990.6841077x; Archer ZA, 2004, J ENDOCRINOL, V182, P409, DOI 10.1677/joe.0.1820409; Backholer K, 2010, ENDOCRINOLOGY, V151, P2233, DOI 10.1210/en.2009-1190; Bojkowska K, 2008, HORM BEHAV, V53, P342, DOI 10.1016/j.yhbeh.2007.10.013; Bonfanti L, 2009, CELL ADHES MIGR, V3, P43, DOI 10.4161/cam.3.1.7258; Booth PJ, 1996, J ANIM SCI, V74, P840; Brito LFC, 2007, REPRODUCTION, V134, P171, DOI 10.1530/REP-06-0353; Brito LFC, 2007, DOMEST ANIM ENDOCRIN, V33, P1, DOI 10.1016/j.domaniend.2006.04.001; CAMERON JL, 1991, J CLIN ENDOCR METAB, V73, P35, DOI 10.1210/jcem-73-1-35; Casanueva FF, 1999, FRONT NEUROENDOCRIN, V20, P317, DOI 10.1006/frne.1999.0187; Castellano JM, 2009, PEPTIDES, V30, P139, DOI 10.1016/j.peptides.2008.06.007; Castellano JM, 2005, ENDOCRINOLOGY, V146, P3917, DOI 10.1210/en.2005-0337; COUNTS DR, 1992, J CLIN ENDOCR METAB, V75, P762, DOI 10.1210/jc.75.3.762; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Estour B, 2010, J CLIN ENDOCR METAB, V95, P2203, DOI 10.1210/jc.2009-2608; Fernandez-Fernandez R, 2006, MOL CELL ENDOCRINOL, V254-255, P127; Garcia-Segura LM, 2004, ENDOCRINOLOGY, V145, P1082, DOI 10.1210/en.2003-1383; Glidewell-Kenney C, 2007, P NATL ACAD SCI USA, V104, P8173, DOI 10.1073/pnas.0611514104; GOODRICK CL, 1983, J GERONTOL, V38, P36, DOI 10.1093/geronj/38.1.36; GUY J, 1988, REGUL PEPTIDES, V23, P209, DOI 10.1016/0167-0115(88)90028-6; Haas VK, 2009, AM J CLIN NUTR, V89, P1005, DOI 10.3945/ajcn.2008.26958; Henry BA, 2004, J NEUROENDOCRINOL, V16, P244, DOI 10.1111/j.0953-8194.2004.01157.x; Hill JW, 2008, AM J PHYSIOL-ENDOC M, V294, pE827, DOI 10.1152/ajpendo.00670.2007; Ichimaru T, 2001, ENDOCRINOLOGY, V142, P2489, DOI 10.1210/en.142.6.2489; Kaiser UB, 2005, ENDOCRINE, V26, P277, DOI 10.1385/ENDO:26:3:277; Kataria H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037080; Kaur G, 2002, BRAIN RES, V954, P21, DOI 10.1016/S0006-8993(02)03301-2; Kinzig KP, 2009, AM J PHYSIOL-ENDOC M, V296, pE282, DOI 10.1152/ajpendo.90523.2008; Kumar S, 2011, MOL CELL ENDO, DOI 10.1016; Langle SL, 2002, J PHYSIOL-PARIS, V96, P169, DOI 10.1016/S0928-4257(02)00003-7; Liu XH, 2008, ENDOCRINOLOGY, V149, P4605, DOI 10.1210/en.2008-0321; Luque RM, 2007, ENDOCRINOLOGY, V148, P4601, DOI 10.1210/en.2007-0500; Martin B, 2008, AGEING RES REV, V7, P209, DOI 10.1016/j.arr.2008.01.002; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Miller KK, 2007, J CLIN ENDOCR METAB, V92, P1334, DOI 10.1210/jc.2006-2501; Nagatani S, 2001, J NEUROENDOCRINOL, V13, P371, DOI 10.1046/j.1365-2826.2001.00638.x; Narita K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028136; Parkash J, 2005, J ENDOCRINOL, V186, P397, DOI 10.1677/joe.1.06156; Parkash J, 2007, NEURON GLIA BIOL, V3, P299, DOI 10.1017/S1740925X07000701; Parkash J, 2007, BRAIN RES BULL, V74, P317, DOI 10.1016/j.brainresbull.2007.07.005; Garcia AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017313; Prevot V, 1998, NEUROSCIENCE, V84, P177, DOI 10.1016/S0306-4522(97)00537-X; Prevot V, 2002, J NEUROENDOCRINOL, V14, P247, DOI 10.1046/j.0007-1331.2001.00772.x; Prevot V, 2010, FRONT NEUROENDOCRIN, V31, P241, DOI 10.1016/j.yfrne.2010.05.003; Quesnel H, 1998, J ANIM SCI, V76, P856; Santos ZA, 2011, J NUTR SCI VITAMINOL, V55, P1; Sharma S, 2008, NEUROCHEM RES, V33, P1178, DOI 10.1007/s11064-007-9503-x; Singh R, 2012, AGE, V34, P917, DOI 10.1007/s11357-011-9289-2; Smith JT, 2008, ENDOCRINOLOGY, V149, P1951, DOI 10.1210/en.2007-1425; Sousa-Ferreira L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022333; Sucajtys-Szulc E, 2008, NEUROSCI LETT, V433, P174, DOI 10.1016/j.neulet.2008.01.004; Tropp J, 2001, PHYSIOL BEHAV, V73, P553, DOI 10.1016/S0031-9384(01)00487-5; True C, 2011, J NEUROENDOCRINOL, V23, P1099, DOI 10.1111/j.1365-2826.2011.02144.x; VELDHUIS JD, 1993, J CLIN ENDOCR METAB, V76, P587, DOI 10.1210/jcem.76.3.8445014; VERMEULEN A, 1993, ENVIRON HEALTH PERSP, V101, P91, DOI 10.2307/3431381; Wade GN, 2004, AM J PHYSIOL-REG I, V287, pR1277, DOI 10.1152/ajpregu.00475.2004; Wagenmaker ER, 2010, BIOL REPROD, V82, P1206, DOI 10.1095/biolreprod.109.078774; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241	60	59	66	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2013	8	1							e52416	10.1371/journal.pone.0052416	http://dx.doi.org/10.1371/journal.pone.0052416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097OK	23409154	Green Published, Green Submitted, gold			2022-12-27	WOS:000315483200038
J	Liu, HJ; Xu, YF; Lin, XJ; Shi, J; Chen, SY				Liu, Hongjie; Xu, Yongfang; Lin, Xinjin; Shi, Jian; Chen, Shiyi			Associations between Perceived HIV Stigma and Quality of Life at the Dyadic Lvel: The Actor-Partner Interdependence Model	PLOS ONE			English	Article							YOUNG ADOLESCENTS; CAREGIVERS; SCHIZOPHRENIA; INDIVIDUALISM; COLLECTIVISM; PERSPECTIVES; SEROSTATUS; INFECTION; HIV/AIDS; DISEASE	Background: Few studies have investigated the relationship between HIV-related stigma and quality life at the dyadic level. The objective of this study was to examine the actor and partner effects of stigma that was perceived by people living with HIV/AIDS (PLWHAs) and caregivers on quality of life at the dyadic level. Method: A survey was conducted among 148 dyads consisting of one PLWHA and one caregiver (296 participants) in Nanning, China. The interdependent relationship between a pair of dyadic members that influences the associations between stigma and quality of life was analyzed, using an innovative dyadic analysis technique: the Actor-Partner Interdependence Model (APIM). Results: We found in this dyadic analysis that (1) PLWHAs compared to their caregivers exhibited a higher level of perceived HIV stigma and lower level of quality of life measured in four domains; (2) both PLWHAs' and caregivers' perceived HIV stigma influenced their own quality of life; (3) The quality of life was not substantially influenced by their partners' perceived stigma; and (4) Both actor and partner effects of stigma on quality of life were similar among PLWHAs and their caregivers. Conclusion: As HIV stigma and quality of life are complex phenomena rooted in cultures, intervention programs should be carefully planned based on social or cognitive theories and should be culturally adopted.	[Liu, Hongjie] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA; [Xu, Yongfang; Lin, Xinjin; Shi, Jian; Chen, Shiyi] Nanning Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China	University System of Maryland; University of Maryland College Park	Liu, HJ (corresponding author), Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA.	hliu1210@umd.edu	; Kaufmann, Stefan HE/I-5454-2014	Liu, Haipeng/0000-0002-3338-6291; Kaufmann, Stefan HE/0000-0001-9866-8268	National Institutes of Health-National Institute of Child Health and Human Development [R01 HD068305-01]; Virginia Commonwealth University School of Medicine	National Institutes of Health-National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Virginia Commonwealth University School of Medicine	This work was partially supported by a research grant (R01 HD068305-01) from the National Institutes of Health-National Institute of Child Health and Human Development and a research grant from the Virginia Commonwealth University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasiubong F, 2011, AIDS CARE, V23, P494, DOI 10.1080/09540121.2010.516340; Andrinopoulos K, 2011, AIDS EDUC PREV, V23, P367, DOI 10.1521/aeap.2011.23.4.367; Aranda-Naranjo B, 2004, J ASSOC NURSE AIDS C, V15, p20S, DOI 10.1177/1055329004269183; Boyer L, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-42; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Caqueo-Urizar A, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-84; Chinese Ministry of Health, 2012, CHIN AIDS RESP PROGR; Cook WL, 2005, INT J BEHAV DEV, V29, P101, DOI 10.1080/01650250444000405; Feaster DJ, 2002, PSYCHOL HEALTH, V17, P339, DOI 10.1080/08870440290029584; Flaskerud J H, 1998, Health Care Women Int, V19, P23, DOI 10.1080/073993398246557; Goffman E., 1968, STIGMA NOTES MANAGEM; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Group W, 1996, WHOQOL BREF INTR ADM; Ha TH, 2012, AIDS CARE, V24, P39, DOI 10.1080/09540121.2011.592820; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Holzemer WL, 2009, J ASSOC NURSE AIDS C, V20, P161, DOI 10.1016/j.jana.2009.02.002; HUI CH, 1986, J CROSS CULT PSYCHOL, V17, P225, DOI 10.1177/0022002186017002006; Kelley H. H, 1978, INTERPERSONAL RELATI; Kenny D. A., 2006, DYADIC DATA ANAL; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Laursen B, 2005, INT J BEHAV DEV, V29, P97, DOI 10.1080/01650250444000450; Lee SJ, 2007, AM J PUBLIC HEALTH, V97, P1820, DOI 10.2105/AJPH.2005.084871; Li Li, 2008, Fam Syst Health, V26, P431; Li XH, 2011, AIDS PATIENT CARE ST, V25, P665, DOI 10.1089/apc.2011.0174; Lin T. Y., 1981, NORMAL ABNORMAL BEHA, P387, DOI DOI 10.1007/978-94-017-4986-2_20; Liu H, 2009, SEX TRANSM INFECT, V85, P65, DOI 10.1136/sti.2008.032714; Liu HJ, 2006, AIDS PATIENT CARE ST, V20, P133, DOI 10.1089/apc.2006.20.133; Liu HJ, 2002, SEX TRANSM DIS, V29, P335, DOI 10.1097/00007435-200206000-00005; Liu HJ, 2012, AIDS PATIENT CARE ST, V26, P565, DOI 10.1089/apc.2012.0227; Liu Hongjie, 2011, Stigma Res Action, V1, P27; Liu HJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-563; Mitchell MM, 2009, AIDS PATIENT CARE ST, V23, P611, DOI 10.1089/apc.2008.0279; Muth?n L.K., 2010, MPLUS USERS GUIDE V; Nelms TP, 2002, J FAMILY NURSING, V8, P282; Poindexter CC, 1999, SOC WORK, V44, P46, DOI 10.1093/sw/44.1.46; Rusbult CE, 2003, ANNU REV PSYCHOL, V54, P351, DOI 10.1146/annurev.psych.54.101601.145059; Scambler G, 1998, LANCET, V352, P1054, DOI 10.1016/S0140-6736(98)08068-4; Shan D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021839; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Thibaut J., 1959, SOCIAL PSYCHOL GROUP; TRIANDIS HC, 1988, J PERS SOC PSYCHOL, V54, P323, DOI 10.1037/0022-3514.54.2.323; WHOQOL Group, 2004, WHO QUAL LIF WHOQOL; Wight RG, 2006, SOC SCI MED, V62, P444, DOI 10.1016/j.socscimed.2005.06.004; Yang LH, 2008, SOC SCI MED, V67, P398, DOI 10.1016/j.socscimed.2008.03.011; Zendjidjian X, 2012, J AFFECT DISORDERS, V136, P660, DOI 10.1016/j.jad.2011.10.011	45	58	61	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2013	8	2							e55680	10.1371/journal.pone.0055680	http://dx.doi.org/10.1371/journal.pone.0055680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085EU	23418602	gold, Green Submitted, Green Published			2022-12-27	WOS:000314597900050
J	Siegmund, U; Heller, J; van Kan, JAL; Tudzynski, P				Siegmund, Ulrike; Heller, Jens; van Kan, Jan A. L.; Tudzynski, Paul			The NADPH Oxidase Complexes in Botrytis cinerea: Evidence for a Close Association with the ER and the Tetraspanin Pls1	PLOS ONE			English	Article							PROTEIN-DISULFIDE-ISOMERASE; APPRESSORIUM-MEDIATED PENETRATION; GRAY MOLD FUNGUS; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; ASCOSPORE GERMINATION; CELL-DIFFERENTIATION; FUNCTIONAL-ANALYSIS; LOCALIZATION; ACTIVATION	NADPH oxidases (Nox) are major enzymatic systems that generate reactive-oxygen species (ROS) in multicellular eukaryotes. In several fungi they have been shown to be involved in sexual differentiation and pathogenicity. However, in contrast to the well characterized mammalian systems, basic information on the composition, recruitment, and localization of fungal Nox complexes and on the molecular mechanisms of their cellular effects are still lacking. Here we give a detailed analysis of components of the Nox complexes in the gray mold fungus Botrytis cinerea. It had previously been shown that the two catalytic transmembrane subunits BcNoxA and B are important for development of sclerotia and for full virulence, with BcNoxA being involved in spreading of lesions and BcNoxB in penetration; BcNoxR functions as a regulator of both subunits. Here we present evidence (using for the first time a functional GFP fusion able to complement the Delta bcnoxA mutant) that BcNoxA localizes mainly to the ER and at the plasma membrane; BcNoxB shows a similar localization pattern, while the regulator BcNoxR is found in vesicles throughout the hyphae and at the hyphal tip. To identify possible interaction partners, which could be involved in the localization or recruitment of the Nox complexes, we functionally characterized the tetraspanin Pls1, a transmembrane protein, which had been suggested to be a NoxB-interacting partner in the saprophyte Podospora anserina. Knock-out experiments and GFP fusions substantiate a link between BcNoxB and BcPls1 because both deletion mutants have overlapping phenotypes (especially a defect in penetration), and the proteins show a similar localization pattern (ER). However, in contrast to the corresponding protein in P. anserina BcPls1 is important for female fertility, but not for ascospore germination.	[Siegmund, Ulrike; Heller, Jens; Tudzynski, Paul] Westfael Wilhelms Univ Muenster, Inst Biol & Biotechnol Pflanzen, Munster, Germany; [van Kan, Jan A. L.] Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Tudzynski, P (corresponding author), Westfael Wilhelms Univ Muenster, Inst Biol & Biotechnol Pflanzen, Munster, Germany.	tudzyns@uni-muenster.de		van Kan, Jan/0000-0003-3563-1550	Deutsche Forschungsgemeinschaft (DFG) [Tu50/17]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding agency: Deutsche Forschungsgemeinschaft (DFG; www.dfg.de), project Tu50/17. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Araki K, 2011, J BIOL CHEM, V286, P32705, DOI 10.1074/jbc.M111.227181; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Brun S, 2009, MOL MICROBIOL, V74, P480, DOI 10.1111/j.1365-2958.2009.06878.x; BUTTNER P, 1994, CURR GENET, V25, P445, DOI 10.1007/BF00351784; Cano-Dominguez N, 2008, EUKARYOT CELL, V7, P1352, DOI 10.1128/EC.00137-08; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chin CF, 2012, MOL BIOL CELL, V23, P45, DOI 10.1091/mbc.E11-05-0434; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Chuang JS, 1996, J CELL BIOL, V135, P597, DOI 10.1083/jcb.135.3.597; Clergeot PH, 2001, P NATL ACAD SCI USA, V98, P6963, DOI 10.1073/pnas.111132998; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Doehlemann G, 2006, MOL MICROBIOL, V59, P821, DOI 10.1111/j.1365-2958.2005.04991.x; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Fernandes DC, 2009, ARCH BIOCHEM BIOPHYS, V484, P197, DOI 10.1016/j.abb.2009.01.022; Giesbert S, 2008, MOL PLANT PATHOL, V9, P317, DOI [10.1111/j.1364-3703.2008.00466.x, 10.1111/J.1364-3703.2008.00466.X]; Gourgues M, 2004, MOL MICROBIOL, V51, P619, DOI 10.1046/j.1365-2958.2003.03866.x; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Gronover CS, 2001, MOL PLANT MICROBE IN, V14, P1293, DOI 10.1094/MPMI.2001.14.11.1293; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Huang SF, 2005, GENOMICS, V86, P674, DOI 10.1016/j.ygeno.2005.08.004; Janiszewski M, 2005, J BIOL CHEM, V280, P40813, DOI 10.1074/jbc.M509255200; Jonkers W, 2011, MOL PLANT PATHOL, V12, P548, DOI 10.1111/J.1364-3703.2010.00689.X; KANGATHARALINGAM N, 1984, CURR MICROBIOL, V10, P99, DOI 10.1007/BF01575767; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Klimpel A, 2002, MOL PLANT PATHOL, V3, P439, DOI 10.1046/j.1364-3703.2002.00137.x; Lalucque H, 2003, TRENDS MICROBIOL, V11, P9, DOI 10.1016/S0966-842X(02)00007-0; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lambou K, 2008, EUKARYOT CELL, V7, P1809, DOI 10.1128/EC.00149-08; Lambou K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-63; Lara-Ortiz T, 2003, MOL MICROBIOL, V50, P1241, DOI 10.1046/j.1365-2958.2003.03800.x; Lardy B, 2005, BBA-MOL CELL RES, V1744, P199, DOI 10.1016/j.bbamcr.2005.02.004; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Letourneur F, 1998, J BIOL CHEM, V273, P33273, DOI 10.1074/jbc.273.50.33273; Malagnac F, 2004, FUNGAL GENET BIOL, V41, P982, DOI 10.1016/j.fgb.2004.07.008; Margittai E, 2011, TRAFFIC, V12, P1, DOI 10.1111/j.1600-0854.2010.01108.x; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Masaki R, 1996, J BIOL CHEM, V271, P16939, DOI 10.1074/jbc.271.28.16939; Meitinger F, 2010, J CELL SCI, V123, P1851, DOI 10.1242/jcs.063891; Miller, 1972, EXPT MOL GENETICS; Pagani M, 2001, FEBS LETT, V508, P117, DOI 10.1016/S0014-5793(01)03034-4; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; Petry A, 2006, ANTIOXID REDOX SIGN, V8, P1473, DOI 10.1089/ars.2006.8.1473; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Rinnerthaler M, 2012, P NATL ACAD SCI USA, V109, P8658, DOI 10.1073/pnas.1201629109; Roca MG, 2012, FUNGAL BIOL-UK, V116, P379, DOI 10.1016/j.funbio.2011.12.007; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Schouten A, 2002, MOL PLANT PATHOL, V3, P227, DOI 10.1046/j.1364-3703.2002.00114.x; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Segmuller N, 2008, MOL PLANT MICROBE IN, V21, P808, DOI 10.1094/MPMI-21-6-0808; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Takemoto D, 2007, FUNGAL GENET BIOL, V44, P1065, DOI 10.1016/j.fgb.2007.04.011; Takemoto D, 2006, PLANT CELL, V18, P2807, DOI 10.1105/tpc.106.046169; Takemoto D, 2011, P NATL ACAD SCI USA, V108, P2861, DOI 10.1073/pnas.1017309108; Tanaka A, 2006, PLANT CELL, V18, P1052, DOI 10.1105/tpc.105.039263; Tanaka A, 2008, MOL MICROBIOL, V68, P1165, DOI 10.1111/j.1365-2958.2008.06217.x; Tenberge KB, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P67; Tudzynski P., 2009, MYCOTA, P29; VANDERVLUGTBERGMANS CJB, 1993, MYCOL RES, V97, P1193, DOI 10.1016/S0953-7562(09)81284-7; Veneault-Fourrey C, 2005, FUNGAL GENET BIOL, V42, P306, DOI 10.1016/j.fgb.2005.01.009; Vogel H.J., 1956, MICROB GENET B, V13, P42; Von Lohneysen K, 2008, J BIOL CHEM, V283, P35273, DOI 10.1074/jbc.M804200200; Wedlich-Soldner R, 2002, MOL BIOL CELL, V13, P965, DOI 10.1091/mbc.01-10-0475; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI [10.1111/j.1364-3703.2007.00417.x, 10.1111/J.1364-3703.2007.00417.X]; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Zhang G, 2006, J CELL BIOL, V174, P207, DOI 10.1083/jcb.200604094	72	53	56	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55879	10.1371/journal.pone.0055879	http://dx.doi.org/10.1371/journal.pone.0055879			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23418468	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300059
J	Chen, SR; Zou, LY; Li, L; Wu, T				Chen, Shaoru; Zou, Liyi; Li, Li; Wu, Tie			The Protective Effect of Glycyrrhetinic Acid on Carbon Tetrachloride-Induced Chronic Liver Fibrosis in Mice via Upregulation of Nrf2	PLOS ONE			English	Article							EXTRACELLULAR-SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; FREE-RADICALS; LIPID-PEROXIDATION; MONOAMINE-OXIDASE; REACTIVE OXYGEN; HEPATITIS-C; MOUSE-LIVER; DNA-DAMAGE; RAT-LIVER	This study was designed to investigate the potentially protective effects of glycyrrhetinic acid (GA) and the role of transcription factor nuclear factor-erythroid 2(NF-E2)-related factor 2 (Nrf2) signaling in the regulation of Carbon Tetrachloride (CCl4)-induced chronic liver fibrosis in mice. The potentially protective effects of GA on CCl4-induced chronic liver fibrosis in mice were depicted histologically and biochemically. Firstly, histopathological changes including regenerative nodules, inflammatory cell infiltration and fibrosis were induced by CCl4. Then, CCl4 administration caused a marked increase in the levels of serum aminotransferases (GOT, GPT), serum monoamine oxidase (MAO) and lipid peroxidation (MDA) as well as MAO in the mice liver homogenates. Also, decreased nuclear Nrf2 expression, mRNA levels of its target genes such as superoxide dismutase 3 (SOD3), catalase (CAT), glutathione peroxidase 2 (GPX2), and activity of cellular antioxidant enzymes were found after CCl4 exposure. All of these phenotypes were markedly reversed by the treatment of the mice with GA. In addition, GA exhibited the antioxidant effects in vitro by on FeCl2-ascorbate induced lipid peroxidation in mouse liver homogenates, and on DPPH scavenging activity. Taken together, these results suggested that GA can protect the liver from oxidative stress in mice, presumably through activating the nuclear translocation of Nrf2, enhancing the expression of its target genes and increasing the activity of the antioxidant enzymes. Therefore, GA may be an effective hepatoprotective agent and viable candidate for treating liver fibrosis and other oxidative stress-related diseases.	[Chen, Shaoru; Zou, Liyi; Li, Li; Wu, Tie] Pharm GuangDong Med Coll, Dongguan, Guangdong, Peoples R China	Guangdong Medical University	Wu, T (corresponding author), Pharm GuangDong Med Coll, Dongguan, Guangdong, Peoples R China.	wutie2@163.com			GuangDong foundation for basic research [2010B06050]	GuangDong foundation for basic research	This work was supported by the GuangDong foundation for basic research (grant 2010B06050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablise M, 2004, CHEM PHARM BULL, V52, P1436, DOI 10.1248/cpb.52.1436; Aslan M, 2004, CURR ALZHEIMER RES, V1, P111, DOI 10.2174/1567205043332162; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Bardag-Gorce F, 2011, EXP MOL PATHOL, V90, P123, DOI 10.1016/j.yexmp.2010.10.013; Bartsch H, 2006, LANGENBECK ARCH SURG, V391, P499, DOI 10.1007/s00423-006-0073-1; BRATTIN W J, 1985, Journal of Free Radicals in Biology and Medicine, V1, P27, DOI 10.1016/0748-5514(85)90026-1; Brautbar N, 2002, INT J HYG ENVIR HEAL, V205, P479, DOI 10.1078/1438-4639-00175; BRENT JA, 1993, J TOXICOL-CLIN TOXIC, V31, P173, DOI 10.3109/15563659309000384; Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Chen J, 2011, SHANDONG MED J, V51, P12; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Choi HK, 2009, TOXICOL APPL PHARM, V240, P377, DOI 10.1016/j.taap.2009.07.030; CHU FF, 1993, J BIOL CHEM, V268, P2571; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; Edmondson DE, 2004, CURR MED CHEM, V11, P1983, DOI 10.2174/0929867043364784; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fan J, 1997, Zhonghua Nei Ke Za Zhi, V36, P808; Farombi EO, 2008, FOOD CHEM TOXICOL, V46, P1279, DOI 10.1016/j.fct.2007.09.095; FOLZ RJ, 1994, GENOMICS, V22, P162, DOI 10.1006/geno.1994.1357; Friedman SL, 2003, SCHIFFS DIS LIVER, P409; Goldring CEP, 2004, HEPATOLOGY, V39, P1267, DOI 10.1002/hep.20183; Gong XL, 2008, STRAIT PHARM J, V20, P4; GRESSNER AM, 1982, J CLIN CHEM CLIN BIO, V20, P509; Guyton A.C., 2006, TXB MED PHYSL, P859; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hare MLC, 1928, BIOCHEM J, V22, P968, DOI 10.1042/bj0220968; He SX, 2006, WORLD J GASTROENTERO, V12, P3924, DOI 10.3748/wjg.v12.i24.3924; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Ivanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024957; Jeong WS, 2006, ANTIOXID REDOX SIGN, V8, P99, DOI 10.1089/ars.2006.8.99; Jia N, 2007, TOXICOLOGY, V237, P1, DOI 10.1016/j.tox.2007.04.015; Jiang T, 2009, TOXICOL APPL PHARM, V240, P8, DOI 10.1016/j.taap.2009.06.010; Jin M, 2009, MED RECAPIT, V15, P1712; JU HS, 1990, ACTA PHARM SINIC, V11, P466; [阚周密 KAN Zhoumi], 2007, [天津医药, Tianjin Medical Journal], V35, P361; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; KARLSSON K, 1988, BIOCHEM J, V255, P223; KARLSSON K, 1994, LAB INVEST, V70, P705; Kim HJ, 2008, FOOD CHEM TOXICOL, V46, P3407, DOI 10.1016/j.fct.2008.08.012; Kim HK, 2009, FOOD SCI BIOTECHNOL, V18, P1186; Kobashi K, 1984, Patent No. [JP: 5914799, 5914799]; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lai MMC, 2002, GASTROENTEROLOGY, V122, P568, DOI 10.1053/gast.2002.31474; Li CY, 2006, J FOOD SCI BIOTECHNO, V25, P1673; Li L, 2011, EXP TOXICOL PATHOL, V4, P1; Luo Ye, 2008, Practical Pharmacy and Clinical Remedies, V11, P182; Makino T, 2008, DRUG METAB DISPOS, V36, P1438, DOI 10.1124/dmd.108.021089; Mann Giovanni E., 2007, Shengli Xuebao, V59, P117; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; Mizrahi Meir, 2008, Harefuah, V147, P381; Molyneux P., 2004, SONGKLANAKARIN J SCI, V26, P211, DOI DOI 10.1287/ISRE.6.2.144; Moro T, 2008, LIFE SCI, V83, P531, DOI 10.1016/j.lfs.2008.07.023; Mulcahy RT, 1997, J BIOL CHEM, V272, P7445, DOI 10.1074/jbc.272.11.7445; NANJI AA, 1995, J LIPID RES, V36, P736; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Patel R, 2008, FREE RADICAL BIO MED, V44, P1897, DOI 10.1016/j.freeradbiomed.2008.02.006; PIERCE RA, 1987, J BIOL CHEM, V262, P1652; Poli Giuseppe, 2000, Molecular Aspects of Medicine, V21, P49, DOI 10.1016/S0098-2997(00)00004-2; Recknagel R.O., 2020, HEPATOTOXICOLOGY, P401; RECKNAGEL RO, 1989, PHARMACOL THERAPEUT, V43, P139, DOI 10.1016/0163-7258(89)90050-8; Reisman SA, 2009, TOXICOL SCI, V108, P35, DOI 10.1093/toxsci/kfn267; [任明 Ren Ming], 2010, [中国病理生理杂志, Chinese Journal of Pathophysiology], V26, P2222; Sikorska K, 2011, HEPATOB PANCREAT DIS, V10, P270, DOI 10.1016/S1499-3872(11)60045-3; Singh B, 2012, CARCINOGENESIS, V33, P2601, DOI 10.1093/carcin/bgs300; SLATER TF, 1984, BIOCHEM J, V222, P1; Slotkin TA, 1999, BRAIN RES BULL, V50, P373, DOI 10.1016/S0361-9230(99)00110-0; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; Thompson K, 1998, HEPATOLOGY, V28, P1597, DOI 10.1002/hep.510280620; Tipton KF, 2004, CURR MED CHEM, V11, P1965, DOI 10.2174/0929867043364810; TSUKAMOTO H, 1995, J GASTROEN HEPATOL, V10, pS50, DOI 10.1111/j.1440-1746.1995.tb01798.x; Van Rossum TGJ, 1998, ALIMENT PHARM THER, V12, P199; Wang JY, 2001, WORLD J GASTROENTERO, V7, P115; Wang YP, 2010, WORLD J GASTROENTERO, V16, P2657, DOI 10.3748/wjg.v16.i21.2657; WILLIAMS AT, 1990, SEMIN LIVER DIS, V10, P279, DOI 10.1055/s-2008-1040483; Wu KC, 2012, TOXICOL APPL PHARM, V263, P14, DOI 10.1016/j.taap.2012.05.017; Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75; Yang YS, 2008, FOOD CHEM TOXICOL, V46, P380, DOI 10.1016/j.fct.2007.08.016; Zhang Qi-sheng, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P664; Zhu H, 2012, J DIGEST DIS, V13, P133, DOI 10.1111/j.1751-2980.2011.00569.x; Zhu W, 2000, FREE RADICAL BIO MED, V29, P870, DOI 10.1016/S0891-5849(00)00396-8	82	187	196	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2013	8	1							e53662	10.1371/journal.pone.0053662	http://dx.doi.org/10.1371/journal.pone.0053662			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087KE	23341968	gold, Green Published, Green Submitted			2022-12-27	WOS:000314759400062
J	Wang, CH; Chang, CC; Liang, YM; Shih, CM; Chiu, WS; Tseng, P; Hung, DL; Tzeng, OJL; Muggleton, NG; Juan, CH				Wang, Chun-Hao; Chang, Che-Chien; Liang, Yen-Ming; Shih, Chun-Ming; Chiu, Wen-Sheng; Tseng, Philip; Hung, Daisy L.; Tzeng, Ovid J. L.; Muggleton, Neil G.; Juan, Chi-Hung			Open vs. Closed Skill Sports and the Modulation of Inhibitory Control	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; BASKETBALL PLAYERS; PHYSICAL-ACTIVITY; REACTION-TIME; BALL GAMES; EXPERTISE; COGNITION; BASEBALL; FITNESS; BRAIN	Background: Inhibitory control, or the ability to suppress planned but inappropriate prepotent actions in the current environment, plays an important role in the control of human performance. Evidence from empirical studies utilizing a sport-specific design has shown that athletes have superior inhibitory control. However, less is known about whether this superiority might (1) still be seen in a general cognitive task without a sport-related context; (2) be modulated differentially by different sporting expertise (e.g., tennis versus swimming). Methodology/Principal Findings: Here we compared inhibitory control across tennis players, swimmers and sedentary non-athletic controls using a stop-signal task without a sport-specific design. Our primary finding showed that tennis players had shorter stop-signal reaction times (SSRTs) when compared to swimmers and sedentary controls, whereas no difference was found between swimmers and sedentary controls. Importantly, this effect was further confirmed after considering potential confounding factors (e.g., BMI, training experience, estimated levels of physical activity and VO2max), indicative of better ability to inhibit unrequired responses in tennis players. Conclusions/Significance: This suggests that fundamental inhibitory control in athletes can benefit from open skill training. Sport with both physical and cognitive demands may provide a potential clinical intervention for those who have difficulties in inhibitory control.	[Wang, Chun-Hao; Hung, Daisy L.; Tzeng, Ovid J. L.] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Wang, Chun-Hao; Shih, Chun-Ming; Tseng, Philip; Hung, Daisy L.; Tzeng, Ovid J. L.; Muggleton, Neil G.; Juan, Chi-Hung] Natl Cent Univ, Inst Cognit Neurosci, Jhongli, Taiwan; [Chang, Che-Chien; Liang, Yen-Ming; Chiu, Wen-Sheng] Natl Cent Univ, Off Phys Educ, Jhongli, Taiwan; [Shih, Chun-Ming] Shu Te Univ, Grad Sch Human Sexual, Kaohsiung, Taiwan; [Hung, Daisy L.; Tzeng, Ovid J. L.; Muggleton, Neil G.; Juan, Chi-Hung] Natl Yang Ming Univ, Labs Cognit Neurosci, Taipei 112, Taiwan; [Tzeng, Ovid J. L.] Acad Sinica, Inst Linguist, Taipei 115, Taiwan; [Muggleton, Neil G.] UCL, Inst Cognit Neurosci, London, England	National Yang Ming Chiao Tung University; National Central University; National Central University; Shu-Te University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; University of London; University College London	Juan, CH (corresponding author), Natl Cent Univ, Inst Cognit Neurosci, Jhongli, Taiwan.	chijuan@cc.ncu.edu.tw	Muggleton, Neil/AAV-8929-2020; Tseng, Philip/AAG-4849-2021	Tseng, Philip/0000-0001-5120-5979; Tzeng, Ovid J. L./0000-0002-0844-7865; Wang, Chun-Hao/0000-0002-0180-7207	National Science Council, Taiwan [NSC-101-2628-H-008-001-MY4, NSC-101-2410-H-008-033-MY3, NSC-99-2410-H-008-022-MY3, NSC-100-2511-S-008-019, NSC-98-2410-H-008-010-MY3, NSC-98-2517-S-004-001-MY3, NSC-099-2811-H-008-005, NSC-100-2410-H-008-074-MY3]; UK Medical Research Council	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CHW, CMS, PT, DLH, OJT and CHJ were supported by the National Science Council, Taiwan (Grant numbers: NSC-101-2628-H-008-001-MY4, NSC-101-2410-H-008-033-MY3, NSC-99-2410-H-008-022-MY3, NSC-100-2511-S-008-019, NSC-98-2410-H-008-010-MY3, NSC-98-2517-S-004-001-MY3, NSC-099-2811-H-008-005). NGM was supported by the UK Medical Research Council and the National Science Council, Taiwan (Grant number: NSC-100-2410-H-008-074-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Batterink L, 2010, NEUROIMAGE, V52, P1696, DOI 10.1016/j.neuroimage.2010.05.059; Boehler CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026386; Bradshaw DI, 2005, RES Q EXERCISE SPORT, V76, P426; Chan JSY, 2011, PSYCHOL SPORT EXERC, V12, P509, DOI 10.1016/j.psychsport.2011.04.006; Chen CY, 2008, BEHAV BRAIN RES, V187, P483, DOI 10.1016/j.bbr.2007.10.011; Chen CY, 2009, NEUROIMAGE, V44, P537, DOI 10.1016/j.neuroimage.2008.09.005; Crevits L, 2000, NEURO-OPHTHALMOLOGY, V24, P331, DOI 10.1076/noph.24.2.331.7155; Dean AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025966; Di Russo F, 2003, VISION RES, V43, P1837, DOI 10.1016/S0042-6989(03)00299-2; Di Russo F, 2006, NEUROSCI LETT, V408, P113, DOI 10.1016/j.neulet.2006.08.085; Di Russo F, 2010, J NEUROTRAUM, V27, P2309, DOI 10.1089/neu.2010.1501; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Fujiwara K, 2009, INT J SPORTS MED, V30, P647, DOI 10.1055/s-0029-1220732; Gauggel S, 2004, J NEUROL NEUROSUR PS, V75, P539; George JD, 1997, MED SCI SPORT EXER, V29, P415, DOI 10.1097/00005768-199703000-00019; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hsu TY, 2011, NEUROIMAGE, V56, P2249, DOI 10.1016/j.neuroimage.2011.03.059; Kida N, 2005, COGNITIVE BRAIN RES, V22, P257, DOI 10.1016/j.cogbrainres.2004.09.003; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Lees A, 2003, J SPORT SCI, V21, P707, DOI 10.1080/0264041031000140275; Lenoir M, 2000, PERCEPT MOTOR SKILL, V91, P546, DOI 10.2466/pms.2000.91.2.546; Li CSR, 2006, NEUROIMAGE, V32, P1918, DOI 10.1016/j.neuroimage.2006.05.017; Li CSR, 2005, EXP BRAIN RES, V167, P305, DOI 10.1007/s00221-005-0110-2; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan Gordon D., 1994, P189; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Marinovic W, 2009, EXP BRAIN RES, V197, P311, DOI 10.1007/s00221-009-1916-0; Maximova K, 2009, AM J EPIDEMIOL, V170, P1084, DOI 10.1093/aje/kwp255; Muggleton NG, 2010, J COGNITIVE NEUROSCI, V22, P2804, DOI 10.1162/jocn.2010.21416; Nakamoto H, 2008, PERCEPT MOTOR SKILL, V106, P163, DOI 10.2466/PMS.106.1.163-170; Nakamoto H, 2008, BRAIN RES, V1189, P179, DOI 10.1016/j.brainres.2007.10.096; Nakata H, 2010, BRAIN RES REV, V62, P197, DOI 10.1016/j.brainresrev.2009.11.006; Overney LS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002380; Ozel S, 2004, J PSYCHOL, V138, P49, DOI 10.3200/JRLP.138.1.49-64; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; Scisco JL, 2008, INT J PSYCHOPHYSIOL, V69, P52, DOI 10.1016/j.ijpsycho.2008.02.009; Senderecka M, 2012, INT J PSYCHOPHYSIOL, V85, P93, DOI 10.1016/j.ijpsycho.2011.05.007; Taddei F, 2012, MED SCI SPORT EXER, V44, P1057, DOI 10.1249/MSS.0b013e31824529c2; Tsai CL, 2009, RES DEV DISABIL, V30, P1268, DOI 10.1016/j.ridd.2009.05.001; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672	46	194	198	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55773	10.1371/journal.pone.0055773	http://dx.doi.org/10.1371/journal.pone.0055773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	104DM	23418458	Green Submitted, Green Published, gold			2022-12-27	WOS:000315970300049
J	Morgan, MAJ; Muller, PSS; Mould, A; Newland, SA; Nichols, J; Robertson, EJ; Cooke, A; Bikoff, EK				Morgan, Marc A. J.; Muller, Pari S. S.; Mould, Arne; Newland, Stephen A.; Nichols, Jennifer; Robertson, Elizabeth J.; Cooke, Anne; Bikoff, Elizabeth K.			The Nonconventional MHC Class II Molecule DM Governs Diabetes Susceptibility in NOD Mice	PLOS ONE			English	Article							INVARIANT CHAIN; ANTIGEN PRESENTATION; PEPTIDE BINDING; CELL MATURATION; MUTANT MICE; H2-M; COMPLEXES; MOUSE; REQUIREMENTS; REPERTOIRE	The spontaneous destruction of insulin producing pancreatic beta cells in non-obese diabetic (NOD) mice provides a valuable model of type 1 diabetes. As in humans, disease susceptibility is controlled by the classical MHC class II genes that guide CD4(+) T cell responses to self and foreign antigens. It has long been suspected that the dedicated class II chaperone designated HLA-DM in humans or H-2M in mice also makes an important contribution, but due to tight linkage within the MHC, a possible role played by DM peptide editing has not been previously tested by conventional genetic approaches. Here we exploited newly established germ-line competent NOD ES cells to engineer a loss of function allele. DM deficient NOD mice display defective class II peptide occupancy and surface expression, and are completely protected against type 1 diabetes. Interestingly the mutation results in increased proportional representation of CD4(+)Foxp3(+) regulatory T cells and the absence of pathogenic CD4(+) T effectors. Overall, this striking phenotype establishes that DM-mediated peptide selection plays an essential role in the development of autoimmune diabetes in NOD mice.	[Morgan, Marc A. J.; Muller, Pari S. S.; Mould, Arne; Robertson, Elizabeth J.; Bikoff, Elizabeth K.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Newland, Stephen A.; Cooke, Anne] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Nichols, Jennifer] Univ Cambridge, MRC, Cambridge Stem Cell Inst, Wellcome Trust, Cambridge, England	University of Oxford; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute	Bikoff, EK (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	elizabeth.bikoff@path.ox.ac.uk	Cooke, Anne/S-4763-2019; Mallat, Ziad/D-4041-2012; Hardy, Christopher/A-8794-2008; Chariton, Anthony/F-2373-2011; Court, Leon/J-7138-2013	Cooke, Anne/0000-0003-3327-6081; Mallat, Ziad/0000-0003-0443-7878; Hardy, Christopher/0000-0002-7419-566X; Chariton, Anthony/0000-0002-5809-3372; , Bin/0000-0001-9190-968X; Nichols, Jennifer/0000-0002-8650-1388; Court, Leon/0000-0003-3673-9504; Mould, Arne/0000-0002-2004-4348	Wellcome Trust; MRC [G0801841] Funding Source: UKRI; Medical Research Council [G0801841] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Wellcome Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders AK, 2011, NAT IMMUNOL, V12, P54, DOI 10.1038/ni.1967; Bikoff EK, 2001, J IMMUNOL, V166, P5087, DOI 10.4049/jimmunol.166.8.5087; Brode S, 2006, J IMMUNOL, V177, P6603, DOI 10.4049/jimmunol.177.10.6603; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Corper AL, 2000, SCIENCE, V288, P505, DOI 10.1126/science.288.5465.505; Denzin LK, 2005, IMMUNOL REV, V207, P279, DOI 10.1111/j.0105-2896.2005.00302.x; Derbinski J, 2010, CURR OPIN IMMUNOL, V22, P592, DOI 10.1016/j.coi.2010.08.003; Fallang LE, 2008, J IMMUNOL, V181, P5451, DOI 10.4049/jimmunol.181.8.5451; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Gunther S, 2010, P NATL ACAD SCI USA, V107, P22219, DOI 10.1073/pnas.1014708107; Guerder S, 2012, CURR OPIN IMMUNOL, V24, P99, DOI 10.1016/j.coi.2012.01.008; Hanna J, 2009, CELL STEM CELL, V5, P124, DOI 10.1016/j.stem.2009.06.007; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; Hausmann DHF, 1999, J EXP MED, V189, P1723, DOI 10.1084/jem.189.11.1723; HERMEL E, 1995, IMMUNOGENETICS, V42, P136, DOI 10.1007/BF00178588; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Hou TY, 2011, J IMMUNOL, V187, P2442, DOI 10.4049/jimmunol.1100255; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; Karlsson L, 2005, CURR OPIN IMMUNOL, V17, P65, DOI 10.1016/j.coi.2004.11.003; Kenty G, 1998, J IMMUNOL, V160, P606; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Koonce CH, 2004, J IMMUNOL, V173, P3271, DOI 10.4049/jimmunol.173.5.3271; Koonce CH, 2003, J IMMUNOL, V170, P3751, DOI 10.4049/jimmunol.170.7.3751; Kovats S, 1998, J EXP MED, V187, P245, DOI 10.1084/jem.187.2.245; Latek RR, 2000, IMMUNITY, V12, P699, DOI 10.1016/S1074-7613(00)80220-4; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Lieberman SM, 2003, TISSUE ANTIGENS, V62, P359, DOI 10.1034/j.1399-0039.2003.00152.x; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Mellanby RJ, 2008, AUTOIMMUNITY, V41, P383, DOI 10.1080/08916930801991021; Mellanby RJ, 2006, J IMMUNOL, V177, P7588, DOI 10.4049/jimmunol.177.11.7588; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Mohan JF, 2011, J EXP MED, V208, P2375, DOI 10.1084/jem.20111502; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Peleraux A, 1996, IMMUNOGENETICS, V43, P204, DOI 10.1007/BF00587301; Rich JD, 2003, J IMMUNOL, V171, P853, DOI 10.4049/jimmunol.171.2.853; Schulze MSED, 2012, CURR OPIN IMMUNOL, V24, P105, DOI 10.1016/j.coi.2011.11.004; Serreze DV, 2001, CURR DIRECT AUTOIMMU, V4, P31; Stadinski B, 2010, IMMUNITY, V32, P446, DOI 10.1016/j.immuni.2010.04.008; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Suri A, 2005, J CLIN INVEST, V115, P2268, DOI 10.1172/JCI25350; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; Tourne S, 1997, P NATL ACAD SCI USA, V94, P9255, DOI 10.1073/pnas.94.17.9255; Yi W, 2010, J CLIN INVEST, V120, P1324, DOI 10.1172/JCI40220	45	84	89	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e56738	10.1371/journal.pone.0056738	http://dx.doi.org/10.1371/journal.pone.0056738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23991013	gold, Green Published, Green Submitted			2022-12-27	WOS:000315970300189
J	Li, FZ; Li, LB; Zhong, Y; Xie, QD; Huang, JH; Kang, XJ; Wang, D; Xu, L; Huang, TH				Li, FangZheng; Li, LianBing; Zhong, Ying; Xie, QingDong; Huang, JiHua; Kang, XiangJin; Wang, Dian; Xu, Lan; Huang, TianHua			Relationship between LTR Methylation and gag Expression of HIV-1 in Human Spermatozoa and SpermDerived Embryos	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GERM-CELL DEVELOPMENT; PATERNAL GENOME; ACTIVE DEMETHYLATION; DNA METHYLATION; HUMAN-SPERM; VERTICAL TRANSMISSION; PARENTAL ALLELES; MOUSE EMBRYO; GENE	Objective: Studying the methylation status of long terminal repeats (LTR) and its relationship to gag expression of HIV-1 in order to explore regulation mechanism of HIV-1 gene expression in vertical transmission from sperm to embryo. Methods/Principal Findings: Sperm samples were collected from a healthy donor and seven patients with HIV/AIDS. Zona-free hamster ova were fertilized by donor's spermatozoa transfected with pIRES2-EGFP-LTR-gag and patient's spermatozoa to obtain zygotes and 2-cell embryos, respectively. Interspecific in vitro fertilization, bisulfite sequencing PCR (BSP), RT-PCR, nested RT-PCR, nested real-time qRT-PCR and 2(-Delta Delta Ct) method, indirect immunofluoresence (IF) assay were performed. For donor's samples, the methylation rates of HIV-1 LTR were 0.56%, 1.67%, 0.56%, 0.56% in plasmid, spermatozoa, zygotes and 2-cell embryos, respectively while spermatozoa were transfected with unmethylated plasmid, and were 95.0%, 84.44%, 3.3%, 1.67% while transfected with methylated plasmid. The positive bands for HIV-1 gag cDNA were detected in spermatozoa and 2-cell embryos. The positive signals for HIV-1 p24 Gag protein were detected in 2-cell embryos but not in spermatozoa. For patient's samples, methylation rates of HIV-1 LTR were different in spermatozoa among patients. After fertilization, CpG sites in HIV-1 LTR were highly demethylated in zygotes and 2-cell embryos. The gag transcription levels increased with decreasing of methylation rates of HIV-1 LTR, which showed a strong negative correlations between gag transcription levels and methylation rates of HIV-LTR ether in the spermatozoa (r = -0.9877, P < 0.0001) or in the sperm-derived 2-cell embryos (r = 20.9092, P = 0.0045). Conclusion: LTR methylation regulates expression of HIV-1 gag in vertical transmission from sperm to embryo.	[Li, FangZheng; Xie, QingDong; Huang, JiHua; Kang, XiangJin; Wang, Dian; Xu, Lan; Huang, TianHua] Shantou Univ, Coll Med, Res Ctr Reprod Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China; [Li, LianBing] Key Lab Birth Defects & Reprod Hlth, Chongqing, Peoples R China; [Zhong, Ying] Chengdu Jinjiang Hosp Maternal & Child Hlth Care, Ctr Reprod Med, Chengdu, Sichuan, Peoples R China	Shantou University	Huang, TH (corresponding author), Shantou Univ, Coll Med, Res Ctr Reprod Med, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China.	thhuang@stu.edu.cn	; Scott, Maxwell/J-1935-2015	li, feng/0000-0003-2227-9893; Scott, Maxwell/0000-0001-6536-4735	National Natural Science Foundation of China; Li Ka Shing Shantou University Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Li Ka Shing Shantou University Foundation	This work was financially supported by the National Natural Science Foundation of China and the Li Ka Shing Shantou University Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla H, 2009, J REPROD DEVELOP, V55, P356, DOI 10.1262/jrd.20234; Ali BA, 2006, ASIAN J ANDROL, V8, P273, DOI 10.1111/j.1745-7262.2006.00141.x; BACCETTI B, 1994, J CELL BIOL, V127, P903, DOI 10.1083/jcb.127.4.903; BACHILLER D, 1991, MOL REPROD DEV, V30, P194, DOI 10.1002/mrd.1080300305; BAGASRA O, 1994, AIDS, V8, P1669, DOI 10.1097/00002030-199412000-00005; BAGASRA O, 1988, J ACQ IMMUN DEF SYND, V1, P431; Beaujean N, 2004, P NATL ACAD SCI USA, V101, P7636, DOI 10.1073/pnas.0400730101; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Davis TL, 2000, HUM MOL GENET, V9, P2885, DOI 10.1093/hmg/9.19.2885; Davis TL, 1999, GENOMICS, V58, P18, DOI 10.1006/geno.1999.5813; Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001; Detich N, 2003, J BIOL CHEM, V278, P20812, DOI 10.1074/jbc.M211813200; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gao YS, 2009, CURR HIV RES, V7, P562, DOI 10.2174/157016209789346237; GOEDERT JJ, 1986, SCIENCE, V231, P992, DOI 10.1126/science.3003917; Gur Y, 2006, GENE DEV, V20, P411, DOI 10.1101/gad.367606; Huang JM, 2002, ASIAN J ANDROL, V4, P209; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KOHLER M, 1995, INFUSIONSTHERAPIE, V22, P46; La Salle S, 2006, DEV BIOL, V296, P71, DOI 10.1016/j.ydbio.2006.04.436; McGowan JP, 2000, J ANTIMICROB CHEMOTH, V46, P657, DOI 10.1093/jac/46.5.657; Miller D, 2006, HUM REPROD UPDATE, V12, P757, DOI 10.1093/humupd/dml037; MONK M, 1990, PHILOS T R SOC B, V326, P299, DOI 10.1098/rstb.1990.0013; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; RAHE B, 1983, NUCLEIC ACIDS RES, V11, P7947, DOI 10.1093/nar/11.22.7947; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Tritel M, 2000, J VIROL, V74, P5845, DOI 10.1128/JVI.74.13.5845-5855.2000; Wang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028586; Wang DA, 2011, J MED VIROL, V83, P16, DOI 10.1002/jmv.21767; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zuccotti M, 2002, MOL REPROD DEV, V61, P14, DOI 10.1002/mrd.1126	37	122	130	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2013	8	1							e54801	10.1371/journal.pone.0054801	http://dx.doi.org/10.1371/journal.pone.0054801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093SF	23409170	Green Submitted, Green Published, gold			2022-12-27	WOS:000315211500028
J	Ai, HS; Huang, LS; Ren, J				Ai, Huashui; Huang, Lusheng; Ren, Jun			Genetic Diversity, Linkage Disequilibrium and Selection Signatures in Chinese and Western Pigs Revealed by Genome-Wide SNP Markers	PLOS ONE			English	Article							B RECEPTOR GENE; DOMESTIC PIG; ADAPTATION; DELETION; TRAITS; ORIGIN; BREEDS; EXTENT	To investigate population structure, linkage disequilibrium (LD) pattern and selection signature at the genome level in Chinese and Western pigs, we genotyped 304 unrelated animals from 18 diverse populations using porcine 60 K SNP chips. We confirmed the divergent evolution between Chinese and Western pigs and showed distinct topological structures of the tested populations. We acquired the evidence for the introgression of Western pigs into two Chinese pig breeds. Analysis of runs of homozygosity revealed that historical inbreeding reduced genetic variability in several Chinese breeds. We found that intrapopulation LD extents are roughly comparable between Chinese and Western pigs. However, interpopulation LD is much longer in Western pigs compared with Chinese pigs with average r(0.3)(2) values of 125 kb for Western pigs and only 10.5 kb for Chinese pigs. The finding indicates that higher-density markers are required to capture LD with causal variants in genome-wide association studies and genomic selection on Chinese pigs. Further, we looked across the genome to identify candidate loci under selection using F-ST outlier tests on two contrast samples: Tibetan pigs versus lowland pigs and belted pigs against non-belted pigs. Interestingly, we highlighted several genes including ADAMTS12, SIM1 and NOS1 that show signatures of natural selection in Tibetan pigs and are likely important for genetic adaptation to high altitude. Comparison of our findings with previous reports indicates that the underlying genetic basis for high-altitude adaptation in Tibetan pigs, Tibetan peoples and yaks is likely distinct from one another. Moreover, we identified the strongest signal of directional selection at the EDNRB loci in Chinese belted pigs, supporting EDNRB as a promising candidate gene for the white belt coat color in Chinese pigs. Altogether, our findings advance the understanding of the genome biology of Chinese and Western pigs.	[Huang, Lusheng] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs	Huang, LS (corresponding author), Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.	lushenghuang@hotmail.com; renjunjxau@hotmail.com	Ren, Jun/H-9793-2019; Cheng, Alfred/C-3327-2014; Wu, William K.K./A-3277-2009; Chan, Franky/M-1043-2018; Chan, Francis K.L./F-4851-2010; SUNG, Joseph J Y/R-3203-2018	Yu, Fei-Hai/0000-0001-5007-1745; Cheng, Alfred/0000-0003-2345-6951; Dong, Bi-Cheng/0000-0002-9658-9969; Wu, William K.K./0000-0002-5662-5240; Chan, Franky/0000-0003-0567-2052; Zhang, Lin/0000-0003-1634-3780; Chan, Francis K.L./0000-0001-7388-2436; SUNG, Joseph J Y/0000-0003-3125-5199	Program for Changjiang Scholars and Innovative Research Team in University [IRT1136]; National Natural Science Foundation of China [31160450]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Program for Changjiang Scholars and Innovative Research Team in University (IRT1136) and National Natural Science Foundation of China (31160450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Amaral AJ, 2008, GENETICS, V179, P569, DOI 10.1534/genetics.107.084277; Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Badke YM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-24; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; CECCHERINI I, 1995, HUM MOL GENET, V4, P2089, DOI 10.1093/hmg/4.11.2089; Fan B, 2002, ANIM GENET, V33, P422, DOI 10.1046/j.1365-2052.2002.00898.x; Fang MY, 2006, P R SOC B, V273, P1803, DOI 10.1098/rspb.2006.3514; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gieling ET, 2011, CURR TOP BEHAV NEURO, V7, P359, DOI 10.1007/7854_2010_112; Giuffra E, 2000, GENETICS, V154, P1785; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Heifetz EM, 2005, GENETICS, V171, P1173, DOI 10.1534/genetics.105.040782; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kijas JMH, 2001, J MOL EVOL, V52, P302, DOI 10.1007/s002390010158; Kline DD, 1998, J PHYSIOL-LONDON, V511, P273, DOI 10.1111/j.1469-7793.1998.273bi.x; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Laval G, 2000, GENET SEL EVOL, V32, P187, DOI 10.1051/gse:2000113; Llamazares M, 2007, J CELL SCI, V120, P3544, DOI 10.1242/jcs.005751; McLaren D. G., 1990, Animal Breeding Abstracts, V58, P347; Metallinos DL, 1998, MAMM GENOME, V9, P426, DOI 10.1007/s003359900790; Okumura N, 2001, ANIM GENET, V32, P139, DOI 10.1046/j.1365-2052.2001.00757.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Ren J, 2011, HEREDITY, V106, P862, DOI 10.1038/hdy.2010.129; Ren Jun, 2002, Acta Genetica Sinica, V29, P774; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SanCristobal M, 2006, ANIM GENET, V37, P189, DOI 10.1111/j.1365-2052.2005.01385.x; Scheinfeldt LB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r1; SVED J A, 1971, Theoretical Population Biology, V2, P125; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Uimari P, 2011, J ANIM SCI, V89, P609, DOI 10.2527/jas.2010-3249; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Woods SL, 2002, J BIOL CHEM, V277, P10236, DOI 10.1074/jbc.M110752200; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang SL, 2003, GENET SEL EVOL, V35, P657, DOI 10.1051/gse:2003045	42	212	229	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2013	8	2							e56001	10.1371/journal.pone.0056001	http://dx.doi.org/10.1371/journal.pone.0056001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092XV	23409110	Green Submitted, gold, Green Published			2022-12-27	WOS:000315157200102
